10087562	0	(ROOT (S (NP (NNP Torsade) (NNP de)) (VP (VBZ pointes) (NP (NNS Doc_10087562_19_42_Disease)) (PP (IN during) (NP (NP (JJ low) (NN dose) (JJ intermittent) (NNS Doc_10087562_72_82_Chemical) (NN treatment)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ dilated) (NNS Doc_10087562_119_133_Disease) (CC and) (NNS Doc_10087562_138_162_Disease)))))))) (. .)))
10087562	1	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBP describe) (S (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (DT a) (JJ 56-year-old) (NN woman)) (PP (IN with) (NP (JJ chronic) (, ,) (JJ severe) (NNS Doc_10087562_238_251_Disease)))))) (ADJP (JJ secondary) (S (VP (TO to) (VP (VP (VB dilated) (NP (NP (NNS Doc_10087562_273_287_Disease) (CC and) (NN absence)) (PP (IN of) (NP (JJ significant) (NNS Doc_10087562_315_338_Disease))) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_10087562_353_368_Disease))))))) (CC and) (VP (VB torsade) (NP (IN de) (NN pointes) (NNS Doc_10087562_392_415_Disease)) (PP (IN during) (NP (NP (CD one) (NN cycle)) (PP (IN of) (NP (NP (JJ intermittent) (JJ low) (NN dose)) (PRN (-LRB- -LRB-) (NP (NP (CD 2.5) (NN mcg/kg)) (PP (IN per) (NP (NN min)))) (-RRB- -RRB-))))))) (NP (NNS Doc_10087562_479_489_Chemical)))))))) (. .)))
10087562	2	(ROOT (S (NP (NP (DT This) (NN report)) (PP (IN of) (NP (NP (JJ torsade) (NNP de) (NN pointes) (NNS Doc_10087562_525_548_Disease)) (PP (IN during) (NP (JJ intermittent) (NNS Doc_10087562_569_579_Chemical)))))) (VP (VBZ supports) (NP (DT the) (NNS hypothesis)) (SBAR (IN that) (S (NP (JJ unpredictable) (JJ fatal) (NNS Doc_10087562_629_640_Disease)) (VP (MD may) (VP (VB occur) (ADVP (RB even)) (PP (PP (IN with) (NP (JJ low) (NNS doses))) (CC and) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (JJ significant) (NNS Doc_10087562_718_737_Disease))))))))))))) (. .)))
10087562	3	(ROOT (S (NP (NP (DT The) (NNS mechanisms)) (PP (IN of) (NP (NP (JJ proarrhythmic) (NNS effects)) (PP (IN of) (NP (NNS Doc_10087562_782_792_Chemical)))))) (VP (VBP are) (VP (VBN discussed))) (. .)))
10219427	0	(ROOT (S (NP (JJ Positive) (NN skin)) (VP (VBZ tests) (PP (IN in) (NP (JJ late) (NNS reactions))) (PP (TO to) (NP (JJ radiographic) (NN contrast) (NNS media)))) (. .)))
10219427	1	(ROOT (S (PP (IN In) (NP (NP (DT the) (JJ last) (JJ few) (NNS years)) (VP (VBN delayed) (NP (NNS reactions)) (NP (JJ several) (NNS hours)) (PP (IN after) (NP (NP (DT the) (NN injection)) (PP (IN of) (NP (NN radiographic) (CC and) (NN contrast) (NNS materials)))))))) (PRN (-LRB- -LRB-) (NP (NNP PRC)) (-RRB- -RRB-)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN with) (NP (VBG increasing) (NN frequency)))))) (. .)))
10219427	2	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBP report) (NP (NP (CD two) (NNS observations)) (PP (IN on) (NP (NNS patients)))) (PP (IN with) (NP (NP (JJ delayed) (NNS reactions)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (NP (NP (NNS intradermoreactions)) (PRN (-LRB- -LRB-) (NP (NNP IDR)) (-RRB- -RRB-))) (CC and) (NP (NP (NN patch) (NNS tests)) (PP (TO to) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (ADJP (JJ ionic) (CC and) (JJ non)) (JJ ionic) (NN PRC))))))) (VP (VBD were) (VP (VBN studied)))))))) (. .)))
10219427	3	(ROOT (S (SBAR (IN After) (S (NP (NP (ADJP (JJ angiography) (PP (IN by) (NP (NP (DT the) (JJ venous) (NN route)) (PP (IN in) (NP (JJ patient) (NN n) (NN degree))))) (NP (CD 1))) (DT a) (JJ biphasic) (NN reaction)) (PP (IN with) (NP (NP (NP (DT an) (JJ immediate) (NN reaction)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_10219427_518_525_Disease)) (, ,) (NP (NNS Doc_10219427_527_548_Disease))) (-RRB- -RRB-))) (CC and) (NP (JJ delayed) (JJ macro-papular) (NNS Doc_10219427_576_580_Disease))))) (VP (VBD appeared)))) (, ,) (NP (JJ whilst) (NN patient)) (VP (VBP n) (SBAR (S (NP (NN degree) (CD 2)) (VP (VBD developed) (NP (NP (NP (DT a) (JJ generalised) (NN sensation)) (PP (IN of) (NP (NN heat)))) (, ,) (NP (NP (JJ persistent) (NNS Doc_10219427_671_675_Disease)) (PP (IN at) (NP (NP (DT the) (NN site)) (PP (IN of) (NP (NN injection))) (ADVP (RB immediately))))) (CC and) (NP (NP (DT a) (JJ generalised) (JJ macro-papular) (NN reaction)) (PP (IN after) (NP (CD 24) (NNS hours))))))))) (. .)))
10219427	4	(ROOT (S (NP (DT The) (NN skin) (NNS tests)) (VP (VBD revealed) (NP (NP (JJ positive) (JJ delayed) (NNS reactions)) (PP (IN of) (NP (NP (CD 24) (NNS hours)) (CC and) (NP (CD 48) (NNS hours))))) (PP (IN by) (NP (NN IDR) (CC and) (NN patch) (NNS tests))) (PP (TO to) (NP (NP (RB only) (DT some) (NNP PRC)) (PP (IN with) (NP (NP (JJ common) (NNS chains)) (PP (IN in) (NP (PRP$ their) (NNS structures)))))))) (. .)))
10219427	5	(ROOT (S (NP (DT The) (JJ positive) (NN skin) (NNS tests)) (VP (VP (VBP are) (PP (IN in) (NP (NP (NN favour)) (PP (IN of) (NP (JJ immunological) (NNS reactions)))))) (CC and) (VP (MD may) (VP (VB help) (PP (IN in) (NP (NP (NN diagnosis)) (PP (IN of) (NP (NP (NNS Doc_10219427_1020_1027_Disease)) (PP (IN in) (NP (DT the) (NNS patients)))))))))) (. .)))
10327032	0	(ROOT (NP (NP (NN Risk)) (PP (IN of) (NP (NP (JJ transient) (JJ hyperammonemic) (NNS Doc_10327032_33_47_Disease)) (PP (IN in) (NP (JJ Doc_10327032_51_57_Disease) (NNS patients))) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (JJ continuous) (NN infusion)) (PP (IN of) (NP (NNS Doc_10327032_103_117_Chemical)))) (PP (IN with) (NP (NP (DT the) (NN complication)) (PP (IN of) (NP (NNS Doc_10327032_143_154_Disease) (CC and) (NNS Doc_10327032_159_168_Disease)))))))))) (. .)))
10327032	1	(ROOT (S (PP (IN From) (NP (CD 1986) (TO to) (CD 1998))) (, ,) (NP (NP (CD 29) (JJ Doc_10327032_192_198_Disease) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (CD 32) (NNS episodes)) (PP (IN of) (NP (NP (JJ transient) (JJ hyperammonemic) (NNS Doc_10327032_256_270_Disease)) (VP (VBN related) (PP (TO to) (NP (NP (JJ continuous) (NN infusion)) (PP (IN of) (NP (NP (NNS Doc_10327032_305_319_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10327032_321_325_Chemical)) (-RRB- -RRB-)))))))))))))) (VP (VBD were) (VP (VBN identified))) (. .)))
10327032	2	(ROOT (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD had) (VP (VBN decompensated) (NP (NNS Doc_10327032_383_396_Disease)))) (. .)))
10327032	3	(ROOT (S (NP (NP (NNP Onset)) (PP (IN of) (NP (JJ hyperammonemic) (NNS Doc_10327032_422_436_Disease)))) (VP (VBD varied) (PP (IN from) (NP (NP (QP (CD 0.5) (TO to) (CD 5)) (NNS days)) (PRN (-LRB- -LRB-) (NP (NP (NN mean)) (: :) (NP (NP (CD 2.6) (JJ +) (NNS /)) (: -) (NP (CD 1.3) (NNS days)))) (-RRB- -RRB-)))) (PP (IN after) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NN chemotherapy)))))) (. .)))
10327032	4	(ROOT (S (NP (NNP Plasma) (NNP Doc_10327032_533_541_Chemical) (NN level)) (VP (VBD ranged) (PP (IN from) (NP (NP (QP (CD 248) (TO to) (CD 2387) (CD microg)) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NN mean)) (: :) (NP (NP (CD 626) (JJ +) (NNS /)) (: -) (NP (CD 431) (CD microg) (NN %)))) (-RRB- -RRB-))))) (. .)))
10327032	5	(ROOT (S (S (PP (IN Among) (NP (DT the) (CD 32) (NNS episodes))) (, ,) (NP (NP (CD 26)) (PRN (-LRB- -LRB-) (NP (CD 81) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (NP (NP (JJ various) (NNS degrees)) (PP (IN of) (NP (NNS Doc_10327032_664_672_Disease)))))) (, ,) (NP (NP (CD 18)) (PRN (-LRB- -LRB-) (NP (CD 56) (NN %)) (-RRB- -RRB-))) (VP (VBD occurred) (PP (IN during) (NP (NP (NNS Doc_10327032_699_719_Disease)) (CC and) (NP (NP (CD 14)) (PRN (-LRB- -LRB-) (NP (CD 44) (NN %)) (-RRB- -RRB-))))) (PP (IN without) (NP (NP (NNS Doc_10327032_741_750_Disease)) (VP (VBN occurred) (PP (IN during) (NP (NP (NNS periods)) (PP (IN of) (NP (NNS Doc_10327032_778_789_Disease))))))))) (. .)))
10327032	6	(ROOT (S (NP (NP (JJR Higher) (NN plasma) (NN Doc_10327032_805_813_Chemical) (NNS levels)) (CC and) (NP (NP (JJR more) (JJ rapid) (NN onset)) (PP (IN of) (NP (NNS Doc_10327032_845_859_Disease))))) (VP (VBD were) (VP (VBN seen) (PP (IN in) (NP (NP (CD 18) (NNS patients)) (PP (PP (IN with) (NP (NNS Doc_10327032_890_910_Disease))) (PRN (-LRB- -LRB-) (S (VP (VBN p) (S (VP (SYM =) (NP (CD 0.003) (CC and) (CD 0.0006)))) (, ,) (ADVP (RB respectively)))) (-RRB- -RRB-)) (CC and) (PP (IN in) (NP (NP (CD nine) (NNS patients)) (VP (VBG receiving) (NP (NP (NP (JJ high) (JJ daily) (NNS doses)) (PRN (-LRB- -LRB-) (NP (QP (CD 2600) (CC or) (CD 1800)) (NNS mg/m2)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS Doc_10327032_1018_1022_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN p)) (SBAR (S (VP (SYM =) (NP (CD 0.0001)))))) (CC and) (NP (NP (NNP <) (CD 0.0001)) (, ,) (ADVP (RB respectively)))) (-RRB- -RRB-))))))))))))) (. .)))
10327032	7	(ROOT (S (PP (IN In) (NP (NP (CD 25)) (PP (RB out) (IN of) (NP (NP (CD 32) (NNS episodes)) (PRN (-LRB- -LRB-) (NP (CD 78) (NN %)) (-RRB- -RRB-)))))) (, ,) (NP (NP (JJ plasma) (JJ Doc_10327032_1101_1109_Chemical) (NNS levels)) (CC and) (NP (JJ mental) (NN status))) (VP (VBD returned) (S (VP (TO to) (VP (ADJP (JJ normal)) (PP (IN within) (NP (CD 2) (NNS days)))))) (PP (IN after) (NP (JJ adequate) (NN management)))) (. .)))
10327032	8	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (JJ hyperammonemic) (NNS Doc_10327032_1225_1239_Disease)) (VP (MD can) (VP (VB occur) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (JJ continuous) (NN infusion)) (PP (IN of) (NP (NNS Doc_10327032_1295_1299_Chemical))))))))) (. .)))
10327032	9	(ROOT (S (ADVP (RB Doc_10327032_1301_1309_Disease)) (, ,) (NP (NP (NN body) (NN fluid) (NN insufficiency)) (CC and) (NP (NNS Doc_10327032_1340_1360_Disease))) (VP (VBD were) (ADVP (RB frequently)) (VP (VBN found) (PP (IN in) (NP (DT these) (NNS patients))))) (. .)))
10327032	10	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB therefore)) (ADJP (JJ important) (S (VP (TO to) (VP (VB recognize) (NP (DT this) (NN condition)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (JJ continuous) (NN infusion)) (PP (IN of) (NP (NNS Doc_10327032_1501_1505_Chemical)))))))))))) (. .)))
10390729	0	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NP (NNS Doc_10390729_15_22_Chemical) (CC and) (NNS Doc_10390729_27_42_Chemical)) (PP (IN on) (NP (JJ conditioned) (NN place) (NN preference)))) (CC and) (NP (NP (NNS changes)) (PP (IN in) (NP (NN motor) (NN activity))))))) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_10390729_116_124_Chemical)) (PP (IN in) (NP (NP (NNP rats) (. .)) (NP (CD 1))))))) (. .)))
10390729	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NP (CD two) (JJ unselective) (NNS Doc_10390729_168_177_Chemical)) (PRN (-LRB- -LRB-) (FRAG (ADJP (JJ Doc_10390729_179_183_Chemical)) (: -)) (-RRB- -RRB-)) (NP (NN channel) (NNS blockers))) (, ,) (NP (NP (NP (NP (NNS Doc_10390729_204_211_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 12.5)) (, ,) (NP (CD 25)) (CC and) (NP (CD 50) (NN mg/kg))) (-RRB- -RRB-))) (CC and) (NP (NNS Doc_10390729_240_255_Chemical))) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (CC and) (NP (CD 2) (NN mg/kg))) (-RRB- -RRB-)) (, ,) (PP (IN on) (NP (JJ conditioned) (NN place) (NN preference)))) (CC and) (NP (NP (JJ biphasic) (NNS changes)) (PP (IN in) (NP (NN motor) (NN activity)))))) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_10390729_355_363_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg/kg)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN tested) (PP (IN in) (NP (NNP Wistar) (NNS rats))))) (. .)))
10390729	2	(ROOT (S (NP (NNP Doc_10390729_403_410_Chemical)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB block) (ADJP (ADJP (ADJP (ADJP (JJ voltage)) (PRN (: -) (FRAG (, ,) (NP (NNS Doc_10390729_439_446_Chemical))) (: -))) (CC and) (ADJP (JJ Doc_10390729_452_455_Chemical-sensitive) (JJ Doc_10390729_466_470_Chemical-channels))) (SBAR (IN while) (S (NP (NNS Doc_10390729_486_501_Chemical)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB block) (NP (JJ voltage-sensitive) (NNS Doc_10390729_538_542_Chemical-channels)))))))) (. .))) (NP (CD 2))))))) (. .)))
10390729	3	(ROOT (S (PP (IN In) (NP (DT the) (JJ counterbalanced) (NN method))) (, ,) (NP (NNS Doc_10390729_587_594_Chemical)) (VP (VBD attenuated) (NP (NN Doc_10390729_606_614_Chemical-induced) (NN place) (NN preference)) (, ,) (SBAR (IN whereas) (S (NP (NNS Doc_10390729_649_664_Chemical)) (VP (VBD was) (ADJP (JJ ineffective)))))) (. .)))
10390729	4	(ROOT (S (S (PP (IN In) (NP (NP (DT the) (NN motor) (NN activity) (NN test)) (VP (VBN measured) (PP (IN with) (NP (DT an) (JJ Animex-activity) (NN meter)))))) (NP (NP (DT neither)) (PP (IN of) (NP (DT the) (NN Doc_10390729_763_767_Chemical-channel)))) (VP (VBZ blockers) (NP (JJ affected) (NN Doc_10390729_794_802_Chemical-induced) (NNS Doc_10390729_811_823_Disease)))) (, ,) (CC but) (S (NP (DT both) (NN Doc_10390729_834_838_Chemical-channel) (NNS blockers)) (VP (VBD prevented) (SBAR (FRAG (X (ADVP (RB Doc_10390729_866_874_Chemical-induced)) (NP (JJ secondary) (NNS Doc_10390729_893_906_Disease)) (. .)) (NP (CD 3)))))) (. .)))
10390729	5	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NP (ADJP (JJ Doc_10390729_952_959_Chemical-sensitive) (CONJP (CC but) (RB not)) (JJ Doc_10390729_978_993_Chemical-sensitive)) (NNS Doc_10390729_1004_1008_Chemical-channels)) (PP (IN in) (NP (JJ Doc_10390729_1021_1029_Chemical) (NN reward))))))) (. .)))
10390729	6	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN suggested) (SBAR (IN that) (S (NP (NP (DT the) (NN blockade)) (PP (IN of) (NP (NP (NNS Doc_10390729_1080_1084_Chemical-channels)) (ADJP (JJ sensitive) (PP (TO to) (NP (DT these) (NNS blockers))))))) (VP (VBZ is) (RB not) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB prevent) (NP (NN Doc_10390729_1151_1159_Chemical-induced) (NNS Doc_10390729_1168_1180_Disease)) (SBAR (IN whereas) (S (NP (NN Doc_10390729_1189_1197_Chemical-induced) (NNS Doc_10390729_1206_1219_Disease)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (VP (VBN connected) (PP (TO to) (NP (DT both) (ADJP (JJ Doc_10390729_1250_1257_Chemical) (: -) (CC and) (JJ Doc_10390729_1263_1278_Chemical-sensitive)) (NN Doc_10390729_1289_1293_Chemical-channels))))))))))))))))))) (. .)))
10401555	0	(ROOT (FRAG (NP (NNP Doc_10401555_0_10_Chemical)) (: /) (FRAG (X (NP (NP (NP (NNP orphanin) (NNP FQ)) (CC and) (NP (NNS Doc_10401555_27_37_Chemical))) (PP (IN on) (NP (NN learning) (CC and) (NNS Doc_10401555_54_71_Disease)))) (NP (NP (NNP induced)) (PP (IN by) (NP (NP (NNS Doc_10401555_83_94_Chemical)) (PP (IN in) (NP (NNS mice)))))) (. .)) (NP (CD 1))) (. .)))
10401555	1	(ROOT (S (NP (NP (NNP Doc_10401555_107_117_Chemical)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NNP orphanin) (NNP FQ)))) (, ,)) (VP (VP (VBZ is) (NP (NP (DT an) (NNS endogenous)) (ADJP (JJ ligand) (PP (IN for) (NP (DT the) (JJ orphan) (JJ opioid) (JJ receptor-like) (NN receptor))) (NP (CD 1))) (PRN (-LRB- -LRB-) (NP (NNP ORL1)) (-RRB- -RRB-)))) (CC and) (VP (VBZ involves) (PP (IN in) (NP (NP (JJ various) (NNS functions)) (PP (IN in) (NP (NP (DT the) (ADJP (JJ central) (JJ nervous)) (NN system)) (PRN (-LRB- -LRB-) (NP (NNP CNS)) (-RRB- -RRB-)))))))) (. .)))
10401555	2	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NNS Doc_10401555_314_324_Chemical)) (VP (VBZ is) (ADVP (RB recently)) (VP (VBN isolated) (PP (IN from) (NP (NP (NP (DT the) (JJ same) (NN precursor)) (PP (IN as) (NP (NN Doc_10401555_373_383_Chemical) (CC and) (NNS blocks) (NNS Doc_10401555_395_405_Chemical-induced) (NNS Doc_10401555_414_423_Disease)))) (CC and) (NP (NP (NNP Doc_10401555_428_440_Disease) (. .)) (NP (CD 2))))))) (. .)))
10401555	3	(ROOT (S (SBAR (IN Although) (S (NP (NP (CD ORL1) (NNS receptors)) (SBAR (WHNP (WDT which)) (S (VP (VBP display) (NP (NP (DT a) (JJ high) (NN degree)) (PP (IN of) (NP (NN sequence) (NN homology)))) (PP (IN with) (NP (JJ classical) (JJ opioid) (NNS receptors))))))) (VP (VBP are) (ADJP (JJ abundant) (PP (IN in) (NP (DT the) (NNS hippocampus))))))) (, ,) (NP (RB little)) (VP (VBZ is) (VP (VBN known) (S (VP (VBG regarding) (NP (PRP$ their) (NN role)) (PP (IN in) (NP (NP (NP (NN learning)) (CC and) (NP (NN memory)) (. .)) (NP (CD 3)))))))) (. .)))
10401555	4	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (FRAG (NP (NNS Doc_10401555_701_711_Chemical)) (: /) (S (NP (NP (NNP orphanin) (NNP FQ)) (CC and) (NP (NNS Doc_10401555_728_738_Chemical))) (VP (MD could) (VP (VB modulate) (NP (NP (NNS Doc_10401555_754_787_Disease)) (VP (VBN induced) (PP (IN by) (S (NP (NP (NNS Doc_10401555_799_810_Chemical)) (, ,) (NP (DT a) (JJ muscarinic) (JJ cholinergic) (NN receptor) (NN antagonist)) (, ,)) (VP (VBG using) (NP (NP (JJ spontaneous) (NN alternation)) (PP (IN of) (NP (NP (ADJP (JJ Y-maze) (CC and) (JJ step-down)) (NN type) (JJ passive) (NN avoidance) (NNS tasks)) (PP (IN in) (NP (NNS mice)))))))))))))) (. .)))))) (NP (CD 4)))) (. .)))
10401555	5	(ROOT (S (SBAR (IN While) (S (NP (NP (JJ Doc_10401555_959_969_Chemical) (PRN (-LRB- -LRB-) (NP (NP (CD 0.5-5) (CD .0) (JJ nmol) (NNS mouse-1)) (, ,) (NP (NN i.c.v.))) (-RRB- -RRB-)) (ADJP (VBN administered) (NP (NP (CD 30) (NN min)) (PP (IN before) (NP (JJ spontaneous) (NN alternation))))) (NN performance)) (CC or) (NP (NP (DT the) (VBG training) (NN session)) (PP (IN of) (NP (DT the) (JJ passive) (NN avoidance) (NN task))))) (, ,) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (JJ spontaneous) (NN alternation) (CC or) (JJ passive) (NN avoidance) (NNS behaviours))))))) (, ,) (NP (NP (DT a) (ADJP (ADJP (JJR lower) (PP (IN per) (NP (NN cent) (NN alternation)))) (CC and) (ADJP (JJR shorter))) (JJ median) (NN step-down) (NN latency)) (PP (IN in) (NP (DT the) (NN retention) (NN test)))) (VP (VBD were) (VP (VBN obtained) (PP (IN in) (NP (NP (NP (NNS Doc_10401555_1298_1308_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 1.5) (CD and/or) (CD 5.0) (JJ nmol) (NNS mouse-1)) (, ,) (NP (NN i.c.v.))) (-RRB- -RRB-))) (PRN (: -) (FRAG (X (ADVP (RB treated)) (NP (JJ normal) (NNS mice)) (. .)) (NP (CD 5)))))))) (. .)))
10401555	6	(ROOT (SINV (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NP (NNS Doc_10401555_1389_1399_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 1.5) (CD and/or) (CD 5.0) (JJ nmol) (NNS mouse-1)) (, ,) (NP (NN i.c.v.))) (-RRB- -RRB-)) (NP (CD 30))))) (VP (VBP min) (PP (IN before) (NP (NP (JJ spontaneous) (NN alternation) (NN performance)) (CC or) (NP (NP (DT the) (NN training) (NN session)) (PP (IN of) (NP (DT the) (JJ passive) (NN avoidance) (NN task)))))))) (, ,) (VP (VBD attenuated) (NP (DT the) (NN Doc_10401555_1558_1569_Chemical-induced))) (NP (NP (NNP Doc_10401555_1578_1648_Disease) (. .)) (ADJP (CD 6))) (. .)))
10401555	7	(ROOT (S (NP (DT These) (NNS results)) (VP (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (NNS Doc_10401555_1682_1692_Chemical)) (, ,) (NP (DT a) (JJ new) (ADJP (RB biologically) (JJ active)) (NN peptide)) (, ,)) (VP (VBZ Doc_10401555_1729_1752_Disease) (PP (IN of) (NP (NP (JJ spontaneous) (NN alternation) (CC and) (NN passive) (NN avoidance)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_10401555_1813_1824_Chemical)))))))))) (, ,) (CC and) (VP (VBD suggested) (SBAR (IN that) (S (NP (DT these) (NNS peptides)) (VP (VBP play) (NP (NP (JJ opposite) (NNS roles)) (PP (IN in) (NP (NN learning) (CC and) (NN memory))))))))) (. .)))
10427794	0	(ROOT (S (VP (VB Doc_10427794_0_9_Chemical-induced) (NP (NN liver) (NNS Doc_10427794_24_32_Disease))) (. .)))
10427794	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT a) (JJ female) (NN patient)))) (PP (IN with) (NP (NP (NNS Doc_10427794_78_98_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (S (NP (NNS Doc_10427794_113_138_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_10427794_146_155_Chemical))))))))))) (. .)))
10427794	2	(ROOT (S (S (ADVP (RB Recently)) (VP (VBN introduced) (PP (IN in) (NP (NNP Belgium))))) (, ,) (NP (NNS Doc_10427794_189_198_Chemical)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (JJ nonsteroidal) (NN antiinflammatory) (NN drug)) (PP (IN with) (NP (NP (JJ selective) (NN action)) (PP (IN on) (NP (NP (DT the) (JJ inducible) (NN form)) (PP (IN of) (NP (JJ cyclooxygenase) (CD 2))))))))) (. .)))
10427794	3	(ROOT (S (NP (DT The) (NNS Doc_10427794_316_341_Disease)) (VP (VP (VBD occurred) (ADVP (RB rapidly)) (PP (IN after) (NP (JJ Doc_10427794_365_374_Chemical) (NN administration)))) (CC and) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN antinuclear) (NNS antibodies))))) (S (VP (VBG suggesting) (NP (DT a) (JJ Doc_10427794_469_485_Disease) (NN mechanism))))))) (. .)))
10427794	4	(ROOT (S (NP (NP (DT This) (JJ first) (NN case)) (PP (IN of) (NP (JJ Doc_10427794_516_525_Chemical) (JJ related) (NN liver) (NNS Doc_10427794_540_548_Disease)))) (VP (VBZ demonstrates) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (DT this) (NN drug) (S (VP (TO to) (VP (VB induce) (NP (NNS Doc_10427794_599_613_Disease))))))))) (. .)))
10462057	0	(ROOT (FRAG (FRAG (NP (NP (NNP Induction)) (PP (IN of) (NP (NNS apoptosis)))) (PP (IN by) (NP (JJ Doc_10462057_26_37_Chemical) (NNS metabolites))) (PP (IN in) (NP (NNP HL60) (CC and) (NNP CD34) (NNP +)))) (: /) (FRAG (NP (NNP CD19)) (: -) (FRAG (NP (NP (JJ human) (NN bone) (NN marrow)) (NP (NN progenitor) (NNS cells))) (: :) (NP (NP (JJ potential) (NN relevance)) (PP (TO to) (NP (NN Doc_10462057_133_144_Chemical-induced) (NNS Doc_10462057_153_168_Disease))))) (. .))))
10462057	1	(ROOT (S (NP (NP (DT The) (JJ antipsychotic) (NN agent)) (, ,) (NP (NNP Doc_10462057_195_206_Chemical) (NNP -LSB-) (NNP Doc_10462057_208_282_Chemical) (NNP -RSB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (VBN acquired) (NNS Doc_10462057_318_333_Disease)))))) (. .)))
10462057	2	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NP (NNS Doc_10462057_367_378_Chemical)) (, ,) (NP (CD three) (JJ Doc_10462057_386_397_Chemical) (NN ring) (NNS metabolites)) (CC and) (NP (CD five) (JJ aromatic) (NN ring) (NNS metabolites)))) (PP (IN of) (NP (DT the) (NN parent) (NN compound)))) (S (VP (TO to) (VP (VB induce) (NP (NNS apoptosis)) (PP (IN in) (NP (NP (CD HL60) (NNS cells)) (CC and) (NP (JJ human) (NN bone) (NN marrow) (NN progenitor) (PRN (-LRB- -LRB-) (NP (NNP HBMP)) (-RRB- -RRB-)) (NNS cells))))))))) (. .)))
10462057	3	(ROOT (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN treated) (PP (IN for) (NP (NP (CD 0-24) (NN h)) (PP (IN with) (NP (NP (DT each) (NN compound)) (PRN (-LRB- -LRB-) (NP (CD 0-200) (NN microM)) (-RRB- -RRB-)))))))) (. .)))
10462057	4	(ROOT (S (NP (NNS Apoptosis)) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (NP (JJ fluorescence) (NN microscopy)) (PP (IN in) (NP (NP (NNS Doc_10462057_672_686_Chemical)) (CC and) (NP (JJ Doc_10462057_691_707_Chemical) (JJ stained) (NN cell) (NNS samples)))))))) (. .)))
10462057	5	(ROOT (S (S (NP (NNS Results)) (VP (VBD were) (VP (VBN confirmed) (PP (IN by) (NP (NP (NN determination)) (PP (IN of) (NP (JJ internucleosomal) (NN DNA) (NN fragmentation))))) (S (VP (VBG using) (NP (NN gel) (NNS electrophoresis)) (PP (IN for) (NP (NNP HL60) (NN cell) (NNS samples)))))))) (CC and) (S (NP (NN terminal) (NN deoxynucleotidyl)) (VP (VBP transferase) (ADVP (RB assay)) (PP (IN in) (NP (NNP HBMP) (NNS cells))))) (. .)))
10462057	6	(ROOT (S (NP (NP (NP (NP (DT The) (NNS Doc_10462057_923_931_Chemical)) (CC and) (NP (JJ Doc_10462057_936_948_Chemical) (NNS metabolites))) (, ,) (NP (NNS Doc_10462057_962_968_Chemical) (CC and) (NNS Doc_10462057_973_979_Chemical)) (, ,) (VP (VBN induced) (NP (NP (NP (NNS apoptosis)) (PP (IN in) (NP (NNP HL60)))) (CC and) (NP (NP (NNP HBMP) (NNS cells)) (PP (IN in) (NP (DT a) (NN time)))) (: -) (CC and) (NP (NN concentration) (JJ dependent) (NN manner))) (, ,) (SBAR (IN while) (FRAG (NP (NP (DT the) (NNS Doc_10462057_1079_1086_Chemical)) (, ,) (NP (NNS Doc_10462057_1088_1094_Chemical)) (, ,) (NP (NNS Doc_10462057_1096_1102_Chemical)) (, ,) (CC and) (NP (NNS Doc_10462057_1108_1114_Chemical))))))) (, ,) (CC and) (NP (NP (DT the) (NNS derivatives)) (VP (VBN formed) (PP (IN by) (NP (NP (NN oxidation)) (PP (IN of) (NP (NP (DT the) (JJ Doc_10462057_1163_1174_Chemical) (NN ring)) (, ,) (NP (NNS Doc_10462057_1181_1187_Chemical)) (, ,) (NP (NNP NCM001)) (, ,) (CC and) (NP (NNP NCL118)))))))) (, ,)) (VP (VBD had) (NP (DT no) (NN effect))) (. .)))
10462057	7	(ROOT (S (S (NP (DT No) (NNS Doc_10462057_1227_1235_Disease)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (NNS cells)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_10462057_1271_1277_Chemical))))))))) (CC but) (S (NP (NNS Doc_10462057_1282_1288_Chemical)) (VP (VBD had) (NP (NP (DT a) (JJ biphasic) (NN effect)) (PP (IN in) (NP (DT both) (NN cell) (NNS types)))) (, ,) (S (VP (VBG inducing) (NP (NNS apoptosis)) (PP (IN at) (NP (NP (JJR lower) (NNS concentrations) (CC and) (NNS Doc_10462057_1378_1386_Disease)) (PP (IN at) (NP (JJR higher) (NNS concentrations))))))))) (. .)))
10462057	8	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ Doc_10462057_1438_1446_Chemical) (CC and) (JJ Doc_10462057_1451_1463_Chemical) (NNS metabolites)) (PP (IN of) (NP (NNS Doc_10462057_1479_1490_Chemical)))) (VP (VBP have) (NP (NP (JJ direct) (JJ toxic) (NNS effects)) (PP (IN in) (NP (NNP HL60) (CC and) (NNP HBMP) (NNS cells))) (, ,) (VP (VBG leading) (PP (TO to) (NP (NNS apoptosis))))) (, ,) (SBAR (IN while) (S (NP (DT the) (JJ Doc_10462057_1573_1579_Chemical) (NNS metabolites)) (VP (VBD were) (ADJP (JJ inactive))))))))) (. .)))
10462057	9	(ROOT (S (ADVP (RB Similarly)) (, ,) (NP (NP (NN Doc_10462057_1618_1625_Chemical-derived) (NNS Doc_10462057_1634_1642_Chemical) (CC and) (NNS Doc_10462057_1647_1659_Chemical)) (, ,) (CONJP (CC but) (RB not)) (NP (NNS Doc_10462057_1669_1675_Chemical)) (, ,)) (VP (VB induce) (NP (NNS apoptosis)) (PP (IN in) (NP (NNP HBMP) (NNS cells) (NNP -LSB-) (NNP Moran) (FW et) (NNP al.) (, ,) (NNP Mol)))) (. .)))
10462057	10	(ROOT (NP (NP (NNP Pharmacol.)) (, ,) (NP (NP (CD 50)) (PRN (-LRB- -LRB-) (NP (CD 1996)) (-RRB- -RRB-)) (NP (CD 610-615) (NNS -RSB-))) (. .)))
10462057	11	(ROOT (S (NP (PRP We)) (VP (VBP propose) (SBAR (SBAR (IN that) (S (NP (NNS Doc_10462057_1776_1787_Chemical) (CC and) (NNS Doc_10462057_1792_1799_Chemical)) (VP (MD may) (VP (VB induce) (NP (NP (NNS Doc_10462057_1811_1826_Disease)) (PP (IN via) (NP (NP (NN production)) (PP (IN of) (NP (JJ similar) (NN reactive) (NNS metabolites)))))))))) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NNS Doc_10462057_1898_1904_Chemical) (CC and) (NNS Doc_10462057_1909_1915_Chemical))) (S (VP (TO to) (VP (VB induce) (NP (NNS apoptosis)) (PP (IN in) (NP (NNP HBMP) (NNS cells))))))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NN mechanism)) (VP (VBG underlying) (NP (NP (VBN acquired) (NNS Doc_10462057_2002_2017_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_10462057_2048_2059_Chemical)))))))))))))))))) (. .)))
10510854	0	(ROOT (NP (NP (JJ Synthesis) (CC and) (JJ preliminary) (NN pharmacological) (NNS investigations)) (PP (IN of) (NP (JJ Doc_10510854_60_103_Chemical) (NNS derivatives))) (PP (IN as) (NP (NP (JJ potential) (JJ atypical) (JJ antipsychotic) (NNS agents)) (PP (IN in) (NP (NNS mice))))) (. .)))
10510854	1	(ROOT (S (PP (IN In) (NP (NP (NN research)) (PP (IN towards) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ new) (JJ atypical) (JJ antipsychotic) (NNS agents))))))) (, ,) (NP (CD one) (NN strategy)) (VP (VBZ is) (SBAR (IN that) (S (NP (DT the) (JJ dopaminergic) (NN system)) (VP (MD can) (VP (VB be) (VP (VBN modulated) (PP (IN through) (NP (NP (NN manipulation)) (PP (IN of) (NP (DT the) (JJ serotonergic) (NN system))))))))))) (. .)))
10510854	2	(ROOT (S (NP (NP (DT The) (NN synthesis) (CC and) (JJ preliminary) (NN pharmacological) (NN evaluation)) (PP (IN of) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (JJ potential) (JJ atypical) (JJ antipsychotic) (NNS agents)) (VP (VBN based) (PP (IN on) (NP (NP (DT the) (NN structure)) (PP (IN of) (NP (NP (NNS Doc_10510854_491_534_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 7)) (-RRB- -RRB-)))))))))))) (VP (VBZ is) (VP (VBN described))) (. .)))
10510854	3	(ROOT (S (NP (NP (JJ Compound) (NNS 7e)) (, ,) (NP (NNS Doc_10510854_566_652_Chemical)) (, ,)) (PRN (SINV (PP (IN from) (NP (DT this) (NN series))) (VP (VBD showed) (NP (JJ significant) (NNS affinities)) (PP (IN at) (NP (DT the) (CD 5-HT1A) (CC and) (CD 5-HT2A)))) (NP (NP (NNS receptors)) (CC and) (NP (NP (JJ moderate) (NN affinity)) (PP (IN at) (NP (DT the) (NNP D2) (NN receptor))))) (. .))) (NP (NNS 7e)) (VP (VBZ exhibits) (NP (NP (DT a) (JJ high) (NN reversal)) (PP (IN of) (NP (NP (NNS Doc_10510854_809_818_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_10510854_830_841_Chemical)) (VP (VBG indicating) (NP (PRP$ its) (JJ atypical) (JJ antipsychotic) (NN nature)))))))))) (. .)))
10672628	0	(ROOT (S (NP (NP (JJ Sub-chronic) (NN inhibition)) (PP (IN of) (NP (JJ Doc_10672628_26_38_Chemical) (NN synthesis)))) (VP (VBZ modifies) (NP (NP (NN Doc_10672628_58_69_Chemical-induced) (NNS Doc_10672628_78_87_Disease)) (CC and) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NN Doc_10672628_106_111_Chemical-diaphorase) (NNS neurons)) (PP (IN in) (NP (NNS mice)))))))) (. .)))
10672628	1	(ROOT (S (NP (NP (NNP Doc_10672628_151_170_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10672628_172_179_Chemical)) (-RRB- -RRB-)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NP (JJ Doc_10672628_198_210_Chemical) (NN synthase)) (PRN (-LRB- -LRB-) (NP (NNP NOS)) (-RRB- -RRB-))))) (, ,)) (VP (VBZ induces) (NP (NP (NNS Doc_10672628_235_244_Disease)) (PP (IN in) (NP (NNS mice))))) (. .)))
10672628	2	(ROOT (S (NP (DT This) (NN effect)) (VP (VBZ undergoes) (NP (JJ rapid) (NN tolerance)) (, ,) (S (VP (VBG showing) (NP (DT a) (JJ significant) (NN decrease)) (PP (IN after) (NP (NP (CD 2) (NNS days)) (PP (IN of) (NP (JJ sub-chronic) (JJ Doc_10672628_352_359_Chemical) (NN treatment)))))))) (. .)))
10672628	3	(ROOT (S (NP (NP (NNP Doc_10672628_371_383_Chemical)) (PRN (-LRB- -LRB-) (INTJ (RB NO)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB influence) (NP (JJ dopaminergic) (NN neurotransmission)) (PP (IN in) (NP (DT the) (NN striatum))))))))) (. .)))
10672628	4	(ROOT (S (NP (NP (JJ Neuroleptic) (NNS drugs)) (PP (JJ such) (IN as) (NP (NNS Doc_10672628_491_502_Chemical))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VB block) (NP (JJ Doc_10672628_516_524_Chemical) (NNS receptors))))) (, ,)) (ADVP (RB also)) (VP (VBP cause) (NP (NP (NNS Doc_10672628_547_556_Disease)) (PP (IN in) (NP (NNS rodents))))) (. .)))
10672628	5	(ROOT (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ subchronic) (JJ Doc_10672628_622_629_Chemical) (NN treatment)))) (PP (IN in) (NP (NN Doc_10672628_643_654_Chemical-induced) (NNS Doc_10672628_663_672_Disease)))))) (CC and) (S (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNP NOS)))) (VP (VBZ neurons) (PP (IN in) (NP (NP (NNS areas)) (VP (VBN related) (PP (TO to) (NP (NN motor) (NN control)))))))) (. .)))
10672628	6	(ROOT (S (NP (JJ Male) (JJ albino) (JJ Swiss) (NNS mice)) (VP (VBD were) (VP (VBN treated) (NP (NP (NN sub-chronically)) (PRN (-LRB- -LRB-) (NP (NP (RB twice) (DT a) (NN day)) (PP (IN for) (NP (CD 4) (NNS days)))) (-RRB- -RRB-))) (PP (IN with) (NP (NP (NNS Doc_10672628_829_836_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_10672628_856_867_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-)))))) (. .)))
10672628	7	(ROOT (S (NP (NNP Doc_10672628_884_893_Disease)) (VP (VBD was) (VP (VBN evaluated) (PP (IN at) (NP (NP (DT the) (NN beginning)) (CC and) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (NNS treatments)))))))) (. .)))
10672628	8	(ROOT (S (NP (NP (JJ Reduced) (NNS Doc_10672628_964_1007_Chemical-diaphorase)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10672628_1020_1025_Chemical-d)) (-RRB- -RRB-))) (ADVP (RB histochemistry)) (VP (VBD was) (ADVP (RB also)) (VP (VBN employed) (S (VP (TO to) (VP (VB visualize) (NP (NP (NNP NOS)) (PP (IN as) (NP (NP (DT an) (NN index)) (PP (IN of) (NP (JJ enzyme) (NN expression)))))) (PP (IN in) (NP (NP (NNS mice) (NN brain) (NNS regions)) (VP (VBN related) (PP (TO to) (NP (NN motor) (NN control))))))))))) (. .)))
10672628	9	(ROOT (S (NP (JJ Doc_10672628_1169_1176_Chemical) (JJ sub-chronic) (NN administration)) (VP (VBD produced) (NP (NN tolerance)) (PP (PP (IN of) (NP (NNS Doc_10672628_1226_1233_Chemical))) (CC and) (PP (IN of) (NP (NN Doc_10672628_1241_1252_Chemical-induced) (NNS Doc_10672628_1261_1270_Disease))))) (. .)))
10672628	10	(ROOT (S (NP (PRP It)) (ADVP (RB also)) (VP (VBN induced) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN Doc_10672628_1317_1322_Chemical-d-positive) (NNS cells)))))) (PP (PP (IN in) (NP (NP (DT the) (JJ dorsal) (NN part)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ caudate) (CC and) (JJ accumbens)) (NN nuclei)) (PP (VBN compared) (PP (IN with) (NP (NNS Doc_10672628_1409_1420_Chemical)))))))) (CC and) (PP (IN in) (NP (NP (DT the) (JJ pedunculopontine) (JJ tegmental) (NN nucleus)) (PP (VBN compared) (PP (IN with) (NP (NN saline)))))))) (. .)))
10672628	11	(ROOT (SINV (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (NN Doc_10672628_1526_1531_Chemical-d) (NN neuron) (NN number)) (PP (IN in) (NP (DT the) (NN substantia) (NN nigra)))))))) (, ,) (VP (VBZ pars)) (NP (NP (NN compacta)) (PP (IN in) (NP (ADJP (DT both) (JJ Doc_10672628_1595_1606_Chemical-treated) (CC and) (JJ Doc_10672628_1619_1626_Chemical-treated)) (NNS animals)))) (. .)))
10672628	12	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP give) (NP (JJ further) (NN support)) (PP (TO to) (NP (DT the) (NNS hypothesis))) (SBAR (IN that) (S (NP (NNP NO)) (VP (VP (VBZ plays) (NP (NP (DT a) (NN role)) (PP (IN in) (NP (NN motor) (NN behavior) (NN control))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (PRP it)) (VP (MD may) (VP (VB take) (NP (NN part)) (PP (IN in) (NP (NP (DT the) (JJ synaptic) (NNS changes)) (VP (VBN produced) (PP (IN by) (NP (JJ antipsychotic) (NN treatment))))))))))))))) (. .)))
10677406	0	(ROOT (S (NP (NNP Doc_10677406_0_38_Disease)) (VP (VBZ occurs) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_10677406_63_86_Disease))))) (PP (IN after) (NP (DT both) (NNS Doc_10677406_98_108_Chemical) (CC and) (NN exercise) (NN induced) (NNS Doc_10677406_130_150_Disease)))) (. .)))
10677406	1	(ROOT (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (JJ pharmacological) (NN stress)) (VP (VBZ leads) (PP (TO to) (NP (ADJP (JJ prolonged) (CC but) (JJ reversible)) (NNS Doc_10677406_241_269_Disease))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_10677406_287_310_Disease))))))))))) (, ,) (NP (NP (JJ similar)) (PP (TO to) (NP (DT that)))) (VP (VBN seen) (PP (IN after) (NP (NN exercise)))) (. .)))
10677406	2	(ROOT (S (NP (NP (DT A) (JJ randomised) (NN crossover) (NN study)) (PP (IN of) (NP (NP (NN recovery) (NN time)) (PP (IN of) (NP (ADJP (JJ systolic) (CC and) (JJ diastolic)) (JJ left) (NN ventricular)))))) (VP (VBP function) (PP (IN after) (NP (NN exercise) (CC and) (JJ Doc_10677406_474_484_Chemical) (NNS induced) (NN ischaemia)))) (. .)))
10677406	3	(ROOT (S (NP (NP (CD 10) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_10677406_531_544_Disease)) (, ,) (NP (JJ angiographically) (JJ proven) (NNS Doc_10677406_570_593_Disease)) (, ,) (CC and) (NP (JJ normal) (JJ left) (NN ventricular))))) (VP (VBP function)) (. .)))
10677406	4	(ROOT (S (NP (NP (JJ Treadmill) (NN exercise)) (CC and) (NP (JJ Doc_10677406_671_681_Chemical) (NN stress))) (VP (VBD were) (VP (VBN performed) (PP (IN on) (NP (JJ different) (NNS days))))) (. .)))
10677406	5	(ROOT (S (NP (NP (JJ Quantitative) (NN assessment)) (PP (IN of) (NP (ADJP (JJ systolic) (CC and) (JJ diastolic)) (JJ left) (NN ventricular) (NN function)))) (VP (VBD was) (VP (VBN performed) (S (VP (VBG using) (NP (JJ transthoracic) (NN echocardiography)) (PP (PP (IN at) (NP (NN baseline))) (CC and) (PP (IN at) (NP (JJ regular) (NNS intervals)))) (PP (IN after) (NP (DT each) (NN test))))))) (. .)))
10677406	6	(ROOT (S (NP (NP (DT Both) (NNS forms)) (PP (IN of) (NP (NN stress)))) (VP (VBD led) (PP (TO to) (NP (ADJP (JJ prolonged) (CC but) (JJ reversible)) (NNS Doc_10677406_966_1000_Disease)))) (. .)))
10677406	7	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (NP (DT the) (JJ maximum) (JJ double) (NN product)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.53))))) (-RRB- -RRB-))) (CC or) (NP (NP (NP (NNP ST) (NNP Doc_10677406_1073_1083_Disease)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (NNS 0.63))))) (-RRB- -RRB-))) (PP (IN with) (NP (NP (DT either) (NN form)) (PP (IN of) (NP (NN stress)))))))))) (. .)))
10677406	8	(ROOT (S (PP (IN After) (NP (NN exercise))) (, ,) (NP (NN ejection) (NN fraction)) (VP (VBD was) (VP (VBN reduced) (PP (PP (IN at) (NP (NP (CD 15) (CC and) (CD 30) (NNS minutes)) (PP (VBN compared) (PP (IN with) (NP (NP (NN baseline)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN mean)) (PRN (-LRB- -LRB-) (NNP SEM) (-RRB- -RRB-)) (, ,) (NP (NP (CD -5.6)) (-LRB- -LRB-) (NP (NP (QP (CD 1.5) (CD -RRB-)) (NN %)) (, ,) (VP (VBN p) (S (VP (SYM <) (NP (CD 0.05)))))) (: ;)) (CC and) (NP (NP (NP (CD -6.1)) (PRN (-LRB- -LRB-) (NP (CD 2.2)) (-RRB- -RRB-))) (VP (VBN %)))) (, ,) (RB p) (NP (NNP <) (NNP 0) (. .) (NNP 01))) (-RRB- -RRB-))))))) (, ,) (CC and) (PP (IN at) (NP (NP (NP (CD 30) (CC and) (CD 45) (NNS minutes)) (PP (IN after) (NP (JJ Doc_10677406_1309_1319_Chemical) (-LRB- -LRB-) (NN -10.8) (-LRB- -LRB-) (CD 1.8) (-RRB- -RRB-) (NNS %)))) (CC and) (NP (NP (NNP -5) (. .)) (NP (NP (CD 5)) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 1.8) (CD -RRB-)) (NN %)) (, ,) (NP (DT both) (FW p) (FW <) (FW 0.01))) (-RRB- -RRB-))))))))) (. .)))
10677406	9	(ROOT (S (NP (NNP Regional) (NN analysis)) (VP (VBD showed) (NP (DT a) (NN reduction)) (PP (PP (IN in) (NP (NP (NP (NP (DT the) (JJS worst) (JJ affected) (NN segment)) (NP (NP (CD 15) (CC and) (CD 30) (NNS minutes)) (PP (IN after) (NP (NP (NN exercise)) (-LRB- -LRB-) (NP (CD -27.9)) (PRN (-LRB- -LRB-) (NP (CD 7.2)) (-RRB- -RRB-)))))) (ADVP (CD %) (CC and) (CD -28.6))) (PRN (-LRB- -LRB-) (NP (NP (CD 5.7) (CD -RRB-) (NN %)) (, ,) (NP (DT both) (FW p) (FW <) (FW 0.01))) (-RRB- -RRB-)))) (, ,) (CC and) (PP (IN at) (NP (CD 30) (NNS minutes)))) (PP (IN after) (NP (NP (NNS Doc_10677406_1540_1550_Chemical)) (-LRB- -LRB-) (NP (CD -32)) (PRN (-LRB- -LRB-) (NP (NP (CD 5.3) (CD -RRB-) (NN %)) (, ,) (NP (FW p) (FW <) (NNS 0.01))) (-RRB- -RRB-))))) (. .)))
10677406	10	(ROOT (S (NP (DT The) (JJ isovolumic) (NN relaxation) (NN period)) (VP (VBD was) (ADJP (JJ prolonged)) (PP (NP (CD 45) (NNS minutes)) (PP (IN after) (NP (NP (DT each) (NN form)) (PP (IN of) (NP (NN stress))))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-)))) (. .)))
10677406	11	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_10677406_1701_1724_Disease))))) (, ,) (NP (NNS Doc_10677406_1726_1736_Chemical)) (VP (VBN induced) (NP (NN ischaemia) (NNS results)) (PP (IN in) (NP (NP (JJ prolonged) (JJ reversible) (NNS Doc_10677406_1787_1815_Disease)) (, ,) (VP (VBN presumed) (S (VP (TO to) (VP (VB be) (NP (NP (NNS Doc_10677406_1832_1851_Disease)) (, ,) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN seen) (PP (IN after) (NP (NN exercise))))))))))))))) (. .)))
10677406	12	(ROOT (S (NP (NNP Doc_10677406_1890_1900_Chemical) (NNP induced) (NNP ischaemia)) (VP (MD could) (ADVP (RB therefore)) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB study) (NP (NP (DT the) (NN pathophysiology)) (PP (IN of) (NP (DT this) (NN phenomenon)))) (PP (ADVP (RBR further)) (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_10677406_2016_2039_Disease))))))))))) (. .)))
10713017	0	(ROOT (NP (NP (NP (NNS Anorexigens) (CC and) (NNS Doc_10713017_16_38_Disease)) (PP (IN in) (NP (DT the) (NNP United) (NNPS States)))) (: :) (NP (NP (NNS results)) (PP (IN from) (NP (NP (DT the) (NN surveillance)) (PP (IN of) (NP (NNP North) (NNP Doc_10713017_100_131_Disease)))))) (. .)))
10713017	1	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NP (NNS Doc_10713017_156_177_Chemical)) (PP (IN in) (NP (NNP Europe)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNS Doc_10713017_232_262_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10713017_264_267_Chemical)) (-RRB- -RRB-))))))))) (. .)))
10713017	2	(ROOT (S (ADVP (RB Recently)) (, ,) (NP (JJ Doc_10713017_280_301_Chemical) (NNS suppressants)) (VP (VP (VBD became) (VP (ADVP (RB widely)) (VBN used) (PP (IN in) (NP (DT the) (NNP United) (NNPS States))))) (CC but) (VP (VBD were) (VP (VBN withdrawn) (PP (IN in) (NP (NNP September) (CD 1997))) (PP (RB because) (IN of) (NP (NP (NNS concerns)) (PP (IN over) (NP (JJ adverse) (NNS effects)))))))) (. .)))
10713017	3	(ROOT (NP (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (S (NP (PRP We)) (VP (VBD conducted) (NP (DT a) (JJ prospective) (NN surveillance) (NN study)) (PP (IN on) (NP (NP (NNS patients)) (VP (VBN diagnosed) (PP (IN with) (NP (NP (NNS Doc_10713017_530_552_Disease)) (PP (IN at) (NP (NP (CD 12) (JJ large) (NN referral) (NNS centers)) (PP (IN in) (NP (NNP North) (NNP America)))))))))))) (. .)))
10713017	4	(ROOT (S (NP (NP (NNP Data)) (VP (VBN collected) (PP (IN on) (NP (NP (NNS patients)) (VP (VBN seen) (PP (IN from) (NP (NNP September) (CD 1) (, ,) (CD 1996) (, ,))) (PP (TO to) (NP (NNP December) (CD 31) (, ,) (CD 1997) (, ,)))))))) (VP (VBD included) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (NP (DT the) (NNS Doc_10713017_704_726_Disease)) (CC and) (NP (PRP$ its) (NN severity)))))) (. .)))
10713017	5	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (DT no) (JJ identifiable) (NN cause)) (PP (IN of) (NP (NNS Doc_10713017_784_806_Disease)))))) (VP (VBD were) (VP (VBN classed) (PP (IN as) (NP (NNS Doc_10713017_823_826_Chemical))))) (. .)))
10713017	6	(ROOT (S (NP (NP (DT A) (NN history)) (PP (IN of) (NP (NN drug) (NN exposure)))) (ADVP (RB also)) (VP (VBD was) (VP (VBN taken) (PP (IN with) (NP (JJ special) (NN attention))) (PP (IN on) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS antidepressants) (, ,) (NNS anorexigens) (, ,) (CC and) (NNS Doc_10713017_941_953_Chemical))))))) (. .)))
10713017	7	(ROOT (S (NP (QP (CD Five) (CD hundred)) (JJ seventy-nine) (NNS patients)) (VP (VBD were) (VP (VP (VBN studied)) (, ,) (VP (VBN 205) (PP (IN with) (NP (NNS Doc_10713017_1022_1025_Chemical)))) (CC and) (VP (VBN 374) (PP (IN with) (NP (NP (NNS Doc_10713017_1039_1061_Disease)) (PP (IN from) (NP (NP (JJ other) (NNS causes)) (PRN (-LRB- -LRB-) (NP (JJ Doc_10713017_1081_1113_Disease) (NNP -LSB-) (NNP Doc_10713017_1115_1118_Disease) (NNP -RSB-)) (-RRB- -RRB-))))))))) (. .)))
10713017	8	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NNS anorexigens)))) (VP (VBD was) (ADJP (JJ common) (PP (IN in) (NP (DT both) (NNS groups))))) (. .)))
10713017	9	(ROOT (S (ADVP (RB However)) (, ,) (PP (IN of) (NP (NP (DT the) (NNS medications)) (VP (VBN surveyed)))) (, ,) (NP (RB only) (DT the) (NNS Doc_10713017_1219_1232_Chemical)) (VP (VBD had) (NP (NP (DT a) (JJ significant) (JJ preferential) (NN association)) (PP (IN with) (NP (NNS Doc_10713017_1281_1284_Chemical)))) (PP (IN as)) (PP (VBN compared) (PP (IN with) (NP (NP (NNS Doc_10713017_1302_1305_Disease)) (PRN (-LRB- -LRB-) (VP (VBN adjusted) (NP (NP (NP (NNS odds) (NN ratio)) (PP (IN for) (NP (NP (NN use) (NNS >)) (NP (CD 6) (NNS months))))) (, ,) (NP (CD 7.5)) (: ;) (NP (NP (CD 95) (NN %) (NN confidence) (NN interval)) (, ,) (NP (QP (CD 1.7) (TO to) (CD 32.4)))))) (-RRB- -RRB-)))))) (. .)))
10713017	10	(ROOT (S (NP (DT The) (NN association)) (VP (VP (VBD was) (ADJP (ADJP (JJR stronger)) (PP (IN with) (NP (NP (JJR longer) (NN duration)) (PP (IN of) (NP (NP (NN use)) (FRAG (WHADVP (WRB when)))))))) (PP (VBN compared) (PP (TO to) (NP (NP (JJR shorter) (NN duration)) (PP (IN of) (NP (NN use))))))) (CC and) (VP (VBD was) (ADJP (RBR more) (JJ pronounced) (PP (IN in) (NP (JJ recent) (NNS users)))) (PP (IN than) (PP (IN in) (NP (JJ remote) (NNS users)))))) (. .)))
10713017	11	(ROOT (S (NP (NP (DT An) (ADJP (ADJP (RB unexpectedly) (JJ high)) (PRN (-LRB- -LRB-) (ADJP (CD 11.4) (NN %)) (-RRB- -RRB-))) (NN number)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_10713017_1604_1607_Disease)))))) (VP (VBD had) (VP (VBN used) (NP (NNS anorexigens)))) (. .)))
10713017	12	(ROOT (S (NP (NP (DT The) (NN magnitude)) (PP (IN of) (NP (NP (NP (DT the) (NN association)) (PP (IN with) (NP (NNS Doc_10713017_1680_1683_Chemical)))) (, ,) (NP (NP (DT the) (NN increase)) (PP (IN of) (NP (NP (NN association)) (PP (IN with) (NP (NP (JJ increasing) (NN duration)) (PP (IN of) (NP (NN use)))))))) (, ,) (CC and) (NP (NP (DT the) (NN specificity)) (PP (IN for) (NP (NNS Doc_10713017_1770_1783_Chemical))))))) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (JJ previous) (NNS studies)) (VP (VBG indicating) (SBAR (IN that) (S (NP (NNS Doc_10713017_1837_1850_Chemical)) (VP (VBP are) (ADJP (RB causally) (VBN related) (PP (TO to) (NP (NNS Doc_10713017_1875_1878_Chemical)))))))))))) (. .)))
10713017	13	(ROOT (S (NP (NP (DT The) (JJ high) (NN prevalence)) (PP (IN of) (NP (NP (NN anorexigen) (NN use)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_10713017_1935_1938_Disease)))))))) (ADVP (RB also)) (VP (VBZ raises) (NP (DT the) (NN possibility)) (SBAR (IN that) (S (NP (DT these) (NNS drugs)) (VP (VBP precipitate) (NP (NP (NNS Doc_10713017_1996_2018_Disease)) (PP (IN in) (NP (NNS patients)))) (PP (IN with) (NP (NP (VBG underlying) (NNS conditions)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_10713017_2074_2077_Disease)))))))))) (. .)))
10726030	0	(ROOT (NP (NP (JJ Clinical) (NNS aspects)) (PP (IN of) (NP (NP (NNS Doc_10726030_20_27_Chemical-induced) (NNS Doc_10726030_36_52_Disease) (CC and) (NNS Doc_10726030_57_67_Disease) (CC and) (JJ other) (NN side) (NNS effects)) (PP (IN of) (NP (JJ Doc_10726030_94_101_Chemical) (NN therapy))))) (. .)))
10726030	1	(ROOT (S (NP (NP (NNP Doc_10726030_111_118_Chemical)) (, ,) (VP (ADVP (RB first)) (VBN used) (S (VP (TO to) (VP (VB prevent) (NP (NP (DT the) (NN clotting)) (PP (IN of) (NP (NN blood)))) (PP (IN in) (ADJP (NN vitro))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (ADJP (RB clinically) (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NP (NNS Doc_10726030_208_218_Disease)) (PP (IN for) (NP (QP (JJR more) (IN than) (CD 50)) (NNS years)))))))))) (. .)))
10726030	2	(ROOT (S (SBAR (IN Although) (S (NP (JJ several) (JJ new) (NN anticoagulant) (NNS drugs)) (VP (VBP are) (PP (IN in) (NP (NN development)))))) (, ,) (NP (NNS Doc_10726030_304_311_Chemical)) (VP (VBZ remains) (S (NP (NP (DT the) (NN anticoagulant)) (PP (IN of) (NP (NN choice)))) (VP (TO to) (VP (VB treat) (NP (JJ acute) (JJ Doc_10726030_363_373_Disease) (NNS episodes)))))) (. .)))
10726030	3	(ROOT (S (S (NP (NP (DT The) (JJ clinical) (NNS effects)) (PP (IN of) (NP (NNS Doc_10726030_408_415_Chemical)))) (VP (VBP are) (ADJP (JJ meritorious)))) (, ,) (CC but) (S (NP (NN side) (NNS effects)) (VP (VBP do) (VP (VB exist)))) (. .)))
10726030	4	(ROOT (S (NP (NNP Doc_10726030_460_468_Disease)) (VP (VBZ is) (NP (NP (DT the) (JJ primary) (JJ untoward) (NN effect)) (PP (IN of) (NP (NNS Doc_10726030_503_510_Chemical))))) (. .)))
10726030	5	(ROOT (S (NP (NNP Doc_10726030_512_526_Disease)) (VP (VBZ is) (PP (IN of) (NP (NP (JJ primary) (NN concern)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ Doc_10726030_571_578_Chemical) (NN therapy)))))))) (. .)))
10726030	6	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (JJ additional) (JJ important) (JJ untoward) (NNS effects)) (PP (IN of) (NP (JJ Doc_10726030_638_645_Chemical) (NN therapy)))) (VP (VBP include) (NP (NP (NN Doc_10726030_662_669_Chemical-induced) (NNS Doc_10726030_678_694_Disease)) (, ,) (NP (NN Doc_10726030_696_703_Chemical-associated) (NNS Doc_10726030_715_727_Disease)) (, ,) (NP (NNS Doc_10726030_729_741_Disease)) (, ,) (NP (NN skin) (NNS reactions)) (, ,) (NP (NP (NNS Doc_10726030_759_777_Disease)) (PP (JJ other) (IN than) (NP (NNS Doc_10726030_789_805_Disease) (, ,) (NNS Doc_10726030_807_815_Disease) (, ,) (NNS transaminasemia) (, ,) (NNS Doc_10726030_834_846_Disease) (, ,) (NNS Doc_10726030_848_865_Disease) (, ,) (CC and) (NNS Doc_10726030_871_879_Disease)))))) (. .)))
10726030	7	(ROOT (S (S (NP (DT These) (NN side) (NNS effects)) (VP (VBP are) (ADJP (RB relatively) (JJ rare) (PP (IN in) (NP (DT a) (VBN given) (NN individual)))))) (, ,) (CC but) (S (PP (VBN given) (NP (NP (DT the) (ADJP (RB extremely) (JJ widespread)) (NN use)) (PP (IN of) (NP (NNS Doc_10726030_985_992_Chemical))))) (, ,) (NP (DT some)) (VP (VBP are) (ADJP (ADJP (RB quite) (JJ common)) (, ,) (ADJP (RB particularly) (JJ HITT)) (CC and) (ADJP (JJ Doc_10726030_1039_1051_Disease))))) (. .)))
10726030	8	(ROOT (S (SBAR (IN Although) (S (NP (NP (JJ reasonable) (NNS incidences)) (PP (IN of) (NP (NP (JJ many)) (PP (IN of) (NP (DT these) (NN side) (NNS effects)))))) (VP (MD can) (VP (VB be) (`` ``) (ADJP (JJ softly)) ('' '') (S (VP (VBN deduced) (PP (IN from) (NP (NP (JJ current) (NNS reports)) (VP (VBG dealing) (PP (IN with) (NP (JJ unfractionated) (NNS Doc_10726030_1187_1194_Chemical)))))) (, ,) (PP (IN at) (ADJP (JJ present))))))))) (NP (NP (DT the) (NNS incidences)) (PP (IN of) (NP (NP (DT these) (NN side) (NNS effects)) (PP (IN with) (NP (JJR newer) (NNS Doc_10726030_1255_1284_Disease)))))) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (ADJP (RB much) (RBR less) (JJ common)))))) (. .)))
10726030	9	(ROOT (S (ADVP (RB However)) (, ,) (NP (RB only) (JJR longer) (NN experience)) (VP (MD will) (ADVP (RBR more) (RB clearly)) (VP (VB define) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (DT each) (NN side) (NN effect)))) (PP (IN with) (NP (JJ low) (JJ molecular) (NN weight) (NNS preparations))))) (. .)))
10764869	0	(ROOT (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NNS Doc_10764869_10_36_Disease))) (PP (IN in) (NP (NP (DT a) (ADJP (JJ patient) (PP (IN on) (NP (NP (NNS Doc_10764869_53_63_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10764869_65_70_Chemical)) (-RRB- -RRB-))))) (NN therapy)) (PP (IN after) (NP (NN liver) (NN transplantation))))) (. .)))
10764869	1	(ROOT (S (VP (TO To) (VP (VB report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NNS Doc_10764869_138_164_Disease)))) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NP (NP (NNS Doc_10764869_188_198_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNP Doc_10764869_200_206_Chemical) (, ,) (NNP Prograf)) (: ;) (NP (NNP Fujisawa) (NNP USA) (, ,) (NNP Inc) (, ,) (NNP Deerfield) (, ,) (NNP Illinois))) (-RRB- -RRB-))) (PP (IN for) (NP (NN immunosuppression)))) (PP (IN after) (NP (JJ orthotropic) (NN liver) (NN transplantation)))))))) (. .)))
10764869	2	(ROOT (S (NP (NNP Case)) (VP (VBP report)) (. .)))
10764869	3	(ROOT (S (PP (IN In) (NP (NP (DT a) (JJ 58-year-old) (NN man)) (VP (VBG receiving) (NP (NNS Doc_10764869_372_382_Chemical)) (PP (IN after) (NP (JJ orthotropic) (NN liver) (NN transplantation)))))) (, ,) (NP (JJ serial) (JJ neuro-ophthalmologic) (NNS examinations) (CC and) (NN laboratory) (NNS studies)) (VP (VBD were) (VP (VBN performed))) (. .)))
10764869	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (JJ episodic) (NNS Doc_10764869_538_561_Disease)) (PP (IN in) (NP (DT both) (NNS eyes)))) (, ,) (PP (IN with) (NP (NP (JJ clinical) (NNS features)) (VP (VBG resembling) (NP (NNS Doc_10764869_610_637_Disease)))))) (. .)))
10764869	5	(ROOT (S (NP (NNP Doc_10764869_639_662_Disease)) (VP (VBD occurred) (PP (IN despite) (NP (NP (NN discontinuation)) (PP (IN of) (NP (DT the) (NNS Doc_10764869_703_713_Chemical)))))) (. .)))
10764869	6	(ROOT (S (NP (NN Doc_10764869_727_737_Chemical) (CC and) (JJ other) (NN immunosuppressive) (NNS agents)) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (JJ optic) (NN nerve) (NNS Doc_10764869_808_816_Disease)))))) (. .)))
10770468	0	(ROOT (S (NP (NP (NNP Doc_10770468_0_13_Disease)) (, ,) (NP (NNS Doc_10770468_15_25_Disease)) (, ,) (CC and) (NP (NN mood))) (VP (VBZ stabilizers)) (. .)))
10770468	1	(ROOT (S (NP (NP (JJ Recent) (NNS findings)) (PP (IN in) (NP (NP (DT a) (JJ Doc_10770468_70_77_Disease) (NN patient)) (VP (VBG receiving) (NP (NP (NN maintenance) (JJ Doc_10770468_108_115_Chemical) (NN therapy)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (NNS Doc_10770468_138_151_Disease)) (CC and) (NP (JJ severe) (NNS Doc_10770468_163_178_Disease))))))))))) (VP (VBD prompted) (NP (DT the) (NNS authors)) (S (VP (TO to) (VP (VB conduct) (NP (NP (DT a) (NN retrospective) (NN study)) (PP (IN of) (NP (JJ Doc_10770468_236_243_Disease) (NNS patients)))) (PP (IN with) (NP (NN Doc_10770468_258_265_Chemical-associated) (NNS Doc_10770468_277_290_Disease))))))) (. .)))
10770468	2	(ROOT (S (NP (NP (DT A) (NN printout)) (PP (IN of) (NP (NP (DT all) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_10770468_319_332_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBN presented) (PP (IN during) (NP (DT a) (JJ 1-year) (NN period))))))))))) (VP (VBD was) (VP (VBN generated))) (. .)))
10770468	3	(ROOT (S (PP (IN After) (S (VP (VBG eliminating) (NP (NP (JJ spurious) (NNS Doc_10770468_413_427_Disease)) (CC or) (NP (NP (DT those)) (VP (VBN associated) (PP (IN with) (NP (JJ intravenous) (NNS fluids))))))))) (, ,) (NP (DT the) (NNS authors)) (VP (VBD identified) (NP (CD 18) (JJ non-Doc_10770468_503_510_Chemical-treated) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_10770468_533_547_Disease)) (VP (VBN related) (PP (TO to) (NP (NP (NNS Doc_10770468_559_571_Disease)) (CC and) (NP (NP (NP (JJ other) (JJ medical) (NNS conditions)) (PRN (-LRB- -LRB-) (NP (NN group) (NN A)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 12) (NNS patients)) (PP (IN with) (NP (NP (NN Doc_10770468_632_639_Chemical-associated) (NNS Doc_10770468_651_664_Disease)) (PRN (-LRB- -LRB-) (NP (NN group) (NN B)) (-RRB- -RRB-)))))))))))) (. .)))
10770468	4	(ROOT (S (NP (NP (NNS Patients)) (PP (IN in) (NP (NN group) (NN B)))) (VP (VBD were) (RB not) (ADJP (JJ comparable) (PP (TO to) (NP (NP (DT those)) (PP (IN in) (NP (NN group) (NN A)))))) (, ,) (SBAR (IN as) (S (NP (DT the) (NN latter)) (VP (VP (VBD were) (ADJP (RB medically) (VBN compromised))) (CC and) (VP (VBD were) (VP (VBG receiving) (NP (JJ multiple) (NNS pharmacotherapies)))))))) (. .)))
10770468	5	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (CD two) (NN control) (NNS groups)) (VP (VBD were) (VP (VBN generated) (: :) (NP (NP (NP (NP (NN group) (NN C1)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD included) (NP (NN age)))))) (: -) (CC and) (NP (NP (JJ sex-comparable) (NNS Doc_10770468_915_922_Chemical-treated)) (NP (JJ Doc_10770468_931_952_Disease) (NNS patients)))) (, ,) (CC and) (NP (NP (NN group) (NN C2)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD included) (NP (NP (JJ Doc_10770468_992_1013_Disease) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (JJ anticonvulsant) (NN mood) (NNS stabilizers)))))))))))) (. .)))
10770468	6	(ROOT (S (NP (NP (DT The) (ADJP (ADJP (JJ electrocardiographic)) (PRN (-LRB- -LRB-) (NP (NNP ECG)) (-RRB- -RRB-))) (NNS findings)) (PP (IN for) (NP (NP (NNS patients)) (PP (IN in) (NP (NN group) (NN B)))))) (VP (VBD were) (VP (VBN compared) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (NNS groups) (NNP C1) (CC and) (NNP C2))))))))) (. .)))
10770468	7	(ROOT (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (NP (DT these) (NNS groups)) (VP (VBD did) (RB not) (VP (VB differ) (PP (IN in) (NP (NP (PRP$ their) (JJ overall) (NN frequency)) (PP (IN of) (NP (NNP ECG) (NNS abnormalities)))))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (JJ significant) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NNS Doc_10770468_1350_1368_Disease)))))))) (. .)))
10770468	8	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (NNS Doc_10770468_1384_1397_Disease)) (VP (VBG resulting) (PP (IN from) (NP (NP (JJ medical) (NNS diseases)) (CC and) (NP (JJ Doc_10770468_1434_1441_Disease) (NNS patients)))) (PP (IN with) (NP (NN Doc_10770468_1456_1463_Chemical-associated) (NNS Doc_10770468_1475_1488_Disease))))))) (VP (VBD had) (NP (NP (ADJP (RB significantly) (JJR higher)) (NNS frequencies)) (PP (IN of) (NP (NNS Doc_10770468_1529_1547_Disease))))) (. .)))
10770468	9	(ROOT (S (NP (NP (NNS Patients)) (PP (IN in) (NP (NN group) (NN A)))) (VP (VBD had) (NP (JJ significant) (NN mortality)) (PP (IN at) (NP (NP (JJ 2-year) (NN follow-up)) (PRN (-LRB- -LRB-) (NP (CD 28) (NN %)) (-RRB- -RRB-)))) (, ,) (PP (IN in) (NP (NN contrast) (S (VP (TO to) (VP (VB zero) (NP (NN mortality)) (PP (IN in) (NP (DT the) (JJ other) (CD three) (NNS groups))))))))) (. .)))
10770468	10	(ROOT (S (NP (NP (DT The) (JJ clinical) (NNS implications)) (PP (IN of) (NP (DT these) (NNS findings)))) (VP (VBP are) (VP (VBN discussed))) (. .)))
10933650	0	(ROOT (NP (NP (NP (NNP Attenuation)) (PP (IN of) (NP (NP (ADJP (JJ nephrotoxicity) (PP (IN by) (NP (DT a) (NN novel) (NN lipid)))) (NN nanosphere)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10933650_59_65_Chemical)) (-RRB- -RRB-))))) (VP (VBG incorporating) (NP (NNS Doc_10933650_81_95_Chemical))) (. .)))
10933650	1	(ROOT (S (NP (NP (NNP Doc_10933650_97_103_Chemical)) (, ,) (NP (NP (DT a) (NN lipid) (NN nanosphere)) (VP (VBG incorporating) (NP (NNS Doc_10933650_138_152_Chemical)))) (, ,)) (VP (VP (VBZ is) (ADJP (JJ effective) (PP (IN against) (NP (JJ pathogenic) (NNS fungi))))) (CC and) (VP (VBZ has) (NP (JJ low) (NNS Doc_10933650_204_212_Disease)))) (. .)))
10933650	2	(ROOT (S (NP (PRP We)) (VP (VBD compared) (NP (NP (DT the) (NNS Doc_10933650_230_238_Disease)) (PP (IN of) (NP (NNS Doc_10933650_242_248_Chemical)))) (PP (PP (IN with) (S (NP (NP (DT that)) (PP (IN of) (NP (NP (NP (NNS Doc_10933650_262_271_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_10933650_273_287_Chemical-Doc_10933650_288_307_Chemical)) (: ;) (NP (NNS Doc_10933650_309_314_Chemical))) (-RRB- -RRB-))) (ADJP (IN in) (NN vitro))))) (VP (VBG using) (NP (JJ renal) (NN cell) (NNS cultures))))) (CC and) (PP (IN in) (NP (NP (NP (NN vivo)) (PP (IN by) (NP (JJ biochemical) (NN analysis)))) (, ,) (NP (NP (JJ histopathological) (NN study)) (PP (IN of) (NP (DT the) (NN kidney)))) (CC and) (NP (NP (JJ pharmacokinetic) (NN study)) (PP (IN of) (NP (NP (NNS Doc_10933650_455_469_Chemical)) (PP (VBG following) (NP (NP (JJ intravenous) (NN infusion)) (PP (IN of) (NP (NP (DT the) (NN formulation)) (PP (IN in) (NP (NNS rats)))))))))))))) (. .)))
10933650	3	(ROOT (S (NP (NP (NNP Incubation)) (PP (IN with) (NP (NNS Doc_10933650_545_551_Chemical)))) (VP (VBD resulted) (PP (IN in) (NP (NP (ADJP (RB significantly) (JJR less)) (NN damage)) (PP (IN of) (NP (NP (JJ cultured) (JJ human) (JJ renal) (JJ proximal) (JJ tubular) (JJ epithelial) (NNS cells)) (PP (VBN compared) (PP (IN with) (NP (NNS Doc_10933650_662_667_Chemical))))))))) (. .)))
10933650	4	(ROOT (S (NP (NP (JJ Serum) (NN blood) (NNS Doc_10933650_681_685_Chemical)) (CC and) (NP (JJ Doc_10933650_690_700_Chemical) (NNS concentrations))) (VP (VBD increased) (PP (RB significantly) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN given) (NP (DT an) (NN iv)) (NP (NP (NN infusion)) (PP (IN of) (NP (NNP Doc_10933650_772_777_Chemical) (CD 3))) (VP (VBG mg/kg)))))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NP (DT those)) (VP (VBN given) (NP (NP (DT the) (JJ same) (NN dose)) (PP (IN of) (NP (NNS Doc_10933650_826_832_Chemical))))))))) (. .)))
10933650	5	(ROOT (S (NP (NP (JJ Histopathological) (NN examination)) (PP (IN of) (NP (DT the) (NN kidney)))) (VP (VBD showed) (NP (NNS Doc_10933650_885_901_Disease)) (PP (IN in) (NP (NP (NN Doc_10933650_905_910_Chemical-treated) (NNS rats)) (PP (CC but) (NP (DT no) (NN change))))) (PP (IN in) (NP (NN Doc_10933650_941_947_Chemical-treated) (NNS rats)))) (. .)))
10933650	6	(ROOT (S (NP (NP (JJ Doc_10933650_962_976_Chemical) (NNS concentrations)) (PP (IN in) (NP (NP (DT the) (NN kidney)) (PP (IN in) (NP (NN Doc_10933650_1009_1015_Chemical-treated) (NNS rats)))))) (VP (VBD were) (ADJP (JJR higher)) (PP (IN than) (NP (NP (DT those)) (PP (IN in) (NP (NN Doc_10933650_1055_1060_Chemical-treated) (NNS rats)))))) (. .)))
10933650	7	(ROOT (S (NP (NP (NNP Our)) (PP (IN in) (NP (UCP (ADJP (NN vitro)) (CC and) (PP (IN in) (NP (NN vivo)))) (NNS results)))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN incorporation)) (PP (IN of) (NP (NP (NNS Doc_10933650_1138_1152_Chemical)) (PP (IN into) (NP (NP (NN lipid) (NNS nanospheres)) (PP (IN of) (NP (NNS Doc_10933650_1179_1185_Chemical)))))))) (VP (VBZ attenuates) (NP (NP (DT the) (NN nephrotoxicity)) (PP (IN of) (NP (NNS Doc_10933650_1219_1233_Chemical)))))))) (. .)))
10939760	0	(ROOT (NP (NP (NNS Patterns)) (PP (IN of) (NP (JJ Doc_10939760_12_24_Chemical) (JJ acute) (NN nephrotoxicity))) (. .)))
10939760	1	(ROOT (S (NP (NNP Doc_10939760_47_59_Chemical) (NNP acute)) (ADVP (RB nephrotoxicity)) (VP (VBZ is) (VP (VBG reviving) (ADVP (RB specially)) (PP (RB because) (IN of) (NP (NP (PRP$ its) (NN use)) (PP (IN in) (NP (NP (NNS toxoplasmosis)) (PP (IN in) (NP (JJ HIV-positive) (NNS patients))))))))) (. .)))
10939760	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (CD 4) (NNS cases)) (, ,) (NP (NP (CD one)) (PP (IN of) (NP (PRP them))))) (PP (IN in) (NP (DT a) (ADJP (RB previously) (JJ healthy)) (NN person)))) (. .)))
10939760	3	(ROOT (S (PP (IN Under) (NP (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_10939760_249_261_Chemical))))) (NP (PRP they)) (VP (VBD developed) (SBAR (S (NP (NP (NNS Doc_10939760_277_285_Disease)) (, ,) (NP (NNS Doc_10939760_287_301_Disease)) (, ,)) (VP (VP (VBZ Doc_10939760_303_316_Disease)) (CC and) (VP (VBD showed) (NP (JJ multiple) (NN radiolucent) (NNS Doc_10939760_349_362_Disease)) (PP (IN in) (NP (NN echography)))))))) (. .)))
10939760	4	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD recovered) (NP (PRP$ their) (JJ previous) (JJ normal) (JJ renal) (NN function)) (PP (IN after) (NP (JJ adequate) (NN hydration) (CC and) (NN alcalinization)))) (. .)))
10939760	5	(ROOT (S (NP (DT A) (JJ nephrostomy) (NN tube)) (VP (VBD had) (S (VP (TO to) (VP (VB be) (VP (VBN placed) (PP (IN in) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS patients)) (PP (IN for) (NP (NP (NNS Doc_10939760_546_564_Disease)) (PP (IN in) (NP (DT a) (ADJP (JJ single) (JJ functional)) (NN kidney)))))))))))))) (. .)))
10939760	6	(ROOT (S (NP (NP (NN None)) (PP (IN of) (NP (PRP them)))) (VP (VBD needed) (NP (NP (NN dialysis)) (CC or) (NP (NP (DT a) (JJ renal) (NN biopsy)) (PP (RB because) (IN of) (NP (DT a) (JJ typical) (JJ benign) (NN course)))))) (. .)))
10939760	7	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN with) (NP (NNS Doc_10939760_694_706_Chemical)))) (VP (VBZ requires) (NP (NP (NP (JJ exquisite) (NN control)) (PP (IN of) (NP (JJ renal) (NN function)))) (, ,) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN water) (NN ingestion)))) (CC and) (NP (NP (RB possibly) (DT the) (NN alcalinization)) (PP (IN of) (NP (DT the) (NN urine)))))) (. .)))
10939760	8	(ROOT (S (NP (PRP We)) (VP (VB communicate) (NP (NP (DT a) (NN case)) (PP (IN in) (NP (NP (DT a) (ADJP (RB previously) (JJ healthy)) (NN person)) (, ,) (VP (ADVP (NP (DT a) (NN fact)) (RB not)) (VBN found) (PP (IN in) (NP (DT the) (JJ recent) (NN literature)))))))) (. .)))
10939760	9	(ROOT (S (ADVP (RB Probably)) (NP (JJ many) (JJR more) (NNS cases)) (VP (VBP are) (RB not) (VP (VBN detected))) (. .)))
10939760	10	(ROOT (S (NP (PRP We)) (VP (VBP think) (SBAR (IN that) (S (NP (DT a) (JJ prospective) (NN study)) (VP (MD would) (VP (VB be) (ADJP (JJ useful))))))) (. .)))
10960401	0	(ROOT (S (NP (JJ Downbeat) (NNS Doc_10960401_9_18_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ intravenous) (JJ patient-controlled) (NN administration)) (PP (IN of) (NP (NNS Doc_10960401_84_92_Chemical)))))) (. .)))
10960401	1	(ROOT (S (NP (DT This) (NN case)) (VP (VBZ documents) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_10960401_152_161_Disease)) (PP (IN with) (S (VP (VBG downbeating) (NP (NNS Doc_10960401_179_188_Disease)) (PP (IN while) (S (VP (VBG receiving) (NP (NP (DT a) (ADJP (RB relatively) (JJ large)) (NN dose)) (PP (IN of) (NP (NNP IV) (JJ patient-controlled) (NN analgesia) (NNS Doc_10960401_264_272_Chemical))))))))))))))) (. .)))
10960401	2	(ROOT (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (NN case) (NNS reports)) (PP (IN of) (NP (JJ epidural) (NNS Doc_10960401_324_332_Chemical)))) (PP (IN with) (NP (DT these) (NNS symptoms) (CC and) (NNS signs))))))) (, ,) (NP (DT this)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (ADVP (RB previously)) (VBN documented) (PP (IN with) (NP (NP (NNP IV)) (CC or) (NP (JJ patient-controlled) (NN analgesia) (NNS Doc_10960401_444_452_Chemical))))))) (. .)))
10975596	0	(ROOT (NP (NP (JJ Hemodynamic) (CC and) (JJ antiadrenergic) (NNS effects)) (PP (IN of) (NP (NNS Doc_10975596_42_53_Chemical) (CC and) (NNS Doc_10975596_58_68_Chemical))) (PP (IN in) (NP (NP (NNS animals)) (PP (IN with) (NP (DT a) (JJ healed) (NNS Doc_10975596_94_115_Disease))))) (. .)))
10975596	1	(ROOT (S (NP (NP (NP (DT The) (ADJP (JJ hemodynamic) (CC and) (JJ antiadrenergic)) (NNS effects)) (PP (IN of) (NP (NNS Doc_10975596_163_174_Chemical)))) (, ,) (NP (NP (DT a) (JJ noniodinated) (NN compound)) (VP (ADVP (RB structurally)) (VBN related) (PP (TO to) (NP (NNS Doc_10975596_224_234_Chemical))))) (, ,)) (VP (VBD were) (VP (VBN compared) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (NNS Doc_10975596_264_274_Chemical))))) (PP (IN after) (NP (JJ prolonged) (JJ oral) (NN administration))) (, ,) (PP (DT both) (PP (IN at) (NP (NN rest))) (CC and) (PP (IN during) (NP (NP (JJ sympathetic) (NN stimulation)) (PP (IN in) (NP (NP (JJ conscious) (NNS dogs)) (PP (IN with) (NP (DT a) (JJ healed) (NNS Doc_10975596_392_413_Disease)))))))))) (. .)))
10975596	2	(ROOT (S (NP (NP (DT All) (NNS dogs)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 6))))) (-RRB- -RRB-))) (ADVP (RB randomly)) (VP (VBD received) (NP (NP (NP (NP (JJ orally) (NNS Doc_10975596_457_468_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 10)) (CC and) (NP (CD 30) (NN mg/kg))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_10975596_488_498_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 10)) (CC and) (NP (CD 30) (NN mg/kg))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN placebo))) (RB twice) (RB daily) (IN for) (NP (CD 7) (NNS days))) (, ,) (PP (IN with) (NP (NP (DT a) (JJ 3-week) (NN washout)) (PP (IN between) (NP (JJ consecutive) (NNS treatments)))))) (. .)))
10975596	3	(ROOT (S (S (NP (NP (NNP Heart) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP HR)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ mean) (JJ arterial) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP MBP)) (-RRB- -RRB-)) (, ,) (NP (NP (JJ positive) (NN rate)) (PP (IN of) (NP (NP (NN increase)) (PP (IN of) (NP (NP (JJ left) (NN ventricular) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP +) (NNP LVdP/dt)) (-RRB- -RRB-))))))) (, ,)) (ADVP (RB echocardiographically)) (VP (VBD assessed) (NP (JJ left) (NN ventricular)) (NP (NP (NP (NP (NN ejection) (NN fraction)) (PRN (-LRB- -LRB-) (NP (NNP LVEF)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ fractional) (NN shortening)) (PRN (-LRB- -LRB-) (NP (NNP FS)) (-RRB- -RRB-)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ chronotropic) (NN response)) (PP (TO to) (NP (NNS Doc_10975596_864_877_Chemical))))))) (CC and) (S (NP (JJ exercise-induced) (JJ sympathetic) (NN stimulation)) (VP (VBD were) (VP (VBN evaluated) (PP (IN under) (NP (NN baseline) (CC and) (NN posttreatment) (NNS conditions)))))) (. .)))
10975596	4	(ROOT (S (NP (NP (VBG Resting) (NNS values)) (PP (IN of) (NP (NP (NNP LVEF)) (, ,) (NP (NNP FS)) (, ,) (NP (NNP +) (NNP LVdP/dt)) (, ,) (CC and) (NP (NNP MBP))))) (VP (VBD remained) (ADJP (JJ unchanged)) (SBAR (WHNP (WDT whatever)) (S (NP (NP (DT the) (NN drug)) (CC and) (NP (NP (DT the) (JJ dosing) (NN regimen)) (, ,) (SBAR (IN whereas) (S (NP (NNP resting) (NNP HR)) (VP (VBD was) (UCP (ADVP (RB significantly)) (CC and) (ADJP (JJ dose-dependently)))))))) (VP (VBD lowered) (PP (PP (IN after) (NP (NNS Doc_10975596_1162_1173_Chemical))) (CC and) (PP (TO to) (NP (DT a) (JJR lesser) (NN extent)))) (PP (IN after) (NP (NNS Doc_10975596_1203_1213_Chemical))))))) (. .)))
10975596	5	(ROOT (S (NP (DT Both) (NNS Doc_10975596_1220_1231_Chemical) (CC and) (NNS Doc_10975596_1236_1246_Chemical)) (ADVP (RB significantly)) (VP (VP (VBD reduced) (NP (DT the) (JJ exercise-induced) (NNS Doc_10975596_1290_1301_Disease))) (CC and) (PRN (, ,) (PP (IN at) (NP (DT the) (JJS highest) (NN dose))) (, ,)) (VP (VBD decreased) (NP (DT the) (NN Doc_10975596_1342_1355_Chemical-induced) (NNS Doc_10975596_1364_1375_Disease)))) (. .)))
10975596	6	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NNS Doc_10975596_1383_1394_Chemical) (CC and) (NNS Doc_10975596_1399_1409_Chemical)) (VP (VP (VBD displayed) (NP (NP (DT a) (JJ similar) (NN level)) (PP (IN of) (NP (JJ antiadrenergic) (NN effect))))) (CC and) (VP (VBD did) (RB not) (VP (VB impair) (NP (DT the) (JJ resting) (JJ left) (NN ventricular) (NN function))))) (. .)))
10975596	7	(ROOT (S (ADVP (RB Consequently)) (, ,) (NP (NNS Doc_10975596_1533_1544_Chemical)) (VP (MD might) (VP (VB be) (ADJP (RB particularly) (JJ suitable)) (PP (IN for) (NP (NP (DT the) (NN treatment) (CC and) (NN prevention)) (PP (IN of) (NP (JJ various) (JJ clinical) (NNS Doc_10975596_1629_1640_Disease))))) (, ,) (PP (IN without) (S (VP (VBG compromising) (NP (DT the) (JJ left) (NN ventricular) (NN function))))))) (. .)))
10985896	0	(ROOT (FRAG (NP (NP (NN Phase) (CD 2) (NN trial)) (PP (IN of) (NP (NP (NP (JJ liposomal) (NNS Doc_10985896_27_38_Chemical)) (-LRB- -LRB-) (NP (CD 40) (NN mg/m)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (-RRB- -RRB-)) (PP (IN in) (NP (NNS Doc_10985896_55_63_Chemical)))))) (: /) (NP (NP (NP (NN Doc_10985896_64_74_Chemical-refractory) (NN ovarian)) (CC and) (NP (NN fallopian) (NNS Doc_10985896_108_120_Disease))) (CC and) (NP (NP (NNS Doc_10985896_125_142_Disease)) (PP (IN of) (NP (DT the) (NN peritoneum))))) (. .)))
10985896	1	(ROOT (S (NP (JJ Several) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (S (NP (NP (JJ liposomal) (NNS Doc_10985896_218_229_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10985896_231_236_Chemical)) (-RRB- -RRB-))) (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ active) (JJ antineoplastic) (NN agent)) (PP (IN in) (NP (NN Doc_10985896_278_286_Chemical-resistant) (NNS Doc_10985896_297_311_Disease)))) (, ,) (PP (IN with) (NP (NP (NN dose)) (VP (VBG limiting) (NP (NP (NNS Doc_10985896_332_340_Disease)) (PP (IN of) (NP (NP (DT the) (JJ standard) (VBG dosing) (NN regimen)) (PRN (-LRB- -LRB-) (S (NP (NP (CD 50) (NN mg/m)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (VP (VBP q) (NP (CD 4) (NNS weeks)))) (-RRB- -RRB-))))))))))) (S (VP (VBG being) (NP (NP (JJ severe) (NN erythrodysesthesia)) (PRN (-LRB- -LRB-) (`` ``) (NP (NNP Doc_10985896_429_447_Disease)) ('' '') (-RRB- -RRB-)) (CC and) (NP (NNS Doc_10985896_454_464_Disease))))))) (. .)))
10985896	2	(ROOT (S (NP (PRP We)) (VP (VBD wished) (S (VP (TO to) (VP (VP (VB develop) (NP (DT a) (ADJP (RBR more) (JJ tolerable)) (JJ liposomal) (JJ Doc_10985896_514_525_Chemical) (NN treatment) (NN regimen))) (CC and) (VP (VB document) (NP (NP (PRP$ its) (NN level)) (PP (IN of) (NP (NN activity)))) (PP (IN in) (NP (NP (DT a) (JJ well-defined) (NN patient) (NN population)) (PP (IN with) (NP (JJ Doc_10985896_621_629_Chemical) (JJ /) (NN Doc_10985896_630_640_Chemical-refractory) (NN disease)))))))))) (. .)))
10985896	3	(ROOT (FRAG (NP (NP (NNP METHODS) (CC AND) (NNP MATERIALS)) (: :) (NP (NP (NP (NNS Patients)) (PP (IN with) (NP (NNS Doc_10985896_698_731_Disease)))) (CC or) (NP (NP (JJ primary) (JJ peritoneal) (NNS Doc_10985896_754_763_Disease)) (PP (IN with) (NP (NNS Doc_10985896_769_777_Chemical)))))) (: /) (S (NP (NP (NN Doc_10985896_778_788_Chemical-refractory) (NN disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (JJ stable) (CC or) (JJ progressive) (NN disease)) (PP (VBG following) (NP (NP (NN treatment)) (PP (IN with) (NP (DT these) (NNS agents)))))) (CC or) (NP (NP (JJ previous) (JJ objective) (NN response)) (PP (NP (QP (CD <) (CD 3)) (NNS months)) (IN in) (NP (NN duration))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (JJ liposomal) (NNS Doc_10985896_959_970_Chemical))) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 40) (NN mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (NP (QP (CD q) (CD 4)) (NNS weeks))))))))) (. .)))
10985896	4	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 49) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (JJ median) (NN age)) (: :) (NP (NP (CD 60)) (: ;) (NP (NN range) (CD 41-81)))) (-RRB- -RRB-))))) (VP (VBD entered) (NP (DT this) (NN phase) (CD 2) (NN trial))) (. .)))
10985896	5	(ROOT (S (NP (NP (DT The) (JJ median) (NN number)) (PP (IN of) (NP (JJ prior) (NNS regimens)))) (VP (VBD was) (NP (NP (CD 2)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (: :) (NP (CD 1-6))) (-RRB- -RRB-)))) (. .)))
10985896	6	(ROOT (S (NP (NP (NP (CD Six)) (PRN (-LRB- -LRB-) (NP (CD 12) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 4)) (PRN (-LRB- -LRB-) (NP (CD 8) (NN %)) (-RRB- -RRB-)))) (VP (NP (NP (NNS patients)) (SBAR (S (VP (VBD experienced) (NP (QP (CD grade) (CD 2)) (NNS Doc_10985896_1202_1220_Disease) (CC and) (NNS Doc_10985896_1225_1235_Disease)) (, ,) (ADVP (RB respectively)))))) (PRN (-LRB- -LRB-) (NP (NP (DT no) (NNS episodes)) (PP (IN of) (NP (NN grade) (CD 3)))) (-RRB- -RRB-))) (. .)))
10985896	7	(ROOT (S (NP (CD One) (NN patient)) (VP (VBD developed) (NP (NN grade) (CD 3) (NN diarrhea)) (S (VP (VBG requiring) (NP (NN hospitalization)) (PP (IN for) (NP (NN hydration)))))) (. .)))
10985896	8	(ROOT (S (NP (NP (CD Six)) (PRN (-LRB- -LRB-) (NP (CD 12) (NN %)) (-RRB- -RRB-)) (NNS individuals)) (VP (VBD required) (NP (NN dose) (NNS reductions))) (. .)))
10985896	9	(ROOT (S (NP (NP (DT The) (JJ median) (NN number)) (PP (IN of) (NP (NP (NNS courses)) (PP (IN of) (NP (NP (JJ liposomal) (NNS Doc_10985896_1446_1457_Chemical)) (VP (VBN administered) (PP (IN on) (NP (DT this) (NN protocol))))))))) (VP (VBD was) (NP (NP (CD 2)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (: :) (NP (CD 1-12))) (-RRB- -RRB-)))) (. .)))
10985896	10	(ROOT (S (NP (NP (CD Four)) (PP (IN of) (NP (NP (CD 44) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 9) (NN %)) (-RRB- -RRB-))))) (VP (VBP evaluable) (PP (IN for) (NP (NP (NN response) (JJ exhibited) (NN objective)) (CC and) (NP (NP (JJ subjective) (NN evidence)) (PP (IN of) (NP (NP (DT an) (JJ antineoplastic) (NN effect)) (PP (IN of) (NP (NN therapy))))))))) (. .)))
10985896	11	(ROOT (S (NP (DT This)) (VP (VBN modified) (NP (JJ liposomal) (JJ Doc_10985896_1677_1688_Chemical) (NN regimen) (NNS results)) (PP (IN in) (NP (NP (JJR less) (NNS Doc_10985896_1713_1721_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_10985896_1723_1733_Disease)) (, ,) (NP (NNS Doc_10985896_1735_1753_Disease))) (-RRB- -RRB-)))) (PP (IN than) (NP (DT the) (JJ standard) (JJ FDA-approved) (NN dose) (NN schedule)))) (. .)))
10985896	12	(ROOT (S (ADVP (RB Doc_10985896_1801_1809_Chemical)) (, ,) (SBAR (IN although) (S (VP (VBN limited)))) (, ,) (NP (JJ antineoplastic) (NN activity)) (VP (VBZ is) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ well-defined) (ADJP (JJ Doc_10985896_1895_1903_Chemical) (: -) (CC and) (JJ Doc_10985896_1909_1919_Chemical-refractory)) (NNS Doc_10985896_1931_1945_Disease))))))) (. .)))
10986547	0	(ROOT (NP (NP (NP (NNP Efficacy)) (PP (IN of) (NP (NP (NNS Doc_10986547_12_22_Chemical)) (PP (IN in) (NP (JJ acute) (NNS Doc_10986547_32_45_Disease)))))) (: :) (NP (DT a) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN study)) (. .)))
10986547	1	(ROOT (S (NP (DT The) (NNS Doc_10986547_93_103_Chemical)) (VP (VBZ HGGW) (NP (NNP Study) (NNP Group))) (. .)))
10986547	2	(ROOT (S (NP (PRP We)) (VP (VBD compared) (NP (NP (DT the) (NN efficacy) (CC and) (NN safety)) (PP (IN of) (NP (JJ Doc_10986547_173_183_Chemical) (NN vs) (NN placebo)))) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ acute) (NNS Doc_10986547_222_235_Disease)))))) (. .)))
10986547	3	(ROOT (NP (NP (NNP Four-week)) (, ,) (NP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ parallel) (NN study)) (. .)))
10986547	4	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 115) (NNS patients)) (PP (IN with) (NP (NP (DT a) (JJ DSM-IV) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_10986547_350_366_Disease))))))) (, ,) (ADJP (JJ Doc_10986547_368_373_Disease) (CC or) (JJ mixed)) (, ,)) (VP (VBD were) (VP (VBN randomized) (PP (TO to) (NP (NP (NP (NP (NNS Doc_10986547_403_413_Chemical)) (, ,) (NP (NP (QP (CD 5) (TO to) (CD 20))) (VP (VBN mg/d)))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 55))))) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 60))))) (-RRB- -RRB-))))))) (. .)))
10986547	5	(ROOT (S (NP (DT The) (JJ primary) (NN efficacy) (NN measure)) (VP (VBD was) (NP (DT the) (NP (NP (NNP Young-Doc_10986547_502_507_Disease) (NNP Rating) (NNP Scale)) (PRN (-LRB- -LRB-) (NP (NNP Y-MRS)) (-RRB- -RRB-))) (NN total) (NN score))) (. .)))
10986547	6	(ROOT (S (NP (NNP Response) (CC and) (NNP euthymia)) (VP (VBD were) (VP (VBN defined) (, ,) (ADVP (FW a) (FW priori)) (, ,) (PP (IN as) (NP (NP (ADVP (IN at) (JJS least)) (DT a) (ADJP (CD 50) (NN %)) (NN improvement)) (PP (IN from) (NP (NP (NN baseline)) (PP (PP (TO to) (NP (NN end) (NN point))) (CC and) (PP (IN as) (NP (NP (DT a) (NN score)) (PP (IN of) (NP (NP (QP (DT no) (JJR less) (IN than) (CD 12))) (PP (IN at) (NP (NP (NN end) (NN point)) (PP (IN in) (NP (DT the) (NNP Y-MRS) (JJ total) (NN score))))))))))))) (, ,) (ADVP (RB respectively))))) (. .)))
10986547	7	(ROOT (S (NP (NNP Safety)) (VP (VBD was) (VP (VBN assessed) (S (VP (VBG using) (NP (NP (JJ adverse) (NNS events)) (, ,) (NP (NP (NNP Extrapyramidal) (NNP Symptom)) (PRN (-LRB- -LRB-) (NP (NNP EPS)) (-RRB- -RRB-)) (NP (NN rating) (NNS scales))) (, ,) (NP (NN laboratory) (NNS values)) (, ,) (NP (NNS electrocardiograms)) (, ,) (NP (JJ vital) (NNS signs)) (, ,) (CC and) (NP (NN weight) (NN change))))))) (. .)))
10986547	8	(ROOT (S (NP (JJ Doc_10986547_898_908_Chemical-treated) (NNS patients)) (VP (VBD demonstrated) (NP (NP (DT a) (NP (NP (ADJP (RB statistically) (JJ significant)) (JJR greater) (NN mean)) (PRN (-LRB- -LRB-) (NP (NNP +) (NNP /)) (, -) (NP (NNP SD)) (-RRB- -RRB-))) (NN improvement)) (PP (IN in) (NP (NNP Y-MRS) (JJ total) (NN score)))) (PP (IN than) (NP (NP (NP (JJ placebo-treated) (NNS patients)) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD -14.8)) (JJ +)) (: /)) (: -) (FRAG (NP (NP (CD 12.5) (CC and) (CD -8.1)) (NP (NNP +) (NNP /))) (: -) (NP (NP (NP (CD 12.7)) (, ,) (ADVP (RB respectively))) (: ;) (NP (NP (NNP P) (NNP <)) (NP (CD .001)))))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBD was) (ADJP (JJ evident) (PP (IN at) (NP (NP (DT the) (JJ first) (NN postbaseline) (NN observation)) (NP (CD 1) (NN week))))) (PP (IN after) (NP (NN randomization)))) (CC and) (VP (VBD was) (VP (VBN maintained) (PP (IN throughout) (NP (NP (DT the) (NN study)) (PRN (-LRB- -LRB-) (NP (NP (JJ last) (NN observation)) (VP (VBN carried) (ADVP (RB forward)))) (-RRB- -RRB-)))))))))))) (. .)))
10986547	9	(ROOT (S (NP (JJ Doc_10986547_1269_1279_Chemical-treated) (NNS patients)) (VP (VBD demonstrated) (NP (NP (DT a) (JJR higher) (NN rate)) (PP (IN of) (NP (NP (NN response)) (PRN (-LRB- -LRB-) (NP (NP (CD 65) (NN %)) (NP (NP (NP (NN vs)) (NP (CD 43) (NN %)) (, ,) (ADVP (RB respectively))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .02)))))))) (-RRB- -RRB-)) (CC and) (NP (NN euthymia)) (PRN (-LRB- -LRB-) (NP (NP (CD 61) (NN %)) (NP (NP (NP (NN vs)) (NP (CD 36) (NN %)) (, ,) (ADVP (RB respectively))) (: ;) (NP (NP (NNP P) (NNP =) (. .)) (NP (CD 01))))) (-RRB- -RRB-))))) (PP (IN than) (NP (JJ placebo-treated) (NNS patients)))) (. .)))
10986547	10	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (ADJP (RB statistically) (JJ significant)) (NNS differences)) (PP (IN in) (NP (NP (NNP EPSs)) (PP (IN between) (NP (NNS groups))))))) (. .)))
10986547	11	(ROOT (S (ADVP (RB However)) (, ,) (NP (NN Doc_10986547_1536_1546_Chemical-treated) (NNS patients)) (VP (VP (VBD had) (NP (NP (DT a) (NP (NP (ADJP (RB statistically) (JJ significant)) (JJR greater) (NN mean)) (PRN (-LRB- -LRB-) (NP (NNP +) (NNP /)) (, -) (NP (NNP SD)) (-RRB- -RRB-))) (NN weight) (NN gain)) (PP (IN than) (NP (NP (JJ placebo-treated) (NNS patients)) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 2.1)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (NP (QP (CD 2.8) (CD vs)) (NNS 0.45)) (JJ +)) (: /)) (: -) (FRAG (NP (CD 2.3) (NN kg)) (, ,) (ADVP (RB respectively))))) (-RRB- -RRB-)))))) (CC and) (VP (ADVP (RB also)) (VBD experienced) (NP (NP (JJR more) (NNS Doc_10986547_1733_1762_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 21) (NNS patients)) (NP (ADJP (QP (CD -LSB-) (CD 38.2)) (NN %)) (JJ -RSB-) (NNP vs) (CD 5) (ADJP (QP (CD -LSB-) (CD 8.3)) (NN %)) (NNS -RSB-))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))))) (. .)))
10986547	12	(ROOT (S (NP (NNP Doc_10986547_1825_1835_Chemical)) (VP (VP (VBD demonstrated) (NP (JJR greater) (NN efficacy)) (PP (IN than) (NP (NN placebo))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ acute) (NNS Doc_10986547_1905_1918_Disease)))))) (CC and) (VP (VBD was) (ADVP (RB generally)) (ADJP (RB well) (JJ tolerated)))) (. .)))
11026989	0	(ROOT (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NNS Doc_11026989_14_28_Disease))) (PP (IN with) (NP (NP (NNS Doc_11026989_34_45_Chemical)) (PP (IN on) (NP (NN vision) (CC and) (NN driving) (NN simulator) (NN performance))))) (. .)))
11026989	1	(ROOT (S (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_11026989_124_138_Disease)) (PP (IN on) (NP (NN vision))))))))) (CC and) (S (VP (VBG driving) (NP (NN ability)))) (. .)))
11026989	2	(ROOT (S (NP (NP (DT A) (NN series)) (PP (IN of) (NP (NP (NNS tests)) (PP (IN on) (NP (NP (JJ various) (NNS parameters)) (PP (IN of) (NP (JJ visual) (NN function) (CC and) (NN driving) (NN simulator) (NN performance)))))))) (VP (VBD were) (VP (VBN performed) (PP (IN on) (NP (CD 12) (JJ healthy) (NNS drivers))) (, ,) (SBAR (IN before) (CC and) (RB after) (S (NP (NP (NNS Doc_11026989_327_341_Disease)) (VP (VBG using) (NP (NN guttae)))) (VP (VBP tropicamide) (NP (CD 1) (NN %))))))) (. .)))
11026989	3	(ROOT (S (NP (NP (DT A) (VBG driving) (NN simulator)) (PRN (-LRB- -LRB-) (NP (NNP Transport) (NNP Research) (NNP Laboratory)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (PP (TO to) (NP (NP (NN measure) (NNS Doc_11026989_443_456_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11026989_458_460_Disease)) (-RRB- -RRB-)) (, ,) (NP (NN speed) (NN maintenance)) (CC and) (NP (NN steering) (NN accuracy)))))) (. .)))
11026989	4	(ROOT (S (NP (NP (NNS Tests)) (PP (IN of) (NP (JJ basic) (JJ visual) (NN function)))) (VP (VBD included) (NP (NP (JJ high)) (: -) (CC and) (NP (NP (NP (NNS Doc_11026989_554_580_Disease)) (PRN (-LRB- -LRB-) (NP (NNP HCVA) (CC and) (NNP LCVA)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ Pelli-Robson) (NN contrast) (NN threshold)) (PRN (-LRB- -LRB-) (NP (NNP CT)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ Goldmann) (NN perimetry)) (PRN (-LRB- -LRB-) (NP (NNP FIELDS)) (-RRB- -RRB-)))))) (. .)))
11026989	5	(ROOT (S (NP (NP (NP (NNP Useful) (NNP Field)) (PP (IN of) (NP (NNP View)))) (PRN (-LRB- -LRB-) (NP (NNP UFOV)) (: --) (NP (NP (DT a) (NN test)) (PP (IN of) (NP (JJ visual) (NN attention)))) (-RRB- -RRB-))) (VP (VBD was) (VP (ADVP (RB also)) (VBN undertaken))) (. .)))
11026989	6	(ROOT (S (NP (NP (DT The) (JJ mean) (NNS differences)) (PP (IN in) (NP (DT the) (ADJP (JJ pre) (: -) (CC and) (JJ post-dilatation)) (NNS measurements)))) (VP (VBD were) (VP (VBN tested) (PP (IN for) (NP (JJ statistical) (NN significance))) (PP (IN at) (NP (NP (DT the) (ADJP (CD 95) (NN %)) (NN level)) (VP (VBG using) (NP (JJ one-tail) (JJ paired) (NNS t-tests))))))) (. .)))
11026989	7	(ROOT (S (NP (NNP Doc_11026989_909_927_Disease)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN deterioration)) (PP (IN in) (NP (NNP CT) (CC and) (NNP HCVA))))) (ADVP (RB only))) (. .)))
11026989	8	(ROOT (S (NP (NP (CD Five)) (PP (IN of) (NP (CD 12) (NNS drivers)))) (ADVP (RB also)) (VP (VBD exhibited) (NP (NN deterioration)) (PP (IN in) (NP (NNP LCVA) (, ,) (NNP CT) (CC and) (NNP Doc_11026989_1067_1069_Disease)))) (. .)))
11026989	9	(ROOT (S (NP (JJ Little) (NN evidence)) (VP (VBD emerged) (PP (IN for) (NP (NN deterioration))) (PP (IN in) (NP (NNP FIELDS) (CC and) (NNP UFOV)))) (. .)))
11026989	10	(ROOT (S (ADVP (RB Also)) (, ,) (NP (NP (CD 7)) (PP (IN of) (NP (CD 12) (NNS drivers)))) (VP (VBD appeared) (S (VP (TO to) (VP (VB adjust) (NP (PRP$ their) (VBG driving) (NN behaviour)) (PP (IN by) (S (VP (VBG reducing) (NP (PRP$ their) (NN speed)) (PP (IN on) (NP (DT the) (VBG driving) (NN simulator))))))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (JJ improved) (NN steering) (NN accuracy)))))) (. .)))
11026989	11	(ROOT (S (NP (NNP Doc_11026989_1300_1318_Disease)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (NN vision) (CC and) (NN daylight) (VBG driving) (NN performance)) (PP (IN in) (NP (JJ young) (NNS people))))))))) (. .)))
11026989	12	(ROOT (S (NP (NP (DT A) (JJR larger) (NN study)) (, ,) (PP (VBG including) (NP (NP (DT a) (JJR broader) (NN spectrum)) (PP (IN of) (NP (NNS subjects))))) (, ,)) (VP (VBZ is) (VP (VBN warranted) (SBAR (IN before) (S (NP (NNS guidelines)) (VP (MD can) (VP (VB be) (VP (VBN recommended)))))))) (. .)))
11105626	0	(ROOT (NP (NP (DT A) (NN case)) (PP (IN of) (NP (JJ Doc_11105626_10_22_Chemical) (NN embryopathy))) (PP (IN with) (NP (NNS Doc_11105626_40_56_Disease) (CC and) (NNS Taussig-Doc_11105626_69_86_Disease))) (. .)))
11105626	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (JJ newborn) (NN infant)) (PP (IN with) (NP (NP (NP (NNS Doc_11105626_120_149_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_11105626_151_157_Disease)) (CC and) (NP (NNS Taussig-Doc_11105626_170_187_Disease))) (-RRB- -RRB-))) (ADJP (JJ due) (PP (TO to) (NP (NN exposure))) (PP (TO to) (NP (NP (NNS Doc_11105626_208_220_Chemical)) (PP (IN within) (NP (DT the) (JJ first) (NN trimester)))))))))) (. .)))
11105626	2	(ROOT (S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBP aim) (S (VP (TO to) (VP (VB draw) (PP (TO to) (NP (DT the) (NN fact))) (SBAR (IN that) (S (NP (NN caution)) (VP (VBZ is) (VP (VBN needed) (SBAR (WHADVP (WRB when)) (S (VP (VBG prescribing) (NP (NN Doc_11105626_330_339_Chemical-containing) (NNS drugs)) (PP (TO to) (NP (NP (NNS women)) (PP (IN of) (NP (VBG childbearing) (NNS years)))))))))))))))) (. .)))
11135381	0	(ROOT (NP (NP (NP (NN Effect)) (PP (IN of) (NP (NP (NNS Doc_11135381_10_21_Chemical)) (PP (IN on) (NP (NP (JJ maximum) (JJ urethral) (NN pressure)) (PP (IN in) (NP (NP (NNS women)) (PP (IN with) (NP (NNS Doc_11135381_65_92_Disease)))))))))) (: :) (NP (DT a) (JJ placebo-controlled) (, ,) (JJ double-blind) (NN crossover) (NN study)) (. .)))
11135381	1	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB evaluate) (NP (DT the) (JJ potential) (NN role)) (PP (IN for) (NP (NP (DT a) (JJ selective) (JJ alpha1-adrenoceptor) (NN agonist)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_11135381_266_293_Disease))))))))))) (. .)))
11135381	2	(ROOT (S (NP (DT A) (ADJP (JJ randomised) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (, ,) (JJ crossover)) (NN study) (NN design)) (VP (VBD was) (VP (VBN employed))) (. .)))
11135381	3	(ROOT (S (NP (NN Half)) (VP (VBP log) (SBAR (S (NP (NP (NP (JJ incremental) (NNS doses)) (PP (IN of) (NP (JJ intravenous) (NNS Doc_11135381_422_433_Chemical) (CC or) (NN placebo)))) (PRN (-LRB- -LRB-) (NP (NN saline)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN administered) (PP (TO to) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NNS women))))) (PP (IN with) (NP (NP (JJ Doc_11135381_497_524_Disease) (NN while) (NN measuring) (NN maximum) (NN urethral) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP MUP)) (-RRB- -RRB-)) (, ,) (NP (NN blood) (NN pressure)) (, ,) (NP (NN heart) (NN rate)) (, ,) (CC and) (NP (JJ symptomatic) (NN side) (NNS effects))))))))) (. .)))
11135381	4	(ROOT (S (NP (NNP Doc_11135381_632_643_Chemical)) (VP (VP (VBD evoked) (NP (JJ non-significant) (NNS Doc_11135381_667_712_Disease))) (CC but) (VP (VBD caused) (NP (NP (DT a) (JJ significant) (NNS Doc_11135381_738_769_Disease) (CC and) (JJ significant) (NN fall)) (PP (IN in) (NP (NN heart) (NN rate)))) (PP (IN at) (NP (JJ maximum) (NN dosage))))) (. .)))
11135381	5	(ROOT (S (NP (NP (JJ Systemic) (NN side) (NNS effects)) (PP (VBG including) (NP (NP (NN piloerection)) (, ,) (NP (NNS Doc_11135381_870_878_Disease)) (, ,) (CC and) (NP (JJ cold) (NNS extremities))))) (VP (VBD were) (VP (VBN experienced) (PP (IN in) (NP (DT all) (NNS subjects))))) (. .)))
11135381	6	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (JJ clinical) (NN usefulness)) (PP (IN of) (NP (NP (JJ direct) (, ,) (JJ peripherally) (JJ acting) (JJ sub-type-selective) (JJ alpha1-adrenoceptor) (NNS agonists)) (PP (IN in) (NP (NP (DT the) (JJ medical) (NN treatment)) (PP (IN of) (NP (NNS Doc_11135381_1092_1111_Disease)))))))) (VP (MD may) (VP (VB be) (VP (VBN limited) (PP (IN by) (NP (JJ associated) (NN piloerection) (CC and) (JJ cardiovascular) (NN side) (NNS effects))))))))) (. .)))
1117341	0	(ROOT (S (NP (NP (JJ Doc_1117341_0_13_Disease) (NN effect)) (PP (IN of) (NP (NNS Doc_1117341_24_29_Chemical)))) (VP (VBZ compounds) (ADJP (RB structurally) (VBN related) (PP (TO to) (NP (NP (NNS Doc_1117341_64_72_Chemical)) (PP (IN in) (NP (NNS rats))))))) (. .)))
1117341	1	(ROOT (S (NP (NP (DT The) (JJ chronic) (NN feeding)) (PP (IN of) (NP (NP (NP (JJ small) (NNS amounts)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.3-3) (NN %)) (PP (IN of) (NP (NN diet) (NN weight)))) (-RRB- -RRB-))) (PP (IN of) (NP (NP (JJ certain) (JJ Doc_1117341_154_159_Chemical) (NNS derivatives)) (PP (IN of) (NP (NNS Doc_1117341_175_183_Chemical)))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NNS Doc_1117341_196_209_Disease)) (, ,) (NP (DT an) (JJ elevated) (JJ Doc_1117341_223_230_Chemical) (NN tolerance) (NN curve)) (CC and) (PRN (, ,) (ADVP (RB occasionally)) (, ,)) (NP (NNS Doc_1117341_266_276_Disease))))) (. .)))
1117341	2	(ROOT (S (NP (NNP Effective)) (VP (VBZ compounds) (PP (VBN included) (NP (NNS Doc_1117341_307_317_Chemical) (, ,) (NNS Doc_1117341_319_328_Chemical) (, ,) (NNS Doc_1117341_330_339_Chemical) (, ,) (NNS Doc_1117341_341_362_Chemical) (, ,) (NNS Doc_1117341_364_374_Chemical) (, ,) (CC and) (NNS Doc_1117341_380_387_Chemical)))) (. .)))
11176729	0	(ROOT (NP (NP (NP (NNP Toleration)) (PP (IN of) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NP (NN Doc_11176729_28_39_Chemical-converting) (NN enzyme) (NNS inhibitors)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_11176729_86_107_Disease)))))))))) (: :) (NP (NP (NNS results)) (PP (IN from) (NP (DT the) (NNP ATLAS) (NN trial)))) (. .)))
11176729	1	(ROOT (NP (NP (DT The) (NNP Assessment)) (PP (IN of) (NP (NNP Treatment))) (PP (IN with) (NP (NNP Doc_11176729_172_182_Chemical) (CC and) (NNP Survival))) (. .)))
11176729	2	(ROOT (S (S (NP (NP (NNP Treatment)) (PP (IN with) (NP (NNS Doc_11176729_224_270_Chemical)))) (VP (VBZ reduces) (NP (NN mortality) (CC and) (NN morbidity)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_11176729_320_341_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11176729_343_346_Disease)) (-RRB- -RRB-)))))))) (, ,) (CC but) (S (NP (RBS most) (JJ affected) (NNS patients)) (VP (VP (VBP are) (RB not) (VP (VBG receiving) (NP (DT these) (NNS agents)))) (CC or) (VP (VBP are) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NNS doses))) (ADVP (ADVP (RBR lower)) (SBAR (IN than) (S (NP (DT those)) (VP (VBD found) (S (VP (TO to) (VP (VB be) (NP (NP (NNS efficacious)) (PP (IN in) (NP (NNS trials)))) (, ,) (ADVP (RB primarily))))) (PP (RB because) (PP (IN of) (NP (NP (NNS concerns)) (PP (IN about) (NP (NP (DT the) (NN safety) (CC and) (NN tolerability)) (PP (IN of) (NP (DT these) (NNS agents))))))) (, ,) (RB especially) (PP (IN at) (NP (DT the) (VBN recommended) (NNS doses))))))))))))) (. .)))
11176729	3	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ examines) (NP (NP (DT the) (NN safety) (CC and) (NN tolerability)) (PP (IN of) (ADJP (JJ high)))) (: -) (PP (VBN compared) (PP (IN with) (NP (NP (JJ low-dose) (NNS Doc_11176729_696_706_Chemical)) (PP (IN in) (NP (NNS Doc_11176729_710_713_Disease))))))) (. .)))
11176729	4	(ROOT (S (NP (NP (DT The) (NNP Assessment)) (PP (IN of) (NP (NNS Doc_11176729_742_752_Chemical) (CC and) (NN Survival) (NN study)))) (VP (VBD was) (NP (NP (DT a) (JJ multicenter) (, ,) (JJ randomized) (, ,) (JJ double-blind) (NN trial)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NNS patients)) (PP (IN with) (CC or) (IN without) (NP (JJ previous) (NNP ACE) (NN inhibitor) (NN treatment)))) (VP (VBD were) (VP (VP (VBN stabilized) (S (VP (VBG receiving) (NP (NP (NP (JJ medium-dose) (NNS Doc_11176729_927_937_Chemical)) (PRN (-LRB- -LRB-) (ADVP (NP (QP (CD 12.5) (CC or) (CD 15.0)) (NN mg)) (RB once)) (NP (JJ daily) (NNP -LSB-) (NNP OD) (NNP -RSB-)) (-RRB- -RRB-))) (PP (IN for) (NP (QP (CD 2) (TO to) (CD 4)) (NNS weeks))))))) (CC and) (VP (ADVP (RB then)) (VBN randomized) (PP (TO to) (NP (ADJP (ADJP (ADJP (RB high) (JJ -)) (PRN (-LRB- -LRB-) (NP (QP (CD 35.0) (CC or) (CD 32.5)) (NN mg) (NN OD)) (-RRB- -RRB-))) (CC or) (ADJP (JJ low-dose))) (PRN (-LRB- -LRB-) (NP (NP (CD 5.0)) (CC or) (NP (CD 2.5) (NN mg) (NNP OD))) (-RRB- -RRB-)) (NNS groups)))))))))) (. .)))
11176729	5	(ROOT (S (NP (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (NP (NNP New) (NNP York) (NNP Heart) (NNP Association) (NNP classes) (NNP II)) (PP (TO to) (NP (NNP IV) (NNP Doc_11176729_1136_1139_Disease)))) (CC and) (NP (NP (JJ left) (NN ventricular) (NN ejection) (NNS fractions)) (PP (IN of) (NP (QP (DT no) (JJR greater) (IN than) (CD 0.30)))))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 3164))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN randomized)) (CC and) (VP (VBN followed) (PRT (RP up)) (PP (IN for) (NP (NP (DT a) (NN median)) (PP (IN of) (NP (CD 46) (NNS months)))))))) (. .)))
11176729	6	(ROOT (S (NP (PRP We)) (VP (VBD examined) (NP (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (JJ adverse) (NNS events)))) (CC and) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NN discontinuation) (CC and) (NN dose) (NN reduction))))) (PP (IN during) (NP (NN treatment))) (, ,) (PP (IN with) (NP (NP (DT a) (NN focus)) (PP (IN on) (NP (NNS Doc_11176729_1405_1416_Disease) (CC and) (NNS Doc_11176729_1421_1438_Disease)))))) (. .)))
11176729	7	(ROOT (S (PP (IN Of) (S (ADVP (NP (CD 405) (NNS patients)) (RB not)) (VP (ADVP (RB previously)) (VBG receiving) (NP (DT an) (NNP ACE) (NN inhibitor))))) (, ,) (NP (NP (NNS doses)) (PP (IN in) (NP (QP (RB only) (CD 4.2)) (NN %)))) (VP (MD could) (RB not) (VP (VB be) (VP (VBN titrated) (PP (TO to) (NP (NP (DT the) (JJ medium) (NNS doses)) (VP (VBN required) (PP (IN for) (NP (NN randomization))) (PP (RB because) (IN of) (NP (NP (NNS symptoms)) (VP (ADVP (RB possibly)) (VBN related) (PP (PP (TO to) (NP (NP (NNS Doc_11176729_1636_1647_Disease)) (PRN (-LRB- -LRB-) (NP (CD 2.0) (NN %)) (-RRB- -RRB-)))) (CC or) (RB because) (PP (IN of) (NP (NP (NNS Doc_11176729_1669_1686_Disease) (CC or) (NNS Doc_11176729_1690_1702_Disease)) (PRN (-LRB- -LRB-) (NP (CD 2.3) (NN %)) (-RRB- -RRB-)))))))))))))) (. .)))
11176729	8	(ROOT (S (S (NP (NP (NNS Doses)) (PP (IN in) (NP (NP (QP (JJR more) (IN than) (CD 90)) (NN %)) (PP (IN of) (NP (NP (JJ randomized) (NNS patients)) (PP (IN in) (NP (DT the) (ADJP (JJ high) (: -) (CC and) (JJ low-dose)) (NNS groups)))))))) (VP (VBD were) (VP (VBN titrated) (PP (TO to) (NP (PRP$ their) (JJ assigned) (NN target)))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ mean) (NNS doses)) (PP (IN of) (NP (NP (JJ blinded) (NN medication)) (PP (IN in) (NP (DT both) (NNS groups)))))) (VP (VBD remained) (ADJP (JJ similar)) (PP (IN throughout) (NP (DT the) (NN study))))) (. .)))
11176729	9	(ROOT (NP (NP (NP (NNS Withdrawals)) (VP (VBN occurred) (PP (IN in) (NP (NP (CD 27.1) (NN %)) (PP (IN of) (NP (DT the) (NN high))))))) (: -) (NP (NP (QP (CC and) (CD 30.7)) (NN %)) (PP (IN of) (NP (DT the) (JJ low-dose) (NNS groups)))) (. .)))
11176729	10	(ROOT (S (NP (NP (NNS Subgroups)) (VP (VBN presumed) (S (VP (TO to) (VP (VB be) (PP (IN at) (NP (NP (JJR higher) (NN risk)) (PP (IN for) (NP (NNP ACE) (NN inhibitor) (NN intolerance))))))))) (PRN (-LRB- -LRB-) (NP (NP (NN blood) (NN pressure)) (, ,) (NP (NP (NP (QP (CD <) (CD 120))) (NP (NNP mm) (NNP Hg))) (: ;) (NP (NP (NNS Doc_11176729_2101_2111_Chemical)) (, ,) (UCP (ADJP (JJ >)) (CC or) (NP (QP (CD =) (CD 132.6)) (JJ micromol/L) (NNS -LSB-)) (NP (QP (CD >) (CC or) (CD =) (CD 1.5)) (JJ mg/dL) (NNS -RSB-)))) (: ;) (NP (NP (NN age) (, ,) (NN >) (CC or) (NN =)) (NP (CD 70) (NNS years))) (: ;) (CC and) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_11176729_2194_2202_Disease)))))) (-RRB- -RRB-))) (ADVP (RB generally)) (VP (VBD tolerated) (NP (DT the) (JJ high-dose) (NN strategy))) (. .)))
11176729	11	(ROOT (S (S (NP (DT These) (NNS findings)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NNP ACE) (NN inhibitor) (NN therapy)) (PP (IN in) (NP (NP (JJS most) (NNS patients)) (PP (IN with) (NP (NNS Doc_11176729_2337_2340_Disease)))))) (VP (MD can) (VP (VB be) (VP (VP (ADVP (RB successfully)) (VBN titrated) (S (VP (TO to)))) (CC and) (VP (VBN maintained) (PP (IN at) (NP (JJ high) (NNS doses))))))))))) (, ,) (CC and) (S (NP (NP (DT that) (ADJP (RBR more) (JJ aggressive)) (NN use)) (PP (IN of) (NP (DT these) (NNS agents)))) (VP (VBZ is) (VP (VBN warranted)))) (. .)))
11229942	0	(ROOT (NP (NP (NNP Doc_11229942_0_7_Chemical)) (, ,) (NP (NNS Doc_11229942_9_16_Chemical)) (, ,) (CC and) (NP (NP (JJ Doc_11229942_22_34_Chemical) (NNS Doc_11229942_35_47_Disease)) (PP (IN in) (NP (NP (DT an) (NN animal) (NN model)) (PP (IN of) (NP (NNS Doc_11229942_70_77_Chemical) (CC and) (NNS Doc_11229942_82_89_Chemical) (NN abuse)))))) (. .)))
11229942	1	(ROOT (S (NP (NP (JJ Simultaneous) (NN abuse)) (PP (IN of) (NP (NNS Doc_11229942_131_138_Chemical) (CC and) (NNS Doc_11229942_143_150_Chemical)))) (VP (VBZ affects) (NP (QP (CD 12) (CD million)) (NNS Americans)) (ADVP (RB annually))) (. .)))
11229942	2	(ROOT (S (PP (IN In) (NP (NN combination))) (, ,) (NP (DT these) (NNS substances)) (VP (VBP are) (ADJP (ADJP (RB substantially) (RBR more) (JJ toxic)) (PP (IN than) (NP (DT either) (NN drug)))) (ADVP (RB alone))) (. .)))
11229942	3	(ROOT (S (S (NP (PRP$ Their) (JJ combined) (NNS Doc_11229942_291_307_Disease)) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ independent) (NNS effects)) (PP (IN of) (NP (DT each) (NN drug))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (PRP they)) (VP (MD may) (ADVP (RB also)) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (NP (NNS Doc_11229942_389_401_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CE)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ Doc_11229942_410_417_Chemical) (NN metabolite)) (VP (VBN formed) (ADVP (RB only)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_11229942_460_467_Chemical))))))))))))) (. .)))
11229942	4	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB delineate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNP CE)))) (PP (IN in) (NP (NP (DT the) (VBN combined) (NNS Doc_11229942_543_557_Disease)) (PP (IN of) (NP (NNS Doc_11229942_561_568_Chemical) (CC and) (NNS Doc_11229942_573_580_Chemical)))))))) (PP (IN in) (NP (NP (DT a) (NN model)) (VP (VBG simulating) (NP (PRP$ their) (NN abuse)))))) (. .)))
11229942	5	(ROOT (S (NP (JJ Twenty-three) (NNS dogs)) (VP (VBD were) (VP (VBN randomized) (S (VP (TO to) (VP (VB receive) (NP (DT either) (NP (LST (LS 1) (-RRB- -RRB-)) (NP (CD three) (JJ intravenous) (-LRB- -LRB-) (JJ IV) (-RRB- -RRB-) (NNS boluses)) (PP (IN of) (NP (NP (NP (NP (NNP Doc_11229942_714_721_Chemical) (CD 7.5)) (VP (VBG mg/kg) (PP (IN with) (NP (NP (NP (NP (NNS Doc_11229942_737_744_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN g/kg)) (-RRB- -RRB-))) (PP (IN as) (NP (DT an) (NNP IV) (NN infusion)))) (PRN (-LRB- -LRB-) (NP (NP (NNP C+E)) (, ,) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 8))))))) (-RRB- -RRB-)) (, ,) (NP (CD 2)) (-RRB- -RRB-)) (ADVP (NP (CD three) (JJ Doc_11229942_795_802_Chemical) (NNS boluses)) (RB only))))) (PRN (-LRB- -LRB-) (NP (NP (NNP C)) (, ,) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 6))))))) (-RRB- -RRB-))) (NP (, ,) (NP (CD 3)) (-RRB- -RRB-) (NNS Doc_11229942_831_838_Chemical)) (NP (NP (NN infusion) (RB only)) (PRN (-LRB- -LRB-) (NP (NP (NN E)) (, ,) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 5))))))) (-RRB- -RRB-)) (, ,)) (CC or) (NP (LST (LS 4) (-RRB- -RRB-)) (VBN placebo) (NN boluses))))) (CC and) (NP (NP (NN infusion)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 4))))) (-RRB- -RRB-))))))))) (. .)))
11229942	6	(ROOT (S (NP (NP (JJ Hemodynamic) (NNS measurements)) (, ,) (NP (NNS electrocardiograms)) (, ,) (CC and) (NP (NN serum) (NN drug) (NNS concentrations))) (VP (VBD were) (VP (VBN obtained) (PP (PP (IN at) (NP (NN baseline))) (, ,) (CC and) (RB then) (PP (IN at) (NP (JJ fixed) (NN time) (NNS intervals)))) (SBAR (IN after) (S (NP (DT each) (NN drug)) (VP (VBD was) (VP (VBN administered))))))) (. .)))
11229942	7	(ROOT (S (NP (NP (CD Two)) (PP (IN of) (NP (NP (CD eight) (NNS dogs)) (PP (IN in) (NP (DT the) (NNP C+E) (NN group)))))) (VP (VBD experienced) (NP (NNS Doc_11229942_1135_1158_Disease))) (. .)))
11229942	8	(ROOT (S (S (NP (DT The) (ADJP (RBS most) (JJ dramatic)) (JJ hemodynamic) (NNS changes)) (VP (VBD occurred) (SBAR (IN after) (S (NP (DT each) (NNS Doc_11229942_1218_1225_Chemical)) (VP (VBZ bolus) (PP (IN in) (NP (DT the) (NNP C+E) (CC and) (NNP C) (JJ only) (NNS groups)))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (JJ persistent) (JJ hemodynamic) (NNS changes)) (VP (VBD occurred) (PP (IN in) (NP (DT the) (NNP C+E) (NN group))))) (. .)))
11229942	9	(ROOT (S (NP (NNP Peak) (NNP CE) (NNS levels)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT a) (ADJP (CD 45) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP SD) (NNP +)) (: /) (NP (NP (NP (PRN (: -) (NP (NP (CD 22) (NN %)) (, ,) (NP (CD 95) (NN %)))) (NNP CI) (NNP =)) (ADJP (CD 22) (NN %))) (PP (TO to) (NP (CD 69) (NN %)))) (-RRB- -RRB-)) (NN decrease)) (PP (IN in) (NP (NP (JJ cardiac) (NN output)) (PRN (-LRB- -LRB-) (NP (NNP p) (NNP <) (NNP 0.05)) (-RRB- -RRB-))))) (, ,) (NP (NP (DT a) (ADJP (CD 56) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NNP SD) (NNP +) (NNP /)) (: -) (NP (CD 23) (NN %))) (, ,) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI) (NNP =)) (NP (QP (CD 32) (NN %) (TO to) (CD 80) (NN %))))) (-RRB- -RRB-)) (NN decrease)) (PP (IN in) (NP (NP (NP (NN dP/dt)) (PRN (-LRB- -LRB-) (NP (NN max)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD .006))) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (DT a) (ADJP (CD 23) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP SD) (NNP +)) (: /) (NP (NP (NP (PRN (: -) (NP (NP (CD 15) (NN %)) (, ,) (NP (CD 95) (NN %)))) (NNP CI) (NNP =)) (ADJP (CD 7) (NN %))) (PP (TO to) (NP (CD 49) (NN %)))) (-RRB- -RRB-)) (NN decrease)) (PP (IN in) (NP (NP (NP (NNP SVO)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP p) (NNP <) (NNP 0.025)) (-RRB- -RRB-))))))))) (. .)))
11229942	10	(ROOT (S (NP (NNP Doc_11229942_1593_1616_Disease)) (VP (VBD were) (ADVP (RB primarily)) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NNP C+E) (NN group)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (CD four)) (PP (IN of) (NP (CD eight) (NNS dogs)))) (VP (VBD experienced) (NP (NNS Doc_11229942_1699_1722_Disease))))))))) (. .)))
11229942	11	(ROOT (S (NP (NP (NNS Doc_11229942_1737_1744_Chemical) (CC and) (NNS Doc_11229942_1749_1756_Chemical)) (PP (IN in) (NP (NN combination)))) (VP (VBD were) (ADJP (RBR more) (JJ toxic) (PP (IN than) (NP (DT either) (NN substance)))) (ADVP (RB alone))) (. .)))
11229942	12	(ROOT (S (NP (NNP Co-administration)) (VP (VP (VBD resulted) (PP (IN in) (NP (JJ prolonged) (NNS Doc_11229942_1857_1873_Disease)))) (CC and) (VP (VBD was) (ADJP (JJ dysrhythmogenic)))) (. .)))
11229942	13	(ROOT (S (NP (NNP Peak) (NNP serum) (NNP Doc_11229942_1910_1922_Chemical) (NNS concentrations)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_11229942_1959_1990_Disease))))) (. .)))
11299446	0	(ROOT (NP (NP (NP (NN Worsening)) (PP (IN of) (NP (NP (NNS Doc_11299446_13_25_Disease)) (PP (IN after) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS Doc_11299446_43_54_Chemical)) (PP (IN for) (NP (NP (NN treatment)) (PP (IN of) (NP (NN menopause)))))))))))) (: :) (NP (NN case) (NN report)) (. .)))
11299446	1	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (DT a) (JJ female) (NN patient)) (PP (IN with) (NP (NP (JJ stable) (NNS Doc_11299446_137_156_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBZ has) (VP (VBN shown) (NP (NP (DT a) (JJ marked) (VBG worsening)) (PP (IN of) (NP (PRP$ her) (NN motor) (NNS functions))) (PP (VBG following) (NP (NP (NN therapy)) (PP (IN of) (NP (NP (NP (JJ menopause) (JJ related) (NNS symptoms)) (PP (IN with) (NP (NNS Doc_11299446_266_277_Chemical)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NN improvement)) (PP (IN of) (NP (NP (PRP$ her) (NNS symptoms)) (ADVP (RB back) (PP (TO to) (NP (NN baseline)))))))))))) (PP (IN after) (NP (NP (NN discontinuation)) (PP (IN of) (NP (DT the) (NN drug)))))))))))) (. .)))
11299446	2	(ROOT (S (NP (PRP We)) (VP (VB emphasize) (NP (NP (DT the) (JJ anti-dopaminergic) (NN effect)) (PP (IN of) (NP (NNS Doc_11299446_419_430_Chemical))))) (. .)))
11366874	0	(ROOT (S (VP (VB Viracept) (CC and) (VB irregular) (NP (NN heartbeat) (NN warning))) (. .)))
11366874	1	(ROOT (S (NP (NP (DT A) (NN group)) (PP (IN of) (NP (NP (NNS doctors)) (PP (IN in) (NP (NNP Boston)))))) (VP (VBP warn) (SBAR (IN that) (S (NP (DT the) (JJ protease) (NN inhibitor) (NN Viracept)) (VP (MD may) (VP (VB cause) (NP (NP (DT an) (NN irregular) (NN heart) (NN beat)) (, ,) (VP (VBN known) (PP (IN as) (NP (NNS Doc_11366874_157_168_Disease)))) (, ,) (PP (IN in) (NP (NP (NNS people)) (PP (IN with) (NP (NNP HIV))))))))))) (. .)))
11366874	2	(ROOT (S (NP (NNP Doc_11366874_190_201_Disease)) (VP (VBD occurred) (PP (IN in) (NP (NP (DT a) (JJ 45-year-old) (JJ male) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (NP (NP (NNP Viracept)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (JJ anti-HIV) (NNS drugs)))))))))))) (. .)))
11366874	3	(ROOT (S (NP (DT The) (NNS symptoms)) (VP (VBD ceased) (PP (IN after) (S (VP (VBG switching) (PP (TO to) (NP (DT another) (NN drug) (NN combination))))))) (. .)))
11380496	0	(ROOT (S (NP (NP (NNP Frequency)) (PP (IN of) (NP (NP (NN appearance)) (PP (IN of) (NP (NP (NP (JJ myeloperoxidase-antineutrophil) (JJ cytoplasmic) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NNP MPO-ANCA)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ Doc_11380496_93_108_Disease) (NNS patients)))))))) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_11380496_131_147_Chemical)) (CC and) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (JJ MPO-ANCA) (CC and) (JJ clinical) (NNS manifestations))))))) (. .)))
11380496	1	(ROOT (NP (NP (JJ Myeloperoxidase) (JJ antineutrophil) (JJ cytoplasmic) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NNP MPO-ANCA)) (-RRB- -RRB-)) (: -) (NP (NP (JJ positive) (NNS Doc_11380496_298_308_Disease)) (SBAR (S (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NNS patients))) (PP (IN with) (NP (NP (NNS Doc_11380496_344_359_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_11380496_382_398_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11380496_400_403_Chemical)) (-RRB- -RRB-)))))))))))))))) (. .)))
11380496	2	(ROOT (S (NP (NP (DT The) (NN appearance)) (PP (IN of) (NP (NP (NNP MPO-ANCA)) (PP (IN in) (NP (DT these) (NNS cases)))))) (VP (VBD was) (VP (VBN suspected) (PP (IN of) (S (VP (VBG being) (VP (VBN related) (PP (TO to) (NP (NNS Doc_11380496_482_485_Chemical))) (SBAR (IN because) (S (NP (NP (DT the) (NNS titres)) (PP (IN of) (NP (NNP MPO-ANCA)))) (VP (VBD decreased) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_11380496_532_535_Chemical)) (VP (VBD was) (VP (VBN stopped)))))))))))))) (. .)))
11380496	3	(ROOT (S (ADVP (RB Nevertheless)) (, ,) (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (DT no) (NNS studies)) (PP (IN on) (NP (NP (DT the) (JJ temporal) (NN relationship)) (PP (IN between) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NNP MPO-ANCA) (CC and) (NNP Doc_11380496_658_668_Disease)))))))) (PP (PP (IN during) (NP (JJ Doc_11380496_676_679_Chemical) (NN therapy))) (, ,) (CC or) (PP (IN on) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NNP MPO-ANCA)) (PP (IN in) (NP (JJ untreated) (JJ Doc_11380496_734_749_Disease) (NNS patients)))))))))) (. .)))
11380496	4	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD sought) (S (VP (TO to) (VP (VB address) (NP (DT these) (NNS parameters)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_11380496_826_841_Disease))))))))) (. .)))
11380496	5	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (NP (CD 102) (JJ untreated) (NNS patients)) (PP (IN with) (NP (JJ Doc_11380496_897_912_Disease) (UCP (ADJP (JJ due) (PP (TO to) (NP (NP (NNS Doc_11380496_920_935_Disease)) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNP MPO-ANCA)))))))) (, ,) (CC and) (PP (IN for) (NP (DT the) (NN development)))) (NNS Doc_11380496_990_1000_Disease))) (PP (IN after) (S (VP (VBG starting) (NP (JJ Doc_11380496_1016_1019_Chemical) (NN therapy)))))) (. .)))
11380496	6	(ROOT (S (NP (NP (NNP Twenty-nine)) (PP (IN of) (NP (PRP them)))) (VP (VBD were) (VP (ADVP (RB later)) (VBN excluded) (UCP (PP (RB because) (IN of) (NP (NP (JJ adverse) (NNS effects)) (PP (IN of) (NP (NNS Doc_11380496_1099_1102_Chemical))))) (CC or) (SBAR (IN because) (S (NP (DT the) (NN observation) (NN period)) (VP (VBD was) (NP (QP (JJR less) (IN than) (CD 3)) (NNS months)))))))) (. .)))
11380496	7	(ROOT (S (NP (NP (NP (DT The) (VBG remaining) (CD 73) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 55) (NNS women)) (CC and) (NP (CD 18) (NNS men))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (DT all) (WHPP (IN of) (WHNP (WP whom)))) (S (VP (VBD were) (VP (VBN examined) (PP (IN for) (NP (QP (JJR more) (IN than) (CD 3)) (NNS months))))))) (, ,)) (VP (VBD were) (VP (VBN adopted) (PP (IN as) (NP (NP (DT the) (NNS subjects)) (PP (IN of) (NP (DT the) (NN investigation))))))) (. .)))
11380496	8	(ROOT (S (NP (DT The) (JJ median) (NN observation) (NN period)) (VP (VBD was) (NP (NP (CD 23.6) (NNS months)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (: :) (NP (CD 3-37) (NNS months))) (-RRB- -RRB-)))) (. .)))
11380496	9	(ROOT (S (NP (NNP MPO-ANCA)) (VP (VBD was) (VP (VBN measured) (PP (IN at) (NP (NP (NNS intervals)) (PP (IN of) (NP (CD 2-6) (NNS months))))))) (. .)))
11380496	10	(ROOT (S (PP (IN Before) (NP (NN treatment))) (, ,) (NP (NP (DT the) (JJ MPO-ANCA) (NNS titres)) (PP (IN of) (NP (DT all) (CD 102) (JJ untreated) (JJ Doc_11380496_1511_1526_Disease) (NNS patients)))) (VP (VBD were) (PP (IN within) (NP (NP (DT the) (NN reference) (NN range)) (PRN (-LRB- -LRB-) (NP (ADVP (IN below) (NP (CD 10))) (NNP U/ml)) (-RRB- -RRB-))))) (. .)))
11380496	11	(ROOT (S (NP (NP (NP (CD Three)) (PRN (-LRB- -LRB-) (NP (CD 4.1) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (CD 73) (NNS patients)))) (VP (VBD were) (ADJP (JJ positive)) (PP (IN for) (NP (ADJP (JJ MPO-ANCA) (PP (IN at) (NP (CD 13) (, ,) (CD 16) (CC and) (CD 17)))) (NNS months))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN after) (NP (NP (DT the) (NN start)) (PP (IN of) (NP (JJ Doc_11380496_1702_1705_Chemical) (NN therapy)))))) (. .)))
11380496	12	(ROOT (S (PP (IN In) (NP (NP (CD two)) (PP (IN of) (NP (PRP them))))) (, ,) (S (NP (DT the) (JJ MPO-ANCA) (NNS titres)) (ADVP (RB transiently)) (VP (VBD increased) (PP (TO to) (NP (QP (CD 12.8) (CC and) (CD 15.0)) (NN U/ml))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN despite) (NP (JJ continued) (JJ Doc_11380496_1828_1831_Chemical) (NN therapy))))) (, ,) (CC but) (S (NP (DT no) (NNS Doc_11380496_1848_1868_Disease)) (VP (VBD developed))) (. .)))
11380496	13	(ROOT (S (PP (IN In) (NP (DT the) (JJ third) (NN patient))) (, ,) (S (NP (DT the) (JJ MPO-ANCA) (NN titre)) (VP (VBD increased) (PP (TO to) (NP (NNP 204) (NNP U/ml))))) (CC and) (S (S (NP (PRP she)) (VP (VBD developed) (NP (NP (DT a) (JJR higher) (NNS Doc_11380496_1970_1988_Disease)) (CC and) (NP (NNS Doc_11380496_1993_2007_Disease))))) (, ,) (CC but) (S (S (NP (DT the) (NNS symptoms)) (VP (VBN resolved) (NP (CD 2) (NNS weeks)) (PP (IN after) (S (VP (VBG stopping) (NP (JJ Doc_11380496_2058_2061_Chemical) (NN therapy))))))) (, ,) (CC and) (S (NP (DT the) (JJ MPO-ANCA) (NN titre)) (VP (VBD decreased) (PP (TO to) (NP (NNP 20.7) (NNP U/ml))) (PP (IN by) (NP (CD 4) (NNS months))) (PP (IN after) (S (VP (VBG discontinuing) (NP (NNS Doc_11380496_2149_2152_Chemical))))))))) (. .)))
11380496	14	(ROOT (S (S (NP (JJ Doc_11380496_2167_2170_Chemical) (NN therapy)) (VP (MD may) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NNP MPO-ANCA))))))))) (, ,) (CC but) (S (NP (NNP MPO-ANCA)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (ADJP (RB closely) (VBN related) (PP (TO to) (NP (NNS Doc_11380496_2279_2289_Disease)))))))))) (. .)))
11385188	0	(ROOT (NP (NP (NNP Prevalence)) (PP (IN of) (NP (NNS Doc_11385188_14_27_Disease))) (PP (IN in) (NP (JJ asymptomatic) (JJ chronic) (JJ Doc_11385188_52_59_Chemical) (NNS users))) (. .)))
11385188	1	(ROOT (S (S (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (NP (NNS Doc_11385188_98_111_Disease)) (PP (IN in) (NP (ADJP (RB outpatient) (JJ young)) (JJ asymptomatic) (JJ chronic) (JJ Doc_11385188_153_160_Chemical) (NNS users))))))))) (, ,) (NP (NP (CD 35) (JJ Doc_11385188_171_178_Chemical) (NNS users)) (CC and) (NP (CD 32) (JJ age-matched) (NNS controls))) (VP (VBD underwent) (NP (NP (JJ resting) (CC and) (NN exercise) (NN electrocardiography)) (PRN (-LRB- -LRB-) (NP (NNP ECG)) (-RRB- -RRB-)) (CC and) (NP (NNP Doppler))) (ADVP (RB echocardiography))) (. .)))
11385188	2	(ROOT (S (NP (NP (NNS Findings)) (ADJP (JJ consistent) (PP (IN with) (NP (NNS Doc_11385188_325_348_Disease))))) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (NP (NP (CD 12)) (PRN (-LRB- -LRB-) (NP (CD 34) (NN %)) (-RRB- -RRB-)) (SBAR (S (NP (NP (NNS patients)) (CC and) (NP (NP (CD 3)) (PRN (-LRB- -LRB-) (NP (CD 9) (NN %)) (-RRB- -RRB-)))) (VP (VBZ controls))))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.01))))) (-RRB- -RRB-)))))) (. .)))
11385188	3	(ROOT (S (NP (NNP Doc_11385188_416_460_Disease)) (VP (VBD was) (VP (VBN demonstrated) (PP (PP (IN in) (NP (ADJP (CD 5)) (PRN (-LRB- -LRB-) (NP (CD 14) (NN %)) (-RRB- -RRB-)) (NNS patients))) (, ,) (CC but) (PP (IN in) (NP (NP (NN none)) (PP (IN of) (NP (DT the) (NNS controls))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.055))))) (-RRB- -RRB-))))))) (. .)))
11385188	4	(ROOT (S (ADVP (RB Finally)) (, ,) (NP (JJ resting) (CC and) (NN peak)) (VP (VBP exercise) (SBAR (S (NP (NP (JJ abnormal) (JJ left) (NN ventricular)) (VP (VBG filling))) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (QP (CD 38) (CC and) (CD 35)) (NN %)) (PP (IN of) (NP (NNS patients) (RB as))))) (PP (VBN compared) (PP (TO to) (NP (NP (QP (CD 19) (CC and) (CD 9)) (NN %)) (PP (IN of) (NP (NP (NP (NNS controls)) (, ,) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.11) (CC and) (CD 0.02)))) (, ,) (S (ADJP (RB respectively)))) (-RRB- -RRB-)))))))))))) (. .)))
11385188	5	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (JJ coronary) (NN artery) (CC or) (NNS Doc_11385188_770_788_Disease)) (VP (VBZ is) (NP (NP (NP (JJ common)) (PRN (-LRB- -LRB-) (NP (CD 38) (NN %)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ young) (JJ asymptomatic) (JJ chronic) (JJ Doc_11385188_835_842_Chemical) (NNS users)))))))) (. .)))
11385188	6	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNP screening) (NNP ECG)) (CC and) (NP (NN echocardiography))) (VP (MD may) (VP (VB be) (VP (VBN warranted) (PP (IN in) (NP (DT these) (NNS patients)))))) (. .)))
11395263	0	(ROOT (NP (NP (JJ Cardioprotective) (NNS effects)) (PP (IN of) (NP (NP (NNP Picrorrhiza) (NNP kurroa)) (PP (IN against) (NP (NN Doc_11395263_55_68_Chemical-induced) (NNS Doc_11395263_77_94_Disease))))) (PP (IN in) (NP (NNS rats))) (. .)))
11395263	1	(ROOT (S (NP (NP (DT The) (JJ cardioprotective) (NN effect)) (PP (IN of) (NP (NP (NP (DT the) (JJ Doc_11395263_139_146_Chemical) (NN extract)) (PP (IN of) (NP (NNP Picrorrhiza) (NN kurroa) (NNS rhizomes)))) (CC and) (NP (NP (NP (NNS roots)) (PRN (-LRB- -LRB-) (NP (NNP PK)) (-RRB- -RRB-))) (PP (IN on) (NP (NP (NN Doc_11395263_204_217_Chemical-induced) (NNS Doc_11395263_226_247_Disease)) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (NP (NN lipid) (NN metabolism)) (PP (IN in) (NP (NN serum) (CC and) (NN heart) (NN tissue))))))))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN investigated)))) (. .)))
11395263	2	(ROOT (S (NP (NP (NP (JJ Oral) (NN pre-treatment)) (PP (IN with) (NP (NNP PK)))) (PRN (-LRB- -LRB-) (NP (NP (NP (QP (CD 80) (CD mg)) (NNP kg) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)) (NN day)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 15) (NNS days)))) (-RRB- -RRB-))) (VP (VP (ADVP (RB significantly)) (VBD prevented) (NP (DT the) (NN Doc_11395263_428_441_Chemical-induced) (NNS Doc_11395263_450_471_Disease))) (CC and) (VP (VBD maintained) (NP (DT the) (NNS rats)) (PP (IN at) (NP (JJ near) (JJ normal) (NN status))))) (. .)))
11401944	0	(ROOT (NP (NP (NP (QP (CD Phase) (CD 2)) (JJ early) (NNS afterdepolarization)) (PP (IN as) (NP (NP (DT a) (NN trigger)) (PP (IN of) (NP (NP (JJ polymorphic) (NNS Doc_11401944_62_85_Disease)) (PP (IN in) (NP (VBN acquired) (NNS Doc_11401944_98_114_Disease)))))))) (: :) (NP (NP (JJ direct) (NN evidence)) (PP (IN from) (NP (NP (NN intracellular) (NNS recordings)) (PP (IN in) (NP (DT the) (ADJP (JJ intact) (NN left)) (NN ventricular) (NN wall)))))) (. .)))
11401944	1	(ROOT (S (NP (DT This) (NN study)) (VP (VBD examined) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN phase) (CD 2) (RB early) (NN afterdepolarization))) (PRN (-LRB- -LRB-) (NP (NNP EAD)) (-RRB- -RRB-))) (PP (IN in) (S (VP (VBG producing) (NP (DT a) (NN trigger) (S (VP (TO to) (VP (VB initiate) (NP (NP (NNS Doc_11401944_319_337_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11401944_339_342_Disease)) (-RRB- -RRB-))) (PP (IN with) (NP (NP (NNS Doc_11401944_349_364_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_11401944_376_386_Chemical) (CC and) (NNS Doc_11401944_391_400_Chemical)))))))))))))) (. .)))
11401944	2	(ROOT (S (NP (NP (DT The) (NN contribution)) (PP (IN of) (NP (NP (JJ transmural) (NN dispersion)) (PP (IN of) (NP (NN repolarization) (PRN (-LRB- -LRB-) (NP (NNP TDR)) (-RRB- -RRB-)) (S (VP (TO to) (VP (VB transmural) (NP (NP (NP (NN propagation)) (PP (IN of) (NP (NNP EAD)))) (CC and) (NP (NP (DT the) (NN maintenance)) (PP (IN of) (NP (NNS Doc_11401944_524_527_Disease))))))))))))) (VP (VBD was) (VP (ADVP (RB also)) (VBN evaluated))) (. .)))
11401944	3	(ROOT (FRAG (NP (NNS METHODS) (CC AND) (NNS RESULTS)) (: :) (S (NP (NP (JJ Transmembrane) (NN action) (NNS potentials)) (PP (IN from) (NP (NNP epicardium) (, ,) (NNS Doc_11401944_618_631_Chemical) (, ,) (CC and) (NN endocardium)))) (VP (VBD were) (VP (VBN recorded) (ADVP (RB simultaneously)) (, ,) (PP (ADVP (RB together)) (IN with) (S (NP (DT a) (JJ transmural) (NN ECG)) (, ,) (PP (IN in) (NP (NP (ADJP (RB arterially) (JJ perfused)) (JJ canine)) (CC and) (NP (NP (ADJP (RB rabbit) (VBN left)) (NN ventricular) (NNS preparations)) (. .) (NP (NP (NP (JJ Doc_11401944_783_793_Chemical) (ADJP (RB preferentially) (JJ prolonged)) (NN action) (NN potential) (NN duration)) (PRN (-LRB- -LRB-) (NP (NNP APD)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNP M) (NNS cells) (NN dose-dependently)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (TO to) (CD 100)) (NNS micromol/L)) (-RRB- -RRB-)))))))) (, ,) (VP (VBG leading) (PP (TO to) (NP (NP (NNS Doc_11401944_913_928_Disease)) (CC and) (NP (DT an) (NN increase)))))) (PP (IN in) (NP (NNP TDR))))))) (. .)))
11401944	4	(ROOT (S (NP (NNP Doc_11401944_953_962_Chemical)) (, ,) (ADVP (RB however)) (, ,) (S (ADJP (RB significantly) (JJ prolonged))) (NP (NNP APD) (CC and) (NNP QT)) (VP (VBP interval) (PP (IN at) (NP (NP (NNS concentrations)) (PP (IN from) (NP (QP (CD 0.1) (TO to) (CD 10)))))) (UCP (ADJP (JJ micromol/L)) (CC but) (VP (VBN shortened) (NP (PRP them)) (PP (IN at) (NP (CD 30) (NN micromol/L)))))) (. .)))
11401944	5	(ROOT (S (PP (IN Unlike) (NP (NNS Doc_11401944_1105_1115_Chemical))) (, ,) (NP (NP (NNS Doc_11401944_1117_1126_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD >) (CD 3)) (NNS micromol/L)) (-RRB- -RRB-))) (VP (VBD increased) (ADVP (NP (JJ epicardial) (NN APD)) (RB markedly)) (, ,) (S (VP (VBG causing) (NP (DT a) (JJ diminished) (NN TDR))))) (. .)))
11401944	6	(ROOT (S (SBAR (IN Although) (S (NP (DT both) (NNS Doc_11401944_1218_1228_Chemical) (CC and) (NNS Doc_11401944_1233_1242_Chemical)) (ADVP (RB rarely)) (VP (VBN induced) (NP (NP (NNP EADs)) (PP (IN in) (NP (JJ canine) (JJ left) (NNS ventricles))))))) (, ,) (NP (PRP they)) (VP (VBD produced) (NP (JJ frequent) (NNS EADs)) (PP (IN in) (NP (NP (NNS rabbits)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (ADJP (RBR more) (JJ pronounced)) (NNS Doc_11401944_1355_1370_Disease)) (VP (VBD was) (VP (VBN seen)))))))) (. .)))
11401944	7	(ROOT (S (NP (NP (DT An) (NN increase)) (PP (IN in) (NP (NP (NNP TDR)) (PP (IN by) (NP (NNS Doc_11401944_1403_1413_Chemical)))))) (VP (VBD facilitated) (NP (NP (JJ transmural) (NN propagation)) (PP (IN of) (NP (NNP EADs))) (SBAR (WHNP (WDT that)) (S (VP (VBD initiated) (NP (NP (JJ multiple) (NNS episodes)) (PP (IN of) (NP (JJ spontaneous) (NNS Doc_11401944_1505_1508_Disease)))) (PP (IN in) (NP (NP (CD 3)) (PP (IN of) (NP (CD 6) (NN rabbit) (NN left) (NNS ventricles)))))))))) (. .)))
11401944	8	(ROOT (S (PP (IN Of) (NP (NN note))) (, ,) (SBAR (IN although) (S (NP (NP (NNS Doc_11401944_1561_1570_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 3) (TO to) (CD 10)) (NNS micromol/L)) (-RRB- -RRB-))) (VP (VBD increased) (NP (NNP APD)) (NP (QP (JJR more) (IN than) (CD Doc_11401944_1616_1626_Chemical)))))) (, ,) (NP (PRP$ its) (NNS EADs)) (ADVP (RB often)) (VP (VBD failed) (S (VP (TO to) (VP (VB propagate) (NP (NN transmurally)) (, ,) (SBAR (ADVP (RB probably)) (IN because) (FRAG (PP (IN of) (NP (DT a) (JJ diminished) (NN TDR))))))))) (. .)))
11401944	9	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ provides) (NP (DT the) (JJ first) (JJ direct) (NN evidence)) (PP (IN from) (NP (NN intracellular) (NN action) (JJ potential) (NNS recordings))) (SBAR (IN that) (S (NP (NN phase) (CD 2)) (ADVP (RB EAD)) (VP (MD can) (VP (VP (VB be) (VP (VBN generated) (PP (IN from) (NP (JJ intact) (NN ventricular) (NN wall))))) (CC and) (VP (VB produce) (NP (DT a) (NN trigger) (S (VP (TO to) (VP (VB initiate) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NNS Doc_11401944_1931_1956_Disease)))))))))))))) (. .)))
11423811	0	(ROOT (S (NP (DT A) (NN pilot)) (VP (VBP study) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN safety)) (PP (IN of) (NP (JJ Doc_11423811_38_48_Chemical) (NN stress) (NN echocardiography)))) (PP (IN in) (NP (NP (DT the) (NN emergency) (NN department) (NN evaluation)) (PP (IN of) (NP (NN Doc_11423811_115_122_Chemical-associated) (NNS Doc_11423811_134_144_Disease))))))))) (. .)))
11423811	1	(ROOT (FRAG (NP (NNP STUDY) (NNP OBJECTIVE)) (: :) (S (NP (NP (NNS Doc_11423811_163_173_Disease)) (PP (IN in) (NP (NP (DT the) (NN setting)) (PP (IN of) (NP (JJ Doc_11423811_192_199_Chemical) (NN use)))))) (VP (VBZ poses) (NP (DT a) (JJ diagnostic) (NN dilemma)))) (. .)))
11423811	2	(ROOT (S (NP (NP (JJ Doc_11423811_232_242_Chemical) (NN stress) (NN echocardiography)) (PRN (-LRB- -LRB-) (NP (NNP DSE)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB widely) (JJ available) (CC and) (JJ sensitive)) (NN test)) (PP (IN for) (S (VP (VBG evaluating) (NP (NNS Doc_11423811_329_345_Disease))))))) (. .)))
11423811	3	(ROOT (S (PP (IN Because) (IN of) (NP (NP (DT the) (JJ theoretical) (NN concern)) (PP (VBG regarding) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NNS Doc_11423811_410_420_Chemical)) (PP (IN in) (NP (NP (DT the) (NN setting)) (PP (IN of) (NP (JJ Doc_11423811_439_446_Chemical) (NN use))))))))))) (, ,) (NP (PRP we)) (VP (VBD conducted) (NP (DT a) (NN pilot) (NN study)) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN safety)) (PP (IN of) (NP (NNP DSE)))) (PP (IN in) (NP (NN emergency) (NN department) (NNS patients))) (PP (IN with) (NP (NN Doc_11423811_545_552_Chemical-associated) (NNS Doc_11423811_564_574_Disease))))))) (. .)))
11423811	4	(ROOT (S (NP (DT A) (JJ prospective) (NN case) (NN series)) (VP (VBD was) (VP (VBN conducted) (PP (IN in) (NP (NP (DT the) (JJ intensive) (NN diagnostic) (CC and) (NN treatment) (NN unit)) (PP (IN in) (NP (NP (DT the) (NNP ED)) (PP (IN of) (NP (DT an) (JJ urban) (JJ tertiary-care) (NN teaching) (NN hospital))))))))) (. .)))
11423811	5	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (ADJP (JJ eligible) (PP (IN for) (NP (NNP DSE)))) (SBAR (IN if) (S (NP (PRP they)) (VP (VP (VBD had) (VP (VBN used) (NP (NNS Doc_11423811_775_782_Chemical)) (PP (IN within) (NP (NP (CD 24) (NNS hours)) (VP (VBG preceding) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NNS Doc_11423811_822_832_Disease))))))))) (CC and) (VP (VBD had) (NP (NP (DT a) (JJ normal) (NN ECG)) (CC and) (NP (JJ Doc_11423811_858_868_Chemical) (NN level)))))))) (. .)))
11423811	6	(ROOT (S (NP (NP (NNS Patients)) (VP (VBG exhibiting) (NP (NP (NNS signs)) (PP (IN of) (NP (VBG continuing) (JJ Doc_11423811_916_923_Chemical) (NN toxicity)))))) (VP (VBD were) (VP (VBN excluded) (PP (IN from) (NP (DT the) (NN study))))) (. .)))
11423811	7	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD were) (VP (VBN admitted) (PP (TO to) (NP (NP (DT the) (NN hospital)) (PP (IN for) (NP (JJ serial) (NN testing))))) (PP (IN after) (NP (NP (DT the) (NNP DSE) (NN testing)) (PP (IN in) (NP (DT the) (JJ intensive) (NN diagnostic) (CC and) (NN treatment) (NN unit))))))) (. .)))
11423811	8	(ROOT (S (NP (NN Twenty-four) (NNS patients)) (VP (VBD were) (VP (VBN enrolled))) (. .)))
11423811	9	(ROOT (S (S (NP (CD Two) (NNS patients)) (VP (VBD had) (NP (JJ inadequate) (JJ resting) (NNS images)))) (, ,) (NP (CD one) (NN DSE)) (VP (VBD was) (VP (VBN terminated) (SBAR (IN because) (S (S (PP (IN of) (NP (JJ inferior) (NNS hypokinesis))) (, ,) (NP (DT another) (NNP DSE)) (VP (VBD was) (VP (VBN terminated) (PP (RB because) (IN of) (NP (DT a) (JJ rate-related) (JJ atrial) (NN conduction) (NN deficit)))))) (, ,) (CC and) (S (NP (CD 1) (NN patient)) (VP (VBD did) (RB not) (VP (VB reach) (NP (DT the) (NN target) (NN heart) (NN rate))))))))) (. .)))
11423811	10	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (CD 19) (NNS patients)) (VP (VP (VBD completed) (NP (DT a) (NNP DSE))) (CC and) (VP (VBD reached) (NP (PRP$ their) (NN target) (NN heart) (NNS rates)))) (. .)))
11423811	11	(ROOT (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD experienced) (NP (NP (NNS signs)) (PP (IN of) (NP (NP (JJ exaggerated) (JJ adrenergic) (NN response)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN defined) (PP (IN as) (NP (NP (DT a) (JJ systolic) (NN blood) (NN pressure)) (PP (IN of) (NP (NP (NP (QP (JJR greater) (IN than) (CD 200))) (NP (NNP mm) (NNP Hg))) (CC or) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NNS tachydysrhythmias)))))) (PRN (-LRB- -LRB-) (PP (VBG excluding) (NP (NNS Doc_11423811_1641_1658_Disease))) (-RRB- -RRB-)))))))))))) (. .)))
11423811	12	(ROOT (S (S (VP (ADVP (RB Further)) (VBG suggesting) (NP (NP (NN lack)) (PP (IN of) (NP (JJ exaggerated) (JJ adrenergic) (NN response)))))) (, ,) (NP (NP (NP (CD 13)) (PRN (-LRB- -LRB-) (NP (CD 65) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (CD 20) (NNS patients)))) (VP (VBD required) (NP (JJ supplemental) (NNS Doc_11423811_1767_1775_Chemical)) (S (VP (TO to) (VP (VB reach) (NP (PRP$ their) (NN target) (NN heart) (NNS rates)))))) (. .)))
11423811	13	(ROOT (S (NP (DT No) (ADJP (JJ exaggerated) (JJ adrenergic)) (NN response)) (VP (VBD was) (VP (VBN detected) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_11423811_1876_1886_Chemical)) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Doc_11423811_1921_1928_Chemical-related) (NNS Doc_11423811_1937_1947_Disease))))))))))) (. .)))
11425091	0	(ROOT (NP (NP (JJ Prenatal) (NNS Doc_11425091_9_16_Chemical)) (NP (NP (NN exposure)) (CC and) (NP (JJ cranial) (JJ sonographic) (NNS findings))) (PP (IN in) (NP (NN preterm) (NNS infants))) (. .)))
11425091	1	(ROOT (S (NP (JJ Prenatal) (JJ Doc_11425091_97_104_Chemical) (NN exposure)) (VP (VBZ has) (VP (VBN been) (VP (VBN linked) (PP (IN with) (NP (NP (NNS Doc_11425091_135_158_Disease)) (CC and) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (NNS cysts)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ detectable) (PP (IN on) (NP (NP (JJ cranial) (NN sonography)) (PP (IN in) (NP (NP (NNS neonates)) (VP (VBN born) (PP (IN at) (NP (NN term)))))))))))))))))))) (. .)))
11425091	2	(ROOT (S (NP (PRP We)) (VP (VBD sought) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (JJ prenatal) (JJ Doc_11425091_289_296_Chemical) (NN exposure)) (VP (VBZ increases) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_11425091_333_351_Disease)) (PP (IN in) (NP (NN preterm) (NNS infants))))))))))))) (. .)))
11425091	3	(ROOT (S (NP (PRP We)) (ADVP (RB retrospectively)) (VP (VBN reviewed) (NP (NP (DT the) (JJ medical) (NNS records)) (CC and) (NP (NP (JJ cranial) (NNS sonograms)) (VP (VBN obtained) (PP (IN during) (NP (NP (DT a) (JJ 1-year) (NN period)) (PP (IN on) (NP (ADJP (NP (CD 122)) (JJ premature)) (PRN (-LRB- -LRB-) (NP (NP (QP (CD <) (CD 36)) (NNS weeks)) (PP (IN of) (NP (NN gestation)))) (-RRB- -RRB-)) (NNS infants))))))))) (. .)))
11425091	4	(ROOT (S (S (NP (NNS Infants)) (VP (VBD were) (VP (VBN categorized) (PP (IN into) (NP (NP (CD 1)) (PP (IN of) (NP (CD 2) (NNS groups)))))))) (: :) (S (S (NP (DT those)) (VP (VBN exposed) (PP (TO to) (NP (NNS Doc_11425091_597_604_Chemical))))) (CC and) (S (NP (DT those)) (VP (RB not) (VBN exposed) (PP (TO to) (NP (NNS Doc_11425091_630_637_Chemical)))))) (. .)))
11425091	5	(ROOT (S (NP (NNS Infants)) (VP (VBD were) (VP (VBN assigned) (PP (TO to) (NP (DT the) (NN Doc_11425091_668_675_Chemical-exposed) (NN group))) (SBAR (SBAR (IN if) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ maternal) (NN history)) (PP (IN of) (NP (JJ Doc_11425091_725_732_Chemical) (NN abuse)))) (PP (IN during) (NP (NN pregnancy)))))) (CC or) (SBAR (IN if) (S (NP (ADJP (JJ maternal) (CC or) (JJ neonatal)) (JJ urine) (NN toxicology) (NNS results)) (VP (VBD were) (ADJP (JJ positive) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NN delivery)))))))))))) (. .)))
11425091	6	(ROOT (S (NP (NP (CD Five)) (PP (IN of) (NP (DT the) (CD 122) (NNS infants)))) (VP (VBD were) (VP (VBN excluded) (PP (IN from) (NP (NP (DT the) (NN study)) (PP (RB because) (IN of) (NP (JJ insufficient) (UCP (JJ medical) (CC and) (NN drug)) (NNS histories))))))) (. .)))
11425091	7	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_11425091_978_996_Disease)) (PP (IN in) (NP (DT the) (CD 117) (VBG remaining) (NNS infants)))))) (VP (VBD was) (NP (NP (CD 14) (NN %)) (PRN (-LRB- -LRB-) (NP (QP (CD 16) (IN of) (CD 117))) (-RRB- -RRB-)))) (. .)))
11425091	8	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_11425091_1064_1082_Disease)) (PP (IN in) (NP (NP (NNS infants)) (VP (VBN exposed) (PP (TO to) (NP (NNS Doc_11425091_1105_1112_Chemical))))))))) (ADVP (RB prenatally)) (VP (VBD was) (NP (NP (CD 44) (NN %)) (PRN (-LRB- -LRB-) (NP (QP (CD 8) (IN of) (CD 18))) (-RRB- -RRB-)) (PP (VBN compared) (PP (IN with) (NP (NP (NP (CD 8) (NN %)) (PRN (-LRB- -LRB-) (NP (QP (CD 8) (IN of) (CD 99))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (JJ unexposed) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP p) (NNP <) (NNP 0.01)) (-RRB- -RRB-))))))))) (. .)))
11425091	9	(ROOT (S (NP (PRP We)) (VP (VBD found) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (NP (JJ Doc_11425091_1252_1269_Disease) (NN formation)) (PP (IN in) (NP (NN preterm) (NNS infants))))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN exposed) (PP (TO to) (NP (JJ Doc_11425091_1319_1326_Chemical) (NN prenatally))))))))) (. .)))
11425091	10	(ROOT (S (NP (DT This) (NN result)) (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (NP (NNS results)) (PP (IN of) (NP (NP (JJ similar) (NNS studies)) (PP (IN in) (NP (NN term) (NNS infants))))))))) (. .)))
11439380	0	(ROOT (S (NP (NP (JJ Doc_11439380_0_11_Chemical) (NNS Doc_11439380_12_22_Disease)) (PP (IN in) (NP (NNS patients)))) (VP (VBN treated) (PP (IN for) (NP (JJ metastatic) (NNS Doc_11439380_58_73_Disease)))) (. .)))
11439380	1	(ROOT (S (NP (PRP We)) (ADVP (RB prospectively)) (VP (VBN evaluated) (S (NP (NN Doc_11439380_102_113_Chemical-induced) (NNS Doc_11439380_122_132_Disease)) (VP (VBG using) (NP (JJ electrodiagnostic) (NNS studies))))) (. .)))
11439380	2	(ROOT (S (NP (NP (JJ Sixty-seven) (NNS men)) (PP (IN with) (NP (NP (JJ metastatic) (JJ androgen-independent) (NNS Doc_11439380_219_234_Disease)) (PP (IN in) (NP (NP (DT an) (JJ open-label) (NN trial)) (PP (IN of) (NP (JJ oral) (NNS Doc_11439380_266_277_Chemical)))))))) (VP (VBD underwent) (ADVP (NP (NP (JJ neurologic) (NNS examinations) (CC and) (NN nerve) (NN conduction) (NNS studies)) (PRN (-LRB- -LRB-) (NP (NNP NCS)) (-RRB- -RRB-))) (RB prior)) (PP (TO to) (CC and) (IN at) (NP (JJ 3-month) (NNS intervals))) (PP (IN during) (NP (NN treatment)))) (. .)))
11439380	3	(ROOT (S (NP (NNP NCS)) (VP (VBD included) (NP (NP (NN recording)) (PP (IN of) (NP (NP (JJ sensory) (NN nerve) (NN action) (NNS potentials)) (PRN (-LRB- -LRB-) (NP (NNP SNAPs)) (-RRB- -RRB-))))) (PP (IN from) (NP (NN median) (, ,) (NN radial) (, ,) (NN ulnar) (, ,) (CC and) (NN sural) (NNS nerves)))) (. .)))
11439380	4	(ROOT (S (S (NP (NP (NNP SNAP) (NNS amplitudes)) (PP (IN for) (NP (DT each) (NN nerve)))) (VP (VBD were) (VP (VBN expressed) (PP (IN as) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (PRP$ its) (NN baseline)))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN mean)) (PP (IN of) (NP (DT the) (CD four)))) (VP (VBD was) (VP (VBN termed) (NP (DT the) (NNP SNAP) (NN index))))) (. .)))
11439380	5	(ROOT (S (NP (NP (DT A) (ADJP (CD 40) (NN %)) (NN decline)) (PP (IN in) (NP (DT the) (NNP SNAP) (NN index)))) (VP (VBD was) (VP (VBN considered) (S (ADJP (RB clinically) (JJ significant))))) (. .)))
11439380	6	(ROOT (S (NP (NNP Doc_11439380_715_726_Chemical)) (VP (VBD was) (VP (VBN discontinued) (PP (IN in) (NP (NP (CD 55) (NNS patients)) (PP (IN for) (NP (NP (NN lack)) (PP (IN of) (NP (JJ therapeutic) (NN response))))))))) (. .)))
11439380	7	(ROOT (S (PP (IN Of) (NP (NP (CD 67) (NNS patients)) (VP (ADVP (RB initially)) (VBN enrolled)))) (, ,) (NP (NP (NP (CD 24)) (VP (VBN remained) (PP (IN on) (NP (NP (NNS Doc_11439380_843_854_Chemical)) (PP (IN for) (NP (CD 3) (NNS months))))))) (, ,) (NP (NP (CD 8)) (VP (VBN remained) (PP (IN at) (NP (CD 6) (NNS months))))) (, ,) (CC and) (NP (CD 3))) (VP (VBD remained) (PP (IN at) (NP (CD 9) (NNS months)))) (. .)))
11439380	8	(ROOT (S (NP (CD Six) (NNS patients)) (VP (VBD developed) (NP (NNS Doc_11439380_944_954_Disease))) (. .)))
11439380	9	(ROOT (S (NP (NP (JJ Clinical) (NNS symptoms)) (CC and) (NP (NP (DT a) (NN decline)) (PP (IN in) (NP (DT the) (NNP SNAP) (NN index))))) (VP (VBD occurred) (ADVP (RB concurrently))) (. .)))
11439380	10	(ROOT (S (NP (NP (JJR Older) (NN age)) (CC and) (NP (JJ cumulative) (NN dose))) (VP (VBD were) (ADJP (JJ possible) (S (VP (VBG contributing) (NP (NNS factors)))))) (. .)))
11439380	11	(ROOT (S (NP (NNP Doc_11439380_1095_1105_Disease)) (VP (MD may) (ADVP (RB thus)) (VP (VB be) (NP (NP (DT a) (JJ common) (NN complication)) (PP (IN of) (NP (NP (NNS Doc_11439380_1143_1154_Chemical)) (PP (IN in) (NP (JJR older) (NNS patients)))))))) (. .)))
11439380	12	(ROOT (S (NP (DT The) (NNP SNAP) (NN index)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB monitor) (NP (NNS Doc_11439380_1212_1233_Disease))))) (, ,) (FRAG (CC but) (RB not) (PP (IN for) (NP (JJ early) (NN detection))))))) (. .)))
11474137	0	(ROOT (FRAG (NP (NP (NNP Overexpression)) (PP (IN of) (NP (NNS Doc_11474137_18_24_Chemical)))) (: /) (S (NP (NN Doc_11474137_25_29_Chemical-Doc_11474137_30_40_Chemical) (NN dismutase)) (VP (VBZ protects) (PP (IN from) (NP (NN Doc_11474137_65_74_Chemical-induced) (NNS Doc_11474137_83_95_Disease))))) (. .)))
11474137	1	(ROOT (S (NP (NP (DT The) (NN participation)) (PP (IN of) (NP (NP (JJ reactive) (JJ Doc_11474137_127_133_Chemical) (NNS species)) (PP (IN in) (NP (NN Doc_11474137_145_159_Chemical-induced) (NNS Doc_11474137_168_179_Disease)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN deduced) (PP (IN from) (NP (NNS observations))) (SBAR (SBAR (IN that) (S (NP (NN Doc_11474137_220_234_Chemical-Doc_11474137_235_239_Chemical) (NNS complexes)) (VP (VBP catalyze) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (JJ Doc_11474137_276_286_Chemical) (NNS radicals)) (PP (IN in) (NP (NNP vitro))))))))) (CC and) (SBAR (IN that) (S (NP (NNS antioxidants)) (VP (VBP attenuate) (NP (NP (NNS Doc_11474137_337_348_Disease)) (PP (IN in) (NP (NN vivo))))))))))) (. .)))
11474137	2	(ROOT (S (NP (PRP We)) (VP (ADVP (RB therefore)) (VBN hypothesized) (SBAR (IN that) (S (NP (NP (NN overexpression)) (PP (IN of) (NP (NP (JJ Doc_11474137_407_409_Chemical) (JJ /) (NN Doc_11474137_410_412_Chemical-Doc_11474137_413_423_Chemical) (NN dismutase)) (PRN (-LRB- -LRB-) (ADJP (JJ h-SOD1)) (-RRB- -RRB-))))) (VP (MD should) (VP (VB protect) (NP (JJ transgenic) (NNS mice)) (PP (IN from) (NP (NNS Doc_11474137_479_490_Disease)))))))) (. .)))
11474137	3	(ROOT (S (NP (NNP Immunocytochemistry)) (VP (VBD confirmed) (NP (NP (NN expression)) (PP (IN of) (NP (ADJP (JJ h-SOD1) (PP (IN in) (NP (NP (JJ inner) (NN ear) (NNS tissues)) (PP (IN of) (NP (JJ transgenic) (NN C57BL/6-TgN) (NNP -LSB-) (NNP SOD1) (NNP -RSB-)))))) (JJ 3Cje) (NNS mice))))) (. .)))
11474137	4	(ROOT (S (NP (NP (NNP Transgenic)) (CC and) (NP (JJ nontransgenic) (NNS littermates))) (VP (VBD received) (NP (NP (NNS Doc_11474137_656_665_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 400) (CD mg/kg)) (NN body) (NN weight/day)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (CD 10) (NNS days)) (VP (VBG beginning) (PP (IN on) (NP (NN day) (CD 10))) (PP (IN after) (NP (NN birth))))))) (. .)))
11474137	5	(ROOT (S (NP (JJ Auditory) (NNS thresholds)) (VP (VBD were) (VP (VBN tested) (PP (IN by) (NP (NP (JJ evoked) (NN auditory) (NN brain) (NN stem) (NNS responses)) (PP (IN at) (NP (CD 1))))) (NP (NN month)) (PP (IN after) (NP (NN birth))))) (. .)))
11474137	6	(ROOT (S (PP (IN In) (NP (JJ nontransgenic) (NNS animals))) (, ,) (NP (NP (DT the) (NN threshold)) (PP (IN in) (NP (DT the) (NN Doc_11474137_882_891_Chemical-treated) (NN group)))) (VP (VBD was) (ADJP (ADJP (NP (CD 45-50) (NNS dB)) (JJR higher)) (PP (IN than) (PP (IN in) (NP (JJ saline-injected) (NNS controls)))))) (. .)))
11474137	7	(ROOT (S (PP (IN In) (NP (DT the) (JJ transgenic) (NN group))) (, ,) (NP (NNS Doc_11474137_985_994_Chemical)) (VP (VBD increased) (NP (DT the) (NN threshold)) (PP (IN by) (NP (QP (RB only) (CD 15)) (NN dB))) (PP (IN over) (NP (DT the) (JJ respective) (NNS controls)))) (. .)))
11474137	8	(ROOT (S (NP (DT The) (NNS effects)) (VP (VBD were) (NP (ADJP (JJ similar) (PP (IN at) (NP (CD 12) (CC and) (CD 24)))) (NN kHz))) (. .)))
11474137	9	(ROOT (S (NP (NP (DT The) (NN protection)) (PP (IN by) (NP (NP (NN overexpression)) (PP (IN of) (NP (JJ Doc_11474137_1142_1152_Chemical) (NN dismutase)))))) (VP (VBZ supports) (NP (DT the) (NNS hypothesis)) (SBAR (IN that) (S (NP (NN oxidant) (NN stress)) (VP (VBZ plays) (NP (NP (DT a) (JJ significant) (NN role)) (PP (IN in) (NP (NN Doc_11474137_1235_1249_Chemical-induced) (NNS Doc_11474137_1258_1269_Disease)))))))) (. .)))
11474137	10	(ROOT (S (NP (DT The) (NNS results)) (ADVP (RB also)) (VP (VBP suggest) (NP (JJ transgenic) (NNS animals)) (PP (IN as) (NP (JJ suitable) (NNS models))) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (VBG underlying) (NNS mechanisms)) (CC and) (NP (NP (JJ possible) (NNS strategies)) (PP (IN for) (NP (NN prevention))))))))) (. .)))
1158089	0	(ROOT (S (NP (NNP Doc_1158089_0_11_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_1158089_23_35_Chemical)) (PP (IN in) (NP (DT the) (NN rat)))))) (. .)))
1158089	1	(ROOT (NP (NP (JJ Dose-response) (NNS relationships) (CC and) (NN effect)) (PP (IN of) (NP (NN sex))) (. .)))
1158089	2	(ROOT (S (NP (NP (JJ Dose-response) (NNS relationships)) (, ,) (NP (JJ biochemical) (NNS mechanisms)) (, ,) (CC and) (NP (NP (NN sex) (NNS differences)) (PP (IN in) (NP (NP (DT the) (JJ experimental) (NNS Doc_1158089_188_199_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_1158089_211_223_Chemical)))))))) (VP (VBD were) (VP (VBN studied) (PP (PP (IN in) (NP (DT the) (JJ intact) (NN rat))) (CC and) (PP (IN with) (NP (NP (DT the) (VBN isolated) (JJ perfused) (NN rat) (NN liver)) (PP (IN in) (NP (NNP vitro)))))))) (. .)))
1158089	3	(ROOT (S (PP (IN In) (NP (DT the) (ADJP (ADJP (JJ intact) (NN male)) (CC and) (ADJP (JJ female))) (NN rat))) (, ,) (NP (DT no) (JJ direct) (NN relationship)) (VP (VBD was) (VP (VBN observed) (PP (IN between) (NP (NP (NP (NN dose)) (PP (IN of) (NP (NNS Doc_1158089_393_405_Chemical)))) (CC and) (NP (NP (JJ hepatic) (NN accumulation)) (PP (IN of) (NP (NNS Doc_1158089_434_446_Chemical)))))))) (. .)))
1158089	4	(ROOT (S (PP (IN With) (NP (NP (NN provision)) (PP (IN of) (NP (NP (JJ adequate) (NNS Doc_1158089_475_485_Chemical)) (PP (IN as) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (DT the) (JJ isolated) (JJ perfused) (NN liver))))))))) (, ,) (NP (DT a) (JJ direct) (NN relationship)) (VP (VBD was) (VP (VBN observed) (PP (IN between) (NP (NP (NP (NN dose)) (PP (IN of) (NP (NNS Doc_1158089_585_597_Chemical)))) (CC and) (NP (NP (DT both) (NN accumulation)) (PP (IN of) (NP (NP (NP (NNS Doc_1158089_623_635_Chemical)) (PP (IN in) (NP (DT the) (NN liver)))) (CC and) (NP (NP (NNS Doc_1158089_653_663_Disease)) (PP (IN of) (NP (NP (NN output)) (PP (IN of) (NP (NNS Doc_1158089_677_689_Chemical))))))))))) (PP (IN by) (NP (NP (NNS livers)) (PP (IN from) (NP (JJ male) (CC and) (JJ female) (NNS rats))))))) (. .)))
1158089	5	(ROOT (S (NP (JJ Marked) (NNS differences)) (VP (VBD were) (VP (VBN observed) (PP (IN between) (NP (JJ female) (CC and) (JJ male) (NNS rats))) (PP (IN with) (NP (NN regard))) (PP (TO to) (NP (NP (JJ base) (NN line) (-LRB- -LRB-) (NN control) (-RRB- -RRB-) (JJ hepatic) (NN concentration)) (PP (IN of) (NP (NNS Doc_1158089_849_861_Chemical) (CC and) (NN output))) (PP (IN of) (NP (NNS Doc_1158089_876_888_Chemical))))))) (. .)))
1158089	6	(ROOT (S (NP (NP (NNP Accumulation)) (PP (IN of) (NP (JJ hepatic) (NNS Doc_1158089_914_926_Chemical))) (, ,) (PP (IN as) (NP (NP (DT a) (ADJP (IN per)) (NN cent)) (PP (IN of) (NP (NN control) (NNS values))) (, ,) (PP (IN in) (NP (NN response) (S (VP (TO to) (VP (VB graded) (NP (NP (NNS doses)) (PP (IN of) (NP (NNS Doc_1158089_992_1004_Chemical))))))))))) (, ,)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PP (IN between) (NP (ADJP (NN male) (, ,) (JJ female) (CC and) (JJ pregnant)) (NN rat) (NNS livers))))) (. .)))
1158089	7	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (NP (NNS livers)) (PP (IN from) (NP (NN female)))) (, ,) (CC and) (NP (ADJP (RB especially) (JJ pregnant)) (JJ female) (NNS rats)) (, ,)) (VP (VBD were) (ADJP (RB strikingly) (JJ resistant) (PP (TO to) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_1158089_1191_1203_Chemical)) (PP (IN on) (NP (NP (NNS Doc_1158089_1207_1217_Disease)) (PP (IN of) (NP (NP (NN output)) (PP (IN of) (NP (NNS Doc_1158089_1231_1243_Chemical)))))))))))) (PP (IN under) (NP (DT these) (JJ experimental) (NNS conditions)))) (. .)))
1158089	8	(ROOT (S (NP (NP (DT These) (NNS differences)) (PP (IN between) (NP (DT the) (NNS sexes)))) (VP (MD could) (RB not) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (NP (NP (VBN altered) (NN disposition)) (PP (IN of) (NP (NNS Doc_1158089_1364_1376_Chemical)))) (CC or) (NP (NP (VBN altered) (NN uptake)) (PP (IN of) (NP (NNS Doc_1158089_1398_1408_Chemical))))))))) (. .)))
1158089	9	(ROOT (S (NP (NP (JJ Depressed) (JJ hepatic) (NN secretion)) (PP (IN of) (NP (NNS Doc_1158089_1441_1453_Chemical)))) (VP (VBD accounted) (ADVP (RB only)) (PP (IN for) (NP (CD 30))) (PP (TO to) (NP (NP (CD 50) (NN %)) (PP (IN of) (NP (VBN accumulated) (JJ hepatic) (NNS Doc_1158089_1506_1518_Chemical))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (JJ additional) (NNS mechanisms)) (VP (MD must) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (DT the) (NN Doc_1158089_1600_1612_Chemical-rich) (NNS Doc_1158089_1618_1629_Disease)) (PP (IN in) (NP (NN response))))))) (PP (TO to) (NP (NNS Doc_1158089_1645_1657_Chemical))))))))))) (. .)))
11708428	0	(ROOT (S (NP (NNP Doc_11708428_0_10_Chemical)) (VP (VBZ induces) (NP (NP (NNS Doc_11708428_19_26_Disease)) (CC and) (NP (NP (JJ glial) (JJ cerebral) (NNS changes)) (PP (IN in) (NP (NNS rats)))))) (. .)))
11708428	1	(ROOT (S (VP (TO To) (VP (VB assess) (SBAR (IN whether) (S (NP (NP (NNS Doc_11708428_92_102_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11708428_104_107_Chemical)) (-RRB- -RRB-))) (VP (VP (VBZ produces) (NP (NNS Doc_11708428_118_125_Disease))) (CC and/or) (VP (VBD cerebral) (NP (JJ glial) (NNS changes)) (PP (IN in) (NP (NNS rats))))))))) (. .)))
11708428	2	(ROOT (S (S (NP (NNP Male) (NNP Wistar) (NNS rats)) (VP (VBD were) (VP (VBN studied)))) (CC and) (S (NP (CD 3) (NNS groups)) (VP (VBD were) (VP (VBN formed) (PRN (-LRB- -LRB-) (NP (NP (CD 8) (NNS rats)) (PP (IN per) (NP (NN group)))) (-RRB- -RRB-))))) (. .)))
11708428	3	(ROOT (S (NP (DT The) (JJ moderate-dose) (NN group)) (VP (VBD received) (NP (NP (CD 5) (JJ mg/kg/day) (NNS Doc_11708428_294_297_Chemical)) (VP (VBN released) (PP (IN from) (NP (DT a) (JJ subcutaneous) (NN implant)))))) (. .)))
11708428	4	(ROOT (S (PP (IN In) (NP (DT the) (JJ high-dose) (NN group))) (, ,) (NP (NP (NNS implants)) (VP (VBG containing) (NP (JJ Doc_11708428_380_383_Chemical) (NN equivalent)) (PP (TO to) (NP (CD 60))))) (ADVP (RB mg/kg/day)) (VP (VBD were) (VP (VBN applied))) (. .)))
11708428	5	(ROOT (S (PP (IN In) (NP (DT the) (NN control))) (NP (NN group) (NNS implants)) (VP (VBD contained) (NP (DT no) (NNS Doc_11708428_468_471_Chemical))) (. .)))
11708428	6	(ROOT (S (NP (NNP Doc_11708428_473_480_Disease)) (VP (VBD was) (VP (VBN assessed) (S (VP (VBG using) (NP (NP (DT an) (JJ open) (NN field)) (CC and) (NP (JJ elevated) (JJ plus-maze) (NNS devices))))))) (. .)))
11708428	7	(ROOT (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NP (NNS cells)) (CC and) (NP (NP (JJ cytoplasmic) (NN transformation)) (PP (IN of) (NP (NNS astrocytes) (CC and) (NN microglia) (NNS cells))))))) (VP (VBD were) (VP (VBN assessed) (PP (IN by) (NP (JJ immunohistochemical) (NNS analyses))))) (. .)))
11708428	8	(ROOT (S (NP (NNP Doc_11708428_687_694_Disease)) (VP (VBD was) (VP (VBN documented) (PP (IN in) (NP (NP (DT both) (NNS groups)) (PP (IN of) (NP (NP (NNS Doc_11708428_728_731_Chemical)) (VP (VBN treated) (NP (NNS rats)) (PP (VBN compared) (PP (IN with) (NP (NNS controls))))))))))) (. .)))
11708428	9	(ROOT (S (NP (NP (DT The) (NN magnitude)) (PP (IN of) (NP (NP (NN transformation)) (PP (IN of) (NP (NP (DT the) (NN microglia)) (VP (VBN assessed) (PP (IN by) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS intersections))))))))))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR higher) (PP (IN in) (ADVP (NP (DT the) (JJ Doc_11708428_890_893_Chemical) (NNS groups)) (IN than)))) (PP (PP (IN in) (NP (NP (NNS controls)) (PP (IN in) (NP (NP (NP (DT the) (JJ prefrontal) (NN cortex)) (-LRB- -LRB-) (NP (NP (NP (NN moderate-dose)) (, ,) (NP (CD 24.1))) (: ;) (NP (NP (NN high-dose)) (, ,) (NP (CD 23.6))) (: ;) (NP (NP (NNS controls)) (NP (CD 18.7))) (: ;) (NP (NP (NN p) (NNS <)) (NP (CD 0.01)))) (-RRB- -RRB-)) (CC and) (NP (NP (NN striatum)) (PRN (-LRB- -LRB-) (NP (NP (JJ moderate-dose) (NNS 25.6)) (: ;) (NP (NP (JJ high-dose) (NNS 26.3)) (: ;) (NP (NP (QP (CD controls) (CD 18.9))) (: ;) (NP (NP (NN p) (NNS <)) (NP (CD 0.01)))))) (-RRB- -RRB-))))))) (, ,) (CC but) (RB not) (PP (IN in) (NP (NNS hippocampus)))))) (. .)))
11708428	10	(ROOT (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (JJ stained) (NN microglia) (NNS cells)))) (VP (VBD was) (ADJP (RB significantly) (JJR higher)) (PP (IN in) (NP (NP (DT the) (NNS Doc_11708428_1177_1180_Chemical)) (VP (VBN treated) (NP (NP (NNS groups)) (PP (IN in) (NP (DT the) (JJ prefrontal) (NN cortex)))) (PP (IN than) (PP (IN in) (NP (NP (NNS controls)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NN moderate-dose)) (, ,) (NP (NNP 29.1))) (: ;) (NP (NP (NN high-dose)) (, ,) (NP (NNP 28.4))) (: ;) (NP (NP (NN control)) (, ,) (NP (NP (JJ 17.7) (NNS cells)) (PP (IN per) (NP (NN field))))) (: ;) (NP (NP (NN p)) (NP (NNP <)))) (NP (CD 0.01))) (-RRB- -RRB-))))))))) (. .)))
11708428	11	(ROOT (S (NP (JJ Stained) (NN microglia) (NNS cells)) (VP (VBD were) (ADVP (RB significantly)) (NP (JJR more) (JJ numerous) (NN striatum) (CC and) (NNS hippocampus)) (PP (IN in) (NP (NP (DT the) (JJ high-dose) (NN group)) (PP (VBN compared) (PP (TO to) (NP (NNS controls))))))) (. .)))
11708428	12	(ROOT (S (NP (NP (JJ Subacute) (NN exposure)) (PP (TO to) (NP (NNS Doc_11708428_1479_1482_Chemical)))) (VP (VBN induced) (NP (NP (NNS Doc_11708428_1491_1498_Disease) (CC and) (NNS reactivity)) (PP (IN of) (NP (NN microglia))))) (. .)))
11708428	13	(ROOT (S (NP (NP (DT The) (NN relevance)) (PP (IN of) (NP (NP (DT these) (NNS features)) (PP (IN for) (NP (NP (NNS patients)) (VP (VBG using) (NP (NNS Doc_11708428_1579_1582_Chemical)))))))) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN elucidated)))))) (. .)))
11745287	0	(ROOT (S (NP (NNP Phase) (NNP II)) (VP (VBP study) (PP (IN of) (NP (JJ Doc_11745287_18_29_Chemical) (CC and) (JJ liposomal) (NNS Doc_11745287_44_55_Chemical))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ recurrent) (NNS Doc_11745287_83_120_Disease)))))) (. .)))
11745287	1	(ROOT (S (NP (NP (DT The) (NN activity)) (PP (IN of) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (JJ Doc_11745287_169_180_Chemical) (CC and) (JJ liposomal) (NNS Doc_11745287_195_206_Chemical)))))) (VP (VBD was) (VP (VBN tested) (PP (IN in) (NP (NP (DT a) (NNP Phase) (NNP II) (NN study)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ recurrent) (JJ cervical) (NNS Doc_11745287_274_283_Disease))))))))) (. .)))
11745287	2	(ROOT (S (NP (NP (DT The) (NN combination)) (PP (IN of) (NP (NP (NNS Doc_11745287_313_324_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NN area)) (PP (IN under) (NP (DT the) (NN concentration) (NN curve))) (ADJP (JJ -LSB-) (NP (NNP AUC) (CD -RSB-) (, ,) (CD 5)))) (-RRB- -RRB-)) (CC and) (NP (JJ liposomal) (NNS Doc_11745287_385_396_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_11745287_398_403_Chemical)) (: ;) (NP (NP (JJ starting) (NN dose)) (, ,) (NP (CD 40) (NN mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN administered) (ADVP (RB intravenously)) (NP (DT every) (CD 28) (NNS days)) (PP (TO to) (NP (CD 37) (NNS patients))) (PP (IN with) (NP (JJ recurrent) (NNS Doc_11745287_507_539_Disease))) (S (VP (TO to) (VP (VB determine) (NP (NP (NN antitumor) (NN activity)) (CC and) (NP (JJ Doc_11745287_576_584_Disease) (NN profile)))))))) (. .)))
11745287	3	(ROOT (S (S (NP (JJ Twenty-nine) (NNS patients)) (VP (VBD were) (ADJP (JJ assessable) (PP (IN for) (NP (NN response)))))) (, ,) (CC and) (S (NP (CD 35) (NNS patients)) (VP (VBD were) (ADJP (JJ assessable) (PP (IN for) (NP (NNS Doc_11745287_690_698_Disease)))))) (. .)))
11745287	4	(ROOT (S (S (NP (DT The) (JJ overall) (NN response) (NN rate)) (VP (VBD was) (NP (CD 38) (NN %)))) (, ,) (S (NP (NP (DT the) (JJ median) (NN time)) (PP (TO to) (NP (NN response)))) (VP (VBD was) (NP (CD 10) (NNS weeks)))) (, ,) (S (NP (NP (DT the) (JJ median) (NN duration)) (PP (IN of) (NP (NN response)))) (VP (VBD was) (NP (CD 26) (NNS weeks)))) (, ,) (CC and) (S (NP (DT the) (JJ median) (NN survival)) (VP (VBD was) (NP (CD 37) (NNS weeks)))) (. .)))
11745287	5	(ROOT (S (NP (DT The) (JJ main) (JJ toxic) (NN effect)) (VP (VBD was) (NP (NP (NP (NN myelosuppression)) (, ,) (PP (IN with) (NP (NNP Grade) (CD 3)))) (CC and) (NP (NP (CD 4) (NNS Doc_11745287_924_935_Disease)) (PP (IN in) (NP (CD 16) (NNS patients)))) (, ,) (NP (NP (NNS Doc_11745287_952_958_Disease)) (PP (IN in) (NP (CD 12) (NNS patients)))) (, ,) (NP (NP (NNS Doc_11745287_975_991_Disease)) (PP (IN in) (NP (CD 11) (NNS patients)))) (, ,) (CC and) (NP (NP (NNS Doc_11745287_1012_1029_Disease)) (PP (IN in) (NP (CD 3) (NNS patients)))))) (. .)))
11745287	6	(ROOT (S (NP (CD Four) (NNS patients)) (VP (VBD had) (NP (NP (CD five) (JJ infusion-related) (NNS reactions)) (PP (IN during) (NP (NP (DT the) (NN infusion)) (PP (IN of) (NP (JJ liposomal) (NNS Doc_11745287_1128_1139_Chemical)))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (NN treatment) (NN discontinuation)) (PP (IN in) (NP (CD three) (NNS patients)))))))) (. .)))
11745287	7	(ROOT (S (NP (NP (NNP Grade) (NNP >)) (CC or) (NP (QP (CD =) (CD 2)) (JJ nonhematologic) (NNS Doc_11745287_1227_1235_Disease))) (VP (VBD included) (NP (NP (NP (NNS Doc_11745287_1245_1251_Disease)) (PP (IN in) (NP (CD 17) (NNS patients)))) (, ,) (NP (NP (NNS emesis)) (PP (IN in) (NP (CD 14) (NNS patients)))) (, ,) (NP (NP (NN fatigue)) (PP (IN in) (NP (CD 9) (NNS patients)))) (, ,) (NP (NP (JJ Doc_11745287_1314_1323_Disease) (JJ and/or) (NNS Doc_11745287_1331_1341_Disease)) (PP (IN in) (NP (CD 8) (NNS patients)))) (, ,) (NP (NP (NNS Doc_11745287_1357_1369_Disease)) (PP (IN in) (NP (CD 6) (NNS patients)))) (, ,) (NP (NP (NNS Doc_11745287_1385_1396_Disease)) (PP (IN in) (NP (CD 5) (NNS patients)))) (, ,) (NP (NP (NNS Doc_11745287_1412_1430_Disease)) (PP (IN in) (NP (CD 2) (NNS patients)))) (, ,) (CC and) (NP (NP (NN skin) (NNS reactions)) (PP (IN in) (NP (CD 3) (NNS patients)))))) (. .)))
11745287	8	(ROOT (S (NP (NP (DT The) (NN combination)) (PP (IN of) (NP (JJ Doc_11745287_1512_1523_Chemical) (CC and) (JJ liposomal) (NNS Doc_11745287_1538_1549_Chemical)))) (VP (VBZ has) (NP (NP (JJ modest) (NN activity)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ recurrent) (JJ cervical) (NNS Doc_11745287_1606_1615_Disease))))))) (. .)))
11799346	0	(ROOT (NP (NP (JJ Antimicrobial-induced) (NNS Doc_11799346_22_27_Disease)) (PRN (-LRB- -LRB-) (NP (NNP antibiomania)) (-RRB- -RRB-)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (JJ spontaneous) (NNS reports)))) (. .)))
11799346	1	(ROOT (S (NP (NP (DT The) (NNS authors)) (VP (VBN reviewed))) (VP (VBD reported) (NP (NP (NNS cases)) (PP (IN of) (NP (JJ antibiotic-induced) (JJ Doc_11799346_135_140_Disease) (NNS episodes)))) (PP (IN by) (NP (NP (NNS means)) (PP (IN of) (NP (NP (DT a) (NN MEDLINE) (CC and) (NN PsychLit) (NN search)) (PP (IN for) (NP (NP (NNS reports)) (PP (IN of) (NP (JJ antibiotic-induced) (NNS Doc_11799346_226_231_Disease)))))))))) (. .)))
11799346	2	(ROOT (S (NP (JJ Unpublished) (NNS reports)) (VP (VBD were) (VP (VBN requested) (PP (IN from) (NP (NP (DT the) (NNP World) (NNP Health) (NNP Organization)) (PRN (-LRB- -LRB-) (NP (NNP WHO)) (-RRB- -RRB-)) (CC and) (NP (DT the) (NNP Food) (CC and) (NNP Drug) (NNP Administration)) (PRN (-LRB- -LRB-) (NP (NNP FDA)) (-RRB- -RRB-)))))) (. .)))
11799346	3	(ROOT (S (NP (NP (CD Twenty-one) (NNS reports)) (PP (IN of) (NP (JJ antimicrobial-induced) (NNS Doc_11799346_397_402_Disease)))) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (DT the) (NN literature))))) (. .)))
11799346	4	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (CD 6) (NNS cases)) (VP (VBG implicating) (NP (NP (NNS Doc_11799346_464_478_Chemical)) (, ,) (NP (CD 13) (JJ implicating) (NNS Doc_11799346_495_504_Chemical)) (, ,) (CC and) (NP (NP (CD 1) (NN case)) (NP (DT each)))) (S (VP (VBG implicating) (NP (NNS Doc_11799346_534_546_Chemical) (CC and) (NNS Doc_11799346_551_562_Chemical))))))) (. .)))
11799346	5	(ROOT (S (NP (DT The) (NN WHO)) (VP (VBD reported) (NP (CD 82) (NNS cases))) (. .)))
11799346	6	(ROOT (S (PP (IN Of) (NP (DT these))) (, ,) (NP (NNS Doc_11799346_601_615_Chemical)) (VP (VBD was) (VP (VBN implicated) (PP (IN in) (NP (NP (NP (CD 23)) (PRN (-LRB- -LRB-) (NP (CD 27.6) (NN %)) (-RRB- -RRB-)) (NP (NNS cases))) (, ,) (NP (NP (NNS Doc_11799346_652_665_Chemical)) (PP (IN in) (NP (ADJP (CD 12)) (PRN (-LRB- -LRB-) (NP (CD 14.4) (NN %)) (-RRB- -RRB-)) (NNS cases)))) (, ,) (CC and) (NP (NP (NNS Doc_11799346_691_700_Chemical)) (PP (IN in) (NP (ADJP (CD 10)) (PRN (-LRB- -LRB-) (NP (CD 12) (NN %)) (-RRB- -RRB-)) (NNS cases)))))))) (. .)))
11799346	7	(ROOT (S (NP (NNP Doc_11799346_720_733_Chemical) (, ,) (NNP Doc_11799346_735_748_Chemical) (, ,) (CC and) (NNP Doc_11799346_754_766_Chemical)) (VP (VBD were) (VP (VBN involved) (PP (IN in) (NP (CD 15) (JJ reported) (JJ Doc_11799346_796_801_Disease) (NNS episodes))))) (. .)))
11799346	8	(ROOT (S (NP (NP (NNS Cases)) (VP (VBN reported) (PP (IN by) (NP (DT the) (NNP FDA))))) (VP (VBD showed) (NP (NNS Doc_11799346_845_859_Chemical) (CC and) (NNS Doc_11799346_864_877_Chemical)) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJS most)) (VP (ADVP (RB frequently)) (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_11799346_939_944_Disease))))))))))) (. .)))
11799346	9	(ROOT (S (NP (NP (NNP Statistical) (NN analysis)) (PP (IN of) (NP (DT the) (NNS data)))) (VP (VP (MD would) (RB not) (VP (VB have) (VP (VBN demonstrated) (NP (DT a) (JJ significant) (JJ statistical) (NN correlative) (NN risk))))) (CC and) (VP (VBD was) (ADVP (RB therefore)) (VP (RB not) (VBN undertaken)))) (. .)))
11799346	10	(ROOT (S (NP (NNS Patients)) (VP (VBP have) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (VBG developing) (NNS Doc_11799346_1130_1135_Disease)))) (SBAR (IN while) (S (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NNS antimicrobials)))))))) (. .)))
11799346	11	(ROOT (S (SBAR (IN Although) (S (NP (DT this)) (VP (VBZ is) (RB not) (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN risk))))) (, ,) (NP (NNS physicians)) (VP (MD must) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (DT the) (NN effect) (CC and) (NN reversibility)))))) (. .)))
11799346	12	(ROOT (S (NP (JJ Further) (NN research)) (ADVP (RB clearly)) (VP (VBZ is) (VP (VBN required) (S (VP (TO to) (VP (VB determine) (NP (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ antimicrobial-induced) (NNS Doc_11799346_1379_1384_Disease)))) (, ,) (NP (NP (DT the) (JJ relative) (NN risk) (NNS factors)) (PP (IN of) (S (VP (VBG developing) (NP (DT an) (JJ antimicrobial-induced) (NNS Doc_11799346_1451_1464_Disease)) (PP (IN among) (NP (JJ various) (JJ demographic) (NNS populations))))))) (, ,) (CC and) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP continue) (S (VP (TO to) (VP (VB have) (NP (JJ persistent) (NNS Doc_11799346_1566_1585_Disease)) (SBAR (IN once) (S (NP (NP (DT the) (JJ initial) (NN episode)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ occurs) (SBAR (IN while) (S (NP (DT the) (NN patient)) (VP (VBZ is) (VP (VBG taking) (NP (NNS antibiotics))))))))) (, ,)) (VP (VBZ subsides))))))))))))))))))) (. .)))
11799346	13	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBD elected) (S (VP (TO to) (VP (VB name) (S (NP (DT this) (NN syndrome)) (`` ``) (ADJP (JJ antibiomania))))))) (. .) ('' '')))
11835460	0	(ROOT (NP (NP (JJ Doc_11835460_0_8_Chemical-induced) (NNS Doc_11835460_17_35_Disease)) (PP (IN in) (NP (NNS Doc_11835460_39_58_Disease))) (. .)))
11835460	1	(ROOT (S (NP (JJ Doc_11835460_60_68_Chemical-induced) (NNS Doc_11835460_77_95_Disease)) (VP (VBP are) (ADJP (RB very) (JJ uncommon))) (. .)))
11835460	2	(ROOT (S (ADVP (RB Usually)) (NP (PRP they)) (VP (VBP occur) (ADVP (RB simultaneously)) (PP (IN with) (NP (CD limb) (JJ peak-dose) (JJ choreatic) (NNS Doc_11835460_179_190_Disease)))) (. .)))
11835460	3	(ROOT (S (NP (PRP We)) (VP (VP (VBP report) (PP (IN on) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (ADJP (JJ leftward) (CC and) (JJ upward)) (NNS deviations)) (PP (IN of) (NP (NNP gaze))))))) (PP (IN during) (NP (NP (DT the) (JJ peak) (NN effect)) (PP (IN of) (NP (NNS Doc_11835460_285_293_Chemical)))))) (, ,) (CC and) (VP (VBP hypothesize) (SBAR (IN that) (S (NP (NP (DT a) (JJ severe) (JJ dopaminergic) (NN denervation)) (PP (IN in) (NP (DT the) (JJ caudate) (NN nucleus)))) (VP (VBZ is) (VP (VBN needed) (PP (IN for) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (DT these) (NN Doc_11835460_411_419_Chemical-induce) (NNS Doc_11835460_427_445_Disease))))))))))) (. .)))
11915580	0	(ROOT (NP (NP (NP (DT A) (NN comparison)) (PP (IN of) (NP (NP (NNS Doc_11915580_16_35_Chemical)) (PP (IN with) (NP (NP (NNS Doc_11915580_41_51_Chemical)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_11915580_73_93_Disease)))))))))) (: :) (NP (DT an) (JJ open) (, ,) (JJ randomized) (, ,) (JJ cross-over) (NN trial)) (. .)))
11915580	1	(ROOT (S (S (NP (JJ Primary) (NNS Doc_11915580_142_154_Disease)) (VP (VBZ is) (NP (NP (DT a) (NN syndrome)) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ painful) (NN uterine)) (VP (ADVP (RB contractility)) (VBN caused) (PP (IN by) (NP (NP (DT a) (NN hypersecretion)) (PP (IN of) (NP (JJ endometrial) (NNS Doc_11915580_258_272_Chemical)))))))))))) (: ;) (S (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)) (VP (VBP are) (NP (NP (DT the) (JJ first) (NN choice)) (PP (IN for) (NP (PRP$ its) (NN treatment)))))) (. .)))
11915580	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (UCP (PP (IN in) (NP (NN vivo))) (CC and) (ADVP (RB in)) (ADJP (NN vitro))) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (JJ myometrial) (NNS cells)) (VP (VBP are) (ADVP (RB also)) (NP (NP (NNS targets)) (PP (IN of) (NP (NP (DT the) (JJ relaxant) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_11915580_474_486_Chemical)) (PRN (-LRB- -LRB-) (INTJ (RB NO)) (-RRB- -RRB-)))))))))))) (. .)))
11915580	3	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NP (NP (NNS Doc_11915580_555_574_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11915580_576_579_Chemical)) (-RRB- -RRB-))) (, ,) (NP (DT an) (JJ NO) (NN donor)) (, ,)))) (PP (IN in) (NP (NP (DT the) (NN resolution)) (PP (IN of) (NP (NP (NNS Doc_11915580_616_636_Disease)) (PP (IN in) (NP (NN comparison))))))) (PP (IN with) (NP (NP (NNS Doc_11915580_656_666_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11915580_668_671_Chemical)) (-RRB- -RRB-)))))))) (. .)))
11915580	4	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 24) (NNS patients)) (PP (IN with) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (JJ severe) (NNS Doc_11915580_726_746_Disease)))))))) (VP (VBD were) (VP (VBN studied) (PP (IN during) (NP (CD two) (JJ consecutive) (JJ menstrual) (NNS cycles))))) (. .)))
11915580	5	(ROOT (S (PP (IN In) (NP (DT an) (JJ open) (, ,) (JJ cross-over) (, ,) (JJ controlled) (NN design))) (, ,) (NP (NNS patients)) (VP (VBD were) (VP (VBN randomized) (S (VP (TO to) (VP (VB receive) (NP (NP (DT either) (NNS Doc_11915580_887_890_Chemical)) (PP (IN per) (NP (NN os) (CC or) (NN Doc_11915580_901_904_Chemical) (NNS patches)))) (NP (DT the) (JJ first) (NNS days)) (PP (IN of) (NP (NP (NNS menses)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (JJ menstrual) (NNS cramps)) (VP (VBD became) (ADJP (JJ unendurable)))))))))))) (. .)))
11915580	6	(ROOT (S (PP (IN In) (NP (DT the) (JJ subsequent) (NN cycle))) (NP (DT the) (JJ other) (NN treatment)) (VP (VBD was) (VP (VBN used))) (. .)))
11915580	7	(ROOT (S (NP (NNS Patients)) (VP (VBD received) (PRT (RP up)) (PP (TO to) (NP (NP (CD 3) (NN doses/day)) (PP (IN of) (NP (NP (CD 50) (NN mg) (NNS Doc_11915580_1080_1083_Chemical)) (CC or) (NP (CD 2.5) (JJ mg/24) (NN h) (NN transdermal) (NNS Doc_11915580_1111_1114_Chemical)))))) (PP (IN for) (NP (NP (DT the) (JJ first) (CD 3) (NNS days)) (PP (IN of) (NP (DT the) (NN cycle))))) (, ,) (PP (VBG according) (PP (TO to) (NP (PRP$ their) (NNS needs))))) (. .)))
11915580	8	(ROOT (S (NP (DT The) (NNS participants)) (VP (VBD recorded) (NP (NP (JJ menstrual) (NNS symptoms)) (CC and) (NP (NP (JJ possible) (NNS side-effects)) (PP (IN at) (NP (NP (JJ different) (NNS times)) (PRN (-LRB- -LRB-) (NP (NP (CD 0)) (, ,) (NP (CD 30)) (, ,) (NP (CD 60)) (, ,) (NP (CD 120) (NNS minutes))) (-RRB- -RRB-)))))) (PP (IN after) (NP (NP (DT the) (JJ first) (NN dose)) (PP (IN of) (NP (NN medication))))) (PP (IN on) (NP (NP (DT the) (JJ first) (NN day)) (PP (IN of) (NP (DT the) (NN cycle))))) (, ,) (PP (IN with) (NP (DT both) (NNS drugs)))) (. .)))
11915580	9	(ROOT (S (NP (NP (DT The) (NN difference)) (PP (IN in) (NP (NP (JJ Doc_11915580_1392_1396_Disease) (NN intensity) (NN score)) (PRN (-LRB- -LRB-) (NP (NNP DPI)) (-RRB- -RRB-))))) (VP (VBD was) (NP (DT the) (JJ main) (NN outcome) (NN variable))) (. .)))
11915580	10	(ROOT (S (NP (DT Both) (NNS treatments)) (ADVP (RB significantly)) (VP (VBD reduced) (ADVP (RB DPI)) (PP (IN by) (NP (DT the) (JJ 30th) (NN minute))) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADVP (RB Doc_11915580_1512_1515_Chemical)) (, ,) (NP (CD -12.8) (CD +)) (: /)) (: -) (FRAG (FRAG (RB 17.9)) (: ;) (FRAG (FRAG (ADVP (RB Doc_11915580_1533_1536_Chemical)) (, ,) (NP (CD -18.9) (CD +)) (: /)) (: -) (FRAG (RB 16.6))))) (-RRB- -RRB-))) (. .)))
11915580	11	(ROOT (S (ADVP (RB However)) (, ,) (NP (NNS Doc_11915580_1564_1567_Chemical)) (VP (VBD continued) (S (VP (TO to) (VP (VB be) (ADJP (JJ effective) (PP (IN in) (S (VP (VBG reducing) (NP (NNS Doc_11915580_1606_1617_Disease)) (PP (IN for) (NP (CD two) (NNS hours))))))) (, ,) (SBAR (IN whereas) (S (NP (JJ Doc_11915580_1641_1644_Chemical) (NNS scores)) (VP (VBD remained) (ADJP (ADJP (JJR more)) (CC or) (ADJP (RBR less) (JJ stable) (PP (IN after) (NP (CD 30) (NN min)))) (CC and) (ADJP (RB significantly) (JJR higher))) (PP (IN than) (NP (NP (DT those)) (PP (IN for) (NP (NNP DFC))) (PRN (-LRB- -LRB-) (SBAR (IN after) (S (NP (NP (CD one) (NN hour)) (: :) (NP (NP (NP (NNS Doc_11915580_1755_1758_Chemical)) (, ,) (NP (CD -12.8) (JJ +) (NNS /))) (: -) (NP (NP (NNP 17.9)) (PRN (: ;) (NP (NP (NNP DFC)) (, ,) (NP (CD -18.9) (NNS +))) (: /))) (: -) (NP (NP (CD 16.6)) (CC and) (NP (IN after) (CD two) (NNS hours))) (: :) (NP (NP (NNS Doc_11915580_1817_1820_Chemical)) (, ,) (NP (CD -23.7) (JJ +) (NNS /))) (: -) (NP (NP (CD 20.5)) (PRN (: ;) (NP (NP (NNP DFC)) (, ,) (NP (CD -59.7) (NNS +))) (: /)))) (: -)) (VP (VBZ 17.9) (, ,) (S (NP (NN p)) (VP (SYM =) (NP (CD 0.0001))))))) (-RRB- -RRB-))))))))))) (. .)))
11915580	12	(ROOT (S (NP (NNP Doc_11915580_1872_1885_Disease)) (VP (VBD was) (ADVP (RB also)) (VP (VBN relieved) (PP (IN by) (NP (DT both) (NNS drugs))))) (. .)))
11915580	13	(ROOT (S (NP (NNP Headache)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN increased) (PP (PP (IN by) (NP (NNS Doc_11915580_1959_1962_Chemical))) (CONJP (CC but) (RB not)) (PP (IN by) (NP (NNS Doc_11915580_1974_1977_Chemical)))))) (. .)))
11915580	14	(ROOT (S (NP (NP (NP (CD Eight) (NNS patients)) (VP (VBN stopped) (S (VP (VBG using) (NP (NNS Doc_11915580_2008_2011_Chemical)) (PP (IN because) (NP (NNS Doc_11915580_2020_2028_Disease))))))) (PRN (: --) (VP (VBN attributed) (PP (TO to) (NP (PRP$ its) (NN use)))) (: --))) (VP (VBD became) (ADJP (JJ intolerable))) (. .)))
11915580	15	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_11915580_2102_2105_Chemical)) (VP (VP (VBZ has) (NP (DT a) (VBN reduced) (NN efficacy))) (CC and) (VP (ADJP (JJ tolerability) (PP (IN by) (NP (NN comparison)))) (PP (IN with) (NP (NP (NNS Doc_11915580_2165_2168_Chemical)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_11915580_2189_2209_Disease)))))))))))) (. .)))
11936424	0	(ROOT (S (NP (NP (NNP Doc_11936424_0_10_Chemical)) (, ,) (NP (NP (DT a) (JJ long-acting) (JJ non-SH) (NN group) (NN angiotensin)) (VP (VBG converting) (NP (JJ enzyme) (NN inhibitor)))) (, ,)) (VP (VBZ modulates) (NP (NP (NNS Doc_11936424_90_107_Disease)) (PP (IN in) (NP (JJ chronic) (JJ Doc_11936424_119_144_Chemical) (NNS Doc_11936424_145_154_Disease))))) (. .)))
11936424	1	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (JJ chronic) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_11936424_240_250_Chemical)) (, ,) (NP (NP (DT a) (JJ long-acting) (JJ non-SH) (NN group) (NN angiotensin)) (VP (VBG converting) (NP (NP (JJ enzyme) (PRN (-LRB- -LRB-) (NP (NNP ACE)) (-RRB- -RRB-)) (NN inhibitor)) (, ,) (NP (JJ reduced) (NNS Doc_11936424_334_345_Disease)) (, ,))))))) (VP (VP (VBD inhibited) (NP (NNS Doc_11936424_357_379_Disease))) (CC and) (VP (VBD prevented) (NP (NNS Doc_11936424_394_412_Disease)) (PP (IN in) (NP (NP (JJ chronic) (NNS Doc_11936424_424_449_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11936424_451_454_Chemical)) (-RRB- -RRB-)) (: -) (NP (JJ induced) (JJ Doc_11936424_466_475_Disease) (NNS rats)))))))))))) (. .)))
11936424	2	(ROOT (S (NP (NNP Doc_11936424_482_491_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (NN injection)) (PP (IN of) (NP (NP (NP (NNS Doc_11936424_520_523_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ 15mg/100g) (NN body) (NN weight)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ male) (JJ Sprague-Dawley) (PRN (-LRB- -LRB-) (NP (NNP SD)) (-RRB- -RRB-)) (NNS rats))))))))) (. .)))
11936424	3	(ROOT (S (NP (CD Four) (NNS groups)) (VP (VBD were) (VP (VBN used) (, ,) (VBN i) (-RRB- -RRB-) (SBAR (WHNP (NP (DT the) (JJ Doc_11936424_612_615_Chemical)) (PRN (NP (NP (NP (NN group)) (PRN (-LRB- -LRB-) (NP (CD 14)) (-RRB- -RRB-))) (, ,) (NP (NN ii))) (-RRB- -RRB-))) (PRN (NP (NP (NNS Doc_11936424_632_635_Chemical)) (NP (NP (NP (JJ /) (NNS Doc_11936424_636_646_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 13)) (-RRB- -RRB-))) (NP (NP (NP (, ,) (NP (NN iii)) (-RRB- -RRB-) (NNS Doc_11936424_658_668_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 14)) (-RRB- -RRB-))) (CC and) (NP (NN iv))))) (-RRB- -RRB-)) (S (NP (NNP untreated)) (VP (VBZ controls) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-))))))) (. .)))
11936424	4	(ROOT (S (NP (NP (NNP Doc_11936424_707_717_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 8) (NN mg/kg/day)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (NP (DT the) (NNS rats)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN killed) (PP (IN at) (NP (NNS weeks))) (NP (CD 4) (, ,) (CD 14) (CC or) (CD 20)))))))))) (. .)))
11936424	5	(ROOT (S (PP (IN At) (NP (DT each) (NN time) (NN point))) (, ,) (S (NP (NP (JJ systolic) (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP BP)) (-RRB- -RRB-))) (, ,) (ADVP (RB urinary)) (NP (NN protein) (NN excretion) (CC and) (JJ renal) (NN histopathological) (NNS findings)) (VP (VBD were) (VP (VBN evaluated)))) (, ,) (CC and) (S (NP (JJ morphometric) (NN image) (NN analysis)) (VP (VBD was) (VP (VBN done)))) (. .)))
11936424	6	(ROOT (S (NP (NP (NNP Systolic) (NNP BP)) (PP (IN in) (NP (DT the) (JJ Doc_11936424_991_994_Chemical) (NN group)))) (VP (VP (VBD was) (ADJP (RB significantly) (JJ high) (PP (IN at) (NP (CD 4) (, ,) (CD 14) (CC and) (CD 20)))) (NP (NNS weeks))) (, ,) (CC but) (VP (VBD was) (ADJP (JJ normal)) (PP (IN in) (NP (DT the) (NNP Doc_11936424_1069_1072_Chemical) (NNP /) (JJ Doc_11936424_1073_1083_Chemical) (NN group))))) (. .)))
11936424	7	(ROOT (S (NP (NP (JJ Urinary) (NN protein) (NN excretion)) (PP (IN in) (NP (DT the) (JJ Doc_11936424_1124_1127_Chemical) (NN group)))) (VP (VP (VBD increased) (ADVP (RB significantly)) (, ,) (S (VP (VBG peaking) (PP (IN at) (NP (NP (CD 8) (NNS days)) (, ,) (VP (ADVP (RB then)) (VBN decreased) (PP (IN at) (NP (CD 4) (NNS weeks))))))))) (, ,) (CC but) (VP (VBD rose) (ADVP (RB again) (RB significantly)) (PP (IN at) (NP (CD 14) (CC and) (CD 20) (NNS weeks))))) (. .)))
11936424	8	(ROOT (S (S (NP (NNP Doc_11936424_1254_1264_Chemical)) (VP (VBD did) (RB not) (VP (VB attenuate) (NP (NNS Doc_11936424_1283_1294_Disease)) (PP (IN at) (NP (CD 8) (NNS days)))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBD did) (ADVP (RB markedly) (JJR lower)) (NP (PRP it)) (PP (IN from) (NP (NNS weeks) (CD 4) (TO to) (CD 20))))) (. .)))
11936424	9	(ROOT (S (NP (NP (DT The) (JJ Doc_11936424_1359_1377_Disease) (NN index)) (PRN (-LRB- -LRB-) (NP (NNP GSI)) (-RRB- -RRB-))) (VP (VBD was) (UCP (NP (NP (CD 6.21) (NN %)) (PP (IN at) (NP (CD 4) (NNS weeks)))) (CC and) (RRC (ADVP (RB respectively)) (NP (NP (QP (CD 25.35) (NN %) (CC and) (CD 30.49) (NN %))) (PP (IN at) (NP (NP (CD 14) (CC and) (CD 20) (NNS weeks)) (PP (IN in) (NP (DT the) (JJ Doc_11936424_1475_1478_Chemical) (NN group))))))))) (. .)))
11936424	10	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN correlation)) (PP (IN between) (NP (NP (NP (JJ urinary) (NN protein) (NN excretion)) (CC and) (NP (NNP GSI))) (PRN (-LRB- -LRB-) (NP (NP (SYM r)) (SBAR (S (S (VP (SYM =) (NP (CD 0.808)))) (, ,) (VP (VBP p) (NP (QP (CD <) (CD 0.0001))))))) (-RRB- -RRB-)))))) (. .)))
11936424	11	(ROOT (S (S (NP (NP (DT The) (NN ratio)) (PP (IN of) (NP (NP (NN glomerular) (NN tuft) (NN area)) (PP (TO to) (NP (NP (DT the) (NN area)) (PP (IN of) (NP (NP (NP (NNP Bowman) (POS 's)) (NNS capsules)) (PRN (-LRB- -LRB-) (NP (NNP GT/BC)) (-RRB- -RRB-)))) (PP (IN in) (NP (DT the) (JJ Doc_11936424_1671_1674_Chemical) (NN group)))))))) (VP (VBD was) (VP (ADVP (RB significantly)) (VBN increased)))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBD was) (ADJP (RB significantly) (JJR lower)) (PP (IN in) (NP (DT the) (NNP Doc_11936424_1748_1751_Chemical) (NNP /) (JJ Doc_11936424_1752_1762_Chemical) (NN group))))) (. .)))
11936424	12	(ROOT (S (NP (PRP It)) (VP (VBZ appears) (SBAR (IN that) (S (NP (NNS Doc_11936424_1786_1796_Chemical)) (VP (VBD was) (ADJP (JJ effective) (PP (IN in) (NP (NP (NNS Doc_11936424_1814_1841_Disease)) (CC and) (NP (NP (VBN protected) (JJ renal) (NN function)) (PP (IN in) (NP (JJ Doc_11936424_1874_1877_Chemical) (JJ neprotic) (NNS rats))))))))))) (. .)))
11988250	0	(ROOT (S (NP (NP (NNP Doc_11988250_0_22_Disease)) (PP (IN after) (NP (NNS Doc_11988250_29_38_Chemical)))) (VP (VBZ prophylaxis) (PP (IN in) (NP (JJ very) (NN preterm) (NNS infants)))) (. .)))
11988250	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (CD three) (NNS cases)) (PP (IN of) (NP (NP (JJ severe) (NN hypoxaemia)) (PP (IN after) (NP (JJ Doc_11988250_125_134_Chemical) (NN administration)))))) (PP (IN during) (NP (NP (DT a) (JJ randomised) (JJ controlled) (NN trial)) (PP (IN of) (NP (NP (JJ prophylactic) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_11988250_216_240_Disease)) (PP (IN with) (NP (NP (NNS Doc_11988250_246_255_Chemical)) (PP (IN in) (NP (NP (JJ premature) (NNS infants)) (VP (VBN born) (PP (IN at) (NP (NP (QP (JJR less) (IN than) (CD 28)) (NNS weeks)) (PP (IN of) (NP (NN gestation))))))))))))))))) (. .)))
11988250	2	(ROOT (S (NP (NNP Echocardiography)) (VP (VBD showed) (ADVP (RB severely)) (NP (VBN decreased) (JJ pulmonary) (NN blood) (NN flow))) (. .)))
11988250	3	(ROOT (S (NP (NNP Hypoxaemia)) (VP (VBD resolved) (ADVP (RB quickly)) (PP (IN on) (NP (JJ inhaled) (JJ Doc_11988250_422_434_Chemical) (NN therapy)))) (. .)))
11988250	4	(ROOT (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS investigators)) (VP (VBN involved) (PP (IN in) (NP (JJ similar) (NNS trials))))) (VP (VBP pay) (NP (JJ close) (NN attention)) (PP (TO to) (NP (JJ pulmonary) (NN pressure))) (SBAR (IN if) (S (NP (NN hypoxaemia)) (VP (VBZ occurs) (PP (IN after) (NP (NP (JJ prophylactic) (NN administration)) (PP (IN of) (NP (NNS Doc_11988250_601_610_Chemical)))))))))))) (. .)))
12051122	0	(ROOT (NP (NP (NP (NN Doc_12051122_0_12_Disease) (CC and) (NN syndrome)) (PP (IN of) (NP (NP (JJ inappropriate) (JJ anti-diuretic) (NN hormone)) (VP (VBN reported) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_12051122_90_101_Chemical))))))))) (: :) (NP (NP (DT an) (NN over-representation)) (PP (IN of) (NP (NNPS Asians)))) (. ?)))
12051122	1	(ROOT (S (NP (DT This) (NN retrospective) (NN study)) (VP (VBD used) (NP (NP (DT a) (JJ pharmaceutical) (NN company) (POS 's)) (JJ global) (NN safety) (NN database)) (S (VP (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN reporting) (NN rate)) (PP (IN of) (NP (NP (JJ Doc_12051122_261_273_Disease) (JJ and/or) (NN syndrome)) (PP (IN of) (NP (NP (JJ inappropriate) (NNS Doc_12051122_307_341_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12051122_343_348_Disease)) (-RRB- -RRB-))))))) (PP (IN among) (NP (NN Doc_12051122_356_367_Chemical-treated) (NNS patients))))) (CC and) (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (JJ at-risk) (NN population) (NNS subgroups))))))))) (. .)))
12051122	2	(ROOT (S (NP (PRP We)) (VP (VBD searched) (SBAR (S (NP (NP (NP (DT the) (NNP Eli) (NNP Lilly) (CC and) (NNP Company) (POS 's)) (JJ computerized) (JJ adverse) (NN event) (NN database)) (PP (IN for) (NP (DT all)))) (VP (VP (VBD reported) (NP (NP (NNS cases)) (PP (IN of) (NP (NNS Doc_12051122_559_571_Disease))))) (CC and/or) (VP (VBZ Doc_12051122_579_584_Disease) (NP (QP (RB as) (IN of) (CD 1))) (NP (NNP November) (CD 1999)) (SBAR (IN that) (S (VP (VBD had) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_12051122_648_659_Chemical))))))))))))))) (. .)))
12051122	3	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 76) (NNS cases)) (PP (IN of) (NP (NP (JJ Doc_12051122_693_705_Disease) (JJ and/or) (NNS Doc_12051122_713_718_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_12051122_735_746_Chemical) (NN use))))))))) (VP (VBD were) (VP (VBN identified))) (. .)))
12051122	4	(ROOT (S (NP (DT The) (JJ overall) (NN reporting) (NN rate)) (VP (VBD was) (VP (VBN estimated) (S (VP (TO to) (VP (VB be) (NP (QP (CD 1.3) (CD /)) (CD 100,000) (NNP treated) (NNS patients))))))) (. .)))
12051122	5	(ROOT (S (S (NP (NP (DT The) (JJ average) (NN age)) (PP (IN of) (NP (NNS patients)))) (VP (VBD was) (ADJP (ADJP (QP (CD 35.6) (CD +)) (NN /)) (: -) (ADJP (CD 28.3) (NNS years))))) (, ,) (CC and) (S (NP (CD 62) (NN %)) (VP (VBD were) (NP (NNS males)))) (. .)))
12051122	6	(ROOT (S (NP (NP (QP (RB Approximately) (CD 75)) (NN %)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD were) (VP (VBG receiving) (NP (NP (NN treatment)) (PP (IN for) (NP (NNS Doc_12051122_981_989_Disease) (CC or) (NNS Doc_12051122_993_1001_Disease)))))) (. .)))
12051122	7	(ROOT (S (PP (IN Among) (NP (NP (DT the) (CD 39) (NNS reports)) (SBAR (WHNP (WDT that)) (S (VP (VBD included) (NP (NN information)) (PP (IN on) (NP (NN race)))))))) (, ,) (NP (DT the) (JJ racial) (NN distribution)) (VP (VP (VBD was)) (: :) (NP (NP (CD 1) (NNP Black) (, ,) (CD 3) (NNS Caucasian)) (, ,) (CC and) (ADJP (CD 35) (JJ Asian)))) (. .)))
12051122	8	(ROOT (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ Asian) (NNS patients)) (VP (MD may) (VP (VB be) (PP (IN at) (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (NP (JJ Doc_12051122_1201_1213_Disease) (JJ and/or) (NNS Doc_12051122_1221_1226_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_12051122_1243_1254_Chemical) (NN use))))))))))))) (. .)))
12051122	9	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT the) (JJ overall) (JJ reported) (NN rate)) (PP (IN of) (NP (NP (NNS Doc_12051122_1298_1303_Disease)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_12051122_1320_1331_Chemical))))))) (VP (VBZ is) (ADJP (RB very) (JJ low))))) (, ,) (NP (NP (NNS physicians)) (VP (VBG caring) (PP (IN for) (NP (JJ Asian) (NN oncology) (NNS patients))))) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (DT this) (JJ potential) (ADJP (JJ serious) (CC but) (JJ reversible)) (JJ adverse) (NN event)))))) (. .)))
12059909	0	(ROOT (NP (NP (JJ Delayed) (NNS Doc_12059909_8_16_Disease)) (PP (IN of) (NP (NP (NNS Doc_12059909_20_36_Chemical)) (PP (IN on) (NP (DT the) (NN bladder))))) (PP (IN of) (NP (NN DBA/2) (CC and) (NN C57BL/6) (NN female) (NN mouse))) (. .)))
12059909	1	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ describes) (NP (NP (DT the) (JJ delayed) (NN development)) (PP (IN of) (NP (DT a) (JJ severe) (NN bladder) (NN pathology)))) (PP (PP (IN in) (NP (NP (DT a) (ADJP (JJ susceptible)) (NN strain)) (PP (IN of) (NP (NP (NNS mice)) (PRN (-LRB- -LRB-) (NP (NNP DBA/2)) (-RRB- -RRB-)))))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NP (DT a) (ADJP (JJ resistant)) (NN strain)) (PRN (-LRB- -LRB-) (NP (NNP C57BL/6)) (-RRB- -RRB-))))) (SBAR (WHADVP (WRB when)) (S (NP (DT both)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (DT a) (JJ single) (CD 300) (NN mg/kg) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_12059909_304_320_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CY)) (-RRB- -RRB-))))))))))) (. .)))
12059909	2	(ROOT (S (S (NP (NP (NNP Inbred) (NNP DBA/2)) (CC and) (NP (CD C57BL/6) (JJ female) (NNS mice))) (VP (VBD were) (VP (VBN injected) (PP (IN with) (NP (NNP CY)))))) (, ,) (CC and) (S (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (DT the) (NN drug)) (PP (IN on) (NP (DT the) (NN bladder)))))) (VP (VBD was) (VP (VBN assessed) (PP (IN during) (NP (CD 100) (NNS days))) (PP (IN by) (NP (NN light))) (S (VP (VP (ADVP (RB microscopy)) (VBG using) (NP (JJ different) (VBG staining) (NNS procedures))) (, ,) (CC and) (VP (PP (IN after) (NP (CD 30) (NNS days))) (PP (IN by) (NP (JJ conventional) (NN electron))) (ADVP (RB microscopy)))))))) (. .)))
12059909	3	(ROOT (S (NP (NNP Early) (NNP CY) (NNS Doc_12059909_579_587_Disease)) (VP (VBD caused) (NP (NP (DT a) (JJ typical) (NNS Doc_12059909_605_626_Disease)) (PP (IN in) (NP (NP (DT both) (NNS strains)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (ADVP (RB completely)) (VP (VBN repaired) (PP (IN in) (NP (RB about) (CD 7-10) (NNS days))))))))))) (. .)))
12059909	4	(ROOT (S (PP (IN After) (NP (NP (CD 30) (NNS days)) (PP (IN of) (NP (NNP CY) (NN injection) (NNS ulcerous) (CC and) (NNS non-ulcerous))))) (NP (NP (NNS forms)) (PP (IN of) (NP (JJ chronic) (NNS Doc_12059909_765_773_Disease)))) (VP (VBD appeared) (PP (PP (IN in) (NP (NP (CD 86) (NN %)) (PP (IN of) (NP (CD DBA/2) (NNS mice))))) (CONJP (CC but) (RB only)) (PP (IN in) (NP (NP (CD 4) (NN %)) (PP (IN of) (NP (CD C57BL/6) (NNS mice))))))) (. .)))
12059909	5	(ROOT (S (NP (JJ Delayed) (NNS Doc_12059909_844_852_Disease)) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NN infiltration) (CC and) (NN transepithelial) (NN passage))) (PP (PP (IN into) (NP (NP (DT the) (NN lumen)) (PP (IN of) (NP (JJ inflammatory) (NNS cells))))) (CC and) (PP (IN by) (NP (NP (JJ frequent) (NN exfoliation)) (PP (IN of) (NP (DT the) (NN urothelium)))))))) (. .)))
12059909	6	(ROOT (S (NP (JJ Mast) (NNS cells)) (VP (VBD appeared) (PP (IN in) (NP (NP (DT the) (NN connective)) (CC and) (NP (NP (JJ muscular) (NNS layers)) (PP (IN of) (NP (DT the) (NN bladder)))))) (PP (IN at) (NP (NP (DT a) (ADJP (RB much) (JJR higher)) (NN number)) (PP (IN in) (NP (CD DBA/2) (NNS mice))))) (PP (IN than) (PP (IN in) (NP (UCP (NP (CD C57BL/6) (NNS mice)) (CC or) (ADJP (JJ untreated))) (NNS controls))))) (. .)))
12059909	7	(ROOT (S (NP (NNP Electron)) (ADVP (RB microscopy)) (VP (VBD disclosed) (SBAR (S (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT the) (JJ typical) (JJ discoidal) (NNS vesicles)))) (ADVP (RB normally)) (VP (VB present) (PP (IN in) (NP (NP (DT the) (NN cytoplasm)) (PP (IN of) (NP (NN surface) (NNS cells))))))))) (. .)))
12059909	8	(ROOT (S (ADVP (RB Instead)) (, ,) (NP (NP (JJ numerous) (JJ abnormal) (NNS vesicles)) (VP (VBG containing) (NP (NP (CD one)) (CC or) (NP (JJ several) (JJ dark) (NNS granules))))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NN cytoplasm)) (PP (IN of) (NP (NNS cells))))) (PP (IN from) (NP (PDT all) (DT the) (JJ epithelial) (NNS layers))))) (. .)))
12059909	9	(ROOT (S (NP (JJ Delayed) (NNS Doc_12059909_1438_1446_Disease)) (ADVP (RB still)) (VP (VBD persisted) (PP (IN in) (NP (CD DBA/2) (NNS mice))) (NP (CD 100) (NNS days)) (PP (IN after) (NP (NN treatment)))) (. .)))
12059909	10	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ delayed) (NNS Doc_12059909_1539_1547_Disease)) (PP (IN of) (NP (NP (NNP CY)) (PP (IN in) (NP (JJ female) (NN DBA/2) (NNS mice)))))) (VP (VBZ causes) (NP (NP (DT a) (NN bladder) (NN pathology)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (RB not) (VP (VBN observed) (PP (IN in) (NP (CD C57BL/6) (NNS mice)))))))))))) (. .)))
12059909	11	(ROOT (S (NP (DT This)) (ADVP (RB pathology)) (VP (VP (VBZ resembles) (NP (NNS Doc_12059909_1665_1686_Disease)) (PP (IN in) (NP (NNS humans)))) (CC and) (VP (MD could) (ADVP (RB perhaps)) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NP (DT an) (NN animal) (NN model)) (PP (IN for) (NP (NP (NNS studies)) (PP (IN on) (NP (DT the) (NN disease))))))))))) (. .)))
12119460	0	(ROOT (FRAG (NP (JJ High-dose) (NNS Doc_12119460_10_24_Chemical)) (: /) (FRAG (NP (NP (NNS Doc_12119460_27_39_Chemical)) (PP (IN in) (NP (NN combination)))) (PP (IN with) (NP (JJ three-weekly) (NNS Doc_12119460_73_84_Chemical))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ advanced) (NNS Doc_12119460_114_128_Disease)))))) (. .)))
12119460	1	(ROOT (S (NP (DT A) (NN phase) (NNP II)) (VP (VBP study)) (. .)))
12119460	2	(ROOT (S (NP (NP (NP (DT The) (JJ 24-hour) (JJ continuous) (NN infusion)) (PP (IN of) (NP (NP (NNS Doc_12119460_195_209_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12119460_211_215_Chemical)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_12119460_221_233_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP FA)) (-RRB- -RRB-)))) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (JJ several) (JJ new) (JJ multidrug) (NN chemotherapy) (NNS regimens)) (PP (IN in) (NP (JJ advanced) (NNS Doc_12119460_306_320_Disease)))))))) (PRN (-LRB- -LRB-) (NP (NNP AGC)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ effective)) (, ,) (PP (IN with) (NP (JJ low) (NNS Doc_12119460_363_371_Disease)))))))) (. .)))
12119460	3	(ROOT (S (PP (IN In) (NP (NP (DT a) (JJ previous) (NN phase) (NNP II) (NN study)) (PP (IN with) (NP (JJ 3-weekly) (NNS bolus) (NNS Doc_12119460_422_426_Chemical))))) (, ,) (NP (NP (NNP FA)) (CC and) (NP (NNS Doc_12119460_435_446_Chemical))) (PRN (-LRB- -LRB-) (NP (NNP Doc_12119460_448_451_Chemical)) (-RRB- -RRB-)) (NP (PRP we)) (VP (VBD found) (NP (NP (DT a) (JJ low) (JJ Doc_12119460_468_476_Disease) (NN rate)) (CC and) (NP (NP (NN response) (NNS rates)) (ADJP (JJ comparable) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (NP (NNS regimens)) (PP (JJ such) (IN as) (NP (NNP ELF) (, ,) (NNP FAM) (CC or) (NNP FAMTX))))))))) (, ,) (CC and) (NP (DT a) (JJ promising) (JJ median) (JJ overall) (NN survival)))) (. .)))
12119460	4	(ROOT (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB improve) (NP (DT this) (NN Doc_12119460_626_629_Chemical-dependent) (NN schedule)))))) (NP (PRP we)) (VP (VBD initiated) (NP (DT a) (NN phase) (NNP II) (NN study)) (PP (IN with) (NP (JJ high-dose) (NNP Doc_12119460_694_698_Chemical) (NNP /) (NNP FA) (CC and) (JJ 3-weekly) (NN bolus) (NNS Doc_12119460_721_724_Chemical)))) (. .)))
12119460	5	(ROOT (FRAG (NP (NNS PATIENTS) (CC AND) (NNS METHODS)) (: :) (S (PP (IN From) (NP (NNP February))) (, ,) (NP (NP (CD 1998)) (PP (TO to) (NP (NP (NNP September)) (, ,) (NP (NP (NP (CD 2000)) (SBAR (S (NP (PRP we)) (VP (VBD recruited) (NP (CD 33) (NNS patients)) (PP (IN with) (NP (NNP AGC))) (S (VP (TO to) (VP (VB receive) (NP (JJ weekly) (JJ 24-hour) (NNS Doc_12119460_847_851_Chemical))))))))) (NP (NP (CD 2,600) (NN mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (VP (VBN preceded) (PP (IN by) (ADJP (JJ 2-hour))))))))) (VP (VBP FA) (NP (NP (CD 500) (NN mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 6) (NNS weeks)))) (, ,) (PP (VBN followed) (PP (IN by) (NP (DT a) (JJ 2-week) (NN rest) (NN period)))))) (. .)))
12119460	6	(ROOT (S (NP (NP (JJ Bolus) (JJ Doc_12119460_953_956_Chemical) (CD 10) (NN mg/m)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN added) (PP (IN in) (NP (JJ 3-weekly) (NNS intervals))))) (. .)))
12119460	7	(ROOT (S (NP (NP (NNP Treatment)) (PP (VBN given) (PP (IN on) (NP (DT an) (NN outpatient) (NN basis))))) (, ,) (S (VP (VBG using) (NP (JJ portable) (NN pump) (NNS systems)))) (, ,) (VP (VBD was) (VP (VBN repeated) (PP (IN on) (NP (NN day) (CD 57))))) (. .)))
12119460	8	(ROOT (S (NP (NP (NNPS Patients) (POS ')) (NNS characteristics)) (VP (VBD were) (: :) (S (S (FRAG (NP (NP (JJ male/female) (NN ratio) (CD 20/13)) (: ;) (NP (NP (JJ median) (NN age) (CD 57)) (PRN (-LRB- -LRB-) (NP (CD 27-75)) (-RRB- -RRB-)) (NP (NNS years)))) (: ;) (NP (NP (JJ median) (JJ WHO) (NN status)) (NP (NP (CD 1)) (PRN (-LRB- -LRB-) (NP (CD 0-2)) (-RRB- -RRB-)))) (. .)) (NP (CD 18) (NNS patients)) (VP (VBD had) (NP (DT a) (JJ primary) (NN AGC)))) (, ,) (CC and) (S (NP (CD 15)) (VP (VBD showed) (NP (DT a) (JJ relapsed) (NN AGC)))))) (. .)))
12119460	9	(ROOT (S (NP (JJ Median) (NN follow-up)) (VP (VBD was) (NP (NP (CD 11.8) (NNS months)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (PP (IN of) (NP (NP (DT those)) (VP (VBG surviving)) (: :) (NP (CD 2.7-11) (CD .8) (NNS months))))) (-RRB- -RRB-)))) (. .)))
12119460	10	(ROOT (S (NP (CD 32) (NNS patients)) (VP (VBD were) (NP (NP (NP (NN evaluable)) (PP (IN for) (NP (NN response)))) (: -) (NP (NP (JJ complete) (NN remission)) (NP (CD 9.1) (NN %))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 3))))) (-RRB- -RRB-)) (, ,) (NP (NP (JJ partial) (NN remission)) (NP (CD 45.5) (NN %))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 15))))) (-RRB- -RRB-)) (, ,) (NP (NP (DT no) (NN change)) (NP (CD 27.3) (NN %))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 9))))) (-RRB- -RRB-)) (, ,) (NP (NP (JJ progressive) (NN disease)) (NP (CD 15.1) (NN %))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 5))))) (-RRB- -RRB-)))) (. .)))
12119460	11	(ROOT (S (NP (NP (NP (JJ Median) (JJ overall) (NN survival) (NN time)) (SBAR (S (VP (VBD was) (VP (NP (CD 10.2) (NNS months)) (VBG -LSB-) (NP (NP (ADJP (CD 95) (NN %)) (NN confidence) (NN interval)) (PRN (-LRB- -LRB-) (NP (NNP CI)) (-RRB- -RRB-)))))))) (: :) (NP (CD 8.7-11) (CD .6) (NNS -RSB-)) (, ,) (CC and) (NP (JJ median) (JJ progression-free) (NN survival) (NN time))) (VP (VBD was) (NP (NP (CD 7.6) (NNS months)) (PRN (-LRB- -LRB-) (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (: :) (NP (CD 4.4-10) (CD .9))) (-RRB- -RRB-)))) (. .)))
12119460	12	(ROOT (S (NP (NP (DT The) (JJS worst) (NNS Doc_12119460_1698_1708_Disease)) (PRN (-LRB- -LRB-) (NP (NNP %)) (-RRB- -RRB-))) (VP (VBD observed) (SBAR (S (VP (VBD were) (NP (NP (-LRB- -LRB-) (QP (CD CTC-NCI) (CD 1/2/3)) (-RRB- -RRB-)) (: :) (NP (NP (ADJP (QP (CD Doc_12119460_1744_1754_Disease) (CD 45.5))) (PRN (: /) (FRAG (FRAG (RB 18.2)) (: /) (FRAG (FRAG (NP (NP (CD 6.1)) (, ,) (NP (NNP Doc_12119460_1770_1786_Disease) (NNP 33.3) (NNP /) (NNP 9.1))) (: /) (NP (NP (CD 6.1)) (, ,) (ADJP (JJ vomitus) (CD 24.2)))) (: /) (FRAG (FRAG (RB 9.1)) (: /) (FRAG (NP (CD 0)) (, ,) (NP (NN diarrhea) (NNS 36.4)) (: /)))))) (NN 6.1) (PRN (: /) (NP (NP (CD 3.0)) (, ,) (NP (NNP Doc_12119460_1844_1854_Disease) (CD 18.2))) (: /)) (NNS 9.1)) (PRN (: /) (NP (NP (CD 0)) (, ,) (NP (NNP Doc_12119460_1867_1885_Disease) (NNP 12.1))) (: /)) (NP (CD 0/0)))))))) (. .)))
12119460	13	(ROOT (S (NP (CD Two) (NNS patients)) (VP (VBD developed) (NP (NP (NNS Doc_12119460_1919_1944_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12119460_1946_1949_Disease)) (-RRB- -RRB-)))) (. .)))
12119460	14	(ROOT (FRAG (NP (JJ High-dose) (NNS Doc_12119460_1975_1979_Chemical)) (: /) (S (NP (NNP FA/Doc) (NNP _) (NNS 12119460_1983_1986_Chemical)) (VP (VBZ is) (NP (NP (DT an) (ADJP (JJ effective) (CC and) (JJ well-tolerated)) (NN outpatient) (NN regimen)) (PP (IN for) (NP (NNP AGC))) (PRN (-LRB- -LRB-) (NP (NP (JJ objective) (NN response) (NN rate)) (NP (CD 54.6) (NN %))) (-RRB- -RRB-))))) (. .)))
12119460	15	(ROOT (S (S (NP (PRP It)) (VP (MD may) (VP (VB serve) (PP (IN as) (NP (DT an) (NN alternative))) (PP (TO to) (NP (NN Doc_12119460_2116_2125_Chemical-containing) (NNS regimens)))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (PRP it)) (VP (VBZ has) (S (VP (TO to) (VP (VB be) (VP (VBN considered) (SBAR (IN that) (S (NP (RB possibly) (NNS Doc_12119460_2194_2197_Disease)) (VP (MD may) (VP (VB occur))))))))))) (. .)))
12165618	0	(ROOT (S (NP (NNP Persistent) (NNP sterile) (NNP leukocyturia)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_12165618_51_74_Disease)) (PP (IN in) (NP (JJ human) (NNP Doc_12165618_84_100_Disease) (NN virus) (NN type) (JJ 1-infected) (NNS children))) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_12165618_145_154_Chemical)))))))) (. .)))
12165618	1	(ROOT (S (NP (NP (JJ Prolonged) (NN administration)) (PP (IN of) (NP (NNS Doc_12165618_196_205_Chemical)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS Doc_12165618_256_275_Disease)) (PP (IN in) (NP (NNS adults))))))))))) (. .)))
12165618	2	(ROOT (S (NP (DT These) (JJ well-documented) (NN side) (NNS effects)) (VP (VBP have) (VP (VBN restricted) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT this) (JJ potent) (NN protease) (NN inhibitor)))) (PP (IN in) (NP (NNS children))))) (. .)))
12165618	3	(ROOT (S (NP (DT A) (JJ prospective) (NN study) (S (VP (TO to) (VP (VB monitor) (NP (NNS Doc_12165618_432_441_Chemical-related)) (ADVP (RB nephrotoxicity)) (PP (IN in) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (CD 30) (JJ human) (JJ Doc_12165618_489_505_Disease) (NN virus) (NN type) (JJ 1-infected) (NNS children))))))))) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_12165618_550_559_Chemical)))) (. .)))
12165618	4	(ROOT (S (NP (NP (JJ Urinary) (NN pH)) (, ,) (NP (NN albumin)) (, ,) (NP (NNS Doc_12165618_591_601_Chemical)) (, ,) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS erythrocytes) (, ,) (NNS leukocytes) (, ,) (NNS bacteria) (CC and) (NNS crystals)))) (, ,) (CC and) (NP (NN culture))) (VP (VBD were) (VP (VBN analyzed) (NP (DT every) (CD 3) (NNS months)) (PP (IN for) (NP (CD 96) (NNS weeks))))) (. .)))
12165618	5	(ROOT (S (NP (JJ Serum) (JJ Doc_12165618_729_739_Chemical) (NNS levels)) (VP (VBD were) (ADVP (RB routinely)) (VP (VBN determined) (PP (IN at) (NP (DT the) (JJ same) (NN time) (NNS points))))) (. .)))
12165618	6	(ROOT (S (NP (NP (JJ Steady-state) (NNS pharmacokinetics)) (PP (IN of) (NP (NNS Doc_12165618_831_840_Chemical)))) (VP (VBD were) (VP (VBN done) (PP (IN at) (NP (NN week) (CD 4))) (PP (IN after) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NNS Doc_12165618_885_894_Chemical))))))) (. .)))
12165618	7	(ROOT (S (NP (NP (DT The) (JJ cumulative) (NN incidence)) (PP (IN of) (NP (NP (ADJP (JJ persistent) (JJ sterile)) (NN leukocyturia)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (NNP >) (CC or) (NNP =)) (NP (CD 75) (NNS cells))) (: /) (NP (NP (NNP micro) (NNP L)) (PP (IN in) (NP (QP (IN at) (JJS least) (CD 2)) (JJ consecutive) (NNS visits))))) (-RRB- -RRB-)))) (PP (IN after) (NP (CD 96) (NNS weeks)))) (VP (VBD was) (NP (CD 53) (NN %))) (. .)))
12165618	8	(ROOT (S (NP (NNP Persistent) (NNP sterile) (NNP leukocyturia)) (VP (VBD was) (ADVP (RB frequently)) (VP (VBN associated) (PP (PP (IN with) (NP (NP (DT a) (JJ mild) (NN increase)) (PP (IN in) (NP (DT the) (JJ urine) (JJ albumin/Doc) (NN _) (JJ 12165618_1148_1158_Chemical) (NN ratio))))) (CC and) (PP (IN by) (NP (JJ microscopic) (NNS Doc_12165618_1184_1193_Disease)))))) (. .)))
12165618	9	(ROOT (S (NP (NP (DT The) (JJ cumulative) (NN incidence)) (PP (IN of) (NP (NP (JJ serum) (JJ Doc_12165618_1229_1239_Chemical) (NNS levels)) (VP (VBG >) (NP (CD 50) (NN %)) (PP (IN above) (ADJP (JJ normal))))))) (VP (VBD was) (NP (CD 33) (NN %)) (PP (IN after) (NP (CD 96) (NNS weeks)))) (. .)))
12165618	10	(ROOT (S (NP (NP (NNP Children)) (PP (IN with) (NP (ADJP (JJ persistent) (JJ sterile)) (NN leukocyturia)))) (ADVP (RBR more) (RB frequently)) (VP (VBD had) (NP (NP (JJ serum) (JJ Doc_12165618_1361_1371_Chemical) (NNS levels)) (PP (IN of) (NP (NP (CD 50) (NN %)) (PP (IN above) (NP (ADJP (JJ normal) (PP (IN than) (NP (DT those)))) (NNS children)))))) (PP (IN without) (NP (ADJP (JJ persistent) (JJ sterile)) (NN leukocyturia)))) (. .)))
12165618	11	(ROOT (S (PP (IN In) (NP (NP (NP (NNS children)) (JJR younger)) (PP (IN than) (NP (CD 5.6) (NNS years))))) (, ,) (NP (ADJP (JJ persistent) (JJ sterile)) (NN leukocyturia)) (VP (VBD was) (ADJP (ADJP (RB significantly) (RBR more) (JJ frequent)) (PP (IN than) (PP (IN in) (NP (JJR older) (NNS children)))))) (. .)))
12165618	12	(ROOT (S (NP (NP (DT A) (JJR higher) (JJ cumulative) (NN incidence)) (PP (IN of) (NP (JJ persistent) (NN leukocyturia)))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (NNS children)) (PP (IN with) (NP (DT an) (NN area))))) (PP (IN under) (NP (NP (DT the) (NN curve) (CD >) (ADJP (CD 19) (JJ mg/L) (NN x)) (NN h)) (CC or) (NP (NP (DT a) (JJ peak) (NN serum) (NN level)) (PP (IN of) (NP (NP (NNP Doc_12165618_1730_1739_Chemical) (NNP >)) (ADJP (CD 12) (JJ mg/L))))))))) (. .)))
12165618	13	(ROOT (S (PP (IN In) (NP (CD 4) (NNS children))) (, ,) (NP (NNS Doc_12165618_1765_1774_Chemical)) (VP (VBD was) (VP (VBN discontinued) (PP (RB because) (IN of) (NP (NN nephrotoxicity))))) (. .)))
12165618	14	(ROOT (S (ADVP (RB Subsequently)) (, ,) (S (NP (DT the) (JJ serum) (JJ Doc_12165618_1843_1853_Chemical) (NNS levels)) (VP (VBD decreased) (, ,) (S (NP (DT the) (NN urine)) (ADJP (JJ albumin/Doc)) (S (VP (VBG _) (NP (NP (JJ 12165618_1890_1900_Chemical) (NNS ratios)) (VP (VBN returned) (PP (TO to) (NP (CD zero)))))))))) (, ,) (CC and) (S (NP (DT the) (NN leukocyturia)) (VP (VBD disappeared) (PP (IN within) (NP (CD 3) (NNS months))))) (. .)))
12165618	15	(ROOT (S (NP (NP (NNP Children)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_12165618_2011_2020_Chemical))))) (VP (VBP have) (NP (NP (DT a) (JJ high) (JJ cumulative) (NN incidence)) (PP (IN of) (NP (ADJP (JJ persistent) (JJ sterile)) (NN leukocyturia))))) (. .)))
12165618	16	(ROOT (S (NP (NP (NNP Children)) (PP (IN with) (NP (ADJP (JJ persistent) (JJ sterile)) (NN leukocyturia)))) (ADVP (RBR more) (RB frequently)) (VP (VBD had) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ serum) (JJ Doc_12165618_2177_2187_Chemical) (NNS levels)) (PP (IN of) (NP (QP (CD >) (CD 50)) (NN %)))))) (PP (IN above) (ADJP (JJ normal)))) (. .)))
12165618	17	(ROOT (S (NP (NNP Younger) (NNS children)) (VP (VBP have) (NP (NP (DT an) (JJ additional) (NN risk)) (PP (IN for) (NP (NNS Doc_12165618_2262_2281_Disease))))) (. .)))
12165618	18	(ROOT (S (NP (NP (DT The) (NN impairment)) (PP (IN of) (NP (NP (DT the) (JJ renal) (NN function)) (PP (IN in) (NP (DT these) (NNS children)))))) (VP (VBD occurred) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (JJ clinical) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_12165618_2386_2401_Disease)))))))) (. .)))
12165618	19	(ROOT (S (NP (NNP Doc_12165618_2403_2412_Chemical-associated)) (ADVP (RB nephrotoxicity)) (VP (MD must) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)) (, ,) (ADVP (RB especially)) (PP (IN in) (NP (NP (NNS children)) (PP (IN with) (NP (NP (NP (NN risk) (NNS factors)) (PP (JJ such) (IN as) (NP (ADJP (JJ persistent) (JJ sterile)) (NN leukocyturia)))) (, ,) (NP (NP (NN age)) (NP (QP (CD <) (CD 5.6)) (NNS years))) (, ,) (NP (NP (DT an) (NN area)) (PP (IN under) (NP (NP (DT the) (NN curve)) (PP (IN of) (NP (NNP Doc_12165618_2591_2600_Chemical) (NNP >) (ADJP (CD 19) (JJ mg/L) (NN x)) (NNS h)))))) (, ,) (CC and) (NP (NP (DT a) (NNP C) (PRN (-LRB- -LRB-) (NP (NN max)) (-RRB- -RRB-)) (NN >)) (ADJP (CD 12) (JJ mg/L)))))))))) (. .)))
12359538	0	(ROOT (NP (NP (NNP Utility)) (PP (IN of) (NP (NN troponin) (NN I))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Doc_12359538_39_46_Chemical-associated) (NNS Doc_12359538_58_68_Disease))))) (. .)))
12359538	1	(ROOT (S (NP (NP (JJ Baseline) (NN electrocardiogram) (NNS abnormalities) (CC and) (NN market) (NNS elevations)) (VP (RB not) (VBN associated) (PP (IN with) (NP (NNS Doc_12359538_153_172_Disease))))) (VP (VBP make) (NP (NP (ADJP (JJ accurate)) (NN diagnosis)) (PP (IN of) (NP (NP (NP (NNS Doc_12359538_200_221_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12359538_223_225_Disease)) (-RRB- -RRB-))) (ADJP (JJ difficult) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Doc_12359538_254_261_Chemical-associated) (NNS Doc_12359538_273_283_Disease)))))))))) (. .)))
12359538	2	(ROOT (S (NP (NN Troponin) (NN sampling)) (VP (MD may) (VP (VB offer) (NP (NP (JJR greater) (JJ diagnostic) (NN utility)) (PP (IN in) (NP (DT these) (NNS patients)))))) (. .)))
12359538	3	(ROOT (S (S (VP (TO To) (VP (VB assess) (NP (NNS outcomes)) (PP (VBN based) (PP (IN on) (NP (NP (NN troponin) (NN positivity)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ Doc_12359538_435_442_Chemical) (NNS Doc_12359538_443_453_Disease))))))))))) (VP (VBD admitted) (PP (IN for) (NP (NP (NN exclusion)) (PP (IN of) (NP (NNS Doc_12359538_480_482_Disease)))))) (. .)))
12359538	4	(ROOT (S (NP (NNS Outcomes)) (VP (VBD were) (VP (VBN examined) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN admitted) (PP (IN for) (NP (JJ possible) (NNS Doc_12359538_550_552_Disease))) (PP (IN after) (NP (JJ Doc_12359538_559_566_Chemical) (NN use)))))))) (. .)))
12359538	5	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD underwent) (NP (NP (DT a) (JJ rapid) (JJ rule-in) (NN protocol)) (SBAR (WHNP (WDT that)) (S (VP (VBD included) (NP (NP (JJ serial) (NN sampling)) (PP (IN of) (NP (NP (NP (JJ Doc_12359538_653_661_Chemical) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NNP CK)) (-RRB- -RRB-))) (, ,) (NP (NNP CK-MB)) (, ,) (CC and) (NP (NP (JJ cardiac) (NN troponin) (NN I)) (PRN (-LRB- -LRB-) (NP (NNP cTnI)) (-RRB- -RRB-)))))) (PP (IN over) (NP (CD eight) (NNS hours)))))))) (. .)))
12359538	6	(ROOT (S (NP (NNS Outcomes)) (VP (VBD included) (SBAR (S (NP (NP (NNS Doc_12359538_748_756_Disease)) (PRN (-LRB- -LRB-) (ADVP (RB CK-MB)) (NP (NP (QP (CD >) (CC or) (CD =) (CD 8)) (NN ng/mL)) (PP (IN with) (NP (NP (DT a) (JJ relative) (NN index) (NN -LSB-)) (PRN (-LRB- -LRB-) (NP (NNP CK-MB) (QP (CD x) (CD 100))) (-RRB- -RRB-))))) (: /))) (VP (VBP total) (NP (NP (NP (NNP CK) (NNP -RSB-) (NNP >)) (CC or) (NP (NNP =) (CD 4) (, ,) (CD Doc_12359538_832_845_Disease))) (, ,) (CC and) (NP (NP (JJ significant) (NNS Doc_12359538_863_879_Disease)) (PRN (-LRB- -LRB-) (NP (QP (CD >) (CC or) (CD =) (CD 50)) (NN %)) (-RRB- -RRB-)))))))) (. .)))
12359538	7	(ROOT (S (PP (IN Of) (NP (DT the) (CD 246) (JJ admitted) (NNS patients))) (, ,) (NP (NP (CD 34)) (PRN (-LRB- -LRB-) (NP (CD 14) (NN %)) (-RRB- -RRB-))) (VP (VBD met) (SBAR (S (NP (NP (NP (JJ CK-MB) (NNS criteria)) (PP (IN for) (NP (CD Doc_12359538_962_964_Disease) (CC and) (CD 38)))) (PRN (-LRB- -LRB-) (NP (CD 16) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (NP (JJ cTnI) (NNS elevations)))))) (. .)))
12359538	8	(ROOT (S (NP (NNP Angiography)) (VP (VBD was) (VP (VBN performed) (PP (IN in) (NP (NP (CD 29)) (PP (IN of) (NP (NP (CD 38) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (ADJP (JJ cTnI-positive)) (, ,) (PP (IN with) (NP (NP (JJ significant) (NN disease) (NN present)) (PP (IN in) (NP (CD 25)))))))) (PRN (-LRB- -LRB-) (NP (CD 86) (NN %)) (-RRB- -RRB-)))))))) (. .)))
12359538	9	(ROOT (S (S (NP (NP (CD Three)) (PP (IN of) (NP (NP (DT the) (CD four) (NNS patients)) (PP (IN without) (NP (JJ significant) (NN disease))) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (JJ cTnI) (NNS elevations)))))))) (VP (VBD met) (NP (JJ CK-MB) (NNS criteria)) (PP (IN for) (NP (NNS Doc_12359538_1218_1220_Disease))))) (, ,) (CC and) (S (NP (DT the) (JJ other)) (VP (VBD had) (NP (NP (DT a) (JJ peak) (JJ CK-MB) (NN level)) (PP (IN of) (NP (CD 13) (NN ng/mL)))))) (. .)))
12359538	10	(ROOT (S (NP (NP (NNS Sensitivities)) (, ,) (NP (NNS specificities)) (, ,) (CC and) (NP (NP (ADJP (JJ positive) (CC and) (JJ negative)) (NN likelihood) (NNS ratios)) (PP (IN for) (NP (NP (NN predicting) (NNS Doc_12359538_1361_1374_Disease)) (CC or) (NP (JJ significant) (NN disease)))))) (VP (VP (VBD were) (ADJP (JJ high)) (PP (IN for) (NP (DT both) (NNS Doc_12359538_1417_1425_Disease) (CC and) (NNS cTnI)))) (CC and) (VP (VBD were) (ADJP (RB not) (RB significantly) (JJ different)))) (. .)))
12359538	11	(ROOT (S (NP (NP (JJS Most) (NNS patients)) (PP (IN with) (NP (NNS cTnI)))) (VP (MD elevations) (VP (VP (VB meet) (NP (JJ CK-MB) (NNS criteria)) (PP (IN for) (NP (NNS Doc_12359538_1545_1547_Disease)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (VP (VB have) (NP (NP (DT a) (JJ high) (NN incidence)) (PP (IN of) (NP (VBG underlying) (JJ significant) (NN disease))))))) (. .)))
12359538	12	(ROOT (S (NP (NNP Troponin)) (VP (VBZ appears) (S (VP (TO to) (VP (VB have) (NP (NP (DT an) (JJ equivalent) (JJ diagnostic) (NN accuracy)) (PP (VBN compared) (PP (IN with) (NP (NNP CK-MB)))))))) (PP (IN for) (S (VP (VBG diagnosing) (NP (NP (NNS Doc_12359538_1711_1719_Disease)) (PP (IN in) (NP (NNS patients)))) (PP (IN with) (NP (NP (NN Doc_12359538_1737_1744_Chemical-associated) (NNS Doc_12359538_1756_1766_Disease)) (CC and) (NP (VBN suspected) (NNS Doc_12359538_1781_1783_Disease)))))))) (. .)))
12372954	0	(ROOT (S (VP (VB Acute) (S (NP (NNS Doc_12372954_6_28_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NP (NNS Doc_12372954_36_47_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Sermion)) (-RRB- -RRB-))))))) (. .)))
12372954	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NP (NNS Doc_12372954_79_107_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12372954_109_112_Disease)) (-RRB- -RRB-))) (ADJP (JJ due) (PP (TO to) (NP (NP (NNS Doc_12372954_121_132_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Sermion)) (-RRB- -RRB-))))))))) (. .)))
12372954	2	(ROOT (S (NP (DT A) (JJ 50-year-old) (NN patient)) (VP (VBD admitted) (PP (TO to) (NP (PRP$ our) (NN hospital))) (PP (IN for) (NP (NNS Doc_12372954_195_200_Disease) (CC and) (NNS Doc_12372954_205_224_Disease)))) (. .)))
12372954	3	(ROOT (S (PP (IN Before) (NP (NN admission))) (, ,) (NP (PRP he)) (VP (VBD had) (VP (VBN been) (VP (VBG taking) (NP (JJ Doc_12372954_263_274_Chemical) (CC and) (JJ bendazac) (NNS Doc_12372954_288_294_Chemical)) (PP (JJ due) (TO to) (NP (NP (NNS Doc_12372954_302_324_Disease)) (PP (IN at) (NP (JJ ophthalmologic) (NN department)))))))) (. .)))
12372954	4	(ROOT (S (ADVP (RB Thereafter)) (, ,) (NP (PRP he)) (VP (VBD experienced) (NP (JJ intermittent) (NNS Doc_12372954_395_400_Disease) (CC and) (NNS Doc_12372954_405_414_Disease))) (. .)))
12372954	5	(ROOT (S (PP (IN On) (NP (NN admission))) (, ,) (NP (NP (NP (JJ clinical) (NNS symptoms)) (PRN (-LRB- -LRB-) (NP (JJ i.e.) (NNS Doc_12372954_454_464_Disease) (CC and) (NN Doc_12372954_469_474_Disease)) (-RRB- -RRB-))) (CC and) (NP (NP (NN laboratory) (NNS findings)) (PRN (-LRB- -LRB-) (NP (JJ i.e.) (NNS Doc_12372954_506_518_Disease) (CC and) (NN Doc_12372954_523_536_Disease)) (-RRB- -RRB-)))) (VP (VBD suggested) (NP (NP (NNS Doc_12372954_548_551_Disease)) (, ,) (CC and) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN confirmed) (PP (IN by) (NP (NP (JJ pathologic) (NNS findings)) (PP (IN on) (NP (JJ renal) (NN biopsy))))))))))) (. .)))
12372954	6	(ROOT (S (NP (DT A) (JJ lymphocyte) (NN transformation) (NN test)) (VP (VBD demonstrated) (NP (DT a) (JJ positive) (NN result)) (PP (IN against) (NP (NNS Doc_12372954_689_700_Chemical)))) (. .)))
12372954	7	(ROOT (S (S (NP (NNP Treatment)) (VP (VBD was) (VP (VBN consisted) (PP (IN of) (NP (NP (NN withdrawal)) (PP (IN of) (NP (JJ Doc_12372954_743_754_Chemical) (CC and) (JJ intravenous) (NNS Doc_12372954_771_789_Chemical)))))))) (, ,) (CC and) (S (NP (PRP$ his) (JJ renal) (NN function)) (VP (VBD was) (VP (ADVP (RB completely)) (VBN recovered)))) (. .)))
12372954	8	(ROOT (S (PP (TO To) (NP (PRP$ our) (NN knowledge))) (, ,) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (NN report)) (PP (IN of) (NP (NN Doc_12372954_886_897_Chemical-associated) (NNS Doc_12372954_909_912_Disease))))) (. .)))
12452552	0	(ROOT (S (NP (NNP Doc_12452552_0_30_Disease)) (VP (VBD complicated) (PP (IN by) (NP (JJ massive) (NNS Doc_12452552_54_73_Disease))) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NNS Doc_12452552_92_113_Disease)))))) (. .)))
12452552	1	(ROOT (S (NP (NP (DT A) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_12452552_130_151_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12452552_153_156_Disease)) (-RRB- -RRB-))))) (VP (VBD developed) (NP (NP (NNS Doc_12452552_168_198_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12452552_200_203_Disease)) (-RRB- -RRB-))) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_12452552_229_240_Chemical) (CC and) (NNS Doc_12452552_245_260_Chemical)))))) (. .)))
12452552	2	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NP (DT the) (JJ typical) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_12452552_301_304_Disease))))))) (, ,) (NP (JJ massive) (NNS Doc_12452552_314_333_Disease)) (VP (VBD was) (VP (VBN observed) (PP (IN during) (NP (DT the) (NN episode))))) (. .)))
12452552	3	(ROOT (S (NP (DT This) (NN report)) (VP (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NNS Doc_12452552_393_396_Disease)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NNS Doc_12452552_415_418_Disease)))))) (VP (MD may) (VP (VB be) (VP (VBN complicated) (PP (IN by) (NP (NNS Doc_12452552_441_460_Disease))))))))) (CC and) (VP (VBZ needs) (NP (JJ special) (NN caution)) (PP (IN for) (NP (DT this) (NN complication))))) (. .)))
12487093	0	(ROOT (S (NP (NP (NN Blood) (NN brain) (NN barrier)) (PP (IN in) (NP (ADJP (JJ right) (: -) (CC and) (JJ left-pawed)) (JJ female) (NNS rats)))) (VP (VBN assessed) (PP (IN by) (NP (DT a) (JJ new) (NN staining) (NN method)))) (. .)))
12487093	1	(ROOT (S (NP (NP (DT The) (JJ asymmetrical) (NN breakdown)) (PP (IN of) (NP (NP (DT the) (JJ blood-brain) (NN barrier)) (PRN (-LRB- -LRB-) (NP (NNP BBB)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (JJ female) (NNS rats))))) (. .)))
12487093	2	(ROOT (S (NP (NNP Paw) (NN preference)) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (NP (DT a) (NN food)) (VP (VBG reaching) (NP (NN test))))))) (. .)))
12487093	3	(ROOT (S (NP (JJ Doc_12487093_233_243_Chemical-induced) (NNS Doc_12487093_252_264_Disease)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB destroy) (NP (NP (DT the) (NNP BBB)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN evaluated) (S (VP (VBG using) (NP (NP (JJ Doc_12487093_320_340_Chemical) (PRN (-LRB- -LRB-) (NP (NNP TTC)) (-RRB- -RRB-)) (NN staining)) (PP (IN of) (NP (DT the) (NN brain) (NNS slices)))) (PP (RB just) (IN after) (S (VP (VBG giving) (NP (NNS Doc_12487093_394_404_Chemical)) (PP (IN for) (NP (CD 30) (NN s.))))))))))))))))))))
12487093	4	(ROOT (S (PP (IN In) (NP (JJ normal) (NNS rats))) (, ,) (NP (DT the) (JJ whole) (NN brain) (NNS sections)) (VP (VBD exhibited) (NP (JJ complete) (NN staining)) (PP (IN with) (NP (NNP TTC)))) (. .)))
12487093	5	(ROOT (S (PP (IN After) (NP (NP (JJ Doc_12487093_500_510_Chemical) (NN infusion)) (PP (IN for) (NP (CD 30) (NNS s))))) (, ,) (NP (EX there)) (VP (VBD were) (UCP (NP (NP (JJ large) (JJ unstained) (NNS areas)) (PP (IN in) (NP (NP (DT the) (JJ left) (NN brain)) (PP (IN in) (NP (JJ right-pawed) (NNS animals)))))) (, ,) (CC and) (ADVP (RB vice) (RB versa)) (PP (IN in) (NP (JJ left-pawed) (NNS animals))))) (. .)))
12487093	6	(ROOT (S (NP (JJ Similar) (NNS results)) (VP (VBD were) (VP (VBN obtained) (PP (IN in) (NP (NP (NN Doc_12487093_676_683_Disease-induced) (NN breakdown)) (PP (IN of) (NP (NNP BBB))))))) (. .)))
12487093	7	(ROOT (S (NP (DT These) (NNS results)) (VP (VBD were) (VP (VBN explained) (PP (IN by) (NP (DT an) (JJ asymmetric) (JJ cerebral) (NN blood) (NN flow))) (PP (VBG depending) (PP (IN upon) (NP (NP (DT the) (NN paw) (NN preference)) (PP (IN in) (NP (NNS rats)))))))) (. .)))
12487093	8	(ROOT (S (NP (PRP It)) (VP (VBD was) (VP (VBN suggested) (SBAR (IN that) (S (NP (NP (DT this) (JJ new) (NN method)) (CC and) (NP (DT the) (NNS results))) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (JJ contralateral) (NN motor) (NN control)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (ADJP (JJ important) (PP (IN in) (S (VP (VBG determining) (NP (DT the) (JJ dominant) (JJ cerebral) (NN hemisphere)) (PP (IN in) (NP (NNS animals))))))))))))))))))) (. .)))
12498738	0	(ROOT (S (NP (NNP Doc_12498738_0_10_Chemical)) (VP (VBZ protects) (PP (IN against) (NP (NN Doc_12498738_28_39_Chemical-induced) (NNS Doc_12498738_48_76_Disease)))) (. .)))
12498738	1	(ROOT (S (NP (JJ Several) (JJ cytopathic) (NNS mechanisms)) (VP (VBP have) (VP (VBN been) (VP (VBN suggested) (S (VP (TO to) (VP (VB mediate) (NP (NP (DT the) (JJ dose-limiting) (ADJP (JJ cumulative) (CC and) (JJ irreversible)) (NNS Doc_12498738_185_199_Disease)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_12498738_210_221_Chemical))))))))))) (. .)))
12498738	2	(ROOT (S (NP (JJ Recent) (NN evidence)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (JJ oxidative) (NN stress) (CC and) (NNS Doc_12498738_275_300_Disease)) (VP (VBP are) (NP (NP (JJ key) (NNS factors)) (PP (IN in) (NP (DT the) (JJ pathogenic) (NN process)))))))) (. .)))
12498738	3	(ROOT (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN investigation)))) (VP (VBD was) (S (VP (TO to) (VP (VB test) (NP (DT the) (NNS hypothesis)) (SBAR (IN that) (S (NP (NP (NNS Doc_12498738_412_422_Chemical)) (, ,) (NP (NP (DT a) (JJ nonselective) (JJ beta-adrenergic) (NN receptor) (NN antagonist)) (PP (IN with) (NP (JJ potent) (NN antioxidant) (NNS properties)))) (, ,)) (VP (VBZ protects) (PP (IN against) (NP (NP (DT the) (NNS Doc_12498738_532_590_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ subchronic) (JJ Doc_12498738_618_629_Chemical) (NNS Doc_12498738_630_638_Disease))))))))))))) (. .)))
12498738	4	(ROOT (S (NP (NNP Heart) (CC and) (NNP Doc_12498738_650_668_Disease)) (VP (VBD were) (VP (VBN isolated) (PP (IN from) (NP (NP (NNS rats)) (VP (VBN treated) (PP (IN for) (NP (NP (CD 7) (NNS weeks)) (PP (IN with) (NP (NP (NP (NNS Doc_12498738_718_729_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN mg/kg) (NN sc/week)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_12498738_749_759_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mg/kg) (NN ip/week)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (DT the) (CD two) (NNS drugs))))))))))))) (. .)))
12498738	5	(ROOT (S (NP (NNP Heart) (NNP mitochondria)) (VP (VBD isolated) (PP (IN from) (NP (NP (NN Doc_12498738_849_860_Chemical-treated) (NNS rats)) (VP (VBN exhibited) (NP (JJ depressed) (NNS rates)) (PP (IN for) (NP (NP (NN state) (CD 3) (NN respiration)) (PRN (-LRB- -LRB-) (NP (CD 336) (NNP +) (NNS /)) (: -) (NP (NP (CD 26) (CD versus) (CD 425) (NNP +) (NNP /)) (: -) (NP (CD 53) (JJ natom) (NNP O/min/mg) (NN protein))) (-RRB- -RRB-)) (CC and) (NP (DT a) (JJR lower) (JJ respiratory) (NN control) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NNP RCR)) (-RRB- -RRB-)))) (PRN (-LRB- -LRB-) (FRAG (NP (CD 4.3) (CD +)) (: /) (NP (NP (NNP -) (CD 0.6)) (PP (IN versus) (NP (QP (CD 5.8) (CD +))))) (: /) (VP (VBN -) (NP (CD 0.4)))) (-RRB- -RRB-)) (PP (VBN compared) (PP (IN with) (NP (NP (JJ cardiac) (NN mitochondria)) (VP (VBN isolated) (PP (IN from) (NP (JJ saline-treated) (NNS rats))))))))))) (. .)))
12498738	6	(ROOT (S (NP (NP (JJ Mitochondrial) (NN Doc_12498738_1139_1146_Chemical-loading) (NN capacity)) (CC and) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NNS Doc_12498738_1184_1188_Chemical-dehydrogenase))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN suppressed) (PP (IN in) (NP (JJ cardiac) (NN mitochondria))) (PP (IN from) (NP (NN Doc_12498738_1253_1264_Chemical-treated) (NNS rats))))) (. .)))
12498738	7	(ROOT (S (NP (JJ Doc_12498738_1279_1290_Chemical) (NN treatment)) (ADVP (RB also)) (VP (VBD caused) (NP (DT a) (NN decrease)) (PP (IN in) (NP (NNP RCR))) (PP (IN for) (NP (NP (NP (NNS Doc_12498738_1335_1353_Disease)) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 3.9)) (JJ +)) (: /)) (: -) (FRAG (NP (NP (CD 0.9) (CC versus)) (NP (CD 5.6) (JJ +) (NNS /))) (: -) (NP (NP (CD 0.7)) (PP (IN for) (NP (NN control) (NNS rats)))))) (-RRB- -RRB-))) (CC and) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ hepatic) (NN cytochrome) (NN oxidase) (NN activity))))))) (. .)))
12498738	8	(ROOT (S (NP (NP (NNP Coadministration)) (PP (IN of) (NP (NNS Doc_12498738_1479_1489_Chemical)))) (VP (VP (VBD decreased) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (JJ cellular) (NN vacuolization)))) (PP (IN in) (NP (JJ cardiac) (NNS myocytes)))) (CC and) (VP (VBD prevented) (NP (NP (DT the) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_12498738_1596_1607_Chemical)) (PP (IN on) (NP (JJ mitochondrial) (NN respiration)))))) (PP (IN in) (NP (DT both) (NN heart) (CC and) (NN liver))))) (. .)))
12498738	9	(ROOT (S (NP (NNP Doc_12498738_1662_1672_Chemical)) (ADVP (RB also)) (VP (VBD prevented) (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NP (JJ mitochondrial) (JJ Doc_12498738_1718_1724_Chemical) (NN loading) (NN capacity)) (CC and) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (DT the) (JJ respiratory) (NNS complexes)) (PP (IN of) (NP (NP (NNS Doc_12498738_1793_1811_Disease)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_12498738_1822_1833_Chemical))))))))))))) (. .)))
12498738	10	(ROOT (S (NP (NP (NNP Doc_12498738_1835_1845_Chemical)) (PP (IN by) (NP (PRP itself)))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (NNS parameters)) (VP (VBN measured) (PP (IN for) (NP (NN heart) (CC or) (NNS Doc_12498738_1915_1933_Disease))))))))) (. .)))
12498738	11	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (NP (DT this) (NN protection)) (PP (IN by) (NP (NP (NNS Doc_12498738_1975_1985_Chemical)) (PP (IN against) (NP (DT both) (NP (DT the) (ADJP (JJ structural) (CC and) (JJ functional)) (JJ cardiac) (NN tissue)) (NN damage)))))) (VP (MD may) (VP (VB afford) (NP (JJ significant) (JJ clinical) (NN advantage)) (PP (IN in) (S (VP (VBG minimizing) (NP (NP (DT the) (JJ dose-limiting) (NNS Doc_12498738_2125_2150_Disease) (CC and) (NNS Doc_12498738_2155_2169_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBZ accompanies) (NP (NP (JJ long-term) (JJ Doc_12498738_2197_2208_Chemical) (NN therapy)) (PP (IN in) (NP (JJ Doc_12498738_2220_2226_Disease) (NNS patients))))))))))))))))) (. .)))
12523489	0	(ROOT (S (NP (JJ Doc_12523489_0_7_Chemical-induced) (NNS Doc_12523489_16_29_Disease)) (VP (VBZ is) (ADVP (RBR more)) (VP (VBN influenced) (PP (IN by) (NP (JJ Doc_12523489_52_61_Chemical) (NN receptor) (NNS agonists))) (PP (IN than) (NP (NN Doc_12523489_85_96_Chemical-induced) (NNS Doc_12523489_105_118_Disease))))) (. .)))
12523489	1	(ROOT (S (NP (NP (DT The) (NN influence)) (PP (IN of) (NP (NP (JJ Doc_12523489_137_146_Chemical) (NN receptor) (NNS agonists) (CC and) (NNS antagonists)) (PP (IN on) (NP (NN Doc_12523489_184_191_Chemical-and) (NN Doc_12523489_196_207_Chemical-induced) (NNS Doc_12523489_216_229_Disease)))))) (VP (VBD was) (VP (VBN examined) (PP (IN in) (NP (NNS mice))))) (. .)))
12523489	2	(ROOT (S (S (NP (DT All) (JJ Doc_12523489_256_265_Chemical) (NN receptor) (NNS agonists)) (ADVP (RB significantly)) (VP (VBD decreased) (NP (DT the) (NN locomotor) (NN activity)) (PP (IN in) (NP (NNS mice))))) (, ,) (CC and) (S (NP (DT the) (NNS effects)) (VP (VBD were) (ADJP (JJ dose-dependent)))) (. .)))
12523489	3	(ROOT (S (NP (PRP It)) (VP (VBZ seems) (SBAR (IN that) (S (NP (NNP Doc_12523489_391_400_Chemical) (NNP A1) (CC and) (NNP A2) (NNS receptors)) (VP (MD might) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (DT this) (NN reaction))))))))) (. .)))
12523489	4	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (DT all) (JJ Doc_12523489_471_480_Chemical) (NN receptor)) (VP (VBZ agonists) (: :) (NP (NP (JJ Doc_12523489_500_565_Chemical) (-LRB- -LRB-) (NNS Doc_12523489_567_576_Chemical) (-RRB- -RRB-)) (, ,) (NP (NN A2A) (NN receptor) (NN agonist)) (, ,) (NP (JJ Doc_12523489_601_624_Chemical) (-LRB- -LRB-) (NNS Doc_12523489_626_629_Chemical) (-RRB- -RRB-)) (, ,) (NP (NN A1) (NN receptor) (NN agonist)) (, ,) (CC and) (NP (NP (NNS Doc_12523489_657_687_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12523489_689_693_Chemical)) (-RRB- -RRB-)) (, ,) (NP (NP (CD A2/A1) (NN receptor)) (VP (VBN agonist) (ADVP (RB significantly)))) (CC and) (NP (JJ dose-dependently) (VBN decreased) (NN Doc_12523489_764_771_Chemical-induced) (NN locomotor) (NN activity))))) (. .)))
12523489	5	(ROOT (S (NP (NNP Doc_12523489_800_803_Chemical)) (VP (VBD reduced) (NP (JJ Doc_12523489_812_819_Chemical) (NN action)) (PP (IN at) (NP (NP (DT the) (NNS doses)) (SBAR (WHNP (WDT which)) (S (, ,) (PP (VBN given) (NP (RB alone))) (, ,) (VP (VBD did) (RB not) (VP (VB influence) (ADVP (RB motility)) (, ,) (SBAR (IN while) (S (NP (NNS Doc_12523489_894_903_Chemical) (CC and) (NNS Doc_12523489_908_912_Chemical)) (VP (VBD decreased) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NNS Doc_12523489_937_944_Chemical)))) (PP (IN at) (NP (NP (DT the) (NNS doses)) (SBAR (WHNP (WDT which)) (S (, ,) (PP (VBN given) (NP (RB alone))) (, ,) (VP (VBD decreased) (NP (NN locomotor) (NN activity)) (PP (IN in) (NP (NNS animals)))))))))))))))))) (. .)))
12523489	6	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NP (DT both) (JJ Doc_12523489_1065_1074_Chemical) (NNS receptors)) (PP (IN in) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NNS Doc_12523489_1102_1109_Chemical)))))))) (SBAR (IN although) (S (NP (NP (NNS agonists)) (PP (IN of) (NP (CD A1) (NNS receptors)))) (VP (VBP seem) (S (VP (TO to) (VP (VB have) (NP (NP (JJR stronger) (NN influence)) (PP (IN on) (NP (PRP it))))))))))) (. .)))
12523489	7	(ROOT (S (NP (NP (DT The) (JJ selective) (NN blockade)) (PP (IN of) (NP (NP (CD A2) (JJ Doc_12523489_1212_1221_Chemical) (NN receptor)) (PP (IN by) (NP (NP (NNS Doc_12523489_1234_1238_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12523489_1240_1272_Chemical)) (-RRB- -RRB-))))))) (ADVP (RB significantly)) (VP (VBD enhanced) (NP (NP (NN Doc_12523489_1297_1304_Chemical-induced) (NN locomotor) (NN activity)) (PP (IN of) (NP (NNS animals))))) (. .)))
12523489	8	(ROOT (S (S (NP (NNP Doc_12523489_1344_1352_Chemical)) (VP (VBD had) (NP (JJ similar) (NN action)))) (CC but) (S (NP (DT the) (NN effect)) (VP (VBD was) (RB not) (ADJP (JJ significant)))) (. .)))
12523489	9	(ROOT (S (NP (NP (NP (NNP Doc_12523489_1408_1411_Chemical)) (PRN (-LRB- -LRB-) (ADJP (JJ 8-cyclopentyltheophylline)) (-RRB- -RRB-))) (: --) (NP (NN A1) (NN receptor) (NN antagonist)) (, ,)) (VP (VBD did) (RB not) (VP (VB show) (NP (NP (DT any) (NN influence)) (PP (IN in) (NP (DT this) (NN test)))))) (. .)))
12523489	10	(ROOT (S (ADVP (RB Similarly)) (, ,) (NP (DT all) (JJ Doc_12523489_1521_1530_Chemical) (NN receptor) (NNS agonists)) (VP (VP (VBD decreased) (NP (NN Doc_12523489_1559_1570_Chemical-induced) (NNS Doc_12523489_1579_1592_Disease))) (, ,) (CC but) (PP (IN at) (NP (DT the) (JJR higher) (NNS doses))) (PP (IN than) (NP (NP (DT those)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (ADJP (JJ active) (PP (IN in) (NP (NN Doc_12523489_1650_1657_Chemical-induced) (NNS Doc_12523489_1666_1679_Disease)))))))))) (. .)))
12523489	11	(ROOT (S (NP (NP (NP (DT The) (JJ selective) (NN blockade)) (PP (IN of) (NP (NP (NP (CD A2) (JJ Doc_12523489_1710_1719_Chemical) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12523489_1731_1735_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ non-selective) (NN blockade)) (PP (IN of) (NP (JJ Doc_12523489_1767_1776_Chemical) (NNS receptors))))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_12523489_1788_1796_Chemical)) (-RRB- -RRB-))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NNS Doc_12523489_1836_1847_Chemical)))) (PP (IN in) (NP (DT the) (NN locomotor) (NN activity) (NN test)))) (. .)))
12523489	12	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (DT all) (JJ Doc_12523489_1912_1921_Chemical) (NN receptor)) (VP (VBZ agonists) (S (-LRB- -LRB-) (NP (NNP A1) (CC and) (NNP A2)) (-RRB- -RRB-) (VP (VP (VB reduce) (NP (ADJP (JJ Doc_12523489_1959_1966_Chemical) (: -) (CC and) (JJ Doc_12523489_1972_1983_Chemical-induced)) (NN locomotor) (NN activity))) (CC and) (VP (VB indicate) (SBAR (IN that) (S (NP (NN Doc_12523489_2029_2036_Chemical-induced) (NNS Doc_12523489_2045_2058_Disease)) (VP (VBZ is) (ADVP (RBR more)) (VP (VBN influenced) (PP (IN by) (NP (NP (JJ Doc_12523489_2081_2090_Chemical) (NN receptor) (NNS agonists)) (PRN (-LRB- -LRB-) (ADVP (RB particularly)) (NP (CD A1) (NNS receptors)) (-RRB- -RRB-)))) (PP (IN than) (NP (NN Doc_12523489_2142_2153_Chemical-induced) (NNS Doc_12523489_2162_2175_Disease))))))))))))))) (. .)))
12535818	0	(ROOT (NP (NP (NP (NNP Doc_12535818_0_10_Chemical)) (CC and) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_12535818_27_42_Disease))))) (VP (VBG requiring) (NP (JJ permanent) (NN pacemaker)) (PP (IN in) (NP (NP (JJ elderly) (NNS patients)) (PP (IN with) (NP (JJ Doc_12535818_98_117_Disease) (CC and) (JJ prior) (NNS Doc_12535818_128_149_Disease)))))) (. .)))
12535818	1	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS Doc_12535818_221_231_Chemical)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_12535818_249_268_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12535818_270_272_Disease)) (-RRB- -RRB-))))))))) (VP (VBZ increases) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_12535818_296_311_Disease)) (VP (VBG requiring) (NP (DT a) (JJ permanent) (NN pacemaker))))))))))))) (. .)))
12535818	2	(ROOT (S (NP (NP (NNS Reports)) (PP (IN of) (NP (NP (JJ severe) (NNS Doc_12535818_375_390_Disease)) (PP (IN during) (NP (JJ Doc_12535818_398_408_Chemical) (NN therapy)))))) (VP (VBP are) (ADJP (JJ infrequent) (CC and) (JJ limited) (PP (TO to) (NP (NP (NNS studies)) (VP (VBG assessing) (NP (NP (NP (DT the) (NN therapy) (POS 's)) (NN use)) (PP (IN in) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_12535818_518_541_Disease))))))))))))) (. .)))
12535818	3	(ROOT (S (NP (NP (NP (DT A) (NN study) (NN cohort)) (PP (IN of) (NP (CD 8,770) (NNS patients) (NN age) (NN >)))) (CC or) (NP (NP (QP (CD =) (CD 65)) (NNS years)) (PP (IN with) (NP (NP (DT a) (JJ new) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_12535818_628_630_Disease))))))) (VP (VBD was) (VP (VBN identified) (PP (IN from) (NP (NP (DT a) (JJ provincewide) (NN database)) (PP (IN of) (NP (NNP Quebec) (NNS residents))))) (PP (IN with) (NP (NP (NP (DT a) (NNS Doc_12535818_702_723_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12535818_725_727_Disease)) (-RRB- -RRB-))) (PP (IN between) (NP (CD 1991) (CC and) (CD 1999))))))) (. .)))
12535818	4	(ROOT (S (S (VP (VBG Using) (NP (DT a) (JJ nested) (JJ case-control) (NN design)))) (, ,) (NP (NP (CD 477) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_12535818_801_816_Disease)) (VP (VBG requiring) (NP (DT a) (JJ permanent) (NN pacemaker)))))) (VP (VBD were) (VP (VBN matched) (-LRB- -LRB-) (NP (CD 1:4)) (-RRB- -RRB-) (PP (TO to) (NP (CD 1,908) (NNS controls))))) (. .)))
12535818	5	(ROOT (S (NP (JJ Multivariable) (JJ logistic) (NN regression)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB estimate) (NP (NP (NP (DT the) (NNS odds) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NNP OR)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN pacemaker) (NN insertion)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_12535818_1001_1011_Chemical) (NN use)))))) (, ,) (NP (NP (VBG controlling)) (PP (IN for) (NP (JJ baseline) (NN risk) (NNS factors)))) (CC and) (NP (NP (NN exposure)) (PP (TO to) (NP (NP (NNS Doc_12535818_1071_1078_Chemical)) (, ,) (NP (NNP Class) (NNP I) (JJ antiarrhythmic) (NNS agents)) (, ,) (NP (NNS beta-blockers)) (, ,) (NP (JJ Doc_12535818_1126_1133_Chemical) (NN channel) (NNS blockers)) (, ,) (CC and) (NP (NNS Doc_12535818_1156_1163_Chemical))))))))))) (. .)))
12535818	6	(ROOT (S (NP (JJ Doc_12535818_1174_1184_Chemical) (NN use)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (NP (NN pacemaker) (NN insertion)) (PRN (-LRB- -LRB-) (NP (NP (NNP OR)) (: :) (NP (NP (CD 2.14) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-)) (: :) (NP (QP (CD 1.30) (TO to) (CD 3.54))))) (-RRB- -RRB-)))))))) (. .)))
12535818	7	(ROOT (S (NP (DT This) (NN effect)) (VP (VBD was) (VP (VBN modified) (PP (IN by) (NP (NN gender))) (, ,) (PP (IN with) (NP (NP (DT a) (JJR greater) (NN risk)) (PP (IN in) (NP (NP (NNS women)) (PP (IN versus) (NP (NP (NNS men)) (PRN (-LRB- -LRB-) (NP (NP (NNP OR)) (: :) (NP (NP (NP (CD 3.86)) (, ,) (NP (ADJP (CD 95) (NN %)) (NNP CI))) (: :) (NP (NP (CD 1.70) (TO to) (CD 8.75)) (PP (IN vs.) (NP (NNP OR)))) (: :) (NP (NP (JJ 1.52) (, ,) (ADJP (CD 95) (NN %)) (NN CI)) (: :) (NP (QP (CD 0.80) (TO to) (CD 2.89)))))) (-RRB- -RRB-)))))))))) (. .)))
12535818	8	(ROOT (S (NP (NNP Doc_12535818_1451_1458_Chemical)) (VP (VBD was) (NP (NP (DT the) (RB only) (JJ other) (NN medication)) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (NP (NN pacemaker) (NN insertion)) (PRN (-LRB- -LRB-) (NP (NP (NNP OR)) (: :) (NP (NP (CD 1.78)) (, ,) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (: :) (NP (QP (CD 1.37) (TO to) (CD 2.31)))))) (-RRB- -RRB-))))))))) (. .)))
12535818	9	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS Doc_12535818_1629_1639_Chemical)) (PP (IN in) (NP (NP (JJ elderly) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_12535818_1665_1667_Disease)) (CC and) (NP (DT a) (JJ previous) (NNS Doc_12535818_1683_1685_Disease))))))))) (VP (VBZ increases) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_12535818_1708_1723_Disease)) (VP (VBG requiring) (NP (DT a) (JJ permanent) (NN pacemaker)))))))))) (. .)))
12535818	10	(ROOT (S (NP (NP (DT The) (NN finding)) (PP (IN of) (NP (NP (DT an) (JJ augmented) (NN risk)) (PP (IN of) (NP (NP (NN pacemaker) (NN insertion)) (PP (IN in) (NP (NP (JJ elderly) (NNS women)) (VP (VBG receiving) (NP (NNS Doc_12535818_1840_1850_Chemical)))))))))) (VP (VBZ requires) (NP (JJ further) (NN investigation))) (. .)))
12559315	0	(ROOT (S (NP (NP (JJ Doc_12559315_0_12_Chemical-induced) (JJ morphologic) (NNS changes)) (PP (IN in) (NP (DT the) (NN rat) (NN urinary) (NN bladder)))) (VP (VBP epithelium)) (. .)))
12559315	1	(ROOT (S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (JJ morphologic) (NNS changes)) (PP (IN in) (NP (NN rat) (NN urothelium))))))) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_12559315_157_169_Chemical)))) (. .)))
12559315	2	(ROOT (S (NP (JJ Nonsteroidal) (JJ anti-inflammatory) (JJ drug-induced) (NNS Doc_12559315_215_223_Disease)) (VP (VBZ is) (NP (DT a) (ADJP (RB poorly) (VBN recognized) (CC and) (VBN under-reported)) (NN condition))) (. .)))
12559315	3	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NNS Doc_12559315_292_308_Chemical))))) (, ,) (NP (NNS Doc_12559315_310_322_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (DT this) (NN condition)))))))))) (. .)))
12559315	4	(ROOT (S (NP (CD Three) (NNS groups)) (VP (VBD were) (VP (VBN established) (: :) (NP (NP (NP (NP (DT a) (NN control) (NN group)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 10))))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ high-dose) (NN group)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 10))))) (-RRB- -RRB-))) (, ,)) (VP (VBN treated) (PP (IN with) (NP (NP (CD one) (JJ intraperitoneal) (NN injection)) (PP (IN of) (NP (NNP Doc_12559315_519_531_Chemical) (CD 20) (NN mg/kg)))))) (, ,) (CC and) (NP (NP (NP (DT a) (JJ therapeutic) (NN dose) (NN group)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 10))))) (-RRB- -RRB-))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (JJ oral) (NNS Doc_12559315_594_606_Chemical)) (VP (VBD was) (VP (VBN administered) (NP (CD 3.25) (JJ mg/kg) (NN body) (NN weight)) (ADVP (RB daily)) (PP (IN for) (NP (CD 3) (NNS weeks))))))))))) (. .)))
12559315	5	(ROOT (S (S (NP (DT The) (NNS animals)) (VP (VBD were) (VP (ADVP (RB then)) (VBN killed)))) (CC and) (S (NP (DT the) (NNS bladders)) (VP (VBN removed) (PP (IN for) (NP (ADJP (JJ light) (CC and) (JJ electron)) (JJ microscopic) (NNS studies))))) (. .)))
12559315	6	(ROOT (S (NP (DT The) (JJ light) (JJ microscopic) (NNS findings)) (VP (VBD showed) (NP (NP (DT some) (JJ focal) (JJ epithelial) (NN degeneration)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (ADJP (RBR more) (JJ prominent)) (PP (IN in) (NP (DT the) (JJ high-dose) (NN group)))))))) (. .)))
12559315	7	(ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VBN compared) (PP (IN with) (NP (DT the) (NN control) (NN group)))))) (, ,) (NP (DT both) (JJ Doc_12559315_937_949_Chemical) (NNS groups)) (VP (VBD revealed) (NP (NP (ADJP (RB statistically) (JJ increased)) (NNS numbers)) (PP (IN of) (NP (JJ mast) (NNS cells)))) (PP (IN in) (NP (NP (NP (DT the) (NN mucosa)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.0001))) (-RRB- -RRB-))) (CC and) (NP (NP (NN penetration)) (PP (IN of) (NP (NNS Doc_12559315_1057_1074_Chemical)))))) (PP (IN through) (NP (NP (NN intercellular) (NNS areas)) (PP (IN of) (NP (DT the) (NN epithelium)))))) (. .)))
12559315	8	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NN difference)) (PP (IN in) (NP (NP (JJ mast) (NN cell) (NNS counts)) (PP (IN between) (NP (DT the) (JJ high) (CC and) (JJ therapeutic) (NN dose) (NNS groups)))))) (VP (VBD was) (ADVP (RB also)) (ADJP (ADJP (RB statistically) (JJ significant)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.0001))) (-RRB- -RRB-)))) (. .)))
12559315	9	(ROOT (NP (NP (NP (NNP Doc_12559315_1276_1288_Chemical)) (VP (VBN resulted) (PP (IN in) (NP (JJ histopathologic) (NNS findings))))) (ADJP (JJ typical) (PP (IN of) (NP (NNS Doc_12559315_1337_1358_Disease)))) (, ,) (PP (JJ such) (IN as) (NP (NP (JJ leaky) (NN bladder) (NN epithelium)) (CC and) (NP (NNS Doc_12559315_1397_1417_Disease)))) (. .)))
12559315	10	(ROOT (S (NP (NP (DT The) (JJ true) (NN incidence)) (PP (IN of) (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (JJ drug-induced) (NNS Doc_12559315_1485_1493_Disease)) (PP (IN in) (NP (NNS humans)))))) (VP (MD must) (VP (VB be) (VP (VBN clarified) (PP (IN by) (NP (JJ prospective) (JJ clinical) (NNS trials)))))) (. .)))
12644816	0	(ROOT (NP (NP (DT An) (JJ open-label) (NN phase) (NNP II) (NN study)) (PP (IN of) (NP (JJ low-dose) (NNS Doc_12644816_41_52_Chemical))) (PP (IN in) (NP (NN Doc_12644816_56_64_Chemical-independent) (NNS Doc_12644816_77_92_Disease))) (. .)))
12644816	1	(ROOT (S (NP (NP (DT The) (JJ antiangiogenic) (NNS effects)) (PP (IN of) (NP (NNS Doc_12644816_124_135_Chemical)))) (VP (VBP have) (VP (VBN been) (VP (VBN assessed) (PP (IN in) (NP (NP (JJ clinical) (NNS trials)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ various) (ADJP (JJ solid) (CC and) (JJ haematological)) (NNS Doc_12644816_224_236_Disease)))))))))) (. .)))
12644816	2	(ROOT (S (NP (NNP Doc_12644816_238_249_Chemical)) (VP (VBZ blocks) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (JJ angiogenic) (NNS agents)) (PP (VBG including) (NP (NNP bFGF) (, ,) (NNP VEGF) (CC and) (NNP IL-6))))))) (. .)))
12644816	3	(ROOT (S (NP (PRP We)) (VP (VBD undertook) (NP (DT an) (JJ open-label) (NN study)) (S (VP (VBG using) (NP (NNS Doc_12644816_361_372_Chemical)) (ADVP (NP (CD 100) (NN mg)) (RB once)) (ADVP (RB daily)) (PP (IN for) (NP (NP (QP (IN up) (TO to) (CD 6)) (NNS months)) (PP (IN in) (NP (NP (CD 20) (NNS men)) (PP (IN with) (NP (JJ androgen-independent) (NNS Doc_12644816_446_461_Disease)))))))))) (. .)))
12644816	4	(ROOT (S (NP (NP (DT The) (JJ mean) (NN time)) (PP (IN of) (NP (NN study)))) (VP (VBD was) (NP (NP (CD 109) (NNS days)) (PRN (-LRB- -LRB-) (NP (NN median) (CD 107)) (, ,) (NP (NN range) (NN 4-184) (NNS days)) (-RRB- -RRB-)))) (. .)))
12644816	5	(ROOT (S (NP (NNS Patients)) (VP (VBD underwent) (NP (NP (JJ regular) (NN measurement)) (PP (IN of) (NP (NP (JJ prostate-specific) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NNP PSA)) (-RRB- -RRB-)) (, ,) (NP (NNS Doc_12644816_606_610_Chemical) (CC and) (NNS electrolytes)) (, ,) (NP (NN serum) (NN bFGF)) (CC and) (NP (NNP VEGF)))))) (. .)))
12644816	6	(ROOT (S (NP (NP (CD Three) (NNS men)) (PRN (-LRB- -LRB-) (NP (CD 15) (NN %)) (-RRB- -RRB-))) (VP (VBD showed) (NP (DT a) (NN decline)) (PP (IN in) (NP (NP (NNP serum) (NNP PSA)) (PP (IN of) (NP (NP (QP (IN at) (JJS least) (CD 50)) (NN %)) (, ,) (VP (VBN sustained) (PP (IN throughout) (NP (NN treatment))))))))) (. .)))
12644816	7	(ROOT (S (PP (IN Of) (NP (NP (CD 16) (NNS men)) (VP (VBN treated) (PP (IN for) (NP (QP (IN at) (JJS least) (CD 2)) (NNS months)))))) (, ,) (NP (NP (CD six)) (PRN (-LRB- -LRB-) (NP (CD 37.5) (NN %)) (-RRB- -RRB-))) (VP (VBD showed) (NP (DT a) (NN fall)) (PP (IN in) (NP (JJ absolute) (NNP PSA))) (PP (IN by) (NP (NP (DT a) (NN median)) (PP (IN of) (NP (CD 48) (NN %)))))) (. .)))
12644816	8	(ROOT (S (S (NP (NP (VBG Increasing) (NNS levels)) (PP (IN of) (NP (NN serum) (NN bFGF) (CC and) (NN VEGF)))) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ progressive) (NN disease)))))) (: ;) (S (S (NP (NP (CD five)) (PP (IN of) (NP (NP (CD six) (NNS men)) (SBAR (WHNP (WP who)) (S (VP (VBD demonstrated) (NP (DT a) (NN fall)) (PP (IN in) (NP (NNP PSA))))))))) (ADVP (RB also)) (VP (VBD showed) (NP (DT a) (NN decline)) (PP (IN in) (NP (NN bFGF) (CC and) (NN VEGF) (NNS levels))))) (, ,) (CC and) (S (NP (NP (CD three)) (PP (IN of) (NP (NP (CD four) (NNS men)) (PP (IN with) (NP (DT a) (VBG rising) (NNP PSA)))))) (VP (VBD showed) (NP (DT an) (NN increase)) (PP (IN in) (NP (DT both) (NN growth) (NNS factors)))))) (. .)))
12644816	9	(ROOT (S (NP (JJ Adverse) (NNS effects)) (VP (VP (VBD included) (NP (NP (NNS Doc_12644816_1133_1145_Disease)) (, ,) (NP (NN morning) (NNS drowsiness)) (, ,) (NP (NNS Doc_12644816_1167_1176_Disease)) (CC and) (NP (NNS Doc_12644816_1181_1185_Disease)))) (, ,) (CC and) (VP (VBD resulted) (PP (IN in) (NP (NN withdrawal))) (PP (IN from) (NP (DT the) (NN study))) (PP (IN by) (NP (CD three) (NNS men))))) (. .)))
12644816	10	(ROOT (S (NP (NP (NN Evidence)) (PP (IN of) (NP (NNS Doc_12644816_1255_1284_Disease)))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (CD nine)) (PP (IN of) (NP (CD 13) (NNS men))))) (PP (IN before) (NP (NN treatment))))) (. .)))
12644816	11	(ROOT (S (PP (IN In) (NP (NP (DT the) (CD seven) (NNS men)) (SBAR (WHNP (WP who)) (S (VP (VBD completed) (NP (CD six) (NNS months)) (PP (IN on) (NP (NNS Doc_12644816_1376_1387_Chemical)))))))) (, ,) (NP (NP (JJ subclinical) (NN evidence)) (PP (IN of) (NP (NNS Doc_12644816_1413_1434_Disease)))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (CD four))) (PP (PP (IN before) (NP (NN treatment))) (, ,) (CC but) (PP (IN in) (NP (DT all) (CD seven))) (PP (IN at) (NP (NN repeat) (NN testing)))))) (. .)))
12644816	12	(ROOT (S (NP (DT The) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_12644816_1534_1545_Chemical)) (VP (MD may) (VP (VB be) (NP (NP (DT an) (NN option)) (PP (IN for) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN failed) (NP (NP (JJ other) (NNS forms)) (PP (IN of) (NP (NN therapy)))) (, ,) (PP (VBD provided) (SBAR (S (NP (JJ close) (NN follow-up)) (VP (VBZ is) (VP (VBN maintained) (PP (IN for) (NP (NP (NN development)) (PP (IN of) (NP (NNS Doc_12644816_1674_1695_Disease)))))))))))))))))))))) (. .)))
12677626	0	(ROOT (NP (NP (NP (NNP Doc_12677626_0_31_Disease)) (PP (VBG following) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_12677626_64_79_Chemical)) (PP (IN for) (NP (NN lumbar) (NNS plexus) (NN block)))))))) (: :) (NP (NP (DT A) (NN report)) (PP (IN of) (NP (CD two) (NNS cases)))) (. .)))
12677626	1	(ROOT (S (NP (NP (NNP BACKGROUND) (CC AND) (NNP OBJECTIVES)) (: :) (NP (NP (ADJP (JJ Central) (JJ nervous)) (NN system)) (CC and) (NP (NP (NNS Doc_12677626_182_198_Disease)) (PP (VBG following) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (JJ local) (NNS anesthetics)))))))) (VP (VBZ is) (NP (NP (DT a) (VBN recognized) (NN complication)) (PP (IN of) (NP (JJ regional) (NN anesthesia))))) (. .)))
12677626	2	(ROOT (S (NP (NP (NNP Doc_12677626_302_317_Chemical)) (, ,) (NP (NP (DT the) (JJ pure) (NNP S) (PRN (-LRB- -LRB-) (NP (NNP -)) (-RRB- -RRB-)) (NN enantiomer)) (PP (IN of) (NP (NNS Doc_12677626_347_358_Chemical)))) (, ,)) (VP (VBD was) (VP (VBN developed) (S (VP (TO to) (VP (VB improve) (NP (NP (DT the) (JJ cardiac) (NN safety) (NN profile)) (PP (IN of) (NP (NNS Doc_12677626_415_426_Chemical))))))))) (. .)))
12677626	3	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (CD 2) (NNS cases)) (PP (IN of) (NP (NP (JJ grand) (NN mal) (NNS Doc_12677626_461_469_Disease)) (PP (VBG following) (NP (NP (JJ accidental) (NN intravascular) (NN injection)) (PP (IN of) (NP (NNS Doc_12677626_518_533_Chemical))))))))) (. .)))
12677626	4	(ROOT (NP (NP (NNP CASE) (NNP REPORT)) (: :) (NP (NP (CD Two) (NNS patients)) (VP (VBG presenting) (SBAR (IN for) (S (NP (NP (JJ elective) (JJ orthopedic) (NN surgery)) (PP (IN of) (NP (DT the) (JJR lower) (NN limb)))) (VP (VBD underwent) (NP (NP (NN blockade)) (PP (IN of) (NP (NP (DT the) (NN lumbar) (NNS plexus)) (PP (IN via) (NP (DT the) (NN posterior) (NN approach))))))))))) (. .)))
12677626	5	(ROOT (S (PP (ADVP (RB Immediately)) (IN after) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_12677626_730_745_Chemical)) (ADJP (CD 0.5) (NN %)) (PP (IN with) (NP (NP (NNS Doc_12677626_756_767_Chemical)) (ADJP (CD 2.5) (JJ microgram/mL)))))))) (, ,) (NP (DT the) (NNS patients)) (VP (VBD developed) (NP (JJ grand) (NN mal) (NNS Doc_12677626_819_827_Disease)) (, ,) (PP (IN despite) (NP (JJ negative) (NN aspiration))) (PP (IN for) (NP (NP (NN blood)) (CC and) (NP (NP (DT no) (JJ clinical) (NNS signs)) (PP (IN of) (NP (JJ intravenous) (JJ Doc_12677626_904_915_Chemical) (NN administration))))))) (. .)))
12677626	6	(ROOT (S (NP (DT The) (NNS Doc_12677626_936_944_Disease)) (VP (VBD were) (ADVP (RB successfully)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_12677626_976_993_Chemical)) (PP (IN in) (NP (NN addition))))) (PP (TO to) (NP (NP (NNS Doc_12677626_1009_1024_Chemical)) (PP (IN in) (NP (CD 1) (NN patient))))))) (. .)))
12677626	7	(ROOT (S (NP (DT Neither) (NN patient)) (VP (VBD developed) (NP (NP (NNS signs)) (PP (IN of) (NP (NNS Doc_12677626_1074_1097_Disease))))) (. .)))
12677626	8	(ROOT (S (NP (DT Both) (NNS patients)) (VP (VBD were) (VP (VBN treated) (ADVP (RB preoperatively)) (PP (IN with) (NP (NP (JJ beta-adrenergic) (NN antagonist) (NNS medications)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB have) (VP (VBN masked) (NP (NP (DT the) (JJ cardiovascular) (NNS signs)) (PP (IN of) (NP (NP (DT the) (JJ unintentional) (NN intravascular) (NN administration)) (PP (IN of) (NP (NNS Doc_12677626_1286_1301_Chemical)))))) (PP (IN with) (NP (NNS Doc_12677626_1307_1318_Chemical)))))))))))) (. .)))
12677626	9	(ROOT (S (SBAR (IN Although) (S (NP (NNS Doc_12677626_1342_1357_Chemical)) (VP (MD may) (VP (VB have) (NP (DT a) (JJR safer) (JJ Doc_12677626_1375_1391_Disease) (NN profile)) (PP (IN than) (NP (JJ racemic) (NNS Doc_12677626_1413_1424_Chemical))) (, ,) (SBAR (IN if) (S (NP (NP (JJ adequate) (NNS amounts)) (PP (IN of) (NP (NNS Doc_12677626_1449_1464_Chemical)))) (VP (VBP reach) (NP (DT the) (NN circulation))))))))) (, ,) (NP (PRP it)) (VP (MD will) (VP (VB result) (PP (IN in) (NP (NNS Doc_12677626_1506_1517_Disease))))) (. .)))
12677626	10	(ROOT (S (NP (NP (NNP Plasma) (NNS concentrations)) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB result) (PP (IN in) (NP (NNS Doc_12677626_1565_1596_Disease)))))))) (VP (VBD did) (RB not) (VP (VB produce) (NP (NP (NNS manifestations)) (PP (IN of) (NP (NP (NNS Doc_12677626_1631_1647_Disease)) (PP (IN in) (NP (DT these) (CD 2) (NNS patients)))))))) (. .)))
12678199	0	(ROOT (NP (NP (NP (JJ Doc_12678199_0_10_Chemical-induced) (NNS Doc_12678199_19_37_Disease)) (PP (IN during) (NP (NN bladder) (NN irrigation)))) (: :) (NP (NP (DT an) (JJ unusual) (NN presentation)) (: --) (NP (DT a) (NN case) (NN report))) (. .)))
12678199	1	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBP present) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (JJ early) (PRN (-LRB- -LRB-) (PP (IN within) (NP (CD 4) (NNS days))) (-RRB- -RRB-)) (NN development)) (PP (IN of) (NP (NP (NNS Doc_12678199_172_190_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12678199_192_195_Disease)) (-RRB- -RRB-)) (VP (VBN associated) (PP (IN with) (NP (JJ oral) (JJ Doc_12678199_218_228_Chemical) (NN therapy)))))))))) (. .)))
12678199	2	(ROOT (S (NP (NP (NNP Consistent)) (PP (IN with) (NP (NP (JJ other) (NNS reports)) (NP (DT this) (NN case)))) (PP (IN of) (NP (NNS Doc_12678199_281_284_Disease)))) (VP (VBD occurred) (PP (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NP (JJ multiple) (JJ exacerbating) (NNS factors)) (PP (VBG including) (NP (NP (NNS Doc_12678199_352_363_Disease)) (CC and) (NP (JJ Doc_12678199_368_375_Chemical) (NN excess))))))))) (. .)))
12678199	3	(ROOT (S (NP (NP (JJ Transient) (NN prolongation)) (PP (IN of) (NP (NP (DT the) (NNP QT)) (PP (IN during) (NP (NN bladder) (NN irrigation)))))) (VP (VBD prompted) (NP (NP (DT the) (NN episode)) (PP (IN of) (NP (NNS Doc_12678199_467_470_Disease))))) (. .)))
12678199	4	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB well)) (VP (VBN known) (SBAR (IN that) (S (NP (NNS Doc_12678199_494_505_Disease)) (VP (VBZ exacerbates) (NP (VBN acquired) (NNS Doc_12678199_527_530_Disease))))))) (. .)))
12678199	5	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBP speculate) (SBAR (IN that) (S (NP (NP (DT the) (VBN increased) (JJ vagal) (NN tone)) (PP (IN during) (NP (NP (NN bladder) (NN irrigation)) (, ,) (NP (DT a) (JJ vagal) (NN maneuver)) (, ,))) (PP (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (JJ Doc_12678199_647_657_Chemical) (NN therapy)))))) (VP (VBD resulted) (PP (IN in) (NP (NN Doc_12678199_678_688_Chemical-induced) (NN proarrhythmia))))))) (. .)))
12678199	6	(ROOT (S (PP (IN In) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ Doc_12678199_730_740_Chemical) (NN therapy))))) (, ,) (NP (DT a) (JJ second) (NN bladder) (NN irrigation)) (VP (VBD did) (RB not) (VP (VB induce) (NP (NNS Doc_12678199_793_796_Disease)) (PP (IN despite) (NP (NNS Doc_12678199_805_816_Disease) (CC and) (NNS Doc_12678199_821_835_Disease))))) (. .)))
12699527	0	(ROOT (NP (NP (NP (JJ Anaesthetic) (NNS complications)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_12699527_42_50_Disease) (NN congenita))))) (: :) (NP (NP (NN case) (NN study) (CC and) (NN comparison)) (PP (IN with) (NP (JJ other) (NNS Doc_12699527_99_117_Disease)))) (. .)))
12699527	1	(ROOT (S (NP (NP (JJ Doc_12699527_119_127_Disease) (NN congenita)) (PRN (-LRB- -LRB-) (NP (NNP MC)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN caused) (PP (IN by) (NP (NP (DT a) (NN defect)) (PP (IN in) (NP (NP (DT the) (JJ skeletal) (NN muscle) (NNS Doc_12699527_188_196_Chemical) (NN channel) (NN function)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB cause) (NP (JJ sustained) (JJ membrane) (NN depolarisation)))))))))))) (. .)))
12699527	2	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (ADJP (RB previously) (JJ healthy)) (JJ 32-year-old) (NN woman)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (DT a) (ADJP (JJ life-threatening)) (NN muscle) (NNS Doc_12699527_357_362_Disease) (CC and) (JJ secondary) (NN ventilation) (NNS difficulties)) (PP (VBG following) (NP (NP (DT a) (JJ preoperative) (NN injection)) (PP (IN of) (NP (NNS Doc_12699527_440_453_Chemical))))))))))) (. .)))
12699527	3	(ROOT (S (S (NP (DT The) (NN muscle) (NNS Doc_12699527_466_472_Disease)) (VP (VBD disappeared) (ADVP (RB spontaneously)))) (CC and) (S (NP (DT the) (NN surgery)) (VP (VBD proceeded) (PP (IN without) (NP (JJ further) (NNS problems))))) (. .)))
12699527	4	(ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (ADVP (RB subsequently)) (VBD questioned)))) (, ,) (NP (PRP she)) (VP (VBD reported) (NP (JJ minor) (NNS symptoms)) (S (VP (VBG suggesting) (NP (DT a) (JJ Doc_12699527_622_630_Disease) (NN condition))))) (. .)))
12699527	5	(ROOT (S (NP (NNP Doc_12699527_642_650_Disease)) (VP (VBD was) (VP (VBN found) (PP (IN on) (NP (NP (JJ clinical) (NN examination)) (CC and) (NP (NNP EMG)))))) (. .)))
12699527	6	(ROOT (S (NP (DT The) (NN diagnosis) (NN MC)) (VP (VBD was) (VP (VBN confirmed) (S (ADJP (JJ genetically))))) (. .)))
12699527	7	(ROOT (S (NP (CC Neither) (NP (DT the) (NN patient)) (CC nor) (NP (DT the) (NN anaesthetist))) (VP (VBD were) (ADJP (JJ aware) (PP (IN of) (NP (DT the) (NN diagnosis)))) (SBAR (IN before) (S (NP (DT this) (ADJP (RB potentially) (JJ lethal)) (NN complication)) (VP (VBD occurred))))) (. .)))
12699527	8	(ROOT (S (NP (PRP We)) (VP (VBP give) (NP (NP (DT a) (JJ brief) (NN overview)) (PP (IN of) (NP (NN ion)))) (NP (NN channel) (NNS disorders)) (PP (VBG including) (NP (NP (NNS Doc_12699527_921_943_Disease)) (CC and) (NP (PRP$ their) (JJ anaesthetic) (NNS considerations))))) (. .)))
12752472	0	(ROOT (NP (NP (JJ Respiratory) (NN pattern)) (PP (IN in) (NP (DT a) (NN rat) (NN model))) (PP (IN of) (NP (NNS Doc_12752472_38_46_Disease))) (. .)))
12752472	1	(ROOT (S (S (NP (NNP Doc_12752472_57_62_Disease)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB occur) (PP (IN during) (NP (NNS Doc_12752472_88_96_Disease))))))))) (, ,) (CC but) (S (NP (NP (JJ systematic) (NNS studies)) (PP (IN of) (NP (NP (JJ ictal) (NN respiratory) (NNS changes)) (PP (IN in) (NP (NNS adults)))))) (VP (VBP are) (ADJP (JJ few)))) (. .)))
12752472	2	(ROOT (S (NP (NP (NNP Data)) (PP (VBG regarding) (NP (NP (JJ respiratory) (NN pattern) (NNS defects)) (PP (IN during) (NP (JJ interictal) (NNS periods)))))) (ADVP (RB also)) (VP (VBP are) (ADJP (JJ scarce))) (. .)))
12752472	3	(ROOT (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBD sought) (S (VP (TO to) (VP (VB generate) (NP (NN information)) (PP (IN with) (NP (NN regard))) (PP (TO to) (NP (NP (DT the) (JJ interictal) (NN period)) (PP (IN in) (NP (NP (NNS animals)) (PP (IN with) (NP (NN Doc_12752472_347_358_Chemical-induced) (NNS Doc_12752472_367_375_Disease))))))))))) (. .)))
12752472	4	(ROOT (S (NP (NP (CD Twelve) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NP (CD six) (RB chronically) (JJ Doc_12752472_415_424_Disease) (NNS animals)) (CC and) (NP (CD six) (NNS controls))) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN anesthetized)) (, ,) (VP (VBN given) (NP (NNS tracheotomies))) (, ,) (CC and) (VP (VBN subjected) (PP (TO to) (NP (NN hyperventilation) (CC or) (NN Doc_12752472_528_543_Disease) (NNS conditions)))))) (. .)))
12752472	5	(ROOT (S (NP (NNP Doc_12752472_556_575_Disease)) (VP (VP (VBD caused) (NP (NNS changes)) (PP (IN in) (NP (JJ thoracic) (NN volume)))) (CC and) (VP (VBD forced) (NP (NN air)) (S (VP (TO to) (VP (VB flow) (ADVP (RB tidally)) (PP (IN through) (NP (DT a) (NN pneumotachograph)))))))) (. .)))
12752472	6	(ROOT (SINV (S (NP (DT This) (NN flow)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (S (VP (VBG using) (NP (DT a) (NN differential) (NN pressure) (NN transducer)))))))) (, ,) (VP (VBD passed) (PP (PP (IN through) (NP (DT a) (NN polygraph))) (, ,) (CC and) (PP (IN from) (NP (NP (DT this)) (PP (TO to) (NP (DT a) (NN computer)))))) (PP (IN with) (NP (NN custom) (NN software)))) (NP (NP (DT that) (JJ derived) (NN ventilation)) (PRN (-LRB- -LRB-) (NP (NNP VE)) (-RRB- -RRB-)) (, ,) (NP (NP (NP (JJ tidal) (NN volume)) (PRN (-LRB- -LRB-) (NP (NNP VT)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ inspiratory) (NN time)) (PRN (-LRB- -LRB-) (NP (NNP TI)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ expiratory) (NN time)) (PRN (-LRB- -LRB-) (NP (NNP TE)) (-RRB- -RRB-))) (, ,) (NP (NP (NN breathing) (NN frequency)) (PRN (-LRB- -LRB-) (X (SYM f)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (JJ mean) (NN inspiratory) (NN flow)) (PRN (-LRB- -LRB-) (NP (NNP VT/TI)) (-RRB- -RRB-))) (PP (IN on) (NP (DT a) (JJ breath-by-breath) (NN basis)))))) (. .)))
12752472	7	(ROOT (S (NP (DT The) (NN hyperventilation) (NN maneuver)) (VP (VBD caused) (NP (DT a) (NN decrease)) (PP (IN in) (NP (JJ spontaneous) (NN ventilation))) (PP (IN in) (NP (NN Doc_12752472_1084_1095_Chemical-treated) (CC and) (NN control) (NNS rats)))) (. .)))
12752472	8	(ROOT (S (SBAR (IN Although) (S (NP (NNP VE)) (VP (VBD had) (NP (NP (DT a) (JJ similar) (NN decrease)) (PP (IN in) (NP (DT both) (NNS groups)))) (, ,) (PP (IN in) (NP (DT the) (JJ Doc_12752472_1180_1189_Disease) (NN group)))))) (, ,) (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NNP VE)))) (VP (VBD was) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (ADJP (ADJP (JJ significant)) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-))) (NN increase)) (PP (IN in) (NP (NNP TE) (NN peak)))))) (PP (IN in) (NP (NN relation))) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (NN control) (NNS animals)))))) (. .)))
12752472	9	(ROOT (S (NP (DT The) (JJ Doc_12752472_1320_1335_Disease) (NN maneuver)) (VP (VBD led) (PP (TO to) (NP (DT an) (NN increase))) (PP (IN in) (NP (DT the) (JJ arterial) (NNS Paco2))) (, ,) (PP (VBN followed) (PP (IN by) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NNP VE))))))) (. .)))
12752472	10	(ROOT (S (PP (IN In) (NP (DT the) (JJ Doc_12752472_1425_1434_Disease) (NN group))) (, ,) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NNP VE)))) (VP (VBD was) (VP (VBN mediated) (PP (IN by) (NP (NP (DT a) (ADJP (ADJP (JJ significant)) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-))) (NN decrease)) (PP (IN in) (NP (NNP TE) (NN peak))))) (PP (VBN compared) (PP (IN with) (NP (DT the) (NN control) (NN group)))))) (. .)))
12752472	11	(ROOT (S (NP (NP (JJ Systemic) (NN application)) (PP (IN of) (NP (NNP KCN)))) (, ,) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ peripheral) (NN chemoreception) (NN activation)))) (PP (IN on) (NP (NN ventilation)))))) (, ,) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (JJ similar) (NN increase)) (PP (IN in) (NP (NNP VE))))) (PP (IN for) (NP (DT both) (NNS groups)))) (. .)))
12752472	12	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN Doc_12752472_1749_1760_Chemical-treated) (NNS animals)) (VP (VBP have) (NP (DT an) (JJ altered) (NN ability) (S (VP (TO to) (VP (VB react) (S (VP (TO to) (VP (VP (PRN (-LRB- -LRB-) (CC or) (VP (VBN compensate) (PP (IN for))) (-RRB- -RRB-)) (VB blood) (NP (NN gas) (NNS changes)) (PP (IN with) (NP (NP (NNS changes)) (PP (IN in) (NP (NN ventilation)))))) (CC and) (VP (VB suggest) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (ADJP (RB centrally) (VBN determined))))))))))))))))) (. .)))
12752472	13	(ROOT (S (NP (PRP We)) (VP (VBP speculate) (PP (IN on) (NP (NP (DT the) (JJ possible) (NN relation)) (PP (IN of) (NP (DT the) (JJ current) (NNS findings))))) (PP (IN on) (S (VP (VBG treating) (NP (JJ different) (NN Doc_12752472_2008_2016_Disease-associated) (NNS conditions)))))) (. .)))
1280054	0	(ROOT (S (VP (VB Fatal) (ADJP (RB myeloencephalopathy) (JJ due) (S (VP (TO to) (VP (VB intrathecal) (NP (JJ Doc_1280054_45_56_Chemical) (NN administration))))))) (. .)))
1280054	1	(ROOT (S (NP (NNP Doc_1280054_73_84_Chemical)) (VP (VBD was) (ADVP (RB accidentally)) (VP (VBN given) (ADVP (RB intrathecally)) (PP (TO to) (NP (DT a) (NN child))) (PP (IN with) (NP (NP (NNS Doc_1280054_138_147_Disease)) (, ,) (NP (NP (VBG producing) (NNS Doc_1280054_159_188_Disease)) (VP (VBN followed) (PP (IN by) (NP (NNS Doc_1280054_201_215_Disease) (CC and) (NNS Doc_1280054_220_225_Disease))))))))) (. .)))
1280054	2	(ROOT (S (NP (NP (JJ Separate) (NNS times)) (PP (IN for) (NP (NP (JJ administering) (NNS Doc_1280054_260_271_Chemical)) (CC and) (NP (JJ intrathecal) (NN therapy))))) (VP (VBZ is) (VP (VBN recommended))) (. .)))
1280707	0	(ROOT (NP (NP (JJ Doc_1280707_0_12_Chemical) (NN potentiation)) (PP (IN of) (NP (JJ Doc_1280707_29_40_Chemical) (NN arrhythmogenicity))) (PP (IN in) (NP (NN Doc_1280707_62_75_Chemical-anesthetized) (NNS rats) (CC and) (NN beating) (NN rat) (NN heart) (NN cell) (NNS cultures))) (. .)))
1280707	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (JJ Doc_1280707_146_158_Chemical) (NN treatment)) (PP (PP (IN on) (NP (NP (JJ Doc_1280707_172_183_Chemical) (NN arrhythmogenicity)) (PP (IN in) (NP (NN beating) (NN rat) (NN heart) (JJ myocyte) (NNS cultures))))) (CC and) (PP (IN on) (NP (JJ anesthetized) (NNS rats))))))) (VP (VBD were) (VP (VBN determined))) (. .)))
1280707	2	(ROOT (S (PP (IN After) (S (VP (VBG determining) (NP (NP (DT the) (JJ Doc_1280707_304_315_Chemical) (NN AD50)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (NNS Doc_1280707_343_354_Chemical)) (SBAR (WHNP (WDT that)) (S (VP (VBD caused) (SBAR (S (NP (NP (CD 50) (NN %)) (PP (IN of) (NP (DT all) (VBG beating) (NN rat) (NN heart)))) (VP (VBP myocyte) (S (NP (NNS cultures)) (VP (TO to) (VP (VB become) (ADJP (JJ arrhythmic)))))))))))))) (-RRB- -RRB-)))))) (, ,) (NP (PRP we)) (VP (VBD determined) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ 1-hour) (JJ Doc_1280707_471_487_Chemical) (NN exposure)))) (PP (IN on) (NP (JJ myocyte) (NN contractile) (NN rhythm)))) (. .)))
1280707	3	(ROOT (S (NP (NP (DT Each) (NN concentration)) (PP (IN of) (NP (NP (NNS Doc_1280707_550_562_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 6.25)) (, ,) (NP (CD 12.5)) (, ,) (NP (CD 25)) (, ,) (CC and) (NP (CD 50) (NN micrograms/ml))) (-RRB- -RRB-))))) (VP (VBD caused) (NP (DT a) (ADJP (JJ significant) (CC and) (JJ concentration-dependent)) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN AD50)) (PP (IN for) (NP (NNS Doc_1280707_677_688_Chemical)))))) (. .)))
1280707	4	(ROOT (S (NP (JJ Doc_1280707_690_699_Chemical) (NN treatment)) (ADVP (RB also)) (VP (VP (VBD increased) (NP (NP (DT the) (NN arrhythmogenicity)) (PP (IN of) (NP (NP (NNS Doc_1280707_750_761_Chemical)) (PP (IN in) (NP (JJ myocyte) (NNS cultures))))))) (, ,) (CC but) (VP (VBD was) (ADVP (RB only) (NP (CD one))) (ADJP (ADJP (RB fourth) (RB as) (JJ potent)) (PP (IN as) (NP (NNS Doc_1280707_820_832_Chemical)))))) (. .)))
1280707	5	(ROOT (S (NP (CC Neither) (NP (NNS Doc_1280707_842_854_Chemical)) (CC nor) (NP (NP (JJ Doc_1280707_859_868_Chemical) (NNS effects)) (PP (IN on) (NP (NNS Doc_1280707_880_891_Chemical))))) (ADVP (RB arrhythmogenicity)) (VP (VBD were) (VP (VBN potentiated) (PP (IN by) (NP (NNS Doc_1280707_930_941_Chemical))))) (. .)))
1280707	6	(ROOT (S (NP (NP (JJ Chronic) (JJ Doc_1280707_951_963_Chemical) (NN pretreatment)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN mg/kg/day)) (PP (IN for) (NP (CD 21) (NNS days)))) (-RRB- -RRB-))) (VP (VBD caused) (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (JJ Doc_1280707_1036_1047_Chemical) (NN arrhythmogenicity))) (PP (IN in) (NP (ADJP (JJ intact) (JJ Doc_1280707_1076_1089_Chemical-anesthetized)) (NNS rats)))) (. .)))
1280707	7	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (DT the) (NN time)))) (PP (TO to) (NP (NP (NN onset)) (PP (IN of) (NP (NNS Doc_1280707_1166_1176_Disease) (RB as))))) (PP (VBN compared) (PP (IN with) (NP (NP (NN control) (NN Doc_1280707_1202_1217_Chemical-treated) (NNS rats)) (PRN (-LRB- -LRB-) (NP (CD 6.2) (NNS +)) (: /) (NP (NP (QP (CD -) (CD 1.3))) (PP (IN vs.) (NP (NP (NP (CD 30.8) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 2.5) (NN min)) (, ,) (NP (JJ mean) (NNS +))) (: /))) (: -) (NP (NNP SE))))) (-RRB- -RRB-)))))) (. .)))
1280707	8	(ROOT (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_1280707_1320_1332_Chemical)) (VP (MD can) (VP (VB potentiate) (NP (JJ Doc_1280707_1348_1359_Chemical) (NN arrhythmogenicity)) (PP (DT both) (PP (IN in) (NP (NN vivo))) (CC and) (PP (IN in) (NP (NNP vitro))))))))) (. .)))
1280707	9	(ROOT (S (NP (NP (NNP Potentiation)) (PP (IN of) (NP (NP (JJ Doc_1280707_1421_1432_Chemical) (NNS Doc_1280707_1433_1443_Disease)) (PP (IN in) (NP (JJ myocyte) (NNS cultures)))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (DT this) (NN effect)) (VP (VBZ is) (ADVP (IN at) (JJS least)) (VP (ADVP (RB partly)) (VBN mediated) (PP (IN at) (NP (DT the) (JJ myocyte) (NN level)))))))) (. .)))
12828076	0	(ROOT (NP (NP (VBN Increased) (NN serum) (JJ soluble) (NN Fas)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ Doc_12828076_45_64_Disease) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_12828076_72_83_Chemical)))) (NNS Doc_12828076_84_92_Disease))))) (. .)))
12828076	1	(ROOT (NP (NP (NNS BACKGROUND/AIMS)) (: :) (S (NP (NNP Experimental) (NNS studies)) (VP (VBP have) (VP (VBN suggested) (SBAR (IN that) (S (NP (NP (NNS apoptosis)) (PP (IN via) (NP (DT the) (NNP Fas/Fas) (NNP Ligand) (NNP signaling) (NN system)))) (VP (MD may) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_12828076_251_270_Disease)))))))))))) (. .)))
12828076	2	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (JJ soluble) (NN form)) (PP (IN of) (NP (NNP Fas)))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_12828076_353_372_Disease))))))))) (. .)))
12828076	3	(ROOT (S (NP (NP (JJ Serum) (NNS levels)) (PP (IN of) (NP (NP (NNS sFas)) (PRN (-LRB- -LRB-) (NP (JJ soluble) (NN Fas)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN measured) (PP (IN by) (NP (NNP ELISA))) (PP (IN in) (NP (NP (CD 24) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_12828076_465_484_Disease)) (CC and) (NP (CD 10) (JJ normal) (NN control) (NNS subjects)))))))) (. .)))
12828076	4	(ROOT (S (NP (NP (JJ Serum) (NNS levels)) (PP (IN of) (NP (NP (JJ Doc_12828076_533_538_Disease) (JJ Doc_12828076_539_547_Disease) (NN factor-alpha)) (CC and) (NP (NN interferon-gamma))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN determined) (PP (IN by) (NP (NNP ELISA))))) (. .)))
12828076	5	(ROOT (S (NP (JJ Serum) (NNS sFas)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN increased) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (NNS Doc_12828076_678_697_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN median)) (, ,) (NP (NP (NNP 26.8) (NNP U/mL)) (: ;) (NP (NN range))) (, ,) (NP (CD 6.9-52) (CD .7) (NN U/mL))) (-RRB- -RRB-))) (PP (VBN compared) (PP (TO to) (NP (DT the) (JJ normal) (NNS controls)))) (PRN (-LRB- -LRB-) (NP (NP (NN median)) (, ,) (NP (NNP 8.6) (NNP U/mL)) (, ;) (NP (NN range)) (, ,) (NP (CD 6.5-12) (CD .0) (NN U/mL)) (, ,) (NP (NNP P) (NNP <) (NNP 0.0001))) (-RRB- -RRB-)))))))) (. .)))
12828076	6	(ROOT (S (NP (NNS Levels)) (VP (VBD were) (ADJP (ADJP (RB significantly) (JJR greater)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ Doc_12828076_877_896_Disease) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_12828076_904_915_Chemical)))) (NNS Doc_12828076_916_924_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NN median)) (, ,) (NP (NNP 28.7) (NNP U/mL))) (: ;) (NP (NN range))) (, ,) (NP (NP (QP (CD 12.8-52) (CD .7))) (NP (NNP U/mL))) (, ,) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 17))))))) (-RRB- -RRB-))))))) (PP (IN than) (NP (NP (DT those) (ADJP (JJ due) (PP (TO to) (NP (NP (NN non-A)) (PP (TO to) (NP (NNP E)))))) (NNS Doc_12828076_1005_1014_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NN median)) (, ,) (NP (CD 12.5) (NN U/mL))) (: ;) (NP (NP (NN range)) (, ,) (NP (CD 6.9-46) (CD .0) (NN U/mL)))) (, ,) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 7)))))) (, ,) (NP (NP (NNP P) (NNP <)) (NP (CD 0.01)))) (-RRB- -RRB-))))) (. .)))
12828076	7	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN relationship)) (PP (IN of) (NP (NNS sFas)))) (PP (TO to) (NP (NP (JJ eventual) (NN outcome)) (PP (IN in) (NP (DT the) (NNS patients)))))) (. .)))
12828076	8	(ROOT (S (NP (DT A) (JJ significant) (NN correlation)) (VP (VBD was) (VP (VBN observed) (PP (IN between) (NP (NP (NP (NN serum) (NNS sFas) (NNS levels)) (CC and) (NP (JJ Doc_12828076_1215_1224_Chemical) (NN aminotransferase))) (PRN (-LRB- -LRB-) (NP (NP (SYM r)) (SBAR (S (S (VP (SYM =) (NP (CD 0.613)))) (, ,) (NP (NNP P)) (VP (VBZ <) (NP (CD 0.01)))))) (-RRB- -RRB-)))))) (. .)))
12828076	9	(ROOT (S (NP (NP (DT The) (VBN increased) (NN concentration)) (PP (IN of) (NP (NP (NNS sFas)) (PP (IN in) (NP (NP (NN serum)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_12828076_1340_1359_Disease)))))))))) (VP (MD may) (VP (VB reflect) (NP (NP (NN activation)) (PP (IN of) (NP (JJ Fas-mediated) (NNS apoptosis)))) (PP (IN in) (NP (NP (DT the) (NN liver)) (CC and) (NP (DT this) (ADVP (RB together) (PP (IN with) (NP (NP (VBN increased) (NNS Doc_12828076_1455_1460_Disease)) (SBAR (S (NP (NNP Doc_12828076_1461_1469_Disease) (NNP factor-alpha)) (VP (MD may) (VP (VB be) (NP (NP (DT an) (JJ important) (NN factor)) (PP (IN in) (NP (NN liver) (NN cell))))))))))) (NN loss)))))) (. .)))
12865514	0	(ROOT (S (VP (VB Bilateral) (NP (JJ subthalamic) (NN nucleus) (NN stimulation)) (PP (IN for) (NP (NNS Doc_12865514_46_65_Disease)))) (. .)))
12865514	1	(ROOT (S (NP (NP (JJ High) (NN frequency) (NN stimulation)) (PP (IN of) (NP (NP (DT the) (JJ subthalamic) (NN nucleus)) (PRN (-LRB- -LRB-) (NP (NNP STN)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB ameliorate) (NP (NP (DT the) (NNS signs) (CC and) (NNS symptoms)) (PP (IN of) (NP (JJ advanced) (NNS Doc_12865514_185_204_Disease))))))))) (. .)))
12865514	2	(ROOT (S (NP (PRP We)) (VP (VBD studied) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ high) (NN frequency) (NNP STN) (NNP stimulation)))) (PP (IN in) (NP (CD 23) (NNS patients)))) (. .)))
12865514	3	(ROOT (S (S (NP (JJ Twenty-three) (NNS patients)) (VP (VBG suffering) (PP (IN from) (NP (NP (NP (JJ severe) (NNS Doc_12865514_335_354_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Stages) (NNP III-V)) (PP (IN on) (NP (NNP Hoehn) (CC and) (NNP Yahr)))) (NP (NN scale))) (-RRB- -RRB-))) (CC and) (NP (ADJP (, ,) (RB particularly) (JJ Doc_12865514_412_424_Disease) (, ,)) (NNS Doc_12865514_426_434_Disease)))))) (, ,) (CC and) (S (NP (NN Doc_12865514_440_448_Chemical-induced) (NNS Doc_12865514_457_468_Disease)) (VP (VBD underwent) (NP (NP (JJ bilateral) (NN implantation)) (PP (IN of) (NP (NNS electrodes)))) (PP (IN in) (NP (DT the) (NNP STN))))) (. .)))
12865514	4	(ROOT (S (NP (NP (ADJP (JJ Preoperative) (CC and) (JJ postoperative)) (NNS assessments)) (PP (IN of) (NP (DT these) (ADJP (JJ patients) (ADVP (IN at)) (NP (CD 1) (, ,) (CD 3) (, ,) (CD 6) (CC and) (CD 12))) (NNS months) (NN follow-up)))) (, ,) (PP (IN in) (NP (`` ``) (NP (IN on)) ('' '') (CC and) (NP (`` ``) (JJ off) ('' '') (NN drug) (NNS conditions)))) (, ,) (VP (VBD was) (VP (VBN carried) (PP (IN out) (S (VP (VBG using) (NP (NP (NP (NNP Unified) (NNP Doc_12865514_690_709_Disease) (NNP Rating) (NNP Scale)) (, ,) (NP (NNP Hoehn)) (CC and) (NP (NNP Yahr) (NNP staging))) (, ,) (NP (NP (NNP England) (NNS activities)) (PP (IN of) (NP (JJ daily) (NN living) (NN score) (CC and) (NN video) (NNS recordings)))))))))) (. .)))
12865514	5	(ROOT (S (PP (IN After) (NP (NP (CD one) (NN year)) (PP (IN of) (NP (NP (JJ electrical) (NN stimulation)) (PP (IN of) (NP (DT the) (NNP STN))))))) (, ,) (NP (NP (NP (NP (DT the) (NNS patients) (POS ')) (NNS scores)) (PP (IN for) (NP (NP (NNS activities)) (PP (IN of) (NP (JJ daily) (NN living) (CC and) (NN motor) (NN examination) (NNS scores)))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Unified) (NNP Doc_12865514_963_982_Disease) (NNP Rating) (NNP Scale)) (NP (NP (NNS parts)) (NP (NNP II) (CC and) (NNP III)))) (-RRB- -RRB-)) (PP (IN off) (NP (NN medication)))) (VP (VBN improved) (PP (IN by) (NP (QP (CD 62) (NN %) (CC and) (CD 61) (NN %))) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.0005))) (-RRB- -RRB-))) (. .)))
12865514	6	(ROOT (S (VP (NP (NP (DT The) (NNS subscores)) (PP (IN for) (NP (DT the) (NNS Doc_12865514_1100_1108_Disease) (, ,) (NNS Doc_12865514_1110_1118_Disease) (, ,) (NNS Doc_12865514_1120_1126_Disease) (CC and) (NN gait))) (SBAR (FRAG (ADJP (ADVP (RB also)) (VBN improved)) (. .)))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.0005))) (-RRB- -RRB-))) (. .)))
12865514	7	(ROOT (S (NP (DT The) (JJ average) (JJ Doc_12865514_1175_1183_Chemical) (NN dose)) (VP (VBD decreased) (PP (IN from) (NP (QP (CD 813) (CD mg)))) (PP (TO to) (NP (QP (CD 359) (CD mg))))) (. .)))
12865514	8	(ROOT (S (NP (DT The) (JJ cognitive) (NNS functions)) (VP (VBD remained) (ADJP (JJ unchanged))) (. .)))
12865514	9	(ROOT (S (NP (CD Two) (NNS patients)) (VP (VBD developed) (SBAR (S (NP (NP (JJ device-related) (NNS complications)) (CC and) (NP (CD two) (NNS patients))) (VP (VBD experienced) (NP (JJ abnormal) (NNS Doc_12865514_1356_1367_Disease)))))) (. .)))
12865514	10	(ROOT (S (NP (JJ Bilateral) (JJ subthalamic) (NN nucleus) (NN stimulation)) (VP (VBZ is) (NP (NP (DT an) (JJ effective) (NN treatment)) (PP (IN for) (NP (VBN advanced) (NNS Doc_12865514_1462_1481_Disease))))) (. .)))
12865514	11	(ROOT (S (NP (PRP It)) (VP (VP (VBZ reduces) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (`` ``) (JJ off) ('' '') (NN phase) (NNS symptoms))))) (, ,) (VP (VBZ improves) (NP (DT the) (JJ axial) (NNS symptoms))) (CC and) (VP (VBZ reduces) (NP (JJ Doc_12865514_1572_1580_Chemical) (NNS requirements)))) (. .)))
12865514	12	(ROOT (S (NP (NP (DT The) (NN reduction)) (PP (IN in) (NP (DT the) (JJ Doc_12865514_1616_1624_Chemical) (NN dose)))) (VP (VBZ is) (ADJP (JJ useful) (PP (IN in) (S (VP (VBG controlling) (NP (JJ drug-induced) (NNS Doc_12865514_1668_1679_Disease))))))) (. .)))
1289188	0	(ROOT (NP (NP (NP (NNP Doc_1289188_0_19_Disease)) (VP (VBG occurring) (PP (IN during) (NP (JJ intravenous) (JJ Doc_1289188_49_64_Chemical) (NN therapy))))) (: :) (NP (NP (NN recovery)) (PP (IN after) (NP (NNS haemodialysis)))) (. .)))
1289188	1	(ROOT (S (NP (NP (DT A) (NN patient)) (PP (IN with) (NP (JJ transfusion-dependent) (NNS Doc_1289188_141_152_Disease)))) (VP (VBD was) (VP (VBG undergoing) (NP (NP (ADVP (NN home)) (JJ intravenous) (NNP Doc_1289188_185_200_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_1289188_202_205_Chemical)) (-RRB- -RRB-)) (NN treatment)) (PP (IN by) (NP (NP (NNS means)) (PP (IN of) (NP (NP (DT a) (ADJP (RB totally) (JJ implanted)) (NN system)) (PP (RB because) (IN of) (NP (PRP$ his) (JJ poor) (NN compliance)))))))) (PP (IN with) (NP (DT the) (JJ nightly) (NNS subcutaneous) (NN therapy))))) (. .)))
1289188	2	(ROOT (S (PP (JJ Due) (TO to) (NP (NP (DT an) (JJ accidental) (NN malfunctioning)) (PP (IN of) (NP (DT the) (NN infusion) (NN pump))))) (, ,) (NP (DT the) (NN patient)) (VP (VBD was) (ADVP (RB inadvertently)) (VP (VBN administered) (NP (NP (DT a) (JJ toxic) (NN dosage)) (PP (IN of) (NP (NP (DT the) (NN drug)) (SBAR (WHNP (WDT which)) (S (VP (VBD caused) (NP (NNS Doc_1289188_467_486_Disease)))))))))) (. .)))
1289188	3	(ROOT (S (PP (VBN Given) (NP (UCP (NP (NP (DT the) (JJ progressive) (NN deterioration)) (PP (IN of) (NP (DT the) (NNS symptoms)))) (CC and) (PP (IN of) (NP (DT the) (NN laboratory)))) (NNS values))) (, ,) (PP (IN despite) (NP (JJ adequate) (JJ medical) (NN treatment))) (, ,) (NP (DT a) (NN decision)) (VP (VBD was) (VP (VBN made) (S (VP (TO to) (VP (VB introduce) (NP (JJ haemodialytical) (NN therapy)) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB remove) (S (NP (DT the) (NN drug) (CC and) (NN therapy)) (VP (VB reduce) (NP (DT the) (NN nephrotoxicity))))))))))))) (. .)))
1289188	4	(ROOT (S (PP (IN From) (NP (NP (DT the) (NNS results)) (VP (VBN obtained)))) (, ,) (NP (NNS haemodialysis)) (VP (MD can) (ADVP (RB therefore)) (VP (VB be) (VP (VBN suggested) (PP (IN as) (NP (NP (DT a) (JJ useful) (NN therapy)) (PP (IN in) (NP (NP (JJ rare) (NNS cases)) (PP (IN of) (NP (NP (JJ progressive) (NNS Doc_1289188_847_866_Disease)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_1289188_877_892_Chemical))))))))))))) (. .)))
12912689	0	(ROOT (S (NP (NNP Ocular)) (ADVP (RB motility)) (VP (VBZ changes) (PP (IN after) (NP (NN subtenon) (NNS Doc_12912689_39_50_Chemical))) (PP (ADVP (RB chemotherapy)) (IN for) (NP (NNS Doc_12912689_68_82_Disease)))) (. .)))
12912689	1	(ROOT (S (NP (JJ Focal) (NN subtenon) (NNS Doc_12912689_111_122_Chemical) (NNS injections)) (VP (VBP have) (ADVP (RB recently)) (VP (VBN been) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (ADJP (ADVP (RB presumably)) (JJ Doc_12912689_174_182_Disease-free)) (NN adjunct)) (PP (TO to) (NP (JJ systemic) (NN chemotherapy))))) (PP (IN for) (NP (NNS Doc_12912689_225_251_Disease)))))) (. .)))
12912689	2	(ROOT (S (S (VP (TO To) (VP (VB report) (NP (PRP$ our) (JJ clinical) (NN experience)) (PP (IN with) (NP (NP (NNS Doc_12912689_303_327_Disease)) (PP (IN in) (NP (NNS patients)))))))) (VP (VBN treated) (PP (IN with) (NP (JJ Doc_12912689_353_373_Chemical) (NN chemotherapy)))) (. .)))
12912689	3	(ROOT (S (NP (PRP We)) (VP (VBD noted) (NP (NNS Doc_12912689_406_430_Disease)) (PP (IN in) (NP (CD 10) (JJ consecutive) (NNS patients))) (PP (IN with) (NP (NP (NNS Doc_12912689_463_477_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN received) (NP (NN subtenon) (NNS Doc_12912689_504_515_Chemical))))))))) (. .)))
12912689	4	(ROOT (S (PP (IN During) (NP (NP (NN ocular) (NN manipulation)) (PP (IN under) (NP (JJ general) (NN anesthesia))))) (, ,) (NP (PRP we)) (VP (VBD assessed) (NP (PRP$ their) (NNS eyes)) (PP (IN by) (NP (VBN forced) (NN duction) (NN testing))) (, ,) (S (VP (VBG comparing) (NP (NN ocular) (NN motility)) (PP (IN after) (NP (NP (JJ Doc_12912689_652_657_Disease) (NN control)) (PP (IN with) (NP (NN ocular) (NN motility))))) (PP (IN at) (NP (NN diagnosis)))))) (. .)))
12912689	5	(ROOT (S (NP (NP (NNS Eyes)) (VP (ADVP (RB subsequently)) (VBN enucleated) (PP (RB because) (IN of) (NP (NP (NN treatment) (NN failure)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 4))))) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN examined) (ADVP (RB histologically)))) (. .)))
12912689	6	(ROOT (S (NP (NP (NNP Limitation)) (PP (IN of) (NP (NN ocular)))) (ADVP (RB motility)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (DT all) (CD 12) (NNS eyes)) (PP (IN of) (NP (NP (CD 10) (NNS patients)) (VP (VBN treated) (PP (IN for) (NP (NP (NNS Doc_12912689_891_917_Disease)) (PP (IN with) (NP (NP (QP (CD 1) (TO to) (CD 6)) (NNS injections)) (PP (IN of) (NP (NN subtenon) (NNS Doc_12912689_953_964_Chemical))))))) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (JJ multimodality) (NN therapy)))))))))))) (. .)))
12912689	7	(ROOT (S (NP (JJ Histopathological) (NN examination)) (VP (VBD revealed) (NP (JJ many) (NNS lipophages)) (PP (IN in) (NP (DT the) (JJ periorbital) (NN fat))) (S (VP (VP (VBG surrounding) (NP (DT the) (JJ optic) (NN nerve)) (PP (IN in) (NP (NP (CD 1) (NN eye)) (, ,) (ADJP (JJ indicative) (PP (IN of) (NP (NP (NNS phagocytosis)) (PP (IN of) (NP (ADJP (RB previously) (VBG existing)) (JJ fat) (NNS cells))))))))) (CC and) (VP (VBG suggesting) (NP (JJ prior) (JJ fat) (NNS Doc_12912689_1200_1208_Disease)))))) (. .)))
12912689	8	(ROOT (S (NP (DT The) (NNS enucleations)) (VP (VBD were) (ADJP (RB technically) (JJ difficult) (CC and) (JJ hazardous)) (PP (IN for) (NP (NP (NNS Doc_12912689_1272_1285_Disease)) (PP (RB because) (IN of) (NP (JJ extensive) (JJ orbital) (JJ soft) (NN tissue) (NNS adhesions)))))) (. .)))
12912689	9	(ROOT (S (NP (NNP Subtenon) (NNP Doc_12912689_1360_1371_Chemical)) (ADVP (RB chemotherapy)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ significant) (NNS Doc_12912689_1416_1424_Disease)) (PP (IN of) (NP (JJ orbital) (JJ soft) (NNS tissues))))) (, ,) (S (VP (VP (VBG leading) (PP (TO to) (NP (NP (JJ mechanical) (NN restriction)) (PP (IN of) (NP (NN eye) (NNS movements)))))) (CC and) (VP (VBG making) (S (NP (JJ subsequent) (NN enucleation)) (ADJP (JJ difficult)))))))) (. .)))
12912689	10	(ROOT (S (S (NP (NNP Subtenon) (NNP Doc_12912689_1555_1566_Chemical)) (VP (VBZ is) (RB not) (ADJP (JJ free) (PP (IN of) (NP (NNS Doc_12912689_1582_1590_Disease)))))) (, ,) (CC and) (S (NP (PRP$ its) (NN use)) (VP (VBZ is) (VP (RBS best) (VBN restricted) (PP (TO to) (NP (JJ specific) (NNS indications)))))) (. .)))
12948256	0	(ROOT (S (VP (VB Doc_12948256_0_10_Chemical) (CC and) (VB Doc_12948256_15_31_Disease)) (. .)))
12948256	1	(ROOT (S (VP (TO To) (VP (VB demonstrate) (NP (NP (DT the) (NN association)) (PP (IN between) (NP (NNS Doc_12948256_81_91_Chemical) (CC and) (NNS Doc_12948256_96_112_Disease)))))) (. .)))
12948256	2	(ROOT (S (NP (NP (NN Thirteen) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_12948256_154_170_Disease)) (PP (IN after) (S (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_12948256_196_206_Chemical)) (PP (IN for) (NP (NP (NNS Doc_12948256_211_223_Disease)) (PP (IN of) (NP (DT the) (NN lung) (CC or) (NN lymph) (NN node))))))) (PP (IN at) (NP (NP (NNP Siriraj) (NNP Hospital)) (PP (IN between) (NP (CD 1997) (CC and) (CD 2001))))))))))))) (VP (VBD were) (VP (ADVP (RB retrospectively)) (VBN reviewed))) (. .)))
12948256	3	(ROOT (S (NP (NP (DT The) (JJ clinical) (NNS characteristics)) (CC and) (NP (NNS Doc_12948256_356_387_Disease))) (VP (VBD were) (VP (VBN analyzed) (S (VP (TO to) (VP (VB determine) (NP (JJ visual) (NN outcome))))))) (. .)))
12948256	4	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD had) (NP (NP (NNS Doc_12948256_457_473_Disease)) (PP (IN between) (NP (QP (CD 1) (TO to) (CD 6)) (NNS months))))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (S (VP (SYM =) (NP (CD 2.9) (NNS months)))))) (-RRB- -RRB-)) (PP (IN after) (S (VP (VBG starting) (NP (JJ Doc_12948256_531_541_Chemical) (NN therapy)) (PP (IN at) (NP (NP (DT a) (NN dosage)) (VP (VBG ranging) (PP (IN from) (NP (QP (CD 13) (TO to) (CD 20))) (ADVP (RB mg/kg/day)))))))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (S (VP (SYM =) (NP (CD 17) (NN mg/kg/day)))))) (-RRB- -RRB-))) (. .)))
12948256	5	(ROOT (S (NP (NP (NP (CD Seven)) (PRN (-LRB- -LRB-) (NP (CD 54) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (CD 13) (NNS patients)))) (VP (VBD experienced) (NP (JJ visual) (NN recovery)) (PP (IN after) (S (VP (VBG stopping) (NP (DT the) (NN drug)))))) (. .)))
12948256	6	(ROOT (S (PP (IN Of) (NP (NP (CD 6) (NNS patients)) (PP (IN with) (NP (JJ irreversible) (NNS Doc_12948256_733_750_Disease))))) (, ,) (NP (CD 4) (NNS patients)) (VP (VBD had) (NP (NP (NNS Doc_12948256_767_784_Disease)) (, ,) (NP (NNS Doc_12948256_786_794_Disease)) (CC and) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ heavy) (NN smoking)))))) (. .)))
12948256	7	(ROOT (S (NP (NP (RB Early) (NN recognition)) (PP (IN of) (NP (NNS Doc_12948256_860_876_Disease)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ Doc_12948256_915_925_Chemical) (NN therapy)))))))) (. .)))
12948256	8	(ROOT (S (NP (NP (DT A) (JJ low) (NN dose) (CC and) (JJ prompt) (NN discontinuation)) (PP (IN of) (NP (DT the) (NN drug)))) (VP (VBZ is) (VP (VBN recommended) (ADVP (RB particularly)) (PP (IN in) (NP (NP (NP (NNS individuals)) (PP (IN with) (NP (NNS Doc_12948256_1033_1050_Disease)))) (, ,) (NP (NNS Doc_12948256_1052_1060_Disease)) (CC or) (SBAR (WHNP (WP who)) (S (VP (VBP are) (NP (JJ heavy) (NNS smokers))))))))) (. .)))
12950111	0	(ROOT (NP (NP (NNP Treatment)) (PP (IN of) (NP (JJ compensatory) (NNS Doc_12950111_26_49_Disease))) (PP (IN with) (NP (JJ topical) (NNS Doc_12950111_63_77_Chemical))) (. .)))
12950111	1	(ROOT (S (NP (NNP Doc_12950111_79_102_Disease)) (VP (VBZ is) (NP (NP (JJ facial) (NN sweating)) (VP (ADVP (RB usually)) (VBN associated) (PP (IN with) (NP (NP (DT the) (NN eating)) (PP (IN of) (NP (JJ hot) (JJ spicy) (NN food) (CC or) (RB even))))) (S (VP (VBG smelling) (NP (DT this) (NN food))))))) (. .)))
12950111	2	(ROOT (S (NP (NP (JJ Current) (NNS options)) (PP (IN of) (NP (NN treatment)))) (VP (VBP include) (NP (NP (JJ oral) (JJ anticholinergic) (NNS drugs)) (, ,) (NP (NP (DT the) (JJ topical) (NN application)) (PP (IN of) (NP (NNS anticholinergics) (CC or) (NNS Doc_12950111_315_332_Chemical)))) (, ,) (CC and) (NP (NP (DT the) (NN injection)) (PP (IN of) (NP (NN botulinum) (NN toxin)))))) (. .)))
12950111	3	(ROOT (S (NP (NN Thirteen) (NNS patients)) (VP (VBP have) (VP (VBN been) (VP (VBN treated) (PP (TO to) (NP (NN date))) (PP (IN with) (NP (QP (CD 1.5) (NN %) (CC or) (CD 2) (NN %)) (JJ topical) (NNS Doc_12950111_440_454_Chemical)))))) (. .)))
12950111	4	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD had) (NP (NP (NNS Doc_12950111_473_496_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD interfered) (PP (IN with) (NP (PRP$ their) (JJ social) (NNS activities))) (, ,) (PP (IN after) (NP (JJ transthroacic) (JJ endoscopic) (NN sympathectomy)))))) (, ,) (CC and) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (JJ compensatory) (JJ focal) (NNS Doc_12950111_640_653_Disease))))))))) (. .)))
12950111	5	(ROOT (S (PP (IN After) (S (VP (VBG applying) (NP (JJ topical) (NNS Doc_12950111_678_692_Chemical))))) (, ,) (NP (DT the) (JJ subjective) (NN effect)) (VP (VBD was) (ADJP (ADJP (ADJP (JJ excellent)) (PRN (-LRB- -LRB-) (NP (NP (DT no) (NN sweating)) (PP (IN after) (NP (JJ eating) (JJ hot) (JJ spicy) (NN food)))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (CD 10) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 77) (NN %)) (-RRB- -RRB-)))) (, ,) (CC and) (ADJP (JJ fair)) (PRN (-LRB- -LRB-) (VP (ADVP (RB clearly)) (VBN reduced) (NP (NN sweating))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (CD 3) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 23) (NN %)) (-RRB- -RRB-))))) (. .)))
12950111	6	(ROOT (S (NP (DT All)) (VP (VBD had) (VP (VBN reported) (NP (NP (NNS incidents)) (PP (IN of) (S (VP (VBG being) (ADJP (RB very) (JJ embarrassed) (SBAR (IN whilst) (S (VP (VBG eating) (NP (JJ hot) (NN spicy) (NNS foods)))))))))))) (. .)))
12950111	7	(ROOT (S (NP (JJ Adverse) (NNS effects)) (VP (VBD included) (NP (NP (DT a) (UCP (ADJP (RB mildly) (JJ Doc_12950111_969_978_Disease)) (CC and) (NP (NP (DT a) (JJ sore) (NN throat)) (PP (IN in) (NP (NP (NP (CD 2) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 2) (NN %)) (NP (NNS Doc_12950111_1015_1029_Chemical))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ light) (NNS Doc_12950111_1040_1048_Disease)) (PP (IN in) (NP (CD 1)))))))) (NN patient)) (PRN (-LRB- -LRB-) (NP (NP (CD 1.5) (NN %)) (NP (NNS Doc_12950111_1068_1082_Chemical))) (-RRB- -RRB-)))) (. .)))
12950111	8	(ROOT (S (NP (NP (DT The) (JJ topical) (NN application)) (PP (IN of) (NP (DT a) (JJ Doc_12950111_1114_1128_Chemical) (NN pad)))) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (NP (NP (ADJP (JJ safe) (, ,) (JJ efficacious) (, ,) (RB well) (JJ tolerated))) (, ,) (CC and) (NP (NP (DT a) (JJ convenient) (NN method)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN for) (NP (ADJP (JJ moderate) (PP (TO to) (NP (NP (JJ severe) (NNS symptoms)) (PP (IN of) (NP (NP (NNS Doc_12950111_1255_1278_Disease)) (PP (IN in) (NP (NN post)))))))) (JJ transthoracic) (JJ endoscopic) (NN sympathectomy) (CC or) (NN sympathicotomy) (NNS patients)))))) (, ,)) (PP (IN with) (NP (JJ few) (NN side) (NNS effects))))))) (. .)))
1359137	0	(ROOT (NP (NN Neuroleptic-associated) (NNS Doc_1359137_23_41_Disease) (. .)))
1359137	1	(ROOT (SQ (MD Can) (NP (PRP it)) (VP (VB be) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_1359137_66_79_Chemical))))) (. ?)))
1359137	2	(ROOT (FRAG (NP (NP (CD Six) (JJ stable) (JJ Doc_1359137_92_103_Disease) (NNS outpatients)) (PP (IN with) (NP (NNS Doc_1359137_121_139_Disease) (CC and) (NNS Doc_1359137_144_154_Disease)))) (: /) (S (NP (NP (NNS Doc_1359137_155_169_Disease)) (VP (VBN associated) (PP (IN with) (NP (PRP$ their) (JJ neuroleptic) (NNS medications))))) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_1359137_234_247_Chemical)))))) (. .)))
1359137	3	(ROOT (S (NP (NP (JJ Daily) (NNS dosages)) (PP (IN of) (NP (JJ 5-10) (NN mg)))) (VP (VP (VBD corrected) (NP (DT the) (NNS Doc_1359137_288_306_Disease))) (CC and) (VP (VBD restored) (NP (NN menstruation)) (PP (IN in) (NP (NP (CD four)) (PP (IN of) (NP (DT the) (CD six) (NNS patients))))))) (. .)))
1359137	4	(ROOT (S (S (NP (CD One) (NN woman)) (, ,) (ADVP (RB however)) (, ,) (VP (VBD developed) (NP (JJ worsened) (JJ Doc_1359137_401_412_Disease) (NNS symptoms)) (PP (IN while) (S (VP (VBG taking) (NP (NNS Doc_1359137_435_448_Chemical))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBD was) (VP (VBN discontinued)))) (. .)))
1359137	5	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (CD three)) (PP (IN of) (NP (CD six) (NNS patients)))) (VP (VBD had) (NP (PRP$ their) (JJ menstrual) (NN irregularity)) (ADVP (RB successfully)) (VP (VBN corrected) (PP (IN with) (NP (NNS Doc_1359137_564_577_Chemical))))) (. .)))
1359137	6	(ROOT (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NNS Doc_1359137_598_611_Chemical)) (VP (MD should) (VP (VB be) (VP (ADVP (RBR further)) (VBN evaluated) (PP (IN as) (NP (NP (JJ potential) (NN therapy)) (PP (IN for) (NP (NP (JJ neuroleptic-associated) (NNS Doc_1359137_688_706_Disease)) (CC and) (NP (JJ Doc_1359137_711_721_Disease) (JJ /) (NNS Doc_1359137_722_734_Disease)))))))))))) (. .)))
1360900	0	(ROOT (S (NP (NP (JJ Doc_1360900_0_15_Chemical-induced) (NNS Doc_1360900_24_35_Disease)) (CC and) (NP (NN brain))) (VP (VBZ neurotransmitters) (PP (IN in) (NP (NNS mice)))) (. .)))
1360900	1	(ROOT (S (NP (NP (JJ Intracerebroventricular) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_1360900_110_125_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 50) (NN %) (NN convulsive) (NN dose)) (: ;) (NP (CD 50) (NN micrograms/mouse))) (-RRB- -RRB-))))) (VP (VP (VBD accelerated) (NP (NP (DT the) (NN synthesis/turnover)) (PP (IN of) (NP (NP (NNS Doc_1360900_207_226_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1360900_228_232_Chemical)) (-RRB- -RRB-)))))) (CC but) (VP (VBD suppressed) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NNS Doc_1360900_266_289_Chemical) (CC and) (NNS Doc_1360900_294_307_Chemical)))) (PP (IN in) (NP (NN mouse) (NN brain))))) (. .)))
1360900	2	(ROOT (S (NP (DT These) (NNS effects)) (VP (VBD were) (ADJP (RB completely) (JJ antagonized) (PP (IN by) (NP (NP (NN pretreatment)) (PP (IN with) (NP (DT a) (NNS Doc_1360900_389_398_Chemical)))))) (PRN (: /) (NP (NP (JJ Doc_1360900_399_419_Chemical) (NN antagonist)) (, ,) (NP (NNS Doc_1360900_432_458_Chemical))))) (. .)))
1360900	3	(ROOT (S (PP (IN In) (NP (NN Doc_1360900_463_478_Chemical-induced) (NNS Doc_1360900_487_498_Disease))) (, ,) (NP (DT these) (NN neurotransmitter) (NNS systems)) (VP (MD may) (VP (VB be) (ADJP (RB differentially) (JJ modulated)) (, ,) (PP (ADVP (RB probably)) (IN through) (NP (NP (NN activation)) (PP (IN of) (NP (NP (JJ glutaminergic) (NNS neurons)) (PP (IN in) (NP (DT the) (NN brain))))))))) (. .)))
1361574	0	(ROOT (NP (NP (NP (NNP Pharmacology)) (PP (IN of) (NP (JJ Doc_1361574_16_40_Chemical) (NN receptor)))) (ADJP (JJ complex) (PP (IN after) (NP (NP (DT the) (RB in) (JJ vivo) (NN administration)) (PP (IN of) (NP (DT the) (ADJP (JJ anxioselective) (CC and) (JJ anticonvulsant)) (JJ Doc_1361574_132_146_Chemical) (JJ derivative) (NNS Doc_1361574_158_167_Chemical)))))) (. .)))
1361574	1	(ROOT (S (PP (IN In) (NP (NNS rodents))) (, ,) (NP (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (DT the) (JJ Doc_1361574_199_213_Chemical) (JJ derivative) (NNS Doc_1361574_225_292_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1361574_294_304_Chemical)) (-RRB- -RRB-))))) (, ,) (NP (NP (DT a) (JJ new) (NN ligand)) (PP (IN for) (NP (NP (JJ Doc_1361574_324_338_Chemical) (NNS receptors)) (VP (VBG possessing) (NP (ADJP (JJ anxiolytic) (CC and) (JJ anticonvulsant)) (NNS properties)))))) (, ,)) (VP (VBD was) (VP (VBN evaluated) (PP (IN on) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NP (NP (JJ central) (NNS Doc_1361574_443_466_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1361574_468_472_Chemical)) (-RRB- -RRB-))) (ADJP (NP (DT A) (NN receptor)) (JJ complex)))))) (, ,) (PP (DT both) (PP (IN in) (NP (NNP vitro))) (CC and) (PP (IN in) (NP (NN vivo)))))) (. .)))
1361574	2	(ROOT (S (S (VP (VBN Added) (PP (IN in) (NP (ADJP (NN vitro) (S (VP (TO to) (VP (VB rat) (NP (JJ cortical) (NNS membrane)))))) (NN preparation))))) (, ,) (NP (NNS Doc_1361574_573_582_Chemical)) (VP (VP (VBD increased) (S (NP (QP (CD -LSB-) (CD 3H)) (JJ -RSB-) (NNS Doc_1361574_597_601_Chemical)) (ADJP (JJ binding)))) (, ,) (VP (VBD enhanced) (NP (JJ Doc_1361574_620_645_Chemical) (NN uptake))) (CC and) (VP (VBD reduced) (NP (NP (DT the) (VBG binding)) (PP (IN of) (NP (NP (NNS Doc_1361574_680_716_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1361574_718_727_Chemical)) (-RRB- -RRB-))))))) (. .)))
1361574	3	(ROOT (S (NP (DT These) (NNS effects)) (VP (VBD were) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_1361574_777_785_Chemical))) (, ,) (SBAR (IN whereas) (S (NP (NP (DT the) (JJ partial) (NN agonist) (NNS Doc_1361574_815_825_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1361574_827_947_Chemical)) (-RRB- -RRB-))) (VP (VBD showed) (ADJP (RB very) (JJ weak)) (ADVP (RB efficacy)) (PP (IN in) (NP (DT these) (JJ biochemical) (NNS tests))))))))))) (. .)))
1361574	4	(ROOT (S (PP (IN After) (NP (NP (NN i.p.) (NN injection)) (PP (TO to) (NP (NNS rats))))) (, ,) (NP (NNS Doc_1361574_1033_1042_Chemical) (CC and) (NNS Doc_1361574_1047_1055_Chemical)) (VP (VBD decreased) (PP (IN in) (NP (NP (DT a) (ADJP (JJ time-dependent) (CC and) (JJ dose-related)) (PRN (-LRB- -LRB-) (NP (CD 0.25-20) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-)) (NN manner)) (ADJP (RB Doc_1361574_1131_1140_Chemical) (JJ binding)) (VP (VBN measured) (NP (JJ ex) (NN vivo)) (PP (IN in) (NP (DT the) (JJ cerebral) (NN cortex))))))) (. .)))
1361574	5	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (DT both) (NNS drugs)) (PP (IN at) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (CD 0.5) (NN mg/kg)))))) (VP (VBD antagonized) (ADVP (RB completely)) (NP (NP (NP (DT the) (JJ convulsant) (NN activity)) (CC and) (NP (NP (DT the) (NN increase)) (PP (IN of) (NP (NP (QP (CD -LSB-) (CD 35S)) (JJ -RSB-) (NNS TBPS)) (ADJP (JJ binding)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_1361574_1332_1342_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 350) (NN mg/kg) (NN s.c.)) (-RRB- -RRB-))))))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NN increase)) (PP (IN of) (NP (NP (JJ Doc_1361574_1387_1396_Chemical) (VBG binding)) (VP (VBN induced) (PP (IN by) (NP (JJ foot-shock) (NN stress))))))))) (. .)))
1361574	6	(ROOT (S (S (VP (TO To) (VP (ADVP (RBR better)) (VB correlate) (NP (NP (DT the) (NN biochemical)) (CC and) (NP (DT the) (JJ pharmacological) (NNS effects)))))) (, ,) (NP (PRP we)) (VP (VBD studied) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NP (NNS Doc_1361574_1529_1538_Chemical)) (PP (IN on) (NP (JJ Doc_1361574_1542_1551_Chemical) (UCP (NP (JJ binding) (, ,) (JJ exploratory) (NN motility)) (CC and) (PP (IN on) (NP (NP (NNS Doc_1361574_1589_1598_Chemical-induced)) (ADJP (JJ biochemical) (CC and) (JJ pharmacological))))) (NNS effects)))))) (PP (IN in) (NP (NNS mice)))) (. .)))
1361574	7	(ROOT (S (PP (IN In) (NP (DT these) (NNS animals))) (, ,) (S (NP (NNS Doc_1361574_1674_1683_Chemical)) (VP (VBD produced) (NP (NP (DT a) (ADJP (JJ paralleled) (JJ dose-dependent)) (PRN (-LRB- -LRB-) (NP (CD 0.05-1) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-)) (NN reduction)) (PP (IN of) (NP (DT both) (NN motor) (NN behavior)))))) (CC and) (S (NP (JJ cortical) (JJ -LSB-) (CD 35S) (JJ -RSB-) (NNS TBPS)) (ADJP (JJ binding))) (. .)))
1361574	8	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (CD 0.05) (NN mg/kg)) (PP (IN of) (NP (DT this) (NNS Doc_1361574_1835_1849_Chemical)))) (VP (VBD reduced) (ADVP (RB markedly) (NP (DT the) (NN increase))) (PP (IN of) (NP (NP (JJ Doc_1361574_1883_1892_Chemical) (VBG binding)) (CC and) (NP (NP (NP (DT the) (NNS Doc_1361574_1909_1920_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_1361574_1932_1941_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 200) (NN mg/kg) (NN s.c.)) (-RRB- -RRB-)))) (. .))) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-))))))))
1395192	0	(ROOT (NP (NP (NP (JJ Recurrent) (NNS Doc_1395192_10_31_Disease)) (PP (IN in) (NP (DT a) (NN postpartum) (NN patient)))) (VP (VBG receiving) (NP (NNS Doc_1395192_66_79_Chemical))) (. .)))
1395192	1	(ROOT (S (NP (NP (NNP Doc_1395192_81_102_Disease)) (PP (IN in) (NP (NN puerperium)))) (VP (VBZ is) (ADJP (RB infrequently) (VBN reported))) (. .)))
1395192	2	(ROOT (S (ADVP (RB Spasm)) (, ,) (NP (NP (JJ coronary) (NN dissection)) (, ,) (CC or) (NP (NNS Doc_1395192_174_186_Disease))) (ADVP (RB etiology)) (VP (VBZ has) (VP (VBN been) (VP (VBN described)))) (. .)))
1395192	3	(ROOT (S (NP (NNP Doc_1395192_216_229_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ several) (JJ previous) (NN case) (NNS reports)) (PP (IN of) (NP (NP (NNS Doc_1395192_286_307_Disease)) (PP (IN in) (NP (DT the) (NN puerperium)))))))))) (. .)))
1395192	4	(ROOT (S (NP (NP (PRP$ Our) (NN case)) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (DT an) (JJ inadvertent) (NN rechallenge))) (-RRB- -RRB-))) (VP (VBZ suggests) (NP (PDT such) (DT a) (NN relationship))) (. .)))
1395192	5	(ROOT (S (SBAR (IN Although) (S (ADVP (RB generally)) (VP (VBN regarded) (PP (IN as) (`` ``) (ADJP (JJ safe)) (, ,) ('' ''))))) (NP (NP (JJ possible) (JJ serious) (JJ cardiac) (NNS effects)) (PP (IN of) (NP (NNS Doc_1395192_480_493_Chemical)))) (VP (MD should) (VP (VB be) (VP (VBN acknowledged)))) (. .)))
1420650	0	(ROOT (S (NP (NNS Asterixis)) (VP (VBN induced) (PP (IN by) (NP (JJ Doc_1420650_21_34_Chemical) (NN therapy)))) (. .)))
1420650	1	(ROOT (S (NP (EX There)) (VP (VBP are) (NP (ADJP (RB very) (JJ few)) (NNS reports)) (PP (IN about) (NP (NP (NNS Doc_1420650_77_86_Disease)) (PP (IN as) (NP (NP (DT a) (NN side) (NN effect)) (PP (IN of) (NP (NN treatment))))))) (PP (IN with) (NP (JJ psychopharmacologic) (NNS agents)))) (. .)))
1420650	2	(ROOT (S (PP (IN In) (NP (DT this) (NN report))) (NP (PRP we)) (VP (VBP present) (NP (NP (CD four) (NNS patients)) (VP (VBN treated) (PP (PP (IN with) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NP (JJ different) (JJ psychotropic) (NNS drugs)) (, ,) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (NNS Doc_1420650_258_267_Disease)) (VP (VBD was) (VP (VBN triggered) (ADVP (RB either)) (PP (IN by) (S (VP (VBG adding) (NP (NP (NNS Doc_1420650_299_312_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1420650_314_317_Chemical)) (-RRB- -RRB-))) (PP (TO to) (NP (DT a) (NN treatment) (NN regimen)))))))))) (, ,))))) (CC or) (PP (IN by) (S (VP (VBG increasing) (NP (PRP$ its) (NN dosage))))))))) (. .)))
1420650	3	(ROOT (S (NP (CC Neither) (NP (NN dosage)) (CC nor) (NP (NP (NN serum) (NNS levels)) (PP (IN of) (NP (NNS Doc_1420650_407_410_Chemical))))) (VP (VBD were) (PP (IN in) (NP (DT a) (JJR higher) (NN range)))) (. .)))
1420650	4	(ROOT (S (NP (PRP We)) (VP (VBP consider) (S (NP (NNS Doc_1420650_447_456_Disease)) (VP (TO to) (VP (VB be) (NP (NP (DT an) (ADJP (RB easily) (JJ overlooked)) (NN sign)) (PP (IN of) (NP (NP (NNS Doc_1420650_492_505_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB occur) (ADVP (RB even)) (PP (IN at) (NP (ADJP (JJ low) (CC or) (JJ moderate)) (NN dosage) (NNS levels))))))))))))) (, ,) (SBAR (IN if) (S (NP (NP (JJ certain) (NNS drugs)) (PP (IN as) (NP (NNS Doc_1420650_582_589_Chemical) (CC or) (NNS Doc_1420650_593_602_Chemical)))) (VP (VBP are) (VP (VBN used) (PP (IN in) (NP (NN combination))) (PP (IN with) (NP (NNS Doc_1420650_632_635_Chemical)))))))) (. .)))
1423336	0	(ROOT (NP (NP (NNS Pharmacodynamics)) (PP (IN of) (NP (DT the) (JJ Doc_1423336_24_35_Disease) (NN effect))) (PP (IN of) (NP (NP (NNS Doc_1423336_46_54_Chemical)) (PP (IN in) (NP (JJ Doc_1423336_58_70_Disease) (NNS patients))))) (. .)))
1423336	1	(ROOT (S (NP (NP (NN Blood) (NN pressure) (NNS effects)) (PP (IN of) (NP (NN i.v.) (NNS Doc_1423336_112_120_Chemical)))) (VP (VBD were) (VP (VBN examined) (PP (IN in) (NP (NP (JJ Doc_1423336_138_150_Disease) (NNS patients)) (PP (IN with) (NP (ADJP (JJ stable) (CC and) (JJ fluctuating)) (NNS responses))))) (PP (TO to) (NP (NNS Doc_1423336_201_209_Chemical))))) (. .)))
1423336	2	(ROOT (S (NP (NP (DT The) (NN magnitude)) (PP (IN of) (NP (NP (DT the) (JJ Doc_1423336_232_243_Disease) (NN effect)) (PP (IN of) (NP (NNS Doc_1423336_254_262_Chemical)))))) (VP (VP (VBD was) (ADJP (RB concentration) (JJ dependent))) (CC and) (VP (VBD was) (ADJP (JJ fit) (PP (TO to) (NP (DT an) (NNP Emax) (NN model)))) (PP (IN in) (NP (VBG fluctuating) (NNS responders))))) (. .)))
1423336	3	(ROOT (S (NP (JJ Stable) (NNS responders)) (VP (VBD demonstrated) (NP (DT a) (JJ small) (JJ Doc_1423336_386_397_Disease) (NN response))) (. .)))
1423336	4	(ROOT (S (NP (JJ Baseline) (NN blood) (NNS pressures)) (VP (VBD were) (ADJP (ADJP (JJR higher)) (PP (IN in) (S (VP (VBG fluctuating) (NP (NP (NNS patients)) (: ;) (NP (NP (DT a) (JJR higher) (JJ baseline) (NN blood) (NN pressure)) (VP (VBN correlated) (PP (IN with) (NP (JJR greater) (JJ Doc_1423336_527_538_Disease) (NNS effects))))))))))) (. .)))
1423336	5	(ROOT (S (NP (NP (NN Antiparkinsonian) (NNS effects)) (PP (IN of) (NP (NNS Doc_1423336_576_584_Chemical)))) (ADVP (RB temporally)) (VP (VBD correlated) (PP (IN with) (NP (NN blood) (NN pressure) (NNS changes)))) (. .)))
1423336	6	(ROOT (S (NP (NP (NNP Doc_1423336_636_649_Chemical)) (, ,) (NP (NP (NP (DT a) (JJ large) (JJ neutral) (NNS Doc_1423336_667_677_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1423336_679_683_Chemical)) (-RRB- -RRB-))) (VP (VBG competing) (PP (IN with) (NP (NP (NNS Doc_1423336_700_708_Chemical)) (PP (IN for) (NP (NN transport))))) (PP (IN across) (NP (DT the) (JJ blood-brain) (NN barrier))))) (, ,)) (VP (VBD reduced) (NP (NP (DT the) (NNS Doc_1423336_767_778_Disease) (CC and) (NN antiparkinsonian) (NNS effects)) (PP (IN of) (NP (NNS Doc_1423336_811_819_Chemical))))) (. .)))
1423336	7	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NNS Doc_1423336_838_846_Chemical)) (VP (VBZ has) (NP (NP (DT a) (JJ central) (JJ Doc_1423336_861_872_Disease) (NN action)) (SBAR (WHNP (WDT that)) (S (VP (VBZ parallels) (NP (NP (DT the) (NN motor) (NNS effects)) (PP (IN in) (NP (VBG fluctuating) (NNS patients)))))))))))) (. .)))
1423336	8	(ROOT (S (S (NP (DT The) (JJ Doc_1423336_942_953_Disease) (NN effect)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (DT the) (JJR higher) (NN baseline) (NN blood) (NN pressure))))))))) (NP (PRP we)) (VP (VBD observed) (PP (IN in) (S (VP (VBG fluctuating) (NP (NNS patients)) (ADVP (JJ relative) (PP (TO to) (NP (JJ stable) (NNS patients)))))))) (. .)))
1424076	0	(ROOT (S (VP (VB Doc_1424076_0_59_Disease) (PP (IN after) (NP (JJ infusional) (NNS Doc_1424076_77_88_Chemical)))) (. .)))
1424076	1	(ROOT (S (NP (NP (DT A) (JJ 77-year-old) (NN woman)) (PP (IN with) (NP (JJ refractory) (JJ multiple) (NNS Doc_1424076_135_142_Disease)))) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (NP (DT a) (JJ 4-day) (JJ continuous) (JJ intravenous) (NN infusion)) (PP (IN of) (NP (NNS Doc_1424076_203_214_Chemical) (CC and) (NNS Doc_1424076_219_230_Chemical)))) (CC and) (NP (NP (CD 4) (NNS days)) (PP (IN of) (NP (JJ oral) (NNS Doc_1424076_250_263_Chemical)))))))) (. .)))
1424076	2	(ROOT (S (PP (NP (CD Nine) (NNS days)) (IN after) (NP (PRP$ her) (JJ second) (NN cycle))) (NP (PRP she)) (VP (VBD presented) (PP (IN with) (NP (NP (NN lethargy) (CC and) (NNS Doc_1424076_330_338_Disease)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_1424076_355_367_Disease))))))) (. .)))
1424076	3	(ROOT (S (NP (NNP Evaluation)) (VP (VBD revealed) (NP (NP (DT the) (NNS Doc_1424076_393_452_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN attributed) (PP (TO to) (NP (DT the) (JJ Doc_1424076_482_493_Chemical) (NN infusion))))))))) (. .)))
1424076	4	(ROOT (S (SBAR (IN After) (S (NP (JJ normal) (NN serum) (NNS Doc_1424076_523_529_Chemical) (NNS levels)) (VP (VBD returned)))) (, ,) (NP (NP (JJ further) (NNS Doc_1424076_555_566_Chemical) (CC and) (NNS Doc_1424076_571_584_Chemical) (NN chemotherapy)) (PP (IN without) (NP (NNS Doc_1424076_606_617_Chemical)))) (VP (VBD did) (RB not) (VP (VB produce) (NP (DT this) (NN complication)))) (. .)))
1449452	0	(ROOT (FRAG (NP (NNP Doc_1449452_0_13_Disease)) (: :) (S (VP (TO to) (VP (VB digitalise) (NP (QP (CC or) (RB not)))))) (. ?)))
1449452	1	(ROOT (NP (NP (DT The) (NN view)) (PP (IN against)) (. .)))
1449452	2	(ROOT (S (PP (IN Despite) (NP (JJ extensive) (JJ clinical) (NN experience))) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNS Doc_1449452_105_112_Chemical)))) (VP (VBZ is) (ADVP (RB still)) (VP (RB not) (ADVP (RB well)) (VBN defined))) (. .)))
1449452	3	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_1449452_157_176_Disease))))) (NP (NNS Doc_1449452_177_184_Chemical)) (VP (VBZ is) (ADJP (JJ beneficial) (PP (IN for) (NP (NN ventricular) (NN rate) (NN control))))) (. .)))
1449452	4	(ROOT (S (PP (IN For) (NP (NP (NNS patients)) (PP (IN in) (NP (JJ sinus) (NN rhythm) (CC and) (NNS Doc_1449452_262_275_Disease))))) (NP (DT the) (NN situation)) (VP (VBZ is) (ADJP (RBR less) (JJ clear))) (. .)))
1449452	5	(ROOT (S (S (NP (NNP Doc_1449452_305_312_Chemical)) (VP (VBZ has) (NP (DT a) (JJ narrow) (JJ therapeutic)))) (: :) (S (NP (JJ toxic) (NN ratio) (CC and) (NNS concentrations)) (VP (VBP are) (VP (VBN affected) (PP (IN by) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NNS drugs)))))))) (. .)))
1449452	6	(ROOT (S (ADVP (RB Also)) (, ,) (NP (NNS Doc_1449452_410_417_Chemical)) (VP (VBZ has) (NP (NP (JJ undesirable) (NNS effects)) (PP (JJ such) (IN as) (S (VP (VP (VBG increasing) (NP (JJ peripheral) (NN resistance) (CC and) (NN myocardial) (NNS demands))) (, ,) (CC and) (VP (VBG causing) (NP (NNS Doc_1449452_519_530_Disease)))))))) (. .)))
1449452	7	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT a) (NN paucity)) (PP (IN of) (NP (NP (NNS data)) (PP (IN from) (NP (JJ well-designed) (NNS trials))))))) (. .)))
1449452	8	(ROOT (S (NP (NP (DT The) (NNS trials)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ available)))))) (VP (VBP are) (ADJP (RB generally) (JJ small) (PP (IN with) (NP (NP (NP (NNS limitations)) (PP (IN in) (NP (NN design)))) (CC and) (NP (NP (DT these) (NN show) (NN variation)) (PP (IN in) (NP (JJ patient) (NN benefit)))))))) (. .)))
1449452	9	(ROOT (S (NP (ADJP (RBR More) (JJ convincing)) (NN evidence)) (VP (VBZ is) (VP (VBN required) (S (VP (VBG showing) (SBAR (IN that) (S (NP (NNS Doc_1449452_758_765_Chemical)) (VP (VBZ improves) (NP (NNS symptoms) (CC or) (NN exercise) (NN capacity))))))))) (. .)))
1449452	10	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (DT no) (NN trial)) (VP (VBZ has) (VP (VBN had) (NP (JJ sufficient) (NN power)) (S (VP (TO to) (VP (VB evaluate) (NP (NN mortality))))))) (. .)))
1449452	11	(ROOT (S (S (NP (NP (JJ Pooled) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ other) (JJ inotropic) (NNS drugs)))))) (VP (VBZ shows) (NP (DT an) (JJ excess) (NN mortality)))) (CC and) (S (NP (EX there)) (VP (VBZ is) (NP (DT a) (NN possibility)) (SBAR (IN that) (S (NP (NNS Doc_1449452_990_997_Chemical)) (VP (MD may) (VP (VB increase) (NP (NN mortality)) (PP (IN after) (NP (NP (NNS Doc_1449452_1027_1048_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1449452_1050_1052_Disease)) (-RRB- -RRB-)))))))))) (. .)))
1449452	12	(ROOT (S (NP (NNP Doc_1449452_1055_1101_Chemical)) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB first)) (SBAR (IN as) (S (NP (PRP they)) (VP (VBP are) (ADJP (ADJP (JJR safer)) (, ,) (SBAR (S (VP (VBP do) (RB not) (VP (VP (VB require) (NP (NN blood) (NN level) (NN monitoring))) (, ,) (VP (VB modify) (NP (NP (NN progression)) (PP (IN of) (NP (NN disease))))) (, ,) (VP (VB relieve) (NP (NNS symptoms))) (, ,) (VP (VB improve) (NP (NN exercise) (NN tolerance))) (CC and) (VP (VB reduce) (NP (NN mortality)))))))))))))) (. .)))
1449452	13	(ROOT (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (PP (IN in) (S (VP (VBG using) (NP (NNS Doc_1449452_1316_1323_Chemical)) (SBAR (IN until) (S (NP (JJ large) (NN mortality) (NNS trials)) (VP (VBP are) (VP (VBN completed) (S (VP (VBG showing) (NP (DT either) (NN benefit) (CC or) (NN harm)))))))))))))) (. .)))
1449452	14	(ROOT (S (PP (IN Until) (NP (RB then))) (NP (NNS Doc_1449452_1410_1417_Chemical)) (VP (MD should) (VP (VB be) (VP (VBN considered) (NP (DT a) (JJ third-line) (NN therapy))))) (. .)))
1451544	0	(ROOT (NP (NP (JJ Doc_1451544_0_10_Chemical) (NN treatment)) (PP (IN for) (NP (NP (NNS Doc_1451544_25_37_Disease)) (PP (IN in) (NP (JJ general) (NN practice))))) (PP (IN in) (NP (NNP Hong) (NNP Kong))) (. .)))
1451544	1	(ROOT (S (NP (NP (DT A) (JJ 6-week) (JJ open) (NN study)) (PP (IN of) (NP (NP (DT the) (NN introduction)) (PP (IN of) (NP (JJ Doc_1451544_115_125_Chemical) (NN treatment)))))) (VP (VBD was) (VP (VBN conducted) (PP (IN in) (NP (JJ general) (NN practice))) (PP (IN in) (NP (NP (NNP Hong) (NNP Kong) (. .) (NNP 303)) (SBAR (S (NP (NP (JJ Chinese) (NNS patients)) (PP (IN with) (NP (ADJP (JJ mild) (TO to) (JJ moderate)) (NNS Doc_1451544_227_239_Disease)))) (VP (VBD entered) (NP (DT the) (NN study))))))))) (. .)))
1451544	2	(ROOT (S (NP (NN Side) (NNS effects)) (VP (VP (VBD were) (VP (VBN reported) (PP (IN in) (NP (NP (CD 21) (NN %)) (PP (IN of) (NP (NNS patients))))))) (CC and) (VP (VBD caused) (NP (NN withdrawal)) (PP (IN from) (NP (NP (DT the) (NN study)) (PP (IN in) (NP (CD 3) (NNS patients))))))) (. .)))
1451544	3	(ROOT (S (S (NP (DT The) (JJ main) (NNS side-effects)) (VP (VBD were) (NP (NNS Doc_1451544_384_392_Disease) (, ,) (NNS Doc_1451544_394_403_Disease) (, ,) (NN palpitation) (CC and) (NN flushing)))) (CC and) (S (NP (DT these)) (VP (VBD were) (RB not) (ADJP (ADJP (RBR more) (JJ frequent)) (SBAR (IN than) (S (VP (VBD reported) (PP (IN in) (NP (JJ other) (NNS studies))) (PP (PP (IN with) (NP (NNS Doc_1451544_499_509_Chemical))) (CC or) (PP (IN with) (NP (NN placebo)))))))))) (. .)))
1451544	4	(ROOT (S (NP (JJ Supine) (NN blood) (NN pressure)) (VP (VBD was) (VP (VBN reduced) (S (VP (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.01))) (-RRB- -RRB-)) (PP (IN from) (FRAG (FRAG (ADJP (NP (CD 170)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (NP (CD 20/102)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (NP (CD 6)) (JJ mmHg) (PP (TO to) (NP (QP (CD 153) (CD +))))) (: /)) (: -) (FRAG (FRAG (ADJP (NP (CD 19/92)) (JJ +)) (: /)) (: -) (FRAG (FRAG (NP (CD 8)) (, ,) (NP (CD 147) (CD +)) (: /)) (: -) (FRAG (FRAG (ADJP (NP (CD 18/88)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (NP (CD 7)) (CC and) (ADJP (RB 144) (JJ +))) (: /)) (: -) (FRAG (FRAG (ADJP (NP (CD 14/87)) (JJ +)) (: /)) (: -) (FRAG (ADJP (NP (CD 6)) (JJ mmHg) (PP (IN at) (NP (CD 2)))) (, ,) (NP (NP (CD 4) (CC and) (CD 6) (NNS weeks)) (ADVP (RB respectively))))))))))))))) (PP (IN in) (NP (JJ evaluable) (NNS patients))))) (. .)))
1451544	5	(ROOT (S (S (NP (NNP Doc_1451544_740_758_Disease)) (VP (VBD occurred) (PP (IN in) (S (VP (VBG standing) (NP (NN blood) (NN pressure))))))) (CC and) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NNS Doc_1451544_824_844_Disease)))))) (. .)))
1451544	6	(ROOT (S (NP (NP (NN Normalization) (CC and) (NN responder) (NNS rates)) (PP (IN at) (NP (CD 6) (NNS weeks)))) (VP (VBD were) (NP (QP (CD 86) (NN %) (CC and) (CD 69)) (NN %)) (ADVP (RB respectively))) (. .)))
1451544	7	(ROOT (SINV (ADVP (RB Dosage)) (VP (VBD was) (VP (VBN increased) (PP (IN from) (NP (CD 2.5) (NN mg) (NN b.d.))) (PP (TO to) (NP (NP (CD 5) (NN mg) (NN b.d.)) (PP (IN at) (NP (NP (CD 4) (NNS weeks)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ diastolic) (NN blood) (NN pressure))))))))))) (NP (NP (QP (JJR greater) (IN than) (CD 90))) (SBAR (S (NP (NP (NN mmHg)) (CC and) (NP (PRP$ their) (JJ further) (NN response))) (VP (VBD was) (ADJP (JJR greater)) (PP (IN than) (NP (NP (DT those) (VBG remaining)) (PP (IN on) (NP (CD 2.5) (NN mg) (NN b.d.)))))))))))
14616590	0	(ROOT (NP (NP (JJ Pharmacological) (NNS characteristics) (CC and) (NN side) (NNS effects)) (PP (IN of) (NP (DT a) (JJ new) (JJ Doc_14616590_58_65_Disease) (NN formulation))) (PP (IN of) (NP (NP (NNS Doc_14616590_81_89_Chemical)) (PP (IN without) (NP (NN soyabean) (NN oil))))) (. .)))
14616590	1	(ROOT (S (NP (PRP We)) (VP (VBD compared) (NP (NP (DT the) (NNS pharmacokinetics) (, ,) (NNS pharmacodynamics) (CC and) (NN safety) (NN profile)) (PP (IN of) (NP (NP (DT a) (JJ new) (JJ Doc_14616590_191_198_Disease) (NN formulation)) (PP (IN of) (NP (NP (NP (NNS Doc_14616590_214_222_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD AM149) (CD 1)) (NN %)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ does) (RB not) (VP (VB contain) (NP (NN soyabean) (NN oil))))))))))) (, ,) (PP (IN with) (NP (NP (DT a) (JJ standard) (NN formulation)) (PP (IN of) (NP (NP (NNS Doc_14616590_303_311_Chemical)) (PRN (-LRB- -LRB-) (VP (VBN Disoprivan) (NP (CD 1) (NN %))) (-RRB- -RRB-))))))) (. .)))
14616590	2	(ROOT (S (PP (IN In) (NP (DT a) (JJ randomised) (, ,) (JJ double-blind) (, ,) (JJ cross-over) (NN study))) (, ,) (NP (CD 30) (JJ healthy) (NNS volunteers)) (VP (VBD received) (NP (NP (DT a) (JJ single) (JJ intravenous) (NNS bolus) (NN injection)) (PP (IN of) (NP (CD 2.5) (JJ mg.kg-1) (NNS Doc_14616590_461_469_Chemical))))) (. .)))
14616590	3	(ROOT (S (NP (NNP Plasma) (NNP Doc_14616590_478_486_Chemical) (NNS levels)) (VP (VBD were) (VP (VP (VBN measured) (PP (IN for) (NP (NP (CD 48) (NN h)) (PP (VBG following) (NP (NN drug) (NN administration)))))) (CC and) (VP (VBN evaluated) (PP (VBG according) (PP (TO to) (NP (DT a) (JJ three-compartment) (NN model))))))) (. .)))
14616590	4	(ROOT (S (NP (NP (DT The) (JJ pharmacodynamic) (NNS parameters)) (VP (VBN assessed))) (VP (VBD included) (NP (NP (NN induction) (CC and) (NN emergence) (NNS times)) (, ,) (NP (JJ respiratory) (CC and) (JJ cardiovascular) (NNS effects)) (, ,) (CC and) (NP (NNS Doc_14616590_725_729_Disease))) (PP (IN on) (NP (NN injection)))) (. .)))
14616590	5	(ROOT (S (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN monitored) (PP (IN for) (NP (NN side) (NNS effects))) (PP (IN over) (NP (NP (CD 48) (NN h.)) (VP (VBG Owing) (PP (TO to) (NP (NP (DT a) (JJ high) (NN incidence)) (PP (IN of) (NP (NNS Doc_14616590_825_841_Disease))))))))))) (, ,) (S (NP (DT the) (NN study)) (VP (VBD was) (VP (VBN terminated) (ADVP (RB prematurely))))) (CC and) (S (NP (NP (RB only) (DT the) (NNS data)) (PP (IN of) (NP (NP (DT the) (CD two) (JJ parallel) (NN treatment) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NP (CD 15) (NNS patients)) (PP (IN in) (NP (DT each) (NN group)))) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN analysed)))) (. .)))
14616590	6	(ROOT (S (NP (NNP Plasma) (NNS concentrations)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PP (IN between) (NP (DT the) (CD two) (NNS formulations))))) (. .)))
14616590	7	(ROOT (S (NP (NP (NNP Anaesthesia) (NN induction) (CC and) (NN emergence) (NNS times)) (, ,) (NP (NN respiratory)) (CC and) (NP (JJ cardiovascular) (NNS variables))) (VP (VBD showed) (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN between) (NP (DT the) (CD two) (NN treatment) (NNS groups))))) (. .)))
14616590	8	(ROOT (S (NP (NP (NNP Doc_14616590_1211_1215_Disease)) (PP (IN on) (NP (NP (NN injection)) (PRN (-LRB- -LRB-) (NP (NP (CD 80)) (PP (IN vs.) (NP (NP (CD 20) (NN %)) (, ,) (NP (NN p)))) (ADJP (JJ <) (NP (CD 0.01)))) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_14616590_1256_1272_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP 93.3)) (PP (IN vs.) (NP (NP (CD 6.6) (NN %)) (, ,) (NP (NN p)))) (ADJP (JJ <) (NP (CD 0.001)))) (-RRB- -RRB-))))) (VP (VBD occurred) (ADVP (RBR more) (RB frequently)) (PP (IN with) (NP (NNS Doc_14616590_1330_1335_Chemical))) (PP (IN than) (PP (IN with) (NP (NNS Doc_14616590_1346_1356_Chemical))))) (. .)))
14616590	9	(ROOT (S (SBAR (IN Although) (S (NP (DT both) (NNS formulations)) (VP (VBD had) (NP (JJ similar) (ADJP (JJ pharmacokinetic) (CC and) (JJ pharmacodynamic)) (NNS profiles))))) (NP (DT the) (JJ new) (NN formulation)) (VP (VBZ is) (RB not) (ADJP (JJ suitable) (PP (IN for) (NP (NP (JJ clinical) (NN use)) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (JJ high) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_14616590_1524_1540_Disease)) (VP (VBN produced))))))))))) (. .)))
146391	0	(ROOT (NP (NP (JJ Pure) (NNS Doc_146391_5_21_Disease)) (, ,) (NP (NP (JJ toxic) (NNS Doc_146391_29_39_Disease) (CC and) (NNS Doc_146391_44_59_Disease)) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (VBG taking) (NP (NNS Doc_146391_80_97_Chemical)))))) (. .)))
146391	1	(ROOT (S (NP (NP (DT A) (NN patient)) (VP (VBG taking) (NP (NP (NNS Doc_146391_116_133_Chemical)) (PP (IN for) (NP (CD 3) (NNS weeks)))))) (VP (VBD developed) (NP (NP (DT a) (JJ generalized) (NNS Doc_146391_170_179_Disease)) (, ,) (NP (NNS Doc_146391_181_196_Disease)) (CC and) (NP (JJ pure) (NNS Doc_146391_206_222_Disease)))) (. .)))
146391	2	(ROOT (S (PP (IN After) (NP (NP (NN withdrawal)) (PP (IN of) (NP (DT the) (NN pharmacon))))) (NP (DT all) (NNS symptoms)) (VP (VBD disappeared) (ADVP (RB spontaneously))) (. .)))
146391	3	(ROOT (S (NP (NNP Doc_146391_298_307_Disease)) (VP (VBZ is) (NP (NP (DT a) (JJ well-known) (NN complication)) (PP (IN of) (NP (JJ Doc_146391_340_357_Chemical) (NN treatment)))) (SBAR (IN as) (S (VP (VBZ is) (NP (ADJP (JJ benign) (CC and) (JJ malignant)) (NNS Doc_146391_395_410_Disease)))))) (. .)))
146391	4	(ROOT (S (NP (NP (JJ Pure) (NNS Doc_146391_417_433_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_146391_450_467_Chemical) (NN medication))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (CD 3) (NNS patients)))))) (. .)))
146391	5	(ROOT (S (NP (NP (DT The) (JJ exact) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NNS Doc_146391_541_558_Chemical)) (VP (VBZ exerts) (NP (PRP$ its) (JJ toxic) (NNS effects)))))) (VP (VBZ is) (RB not) (VP (VBN known))) (. .)))
146391	6	(ROOT (S (PP (IN In) (NP (NP (NP (DT this) (ADJP (JJ patient) (NP (DT the) (NN time))) (NN relation)) (PP (IN between) (NP (NP (DT the) (NN ingestion)) (PP (IN of) (NP (NNS Doc_146391_657_674_Chemical)))))) (CC and) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (DT the) (NNS Doc_146391_701_710_Disease)))))) (, ,) (NP (NP (NNS Doc_146391_712_727_Disease)) (CC and) (NP (JJ pure) (NNS Doc_146391_737_753_Disease))) (VP (VBZ is) (ADJP (RB very) (JJ suggestive) (PP (IN of) (NP (DT a) (JJ direct) (NN connection))))) (. .)))
14748761	0	(ROOT (NP (NP (JJ Doc_14748761_0_11_Chemical-related) (NNS Doc_14748761_20_34_Disease)) (: :) (NP (NP (DT a) (NNS meta-analysis)) (PP (IN of) (NP (JJ randomized) (JJ clinical) (NNS trials)))) (. .)))
14748761	1	(ROOT (S (NP (NP (JJ Several) (NNS cases)) (PP (IN of) (NP (NP (JJ cardiac) (JJ adverse) (NNS reactions)) (VP (VBN related) (PP (TO to) (NP (NP (NNS Doc_14748761_137_148_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP VNR)) (-RRB- -RRB-)))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (DT the) (NN literature)))))) (. .)))
14748761	2	(ROOT (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB quantify) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (DT these) (NNS Doc_14748761_237_251_Disease)))))))) (, ,) (NP (PRP we)) (VP (VBD performed) (NP (NP (DT a) (NNS meta-analysis)) (PP (IN of) (NP (NP (JJ clinical) (NNS trials)) (VP (VBG comparing) (NP (NP (NNP VNR)) (PP (IN with) (NP (NP (JJ other) (JJ chemotherapeutic) (NNS agents)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_14748761_370_390_Disease))))))))))))) (. .)))
14748761	3	(ROOT (S (NP (NP (JJ Randomized) (JJ clinical) (NNS trials)) (VP (VBG comparing) (NP (NP (NNP VNR)) (PP (IN with) (NP (JJ other) (NNS drugs)))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_14748761_470_476_Disease))))))) (VP (VBD were) (VP (VBN searched) (PP (IN in) (NP (NP (NNP Medline)) (, ,) (NP (NNP Embase)) (, ,) (NP (JJ Evidence-based) (NNP Medicine) (NNP Reviews) (NNS databases)) (CC and) (NP (DT the) (JJ Cochrane) (NN library)))) (PP (IN from) (NP (CD 1987) (TO to) (CD 2002))))) (. .)))
14748761	4	(ROOT (S (NP (NP (NNS Outcomes)) (PP (IN of) (NP (NN interest)))) (VP (VBD were) (NP (NP (JJ severe) (NNS Doc_14748761_630_644_Disease)) (, ,) (NP (JJ toxic) (NNS Doc_14748761_652_658_Disease)) (CC and) (NP (NP (JJ cardiac) (JJ event-related) (NNS Doc_14748761_685_691_Disease)) (VP (VBN reported) (PP (IN in) (NP (DT each) (NN publication))))))) (. .)))
14748761	5	(ROOT (S (NP (PRP We)) (VP (VBD found) (NP (CD 19) (NNS trials)) (, ,) (S (VP (VBG involving) (NP (NP (CD 2441) (NNS patients)) (VP (VBN treated) (PP (IN by) (NP (NP (NNP VNR)) (CC and) (NP (CD 2050) (NN control) (NNS patients))))))))) (. .)))
14748761	6	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_14748761_825_839_Disease)) (PP (IN with) (NP (NNP VNR)))))) (VP (VBD was) (NP (NP (CD 1.19) (NN %)) (VP (VBG -LSB-) (NP (NP (NP (ADJP (CD 95) (NN %)) (NN confidence) (NN interval)) (PRN (-LRB- -LRB-) (NP (NNP CI)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (CD 0.75)) (: ;) (NP (CD 1.67))) (-RRB- -RRB-))) (S (ADJP (JJ -RSB-)))))) (. .)))
14748761	7	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NP (NNS Doc_14748761_943_957_Disease)) (PP (IN between) (NP (NNP VNR)))) (CC and) (NP (NP (NP (JJ other) (NNS drugs)) (NP (JJ -LSB-) (NNS odds) (NN ratio))) (: :) (NP (JJ 0.92) (, ,) (ADJP (CD 95) (NN %)) (NNP CI) (PRN (-LRB- -LRB-) (NP (NP (CD 0.54)) (: ;) (NP (CD 1.55))) (-RRB- -RRB-)) (NNS -RSB-))))))))) (. .)))
14748761	8	(ROOT (S (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (NNP VNR) (NNP Doc_14748761_1043_1057_Disease)))) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (NP (NNS Doc_14748761_1073_1082_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP VDS)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ other) (JJ Doc_14748761_1099_1110_Disease) (NNS drugs)) (NP (JJ -LSB-) (NNS Doc_14748761_1118_1130_Chemical)))))))) (, ,) (NP (NP (NNS Doc_14748761_1132_1146_Chemical)) (, ,) (NP (NP (NNS Doc_14748761_1148_1159_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_14748761_1161_1164_Chemical)) (-RRB- -RRB-)))) (VP (VBP em) (NP (NN leader) (NNS -RSB-))) (. .)))
14748761	9	(ROOT (S (SBAR (RB Even) (IN if) (S (NP (PRP it)) (VP (VBD did) (RB not) (VP (VB reach) (NP (NP (JJ statistical) (NN significance)) (PP (RB because) (IN of) (NP (NP (DT a) (JJ few) (NN number)) (PP (IN of) (NP (NNS cases)))))))))) (, ,) (NP (DT the) (NN risk)) (VP (VP (VBD was) (ADJP (JJR lower)) (PP (IN in) (NP (NP (NNS trials)) (PP (VBG excluding) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ cardiac) (NN history)))))))) (, ,) (CC and) (VP (VBD seemed) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (JJR higher)) (PP (IN in) (NP (NP (NNS trials)) (PP (VBG including) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ pre-existing) (NNS Doc_14748761_1404_1420_Disease))))))))))))) (. .)))
14748761	10	(ROOT (NP (NP (JJ Doc_14748761_1422_1433_Chemical-related) (JJ Doc_14748761_1442_1456_Disease) (NN concern)) (NP (NP (QP (RB about) (CD 1)) (NN %)) (PP (IN of) (NP (NP (JJ treated) (NNS patients)) (PP (IN in) (NP (JJ clinical) (NNS trials)))))) (. .)))
14748761	11	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN risk)) (VP (VBN associated) (PP (IN with) (NP (NNP VNR))))) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (JJ other) (JJ chemotherapeutic) (NNS agents)))))) (PP (IN in) (NP (DT the) (JJ same) (NNS indications))))))) (. .)))
15018178	0	(ROOT (NP (NP (NNP MRI) (NNS findings)) (PP (IN of) (NP (JJ hypoxic) (NNS Doc_15018178_24_49_Disease))) (PP (IN in) (NP (NP (DT a) (NN child)) (PP (IN with) (NP (JJ Doc_15018178_66_82_Disease) (NN crisis))))) (. .)))
15018178	1	(ROOT (S (NP (PRP We)) (VP (VBP present) (NP (NP (JJ magnetic) (NN resonance) (NN imaging) (NNS findings)) (PP (IN of) (NP (NP (DT a) (JJ 5-year-old) (NN girl)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (DT a) (ADJP (RB rapidly) (VBN installing)) (JJ Doc_15018178_188_204_Disease) (NN crisis)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_15018178_223_235_Chemical-Doc_15018178_236_252_Chemical)))) (, ,) (VP (VBG resulting) (PP (IN in) (NP (NP (NNS Doc_15018178_267_282_Disease)) (VP (VBG leading) (PP (TO to) (NP (JJ permanent) (NN damage))))))))))))))) (. .)))
15018178	2	(ROOT (S (NP (JJ Magnetic) (JJ Resonance) (NN imaging)) (VP (VBD revealed) (NP (NNS Doc_15018178_348_373_Disease)) (PP (IN in) (NP (NNS Doc_15018178_377_398_Disease))) (PP (PP (IN in) (NP (NP (DT both) (JJ cerebral) (NNS hemispheres)) (, ,) (NP (NP (JJ ischemic) (NNS changes)) (PP (IN in) (NP (NP (JJ subcortical) (JJ white) (NN matter)) (PP (IN of) (NP (JJ left) (JJ cerebral) (NN hemisphere)))))) (, ,))) (CC and) (PP (IN in) (NP (DT the) (JJ left) (NN putamen))))) (. .)))
15018178	3	(ROOT (S (SBAR (IN Although) (S (NP (NNS Doc_15018178_537_562_Disease)) (VP (VBZ is) (NP (NP (DT a) (JJ classic) (NN entity)) (PP (IN in) (NP (JJ adulthood) (ADJP (VBN related) (PP (TO to) (NP (NP (NNS conditions)) (PP (IN of) (NP (NN energy)))))) (NNS depletions))))))) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (JJ few) (NNS reports)) (ADJP (JJ available) (PP (IN in) (NP (NNS children)))))) (. .)))
15018178	4	(ROOT (S (NP (NP (DT A) (JJ wide) (NN review)) (PP (IN of) (NP (DT the) (NN literature)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN presented))) (. .)))
15094729	0	(ROOT (S (NP (NP (DT The) (JJ natural) (NN history)) (PP (IN of) (NP (NNS Doc_15094729_23_33_Chemical)))) (VP (JJ associated) (NP (NP (NNS Doc_15094729_45_65_Disease)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG electing) (S (VP (TO to) (VP (VB continue) (NP (PRP$ their) (NN medication)))))))))) (. .)))
15094729	1	(ROOT (S (S (VP (TO To) (VP (VB determine) (NP (NP (DT the) (JJ natural) (NN history)) (PP (IN of) (NP (NP (NNS Doc_15094729_162_182_Disease)) (PP (IN in) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NNS patients))))))))))) (VP (VBN known) (S (VP (TO to) (VP (VB have) (NP (NP (NN Doc_15094729_220_230_Chemical-associated) (NNS changes)) (SBAR (WHNP (WP who)) (S (VP (VBD elected) (S (VP (TO to) (VP (VB continue) (NP (NP (DT the) (NN medication)) (PP (RB because) (IN of) (NP (JJ good) (JJ Doc_15094729_305_312_Disease) (NN control))))))))))))))) (. .)))
15094729	2	(ROOT (S (NP (NP (DT All) (NNS patients)) (VP (VBG taking) (NP (JJ Doc_15094729_351_361_Chemical) (UCP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (JJ other) (JJ antiepileptic) (NNS drugs)) (PP (IN for) (NP (QP (IN at) (JJS least) (CD 5))))))))) (NNS years)) (PRN (-LRB- -LRB-) (S (VP (VB range) (NP (CD 5-12) (NNS years)))) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN entered) (PP (IN into) (NP (DT a) (JJ visual) (NN surveillance) (NN programme))))) (. .)))
15094729	3	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN followed) (PRT (RP up)) (PP (IN at) (NP (NP (JJ 6-monthly) (NNS intervals)) (PP (IN for) (NP (NP (RB not) (QP (JJR less) (IN than) (CD 18)) (NNS months)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (NP (CD 18-43) (NNS months))) (-RRB- -RRB-)))))))) (. .)))
15094729	4	(ROOT (S (PP (IN In) (NP (DT all))) (, ,) (NP (NP (CD 16) (NNS patients)) (PP (IN with) (NP (JJ unequivocal) (NNS defects)))) (VP (VBD continued) (NP (DT the) (NN medication))) (. .)))
15094729	5	(ROOT (S (PP (VBG Following) (NP (ADJP (RB already) (VBN published)) (NN methodology))) (PRN (-LRB- -LRB-) (NP (NP (NNP Eye) (CD 2002)) (: ;) (NP (CD 16) (: ;) (CD 567-571))) (-RRB- -RRB-)) (NP (NP (NP (NN monocular) (NNS Doc_15094729_751_770_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15094729_772_776_Disease)) (-RRB- -RRB-))) (PP (TO to) (NP (NP (DT the) (JJ I/4e) (NN isopter)) (PP (IN on) (NP (NNP Goldmann))))) (ADVP (RB perimetry))) (VP (VBD was) (VP (VBN calculated) (PP (IN for) (NP (NP (DT the) (JJ right) (NN eye)) (PP (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NP (NN discovery)) (PP (IN of) (NP (DT a) (NNS Doc_15094729_883_902_Disease))))))) (CC and) (ADVP (RB again)) (PP (IN after) (FRAG (RB not) (ADJP (NP (QP (JJR less) (IN than) (CD 18)) (NNS months)) (JJ follow-up))))))))) (. .)))
15094729	6	(ROOT (S (NP (NP (JJ Mean) (JJ right) (NN eye) (NNS Doc_15094729_978_981_Disease)) (PP (IN at) (NP (NN presentation)))) (VP (VBD was) (NP (NP (CD 36.98) (NNS degrees)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (NP (CD 22.25-51) (CD .0))) (-RRB- -RRB-))) (, ,) (PP (VBN compared) (PP (TO to) (NP (NP (NP (NP (CD 38.40) (NNS degrees)) (PRN (-LRB- -LRB-) (S (VP (VB range) (NP (CD 22.5-49) (CD .75)))) (-RRB- -RRB-))) (PP (IN after) (NP (NN follow-up)))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.338) (JJ unpaired) (NN t-test)))))))))) (. .)))
15094729	7	(ROOT (S (NP (RB Only) (CD one) (NN patient)) (VP (VBD demonstrated) (NP (DT a) (NN deterioration)) (PP (IN in) (NP (JJ visual) (NN field))) (PP (IN during) (NP (NP (DT the) (NN study) (NN period)) (CC and) (NP (VBN discontinued) (NN treatment))))) (. .)))
15094729	8	(ROOT (S (NP (NP (JJ Established) (NNS Doc_15094729_1261_1281_Disease)) (VP (VBN presumed) (S (VP (TO to) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (JJ Doc_15094729_1304_1314_Chemical) (NN therapy))))))))) (VP (VBD did) (RB not) (ADVP (RB usually)) (VP (VB progress) (PP (IN in) (NP (NP (NN spite)) (PP (IN of) (NP (NP (VBG continuing) (NN use)) (PP (IN of) (NP (DT the) (NN medication))))))))) (. .)))
15094729	9	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP give) (NP (NN support)) (PP (TO to) (NP (DT the) (NNS hypothesis))) (SBAR (IN that) (S (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (NN Doc_15094729_1461_1471_Chemical-associated) (NNS Doc_15094729_1483_1503_Disease)))) (VP (MD may) (VP (VB be) (NP (NP (DT an) (JJ idiosyncratic) (JJ adverse) (NN drug) (NN reaction)) (CONJP (RB rather) (IN than)) (NP (JJ dose-dependent) (NNS Doc_15094729_1577_1585_Disease)))))))) (. .)))
15096374	0	(ROOT (NP (NP (NNP Induction)) (PP (IN of) (NP (NN rosaceiform) (NNS Doc_15096374_25_35_Disease))) (PP (IN during) (NP (NN treatment))) (PP (IN of) (NP (NP (JJ facial) (JJ inflammatory) (NNS dermatoses)) (PP (IN with) (NP (JJ Doc_15096374_92_102_Chemical) (NN ointment))))) (. .)))
15096374	1	(ROOT (S (S (NP (NNP Doc_15096374_125_135_Chemical) (NNP ointment)) (VP (VBZ is) (ADVP (RB increasingly)) (VP (VBN used) (PP (IN for) (NP (NP (JJ anti-inflammatory) (NN treatment)) (PP (IN of) (NP (NP (JJ sensitive) (NNS areas)) (PP (JJ such) (IN as) (NP (DT the) (NN face)))))))))) (, ,) (CC and) (S (NP (JJ recent) (NNS observations)) (VP (VBP indicate) (SBAR (IN that) (S (NP (DT the) (NN treatment)) (VP (VBZ is) (ADJP (JJ effective) (PP (IN in) (NP (NP (NN Doc_15096374_303_310_Chemical-aggravated) (NNS Doc_15096374_322_329_Disease)) (CC and) (NP (JJ perioral) (NNS Doc_15096374_343_353_Disease)))))))))) (. .)))
15096374	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (PP (IN on) (NP (NP (NN rosaceiform) (NNS Doc_15096374_380_390_Disease)) (PP (IN as) (NP (NP (DT a) (NN complication)) (PP (IN of) (NP (NN treatment))))))) (PP (IN with) (NP (JJ Doc_15096374_427_437_Chemical) (NN ointment)))) (. .)))
15096374	3	(ROOT (S (NP (NP (CD Six) (JJ adult) (NNS patients)) (PP (IN with) (NP (JJ inflammatory) (NNS Doc_15096374_499_516_Disease)))) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (JJ Doc_15096374_535_545_Chemical) (NN ointment)) (PP (RB because) (IN of) (NP (NP (DT the) (NN ineffectiveness)) (PP (IN of) (NP (JJ standard) (NNS treatments))))))))) (. .)))
15096374	4	(ROOT (S (PP (IN Within) (NP (NP (QP (CD 2) (TO to) (CD 3)) (NNS weeks)) (PP (IN of) (NP (ADJP (ADJP (ADVP (RB initially)) (JJ effective)) (CC and) (ADJP (JJ well-tolerated))) (NN treatment))))) (, ,) (NP (NP (CD 3) (NNS patients)) (PP (IN with) (NP (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS Doc_15096374_712_719_Disease)))) (CC and) (NP (NP (CD 1)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN acne))))))))) (VP (VBD experienced) (NP (NP (JJ sudden) (VBG worsening)) (PP (IN with) (NP (NNS Doc_15096374_783_811_Disease))))) (. .)))
15096374	5	(ROOT (S (NP (NNP Biopsy)) (VP (VBD revealed) (NP (NP (DT an) (NN abundance)) (PP (IN of) (NP (NNP Demodex) (NNS mites)))) (PP (IN in) (NP (NP (CD 2)) (PP (IN of) (NP (DT these) (NNS patients)))))) (. .)))
15096374	6	(ROOT (S (PP (IN In) (NP (NP (CD 1) (NN patient)) (PP (IN with) (NP (NNS Doc_15096374_901_914_Disease))))) (, ,) (NP (NN rosaceiform) (NN periocular) (NNS Doc_15096374_939_949_Disease)) (ADVP (RB gradually)) (VP (VBD appeared) (PP (IN after) (NP (NP (CD 3) (NNS weeks)) (PP (IN of) (NP (NN treatment)))))) (. .)))
15096374	7	(ROOT (S (PP (IN In) (NP (NP (CD 1) (NN patient)) (PP (IN with) (NP (NNS Doc_15096374_1015_1032_Disease))))) (, ,) (NP (NNS Doc_15096374_1034_1048_Disease) (CC and) (NN papular) (NNS Doc_15096374_1061_1068_Disease)) (ADVP (RB insidiously)) (VP (VBD appeared) (PP (IN after) (NP (NP (CD 5) (NNS months)) (PP (IN of) (NP (NN treatment)))))) (. .)))
15096374	8	(ROOT (S (NP (PRP$ Our) (NNS observations)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN spectrum)) (PP (IN of) (NP (NP (NN rosaceiform) (NNS Doc_15096374_1190_1200_Disease)) (PP (IN as) (NP (NP (DT a) (NN complication)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (JJ Doc_15096374_1237_1247_Chemical) (NN ointment)))))))))) (VP (VBZ is) (ADJP (JJ heterogeneous)))))) (. .)))
15096374	9	(ROOT (S (NP (NP (DT A) (NN variety)) (PP (IN of) (NP (NNS factors))) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (JJ vasoactive) (NNS properties)) (PP (IN of) (NP (NNS Doc_15096374_1330_1340_Chemical)))) (, ,) (NP (NP (NN proliferation)) (PP (IN of) (NP (NP (NNP Demodex)) (ADJP (JJ due) (PP (TO to) (NP (JJ local) (NN immunosuppression))))))) (, ,) (CC and) (NP (NP (DT the) (JJ occlusive) (NNS properties)) (PP (IN of) (NP (DT the) (NN ointment)))))) (, ,)) (VP (MD may) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (DT the) (ADJP (JJ observed)) (NNS phenomena)))))) (. .)))
15096374	10	(ROOT (S (NP (JJ Future) (NNS studies)) (VP (VBP are) (VP (VBN needed) (S (VP (TO to) (VP (VB identify) (NP (JJ individual) (NN risk) (NNS factors))))))) (. .)))
1522360	0	(ROOT (NP (NP (NNS Doc_1522360_0_23_Disease) (CC and) (NNS Doc_1522360_28_47_Disease)) (PP (VBG following) (NP (JJ intermittent) (JJ Doc_1522360_71_79_Chemical) (NN therapy))) (. .)))
1522360	1	(ROOT (S (NP (NNP Doc_1522360_89_102_Disease)) (VP (VBZ is) (NP (NP (DT a) (JJ rare) (NN complication)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_1522360_153_161_Chemical)))))))) (. .)))
1522360	2	(ROOT (S (NP (NP (NNP Doc_1522360_163_186_Disease)) (VP (VBG leading) (PP (TO to) (NP (NP (NNS Doc_1522360_198_217_Disease)) (PP (VBG following) (NP (JJ Doc_1522360_228_236_Chemical) (NN therapy))))))) (VP (VBZ is) (ADJP (RB extremely) (JJ rare))) (. .)))
1522360	3	(ROOT (S (NP (NP (CD Two) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_1522360_282_289_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (NNS Doc_1522360_304_313_Disease) (CC and) (NNS Doc_1522360_318_337_Disease)) (PP (VBG following) (NP (NNS Doc_1522360_348_356_Chemical)))))))))) (VP (VBP are) (VP (VBN reported))) (. .)))
15229250	0	(ROOT (NP (NP (NNP Doc_15229250_0_24_Disease)) (PP (IN in) (NP (NP (DT the) (NNS brains)) (PP (IN of) (NP (JJ human) (NNS subjects))) (SBAR (WHNP (WP who)) (S (VP (VBP use) (NP (NNS Doc_15229250_65_80_Chemical))))))) (. .)))
15229250	1	(ROOT (S (NP (PRP We)) (VP (VB visualize) (, ,) (PP (IN for) (NP (DT the) (JJ first) (NN time))) (, ,) (NP (NP (DT the) (NN profile)) (PP (IN of) (NP (NP (JJ structural) (NNS deficits)) (PP (IN in) (NP (NP (DT the) (JJ human) (NN brain)) (VP (VBN associated) (PP (IN with) (NP (JJ chronic) (JJ Doc_15229250_194_209_Chemical) (-LRB- -LRB-) (NNP MA) (-RRB- -RRB-) (NN abuse)))))))))) (. .)))
15229250	2	(ROOT (S (NP (NP (NNS Studies)) (PP (IN of) (NP (NP (JJ human) (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN used) (NP (NNP MA) (NNP chronically))))))))) (VP (VBP have) (VP (VBN revealed) (NP (NNS Doc_15229250_291_377_Disease)))) (. .)))
15229250	3	(ROOT (S (S (VP (VBG Using) (NP (NP (JJ magnetic) (NN resonance) (NN imaging)) (PRN (-LRB- -LRB-) (NP (NNP MRI)) (-RRB- -RRB-)) (CC and) (NP (JJ new) (JJ computational) (JJ brain-mapping) (NNS techniques))))) (, ,) (NP (PRP we)) (VP (VBD determined) (NP (NP (DT the) (NN pattern)) (PP (IN of) (NP (NP (JJ structural) (NN brain) (NNS alterations)) (VP (VP (VBN associated) (PP (IN with) (NP (NP (JJ chronic) (NNS Doc_15229250_548_556_Disease)) (PP (IN in) (NP (JJ human) (NNS subjects)))))) (CC and) (VP (VBN related) (NP (DT these) (NNS Doc_15229250_593_625_Disease)))))))) (. .)))
15229250	4	(ROOT (S (NP (PRP We)) (VP (VBD used) (NP (JJ high-resolution) (JJ MRI) (CC and) (JJ surface-based) (JJ computational) (NN image) (NNS analyses)) (PP (TO to) (NP (NN map) (JJ regional) (NNS abnormalities))) (PP (IN in) (NP (NP (DT the) (NN cortex)) (, ,) (NP (NNS hippocampus)) (, ,) (NP (JJ white) (NN matter)) (, ,) (CC and) (NP (NNS ventricles)))) (PP (IN in) (NP (NP (CD 22) (JJ human) (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBD used) (NP (NP (NNP MA)) (CC and) (NP (CD 21) (JJ age-matched) (, ,) (JJ healthy) (NNS controls))))))))) (. .)))
15229250	5	(ROOT (S (NP (JJ Cortical) (NNS maps)) (VP (VBD revealed) (NP (NP (NP (JJ severe) (NNS Doc_15229250_890_910_Disease)) (PP (IN in) (NP (DT the) (NN cingulate)))) (, ,) (NP (NP (ADJP (JJ limbic) (, ,) (CC and) (JJ paralimbic)) (NNS cortices)) (PP (IN of) (NP (NNP MA) (NNS abusers)))) (PRN (-LRB- -LRB-) (VP (VBG averaging) (NP (CD 11.3) (NN %)) (PP (IN below) (NP (NP (NN control)) (: ;) (NP (NP (NN p)) (VP (VBG <) (NP (CD 0.05))))))) (-RRB- -RRB-)))) (. .)))
15229250	6	(ROOT (S (PP (IN On) (NP (NN average))) (, ,) (NP (NNP MA) (NNS abusers)) (VP (VBD had) (NP (ADJP (NP (CD 7.8) (NN %)) (JJR smaller)) (JJ hippocampal) (NNS volumes)) (PP (IN than) (NP (NP (NN control) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NN p) (NNS <)) (NP (CD 0.01))) (: ;) (NP (NP (NN left)) (, ,) (NP (NP (NN p)) (SBAR (S (VP (SYM =) (NP (CD 0.01))))))) (: ;) (NP (NP (NN right)) (, ,) (NP (NN p) (NNS <)))) (NP (CD 0.05))) (-RRB- -RRB-)) (CC and) (NP (JJ significant) (JJ white-matter) (NNS Doc_15229250_1173_1184_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 7.0) (NN %)) (: ;) (NP (NNP p) (NNP <) (NNP 0.01))) (-RRB- -RRB-))))) (. .)))
15229250	7	(ROOT (S (NP (NNP Doc_15229250_1203_1223_Disease)) (VP (VP (VBD were) (VP (VBN mapped))) (CC and) (VP (VBD correlated) (PP (IN with) (NP (NN memory) (NN performance))) (PP (IN on) (NP (DT a) (JJ word-recall) (NN test))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-)))) (. .)))
15229250	8	(ROOT (S (NP (JJ MRI-based) (NNS maps)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ chronic) (JJ Doc_15229250_1345_1360_Chemical) (NN abuse)) (VP (VBZ causes) (NP (NP (DT a) (JJ selective) (NN pattern)) (PP (IN of) (NP (JJ cerebral) (NN deterioration))) (SBAR (WHNP (WDT that)) (S (VP (VBZ contributes) (PP (TO to) (NP (VBN impaired) (NN memory) (NN performance))))))))))) (. .)))
15229250	9	(ROOT (S (NP (NNP MA)) (VP (MD may) (ADVP (RB selectively)) (VP (VB damage) (NP (NP (DT the) (JJ medial) (JJ temporal) (NN lobe)) (CC and) (, ,) (ADJP (JJ consistent) (PP (IN with) (NP (NP (JJ metabolic) (NNS studies)) (, ,) (NP (DT the) (JJ cingulate-limbic) (NN cortex)) (, ,) (NP (JJ inducing) (NN neuroadaptation)) (, ,) (NP (NNS Doc_15229250_1615_1633_Disease)) (, ,) (CC or) (NP (NN cell) (NN death)))))))) (. .)))
15229250	10	(ROOT (S (NP (JJ Prominent) (JJ white-matter) (NNS Doc_15229250_1673_1684_Disease)) (VP (MD may) (VP (VP (VB result) (PP (IN from) (NP (JJ altered) (NN myelination)))) (CC and) (VP (VB adaptive) (NP (NP (JJ glial) (NNS changes)) (, ,) (PP (VBG including) (NP (NP (NNS Doc_15229250_1759_1766_Disease)) (ADJP (JJ secondary) (PP (TO to) (NP (NNS Doc_15229250_1780_1795_Disease)))))))))) (. .)))
15229250	11	(ROOT (S (NP (DT These) (NN brain) (NNS substrates)) (VP (MD may) (VP (VB help) (NP (NN account)) (PP (IN for) (NP (NP (DT the) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_15229250_1857_1865_Disease))))) (, ,) (S (VP (VBG providing) (NP (JJ therapeutic) (NNS targets)) (PP (IN for) (NP (JJ drug-induced) (NNS Doc_15229250_1914_1926_Disease))))))) (. .)))
15265979	0	(ROOT (S (NP (NP (NNP Disruption)) (PP (IN of) (NP (NP (JJ hepatic) (NN lipid) (NNS homeostasis)) (PP (IN in) (NP (NP (NNS mice)) (PP (IN after) (NP (JJ Doc_15265979_54_64_Chemical) (NN treatment)))))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (JJ peroxisome) (JJ proliferator-activated) (JJ receptor-alpha) (NN target) (NN gene) (NN activation))))) (. .)))
15265979	1	(ROOT (S (NP (NP (NNP Doc_15265979_167_177_Chemical)) (, ,) (NP (NP (DT an) (NNS efficacious)) (CC and) (NP (ADJP (RB widely) (VBN used)) (JJ antiarrhythmic) (NN agent))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB cause) (ADVP (RB hepatotoxicity)) (PP (IN in) (NP (DT some) (NNS patients))))))))) (. .)))
15265979	2	(ROOT (S (S (VP (TO To) (VP (VB gain) (NP (NN insight)) (PP (IN into) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (DT this) (JJ unwanted) (NN effect)))))))) (, ,) (NP (NNS mice)) (VP (VBD were) (VP (VP (VBN administered) (NP (NP (JJ various) (NNS doses)) (PP (IN of) (NP (NNS Doc_15265979_392_402_Chemical))))) (CC and) (VP (VBN examined) (PP (IN for) (NP (NP (NNS changes)) (PP (IN in) (NP (JJ hepatic) (NN histology) (CC and) (NN gene) (NN regulation)))))))) (. .)))
15265979	3	(ROOT (NP (NP (NNP Doc_15265979_470_480_Chemical) (NNP induced) (NNP Doc_15265979_489_501_Disease)) (, ,) (NP (JJ hepatocyte) (NN microvesicular) (NN lipid) (NN accumulation)) (, ,) (CC and) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (NN serum) (NNS Doc_15265979_585_598_Chemical) (CC and) (NNS Doc_15265979_603_610_Chemical)))) (. .)))
15265979	4	(ROOT (S (NP (NP (JJ Northern) (NN blot) (NN analysis)) (PP (IN of) (NP (JJ hepatic) (NNP RNA)))) (VP (VBD revealed) (NP (DT a) (JJ dose-dependent) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NNS genes)) (ADJP (JJ critical) (PP (IN for) (NP (NP (JJ Doc_15265979_737_747_Chemical) (NN oxidation)) (, ,) (NP (NN lipoprotein) (NN assembly)) (, ,) (CC and) (NP (NN lipid) (NN transport)))))))))))) (. .)))
15265979	5	(ROOT (S (NP (NP (JJ Many)) (PP (IN of) (NP (DT these) (NNS genes)))) (VP (VBP are) (VP (VBN regulated) (PP (IN by) (NP (NP (NP (DT the) (JJ peroxisome) (JJ proliferator-activated) (NN receptor-alpha)) (PRN (-LRB- -LRB-) (NP (NNP PPARalpha)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ ligand-activated) (JJ nuclear) (NN hormone) (NN receptor) (NN transcription) (NN factor)))))) (. .)))
15265979	6	(ROOT (S (NP (NP (DT The) (NN absence)) (PP (IN of) (NP (NP (NP (NN induction)) (PP (IN of) (NP (DT these) (NNS genes)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (NNS Doc_15265979_1022_1034_Disease)) (PP (IN in) (NP (NNP PPARalpha) (NNP knockout) (NNP -LSB-) (NNP PPARalpha)))) (: -) (NP (NP (NNP /)) (: -) (NP (JJ -RSB-) (NNS mice))))))) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_15265979_1107_1117_Chemical)))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN upon) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT a) (NNP functional) (NNP PPARalpha) (NN gene)))))))))) (. .)))
15265979	7	(ROOT (S (PP (VBN Compared) (PP (TO to) (NP (JJ wild-type) (NNS mice)))) (, ,) (NP (NP (NN treatment)) (PP (IN of) (NP (NP (NNP PPARalpha)) (: -) (NP (NNP /)) (: -) (NP (NNS mice)) (PP (IN with) (NP (NNS Doc_15265979_1247_1257_Chemical)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (VBN increased) (NN rate)) (CC and) (NP (NP (NN extent)) (PP (IN of) (NP (JJ total) (NN body) (NNS Doc_15265979_1313_1324_Disease))))))) (. .)))
15265979	8	(ROOT (S (NP (NP (DT The) (NN inability)) (PP (IN of) (NP (NP (NNS Doc_15265979_1343_1353_Chemical)) (PP (TO to) (NP (ADJP (ADJP (RB directly) (JJ activate)) (SBAR (UCP (DT either) (NN human) (CC or) (JJ mouse)) (S (NP (NNP PPARalpha)) (ADVP (RB transiently)) (VP (VBD expressed) (PP (IN in) (NP (JJ human) (NNS HepG2))))))) (JJ Doc_15265979_1444_1452_Disease) (NNS cells)))))) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_15265979_1489_1499_Chemical)) (PP (IN on) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (DT this) (NN receptor)))))))) (VP (VBD were) (ADJP (JJ indirect)))))) (. .)))
15265979	9	(ROOT (S (PP (VBN Based) (PP (IN upon) (NP (DT these) (NNS results)))) (, ,) (NP (PRP we)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP (NNS Doc_15265979_1591_1601_Chemical)) (VP (VBZ disrupts) (NP (JJ hepatic) (NN lipid) (NNS homeostasis))))) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (VBN increased) (NN expression)) (PP (IN of) (NP (NNP PPARalpha) (NN target) (NNS genes)))) (VP (VBZ is) (ADJP (JJ secondary) (PP (TO to) (NP (DT this) (JJ toxic) (NN effect))))))))) (. .)))
15265979	10	(ROOT (S (NP (DT These) (NNS results)) (VP (VP (VBP provide) (NP (NP (JJ important) (JJ new) (JJ mechanistic) (NN information)) (PP (VBG regarding) (NP (NP (DT the) (JJ hepatotoxic) (NNS effects)) (PP (IN of) (NP (NNS Doc_15265979_1829_1839_Chemical))))))) (CC and) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNP PPARalpha)) (VP (VBZ protects) (PP (IN against) (NP (NN Doc_15265979_1885_1895_Chemical-induced) (NN hepatotoxicity)))))))) (. .)))
15276093	0	(ROOT (S (NP (NP (NN Safety) (CC and) (NN compliance)) (PP (IN with) (NP (JJ once-daily) (NNS Doc_15276093_38_44_Chemical)))) (VP (VBD extended-release/Doc) (NP (JJ _) (NNS 15276093_62_72_Chemical)) (PP (IN as) (NP (NP (JJ initial) (NN therapy)) (PP (IN in) (NP (NP (DT the) (NN Impact)) (PP (IN of) (NP (NP (NNP Medical) (NNP Subspecialty)) (PP (IN on) (NP (NNP Patient) (NNP Compliance))))))))) (PP (TO to) (NP (NNP Treatment) (PRN (-LRB- -LRB-) (NP (NNP IMPACT)) (-RRB- -RRB-)) (NN study)))) (. .)))
15276093	1	(ROOT (S (NP (JJ Doc_15276093_181_187_Chemical) (JJ extended-release/Doc) (NN _) (NNS 15276093_205_215_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ new) (NN combination) (NN product)) (VP (VBN approved) (PP (IN for) (NP (NP (NN treatment)) (PP (IN of) (NP (NP (JJ primary) (NNS Doc_15276093_279_299_Disease)) (CC and) (NP (VBN mixed) (NNS Doc_15276093_310_322_Disease))))))))) (. .)))
15276093	2	(ROOT (S (NP (NP (DT This) (JJ open-labeled) (, ,) (JJ multicenter) (NN study)) (VP (VBN evaluated) (NP (NP (DT the) (NN safety)) (PP (IN of) (NP (JJ bedtime) (NNS Doc_15276093_393_399_Chemical)))))) (VP (VBD extended-release/Doc) (NP (JJ _) (NNS 15276093_417_427_Chemical)) (SBAR (WHADVP (WRB when)) (S (VP (VBD dosed) (PP (IN as) (NP (JJ initial) (NN therapy) (CC and) (NN patient) (NN compliance))) (PP (TO to) (NP (NP (NN treatment)) (PP (IN in) (NP (JJ various) (JJ clinical) (NN practice) (NNS settings))))))))) (. .)))
15276093	3	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 4,499) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_15276093_564_576_Disease)) (VP (VBG requiring) (NP (NN drug) (NN intervention)))))))) (VP (VBD was) (VP (VBN enrolled) (PP (IN at) (NP (CD 1,081) (NNS sites))))) (. .)))
15276093	4	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (CD 1) (NN tablet) (PRN (-LRB- -LRB-) (NP (NP (CD 500) (NN mg)) (PP (IN of) (NP (NP (JJ Doc_15276093_681_687_Chemical) (JJ extended-release/20) (NN mg)) (PP (IN of) (NP (NNS Doc_15276093_714_724_Chemical)))))) (-RRB- -RRB-))) (RRC (RRC (VP (ADVP (RB once)) (VBN nightly) (PP (IN for) (NP (CD 4) (NNS weeks))))) (CC and) (RRC (ADVP (RB then)) (NP (NP (CD 2) (NNS tablets)) (PP (IN for) (NP (CD 8) (NNS weeks)))))))))) (. .)))
15276093	5	(ROOT (S (NP (NNS Patients)) (ADVP (RB also)) (VP (VBD received) (NP (NP (JJ dietary) (NN counseling)) (, ,) (NP (JJ educational) (NNS materials)) (, ,) (CC and) (NP (NNS reminders))) (S (VP (TO to) (VP (VB call) (NP (NP (DT a) (JJ toll-free) (NN number)) (SBAR (WHNP (WDT that)) (S (VP (VBD provided) (NP (JJ further) (NN education)) (PP (IN about) (NP (NP (NNS Doc_15276093_928_940_Disease)) (CC and) (NP (JJ Doc_15276093_945_951_Chemical) (JJ extended-release/Doc) (JJ _) (NNS 15276093_969_979_Chemical)))))))))))) (. .)))
15276093	6	(ROOT (SINV (S (NP (JJ Primary) (NN end) (NNS points)) (VP (VBD were) (NP (NN study) (NN compliance)))) (, ,) (VP (VBZ increases) (PP (IN in) (NP (NN liver) (NNS transaminases))) (PP (TO to) (NP (QP (CD >) (CD 3)) (NNS times)))) (NP (NP (NP (DT the) (JJ upper) (NN limit)) (PP (IN of) (NP (JJ normal)))) (, ,) (CC and) (NP (JJ clinical) (NNS Doc_15276093_1108_1116_Disease))) (. .)))
15276093	7	(ROOT (S (NP (JJ Final) (NN study) (NN status)) (VP (VBD was) (ADJP (JJ available) (PP (IN for) (NP (NP (CD 4,217) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 94) (NN %)) (-RRB- -RRB-)))))) (. .)))
15276093	8	(ROOT (S (NP (NP (NN Compliance)) (PP (TO to) (NP (JJ Doc_15276093_1191_1197_Chemical) (JJ extended-release/Doc) (NN _) (NNS 15276093_1215_1225_Chemical)))) (VP (VBD was) (NP (CD 77) (NN %)) (, ,) (PP (IN with) (NP (NP (CD 3,245) (NNS patients)) (VP (VBG completing) (NP (DT the) (NN study)))))) (. .)))
15276093	9	(ROOT (S (NP (NP (NNS Patients)) (PP (IN in) (NP (NP (DT the) (NN southeast)) (CC and) (NP (NP (DT those)) (VP (VBN enrolled) (PP (IN by) (NP (NNS endocrinologists)))))))) (VP (VBD had) (NP (NP (DT the) (JJS lowest) (NN compliance)) (CC and) (NP (ADJP (RBS highest) (JJ adverse)) (NN event) (NNS rates)))) (. .)))
15276093	10	(ROOT (S (NP (NNP Flushing)) (VP (VBD was) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (JJ adverse) (NN event)) (, ,) (UCP (VP (VBN reported) (PP (IN by) (NP (NP (CD 18) (NN %)) (PP (IN of) (NP (NNS patients)))))) (CC and) (ADJP (JJ leading) (PP (TO to) (NP (NP (NN discontinuation)) (PP (IN by) (NP (CD 6) (NN %))))))))) (. .)))
15276093	11	(ROOT (S (NP (NP (NNP Incidence)) (PP (IN of) (NP (VBN increased) (JJ Doc_15276093_1534_1543_Chemical) (NN aminotransferase) (NNP and/or) (NNP Doc_15276093_1568_1575_Chemical)))) (VP (VBP aminotransferase) (NP (NP (QP (CD >) (CD 3)) (NNS times)) (SBAR (S (NP (NP (DT the) (JJ upper) (NN limit)) (PP (IN of) (NP (JJ normal)))) (VP (VBD was) (VP (VBG <) (NP (CD 0.3) (NN %)))))))) (. .)))
15276093	12	(ROOT (S (S (NP (NP (DT An) (NN increase)) (PP (IN of) (NP (NNS Doc_15276093_1654_1662_Chemical)))) (VP (VBP phosphokinase) (S (VP (TO to) (VP (VB >) (NP (CD 5) (NNS times)) (NP (NP (DT the) (JJ upper) (NN limit)) (PP (IN of) (NP (NP (JJ normal)) (VP (VBN occurred) (PP (IN in) (NP (NP (CD 0.24) (NN %)) (PP (IN of) (NP (NNS patients)))))))))))))) (, ,) (CC and) (S (NP (NP (DT no) (NNS cases)) (PP (IN of) (NP (NNS Doc_15276093_1762_1783_Disease)))) (VP (VBD were) (ADJP (JJ observed)))) (. .)))
15276093	13	(ROOT (S (NP (CD Doc_15276093_1799_1805_Chemical) (JJ extended-release/Doc) (NNP _) (CD 15276093_1823_1833_Chemical) (CD 1,000) (NNP /) (CD 40) (NN mg)) (, ,) (S (VP (VBN dosed) (PP (IN as) (NP (JJ initial) (NN therapy))))) (, ,) (VP (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (JJ good) (NN compliance) (CC and) (NN safety))))) (CC and) (VP (VBD had) (NP (NP (ADJP (RB very) (JJ low)) (NNS incidences)) (PP (IN of) (NP (VBN increased) (NN liver) (CC and) (NN muscle) (NNS enzymes)))))) (. .)))
15282950	0	(ROOT (S (NP (NP (JJ Protective) (NN effect)) (PP (IN of) (NP (NP (NNP Terminalia) (NNP chebula)) (PP (IN against) (NP (JJ experimental) (NNS Doc_15282950_61_78_Disease)))))) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_15282950_90_103_Chemical)))) (. .)))
15282950	1	(ROOT (S (NP (NP (NP (JJ Cardioprotective) (NN effect)) (PP (IN of) (NP (NP (JJ ethanolic) (NNS extract)) (PP (IN of) (NP (NNP Terminalia) (NN chebula) (NNS fruits)))))) (PRN (-LRB- -LRB-) (NP (QP (CD 500) (CD mg/kg)) (NN body) (NN wt)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN examined) (PP (IN in) (NP (NP (NNS Doc_15282950_215_228_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 200) (CD mg/kg)) (NN body) (NN wt)) (-RRB- -RRB-)) (VP (VBN induced) (NP (NP (NNS Doc_15282950_257_274_Disease)) (PP (IN in) (NP (NNS rats))))))))) (. .)))
15282950	2	(ROOT (S (PP (IN In) (NP (ADJP (RB Doc_15282950_287_300_Chemical) (VBN administered)) (NNS rats))) (, ,) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN lipid) (NNS Doc_15282950_339_348_Chemical)))) (VP (VBD increased) (ADVP (RB significantly)) (PP (IN in) (NP (DT the) (NN serum) (CC and) (NN heart)))) (. .)))
15282950	3	(ROOT (S (NP (DT A) (JJ significant) (NN decrease)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT the) (JJ myocardial) (NN marker) (NNS enzymes))))) (PP (IN with) (NP (NP (DT a) (JJ concomitant) (NN increase)) (PP (IN in) (NP (NP (PRP$ their) (NN activity)) (PP (IN in) (NP (NN serum))))))))) (. .)))
15282950	4	(ROOT (S (NP (JJ Histopathological) (NN examination)) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (S (VP (TO to) (VP (VB confirm) (NP (DT the) (NNS Doc_15282950_599_618_Disease))))))) (. .)))
15282950	5	(ROOT (S (NP (NNP T.) (NNP chebula) (NNP extract) (NNP pretreatment)) (VP (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB ameliorate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_15282950_690_703_Chemical)) (PP (IN on) (NP (JJ lipid) (JJ Doc_15282950_713_721_Chemical) (NN formation))))))))))) (CC and) (VP (VBD retained) (NP (NP (DT the) (NNS activities)) (PP (IN of) (NP (DT the) (JJ diagnostic) (NN marker) (NNS enzymes)))))) (. .)))
15321332	0	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (JJ Doc_15321332_10_31_Disease) (ADJP (JJ due) (PP (TO to) (NP (JJ low) (NN dose)))) (NNS Doc_15321332_48_58_Chemical)))) (VP (VBN used) (PP (IN with) (NP (JJ patient-controlled) (NN analgesia)))) (. .)))
15321332	1	(ROOT (S (NP (NP (DT A) (JJ multiparous) (NN woman)) (PP (IN in) (NP (JJ good) (NNS Doc_15321332_127_147_Disease)))) (VP (VBD underwent) (NP (JJ urgent) (NN caesarean) (NN section)) (PP (IN in) (NP (NN labour)))) (. .)))
15321332	2	(ROOT (S (ADVP (RB Postoperatively)) (, ,) (NP (PRP she)) (VP (VBD was) (VP (VBN given) (NP (DT a) (JJ patient-controlled) (NN analgesia)) (NP (NP (NN device)) (VP (VBG delivering) (NP (NP (NNS boluses)) (PP (IN of) (NP (NN Doc_15321332_285_296_Chemical) (CD 0.5) (NN mg) (CC and) (JJ Doc_15321332_308_318_Chemical) (CD 0.025) (NN mg)))))))) (. .)))
15321332	3	(ROOT (S (PP (IN Whilst) (S (VP (VBG using) (NP (NP (DT the) (NN device)) (SBAR (S (NP (PRP she)) (ADVP (RB gradually)) (VP (VBD became) (ADJP (JJ anxious))))))))) (, ,) (NP (DT the) (NN feeling)) (VP (VBZ worsening) (PP (IN after) (NP (DT each) (NNS bolus)))) (. .)))
15321332	4	(ROOT (S (NP (NP (DT The) (NN diagnosis)) (PP (IN of) (NP (NN Doc_15321332_440_450_Chemical-induced) (NNS Doc_15321332_459_484_Disease)))) (VP (VBD was) (RB not) (VP (VBN made) (PP (RB straight) (RB away) (IN although) (PP (IN on) (NP (JJ subsequent) (NN close)))) (S (VP (VBG questioning) (SBAR (S (NP (DT the) (NN patient)) (VP (VBD gave) (NP (DT a) (ADJP (RB very) (JJ clear)) (NN history))))))))) (. .)))
15321332	5	(ROOT (S (SBAR (IN After) (S (NP (PRP she)) (VP (VBD had) (VP (VBN received) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (QP (RB only) (CD 0.9)) (NN mg) (NNS Doc_15321332_638_648_Chemical)))))))) (, ,) (S (NP (NP (DT a) (NN syringe)) (VP (VBG containing) (NP (NNS Doc_15321332_671_682_Chemical)))) (ADVP (RB only)) (VP (VBD was) (VP (VBN substituted)))) (CC and) (S (NP (PRP$ her) (NN unease)) (VP (VBN resolved) (ADVP (RB completely)))) (. .)))
15321332	6	(ROOT (S (NP (PRP We)) (VP (VBP feel) (SBAR (IN that) (, ,) (S (SBAR (IN although) (S (NP (NP (DT the) (JJ dramatic) (JJ extrapyramidal) (NN side) (NNS effects)) (PP (IN of) (NP (JJ dopaminergic) (NNS antiemetics)))) (VP (VBP are) (ADJP (RB well) (VBN known))))) (, ,) (NP (RBR more) (JJ subtle) (NNS manifestations)) (VP (MD may) (ADVP (RB easily)) (VP (VB be) (VP (VBN overlooked))))))) (. .)))
15366550	0	(ROOT (S (NP (JJ Accurate) (NN patient) (NN history)) (VP (VBZ contributes) (PP (TO to) (S (VP (VBG differentiating) (NP (NP (NNS Doc_15366550_56_74_Disease)) (: :) (NP (DT a) (NN case) (NN study))))))) (. .)))
15366550	1	(ROOT (S (NP (DT This) (NN case) (NN study)) (VP (VBZ highlights) (NP (NP (DT the) (JJ important) (NN contribution)) (PP (IN of) (S (VP (VBG nursing) (PP (IN in) (S (VP (VBG obtaining) (NP (DT an) (ADJP (JJ accurate) (NN health)) (NN history)))))))))) (. .)))
15366550	2	(ROOT (S (NP (DT The) (NN case)) (VP (VBD discussed) (SBAR (S (NP (NN herein)) (ADVP (RB initially)) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (NP (NP (NNS Doc_15366550_247_276_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15366550_278_280_Disease)) (-RRB- -RRB-)) (ADJP (JJ secondary) (PP (TO to) (NP (DT a) (JJ traumatic) (NNS Doc_15366550_307_319_Disease)))))))))))) (. .)))
15366550	3	(ROOT (S (NP (NP (DT The) (NN nursing) (NN staff)) (, ,) (PP (IN by) (S (VP (VBG reviewing) (NP (NP (DT the) (NN patient) (POS 's)) (NN health) (NN history)) (PP (IN with) (NP (PRP$ his) (NN family)))))) (, ,)) (VP (VBD discovered) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS Doc_15366550_423_433_Disease) (CC and) (JJ long-standing) (NNS Doc_15366550_452_459_Chemical) (NN use))))) (. .)))
15366550	4	(ROOT (S (S (NP (NNP Doc_15366550_465_472_Chemical)) (VP (VBZ is) (VP (VBN implicated) (PP (IN in) (NP (JJ drug-induced) (NNS Doc_15366550_503_517_Disease)))))) (, ,) (CC and) (S (SBAR (IN because) (S (NP (DT the) (NN patient)) (VP (VBD had) (RB not) (VP (VBN received) (NP (NNS Doc_15366550_560_567_Chemical)) (PP (IN since) (S (VP (VBG being) (VP (VBN admitted) (PP (TO to) (NP (DT the) (NN hospital))))))))))) (, ,) (NP (PRP$ his) (NN treatment)) (VP (VBD changed) (S (VP (TO to) (VP (VB focus) (PP (IN on) (NP (NNS Doc_15366550_640_654_Disease)))))))) (. .)))
15366550	5	(ROOT (S (PP (IN By) (S (VP (VBG combining) (NP (NN information)) (PP (IN from) (NP (NP (DT the) (JJ patient) (NN history)) (, ,) (NP (DT the) (JJ physical) (NN examination)) (, ,) (CC and) (NP (NN radiologic) (CC and) (NN laboratory) (NNS studies))))))) (, ,) (NP (DT the) (JJ critical) (NN care) (NN team)) (VP (VP (VBD demonstrated) (SBAR (IN that) (S (NP (DT the) (NN patient)) (VP (VBD had) (VP (VBN been) (VP (VBG self-treating) (NP (PRP$ his) (NN Doc_15366550_852_859_Chemical-induced) (NNS Doc_15366550_868_882_Disease)))))))) (CC and) (VP (VBD developed) (S (NP (JJ neurogenic) (NNS Doc_15366550_908_910_Disease)) (ADJP (JJ secondary) (PP (TO to) (NP (NNS Doc_15366550_924_936_Disease))))))) (. .)))
15366550	6	(ROOT (S (ADVP (RB Thus)) (NP (JJ successful) (NN treatment)) (VP (VBD required) (SBAR (IN that) (S (NP (NNS Doc_15366550_978_1007_Disease)) (VP (VB be) (VP (VBN treated) (ADVP (RB concomitantly))))))) (. .)))
15482540	0	(ROOT (NP (NP (NNS Factors)) (VP (VBG contributing) (PP (TO to) (NP (NN Doc_15482540_24_33_Chemical-induced) (NNS Doc_15482540_42_48_Disease)))) (. .)))
15482540	1	(ROOT (NP (NP (NNP BACKGROUND) (CC AND) (NNP AIM)) (: :) (S (NP (NP (NNP Interferon)) (CC and) (NP (NP (JJ Doc_15482540_85_94_Chemical) (NN combination) (NN therapy)) (PP (IN for) (NP (NNS Doc_15482540_119_138_Disease))))) (VP (VBZ produces) (NP (NNS Doc_15482540_148_164_Disease)))) (. .)))
15482540	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN conducted) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (NNS factors)) (VP (VBG contributing) (PP (TO to) (NP (NN Doc_15482540_231_240_Chemical-induced) (NNS Doc_15482540_249_255_Disease)))))))))) (. .)))
15482540	3	(ROOT (S (NP (NP (JJ Eighty-eight) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_15482540_293_312_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (ADJP (JJ interferon-alpha-2b)) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 6) (NN MU)) (VP (VBN administered) (ADVP (RB intramuscularly)) (PP (IN for) (NP (NP (CD 24) (NNS weeks)) (PP (IN in) (NP (NN combination))))) (PP (IN with) (NP (NP (NNS Doc_15482540_426_435_Chemical)) (VP (VBN administered) (ADVP (RB orally)) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (QP (CD 600) (CD mg) (CC or) (CD 800) (CD mg)))))))))))))))))))) (VP (VBD participated) (PP (IN in) (NP (DT the) (NN study)))) (. .)))
15482540	4	(ROOT (S (NP (NP (DT A) (NN hemoglobin) (NN concentration)) (PP (IN of) (NP (QP (CD <) (CD 10)) (NN g/dL)))) (VP (VBD was) (VP (VBN defined) (PP (IN as) (NP (NN Doc_15482540_567_576_Chemical-induced) (NNS Doc_15482540_585_591_Disease))))) (. .)))
15482540	5	(ROOT (S (NP (JJ Doc_15482540_602_611_Chemical-induced) (NNS Doc_15482540_620_626_Disease)) (VP (VBD occurred) (PP (IN in) (NP (ADJP (CD 18)) (PRN (-LRB- -LRB-) (NP (CD 20.5) (NN %)) (-RRB- -RRB-)) (NNS patients))) (PP (IN during) (NP (NN treatment)))) (. .)))
15482540	6	(ROOT (S (NP (NP (DT A) (ADJP (CD 2) (JJ g/dL)) (NN decrease)) (PP (IN in) (NP (NP (NN hemoglobin) (NNS concentrations)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_15482540_741_747_Disease)))))))) (VP (VBD was) (VP (VBN observed) (PP (IN at) (NP (NN week) (CD 2))) (PP (IN after) (NP (NP (DT the) (NN start)) (PP (IN of) (NP (NN treatment))))))) (. .)))
15482540	7	(ROOT (S (NP (NP (DT The) (NN hemoglobin) (NN concentration)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (QP (CD >) (CC or) (CD =) (CD 2)) (JJ g/dL) (NN decrease)) (PP (IN at) (NP (NN week) (CD 2)))))))) (VP (VBD was) (ADJP (JJ observed) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (RB significantly) (JJR lower)) (PP (RB even) (IN after) (NP (NN week)))) (PP (ADVP (NP (CD 2)) (IN than)) (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (QP (CD <) (CD 2)) (JJ g/dL) (NN decrease)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-))))))))))) (. .)))
15482540	8	(ROOT (S (NP (DT A) (JJ significant) (NN relationship)) (VP (VBD was) (VP (VBN observed) (PP (IN between) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN reduction)) (PP (IN of) (NP (NP (NP (NN hemoglobin) (NNS concentrations)) (PP (IN at) (NP (NN week) (CD 2)))) (CC and) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NP (NNS Doc_15482540_1116_1122_Disease)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-))))))))))))) (. .)))
15482540	9	(ROOT (S (NP (NP (NP (NP (JJ Such) (NNS factors)) (PP (IN as) (NP (NN sex))) (PRN (-LRB- -LRB-) (NP (NN female)) (-RRB- -RRB-))) (, ,) (NP (NP (NN age)) (PRN (-LRB- -LRB-) (ADJP (NP (QP (CD >) (CC or) (CD =) (CD 60)) (NNS years)) (JJ old)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (DT the) (JJ Doc_15482540_1199_1208_Chemical) (NN dose)) (PP (IN by) (NP (NN body) (NN weight))))) (PRN (-LRB- -LRB-) (NP (NP (CD 12) (NN mg/kg)) (CC or) (NP (JJR more))) (-RRB- -RRB-))) (VP (VBD were) (ADJP (JJ significant) (PP (IN by) (NP (JJ univariate) (NN analysis))))) (. .)))
15482540	10	(ROOT (S (NP (JJ Careful) (NN administration)) (VP (VBZ is) (ADJP (JJ necessary) (PP (IN in) (NP (NP (NNS patients) (CD >) (CC or) (CD =)) (ADJP (NP (CD 60) (NNS years)) (JJ old)) (, ,) (PP (PP (IN in) (NP (JJ female) (NNS patients))) (, ,) (CC and) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (DT a) (JJ Doc_15482540_1418_1427_Chemical) (NN dose)) (PP (IN of) (NP (CD 12))) (VP (VBG mg/kg) (NP (QP (CC or) (JJR more))))))))))))) (. .)))
15482540	11	(ROOT (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBP experience) (S (NP (NP (DT a) (NN fall)) (PP (IN in) (NP (NP (NN hemoglobin) (NNS concentrations)) (PP (IN of) (NP (CD 2)))))) (VP (VB g/dL) (NP (QP (CC or) (JJR more))) (PP (IN at) (NP (NN week) (CD 2))) (PP (IN after) (NP (NP (DT the) (NN start)) (PP (IN of) (NP (NN treatment))))))))))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (PP (IN with) (NP (JJ particular) (NN care)))))) (. .)))
1556529	0	(ROOT (NP (CD Doc_1556529_0_10_Chemical-induced) (NNS Doc_1556529_19_28_Disease) (. .)))
1556529	1	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (JJ acute) (NNS Doc_1556529_46_55_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_1556529_67_77_Chemical)) (PP (IN in) (NP (DT a) (JJ 38-year-old) (NN patient))))) (PP (IN with) (NP (NNS Doc_1556529_108_112_Disease))))))) (VP (VBZ is) (VP (VBN presented))) (. .)))
1556529	2	(ROOT (S (NP (NP (DT The) (NN mechanism)) (SBAR (WHADVP (WRB whereby)) (S (NP (DT the) (NNS Doc_1556529_153_162_Disease)) (VP (VBD was) (VP (VBN induced)))))) (VP (VBZ is) (RB not) (VP (VBN known))) (. .)))
1556529	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT the) (NN patient)) (VP (VBD tolerated) (ADVP (RB well)) (NP (NP (DT an) (JJ alternative) (JJ reverse) (NN transcriptase) (NN inhibitor)) (, ,) (NP (NNS Doc_1556529_273_292_Chemical)))) (. .)))
1556529	4	(ROOT (S (NP (NP (NNP Physicians) (NNP caring)) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_1556529_330_334_Disease)))))) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (NP (DT this) (NN hitherto)) (VP (ADVP (RB rarely)) (VBN reported) (NP (NN complication)))))))) (. .)))
15605432	0	(ROOT (S (NP (JJ Oxidative) (NN damage)) (VP (VBZ precedes) (NP (NP (JJ nitrative) (NN damage)) (PP (IN in) (NP (NN Doc_15605432_46_56_Chemical-induced) (NNS Doc_15605432_65_93_Disease))))) (. .)))
15605432	1	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (NP (JJ elevated) (NN reactive) (NNS Doc_15605432_166_172_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP ROS)) (-RRB- -RRB-))) (PRN (: /) (NP (NP (NP (JJ Doc_15605432_179_187_Chemical) (NNS species)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15605432_197_200_Disease)) (-RRB- -RRB-))) (SBAR (S (VP (VBD reported) (S (VP (TO to) (VP (VB be) (ADJP (JJ present)))))))) (PP (IN in) (NP (NP (NNS Doc_15605432_228_238_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15605432_240_243_Chemical)) (-RRB- -RRB-))))) (: -))) (VP (VBN induced) (NP (NP (NNS Doc_15605432_253_267_Disease)) (VP (ADVP (RB actually)) (VBN resulted) (PP (IN in) (NP (JJ cardiomyocyte) (NN oxidative/nitrative) (NN damage)))))))))) (, ,) (CC and) (VP (TO to) (VP (ADVP (RB quantitatively)) (VB determine) (NP (NP (DT the) (NN time) (NN course) (CC and) (NN subcellular) (NN localization)) (PP (IN of) (NP (NP (DT these) (JJ postulated) (NN damage) (NNS products)) (VP (VBG using) (NP (DT an) (RB in) (JJ vivo) (NN approach))))))))))) (. .)))
15605432	2	(ROOT (S (NP (NNP B6C3) (NNS mice)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (CD 20) (JJ mg/kg) (NNS Doc_15605432_525_528_Chemical))))))) (. .)))
15605432	3	(ROOT (S (NP (NP (NP (NP (NNS Doc_15605432_530_552_Disease) (CC and) (NNS levels)) (PP (IN of) (NP (NP (NNS Doc_15605432_567_586_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15605432_588_592_Chemical)) (-RRB- -RRB-))))) (: -) (NP (NP (NN protein) (NNS adducts)) (CC and) (NP (NNS Doc_15605432_614_629_Chemical)))) (PRN (-LRB- -LRB-) (NP (NNP Doc_15605432_631_634_Chemical)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN analyzed))) (. .)))
15605432	4	(ROOT (S (NP (NP (JJ Quantitative) (JJ ultrastructural) (NN damage)) (VP (VBG using) (NP (JJ computerized) (NN image) (NNS techniques)))) (VP (VBD showed) (NP (JJ cardiomyocyte) (NN injury)) (PP (IN as) (NP (JJ early) (QP (RB as) (CD 3)) (NNS hours))) (, ,) (PP (IN with) (S (NP (NN mitochondria)) (VP (VBG being) (NP (DT the) (ADJP (ADJP (RBS most) (JJ extensively)) (CC and) (ADJP (RB progressively) (VBN injured))) (NN subcellular) (NN organelle)))))) (. .)))
15605432	5	(ROOT (S (NP (NP (NNP Analysis)) (PP (IN of) (NP (NP (CD 4HNE) (NN protein) (NNS adducts)) (PP (IN by) (NP (JJ immunogold) (NN electron)))))) (ADVP (RB microscopy)) (VP (VP (VBD showed) (SBAR (S (NP (NP (NP (NN appearance)) (PP (IN of) (NP (NP (CD 4HNE) (NN protein) (NNS adducts)) (PP (IN in) (NP (NN mitochondria)))))) (RB as) (RB early) (IN as) (NP (NP (CD 3) (NNS hours)) (, ,) (RRC (PP (IN with) (NP (NP (NP (DT a) (NN peak)) (PP (IN at) (NP (CD 6) (NNS hours)))) (CC and) (NP (NP (JJ subsequent) (NN decline)) (PP (IN at) (NP (CD 24) (NNS hours))))) (. .)) (NP (CD 3NT) (NNS levels))))) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN increased) (PP (IN in) (NP (DT all) (NN subcellular) (NNS compartments))) (PP (IN at) (NP (CD 6) (NNS hours)))))))) (CC and) (VP (ADVP (RB subsequently)) (VBD declined) (PP (IN at) (NP (CD 24) (NNS hours))))) (. .)))
15605432	6	(ROOT (S (NP (PRP$ Our) (NNS data)) (VP (VBD showed) (NP (NP (NNS Doc_15605432_1209_1212_Chemical)) (VP (VBN induced) (NP (NP (JJ 4HNE-protein) (NNS adducts)) (PP (IN in) (NP (NN mitochondria)))) (PP (IN at) (NP (DT the) (JJ same) (NN time) (NN point))) (PP (IN as) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_15605432_1289_1309_Disease)) (ADVP (RB initially)) (VP (VBD appeared)))))))) (. .)))
15605432	7	(ROOT (S (NP (DT These)) (VP (VBZ results) (NP (NN document)) (PP (IN for) (NP (NP (DT the) (JJ first) (NN time)) (PP (IN in) (NP (NN vivo))))) (SBAR (IN that) (S (NP (JJ mitochondrial) (NN oxidative) (NN damage)) (VP (VBZ precedes) (NP (JJ nitrative) (NN damage)))))) (. .)))
15605432	8	(ROOT (S (NP (NP (DT The) (JJ progressive) (NN nature)) (PP (IN of) (NP (NNS Doc_15605432_1469_1489_Disease)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NN mitochondria)) (, ,) (RB not) (NP (JJ other) (NN subcellular) (NNS organelles)) (, ,)) (VP (VBP are) (NP (NP (DT the) (JJ major) (NN site)) (PP (IN of) (NP (NN intracellular) (NN injury)))))))) (. .)))
15609701	0	(ROOT (S (NP (NP (JJ Doc_15609701_0_7_Chemical-induced) (NNS Doc_15609701_16_30_Disease)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NNS Doc_15609701_49_71_Disease)))))) (VP (VBN associated) (PP (IN with) (NP (JJ sustained) (NNS Doc_15609701_98_121_Disease)))) (. .)))
15609701	1	(ROOT (S (NP (NP (DT A) (JJ 54-year-old) (NN man)) (PP (IN with) (NP (NP (JJ severe) (JJ left) (NNS Doc_15609701_158_181_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_15609701_189_211_Disease))))))) (VP (VBD was) (VP (VBN referred) (PP (TO to) (NP (NP (PRP$ our) (NN hospital)) (PP (IN for) (NP (NP (JJ symptomatic) (JJ incessant) (JJ sustained) (NNS Doc_15609701_277_300_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15609701_302_304_Disease)) (-RRB- -RRB-)))))))) (. .)))
15609701	2	(ROOT (S (PP (IN After) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (JJ nifekalant) (NNS Doc_15609701_346_359_Chemical))))) (, ,) (NP (JJ sustained) (NNS Doc_15609701_371_373_Disease)) (VP (VBD was) (VP (VBN terminated))) (. .)))
15609701	3	(ROOT (S (NP (NP (DT An) (JJ alternate) (NN class) (NNP III) (NN agent)) (, ,) (NP (NNS Doc_15609701_420_427_Chemical)) (, ,)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ effective) (PP (IN for) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (NNS Doc_15609701_470_472_Disease))))))) (. .)))
15609701	4	(ROOT (S (ADVP (RB However)) (, ,) (PP (NP (CD one) (NN month)) (IN after) (S (VP (VBG switching) (PRT (RP over)) (NP (NN nifekalant)) (PP (TO to) (NP (NNS Doc_15609701_528_535_Chemical)))))) (, ,) (NP (NP (DT a) (JJ short) (NN duration)) (PP (IN of) (NP (NNP ST) (NNP elevation)))) (VP (VBD was) (VP (VBN documented) (PP (IN in) (NP (NP (NNP ECG)) (VP (VBG monitoring) (PP (IN at) (NP (NP (RB almost) (DT the) (JJ same) (NN time)) (PP (IN for) (NP (CD three) (JJ consecutive) (NNS days)))))))))) (. .)))
15609701	5	(ROOT (S (NP (NP (NNP ST) (NNP elevation)) (PP (IN with) (NP (NN chest) (NN discomfort)))) (VP (VBD disappeared) (SBAR (IN since) (S (NP (PRP he)) (VP (VBD began) (S (VP (VBG taking) (NP (JJ long-acting) (NNS Doc_15609701_736_745_Chemical)))))))) (. .)))
15609701	6	(ROOT (S (NP (NNP Doc_15609701_747_765_Disease)) (VP (MD may) (VP (VB be) (VP (VBN induced) (PP (IN by) (NP (NP (DT the) (JJ non-selective) (JJ beta-blocking) (NNS properties)) (PP (IN of) (NP (NNS Doc_15609701_830_837_Chemical)))))))) (. .)))
15614572	0	(ROOT (S (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (NP (DT the) (JJ antidepressant) (NNS Doc_15614572_30_39_Chemical)) (, ,) (NP (DT a) (JJ 5-HT) (CD 2A/2C) (NN receptor) (NN antagonist)) (, ,)) (PP (IN on) (NP (NNS Doc_15614572_78_86_Chemical-dependent)))))) (VP (VBZ behaviors) (PP (IN in) (NP (NNS rats)))) (. .)))
15614572	1	(ROOT (S (NP (NP (NNP Doc_15614572_127_146_Chemical)) (, ,) (PP (IN via) (NP (NP (NN stimulation)) (PP (IN of) (NP (CD 5-HT) (CD 2C) (NNS receptors))))) (, ,)) (VP (VBZ exerts) (NP (NP (DT a) (NN tonic) (NN inhibitory) (NN influence)) (PP (IN on) (NP (JJ dopaminergic) (NN neurotransmission)))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN activation)) (PP (IN of) (NP (CD 5-HT) (CD 2A) (NNS receptors)))) (VP (VBZ enhances) (VP (VBN stimulated) (NP (JJ DAergic) (NN neurotransmission))))))) (. .)))
15614572	2	(ROOT (S (NP (DT The) (NN antidepressant) (NNS Doc_15614572_363_372_Chemical)) (VP (VBZ is) (NP (DT a) (ADJP (QP (CD 5-HT) (CD 2A/2C))) (NN receptor) (NN antagonist))) (. .)))
15614572	3	(ROOT (S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ Doc_15614572_448_457_Chemical) (NN treatment)))) (PP (IN on))))) (VP (VBZ behaviors) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (ADJP (JJ functional)) (NN status)) (PP (IN of) (NP (DT the) (JJ nigrostriatal) (JJ DAergic) (NN system))))))) (. .)))
15614572	4	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (ADJP (JJ pretreatment) (PP (IN with) (NP (NP (NNS Doc_15614572_594_603_Chemical)) (PP (IN on) (NP (ADJP (JJ Doc_15614572_607_621_Chemical) (: -) (CC and) (JJ Doc_15614572_627_638_Chemical-induced)) (JJ oral) (NNS stereotypies))))) (, ,) (PP (IN on) (NP (NP (NNS Doc_15614572_669_678_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_15614572_690_701_Chemical) (CC and) (NNS Doc_15614572_706_717_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.05) (NN mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-)) (, ,) (PP (IN on) (NP (NP (ADJP (JJ Doc_15614572_741_752_Chemical-induced) (JJ wet)) (NN dog) (NN shake)) (PRN (-LRB- -LRB-) (NP (NNP WDS)) (-RRB- -RRB-)))))))))) (UCP (NP (NN behavior)) (CC and) (ADJP (JJ Doc_15614572_794_804_Chemical-induced) (JJ penile))) (NNS erections)))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (NNS rats))))) (. .)))
15614572	5	(ROOT (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (NNS Doc_15614572_880_889_Chemical)) (VP (VBZ induces) (NP (NP (NNS Doc_15614572_898_907_Disease)) (PP (IN in) (NP (NNS rats)))))))) (. .)))
15614572	6	(ROOT (S (NP (ADJP (JJ Doc_15614572_926_935_Chemical) (PP (IN at) (NP (CD 2.5-20)))) (VBG mg/kg) (NN i.p.)) (VP (VP (VBD did) (RB not) (VP (VB induce) (NP (NNS Doc_15614572_972_981_Disease)))) (, ,) (CC and) (VP (VBD did) (RB not) (VP (VB antagonize) (NP (NP (NP (JJ Doc_15614572_1006_1017_Chemical) (PRN (-LRB- -LRB-) (NP (NP (CD 1.5)) (CC and) (NP (CD 3) (NN mg/kg))) (-RRB- -RRB-)) (NN stereotypy)) (CC and) (NP (NP (NNS Doc_15614572_1051_1062_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.05) (NN mg/kg)) (-RRB- -RRB-)))) (: -) (NP (JJ induced) (NNS Doc_15614572_1084_1093_Disease)))))) (. .)))
15614572	7	(ROOT (S (ADVP (RB However)) (, ,) (NP (ADJP (JJ pretreatment) (PP (IN with) (NP (CD 5) (, ,) (CD 10) (CC and) (CD 20)))) (VBG mg/kg) (NN i.p.)) (VP (VP (VBZ Doc_15614572_1146_1155_Chemical) (NP (VBN enhanced) (NNS Doc_15614572_1165_1179_Chemical)) (ADVP (RB stereotypy))) (, ,) (CC and) (VP (VBD antagonized) (NP (JJ Doc_15614572_1208_1219_Chemical) (UCP (NP (JJ Doc_15614572_1220_1229_Disease) (, ,) (JJ Doc_15614572_1231_1242_Chemical-induced) (NNP WDS) (NN behavior)) (CC and) (ADJP (JJ Doc_15614572_1268_1278_Chemical-induced))) (NN penile) (NNS erections)))) (. .)))
15614572	8	(ROOT (S (NP (ADJP (JJ Doc_15614572_1305_1314_Chemical) (PP (IN at) (NP (CD 30) (, ,) (CD 40) (CC and) (CD 50)))) (VBG mg/kg) (NN i.p.)) (VP (VBN induced) (NP (NP (JJ Doc_15614572_1351_1360_Disease) (CC and) (JJ antagonized) (NNS Doc_15614572_1377_1388_Chemical)) (CC and) (NP (JJ Doc_15614572_1393_1407_Chemical) (NNS stereotypies)))) (. .)))
15614572	9	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NNS Doc_15614572_1461_1470_Chemical)) (PP (IN at) (NP (CD 2.5-20) (NN mg/kg)))) (VP (VBZ does) (RB not) (VP (VB block) (NP (NP (NN pre)) (: -) (CC and) (NP (JJ postsynaptic) (JJ striatal) (NNP D2) (NNP DA) (NNS receptors))) (, ,) (SBAR (IN while) (FRAG (PP (IN at) (NP (CD 30) (, ,) (CD 40) (CC and) (CD 50))))) (S (VP (VBG mg/kg) (SBAR (S (NP (PRP it)) (VP (VBZ blocks) (NP (JJ postsynaptic) (JJ striatal) (NNP D2) (NNP DA) (NNS receptors)))))))))))) (. .)))
15614572	10	(ROOT (S (ADVP (RB Furthermore)) (, ,) (PP (IN at) (NP (NP (CD 5)) (, ,) (NP (CD 10)) (CC and) (NP (CD 20) (NN mg/kg)))) (, ,) (NP (NNS Doc_15614572_1664_1673_Chemical)) (VP (VBZ blocks) (NP (NP (CD 5-HT) (CD 2A)) (CC and) (NP (CD 5-HT) (CD 2C) (NNS receptors)))) (. .)))
15614572	11	(ROOT (S (NP (PRP We)) (VP (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS Doc_15614572_1728_1737_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 5)) (, ,) (NP (CD 10)) (CC and) (NP (CD 20) (NN mg/kg))) (-RRB- -RRB-)) (, ,) (PP (IN by) (S (VP (VBG blocking) (NP (DT the) (CD 5-HT) (CD 2C) (NNS receptors))))) (, ,)) (VP (VP (VBZ releases) (NP (DT the) (JJ nigrostriatal) (JJ DAergic) (NNS neurons)) (PP (IN from) (NP (NP (NN tonic) (NN inhibition)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_15614572_1870_1874_Chemical))))))) (, ,) (CC and) (VP (ADVP (RB thereby)) (VBZ potentiates) (NP (NNS Doc_15614572_1900_1914_Chemical)) (ADVP (RB stereotypy))))))) (CC and) (VP (VBZ antagonizes) (NP (JJ Doc_15614572_1942_1953_Chemical) (NNS Doc_15614572_1954_1963_Disease)))) (. .)))
15625689	0	(ROOT (NP (NP (NNS Doc_15625689_0_24_Disease) (CC and) (NNS Doc_15625689_29_39_Disease)) (PP (IN in) (NP (NNS Doc_15625689_43_62_Disease))) (. .)))
15625689	1	(ROOT (S (S (NP (NP (NNP Doc_15625689_64_94_Disease)) (PP (IN in) (NP (NP (NNS Doc_15625689_98_117_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15625689_119_121_Disease)) (-RRB- -RRB-))))) (VP (VBP have) (VP (VBN been) (VP (VBN known) (PP (IN for) (NP (RB almost) (CD two) (NNS centuries))))))) (, ,) (CC but) (S (NP (NP (JJ many) (NNS aspects)) (PP (VBG concerning) (NP (PRP$ their) (NN pathophysiology)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (ADVP (RB completely)) (VBN clarified))))) (. .)))
15625689	2	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB characterize) (NP (NP (DT the) (JJ oropharyngeal) (NNS dynamics)) (PP (IN in) (NP (JJ Doc_15625689_323_325_Disease) (NNS patients)))) (PP (IN with) (CC and) (IN without) (NP (NN Doc_15625689_352_360_Chemical-induced) (NNS Doc_15625689_369_379_Disease))))))) (. .)))
15625689	3	(ROOT (S (NP (NP (NNP Fifteen) (NNP Doc_15625689_389_399_Disease)) (, ,) (NP (CD 12) (JJ nondyskinetic) (NNS patients)) (, ,) (CC and) (NP (DT a) (NN control) (NN group))) (VP (VBD were) (VP (VBN included))) (. .)))
15625689	4	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VP (VBN asked) (PP (IN about) (NP (NNS Doc_15625689_489_498_Disease)))) (CC and) (VP (VBN evaluated) (PP (IN with) (NP (NP (DT the) (NNP Unified) (NNP Doc_15625689_530_549_Disease) (NNP Rating) (NNP Scale) (NNP Parts) (NNP II)) (CC and) (NP (NP (NNP III)) (CC and) (NP (DT the) (NNP Hoehn) (CC and) (NNP Yahr) (NN scale)))))))) (. .)))
15625689	5	(ROOT (S (NP (NNP Deglutition)) (VP (VBD was) (VP (VBN assessed) (S (VP (VBG using) (NP (VBN modified) (NN barium) (NNS swallow)) (PP (IN with) (NP (NN videofluoroscopy))))))) (. .)))
15625689	6	(ROOT (S (NP (NP (JJ Nondyskinetic) (NNS patients)) (, ,) (CONJP (CC but) (RB not)) (NP (DT the) (JJ Doc_15625689_724_734_Disease) (NNS ones)) (, ,)) (VP (VBD showed) (NP (NP (ADJP (RBR less) (JJ oropharyngeal)) (JJ swallowing) (NN efficiency)) (PRN (-LRB- -LRB-) (NP (NNP OPSE)) (-RRB- -RRB-))) (PP (IN for) (NP (JJ liquid) (NN food))) (PP (IN than) (NP (NP (NNS controls)) (PRN (-LRB- -LRB-) (NP (NNP Dunnett)) (, ,) (NP (NNP P) (NNP =) (NNP 0.02)) (-RRB- -RRB-))))) (. .)))
15625689	7	(ROOT (S (NP (JJ Doc_15625689_847_857_Disease) (NNS patients)) (VP (VBD tended) (S (VP (TO to) (VP (VB have) (NP (NP (DT a) (JJR greater) (NN OPSE)) (PP (IN than) (NP (NP (NN nondyskinetic)) (PRN (-LRB- -LRB-) (NP (NNP Dunnett)) (, ,) (NP (NNP P) (NNP =) (NNP 0.06)) (-RRB- -RRB-))))))))) (. .)))
15625689	8	(ROOT (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBG using) (NP (NP (DT a) (JJR higher) (NN dose)) (PP (IN of) (NP (NNS Doc_15625689_978_986_Chemical))))))))) (VP (VBD had) (NP (NP (DT a) (JJR greater) (NN OPSE)) (CC and) (NP (DT a) (NN trend))) (PP (IN toward) (NP (NP (DT a) (JJR smaller) (JJ oral) (NN transit) (NN time)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NNP Pearson) (POS 's)) (NN correlation)) (, ,) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.01) (CC and) (CD 0.08))))))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))))) (. .)))
15625689	9	(ROOT (S (NP (CC Neither) (NP (NP (NP (DT the) (NN report)) (PP (IN of) (NP (NNS Doc_15625689_1133_1142_Disease)))) (CC nor) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (JJ Doc_15625689_1158_1160_Disease) (NN severity) (NNS parameters)))))) (VP (VBD correlated) (PP (TO to) (NP (DT the) (JJ videofluoroscopic) (NNS variables)))) (. .)))
15625689	10	(ROOT (S (PP (IN In) (NP (DT the) (JJ current) (NN study))) (, ,) (NP (JJ Doc_15625689_1250_1260_Disease) (NNS patients)) (VP (VBD performed) (ADVP (RBR better)) (PP (IN in) (S (VP (VBG swallowing) (NP (NP (NN function)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB be) (VP (VBN explained) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (DT a) (JJR greater) (JJ Doc_15625689_1362_1370_Chemical) (NN dose))))))))))))))) (. .)))
15625689	11	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VP (VBP suggest) (NP (DT a) (NN role)) (PP (IN for) (NP (NP (NNS Doc_15625689_1408_1416_Chemical)) (PP (IN in) (NP (NP (DT the) (JJ oral) (NN phase)) (PP (IN of) (NP (NN deglutition)))))))) (CC and) (VP (VBP confirm) (SBAR (IN that) (S (NP (NNS Doc_15625689_1467_1476_Disease)) (VP (VBZ is) (RB not) (NP (NP (DT a) (JJ good) (NN predictor)) (PP (IN of) (NP (NP (NN deglutition) (NNS alterations)) (PP (IN in) (NP (NNS Doc_15625689_1531_1533_Disease))))))))))) (. .)))
15627798	0	(ROOT (S (NP (NP (NNP Inhibition)) (PP (IN of) (NP (JJ nuclear) (JJ factor-kappaB) (NN activation)))) (VP (VBZ attenuates) (NP (NP (NNS Doc_15627798_58_86_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_15627798_98_108_Chemical)))))) (. .)))
15627798	1	(ROOT (S (NP (NP (NNS Animals)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_15627798_143_153_Chemical))))) (VP (MD can) (VP (VB show) (NP (NP (JJ residual) (NNS areas)) (PP (IN of) (NP (JJ interstitial) (NNS Doc_15627798_194_202_Disease)))) (PP (IN in) (NP (DT the) (JJ renal) (NN cortex))))) (. .)))
15627798	2	(ROOT (SINV (S (NP (DT This) (NN study)) (VP (VBD investigated) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NP (NP (JJ nuclear) (NN factor-kappaB)) (PRN (-LRB- -LRB-) (NP (NNP NF-kappaB)) (-RRB- -RRB-))) (, ,) (NP (JJ mitogen-activated) (NN protein) (PRN (-LRB- -LRB-) (NP (NNP MAP)) (-RRB- -RRB-)) (NNS kinases)) (CC and) (NP (NP (NNS macrophages)) (PP (IN in) (NP (DT the) (JJ renal) (NN cortex))))) (CC and) (NP (NP (ADJP (JJ structural) (CC and) (JJ functional)) (JJ renal) (NNS changes)) (PP (IN of) (NP (NNS rats))))))))) (VP (VBD treated) (PP (IN with) (NP (NNS Doc_15627798_442_452_Chemical) (CC or) (NNS Doc_15627798_456_466_Chemical)))) (NP (NP (JJ +) (NNS Doc_15627798_469_496_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15627798_498_502_Chemical)) (-RRB- -RRB-)) (, ,) (NP (DT an) (JJ NF-kappaB) (NN inhibitor))) (. .)))
15627798	3	(ROOT (S (NP (CD 38) (JJ female) (NN Wistar) (NNS rats)) (VP (VBD were) (VP (VBN injected) (PP (IN with) (NP (NP (NP (NNS Doc_15627798_579_589_Chemical)) (, ,) (NP (CD 40) (NN mg/kg))) (, ,) (RB twice) (NP (NP (DT a) (NN day)) (PP (IN for) (NP (CD 9) (NNS days)))) (, ,) (NP (NP (CD 38)) (PP (IN with) (NP (JJ Doc_15627798_633_643_Chemical) (JJ +) (NNS Doc_15627798_646_650_Chemical)))) (, ,) (CC and) (NP (NP (CD 28)) (PP (IN with) (NP (CD 0.15) (NNP M) (NNP Doc_15627798_671_675_Chemical) (NN solution)))))))) (. .)))
15627798	4	(ROOT (S (S (NP (DT The) (NNS animals)) (VP (VBD were) (VP (VBN killed) (NP (NP (CD 5) (CC and) (CD 30) (NNS days)) (PP (IN after) (NP (DT these) (NNS injections))))))) (CC and) (S (NP (DT the) (NNS kidneys)) (VP (VBD were) (VP (VBN removed) (PP (IN for) (NP (ADJP (JJ histological) (CC and) (JJ immunohistochemical)) (NNS studies)))))) (. .)))
15627798	5	(ROOT (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT the) (JJ immunohistochemical) (NNS studies)))) (VP (VBD were) (VP (VBN scored) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN staining)))))))) (. .)))
15627798	6	(ROOT (S (NP (DT The) (JJ fractional) (JJ interstitial) (NN area)) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NN morphometry))))) (. .)))
15627798	7	(ROOT (S (NP (JJ Doc_15627798_995_1005_Chemical-treated) (NNS rats)) (VP (VBD presented) (NP (DT a) (JJ transitory) (NN increase)) (PP (IN in) (NP (NN plasma) (NNS Doc_15627798_1061_1071_Chemical) (NNS levels)))) (. .)))
15627798	8	(ROOT (S (NP (NP (VBN Increased) (NN ED-1)) (, ,) (NP (NNP MAP) (NNS kinases)) (CC and) (NP (JJ NF-kappaB) (NN staining))) (VP (VBD were) (ADVP (RB also)) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (JJ renal) (NN cortex)) (PP (IN from) (NP (DT all) (NN Doc_15627798_1179_1189_Chemical-treated) (NNS rats))))) (PP (VBN compared) (PP (TO to) (NP (NP (NN control)) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (CD <) (CD 0.05))) (-RRB- -RRB-))))))) (. .)))
15627798	9	(ROOT (S (NP (NP (DT The) (NNS animals)) (VP (VBN killed) (PP (IN on) (NP (NN day) (CD 30))))) (ADVP (RB also)) (VP (VBD presented) (NP (NNS Doc_15627798_1279_1287_Disease)) (PP (IN in) (NP (DT the) (JJ renal) (NN cortex))) (PP (IN despite) (NP (NP (DT the) (NN recovery)) (PP (IN of) (NP (JJ renal) (NN function)))))) (. .)))
15627798	10	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN with) (NP (NNS Doc_15627798_1363_1367_Chemical)))) (VP (VBD reduced) (NP (NP (DT the) (ADJP (JJ functional) (CC and) (JJ structural)) (NNS changes)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_15627798_1425_1435_Chemical)))))) (. .)))
15627798	11	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ NF-kappaB) (NN activation)))) (VP (VBZ attenuates) (NP (NP (NNS Doc_15627798_1517_1545_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_15627798_1557_1567_Chemical))))))))) (. .)))
15630069	0	(ROOT (NP (NP (NP (JJ Doc_15630069_0_7_Chemical) (NN metabolism)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_15630069_36_49_Disease)) (VP (VBN treated) (PP (IN with) (NP (JJ atypical) (JJ antipsychotic) (NNS agents))))))))) (: :) (NP (NP (DT a) (NNP frequently) (NNP sampled) (JJ intravenous) (JJ Doc_15630069_127_134_Chemical) (NN tolerance) (NN test)) (CC and) (NP (JJ minimal) (NN model) (NN analysis))) (. .)))
15630069	1	(ROOT (S (SBAR (IN While) (S (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_15630069_213_240_Disease)))) (VP (MD may) (VP (VB be) (VP (VBG increasing) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_15630069_276_289_Disease)) (VP (VBN treated) (PP (IN with) (NP (JJ certain) (JJ atypical) (JJ antipsychotic) (NNS agents))))))))))))) (, ,) (NP (PRP it)) (VP (VBZ remains) (ADJP (JJ unclear)) (SBAR (IN whether) (S (NP (JJ atypical) (NNS agents)) (VP (VBP are) (ADVP (RB directly)) (VP (VP (VBG affecting) (NP (JJ Doc_15630069_408_415_Chemical) (NN metabolism))) (CC or) (VP (ADVP (RB simply)) (VBG increasing) (NP (NP (VBN known) (NN risk) (NNS factors)) (PP (IN for) (NP (NNS Doc_15630069_471_479_Disease)))))))))) (. .)))
15630069	2	(ROOT (S (S (VP (TO To) (VP (VB study) (NP (NP (DT the) (CD 2) (NNS drugs)) (ADJP (RBS most) (RB clearly) (JJ implicated)) (PRN (-LRB- -LRB-) (NP (JJ Doc_15630069_538_547_Chemical) (CC and) (JJ Doc_15630069_552_562_Chemical)) (-RRB- -RRB-)))))) (CC and) (S (NP (NNS Doc_15630069_568_579_Chemical)) (VP (VBG using) (NP (DT a) (ADJP (ADVP (RB frequently)) (JJ sampled)) (JJ intravenous) (JJ Doc_15630069_619_626_Chemical) (NN tolerance) (NN test)))) (. .)))
15630069	3	(ROOT (S (NP (NP (DT A) (JJ cross-sectional) (NN design)) (PP (IN in) (ADJP (JJ stable)))) (, ,) (VP (VBD treated) (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_15630069_709_722_Disease)) (VP (VBN evaluated) (S (VP (VBG using) (NP (NP (DT a) (ADJP (ADVP (RB frequently)) (JJ sampled)) (JJ intravenous) (NN Doc_15630069_772_779_Chemical) (NN tolerance) (NN test)) (CC and) (NP (DT the) (NNP Bergman) (JJ minimal) (NN model) (NN analysis))))))))) (. .)))
15630069	4	(ROOT (S (NP (NNS Subjects)) (VP (VP (VBD were) (VP (VBN recruited) (PP (IN from) (NP (DT an) (JJ urban) (NN community) (JJ mental) (NN health) (NN clinic))))) (CC and) (VP (VBD were) (VP (VBN studied) (PP (IN at) (NP (DT a) (JJ general) (JJ clinical) (NN research) (NN center)))))) (. .)))
15630069	5	(ROOT (S (NP (NP (NNS Patients)) (NP (CD Fifty) (NNS subjects))) (VP (VBD signed) (SBAR (S (NP (NP (VBN informed) (NN consent)) (CC and) (NP (CD 41))) (VP (VBD underwent) (NP (DT the) (ADJP (ADVP (RB frequently)) (JJ sampled)) (JJ intravenous) (JJ Doc_15630069_1069_1076_Chemical) (NN tolerance) (NN test)))))) (. .)))
15630069	6	(ROOT (S (NP (NP (JJ Thirty-six) (NN nonobese) (NNS subjects)) (PP (IN with) (NP (NNS Doc_15630069_1127_1140_Disease) (CC or) (NNS Doc_15630069_1144_1168_Disease))) (, ,) (VP (VP (VBN matched) (PP (IN by) (NP (NN body) (NN mass) (NN index)))) (CC and) (VP (VBN treated) (PP (IN with) (NP (NP (DT either) (NNS Doc_15630069_1221_1230_Chemical)) (, ,) (NP (NNS Doc_15630069_1232_1242_Chemical)) (, ,) (CC or) (NP (NNS Doc_15630069_1247_1258_Chemical)))))) (, ,)) (VP (VBD were) (VP (VBN included) (PP (IN in) (NP (DT the) (NN analysis))))) (. .)))
15630069	7	(ROOT (NP (NP (NNP MAIN) (NNP OUTCOME) (NNP MEASURES)) (: :) (NP (NP (NP (VBG Fasting) (NN plasma) (NNS Doc_15630069_1329_1336_Chemical)) (CC and) (NP (VBG fasting) (NN serum) (NN insulin) (NNS levels))) (, ,) (NP (NN insulin) (NN sensitivity) (NN index)) (, ,) (NP (NP (JJ homeostasis) (NN model) (NN assessment)) (PP (IN of) (NP (NN insulin) (NN resistance)))) (, ,) (CC and) (NP (JJ Doc_15630069_1454_1461_Chemical) (NN effectiveness))) (. .)))
15630069	8	(ROOT (NP (NP (NP (DT The) (JJ mean) (NN +)) (PRN (: /) (NP (NP (NNP -) (NNP SD)) (SBAR (S (NP (NP (NN duration)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (DT the) (ADJP (VBN identified) (JJ atypical)) (JJ antipsychotic) (NN agent)))))) (VP (VBD was) (NP (QP (CD 68.3) (CD +))))))) (: /))) (: -) (NP (NP (CD 28.9) (NNS months) (PRN (-LRB- -LRB-) (NP (NNP Doc_15630069_1599_1608_Chemical)) (-RRB- -RRB-))) (, ,) (NP (QP (CD 29.5) (CD +)) (NNS /))) (: -) (NP (NP (CD 17.5) (NNS months) (PRN (-LRB- -LRB-) (NP (NNP Doc_15630069_1633_1643_Chemical)) (-RRB- -RRB-))) (, ,) (CC and) (NP (QP (CD 40.9) (CD +)) (NNS /))) (: -) (NP (NP (CD 33.7)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15630069_1665_1676_Chemical)) (-RRB- -RRB-))) (. .)))
15630069	9	(ROOT (S (NP (JJ Fasting) (NN serum) (NN insulin) (NNS concentrations)) (VP (VBD differed) (PP (IN among) (NP (NP (NP (NNS groups)) (-LRB- -LRB-) (NP (NP (NP (NP (NN F)) (PRN (-LRB- -LRB-) (NP (CD 33)) (-RRB- -RRB-))) (ADJP (JJ =) (NP (CD 3.35)))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .047))))))) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (JJ Doc_15630069_1764_1773_Chemical) (NNP >) (NNP Doc_15630069_1774_1784_Chemical) (NNP >) (NNP Doc_15630069_1785_1796_Chemical)) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NP (JJ significant) (NNS differences)) (PP (IN between) (NP (NNS Doc_15630069_1835_1844_Chemical) (CC and) (NNS Doc_15630069_1849_1860_Chemical)))) (PRN (-LRB- -LRB-) (VP (VP (VBP t) (S (NP (PRN (-LRB- -LRB-) (NP (CD 33)) (-RRB- -RRB-))) (VP (SYM =) (NP (CD 2.32))))) (: ;) (NP (NP (NNP P)) (S (VP (SYM =) (NP (CD .03)))))) (-RRB- -RRB-)) (CC and) (NP (NP (NNS Doc_15630069_1889_1899_Chemical) (CC and) (NNS Doc_15630069_1904_1915_Chemical)) (-LRB- -LRB-) (NP (S (VP (VB t) (S (NP (PRN (-LRB- -LRB-) (NP (CD 33)) (-RRB- -RRB-))) (VP (SYM =) (NP (CD 2.15)))))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .04))))))) (-RRB- -RRB-))))) (. .)))
15630069	10	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN difference)) (PP (IN in) (NP (NP (NN insulin) (NN sensitivity) (NN index)) (PP (IN among) (NP (NP (NP (NNS groups)) (-LRB- -LRB-) (NP (NP (NP (NP (NN F)) (PRN (-LRB- -LRB-) (NP (CD 33)) (-RRB- -RRB-))) (ADJP (JJ =) (NP (CD 10.66)))) (: ;) (NP (NP (NNP P) (NNP <)) (NP (CD .001)))) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (JJ Doc_15630069_2043_2052_Chemical) (NNP <) (NNP Doc_15630069_2053_2063_Chemical) (NNP <) (NNP Doc_15630069_2064_2075_Chemical)) (-RRB- -RRB-)))) (, ,) (PP (IN with) (NP (NP (NP (NP (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (SBAR (S (NP (NP (NNS Doc_15630069_2105_2114_Chemical) (CC and) (NNS Doc_15630069_2119_2129_Chemical)) (VP (VBG exhibiting) (NP (JJ significant) (NN insulin) (NN resistance)) (PP (VBN compared) (PP (IN with) (NP (NP (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NNS Doc_15630069_2217_2228_Chemical)) (-LRB- -LRB-) (NP (JJ Doc_15630069_2230_2239_Chemical) (NN vs) (NNS Doc_15630069_2243_2254_Chemical)) (, ,) (ADVP (RB t))) (PRN (-LRB- -LRB-) (NP (CD 33)) (-RRB- -RRB-))))))))))))) (VP (SYM =) (NP (CD -4.29))))))))) (: ;) (NP (NP (NNP P) (NNP <)) (NP (CD .001)))) (: ;) (NP (NP (JJ Doc_15630069_2279_2289_Chemical) (NN vs) (NNS Doc_15630069_2293_2304_Chemical)) (, ,) (VP (VBN t) (S (NP (PRN (-LRB- -LRB-) (NP (CD 33)) (-RRB- -RRB-))) (VP (SYM =) (NP (CD -3.62)))))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .001) (NNP -LSB-) (NNP P) (NNP <) (CD .001) (NNS -RSB-)))))))) (-RRB- -RRB-))))) (. .)))
15630069	11	(ROOT (S (NP (NP (DT The) (JJ homeostasis) (NN model) (NN assessment)) (PP (IN of) (NP (NN insulin) (NN resistance)))) (ADVP (RB also)) (VP (VBD differed) (ADVP (RB significantly)) (PP (IN among) (NP (NP (NP (NNS groups)) (-LRB- -LRB-) (NP (NP (NP (NP (NN F)) (PRN (-LRB- -LRB-) (NP (CD 33)) (-RRB- -RRB-))) (ADJP (JJ =) (NP (CD 4.92)))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .01))))))) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (JJ Doc_15630069_2462_2471_Chemical) (NNP >) (NNP Doc_15630069_2472_2482_Chemical) (NNP >) (NNP Doc_15630069_2483_2494_Chemical)) (-RRB- -RRB-)))) (PRN (-LRB- -LRB-) (NP (NP (JJ Doc_15630069_2497_2506_Chemical) (NN vs) (NNS Doc_15630069_2510_2521_Chemical)) (, ,) (NP (NP (NP (NN t)) (PRN (-LRB- -LRB-) (NP (CD 33)) (-RRB- -RRB-)) (NP (NNP =) (NNP 2.94))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .006)))))) (: ;) (NP (NP (JJ Doc_15630069_2547_2557_Chemical) (NN vs) (NNS Doc_15630069_2561_2572_Chemical)) (, ,) (NP (NP (NP (NN t)) (PRN (-LRB- -LRB-) (NP (CD 33)) (-RRB- -RRB-))) (ADJP (JJ =) (NP (CD 2.42))))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .02)))))))) (-RRB- -RRB-))) (. .)))
15630069	12	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN difference)) (PP (IN among) (NP (NP (NNS groups)) (PP (IN in) (NP (NP (NP (JJ Doc_15630069_2649_2656_Chemical) (NN effectiveness)) (-LRB- -LRB-) (NP (NP (NP (NP (NN F)) (PRN (-LRB- -LRB-) (NP (CD 30)) (-RRB- -RRB-))) (ADJP (JJ =) (NP (CD 4.18)))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .02))))))) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (JJ Doc_15630069_2696_2705_Chemical) (NNP <) (NNP Doc_15630069_2706_2716_Chemical) (NNP <) (NNP Doc_15630069_2717_2728_Chemical)) (-RRB- -RRB-))))))) (PP (IN with) (NP (NP (NP (JJ significant) (NNS differences)) (PP (IN between) (NP (NNS Doc_15630069_2767_2776_Chemical) (CC and) (NNS Doc_15630069_2781_2792_Chemical)))) (PRN (-LRB- -LRB-) (VP (VP (VBP t) (S (NP (PRN (-LRB- -LRB-) (NP (CD 30)) (-RRB- -RRB-))) (VP (SYM =) (NP (CD -2.59))))) (: ;) (NP (NP (NNP P)) (S (VP (SYM =) (NP (CD .02)))))) (-RRB- -RRB-)) (CC and) (NP (NP (NNS Doc_15630069_2822_2832_Chemical) (CC and) (NNS Doc_15630069_2837_2848_Chemical)) (PRN (-LRB- -LRB-) (S (VP (VP (VB t) (S (NP (PRN (-LRB- -LRB-) (NP (CD 30)) (-RRB- -RRB-))) (VP (SYM =) (NP (CD -2.34))))) (, ,) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .03)))))))) (-RRB- -RRB-)))))) (. .)))
15630069	13	(ROOT (S (NP (DT Both) (JJ nonobese) (ADJP (JJ Doc_15630069_2902_2911_Chemical) (: -) (CC and) (JJ Doc_15630069_2917_2927_Chemical-treated)) (NNS groups)) (VP (VBD displayed) (NP (NP (JJ significant) (NN insulin) (NN resistance) (CC and) (NN impairment)) (PP (IN of) (NP (JJ Doc_15630069_3002_3009_Chemical) (NN effectiveness)))) (PP (VBN compared) (PP (IN with) (NP (NN Doc_15630069_3038_3049_Chemical-treated) (NNS subjects))))) (. .)))
15630069	14	(ROOT (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NNS Doc_15630069_3084_3093_Chemical) (CC and) (NNS Doc_15630069_3098_3108_Chemical)))) (VP (MD must) (VP (VB be) (VP (VBN examined) (PP (IN for) (NP (NP (NN insulin) (NN resistance)) (CC and) (NP (PRP$ its) (NNS consequences))))))) (. .)))
1563460	0	(ROOT (NP (NP (NP (JJ Thoracic) (NNS Doc_1563460_9_21_Disease)) (ADJP (JJ secondary) (PP (TO to) (NP (JJ Doc_1563460_35_43_Chemical) (NN anticoagulant) (NN therapy))))) (: :) (NP (DT a) (NN case) (NN report)) (. .)))
1563460	1	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (JJ thoracic) (NNS Doc_1563460_101_113_Disease)) (ADJP (JJ secondary) (PP (TO to) (NP (JJ anticoagulant) (NN therapy))))))) (VP (VBZ is) (VP (VBN presented))) (. .)))
1563460	2	(ROOT (S (NP (NP (JJ Clinical) (NNS features)) (, ,) (ADJP (JJ similar) (PP (TO to) (NP (ADJP (CD 2) (JJ other)) (ADJP (RB previously) (VBN reported)) (NNS cases)))) (, ,)) (VP (VBP are) (VP (VBN discussed))) (. .)))
1563460	3	(ROOT (S (NP (NP (DT A) (JJ high) (NN index)) (PP (IN of) (NP (NN suspicion)))) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (DT a) (JJ quick) (JJ diagnostic) (NN procedure)) (CC and) (NP (JJ successful) (NN decompressive) (NN surgery)))))) (. .)))
1564030	0	(ROOT (S (NP (NNP Doc_1564030_0_5_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ Doc_1564030_22_32_Chemical) (NN treatment)) (PP (IN in) (NP (NNS adolescents)))))) (. .)))
1564030	1	(ROOT (S (NP (NP (NNP Doc_1564030_59_69_Chemical)) (, ,) (NP (DT a) (JJ selective) (JJ Doc_1564030_83_92_Chemical) (NN reuptake) (NN inhibitor)) (, ,)) (VP (VBZ is) (VP (VBG gaining) (NP (NP (VBN increased) (NN acceptance)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ adolescent) (NNS Doc_1564030_176_186_Disease)))))))) (. .)))
1564030	2	(ROOT (S (S (ADVP (RB Generally)) (ADJP (ADJP (JJ safe)) (CC and) (ADJP (RB well) (JJ tolerated) (PP (IN by) (NP (NNS adults)))))) (, ,) (NP (NNS Doc_1564030_233_243_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB induce) (NP (NNS Doc_1564030_272_277_Disease)))))))) (. .)))
1564030	3	(ROOT (S (NP (NP (DT The) (NNS cases)) (PP (IN of) (NP (NP (CD five) (JJ Doc_1564030_297_306_Disease) (NNS adolescents)) (, ,) (NP (NP (CD 14-16) (NNS years)) (PP (IN of) (NP (NN age)))))) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_1564030_354_359_Disease)) (PP (IN during) (NP (NN pharmacotherapy))) (PP (IN with) (NP (NNS Doc_1564030_388_398_Chemical)))))) (, ,)) (VP (VBP are) (VP (VBN reported) (ADVP (RB here)))) (. .)))
1564030	4	(ROOT (S (NP (NP (JJ Apparent) (NN risk) (NNS factors)) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_1564030_464_469_Disease) (CC or) (NN hypomania))) (PP (IN during) (NP (NP (JJ Doc_1564030_490_500_Chemical) (NN pharmacotherapy)) (PP (IN in) (NP (DT this) (NN population)))))))) (VP (VBD were) (NP (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (JJ attention-deficit) (NNS Doc_1564030_578_600_Disease)))) (CC and) (NP (NP (JJ affective) (NNS Doc_1564030_615_644_Disease)) (PP (IN with) (NP (JJ Doc_1564030_650_659_Disease) (NNS features)))) (: ;) (NP (NP (DT a) (NN family) (NN history)) (PP (IN of) (NP (NP (NNS Doc_1564030_690_708_Disease)) (, ,) (RB especially) (NP (NNS Doc_1564030_721_737_Disease))))) (: ;) (CC and) (NP (NP (DT a) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_1564030_758_774_Disease)))))) (. .)))
1564030	5	(ROOT (S (NP (JJ Further) (NN study)) (VP (VBZ is) (VP (VBN needed) (S (VP (VP (TO to) (VP (VB determine) (NP (DT the) (JJ optimal) (NN dosage)))) (CC and) (VP (TO to) (VP (VB identify) (NP (NP (NN risk) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VB increase) (NP (JJ individual) (NN vulnerability)) (PP (TO to) (NP (NP (JJ Doc_1564030_903_913_Chemical) (JJ induced) (NNS Doc_1564030_922_927_Disease)) (PP (IN in) (NP (NNS adolescents))))))))))))))) (. .)))
15696449	0	(ROOT (S (VP (VBN Doc_15696449_0_25_Disease) (PP (IN after) (NP (JJ high-dose) (NN melphalan))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_15696449_69_97_Disease))))) (PP (IN during) (NP (NN stem) (NN cell) (NN transplantation)))) (. .)))
15696449	1	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (NNS Doc_15696449_158_186_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15696449_188_190_Disease)) (-RRB- -RRB-))))) (VP (VBP have) (NP (DT a) (JJ poor) (NN prognosis))) (. .)))
15696449	2	(ROOT (S (NP (NP (JJ Median) (NN survival) (NN time)) (PP (IN from) (NP (JJ standard) (NNS treatments)))) (VP (VBZ is) (NP (QP (RB only) (CD 17)) (NNS months))) (. .)))
15696449	3	(ROOT (S (S (NP (NP (JJ High-dose) (JJ intravenous) (NNS Doc_15696449_302_311_Chemical)) (VP (VBN followed) (PP (IN by) (NP (JJ peripheral) (NN blood))))) (VP (VBP stem) (SBAR (S (NP (NP (NN cell) (NN transplant)) (PRN (-LRB- -LRB-) (NP (NNP PBSCT)) (-RRB- -RRB-))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (DT the) (ADJP (RBS most) (JJ promising)) (NN therapy)))))))))) (, ,) (CC but) (S (NP (NN treatment) (NN mortality)) (VP (MD can) (VP (VB be) (ADJP (JJ high))))) (. .)))
15696449	4	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBP have) (VP (VBN noted) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_15696449_491_516_Disease)))) (PP (ADVP (RB immediately)) (IN after) (NP (NN melphalan) (NN conditioning))))) (. .)))
15696449	5	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN undertaken) (S (VP (TO to) (VP (ADVP (RBR further)) (VB examine) (NP (PRP$ its) (NN risk) (NNS factors) (CC and) (NN impact)) (PP (IN on) (NP (JJ posttransplant) (NN mortality)))))))) (. .)))
15696449	6	(ROOT (S (VP (VB Consecutive) (NP (NP (JJ Doc_15696449_682_684_Disease) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (SBAR (S (NP (NNP PBSCT)) (VP (VBD were) (VP (VBN studied) (ADVP (RB retrospectively))))))))))) (. .)))
15696449	7	(ROOT (S (NP (NP (NP (NNP Doc_15696449_744_769_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15696449_771_774_Disease)) (-RRB- -RRB-))) (PP (IN after) (NP (JJ high-dose) (NN melphalan)))) (VP (VBD was) (VP (VBN defined) (PP (IN by) (NP (NP (DT a) (JJ minimum) (NN increase)) (PP (IN of) (NP (NP (CD 0.5) (NN mg/dL)) (PRN (-LRB- -LRB-) (NP (CD 44) (NN micromol/L)) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (DT the) (JJ serum) (JJ Doc_15696449_878_888_Chemical) (NN level)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (NP (NP (QP (JJR greater) (IN than) (CD 50)) (NN %)) (PP (IN of) (NP (NN baseline)))) (ADVP (RB immediately)) (PP (IN after) (NP (NN conditioning)))))))))) (. .)))
15696449	8	(ROOT (S (NP (JJ Urine) (NN sediment) (NN score)) (VP (VBD was) (NP (NP (DT the) (NN sum)) (PP (IN of) (NP (NP (DT the) (JJ individual) (NNS types)) (PP (IN of) (NP (NP (NN sediment)) (VP (VBN identified) (PP (IN on) (NP (NN urine) (NN microscopy)))))))))) (. .)))
15696449	9	(ROOT (S (PP (IN Of) (NP (NP (DT the) (CD 80) (NNS patients)) (VP (VBN studied)))) (, ,) (NP (NNS Doc_15696449_1102_1105_Disease)) (VP (VBD developed) (PP (IN in) (NP (NP (CD 18.8) (NN %)) (PP (IN of) (NP (DT the) (NNS patients))))) (PP (IN after) (NP (JJ high-dose) (NN melphalan)))) (. .)))
15696449	10	(ROOT (S (NP (JJ Univariate) (NN analysis)) (VP (VBD identified) (NP (NP (NN age)) (, ,) (NP (NNS Doc_15696449_1204_1219_Disease)) (, ,) (NP (JJ heavy) (NNS Doc_15696449_1227_1238_Disease)) (, ,) (NP (JJ diuretic) (NN use)) (, ,) (CC and) (NP (NN urine) (NN sediment) (NN score))) (PRN (-LRB- -LRB-) (ADJP (QP (CD >) (CD 3))) (-RRB- -RRB-)) (PP (IN as) (NP (NN risk) (NNS factors)))) (. .)))
15696449	11	(ROOT (S (NP (NP (NNP Age)) (CC and) (NP (NN urine) (NN sediment) (NN score))) (VP (VBD remained) (ADVP (RB independently)) (NP (NP (JJ significant) (NN risk) (NNS factors)) (PP (IN in) (NP (DT the) (JJ multivariate) (NN analysis))))) (. .)))
15696449	12	(ROOT (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN Doc_15696449_1425_1428_Disease) (PP (IN after) (NP (JJ high-dose) (NN melphalan)))))))) (VP (VP (VBD underwent) (NP (NN dialysis)) (ADVP (ADVP (RBR more) (RB often)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.007))) (-RRB- -RRB-)))) (, ,) (CC and) (VP (VBD had) (NP (NP (DT a) (ADJP (JJR worse) (JJ 1-year)) (NN survival)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP =) (NNP 0.03)) (-RRB- -RRB-))))) (. .)))
15696449	13	(ROOT (S (NP (NP (DT The) (NN timing)) (PP (IN of) (NP (NNS Doc_15696449_1568_1580_Disease)))) (ADVP (RB strongly)) (VP (VBZ suggests) (NP (NN melphalan)) (PP (IN as) (NP (DT the) (JJ causative) (NN agent)))) (. .)))
15696449	14	(ROOT (S (NP (VBG Ongoing) (NNS Doc_15696449_1641_1655_Disease)) (VP (MD may) (VP (VB be) (NP (NP (DT a) (NN prerequisite)) (PP (IN for) (NP (NP (NNS Doc_15696449_1682_1694_Disease)) (PP (IN by) (NP (NN melphalan)))))) (SBAR (IN as) (S (VP (VBN evidenced) (PP (IN by) (NP (DT the) (JJ active) (NN urinary) (NN sediment)))))))) (. .)))
15696449	15	(ROOT (S (NP (NP (NNP Development)) (PP (IN of) (NP (NNS Doc_15696449_1768_1771_Disease)))) (ADVP (RB adversely)) (VP (VBD affected) (NP (DT the) (NN outcome)) (PP (IN after) (NP (NNP PBSCT)))) (. .)))
15696449	16	(ROOT (S (NP (JJ Effective) (NN preventive) (NNS measures)) (VP (MD may) (VP (VB help) (VP (VB decrease) (NP (NP (DT the) (NN treatment) (NN mortality)) (PP (IN of) (NP (NNP PBSCT)))) (PP (IN in) (NP (JJ Doc_15696449_1900_1902_Disease) (NNS patients)))))) (. .)))
15815446	0	(ROOT (NP (NP (NP (JJ Focal) (NNS Doc_15815446_6_23_Disease)) (PP (IN in) (NP (NNS rats)))) (: :) (NP (NP (NN effect)) (PP (IN of) (NP (NP (NN Doc_15815446_43_56_Chemical-induced) (NNS Doc_15815446_65_77_Disease)) (PP (IN during) (NP (NN reperfusion)))))) (. .)))
15815446	1	(ROOT (S (PP (IN After) (NP (NP (CD 180) (NN min)) (PP (IN of) (NP (NP (NNS Doc_15815446_115_157_Disease)) (PP (IN in) (NP (JJ spontaneously) (JJ Doc_15815446_175_187_Disease) (NNS rats))))))) (, ,) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NN Doc_15815446_208_221_Chemical-induced) (NNS Doc_15815446_230_242_Disease)) (PP (IN on) (NP (NP (NNS Doc_15815446_246_267_Disease)) (CC and) (NP (JJ blood-brain) (NN barrier) (NN permeability))))))) (VP (VBD was) (VP (VBN determined))) (. .)))
15815446	2	(ROOT (S (NP (NN Blood) (NN pressure)) (VP (VBD was) (VP (VBN manipulated) (PP (IN by) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (JJ following) (NNS schedules))))) (PP (IN during) (NP (NP (NP (NP (CD 120) (NN min)) (PP (IN of) (NP (NN reperfusion)))) (: :) (NP (NP (NNP Control)) (, ,) (NP (JJ normotensive) (NN reperfusion))) (: ;) (NP (NP (JJ 90/Doc) (JJ _) (NNS 15815446_455_467_Disease)) (PRN (-LRB- -LRB-) (NP (CD 90/HTN)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN blood) (NN pressure)) (SBAR (S (VP (VBD was) (VP (VBN increased) (PP (IN by) (NP (CD 35) (NN mm) (NNP Hg))) (PP (IN during) (NP (NP (DT the) (JJ initial) (CD 90) (NN min)) (PP (IN of) (NP (NN reperfusion) (RB only)))))))))) (: ;) (NP (NP (JJ 15/Doc) (VBG _) (NNS 15815446_569_581_Disease)) (PRN (-LRB- -LRB-) (NP (CD 15/HTN)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ normotensive) (NN reperfusion)) (PP (IN for) (NP (NP (CD 30) (NN min)) (VP (VBN followed) (PP (IN by) (NP (NP (NP (CD 15) (NN min)) (PP (IN of) (NP (NNS Doc_15815446_650_662_Disease)))) (CC and) (NP (NP (CD 75) (NN min)) (PP (IN of) (NP (NN normotension)))))))))))))) (. .)))
15815446	3	(ROOT (S (NP (NP (NNP Part) (NNP A)) (, ,) (PP (IN for) (NP (NP (CD eight) (NNS rats)) (PP (IN in) (NP (DT each) (NN group) (NNS Doc_15815446_728_740_Disease)))))) (VP (VBD was) (VP (VBN evaluated) (PP (IN by) (S (VP (VBG staining) (NP (NN tissue)) (S (VP (VBG using) (SBAR (S (NP (NNS Doc_15815446_780_815_Chemical) (CC and) (NNS Doc_15815446_820_825_Disease)) (VP (VBD was) (VP (VBN evaluated) (PP (IN by) (NP (NN microgravimetry)))))))))))))) (. .)))
15815446	4	(ROOT (S (NP (NP (NNP Part) (NNP B)) (, ,) (PP (IN for) (NP (NP (CD eight) (JJ different) (NNS rats)) (PP (IN in) (NP (DT each) (NN group) (NN blood-brain) (NN barrier)))))) (ADVP (RB permeability)) (VP (VBD was) (VP (VBN evaluated) (PP (IN by) (S (VP (VBG measuring) (NP (NP (DT the) (NN amount) (CC and) (NN extent)) (PP (IN of) (NP (NP (NN extravasation)) (PP (IN of) (NP (NNP Evans) (NNP Blue) (NNP dye))))))))))) (. .)))
15815446	5	(ROOT (S (NP (NP (NNP Doc_15815446_1025_1037_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN percentage)) (PP (IN of) (NP (DT the) (JJ ischemic) (NN hemisphere)))) (-RRB- -RRB-))) (VP (VBD was) (ADJP (JJR less)) (PP (IN in) (NP (NP (NP (DT the) (CD 15/HTN) (NN group)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (CD 16)) (NP (NNP +) (NNP /))) (: -) (NP (NP (CD 6)) (, ,) (NP (JJ mean) (JJ +) (NNS /)) (: -) (NP (NNP SD)))) (-RRB- -RRB-))) (PP (IN versus) (NP (NP (NP (DT the) (CD 90/HTN) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 30) (NNP +) (NNS /)) (, -) (NP (CD 6)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (PP (PP (IN in) (NP (NN turn))) (CC less) (PP (IN than) (NP (DT the) (NN control) (NN group))))))))) (PRN (-LRB- -LRB-) (NP (CD 42) (NNP +) (NNS /)) (, -) (NP (CD 5)) (-RRB- -RRB-))))) (. .)))
15815446	6	(ROOT (S (NP (JJ Specific) (NN gravity)) (VP (VBD was) (NP (ADJP (JJR greater) (PP (IN in) (NP (NP (NP (DT the) (CD 15/HTN) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 1.043) (NNP +) (NNS /)) (, -) (NP (CD 0.002)) (-RRB- -RRB-))) (PP (IN versus) (NP (NP (DT the) (CD 90/HTN)) (PRN (-LRB- -LRB-) (NP (CD 1.036) (NNP +) (NNS /)) (, -) (NP (CD 0.003)) (-RRB- -RRB-)) (CC and) (NP (NN control)) (PRN (-LRB- -LRB-) (NP (CD 1.037) (NNP +) (NNS /)) (, -) (NP (CD 0.003)) (-RRB- -RRB-))))))) (NNS groups))) (. .)))
15815446	7	(ROOT (S (NP (NP (NNP Doc_15815446_1366_1376_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NN mug) (NN g-1)) (PP (IN of) (NP (NN brain) (NN tissue)))) (-RRB- -RRB-))) (VP (VBD was) (ADJP (JJR greater)) (PP (IN in) (NP (NP (NP (DT the) (CD 90/HTN) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 24.4) (NNP +) (NNS /)) (, -) (NP (CD 6.0)) (-RRB- -RRB-))) (PP (IN versus) (NP (NP (NP (DT the) (NN control) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 12.3) (NNP +) (NNS /)) (, -) (NP (CD 4.1)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (PP (IN in) (NP (NN turn))) (ADJP (ADJP (JJR greater)) (PP (IN than) (NP (DT the) (CD 15/HTN) (NN group))))))))) (PRN (-LRB- -LRB-) (NP (CD 7.3) (NNP +) (NNS /)) (, -) (NP (CD 3.2)) (-RRB- -RRB-))))) (. .)))
15815446	8	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ supports) (NP (DT a) (NNS hypothesis)) (SBAR (SBAR (IN that) (S (PP (IN during) (NP (NN reperfusion))) (, ,) (NP (NP (DT a) (JJ short) (NN interval)) (PP (IN of) (NP (NNS Doc_15815446_1632_1644_Disease)))) (VP (VBZ decreases) (NP (NNS Doc_15815446_1655_1667_Disease) (CC and) (NNS Doc_15815446_1672_1677_Disease))))) (: ;) (CC and) (SBAR (IN that) (S (NP (JJ sustained) (NNS Doc_15815446_1698_1710_Disease)) (VP (VBZ increases) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ vasogenic) (NNS Doc_15815446_1743_1748_Disease))))))))) (. .)))
15817013	0	(ROOT (NP (NP (NP (NNS People)) (VP (VBN aged) (PP (IN over) (NP (CD 75))) (PP (IN in) (NP (NP (NNS Doc_15817013_23_42_Disease)) (PP (IN on) (NP (NNS Doc_15817013_46_54_Chemical))))))) (: :) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (JJ major) (NNS Doc_15817013_74_84_Disease) (CC and) (NNS Doc_15817013_89_95_Disease)) (PP (IN in) (NP (NP (QP (JJR more) (IN than) (CD 500)) (NNS patient-years)) (PP (IN of) (NP (NN follow-up)))))))) (. .)))
15817013	1	(ROOT (S (S (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ major) (NNS Doc_15817013_189_199_Disease) (CC and) (NNS Doc_15817013_204_210_Disease)))) (PP (IN in) (NP (NP (NNS people)) (VP (VBN aged) (NP (CD 76)))))))) (CC and) (S (ADJP (JJR older) (PP (IN with) (NP (NP (NNS Doc_15817013_244_263_Disease)) (PP (IN on) (NP (JJ adjusted-dose) (NNS Doc_15817013_281_289_Chemical))) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN been) (ADVP (RB recently)) (VP (VBN been) (VP (VBN admitted) (PP (TO to) (NP (NN hospital))))))))))))) (. .)))
15817013	2	(ROOT (S (NP (DT A) (ADJP (JJ retrospective) (JJ observational)) (NN cohort)) (VP (VBP study)) (. .)))
15817013	3	(ROOT (NP (NP (DT A) (JJ major) (NN healthcare) (NN network)) (VP (VBG involving) (NP (CD four) (JJ tertiary) (NNS hospitals))) (. .)))
15817013	4	(ROOT (S (S (NP (NP (CD Two) (CD hundred) (JJ thirty-five) (NNS patients)) (VP (VBN aged) (UCP (NP (CD 76)) (CC and) (ADJP (JJR older))))) (VP (VBD admitted) (PP (TO to) (NP (NP (DT a) (JJ major) (NN healthcare) (NN network)) (PP (IN between) (NP (NNP July) (CD 1) (, ,) (CD 2001))))))) (, ,) (CC and) (S (NP (NP (NNP June) (CD 30) (, ,) (CD 2002) (, ,)) (PP (IN with) (NP (NP (NNS Doc_15817013_612_631_Disease)) (PP (IN on) (NP (NNS Doc_15817013_635_643_Chemical)))))) (VP (VBD were) (VP (VBN enrolled)))) (. .)))
15817013	5	(ROOT (S (NP (NP (NNP Information)) (PP (VBG regarding) (NP (NP (JJ major) (JJ Doc_15817013_701_709_Disease) (NNS episodes)) (, ,) (NP (NNS Doc_15817013_720_727_Disease)) (, ,) (CC and) (NP (JJ Doc_15817013_733_741_Chemical) (NN use))))) (VP (VBD was) (VP (VBN obtained) (PP (IN from) (NP (NP (NNS patients)) (, ,) (NP (NNS relatives)) (, ,) (NP (JJ primary) (NNS physicians)) (, ,) (CC and) (NP (JJ medical) (NNS records)))))) (. .)))
15817013	6	(ROOT (S (NP (NP (NP (NP (CD Two) (CD hundred) (JJ twenty-eight) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 42) (NN %)) (NP (NNS men))) (-RRB- -RRB-))) (PP (IN with) (NP (NP (DT a) (JJ mean) (NN age)) (PP (IN of) (NP (CD 81.1)))))) (PRN (-LRB- -LRB-) (NP (NN range) (CD 76-94)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN included) (PP (IN in) (NP (DT the) (NN analysis))))) (. .)))
15817013	7	(ROOT (S (NP (NP (JJ Total) (NN follow-up)) (PP (IN on) (NP (NNS Doc_15817013_967_975_Chemical)))) (VP (VBD was) (NP (NP (JJ 530) (NNS years)) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (CD 28) (NNS months)))) (-RRB- -RRB-)))) (. .)))
15817013	8	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (CD 53) (JJ major) (NNS Doc_15817013_1028_1039_Disease)) (, ,) (PP (IN for) (NP (NP (DT an) (JJ annual) (NN rate)) (PP (IN of) (NP (CD 10.0) (NN %))))) (, ,) (PP (VBG including) (NP (NP (NP (NP (CD 24)) (PRN (-LRB- -LRB-) (NP (CD 45.3) (NN %)) (-RRB- -RRB-))) (ADJP (JJ life-threatening))) (CC and) (NP (NP (CD five)) (PRN (-LRB- -LRB-) (NP (CD 9.4) (NN %)) (-RRB- -RRB-)) (NP (JJ fatal) (NNS Doc_15817013_1130_1136_Disease)))))) (. .)))
15817013	9	(ROOT (S (NP (NP (DT The) (JJ Doc_15817013_1142_1155_Disease) (NN rate)) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NNS Doc_15817013_1181_1189_Chemical)))))) (VP (VBD was) (NP (CD 2.6) (NN %))) (. .)))
15817013	10	(ROOT (S (S (NP (NP (DT The) (NN rate)) (PP (IN of) (NP (JJ major) (NNS Doc_15817013_1230_1240_Disease)))) (VP (VBD was) (UCP (ADJP (JJ high) (PP (IN in) (NP (DT this) (JJ old) (, ,) (JJ frail) (NN group)))) (, ,) (CC but) (PP (VBG excluding) (NP (NP (NNS fatalities)) (, ,) (VP (VBN resulted) (PP (IN in) (NP (DT no) (JJ long-term) (NN sequelae))))))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ Doc_15817013_1345_1351_Disease) (NN rate)) (PP (IN on) (NP (NNS Doc_15817013_1360_1368_Chemical)))) (VP (VBD was) (ADJP (JJ low)) (, ,) (S (VP (VBG demonstrating) (SBAR (WHADVP (WRB how)) (S (NP (JJ effective) (JJ Doc_15817013_1406_1414_Chemical) (NN treatment)) (VP (VBZ is)))))))) (. .)))
15859361	0	(ROOT (S (NP (NP (NNP Safety)) (PP (IN of) (NP (NP (NNS Doc_15859361_10_19_Chemical)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ adverse) (NN skin) (NNS reactions)) (PP (TO to) (NP (NP (NP (NNS Doc_15859361_63_76_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15859361_78_89_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NNS Doc_15859361_95_105_Chemical))))))))))) (VP (VBN associated) (NP (QP (CC or) (RB not))) (PP (IN with) (NP (JJ common) (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)))) (. .)))
15859361	1	(ROOT (S (NP (NP (NP (NNP Doc_15859361_187_200_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_15859361_202_213_Chemical)) (: --) (NP (NNS Doc_15859361_215_216_Chemical))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_15859361_222_232_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15859361_234_235_Chemical)) (-RRB- -RRB-)))) (VP (VBP are) (ADVP (RB widely)) (VP (VBN used) (NP (JJ analgesic-antipyretic/anti-inflammatory) (NNS drugs)))) (. .)))
15859361	2	(ROOT (S (NP (NP (DT The) (NN rate)) (PP (IN of) (NP (NP (JJ adverse) (JJ Doc_15859361_320_336_Disease) (NNS reactions)) (PP (TO to) (NP (DT these) (NNS agents)))))) (VP (VBZ is) (ADJP (RB generally) (JJ low))) (. .)))
15859361	3	(ROOT (S (PP (IN On) (NP (DT the) (NN contrary))) (NP (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNP NSAIDs)) (-RRB- -RRB-))) (VP (VBP are) (ADVP (RB commonly)) (VP (VBN involved) (PP (IN in) (NP (JJ such) (NNS reactions))))) (. .)))
15859361	4	(ROOT (S (NP (NP (NNP Doc_15859361_485_494_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CE)) (-RRB- -RRB-))) (VP (VBZ is) (NP (DT a) (NN novel) (NN drug)) (, ,) (PP (IN with) (NP (NP (JJ high) (NN selectivity) (CC and) (NN affinity)) (PP (IN for) (NP (NN COX-2) (NN enzyme)))))) (. .)))
15859361	5	(ROOT (S (NP (PRP We)) (VP (VBN evaluated) (NP (NP (DT the) (NN tolerability)) (PP (IN of) (NP (NNP CE)))) (PP (IN in) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (VBN documented) (NN history)) (PP (IN of) (NP (NP (JJ adverse) (NNS cutaneous) (NNS reactions)) (PP (PP (TO to) (NP (NNP P) (CC and) (NNP Doc_15859361_704_705_Chemical) (JJ associated))) (CC or) (RB not) (PP (TO to) (NP (JJ classic) (NNS NSAIDs))))))))))))) (. .)))
15859361	6	(ROOT (S (NP (PRP We)) (VP (VBD studied) (NP (CD 9) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_15859361_779_795_Disease)) (PP (TO to) (NP (NNP P) (CC and) (NNP Doc_15859361_805_806_Chemical))))) (PP (IN with) (CC or) (IN without) (NP (JJ associated) (NNS reactions))) (PP (TO to) (NP (JJ classic) (NNS NSAIDs)))) (. .)))
15859361	7	(ROOT (S (NP (NP (DT The) (NN diagnosis)) (PP (IN of) (NP (NN P) (CC and) (NN Doc_15859361_886_887_Chemical-induced) (NN skin) (NNS reactions)))) (VP (VBD was) (VP (VBN based) (PP (IN in) (NP (NN vivo) (NN challenge))))) (. .)))
15859361	8	(ROOT (S (NP (DT The) (NN placebo)) (VP (VBD was) (ADVP (RB blindly)) (VP (VBN administered) (PP (IN at) (NP (NP (DT the) (NN beginning)) (PP (IN of) (NP (DT each) (NN challenge))))))) (. .)))
15859361	9	(ROOT (S (PP (IN After) (NP (CD three) (NNS days))) (, ,) (NP (NP (DT a) (JJ cumulative) (NN dosage)) (PP (IN of) (NP (NP (CD 200) (NN mg)) (PP (IN of) (NP (NP (NNP CE)) (PP (IN in) (NP (JJ refracted) (NNS doses)))))))) (VP (VBD were) (VP (VBN given))) (. .)))
15859361	10	(ROOT (S (PP (IN After) (NP (CD 2-3) (NNS days))) (, ,) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (CD 200) (NN mg)))) (VP (VBD was) (VP (VBN administered))) (. .)))
15859361	11	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD were) (VP (VP (VBN observed) (PP (IN for) (NP (CD 6) (NNS hours))) (PP (IN after) (NP (DT each) (NN challenge)))) (, ,) (CC and) (VP (VBN controlled) (ADVP (RB again)) (PP (IN after) (NP (CD 24) (NNS hours))) (S (VP (TO to) (VP (VB exclude) (NP (JJ delayed) (NNS reactions)))))))) (. .)))
15859361	12	(ROOT (S (NP (DT The) (NN challenge)) (VP (VBD was) (VP (VBN considered) (ADJP (JJ positive)) (SBAR (IN if) (S (NP (NP (QP (CD one) (CC or) (JJR more))) (PP (IN of) (NP (DT the) (NN following)))) (VP (VP (VBD appeared)) (: :) (NP (NP (NN erythema)) (, ,) (NP (NN rush)) (CC or) (NP (NNS Doc_15859361_1381_1390_Disease-Doc_15859361_1391_1401_Disease)))))))) (. .)))
15859361	13	(ROOT (S (S (NP (DT No) (NN reaction)) (VP (VBD was) (VP (VBN observed) (PP (IN with) (NP (NN placebo)))))) (CC and) (S (NP (NP (CD eight) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 88.8) (NN %)) (-RRB- -RRB-))) (VP (VBD tolerated) (NP (NNP CE)))) (. .)))
15859361	14	(ROOT (S (NP (RB Only) (CD one) (NN patient)) (VP (VBD developed) (NP (NP (DT a) (JJ moderate) (NNS Doc_15859361_1529_1539_Disease)) (PP (IN of) (NP (DT the) (NNS lips))))) (. .)))
15859361	15	(ROOT (S (NP (NP (RB Only) (CD one) (JJ Doc_15859361_1574_1590_Disease) (NN reaction)) (PP (TO to) (NP (NNP CE)))) (VP (VBD was) (VP (VBN documented) (PP (IN among) (NP (NP (CD 9) (NN P)) (CC and) (NP (JJ Doc_15859361_1635_1636_Chemical-highly) (NNP NSAIDs) (NN intolerant) (NNS patients)))))) (. .)))
15859361	16	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (PRP we)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NNP CE)) (VP (VBZ is) (NP (DT a) (ADJP (RB reasonably) (JJ safe)) (NN alternative) (S (VP (TO to) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBP do) (RB not) (VP (VB tolerate) (NP (NNP P) (CC and) (NNP Doc_15859361_1780_1781_Chemical))))))))))))))))) (. .)))
15882284	0	(ROOT (NP (NP (JJ Case-control) (NN study)) (PP (IN of) (NP (NP (JJ regular) (NNS analgesic)) (CC and) (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NN use)) (CC and) (NP (NNS Doc_15882284_83_106_Disease))))) (. .)))
15882284	1	(ROOT (S (NP (NP (NNS Studies)) (PP (IN on) (NP (NP (DT the) (NN association)) (PP (IN between) (NP (NP (NP (DT the) (JJ long-term) (NN use)) (PP (IN of) (NP (JJ Doc_15882284_176_183_Chemical) (CC and) (JJ other) (NNS analgesic)))) (CC and) (NP (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNP NSAIDs)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_15882284_258_281_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15882284_283_287_Disease)) (-RRB- -RRB-))))))))) (VP (VBP have) (VP (VBN given) (NP (JJ conflicting) (NNS results)))) (. .)))
15882284	2	(ROOT (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB examine) (NP (DT this) (NN association)))))) (, ,) (NP (NP (DT a) (JJ case-control) (NN study)) (PP (IN with) (NP (NP (NN incident) (NNS cases)) (PP (IN of) (NP (NNS Doc_15882284_403_407_Disease)))))) (VP (VBD was) (VP (VBN carried) (PRT (RP out)))) (. .)))
15882284	3	(ROOT (S (NP (DT The) (NNS cases)) (VP (VBD were) (NP (NP (DT all) (NNS patients)) (VP (VBG entering) (NP (NP (DT the) (JJ local) (NN dialysis) (NN program)) (PP (RB because) (IN of) (NP (NP (NNS Doc_15882284_509_513_Disease)) (PP (IN in) (NP (NP (DT the) (NN study) (NN area)) (PP (IN between) (NP (NP (NNP June) (CD 1) (, ,) (CD 1995)) (CC and) (NP (NNP November) (CD 30) (, ,) (CD 1997)))))))))))) (. .)))
15882284	4	(ROOT (S (NP (PRP They)) (VP (VBD were) (VP (VBN classified) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (VBG underlying) (NN disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD had) (ADVP (RB presumably)) (VP (VBN led) (NP (PRP them)) (PP (TO to) (NP (NNS Doc_15882284_667_671_Disease)))))))))))) (. .)))
15882284	5	(ROOT (S (NP (NNS Controls)) (VP (VBD were) (NP (NP (NNS patients)) (VP (VBN admitted) (PP (TO to) (NP (DT the) (JJ same) (NNS hospitals))) (PP (IN from) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NNS cases)) (VP (VBD arose)))))) (, ,) (VP (ADVP (RB also)) (VBN matched) (PP (IN by) (NP (NN age) (CC and) (NN sex)))))) (. .)))
15882284	6	(ROOT (S (NP (NNS Odds) (NNS ratios)) (VP (VBD were) (VP (VBN calculated) (S (VP (VBG using) (NP (DT a) (JJ conditional) (JJ logistic) (NN model)))) (, ,) (PP (VBG including) (NP (NP (JJ potential) (VBG confounding) (NNS factors)) (, ,) (PP (DT both) (PP (IN for) (NP (DT the) (JJ whole) (NN study) (NN population))) (CC and) (PP (IN for) (NP (DT the) (JJ various) (VBG underlying) (NNS diseases)))))))) (. .)))
15882284	7	(ROOT (S (NP (NP (CD Five) (CD hundred)) (CC and) (NP (NP (JJ eighty-three) (NNS cases)) (CC and) (NP (CD 1190) (NNS controls)))) (VP (VBD were) (VP (VBN included) (PP (IN in) (NP (DT the) (NN analysis))))) (. .)))
15882284	8	(ROOT (S (NP (NP (JJ Long-term) (NN use)) (PP (IN of) (NP (DT any) (JJ analgesic)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (JJ overall) (NNS odds) (NN ratio)) (PP (IN of) (NP (NP (CD 1.22)) (PRN (-LRB- -LRB-) (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (, ,) (NP (CD 0.89-1) (CD .66))) (-RRB- -RRB-)))))))) (. .)))
15882284	9	(ROOT (S (PP (IN For) (NP (NP (JJ specific) (NNS groups)) (PP (IN of) (NP (NNS drugs))))) (, ,) (NP (DT the) (NNS risks)) (VP (VBD were) (NP (NP (NP (NP (CD 1.56)) (PRN (-LRB- -LRB-) (NP (QP (CD 1.05-2) (CD .30))) (-RRB- -RRB-))) (PP (IN for) (NP (NNS Doc_15882284_1228_1235_Chemical)))) (, ,) (NP (NP (NP (CD 1.03)) (PRN (-LRB- -LRB-) (NP (QP (CD 0.60-1) (CD .76))) (-RRB- -RRB-))) (PP (IN for) (NP (NNS Doc_15882284_1258_1269_Chemical)))) (, ,) (NP (NP (NP (CD 0.80)) (PRN (-LRB- -LRB-) (NP (QP (CD 0.39-1) (CD .63))) (-RRB- -RRB-))) (PP (IN for) (NP (NNS Doc_15882284_1292_1303_Chemical)))) (, ,) (CC and) (NP (NP (NP (CD 0.94)) (PRN (-LRB- -LRB-) (NP (QP (CD 0.57-1) (CD .56))) (-RRB- -RRB-))) (PP (IN for) (NP (NNP Doc_15882284_1330_1340_Chemical) (NNPS NSAIDs)))))) (. .)))
15882284	10	(ROOT (S (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_15882284_1361_1365_Disease)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_15882284_1382_1389_Chemical))))))) (VP (VBD was) (VP (VBN related) (PP (TO to) (NP (NP (DT the) (JJ cumulated) (NN dose) (CC and) (NN duration)) (PP (IN of) (NP (NN use)))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBD was) (ADJP (RB particularly) (JJ high) (PP (IN among) (NP (NP (DT the) (NN subset)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN vascular) (NNS Doc_15882284_1517_1528_Disease)))))))) (PP (IN as) (NP (NP (VBG underlying) (NN disease)) (VP (VBG -LSB-) (NP (JJ 2.35) (PRN (-LRB- -LRB-) (NP (QP (CD 1.17-4) (CD .72))) (-RRB- -RRB-)) (NNS -RSB-))))))) (. .)))
15882284	11	(ROOT (S (NP (PRP$ Our) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ long-term) (NN use)) (PP (IN of) (NP (NP (JJ Doc_15882284_1623_1633_Chemical) (JJ analgesic) (NNS drugs)) (CC and) (NP (NNP NSAIDs))))) (VP (VBZ is) (RB not) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (NNS Doc_15882284_1705_1709_Disease)))))))))) (. .)))
15882284	12	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ chronic) (NN use)) (PP (IN of) (NP (NNS Doc_15882284_1739_1746_Chemical)))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_15882284_1772_1776_Disease)))))) (. .)))
15953230	0	(ROOT (NP (NP (NP (CD Two) (NNS cases)) (PP (IN of) (NP (JJ Doc_15953230_13_24_Chemical) (NNS Doc_15953230_25_33_Disease)))) (: :) (NP (NP (DT a) (NN cause)) (PP (IN for) (NP (NNS Doc_15953230_47_68_Disease)))) (. .)))
15953230	1	(ROOT (S (NP (NP (CD Two) (NNS cases)) (PP (IN of) (NP (NP (NP (ADJP (JJ deliberate)) (NN self-poisoning)) (PP (IN with) (NP (CD 5) (NN g)))) (CC and) (NP (NP (CD 3.6) (NN g)) (PP (IN of) (NP (NNS Doc_15953230_131_142_Chemical))))))) (, ,) (ADVP (RB respectively)) (, ,) (VP (VBP are) (VP (VBN reported))) (. .)))
15953230	2	(ROOT (S (PP (IN In) (NP (DT both) (NNS cases))) (, ,) (NP (NNS Doc_15953230_187_202_Disease) (CC and) (NNS hypocalcaemia)) (VP (VBD were) (VP (VBN noted))) (. .)))
15953230	3	(ROOT (S (NP (DT The) (NNS Doc_15953230_237_252_Disease)) (VP (VBD appeared) (S (VP (TO to) (VP (VB respond) (PP (TO to) (NP (NP (NN administration)) (PP (IN of) (NP (NN i.v.) (NNS Doc_15953230_299_316_Chemical))))))))) (. .)))
15987266	0	(ROOT (S (NP (NP (JJ Growth-associated) (NN protein) (NN 43) (NN expression)) (PP (IN in) (NP (NP (JJ hippocampal) (JJ molecular) (NN layer)) (PP (IN of) (NP (JJ chronic) (JJ Doc_15987266_82_91_Disease) (NNS rats)))))) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_15987266_110_123_Chemical)))) (. .)))
15987266	1	(ROOT (S (NP (NNP GAP43)) (VP (VBZ has) (VP (VBN been) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (VP (VBN linked) (PP (IN with) (NP (NP (NP (NNS Doc_15987266_175_196_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15987266_198_201_Disease)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (JJ various) (JJ experimental) (NNS models)) (PP (IN of) (NP (NNS Doc_15987266_237_245_Disease)))))))))))))) (. .)))
15987266	2	(ROOT (S (S (VP (TO To) (VP (VB investigate) (SBAR (WHADVP (WRB how)) (S (NP (NP (CD GAP43) (NN expression)) (PRN (-LRB- -LRB-) (NP (NNP GAP43-ir)) (-RRB- -RRB-))) (VP (VBZ correlates) (PP (IN with) (NP (NNS Doc_15987266_310_313_Disease))))))))) (, ,) (NP (PRP we)) (VP (VBD assessed) (NP (NP (NP (DT the) (NN intensity)) (PRN (-LRB- -LRB-) (NP (NN densitometry)) (-RRB- -RRB-))) (CC and) (NP (NP (NN extension)) (PRN (-LRB- -LRB-) (NP (NNP width)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS GAP43-ir)) (PP (IN in) (NP (DT the) (JJ inner) (JJ molecular) (NN layer))))) (PP (IN of) (NP (NP (NP (DT the) (JJ dentate) (NNS gyrus)) (PRN (-LRB- -LRB-) (NP (NNP IML)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS rats)) (UCP (ADJP (JJ subject) (PP (TO to) (NP (NP (NNS Doc_15987266_465_483_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_15987266_495_506_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Pilo)) (-RRB- -RRB-)))))))) (, ,) (VP (ADVP (RB previously)) (VBN injected)) (CC or) (PP (RB not) (IN with) (NP (NNS Doc_15987266_547_560_Chemical)))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_15987266_562_565_Chemical)) (-RRB- -RRB-)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB inhibit) (NP (NNS Doc_15987266_600_603_Disease)))))))))))) (. .)))
15987266	3	(ROOT (S (NP (NNP Doc_15987266_614_617_Chemical)) (VP (VBD was) (VP (VBN injected) (PP (IN before) (NP (DT the) (NNP Pilo) (NN injection))) (PP (IN in) (NP (JJ adult) (NNP Wistar) (NNS rats))))) (. .)))
15987266	4	(ROOT (S (NP (DT The) (NNP Pilo) (NN group)) (VP (VBD was) (VP (VBN injected) (PP (IN with) (NP (DT the) (JJ same) (NNS drugs))) (, ,) (PP (IN except) (PP (IN for) (NP (NNS Doc_15987266_739_742_Chemical)))))) (. .)))
15987266	5	(ROOT (S (S (NP (NNS Animals)) (VP (VBD were) (VP (VBN killed) (ADVP (NP (QP (IN between) (CD 30) (CC and) (CD 60)) (NNS days)) (RB later))))) (, ,) (CC and) (S (NP (NN brain) (NNS sections)) (VP (VBD were) (VP (VBN processed) (PP (IN for) (NP (NN GAP43) (NN immunohistochemistry)))))) (. .)))
15987266	6	(ROOT (S (NP (NNP Densitometry)) (VP (VBD showed) (NP (NP (DT no) (JJ significant) (NN difference)) (PP (VBG regarding) (NP (NP (NNS GAP43-ir)) (PP (IN in) (NP (NP (DT the) (NNP IML)) (PP (IN between) (NP (NP (NNP Pilo)) (, ,) (NP (NNP Doc_15987266_959_962_Chemical) (NNP +) (NNP Pilo)) (, ,) (CC and) (NP (NN control) (NNS groups)))))))))) (. .)))
15987266	7	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NP (DT the) (NN width)) (PP (IN of) (NP (NP (DT the) (NN GAP43-ir) (NN band)) (PP (IN in) (NP (DT the) (NNP IML)))))))) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NNP Doc_15987266_1067_1070_Chemical) (NNP +) (NNP Pilo)) (CC and) (NP (NN control) (NNS animals))) (VP (VBD had) (NP (NP (NP (DT a) (ADJP (RB significantly) (JJR larger)) (NN band)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.03))))) (-RRB- -RRB-))) (PP (IN as) (PP (VBN compared) (PP (IN with) (NP (NP (DT that)) (PP (IN in) (NP (DT the) (NNP Pilo) (NN group)))))))))))) (. .)))
15987266	8	(ROOT (S (NP (NP (PRP$ Our) (JJ current) (NN finding)) (SBAR (WHNP (WHNP (WDT that) (NNS animals)) (PP (IN in) (NP (DT the) (JJ Doc_15987266_1233_1236_Chemical) (NNP +) (NNP Pilo) (NN group)))) (S (VP (VBP have) (NP (NP (NP (DT a) (NN GAP43-ir) (NN band)) (PP (IN in) (NP (DT the) (NNP IML)))) (, ,) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NNS controls)))))) (, ,)))))) (VP (VBZ reinforces) (NP (JJ prior) (NNS data)) (PP (IN on) (NP (NP (DT the) (NN blockade)) (PP (IN of) (NP (NP (NNS Doc_15987266_1351_1354_Disease)) (PP (IN in) (NP (DT these) (NNS animals)))))))) (. .)))
15987266	9	(ROOT (S (NP (NP (DT The) (NN change)) (PP (IN in) (NP (NP (NN GAP43-ir) (NN present)) (PP (IN in) (NP (JJ Pilo-treated) (NNS animals)))))) (VP (VBD was) (NP (NP (DT a) (NN thinning)) (PP (IN of) (NP (NP (DT the) (NN band)) (PP (TO to) (NP (NP (DT a) (ADJP (RB very) (JJ narrow)) (NN layer) (RB just)) (PP (IN above) (NP (NP (DT the) (JJ granule) (NN cell) (NN layer)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN hilar) (NN cell) (NNS projections))) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (ADJP (JJ GAP-43))))))))))))))))))))))) (. .)))
15991002	0	(ROOT (FRAG (FRAG (ADVP (RB Doc_15991002_0_8_Chemical)) (NP (JJ antagonizes) (NNS Doc_15991002_21_29_Chemical))) (: -) (FRAG (CC but) (RB not) (NP (JJ Doc_15991002_39_57_Chemical-induced) (JJ anxiogenic) (NN effect)) (PP (IN in) (NP (NNS mice))) (. .))))
15991002	1	(ROOT (S (NP (NNS Doc_15991002_104_112_Chemical) (CC and) (NNS Doc_15991002_117_125_Chemical)) (VP (VBP are) (ADVP (RB widely)) (VP (VBN consumed) (NP (JJ licit) (NN psychoactive) (NNS drugs)) (ADVP (RB worldwide)))) (. .)))
15991002	2	(ROOT (S (NP (JJ Epidemiological) (NNS studies)) (VP (VBD showed) (SBAR (IN that) (S (NP (PRP they)) (VP (VBD were) (ADVP (RB generally)) (VP (VBN used) (ADVP (RB concurrently))))))) (. .)))
15991002	3	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT some) (NNS studies)) (PP (IN in) (NP (JJ experimental) (NNS animals)))) (VP (VBP indicate) (NP (NP (JJ clear) (JJ pharmacological) (NNS interactions)) (PP (IN between) (NP (PRP them))))))) (, ,) (NP (DT no) (NNS studies)) (VP (VBP have) (VP (VBN shown) (NP (DT a) (JJ specific) (NN interaction)) (PP (IN on) (NP (JJ Doc_15991002_409_416_Disease) (NNS responses))))) (. .)))
15991002	4	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ investigates) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_15991002_486_494_Chemical)) (PP (IN on) (NP (NP (NNS Doc_15991002_498_505_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_15991002_517_525_Chemical)) (CC and) (NP (NP (NP (DT another) (JJ anxiogenic) (NN drug)) (, ,) (NP (NNS Doc_15991002_555_573_Chemical)) (, ,)) (PP (IN in) (NP (NNS mice))))))))))))) (. .)))
15991002	5	(ROOT (S (NP (DT The) (JJ elevated) (NN plus-maze) (PRN (-LRB- -LRB-) (NP (NNP EPM)) (-RRB- -RRB-)) (NN test)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS drugs)) (PP (IN on) (NP (NNS Doc_15991002_663_670_Disease))))))))))) (. .)))
15991002	6	(ROOT (S (NP (NP (JJ Adult) (JJ male) (JJ Swiss) (NNP Webster) (NNS mice)) (PRN (-LRB- -LRB-) (NP (CD 25-32) (NNS g)) (-RRB- -RRB-))) (VP (VBD were) (NP (NP (NP (VBN given) (NNS Doc_15991002_732_740_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 0.05-0) (CD .25)) (NN mg/kg) (NN s.c.)) (-RRB- -RRB-))) (CC or) (NP (ADJP (JJ saline) (NP (NP (CD 10) (NN min)) (PP (IN before) (NP (NP (NNS Doc_15991002_788_796_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 70) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_15991002_816_834_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 15) (CC and) (CD 30)) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-)))))) (NNS injections)))) (. .)))
15991002	7	(ROOT (S (PP (IN After) (NP (CD 15) (NN min))) (, ,) (NP (NNS mice)) (VP (VBD were) (VP (VBN evaluated) (PP (IN for) (NP (NP (PRP$ their) (ADJP (JJ open) (: -) (CC and) (JJ closed-arm)) (NN time)) (CC and) (NP (NP (NNS entries)) (PP (IN on) (NP (DT the) (NNP EPM)))))) (PP (IN for) (NP (DT a) (JJ 10-min) (NN session))))) (. .)))
15991002	8	(ROOT (S (NP (JJ Locomotor) (NN activity)) (VP (VBD was) (VP (VBN recorded) (PP (IN for) (NP (JJ individual) (NNS groups))) (PP (IN by) (S (VP (VBG using) (NP (DT the) (JJ same) (NN treatment) (NN protocol)) (PP (IN with) (NP (DT the) (NNP EPM) (NN test)))))))) (. .)))
15991002	9	(ROOT (S (ADVP (RB Doc_15991002_1104_1112_Chemical)) (PRN (-LRB- -LRB-) (S (NP (CD 0.05-0) (CD .25)) (VP (VBG mg/kg))) (-RRB- -RRB-)) (NP (PRP itself)) (VP (VBD did) (RB not) (VP (VB produce) (NP (DT any) (JJ significant) (NN effect)) (PP (IN in) (NP (DT the) (NNP EPM) (NN test))) (, ,) (SBAR (IN whereas) (S (NP (NP (NP (NNS Doc_15991002_1202_1210_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 70) (NN mg/kg)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_15991002_1226_1244_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN mg/kg)) (-RRB- -RRB-)))) (VP (VBD produced) (NP (NP (DT an) (JJ anxiogenic) (NN effect)) (, ,) (ADJP (JJ apparent) (PP (IN with) (NP (NNS decreases))))) (PP (IN in) (NP (JJ open-arm) (NN time) (CC and) (NN entry)))))))) (. .)))
15991002	10	(ROOT (S (NP (NP (NNP Doc_15991002_1339_1347_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.25) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBP pretreatment) (S (VP (VP (VBG blocked) (NP (DT the) (NNS Doc_15991002_1386_1394_Chemical))) (: -) (CONJP (CC but) (RB not)) (VP (VBG Doc_15991002_1404_1422_Chemical-induced) (NP (NNS Doc_15991002_1431_1438_Disease)))))) (. .)))
15991002	11	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NP (DT each) (NN drug)) (CC and) (NP (PRP$ their) (NNS combinations))))) (VP (VBD did) (RB not) (VP (VB produce) (NP (DT any) (NN effect)) (PP (IN on) (NP (NN locomotor) (NN activity))))) (. .)))
15991002	12	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ antagonistic) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_15991002_1606_1614_Chemical)) (PP (IN on) (NP (NN Doc_15991002_1618_1626_Chemical-induced) (NNS Doc_15991002_1635_1642_Disease)))))) (VP (VBZ is) (ADJP (JJ specific) (PP (TO to) (NP (NP (NNS Doc_15991002_1658_1666_Chemical)) (, ,) (CONJP (RB instead) (IN of)) (NP (DT a) (JJ non-specific) (JJ anxiolytic) (NN effect))))))))) (. .)))
15991002	13	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB extend) (NP (DT the) (JJ current) (NNS findings)) (PP (IN on) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NNS Doc_15991002_1781_1789_Chemical) (CC and) (NNS Doc_15991002_1794_1802_Chemical))))))) (. .)))
16034922	0	(ROOT (NP (NP (JJ Long) (NN term) (NN hormone) (NN therapy)) (PP (IN for) (NP (ADJP (JJ perimenopausal) (CC and) (JJ postmenopausal)) (NNS women))) (. .)))
16034922	1	(ROOT (S (NP (NP (JJ Hormone) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NNP HT)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB widely)) (VP (VBN used) (PP (IN for) (NP (VBG controlling) (JJ menopausal) (NNS symptoms))))) (. .)))
16034922	2	(ROOT (S (S (NP (PRP It)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN used) (PP (IN for) (NP (NP (DT the) (NN management) (CC and) (NN prevention)) (PP (IN of) (NP (NNS Doc_16034922_215_237_Disease) (, ,) (NNS Doc_16034922_239_251_Disease) (CC and) (NNS Doc_16034922_256_264_Disease))))) (PP (IN in) (NP (JJR older) (NNS women))))))) (CC but) (S (NP (NP (DT the) (NN evidence)) (VP (VBG supporting) (NP (PRP$ its) (NN use)) (PP (IN for) (NP (DT these) (NNS indications))))) (VP (VBZ is) (ADJP (RB largely) (JJ observational)))) (. .)))
16034922	3	(ROOT (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ long-term) (NNP HT))) (PP (IN on) (NP (NN mortality) (, ,) (NN Doc_16034922_427_440_Disease) (, ,) (NNS Doc_16034922_442_464_Disease) (, ,) (NNS Doc_16034922_466_472_Disease) (, ,) (CD transient) (NN ischaemic) (NNS attacks) (, ,) (NNS Doc_16034922_503_516_Disease) (, ,) (NNS Doc_16034922_518_535_Disease) (, ,) (NNS Doc_16034922_537_551_Disease) (, ,) (NNS Doc_16034922_553_571_Disease) (, ,) (NNS Doc_16034922_573_592_Disease) (, ,) (NN cognitive) (NN function) (, ,) (NNS Doc_16034922_614_622_Disease) (, ,) (NNS Doc_16034922_624_633_Disease) (CC and) (NN quality))) (PP (IN of) (NP (NN life)))))) (. .)))
16034922	4	(ROOT (NP (NP (NNP SEARCH) (NNP STRATEGY)) (: :) (NP (NP (PRP We)) (VP (VBD searched) (NP (DT the) (JJ following) (NNS databases)) (PRT (RP up)) (PP (TO to) (NP (NNP November) (CD 2004))))) (: :) (NP (NP (DT the) (NNP Cochrane) (NNP Doc_16034922_742_761_Disease)) (CC and) (NP (NNP Subfertility) (NNP Group) (NNPS Trials) (NNP Register))) (, ,) (NP (NP (NNP Cochrane) (NNP Central) (NNP Register)) (PP (IN of) (NP (NP (NNP Controlled) (NNP Trials)) (PRN (-LRB- -LRB-) (NP (NNP CENTRAL)) (-RRB- -RRB-))))) (, ,) (NP (NNP MEDLINE)) (, ,) (NP (NNP EMBASE)) (, ,) (NP (NNP Biological) (NNP Abstracts)) (. .)))
16034922	5	(ROOT (S (NP (JJ Relevant) (JJ non-indexed) (NNS journals) (CC and) (NN conference) (NNS abstracts)) (VP (VBD were) (ADVP (RB also)) (ADJP (JJ searched))) (. .)))
16034922	6	(ROOT (NP (NP (NNP SELECTION) (NNP CRITERIA)) (: :) (NP (NP (JJ Randomised) (JJ double-blind) (NNS trials)) (PP (IN of) (NP (NP (NP (NNP HT)) (PRN (-LRB- -LRB-) (NP (NP (NNS oestrogens)) (PP (IN with) (CC or) (IN without) (NP (NNS Doc_16034922_1059_1071_Chemical)))) (-RRB- -RRB-))) (PP (IN versus) (NP (NN placebo))) (, ,) (VP (VBN taken) (PP (IN for) (NP (QP (IN at) (JJS least) (CD one)))) (NP (NN year)) (PP (IN by) (NP (JJ perimenopausal) (CC or) (JJ postmenopausal) (NNS women))))))) (. .)))
16034922	7	(ROOT (NP (NP (NNP DATA) (NNP COLLECTION) (CC AND) (NNP ANALYSIS)) (: :) (S (NP (NNP Fifteen) (NNP RCTs)) (VP (VBD were) (VP (VBN included)))) (. .)))
16034922	8	(ROOT (S (NP (NNS Trials)) (VP (VBD were) (VP (VBN assessed) (PP (IN for) (NP (NP (NN quality) (CC and) (CD two) (NN review) (NNS authors)) (VP (VBN extracted) (NP (NNS data)) (ADVP (RB independently))))))) (. .)))
16034922	9	(ROOT (S (NP (PRP They)) (VP (VBD calculated) (NP (NN risk) (NNS ratios)) (PP (IN for) (NP (NP (JJ dichotomous) (NNS outcomes)) (CC and) (NP (JJ weighted) (JJ mean) (NNS differences)))) (PP (IN for) (NP (JJ continuous) (NNS outcomes)))) (. .)))
16034922	10	(ROOT (S (VP (VB Clinical) (NP (NP (ADJP (RB heterogeneity) (JJ precluded)) (NNS meta-analysis)) (PP (IN for) (NP (JJS most) (NNS outcomes))))) (. .)))
16034922	11	(ROOT (NP (NP (NNP MAIN) (NNP RESULTS)) (: :) (S (NP (PDT All) (DT the) (JJ statistically) (JJ significant) (NNS results)) (VP (VBD were) (VP (VBN derived) (PP (IN from) (NP (DT the) (CD two) (JJS biggest) (NNS trials)))))) (. .)))
16034922	12	(ROOT (S (PP (IN In) (NP (ADJP (RB relatively) (JJ healthy)) (NNS women))) (, ,) (NP (JJ combined) (JJ continuous) (NN HT)) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_16034922_1664_1686_Disease)))) (CC or) (NP (NP (NP (JJ coronary) (NN event)) (PRN (-LRB- -LRB-) (PP (IN after) (NP (NP (CD one) (NN year) (POS 's)) (NN use))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_16034922_1729_1735_Disease)) (PRN (-LRB- -LRB-) (PP (IN after) (NP (CD 3) (NNS years))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_16034922_1753_1766_Disease)) (PRN (-LRB- -LRB-) (PP (IN after) (NP (CD 5) (NNS years))) (-RRB- -RRB-))) (CC and) (NP (NNS Doc_16034922_1787_1806_Disease))))) (. .)))
16034922	13	(ROOT (S (NP (JJ Long-term) (NN Doc_16034922_1818_1827_Chemical-only) (NNP HT)) (ADVP (RB also)) (VP (ADVP (RB significantly)) (VBD increased) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_16034922_1877_1883_Disease) (CC and) (NNS Doc_16034922_1888_1907_Disease))))) (. .)))
16034922	14	(ROOT (S (ADVP (RB Overall)) (, ,) (NP (NP (DT the) (ADJP (RB only) (RB statistically) (JJ significant)) (NNS benefits)) (PP (IN of) (NP (NNP HT)))) (VP (VBD were) (NP (NP (DT a) (VBN decreased) (NN incidence)) (PP (IN of) (NP (NNS Doc_16034922_1998_2007_Disease) (CC and) (NNS Doc_16034922_2012_2024_Disease))) (PP (IN with) (NP (JJ long-term) (NN use))))) (. .)))
16034922	15	(ROOT (S (PP (IN Among) (S (NP (NP (ADJP (RB relatively) (JJ healthy)) (NNS women)) (PP (IN over) (NP (CD 65) (NNS years)))) (VP (VBG taking) (NP (JJ continuous) (VBN combined) (NN HT))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_16034922_2188_2196_Disease))))))) (. .)))
16034922	16	(ROOT (S (PP (IN Among) (NP (NP (NNS women)) (PP (IN with) (NP (NNS Doc_16034922_2215_2237_Disease))))) (, ,) (NP (NP (JJ long-term) (NN use)) (PP (IN of) (NP (JJ combined) (JJ continuous) (NN HT)))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_16034922_2315_2337_Disease))))) (. .)))
16034922	17	(ROOT (S (NP (DT No) (NNS trials)) (VP (VBD focussed) (ADVP (RB specifically)) (PP (IN on) (NP (JJR younger) (NNS women)))) (. .)))
16034922	18	(ROOT (S (ADVP (RB However)) (, ,) (NP (CD one) (NN trial)) (VP (VBD analysed) (S (NP (NP (NNS subgroups)) (PP (IN of) (NP (NP (CD 2839)) (ADJP (RB relatively) (JJ healthy))))) (NP (NP (QP (CD 50) (TO to) (CD 59)) (JJ year-old) (NNS women)) (VP (VBG taking) (NP (NP (VBN combined) (JJ continuous) (NN HT)) (CC and) (NP (NP (CD 1637)) (VP (VBG taking) (NP (NP (NNP Doc_16034922_2524_2533_Chemical-only) (NNP HT)) (, ,) (CC versus) (NP (JJ similar-sized) (NN placebo) (NNS groups)))))))))) (. .)))
16034922	19	(ROOT (S (S (NP (DT The) (ADJP (RB only) (RB significantly) (JJ increased)) (NN risk)) (VP (VBD reported) (SBAR (S (VP (VBD was) (PP (IN for) (NP (NP (NNS Doc_16034922_2635_2657_Disease)) (PP (IN in) (NP (NP (NNS women)) (VP (VBG taking) (NP (JJ combined) (JJ continuous) (NN HT)))))))))))) (: ;) (S (NP (PRP$ their) (JJ absolute) (NN risk)) (VP (VBD remained) (ADJP (RB very) (JJ low)))) (. .)))
16034922	20	(ROOT (S (S (NP (NNP AUTHORS) (POS ')) (VP (VBZ CONCLUSIONS))) (: :) (S (NP (NNP HT)) (VP (VBZ is) (RB not) (VP (VBN indicated) (PP (IN for) (NP (NP (DT the) (JJ routine) (NN management)) (PP (IN of) (NP (JJ chronic) (NN disease)))))))) (. .)))
16034922	21	(ROOT (S (NP (PRP We)) (VP (VBP need) (NP (JJR more) (NN evidence)) (PP (IN on) (NP (NP (DT the) (NN safety)) (PP (IN of) (NP (NP (NNP HT)) (PP (IN for) (NP (JJ menopausal) (NN symptom) (NN control))))))) (, ,) (SBAR (IN though) (S (NP (JJ short-term) (NN use)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (RB relatively) (JJ safe) (PP (IN for) (NP (JJ healthy) (JJR younger) (NNS women))))))))))) (. .)))
16083708	0	(ROOT (NP (NP (NNP Doc_16083708_0_25_Disease)) (: :) (NP (NP (DT an) (NN analysis)) (PP (IN of) (NP (NP (JJ 461) (NNS incidences)) (VP (VBN submitted) (PP (TO to) (NP (NP (DT the) (JJ Spanish) (NN registry)) (PP (IN over) (NP (DT a) (JJ 10-year) (NN period))))))))) (. .)))
16083708	1	(ROOT (NP (NP (NNP BACKGROUND) (CC &) (NNP AIMS)) (: :) (S (S (VP (VBG Progress) (PP (IN in) (NP (NP (DT the) (NN understanding)) (PP (IN of) (NP (JJ susceptibility) (NNS factors))))) (PP (TO to) (NP (NP (NNS Doc_16083708_192_217_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16083708_219_223_Disease)) (-RRB- -RRB-)))))) (CC and) (S (NP (NN outcome) (NN predictability)) (VP (VBP are) (VP (VBN hampered) (PP (IN by) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (JJ systematic) (NNS programs))))) (S (VP (TO to) (VP (VB detect) (NP (ADJP (JJ bona) (JJ fide)) (NNS cases))))))))) (. .)))
16083708	2	(ROOT (S (NP (DT A) (JJ cooperative) (NN network)) (VP (VBD was) (VP (VBN created) (PP (IN in) (NP (CD 1994))) (PP (IN in) (NP (NNP Spain))) (S (VP (TO to) (VP (VB identify) (NP (NP (DT all) (NNS suspicions)) (PP (IN of) (NP (NP (NNS Doc_16083708_417_421_Disease)) (PP (VBG following) (NP (DT a) (JJ prospective) (JJ structured) (NN report) (NN form))))))))))) (. .)))
16083708	3	(ROOT (S (NP (DT The) (NNS Doc_16083708_474_486_Disease)) (VP (VBD was) (VP (VBN characterized) (PP (VBG according) (PP (PP (TO to) (NP (NP (NN hepatocellular)) (, ,) (NP (ADJP (JJ cholestatic) (, ,) (CC and) (JJ mixed)) (NN laboratory) (NNS criteria)))) (CC and) (PP (TO to) (NP (NP (JJ histologic) (NNS criteria)) (FRAG (ADJP (WHADVP (WRB when)) (JJ available))))))))) (. .)))
16083708	4	(ROOT (S (NP (NP (JJ Further) (NN evaluation)) (PP (IN of) (NP (JJ causality) (NN assessment)))) (VP (VBD was) (ADJP (RB centrally) (JJ performed))) (. .)))
16083708	5	(ROOT (S (PP (IN Since) (NP (NP (NNP April) (CD 1994)) (PP (TO to) (NP (NNP August) (CD 2004))))) (, ,) (NP (QP (CD 461) (IN out) (IN of) (CD 570))) (VP (VBD submitted) (SBAR (S (NP (NP (NNS cases)) (, ,) (VP (VBG involving) (NP (CD 505) (NNS drugs))) (, ,)) (VP (VBD were) (VP (VBN deemed) (S (VP (TO to) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (NNS Doc_16083708_812_816_Disease)))))))))))) (. .)))
16083708	6	(ROOT (S (NP (NP (DT The) (JJ antiinfective) (NN group)) (PP (IN of) (NP (NNS drugs)))) (VP (VBD was) (NP (NP (DT the) (ADJP (ADVP (RBR more) (RB frequently)) (ADJP (JJ incriminated)) (, ,) (ADJP (JJ Doc_16083708_889_900_Chemical-Doc_16083708_901_912_Chemical))) (NN accounting)) (PP (IN for) (NP (NP (DT the) (CD 12.8) (NN %)) (PP (IN of) (NP (DT the) (JJ whole) (NN series))))))) (. .)))
16083708	7	(ROOT (S (S (NP (NP (DT The) (NN hepatocellular) (NN pattern)) (PP (IN of) (NP (NN damage)))) (VP (VBD was) (NP (NP (DT the) (ADJP (RBS most) (JJ common))) (PRN (-LRB- -LRB-) (NP (CD 58) (NN %)) (-RRB- -RRB-))))) (, ,) (VP (VBD was) (ADVP (RB inversely)) (VP (VBN correlated) (PP (IN with) (NP (NP (NN age)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .0001))) (-RRB- -RRB-)))))) (, ,) (CC and) (VP (VBD had) (NP (NP (DT the) (JJS worst) (NN outcome)) (PRN (-LRB- -LRB-) (NP (NP (NNP Cox) (NNP regression)) (, ,) (NP (NNP P) (NNP <) (NNP .034))) (-RRB- -RRB-)))) (. .)))
16083708	8	(ROOT (S (ADVP (RB Indeed)) (, ,) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NN liver) (NN transplantation) (CC and) (NNS Doc_16083708_1175_1180_Disease)) (PP (IN in) (NP (DT this) (NN group)))))) (VP (VBD was) (NP (CD 11.7) (NN %)) (SBAR (IN if) (S (NP (NNS patients)) (VP (VBD had) (NP (NNS Doc_16083708_1221_1229_Disease)) (PP (IN at) (NP (NN presentation))) (, ,) (SBAR (IN whereas) (S (NP (DT the) (JJ corresponding) (NN figure)) (VP (VBD was) (NP (NP (CD 3.8) (NN %)) (PP (IN in) (NP (NP (JJ nonjaundiced) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .04))) (-RRB- -RRB-)))))))))))) (. .)))
16083708	9	(ROOT (S (NP (NP (NNS Factors)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_16083708_1368_1393_Disease))))))) (VP (VBD were) (NP (NP (NP (JJ female) (NN sex)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NNP OR)) (SBAR (S (VP (SYM =) (NP (CD 25)))))) (: ;) (NP (NP (CD 95) (NN %)) (NP (NNP CI))) (: :) (NP (NP (CD 4.1-151)) (PRN (: ;) (ADVP (RB P)) (NP (QP (CD <) (CD .0001))) (-RRB- -RRB-)) (, ,) (NP (NP (NNP Doc_16083708_1449_1470_Disease) (-LRB- -LRB-) (NNP OR)) (SBAR (S (VP (SYM =) (NP (CD 7.9))))))) (: ;) (NP (NP (CD 95) (NN %)) (NP (NNP CI))) (: :) (NP (NP (CD 1.6-37)) (: ;) (NP (NNP P) (NNP <)))) (NP (CD .009))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJR higher) (JJ baseline) (NN plasma) (NNS Doc_16083708_1536_1545_Chemical)) (NP (NP (NN value)) (-LRB- -LRB-) (NP (NP (NP (NNP OR)) (SBAR (S (VP (SYM =) (NP (CD 1.15)))))) (: ;) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (: :) (NP (QP (CD 1.09-1) (CD .22)))) (: ;) (NP (NP (NNP P) (NNP <)) (NP (CD .0001)))) (-RRB- -RRB-))))) (. .)))
16083708	10	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (JJ drug-induced) (NN hepatocellular) (NNS Doc_16083708_1650_1658_Disease)))) (VP (VBP have) (NP (NP (CD 11.7) (NN %) (NN chance)) (PP (IN of) (S (VP (VBG progressing) (PP (TO to) (NP (NNS Doc_16083708_1695_1700_Disease) (CC or) (NN transplantation)))))))) (. .)))
16083708	11	(ROOT (S (NP (NNP Doc_16083708_1721_1744_Chemical)) (VP (VBZ stands) (PRT (RP out)) (PP (IN as) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (NN drug)) (VP (VBN related) (PP (TO to) (NP (NNS Doc_16083708_1791_1795_Disease))))))) (. .)))
16092435	0	(ROOT (NP (NP (JJ Morphological) (NN evaluation)) (PP (IN of) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_16092435_42_50_Chemical)) (PP (IN on) (NP (NN Doc_16092435_54_64_Chemical-evoked) (NNS Doc_16092435_72_86_Disease))))))) (PP (IN in) (NP (NNS rats))) (. .)))
16092435	1	(ROOT (S (NP (NP (DT The) (NN influence)) (PP (IN of) (NP (NP (NNS Doc_16092435_113_121_Chemical)) (PP (IN on) (NP (NP (NN Doc_16092435_125_135_Chemical-induced) (NNS Doc_16092435_144_158_Disease)) (PP (IN in) (NP (NNS rats)))))))) (VP (VBD was) (VP (VBN studied))) (. .)))
16092435	2	(ROOT (S (NP (NP (NNP Doc_16092435_180_190_Chemical)) (PP (IN in) (NP (NP (DT the) (JJ cumulative) (NN dose)) (PP (IN of) (NP (CD 25) (NN mg/kg)))))) (VP (VBD evoked) (NP (ADJP (RB fully) (JJ developed)) (NNS Doc_16092435_249_265_Disease))) (. .)))
16092435	3	(ROOT (S (NP (NP (NNP Doc_16092435_267_275_Chemical)) (PP (IN in) (NP (NP (DT the) (JJ multiple) (NNS doses)) (PP (IN of) (NP (CD 200) (NN mg/kg)))))) (VP (VBD did) (RB not) (VP (VB influence) (NP (JJ Doc_16092435_329_332_Chemical) (NNS Doc_16092435_333_347_Disease)))) (. .)))
16112787	0	(ROOT (S (PP (IN In) (NP (NN vivo) (NNS evidences))) (S (VP (VBG suggesting) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN oxidative)))))) (VP (VBP stress) (PP (IN in) (NP (NP (NP (NNS pathogenesis)) (PP (IN of) (NP (NN Doc_16112787_77_87_Chemical-induced) (NN nephrotoxicity)))) (: :) (NP (NP (NN protection)) (PP (IN by) (NP (NNS Doc_16112787_126_136_Chemical))))))) (. .)))
16112787	1	(ROOT (S (NP (NP (DT The) (NNS aims)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD were) (S (VP (VP (TO to) (VP (VB examine) (NP (NP (NNS Doc_16112787_177_187_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16112787_189_192_Chemical)) (-RRB- -RRB-)) (: -) (NP (NP (JJ induced) (NN oxidative) (NN stress)) (SBAR (WHNP (WDT that)) (S (VP (VBZ promotes) (NP (NP (NN production)) (PP (IN of) (NP (NP (JJ reactive) (JJ Doc_16112787_256_262_Chemical) (NNS species)) (PRN (-LRB- -LRB-) (NP (NNP ROS)) (-RRB- -RRB-)))))))))))) (CC and) (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (NNS Doc_16112787_308_318_Chemical)) (, ,) (NP (DT an) (JJ expectorant) (NN agent)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (ADVP (RB also)) (VP (VBN antioxidant) (NP (NNS properties)) (, ,) (PP (IN on) (NP (NP (NN kidney) (NN tissue)) (PP (IN against) (NP (NP (DT the) (JJ possible) (NN Doc_16112787_419_422_Chemical-induced) (NNS Doc_16112787_431_447_Disease)) (PP (IN in) (NP (NNS rats))))))))))))))))))) (. .)))
16112787	2	(ROOT (S (NP (NNS Rats)) (VP (VBD were) (VP (VBN divided) (PP (IN into) (NP (NP (CD three) (NNS groups)) (: :) (NP (NP (NN sham)) (, ,) (NP (NNS Doc_16112787_500_503_Chemical)) (CC and) (NP (NNP Doc_16112787_508_511_Chemical) (CC plus) (NNP Doc_16112787_517_527_Chemical))))))) (. .)))
16112787	3	(ROOT (S (NP (NNP Doc_16112787_529_532_Chemical)) (VP (VBD was) (VP (VBN administrated) (NP (NP (NN intraperitoneally)) (PRN (-LRB- -LRB-) (NP (NNP i.p.)) (-RRB- -RRB-))) (PP (IN with) (NP (NP (NNS 200mgkg)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (ADVP (RB twice) (JJ daily) (PP (IN for) (NP (CD 7) (NNS days))))))) (. .)))
16112787	4	(ROOT (S (NP (NNP Doc_16112787_617_627_Chemical)) (VP (VBD was) (VP (VBN administered) (ADVP (RB orally)))) (. .)))
16112787	5	(ROOT (S (NP (NP (JJ Doc_16112787_653_656_Chemical) (NN administration)) (PP (TO to) (NP (NN control) (NNS rats)))) (ADVP (RB significantly)) (VP (VP (VBD increased) (NP (NP (NP (JJ renal) (NNS Doc_16112787_718_733_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16112787_735_738_Chemical)) (-RRB- -RRB-))) (CC and) (NP (ADJP (ADJP (RB urinary) (JJ Doc_16112787_752_760_Chemical-beta-d-glucosaminidase)) (PRN (-LRB- -LRB-) (NP (NP (NNP NAG)) (, ,) (NP (DT a) (NN marker))) (PP (IN of) (NP (NNS Doc_16112787_802_822_Disease))) (-RRB- -RRB-))) (NN excretion)))) (CC but) (VP (VBD decreased) (NP (NP (NP (JJ Doc_16112787_848_858_Chemical) (NN dismutase)) (PRN (-LRB- -LRB-) (NP (NNP SOD)) (-RRB- -RRB-))) (CC and) (NP (NP (NN catalase)) (PRN (-LRB- -LRB-) (NP (NNP CAT)) (-RRB- -RRB-))) (NP (NNS activities))))) (. .)))
16112787	6	(ROOT (S (NP (NP (JJ Doc_16112787_906_916_Chemical) (NN administration)) (PP (IN with) (NP (NP (JJ Doc_16112787_937_940_Chemical) (NNS injections)) (VP (VBN caused) (ADVP (RB significantly)))))) (VP (VP (VBD decreased) (NP (NP (JJ renal) (NNS Doc_16112787_989_992_Chemical)) (CC and) (NP (JJ urinary) (NN NAG) (NN excretion)))) (, ,) (CC and) (VP (VBD increased) (NP (NP (NNP SOD) (NN activity)) (, ,) (CONJP (CC but) (RB not)) (NP (NP (NNP CAT) (NN activity)) (PP (IN in) (NP (JJ renal) (NN tissue))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (NNS Doc_16112787_1104_1107_Chemical))) (ADVP (RB alone))))))) (. .)))
16112787	7	(ROOT (S (NP (NNP Doc_16112787_1115_1125_Chemical)) (VP (VBD showed) (NP (JJ histopathological) (NN protection)) (PP (IN against) (NP (NN Doc_16112787_1170_1173_Chemical-induced) (NN nephrotoxicity)))) (. .)))
16112787	8	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT a) (JJ significant) (NN dilatation)) (PP (IN of) (NP (NP (JJ tubular) (NNS lumens)) (, ,) (NP (JJ extensive) (JJ epithelial) (NN cell) (NN vacuolization)) (, ,) (NP (NNS Doc_16112787_1294_1301_Disease)) (, ,) (NP (NN desquamation)) (, ,) (CC and) (NP (NNS Doc_16112787_1321_1329_Disease))))) (PP (IN in) (PP (ADVP (NP (CD Doc_16112787_1333_1336_Chemical-treated) (NNS rats)) (RBR more)) (IN than) (NP (NP (DT those)) (PP (IN of) (NP (NP (DT the) (NN control)) (CC and) (NP (DT the) (JJ Doc_16112787_1389_1399_Chemical) (NNS groups)))))))) (. .)))
16112787	9	(ROOT (S (NP (NNP Doc_16112787_1408_1418_Chemical)) (VP (VBD caused) (NP (DT a) (JJ marked) (NNS Doc_16112787_1435_1476_Disease))) (. .)))
16112787	10	(ROOT (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (JJ oxidative) (JJ tubular) (NN damage)) (VP (VBZ plays) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (DT the) (NN Doc_16112787_1555_1558_Chemical-induced) (NN nephrotoxicity)))))))))) (CC and) (S (NP (NP (DT the) (NN modulation)) (PP (IN of) (NP (NP (JJ oxidative) (NN stress)) (PP (IN with) (NP (NNS Doc_16112787_1626_1636_Chemical)))))) (VP (VBZ reduces) (NP (DT the) (NN Doc_16112787_1649_1652_Chemical-induced) (NNS Doc_16112787_1661_1674_Disease)) (PP (DT both) (IN at) (NP (NP (DT the) (NN biochemical)) (CC and) (NP (JJ histological) (NNS levels)))))) (. .)))
1615846	0	(ROOT (NP (NP (JJ Doc_1615846_0_11_Chemical-Doc_1615846_12_22_Chemical) (NN therapy)) (PP (IN for) (NP (JJ primary) (NNS Doc_1615846_43_64_Disease))) (. .)))
1615846	1	(ROOT (S (NP (NP (DT The) (JJ specific) (NN aim)) (PP (IN of) (NP (DT this) (ADJP (JJ retrospective) (, ,) (JJ observational)) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB assess) (NP (NP (NP (NN safety) (CC and) (NN efficacy)) (PP (IN of) (NP (NP (JJ long-term)) (PRN (-LRB- -LRB-) (NP (CD 21) (NN months/patient)) (-RRB- -RRB-))))) (, ,) (NP (NP (JJ open-label) (, ,) (JJ Doc_1615846_206_228_Chemical) (NN treatment)) (PP (IN in) (NP (NP (CD 80) (NNS patients)) (PP (IN with) (NP (JJ primary) (JJ mixed) (NNS Doc_1615846_273_287_Disease)))))) (PRN (-LRB- -LRB-) (NP (NP (CD 68) (NN %)) (PP (IN of) (SBAR (WHNP (WP whom)) (S (VP (VBD had) (NP (NNS Doc_1615846_305_337_Disease))))))) (-RRB- -RRB-))))))) (. .)))
1615846	2	(ROOT (S (SBAR (IN Because) (S (NP (JJ ideal) (NN lipid) (NNS targets)) (VP (VBD were) (RB not) (VP (VBN reached) (PRN (-LRB- -LRB-) (VP (VBN low-density) (NP (JJ lipoprotein) (PRN (-LRB- -LRB-) (NP (NNP LDL)) (-RRB- -RRB-)) (NNS Doc_1615846_416_427_Chemical)) (NP (QP (JJR less) (IN than) (CD 130)) (JJ mg/dl) (, ,) (JJ high-density) (NN lipoprotein) (PRN (-LRB- -LRB-) (NP (NNP HDL)) (-RRB- -RRB-)) (NNS Doc_1615846_480_491_Chemical)) (PP (ADVP (JJR greater)) (IN than) (NP (NP (CD 35) (NN mg/dl)) (, ,) (CC or) (NP (JJ total) (NNS Doc_1615846_524_535_Chemical)) (PRN (: /) (S (NP (NNP HDL) (NNP Doc_1615846_540_551_Chemical)) (ADJP (NP (QP (JJR less) (IN than) (CD 4.5))) (JJ mg/dl))))))) (-RRB- -RRB-)) (PP (IN with) (NP (NN diet))))))) (NP (CC plus) (NP (DT a) (JJ single) (NN drug)) (, ,) (NP (NP (NP (NNS Doc_1615846_603_614_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1.2) (NN g/day)) (-RRB- -RRB-))) (: -) (NP (JJ Doc_1615846_627_637_Chemical) (PRN (-LRB- -LRB-) (ADVP (RB primarily)) (NP (QP (CD 20) (CC or) (CD 40) (CD mg))) (-RRB- -RRB-)) (NN treatment)))) (VP (VBD was) (VP (VBN given))) (. .)))
1615846	3	(ROOT (S (NP (JJ Follow-up) (NNS visits)) (VP (VBD were) (VP (VBN scheduled) (PP (IN with) (NP (NP (NP (JJ 2-drug) (NN therapy)) (NP (QP (DT every) (CD 6) (TO to) (CD 8)) (NNS weeks))) (, ,) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (NP (CD 10.3) (NNS visits)) (PP (IN per) (NP (NN patient)))))))) (, ,) (PP (IN with) (NP (NP (NP (CD 741) (NNS batteries)) (PP (IN of) (NP (CD 6) (NN liver) (NN function) (NNS tests)))) (CC and) (NP (NP (CD 714) (JJ Doc_1615846_847_855_Chemical) (NN phosphokinase) (NNS levels)) (VP (VBN measured))))))) (. .)))
1615846	4	(ROOT (S (NP (NP (QP (RB Only) (CD 1))) (PP (IN of) (NP (DT the) (CD 4,446) (NN liver) (NN function) (NNS tests))) (PRN (-LRB- -LRB-) (NP (CD 0.02) (NN %)) (-RRB- -RRB-)) (, ,) (ADJP (NP (DT a) (NNS Doc_1615846_939_953_Chemical)) (JJ transferase)) (, ,)) (VP (VBD was) (ADJP (ADJP (JJR greater) (PP (IN than))) (CC or) (ADJP (JJ equal) (PP (TO to) (NP (NP (QP (CD 3) (NNS times))) (NP (DT the) (JJ upper) (JJ normal) (NN limit))))))) (. .)))
1615846	5	(ROOT (S (S (PP (IN Of) (NP (DT the) (CD 714) (JJ Doc_1615846_1039_1047_Chemical) (NN phosphokinase) (NNS levels))) (, ,) (NP (CD 9) (NN %)) (VP (VBD were) (ADJP (JJ high)))) (: ;) (S (NP (QP (RB only) (CD 1)) (PRN (-LRB- -LRB-) (NP (CD 0.1) (NN %)) (-RRB- -RRB-))) (VP (VBD was) (ADJP (ADJP (JJR greater) (PP (IN than))) (CC or) (ADJP (JJ equal) (PP (TO to) (NP (NP (QP (CD 3) (NNS times))) (NP (DT the) (JJ upper) (JJ normal) (NN limit)))))))) (. .)))
1615846	6	(ROOT (S (PP (IN With) (NP (JJ 2-drug) (NN therapy))) (, ,) (S (NP (JJ mean) (JJ total) (NNS Doc_1615846_1191_1202_Chemical)) (VP (VBD decreased) (NP (CD 22) (NN %)) (PP (IN from) (NP (QP (CD 255) (TO to) (CD 200)) (NN mg/dl))))) (, ,) (S (NP (JJ Doc_1615846_1240_1252_Chemical) (NNS levels)) (VP (VBD decreased) (NP (CD 35) (NN %)) (PP (IN from) (NP (QP (CD 236) (TO to) (CD 154)) (NN mg/dl))))) (, ,) (S (NP (NNP LDL) (NNP Doc_1615846_1301_1312_Chemical)) (VP (VBD decreased) (NP (CD 26) (NN %)) (PP (IN from) (NP (QP (CD 176) (TO to) (CD 131)) (NN mg/dl))))) (, ,) (CC and) (S (NP (DT the) (JJ total) (NNP Doc_1615846_1364_1375_Chemical) (NNP /) (NNP HDL) (NNP Doc_1615846_1380_1391_Chemical) (NN ratio)) (VP (VP (VBD decreased) (NP (CD 24) (NN %)) (PP (IN from) (NP (QP (CD 7.1) (TO to) (CD 5.4))))) (, ,) (VP (NP (DT all) (NN p)) (ADVP (RBR less) (IN than))) (CC or) (VP (JJ equal) (PP (TO to) (NP (CD 0.0001)))))) (. .)))
1615846	7	(ROOT (S (S (NP (NP (NNP Doc_1615846_1465_1473_Disease)) (, ,) (ADJP (ADJP (JJ attributable) (PP (TO to) (NP (DT the) (NN drug) (NN combination)))) (CC and) (ADJP (JJ symptomatic) (RB enough) (S (VP (TO to) (VP (VB discontinue) (NP (PRP it))))))) (, ,)) (VP (VBD occurred) (PP (PP (IN in) (NP (NP (CD 3) (NN %)) (PP (IN of) (NP (NNS patients))))) (, ,) (CC and) (PP (IN in) (NP (CD 1) (NN %)))) (PP (IN with) (NP (NP (ADJP (JJ concurrent) (JJ high)) (JJ Doc_1615846_1613_1621_Chemical) (NN phosphokinase)) (PRN (-LRB- -LRB-) (NP (NNP 769) (NNP U/liter)) (-RRB- -RRB-)))))) (: ;) (S (NP (DT no) (NNS patients)) (VP (VBD had) (NP (NP (NP (NNS Doc_1615846_1667_1681_Disease)) (CC or) (NP (NNS Doc_1615846_1685_1698_Disease)) (. .)) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-)))))))
16309808	0	(ROOT (SQ (NNP Does) (NP (NNS Doc_16309808_5_16_Chemical)) (VP (VB potentiate) (NP (NN Doc_16309808_28_39_Chemical-associated) (NNS Doc_16309808_51_73_Disease))) (. ?)))
16309808	1	(ROOT (S (NP (EX There)) (VP (VBZ is) (ADVP (RB now)) (NP (NN evidence) (S (VP (TO to) (VP (VB suggest) (NP (DT a) (JJ central) (NN role)) (PP (IN for) (NP (NP (DT the) (JJ dopaminergic) (NN system)) (PP (IN in) (NP (NP (NNS Doc_16309808_154_176_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16309808_178_181_Disease)) (-RRB- -RRB-))))))))))) (. .)))
16309808	2	(ROOT (S (PP (IN For) (NP (NN example))) (, ,) (NP (NP (DT the) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_16309808_213_216_Disease)))) (VP (MD can) (VP (VB be) (VP (ADVP (RB dramatically)) (VBN improved) (PP (IN by) (NP (JJ Doc_16309808_249_257_Chemical) (CC and) (JJ Doc_16309808_262_270_Chemical) (NNS agonists))) (, ,) (SBAR (IN whereas) (S (NP (JJ central) (JJ Doc_16309808_297_305_Chemical) (NN D2) (NN receptor) (NNS antagonists)) (VP (MD can) (VP (VB induce) (CC or) (VB aggravate) (NP (JJ Doc_16309808_354_357_Disease) (NNS symptoms))))))))) (. .)))
16309808	3	(ROOT (S (PP (TO To) (NP (PRP$ our) (NN knowledge))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (JJ previous) (NN report)) (VP (VBG regarding) (SBAR (IN whether) (S (NP (NP (NNS Doc_16309808_432_443_Chemical)) (, ,) (NP (DT a) (JJ peripheral) (NNP Doc_16309808_458_466_Chemical) (NNP D2) (NN receptor) (NN antagonist)) (, ,)) (VP (MD can) (ADVP (RB also)) (VP (VB induce) (CC or) (VB aggravate) (NP (NP (NNS symptoms)) (PP (IN of) (NP (NNS Doc_16309808_532_535_Disease))))))))))) (. .)))
16309808	4	(ROOT (S (NP (NP (NNP Doc_16309808_537_548_Chemical)) (, ,) (NP (NP (DT the) (JJ first) (ADJP (JJ noradrenergic) (CC and) (JJ specific)) (JJ serotonergic) (NN antidepressant)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16309808_616_621_Chemical)) (-RRB- -RRB-))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_16309808_649_652_Disease)) (PP (IN in) (NP (JJ several) (JJ recent) (NNS publications)))))))) (. .)))
16309808	5	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBP report) (ADVP (RB here)) (NP (NP (DT a) (JJ Doc_16309808_711_720_Disease) (NN patient)) (VP (VBN comorbid) (PP (IN with) (NP (NP (JJ postprandial) (NNS Doc_16309808_756_765_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_16309808_780_783_Disease)) (SBAR (IN after) (S (NP (NNS Doc_16309808_790_801_Chemical)) (VP (VBD had) (VP (VBN been) (VP (VBN added) (PP (TO to) (NP (PRP$ his) (JJ Doc_16309808_824_835_Chemical) (NN therapy)))))))))))))))) (. .)))
16309808	6	(ROOT (S (S (NP (PRP$ Our) (NN patient)) (VP (VBD started) (S (VP (TO to) (VP (VB have) (NP (NP (NNS symptoms)) (PP (IN of) (NP (NNS Doc_16309808_885_888_Disease)))) (SBAR (RB only) (IN after) (S (NP (PRP he)) (VP (VBD had) (VP (VBN been) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_16309808_925_936_Chemical))))))))))))) (, ,) (CC and) (S (NP (PRP$ his) (JJ Doc_16309808_946_949_Disease) (NNS symptoms)) (VP (VBN resolved) (ADVP (RB completely)) (PP (IN upon) (NP (NP (NN discontinuation)) (PP (IN of) (NP (PRP$ his) (NNS Doc_16309808_1007_1018_Chemical))))))) (. .)))
16309808	7	(ROOT (S (NP (NP (PDT Such) (DT a) (JJ temporal) (NN relationship)) (PP (IN between) (NP (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_16309808_1068_1079_Chemical)))) (CC and) (NP (NP (DT the) (NNS symptoms)) (PP (IN of) (NP (NP (NNS Doc_16309808_1100_1103_Disease)) (PP (IN in) (NP (PRP$ our) (NN patient))))))))) (VP (VBD did) (RB not) (VP (VB support) (NP (NP (DT a) (VBG potentiating) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_16309808_1160_1170_Chemical)) (PP (IN on) (NP (NN Doc_16309808_1174_1185_Chemical-associated) (NNS Doc_16309808_1197_1200_Disease)))))))) (. .)))
16309808	8	(ROOT (S (ADVP (RB However)) (, ,) (NP (NNS physicians)) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (DT the) (NN possibility)))) (SBAR (IN that) (S (NP (NNS Doc_16309808_1262_1273_Chemical)) (VP (MD can) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_16309808_1297_1300_Disease)) (PP (IN in) (NP (NP (DT some) (NNS individuals)) (, ,) (RB especially) (NP (DT those)))))) (S (VP (VBG receiving) (NP (JJ concomitant) (JJ Doc_16309808_1361_1369_Chemical) (NNP D2) (NN receptor) (NNS antagonists))))))))))) (. .)))
16323982	0	(ROOT (S (NP (JJ Antiandrogenic) (NN therapy)) (VP (MD can) (VP (VB cause) (NP (NNS Doc_16323982_33_58_Disease)))) (. .)))
16323982	1	(ROOT (S (VP (TO To) (VP (VB study) (NP (NP (DT the) (NN change)) (PP (IN of) (NP (NN lipid) (NN metabolism)))) (PP (IN by) (NP (NN antiandrogen) (NN therapy))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_16323982_146_161_Disease))))))) (. .)))
16323982	2	(ROOT (NP (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (S (NP (PRP We)) (VP (VBD studied) (PP (IN with) (NP (NP (DT a) (CD 2.5) (NNS years)) (VP (VBG follow-up) (NP (DT the) (NNS changes)) (PP (IN in) (NP (NP (NP (NP (NN plasma) (NNS Doc_16323982_246_258_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP C)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_16323982_264_277_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16323982_279_281_Disease)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS lipoproteins)) (PRN (-LRB- -LRB-) (NP (NNP LP)) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ apolipoproteins) (PRN (-LRB- -LRB-) (NP (NNP Apo)) (-RRB- -RRB-)) (NN B-100))) (, ,) (NP (NNP A-I)))) (PRN (, ,) (CC and) (NP (NP (NNP A-II) (FW pro) (NNP fi) (NNP les)) (PP (IN in) (NP (NP (CD 24) (NNS patients)) (PP (IN of) (NP (JJ mean) (NN age))) (NP (CD 60) (NNS years)))) (PP (IN with) (NP (NNS Doc_16323982_402_426_Disease))))) (FRAG (-LRB- -LRB-) (NP (NN stage)) (: :) (NP (NP (NNS T1cN0M0)) (, ,) (NP (JJ Gleason) (NN score)) (: :) (NP (NNP 2-5))) (-RRB- -RRB-))))) (PP (IN during) (NP (NN treatment))) (PP (IN with) (NP (NP (NNS Doc_16323982_486_505_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16323982_507_510_Chemical)) (-RRB- -RRB-)))) (PP (IN without) (NP (JJ surgical) (NN management) (CC or) (NN radiation) (NN therapy))))) (. .)))
16323982	3	(ROOT (S (NP (NP (JJ Significant) (NNS decreases)) (PP (IN of) (NP (NP (NP (NNP HDL-C)) (, ,) (NP (NNP Apo) (NNP A-I)) (CC and) (NP (NNP Apo) (NNP A-II))) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NP (JJ Doc_16323982_643_655_Chemical) (NNS levels)) (PP (IN in) (NP (NNP VLDL))))))))) (VP (VBD were) (VP (VBN induced) (PP (IN by) (NP (NNP CPA))))) (. .)))
16323982	4	(ROOT (S (PP (IN After) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (NP (CD 2.5) (NNS years)) (PP (IN on) (NP (NNP CPA) (NN treatment))))))) (, ,) (NP (NP (CD four) (NNS patients)) (PP (RB out) (IN of) (NP (NN twenty-four)))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB be) (VP (VBN affected) (PP (IN by) (NP (NNS Doc_16323982_800_822_Disease))))))))) (. .)))
16323982	5	(ROOT (S (NP (NP (JJ Ischaemic) (NNS Doc_16323982_847_872_Disease)) (PP (IN with) (NP (NP (DT an) (NN incidence) (NN rate)) (PP (IN of) (ADVP (NP (CD 16.6) (NN %)) (RB as))))) (VP (VBN caused) (PP (IN by) (NP (VBN prolonged) (NNP CPA) (NN therapy))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN through) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NNP HDL) (NNP Doc_16323982_975_986_Chemical)) (, ,) (NP (NNP Apo) (NNP A-I)) (CC and) (NP (NNP Apo) (NNP A-II) (FW pro) (NNP fi) (NNP les)))))) (, ,) (ADVP (JJ other) (PP (IN than) (NP (NP (DT the) (JJ well-known) (JJ hyperglyceridemic) (NN effect)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_16323982_1082_1090_Chemical))))))))) (. .)))
16369751	0	(ROOT (S (NP (JJ Doc_16369751_0_14_Chemical) (NNS Doc_16369751_15_29_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_16369751_41_66_Chemical)))) (. .)))
16369751	1	(ROOT (S (NP (NNP Doc_16369751_68_82_Disease)) (VP (VBZ is) (NP (NP (DT a) (JJ rare) (NN complication)) (VP (VBG occurring) (PP (IN during) (NP (NP (JJ Doc_16369751_123_137_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_16369751_139_143_Chemical)) (-RRB- -RRB-)) (NN treatment)) (PP (IN for) (NP (NNS Doc_16369751_159_171_Disease)))))))) (. .)))
16369751	2	(ROOT (S (NP (PRP We)) (VP (VBP herein) (VP (VB report) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT a) (JJ 70-year-old) (NN man)))) (PP (IN with) (NP (NP (NN Doc_16369751_225_229_Chemical-induced) (NNS Doc_16369751_238_252_Disease)) (, ,) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (NP (DT a) (JJ high) (NN serum) (NN level)) (PP (IN of) (NP (NP (NNS Doc_16369751_284_309_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16369751_311_315_Chemical)) (-RRB- -RRB-))))) (VP (VBD was) (ADJP (JJ observed))))))))) (. .)))
16369751	3	(ROOT (S (S (NP (NP (DT The) (NN patient)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (JJ unresectable) (NN colon) (NN cancer) (NNS Doc_16369751_378_388_Disease)) (PP (TO to) (NP (DT the) (NN liver) (CC and) (NN lung))))))) (, ,)) (VP (VBD was) (VP (VBN referred) (PP (TO to) (NP (PRP us))) (PP (IN for) (NP (NN chemotherapy))) (PP (IN from) (NP (DT an) (JJ affiliated) (NN hospital)))))) (: ;) (S (NP (PRP he)) (VP (VBD had) (NP (DT no) (JJ cardiac) (NN history)))) (. .)))
16369751	4	(ROOT (S (PP (IN After) (NP (NN admission))) (, ,) (NP (DT the) (NN patient)) (VP (VBD received) (NP (NP (DT a) (JJ continuous) (JJ intravenous) (NN infusion)) (PP (IN of) (NP (NP (NP (NNS Doc_16369751_579_583_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1000) (NN mg/day)) (-RRB- -RRB-))) (, ,) (SBAR (WHPP (IN during) (WHNP (WDT which))) (S (NP (NP (NNS Doc_16369751_612_627_Disease)) (PP (IN with) (NP (NNS Doc_16369751_633_658_Disease)))) (VP (VBD occurred) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (DT a) (JJ high) (NN serum) (NN Doc_16369751_700_704_Chemical) (NN concentration)) (PP (IN of) (NP (CD 1955) (NN ng/ml)))))))))))) (. .)))
16369751	5	(ROOT (S (NP (NP (PDT Both) (DT the) (NNS Doc_16369751_743_758_Disease)) (CC and) (NP (DT the) (JJ electrocardiographic) (NNS changes))) (VP (VBD disappeared) (ADVP (RB spontaneously)) (PP (IN after) (NP (NP (DT the) (NN discontinuation)) (PP (IN of) (NP (NNS Doc_16369751_851_855_Chemical)))))) (. .)))
16369751	6	(ROOT (S (SBAR (IN As) (S (NP (NP (DT the) (NNS Doc_16369751_864_879_Disease)) (PP (IN in) (NP (DT this) (NN patient)))) (VP (VBD was) (VP (VBN considered) (S (VP (TO to) (VP (VB have) (VP (VBN been) (ADJP (JJ due) (PP (TO to) (NP (NN Doc_16369751_931_935_Chemical-induced) (NNS Doc_16369751_944_958_Disease)))))))))))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NNS Doc_16369751_982_986_Chemical)))) (VP (VBD was) (VP (VBN abandoned))) (. .)))
16369751	7	(ROOT (S (ADVP (RB Instead)) (, ,) (NP (NP (JJ oral) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_16369751_1034_1037_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN derivative)) (PP (IN of) (NP (NNS Doc_16369751_1055_1059_Chemical)))) (-RRB- -RRB-)))) (, ,) (PP (IN at) (NP (NP (CD 200) (NN mg/day)) (NP (RB twice) (DT a) (NN week)))) (, ,)) (VP (VBD was) (VP (VBN instituted) (, ,) (SBAR (IN because) (S (NP (NNP S-1)) (VP (VBZ has) (NP (NP (DT a) (JJ strong) (NN inhibitory) (NN effect)) (PP (IN on) (NP (NP (JJ Doc_16369751_1152_1169_Chemical) (NN dehydrogenase)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ catalyzes) (NP (NP (DT the) (NN degradative)) (PP (IN of) (NP (NNS Doc_16369751_1220_1224_Chemical)))) (PP (IN into) (NP (NNS Doc_16369751_1230_1234_Chemical)))))))))))))) (. .)))
16369751	8	(ROOT (S (NP (DT The) (NN serum) (NNS Doc_16369751_1246_1250_Chemical) (NN concentration)) (ADVP (RB subsequently)) (VP (VBD decreased) (PP (TO to) (NP (QP (CD 352) (CD ng/ml)))) (, ,) (PP (NP (DT the) (JJ same)) (IN as) (NP (NP (DT the) (NN value)) (VP (VBN measured) (PP (IN on) (NP (NP (DT the) (JJ first) (NN day)) (PP (IN of) (NP (NN S-1) (NN administration))))))))) (. .)))
16369751	9	(ROOT (S (ADVP (RB Thereafter)) (, ,) (NP (DT no) (JJ cardiac) (NNS symptoms)) (VP (VBD were) (ADJP (JJ observed))) (. .)))
16369751	10	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD achieved) (NP (DT a) (JJ partial) (NN response)) (NP (CD 6) (NNS months)) (PP (IN after) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (DT the) (NN S-1) (NN treatment)))))) (. .)))
16369751	11	(ROOT (S (NP (NP (NP (DT The) (NN experience)) (PP (IN of) (NP (DT this) (NN case)))) (, ,) (RRC (ADVP (RB together)) (PP (IN with) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (DT the) (NN literature)))))) (, ,)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NNS Doc_16369751_1597_1601_Chemical)) (VP (VBZ is) (VP (VBN related) (PP (TO to) (NP (NN Doc_16369751_1616_1620_Chemical-induced) (NNS Doc_16369751_1629_1643_Disease)))))))) (. .)))
16369751	12	(ROOT (S (NP (NNP S-1)) (VP (MD may) (VP (VB be) (VP (VBN administered) (ADVP (RB safely)) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Doc_16369751_1693_1697_Chemical-induced) (NNS Doc_16369751_1706_1720_Disease)))))))) (. .)))
1655018	0	(ROOT (S (NP (NP (NNP Doc_1655018_0_24_Disease)) (PP (IN in) (NP (NNS Doc_1655018_28_44_Disease)))) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_1655018_58_66_Chemical) (CC and) (NNS Doc_1655018_71_85_Chemical)))) (. .)))
1655018	1	(ROOT (S (NP (NP (DT The) (NN case)) (PP (IN of) (NP (DT an) (JJ 11-year-old) (NN boy)))) (VP (VP (VBZ is) (VP (VBN reported) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBN known) (S (VP (TO to) (VP (VB have) (NP (NP (NNS Doc_1655018_152_168_Disease)) (PP (IN for) (NP (CD 3) (NNS years))))))))))))) (CC and) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_1655018_202_211_Chemical) (, ,) (NNS Doc_1655018_213_228_Chemical) (CC and) (NNS transfusions)))))) (. .)))
1655018	2	(ROOT (S (PP (NP (CD Two) (NNS weeks)) (IN before) (NP (PRP$ his) (NNS Doc_1655018_268_273_Disease))) (NP (PRP he)) (VP (VBD was) (VP (VP (VBN readmitted) (PP (RB because) (IN of) (NP (NP (NNS Doc_1655018_303_318_Disease)) (PP (IN with) (NP (JJ Doc_1655018_324_334_Disease) (CC and) (JJ marked) (NNS Doc_1655018_346_377_Disease)))))) (CC and) (VP (VBN died) (PP (IN of) (NP (NNS Doc_1655018_390_418_Disease)))))) (. .)))
1655018	3	(ROOT (S (PP (IN At) (NP (NN autopsy))) (NP (NNS peliosis) (CC and) (NNS Doc_1655018_444_467_Disease)) (VP (VBD were) (VP (VBN found) (SBAR (WHNP (WDT which)) (S (ADVP (RB histologically)) (VP (VBD proved) (S (VP (TO to) (VP (VB be) (NP (JJ well-differentiated) (NNS Doc_1655018_533_557_Disease)))))))))) (. .)))
1655018	4	(ROOT (S (NP (DT This) (NN case)) (VP (VBZ contributes) (PP (TO to) (NP (DT the) (JJ previous) (NNS observations))) (SBAR (IN that) (S (NP (JJ non-metastasizing) (NNS Doc_1655018_633_650_Disease) (CC and) (NNS peliosis)) (VP (MD can) (VP (VB develop) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ Doc_1655018_693_701_Chemical) (: -) (CC and) (JJ corticosteroid-treated) (NNS Doc_1655018_730_746_Disease)))))))))) (. .)))
16565833	0	(ROOT (NP (NP (DT The) (NN influence)) (PP (IN of) (NP (NP (DT the) (NN time) (NN interval)) (PP (IN between) (NP (NNS Doc_16565833_43_50_Chemical) (CC and) (NNS Doc_16565833_55_66_Chemical) (NN administration))))) (PP (IN on) (NP (NP (DT the) (NN protection)) (PP (IN against) (NP (NN Doc_16565833_108_119_Chemical-induced) (NNS Doc_16565833_128_142_Disease))))) (PP (IN in) (NP (NNS mice))) (. .)))
16565833	1	(ROOT (S (PP (IN Despite) (NP (PRP$ its) (JJ well-known) (NNS Doc_16565833_184_198_Disease))) (, ,) (NP (NP (DT the) (NNS Doc_16565833_204_228_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16565833_230_233_Chemical)) (-RRB- -RRB-))) (VP (VBZ continues) (S (VP (TO to) (VP (VB be) (NP (DT an) (ADJP (ADJP (JJ effective)) (CC and) (ADJP (RB widely) (VBN used))) (JJ chemotherapeutic) (NN agent)))))) (. .)))
16565833	2	(ROOT (S (NP (JJ Doc_16565833_304_307_Chemical-induced) (NNS Doc_16565833_316_330_Disease)) (ADVP (RB presumably)) (VP (VBZ results) (PP (IN from) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (JJ free) (NNS radicals))))) (PP (IN by) (NP (NNS Doc_16565833_389_392_Chemical)))) (. .)))
16565833	3	(ROOT (S (NP (JJ Reactive) (JJ Doc_16565833_403_409_Chemical) (NNS species)) (ADVP (RB particularly)) (VP (VBP affect) (NP (DT the) (JJ cardiac) (NNS myocytes)) (SBAR (IN because) (S (NP (DT these) (NNS cells)) (VP (VBP seem) (S (VP (TO to) (VP (VB have) (NP (DT a) (ADJP (RB relatively) (JJ poor)) (JJ antioxidant) (NN defense) (NN system))))))))) (. .)))
16565833	4	(ROOT (S (NP (NP (DT The) (JJ semisynthetic) (NNS Doc_16565833_556_590_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16565833_592_599_Chemical)) (-RRB- -RRB-))) (VP (VBD showed) (NP (NN cardioprotection)) (PP (IN against) (NP (NN Doc_16565833_633_636_Chemical-induced) (NNS Doc_16565833_645_659_Disease))) (PP (IN through) (NP (PRP$ its) (JJ radical) (NN scavenging) (CC and) (JJ Doc_16565833_695_699_Chemical) (VBG chelating) (NNS properties)))) (. .)))
16565833	5	(ROOT (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (ADJP (RB relatively) (JJ short)) (JJ final) (NN half-life)) (PP (IN of) (NP (NP (NNS Doc_16565833_773_780_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (RB about) (CD 30) (CD min))) (-RRB- -RRB-))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN expected) (SBAR (IN that) (S (NP (NP (DT the) (NN time) (NN interval)) (PP (IN between) (NP (NNS Doc_16565833_843_850_Chemical) (CC and) (NNS Doc_16565833_855_858_Chemical)))) (VP (MD might) (VP (VB be) (PP (IN of) (NP (NN influence))) (PP (IN on) (NP (NP (DT the) (JJ cardioprotective) (NN effect)) (PP (IN of) (NP (NNS Doc_16565833_915_922_Chemical))))))))))) (. .)))
16565833	6	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NN aim)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (NP (DT this) (JJ possible) (NN effect)))))) (. .)))
16565833	7	(ROOT (S (S (NP (NP (CD Six) (NNS groups)) (PP (IN of) (NP (CD 6) (JJ BALB/c) (NNS mice)))) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NN saline)))))) (, ,) (S (NP (NNS Doc_16565833_1068_1071_Chemical)) (ADJP (RB alone))) (CC or) (S (NP (NP (NNS Doc_16565833_1081_1084_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 4) (NN mg/kg) (NN i.v.)) (-RRB- -RRB-))) (VP (VBN preceded) (PP (IN by) (NP (NP (NP (NNS Doc_16565833_1112_1119_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 500) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-))) (PP (IN with) (NP (DT an) (ADJP (JJ interval) (ADVP (IN of)) (NP (CD 10) (, ,) (CD 30) (, ,) (CD 60) (CC or) (CD 120))) (NN min))))))) (. .)))
16565833	8	(ROOT (S (PP (IN After) (NP (NP (DT a) (JJ 6-week) (NN treatment) (NN period)) (CC and) (NP (NP (JJ additional) (NN observation)) (PP (IN for) (NP (CD 2) (NNS weeks)))))) (, ,) (NP (DT the) (NNS mice)) (VP (VBD were) (VP (VBN sacrificed))) (. .)))
16565833	9	(ROOT (S (NP (PRP$ Their) (JJ cardiac) (NNS tissues)) (VP (VBD were) (VP (VBN processed) (PP (IN for) (NP (NP (JJ light) (NN microscopy)) (, ,) (SBAR (WHPP (IN after) (WHNP (WDT which))) (S (NP (JJ cardiomyocyte) (NN damage)) (VP (VBD was) (VP (VBN evaluated) (PP (VBG according) (PP (TO to) (NP (NP (NNP Billingham)) (PRN (-LRB- -LRB-) (NP (PP (IN in) (NP (NNP Doc_16565833_1412_1418_Disease) (NNP Treat) (NNP Rep))) (NP (NP (CD 62)) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-)) (NP (NNP :865) (CD -872) (, ,) (CD 1978)))) (-RRB- -RRB-))))))))))))) (. .)))
16565833	10	(ROOT (S (NP (JJ Microscopic) (NN evaluation)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_16565833_1503_1506_Chemical)))) (ADVP (RB alone)) (VP (VBN induced) (NP (JJ significant) (NNS Doc_16565833_1533_1547_Disease)) (PP (IN in) (NP (NN comparison))) (PP (TO to) (NP (NP (DT the) (JJ saline) (NN control) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))))))) (. .)))
16565833	11	(ROOT (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (VBN damaged) (NNS cardiomyocytes)))) (VP (VBD was) (ADVP (ADVP (NP (NP (JJ 9.6-fold)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI) (CD 4.4-21)) (NP (CD .0)))) (-RRB- -RRB-))) (JJR higher)) (PP (IN in) (NP (NNS mice)))) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_16565833_1706_1709_Chemical))) (PP (ADVP (RB alone)) (IN than) (NP (NP (DT that)) (PP (IN in) (NP (NP (NNS animals)) (PP (IN of) (NP (DT the) (NN control) (NN group))))))))) (. .)))
16565833	12	(ROOT (S (NP (NP (DT The) (NN ratio)) (PP (IN of) (NP (NN aberrant)))) (VP (VBZ cardiomyocytes) (PP (IN in) (NP (NP (NNS mice)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_16565833_1817_1820_Chemical)) (VP (VBN preceded) (PP (IN by) (NP (NP (NNS Doc_16565833_1833_1840_Chemical)) (CC and) (NP (DT those)))) (PP (IN in) (NP (NP (NNS mice)) (VP (VBN treated) (PP (IN with) (NP (NP (NN saline)) (VP (VBN ranged) (PP (IN from) (NP (QP (CD 1.6) (TO to) (CD 2.8)))))))))))))))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (SBAR (S (NP (NP (CD 2.2)) (, ,) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (NP (CD 1.2-4) (CD .1))) (, ,)) (VP (VBP P) (S (VP (SYM =) (NP (CD 0.019))))))))) (-RRB- -RRB-))) (. .)))
16565833	13	(ROOT (S (NP (NP (DT The) (JJ mean) (JJ protective) (NN effect)) (PP (IN by) (S (VP (VBG adding) (NP (NNS Doc_16565833_1976_1983_Chemical)) (PP (IN before) (NP (NNS Doc_16565833_1991_1994_Chemical))))))) (VP (VBD led) (PP (TO to) (NP (NP (NP (DT a) (JJ significant) (JJ 4.4-fold) (NN reduction)) (PRN (-LRB- -LRB-) (NP (NP (NNP P)) (NP (NP (ADJP (QP (CD <) (CD 0.001))) (, ,) (ADJP (CD 95) (NN %)) (NN CI)) (NP (CD 2.3-8) (CD .2)))) (-RRB- -RRB-))) (PP (IN of) (NP (JJ abnormal) (NNS cardiomyocytes)))))) (. .)))
16565833	14	(ROOT (S (NP (DT This) (JJ protective) (NN effect)) (VP (VBD did) (RB not) (VP (VB depend) (PP (IN on) (NP (NP (DT the) (NN time) (NN interval)) (PP (IN between) (NP (NP (NNS Doc_16565833_2156_2163_Chemical)) (CC and) (NP (NP (JJ Doc_16565833_2168_2171_Chemical) (NN administration)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.345))) (-RRB- -RRB-))))))))) (. .)))
16565833	15	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (PP (IN in) (NP (DT an) (NN outpatient))) (NP (JJ clinical) (NN setting) (NNS Doc_16565833_2270_2277_Chemical)) (VP (MD may) (VP (VB be) (VP (VBN administered) (ADVP (RB shortly)) (PP (IN before) (NP (NNS Doc_16565833_2313_2316_Chemical))))))))) (. .)))
16723784	0	(ROOT (NP (NP (JJ Clinical) (NN evaluation)) (PP (IN of) (NP (JJ adverse) (NNS effects))) (PP (IN during) (NP (JJ Doc_16723784_46_54_Chemical) (NN administration))) (PP (IN for) (NP (NNS Doc_16723784_74_93_Disease) (CC and) (NN flutter))) (. .)))
16723784	1	(ROOT (S (NP (NP (NNP Doc_16723784_119_141_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Bpd)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN attracted) (NP (NN attention)) (PP (IN as) (NP (NP (DT an) (JJ effective) (NN drug)) (PP (IN for) (NP (NP (NNS Doc_16723784_197_216_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16723784_218_220_Disease)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_16723784_226_240_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16723784_242_245_Disease)) (-RRB- -RRB-)))))))) (. .)))
16723784	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (JJ serious) (JJ adverse) (NNS effects)) (, ,) (PP (VBG including) (NP (NP (NNS Doc_16723784_292_310_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16723784_312_315_Disease)) (-RRB- -RRB-)))) (, ,)) (VP (VBP have) (VP (VBN been) (VP (VBN reported)))) (. .)))
16723784	3	(ROOT (FRAG (NP (NNS METHODS) (CC AND) (NNS RESULTS)) (: :) (S (NP (NP (JJ Adverse) (NNS effects)) (PP (IN of) (NP (NP (NNP Bpd) (NNP requiring) (NNP discontinuation)) (PP (IN of) (NP (NN treatment)))))) (VP (VBD were) (VP (VBN evaluated)))) (. .)))
16723784	4	(ROOT (S (NP (NNP Bpd)) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (NP (CD 459) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 361) (NNS males)) (, ,) (NP (NP (QP (CD 63) (CD +)) (NNS /)) (ADJP (NP (CD -12) (NNS years)) (JJ old)))) (-RRB- -RRB-)))) (S (VP (VBG comprising) (NP (NP (JJ 378) (NNS Doc_16723784_520_522_Disease)) (CC and) (NP (CD 81) (JJ Doc_16723784_530_533_Disease) (NNS cases))))))) (. .)))
16723784	5	(ROOT (S (NP (NNP Mean)) (VP (VBD left) (SBAR (S (NP (NP (NN ventricular) (NN ejection) (NN fraction) (CC and) (NN atrial) (NN dimension)) (PRN (-LRB- -LRB-) (NP (NNP LAD)) (-RRB- -RRB-))) (VP (VBD were) (NP (NP (NP (CD 66) (NNS +)) (PRN (: /) (NP (NP (CD -11) (NN %)) (CC and) (NP (CD 40) (NNS +))) (: /)) (NP (CD -6) (NN mm))) (, ,) (ADVP (RB respectively))))))) (. .)))
16723784	6	(ROOT (S (NP (JJ Adverse) (NNS effects)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (CD 19) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 4) (NN %)) (-RRB- -RRB-)))) (PP (IN during) (NP (NP (DT an) (JJ average) (NN follow-up)) (PP (IN of) (NP (CD 20) (NNS months))))))) (. .)))
16723784	7	(ROOT (S (NP (EX There)) (VP (VBD was) (VP (VBN marked) (NP (NP (NNS Doc_16723784_760_775_Disease)) (SBAR (S (NP (QP (JJR greater) (IN than) (CD 0.55))) (VP (VBZ s) (PP (IN in) (NP (NP (CD 13) (NNS patients)) (, ,) (NP (NP (NNS Doc_16723784_812_823_Disease)) (VP (QP (JJR less) (IN than) (CD 40)) (VBN beats/min) (PP (IN in) (NP (NP (CD 6) (NNS patients)) (, ,) (NP (NN dizziness)) (CC and) (NP (JJ general) (NN fatigue)))) (PP (IN in) (NP (NP (CD 1) (NN patient)) (NP (DT each)))))))))))))) (. .)))
16723784	8	(ROOT (S (PP (IN In) (NP (NP (CD 4)) (PP (IN of) (NP (NP (CD 13) (NNS patients)) (PP (IN with) (NP (NNS Doc_16723784_936_951_Disease))))))) (, ,) (NP (NNS Doc_16723784_953_956_Disease)) (VP (VBD occurred)) (. .)))
16723784	9	(ROOT (S (NP (NP (DT The) (JJ major) (VBG triggering) (NNS factors)) (PP (IN of) (NP (NNS Doc_16723784_999_1002_Disease)))) (VP (VBD were) (NP (NP (JJ Doc_16723784_1008_1019_Disease) (CC and) (JJ sudden) (NN decrease)) (PP (IN in) (NP (NN heart) (NN rate))))) (. .)))
16723784	10	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (NNS differences)) (PP (IN in) (NP (NP (DT the) (JJ clinical) (NNS backgrounds)) (PP (IN of) (NP (DT the) (NNS patients)))))) (PP (IN with) (CC and) (IN without) (NP (NNP Doc_16723784_1142_1145_Disease) (JJ other))) (PP (IN than) (NP (NP (NN LAD) (CC and) (NN age)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (ADJP (ADJP (JJR larger) (CC and) (JJR older)) (PP (IN in) (NP (DT the) (NNS patients)))) (PP (IN with) (NP (NNS Doc_16723784_1219_1222_Disease))))))))) (. .)))
16723784	11	(ROOT (S (NP (NP (JJ Careful) (NN observation)) (PP (IN of) (NP (NP (NN serum) (JJ Doc_16723784_1265_1274_Chemical) (NN concentration)) (CC and) (NP (DT the) (NNP ECG))))) (VP (MD should) (ADVP (RB always)) (VP (VB be) (VP (VBN done) (PP (PP (IN during) (NP (NNP Bpd) (NN administration))) (, ,) (RB particularly) (PP (IN in) (NP (JJ elderly) (NNS patients))))))) (. .)))
16731636	0	(ROOT (NP (NP (JJ Enhanced) (NN Doc_16731636_9_22_Chemical-induced) (NNS Doc_16731636_31_50_Disease)) (PP (IN in) (NP (JJ transgenic) (NNS rats))) (PP (IN with) (NP (JJ low) (NN brain) (NN angiotensinogen))) (. .)))
16731636	1	(ROOT (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT a) (JJ permanent) (NNS Doc_16731636_144_154_Disease)) (PP (IN in) (NP (NP (DT the) (NN brain) (NN renin-angiotensin) (NN system)) (PRN (-LRB- -LRB-) (NP (NNP RAS)) (-RRB- -RRB-))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN sensitivity)) (PP (IN of) (NP (NP (DT the) (NN baroreflex) (NN control)) (PP (IN of) (NP (NN heart) (NN rate)))))))))))) (. .)))
16731636	2	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (NP (PRP we)) (VP (VBD aimed) (PP (IN at) (S (VP (VBG studying) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NP (DT the) (NN brain) (NN RAS)) (PP (IN in) (NP (DT the) (JJ cardiac) (NN reactivity)))))) (PP (TO to) (NP (NP (DT the) (JJ beta-adrenoceptor) (PRN (-LRB- -LRB-) (NP (NN beta-AR)) (-RRB- -RRB-)) (NN agonist) (NNS Doc_16731636_406_419_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Iso)) (-RRB- -RRB-)))))))) (. .)))
16731636	3	(ROOT (S (NP (NP (NNP Transgenic) (NNS rats)) (PP (IN with) (NP (NP (JJ low) (NN brain) (NN angiotensinogen)) (PRN (-LRB- -LRB-) (NP (NNP TGR)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN used))) (. .)))
16731636	4	(ROOT (S (PP (IN In) (NP (JJ isolated) (NNS hearts))) (, ,) (NP (NP (NNP Iso)) (VP (VBN induced) (NP (NP (DT a) (ADJP (RB significantly) (JJR greater)) (NN increase)) (PP (IN in) (NP (JJ left) (NN ventricular))))) (PRN (-LRB- -LRB-) (NP (NNP LV)) (-RRB- -RRB-))) (VP (VBP pressure) (CC and) (VBP maximal) (NP (NP (NP (NN contraction)) (-LRB- -LRB-) (NP (JJ +) (NN dP/dt)) (PRN (-LRB- -LRB-) (NP (NN max)) (-RRB- -RRB-)) (-RRB- -RRB-)) (PP (IN in) (NP (DT the) (NNP TGR)))) (ADVP (IN than) (PP (IN in) (NP (DT the) (JJ Sprague-Dawley) (PRN (-LRB- -LRB-) (NP (NNP SD)) (-RRB- -RRB-)) (NNS rats))))) (. .)))
16731636	5	(ROOT (S (NP (NP (NNP Doc_16731636_677_691_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNP Iso) (NN treatment))))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR higher) (PP (IN in) (NP (NNP TGR)))) (PP (IN than) (PP (IN in) (NP (NNP SD) (NNS rats))))) (PRN (-LRB- -LRB-) (FRAG (FRAG (PP (IN in) (NP (JJ g) (NNP LV) (JJ wt/100) (NN g) (NN body) (NN wt))) (, ,) (NP (CD 0.28) (CD +)) (: /)) (: -) (FRAG (FRAG (NP (CD 0.004)) (PP (FW vs.) (NP (CD 0.24) (NNS +)))) (: /) (FRAG (NP (CD -) (CD 0.004)) (, ,) (ADVP (RB respectively))))) (-RRB- -RRB-))) (. .)))
16731636	6	(ROOT (S (NP (NP (DT The) (JJR greater) (NNS Doc_16731636_854_868_Disease)) (PP (IN in) (NP (NNP TGR) (NNS rats)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (ADJP (RBR more) (JJ pronounced)) (NN downregulation)) (PP (IN of) (NP (NN beta-AR) (CC and) (NN upregulation))) (PP (IN of) (NP (NNP LV) (NNP beta-AR) (JJ kinase-1) (NN mRNA) (NNS levels))))) (PP (VBN compared) (PP (IN with) (NP (NP (DT those)) (PP (IN in) (NP (NNP SD) (NNS rats)))))))) (. .)))
16731636	7	(ROOT (S (NP (NP (DT The) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN heart) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP HR)) (-RRB- -RRB-)) (VP (VBN induced) (PP (IN by) (NP (NP (DT the) (JJ beta-AR) (NN antagonist) (NNS Doc_16731636_1097_1107_Chemical)) (PP (IN in) (NP (JJ conscious) (NNS rats))))))))) (VP (VBD was) (ADJP (RB significantly) (JJ attenuated)) (PP (IN in) (NP (NNP TGR))) (PP (VBN compared) (PP (IN with) (NP (NP (NNP SD) (NNS rats)) (PRN (-LRB- -LRB-) (NP (CD -9.9) (NNP +) (NNS /)) (: -) (NP (NP (CD 1.7) (NN %)) (PP (IN vs.) (NP (NP (CD -18.1) (JJ +) (NNS /)) (: -) (NP (CD 1.5) (NN %))))) (-RRB- -RRB-))))) (, ,) (SBAR (IN whereas) (S (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (JJ parasympathetic) (NN blockade)) (PP (IN by) (NP (NP (NNS Doc_16731636_1270_1278_Chemical)) (PP (IN on) (NP (NNP HR)))))))) (VP (VBD was) (ADJP (JJ similar) (PP (IN in) (NP (DT both) (NNS strains)))))))) (. .)))
16731636	8	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNP TGR)) (VP (VBP are) (ADJP (RBR more) (JJ sensitive) (PP (TO to) (NP (NP (JJ beta-AR) (JJ agonist-induced) (JJ cardiac) (JJ inotropic) (NN response)) (CC and) (NP (NNS Doc_16731636_1423_1434_Disease))))) (, ,) (ADVP (RB possibly)) (ADJP (JJ due) (PP (TO to) (NP (NP (ADJP (RB chronically) (JJ low)) (JJ sympathetic) (NN outflow)) (VP (VBN directed) (PP (TO to) (NP (DT the) (NN heart))))))))))) (. .)))
16801510	0	(ROOT (NP (NP (NP (JJ Drug-induced) (NNS Doc_16801510_13_29_Disease)) (PP (IN in) (NP (NP (NN injection) (NN drug) (NNS users)) (VP (VBG receiving) (NP (NNS Doc_16801510_64_73_Chemical)))))) (: :) (NP (NP (JJ high) (NN frequency)) (PP (IN in) (NP (JJ hospitalized) (NNS patients) (CC and) (NN risk) (NNS factors)))) (. .)))
16801510	1	(ROOT (S (NP (JJ Drug-induced) (NNS Doc_16801510_158_174_Disease)) (VP (VBZ is) (NP (DT a) (JJ serious) (NNS Doc_16801510_188_209_Disease))) (. .)))
16801510	2	(ROOT (S (NP (NNP Doc_16801510_211_220_Chemical)) (VP (VBZ prolongs) (NP (DT the) (NNP QT) (NN interval)) (PP (IN in) (ADJP (NN vitro) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner)))))) (. .)))
16801510	3	(ROOT (S (PP (IN In) (NP (DT the) (JJ inpatient) (NN setting))) (, ,) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NP (NNP QT) (JJ interval) (NN prolongation)) (PP (IN with) (NP (NP (JJ Doc_16801510_356_365_Chemical) (NN treatment)) (, ,) (NP (PRP$ its) (NN dose) (NN dependence)) (, ,) (CC and) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NP (NNS cofactors)) (PP (JJ such) (IN as) (NP (JJ drug-drug) (NNS interactions))))))))))) (VP (VBP remain) (ADJP (JJ unknown))) (. .)))
16801510	4	(ROOT (S (NP (PRP We)) (VP (VBD performed) (NP (NP (DT a) (ADJP (JJ systematic) (, ,) (JJ retrospective)) (NN study)) (VP (VBG comparing) (NP (NP (JJ active) (CC or) (JJ former) (JJ intravenous) (NN drug) (NNS users)) (VP (VBG receiving) (S (NP (NP (NNS Doc_16801510_593_602_Chemical)) (CC and) (NP (DT those))) (VP (RB not) (VBG receiving) (NP (NNS Doc_16801510_627_636_Chemical)) (PP (IN among) (NP (NP (DT all) (NNS patients)) (VP (VBN hospitalized) (PP (IN over) (NP (NP (DT a) (JJ 5-year) (NN period)) (PP (IN in) (NP (DT a) (JJ tertiary) (NN care) (NN hospital))))))))))))))) (. .)))
16801510	5	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 167) (NNS patients)) (VP (VBG receiving) (NP (NNS Doc_16801510_753_762_Chemical)))))) (VP (VP (VBD fulfilled) (NP (DT the) (NN inclusion) (NNS criteria))) (CC and) (VP (VBD were) (VP (VBN compared) (PP (IN with) (S (NP (NP (DT a) (NN control) (NN group)) (PP (IN of) (NP (CD 80) (NN injection) (NN drug) (NNS users)))) (RB not) (VP (VBG receiving) (NP (NNS Doc_16801510_876_885_Chemical)))))))) (. .)))
16801510	6	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (JJ Doc_16801510_902_911_Chemical) (NN dose))) (, ,) (ADJP (CD 15) (JJ demographic)))) (, ,) (NP (JJ biological) (, ,) (CC and) (NN pharmacological) (NNS variables)) (VP (VBD were) (VP (VBN considered) (PP (IN as) (NP (NP (JJ potential) (NN risk) (NNS factors)) (PP (IN for) (NP (NNS Doc_16801510_1022_1037_Disease))))))) (. .)))
16801510	7	(ROOT (S (PP (IN Among) (NP (QP (CD 167) (NNS Doc_16801510_1058_1067_Chemical)) (NN maintenance) (NNS patients))) (, ,) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (NP (NNS Doc_16801510_1108_1124_Disease)) (PP (TO to) (NP (NP (NP (CD 0.50) (NN second)) (PRN (-LRB- -LRB-) (NP (QP (CD -LRB-) (CD 1/2))) (-RRB- -RRB-)) (-RRB- -RRB-)) (ADVP (CC or) (RB longer))))))) (VP (VBD was) (NP (CD 16.2) (NN %)) (PP (VBN compared) (PP (IN with) (NP (NP (CD 0) (NN %)) (PP (IN in) (NP (CD 80) (NN control) (NNS subjects))))))) (. .)))
16801510	8	(ROOT (S (NP (NP (NP (CD Six) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 3.6) (NN %)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (JJ Doc_16801510_1235_1244_Chemical) (NN group)))) (VP (VBD presented) (NP (NNS Doc_16801510_1261_1280_Disease))) (. .)))
16801510	9	(ROOT (S (NP (NNP QTc) (NN length)) (VP (VBD was) (UCP (ADJP (JJ weakly)) (CC but) (VP (ADVP (RB significantly)) (VBN associated) (PP (IN with) (NP (NP (JJ Doc_16801510_1338_1347_Chemical) (JJ daily) (NN dose)) (PRN (-LRB- -LRB-) (NP (NP (NNP Spearman) (NN rank) (NN correlation) (NN coefficient)) (, ,) (NP (CD 0.20))) (: ;) (S (NP (NNP P)) (VP (VBZ <) (NP (CD .01)))) (-RRB- -RRB-))))))) (. .)))
16801510	10	(ROOT (SINV (S (NP (JJ Multivariate) (NN regression) (NN analysis)) (VP (VBD allowed) (NP (NP (NN attribution)) (PP (IN of) (NP (NP (CD 31.8) (NN %)) (PP (IN of) (NP (NNP QTc) (NN variability)))))) (PP (TO to) (NP (JJ Doc_16801510_1497_1506_Chemical) (NN dose))))) (, ,) (VP (VBP cytochrome) (ADJP (JJ P-450))) (NP (NP (CD 3A4) (JJ drug-drug) (NNS interactions)) (, ,) (NP (NP (NNS Doc_16801510_1558_1569_Disease)) (, ,) (CC and) (NP (JJ altered) (NN liver) (NN function)))) (. .)))
16801510	11	(ROOT (S (NP (NP (NNP QT) (JJ interval) (NN prolongation)) (PP (IN in) (NP (NP (JJ Doc_16801510_1640_1649_Chemical) (NN maintenance) (NNS patients)) (VP (VBN hospitalized) (PP (IN in) (NP (DT a) (JJ tertiary) (NN care) (NN center))))))) (VP (VBZ is) (NP (DT a) (JJ frequent) (NN finding))) (. .)))
16801510	12	(ROOT (S (NP (NP (JJ Doc_16801510_1733_1742_Chemical) (NN dose)) (, ,) (NP (NP (NN presence)) (PP (IN of) (NP (NP (JJ cytochrome) (NN P-450) (CD 3A4) (NNS inhibitors)) (, ,) (NP (JJ Doc_16801510_1794_1803_Chemical) (NN level)) (, ,) (CC and) (NP (NN liver) (NN function)))))) (VP (VBP contribute) (PP (TO to) (NP (NNS Doc_16801510_1844_1859_Disease)))) (. .)))
16801510	13	(ROOT (S (NP (NNP Doc_16801510_1861_1877_Disease)) (VP (MD can) (VP (VB occur) (PP (IN with) (NP (NP (JJ low) (NNS doses)) (PP (IN of) (NP (NNS Doc_16801510_1906_1915_Chemical))))))) (. .)))
16810074	0	(ROOT (NP (NP (NP (NNPS Mechanisms)) (PP (IN of) (NP (NP (NNS Doc_16810074_14_26_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNP Doc_16810074_38_50_Chemical) (PRN (-LRB- -LRB-) (INTJ (RB NO)) (-RRB- -RRB-)) (NN deficiency))))))) (: :) (NP (NP (NN focus)) (PP (IN on) (NP (JJ venous) (NN function)))) (. .)))
16810074	1	(ROOT (S (NP (NP (NN Loss)) (PP (IN of) (NP (NP (NP (JJ endothelial) (JJ cell-derived) (NNS Doc_16810074_127_139_Chemical)) (PRN (-LRB- -LRB-) (INTJ (RB NO)) (-RRB- -RRB-))) (PP (IN in) (NP (NNS Doc_16810074_148_160_Disease)))))) (VP (VBZ is) (NP (NP (DT a) (NN hallmark)) (PP (IN of) (NP (NNS Doc_16810074_178_198_Disease))))) (. .)))
16810074	2	(ROOT (S (NP (NP (JJ Experimental) (NNS Doc_16810074_213_225_Disease)) (VP (VBN created) (PP (IN by) (NP (NP (DT the) (NN removal)) (PP (IN of) (NP (INTJ (RB NO)))))))) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ involves) (NP (NP (NNS mechanisms)) (PP (IN in) (NP (NN addition)))) (PP (TO to) (NP (VBN decreased) (JJ arterial) (NN vasodilator) (NN activity)))) (. .)))
16810074	3	(ROOT (S (NP (DT These)) (VP (VP (VBP include) (NP (ADJP (ADJP (RB augmented) (JJ endothelin-1)) (PRN (-LRB- -LRB-) (NP (NNP ET-1)) (-RRB- -RRB-))) (NN release))) (, ,) (VP (VBD increased) (NP (ADJP (JJ sympathetic) (JJ nervous)) (NN system) (NN activity))) (, ,) (CC and) (VP (VBD elevated) (NP (NN tissue) (NN oxidative) (NN stress)))) (. .)))
16810074	4	(ROOT (S (NP (PRP We)) (VP (VBD hypothesized) (SBAR (S (NP (DT that) (JJ Doc_16810074_500_530_Disease) (-LRB- -LRB-) (NN venomotor) (-RRB- -RRB-) (NN tone)) (VP (VBZ plays) (NP (NP (DT a) (NN role)) (PP (IN in) (NP (JJ Doc_16810074_564_587_Chemical) (PRN (-LRB- -LRB-) (NP (NNP LNNA)) (-RRB- -RRB-)) (NNS Doc_16810074_595_607_Disease)))) (PP (IN through) (NP (DT these) (NNS mechanisms))))))) (. .)))
16810074	5	(ROOT (S (NP (NNS Rats)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (DT the) (JJ NO) (JJ synthase) (NN inhibitor) (NNS Doc_16810074_683_687_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.5) (NN g/L)) (PP (IN in) (NP (NN drinking) (NN water)))) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 2) (NNS weeks))))) (. .)))
16810074	6	(ROOT (S (S (NP (NP (JJ Mean) (JJ arterial) (NN pressure)) (PP (IN of) (NP (JJ conscious) (NNS rats)))) (VP (VBD was) (NP (NP (QP (CD 119) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 2) (NN mm) (NNP Hg)) (PP (IN in) (NP (NP (NN control)) (CC and) (NP (CD 194) (NNS +))))) (: /))))) (: -) (S (NP (CD 5) (NN mm)) (VP (VBN Hg) (PP (IN in) (NP (NNP LNNA) (NNS rats))) (PRN (-LRB- -LRB-) (ADVP (RB P)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-)))) (. .)))
16810074	7	(ROOT (S (NP (NP (JJ Carotid) (NNS arteries)) (CC and) (NP (NN vena) (NN cava))) (VP (VBD were) (VP (VBN removed) (PP (IN for) (NP (NP (NN measurement)) (PP (IN of) (NP (JJ isometric) (NN contraction))))))) (. .)))
16810074	8	(ROOT (S (NP (NP (JJ Maximal) (NN contraction)) (PP (TO to) (NP (NNS Doc_16810074_953_967_Chemical)))) (VP (VBD was) (ADVP (RB modestly)) (VP (VBN reduced) (PP (IN in) (NP (NP (NNS arteries)) (PP (IN from) (NP (NNP LNNA))))) (PP (VBN compared) (PP (IN with) (NP (NP (NN control) (NNS rats)) (SBAR (IN whereas) (S (NP (NP (DT the) (JJ maximum) (NN contraction)) (PP (TO to) (NP (NN ET-1)))) (VP (VBD was) (VP (ADVP (RB significantly)) (VBN reduced))))) (PRN (-LRB- -LRB-) (NP (NP (CD 54) (NN %)) (NP (NN control))) (-RRB- -RRB-))))))) (. .)))
16810074	9	(ROOT (S (S (NP (NP (JJ Maximum) (NN contraction)) (PP (IN of) (NP (NP (NN vena) (NN cava)) (PP (TO to) (NP (NP (NNS Doc_16810074_1155_1169_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 37) (NN %)) (NP (NN control))) (-RRB- -RRB-))))))) (ADVP (RB also)) (VP (VBD was) (VP (VBN reduced)))) (CC but) (S (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN ET-1)))))) (VP (VBD was) (ADJP (JJ observed)))) (. .)))
16810074	10	(ROOT (S (NP (NP (JJ Mean) (JJ circulatory) (NN filling) (NN pressure)) (, ,) (NP (NP (DT an) (RB in) (JJ vivo) (NN measure)) (PP (IN of) (NP (NN venomotor) (NN tone)))) (, ,)) (VP (VBD was) (RB not) (VP (VBD elevated) (PP (IN in) (NP (NNP LNNA) (NNP Doc_16810074_1347_1359_Disease))) (PP (NP (QP (IN at) (CD 1) (CC or) (CD 2)) (NNS weeks)) (IN after) (NP (NNP LNNA))))) (. .)))
16810074	11	(ROOT (S (NP (NP (DT The) (JJ Doc_16810074_1392_1402_Chemical) (NN scavenger) (NNS Doc_16810074_1413_1419_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 30) (, ,) (CD 100) (, ,) (CC and) (CD 300)) (NP (NP (JJ micromol) (NN kg)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)) (, ,) (NP (NNP IV)))) (-RRB- -RRB-))) (VP (VP (VBD did) (RB not) (VP (VB change) (NP (JJ arterial) (NN pressure)) (PP (IN in) (NP (NN control) (NNS rats))))) (CC but) (VP (VBD caused) (NP (DT a) (JJ dose-dependent) (NN decrease)) (PP (IN in) (NP (NNP LNNA) (NNS rats))) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD -18)) (JJ +)) (: /)) (: -) (FRAG (FRAG (NP (CD 8)) (, ,) (NP (CD -26) (CD +)) (: /)) (: -) (FRAG (FRAG (NP (CD 15)) (, ,) (PP (CC and) (NP (CD -54) (NNS +))) (: /)) (: -) (FRAG (NP (CD 11) (NN mm)) (NP (NNP Hg)))))) (-RRB- -RRB-)))) (. .)))
16810074	12	(ROOT (S (ADVP (RB Similarly)) (, ,) (NP (NP (JJ ganglionic) (NN blockade)) (PP (IN with) (NP (NNS Doc_16810074_1641_1654_Chemical)))) (VP (VBD caused) (NP (NP (DT a) (ADJP (RB significantly) (JJR greater)) (NN fall)) (PP (IN in) (NP (NNP LNNA) (NNP Doc_16810074_1699_1711_Disease) (NNS rats))) (PRN (-LRB- -LRB-) (NP (CD 76) (NNP +) (NNS /)) (, -) (NP (CD 9) (NN mm) (NN Hg)) (-RRB- -RRB-))) (PP (VBN compared) (PP (IN with) (NP (NP (NN control) (NNS rats)) (PRN (-LRB- -LRB-) (NP (CD 35) (NNP +) (NNS /)) (, -) (NP (CD 10) (NN mm) (NN Hg)) (-RRB- -RRB-)))))) (. .)))
16810074	13	(ROOT (S (NP (NP (JJ Carotid) (NNS arteries)) (, ,) (NP (NN vena) (NN cava)) (, ,) (CC and) (NP (NP (JJ sympathetic) (NN ganglia)) (PP (IN from) (NP (NNP LNNA) (NNS rats))))) (VP (VBD had) (NP (NP (JJR higher) (NN basal) (NNS levels)) (PP (IN of) (NP (NNS Doc_16810074_1875_1885_Chemical)))) (PP (VBN compared) (PP (IN with) (NP (NP (DT those)) (PP (IN from) (NP (NN control) (NNS rats))))))) (. .)))
16810074	14	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (SBAR (IN while) (S (NP (DT NO) (NN deficiency)) (VP (VBZ increases) (NP (NP (JJ oxidative) (NN stress) (CC and) (JJ sympathetic) (NN activity)) (PP (IN in) (NP (ADJP (DT both) (JJ arterial) (CC and) (JJ venous)) (NNS vessels))))))) (, ,) (NP (NP (DT the) (NN impact)) (PP (IN on) (NP (NNS veins)))) (VP (VBZ does) (RB not) (VP (VB make) (NP (DT a) (JJ major) (NN contribution)) (PP (TO to) (NP (NP (DT this) (NN form)) (PP (IN of) (NP (NNS Doc_16810074_2129_2141_Disease)))))))))) (. .)))
16867246	0	(ROOT (NP (NP (NNP Association)) (PP (IN of) (NP (NN DRD2) (NNS polymorphisms) (CC and) (NN Doc_16867246_38_52_Chemical-induced) (NNS Doc_16867246_61_84_Disease))) (PP (IN in) (NP (JJ Chinese) (JJ Doc_16867246_96_109_Disease) (NNS patients))) (. .)))
16867246	1	(ROOT (S (NP (NP (NNP Doc_16867246_125_148_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16867246_150_153_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RBS most) (RB commonly)) (VP (VBN affected) (PP (IN by) (NP (NP (JJ typical) (JJ antipsychotic) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (NP (DT a) (JJ high) (NN affinity)) (PP (IN with) (NP (DT the) (NNP D2) (NN receptor))))))))))) (. .)))
16867246	2	(ROOT (S (ADVP (RB Recently)) (, ,) (NP (JJ many) (NN research) (NNS groups)) (VP (VBP have) (VP (VBN reported) (PP (IN on) (NP (NP (DT the) (JJ positive) (NN relationship)) (PP (IN between) (NP (NP (NP (DT the) (JJ genetic) (NNS variations)) (PP (IN in) (NP (DT the) (NNP DRD2) (NN gene)))) (CC and) (NP (NP (DT the) (JJ therapeutic) (NN response)) (PP (IN in) (NP (JJ Doc_16867246_414_427_Disease) (NNS patients)))))))) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (NNS variations)) (PP (IN in) (NP (NP (DT the) (NN receptor)) (PP (IN in) (NP (VBG modulating) (NN receptor) (NN expression))))))))))))) (. .)))
16867246	3	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VB evaluate) (SBAR (S (NP (DT the) (NN role) (NN DRD2)) (VP (VBZ plays) (PP (IN in) (NP (NP (NN Doc_16867246_576_590_Chemical-induced) (NNS Doc_16867246_599_602_Disease)) (PP (IN in) (NP (JJ Doc_16867246_606_619_Disease) (NNS patients))))))))) (. .)))
16867246	4	(ROOT (S (NP (PRP We)) (VP (VBD identified) (NP (NP (CD seven) (NN SNP) (PRN (-LRB- -LRB-) (NP (JJ single) (JJ nucleotide) (NN polymorphism)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NNP -141) (NNP Cins) (NNP >) (NNP del)) (, ,) (NP (NNP TaqIB) (, ,) (NNP TaqID) (, ,) (NNP Ser311Cys) (, ,) (NNP rs6275) (, ,) (NNP rs6277) (CC and) (NNP TaqIA))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NP (DT the) (NN DRD2) (NN gene)) (PP (IN in) (NP (CD 146) (JJ Doc_16867246_785_798_Disease) (NNS inpatients)))) (PRN (-LRB- -LRB-) (NP (NP (CD 59)) (PP (IN with) (NP (CD Doc_16867246_819_822_Disease) (CC and) (CD 87))) (PP (IN without) (NP (NP (NNS Doc_16867246_838_841_Disease)) (PP (VBG according) (PP (TO to) (NP (DT the) (NNP Simpson-Angus) (NNP Scale))))))) (-RRB- -RRB-)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_16867246_893_907_Chemical))) (PP (IN after) (NP (CD 8) (NNS weeks))))))) (. .)))
16867246	5	(ROOT (S (NP (NP (DT The) (NNS alleles)) (PP (IN of) (NP (DT all) (NN loci)))) (VP (VBD were) (VP (VBN determined) (PP (IN by) (NP (NP (NNP PCR)) (PRN (-LRB- -LRB-) (NP (CD polymerase) (NN chain) (NN reaction)) (-RRB- -RRB-)))))) (. .)))
16867246	6	(ROOT (S (NP (NNP Polymorphisms) (NNP TaqID) (, ,) (NNS Ser311Cys) (CC and) (NNS rs6277)) (VP (VBD were) (RB not) (ADJP (JJ polymorphic) (PP (IN in) (NP (NP (DT the) (NN population)) (VP (VBN recruited) (PP (IN in) (NP (DT the) (JJ present) (NN study)))))))) (. .)))
16867246	7	(ROOT (S (NP (DT No) (JJ statistical) (NN significance)) (VP (VBD was) (VP (VBN found) (PP (PP (IN in) (NP (NP (DT the) (JJ allele) (NN distribution)) (PP (IN of) (NP (NNP -141) (NNP Cins) (NNP >) (NNP del) (, ,) (NNP TaqIB) (, ,) (NNP rs6275) (CC and) (NNP TaqIA))))) (CC or) (PP (IN in) (NP (NP (NP (DT the) (VBN estimated) (NNS haplotypes)) (PRN (-LRB- -LRB-) (VP (VBD constituted) (PP (IN by) (NP (NNP TaqIB) (, ,) (NNP rs6275) (CC and) (NNP TaqIA)))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (JJ linkage) (NN disequilibrium)) (PP (IN between) (NP (DT the) (CD two) (NNS groups)))))))))) (. .)))
16867246	8	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBD did) (RB not) (VP (VB lend) (NP (JJ strong) (NN support)) (PP (TO to) (NP (DT the) (NN view))) (SBAR (IN that) (S (NP (NP (DT the) (JJ genetic) (NN variation)) (PP (IN of) (NP (DT the) (NNP DRD2) (NN gene)))) (VP (VBZ plays) (NP (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ individually) (JJ variable) (JJ adverse) (NN effect)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_16867246_1531_1545_Chemical)) (, ,) (ADVP (IN at) (JJS least)))) (PP (IN in) (NP (JJ Chinese) (NNS patients))) (PP (IN with) (NP (NNS Doc_16867246_1581_1594_Disease)))))))))))) (. .)))
16867246	9	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBD confirmed) (NP (DT a) (JJ previous) (NN study)) (PP (IN on) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NNP DRD2) (CC and) (NNP Doc_16867246_1672_1675_Disease))))) (PP (IN in) (NP (NNP Caucasians)))) (. .)))
16876986	0	(ROOT (S (NP (JJ Physical) (NN training)) (VP (VBZ decreases) (ADVP (RB susceptibility)) (PP (TO to) (NP (NP (JJ subsequent) (NN Doc_16876986_57_68_Chemical-induced) (NNS Doc_16876986_77_85_Disease)) (PP (IN in) (NP (DT the) (NN rat)))))) (. .)))
16876986	1	(ROOT (S (S (NP (JJ Regular) (NN motor) (NN activity)) (VP (VBZ has) (NP (NP (JJ many) (NNS benefits)) (PP (IN for) (NP (JJ mental) (CC and) (JJ physical) (NN condition)))))) (CC but) (S (NP (NP (PRP$ its) (NNS implications)) (PP (IN for) (NP (NNS Doc_16876986_198_206_Disease)))) (VP (VBP are) (ADVP (RB still)) (ADJP (JJ controversial)))) (. .)))
16876986	2	(ROOT (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB elucidate) (NP (DT this) (NN problem)))))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN studied) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ long-term) (JJ physical) (NN activity)))) (PP (IN on) (NP (NN susceptibility))) (PP (TO to) (NP (JJ subsequent) (NNS Doc_16876986_358_366_Disease))))) (. .)))
16876986	3	(ROOT (S (NP (NNP Male) (NNP Wistar) (NNS rats)) (VP (VBD were) (VP (VBN subjected) (PP (TO to) (NP (NP (VBN repeated) (NN training) (NNS sessions)) (PP (IN in) (NP (DT a) (NN treadmill) (CC and) (NN swimming) (NN pool))))))) (. .)))
16876986	4	(ROOT (S (ADVP (RB Thereafter)) (, ,) (NP (NNS Doc_16876986_476_484_Disease)) (VP (VBD were) (VP (VBN induced) (PP (IN by) (NP (NP (JJ Doc_16876986_501_512_Chemical) (NNS injections)) (PP (IN in) (NP (ADJP (JJ trained) (CC and) (JJ non-trained)) (NN control) (NNS groups))))))) (. .)))
16876986	5	(ROOT (S (PP (IN During) (NP (NP (DT the) (JJ acute) (NN period)) (PP (IN of) (NP (NNS Doc_16876986_594_612_Disease))))) (, ,) (NP (PRP we)) (VP (VBD measured) (: :) (NP (NP (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (DT the) (NN latency)) (PP (IN of) (NP (NP (NP (DT the) (JJ first) (NN motor) (NN sign)) (, ,) (NP (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (DT the) (NN intensity)) (PP (IN of) (NP (NNS Doc_16876986_689_697_Disease)))) (, ,) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))) (NP (DT the) (NN time)) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBD occurred) (PP (IN within) (NP (DT the) (JJ 6-h) (NN observation) (NN period))))))))) (, ,) (CC and) (PRN (-LRB- -LRB-) (NP (CD 4)) (-RRB- -RRB-)) (NP (DT the) (NN time)))) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (JJ acute) (NN period)) (VP (VBD ended)))) (. .)))
16876986	6	(ROOT (S (NP (PDT All) (DT these) (JJ behavioral) (NNS parameters)) (VP (VBD showed) (NP (ADJP (RB statistically) (JJ significant)) (NNS changes)) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ regular) (JJ physical) (NNS exercises)) (VP (VP (VB decrease) (ADVP (RB susceptibility)) (S (VP (TO to) (VP (ADVP (RB subsequently)) (VB induced) (NP (NNS Doc_16876986_974_982_Disease)))))) (CC and) (VP (VB ameliorate) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (JJ experimentally) (JJ induced) (NNS Doc_16876986_1035_1053_Disease))))))))))) (. .)))
16880771	0	(ROOT (S (NP (JJ Tonic) (JJ dopaminergic) (NN stimulation) (NNS impairs)) (VP (VBP associative) (S (VP (VBG learning) (PP (IN in) (NP (JJ healthy) (NNS subjects)))))) (. .)))
16880771	1	(ROOT (S (NP (JJ Endogenous) (NNS Doc_16880771_92_100_Chemical)) (VP (VBZ plays) (NP (NP (DT a) (JJ central) (NN role)) (PP (IN in) (NP (NP (NN salience)) (VP (VBG coding) (PP (IN during) (NP (JJ associative) (NN learning)))))))) (. .)))
16880771	2	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (DT the) (JJ Doc_16880771_192_200_Chemical) (NN precursor) (NN levodopa)))) (VP (VBZ enhances) (S (VP (VBG learning) (PP (IN in) (NP (NP (JJ healthy) (NNS subjects)) (CC and) (NP (JJ Doc_16880771_262_268_Disease) (NNS patients))))))) (. .)))
16880771	3	(ROOT (S (SBAR (IN Because) (S (NP (NNS Doc_16880771_287_295_Chemical)) (VP (VBZ increases) (NP (DT both) (ADJP (JJ phasic) (CC and) (JJ tonic)) (JJ dopaminergic) (NN neurotransmission))))) (, ,) (NP (NP (DT the) (JJ critical) (NN mechanism)) (VP (VBG mediating) (NP (NP (DT the) (NN enhancement)) (PP (IN of) (S (VP (VBG learning))))))) (VP (VBZ is) (ADJP (JJ unresolved))) (. .)))
16880771	4	(ROOT (S (NP (PRP We)) (ADVP (RB here)) (VP (VBD probed) (SBAR (WHADVP (WRB how)) (S (NP (JJ selective) (NN tonic) (NN dopaminergic) (NN stimulation)) (VP (VBZ affects) (NP (JJ associative) (NN learning)))))) (. .)))
16880771	5	(ROOT (S (NP (JJ Forty) (JJ healthy) (NNS subjects)) (VP (VBD were) (VP (VBN trained) (PP (IN in) (NP (NP (DT a) (NN novel) (NN vocabulary)) (PP (IN of) (NP (NP (CD 45) (JJ concrete) (NNS nouns)) (PP (IN over) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (NP (CD 5) (JJ consecutive) (NN training) (NNS days)) (PP (IN in) (NP (DT a) (JJ prospective) (, ,) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN design))))))))))))) (. .)))
16880771	6	(ROOT (S (NP (NNS Subjects)) (VP (VBD received) (NP (DT the) (VP (ADVP (RB tonically)) (JJ stimulating) (NP (NNS Doc_16880771_767_775_Chemical-receptor)) (SBAR (S (NP (NP (JJ agonist) (NNS Doc_16880771_793_802_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.1) (NNS mg)) (-RRB- -RRB-))) (VP (VBP vs) (NP (QP (CD placebo) (CD 120))))))) (NN min)) (PP (IN before) (S (VP (VBG training) (PP (IN on) (NP (DT each) (NN training) (NN day))))))) (. .)))
16880771	7	(ROOT (S (NP (DT The) (NNS Doc_16880771_873_881_Chemical)) (VP (VBP agonist) (NP (ADJP (RB significantly) (JJ impaired)) (NN novel) (NN word)) (VP (VBG learning) (PP (VBN compared) (PP (TO to) (NP (NN placebo)))))) (. .)))
16880771	8	(ROOT (S (NP (DT This) (NN learning) (NN decrement)) (VP (VBD persisted) (PRT (RP up)) (PP (TO to) (NP (NP (DT the) (JJ last) (NN follow-up)) (ADJP (NP (CD 4) (NNS weeks)) (JJ post-training))))) (. .)))
16880771	9	(ROOT (S (NP (NP (NNS Subjects)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_16880771_1058_1067_Chemical))))) (ADVP (RB also)) (VP (VBD showed) (NP (JJ restricted) (JJ emotional) (NNS responses)) (PP (VBN compared) (PP (TO to) (NP (DT the) (NNP PLACEBO) (NN group))))) (. .)))
16880771	10	(ROOT (S (NP (NP (DT The) (NN extent)) (PP (IN of) (NP (NP (`` `) (JJ flattened) ('' ') (NN affect)) (PP (IN with) (NP (NNS Doc_16880771_1180_1189_Chemical)))))) (VP (VBD was) (VP (VBN related) (PP (TO to) (NP (NP (DT the) (NN degree)) (PP (IN of) (S (VP (VBG learning) (NP (NN inhibition))))))))) (. .)))
16880771	11	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN tonic) (NN occupation)) (PP (IN of) (NP (JJ Doc_16880771_1288_1296_Chemical) (NNS receptors)))) (VP (VBZ impairs) (S (VP (VBG learning) (PP (IN by) (NP (NN competition))) (PP (IN with) (NP (JJ phasic) (JJ Doc_16880771_1351_1359_Chemical) (NNS signals))))))))) (. .)))
16880771	12	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (JJ phasic) (NNS signaling)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ critical) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NNS Doc_16880771_1436_1444_Chemical)) (VP (VBZ enhances) (NP (NP (NN associative)) (VP (VBG learning) (PP (IN in) (NP (NP (JJ healthy) (NNS subjects)) (CC and) (NP (JJ Doc_16880771_1499_1505_Disease) (NNS patients)))))))))))))) (. .)))
16906379	0	(ROOT (NP (NP (JJ Doc_16906379_0_11_Chemical-induced) (NNS Doc_16906379_20_30_Disease)) (VP (VBG fulfilling) (NP (NP (DT the) (NNS criteria)) (PP (IN of) (NP (NNS Doc_16906379_58_78_Disease))))) (. .)))
16906379	1	(ROOT (S (NP (NP (DT A) (JJ 47-year-old) (NN man)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN been) (VP (VBG taking) (NP (NP (NNS Doc_16906379_118_129_Chemical)) (PP (IN for) (NP (NNS Doc_16906379_134_157_Disease)))))))))) (VP (VBD developed) (NP (NP (NNS Doc_16906379_168_173_Disease)) (, ,) (NP (NNS Doc_16906379_175_183_Disease)) (, ,) (NP (NNS Doc_16906379_185_199_Disease)) (, ,) (CC and) (NP (NNS Doc_16906379_205_220_Disease))) (, ,) (PP (IN with) (NP (NP (JJ elevated) (JJ C-reactive) (NN protein)) (PRN (-LRB- -LRB-) (NP (NNP CRP)) (-RRB- -RRB-))))) (. .)))
16906379	2	(ROOT (FRAG (NP (DT Neither) (NN myeloperoxidase)) (: -) (S (CC nor) (NP (JJ proteinase-3-antineutrophil) (JJ cytoplasmic) (NN antibody)) (VP (VBD was) (ADJP (JJ positive)))) (. .)))
16906379	3	(ROOT (S (NP (DT These) (NNS manifestations)) (VP (VBD met) (NP (NP (DT the) (NNP American) (NNP College)) (PP (IN of) (NP (NNP Rheumatology) (CD 1990) (NNS criteria)))) (PP (IN for) (NP (NP (DT the) (NN classification)) (PP (IN of) (NP (NNS Doc_16906379_456_476_Disease)))))) (. .)))
16906379	4	(ROOT (S (NP (VBG Stopping) (NNS Doc_16906379_487_498_Chemical)) (VP (VBD led) (S (VP (TO to) (VP (VB amelioration) (PP (IN of) (NP (NP (NNS symptoms) (CC and) (NNS normalization)) (PP (IN of) (NP (NNP CRP) (NN level))))))))) (. .)))
16906379	5	(ROOT (S (PP (TO To) (NP (PRP$ our) (NN knowledge))) (, ,) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ second) (NN case)) (PP (IN of) (NP (NP (NN Doc_16906379_608_619_Chemical-induced) (NNS Doc_16906379_628_638_Disease)) (VP (VBG satisfying) (NP (DT the) (NNS criteria))))))) (. .)))
16906379	6	(ROOT (S (NP (NP (JJ Differential) (NN diagnosis)) (PP (IN for) (NP (JJ drug-induced) (NN disease)))) (VP (VBZ is) (ADJP (JJ invaluable)) (ADVP (RB even)) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ classical) (NNS Doc_16906379_759_779_Disease)))))) (. .)))
16911931	0	(ROOT (S (NP (NNP Intramuscular) (NNP Doc_16911931_14_25_Disease) (JJ immune) (NN globulin)) (VP (VBD combined) (PP (IN with) (NP (NP (NNS Doc_16911931_56_66_Chemical)) (PP (IN in) (NP (NP (NN prevention)) (PP (IN of) (NP (JJ Doc_16911931_84_95_Disease) (NN recurrence))))))) (PP (IN after) (NP (NN liver) (NN transplantation)))) (. .)))
16911931	1	(ROOT (S (NP (NP (NP (JJ Combined) (NNS Doc_16911931_157_168_Disease)) (NP (NP (JJ immune) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NNP HBIg)) (-RRB- -RRB-)))) (CC and) (NP (NP (NNS Doc_16911931_196_206_Chemical)) (PP (IN in) (NP (NP (NNS prophylaxis)) (PP (IN of) (NP (NP (DT the) (NN recurrence)) (PP (IN of) (NP (NP (NNS Doc_16911931_243_254_Disease)) (PP (IN after) (NP (NN liver) (NN transplantation))))))))))) (VP (VBZ has) (ADVP (RB significantly)) (VP (VBN improved) (NP (NP (DT the) (NN survival)) (PP (IN of) (NP (JJ Doc_16911931_326_331_Chemical) (JJ positive) (NNS patients)))))) (. .)))
16911931	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN undertaken) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NNS outcomes)) (PP (IN of) (NP (NN liver) (NN transplantation)))) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_16911931_445_462_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16911931_464_467_Disease)) (-RRB- -RRB-))))))))))) (. .)))
16911931	3	(ROOT (S (NP (NP (DT A) (NN retrospective) (NN chart) (NN analysis)) (CC and) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (DT the) (NN organ) (NN transplant) (NN database))))) (VP (VBD identified) (SBAR (S (NP (NP (CD 51) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 43) (NNS men)) (CC and) (NP (CD 8) (NNS women))) (-RRB- -RRB-))) (VP (VBZ transplanted) (PP (IN for) (NP (NP (NP (ADJP (JJ benign) (JJ Doc_16911931_624_627_Disease-related)) (JJ cirrhotic) (NNS diseases)) (PP (IN between) (NP (NNP June) (CD 2002)))) (CC and) (NP (NP (NNP December) (CD 2004)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN survived) (NP (QP (JJR more) (IN than) (CD 3)) (NNS months))))))))))))) (. .)))
16911931	4	(ROOT (S (NP (NNP HBIg)) (VP (VBD was) (VP (VBN administered) (ADVP (RB intravenously)) (PP (IN during) (NP (NP (DT the) (JJ first) (NN week) (CC and) (NN intramuscularly)) (ADVP (RB thereafter)))))) (. .)))
16911931	5	(ROOT (S (PP (IN At) (NP (NP (DT a) (JJ median) (NN follow-up)) (PP (IN of) (NP (CD 14.1) (NNS months))))) (, ,) (NP (NP (DT the) (JJ overall) (NN recurrence) (NN rate)) (PP (IN in) (NP (DT the) (CD 51) (NNS patients)))) (VP (VBD was) (NP (NP (CD 3.9) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 2/51)) (-RRB- -RRB-)))) (. .)))
16911931	6	(ROOT (S (NP (DT The) (JJ overall) (NN patient) (NN survival)) (VP (VBD was) (NP (NP (CD 88.3) (NN %)) (, ,) (CC and) (NP (NP (CD 82.4) (NN %)) (PP (IN after) (NP (QP (CD 1) (CC and) (CD 2)) (NNS years)))) (, ,)) (ADVP (RB respectively))) (. .)))
16911931	7	(ROOT (S (NP (NP (DT A) (JJ daily) (JJ oral) (NN dose)) (PP (IN of) (NP (NP (CD 100) (NN mg) (NNS Doc_16911931_1042_1052_Chemical)) (PP (IN for) (NP (NP (CD 2) (NNS weeks)) (PP (IN before) (NP (NP (NN transplantation)) (PP (IN for) (NP (CD 10) (NNS patients)))))))))) (VP (VBD enabled) (NP (NP (CD 57.1) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 4/7)) (-RRB- -RRB-)) (CC and) (NP (NP (NP (CD 62.5) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 5/8)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS Doc_16911931_1143_1146_Disease-DNA)) (CC and) (NP (JJ Doc_16911931_1155_1160_Chemical) (JJ positive) (NNS patients)))))) (ADVP (RB respectively)) (S (VP (TO to) (VP (VB convert) (S (VP (TO to) (VP (VB be) (ADJP (JJ negative))))))))) (. .)))
16911931	8	(ROOT (S (NP (NNP Intramuscular) (NNP HBIg)) (VP (VBD was) (ADVP (RB well)) (VP (VBN tolerated) (PP (IN in) (NP (DT all) (NNS patients))))) (. .)))
16911931	9	(ROOT (S (NP (NP (NNP Doc_16911931_1286_1296_Chemical)) (PP (VBN combined) (PP (IN with) (NP (NN intramuscular) (NN HBIg))))) (VP (MD can) (ADVP (RB effectively)) (VP (VB prevent) (NP (NN allograft)) (PP (IN from) (NP (NP (DT the) (NN recurrence)) (PP (IN of) (NP (NNS Doc_16911931_1387_1390_Disease))))) (PP (IN after) (NP (NN liver) (NN transplantation))))) (. .)))
16920333	0	(ROOT (S (NP (NP (JJ Anticonvulsant) (NN effect)) (PP (IN of) (NP (NP (NP (NNS Doc_16920333_25_48_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16920333_50_59_Chemical)) (-RRB- -RRB-))) (PP (IN on) (NP (NNS Doc_16920333_64_72_Disease)))))) (VP (VBN induced) (PP (IN by) (NP (NP (NN microperfusion)) (PP (IN of) (NP (NP (NNS Doc_16920333_102_112_Chemical)) (PP (IN in) (NP (NP (DT the) (NNS hippocampus)) (PP (IN of) (NP (ADJP (RB freely) (JJ moving)) (NNS rats)))))))))) (. .)))
16920333	1	(ROOT (S (NP (NP (NNP Doc_16920333_155_178_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_16920333_180_189_Chemical)) (, ,) (NP (NNS Doc_16920333_191_258_Chemical))) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ novel) (JJ antiepileptic) (NN drug)) (, ,) (RRC (ADVP (RB now)) (PP (IN in) (NP (NNP Phase) (NNP III) (JJ clinical) (NNS trials)))) (, ,) (VP (VBN designed) (PP (IN with) (NP (NP (DT the) (NN aim)) (PP (IN of) (S (VP (VBG improving) (NP (NN efficacy) (CC and) (NN safety)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (DT the) (JJ structurally) (JJ related) (NNS drugs) (NN Doc_16920333_430_443_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16920333_445_448_Chemical)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_16920333_454_467_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16920333_469_472_Chemical)) (-RRB- -RRB-)))))))))))))) (. .)))
16920333	2	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN studied) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ oral) (NN treatment)))) (PP (IN with) (NP (NP (NNS Doc_16920333_526_549_Chemical)) (PP (IN on) (NP (NP (DT a) (JJ whole-animal) (NN model)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (JJ partial) (NNS Doc_16920333_591_599_Disease)) (VP (MD can) (VP (VB be) (VP (VBN elicited) (ADVP (RB repeatedly)) (PP (IN on) (NP (JJ different) (NNS days))) (PP (IN without) (NP (NP (NNS changes)) (PP (IN in) (NP (NN threshold) (CC or) (NN Doc_16920333_677_684_Disease) (NNS patterns)))))))))))))))) (. .)))
16920333	3	(ROOT (S (PP (IN In) (NP (NP (DT the) (NNS animals)) (VP (VBN treated) (PP (IN with) (NP (NP (NN threshold) (NNS doses)) (PP (IN of) (NP (NNS Doc_16920333_742_752_Chemical)))))))) (, ,) (S (NP (NP (DT the) (JJ average) (NN number)) (PP (IN of) (NP (NNS Doc_16920333_776_784_Disease)))) (VP (VBD was) (NP (QP (CD 2.3) (CD +)) (NNP /) (CD -1.2)))) (, ,) (CC and) (S (NP (JJ average) (JJ Doc_16920333_812_819_Disease) (NN duration)) (VP (VBD was) (NP (NP (QP (CD 39.5) (CD +)) (NNP /) (CD -8.4) (NN s.) (NN Pre-treatment)) (PP (IN with) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 30) (JJ mg/kg) (NNS 2h)))))) (SBAR (IN before) (S (NP (JJ Doc_16920333_894_904_Chemical) (NN microperfusion)) (VP (VBD prevented) (NP (NNS Doc_16920333_930_938_Disease)) (PP (IN in) (NP (NP (DT the) (CD 75) (NN %)) (PP (IN of) (NP (DT the) (NNS rats)))))))))) (. .)))
16920333	4	(ROOT (S (NP (NP (JJR Lower) (NNS doses)) (PRN (-LRB- -LRB-) (NP (QP (CD 3) (CC and) (CD 10mg/kg))) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB suppress) (NP (NNS Doc_16920333_1008_1016_Disease)) (, ,) (ADVP (RB however)) (, ,) (SBAR (IN after) (S (NP (NP (NN administration)) (PP (IN of) (NP (NP (JJ 10mg/kg) (, ,) (JJ significant) (NNS reductions)) (PP (IN in) (NP (NP (JJ Doc_16920333_1086_1094_Disease) (NN duration)) (PRN (-LRB- -LRB-) (NP (NNP 24.3) (NNP +)) (: /) (NP (NP (CD -6.8)) (NP (PRP s))) (-RRB- -RRB-)) (CC and) (NP (JJ Doc_16920333_1122_1129_Disease) (NN number)) (PRN (-LRB- -LRB-) (NP (QP (CD 1.6) (CD +)) (NN /) (NN -0.34)) (-RRB- -RRB-))))))) (VP (VBD were) (VP (VBN found))))))) (. .)))
16920333	5	(ROOT (S (NP (NP (DT No) (JJ adverse) (NNS effects)) (PP (IN of) (NP (NNS Doc_16920333_1184_1207_Chemical)))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (VBG behavioral/EEG) (NNS patterns)) (VP (VBN studied) (, ,) (PP (VBG including) (NP (JJ sleep/wakefulness) (NN cycle))) (, ,) (PP (IN at) (NP (NP (DT the) (NNS doses)) (VP (VBN studied))))))))) (. .)))
17028363	0	(ROOT (S (NP (NNP Doc_17028363_0_19_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (VBN prolonged) (NN intake)) (PP (IN of) (S (VP (VBG slimming) (NP (NNS pills)) (S (VP (VBG containing) (NP (NNS Doc_17028363_82_96_Chemical)))))))))) (. .)))
17028363	1	(ROOT (S (NP (JJ Chinese) (JJ herbal) (NN medicine) (NNS preparations)) (VP (VBP are) (ADJP (ADJP (RB widely) (JJ available)) (CC and) (ADJP (RB often) (VBN regarded) (PP (IN by) (NP (NP (DT the) (NN public)) (PP (IN as) (NP (NP (ADJP (JJ natural) (CC and) (JJ safe)) (NNS remedies)) (PP (IN for) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ medical) (NNS conditions)))))))))))) (. .)))
17028363	2	(ROOT (S (NP (NP (NNP Doc_17028363_255_266_Disease)) (VP (VBN caused) (PP (IN by) (NP (JJ Chinese) (NNS herbs))))) (VP (VBZ has) (ADVP (RB previously)) (VP (VBN been) (ADJP (VBN reported)) (, ,) (ADVP (RB usually)) (VP (VBG involving) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ aristolochic) (NNS acids))))))) (. .)))
17028363	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (JJ 23-year-old) (NN woman)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (NNS Doc_17028363_414_433_Disease)) (PP (VBG following) (NP (NP (VBN prolonged) (NN use)) (PP (IN of) (NP (NP (DT a) (JJ proprietary) (JJ Chinese) (JJ herbal) (NN slimming) (NN pill)) (SBAR (WHNP (WDT that)) (S (VP (VBD contained) (NP (NP (JJ Doc_17028363_519_532_Chemical) (NNS derivatives)) (, ,) (VP (VBN extracted) (PP (IN from) (NP (NP (NNP Rhizoma) (NNP Rhei)) (PRN (-LRB- -LRB-) (NP (NN rhubarb)) (-RRB- -RRB-))))))))))))))))))) (. .)))
17028363	4	(ROOT (S (NP (DT The) (NNS Doc_17028363_589_601_Disease)) (VP (VBD was) (ADVP (RB probably)) (VP (VBN aggravated) (PP (IN by) (NP (NP (DT the) (JJ concomitant) (NN intake)) (PP (IN of) (NP (NP (DT a) (JJ non-steroidal) (JJ anti-inflammatory) (NN drug)) (, ,) (NP (NNS Doc_17028363_695_705_Chemical)))))))) (. .)))
17028363	5	(ROOT (S (NP (NNP Renal)) (ADVP (RB pathology)) (VP (VBD was) (NP (NP (DT that)) (PP (IN of) (NP (NN hypocellular) (NNS Doc_17028363_748_769_Disease))))) (. .)))
17028363	6	(ROOT (S (S (NP (JJ Spontaneous) (JJ renal) (NN recovery)) (VP (VBD occurred) (PP (IN upon) (NP (NP (NN cessation)) (PP (IN of) (NP (DT the) (JJ slimming) (NNS pills))))))) (, ,) (CC but) (S (NP (JJ mild) (NNS Doc_17028363_854_875_Disease) (CC and) (NNS Doc_17028363_880_895_Disease)) (VP (VBD was) (ADVP (RB still)) (ADJP (JJ evident) (RB histologically)) (NP (CD 4) (NNS months) (RB later)))) (. .)))
17028363	7	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT a) (JJ causal) (NN relationship)) (PP (IN between) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (DT an) (JJ Doc_17028363_998_1011_Chemical-containing) (JJ herbal) (NN agent)) (CC and) (NP (NNS Doc_17028363_1040_1052_Disease))))))) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN proven)))))))) (, ,) (NP (JJ phytotherapy-associated) (JJ interstitial) (NNS Doc_17028363_1112_1123_Disease)) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP present) (PP (IN with) (NP (JJ unexplained) (NNS Doc_17028363_1186_1199_Disease))))))))))) (. .)))
17035713	0	(ROOT (NP (NP (NP (NNP Doc_17035713_0_18_Chemical)) (PP (IN as) (NP (DT a) (JJ Doc_17035713_24_34_Chemical) (NN reagent)))) (: :) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (JJ critical) (JJ Doc_17035713_65_70_Chemical) (NNS groups)) (PP (IN in) (NP (JJ Doc_17035713_81_91_Chemical) (NNS Doc_17035713_92_103_Disease)))))) (. .)))
17035713	1	(ROOT (S (NP (NP (NNP Doc_17035713_105_123_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17035713_125_128_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN metabolite)) (PP (IN of) (NP (NP (NP (DT the) (VBG alkylating) (NN agent) (NNS Doc_17035713_170_180_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17035713_182_185_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NP (ADJP (RB putatively) (JJ responsible) (PP (IN for) (NP (NNS Doc_17035713_218_230_Disease)))) (JJ following) (JJ anti-Doc_17035713_246_251_Disease) (NN therapy)) (PP (IN with) (NP (NNS Doc_17035713_265_268_Chemical)))))))) (. .)))
17035713	2	(ROOT (S (NP (NP (NNP Depletion)) (PP (IN of) (NP (JJ Doc_17035713_283_293_Chemical) (PRN (-LRB- -LRB-) (NP (NNP SH)) (-RRB- -RRB-)) (NNS groups)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN from) (NP (NP (NN cell) (NN culture)) (, ,) (NP (NN animal)) (CC and) (NP (JJ clinical) (NNS studies))))))) (. .)))
17035713	3	(ROOT (S (PP (IN In) (NP (DT this) (NN work))) (NP (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_17035713_399_402_Chemical)) (PP (IN on) (NP (NP (JJ human) (JJ proximal) (NN tubule) (NNS cells)) (PP (IN in) (NP (JJ primary) (NN culture)))))))) (PRN (-LRB- -LRB-) (ADJP (JJ hRPTEC)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN investigated))) (. .)))
17035713	4	(ROOT (S (NP (NP (NNP Doc_17035713_480_488_Disease)) (PP (IN of) (NP (NNS Doc_17035713_492_495_Chemical)))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NP (NN protein) (NN content)) (, ,) (NP (NN cell) (NN number)) (, ,) (NP (NNP LDH) (NN release)) (, ,) (NP (JJ Doc_17035713_557_568_Chemical) (NN exclusion) (NN assay)) (CC and) (NP (JJ caspase-3) (NN activity)))))) (. .)))
17035713	5	(ROOT (S (NP (NNP Free) (NNP Doc_17035713_614_620_Chemical)) (VP (VBD were) (VP (VBN measured) (PP (IN by) (NP (NP (DT the) (NN method)) (PP (IN of) (NP (NNP Ellman))))))) (. .)))
17035713	6	(ROOT (S (NP (NNP Doc_17035713_660_663_Chemical)) (VP (VBD reduced) (NP (JJ hRPTEC) (NN cell)) (NP (NP (NN number) (CC and) (NN protein)) (, ,) (VP (VBN induced) (NP (NP (NP (DT a) (NN loss)) (PP (IN in) (NP (JJ free) (NN intracellular) (NNS Doc_17035713_741_747_Chemical)))) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ Doc_17035713_767_775_Disease) (NNS markers)))))))) (. .)))
17035713	7	(ROOT (S (NP (NNS Doc_17035713_785_788_Chemical) (CONJP (CC but) (RB not)) (NNS Doc_17035713_797_805_Chemical)) (VP (VBD inhibited) (SBAR (S (NP (DT the) (NNS Doc_17035713_820_828_Chemical)) (VP (VBZ proteases) (SBAR (S (NP (NP (ADJP (JJ caspase-3) (, ,) (JJ caspase-8) (CC and) (JJ cathepsin)) (NNP B.) (NNP Caspase) (NN activation)) (PP (IN by) (NP (NNS Doc_17035713_899_908_Chemical)))) (VP (VBD was) (VP (VBN inhibited) (PP (IN by) (NP (NNS Doc_17035713_926_929_Chemical))))))))))) (. .)))
17035713	8	(ROOT (S (PP (IN In) (NP (NP (NNS cells)) (VP (VBN stained) (PP (IN with) (NP (JJ fluorescent) (NNS dyes))) (S (VP (VBG targeting) (NP (NNS lysosomes))))))) (, ,) (NP (NNS Doc_17035713_991_994_Chemical)) (VP (VBZ induced) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ lysosomal) (NN size) (CC and) (NN lysosomal) (NN leakage))))) (. .)))
17035713	9	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_17035713_1071_1074_Chemical)) (PP (IN on) (NP (JJ Doc_17035713_1078_1086_Chemical) (NN protease) (NNS activities) (CC and) (NNS Doc_17035713_1111_1117_Chemical)))))) (VP (MD could) (VP (VB be) (VP (VBN reproduced) (PP (IN in) (NP (NN cell) (NN lysate)))))) (. .)))
17035713	10	(ROOT (S (NP (NP (NNP Acidification)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD slowed) (NP (NP (DT the) (NN reaction)) (PP (IN of) (NP (NNS Doc_17035713_1198_1201_Chemical)))) (PP (IN with) (NP (JJ Doc_17035713_1207_1212_Chemical) (NNS donors)))))) (, ,)) (VP (MD could) (ADVP (RB also)) (VP (VB attenuate) (NP (NP (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_17035713_1253_1256_Chemical)) (PP (IN on) (NP (NP (JJ Doc_17035713_1260_1268_Disease) (NNS markers)) (, ,) (NP (JJ Doc_17035713_1278_1283_Chemical) (NN depletion)) (CC and) (NP (JJ Doc_17035713_1298_1306_Chemical) (NN protease) (NN inhibition))))))) (PP (IN in) (NP (VBG living) (NNS cells))))) (. .)))
17035713	11	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NNS Doc_17035713_1350_1353_Chemical)) (ADVP (RB directly)) (VP (VBZ reacts) (PP (IN with) (NP (JJ cellular) (NN protein) (CC and) (NN non-protein) (NNS Doc_17035713_1408_1414_Chemical))) (, ,) (S (VP (VBG mediating) (NP (PRP$ its) (NNS Doc_17035713_1430_1438_Disease)) (PP (IN on) (NP (NN hRPTEC)))))) (. .)))
17035713	12	(ROOT (S (NP (DT This) (NN effect)) (VP (MD can) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (NN acidification)))))) (. .)))
17035713	13	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (JJ urinary) (NN acidification)) (VP (MD could) (VP (VB be) (NP (DT an) (NN option) (S (VP (TO to) (VP (VB prevent) (NP (JJ Doc_17035713_1558_1561_Chemical) (NNS Doc_17035713_1562_1573_Disease)) (PP (IN in) (NP (NNS patients))))))))) (. .)))
17042797	0	(ROOT (S (NP (JJ Stereological) (NNS methods)) (VP (VBP reveal) (NP (NP (DT the) (JJ robust) (NN size) (CC and) (NN stability)) (PP (IN of) (NP (JJ ectopic) (NN hilar) (NN granule) (NNS cells)))) (PP (IN after) (NP (NP (NN Doc_17042797_96_107_Chemical-induced) (NNS Doc_17042797_116_134_Disease)) (PP (IN in) (NP (DT the) (JJ adult) (NN rat)))))) (. .)))
17042797	1	(ROOT (S (PP (VBG Following) (NP (NP (NNS Doc_17042797_163_181_Disease)) (PP (IN in) (NP (DT the) (NN rat))))) (, ,) (S (NP (JJ dentate) (JJ granule) (NN cell) (NNS neurogenesis)) (VP (VBZ increases) (ADVP (RB greatly)))) (, ,) (CC and) (S (NP (NP (JJ many)) (PP (IN of) (NP (DT the) (JJ new) (NNS neurons)))) (VP (VBP appear) (S (VP (TO to) (VP (VB develop) (ADVP (RB ectopically)) (, ,) (PP (IN in) (NP (NP (DT the) (NN hilar) (NN region)) (PP (IN of) (NP (DT the) (JJ hippocampal) (NN formation)))))))))) (. .)))
17042797	2	(ROOT (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (SBAR (IN that) (S (NP (DT the) (JJ ectopic) (NN hilar) (NN granule) (NNS cells)) (VP (MD could) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (JJ spontaneous) (NNS Doc_17042797_451_459_Disease)) (SBAR (WHNP (WDT that)) (S (ADVP (RB ultimately)) (VP (VBP develop) (PP (IN after) (NP (NNS Doc_17042797_490_508_Disease))))))))))))))) (. .)))
17042797	3	(ROOT (S (ADVP (RB However)) (, ,) (S (NP (DT the) (NN population)) (VP (VBZ has) (ADVP (RB never)) (VP (VBN been) (VP (VBN quantified))))) (, ,) (IN so) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ unclear)) (SBAR (IN whether) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ substantial) (RB enough) (S (VP (TO to) (VP (VB have) (NP (NP (DT a) (JJ strong) (NN influence)) (PP (IN on) (NP (NNS epileptogenesis))))))))))))) (. .)))
17042797	4	(ROOT (S (S (VP (TO To) (VP (VB quantify) (NP (DT this) (NN population))))) (, ,) (NP (NP (DT the) (JJ total) (NN number)) (PP (IN of) (NP (JJ ectopic) (NN hilar) (NN granule) (NNS cells)))) (VP (VBD was) (VP (VBN estimated) (S (VP (VBG using) (NP (JJ unbiased) (NN stereology)) (PP (IN at) (NP (JJ different) (NNS times))) (PP (IN after) (NP (NN Doc_17042797_800_811_Chemical-induced) (NNS Doc_17042797_820_838_Disease))))))) (. .)))
17042797	5	(ROOT (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NN hilar) (NNS neurons)))) (VP (VBP immunoreactive) (SBAR (IN for) (S (NP (NP (NNS Prox-1)) (, ,) (NP (DT a) (JJ granule-cell-specific) (NN marker)) (, ,)) (VP (VBD was) (VP (VBN estimated) (S (VP (VBG using) (NP (DT the) (JJ optical) (NN fractionator) (NN method))))))))) (. .)))
17042797	6	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (NN size)) (PP (IN of) (NP (NP (DT the) (JJ hilar) (JJ ectopic) (NN granule) (NN cell) (NN population)) (PP (IN after) (NP (NNS Doc_17042797_1066_1084_Disease)))))) (VP (VBZ is) (ADJP (ADJP (JJ substantial)) (, ,) (CC and) (ADJP (JJ stable) (PP (IN over) (NP (NN time))))))))) (. .)))
17042797	7	(ROOT (S (ADVP (RB Interestingly)) (, ,) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (DT the) (NN population)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN correlated) (PP (IN with) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (JJ behavioral) (NNS Doc_17042797_1223_1231_Disease))))))))) (, ,) (SBAR (IN because) (S (NP (NP (NNS animals)) (PP (IN with) (NP (NP (JJR more) (JJ ectopic) (NN granule) (NNS cells)) (PP (IN in) (NP (DT the) (NNS hilus)))))) (VP (VBP have) (NP (ADJP (RBR more) (JJ frequent)) (JJ behavioral) (NNS Doc_17042797_1324_1332_Disease)))))) (. .)))
17042797	8	(ROOT (S (NP (DT The) (NN hilar) (JJ ectopic) (NN granule) (NN cell) (NN population)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB vary) (ADVP (RB systematically)) (PP (IN across) (NP (DT the) (JJ septotemporal) (NNS axis)))))) (, ,) (SBAR (IN although) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN volume)) (PP (IN of) (NP (DT the) (NNS hilus))))))))))))) (. .)))
17042797	9	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP provide) (NP (JJ new) (NN insight)) (PP (IN into) (NP (NP (DT the) (JJ potential) (NN role)) (PP (IN of) (NP (NP (JJ ectopic) (NN hilar) (NN granule) (NNS cells)) (PP (IN in) (NP (NP (DT the) (JJ Doc_17042797_1607_1618_Chemical) (NN model)) (PP (IN of) (NP (NNS Doc_17042797_1628_1650_Disease)))))))))) (. .)))
17069550	0	(ROOT (NP (NP (DT A) (JJ prospective) (, ,) (JJ open-label) (NN trial)) (PP (IN of) (NP (NNS Doc_17069550_35_46_Chemical))) (PP (IN in) (NP (NNS Doc_17069550_50_67_Disease))) (. .)))
17069550	1	(ROOT (S (NP (JJ Post-mortem) (NNS studies)) (VP (VBP have) (VP (VBN reported) (NP (NP (NNS abnormalities)) (PP (IN of) (NP (DT the) (JJ cholinergic) (NN system)))) (PP (IN in) (NP (NNS Doc_17069550_157_163_Disease))))) (. .)))
17069550	2	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS Doc_17069550_216_227_Chemical)) (, ,) (NP (DT an) (JJ acetylcholinesterase) (NN inhibitor)) (CC and) (NP (JJ nicotinic) (NN receptor) (NN modulator))))) (, ,) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (S (VP (VBG interfering) (NP (NNS behaviors)) (PP (IN in) (NP (NP (NNS children)) (PP (IN with) (NP (NNS Doc_17069550_356_362_Disease)))))))))))))) (. .)))
17069550	3	(ROOT (S (NP (NP (JJ Thirteen) (JJ medication-free) (NNS children)) (PP (IN with) (NP (NP (NNS Doc_17069550_412_418_Disease)) (PRN (-LRB- -LRB-) (NP (JJ mean) (NN age)) (, ,) (NP (CD 8.8) (NNP +) (NNS /)) (, -) (NP (CD 3.5) (NNS years)) (-RRB- -RRB-))))) (VP (VBD participated) (PP (IN in) (NP (NP (DT a) (JJ 12-week) (, ,) (JJ open-label) (NN trial)) (PP (IN of) (NP (NNS Doc_17069550_496_507_Chemical)))))) (. .)))
17069550	4	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN rated) (ADVP (RB monthly)) (PP (PP (IN by) (NP (NP (NNS parents)) (PP (IN on) (NP (NP (NP (DT the) (NNP Aberrant) (NNP Behavior) (NNP Checklist)) (PRN (-LRB- -LRB-) (NP (NNP ABC)) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NNPS Conners) (POS ')) (NNP Parent) (NNP Rating) (NNP Scale-Revised)))))) (, ,) (CC and) (PP (IN by) (NP (NP (DT a) (NN physician)) (VP (VBG using) (NP (NP (NP (DT the) (NNP Children) (POS 's)) (NNP Psychiatric) (NNP Rating) (NNP Scale)) (CC and) (NP (DT the) (NNP Clinical) (NNP Global) (NNP Impressions) (NN scale))))))))) (. .)))
17069550	5	(ROOT (S (S (NP (NNS Patients)) (VP (VBD showed) (NP (DT a) (JJ significant) (NN reduction)) (PP (IN in) (NP (NP (JJ parent-rated) (NNS Doc_17069550_808_820_Disease)) (CC and) (NP (JJ social) (NN withdrawal)))) (PP (PP (IN on) (NP (DT the) (NNP ABC))) (CONJP (RB as) (RB well) (IN as)) (PP (NP (NP (JJ significant) (NNS improvements)) (PP (IN in) (NP (JJ emotional) (NN lability) (CC and) (NN inattention)))) (IN on) (NP (NP (DT the) (NNPS Conners) (POS ')) (NNP Parent) (NNP Rating) (NNP Scale)))))) (: --) (S (VP (VBN Revised))) (. .)))
17069550	6	(ROOT (S (ADVP (RB Similarly)) (, ,) (NP (NN clinician) (NNS ratings)) (VP (VBD showed) (NP (NNS reductions)) (PP (IN in) (NP (NP (DT the) (NN anger) (NN subscale)) (PP (IN of) (NP (NP (DT the) (NNP Children) (POS 's)) (NNP Psychiatric) (NNP Rating) (NNP Scale)))))) (. .)))
17069550	7	(ROOT (S (NP (NP (CD Eight)) (PP (IN of) (NP (CD 13) (NNS participants)))) (VP (VBD were) (VP (VBN rated) (PP (IN as) (NP (NP (NNS responders)) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (PRP$ their) (NN improvement) (NNS scores))))))) (PP (IN on) (NP (DT the) (NNP Clinical) (NNP Global) (NNP Impressions) (NN scale))))) (. .)))
17069550	8	(ROOT (S (ADVP (RB Overall)) (, ,) (NP (NNS Doc_17069550_1229_1240_Chemical)) (VP (VBD was) (ADJP (JJ well-tolerated)) (, ,) (PP (IN with) (NP (NP (DT no) (JJ significant) (JJ adverse) (NNS effects)) (ADVP (RB apart) (PP (IN from) (NP (NP (NNS Doc_17069550_1308_1317_Disease)) (PP (IN in) (NP (CD one) (NN patient))))))))) (. .)))
17069550	9	(ROOT (S (PP (IN In) (NP (DT this) (JJ open) (NN trial))) (, ,) (NP (NNS Doc_17069550_1366_1377_Chemical)) (VP (VP (VBD was) (ADJP (JJ well-tolerated))) (CC and) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (ADJP (JJ beneficial) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (S (VP (VBG interfering) (NP (NNS behaviors)) (PP (IN in) (NP (NP (NNS children)) (PP (IN with) (NP (NP (NNS Doc_17069550_1487_1493_Disease)) (, ,) (NP (RB particularly) (NNS Doc_17069550_1508_1518_Disease)) (, ,) (NP (JJ behavioral) (NN dyscontrol)) (, ,) (CC and) (NP (NN inattention))))))))))))))))) (. .)))
17069550	10	(ROOT (S (NP (JJ Further) (JJ controlled) (NNS trials)) (VP (VBP are) (VP (VBN warranted))) (. .)))
17151160	0	(ROOT (NP (NP (NP (JJ Randomized) (NN comparison)) (PP (IN of) (NP (NP (NNS Doc_17151160_25_35_Chemical)) (PP (IN versus) (NP (NP (NNS Doc_17151160_43_54_Chemical)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ first-episode) (NNS Doc_17151160_90_103_Disease)))))))))) (: :) (NP (JJ 4-month) (NNS outcomes)) (. .)))
17151160	1	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBD compared) (NP (JJ 4-month) (NN treatment) (NNS outcomes)) (PP (IN for) (NP (NP (NNS Doc_17151160_186_196_Chemical)) (PP (IN versus) (NP (NP (NNS Doc_17151160_204_215_Chemical)) (PP (IN in) (NP (NNS patients))))))) (PP (IN with) (NP (JJ first-episode) (JJ Doc_17151160_247_260_Disease) (NN spectrum) (NNS disorders)))) (. .)))
17151160	2	(ROOT (S (NP (NP (NP (NP (CD One) (CD hundred) (CD twelve) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NP (NP (ADJP (CD 70) (NN %)) (NN male)) (: ;) (NP (NP (JJ mean) (NN age)) (SBAR (S (VP (SYM =) (NP (JJ 23.3) (NNS years))))))) (NP (NNP -LSB-) (NNP SD) (NNP =) (NNP 5.1) (NNP -RSB-))) (-RRB- -RRB-))) (PP (IN with) (NP (NP (NP (JJ first-episode) (NNS Doc_17151160_379_392_Disease)) (PRN (-LRB- -LRB-) (NP (CD 75) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_17151160_400_425_Disease)) (PRN (-LRB- -LRB-) (NP (CD 17) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NNS Doc_17151160_433_460_Disease))))) (PRN (-LRB- -LRB-) (NP (CD 8) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN assigned) (PP (TO to) (NP (NN treatment))) (PP (IN with) (NP (NP (NNS Doc_17151160_507_517_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2.5-20) (NN mg/day)) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_17151160_537_548_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1-6) (NN mg/day)) (-RRB- -RRB-)))))) (. .)))
17151160	3	(ROOT (S (NP (NNP Response) (NNS rates)) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB differ) (PP (IN between) (NP (NP (NNS Doc_17151160_624_634_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 43.7) (NN %)) (, ,) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 28.8) (NN %)))))))) (NP (CD -58.6) (NN %))) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_17151160_667_678_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 54.3) (NN %)) (, ,) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 39.9) (NN %)))))))) (NP (CD -68.7) (NN %))) (-RRB- -RRB-)))))) (. .)))
17151160	4	(ROOT (S (PP (IN Among) (S (NP (DT those)) (VP (VBG responding) (PP (TO to) (NP (NN treatment)))))) (, ,) (NP (NP (JJR more) (NNS subjects)) (PP (IN in) (NP (NP (DT the) (JJ Doc_17151160_766_776_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 40.9) (NN %)) (, ,) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 16.8) (NN %)))))))) (NP (CD -65.0) (NN %))) (-RRB- -RRB-))))) (ADVP (IN than) (PP (IN in) (NP (NP (DT the) (JJ Doc_17151160_823_834_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 18.9) (NN %)) (, ,) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 0) (NN %)))))))) (NP (CD -39.2) (NN %))) (-RRB- -RRB-))))) (VP (VBD had) (NP (NP (JJ subsequent) (NNS ratings)) (VP (RB not) (VBG meeting) (NP (NN response) (NNS criteria))))) (. .)))
17151160	5	(ROOT (S (NP (NP (JJ Negative) (NN symptom) (NNS outcomes) (CC and) (NNS measures)) (PP (IN of) (NP (NNS Doc_17151160_962_974_Disease) (CC and) (NNS Doc_17151160_979_988_Disease)))) (VP (VBD did) (RB not) (VP (VB differ) (PP (IN between) (NP (NNS medications))))) (. .)))
17151160	6	(ROOT (S (NP (JJ Extrapyramidal) (NN symptom) (NN severity) (NNS scores)) (VP (VBD were) (NP (NP (NP (CD 1.4)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 1.2-1) (CD .6))))))) (-RRB- -RRB-))) (PP (IN with) (NP (NP (QP (CD Doc_17151160_1095_1106_Chemical) (CC and) (CD 1.2))) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 1.0-1) (CD .4))))))) (-RRB- -RRB-))))) (PP (IN with) (NP (NNS Doc_17151160_1137_1147_Chemical)))) (. .)))
17151160	7	(ROOT (S (S (NP (ADJP (RB Significantly) (JJR more)) (NNS Doc_17151160_1168_1179_Disease)) (VP (VBD occurred) (PP (IN with) (NP (NNS Doc_17151160_1194_1204_Chemical))) (PP (IN than) (PP (IN with) (NP (NNS Doc_17151160_1215_1226_Chemical)))))) (: :) (S (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (NN weight)) (PP (IN at) (NP (NP (CD 4) (NNS months)) (ADVP (JJ relative) (PP (TO to) (NP (NN baseline) (NN weight))))))))) (VP (VBD was) (NP (NP (NP (CD 17.3) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 95) (NN %)) (NP (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 14.2) (NN %)))))) (NP (CD -20.5) (NN %))) (-RRB- -RRB-))) (PP (IN with) (NP (NP (QP (CD Doc_17151160_1327_1337_Chemical) (CC and) (CD 11.3)) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 95) (NN %)) (NP (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 8.4) (NN %)))))) (NP (CD -14.3) (NN %))) (-RRB- -RRB-))))) (PP (IN with) (NP (NNS Doc_17151160_1373_1384_Chemical))))) (. .)))
17151160	8	(ROOT (S (NP (NP (NN Body) (NN mass) (NN index)) (PP (PP (IN at) (NP (NN baseline))) (CC and) (PP (IN at) (NP (CD 4) (NNS months))))) (VP (VBD was) (VP (VBN 24.3) (PRN (-LRB- -LRB-) (S (NP (CD 95) (NN %)) (VP (VBP CI) (S (VP (SYM =) (NP (CD 22.8-25) (CD .7)))))) (-RRB- -RRB-)) (PP (FW versus) (NP (NP (NP (NP (NNP 28.2)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 26.7-29) (CD .7))))))) (-RRB- -RRB-))) (PP (IN with) (NP (NNS Doc_17151160_1494_1504_Chemical)))) (CC and) (NP (NP (NP (CD 23.9)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 22.5-25) (CD .3))))))) (-RRB- -RRB-))) (PP (IN versus) (NP (NP (NNP 26.7)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 25.2-28) (CD .2))))))) (-RRB- -RRB-))))))) (PP (IN with) (NP (NNS Doc_17151160_1569_1580_Chemical))))) (. .)))
17151160	9	(ROOT (S (S (NP (NP (JJ Clinical) (NNS outcomes)) (PP (IN with) (NP (NNS Doc_17151160_1618_1629_Chemical)))) (VP (VBD were) (ADJP (JJ equal) (PP (TO to) (NP (NP (DT those)) (PP (IN with) (NP (NNS Doc_17151160_1655_1665_Chemical)))))))) (, ,) (CC and) (S (NP (NN response)) (VP (MD may) (VP (VB be) (ADJP (RBR more) (JJ stable))))) (. .)))
17151160	10	(ROOT (S (NP (NNP Doc_17151160_1700_1710_Chemical)) (VP (MD may) (VP (VB have) (NP (NP (DT an) (NN advantage)) (PP (IN for) (NP (NN motor) (NN side) (NNS effects)))))) (. .)))
17151160	11	(ROOT (S (S (NP (DT Both) (NNS medications)) (VP (VBD caused) (NP (JJ substantial) (JJ rapid) (NNS Doc_17151160_1799_1810_Disease)))) (, ,) (CC but) (S (NP (NNS Doc_17151160_1816_1827_Disease)) (VP (VBD was) (ADJP (JJR greater)) (PP (IN with) (NP (NNS Doc_17151160_1845_1855_Chemical))))) (. .)))
17159032	0	(ROOT (NP (NP (NP (RB Early) (JJ paracentral) (NNS Doc_17159032_18_35_Disease)) (PP (IN in) (NP (NNS patients)))) (VP (VBG taking) (NP (NNS Doc_17159032_55_73_Chemical))) (. .)))
17159032	1	(ROOT (S (S (VP (TO To) (VP (VB review) (NP (DT the) (JJ natural) (NN history) (CC and) (NN ocular))))) (CC and) (S (NP (NP (JJ systemic) (JJ adverse) (NNS effects)) (PP (IN of) (NP (NNS patients)))) (VP (VBG taking) (NP (NP (NNS Doc_17159032_175_201_Chemical)) (SBAR (WHNP (WP who)) (S (VP (VBD attended) (NP (DT an) (JJ ophthalmic) (NN screening) (NN program)))))))) (. .)))
17159032	2	(ROOT (S (NP (NNP Retrospective)) (VP (VBP study)) (. .)))
17159032	3	(ROOT (S (NP (NP (NNP Records)) (PP (IN of) (NP (NP (CD 262) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD were) (VP (VBG taking) (NP (NNS Doc_17159032_326_344_Chemical)))) (CC and) (VP (VBD screened) (PP (IN in) (NP (NP (DT the) (NNP Department)) (PP (IN of) (NP (NNP Ophthalmology)))))))))))) (VP (VBD were) (VP (VBN reviewed))) (. .)))
17159032	4	(ROOT (S (PP (IN Of) (NP (DT the) (CD 262) (NNS patients))) (, ,) (NP (NP (NP (CD 14)) (PRN (-LRB- -LRB-) (NP (CD 18) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (CD 76)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN stopped) (NP (NN treatment)) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (DT the) (NN study)))))))))))) (VP (VBD experienced) (NP (VBN documented) (JJ adverse) (NNS effects))) (. .)))
17159032	5	(ROOT (S (NP (JJ Systemic) (JJ adverse) (NNS effects)) (VP (VBD occurred) (PP (IN in) (NP (NP (CD 8) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 10.5) (NN %)) (-RRB- -RRB-)) (CC and) (NP (JJ ocular) (JJ adverse) (NNS effects)) (, ,))) (PP (IN in) (NP (NP (CD 5)) (PRN (-LRB- -LRB-) (NP (CD 6.5) (NN %)) (-RRB- -RRB-))))) (. .)))
17159032	6	(ROOT (S (NP (NP (JJ Thirty-five) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 13.4) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (NP (NP (NNS Doc_17159032_665_691_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN attributed) (PP (TO to) (NP (NP (JJ Doc_17159032_718_736_Chemical) (NN treatment)) (PP (IN in) (NP (NP (CD 4) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 1.5) (NN %)) (-RRB- -RRB-)))))))))))) (. .)))
17159032	7	(ROOT (S (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (CD 4) (NNS patients)))) (VP (VBD were) (VP (VBG taking) (NP (NP (QP (JJR less) (IN than) (CD 6.5)) (NN mg/kg)) (PP (IN per) (NP (NN day))))))) (CC and) (S (NP (DT all) (NNS patients)) (VP (VBD had) (NP (JJ normal) (JJ renal) (CC and) (NN liver) (NN function) (NN test) (NNS results)))) (. .)))
17159032	8	(ROOT (S (S (NP (DT The) (JJ current) (NN study)) (VP (VP (VBD used) (NP (NP (DT a) (NN protocol)) (PP (IN of) (NP (NP (JJ visual) (NN acuity) (CC and) (NN color) (NN vision) (NN assessment)) (, ,) (NP (NN funduscopy)) (, ,) (CC and) (NP (NNP Humphrey) (NNP 10-2) (JJ visual) (NN field) (NN testing)))))) (CC and) (VP (VBZ shows) (SBAR (IN that) (S (NP (JJ visual) (NN field) (NNS defects)) (VP (VBD appeared) (SBAR (IN before) (S (NP (NP (DT any) (JJ corresponding) (NNS changes)) (PP (IN in) (NP (DT any) (JJ other)))) (VP (VBD tested) (NP (JJ clinical) (NNS parameters))))))))))) (: ;) (S (S (NP (DT the) (NNS defects)) (VP (VBD were) (ADJP (JJ reproducible)))) (CC and) (S (NP (DT the) (NN test) (NNS parameters)) (VP (VBD were) (ADJP (JJ reliable))))) (. .)))
17159032	9	(ROOT (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NNS Doc_17159032_1248_1266_Chemical)))) (VP (MD can) (VP (VB demonstrate) (NP (NP (DT a) (JJ toxic) (NN reaction)) (PP (IN in) (NP (DT the) (NN retina)))) (PP (IN despite) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (VBN known) (NN risk) (NNS factors))))))) (. .)))
17159032	10	(ROOT (S (NP (NP (NN Screening)) (, ,) (PP (VBG including) (NP (NNP Humphrey) (NNP 10-2) (JJ visual) (NN field) (NN assessment))) (, ,)) (VP (VBZ is) (VP (VBN recommended) (NP (CD 2) (NNS years)) (PP (IN after) (NP (NP (DT the) (JJ initial) (NN baseline)) (CC and) (NP (JJ yearly)))) (ADVP (RB thereafter)))) (. .)))
17223814	0	(ROOT (NP (NP (JJ Peri-operative) (NNS Doc_17223814_15_37_Disease)) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NN chemotherapy))))) (PP (IN with) (NP (NNS Doc_17223814_71_81_Chemical) (CC and) (NNS Doc_17223814_86_96_Chemical))) (. .)))
17223814	1	(ROOT (S (NP (DT A) (JJ 47-year-old) (NN woman)) (VP (VBD presented) (PP (IN for) (NP (NN mastectomy) (CC and) (JJ immediate) (NNS latissimus) (NN dorsi) (NN flap) (NN reconstruction))) (S (VP (VBG having) (VP (VBN been) (VP (VBN diagnosed) (PP (IN with) (NP (JJ Doc_17223814_221_246_Disease) (NNS months))) (ADVP (RB previously))))))) (. .)))
17223814	2	(ROOT (S (PP (IN In) (NP (DT the) (VBG preceding) (NNS months))) (NP (PRP she)) (VP (VBD had) (VP (VBN received) (NP (JJ neo-adjuvant) (NN chemotherapy)) (PP (IN with) (NP (NP (NNS Doc_17223814_338_348_Chemical)) (, ,) (NP (JJ Doc_17223814_350_360_Chemical) (-LRB- -LRB-) (NNS Doc_17223814_362_367_Chemical) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_17223814_373_389_Chemical)))))) (. .)))
17223814	3	(ROOT (S (S (NP (DT This)) (VP (VBD had) (VP (VBN been) (VP (ADVP (RB apparently)) (VBN uncomplicated))))) (CC and) (S (NP (PRP she)) (VP (VBD had) (VP (VBN maintained) (NP (NP (DT a) (ADJP (RB remarkably) (JJ high)) (NN level)) (PP (IN of) (NP (JJ physical) (NN activity))))))) (. .)))
17223814	4	(ROOT (S (NP (PRP She)) (VP (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (JJ bradycardic) (PP (IN at) (NP (JJ pre-operative) (NN assessment))))))))) (CC but) (VP (VBD had) (NP (DT no) (JJ cardiac) (NNS symptoms)))) (. .)))
17223814	5	(ROOT (S (S (LST (JJ Second)) (NP (NNP degree) (NNP Mobitz) (NN type) (NNP II) (NNP Doc_17223814_617_639_Disease)) (VP (VBD was) (VP (VBN diagnosed) (PP (IN on) (NP (NN electrocardiogram)))))) (, ,) (CC and) (S (NP (JJ temporary) (NNS transvenous)) (VP (VBP ventricular) (NP (NP (NN pacing)) (VP (VBN instituted) (PP (IN in) (NP (DT the) (JJ peri-operative) (NN period))))))) (. .)))
17223814	6	(ROOT (S (NP (PRP We)) (VP (VB discuss) (SBAR (SBAR (WHADVP (WRB how)) (S (NP (JJ evidence-based) (NNS guidelines)) (VP (MD would) (RB not) (VP (VB have) (VP (VBN been) (ADJP (JJ helpful)) (PP (IN in) (NP (DT this) (NN case)))))))) (, ,) (CC and) (SBAR (WHADVP (WRB how)) (S (NP (NN chemotherapy)) (VP (MD can) (VP (VB exhibit) (NP (NP (JJ substantial) (NNS Doc_17223814_890_904_Disease)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB develop) (PP (IN over) (NP (JJ many) (NNS years)))))))))))))) (. .)))
17223814	7	(ROOT (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN received) (ADVP (RB chemotherapy)) (PP (IN at) (NP (DT any) (NN time)))))))) (VP (MD should) (VP (VB have) (NP (DT a) (JJ pre-operative) (NN electrocardiogram)) (SBAR (RB even) (IN if) (S (NP (PRP they)) (VP (VBP are) (ADJP (JJ asymptomatic)))))))))) (. .)))
17255138	0	(ROOT (S (NP (NP (NNS Risks) (CC and) (NNS benefits)) (PP (IN of) (NP (NN COX-2) (NNS inhibitors)))) (VP (VBP vs) (NP (NP (JJ non-selective) (NNS NSAIDs)) (: :) (SQ (VBZ does) (NP (PRP$ their) (JJ cardiovascular) (NN risk)) (VP (VB exceed) (NP (PRP$ their) (JJ gastrointestinal) (NN benefit)))))) (. ?)))
17255138	1	(ROOT (S (NP (DT A) (NN retrospective) (NN cohort)) (VP (VBP study)) (. .)))
17255138	2	(ROOT (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (NP (NP (NNS Doc_17255138_188_215_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17255138_217_220_Disease)) (-RRB- -RRB-))) (PP (IN with) (NP (NN COX-2) (NNS inhibitors)))))) (VP (MD may) (VP (VB offset) (NP (PRP$ their) (ADJP (ADJP (JJ gastrointestinal)) (PRN (-LRB- -LRB-) (NP (NNP GI)) (-RRB- -RRB-))) (NN benefit)) (PP (VBN compared) (PP (IN with) (NP (NP (ADJP (ADJP (JJ non-selective)) (PRN (-LRB- -LRB-) (NP (NNP NS)) (-RRB- -RRB-))) (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNP NSAIDs)) (-RRB- -RRB-))))))) (. .)))
17255138	3	(ROOT (S (NP (PRP We)) (VP (VBD aimed) (S (VP (TO to) (VP (VB compare) (NP (NP (DT the) (NNS risks)) (PP (IN of) (NP (NP (NN hospitalization)) (PP (IN for) (NP (NNS Doc_17255138_425_428_Disease) (CC and) (NNS Doc_17255138_433_444_Disease)))))) (PP (IN among) (NP (NP (JJ elderly) (NNS patients)) (VP (VBG using) (NP (NN COX-2) (NNS inhibitors) (, ,) (NNS NS-NSAIDs) (CC and) (NNS Doc_17255138_506_519_Chemical))))))))) (. .)))
17255138	4	(ROOT (S (NP (PRP We)) (VP (VBD conducted) (NP (NP (NP (DT a) (NN retrospective) (NN cohort) (NN study)) (VP (VBG using) (NP (NP (JJ administrative) (NNS data)) (PP (IN of) (NP (NNS patients) (NNS >)))))) (CC or) (SBAR (S (VP (SYM =) (NP (CD 65) (NNS years)))))) (PP (IN of) (NP (NP (NN age)) (SBAR (WHNP (WP who)) (S (VP (VBD filled) (NP (DT a) (NN prescription)) (PP (IN for) (NP (NNP NSAID) (CC or) (NNP Doc_17255138_671_684_Chemical))) (PP (IN during) (NP (CD 1999-2002))))))))) (. .)))
17255138	5	(ROOT (S (NP (NNS Outcomes)) (VP (VBD were) (VP (VBN compared) (S (VP (VBG using) (NP (NNP Cox) (NN regression) (NNS models)) (PP (IN with) (NP (JJ time-dependent) (NNS exposures))))))) (. .)))
17255138	6	(ROOT (S (NP (NP (NNS Person-years)) (PP (IN of) (NP (NP (NN exposure)) (PP (IN among) (NP (NP (NNS non-users)) (PP (IN of) (NP (NNS Doc_17255138_838_845_Chemical)))))))) (VP (VBD were) (: :) (S (NP (NP (CD 75,761)) (PP (TO to) (NP (NP (NNS Doc_17255138_862_875_Chemical)) (, ,) (NP (CD 42,671))))) (VP (TO to) (VP (VB Doc_17255138_887_896_Chemical) (NP (NP (QP (CD 65,860) (TO to) (CD Doc_17255138_907_916_Chemical))) (, ,) (CC and) (NP (NP (CD 37,495)) (PP (TO to) (NP (NNP NS-NSAIDs))))))))) (. .)))
17255138	7	(ROOT (S (PP (IN Among) (NP (NP (NNS users)) (PP (IN of) (NP (NNS Doc_17255138_958_965_Chemical))))) (, ,) (NP (PRP they)) (VP (VBD were) (NP (NP (: :) (NP (NP (CD 14,671)) (PP (TO to) (NP (NNS Doc_17255138_988_997_Chemical)))) (, ,) (NP (NP (CD 22,875)) (PP (TO to) (NP (NNS Doc_17255138_1009_1018_Chemical))))) (, ,) (NP (NP (CD 9,832)) (PP (TO to) (NP (NNP NS-NSAIDs)))) (CC and) (NP (NP (CD 38,048)) (PP (TO to) (NP (NNS Doc_17255138_1053_1066_Chemical)))))) (. .)))
17255138	8	(ROOT (S (PP (IN Among) (NP (NP (NNS non-users)) (PP (IN of) (NP (NNS Doc_17255138_1087_1094_Chemical))))) (, ,) (NP (NP (NP (DT the) (JJ adjusted) (NN hazard) (NNS ratios)) (-LRB- -LRB-) (NP (CD 95) (NN %) (NN confidence) (NN interval)) (-RRB- -RRB-)) (PP (IN of) (NP (NP (NN hospitalization)) (PP (IN for) (NP (NNP Doc_17255138_1172_1175_Disease) (NNP /) (NNP GI)))))) (VP (VBP vs) (NP (NP (NP (DT the) (NNS Doc_17255138_1186_1199_Chemical)) (PRN (-LRB- -LRB-) (PP (IN with) (NP (DT no) (NNS Doc_17255138_1209_1216_Chemical))) (-RRB- -RRB-)) (SBAR (S (NP (NN group)) (VP (VBD were))))) (: :) (NP (NP (NP (NNP Doc_17255138_1230_1239_Chemical) (CD 1.27)) (PRN (-LRB- -LRB-) (NP (CD 1.13)) (, ,) (NP (CD 1.42)) (-RRB- -RRB-))) (, ,) (NP (NP (QP (CD Doc_17255138_1259_1268_Chemical) (CD 0.93))) (PRN (-LRB- -LRB-) (NP (CD 0.83)) (, ,) (NP (CD 1.03)) (-RRB- -RRB-))) (, ,) (NP (NP (QP (CD Doc_17255138_1288_1296_Chemical) (CD 1.59))) (PRN (-LRB- -LRB-) (NP (CD 1.31)) (, ,) (NP (CD 1.93)) (-RRB- -RRB-))) (, ,) (NP (NP (QP (CD Doc_17255138_1316_1326_Chemical) (CD 1.17))) (PRN (-LRB- -LRB-) (NP (CD 0.99)) (, ,) (NP (CD 1.38)) (-RRB- -RRB-))) (CC and) (NP (NP (NNP Doc_17255138_1349_1358_Chemical) (CD 1.05)) (PRN (-LRB- -LRB-) (NP (CD 0.74)) (, ,) (NP (CD 1.51)) (-RRB- -RRB-)))))) (. .)))
17255138	9	(ROOT (S (PP (IN Among) (NP (NP (NNS users)) (PP (IN of) (NP (NNS Doc_17255138_1393_1400_Chemical))))) (, ,) (NP (PRP they)) (VP (VP (VBD were)) (: :) (NP (NP (NP (QP (CD Doc_17255138_1413_1422_Chemical) (CD 1.73))) (PRN (-LRB- -LRB-) (NP (NNP 1.52)) (, ,) (NP (NNP 1.98)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (QP (CD Doc_17255138_1442_1451_Chemical) (CD 1.34))) (PRN (-LRB- -LRB-) (NP (CD 1.19)) (, ,) (NP (NNP 1.52)) (-RRB- -RRB-))) (, ,) (NP (NP (QP (CD Doc_17255138_1471_1480_Chemical) (CD 1.51))) (PRN (-LRB- -LRB-) (NP (CD 0.95)) (, ,) (NP (NNP 2.41)) (-RRB- -RRB-))) (, ,) (NP (NP (QP (CD Doc_17255138_1500_1510_Chemical) (CD 1.69))) (PRN (-LRB- -LRB-) (NP (CD 1.35)) (, ,) (NP (CD 2.10)) (-RRB- -RRB-))) (, ,) (NP (NP (QP (CD Doc_17255138_1530_1538_Chemical) (CD 1.35))) (PRN (-LRB- -LRB-) (NP (CD 0.97)) (, ,) (NP (CD 1.88)) (-RRB- -RRB-))) (CC and) (NP (NP (QP (CD Doc_17255138_1561_1574_Chemical) (CD 1.29))) (PRN (-LRB- -LRB-) (NP (CD 1.17)) (, ,) (NP (CD 1.42)) (-RRB- -RRB-)))))) (. .)))
17255138	10	(ROOT (S (PP (IN Among) (NP (NP (NNS non-users)) (PP (IN of) (NP (NNS Doc_17255138_1625_1632_Chemical))))) (, ,) (NP (NNS Doc_17255138_1634_1642_Chemical)) (VP (VBD seemed) (S (VP (TO to) (VP (VB carry) (NP (NP (DT the) (JJS highest) (NN risk)) (PP (IN for) (NP (NNS Doc_17255138_1680_1695_Disease)))))))) (. .)))
17255138	11	(ROOT (FRAG (NP (DT The) (NNS Doc_17255138_1701_1704_Disease)) (: /) (S (NP (NP (NNS Doc_17255138_1705_1716_Disease)) (PP (IN of) (NP (NNS Doc_17255138_1720_1729_Chemical)))) (VP (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NNS Doc_17255138_1753_1766_Chemical))))))) (CC and) (VP (VBD seemed) (S (VP (TO to) (VP (VB be) (ADJP (JJR better)) (PP (IN than) (NP (NP (DT those)) (PP (IN of) (NP (NNS Doc_17255138_1805_1814_Chemical) (CC and) (NNS NS-NSAIDs))))))))))) (. .)))
17255138	12	(ROOT (S (PP (IN Among) (NP (NP (NNS users)) (PP (IN of) (NP (NNS Doc_17255138_1845_1852_Chemical))))) (, ,) (NP (DT both) (NNS Doc_17255138_1859_1868_Chemical) (CC and) (NNS Doc_17255138_1873_1881_Chemical)) (VP (VBD seemed) (S (VP (TO to) (VP (VB be) (NP (DT the) (ADJP (JJS least) (NN toxic))))))) (. .)))
17297207	0	(ROOT (NP (NP (JJ Doc_17297207_0_7_Chemical-induced) (NNS Doc_17297207_16_26_Disease)) (PP (IN in) (NP (DT a) (NN patient))) (PP (IN with) (NP (JJ severe) (NNS Doc_17297207_52_59_Disease))) (. .)))
17297207	1	(ROOT (S (NP (PRP It)) (VP (VBD was) (VP (VBN reported) (SBAR (IN that) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (JJ severe) (JJ Doc_17297207_109_116_Disease) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_17297207_130_138_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD presented) (PP (IN with) (NP (NP (NNS Doc_17297207_158_168_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17297207_170_203_Disease)) (-RRB- -RRB-)))) (SBAR (IN while) (S (S (VP (VBG getting) (NP (JJ Doc_17297207_219_226_Chemical) (NN infusion)))) (VP (VBD was) (VP (VBN reported)))))))))))))))))) (. .)))
17297207	2	(ROOT (S (NP (NP (DT A) (NN man)) (, ,) (ADJP (NP (CD 25) (NNS years)) (JJ old)) (, ,)) (VP (VBD was) (VP (VBN admitted) (PP (TO to) (NP (NN hospital))) (PP (IN with) (NP (NP (JJ high) (NN fever)) (, ,) (NP (NN chill)) (, ,) (NP (NNS Doc_17297207_320_328_Disease)) (, ,) (NP (NNS Doc_17297207_330_338_Disease)))))) (. .)))
17297207	3	(ROOT (S (S (NP (DT The) (NN patient)) (VP (VBD was) (ADJP (RB fully) (JJ conscious)))) (, ,) (NP (NN blood)) (VP (VBP pressure) (S (NP (NP (CD 120/80) (NN mmHg)) (, ,) (NP (NP (NN pulse) (NN rate)) (NP (CD 100) (NN x/minute))) (, ,)) (ADJP (JJ regular)))) (. .)))
17297207	4	(ROOT (S (PP (IN On) (NP (NN admission))) (, ,) (NP (NN laboratory) (NN examination)) (VP (VBD showed) (SBAR (S (NP (NP (NNP Plasmodium) (NNP falciparum)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17297207_502_506_Chemical)) (-RRB- -RRB-)) (, ,) (NP (NP (JJ total) (NNS Doc_17297207_515_524_Chemical)) (NP (CD 8.25) (NN mg/dL))) (, ,) (NP (NP (JJ conjugated) (NNS Doc_17297207_548_557_Chemical)) (NP (CD 4.36) (NN mg/dL))) (, ,) (NP (NP (JJ unconjugated) (NNS Doc_17297207_583_592_Chemical)) (NP (CD 3.89) (NN mg/dL))) (, ,)) (VP (VBD Doc_17297207_605_614_Chemical) (SBAR (S (NP (CD 3.52) (JJ meq/L) (NN Patient)) (VP (VBD was) (VP (VP (VBN diagnosed) (PP (IN as) (NP (JJ severe) (NNS Doc_17297207_658_665_Disease))) (PP (IN with) (NP (NNS Doc_17297207_671_679_Disease)))) (CC and) (VP (VBD got) (NP (JJ Doc_17297207_688_695_Chemical) (NN infusion)) (PP (IN in) (NP (NP (NNS Doc_17297207_708_716_Chemical)) (ADJP (CD 5) (NN %))))) (NP (CD 500) (JJ mg/8) (NN hour)))))))))) (. .)))
17297207	5	(ROOT (S (PP (IN On) (NP (DT the) (JJ second) (NN day))) (NP (DT the) (NN patient)) (VP (VBD had) (NP (NP (NNS vomitus) (, ,) (NNS Doc_17297207_778_786_Disease) (, ,) (NNS Doc_17297207_788_796_Disease) (, ,) (NN loss)) (PP (IN of) (NP (NN hearing))))) (. .)))
17297207	6	(ROOT (SINV (S (PP (IN After) (NP (NP (CD 30) (NNS hours)) (PP (IN of) (NP (JJ Doc_17297207_833_840_Chemical) (NN infusion))))) (NP (DT the) (NN patient)) (VP (VBD felt) (NP (NP (NN palpitation)) (CC and) (NP (JJ electrocardiography) (PRN (-LRB- -LRB-) (NP (NNP ECG)) (-RRB- -RRB-)) (NN recording))))) (VP (VBD showed) (NP (JJ Doc_17297207_926_959_Disease) (PRN (-LRB- -LRB-) (NP (NNP Doc_17297207_961_964_Disease)) (-RRB- -RRB-)) (NNS >))) (NP (NP (CD 5) (NN x/minute)) (, ,) (NP (NP (NP (NNS trigemini)) (, ,) (NP (JJ constant) (NN type))) (: --) (NP (NP (JJ sinoatrial) (NN block)) (, ,) (NP (JJ positive) (NNP U) (NN wave))))) (. .)))
17297207	7	(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (NN Doc_17297207_1061_1070_Chemical) (CD 50) (NN mg) (NN intravenously)) (VP (VBN followed) (PP (IN by) (NP (NP (NN infusion) (CD 1500) (NN mg)) (PP (IN in) (NP (NP (QP (CD Doc_17297207_1123_1131_Chemical) (CD 5)) (NN %)) (PRN (: /) (NP (NP (CD 24) (NN hour)) (CC and) (NP (JJ Doc_17297207_1147_1166_Chemical) (NN tablet))))))))))))) (. .)))
17297207	8	(ROOT (S (NP (JJ Doc_17297207_1175_1182_Chemical) (NN infusion)) (VP (VBD was) (VP (VBN discontinued) (CC and) (VBN changed) (PP (IN with) (NP (JJ sulfate) (JJ Doc_17297207_1234_1241_Chemical) (NNS tablets))))) (. .)))
17297207	9	(ROOT (S (S (ADVP (NP (CD Three) (NNS hours)) (RB later)) (NP (DT the) (NN patient)) (VP (VBD felt) (NP (NP (JJR better)) (, ,) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NP (NNS Doc_17297207_1311_1314_Disease)) (VP (VBN reduced) (PP (TO to) (NP (CD 4)))))))))) (: -) (S (SBAR (UCP (NP (CD 5) (NN x/minute)) (CC and) (PP (IN on) (NP (DT the) (JJ third) (NN day)))) (S (NP (NNP ECG)) (VP (VBD was) (ADJP (JJ normal))))) (, ,) (NP (JJ Doc_17297207_1378_1387_Chemical) (NN level)) (VP (VBD was) (ADJP (RB 3.34) (JJ meq/L)))) (. .)))
17297207	10	(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN discharged) (PP (IN on) (NP (NP (JJ 7th) (NN day)) (PP (IN in) (NP (JJ good) (NN condition))))))) (. .)))
17297207	11	(ROOT (S (ADVP (RB Doc_17297207_1458_1465_Chemical)) (, ,) (PP (IN like) (NP (NNS Doc_17297207_1472_1481_Chemical))) (, ,) (VP (VBZ is) (NP (NP (DT a) (NN chincona) (NN alkaloid)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (NP (JJ anti-arrhythmic) (NN property)) (, ,) (SBAR (IN although) (S (NP (PRP it)) (ADVP (RB also)) (VP (VBZ pro-arrhythmic) (SBAR (IN that) (S (VP (MD can) (VP (VB cause) (NP (NNS Doc_17297207_1588_1607_Disease))))))))) (, ,) (PP (VBG including) (NP (NP (JJ severe) (NNS Doc_17297207_1626_1636_Disease)) (PP (JJ such) (IN as) (NP (JJ multiple) (NNS Doc_17297207_1654_1657_Disease)))))))))) (. .)))
17297207	12	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (JJ parenteral) (NNS Doc_17297207_1688_1695_Chemical)))) (VP (MD must) (VP (VB be) (VP (VBN done) (UCP (ADVP (RB carefully)) (CC and) (PP (IN with) (NP (NP (JJ good) (NN observation)) (PP (RB because) (IN of) (NP (PRP$ its) (JJ pro-arrhythmic) (NN effect)))))) (, ,) (PP (RB especially) (IN in) (NP (NP (NP (JJR older) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (NP (NP (NNS Doc_17297207_1821_1835_Disease) (CC or) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_17297207_1853_1873_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17297207_1875_1886_Disease)) (-RRB- -RRB-)) (SBAR (WHNP (WDT which)) (S (ADVP (RB frequently)) (VP (VBZ occurs) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_17297207_1919_1927_Disease)))))))))))))) (CC and) (CC or) (NP (NP (NNS Doc_17297207_1935_1943_Disease)) (PP (IN in) (NP (JJ Doc_17297207_1947_1954_Disease) (NNS cases))))))))) (. .)))
17346443	0	(ROOT (NP (NP (JJ Doc_17346443_0_13_Chemical-related) (NNS Doc_17346443_22_42_Disease) (CC and) (NN utility)) (PP (IN of) (NP (NP (NNS Doc_17346443_58_70_Chemical)) (PP (IN in) (NP (DT a) (JJ Doc_17346443_76_90_Disease) (NN patient))))) (PP (IN with) (NP (JJ hepatic) (NN presentation) (, ,) (NN Doc_17346443_126_133_Disease) (CC and) (NN SPECT) (NNS abnormalities))) (. .)))
17346443	1	(ROOT (S (NP (NNP Doc_17346443_159_175_Disease)) (VP (VBZ is) (NP (NP (DT an) (JJ autosomal) (NN recessive) (NN disorder)) (PP (IN of) (NP (NP (JJ hepatic) (JJ Doc_17346443_222_228_Chemical) (NN metabolism)) (PP (IN with) (NP (NP (JJ consequent) (NNS Doc_17346443_256_262_Chemical) (NX (NX (NX (NN accumulation)) (PRN (CC and) (NP (NP (NNS Doc_17346443_280_288_Disease)) (PP (IN in) (NP (JJ many) (NNS tissues)))))) (CC and) (NX (JJ consequent)))) (ADJP (JJ hepatic) (, ,) (JJ neurologic) (CC and) (JJ Doc_17346443_344_365_Disease)))))))) (. .)))
17346443	2	(ROOT (S (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NNS Doc_17346443_387_403_Disease)) (PP (IN with) (NP (NNS Doc_17346443_409_430_Disease)))))))) (: ;) (S (ADVP (RB moreover)) (, ,) (PP (IN in) (NP (NP (PRP$ our) (NN patient)) (, ,) (VP (VBG presenting) (ADVP (RB also)) (PP (IN with) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN state) (NNS Doc_17346443_500_507_Disease)) (PP (IN without) (NP (NNS Doc_17346443_516_526_Disease)))))))))) (, ,) (NP (JJ 99mTc-ECD-SPECT)) (VP (VBD showed) (NP (JJ cortical) (NN hypoperfusion)) (PP (IN in) (NP (JJ frontal) (NNS lobes))) (, ,) (S (ADJP (RBR more) (JJ marked) (PP (IN on) (NP (DT the) (JJ left) (JJ frontal) (NN lobe))))))) (. .)))
17346443	3	(ROOT (S (PP (IN During) (NP (NP (DT the) (NN follow-up)) (PP (IN of) (NP (PRP$ our) (NN patient))))) (, ,) (S (NP (NNS Doc_17346443_667_680_Chemical)) (VP (VBD was) (VP (VBN interrupted) (PP (IN after) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (DT a) (NNS Doc_17346443_723_743_Disease)))))))) (, ,) (CC and) (S (NP (NNS Doc_17346443_749_761_Chemical)) (VP (VBD permitted) (S (VP (TO to) (VP (VB continue) (NP (NP (DT the) (JJ successful) (NN treatment)) (PP (IN of) (NP (DT the) (NN patient)))) (PP (IN without) (NP (NNS side-effects)))))))) (. .)))
17346443	4	(ROOT (S (PP (IN In) (NP (PRP$ our) (NN case))) (NP (NP (DT the) (NN therapy)) (PP (IN with) (NP (NNS Doc_17346443_875_887_Chemical)))) (VP (VBD represented) (NP (DT an) (JJ effective) (NN treatment)) (PP (IN for) (NP (NP (DT a) (JJ Doc_17346443_929_945_Disease) (NN patient)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN Doc_17346443_963_976_Chemical-related) (NN side) (NNS effects)) (VP (VBD appeared))))))) (. .)))
17346443	5	(ROOT (S (S (NP (NP (DT The) (NN safety)) (PP (IN of) (NP (DT the) (NNS Doc_17346443_1026_1038_Chemical)))) (VP (VBD allowed) (S (NP (PRP us)) (VP (TO to) (VP (VB avoid) (NP (JJ other) (ADJP (RB potentially) (JJ toxic)) (NN chelating) (NNS drugs))))))) (: ;) (S (NP (DT this) (NN observation)) (VP (VBZ is) (PP (IN in) (NP (NN line))) (PP (IN with) (NP (NP (DT the) (VBG growing) (NN evidence)) (PP (IN on) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NP (DT the) (NN drug)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_17346443_1202_1218_Disease))))))))))))) (. .)))
17346443	6	(ROOT (S (SBAR (IN Since) (S (NP (NP (JJS most)) (PP (IN of) (NP (JJ Doc_17346443_1234_1250_Disease) (NN Doc_17346443_1251_1264_Chemical-treated) (NNS patients)))) (VP (VBP do) (RB not) (VP (VB seem) (S (VP (TO to) (VP (VB develop) (NP (DT this) (NNS Doc_17346443_1310_1321_Disease))))))))) (, ,) (NP (PRP it)) (VP (MD could) (VP (VB be) (ADJP (JJ conceivable)) (SBAR (IN that) (S (NP (DT a) (JJ specific) (JJ genetic) (NN factor)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NN drug) (NN response))))))))) (. .)))
17346443	7	(ROOT (S (NP (JJ Further) (NNS studies)) (VP (VBP are) (VP (VBN needed) (PP (PP (IN for) (NP (NP (DT a) (JJR better) (NN clarification)) (PP (IN of) (NP (JJ Doc_17346443_1465_1481_Disease) (NN therapy))))) (, ,) (CC and) (PP (IN in) (NP (ADJP (JJ particular) (S (VP (TO to) (VP (VB differentiate) (NP (JJ specific) (NNS therapies)) (PP (IN for) (NP (JJ different) (NNS Doc_17346443_1559_1575_Disease))))))) (NNS phenotypes)))))) (. .)))
17351238	0	(ROOT (S (NP (NP (DT A) (JJ dramatic) (NN drop)) (PP (IN in) (NP (NN blood)))) (VP (NN pressure) (PP (VBG following) (NP (JJ prehospital) (JJ Doc_17351238_56_59_Chemical) (NN administration)))) (. .)))
17351238	1	(ROOT (S (NP (NP (DT A) (NN male)) (PP (IN in) (NP (NP (PRP$ his) (NNS sixties)) (PP (IN with) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (JJ cardiac) (NNS Doc_17351238_125_135_Disease)))))))) (VP (VBD awoke) (PP (IN with) (NP (NP (NNS Doc_17351238_147_157_Disease)) (PP (VBG following) (NP (DT an) (NN afternoon) (NN sleep)))))) (. .)))
17351238	2	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD did) (RB not) (VP (VB self) (NP (NN medicate)))) (. .)))
17351238	3	(ROOT (S (S (NP (NP (DT The) (NN patient) (POS 's)) (NNS observations)) (VP (VBD were) (PP (IN within) (NP (JJ normal) (NNS limits))))) (, ,) (NP (PRP he)) (VP (VBD was) (VP (VBN administered) (NP (NP (NNS Doc_17351238_297_303_Chemical)) (PP (IN via) (NP (NP (DT a) (NN face) (NN mask)) (CC and) (NP (NP (NNS Doc_17351238_324_343_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17351238_345_348_Chemical)) (-RRB- -RRB-)))))))) (. .)))
17351238	4	(ROOT (S (S (PP (NP (JJ Several) (NNS minutes)) (IN after) (NP (DT the) (NNS Doc_17351238_377_380_Chemical))) (NP (DT the) (NN patient)) (VP (VBD experienced) (NP (DT a) (JJ sudden) (NN drop)) (PP (IN in) (NP (NP (NN blood) (NN pressure)) (CC and) (NP (NN heart) (NN rate)))))) (, ,) (NP (DT this)) (VP (VBD was) (VP (VBN rectified) (PP (IN by) (NP (NP (NNS Doc_17351238_475_492_Chemical)) (CC and) (NP (DT a) (JJ fluid) (NN challenge)))))) (. .)))
17351238	5	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (JJ further) (NN deterioration)) (PP (IN in) (NP (NP (DT the) (NN patient) (POS 's)) (NN condition)))) (PP (IN during) (NP (NP (NN transport)) (PP (TO to) (NP (NN hospital)))))) (. .)))
17351238	6	(ROOT (S (NP (EX There)) (VP (VBP are) (NP (NP (ADJP (RB very) (JJ few)) (VBN documented) (NN case)) (PP (IN like) (NP (NP (DT this)) (PP (IN in) (NP (DT the) (JJ prehospital) (JJ scientific) (NN literature))))))) (. .)))
17351238	7	(ROOT (S (NP (DT The) (NN cause)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ Bezold-Jarish) (NN reflex)) (, ,) (NP (NP (NN stimulation)) (PP (IN of) (NP (DT the) (NN ventricular) (NNS walls))) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN turn))) (VP (VBZ decreases) (NP (JJ sympathetic) (NN outflow)) (PP (IN from) (NP (DT the) (NN vasomotor) (NN centre)))))))))))) (. .)))
17351238	8	(ROOT (S (NP (NP (JJ Prehospital) (NN care) (NNS providers)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG managing) (NP (DT any) (NN patient)) (PP (IN with) (NP (NP (DT a) (NNS Doc_17351238_916_932_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBZ fails) (S (VP (TO to) (VP (VB recover) (PP (IN within) (NP (DT a) (JJ reasonable) (NN time) (NN frame)))))))))))))))) (VP (MD should) (VP (VP (VB consider) (NP (DT the) (JJ Bezold-Jarisch) (NN reflex)) (PP (IN as) (NP (DT the) (NN cause)))) (CC and) (VP (VB manage) (NP (DT the) (NN patient)) (ADVP (RB accordingly))))) (. .)))
1735570	0	(ROOT (NP (NP (JJ Chronic) (NN lesion)) (PP (IN of) (NP (JJ rostral) (JJ ventrolateral) (NN medulla))) (PP (IN in) (NP (JJ spontaneously) (JJ Doc_1735570_65_77_Disease) (NNS rats))) (. .)))
1735570	1	(ROOT (S (NP (PRP We)) (VP (VBD studied) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ chronic) (JJ selective) (JJ neuronal) (NN lesion)) (PP (IN of) (NP (JJ rostral) (JJ ventrolateral) (NN medulla)))))) (PP (IN on) (NP (NP (JJ mean) (JJ arterial) (NN pressure)) (, ,) (NP (NN heart) (NN rate)) (, ,) (CC and) (NP (JJ neurogenic) (NN tone)))) (PP (IN in) (NP (ADJP (JJ conscious) (, ,) (JJ unrestrained)) (JJ spontaneously) (JJ Doc_1735570_277_289_Disease) (NNS rats)))) (. .)))
1735570	2	(ROOT (S (NP (DT The) (NNS lesions)) (VP (VBD were) (VP (VBN placed) (PP (IN via) (NP (NP (JJ bilateral) (NNS microinjections)) (PP (IN of) (NP (CD 30) (JJ nmol/200) (NN nl) (NNS Doc_1735570_368_392_Chemical))))))) (. .)))
1735570	3	(ROOT (S (NP (NP (DT The) (NN restimulation)) (PP (IN of) (NP (NP (DT this) (NN area)) (PP (IN with) (NP (NP (NNS Doc_1735570_430_454_Chemical)) (ADJP (NP (CD 15) (NNS days)) (JJ postlesion))))))) (VP (VBD failed) (S (VP (TO to) (VP (VB produce) (NP (DT a) (NN pressor) (NN response)))))) (. .)))
1735570	4	(ROOT (S (NP (NP (CD One) (NN day) (NN postlesion)) (, ,) (NP (DT the) (JJ resting) (JJ mean) (NN arterial) (NN pressure))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN decreased) (PP (IN in) (NP (JJ lesioned) (NNS rats))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (NN sham) (NNS rats))) (PRN (-LRB- -LRB-) (PP (ADVP (NP (NP (CD 100) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 7)) (CC versus) (NP (CD 173) (NNS +))) (: /)) (PRN (: -) (NP (NP (CD 4) (NN mm) (NNP Hg)) (, ,) (NP (NN p))))) (JJR less)) (IN than) (NP (CD 0.05))) (-RRB- -RRB-))))))) (. .)))
1735570	5	(ROOT (S (NP (CD Fifteen) (NNS days) (RB later)) (, ,) (NP (DT the) (JJ lesioned) (NN group)) (ADVP (RB still)) (VP (VBD showed) (S (NP (NNS values)) (ADJP (ADJP (RB significantly) (JJR lower) (PP (IN than) (NP (DT the) (NN sham) (NN group)))) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 150)) (JJ +)) (: /)) (: -) (FRAG (NP (NP (CD 6)) (PP (IN versus) (NP (QP (CD 167) (CD +)) (NNS /)))) (: -) (NP (NP (CD 5) (NN mm) (NNP Hg)) (, ,) (ADJP (JJ p) (ADVP (RBR less) (IN than)) (NP (CD 0.05)))))) (-RRB- -RRB-))))) (. .)))
1735570	6	(ROOT (S (NP (DT No) (JJ significant) (NN heart) (NN rate) (NNS differences)) (VP (VBD were) (VP (VBN observed) (PP (IN between) (NP (NP (DT the) (NN sham)) (CC and) (NP (JJ lesioned) (NNS groups)))))) (. .)))
1735570	7	(ROOT (S (NP (NP (DT The) (JJ ganglionic) (NN blocker) (NNS Doc_1735570_961_973_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg) (NN i.v.)) (-RRB- -RRB-))) (VP (VBD caused) (NP (JJ similar) (NNS reductions)) (PP (IN in) (NP (JJ mean) (JJ arterial) (NN pressure))) (PP (IN in) (NP (DT both) (NN lesioned) (CC and) (NN sham) (NNS groups)))) (. .)))
1735570	8	(ROOT (S (NP (DT The) (NN Doc_1735570_1079_1091_Chemical-induced) (NNS Doc_1735570_1100_1111_Disease)) (VP (VBD was) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT a) (JJ significant) (NNS Doc_1735570_1145_1156_Disease)) (PP (IN in) (NP (NP (NP (JJ lesioned) (NNS rats)) (PRN (-LRB- -LRB-) (NP (CD -32) (NNP +) (NNS /)) (: -) (NP (NP (CD 13) (NNS beats)) (PP (IN per) (NP (NN minute)))) (-RRB- -RRB-))) (PP (CC but) (NP (DT a) (ADJP (JJ Doc_1735570_1210_1221_Disease) (PP (IN in) (NP (NP (NN sham) (NNS rats)) (PRN (-LRB- -LRB-) (NP (CD +33) (NNP +) (NNS /)) (: -) (NP (NP (CD 12) (NNS beats)) (PP (IN per) (NP (NN minute)))) (-RRB- -RRB-))))) (CD 1) (NN day) (NN postlesion))))))))) (. .)))
1735570	9	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (JJ rostral) (JJ ventrolateral) (NN medulla) (NNS neurons)) (VP (VBP appear) (S (VP (TO to) (VP (VB play) (NP (DT a) (JJ significant) (NN role)) (PP (IN in) (S (VP (VBG maintaining) (NP (NNS Doc_1735570_1381_1393_Disease)) (PP (IN in) (NP (JJ conscious) (NNP spontaneously) (NNP Doc_1735570_1421_1433_Disease) (NNS rats)))))))))) (. .)))
1735570	10	(ROOT (S (NP (NN Spinal) (CC or) (NN suprabulbar) (NNS structures)) (VP (MD could) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (JJ gradual) (NN recovery)) (PP (IN of) (NP (NP (DT the) (NNS Doc_1735570_1526_1538_Disease)) (PP (IN in) (NP (DT the) (JJ lesioned) (NNS rats)))))))))) (. .)))
17356399	0	(ROOT (S (VP (VB Acute) (NP (NNS Doc_17356399_6_20_Disease) (CC and) (NNS Doc_17356399_25_43_Disease)) (PP (IN after) (NP (NP (JJ multiagent) (NN chemotherapy)) (PP (VBG including) (NP (NP (ADJP (JJ Doc_17356399_84_87_Chemical-asparaginase) (CC and) (JJ intrathecal)) (NNS Doc_17356399_117_127_Chemical)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_17356399_149_177_Disease)))))))))) (. .)))
17356399	1	(ROOT (S (NP (NP (DT A) (JJ 7-year-old) (NN girl)) (PP (IN with) (NP (DT an) (JJ unusual) (NN reaction) (S (VP (TO to) (VP (VB induction) (ADVP (RB chemotherapy)) (PP (IN for) (NP (NP (NNP precursor) (NNP B-cell) (NNP Doc_17356399_269_297_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17356399_299_302_Disease)) (-RRB- -RRB-)))))))))) (VP (VBZ is) (VP (VBN described))) (. .)))
17356399	2	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD developed) (NP (NP (JJ acute) (NNS Doc_17356399_346_360_Disease)) (VP (VBN evidenced) (PP (IN by) (NP (NP (JJ behavioral) (NNS changes)) (, ,) (NP (NNS Doc_17356399_394_401_Disease)) (, ,) (NP (NN incontinence)) (, ,) (NP (NNS Doc_17356399_417_438_Disease)) (, ,) (CC and) (NP (JJ right-sided) (NN weakness)))) (PP (IN with) (NP (NP (JJ diffuse) (NNS Doc_17356399_478_496_Disease)) (PP (IN on) (NP (JJ magnetic) (NN resonance) (NN angiography))))) (PP (IN after) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (JJ intrathecal) (NNS Doc_17356399_571_581_Chemical)))))))) (. .)))
17356399	3	(ROOT (S (NP (NNP Doc_17356399_583_594_Chemical) (, ,) (NNP Doc_17356399_596_609_Chemical) (, ,) (CC and) (NNP Doc_17356399_615_634_Chemical-asparaginase)) (VP (VBD were) (ADVP (RB also)) (VP (VBN administered) (PP (IN before) (NP (NP (DT the) (NN episode)) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NN induction) (NN therapy))))))))) (. .)))
17356399	4	(ROOT (S (S (NP (JJ Neurologic) (NN status)) (VP (VBD returned) (PP (TO to) (NP (NN baseline))) (PP (IN within) (NP (NP (CD 10) (NNS days)) (PP (IN of) (NP (DT the) (JJ acute) (NN event))))))) (, ,) (CC and) (S (NP (JJ magnetic) (NN resonance) (NN angiography) (NNS findings)) (VP (VBD returned) (PP (TO to) (ADJP (JJ normal))) (NP (CD 4) (NNS months) (RB later)))) (. .)))
17379047	0	(ROOT (S (FRAG (NP (NP (NNP Comparison)) (PP (IN of) (NP (NNS Doc_17379047_14_23_Chemical)))) (: /) (NP (NP (JJ Doc_17379047_24_43_Chemical) (NN combination) (NN therapy)) (PP (IN at) (NP (NP (NNS doses)) (ADVP (RB up) (PP (TO to) (NP (CD 320/25) (NN mg)))))) (PP (IN versus) (NP (NN monotherapy))))) (: :) (S (NP (DT a) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN study)) (VP (VBD followed) (PP (IN by) (NP (JJ long-term) (NN combination) (NN therapy))) (PP (IN in) (NP (JJ Doc_17379047_195_207_Disease) (NNS adults))))) (. .)))
17379047	1	(ROOT (S (NP (NP (CD One) (NN third)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN for) (NP (NP (JJ Doc_17379047_262_274_Disease) (ADJP (RB attain) (JJ adequate)) (NN blood) (NN pressure) (PRN (-LRB- -LRB-) (NP (NNP BP)) (-RRB- -RRB-)) (NN control)) (, ,) (CC and) (NP (VBG multidrug) (NNS regimens)))))))) (VP (VBP are) (ADVP (RB often)) (VP (VBN required))) (. .)))
17379047	2	(ROOT (S (PP (VBN Given) (NP (NP (DT the) (JJ lifelong) (NN nature)) (PP (IN of) (NP (NNS Doc_17379047_392_404_Disease))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (DT a) (NN need) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (JJ long-term) (NN efficacy) (CC and) (NN tolerability)) (PP (IN of) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN combination) (JJ anti-Doc_17379047_510_522_Disease) (NNS therapies))))))))))) (. .)))
17379047	3	(ROOT (S (NP (DT This) (NN study)) (VP (VBD investigated) (NP (NP (NP (DT the) (NN efficacy) (CC and) (NN tolerability)) (PP (IN of) (NP (NP (NNS Doc_17379047_602_611_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17379047_613_616_Chemical)) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_17379047_621_640_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17379047_642_646_Chemical)) (-RRB- -RRB-))))) (: -) (NP (NP (JJ monotherapy) (CC and) (JJ higher-dose) (NNS combinations)) (PP (IN in) (NP (NNS patients))))) (PP (IN with) (NP (JJ essential) (NNS Doc_17379047_716_728_Disease)))) (. .)))
17379047	4	(ROOT (S (NP (NP (DT The) (JJ first) (NN part)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (NP (DT an) (ADJP (JJ 8-week) (, ,) (JJ multicenter) (, ,) (JJ randomized) (, ,) (JJ double-blind) (, ,) (IN placebo) (JJ controlled) (, ,)) (JJ parallel-group) (NN trial))) (. .)))
17379047	5	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (JJ essential) (NNS Doc_17379047_888_900_Disease)))) (PRN (-LRB- -LRB-) (VP (VB mean) (S (VP (VBG sitting) (NP (NP (NP (JJ diastolic) (NNP BP) (NNP -LSB-) (NNP MSDBP) (NNP -RSB-)) (, ,) (VP (VBN >))) (CC or) (SBAR (S (VP (SYM =) (NP (CD 95) (NNP mm) (NNP Hg) (CC and) (NNP <) (CD 110) (NN mm) (NNS Hg))))))))) (-RRB- -RRB-)) (VP (VBD were) (VP (VBN randomized) (PP (TO to) (NP (NP (NP (CD 1)) (PP (IN of) (NP (CD 8) (NN treatment) (NNS groups)))) (: :) (NP (NP (NNS Doc_17379047_1012_1015_Chemical)) (NP (QP (CD 160) (CC or) (CD 320)) (NN mg))) (: ;) (NP (NP (NNP Doc_17379047_1031_1035_Chemical) (CD 12.5)) (CC or) (NP (CD 25) (NN mg))) (: ;) (NP (NP (JJ Doc_17379047_1051_1054_Chemical) (JJ /) (NNS Doc_17379047_1055_1059_Chemical)) (NP (QP (CD 160/12) (CD .5)))) (, ,) (NP (NP (QP (CD 320/12) (CD .5))) (, ,) (CC or) (NP (NP (CD 320/25)) (NP (NN mg)))) (: ;) (CC or) (NP (NN placebo)))))) (. .)))
17379047	6	(ROOT (S (NP (NP (NP (NN Mean) (NNS changes)) (PP (IN in) (NP (NNP MSDBP)))) (CC and) (NP (NP (JJ mean) (VBG sitting) (JJ systolic) (NNS BP)) (PRN (-LRB- -LRB-) (NP (NNP MSSBP)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN analyzed) (PP (IN at) (NP (DT the) (JJ 8-week) (JJ core) (NN study) (NN end) (NN point))))) (. .)))
17379047	7	(ROOT (FRAG (NP (NNP Doc_17379047_1215_1218_Chemical)) (: /) (S (NP (NP (JJ Doc_17379047_1219_1223_Chemical) (QP (CD 320/12) (CD .5))) (CC and) (NP (CD 320/25) (NN mg))) (VP (VBD were) (ADVP (RBR further)) (VP (VBN investigated) (PP (IN in) (NP (DT a) (JJ 54-week) (, ,) (JJ open-label) (NN extension)))))) (. .)))
17379047	8	(ROOT (S (NP (NNP Response)) (VP (VBD was) (VP (VBN defined) (PP (IN as) (NP (NP (NNP MSDBP) (CD <) (CD 90) (NNP mm) (NNP Hg)) (CC or) (NP (DT a) (ADJP (NP (QP (CD >) (CC or) (CD =) (CD 10)) (NN mm)) (JJ Hg)) (NN decrease)))) (PP (VBN compared) (PP (TO to) (NP (NN baseline)))))) (. .)))
17379047	9	(ROOT (S (NP (NNP Control)) (VP (VBD was) (VP (VBN defined) (PP (IN as) (NP (NNP MSDBP) (NNP <) (CD 90) (NN mm) (NNP Hg))) (PP (VBN compared) (PP (IN with) (NP (NN baseline)))))) (. .)))
17379047	10	(ROOT (S (NP (NNP Tolerability)) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (S (VP (VBG monitoring) (NP (JJ adverse) (NNS events)) (PP (IN at) (NP (NP (NP (NN randomization)) (CC and) (NP (DT all) (JJ subsequent) (NN study) (NNS visits))) (CC and) (NP (NP (JJ regular) (NN evaluation)) (PP (IN of) (NP (NN hematology) (CC and) (NN blood) (NN chemistry))))))))))) (. .)))
17379047	11	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (CD 1346) (NNS patients)))) (VP (VBD were) (VP (VBN randomized) (PP (IN into) (NP (NP (DT the) (JJ 8-week) (NN core) (NN study)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (CD 734) (NNS men)) (, ,) (NP (CD 612) (NNS women))) (: ;) (NP (NP (CD 924)) (NP (NP (JJ white)) (PRN (, ,) (NP (CD 291)) (ADJP (JJ black)) (, ,) (NP (CD 23)) (ADJP (JJ Asian) (, ,) (JJ 108) (JJ other))))) (: ;) (NP (NP (JJ mean) (NN age)) (, ,) (NP (CD 52.7) (NNS years))) (: ;) (NP (NP (JJ mean) (NN weight)) (, ,) (NP (NNP 92.6)))) (NP (NN kg))) (-RRB- -RRB-)))))) (. .)))
17379047	12	(ROOT (S (NP (DT All) (JJ active) (NNS treatments)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (ADJP (ADJP (RB significantly) (JJ reduced)) (SBAR (S (VP (VBP MSSBP) (CC and) (VBP MSDBP) (PP (IN during) (NP (DT the) (JJ core) (JJ 8-week) (NN study))) (, ,) (PP (IN with) (NP (NP (DT each) (NN monotherapy)) (VP (ADVP (RB significantly)) (VBG contributing) (PP (TO to) (NP (NP (DT the) (JJ overall) (NN effect)) (PP (IN of) (NP (NP (NN combination) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_17379047_2017_2020_Chemical) (CC and) (NNS Doc_17379047_2025_2029_Chemical)) (, ,) (NP (NNP P) (NNP <) (NNP 0.001))) (-RRB- -RRB-)))))))))))))))) (. .)))
17379047	13	(ROOT (S (NP (DT Each) (NN combination)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (ADJP (RB significantly) (JJR greater)) (NNS reductions)) (PP (IN in) (NP (NNP MSSBP) (CC and) (NNP MSDBP))))) (PP (VBN compared) (PP (IN with) (NP (NP (DT the) (NN monotherapies) (CC and) (NN placebo)) (PRN (-LRB- -LRB-) (NP (NP (DT all)) (, ,) (NP (NNP P) (NNP <) (NNP 0.001))) (-RRB- -RRB-))))))) (. .)))
17379047	14	(ROOT (S (NP (NP (DT The) (JJ mean) (NN reduction)) (PP (IN in) (NP (NP (NNP MSSBP/MSDBP)) (PP (IN with) (NP (NNS Doc_17379047_2233_2236_Chemical)))))) (PRN (: /) (S (NP (JJ Doc_17379047_2237_2241_Chemical) (CD 320/25) (NN mg)) (VP (VBD was) (ADJP (NP (QP (CD 24.7) (CD /)) (QP (CD 16.6) (CD mm))) (JJ Hg)) (, ,) (PP (VBN compared) (PP (IN with) (NP (CD 5.9)))))) (: /)) (VP (VBZ 7.0) (NP (NP (NNP mm) (NNP Hg)) (PP (IN with) (NP (NN placebo))))) (. .)))
17379047	15	(ROOT (S (NP (NP (DT The) (NN reduction)) (PP (IN in) (NP (NNP MSSBP)))) (VP (VBD was) (ADJP (RB significantly) (JJR greater)) (PP (IN with) (NP (NP (NNS Doc_17379047_2369_2372_Chemical)) (PRN (: /) (NP (NP (NNP Doc_17379047_2373_2377_Chemical) (CD 320/25) (NN mg)) (PP (VBN compared) (PP (IN with) (NP (NNS Doc_17379047_2402_2405_Chemical))))) (: /)) (VP (VBG Doc_17379047_2406_2410_Chemical) (NP (NP (QP (CD 160/12) (CD .5)) (NN mg)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.002))) (-RRB- -RRB-))))))) (. .)))
17379047	16	(ROOT (S (NP (NP (NNS Rates)) (PP (IN of) (NP (NN response) (CC and) (NN BP) (NN control)))) (VP (VBD were) (ADJP (RB significantly) (JJR higher)) (PP (IN in) (NP (NP (DT the) (NNS groups)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (NP (NN combination) (NN treatment)) (PP (VBN compared) (PP (IN with) (NP (NP (DT those)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (ADVP (RB monotherapy)))))))))))))) (. .)))
17379047	17	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NNS Doc_17379047_2609_2620_Disease)))) (VP (VBD was) (ADJP (ADJP (JJR lower)) (PP (IN with) (NP (NP (JJ Doc_17379047_2636_2639_Chemical) (JJ /) (JJ Doc_17379047_2640_2644_Chemical) (NNS combinations)) (PRN (-LRB- -LRB-) (NP (NP (CD 1.8) (NN %)) (NP (CD -6.1) (NN %))) (-RRB- -RRB-))))) (PP (IN than) (PP (IN with) (NP (NP (JJ Doc_17379047_2680_2684_Chemical) (NNS monotherapies)) (PRN (-LRB- -LRB-) (NP (NP (CD 7.1) (NN %)) (NP (CD -13.3) (NN %))) (-RRB- -RRB-)))))) (. .)))
17379047	18	(ROOT (S (NP (NP (DT The) (NN majority)) (PP (IN of) (NP (NP (JJ adverse) (NNS events)) (PP (IN in) (NP (DT the) (JJ core) (NN study)))))) (VP (VBD were) (PP (IN of) (NP (ADJP (JJ mild) (TO to) (JJ moderate)) (NN severity)))) (. .)))
17379047	19	(ROOT (FRAG (NP (NP (DT The) (NN efficacy) (CC and) (NN tolerability)) (PP (IN of) (NP (NNS Doc_17379047_2830_2833_Chemical)))) (: /) (S (NP (JJ Doc_17379047_2834_2838_Chemical) (NNS combinations)) (VP (VBD were) (VP (VBN maintained) (PP (IN during) (NP (NP (DT the) (NN extension)) (PRN (-LRB- -LRB-) (NP (CD 797) (NNS patients)) (-RRB- -RRB-))))))) (. .)))
17379047	20	(ROOT (S (PP (IN In) (NP (DT this) (NN study) (NN population))) (, ,) (NP (NP (NN combination) (NNS therapies)) (PP (IN with) (NP (JJ Doc_17379047_2971_2974_Chemical) (JJ /) (NNS Doc_17379047_2975_2979_Chemical)))) (VP (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (ADJP (RB significantly) (JJR greater)) (NN BP) (NNS reductions))) (PP (VBN compared) (PP (IN with) (NP (DT either) (NN monotherapy)))))) (, ,) (VP (VBD were) (ADJP (RB well) (JJ tolerated))) (, ,) (CC and) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (NP (JJR less) (NNS Doc_17379047_3122_3133_Disease)) (PP (IN than) (NP (NNS Doc_17379047_3139_3143_Chemical))))) (ADVP (RB alone))))) (. .)))
17384765	0	(ROOT (S (NP (NNP Succimer) (NNP chelation)) (VP (VP (VBZ improves) (NP (NP (NN learning)) (, ,) (NP (NN attention)) (, ,) (CC and) (NP (JJ arousal) (NN regulation))) (PP (IN in) (NP (JJ lead-exposed) (NNS rats)))) (CC but) (VP (VBZ produces) (NP (JJ lasting) (NNS Doc_17384765_114_134_Disease)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ lead) (NN exposure))))))) (. .)))
17384765	1	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (VBG growing) (NN pressure)) (PP (IN for) (NP (ADJP (JJ clinicians) (S (VP (TO to) (VP (VB prescribe) (NP (NN chelation) (NN therapy)) (PP (IN at) (NP (RB only) (RB slightly) (JJ elevated) (NN blood))))))) (JJ lead) (NNS levels))))) (. .)))
17384765	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (ADJP (RB very) (JJ few)) (NNS studies)) (VP (VBP have) (VP (VBN evaluated) (SBAR (SBAR (IN whether) (S (NP (NN chelation)) (VP (VBZ improves) (NP (NP (JJ cognitive) (NNS outcomes)) (PP (IN in) (NP (NN Doc_17384765_387_389_Chemical-exposed) (NNS children))))))) (, ,) (CC or) (SBAR (IN whether) (S (NP (DT these) (NNS agents)) (VP (VBP have) (NP (NP (JJ adverse) (NNS effects)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB affect) (NP (NN brain) (NN development)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ Doc_17384765_505_507_Chemical) (NN exposure)))))))))))))))) (. .)))
17384765	3	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB answer) (NP (DT these) (NNS questions))))) (, ,) (S (VP (VBG using) (NP (NP (DT a) (JJ rodent) (NN model)) (PP (IN of) (NP (JJ early) (NN childhood) (NNS Doc_17384765_628_630_Chemical) (NN exposure) (CC and) (NN treatment)))) (PP (IN with) (NP (NP (NN succimer)) (, ,) (NP (NP (DT a) (ADJP (RB widely) (VBN used)) (VBG chelating) (NN agent)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ Doc_17384765_720_722_Chemical) (NN poisoning)))))))))))) (. .)))
17384765	4	(ROOT (S (NP (JJ Doc_17384765_743_745_Chemical) (NN exposure)) (VP (VBD produced) (NP (NNS Doc_17384765_764_783_Disease)) (PP (IN in) (NP (NP (NN learning)) (, ,) (NP (NN attention)) (, ,) (NP (JJ inhibitory) (NN control)) (, ,) (CC and) (NP (JJ arousal) (NN regulation)))) (, ,) (S (VP (VBG paralleling) (NP (NP (DT the) (NNS areas)) (PP (IN of) (NP (NP (NN dysfunction)) (VP (VBN seen) (PP (IN in) (NP (NN Doc_17384765_897_899_Chemical-exposed) (NNS children)))))))))) (. .)))
17384765	5	(ROOT (S (NP (NP (JJ Succimer) (NN treatment)) (PP (IN of) (NP (DT the) (NN Doc_17384765_944_946_Chemical-exposed) (NNS rats)))) (ADVP (RB significantly)) (VP (VBD improved) (NP (NP (NN learning)) (, ,) (NP (NN attention)) (, ,) (CC and) (NP (JJ arousal) (NN regulation))) (, ,) (SBAR (IN although) (S (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (DT the) (NN treatment)))) (VP (VBD varied) (PP (IN as) (NP (NP (NP (DT a) (NN function)) (PP (IN of) (NP (DT the) (JJ Doc_17384765_1095_1097_Chemical) (NN exposure) (NN level)))) (CC and) (NP (DT the) (ADJP (JJ specific) (JJ functional)) (NN deficit)))))))) (. .)))
17384765	6	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN succimer) (NN treatment)) (PP (IN of) (NP (NP (NNS rats)) (VP (RB not) (ADVP (RB previously)) (VBN exposed) (PP (TO to) (NP (NNS Doc_17384765_1216_1218_Chemical))))))) (VP (VBD produced) (NP (NP (ADJP (JJ lasting) (CC and) (JJ pervasive)) (NNS Doc_17384765_1250_1285_Disease)) (ADJP (JJ comparable) (PP (IN in) (NP (NN magnitude))))) (PP (TO to) (NP (NP (DT that)) (VP (VBN produced) (PP (IN by) (NP (DT the) (JJR higher) (JJ Doc_17384765_1341_1343_Chemical) (NN exposure) (NN regimen))))))) (. .)))
17384765	7	(ROOT (S (NP (DT These)) (VP (VBP are) (NP (NP (DT the) (JJ first) (NNS data)) (, ,) (PP (TO to) (NP (PRP$ our) (NN knowledge))) (, ,) (S (VP (TO to) (VP (VB show) (SBAR (IN that) (S (NP (NP (NN treatment)) (PP (IN with) (NP (DT any) (JJ chelating) (NN agent)))) (VP (MD can) (VP (VB alleviate) (S (NP (NNS Doc_17384765_1481_1499_Disease)) (ADJP (JJ due) (PP (TO to) (NP (JJ Doc_17384765_1507_1509_Chemical) (NN exposure)))))))))))))) (. .)))
17384765	8	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (PRP it)) (VP (MD may) (VP (VB be) (ADJP (JJ possible) (S (VP (TO to) (VP (VB identify) (NP (NP (DT a) (NN succimer) (NN treatment) (NN protocol)) (SBAR (WHNP (WDT that)) (S (VP (VBZ improves) (NP (NP (JJ cognitive) (NNS outcomes)) (PP (IN in) (NP (NN Doc_17384765_1645_1647_Chemical-exposed) (NNS children))))))))))))))))) (. .)))
17384765	9	(ROOT (S (ADVP (RB However)) (, ,) (NP (PRP they)) (ADVP (RB also)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN succimer) (NN treatment)) (VP (MD should) (VP (VB be) (VP (ADVP (RB strongly)) (VBN discouraged) (PP (IN for) (NP (NP (NNS children)) (SBAR (WHNP (WP who)) (S (VP (VBP do) (RB not) (VP (VB have) (NP (NP (JJ elevated) (NN tissue) (NNS levels)) (PP (IN of) (NP (NP (NNS Doc_17384765_1803_1805_Chemical)) (CC or) (NP (JJ other) (JJ heavy) (NNS metals))))))))))))))))) (. .)))
17445520	0	(ROOT (S (NP (JJ Doc_17445520_0_8_Chemical) (NN challenge)) (VP (VBP test) (PP (IN in) (NP (NNS Doc_17445520_27_41_Disease) (CC and) (NNS Doc_17445520_46_56_Disease))) (PP (IN with) (NP (NNS Doc_17445520_62_75_Disease)))) (. .)))
17445520	1	(ROOT (S (NP (PRP$ Our) (NN aim)) (VP (VBD was) (S (VP (TO to) (VP (VB observe) (SBAR (IN if) (S (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (NNS Doc_17445520_117_131_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17445520_133_135_Disease)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (NNS Doc_17445520_155_190_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17445520_192_195_Disease)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NNP Diagnostic) (CC and) (NNP Statistical) (NNP Manual)) (PP (IN of) (NP (JJ Doc_17445520_235_251_Disease) (, ,) (JJ Fourth) (JJ Edition) (NNS criteria)))) (-RRB- -RRB-)))))))) (VP (VB respond) (PP (IN in) (NP (DT a) (JJ similar) (NN way))) (PP (TO to) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NNS Doc_17445520_323_336_Disease))))) (PP (IN by) (NP (DT an) (JJ oral) (JJ Doc_17445520_348_356_Chemical) (NN challenge) (NN test)))))))))) (. .)))
17445520	2	(ROOT (S (NP (PRP We)) (ADVP (RB randomly)) (VP (VBD selected) (NP (NP (NP (CD 29) (NNS patients)) (PP (IN with) (NP (NNS Doc_17445520_411_413_Disease)))) (, ,) (NP (NP (CD 27)) (PP (IN with) (NP (NNS Doc_17445520_423_426_Disease)))) (, ,) (NP (NP (CD 25)) (PP (IN with) (NP (NP (NNS Doc_17445520_436_452_Disease)) (PP (IN without) (NP (NP (NNS Doc_17445520_461_474_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17445520_476_478_Disease)) (-RRB- -RRB-))))))) (, ,) (CC and) (NP (CD 28) (JJ healthy) (NNS volunteers)))) (. .)))
17445520	3	(ROOT (S (NP (DT The) (NNS patients)) (VP (VBD had) (NP (NP (DT no) (JJ psychotropic) (NN drug)) (PP (IN for) (NP (ADVP (IN at) (JJS least)) (DT a) (JJ 4-week) (NN period))))) (. .)))
17445520	4	(ROOT (S (PP (IN In) (NP (NP (DT a) (JJ randomized) (JJ double-blind) (NN experiment)) (VP (VBN performed) (PP (IN in) (NP (CD 2) (NNS occasions))) (NP (CD 7) (NNS days) (RB apart))))) (, ,) (S (NP (NP (QP (CD 480) (CD mg)) (NNS Doc_17445520_662_670_Chemical)) (CC and) (NP (DT a) (ADJP (JJ Doc_17445520_677_685_Chemical-free)) (PRN (-LRB- -LRB-) (NP (NN placebo)) (-RRB- -RRB-)) (NN solution))) (VP (VBD were) (VP (VBN administered) (PP (IN in) (NP (DT a) (NN coffee) (NN form)))))) (CC and) (S (NP (JJ Doc_17445520_749_756_Disease) (NNS scales)) (VP (VBD were) (VP (VBN applied) (PP (IN before) (CC and) (IN after) (NP (DT each) (NN test)))))) (. .)))
17445520	5	(ROOT (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 58.6) (NN %)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 17))))) (-RRB- -RRB-)))) (PP (IN of) (NP (NNS patients))) (PP (IN with) (NP (NP (NP (NNS Doc_17445520_848_850_Disease)) (, ,) (NP (CD 44.4) (NN %))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 12))))) (-RRB- -RRB-)))) (PP (IN of) (NP (NNS patients))) (PP (IN with) (NP (NP (NP (NNS Doc_17445520_884_887_Disease)) (, ,) (NP (CD 12.0) (NN %)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 3))))) (-RRB- -RRB-))) (PP (IN of) (NP (NNS patients))) (PP (IN with) (NP (NNS Doc_17445520_920_922_Disease))) (, ,) (CC and) (NP (NP (CD 7.1) (NN %)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 2))))) (-RRB- -RRB-))))) (PP (IN of) (NP (NN control) (NNS subjects))) (VP (VBN had) (NP (DT a) (JJ Doc_17445520_966_971_Disease) (NN attack)) (PP (IN after) (NP (NP (DT the) (JJ 480-mg) (JJ Doc_17445520_996_1004_Chemical) (NN challenge) (NN test)) (PRN (-LRB- -LRB-) (S (NP (NP (NP (NN chi)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))) (VP (VBZ =) (S (NP (NNP 16.22) (, ,) (NNP P)) (VP (SYM =) (NP (CD .001)))))) (-RRB- -RRB-))))) (. .)))
17445520	6	(ROOT (S (NP (NP (DT The) (NNS patients)) (PP (IN with) (NP (NNS Doc_17445520_1069_1071_Disease) (CC and) (NNS Doc_17445520_1076_1079_Disease)))) (VP (VBD were) (ADJP (ADJP (RBR more) (JJ sensitive) (PP (TO to) (NP (NNS Doc_17445520_1103_1111_Chemical)))) (SBAR (IN than) (S (VP (VBD were) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ Doc_17445520_1136_1138_Disease) (CC and) (JJ healthy) (NNS volunteers))))))))) (. .)))
17445520	7	(ROOT (S (NP (DT No) (JJ Doc_17445520_1166_1171_Disease) (NN attack)) (VP (VBD was) (VP (VBN observed) (PP (IN after) (NP (DT the) (NN Doc_17445520_1202_1210_Chemical-free) (NN solution) (NN intake))))) (. .)))
17445520	8	(ROOT (S (NP (NP (DT The) (NNS patients)) (PP (IN with) (NP (NNS Doc_17445520_1251_1253_Disease)))) (VP (VBD had) (NP (DT a) (ADJP (JJR lower)) (NN heart) (NN rate) (NN response)) (PP (TO to) (NP (NP (DT the) (NN test)) (PP (IN than) (NP (NP (PDT all) (DT the) (JJ other) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NP (NP (JJ 2-way) (NN analysis)) (PP (IN of) (NP (NN variance)))) (, ,) (NP (NP (NP (NN group)) (PP (IN by) (NP (NP (NN time) (NN interaction)) (PP (IN with) (NP (JJ Greenhouse-Geisser) (NN correction)))))) (: :) (S (VP (NNP F) (S (NP (PRN (-LRB- -LRB-) (NP (CD 3,762)) (-RRB- -RRB-))) (VP (SYM =) (NP (NNS 2.85))))))) (, ,) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .026))))))) (-RRB- -RRB-))))))) (. .)))
17445520	9	(ROOT (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NNS Doc_17445520_1497_1510_Disease)))) (, ,) (SBAR (ADVP (DT no) (NN matter)) (IN if) (S (S (VP (VBN associated) (PP (IN with) (NP (NNS Doc_17445520_1541_1543_Disease) (CC or) (NNS Doc_17445520_1547_1550_Disease))))) (, ,) (CC and) (S (VP (VBG Doc_17445520_1556_1571_Disease) (PP (TO to) (NP (DT an) (JJ oral) (JJ Doc_17445520_1583_1591_Chemical) (NN challenge) (NN test))))))))))) (. .)))
17484470	0	(ROOT (NP (NP (NP (JJ Mitral) (NN annuloplasty)) (PP (IN as) (NP (NP (DT a) (NN ventricular) (NN restoration) (NN method)) (PP (IN for) (NP (DT the) (VBG failing) (NN left) (NN ventricle)))))) (: :) (NP (NP (DT a) (NN pilot)) (NP (NN study))) (. .)))
17484470	1	(ROOT (S (S (NP (NP (NNP BACKGROUND) (CC AND) (NNP AIM)) (PP (IN OF) (NP (NP (DT THE) (NN STUDY)) (: :) (NP (NNP Undersized) (JJ mitral) (NN annuloplasty)) (PRN (-LRB- -LRB-) (NP (NNP MAP)) (-RRB- -RRB-))))) (VP (VBZ is) (ADJP (JJ effective) (PP (IN in) (S (VP (VP (VBG patients) (PP (IN with) (NP (NP (NNS Doc_17484470_203_225_Disease) (CC and) (NNS Doc_17484470_230_261_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17484470_263_265_Disease)) (-RRB- -RRB-)))) (ADVP (IN since))) (, ,) (CONJP (RB as) (RB well) (IN as)) (VP (VBG addressing) (NP (DT the) (NNS Doc_17484470_300_302_Disease))))))))) (, ,) (NP (DT the) (NNP MAP)) (VP (MD may) (ADVP (RB also)) (VP (VB reshape) (NP (DT the) (JJ dilated) (JJ left) (NN ventricular) (PRN (-LRB- -LRB-) (NP (NNP LV)) (-RRB- -RRB-)) (NN base)))) (. .)))
17484470	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ direct) (NNS benefits)) (PP (IN of) (NP (NP (DT this) (ADJP (JJ possible) (S (VP (VBG reshaping) (PP (IN on) (NP (NNP LV)))))) (NN function)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (VBG underlying) (NNS Doc_17484470_469_471_Disease)))))))) (VP (VBP remain) (ADVP (RB incompletely)) (VP (VBN understood))) (. .)))
17484470	3	(ROOT (S (NP (DT The) (NN study) (NN aim)) (VP (VBD was) (S (VP (TO to) (VP (VB identify) (NP (DT these) (NNS benefits)) (PP (IN in) (NP (NP (DT a) (JJ canine) (NN model)) (PP (IN of) (NP (NNS Doc_17484470_570_589_Disease))))))))) (. .)))
17484470	4	(ROOT (S (NP (CD Six) (NNS dogs)) (VP (VBD underwent) (NP (NNP MAP)) (PP (IN with) (NP (DT a) (JJ prosthetic) (NN band))) (PP (IN on) (NP (DT the) (JJ posterior) (JJ mitral) (NNS annulus))) (, ,) (S (VP (VBG using) (NP (CD four) (NNS mattress) (NNS sutures))))) (. .)))
17484470	5	(ROOT (S (NP (DT The) (NNS sutures)) (VP (VBD were) (VP (VBN passed) (ADVP (RB individually)) (PP (IN through) (NP (NP (CD four) (NNS tourniquets)) (CC and) (NP (NP (JJ exteriorized) (NN untied)) (PP (IN via) (NP (DT the) (JJ left) (NN atriotomy)))))))) (. .)))
17484470	6	(ROOT (S (NP (JJ Sonomicrometry) (NNS crystals)) (VP (VBD were) (VP (VP (VBN implanted) (PP (IN around) (NP (DT the) (JJ mitral) (NNS annulus)))) (CC and) (VP (VBN left) (S (ADJP (JJ ventricle) (PP (TO to) (NP (NP (NN measure) (NN geometry)) (CC and) (NP (JJ regional) (NN function))))))))) (. .)))
17484470	7	(ROOT (S (S (NP (NNP Doc_17484470_945_964_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_17484470_980_991_Chemical) (CC and) (NN volume) (NN loading))) (PP (IN after) (S (VP (VBG weaning) (PP (IN from) (NP (JJ cardiopulmonary) (NN bypass))))))))) (: ;) (S (NP (NP (DT an) (NN absence)) (PP (IN of) (NP (NNS Doc_17484470_1068_1070_Disease)))) (VP (VBD was) (VP (VBN confirmed) (PP (IN by) (NP (NN echocardiography)))))) (. .)))
17484470	8	(ROOT (S (NP (NNP MAP)) (VP (VBD was) (VP (VBN accomplished) (PP (IN by) (S (VP (VBG cinching) (NP (DT the) (NNS tourniquets))))))) (. .)))
17484470	9	(ROOT (S (NP (NNP Data)) (VP (VBD were) (VP (VBN acquired) (PP (PP (IN at) (NP (NN baseline))) (, ,) (PP (IN after) (NP (NP (NN induction)) (PP (IN of) (NP (NNS Doc_17484470_1207_1226_Disease))))) (, ,) (CC and) (PP (IN after) (NP (NNP MAP)))))) (. .)))
17484470	10	(ROOT (S (NP (NNP MAP)) (VP (VBD decreased) (NP (JJ mitral) (NN annular) (NNS dimensions)) (PP (IN in) (NP (DT both) (JJ commissure-commissure) (CC and) (JJ septal-lateral) (NNS directions)))) (. .)))
17484470	11	(ROOT (S (ADVP (RB Concomitantly)) (, ,) (NP (NP (DT the) (JJ diastolic) (NN diameter)) (PP (IN of) (NP (DT the) (NNP LV)))) (VP (VBP base) (CC and) (VBP LV) (NP (NP (NP (NP (JJ sphericity) (NNS decreased)) (PRN (-LRB- -LRB-) (FW i.e.) (, ,) (ADJP (JJ improved)) (-RRB- -RRB-))) (PP (PP (IN from) (NP (NP (NP (NP (CD 37.4) (JJ +) (NNS /)) (PRN (: -) (NP (QP (CD 9.3) (TO to) (CD 35.9)) (NNS +)) (: /))) (: -) (NP (QP (CD 10) (CD mm)))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.063))))) (-RRB- -RRB-)))) (, ,) (CC and) (PP (IN from) (NP (NP (QP (CD 67.9) (CD +)) (NNS /)) (PRN (: -) (NP (QP (CD 18.6) (NN %) (TO to) (CD 65.3)) (NNS +)) (: /)))))) (: -) (NP (NP (CD 18.9) (NN %)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.016))))) (-RRB- -RRB-)))) (, ,) (ADVP (RB respectively))) (. .)))
17484470	12	(ROOT (S (NP (NNS Decreases)) (VP (VBD were) (ADJP (JJ evident) (PP (IN in) (NP (NP (NP (NP (DT both) (NNP LV) (JJ end-diastolic) (NN pressure)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NP (QP (CD 17) (CD +)) (NNS /)) (PRN (: -) (NP (QP (CD 7) (TO to) (CD 15)) (NNS +)) (: /)))) (, -) (NP (NP (CD 6) (NN mmHg)) (, ,) (NP (NP (NP (NN p)) (SBAR (S (VP (SYM =) (NP (CD 0.0480)))))) (CC and) (NP (NP (NNS Doc_17484470_1674_1677_Chemical)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NP (NP (CD 48) (JJ +) (NNS /)) (PRN (: -) (NP (QP (CD 8) (TO to) (CD 45)) (NNS +)) (: /))) (: -) (NP (NP (CD 8) (NN ms)) (, ,) (NP (NNP p) (NNP <) (NNP 0.01))))) (-RRB- -RRB-)) (, ,) (SBAR (IN while) (S (NP (NP (JJ fractional) (NN shortening)) (PP (IN at) (NP (DT the) (NNP LV) (NN base)))) (VP (VBD increased) (PP (IN from) (NP (QP (CD 7.7) (CD +)))))))))) (: /))) (PRN (: -) (NP (QP (CD 4.5) (NN %) (TO to) (CD 9.4)) (NNS +)) (: /))) (: -) (NP (NP (CD 4.5) (NN %)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.045))))) (-RRB- -RRB-))))))) (. .)))
17484470	13	(ROOT (S (PP (IN After) (NP (NNP MAP))) (, ,) (NP (NNS increases)) (VP (VBD were) (VP (VBN identified) (PP (IN in) (NP (NP (DT both) (JJ cardiac) (NN output)) (PRN (-LRB- -LRB-) (FRAG (FRAG (PP (IN from) (NP (CD 1.54))) (NP (CD +)) (: /)) (: -) (FRAG (FRAG (ADJP (JJ 0.57) (PP (TO to) (NP (CD 1.65) (NNS +)))) (: /)) (: -) (FRAG (ADJP (JJ 0.57)) (ADJP (JJ 1/min))))) (-RRB- -RRB-)) (CC and) (NP (NNP Emax)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NP (NP (QP (CD 1.86) (CD +)) (NNS /)) (PRN (: -) (NP (QP (CD 0.9) (TO to) (CD 2.41)) (NNS +)) (: /))) (: -) (NP (CD 1.31) (NN mmHg/ml)))) (-RRB- -RRB-)))))) (. .)))
17484470	14	(ROOT (S (S (NP (DT The) (NNS data)) (VP (VBD acquired) (SBAR (S (VP (VBP suggest) (SBAR (IN that) (S (NP (NNP isolated) (NNP MAP)) (VP (MD may) (VP (VB have) (NP (NP (JJ certain) (NNS benefits)) (PP (IN on) (NP (NP (NNP LV) (NNP dimension/function)) (PP (IN in) (NP (NP (NNS Doc_17484470_2088_2107_Disease)) (, ,) (RRC (ADVP (RB even)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NNS Doc_17484470_2132_2134_Disease)))) (. .)))))))) (ADVP (RB However))))))))))) (, ,) (NP (JJ further) (NNS investigations)) (VP (VBP are) (VP (VBN warranted) (PP (IN in) (NP (NP (DT a) (NN model)) (PP (IN of) (NP (NNS Doc_17484470_2196_2217_Disease))))))) (. .)))
17496739	0	(ROOT (FRAG (NP (NNP Doc_17496739_0_12_Chemical)) (: /) (S (NP (NN Doc_17496739_13_23_Chemical-induced) (NNS Doc_17496739_32_39_Disease)) (ADVP (RB rapidly)) (VP (VBD reversed) (PP (IN by) (NP (JJ high) (NN flux) (NNS hemodialysis))) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN on) (NP (JJ peritoneal) (NN dialysis))))))) (. .)))
17496739	1	(ROOT (S (PP (IN Despite) (NP (NP (JJ popular) (NN use)) (PP (IN of) (NP (NNS Doc_17496739_143_155_Chemical))))) (, ,) (NP (NP (DT the) (JJ dire) (NNS Doc_17496739_166_179_Disease)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_17496739_196_208_Chemical))))) (ADVP (RB still)) (VP (VBZ goes) (NP (JJ unrecognized)) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (DT a) (NN delay)) (PP (IN in) (NP (JJ appropriate) (NN management)))))))) (. .)))
17496739	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (DT a) (JJ 57-year-old) (NN woman)) (PP (IN with) (NP (NP (NNS Doc_17496739_315_338_Disease)) (VP (VBG receiving) (NP (NP (NP (JJ continuous) (JJ ambulatory) (JJ peritoneal) (NN dialysis)) (PRN (-LRB- -LRB-) (NP (NNP CAPD)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (JJ slurred) (NN speech)) (, ,) (NP (NNS Doc_17496739_429_435_Disease)) (, ,) (NP (JJ bizarre) (NN behavior)) (, ,) (NP (JJ progressive) (JJ mental) (NNS Doc_17496739_474_483_Disease)) (, ,) (CC and) (NP (NP (CD 2) (NNS episodes)) (PP (IN of) (NP (NP (JJ generalized) (NNS Doc_17496739_515_535_Disease)) (PRN (-LRB- -LRB-) (NP (NNP GTCS)) (-RRB- -RRB-)))))) (SBAR (IN after) (S (NP (NP (CD 5) (NNS doses)) (PP (IN of) (NP (NP (JJ Doc_17496739_560_572_Chemical) (JJ /) (NNS Doc_17496739_573_583_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN g/250) (NN mg)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN given) (PP (IN for) (NP (NP (NNS Doc_17496739_612_626_Disease)) (PP (IN with) (NP (JJ secondary) (NNS Doc_17496739_642_651_Disease))))))))))))))))) (. .)))
17496739	3	(ROOT (S (NP (DT The) (NN laboratory) (NNS data)) (VP (VP (VBD revealed) (NP (JJ normal) (NN plasma) (NN electrolyte) (CC and) (NNS Doc_17496739_712_719_Chemical) (NNS levels))) (CC but) (VP (VBZ Doc_17496739_731_743_Disease))) (. .)))
17496739	4	(ROOT (S (NP (JJ Neurologic) (NNS examinations)) (VP (VBD showed) (NP (NP (NNS Doc_17496739_776_786_Disease)) (CC and) (NP (JJ bilateral) (JJ Babinski) (NN sign)))) (. .)))
17496739	5	(ROOT (S (NP (NP (JJ Computed) (NN tomography)) (PP (IN of) (NP (NN brain) (CC and) (NN electroencephalogram)))) (VP (VBD were) (ADJP (JJ unremarkable))) (. .)))
17496739	6	(ROOT (S (PP (IN Despite) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ antiepileptic) (NNS agents))))) (, ,) (NP (DT another) (NNP GTCS) (NN episode)) (VP (VBD recurred) (PP (IN after) (NP (NP (DT the) (JJ sixth) (NN dose)) (PP (IN of) (NP (JJ Doc_17496739_984_996_Chemical) (JJ /) (NNS Doc_17496739_997_1007_Chemical)))))) (. .)))
17496739	7	(ROOT (S (NP (CD Brain) (JJ magnetic) (NN resonance) (NN imaging)) (VP (VBD did) (RB not) (VP (VB demonstrate) (NP (NP (JJ acute) (NNS Doc_17496739_1068_1078_Disease)) (CC and) (NP (JJ organic) (NNS Doc_17496739_1091_1104_Disease))))) (. .)))
17496739	8	(ROOT (S (NP (NP (NNP Initiation)) (PP (IN of) (NP (JJ high-flux) (NNS hemodialysis)))) (ADVP (RB rapidly)) (VP (VBD reversed) (NP (DT the) (JJ neurologic) (NNS symptoms)) (PP (IN within) (NP (CD 4) (NNS hours)))) (. .)))
17496739	9	(ROOT (S (NP (JJ Doc_17496739_1200_1212_Chemical-induced) (NNS Doc_17496739_1221_1235_Disease)) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (DT any) (JJ uremic) (NNS patients)) (PP (IN with) (NP (JJ unexplained) (JJ neurological) (NNS manifestations)))))))) (. .)))
17496739	10	(ROOT (S (NP (NNP CAPD)) (VP (VBZ is) (ADJP (JJ inefficient) (PP (IN in) (S (VP (VBG removing) (NP (NNS Doc_17496739_1358_1370_Chemical)))))) (, ,) (SBAR (IN whereas) (S (NP (NNS hemodialysis)) (VP (MD can) (ADVP (RB rapidly)) (VP (VB terminate) (NP (DT the) (NN Doc_17496739_1419_1431_Chemical-induced) (NNS Doc_17496739_1440_1454_Disease))))))) (. .)))
17543491	0	(ROOT (S (NP (NP (NNP Frequency)) (PP (IN of) (NP (NP (JJ transient) (JJ ipsilateral) (NNS Doc_17543491_35_55_Disease)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG undergoing))))))) (VP (VBD carotid) (ADVP (RB endarterectomy)) (PP (IN under) (NP (JJ local) (NN anesthesia)))) (. .)))
17543491	1	(ROOT (S (PP (ADVP (RB Especially)) (IN because) (IN of) (NP (NP (NNS improvements)) (PP (IN in) (NP (JJ clinical) (JJ neurologic) (NN monitoring))))) (, ,) (NP (NP (JJ carotid) (NN endarterectomy)) (VP (VBN done) (PP (IN under) (NP (JJ local) (NN anesthesia))))) (VP (VBZ has) (VP (VBN become) (NP (NP (DT the) (NN technique)) (PP (IN of) (NP (NN choice)))) (PP (IN in) (NP (JJ several) (NNS centers))))) (. .)))
17543491	2	(ROOT (S (NP (NP (NNP Doc_17543491_314_355_Disease)) (ADJP (JJ due) (PP (TO to) (NP (JJ local) (NNS anesthetics))))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (, ,) (ADVP (RB however))))) (. .)))
17543491	3	(ROOT (S (NP (JJ Such) (NNS complications)) (VP (VBP are) (ADJP (RBS most) (JJ important) (PP (IN in) (NP (NP (NNS situations)) (SBAR (WHADVP (WRB where)) (S (NP (EX there)) (VP (VBZ is) (NP (DT a) (JJ pre-existing) (NNS Doc_17543491_493_516_Disease))))))))) (. .)))
17543491	4	(ROOT (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD examined) (SBAR (S (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (JJ local) (NN anesthesia)) (PP (IN on) (NP (JJ vocal) (NN cord)))))) (VP (VBP function) (S (VP (TO to) (VP (ADVP (RBR better)) (VB understand) (NP (PRP$ its) (JJ possible) (NNS consequences))))))))) (. .)))
17543491	5	(ROOT (S (NP (DT This) (JJ prospective) (NN study)) (VP (VBD included) (NP (NP (CD 28) (NNS patients)) (VP (VBG undergoing) (NP (JJ carotid) (NN endarterectomy)) (PP (IN under) (NP (JJ local) (NN anesthesia)))))) (. .)))
17543491	6	(ROOT (S (NP (JJ Vocal) (NN cord) (NN function)) (VP (VBD was) (VP (VBN evaluated) (ADVP (RB before)) (, ,) (PP (PP (IN during)) (, ,) (CC and) (PP (IN after) (NP (NN surgery) (PRN (-LRB- -LRB-) (NP (NP (JJ postoperative) (NN day)) (NP (CD 1))) (-RRB- -RRB-)) (S (VP (VBG using) (NP (JJ flexible) (NN laryngoscopy))))))))) (. .)))
17543491	7	(ROOT (S (NP (NNP Anesthesia)) (VP (VBD was) (VP (VBN performed) (PP (IN by) (S (VP (VBG injecting) (NP (NP (QP (CD 20) (TO to) (CD 40)) (NN mL)) (PP (IN of) (NP (NP (DT a) (NN mixture)) (PP (IN of) (NP (NP (NP (NN long-acting)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17543491_951_962_Chemical)) (-RRB- -RRB-))) (CC and) (NP (JJ short-acting) (PRN (-LRB- -LRB-) (NP (NNP Doc_17543491_982_992_Chemical)) (-RRB- -RRB-)) (NN anesthetic)))))))))))) (. .)))
17543491	8	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD had) (NP (JJ normal) (JJ vocal) (NN cord) (NN function)) (ADVP (RB preoperatively))) (. .)))
17543491	9	(ROOT (S (NP (NP (CD Twelve) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 43) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (JJ intraoperative) (JJ ipsilateral) (NNS Doc_17543491_1143_1163_Disease))))))) (. .)))
17543491	10	(ROOT (S (NP (PRP It)) (VP (VBN resolved) (PP (IN in) (NP (NP (DT all) (NNS cases) (NN <)) (CC or) (NP (QP (CD =) (CD 24)) (NNS hours))))) (. .)))
17543491	11	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN in) (NP (NP (VBG operating) (NN time)) (CC or) (NP (NP (NN volume) (CC or) (NN frequency)) (PP (IN of) (NP (NP (JJ anesthetic) (NN administration)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ temporary) (NNS Doc_17543491_1341_1361_Disease)) (PP (VBN compared) (PP (IN with) (NP (NP (DT those)) (PP (IN without)))))))))))))))) (. .)))
17543491	12	(ROOT (S (NP (JJ Local) (NN anesthesia)) (VP (VBD led) (PP (TO to) (NP (JJ temporary) (JJ ipsilateral) (NNS Doc_17543491_1449_1469_Disease))) (PP (IN in) (NP (NP (QP (RB almost) (PDT half))) (PP (IN of) (NP (DT these) (NNS patients)))))) (. .)))
17543491	13	(ROOT (S (SBAR (IN Because) (S (NP (JJ pre-existing) (NNS Doc_17543491_1525_1534_Disease)) (VP (VBZ is) (PP (IN of) (NP (NP (DT a) (JJ relevant) (NN frequency)) (PRN (-LRB- -LRB-) (NP (QP (IN up) (TO to) (CD 3) (NN %))) (-RRB- -RRB-))))))) (, ,) (NP (NP (DT a) (JJ preoperative) (NN evaluation)) (PP (IN of) (NP (JJ vocal) (NN cord)))) (VP (VBP function) (SBAR (IN before) (S (NP (NP (JJ carotid) (NN endarterectomy)) (PP (IN under) (NP (JJ local) (NN anesthesia)))) (VP (VBZ is) (VP (VBN recommended) (S (VP (TO to) (VP (VB avoid) (NP (JJ intraoperative) (NNS Doc_17543491_1715_1734_Disease)))))))))) (. .)))
17543491	14	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ preoperative) (JJ contralateral) (NNS Doc_17543491_1780_1800_Disease))))) (, ,) (NP (NP (NN surgery)) (PP (IN under) (NP (JJ general) (NN anesthesia)))) (VP (MD should) (VP (VB be) (VP (VBN considered)))) (. .)))
17554526	0	(ROOT (S (VP (VB Doc_17554526_0_25_Disease) (PP (IN in) (NP (JJ regular) (JJ recreational) (JJ Doc_17554526_50_57_Chemical) (NNS users)))) (. .)))
17554526	1	(ROOT (S (NP (DT The) (NN ability) (S (VP (TO to) (VP (VB read) (NP (JJ facial) (NNS expressions)))))) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (JJ normal) (JJ human) (JJ social) (NN interaction))))) (. .)))
17554526	2	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB conduct) (NP (NP (DT the) (JJ first) (NN investigation)) (PP (IN of) (NP (JJ facial) (NN expression) (NN recognition) (NN performance)))) (PP (IN in) (NP (JJ recreational) (JJ Doc_17554526_297_304_Chemical) (NNS users))))))) (. .)))
17554526	3	(ROOT (S (NP (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (NP (NP (NP (CD Three) (NNS groups)) (, ,) (VP (VBN comprised) (PP (IN of) (NP (NP (ADJP (NP (CD 21) (NNS Doc_17554526_365_372_Chemical)) (JJ naive)) (NNS participants)) (PRN (-LRB- -LRB-) (NP (NNP CN)) (-RRB- -RRB-)))))) (, ,) (NP (NP (CD 30) (JJ occasional) (NNS Doc_17554526_413_420_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP OC)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (CD 48) (JJ regular) (JJ recreational) (NNS Doc_17554526_455_462_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP RC)) (-RRB- -RRB-)) (NP (NNS users)))) (, ,)) (VP (VBD were) (VP (VBN compared))) (. .)))
17554526	4	(ROOT (S (NP (NP (DT An) (ADJP (JJ emotional)) (JJ facial) (NN expression) (PRN (-LRB- -LRB-) (NP (NNP EFE)) (-RRB- -RRB-)) (NN task)) (VP (VBG consisting) (PP (IN of) (NP (NP (DT a) (ADJP (NN male) (CC and) (JJ female)) (NN face)) (VP (VBG expressing) (NP (NP (CD six) (JJ basic) (NNS emotions)) (PRN (-LRB- -LRB-) (NP (NP (NN happiness)) (, ,) (NP (NN surprise) (, ,) (NN sadness) (, ,) (NN anger) (, ,) (NN fear) (, ,) (CC and) (NN disgust))) (-RRB- -RRB-)))))))) (VP (VBD was) (VP (VBN administered))) (. .)))
17554526	5	(ROOT (S (NP (NP (NN Mean) (NN percent) (NN accuracy)) (CC and) (NP (NP (NNS latencies)) (PP (IN for) (NP (NP (JJ correct) (NNS responses)) (PP (IN across) (NP (NP (CD eight) (NNS presentations)) (PP (IN of) (NP (DT each) (JJ basic) (NN emotion))))))))) (VP (VBD were) (VP (VBN derived))) (. .)))
17554526	6	(ROOT (S (NP (NNS Participants)) (VP (VBD were) (VP (ADVP (RB also)) (VBN assessed) (PP (IN with) (NP (DT the) (`` ``) (JJ Eyes) (NN task) ('' ''))) (S (VP (TO to) (VP (VB investigate) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB recognize) (NP (NP (ADJP (RBR more) (JJ complex)) (JJ emotional) (NNS states)) (CC and) (NP (DT the) (NNP Symptom) (NN CheckList-90-Revised))) (S (VP (TO to) (VP (VB measure) (ADVP (RB psychopathology)))))))))))))) (. .)))
17554526	7	(ROOT (S (S (NP (EX There)) (VP (VBD were) (NP (NP (NP (DT no) (NN group) (NNS differences)) (PP (IN in) (NP (NN psychopathology)))) (CC or) (NP (NP (`` ``) (JJ eyes) (NN task) ('' '')) (NP (NN performance)))))) (, ,) (CC but) (S (NP (NP (DT the) (NNP RC) (NN group)) (, ,) (SBAR (WHNP (WP who)) (S (ADVP (RB otherwise)) (VP (VBD had) (NP (NP (JJ similar) (JJ illicit) (NN substance) (NN use) (NNS histories)) (PP (TO to) (NP (DT the) (NNP OC) (NN group))))))) (, ,)) (VP (VBD exhibited) (NP (NNS Doc_17554526_1176_1210_Disease)) (PP (VBN compared) (PP (TO to) (NP (DT the) (NNP OC) (CC and) (NNP CN) (NNS groups)))))) (. .)))
17554526	8	(ROOT (S (NP (DT The) (NNP RC) (NN group)) (ADVP (RB also)) (VP (ADVP (RB correctly)) (VBD identified) (NP (NP (NN anger) (, ,) (NN fear) (, ,) (NN happiness) (, ,) (CC and) (NN surprise) (, ,)) (VP (VP (ADVP (RBR more) (RB slowly)) (PP (IN than) (NP (NNP CN)))) (, ,) (CC but) (RB not) (VP (VB OC) (NP (NNS participants)))))) (. .)))
17554526	9	(ROOT (S (NP (DT The) (NNP OC) (NN group)) (VP (VBD was) (ADJP (ADJP (JJR slower)) (PP (IN than) (NP (NNP CN)))) (SBAR (WHADVP (WRB when)) (S (ADVP (RB correctly)) (VP (VBG identifying) (NP (NN disgust)))))) (. .)))
17554526	10	(ROOT (S (NP (NP (DT The) (JJ selective) (NN deficit)) (PP (IN in) (NP (NP (NN fear) (NN recognition) (NN accuracy)) (VP (VBN manifested) (PP (IN by) (NP (DT the) (NNP RC) (NN group))))))) (VP (MD can) (RB not) (VP (VB be) (VP (VBN explained) (PP (IN by) (NP (NP (DT the) (JJ subacute) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_17554526_1561_1568_Chemical)) (, ,) (CC or) (NP (NNS Doc_17554526_1573_1580_Chemical)) (, ,))))) (SBAR (IN because) (S (NP (NP (ADJP (ADJP (JJ recent)) (CC and) (ADJP (RBR less) (JJ recent))) (NNS users)) (PP (IN of) (NP (NP (DT these) (NNS drugs)) (PP (IN within) (NP (DT this) (NN group)))))) (VP (VBD were) (ADJP (RB similarly) (JJ impaired)))))))) (. .)))
17554526	11	(ROOT (S (NP (NP (JJ Possible) (NNS parallels)) (PP (IN between) (NP (NNP RC) (NNS users) (CC and) (NNS Doc_17554526_1717_1728_Disease))) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (NNS Doc_17554526_1745_1770_Disease) (, ,) (NNS Doc_17554526_1772_1792_Disease) (, ,) (CC and) (NN etiology)))))) (VP (VBP are) (VP (VBN discussed))) (. .)))
1756784	0	(ROOT (S (NP (NP (NN Damage)) (PP (IN of) (NP (NN substantia) (NN nigra)))) (VP (VBZ pars) (NP (NN reticulata)) (PP (IN during) (NP (NP (NN Doc_1756784_50_61_Chemical-induced) (NNS Doc_1756784_70_88_Disease)) (PP (IN in) (NP (DT the) (NN rat))))) (: :) (NP (NP (JJ immunohistochemical) (NN study)) (PP (IN of) (NP (NNS neurons) (, ,) (NNS astrocytes) (CC and) (NN serum-protein) (NNS extravasation))))) (. .)))
1756784	1	(ROOT (S (NP (DT The) (NN substantia) (NN nigra)) (VP (VBZ has) (NP (NP (DT a) (VBG gating) (NN function)) (VP (VBG controlling) (NP (NP (DT the) (NN spread)) (PP (IN of) (NP (JJ Doc_1756784_252_269_Disease) (NN activity))))))) (. .)))
1756784	2	(ROOT (S (ADVP (RB Additionally)) (, ,) (PP (IN in) (NP (NP (NNS models)) (PP (IN of) (NP (JJ prolonged) (NNS Doc_1756784_317_335_Disease))))) (NP (NP (NP (DT the) (JJ pars) (NN reticulata)) (PP (IN of) (NP (NN substantia) (NN nigra)))) (PRN (-LRB- -LRB-) (NP (NNP SNR)) (-RRB- -RRB-))) (VP (VBZ suffers) (PP (IN from) (NP (NP (DT a) (JJ massive) (NN lesion)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VP (VB arise) (PP (IN from) (NP (DT a) (JJ massive) (JJ metabolic) (NN derangement)))) (CC and) (VP (VB hyperexcitation) (S (VP (VBG developing) (PP (IN in) (NP (DT the) (VBN activated) (NN SNR))))))))))))) (. .)))
1756784	3	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NNS Doc_1756784_533_551_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (JJ systemic) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_1756784_589_600_Chemical)) (PP (IN in) (NP (NNS rats))))))))) (. .)))
1756784	4	(ROOT (S (NP (NP (DT The) (NN neuropathology)) (PP (IN of) (NP (NNP SNR)))) (VP (VBD was) (VP (VBN investigated) (S (VP (VBG using) (NP (JJ immunohistochemical) (NNS techniques)) (PP (IN with) (NP (NP (DT the) (JJ major) (NN emphasis)) (PP (IN on) (NP (NP (DT the) (NN time-course)) (PP (IN of) (NP (NP (NNS changes)) (PP (IN in) (NP (NNS neurons) (CC and) (NNS astrocytes))))))))))))) (. .)))
1756784	5	(ROOT (S (S (NP (NP (NNS Animals)) (VP (VBG surviving) (NP (NP (CD 20)) (, ,) (NP (CD 30)) (, ,) (NP (CD 40)) (, ,) (NP (CD 60) (NN min)) (, ,) (NP (CD 2)) (, ,) (NP (CD 3)) (, ,) (NP (CD 6) (NNS hours)) (, ,) (NP (CD 1)) (, ,) (NP (CD 2)) (, ,) (CC and) (NP (CD 3) (NNS days))) (PP (IN after) (NP (NP (NN induction)) (PP (IN of) (NP (NNS Doc_1756784_860_878_Disease))))))) (VP (VBD were) (ADJP (JJ perfusion-fixed)))) (, ,) (CC and) (S (NP (NNS brains)) (VP (VBN processed) (PP (IN for) (NP (NP (JJ immunohistochemical) (NN staining)) (PP (IN of) (NP (NNP SNR))))))) (. .)))
1756784	6	(ROOT (S (NP (NP (NN Nissl-staining) (CC and) (NNS antibodies)) (PP (IN against) (NP (NP (DT the) (JJ neuron-specific) (NN Doc_1756784_1021_1028_Chemical-binding) (NN protein)) (, ,) (NP (NN parvalbumin)) (, ,)))) (VP (VBD served) (S (VP (TO to) (VP (VB detect) (NP (NNS Doc_1756784_1076_1091_Disease)) (PP (IN in) (NP (NNP SNR))))))) (. .)))
1756784	7	(ROOT (S (NP (NP (NNS Antibodies)) (PP (PP (IN against) (NP (NP (DT the) (JJ astroglia-specific) (JJ cytoskeletal) (NN protein)) (, ,) (NP (NP (JJ glial) (JJ fibrillary) (JJ acidic) (NN protein)) (PRN (-LRB- -LRB-) (NP (NNP GFAP)) (-RRB- -RRB-))) (, ,))) (CC and) (PP (IN against) (NP (NP (DT the) (JJ glial) (NN Doc_1756784_1226_1233_Chemical-binding) (NN protein)) (, ,) (NP (NN S-100) (NN protein)) (, ,))))) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN status)) (PP (IN of) (NP (NNS astrocytes))))))))) (. .)))
1756784	8	(ROOT (S (NP (NP (JJ Immunohistochemical) (NN staining)) (PP (IN for) (NP (NN serum-albumin) (CC and) (NNS immunoglobulins))) (PP (IN in) (NP (NN brain) (NN tissue)))) (VP (VBD was) (VP (VBN taken) (PP (IN as) (NP (NP (NN indicator)) (PP (IN of) (NP (NP (JJ blood-brain) (NN barrier) (NNS disturbances)) (CC and) (NP (JJ vasogenic) (JJ Doc_1756784_1468_1473_Disease) (NN formation)))))))) (. .)))
1756784	9	(ROOT (S (NP (JJ Immunohistochemical) (NN staining)) (VP (VBD indicated) (NP (NP (NN loss)) (PP (IN of) (NP (NNP GFAP-staining)))) (PP (ADVP (RB already)) (IN at) (NP (CD 30) (NN min))) (PP (IN after) (NP (NP (NN induction)) (PP (IN of) (NP (NNS Doc_1756784_1583_1591_Disease))))) (PP (IN in) (NP (NP (DT an) (JJ oval) (NN focus)) (VP (VBN situated) (PP (IN in) (NP (NP (DT the) (NN center)) (PP (IN of) (NP (NNP SNR))))) (PP (IN while) (S (VP (VBG sparing) (NP (ADJP (JJ medial) (CC and) (JJ lateral)) (NNS aspects))))))))) (. .)))
1756784	10	(ROOT (S (PP (IN At) (NP (CD 1) (NN h))) (NP (EX there)) (VP (VBD was) (NP (NP (JJ additional) (NN vacuolation)) (PP (IN in) (NP (NN S-100) (NN protein) (NN staining))))) (. .)))
1756784	11	(ROOT (S (PP (IN By) (NP (CD 2) (NNS hours))) (, ,) (S (NP (NN parvalbumin-staining)) (VP (VBD changed) (PP (IN in) (NP (DT the) (JJ central) (NN SNR))) (S (VP (VBG indicating) (NP (NNS Doc_1756784_1819_1834_Disease)))))) (, ,) (CC and) (S (NP (NNP Nissl-staining)) (VP (VBD visualized) (NP (DT some) (NNS Doc_1756784_1871_1890_Disease)))) (. .)))
1756784	12	(ROOT (S (S (VP (VBG Staining) (PP (IN for) (NP (NNS serum-proteins))))) (VP (VBD occurred) (PP (IN in) (NP (NP (DT a) (JJ patchy) (NN manner)) (PP (IN throughout) (NP (DT the) (NN forebrain))))) (PP (IN during) (NP (DT the) (JJ first) (NNS hours)))) (. .)))
1756784	13	(ROOT (S (PP (IN By) (NP (CD 6) (NN h))) (, ,) (NP (JJ vasogenic) (NNS Doc_1756784_2015_2020_Disease)) (VP (VBD covered) (NP (DT the) (JJ lesioned) (NN SNR))) (. .)))
1756784	14	(ROOT (S (PP (IN By) (NP (CD 24) (NN h))) (, ,) (NP (ADJP (JJ glial) (CC and) (JJ neuronal)) (NNS markers)) (VP (VBD indicated) (NP (DT a) (JJ massive) (NN lesion)) (PP (IN in) (NP (NP (DT the) (NN center)) (PP (IN of) (NP (NNP SNR)))))) (. .)))
1756784	15	(ROOT (S (PP (IN By) (NP (CD 48-72) (NN h))) (, ,) (S (NP (NP (NNS astrocytes)) (VP (VBG surrounding) (NP (DT the) (NN lesion)))) (VP (VBD increased) (PP (IN in) (NP (NN size))))) (, ,) (CC and) (S (NP (JJ polymorphic) (JJ phagocytotic) (NNS cells)) (VP (VBD invaded) (NP (DT the) (VBN damaged) (NN area)))) (. .)))
1756784	16	(ROOT (S (PP (IN In) (NP (NP (DT a) (JJ further) (NN group)) (PP (IN of) (NP (NP (NNS animals)) (VP (VBG surviving) (NP (QP (CD 1) (TO to) (CD 5)) (NNS days))))))) (, ,) (NP (JJ conventional) (NNS paraffin-sections)) (VP (VBD confirmed) (NP (NP (DT the) (ADJP (JJ neuronal) (CC and) (JJ glial)) (NN damage)) (PP (IN of) (NP (NNP SNR))))) (. .)))
1756784	17	(ROOT (S (NP (NP (JJ Additional) (NN pathology)) (PP (IN of) (NP (JJ similar) (NN quality)))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (DT the) (JJ globus) (NNS pallidus))))) (. .)))
1756784	18	(ROOT (S (SBAR (IN Since) (S (NP (NNS astrocytes)) (VP (VBD were) (ADVP (RB always)) (VP (VBN damaged) (PP (IN in) (NP (NN parallel))) (PP (IN with) (NP (NP (NNS neurons)) (PP (IN in) (NP (NNP SNR))))))))) (NP (PRP it)) (VP (VBZ is) (VP (VBN proposed) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (JJ anatomical) (CC and) (JJ functional)) (NN interrelationship)) (PP (IN between) (NP (NNS neurons) (CC and) (NNS astrocytes)))) (VP (VBZ is) (ADJP (RB particularly) (JJ tight) (PP (IN in) (NP (NNP SNR))))))))) (. .)))
1756784	19	(ROOT (S (NP (DT Both) (NN cell) (NNS elements)) (VP (MD may) (VP (VB suffer) (PP (IN in) (NP (NP (JJ common)) (PP (IN from) (NP (NNS Doc_1756784_2707_2728_Disease) (CC and) (NNS Doc_1756784_2733_2761_Disease))))) (SBAR (IN as) (S (VP (VBP occur) (PP (IN during) (NP (JJ massive) (NNS Doc_1756784_2786_2804_Disease)))))))) (. .)))
17572393	0	(ROOT (NP (NP (JJ Neuroprotective) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_17572393_27_36_Chemical)) (PP (IN upon) (NP (DT the) (NN offspring) (NN cerebellar) (NN cortex))))) (PP (IN in) (NP (DT the) (NN rat) (NN model))) (PP (IN of) (NP (NN Doc_17572393_94_98_Chemical-induced) (NNS Doc_17572393_107_125_Disease))) (. .)))
17572393	1	(ROOT (S (NP (NNP Doc_17572393_127_145_Disease)) (VP (VBZ is) (NP (NP (DT a) (NNS Doc_17572393_151_163_Disease)) (VP (VBN characterized) (PP (IN by) (NP (NP (NNS defects)) (PP (IN in) (NP (NN proliferation) (, ,) (NN migration) (CC and) (NN maturation)))))))) (. .)))
17572393	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (VP (TO to) (VP (VB evaluate) (NP (DT the) (NNS alterations)) (PP (IN in) (NP (NP (NN offspring) (NN rat) (NN cerebellum)) (VP (VBN induced) (PP (IN by) (NP (JJ maternal) (NN exposure))) (PP (TO to) (NP (NP (NNS Doc_17572393_345_394_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17572393_396_400_Chemical)) (-RRB- -RRB-))))))))) (CC and) (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ exogenous) (NNS Doc_17572393_446_455_Chemical)))) (PP (IN upon) (NP (NN cerebellar) (NN Doc_17572393_472_476_Chemical-induced) (NNS Doc_17572393_485_503_Disease))) (, ,) (S (VP (VBG using) (NP (ADJP (JJ histological) (CC and) (JJ biochemical)) (NNS analyses)))))))))) (. .)))
17572393	3	(ROOT (S (NP (NNP Pregnant) (NNP Wistar) (NNS rats)) (VP (VBD were) (VP (VBN assigned) (PP (TO to) (NP (CD five) (NNS groups))) (: :) (NP (JJ intact-control) (, ,) (JJ saline-control) (, ,) (ADJP (JJ Doc_17572393_633_642_Chemical-treated) (, ,) (JJ Doc_17572393_652_656_Chemical-exposed) (CC and) (JJ Doc_17572393_669_673_Chemical-exposed)) (NN plus) (NNS Doc_17572393_687_696_Chemical)))) (. .)))
17572393	4	(ROOT (S (NP (NNS Rats)) (VP (VBD were) (VP (VBN exposed) (PP (TO to) (NP (NP (NNS Doc_17572393_719_723_Chemical)) (PP (IN on) (NP (NP (JJ embryonic) (NN day)) (SBAR (S (NP (NP (CD 15)) (CC and) (NP (NNS Doc_17572393_748_757_Chemical))) (VP (VBD was) (VP (VBN given) (PP (IN until) (NP (NN delivery))))))))))))) (. .)))
17572393	5	(ROOT (S (S (NP (NN Immuno/histochemistry) (CC and) (NN electron)) (ADVP (RB microscopy)) (VP (VBD were) (VP (VBN carried) (PRT (RP out)) (PP (IN on) (NP (DT the) (NN offspring) (NN cerebellum)))))) (, ,) (CC and) (S (NP (NP (NNS levels)) (PP (IN of) (NP (NNS Doc_17572393_890_905_Chemical) (CC and) (NNS Doc_17572393_910_920_Chemical) (NN dismutase)))) (VP (VBD were) (VP (VBN determined)))) (. .)))
17572393	6	(ROOT (S (S (ADVP (RB Histopathologically)) (, ,) (NP (JJ typical) (NNS findings)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NN cerebella)) (PP (IN from) (NP (DT the) (NN control) (NNS groups)))))))) (, ,) (CC but) (S (NP (NP (DT the) (NNS findings)) (ADJP (JJ consistent) (PP (IN with) (NP (JJ early) (JJ embryonic) (NN development))))) (VP (VBD were) (VP (VBN noted) (PP (IN in) (NP (JJ Doc_17572393_1117_1121_Chemical-exposed) (JJ Doc_17572393_1130_1148_Disease) (NN group)))))) (. .)))
17572393	7	(ROOT (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ marked) (NN increase)) (PP (IN in) (NP (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ TUNEL) (JJ positive) (NNS cells)))) (CC and) (NP (NP (JJ nestin) (JJ positive) (NNS cells)) (PP (IN in) (NP (NN Doc_17572393_1251_1255_Chemical-exposed) (NN group))))))))) (, ,) (CC but) (S (S (NP (NP (DT a) (VBN decreased) (NN immunoreactivity)) (PP (TO to) (NP (JJ glial) (NN fibrillary) (JJ acidic) (NN protein) (, ,) (NN synaptophysin) (CC and) (JJ transforming) (NN growth) (NN factor) (NNS beta1)))) (VP (VBD was) (ADJP (JJ observed)) (, ,) (S (VP (VBG indicating) (NP (DT a) (JJ delayed) (NN maturation)))))) (, ,) (CC and) (S (NP (NNS Doc_17572393_1442_1451_Chemical)) (ADVP (RB significantly)) (VP (VBD reversed) (NP (DT these) (NNS changes))))) (. .)))
17572393	8	(ROOT (S (NP (NP (JJ Doc_17572393_1490_1505_Chemical) (NN level)) (PP (IN in) (NP (NN Doc_17572393_1515_1519_Chemical-exposed) (NN group)))) (VP (VBD was) (ADJP (ADJP (JJR higher)) (SBAR (IN than) (S (NP (NP (DT those)) (PP (IN in) (NP (NN control) (NNS groups) (CC and) (NNS Doc_17572393_1578_1587_Chemical)))) (VP (VBD decreased) (NP (JJ Doc_17572393_1598_1613_Chemical) (NNS levels)) (PP (IN in) (NP (NP (JJ Doc_17572393_1624_1628_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-)))) (, ,) (SBAR (IN while) (S (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN in) (NP (NP (DT the) (JJ Doc_17572393_1696_1706_Chemical) (JJ dismutase) (NNS levels)) (PP (IN between) (NP (DT these) (NNS groups)))))))))))))) (. .)))
17572393	9	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (S (NP (NP (NN exposure)) (PP (IN of) (NP (NP (NNS animals)) (PP (TO to) (NP (NP (NNS Doc_17572393_1793_1797_Chemical)) (PP (IN during) (NP (NN pregnancy)))))))) (VP (VBZ leads) (PP (TO to) (NP (NP (VBN delayed) (NN maturation)) (PP (IN of) (NP (NN offspring) (NN cerebellum))))))) (CC and) (S (NP (NNS Doc_17572393_1871_1880_Chemical)) (VP (VBZ protects) (NP (NP (DT the) (NN cerebellum)) (PP (IN against) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_17572393_1928_1932_Chemical))))))))))) (. .)))
1760851	0	(ROOT (S (NP (NP (JJ Reduced) (NNS Doc_1760851_8_22_Disease)) (PP (IN of) (NP (NP (NNS Doc_1760851_26_37_Chemical)) (PP (VBN given) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NNS Doc_1760851_59_92_Chemical))))))))) (VP (VP (VBZ conjugates)) (: :) (CC and) (VP (NP (JJ experimental) (NN study)) (PP (IN in) (NP (DT the) (NN rat))))) (. .)))
1760851	1	(ROOT (S (S (NP (DT A) (NN rat) (NN model)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB evaluate) (NP (DT the) (JJ general) (JJ acute) (NNS Doc_1760851_191_199_Disease)))))))) (CC and) (S (NP (NP (DT the) (JJ late) (NNS Doc_1760851_213_227_Disease)) (PP (IN of) (NP (NP (CD 4) (JJ mg/kg) (NNS Doc_1760851_239_250_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1760851_252_255_Chemical)) (-RRB- -RRB-)) (VP (VBN given) (PP (CC either) (PP (IN as) (NP (JJ free) (NN drug))) (CC or) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (CD three) (NNS Doc_1760851_307_340_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1760851_342_346_Chemical)) (-RRB- -RRB-))))))))))) (VP (VBP copolymer) (NP (NNS conjugates)))) (. .)))
1760851	2	(ROOT (S (PP (IN In) (NP (DT these) (JJ Doc_1760851_379_383_Chemical) (NNS copolymers))) (, ,) (NP (NNS Doc_1760851_396_399_Chemical)) (VP (VBD was) (ADJP (ADJP (ADJP (RB covalently) (VBN bound)) (PP (IN via) (NP (NP (JJ peptide) (NNS linkages)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (RB either) (ADJP (JJ non-biodegradable))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_1760851_478_485_Chemical)) (-RRB- -RRB-))))) (CC or) (ADJP (JJ degradable) (PP (IN by) (NP (NP (JJ lysosomal) (NNS proteinases)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1760851_527_542_Chemical)) (-RRB- -RRB-))))))) (. .)))
1760851	3	(ROOT (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (CD one) (ADJP (JJ biodegradable) (JJ conjugate)) (NN containing) (NNS Doc_1760851_597_610_Chemical)) (VP (VBD was) (VP (VBN used)))) (: ;) (S (NP (DT this) (NN residue)) (VP (VBD was) (VP (VBN targeted) (PP (TO to) (NP (DT the) (NN liver)))))) (. .)))
1760851	4	(ROOT (S (PP (IN Over) (NP (DT the) (JJ first) (CD 3) (NNS weeks))) (PP (IN after) (NP (NP (DT the) (NN i.v.) (NN administration)) (PP (IN of) (NP (JJ free) (CC and) (JJ polymer-bound) (NNS Doc_1760851_740_743_Chemical))))) (, ,) (NP (DT all) (NNS animals)) (VP (VBD showed) (NP (DT a) (JJ transient) (NN reduction)) (PP (IN in) (NP (NN body) (NN weight)))) (. .)))
1760851	5	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ maximal) (NN reduction)) (PP (IN in) (NP (NN body) (NN weight)))) (VP (VBN seen) (PP (IN in) (NP (NP (NNS animals)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (SBAR (S (NP (NP (JJ polymer-bound) (NNS Doc_1760851_892_895_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 4) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR lower)) (SBAR (IN than) (S (NP (DT that)) (VP (VBD observed) (PP (IN in) (NP (NP (DT those)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (NP (NP (JJ free) (NNS Doc_1760851_977_980_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 4) (NN mg/kg)) (-RRB- -RRB-)) (CC or) (NP (NP (DT a) (NN mixture)) (PP (IN of) (NP (NP (DT the) (JJ unmodified) (NN parent) (NNS Doc_1760851_1029_1033_Chemical) (NN copolymer) (CC and) (JJ free) (NNS Doc_1760851_1053_1056_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 4) (NN mg/kg)) (: ;) (NP (NP (NNP P)) (NP (QP (JJR less) (IN than) (CD 0.01))))) (-RRB- -RRB-)))))))))))))))))))))))) (. .)))
1760851	6	(ROOT (S (S (PP (IN Throughout) (NP (NP (DT the) (NN study)) (PRN (-LRB- -LRB-) (NP (CD 20) (NNS weeks)) (-RRB- -RRB-)))) (, ,) (NP (NP (NNS deaths)) (VP (VBN related) (PP (TO to) (NP (NNS Doc_1760851_1137_1151_Disease))))) (VP (VBD were) (VP (VBN observed) (ADVP (RB only)) (PP (IN in) (NP (NP (NNS animals)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (NP (NP (DT either) (JJ free) (NNS Doc_1760851_1208_1211_Chemical)) (CC or) (NP (NP (DT the) (NN mixture)) (PP (IN of) (NP (NP (JJ Doc_1760851_1230_1234_Chemical) (NN copolymer)) (CC and) (NP (JJ free) (NNS Doc_1760851_1254_1257_Chemical)))))))))))))) (: ;) (S (PP (IN in) (NP (DT these) (NNS cases))) (, ,) (NP (JJ histological) (NNS investigations)) (VP (VBD revealed) (NP (JJ marked) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN heart)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (JJ consistent) (PP (IN with) (NP (NN Doc_1760851_1366_1369_Chemical-induced) (NNS Doc_1760851_1378_1392_Disease))))))))))) (. .)))
1760851	7	(ROOT (S (NP (NP (JJ Sequential) (NNS measurements)) (PP (IN of) (NP (NP (JJ cardiac) (NN output)) (PP (IN in) (NP (NP (VBG surviving) (NNS animals) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (NP (DT either) (JJ free) (NNS Doc_1760851_1483_1486_Chemical)))))) (CC or) (NP (NP (DT the) (NN mixture)) (PP (IN of) (NP (NP (JJ Doc_1760851_1505_1509_Chemical) (NN copolymer)) (CC and) (NP (JJ free) (NNS Doc_1760851_1529_1532_Chemical)))))))))) (VP (VBD showed) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NP (QP (RB approximately) (CD 30)) (NN %)) (PP (IN in) (NP (NN function)))))) (PP (VBG beginning) (PP (IN at) (NP (NP (DT the) (JJ 4th) (NN week)) (PP (IN after) (NP (NN drug) (NN administration))))))) (. .)))
1760851	8	(ROOT (S (NP (NP (DT The) (NN heart) (NN rate)) (PP (IN in) (NP (DT these) (NNS animals)))) (VP (VBD was) (ADJP (ADJP (NP (QP (RB approximately) (CD 12)) (NN %)) (JJR lower)) (PP (IN than) (SBAR (WHNP (WDT that)) (S (VP (VBN measured) (PP (IN in) (NP (JJ age-matched) (NN control) (NNS rats))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-)))))))) (. .)))
1760851	9	(ROOT (S (NP (NP (NNS Animals)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN given) (NP (DT the) (JJ Doc_1760851_1793_1797_Chemical) (NN copolymer)) (NP (NP (NNS conjugates)) (VP (VBG containing) (NP (NNS Doc_1760851_1830_1833_Chemical))))))))) (VP (VBD exhibited) (NP (DT no) (JJ significant) (NN change)) (PP (IN in) (NP (JJ cardiac) (NN output))) (PP (IN throughout) (NP (NP (DT the) (NN study)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))))) (. .)))
1760851	10	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT no) (JJ significant) (JJ histological) (NN change)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NN heart)) (PP (IN of) (NP (NP (NNS animals)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBD received) (NP (NNS Doc_1760851_2024_2027_Chemical)) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (JJ Doc_1760851_2043_2047_Chemical) (NN copolymer) (NNS conjugates)))))) (CC and) (VP (VBD were) (VP (VBN killed) (PP (IN at) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (NN study)))))))))))))))) (. .)))
1760851	11	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT these) (NNS animals)) (VP (VBD had) (VP (VBN shown) (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (FRAG (NP (NP (NN heart) (NN rate) (NN beginning)) (ADVP (IN at) (NP (CD 8) (NNS weeks)) (PP (IN after) (NP (NP (NN drug) (NN administration)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.01))) (-RRB- -RRB-)))))) (. .))) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 400) (NNS WORDS))) (-RRB- -RRB-))))))
17721298	0	(ROOT (S (NP (NP (JJ Corneal) (NNS Doc_17721298_8_14_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ aerosolized) (NN crack) (NNS Doc_17721298_49_56_Chemical))))) (VP (VBP use)) (. .)))
17721298	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (CD 4) (NNS cases)) (PP (IN of) (NP (NP (JJ corneal) (NNS Doc_17721298_100_106_Disease)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_17721298_123_133_Disease)))))))) (. .)))
17721298	2	(ROOT (S (NP (NP (DT The) (NNS pathogenesis)) (PP (IN of) (NP (NP (DT these) (NN Doc_17721298_161_167_Disease) (CC and) (NN management)) (PP (IN of) (NP (DT these) (NNS patients)))))) (VP (VBP are) (ADVP (RB also)) (VP (VBN reviewed))) (. .)))
17721298	3	(ROOT (S (NP (NP (NNP Review)) (PP (IN of) (NP (NP (DT all) (NNS cases)) (PP (IN of) (NP (JJ corneal) (NNS Doc_17721298_260_266_Disease)))))) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_17721298_283_293_Disease)) (VP (VBN seen) (PP (IN at) (NP (PRP$ our) (NN institution))) (PP (IN from) (NP (NNP July) (CD 2006))) (PP (TO to) (NP (NNP December) (CD 2006))))))) (. .)))
17721298	4	(ROOT (S (NP (NP (CD Four) (NNS patients)) (PP (IN with) (NP (NP (JJ corneal) (NNS Doc_17721298_387_393_Disease)) (VP (VBN associated) (PP (IN with) (NP (NN crack) (JJ Doc_17721298_416_423_Chemical) (NN use))))))) (VP (VBD were) (VP (VBN reviewed))) (. .)))
17721298	5	(ROOT (S (S (NP (DT All) (JJ corneal) (NNS Doc_17721298_455_461_Disease)) (VP (VBD were) (VP (VBN cultured)))) (, ,) (CC and) (S (NP (DT the) (NNS patients)) (VP (VBD were) (VP (VBN admitted) (PP (TO to) (NP (NP (DT the) (NN hospital)) (PP (IN for) (NP (JJ intensive) (JJ topical) (JJ antibiotic) (NN treatment)))))))) (. .)))
17721298	6	(ROOT (S (NP (DT Each) (NN patient)) (VP (VBD received) (NP (NP (JJ comprehensive) (NN health) (NN care)) (, ,) (PP (VBG including) (NP (JJ medical) (CC and) (NN substance) (NN abuse) (NNS consultations))))) (. .)))
17721298	7	(ROOT (S (NP (JJ Streptococcal) (NNS organisms)) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (CD 3) (NNS cases)) (CC and) (NP (NNP Capnocytophaga) (CC and) (NNP Brevibacterium) (NNS casei)))) (PP (IN in) (NP (CD 1) (NN patient))))) (. .)))
17721298	8	(ROOT (S (NP (DT The) (NNS Doc_17721298_778_788_Disease)) (VP (VBD responded) (PP (TO to) (NP (JJ antibiotic) (NN treatment)))) (. .)))
17721298	9	(ROOT (S (NP (CD Two) (NNS patients)) (VP (VBD needed) (NP (DT a) (JJ lateral) (NN tarsorrhaphy)) (PP (IN for) (NP (JJ persistent) (JJ epithelial) (NNS defects)))) (. .)))
17721298	10	(ROOT (S (NP (JJ Aerosolized) (NN crack) (NNS Doc_17721298_933_940_Chemical)) (VP (VBP use) (SBAR (S (VP (MD can) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ corneal) (NNS Doc_17721298_995_1001_Disease))))))))))) (. .)))
17721298	11	(ROOT (S (NP (NNP Doc_17721298_1003_1013_Disease)) (VP (VBZ provides) (NP (NP (JJ additional) (NNS challenges)) (PP (IN for) (NP (NN management))))) (. .)))
17721298	12	(ROOT (S (NP (NP (CONJP (RB Not) (JJ only)) (NP (NP (NN treatment)) (PP (IN of) (NP (PRP$ their) (NNS Doc_17721298_1089_1099_Disease)))) (CONJP (CC but) (RB also)) (NP (DT the) (JJ overall) (JJ poor) (NN health))) (PP (IN of) (NP (NP (DT the) (NNS patients)) (CC and) (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (NN noncompliance))))))) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN addressed)))))) (. .)))
17721298	13	(ROOT (S (NP (NNP Comprehensive) (NN care)) (VP (MD may) (VP (VB provide) (NP (DT the) (NN patient)) (NP (DT the) (NN opportunity) (S (VP (TO to) (VP (VP (VB discontinue) (NP (PRP$ their) (NN substance) (NN abuse))) (, ,) (VP (VB improve) (NP (PRP$ their) (JJ overall) (NN health))) (, ,) (CC and) (VP (VB prevent) (NP (JJ future) (JJ corneal) (NNS complications))))))))) (. .)))
1779253	0	(ROOT (NP (NP (NP (JJ Topical) (ADJP (CD 0.025) (NN %)) (NNS Doc_1779253_15_24_Chemical)) (PP (IN in) (NP (JJ chronic) (NNS Doc_1779253_36_59_Disease)))) (: :) (NP (NP (NN efficacy)) (, ,) (NP (NP (NNS predictors)) (PP (IN of) (NP (NN response)))) (CC and) (NP (JJ long-term) (NN course))) (. .)))
1779253	1	(ROOT (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN efficacy)) (, ,) (NP (NP (NN time-course)) (PP (IN of) (NP (NN action)))) (CC and) (NP (NP (NNS predictors)) (PP (IN of) (NP (NN response))))) (PP (TO to) (NP (JJ topical) (NNS Doc_1779253_211_220_Chemical))))))) (, ,) (NP (NP (NP (CD 39) (NNS patients)) (PP (IN with) (NP (NP (JJ chronic) (NNS Doc_1779253_247_270_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1779253_272_275_Disease)) (-RRB- -RRB-))))) (, ,) (NP (NP (JJ median) (NN duration)) (NP (CD 24) (NNS months))) (, ,)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (CD 0.025) (NN %) (NN Doc_1779253_330_339_Chemical) (NN cream)) (PP (IN for) (NP (CD 8) (NNS weeks))))))) (. .)))
1779253	2	(ROOT (S (PP (IN During) (NP (NN therapy))) (NP (DT the) (NNS patients)) (VP (VBD rated) (NP (PRP$ their) (NNS Doc_1779253_399_403_Disease)) (PP (IN on) (NP (NP (NP (DT a) (JJ visual) (JJ analogue) (NN scale)) (PRN (-LRB- -LRB-) (NP (NNP VAS)) (-RRB- -RRB-))) (CC and) (NP (DT a) (JJ verbal) (NN outcome) (NN scale))))) (. .)))
1779253	3	(ROOT (S (NP (DT A) (NN follow-up) (NN investigation)) (VP (VBD was) (VP (VBN performed) (PP (NP (CD 10-12) (NNS months)) (IN after) (NP (NN study) (NN onset))) (PP (IN on) (NP (NP (DT the) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN improved))))))))) (. .)))
1779253	4	(ROOT (S (S (NP (NP (NN Nineteen) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 48.7) (NN %)) (-RRB- -RRB-))) (ADVP (RB substantially)) (VP (VBD improved) (PP (IN after) (NP (NP (DT the) (JJ 8-week) (NN trial)) (: ;) (NP (CD 5)) (PRN (-LRB- -LRB-) (NP (CD 12.8) (NN %)) (-RRB- -RRB-)))) (NP (NP (VBN discontinued) (NN therapy)) (ADJP (JJ due) (PP (TO to) (NP (NP (NNS side-effects)) (PP (JJ such) (IN as) (NP (NP (NP (ADJP (JJ intolerable) (JJ Doc_1779253_714_723_Chemical-induced)) (NNS Doc_1779253_732_750_Disease)) (PRN (-LRB- -LRB-) (NP (CD 4)) (-RRB- -RRB-))) (CC or) (NP (NP (NNS Doc_1779253_758_766_Disease)) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-))))))))))) (: ;) (S (NP (NP (CD 15)) (PRN (-LRB- -LRB-) (NP (CD 38.5) (NN %)) (-RRB- -RRB-))) (VP (VBD reported) (NP (DT no) (NN benefit)))) (. .)))
1779253	5	(ROOT (S (NP (NP (DT The) (NN decrease)) (PP (IN in) (NP (NNP VAS) (NNS ratings)))) (VP (VBD was) (ADJP (JJ significant) (PP (IN after) (NP (NP (CD 2) (NNS weeks)) (PP (IN of) (NP (JJ continuous) (NN application))))))) (. .)))
1779253	6	(ROOT (S (S (PP (IN Of) (NP (DT the) (NNS responders))) (NP (CD 72.2) (NN %)) (VP (VBD were) (ADVP (RB still)) (VP (VBN improved) (PP (IN at) (NP (DT the) (NN follow-up)))))) (: ;) (S (NP (NP (QP (RB only) (NN one-third))) (PP (IN of) (NP (PRP them)))) (VP (VBD had) (VP (VBN continued) (NP (NN application)) (ADVP (RB irregularly))))) (. .)))
1779253	7	(ROOT (S (NP (NNP Treatment) (NN effect)) (VP (VBD was) (RB not) (ADJP (JJ dependent) (PP (IN on) (NP (NP (NP (NN patient) (POS 's)) (NN age)) (, ,) (NP (NP (NN duration) (CC or) (NN localization)) (PP (IN of) (NP (NP (NP (NNS Doc_1779253_1094_1097_Chemical)) (PRN (-LRB- -LRB-) (S (NP (JJ trigeminal) (NN involvement)) (VP (VBD was) (VP (VBN excluded)))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_1779253_1137_1156_Disease)) (CC or) (NP (JJ Doc_1779253_1160_1164_Disease) (NN character)))))))))) (. .)))
1779253	8	(ROOT (S (NP (NNP Treatment) (NN response)) (VP (VBD was) (RB not) (VP (VBN correlated) (PP (IN with) (NP (NP (DT the) (NN incidence) (, ,) (NN time-course) (CC or) (NN severity)) (PP (IN of) (NP (NN Doc_1779253_1261_1270_Chemical-induced) (NN burning))))))) (. .)))
1779253	9	(ROOT (S (SBAR (IN If) (S (VP (VBD confirmed) (PP (IN in) (NP (JJ controlled) (NNS trials)))))) (, ,) (NP (NP (DT the) (JJ long-term) (NNS results)) (PP (IN of) (NP (DT this) (JJ open) (, ,) (JJ non-randomized) (NN study)))) (VP (MD might) (VP (VB indicate) (SBAR (IN that) (S (NP (NP (DT the) (JJ analgesic) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_1779253_1424_1433_Chemical)) (PP (IN in) (NP (NNS Doc_1779253_1437_1440_Disease)))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (DT both) (NN interference)) (PP (IN with) (NP (NP (NP (JJ neuropeptide) (NN metabolism) (CC and) (NN morphological) (NNS changes)) (PRN (-LRB- -LRB-) (NP (RB perhaps) (NN degeneration)) (-RRB- -RRB-))) (PP (IN of) (NP (JJ nociceptive) (NNS afferents))))))))))))) (. .)))
17828434	0	(ROOT (NP (NP (NP (NNP Doc_17828434_0_24_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP MIP)) (-RRB- -RRB-)) (NP (JJ synthase) (NN inhibition))) (: :) (NP (NP (JJ in-vivo) (NN study)) (PP (IN in) (NP (NNS rats)))) (. .)))
17828434	1	(ROOT (S (NP (NNS Doc_17828434_75_82_Chemical) (CC and) (NNS Doc_17828434_87_96_Chemical)) (VP (VBP are) (NP (NP (DT the) (JJ prototypic) (NN mood)) (SBAR (S (VP (VP (VBZ stabilizers)) (CC and) (VP (VBP have) (NP (JJ diverse) (NNS structures) (CC and) (NNS targets)))))))) (. .)))
17828434	2	(ROOT (S (NP (DT Both) (NNS drugs)) (VP (VBP influence) (NP (JJ Doc_17828434_195_203_Chemical) (NN metabolism))) (. .)))
17828434	3	(ROOT (S (NP (NP (NNP Doc_17828434_216_223_Chemical) (NNP inhibits) (NNP IMPase)) (CC and) (NP (NNS Doc_17828434_244_253_Chemical))) (VP (VBZ inhibits) (S (NP (NNP MIP)) (ADJP (JJ synthase)))) (. .)))
17828434	4	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NNP MIP) (NN synthase) (NN inhibition)) (VP (VBZ does) (RB not) (VP (VB replicate) (CC or) (VB augment) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_17828434_368_375_Chemical)))) (PP (IN in) (NP (DT the) (JJ Doc_17828434_383_391_Chemical) (ADJP (JJ sensitive) (JJ Doc_17828434_402_413_Chemical-induced)) (JJ Doc_17828434_422_430_Disease) (NN model)))))))) (. .)))
17828434	5	(ROOT (S (NP (NP (DT This) (NN lack)) (PP (IN of) (NP (NNS effects)))) (VP (MD may) (VP (VB stem) (PP (IN from) (NP (NP (DT the) (JJ low) (NN contribution)) (PP (IN of) (NP (JJ de-novo) (NN synthesis))))) (PP (PP (TO to) (NP (JJ cellular) (JJ Doc_17828434_527_535_Chemical) (NN supply))) (CC or) (PP (TO to) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (DT the) (JJ de-novo) (NN synthesis)) (PP (IN by) (NP (NNS Doc_17828434_592_599_Chemical))))))) (NP (PRP itself))))) (. .)))
17879100	0	(ROOT (S (NP (NNP Non-steroidal)) (ADVP (RB anti-inflammatory)) (VP (VBD drugs-associated) (NP (JJ acute) (NNS Doc_17879100_55_77_Disease)) (PP (IN with) (NP (JJ granular) (JJ tubular) (NN basement) (NN membrane) (NNS deposits)))) (. .)))
17879100	1	(ROOT (S (S (NP (NP (NNP Doc_17879100_128_163_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17879100_165_169_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN cause)) (PP (IN of) (NP (NP (NNS Doc_17879100_196_215_Disease)) (VP (VBG resulting) (PP (IN from) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS insults))) (, ,) (PP (VBG including) (NP (JJ immune) (JJ complex-mediated) (NN tubulo-Doc_17879100_294_313_Disease))))))))))) (, ,) (CC but) (S (NP (NP (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNP NSAIDs)) (-RRB- -RRB-))))) (VP (VBP are) (NP (DT a) (ADJP (RB far) (RBR more) (JJ frequent)) (NN cause)))) (. .)))
17879100	2	(ROOT (S (ADVP (RB Overall)) (, ,) (PP (IN as) (NP (DT an) (NN entity))) (, ,) (NP (NNS Doc_17879100_434_438_Disease)) (VP (VBZ remains) (ADJP (JJ under-diagnosed)) (, ,) (SBAR (IN as) (S (NP (NNS symptoms)) (VP (VB resolve) (ADVP (RB spontaneously)) (SBAR (IN if) (S (NP (DT the) (NN medication)) (VP (VBZ is) (VP (VBN stopped))))))))) (. .)))
17879100	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (PP (IN on) (NP (NP (DT a) (JJ 14-year-old) (NN boy)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_17879100_573_592_Disease)) (NP (CD 2) (NNS weeks)) (PP (IN after) (NP (JJ aortic) (NN valve) (NN surgery))))))))) (. .)))
17879100	4	(ROOT (S (NP (PRP He)) (VP (VP (VBD was) (VP (VBN put) (PP (IN on) (NP (NP (NNS Doc_17879100_643_650_Chemical)) (PP (VBG following) (NP (NN surgery))))))) (CC and) (VP (VBD took) (NP (NP (NNS Doc_17879100_678_687_Chemical)) (PP (IN for) (NP (NN fever)))) (PP (IN for) (NP (RB nearly) (DT a) (NN week))) (ADVP (RB prior) (PP (TO to) (NP (NN presentation)))))) (. .)))
17879100	5	(ROOT (S (NP (PRP He)) (ADVP (RB then)) (VP (VP (VBD presented) (PP (TO to) (NP (NP (DT the) (NN emergency) (NN department)) (VP (VBG feeling) (ADJP (RB quite) (JJ ill)))))) (CC and) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NP (DT a) (NP (NP (NN blood) (NNS Doc_17879100_833_846_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP BUN)) (-RRB- -RRB-))) (NN concentration)) (PP (IN of) (IN of) (NP (NP (CD 147) (NN mg/dl)) (, ,) (NP (NP (NNS Doc_17879100_884_894_Chemical)) (PP (IN of) (NP (NP (CD 15.3) (NN mg/dl) (CC and) (NN serum) (NNS Doc_17879100_919_928_Chemical)) (PP (IN of) (NP (CD 8.7) (NN mEq/l))))))))))))))) (. .)))
17879100	6	(ROOT (S (NP (NNS Dialysis)) (VP (VBD was) (VP (ADVP (RB immediately)) (VBN initiated))) (. .)))
17879100	7	(ROOT (S (NP (DT A) (NN kidney)) (ADVP (RB biopsy)) (VP (VBD showed) (S (NP (JJ inflammatory) (NNS infiltrate)) (ADJP (JJ consistent) (PP (IN with) (NP (NNS Doc_17879100_1042_1046_Disease)))))) (. .)))
17879100	8	(ROOT (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (DT the) (JJ tubular) (NN basement) (NN membrane)) (PRN (-LRB- -LRB-) (NP (NNP TBM)) (-RRB- -RRB-)))) (, ,) (NP (NP (ADJP (RB very) (JJ intense)) (JJ granular) (NNS deposits)) (PP (IN of) (NP (JJ polyclonal) (NNP IgG) (CC and) (NNP C3)))) (VP (VBD were) (VP (VBN noted))) (. .)))
17879100	9	(ROOT (S (NP (PRP He)) (VP (VP (VBD needed) (NP (NN dialysis)) (PP (IN for) (NP (CD 2) (NNS weeks)))) (CC and) (VP (VBD was) (VP (VBN treated) (ADVP (RB successfully)) (PP (IN with) (NP (NP (NNS Doc_17879100_1230_1238_Chemical)) (PP (IN for) (NP (CD 6) (NNS months)))))))) (. .)))
17879100	10	(ROOT (S (NP (NP (PRP$ His) (JJ renal) (NN recovery) (CC and) (NN disappearance)) (PP (IN of) (NP (NNS Doc_17879100_1293_1304_Disease)))) (VP (VBD took) (NP (DT a) (NN year))) (. .)))
17879100	11	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (DT this)) (VP (VBZ is) (NP (NP (DT a) (JJ first) (NN report)) (PP (IN of) (NP (JJ NSAIDs-associated) (NNS Doc_17879100_1377_1381_Disease)))) (, ,) (S (VP (VBG showing) (NP (NP (NNS deposits)) (PP (IN of) (NP (JJ granular) (JJ immune) (JJ complex) (NN present)))) (PP (RB only) (PP (IN in) (NP (DT the) (NNP TBM))) (CC and) (RB not) (PP (IN in) (NP (DT the) (NN glomeruli))))))) (. .)))
17879217	0	(ROOT (S (NP (NNP Doc_17879217_0_10_Chemical-associated)) (VP (VBP segmental) (S (VP (VBG necrotizing) (NP (NNS Doc_17879217_44_62_Disease)) (PP (IN in) (NP (NNS Doc_17879217_66_93_Disease)))))) (. .)))
17879217	1	(ROOT (S (NP (JJ Segmental) (NN necrotising) (NNS Doc_17879217_117_135_Disease)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN as) (NP (NP (NN complication)) (PP (IN of) (NP (JJ Doc_17879217_173_183_Chemical) (NN therapy))))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN treatment)) (PP (IN for) (NP (NNS Doc_17879217_228_240_Disease)))))))))) (. .)))
17879217	2	(ROOT (S (NP (NP (JJ Changing) (NN epidemiology)) (PP (IN of) (NP (NP (NNS Doc_17879217_267_277_Disease)) (PP (JJ such) (IN as) (NP (NP (NNS Doc_17879217_286_308_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17879217_310_312_Disease)) (-RRB- -RRB-))))))) (VP (VBZ has) (VP (VBN led) (PP (TO to) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS Doc_17879217_351_361_Chemical)) (PP (IN for) (NP (NNS Doc_17879217_366_391_Disease))))))))))) (. .)))
17879217	3	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (DT a) (NN patient)))) (PP (IN with) (NP (NP (NNP Staphylococcal) (NNP Doc_17879217_445_447_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (S (NP (NNS Doc_17879217_462_481_Disease)) (ADJP (JJ secondary) (PP (TO to) (NP (DT a) (JJ segmental) (JJ necrotising) (NNS Doc_17879217_519_537_Disease)))) (SBAR (IN while) (S (S (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_17879217_563_573_Chemical)))))) (, ,) (CC and) (S (VP (VB review) (NP (NP (DT the) (NN literature)) (PP (VBG regarding) (NP (NP (DT this) (NN complication)) (PP (IN of) (NP (JJ Doc_17879217_632_642_Chemical) (NN therapy))))))))))))))))) (. .)))
17954033	0	(ROOT (S (NP (NP (NNP Rate)) (PP (IN of) (NP (JJ YMDD) (NN motif)))) (VP (VBZ mutants) (PP (IN in) (NP (NP (JJ Doc_17954033_30_40_Chemical-untreated) (JJ Iranian) (NNS patients)) (PP (IN with) (NP (JJ chronic) (NNS Doc_17954033_81_108_Disease)))))) (. .)))
17954033	1	(ROOT (S (NP (NNP Doc_17954033_122_132_Chemical)) (VP (VBZ is) (VP (VBN used) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ chronic) (JJ Doc_17954033_170_181_Disease) (NNS patients))))))) (. .)))
17954033	2	(ROOT (S (NP (JJ Recent) (NNS studies)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ YMDD) (NN motif) (NNS mutants)) (PRN (-LRB- -LRB-) (NP (JJ resistant) (JJ Doc_17954033_251_262_Disease) (NN virus)) (-RRB- -RRB-))) (VP (VBP occur) (PP (IN as) (NP (NP (JJ natural) (NN genome) (NN variability)) (PP (IN in) (NP (CD Doc_17954033_309_319_Chemical-untreated) (JJ chronic) (JJ Doc_17954033_338_349_Disease) (NNS patients))))))))) (. .)))
17954033	3	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (NP (PRP we)) (VP (VBD aimed) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (JJ YMDD) (NN motif) (NNS mutants)))) (PP (IN in) (NP (NP (JJ Doc_17954033_430_440_Chemical-untreated) (JJ chronic) (JJ Doc_17954033_459_470_Disease) (NNS patients)) (PP (IN in) (NP (NNP Iran))))))))) (. .)))
17954033	4	(ROOT (FRAG (NP (NNS PATIENTS) (CC AND) (NNS METHODS)) (: :) (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (CD 77) (JJ chronic) (JJ Doc_17954033_533_544_Disease) (NNS patients))) (SBAR (WHNP (WP who)) (S (VP (VBD had) (RB not) (VP (VBN been) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_17954033_584_594_Chemical))))))))) (VP (VBD were) (VP (VBN included) (PP (IN in) (NP (DT the) (NN study)))))) (. .)))
17954033	5	(ROOT (S (NP (NP (JJ Serum) (NNS samples)) (PP (IN from) (NP (NNS patients)))) (VP (VBD were) (VP (VBN tested) (PP (IN by) (NP (NP (NP (NN polymerase) (NN chain) (NN reaction-restriction) (NN fragment) (NN length) (NN polymorphism)) (PRN (-LRB- -LRB-) (NP (NNP PCR-RFLP)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (NN detection)) (PP (IN of) (NP (JJ YMDD) (NN motif) (NNS mutants))))))))) (. .)))
17954033	6	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD were) (ADVP (RB also)) (VP (VBN tested) (PP (IN for) (NP (NP (NN liver) (NNS enzymes)) (, ,) (NP (NNP anti-HCV)) (, ,) (NP (NNS Doc_17954033_840_845_Chemical)) (, ,) (CC and) (NP (NN anti-HBe)))))) (. .)))
17954033	7	(ROOT (S (PP (IN Of) (NP (NP (DT the) (CD 77) (NNS patients)) (VP (VBN enrolled) (PP (IN in) (NP (DT the) (NN study)))))) (, ,) (S (NP (CD 73) (NN %)) (VP (VBD were) (ADJP (JJ male)))) (CC and) (S (NP (CD 27) (NN %)) (VP (VBD were) (ADJP (JJ female)))) (. .)))
17954033	8	(ROOT (S (NP (NNP Mean) (NNP ALT) (CC and) (NNP AST) (NNS levels)) (VP (VBD were) (NP (NP (NP (CD 124.4) (NNS +)) (PRN (: /) (NP (NP (CD -73.4)) (CC and) (NP (CD 103.1) (NNS +))) (: /)) (NP (NNP -81) (NNP IU/l))) (, ,) (ADVP (RB respectively)))) (. .)))
17954033	9	(ROOT (S (NP (NNP Doc_17954033_1024_1029_Chemical)) (VP (VBD was) (ADJP (JJ positive) (PP (IN in) (NP (NP (CD 40) (NN %)) (CC and) (NP (NN anti-HBe))))) (PP (IN in) (NP (NP (CD 60) (NN %)) (PP (IN of) (NP (DT the) (NNS patients)))))) (. .)))
17954033	10	(ROOT (S (NP (NNP Anti-HCV)) (VP (VBD was) (ADJP (JJ negative) (PP (IN in) (NP (NP (DT all)) (PP (IN of) (NP (PRP them))))))) (. .)))
17954033	11	(ROOT (S (NP (NNP YMDD) (NN motif) (NNS mutants)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NNS patients))))) (PP (IN despite) (NP (NP (NP (DT the) (NN liver)) (NP (JJ enzyme) (NNS levels))) (CC and) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_17954033_1237_1242_Chemical) (CC or) (NN anti-HBe)))))))) (. .)))
17954033	12	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT the) (JJ natural) (NN occurrence)) (PP (IN of) (NP (NP (JJ YMDD) (NN motif) (NNS mutants)) (PP (IN in) (NP (NP (NN Doc_17954033_1325_1335_Chemical-untreated) (NNS patients)) (PP (IN with) (NP (JJ chronic) (NNS Doc_17954033_1368_1379_Disease)))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported)))))) (, ,) (NP (DT these) (NNS mutants)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (JJ Iranian) (NN Doc_17954033_1442_1452_Chemical-untreated) (NN chronic) (JJ Doc_17954033_1471_1482_Disease) (NNS patients))))) (. .)))
18025637	0	(ROOT (S (VP (VB Doc_18025637_0_29_Disease) (CC and) (VB Doc_18025637_34_44_Chemical)) (. .)))
18025637	1	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (NNS Doc_18025637_56_85_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_18025637_102_112_Chemical-induced) (JJ secondary) (NNS Doc_18025637_131_143_Disease))))))) (VP (VBZ is) (VP (VBN described))) (. .)))
18025637	2	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT an) (ADJP (JJ infrequent)) (NN complication)) (PP (IN of) (NP (JJ selective) (NNS Doc_18025637_207_216_Chemical)))) (VP (VBP reuptake) (NP (NN inhibitor) (NN therapy))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ important)) (SBAR (IN that) (S (NP (NNS ophthalmologists)) (VP (VBP are) (ADJP (JJ aware) (SBAR (IN that) (S (NP (DT these) (NNS agents)) (VP (MD can) (VP (VB cause) (NP (NNS Doc_18025637_321_333_Disease)) (SBAR (IN because) (S (NP (NP (DT this) (NN class)) (PP (IN of) (NP (NNS drugs)))) (VP (VBZ is) (ADVP (RB widely)) (VP (VBN prescribed)))))))))))))) (. .)))
18165598	0	(ROOT (NP (NP (DT The) (NN differential) (NNS effects)) (PP (IN of) (NP (NNS Doc_18165598_28_39_Chemical) (CC and) (NNS Doc_18165598_44_53_Chemical))) (PP (IN on) (NP (NP (JJ Doc_18165598_57_73_Chemical) (NN release)) (, ,) (NP (JJ cyclooxygenase) (NN gene) (NN expression)) (CC and) (NP (NNS Doc_18165598_118_122_Disease)))) (PP (IN in) (NP (DT a) (JJ clinical) (JJ Doc_18165598_137_141_Disease) (NN model))) (. .)))
18165598	1	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (S (VP (VBG blocking) (NP (JJ nociceptive) (NN input)) (PP (IN from) (NP (JJ surgical) (NNS sites)))))))) (, ,) (NP (JJ long-acting) (JJ local) (NNS anesthetics)) (VP (MD might) (ADVP (RB directly)) (VP (VB modulate) (NP (NNS Doc_18165598_278_290_Disease)))) (. .)))
18165598	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBP describe) (NP (NP (DT the) (NAC (NP (JJ proinflammatory) (NNS effects)) (PP (IN of) (NP (NNS Doc_18165598_357_368_Chemical))) (PP (IN on) (NP (NP (JJ local) (NNS Doc_18165598_378_394_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18165598_396_400_Chemical)) (-RRB- -RRB-))))) (NN production) (CC and) (JJ cyclooxygenase) (PRN (-LRB- -LRB-) (NP (NNP COX)) (-RRB- -RRB-)) (NN gene) (NN expression)) (SBAR (WHNP (WDT that)) (S (VP (VBZ increases) (NP (NP (NNS Doc_18165598_469_487_Disease)) (PP (IN in) (NP (JJ human) (NNS subjects))))))))) (. .)))
18165598	3	(ROOT (S (NP (NP (NP (NNS Subjects)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 114))))) (-RRB- -RRB-))) (VP (VBG undergoing) (NP (NP (NN extraction)) (PP (IN of) (NP (JJ impacted) (JJ third) (NNS molars))) (UCP (VP (VBN received) (NP (NP (DT either) (ADJP (CD 2) (NN %)) (NNS Doc_18165598_601_610_Chemical)) (CC or) (NP (ADJP (CD 0.5) (NN %)) (NNS Doc_18165598_619_630_Chemical))) (PP (IN before) (NP (NN surgery)))) (CC and) (RB either) (NP (NP (QP (CD Doc_18165598_657_666_Chemical) (CD 50)) (NN mg)) (CC or) (NP (JJ placebo) (JJ orally) (UCP (NP (NP (CD 90) (NN min)) (PP (IN before) (NP (NN surgery)))) (CC and) (PP (IN for) (NP (DT the) (JJ following) (CD 48) (NNS h.)))) (JJ Oral) (NN mucosal) (NNS biopsies))))))) (VP (VBD were) (VP (VBN taken) (PP (IN before) (NP (NP (NN surgery)) (CC and) (NP (CD 48) (NN h)))) (PP (IN after) (NP (NN surgery))))) (. .)))
18165598	4	(ROOT (S (PP (IN After) (NP (NN extraction))) (, ,) (NP (DT a) (NNS microdialysis) (NN probe)) (VP (VBD was) (VP (VBN placed) (PP (IN at) (NP (NP (DT the) (JJ surgical) (NN site)) (PP (IN for) (NP (ADJP (JJ Doc_18165598_889_893_Chemical) (CC and) (JJ Doc_18165598_898_912_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18165598_914_918_Chemical)) (-RRB- -RRB-)) (NNS measurements))))))) (. .)))
18165598	5	(ROOT (FRAG (NP (DT The) (NNS Doc_18165598_947_958_Chemical)) (: /) (S (NP (JJ Doc_18165598_959_968_Chemical) (NN group)) (VP (VBD reported) (ADJP (RB significantly) (JJ Doc_18165598_998_1007_Disease)) (, ,) (SBAR (IN as) (S (S (S (VP (VBN assessed) (PP (IN by) (NP (DT a) (JJ visual) (JJ analog) (NN scale))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (DT the) (JJ other) (CD three) (NN treatment) (NNS groups)) (PP (IN over) (NP (DT the) (JJ first) (CD 4) (NNS h.)))) (ADVP (RB However)))))) (, ,) (NP (DT the) (JJ Doc_18165598_1127_1138_Chemical) (JJ /) (NN placebo) (NN group)) (VP (VBD reported) (NP (ADJP (RB significantly) (JJR more)) (NNS Doc_18165598_1181_1185_Disease)) (PP (IN at) (NP (CD 24) (NN h))))) (CC and) (S (NP (NP (JJ Doc_18165598_1198_1202_Chemical) (NNS levels)) (PP (IN during) (NP (DT the) (JJ first) (CD 4) (NNS h)))) (VP (VBD were) (ADJP (RB significantly) (JJR higher)) (PP (IN than) (NP (DT the) (JJ other) (CD three) (NN treatment) (NNS groups))))))))) (. .)))
18165598	6	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NNS Doc_18165598_1306_1317_Chemical)) (ADVP (RB significantly)) (VP (VBD increased) (NP (NN COX-2) (NN gene) (NN expression)) (PP (IN at) (ADVP (NP (CD 48) (NN h)) (RB as))) (PP (VBN compared) (PP (IN with) (NP (DT the) (JJ Doc_18165598_1393_1402_Chemical) (JJ /) (NN placebo) (NN group))))) (. .)))
18165598	7	(ROOT (S (NP (JJ Doc_18165598_1418_1429_Chemical) (NNS levels)) (VP (VBD were) (RB not) (ADJP (RB significantly) (JJ affected) (PP (IN by) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NNS treatments)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (NNS effects)) (VP (VBN seen))) (VP (VBD were) (ADJP (ADJP (JJ attributable) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN COX-2)))))) (, ,) (CC but) (ADJP (RB not) (JJ COX-1))))))))) (. .)))
18165598	8	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_18165598_1625_1636_Chemical)) (VP (VBZ stimulates) (NP (NN COX-2) (NN gene) (NN expression)) (PP (IN after) (NP (NP (NNS Doc_18165598_1676_1689_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJR higher) (JJ Doc_18165598_1723_1727_Chemical) (NN production)) (CC and) (NP (NNS Doc_18165598_1743_1747_Disease)))) (PP (IN after) (NP (DT the) (JJ local) (JJ anesthetic) (NN effect) (NNS dissipates))))))))))))) (. .)))
18189308	0	(ROOT (S (NP (NP (JJ p75NTR) (NN expression)) (PP (IN in) (NP (NN rat)))) (ADVP (RB urinary)) (VP (VBD bladder) (NP (NP (JJ sensory) (NNS neurons)) (CC and) (NP (JJ spinal) (NN cord))) (PP (IN with) (NP (NN Doc_18189308_78_94_Chemical-induced) (NNS Doc_18189308_103_111_Disease)))) (. .)))
18189308	1	(ROOT (S (NP (NP (DT A) (NN role)) (PP (IN for) (NP (NN nerve) (NN growth) (NN factor))) (PRN (-LRB- -LRB-) (NP (NNP NGF)) (-RRB- -RRB-)) (PP (IN in) (S (VP (VBG contributing) (PP (TO to) (NP (NP (VBN increased) (VBG voiding) (NN frequency) (CC and) (VBN altered) (NNS sensation)) (PP (IN from) (NP (DT the) (JJ urinary) (NN bladder))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested)))) (. .)))
18189308	2	(ROOT (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (NN expression) (CC and) (NN regulation)) (PP (IN of) (NP (NP (JJ Doc_18189308_328_336_Chemical) (NN kinase) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NNP Trks)) (-RRB- -RRB-))))) (PP (IN in) (NP (NN micturition) (NNS reflexes))) (PP (IN with) (NP (NNS Doc_18189308_390_418_Disease))))) (. .)))
18189308	3	(ROOT (S (NP (DT The) (JJ present) (NNS studies)) (VP (VBP examine) (NP (NP (DT the) (NN expression) (CC and) (NN regulation)) (PP (IN of) (NP (NP (DT another) (NN receptor)) (VP (VBN known) (PP (TO to) (NP (NP (NNP bind) (NNP NGF)) (, ,) (NP (NP (NNS p75)) (PRN (-LRB- -LRB-) (NP (NNP NTR)) (-RRB- -RRB-))) (, ,))) (PP (IN after) (NP (NP (JJ various) (NNS durations)) (PP (IN of) (NP (NP (NNS Doc_18189308_554_574_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_18189308_586_602_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18189308_604_607_Chemical)) (-RRB- -RRB-)))))))))))))) (. .)))
18189308	4	(ROOT (S (NP (JJ Doc_18189308_610_613_Chemical-induced) (NNS Doc_18189308_622_630_Disease)) (VP (VBD increased) (NP (NP (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <)) (CC or) (NP (NNP =) (CD 0.001))) (-RRB- -RRB-)) (NNS p75)) (PRN (-LRB- -LRB-) (NP (NNP NTR)) (-RRB- -RRB-))) (NP (NP (NN expression)) (PP (IN in) (NP (NP (DT the) (JJ superficial) (ADJP (JJ lateral) (CC and) (JJ medial)) (NN dorsal) (NN horn)) (PP (IN in) (NP (ADJP (JJ L1-L2) (CC and) (JJ L6-S1)) (JJ spinal) (NNS segments))))))) (. .)))
18189308	5	(ROOT (NP (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NP (NNS p75)) (PRN (-LRB- -LRB-) (NP (NNP NTR)) (-RRB- -RRB-))))) (: -) (NP (NP (NN immunoreactive)) (PRN (-LRB- -LRB-) (NP (NNP -) (NNP IR)) (-RRB- -RRB-)) (SBAR (S (NP (NP (NNS cells)) (PP (IN in) (NP (NP (DT the) (ADJP (JJ lumbosacral) (JJ dorsal)) (NN root) (NN ganglia)) (PRN (-LRB- -LRB-) (NP (NNP DRG)) (-RRB- -RRB-))))) (ADVP (RB also)) (VP (VBN increased) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <)) (CC or) (NP (NNP =) (CD 0.05))) (-RRB- -RRB-)) (PP (IN with) (NP (NP (NN Doc_18189308_895_898_Chemical-induced) (NNS Doc_18189308_907_915_Disease)) (PRN (-LRB- -LRB-) (NP (NP (JJ acute)) (, ,) (NP (JJ intermediate)) (, ,) (CC and) (NP (NN chronic))) (-RRB- -RRB-)))))))) (. .)))
18189308	6	(ROOT (S (ADVP (RB Quantitative)) (, ,) (NP (JJ real-time) (NN polymerase) (NN chain) (NN reaction)) (ADVP (RB also)) (VP (VBD demonstrated) (NP (NP (JJ significant) (NNS increases)) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <)) (CC or) (NP (NNP =) (CD 0.01))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (JJ p75) (PRN (-LRB- -LRB-) (NP (NNP NTR)) (-RRB- -RRB-)) (NN mRNA)) (PP (IN in) (NP (NNP DRG))))) (PP (IN with) (NP (JJ intermediate) (CC and) (JJ chronic) (NN Doc_18189308_1112_1115_Chemical-induced) (NNS Doc_18189308_1124_1132_Disease)))) (. .)))
18189308	7	(ROOT (S (NP (NP (JJ Retrograde) (JJ dye-tracing) (NNS techniques)) (PP (IN with) (NP (NNP Fastblue)))) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB identify) (NP (JJ presumptive) (NN bladder) (NN afferent) (NNS cells)) (PP (IN in) (NP (DT the) (JJ lumbosacral) (NN DRG)))))))) (. .)))
18189308	8	(ROOT (S (PP (IN In) (NP (NP (NP (NN bladder) (NN afferent) (NNS cells)) (PP (IN in) (NP (NNP DRG)))) (, ,) (NP (NP (NNS p75)) (PRN (-LRB- -LRB-) (NP (NNP NTR)) (-RRB- -RRB-))) (: -))) (NP (NNP IR)) (VP (VBD was) (ADVP (RB also)) (VP (VBN increased) (S (VP (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <)) (CC or) (NP (NNP =) (CD 0.01))) (-RRB- -RRB-)) (PP (IN with) (NP (NNS Doc_18189308_1349_1357_Disease))))))) (. .)))
18189308	9	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NP (NNS p75)) (PRN (-LRB- -LRB-) (NP (NNP NTR)) (-RRB- -RRB-))) (: -) (NP (NP (NNP IR)) (PP (IN in) (NP (NNP DRG) (NN cell) (NNS bodies)))))))))) (, ,) (NP (NP (NP (NNS increases)) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <)) (CC or) (NP (NNP =) (CD 0.001))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NP (JJ pericellular) (PRN (-LRB- -LRB-) (NP (CD encircling) (NNP DRG) (NNS cells)) (-RRB- -RRB-)) (NN p75)) (PRN (-LRB- -LRB-) (NP (NNP NTR)) (-RRB- -RRB-))) (: -) (NP (NP (NNP IR)) (PP (IN in) (NP (NNP DRG))))))) (ADVP (RB also)) (VP (VBD increased)) (. .)))
18189308	10	(ROOT (S (NP (JJ Confocal) (NNS analyses)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN pericellular) (NNS p75)) (PRN (-LRB- -LRB-) (NP (NNP NTR)) (-RRB- -RRB-))) (: -) (NP (NNP IR)) (VP (VBD was) (RB not) (VP (VBN colocalized) (PP (IN with) (NP (NP (DT the) (JJ glial) (NN marker)) (, ,) (NP (NP (JJ glial) (JJ fibrillary) (JJ acidic) (NN protein)) (PRN (-LRB- -LRB-) (NP (NNP GFAP)) (-RRB- -RRB-)))))))))) (. .)))
18189308	11	(ROOT (S (NP (DT These) (NNS studies)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (JJ p75) (PRN (-LRB- -LRB-) (NP (NNP NTR)) (-RRB- -RRB-)) (NN expression)) (PP (IN in) (NP (NN micturition) (NNS reflexes)))) (VP (VBZ is) (UCP (ADJP (JJ present) (RB constitutively)) (CC and) (VP (VBN modified) (PP (IN by) (NP (NNS Doc_18189308_1781_1801_Disease))))))))) (. .)))
18189308	12	(ROOT (S (NP (NP (DT The) (ADJP (JJ functional)) (NN significance)) (PP (IN of) (NP (NP (JJ p75) (PRN (-LRB- -LRB-) (NP (NNP NTR)) (-RRB- -RRB-)) (NN expression)) (PP (IN in) (NP (NN micturition) (NNS reflexes)))))) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN determined)))))) (. .)))
18340638	0	(ROOT (S (NP (NNP Doc_18340638_0_12_Chemical-induced)) (VP (VBP suicidal) (NP (JJ erythrocyte) (NN death))) (. .)))
18340638	1	(ROOT (S (NP (NNP Doc_18340638_61_73_Chemical)) (VP (VBZ is) (ADVP (RB widely)) (VP (VBN used) (PP (IN as) (NP (DT an) (JJ immunosuppressive) (NN drug))))) (. .)))
18340638	2	(ROOT (S (NP (NP (DT The) (NN side) (NNS effects)) (PP (IN of) (NP (NNS Doc_18340638_139_151_Chemical)))) (VP (VBP include) (NP (NP (NNS Doc_18340638_160_166_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (NNS Doc_18340638_197_220_Disease)))))))))) (. .)))
18340638	3	(ROOT (S (ADVP (RB Alternatively)) (, ,) (NP (NNS Doc_18340638_237_243_Disease)) (VP (MD could) (VP (VB result) (PP (IN from) (NP (NP (VBN accelerated) (JJ suicidal) (NN erythrocyte) (NN death)) (CC or) (NP (NP (NNS eryptosis)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (NN exposure)) (PP (IN of) (NP (NP (NNS Doc_18340638_353_371_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP PS)) (-RRB- -RRB-)))))) (PP (PP (IN at) (NP (DT the) (JJ erythrocyte) (NN surface))) (CC and) (PP (IN by) (NP (NN cell) (NN shrinkage))))))))))))) (. .)))
18340638	4	(ROOT (S (NP (DT The) (JJ present) (NNS experiments)) (VP (VBD explored) (SBAR (IN whether) (S (NP (JJ Doc_18340638_477_489_Chemical) (NNS influences)) (VP (VBZ eryptosis))))) (. .)))
18340638	5	(ROOT (S (PP (VBG According) (PP (TO to) (NP (NN annexin) (NNP V) (NNP binding)))) (, ,) (NP (NP (NNS erythrocytes)) (PP (IN from) (NP (NNS patients)))) (ADVP (RB indeed)) (VP (VBD showed) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN of) (NP (NNP PS) (NN exposure)))) (PP (IN within) (NP (NP (CD 1) (NN week)) (PP (IN of) (NP (NN treatment))))) (PP (IN with) (NP (NNS Doc_18340638_655_667_Chemical)))) (. .)))
18340638	6	(ROOT (S (PP (IN In) (NP (DT a) (JJ second) (NN series))) (, ,) (NP (NP (NP (NP (JJ cytosolic) (JJ Doc_18340638_699_703_Chemical) (NN activity)) (PRN (-LRB- -LRB-) (NP (JJ Doc_18340638_714_719_Chemical) (NN fluorescence)) (-RRB- -RRB-))) (, ,) (NP (NP (NN cell) (NN volume)) (PRN (-LRB- -LRB-) (NP (RB forward) (NN scatter)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NNP PS-exposure))) (PRN (-LRB- -LRB-) (VP (VBN annexin) (S (NP (NNP V)) (ADJP (JJ binding)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN determined) (PP (IN by) (NP (NNP FACS) (NN analysis))) (PP (IN in) (NP (NP (NNS erythrocytes)) (PP (IN from) (NP (JJ healthy) (NNS volunteers))))))) (. .)))
18340638	7	(ROOT (S (NP (NP (NNP Exposure)) (PP (TO to) (NP (NP (NP (NNS Doc_18340638_897_909_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD >) (CC or) (CD =) (CD 2) (CD microg/mL))) (-RRB- -RRB-))) (PP (IN for) (NP (CD 48) (NNS hours)))))) (VP (VP (VBD increased) (S (NP (JJ cytosolic) (JJ Doc_18340638_963_967_Chemical) (NN activity) (CC and) (NN annexin) (NNS V)) (ADJP (JJ binding)))) (CC and) (VP (VBD decreased) (PRT (RP forward)) (NP (NN scatter)))) (. .)))
18340638	8	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_18340638_1044_1056_Chemical)) (PP (IN on) (NP (DT both) (JJ annexin) (NNP V) (JJ binding) (CC and) (JJ forward) (NN scatter)))))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN blunted) (PP (IN in) (NP (NP (DT the) (JJ nominal) (NN absence)) (PP (IN of) (NP (NN extracellular) (NNS Doc_18340638_1169_1173_Chemical))))))) (. .)))
18340638	9	(ROOT (SINV (ADJP (JJ Doc_18340638_1188_1200_Chemical)) (VP (VBZ triggers)) (NP (NP (JJ suicidal) (NN erythrocyte) (NN death)) (, ,) (NP (NP (DT an) (NN effect)) (VP (ADVP (RB presumably)) (VBG contributing) (PP (TO to) (NP (NN Doc_18340638_1275_1287_Chemical-induced) (NNS Doc_18340638_1296_1302_Disease)))))) (. .)))
18341442	0	(ROOT (S (VP (VB Doc_18341442_0_13_Chemical) (ADVP (RB as) (NP (DT an) (NN adjunct)) (PP (TO to) (NP (JJ Doc_18341442_31_44_Chemical) (NN treatment)))) (PP (IN in) (NP (NP (NNS cats)) (PP (IN with) (NP (VBN suspected) (NNS Doc_18341442_78_97_Disease)))))) (. .)))
18341442	1	(ROOT (S (S (VP (TO To) (VP (VB assess) (NP (NP (NN pharmacokinetics) (, ,) (NN efficacy) (, ,) (CC and) (NN tolerability)) (PP (IN of) (NP (JJ oral) (NNS Doc_18341442_173_186_Chemical))))))) (VP (VBN administered) (PP (IN as) (NP (NP (DT an) (NN adjunct)) (PP (TO to) (NP (JJ Doc_18341442_217_230_Chemical) (NN treatment))))) (PP (IN in) (NP (NP (NNS cats)) (PP (IN with) (NP (ADJP (RB poorly) (JJ controlled)) (VBN suspected) (NNS Doc_18341442_282_301_Disease)))))) (. .)))
18341442	2	(ROOT (S (NP (NNP DESIGN-Open-label)) (, ,) (VP (VB noncomparative) (NP (JJ clinical) (NN trial))) (. .)))
18341442	3	(ROOT (S (NP (CD 12) (NNS cats)) (VP (VBD suspected) (S (VP (TO to) (VP (VB have) (NP (NNS Doc_18341442_388_407_Disease)) (SBAR (SBAR (WHNP (WDT that)) (S (VP (VBD was) (ADVP (RB poorly)) (VP (VBN controlled) (PP (IN with) (NP (NNS Doc_18341442_440_453_Chemical))))))) (CC or) (SBAR (WHNP (WDT that)) (S (VP (VBD had) (NP (ADJP (JJ unacceptable) (JJ adverse)) (NNS effects))))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN treated) (PP (IN with) (NP (NNS Doc_18341442_513_526_Chemical))))))) (. .)))
18341442	4	(ROOT (S (NP (NNS Cats)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_18341442_563_576_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (JJ mg/kg) (NNP -LSB-) (NNP 9.1) (NN mg/lb) (NNS -RSB-)) (, ,) (NP (NNP PO)) (, ,) (NP (NN q) (CD 8) (NN h))) (-RRB- -RRB-)))))) (. .)))
18341442	5	(ROOT (S (PP (IN After) (NP (NP (DT a) (NN minimum)) (PP (IN of) (NP (NP (CD 1) (NN week)) (PP (IN of) (NP (NN treatment))))))) (, ,) (S (NP (JJ serum) (JJ Doc_18341442_658_671_Chemical) (NNS concentrations)) (VP (VBD were) (VP (VBN measured) (PP (PP (IN before) (NP (NNP and) (CD 2) (, ,) (CD 4) (, ,))) (CC and) (PP (NP (CD 6) (NNS hours)) (IN after) (NP (NN drug) (NN administration))))))) (, ,) (CC and) (S (NP (NP (JJ maximum) (CC and) (JJ minimum) (NN serum) (NNS concentrations)) (CC and) (NP (NN elimination) (NN half-life))) (VP (VBD were) (VP (VBN calculated)))) (. .)))
18341442	6	(ROOT (S (S (NP (NNP Doc_18341442_845_852_Disease)) (VP (VBZ frequencies) (SBAR (IN before) (CC and) (RB after) (S (NP (NP (NN initiation)) (PP (IN of) (NP (JJ Doc_18341442_896_909_Chemical) (NN treatment)))) (VP (VBD were) (VP (VBN compared))))))) (, ,) (CC and) (S (NP (JJ adverse) (NNS effects)) (VP (VBD were) (VP (VBN recorded)))) (. .)))
18341442	7	(ROOT (S (S (NP (JJ Median) (JJ maximum) (NN serum) (NNS Doc_18341442_1000_1013_Chemical)) (ADVP (RB concentration)) (VP (VBD was) (NP (NP (CD 25.5) (JJ microg/mL) (, ,) (JJ median) (NN minimum) (NN serum) (NNS Doc_18341442_1069_1082_Chemical)) (SBAR (S (NP (NN concentration)) (VP (VBD was) (NP (CD 8.3) (NN microg/mL)))))))) (, ,) (CC and) (S (NP (JJ median) (NN elimination) (NN half-life)) (VP (VBD was) (NP (CD 2.9) (NNS hours)))) (. .)))
18341442	8	(ROOT (S (S (NP (JJ Median) (JJ Doc_18341442_1171_1178_Disease) (NN frequency)) (ADVP (RB prior) (PP (TO to) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (NNS Doc_18341442_1213_1226_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 2.1) (CD Doc_18341442_1232_1240_Disease)) (NN /) (NN mo)) (-RRB- -RRB-))))))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN than) (NP (JJ median) (JJ Doc_18341442_1282_1289_Disease) (NN frequency)))) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (JJ Doc_18341442_1320_1333_Chemical) (NN treatment)) (PRN (-LRB- -LRB-) (NP (CD 0.42) (NNP Doc_18341442_1350_1358_Disease) (NN /) (NNS mo)) (-RRB- -RRB-)))))))) (, ,) (CC and) (S (NP (NP (CD 7)) (PP (IN of) (NP (CD 10) (NNS cats)))) (VP (VBD were) (VP (VBN classified) (PP (IN as) (S (VP (VBG having) (VP (VBN responded) (PP (TO to) (NP (JJ Doc_18341442_1420_1433_Chemical) (NN treatment))) (PRN (-LRB- -LRB-) (NP (NP (NN ie)) (, ,) (NP (NN reduction))) (PP (IN in) (NP (NP (JJ Doc_18341442_1462_1469_Disease) (NN frequency)) (PP (IN of) (NP (QP (CD >) (CC or) (CD =) (CD 50)) (NN %))))) (-RRB- -RRB-))))))))) (. .)))
18341442	9	(ROOT (S (NP (CD Two) (NNS cats)) (VP (VBD had) (NP (JJ transient) (NN lethargy) (CC and) (NN inappetence))) (. .)))
18341442	10	(ROOT (NP (NP (NNP CONCLUSIONS) (CC AND) (NNP CLINICAL) (NNP RELEVANCE)) (: :) (S (NP (NNS Results)) (VP (VP (VBD suggested) (SBAR (IN that) (S (NP (NNS Doc_18341442_1601_1614_Chemical)) (VP (VBZ is) (ADVP (RB well)) (VP (VBN tolerated) (PP (IN in) (NP (NNS cats)))))))) (CC and) (VP (MD may) (VP (VB be) (ADJP (JJ useful) (PP (IN as) (NP (DT an) (NN adjunct)))) (PP (TO to) (NP (NP (JJ Doc_18341442_1676_1689_Chemical) (NN treatment)) (PP (IN in) (NP (NP (NNS cats)) (PP (IN with) (NP (NNS Doc_18341442_1713_1732_Disease))))))))))) (. .)))
1837756	0	(ROOT (S (NP (NNP Doc_1837756_0_9_Chemical)) (VP (VBP reuptake) (NP (NP (NNS inhibitors)) (, ,) (NP (NNS Doc_1837756_31_39_Disease)) (, ,) (CC and) (NP (DT the) (JJ ventral) (JJ basal) (NN ganglia)))) (. .)))
1837756	1	(ROOT (S (NP (NNS Antidepressants)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (JJ paranoid) (NNS reactions)) (PP (IN in) (NP (JJ Doc_1837756_147_158_Disease) (NNS patients)))))))) (. .)))
1837756	2	(ROOT (S (NP (NP (CD Five) (NNS cases)) (PP (IN of) (NP (NP (JJ paranoid) (NN exacerbation)) (PP (IN with) (NP (DT the) (JJ Doc_1837756_214_223_Chemical) (NN reuptake)))))) (VP (VBZ inhibitors) (SBAR (S (NP (NNS Doc_1837756_244_254_Chemical) (CC and) (NNS Doc_1837756_259_272_Chemical)) (VP (VBP are) (VP (VBN reported) (ADVP (RB here))))))) (. .)))
1837756	3	(ROOT (S (NP (NP (NNS Elements)) (ADJP (JJ common) (PP (TO to) (NP (DT these) (NNS cases))))) (VP (VBD included) (NP (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ paranoid) (NN symptomatology)))) (CC and) (NP (NP (DT the) (JJ concomitant) (NN occurrence)) (PP (IN of) (NP (NNS Doc_1837756_403_436_Disease)))))) (. .)))
1837756	4	(ROOT (S (NP (NP (JJ Complicated) (NNS Doc_1837756_450_470_Disease)) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (NP (NN atypicality)) (PP (IN of) (NP (NP (NN course) (CC and) (NN symptomatology)) (, ,) (NP (NN chronicity)) (, ,) (NP (NNS Doc_1837756_536_545_Disease)) (, ,) (NP (NNS Doc_1837756_547_557_Disease)) (, ,) (CC and) (NP (NP (JJ secondary) (NN onset)) (PP (IN in) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (DT a) (JJ primary) (NNS Doc_1837756_606_615_Disease)))))))))) (-RRB- -RRB-))) (VP (MD may) (VP (VB present) (NP (JJ particular) (NN vulnerability)) (PP (TO to) (NP (NP (JJ paranoid) (NNS exacerbations)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_1837756_696_705_Chemical) (NN reuptake) (NNS inhibitors)))))))) (. .)))
1837756	5	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT the) (NN pharmacology) (CC and) (NN neurobiology)) (PP (IN of) (NP (NNS Doc_1837756_773_781_Disease)))) (VP (VBP remain) (ADJP (JJ cryptic))))) (, ,) (NP (NP (JJ several) (NNS mechanisms)) (, ,) (PP (VBG including) (NP (NP (CD 5HT3) (JJ receptor-mediated) (JJ Doc_1837756_851_859_Chemical) (NN release)) (, ,) (NP (JJ beta-noradrenergic) (NN receptor) (NN downregulation)) (, ,) (CC or) (NP (NP (JJ GABAB) (NN receptor) (NN upregulation)) (VP (VBG acting) (PP (IN in) (NP (NP (DT the) (NN vicinity)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ ventral) (JJ basal)) (NN ganglia)) (PRN (-LRB- -LRB-) (PP (ADVP (RB possibly)) (IN in) (NP (JJ lateral) (NN orbitofrontal) (CC or) (NN anterior) (NN cingulate) (NNS circuits))) (-RRB- -RRB-)))))))))) (, ,)) (VP (MD might) (VP (VB apply) (PP (TO to) (NP (DT this) (NN phenomenon))))) (. .)))
1837756	6	(ROOT (S (NP (DT These) (NNS cases)) (VP (VP (VB call) (NP (NN attention)) (PP (TO to) (NP (JJ possible) (JJ paranoid) (NNS exacerbations))) (PP (IN with) (NP (NP (JJ Doc_1837756_1163_1172_Chemical) (NN reuptake) (NNS blockers)) (PP (IN in) (NP (JJ select) (NNS patients)))))) (CC and) (VP (VB raise) (NP (NP (JJ neurobiological) (NNS considerations)) (PP (VBG regarding) (NP (NNS Doc_1837756_1261_1269_Disease)))))) (. .)))
18399341	0	(ROOT (NP (NP (JJ Clinical) (NN comparison)) (PP (IN of) (NP (JJ cardiorespiratory) (NNS effects))) (PP (IN during) (NP (NP (JJ unilateral)) (CC and) (NP (JJ conventional) (JJ spinal) (NN anaesthesia)))) (. .)))
18399341	1	(ROOT (S (NP (NNP Spinal) (NNP anaesthesia)) (VP (VP (VBZ is) (ADVP (RB widely)) (VP (VBN employed) (PP (IN in) (NP (JJ clinical) (NN practice))))) (CC but) (VP (VBZ has) (NP (NP (DT the) (JJ main) (NN drawback)) (PP (IN of) (NP (JJ post-spinal) (NNS Doc_18399341_216_233_Disease)))))) (. .)))
18399341	2	(ROOT (S (NP (NNS Efforts)) (VP (MD must) (ADVP (RB therefore)) (VP (VB continue) (S (VP (TO to) (VP (VB be) (VP (VBN made) (S (VP (TO to) (VP (VB obviate) (NP (NP (DT this) (NN setback) (NN OBJECTIVE)) (: :) (S (VP (TO To) (VP (VB evaluate) (NP (DT the) (JJ cardiovascular) (CC and) (JJ respiratory) (NNS changes)) (PP (IN during) (NP (NP (JJ unilateral)) (CC and) (NP (JJ conventional) (JJ spinal) (NN anaesthesia))))))))))))))))) (. .)))
18399341	3	(ROOT (S (PP (IN With) (NP (JJ ethical) (NN approval))) (, ,) (NP (PRP we)) (VP (VBD studied) (NP (NP (NP (CD 74) (NNP American) (NNP Society)) (PP (IN of) (NP (NP (NNP Anesthesiologists)) (PRN (-LRB- -LRB-) (NP (NNP ASA)) (-RRB- -RRB-))))) (, ,) (NP (NP (JJ physical) (NN status) (NN class)) (NP (CD 1))) (CC and) (NP (ADJP (NP (CD 2) (NNS patients)) (VBN scheduled) (PP (IN for) (NP (JJ elective) (JJ unilateral) (JJR lower) (NN limb)))) (NN surgery)))) (. .)))
18399341	4	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN allocated) (PP (IN into) (NP (NP (CD one)) (PP (IN of) (NP (NP (CD two) (NNS groups)) (: :) (NP (ADJP (JJ lateral) (CC and) (JJ conventional)) (JJ spinal) (NN anaesthesia) (NNS groups)))))))) (. .)))
18399341	5	(ROOT (S (PP (IN In) (NP (NP (DT the) (JJ lateral) (NN position)) (PP (IN with) (NP (JJ operative) (NN side) (RP down))))) (, ,) (NP (NNS patients)) (VP (VBD recived) (NP (NP (CD 10) (NN mg) (PRN (-LRB- -LRB-) (NP (NNP 2mls)) (-RRB- -RRB-))) (PP (IN of) (NP (ADJP (CD 0.5) (NN %)) (JJ hyperbaric) (NNS Doc_18399341_815_826_Chemical)))) (PP (IN through) (NP (DT a) (JJ 25-gauge) (JJ spinal) (NN needle)))) (. .)))
18399341	6	(ROOT (S (NP (NP (NNS Patients)) (PP (IN in) (NP (DT the) (JJ unilateral) (NN group)))) (VP (VBD were) (VP (VBN maintained) (PP (IN in) (NP (NP (DT the) (JJ lateral) (NN position)) (PP (IN for) (NP (NP (CD 15) (NNS minutes)) (PP (VBG following) (NP (NP (JJ spinal) (NN injection)) (SBAR (IN while) (S (NP (NP (DT those)) (PP (IN in) (NP (DT the) (JJ conventional) (NN group)))) (VP (VBD were) (VP (VBN turned) (S (VP (VB supine) (ADVP (RB immediately)) (PP (IN after) (NP (NN injection))))))))))))))))) (. .)))
18399341	7	(ROOT (S (NP (NP (NN Blood) (NN pressure)) (, ,) (NP (NN heart) (NN rate)) (, ,) (NP (JJ respiratory) (NN rate)) (CC and) (NP (JJ Doc_18399341_1111_1117_Chemical) (NN saturation))) (VP (VBD were) (VP (VBN monitored) (PP (IN over) (NP (CD 1) (NN hour))))) (. .)))
18399341	8	(ROOT (S (NP (NP (NP (CD Three) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 8.1) (NN %)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (JJ unilateral) (NN group)) (CC and) (NP (NP (NP (CD 5)) (PRN (-LRB- -LRB-) (NP (CD 13.5) (NN %)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (JJ conventional) (NN group))))))) (VP (VBD developed) (S (NP (NNP Doc_18399341_1262_1273_Disease) (, ,) (NNP P)) (VP (SYM =) (NP (CD 0.71))))) (. .)))
18399341	9	(ROOT (S (NP (NP (CD Four)) (PRN (-LRB- -LRB-) (NP (QP (CD 10.8) (NN %))) (-RRB- -RRB-)) (NNS patients)) (PP (IN in) (NP (NP (DT the) (JJ conventional) (NN group)) (CC and) (NP (NP (NP (CD 1)) (PRN (-LRB- -LRB-) (NP (CD 2.7) (NN %)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (JJ unilateral) (NN group)))))) (, ,) (NP (NNP P) (NNP =) (NNP 0.17)) (VP (VBD required) (NP (JJ Doc_18399341_1387_1398_Chemical) (NN infusion)) (S (VP (TO to) (VP (VB treat) (NP (NNS Doc_18399341_1417_1428_Disease)))))) (. .)))
18399341	10	(ROOT (S (NP (NP (NNS Patients)) (PP (IN in) (NP (DT the) (JJ conventional) (NN group)))) (VP (VBD had) (NP (NP (ADJP (RB statistically) (JJ significant)) (JJR greater) (NN fall)) (PP (IN in) (NP (NP (DT the) (JJ systolic) (NN blood) (NNS pressures)) (PP (IN at) (NP (CD 15) (, ,) (CD 30) (CC and) (CD 45)))))) (NP (NNS minutes)) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (DT the) (NN baseline))) (PRN (-LRB- -LRB-) (ADVP (RB P)) (ADJP (JJ =) (NP (CD 0.003) (, ,) (CD 0.001) (CC and) (CD 0.004))) (-RRB- -RRB-)))))) (. .)))
18399341	11	(ROOT (S (NP (NP (DT The) (JJ mean) (NN respiratory) (NN rate)) (CC and) (NP (NP (JJ Doc_18399341_1654_1660_Chemical) (NNS saturations)) (PP (IN in) (NP (DT the) (CD two) (NNS groups))))) (VP (VBD were) (ADJP (JJ similar))) (. .)))
18399341	12	(ROOT (S (PP (VBN Compared) (PP (TO to) (NP (JJ conventional) (JJ spinal) (NN anaesthesia)))) (, ,) (NP (JJ unilateral) (JJ spinal) (NN anaesthesia)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (JJR fewer) (NNS Doc_18399341_1818_1846_Disease))))) (. .)))
18399341	13	(ROOT (S (ADVP (RB Also)) (, ,) (NP (NP (DT the) (NN type)) (PP (IN of) (NP (JJ spinal) (NN block)))) (VP (VBD instituted) (VP (VBN affected) (S (NP (CC neither) (NP (DT the) (JJ respiratory) (NN rate)) (CC nor) (NP (DT the) (JJ arterial) (JJ Doc_18399341_1945_1951_Chemical) (NN saturation)))))) (. .)))
18422462	0	(ROOT (NP (NP (NNP Spectrum)) (PP (IN of) (NP (JJ adverse) (NNS events))) (PP (IN after) (NP (JJ generic) (NN HAART))) (PP (IN in) (NP (JJ southern) (JJ Indian) (JJ Doc_18422462_66_78_Disease) (NNS patients))) (. .)))
18422462	1	(ROOT (S (S (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (ADJP (RB clinically) (JJ significant)) (JJ adverse) (NNS events)))) (PP (IN after) (NP (ADJP (ADJP (JJ long-term)) (, ,) (ADJP (JJ fixed-dose)) (, ,)) (JJ generic) (ADJP (RB highly) (JJ active)) (JJ antiretroviral) (NN therapy) (PRN (-LRB- -LRB-) (NP (NNP HAART)) (-RRB- -RRB-)) (NN use))) (PP (IN among) (NP (NP (JJ Doc_18422462_249_261_Disease) (NNS individuals)) (PP (IN in) (NP (NNP South) (NNP India)))))))) (, ,) (NP (PRP we)) (VP (VBD examined) (NP (NP (DT the) (NNS experiences)) (PP (IN of) (NP (NP (CD 3154) (JJ Doc_18422462_326_338_Disease) (NNS individuals)) (SBAR (WHNP (WP who)) (S (VP (VP (VBN received) (NP (NP (DT a) (NN minimum)) (PP (IN of) (NP (NP (CD 3) (NNS months)) (PP (IN of) (NP (NP (JJ generic) (NN HAART)) (PP (IN between) (NP (NNP February) (CD 1996))))))))) (CC and) (VP (NP (NNP December) (CD 2006)) (PP (IN at) (NP (NP (DT a) (NNS Doc_18422462_448_481_Disease)) (PP (IN in) (NP (NNP South) (NNP India))))))))))))) (. .)))
18422462	2	(ROOT (S (S (NP (DT The) (RBS most) (JJ common) (NNS regimens)) (VP (VBD were) (NP (NP (NP (NNP Doc_18422462_528_531_Chemical) (NNP +) (NNP Doc_18422462_534_537_Chemical) (NNP +) (NNP Doc_18422462_540_550_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18422462_552_555_Chemical)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD 54.8) (NN %)) (-RRB- -RRB-))))) (, ,) (NP (NP (NNS Doc_18422462_566_576_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18422462_578_581_Chemical)) (-RRB- -RRB-))) (VP (VBZ +) (NP (NP (NP (JJ Doc_18422462_585_588_Chemical) (VBG +) (NNS Doc_18422462_591_594_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 14.5) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NNP Doc_18422462_604_607_Chemical) (NNP +) (NNP Doc_18422462_610_613_Chemical) (NNP +) (NNP Doc_18422462_616_625_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18422462_627_630_Chemical)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD 20.1) (NN %)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNP Doc_18422462_645_648_Chemical) (NNP +) (NNP Doc_18422462_651_654_Chemical) (NNP +) (NNP Doc_18422462_657_660_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5.4) (NN %)) (-RRB- -RRB-))))) (. .)))
18422462	3	(ROOT (S (NP (NP (DT The) (ADJP (RBS most) (JJ common)) (JJ adverse) (NNS events)) (CC and) (NP (NP (JJ median) (NN CD4)) (PP (IN at) (NP (NP (NN time)) (PP (IN of) (NP (NN event))))))) (VP (VBD were) (NP (NP (NP (NNS Doc_18422462_737_741_Disease)) (PRN (-LRB- -LRB-) (NP (CD 15.2) (NN %)) (: ;) (NP (NP (NNP CD4)) (, ,) (NP (CD 285) (NN cells/microL))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_18422462_777_798_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 9.0) (NN %)) (CC and) (NP (CD 348) (NN cells/microL))) (-RRB- -RRB-))))) (. .)))
18422462	4	(ROOT (S (NP (NP (ADJP (RB Clinically) (JJ significant)) (NNS Doc_18422462_851_857_Disease)) (PRN (-LRB- -LRB-) (S (NP (NN hemoglobin) (NNS <)) (ADJP (CD 7) (JJ g/dL))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (CD 5.4) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (PRN (-LRB- -LRB-) (NP (NNP CD4)) (, ,) (NP (CD 165) (NN cells/microL)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_18422462_940_949_Disease)) (PRN (-LRB- -LRB-) (X (NP (NP (JJ clinical) (NNS Doc_18422462_960_968_Disease)) (PP (IN with) (NP (NNS Doc_18422462_974_981_Chemical)))) (NP (NN aminotransferase) (CD >)) (NP (NP (QP (CD 5) (NNS times)) (JJ upper) (NNS limits)) (PP (IN of) (NP (JJ normal))))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (CD 3.5) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (PRN (-LRB- -LRB-) (NP (NNP CD4)) (, ,) (NP (CD 260) (NN cells/microL)) (-RRB- -RRB-)))))))) (. .)))
18422462	5	(ROOT (S (NP (NNP Women)) (VP (VBD were) (ADJP (RB significantly) (RBR more) (JJ likely)) (PP (TO to) (NP (NN experience) (NNS Doc_18422462_1129_1144_Disease))) (, ,) (SBAR (IN while) (S (NP (NNS men)) (VP (VBD were) (ADJP (ADJP (RB significantly) (RBR more) (JJ likely)) (PP (TO to) (NP (NN experience) (NNS Doc_18422462_1201_1231_Disease)))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-)))))) (. .)))
18422462	6	(ROOT (S (PP (IN Among) (NP (NP (DT the) (NNS patients)) (PP (IN with) (NP (NP (CD 1) (NN year)) (PP (IN of) (NP (NN follow-up))))))) (, ,) (NP (JJ Doc_18422462_1289_1292_Chemical) (NN therapy)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN associated) (PP (IN with) (NP (NP (VBG developing) (NNS Doc_18422462_1346_1350_Disease)) (CC and) (NP (NP (NP (JJ Doc_18422462_1355_1358_Chemical) (NN therapy)) (PP (IN with) (NP (VBG developing) (NNS Doc_18422462_1383_1404_Disease)))) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (CD <) (CD 0.05))) (-RRB- -RRB-))))))) (. .)))
18422462	7	(ROOT (S (NP (NNS Doc_18422462_1417_1423_Disease) (CC and) (NNS Doc_18422462_1428_1437_Disease)) (ADVP (RB often)) (VP (VBP occur) (PP (IN within) (NP (NP (CD 12) (NNS weeks)) (PP (IN of) (S (VP (VBG initiating) (NP (JJ generic) (NN HAART)))))))) (. .)))
18422462	8	(ROOT (S (NP (NP (JJ Frequent) (CC and) (JJ early) (NN monitoring)) (PP (IN for) (NP (DT these) (NNS Doc_18422462_1535_1545_Disease)))) (VP (VBZ is) (VP (VBN warranted) (PP (IN in) (NP (NP (VBG developing) (NNS countries)) (SBAR (WHADVP (WRB where)) (S (NP (JJ generic) (NN HAART)) (VP (VBZ is) (ADJP (RB increasingly) (JJ available))))))))) (. .)))
18450790	0	(ROOT (NP (NP (JJ Doc_18450790_0_11_Chemical) (CC and) (JJ sensory) (NNS Doc_18450790_24_37_Disease)) (: :) (NP (DT a) (JJ neurophysiological) (NN study)) (. .)))
18450790	1	(ROOT (S (NP (JJ Recent) (NNS studies)) (VP (VBD confirmed) (NP (NP (DT a) (JJ high) (NN incidence)) (PP (IN of) (NP (NNS Doc_18450790_124_149_Disease)))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ different) (NNS doses)) (PP (IN of) (NP (NNS Doc_18450790_194_205_Chemical))))))))) (. .)))
18450790	2	(ROOT (S (NP (NP (DT The) (NN study) (POS 's)) (NNS aims)) (VP (VBD were) (S (VP (TO to) (VP (VP (VB measure) (NP (NP (NNS variations)) (PP (IN in) (NP (JJ sural) (NN nerve) (JJ sensory) (NN action) (NN potential))) (PRN (-LRB- -LRB-) (NP (NNP SAP)) (-RRB- -RRB-)) (NP (NP (NN amplitude)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ refractory) (NNS Doc_18450790_335_364_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18450790_366_369_Disease)) (-RRB- -RRB-)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_18450790_384_395_Chemical))))))))))) (CC and) (VP (VB use) (S (NP (DT these) (NNS findings)) (VP (TO to) (VP (VB identify) (NP (NP (NP (DT the) (JJ Doc_18450790_435_445_Disease) (NN potential)) (PP (IN of) (NP (NNS Doc_18450790_459_470_Chemical)))) (CC and) (NP (NP (DT the) (NN recovery) (NN capacity)) (PP (IN of) (NP (JJ sensory) (NNS fibres))))) (PP (IN after) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NN treatment))))))))))))) (. .)))
18450790	3	(ROOT (NP (NP (NNP PATIENTS) (CC AND) (NNP METHODS)) (: :) (NP (NP (JJ Clinical) (CC and) (JJ electrophysiological) (NNS data)) (PP (IN in) (NP (NP (CD 12) (JJ female) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_18450790_639_642_Disease)) (PP (IN during) (NP (NN treatment))))))) (UCP (PP (IN with) (NP (NNS Doc_18450790_665_676_Chemical))) (CC and) (ADVP (RB up) (PP (TO to) (NP (CD 47) (NNS months)))) (SBAR (IN after) (S (NP (NP (NN discontinuation)) (PP (IN of) (NP (NN treatment)))) (VP (VBD were) (VP (VBN analysed))))))) (. .)))
18450790	4	(ROOT (S (NP (NP (JJ Sural) (NN nerve) (NNP SAP) (JJ amplitude) (NN reduction) (NN >)) (CC or) (NP (QP (CD =) (CD 40)) (NN %))) (VP (VBD was) (NP (NP (DT the) (NNS criteria)) (PP (IN for) (S (VP (VBG discontinuing) (NP (NN therapy))))))) (. .)))
18450790	5	(ROOT (S (PP (IN During) (NP (NN treatment))) (, ,) (NP (CD 11) (NNS patients)) (VP (VBD showed) (NP (DT a) (NNS Doc_18450790_885_923_Disease)) (PP (VBN compared) (PP (TO to) (NP (NP (NN baseline) (NNS values)) (PRN (-LRB- -LRB-) (NP (NP (CD 9)) (PP (IN with) (NP (NP (DT a) (NN reduction) (NN >)) (CC or) (NP (QP (IN =) (CD 50) (NN %) (CC and) (CD 2) (CD <) (CD 50)) (NN %))))) (-RRB- -RRB-)))))) (. .)))
18450790	6	(ROOT (S (NP (CD One) (NN patient)) (VP (VBD showed) (NP (DT no) (NNS changes)) (PP (IN in) (NP (NNP SAP) (NN amplitude)))) (. .)))
18450790	7	(ROOT (S (NP (CD Five) (NNS patients)) (VP (VBD complained) (PP (IN of) (NP (NNS paresthesias) (CC and) (NN leg) (NNS cramps)))) (. .)))
18450790	8	(ROOT (S (PP (IN After) (NP (JJ Doc_18450790_1106_1117_Chemical) (NN treatment))) (, ,) (NP (JJ sural) (NN SAP) (NN amplitude)) (VP (VBD recovered) (PP (IN in) (NP (CD 3) (NNS patients)))) (. .)))
18450790	9	(ROOT (S (PP (IN At) (NP (NP (NN detection)) (PP (IN of) (NP (NNS Doc_18450790_1190_1228_Disease))))) (, ,) (NP (DT the) (JJ median) (JJ Doc_18450790_1241_1252_Chemical) (JJ cumulative) (NN dose)) (VP (VBD was) (NP (QP (CD 21.4) (CD g.))))))
18450790	10	(ROOT (S (NP (DT The) (NN threshold) (NNS Doc_18450790_1295_1312_Disease)) (VP (VBZ is) (ADVP (JJR lower) (IN than)) (ADJP (RB previously) (VBN reported))) (. .)))
18450790	11	(ROOT (S (NP (NNP Sural) (NNP nerve) (NNP SAP) (NN amplitude) (NN reduction)) (VP (VBZ is) (NP (NP (DT a) (ADJP (JJ reliable) (CC and) (JJ sensitive)) (NN marker)) (PP (IN of) (NP (NN degeneration) (CC and) (NN recovery))) (PP (IN of) (NP (JJ sensory) (NNS fibres))))) (. .)))
18450790	12	(ROOT (S (NP (DT This) (JJ electrophysiological) (NN parameter)) (VP (VP (VBZ provides) (NP (NN information)) (PP (IN about) (NP (NP (JJ subclinical) (JJ Doc_18450790_1555_1565_Disease) (NN potential)) (PP (IN of) (NP (NNS Doc_18450790_1579_1590_Chemical)))))) (CC but) (VP (VBZ is) (RB not) (ADJP (JJ helpful) (PP (IN in) (S (VP (VBG predicting) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (JJ sensory) (NNS symptoms)))))))))) (. .)))
1858969	0	(ROOT (NP (NP (CD Five) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_1858969_14_26_Disease)) (PP (IN during) (NP (NN treatment))))) (PP (IN of) (NP (NP (NNS Doc_1858969_47_54_Disease)) (PP (IN with) (NP (NNS Doc_1858969_60_78_Chemical))))) (. .)))
1858969	1	(ROOT (S (NP (NP (CD Five) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_1858969_94_106_Disease)) (PP (VBG following) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (NNS Doc_1858969_132_150_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1858969_152_155_Chemical)) (-RRB- -RRB-))))))))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (JJ Congolese) (NNS patients))) (PP (IN with) (NP (NNS Doc_1858969_198_216_Disease))))) (. .)))
1858969	2	(ROOT (S (NP (CD Two) (NNS cases)) (VP (VBD had) (NP (NP (DT a) (JJ fatal) (NN outcome)) (CC and) (NP (NP (CD one)) (VP (VBN resulted) (PP (IN in) (NP (JJ severe) (NN sequelae))))))) (. .)))
1858969	3	(ROOT (S (NP (DT The) (JJ notable) (NN fact)) (VP (VBD was) (SBAR (IN that) (S (NP (DT this) (NN complication)) (VP (VBD occurred) (PP (IN in) (NP (NP (CD three) (NNS patients)) (S (S (VP (VBN hospitalized) (SBAR (IN before) (S (NP (NN treatment)) (VP (VBD began) (, ,) (PP (IN with) (SBAR (WHNP (WP whom)) (S (NP (RB particularly) (JJ strict) (JJ therapeutic) (NNS precautions)) (VP (VBD were) (VP (VBN taken))))))))))) (, ,) (FW i.e.) (, ,) (S (UCP (NP (NP (JJ initial) (NN dose)) (NP (NP (QP (JJR less) (IN than) (CD 10)) (NN mg)) (PP (IN of) (NP (NP (NNP DEC)) (, ,) (RB very) (NP (JJ gradual) (NN dose) (NNS increases)))))) (, ,) (CC and) (VP (VBN associated) (NP (JJ anti-allergic) (NN treatment)))))))))))) (. .)))
1858969	4	(ROOT (S (NP (NP (DT This) (NN type)) (PP (IN of) (NP (JJ drug-induced) (NN complication)))) (VP (MD may) (RB not) (VP (VB be) (ADJP (RB that) (JJ uncommon) (PP (IN in) (NP (ADJP (RB highly) (JJ endemic)) (NNS regions)))))) (. .)))
1858969	5	(ROOT (S (NP (PRP It)) (VP (VBZ occurs) (ADVP (ADVP (RB primarily)) (, ,) (CC but) (ADVP (RB not) (RB exclusively))) (, ,) (PP (IN in) (NP (NP (NNS subjects)) (VP (VBG presenting) (PP (IN with) (NP (DT a) (JJ high) (JJ microfilarial) (NN load))))))) (. .)))
1858969	6	(ROOT (S (NP (NP (DT The) (NN relationship)) (PP (IN between) (NP (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NNS Doc_1858969_802_814_Disease)))) (CC and) (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NN microfilaremia))))))) (VP (VBZ is) (ADJP (JJ evident))) (. .)))
1858969	7	(ROOT (S (NP (DT The) (JJ pathophysiological) (NNS mechanisms)) (VP (VBP are) (VP (VBN discussed) (PP (IN in) (NP (NP (DT the) (NN light)) (PP (IN of) (NP (NP (DT these) (NNS observations)) (CC and) (NP (DT the) (JJ few) (JJ other) (NNS comments)))))) (PP (IN on) (NP (NP (DT this) (NN subject)) (VP (VBN published) (PP (IN in) (NP (DT the) (NN literature)))))))) (. .)))
18801087	0	(ROOT (NP (NP (NP (CD Doc_18801087_0_10_Chemical-related) (JJ pulmonary) (NN mass) (CC and) (JJ unique) (NNS Doc_18801087_45_74_Disease)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NNS Doc_18801087_93_115_Disease)))))) (: :) (NP (NP (NNP Diagnostic) (NNP pitfall)) (CC and) (NP (JJ new) (NNS findings))) (. .)))
18801087	1	(ROOT (S (S (NP (NNP Doc_18801087_154_164_Chemical)) (VP (VBZ is) (NP (NP (DT an) (JJ anti-arrhythmic) (NN drug)) (PP (IN for) (NP (JJ life-threatening) (NNS Doc_18801087_213_224_Disease)))))) (, ,) (CC but) (S (NP (JJ various) (JJ adverse) (NNS effects)) (VP (VBP have) (VP (VBN been) (VP (VBN reported))))) (. .)))
18801087	2	(ROOT (S (NP (JJ Reported) (NN herein)) (VP (VBZ is) (NP (NP (DT an) (JJ autopsy) (NN case)) (PP (IN of) (NP (NNS Doc_18801087_312_334_Disease))) (, ,) (PP (IN in) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (NP (DT a) (NN lung) (NN mass)) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 1.5) (CD cm))) (PP (IN in) (NP (NN diameter)))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_18801087_400_411_Disease)) (PRN (-LRB- -LRB-) (NP (QP (CD 2.76) (CD g/day))) (-RRB- -RRB-)))) (PP (IN after) (NP (NN treatment))) (PP (IN with) (NP (NP (NNS Doc_18801087_446_456_Chemical)) (PP (IN for) (NP (DT a) (JJ long) (NN time)))))))))))) (. .)))
18801087	3	(ROOT (S (S (NP (DT The) (NN lung) (NN mass)) (VP (VBD was) (ADVP (RB highly)) (VP (VBN suspected) (S (VP (TO to) (VP (VB be) (VP (VBN Doc_18801087_515_526_Disease) (PP (IN on) (NP (NP (NNP CT)) (CC and) (NP (NN positron) (NN emission) (NN tomography))))))))))) (, ,) (CC but) (S (ADVP (RB histologically)) (NP (DT the) (NN lesion)) (VP (VBD was) (VP (VBN composed) (PP (IN of) (NP (NP (NP (JJ lymphoplasmacytic) (NNS infiltrates)) (PP (IN in) (NP (NN alveolar) (NNS walls)))) (CC and) (NP (NP (JJ intra-alveolar) (NN accumulation)) (PP (IN of) (NP (JJ foamy) (NNS macrophages)))))) (S (VP (VP (VBG containing) (NP (JJ characteristic) (JJ myelinoid) (NNS bodies))) (, ,) (VP (VBG indicating) (SBAR (IN that) (S (NP (PRP it)) (VP (VBD was) (NP (DT an) (NN Doc_18801087_784_794_Chemical-related) (NN lesion))))))))))) (. .)))
18801087	4	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (S (NP (DT the) (NN lung) (NN tissue)) (VP (VBD had) (ADVP (RB unevenly)) (VP (VBN distributed) (NP (JJ Doc_18801087_865_876_Chemical) (NN deposition))))) (, ,) (CC and) (S (NP (JJ abnormally) (JJ tortuous) (NNS capillaries)) (VP (VBD were) (VP (VBN seen) (PP (PP (IN in) (NP (DT the) (NN mass))) (CC and) (PP (IN in) (NP (ADJP (RB heavily) (JJ hemosiderotic)) (NN lung) (NNS portions)))) (PP (IN outside) (NP (DT the) (NN mass)))))) (. .)))
18801087	5	(ROOT (S (PP (IN In) (NP (DT the) (NNS kidneys))) (, ,) (NP (NNS glomeruli)) (VP (VBD had) (NP (NP (JJ membrane) (NNS spikes)) (, ,) (NP (NP (JJ prominent) (VBG swelling)) (PP (IN of) (NP (NP (ADJP (JJ podocytes) (CC and) (JJ subepithelial)) (NNS deposits)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (ADJP (RB sometimes) (JJ large) (CC and) (JJ hump-like)))))))))) (. .)))
18801087	6	(ROOT (S (ADVP (RB Doc_18801087_1157_1176_Disease)) (, ,) (NP (NP (NNS Doc_18801087_1178_1193_Disease)) (, ,) (NP (NNS Doc_18801087_1195_1214_Disease)) (CC or) (NP (NP (JJ other) (NNS diseases)) (PP (IN with) (NP (NP (DT a) (JJ known) (NN relationship)) (PP (TO to) (NP (NNS Doc_18801087_1262_1291_Disease))))))) (VP (VBD were) (RB not) (VP (VBN found))) (. .)))
18801087	7	(ROOT (S (NP (DT The) (JJ present) (NN case)) (VP (VBZ highlights) (NP (DT the) (NN possibility)) (SBAR (IN that) (S (NP (NP (NN differential) (NN diagnosis)) (PP (IN between) (NP (NP (DT an) (NN Doc_18801087_1391_1401_Chemical-related) (NNS Doc_18801087_1410_1426_Disease)) (CC and) (NP (DT a) (NNS Doc_18801087_1433_1441_Disease))))) (VP (VP (MD can) (VP (VB be) (ADJP (RB very) (JJ difficult)) (ADVP (RB radiologically)))) (, ,) (CC and) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NNS Doc_18801087_1498_1527_Disease)) (VP (MD might) (VP (VB be) (NP (NP (DT another) (JJ possible) (NN complication)) (PP (IN of) (NP (JJ Doc_18801087_1570_1580_Chemical) (NN treatment))))))))))))) (. .)))
18945509	0	(ROOT (S (NP (NP (NN Risk)) (PP (IN of) (NP (NNS Doc_18945509_8_31_Disease)))) (VP (VBN associated) (PP (IN with) (NP (NP (NP (JJ initial) (JJ Doc_18945509_56_69_Chemical) (NN treatment)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (QP (CD Doc_18945509_97_101_Disease) (CD 2)) (NNS Doc_18945509_104_112_Disease)))))) (: :) (NP (DT a) (VBN matched) (JJ case-control) (NN study))))) (. .)))
18945509	1	(ROOT (S (NP (DT This) (NN study)) (VP (VBD sought) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NP (VBG developing) (NNS Doc_18945509_201_224_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18945509_226_229_Disease)) (-RRB- -RRB-))) (VP (VBN associated) (PP (IN with) (NP (NP (JJ initial) (NN treatment)) (PP (IN of) (NP (QP (CD Doc_18945509_268_272_Disease) (CD 2)) (NNS Doc_18945509_275_283_Disease))))) (PP (IN with) (NP (JJ different) (NNS Doc_18945509_299_313_Chemical))))))))))) (. .)))
18945509	2	(ROOT (S (PP (IN In) (NP (QP (CD Doc_18945509_327_331_Disease) (CD 2)) (JJ Doc_18945509_334_342_Disease) (NNS patients))) (, ,) (NP (NP (NNS cases)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_18945509_373_376_Disease)))))) (VP (VBD were) (VP (VBN compared) (ADVP (RB retrospectively)) (PP (IN with) (NP (NP (NNS controls)) (SBAR (WHNP (WDT that)) (S (VP (VBD did) (RB not)))))))) (. .)))
18945509	3	(ROOT (S (NP (NP (DT The) (JJ 20-year) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_18945509_455_458_Disease)) (PP (IN at) (NP (NP (NN diagnosis)) (PP (IN of) (NP (NNS Doc_18945509_475_483_Disease)))))))) (, ,) (S (VP (VBG using) (NP (DT the) (NNP UKPDS) (NN risk) (NN engine)))) (, ,) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB match) (NP (NNS cases)) (PP (IN with) (NP (NNS controls)))))))) (. .)))
18945509	4	(ROOT (S (NP (NP (DT The) (CD 76) (NNS cases)) (PP (IN of) (NP (NNS Doc_18945509_578_581_Disease)))) (VP (VBD were) (VP (VBN compared) (PP (IN with) (NP (CD 152) (NNS controls))))) (. .)))
18945509	5	(ROOT (S (NP (NP (DT The) (NN hazard)) (PP (IN of) (NP (NP (NP (VBG developing) (NNS Doc_18945509_640_643_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NNP CI))) (-RRB- -RRB-))) (VP (VBN associated) (PP (IN with) (NP (JJ initial) (NN treatment))))))) (VP (VP (VBD increased) (PP (IN by) (NP (NP (ADJP (ADJP (ADJP (JJ 2.4-fold)) (PRN (-LRB- -LRB-) (NP (NP (CD 1.3-4) (CD .3)) (, ,) (NP (NNP P) (NNP =) (NNP 0.004))) (-RRB- -RRB-))) (PP (IN with) (NP (NP (NNS Doc_18945509_733_746_Chemical)) (: ;) (NP (NP (NP (JJ 2-fold)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.9-4) (CD .6)) (, ,) (NP (NNP P) (NNP =) (NNP 0.099))) (-RRB- -RRB-))) (PP (IN with) (NP (NNS Doc_18945509_779_788_Chemical)))) (: ;)))) (JJ 2.9-fold)) (PRN (-LRB- -LRB-) (NP (NP (CD 1.6-5) (CD .1)) (, ,) (NP (NNP P) (NNP =) (NNP 0.000))) (-RRB- -RRB-)))) (PP (IN with) (NP (DT either)))) (, ,) (CC and) (VP (VBD was) (ADJP (JJ unchanged)) (PP (IN with) (NP (NNS Doc_18945509_854_863_Chemical))))) (. .)))
18945509	6	(ROOT (S (NP (DT The) (NN hazard)) (VP (VBD decreased) (ADJP (ADJP (ADJP (ADJP (JJ 0.3-fold)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.7-1) (CD .7)) (, ,) (NP (NNP P) (NNP =) (NNP 0.385))) (-RRB- -RRB-))) (PP (IN with) (NP (NNS Doc_18945509_919_930_Chemical)))) (, ,) (ADJP (ADJP (ADJP (JJ 0.4-fold)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.7-1) (CD .3)) (, ,) (NP (NNP P) (NNP =) (NNP 0.192))) (-RRB- -RRB-))) (PP (IN with) (NP (NNS Doc_18945509_965_975_Chemical)))) (, ,) (CC and) (ADJP (ADJP (JJ 0.4-fold)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.7-1) (CD .1)) (, ,) (NP (NNP P) (NNP =) (NNP 0.09))) (-RRB- -RRB-)))) (PP (IN with) (NP (DT either)))) (. .)))
18945509	7	(ROOT (S (NP (NP (VBG Initiating) (NN treatment)) (PP (IN of) (NP (NP (QP (CD Doc_18945509_1058_1062_Disease) (CD 2)) (NNS Doc_18945509_1065_1073_Disease)) (PP (IN with) (NP (NNS Doc_18945509_1079_1092_Chemical) (CC or) (NNS Doc_18945509_1096_1105_Chemical)))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_18945509_1143_1146_Disease)) (PP (IN in) (NP (NP (NN comparison)) (PP (TO to) (NP (NNS Doc_18945509_1164_1174_Chemical) (CC or) (NNS Doc_18945509_1178_1189_Chemical))))))))))) (. .)))
18945509	8	(ROOT (S (S (SBAR (IN If) (S (VP (VBD confirmed)))) (, ,) (NP (DT this)) (VP (MD may) (VP (VB be) (ADJP (JJ important)) (SBAR (IN because) (S (NP (RBS most) (JJ Indian) (NNS patients)) (VP (VBP receive) (NP (DT the) (ADJP (JJR cheaper)) (JJR older) (NN sulphonylureas)))))))) (, ,) (CC and) (S (NP (JJ present) (NNS guidelines)) (VP (VBP do) (RB not) (VP (VB distinguish) (PP (IN between) (NP (JJ individual) (NNS agents)))))) (. .)))
18987260	0	(ROOT (S (NP (NP (JJ Reduced) (NN progression)) (PP (IN of) (NP (NP (JJ Doc_18987260_23_33_Chemical) (NNS Doc_18987260_34_45_Disease)) (PP (IN in) (NP (JJ spontaneously) (JJ Doc_18987260_63_75_Disease) (NNS rats)))))) (VP (VBN treated) (PP (IN by) (NP (NNS Doc_18987260_92_100_Chemical)))) (. .)))
18987260	1	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (JJ antihypertensive) (NNS effects)) (PP (IN of) (NP (NP (NNP angiotensin) (NNP II) (JJ type-1) (NN receptor) (NN blocker)) (, ,) (NP (NNS Doc_18987260_226_234_Chemical)) (, ,) (CC and) (NP (PRP$ its) (NN potential))))) (PP (IN in) (NP (NP (VBG slowing) (NNS Doc_18987260_265_295_Disease)) (PP (IN in) (NP (NP (ADVP (RB spontaneously)) (JJ Doc_18987260_313_325_Disease) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NNP SHR)) (-RRB- -RRB-)))) (PP (IN with) (NP (JJ Doc_18987260_342_352_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_18987260_354_357_Chemical)) (-RRB- -RRB-)) (NNS Doc_18987260_359_370_Disease))))))))) (. .)))
18987260	2	(ROOT (S (NP (JJ Six-month-old) (JJ female) (NN SHR)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN selected) (PP (IN in) (NP (CD six) (NNS groups))))) (. .)))
18987260	3	(ROOT (S (NP (NP (CD Two) (NN control) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP SH)) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-))) (, ,) (NP (NNS Doc_18987260_471_477_Chemical))) (-RRB- -RRB-))) (VP (VBD received) (NP (NN vehicle))) (. .)))
18987260	4	(ROOT (S (NP (NP (NP (NP (NNS Groups) (NNS Doc_18987260_504_507_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-))) (, ,) (NP (NP (NNP Doc_18987260_512_515_Chemical) (NNP +) (NNP LOS)) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_18987260_527_530_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-)))) (, ,) (CC and) (NP (NP (NNP Doc_18987260_540_543_Chemical) (NNP +) (NNP LOS)) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-)))) (VP (VBD received) (SBAR (S (VP (VBD Doc_18987260_561_564_Chemical) (S (-LRB- -LRB-) (NP (CD 2) (NNP mg/kg/b) (. .) (NN w.) (NN i.v.)) (-RRB- -RRB-) (ADVP (RB twice))) (PP (IN in) (NP (DT a) (JJ 3-week) (NN interval))))))) (. .)))
18987260	5	(ROOT (S (NP (NP (NNP Group) (NNP Doc_18987260_619_622_Chemical) (NNP +) (NNP LOS)) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-))) (VP (VBD received) (NP (NP (NP (NP (NNS Doc_18987260_639_647_Chemical)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (CD 10)) (NP (NNP mg/kg/b) (. .) (NN w.))) (: /) (NP (NP (NN day)) (PP (IN by) (NP (NNS gavages))))) (-RRB- -RRB-))) (PP (IN for) (NP (CD 6) (NNS weeks)))) (CC and) (NP (NP (NN group) (NNS Doc_18987260_701_704_Chemical)) (NP (NP (NNP +) (NNP LOS)) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-))))) (PP (IN for) (NP (CD 12) (NNS weeks))) (PP (IN after) (NP (NP (JJ second) (NN injection)) (PP (IN of) (NP (NNS Doc_18987260_752_755_Chemical)))))) (. .)))
18987260	6	(ROOT (S (NP (NNS Animals)) (VP (VBD were) (VP (VBN killed) (PP (IN after) (NP (QP (CD 6) (CC or) (CD 12)) (NNS weeks))) (, ,) (ADVP (RB respectively)))) (. .)))
18987260	7	(ROOT (S (S (NP (JJ Haemodynamic) (NNS measurements)) (VP (VBD were) (VP (VBN performed) (PP (IN on) (NP (JJ anaesthetized) (NNS animals)))))) (, ,) (S (NP (NN blood) (CC and) (NN urine) (NNS samples)) (VP (VBD were) (VP (VBN taken) (PP (IN for) (NP (JJ biochemical) (NN analysis)))))) (CC and) (S (NP (DT the) (JJ left) (NN kidney)) (VP (VBD was) (VP (VBN processed) (PP (IN for) (NP (JJ morphological) (NNS studies)))))) (. .)))
18987260	8	(ROOT (S (NP (NP (JJ Short-term) (JJ Doc_18987260_1020_1028_Chemical) (NN treatment)) (, ,) (PP (IN besides) (NP (JJ antihypertensive) (NN effect))) (, ,)) (VP (VBD improved) (NP (NN glomerular) (NN filtration) (NN rate) (CC and) (NN ameliorated) (NNS Doc_18987260_1125_1143_Disease)) (S (VP (VBG resulting) (PP (IN in) (NP (VBN decreased) (NNS Doc_18987260_1167_1178_Disease)))))) (. .)))
18987260	9	(ROOT (S (NP (NP (JJ Prolonged) (NN treatment)) (PP (IN with) (NP (NNS Doc_18987260_1205_1213_Chemical)))) (VP (VBD showed) (NP (NP (JJ further) (NN reduction)) (PP (IN of) (NP (NP (NNS Doc_18987260_1242_1260_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ reduced) (NN progression)) (PP (IN of) (NP (JJ Doc_18987260_1300_1315_Disease) (CC and) (JJ interstitial) (NNS Doc_18987260_1333_1341_Disease))))) (, ,) (S (ADVP (RB thus)) (VP (VBG preventing) (NP (JJ heavy) (NNS Doc_18987260_1365_1376_Disease) (CC and) (NNS Doc_18987260_1381_1402_Disease))))))))) (. .)))
18987260	10	(ROOT (S (NP (NNP Doc_18987260_1404_1412_Chemical)) (VP (VBD reduced) (NP (NN uraemia) (CC and) (JJ increased) (NNS Doc_18987260_1443_1447_Chemical) (NN clearance)) (PP (IN in) (NP (JJ advanced) (JJ Doc_18987260_1470_1473_Chemical) (NNS Doc_18987260_1474_1485_Disease))) (PP (IN in) (NP (NNP SHR)))) (. .)))
18987260	11	(ROOT (S (NP (JJ Histological) (NN examination)) (VP (VBD showed) (SBAR (IN that) (S (NP (NNS Doc_18987260_1531_1539_Chemical)) (VP (MD could) (VP (VB prevent) (NP (NNS Doc_18987260_1554_1569_Disease) (, ,) (NNS Doc_18987260_1571_1596_Disease) (CC and) (NNS Doc_18987260_1601_1609_Disease)) (PP (IN in) (NP (JJ Doc_18987260_1613_1616_Chemical) (NNS Doc_18987260_1617_1628_Disease)))))))) (. .)))
18987260	12	(ROOT (S (NP (NNP Doc_18987260_1642_1650_Chemical)) (VP (VBZ reduces) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN progression)) (PP (IN of) (NP (NN Doc_18987260_1686_1689_Chemical-induced) (NNS Doc_18987260_1698_1732_Disease)))))) (PP (TO to) (NP (NP (NNS Doc_18987260_1736_1759_Disease)) (PP (IN in) (NP (NNP SHR)))))) (. .)))
19020118	0	(ROOT (NP (NP (NP (DT The) (NNS risks)) (PP (IN of) (NP (NN aprotinin) (CC and) (NNS Doc_19020118_27_42_Chemical))) (PP (IN in) (NP (JJ cardiac) (NN surgery)))) (: :) (NP (NP (DT a) (JJ one-year) (NN follow-up)) (PP (IN of) (NP (CD 1188) (JJ consecutive) (NNS patients)))) (. .)))
19020118	1	(ROOT (S (NP (PRP$ Our) (NN aim)) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (NP (JJ postoperative) (NNS complications) (CC and) (NN mortality)) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (NN aprotinin))))) (PP (VBN compared) (PP (TO to) (NP (NP (NNS Doc_19020118_241_256_Chemical)) (PP (IN in) (NP (DT an) (JJ unselected) (, ,) (JJ consecutive) (NN cohort)))))))))) (. .)))
19020118	2	(ROOT (S (NP (NP (JJ Perioperative) (NNS data)) (PP (IN from) (NP (JJ consecutive) (JJ cardiac) (NN surgery) (NNS patients)))) (VP (VBD were) (ADVP (RB prospectively)) (VP (VBN collected) (PP (IN between) (NP (NP (NNP September) (CD 2005)) (CC and) (NP (NNP June) (CD 2006)))) (PP (IN in) (NP (NP (DT a) (JJ university-affiliated) (NN clinic)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 1188))))) (-RRB- -RRB-)))))) (. .)))
19020118	3	(ROOT (S (S (PP (IN During) (NP (DT the) (JJ first) (CD 5) (NNS mo))) (, ,) (NP (CD 596) (NNS patients)) (VP (VBD received) (NP (NP (NN aprotinin)) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP A)) (-RRB- -RRB-))))) (: ;) (S (PP (IN in) (NP (DT the) (JJ next) (CD 5) (NNS mo))) (, ,) (NP (CD 592) (NNS patients)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_19020118_592_607_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP T)) (-RRB- -RRB-))))))) (. .)))
19020118	4	(ROOT (S (PP (IN Except) (PP (IN for) (NP (JJ antifibrinolytic) (NN therapy)))) (, ,) (NP (DT the) (JJ anesthetic) (CC and) (JJ surgical) (NNS protocols)) (VP (VBD remained) (ADJP (JJ unchanged))) (. .)))
19020118	5	(ROOT (S (NP (DT The) (ADJP (JJ pre) (: -) (CC and) (JJ intraoperative)) (NNS variables)) (VP (VBD were) (ADJP (JJ comparable) (PP (IN between) (NP (DT the) (NN treatment) (NNS groups))))) (. .)))
19020118	6	(ROOT (S (ADVP (RB Postoperatively)) (, ,) (NP (NP (DT a) (ADJP (RB significantly) (JJR higher)) (NN incidence)) (PP (IN of) (NP (NNS Doc_19020118_860_868_Disease)))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (NNP Group) (NNP T)) (PRN (-LRB- -LRB-) (NP (NP (NP (ADJP (CD 4.6) (NN %)) (NN vs)) (ADJP (CD 1.2) (NN %))) (, ,) (NP (NNP P) (NNP <) (NNP 0.001))) (-RRB- -RRB-)))))) (. .)))
19020118	7	(ROOT (S (NP (DT This) (NN difference)) (VP (VBD was) (ADVP (RB also)) (NP (NP (ADJP (JJ significant) (PP (IN in) (NP (NP (DT the) (JJ primary) (NN valve) (NN surgery)) (CC and) (NP (DT the) (JJ high) (NN risk))))) (NN surgery) (NNS subgroups)) (PRN (-LRB- -LRB-) (NP (NP (NP (ADJP (CD 7.9) (NN %)) (NN vs)) (ADJP (CD 1.2) (NN %))) (, ,) (NP (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.003)))))) (: ;) (NP (NP (ADJP (CD 7.3) (NN %)) (NN vs)) (ADJP (CD 2.4) (NN %)))) (, ,) (NP (NP (NNP P) (NNP =)) (NP (CD 0.035)) (, ,) (ADVP (RB respectively)))) (-RRB- -RRB-)))) (. .)))
19020118	8	(ROOT (S (NP (NP (NP (JJ Persistent) (NNS Doc_19020118_1096_1115_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (ADJP (CD 7.9) (NN %)) (NN vs)) (ADJP (CD 2.3) (NN %))) (, ,) (NP (NNP P) (NNP =) (NNP 0.020))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_19020118_1146_1159_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 9.7) (NN %)) (NP (NP (QP (CD vs) (CD 1.7)) (NN %)) (, ,) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.002)))))))) (-RRB- -RRB-)))) (VP (VBD were) (ADVP (RB also)) (ADJP (RBR more) (JJ common) (PP (PP (IN in) (NP (NNP Group) (NNP T))) (, ,) (PP (IN in) (NP (DT the) (JJ primary) (NN valve) (NN surgery) (NN subgroup)))))) (. .)))
19020118	9	(ROOT (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (PP (IN among) (NP (JJ primary) (JJ coronary) (NN artery) (NN bypass) (NN surgery) (NNS patients))) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (ADJP (RBR more) (JJ acute)) (NNS Doc_19020118_1353_1375_Disease) (CC and) (NNS Doc_19020118_1380_1397_Disease)) (PP (IN in) (NP (NP (NNP Group) (NNP A)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 5.8) (NN %)) (NP (QP (CD vs) (CD 2.0)) (NN %))) (, ,) (NP (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.027)))))) (: ;) (NP (NP (ADJP (CD 22.5) (NN %)) (NN vs)) (ADJP (CD 15.2) (NN %)))) (, ,) (NP (NP (NNP P) (NNP =)) (NP (CD 0.036)) (, ,) (ADVP (RB respectively)))) (-RRB- -RRB-)))))) (. .)))
19020118	10	(ROOT (S (NP (DT The) (JJ 1-yr) (NN mortality)) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN after) (NP (NP (NN aprotinin) (NN treatment)) (PP (IN in) (NP (DT the) (JJ high) (NN risk) (NN surgery) (NN group))) (PRN (-LRB- -LRB-) (NP (NP (CD 17.7) (NN %)) (VP (VBN vs) (NP (NP (CD 9.8) (NN %)) (, ,) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.034))))))))) (-RRB- -RRB-)))))) (. .)))
19020118	11	(ROOT (S (NP (DT Both) (JJ antifibrinolytic) (NNS drugs)) (VP (VBP bear) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ adverse) (NN outcome)))) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (NN type)) (PP (IN of) (NP (JJ cardiac) (NN surgery))))))) (. .)))
19020118	12	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NN aprotinin)))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (PP (IN in) (NP (JJ coronary) (NN artery) (NN bypass) (NN graft) (CC and) (JJ high) (NN risk) (NNS patients))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_19020118_1849_1864_Chemical)))) (VP (VBZ is) (RB not) (VP (VBN recommended) (PP (IN in) (NP (NN valve) (NN surgery)))))))))) (. .)))
1905439	0	(ROOT (S (NP (NP (NNP Delirium)) (PP (IN in) (NP (DT an) (JJ elderly) (NN woman)))) (VP (ADVP (RB possibly)) (VBN associated) (PP (IN with) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_1905439_72_83_Chemical)))))) (. .)))
1905439	1	(ROOT (S (NP (NNP Doc_1905439_85_96_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (JJ adverse) (NNS reactions))) (, ,) (PP (VBG including) (NP (NP (NNS Doc_1905439_151_176_Disease)) (, ,) (NP (JJ gynecologic) (NNS problems)) (, ,) (CC and) (NP (NNS Doc_1905439_204_212_Disease))))))) (. .)))
1905439	2	(ROOT (S (NP (NP (NNS Changes)) (PP (IN in) (NP (JJ mental) (NN status)))) (, ,) (ADVP (RB however)) (, ,) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN reported)))) (. .)))
1905439	3	(ROOT (S (NP (PRP We)) (VP (VBP present) (NP (NP (DT a) (NN case)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT an) (JJ 89-year-old) (NN woman)) (PP (IN in) (NP (DT a) (JJ long-term) (NN care) (NN facility)))) (VP (VBD became) (NP (NNS Doc_1905439_357_365_Disease)) (PP (IN after) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (JJ Doc_1905439_390_401_Chemical) (NN therapy)))))))))) (. .)))
1905439	4	(ROOT (S (NP (NP (NP (DT The) (NN patient) (POS 's)) (NN change)) (PP (IN in) (NP (JJ mental) (NN status)))) (VP (VBD was) (ADVP (RB first)) (VP (VBN reported) (NP (CD nine) (NNS days)) (PP (IN after) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NN therapy))))))) (. .)))
1905439	5	(ROOT (S (NP (PRP$ Her) (NNS Doc_1905439_515_523_Disease)) (ADVP (RB significantly)) (VP (VBD improved) (SBAR (IN after) (S (S (NP (NNS Doc_1905439_553_564_Chemical)) (VP (VBD was) (VP (VBN discontinued)))) (CC and) (S (NP (PRP$ her) (JJ mental) (NN status)) (VP (VBD returned) (PP (TO to) (ADJP (JJ normal))) (PP (IN within) (NP (DT a) (NN week)))))))) (. .)))
1905439	6	(ROOT (S (PP (IN Because) (NP (NP (DT no) (JJ other) (NNS factors)) (VP (VBN related) (PP (TO to) (NP (NP (DT this) (NN patient)) (VP (VBN changed) (ADVP (RB significantly)))))))) (, ,) (NP (DT the) (NNS Doc_1905439_714_722_Disease)) (VP (VBD experienced) (PP (IN by) (NP (NP (DT this) (NN patient)) (VP (ADVP (RB possibly)) (VBN resulted) (PP (IN from) (NP (JJ Doc_1905439_774_785_Chemical) (NN therapy))))))) (. .)))
19108278	0	(ROOT (NP (NP (DT The) (JJ biological) (NNS properties)) (PP (IN of) (NP (NP (DT the) (JJ optical) (NNS isomers)) (PP (IN of) (NP (NP (NNS Doc_19108278_52_63_Chemical)) (CC and) (NP (PRP$ their) (NNS effects)))))) (PP (IN on) (NP (NP (NNP Doc_19108278_85_104_Disease) (. .)) (NP (CD 1)))) (. .)))
19108278	1	(ROOT (S (NP (NP (DT The) (JJ optical) (NNS isomers)) (PP (IN of) (NP (NNS Doc_19108278_132_143_Chemical)))) (VP (VBP have) (VP (VBN been) (VP (VBN compared) (PP (IN for) (NP (NP (PRP$ their) (NN beta-blocking)) (CC and) (NP (NP (JJ antiarrhythmic) (NNS activities)) (NP (CD .2)))))))) (. .)))
19108278	2	(ROOT (S (PP (IN In) (S (VP (VBG blocking) (NP (DT the) (JJ positive) (ADJP (JJ inotropic) (CC and) (JJ chronotropic)) (NNS responses)) (PP (TO to) (NP (NNS Doc_19108278_285_297_Chemical)))))) (, ,) (NP (NNS Doc_19108278_299_314_Chemical)) (VP (VBD had) (NP (NP (QP (JJR less) (IN than) (CD one) (CD hundredth)) (DT the) (NN potency)) (PP (IN of) (NP (NNS Doc_19108278_358_373_Chemical))))) (. .)))
19108278	3	(ROOT (S (PP (IN At) (NP (NP (NN dose) (NNS levels)) (PP (IN of) (NP (NP (NNS Doc_19108278_393_408_Chemical)) (SBAR (WHNP (WDT which)) (S (VP (VBD attenuated) (NP (DT the) (NNS responses)) (PP (TO to) (NP (NNS Doc_19108278_443_455_Chemical)))))))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN prolongation)) (PP (IN of) (NP (NP (DT the) (NNP PR) (NN interval)) (PP (IN of) (NP (DT the) (NN electrocardiogram) (CD .3))))))) (. .)))
19108278	4	(ROOT (S (NP (NP (NP (DT The) (JJ metabolic) (NNS responses)) (PP (TO to) (NP (NP (NNS Doc_19108278_568_580_Chemical)) (PP (IN in) (NP (NNS dogs)))))) (PRN (-LRB- -LRB-) (NP (NP (DT an) (NN increase)) (PP (IN in) (S (VP (VBG circulating) (NP (NNS Doc_19108278_617_624_Chemical) (, ,) (NNS Doc_19108278_626_633_Chemical) (CC and) (NNS Doc_19108278_638_654_Chemical)))))) (-RRB- -RRB-))) (VP (VBD were) (RB all) (VP (VBN blocked) (PP (IN by) (NP (NP (NNP Doc_19108278_676_691_Chemical) (. .)) (SBAR (S (NP (NNS Doc_19108278_693_708_Chemical)) (VP (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (JJ Doc_19108278_726_736_Chemical) (NN mobilization))))) (CC but) (ADVP (RB significantly)) (VP (VBD reduced) (NP (NP (DT the) (NNS increments)) (PP (IN in) (NP (DT both) (NNS Doc_19108278_799_806_Chemical) (CC and) (NNS Doc_19108278_811_818_Chemical)))) (NP (CD .4)))))))))) (. .)))
19108278	5	(ROOT (S (NP (NP (DT Both) (NNS isomers)) (PP (IN of) (NP (NNS Doc_19108278_838_849_Chemical)))) (VP (VBD possessed) (NP (JJ similar) (NN depressant)) (ADVP (RB potency)) (PP (IN on) (NP (NP (VBN isolated) (NNS Doc_19108278_899_912_Disease)) (VP (VBN taken) (PP (IN from) (NP (JJ guinea-pigs) (CD .5))))))) (. .)))
19108278	6	(ROOT (S (NP (NP (DT The) (NNS isomers)) (PP (IN of) (NP (NNS Doc_19108278_954_965_Chemical)))) (VP (VBD exhibited) (NP (NP (ADJP (JJ similar)) (JJ local) (JJ anaesthetic) (NNS potencies)) (PP (IN on) (NP (NP (DT an) (VBN isolated) (NN frog) (NN nerve) (NN preparation)) (PP (IN at) (NP (DT a) (NN level))) (NP (QP (RB approximately) (CD three)) (NNS times)))) (SBAR (IN that) (FRAG (PP (IN of) (NP (NNS Doc_19108278_1095_1103_Chemical))))))) (. .)))
19108278	7	(ROOT (S (NP (DT The) (JJ racemic) (NN compound)) (VP (VBD was) (ADJP (RB significantly) (RBR less) (JJ potent)) (PP (IN than) (NP (DT either) (NN isomer) (CD .6)))) (. .)))
19108278	8	(ROOT (S (S (NP (NP (DT Both) (NNS isomers)) (PP (IN of) (NP (NNS Doc_19108278_1194_1205_Chemical)))) (VP (VBD were) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG preventing) (NP (NN Doc_19108278_1233_1243_Chemical-induced) (NNS Doc_19108278_1252_1271_Disease)) (PP (IN in) (NP (NP (NNS cats)) (VP (VBN anaesthetized) (PP (IN with) (NP (NNS Doc_19108278_1299_1308_Chemical)))))))))))) (, ,) (CC but) (S (NP (NP (DT the) (JJ mean) (NN dose)) (PP (IN of) (NP (NNS Doc_19108278_1331_1346_Chemical)))) (VP (VBD was) (NP (NP (NP (CD 0.09)) (VP (VBN +))) (PRN (: /) (NP (NP (CD -0.02) (NN mg/kg)) (SBAR (IN whereas) (S (NP (NP (DT that)) (PP (IN of) (NP (NNS Doc_19108278_1385_1400_Chemical)))) (VP (VBD was) (NP (QP (CD 4.2) (CD +))))))) (: /)) (NP (CD -1.2) (NN mg/kg))))) (. .)))
19108278	9	(ROOT (S (PP (IN At) (NP (NP (DT the) (JJ effective) (NN dose) (NN level)) (PP (IN of) (NP (NNS Doc_19108278_1453_1468_Chemical))))) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN prolongation)) (PP (IN of) (NP (NP (DT the) (NNP PR) (NN interval)) (PP (IN of) (NP (DT the) (NN electrocardiogram))))))) (. .)))
19108278	10	(ROOT (S (NP (NP (NNP Blockade)) (PP (IN of) (NP (NP (NNS Doc_19108278_1563_1574_Disease)) (PP (IN with) (NP (DT both) (NNS isomers)))))) (VP (VBD was) (ADJP (JJ surmountable) (PP (IN by) (S (VP (VBG increasing) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NNP Doc_19108278_1636_1646_Chemical) (CD .7))))))))) (. .)))
19108278	11	(ROOT (S (NP (NP (DT Both) (NNS isomers)) (PP (IN of) (NP (NNS Doc_19108278_1666_1677_Chemical)))) (VP (VBD were) (ADVP (RB also)) (ADJP (JJ capable)) (PP (IN of) (S (VP (VBG reversing) (NP (NP (NNS Doc_19108278_1709_1732_Disease)) (VP (VBN caused) (PP (IN by) (NP (NP (NNS Doc_19108278_1743_1750_Chemical)) (PP (IN in) (NP (JJ anaesthetized) (NNS cats) (CC and) (NNS dogs))))))))))) (. .)))
19108278	12	(ROOT (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NNS Doc_19108278_1795_1810_Chemical)))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR smaller) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NP (NNS Doc_19108278_1850_1865_Chemical)) (PP (IN in) (NP (DT both) (NN species)))))))) (CC but) (ADJP (RB much) (JJR higher))) (PP (IN than) (NP (NP (DT that)) (VP (VBN required) (S (VP (TO to) (VP (VB produce) (NP (NP (NN evidence)) (PP (IN of) (NP (JJ beta-blockade) (CD .8))))))))))) (. .)))
19108278	13	(ROOT (S (NP (NP (DT The) (NNS implications)) (PP (IN of) (NP (DT these) (NNS results)))) (VP (VBP are) (VP (VBN discussed))) (. .)))
19139825	0	(ROOT (NP (NP (NP (NNP Doc_19139825_0_9_Chemical)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NN radiotherapy)) (PP (IN in) (NP (JJ unresectable) (NNS Doc_19139825_59_71_Disease)))))))) (: :) (NP (NP (DT a) (NN phase)) (NP (CD 2) (NN study))) (. .)))
19139825	1	(ROOT (S (NP (NN Improving) (NNS Doc_19139825_100_112_Disease)) (VP (VBP multiforme) (SBAR (S (PRN (-LRB- -LRB-) (NP (NNP GBM)) (-RRB- -RRB-)) (NP (NP (NN treatment)) (PP (IN with) (NP (NN radio-chemotherapy)))) (VP (VBZ remains) (NP (DT a) (NN challenge)))))) (. .)))
19139825	2	(ROOT (S (NP (NNP Doc_19139825_185_194_Chemical)) (VP (VBZ is) (NP (DT an) (JJ attractive) (NN option)) (SBAR (IN as) (S (NP (PRP it)) (VP (VBZ exhibits) (NP (NP (NP (NN growth) (NN inhibition)) (PP (IN of) (NP (JJ human) (NNS Doc_19139825_261_267_Disease)))) (CONJP (RB as) (RB well) (IN as)) (NP (NN brain) (NN penetration))))))) (. .)))
19139825	3	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBD assessed) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (NN radiotherapy)) (PRN (-LRB- -LRB-) (NP (NP (CD 60) (NNS Gy/30)) (NP (CD fractions/40) (NNS days))) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_19139825_390_399_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.9) (NN mg/m)) (NP (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (JJ /) (NN day)) (PP (IN on) (NP (NP (NNS days)) (ADJP (JJ 1-5) (PP (IN on) (NP (NNS weeks))) (NP (CD 1) (, ,) (CD 3) (CC and) (CD 5))))))) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (CD 50) (NNS adults)) (PP (IN with) (NP (ADJP (RB histologically) (JJ proven) (CC and) (JJ untreated)) (NNP GBM)))))) (. .)))
19139825	4	(ROOT (S (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (JJ non-hematological) (NNS Doc_19139825_544_554_Disease)))) (VP (VBD was) (ADJP (JJ low)))) (CC and) (S (NP (NP (NN grade)) (NP (CD 3-4) (JJ hematological) (NNS Doc_19139825_591_601_Disease))) (VP (VBD were) (VP (VBN reported) (PP (IN in) (NP (NP (CD 20) (NNS patients)) (PRN (-LRB- -LRB-) (NP (RB mainly) (NN Doc_19139825_639_650_Disease) (CC and) (NNS Doc_19139825_655_666_Disease)) (-RRB- -RRB-))))))) (. .)))
19139825	5	(ROOT (S (NP (JJ Partial) (NN response) (CC and) (NN stabilization) (NNS rates)) (VP (VBD were) (NP (QP (CD 2) (NN %) (CC and) (CD 32) (NN %))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN with) (NP (DT an) (JJ overall) (NN time) (S (VP (TO to) (VP (VB progression) (PP (IN of) (NP (CD 12) (NNS weeks))))))))) (. .)))
19139825	6	(ROOT (S (NP (NP (NP (JJ One-year) (JJ overall) (NN survival)) (PRN (-LRB- -LRB-) (NP (NNP OS)) (-RRB- -RRB-))) (ADJP (NN rate))) (VP (VBD was) (NP (CD 42) (NN %)) (, ,) (PP (IN with) (NP (NP (DT a) (JJ median) (NN OS)) (PP (IN of) (NP (CD 40) (NNS weeks)))))) (. .)))
19139825	7	(ROOT (S (NP (NP (NNP Doc_19139825_865_874_Chemical)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN radiotherapy)))))) (VP (VBD was) (ADJP (RB well) (JJ tolerated))) (. .)))
19139825	8	(ROOT (S (ADVP (RB However)) (, ,) (SBAR (IN while) (S (NP (NN response) (CC and) (NN stabilization)) (VP (VBD concerned) (NP (NP (NN one-third)) (PP (IN of) (NP (DT the) (NNS patients))))))) (, ,) (NP (DT the) (NN study)) (VP (VBD did) (RB not) (VP (VB show) (NP (VBN increased) (NNS benefits)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN survival))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ unresectable) (NNP GBM))))))) (. .)))
19154241	0	(ROOT (NP (NP (NP (JJ Long-term) (JJ Doc_19154241_10_17_Chemical) (NN therapy)) (VP (VBG leading) (PP (TO to) (NP (NNS Doc_19154241_37_56_Disease))))) (: :) (NP (NP (DT a) (NN case)) (NP (NN report))) (. .)))
19154241	1	(ROOT (S (NP (DT This) (NN paper)) (VP (VP (VBZ reviews) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ chronic) (JJ Doc_19154241_123_130_Chemical) (NN therapy)))) (PP (IN on) (NP (JJ serum) (JJ Doc_19154241_148_155_Chemical) (NN level)))) (CC and) (VP (VBD parathyroid) (NP (NP (NNS glands)) (, ,) (NP (PRP$ its) (NNS pathogenesis)) (, ,) (CC and) (NP (NN treatment) (NNS options))))) (. .)))
19154241	2	(ROOT (S (NP (PRP We)) (VP (VBD examined) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT a) (NN Doc_19154241_253_260_Chemical-treated) (NN patient))) (SBAR (WHNP (WP who)) (S (VP (VBD had) (S (NP (NN recurrent) (NNS Doc_19154241_295_308_Disease)) (VP (TO to) (VP (ADVP (RBR better)) (VB understand) (NP (DT the) (NN disease) (NN process)))))))))) (. .)))
19154241	3	(ROOT (S (NP (NNP Doc_19154241_363_390_Disease)) (VP (VBZ is) (NP (NP (DT a) (ADJP (ADJP (JJ rare)) (CC but) (ADJP (RB potentially) (JJ life-threatening))) (NN side) (NN effect)) (PP (IN of) (NP (JJ long-term) (JJ Doc_19154241_459_466_Chemical) (NN therapy))))) (. .)))
19154241	4	(ROOT (S (NP (NP (JJ Careful) (NN patient) (NN selection)) (CC and) (NP (JJ long-term) (NN follow-up))) (VP (MD can) (VP (VB reduce) (NP (NN morbidity)))) (. .)))
19154241	5	(ROOT (NP (NP (NNP PRACTICAL) (NNP IMPLICATIONS)) (: :) (NP (NP (QP (RB As) (JJ much) (IN as) (CD 15) (NN %))) (PP (IN of) (NP (NN Doc_19154241_590_597_Chemical-treated) (NNS patients))) (VP (VBN become) (S (ADJP (JJ hypercalcemic))))) (. .)))
19154241	6	(ROOT (S (PP (IN By) (S (ADVP (RB routinely)) (VP (VBG monitoring) (NP (JJ serum) (JJ Doc_19154241_667_674_Chemical) (NNS levels))))) (, ,) (NP (NN healthcare) (NNS providers)) (VP (MD can) (VP (VB improve) (NP (NP (DT the) (NN quality)) (PP (IN of) (NP (NP (NN life)) (PP (IN of) (NP (DT this) (JJ patient) (NN group)))))))) (. .)))
19178808	0	(ROOT (NP (NP (NNP Comparison)) (PP (IN of) (NP (JJ laryngeal) (NN mask))) (PP (IN with) (NP (NP (JJ endotracheal) (NN tube)) (PP (IN for) (NP (NN anesthesia))))) (PP (IN in) (NP (JJ endoscopic) (NNS sinus) (NN surgery))) (. .)))
19178808	1	(ROOT (SINV (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB compare) (NP (JJ surgical) (NNS conditions)) (, ,) (PP (VBG including) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NNS Doc_19178808_194_217_Disease)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ intraoperative) (NN blood) (NN pressure)))))) (, ,) (PP (IN during) (NP (NP (NP (ADJP (JJ functional) (JJ endoscopic)) (JJ sinus) (NN surgery)) (PRN (-LRB- -LRB-) (NP (NNP FESS)) (-RRB- -RRB-))) (VP (VBG using) (ADJP (JJ flexible)))))))))) (VP (VBD reinforced) (NP (NP (NP (JJ laryngeal) (NN mask) (NN airway)) (PRN (-LRB- -LRB-) (NP (NNP FRLMA)) (-RRB- -RRB-))) (PP (IN versus) (NP (NP (JJ endotracheal) (NN tube)) (PRN (-LRB- -LRB-) (NP (NNP ETT)) (-RRB- -RRB-))))) (PP (IN in) (S (VP (VBG maintaining) (NP (NP (VBN controlled) (JJ Doc_19178808_423_434_Disease) (NN anesthesia)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_19178808_457_465_Chemical-Doc_19178808_466_478_Chemical))))))))) (NP (NP (JJ total) (NN i.v.) (NN anesthesia)) (PRN (-LRB- -LRB-) (NP (NNP TIVA)) (-RRB- -RRB-))) (. .)))
19178808	2	(ROOT (NP (NP (NP (CD Sixty) (NN normotensive)) (SBAR (S (NP (NP (NNP American) (NNP Society)) (PP (IN of) (NP (NNP Anesthesiologists) (NNP I-II) (NN adult) (NNS patients))) (VP (VBG undergoing) (NP (NNS FESS)) (PP (IN under) (NP (NP (JJ controlled) (JJ Doc_19178808_628_639_Disease) (NN anesthesia)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_19178808_661_669_Chemical-Doc_19178808_670_682_Chemical-TIVA)))))))) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN assigned) (PP (IN into) (NP (CD two) (NNS groups)))))))) (: :) (NP (NP (NN group) (NN I)) (, ,) (NP (NNP FRLMA))) (: ;) (NP (NP (NN group)) (NP (NNP II) (, ,) (NNP ETT))) (. .)))
19178808	3	(ROOT (S (S (NP (NNP Doc_19178808_759_769_Disease)) (VP (VBD was) (VP (VBN measured)))) (CC and) (S (NP (NP (DT the) (NN visibility)) (PP (IN of) (NP (DT the) (JJ operative) (NN field)))) (VP (VBD was) (VP (VBN evaluated) (PP (VBG according) (PP (TO to) (NP (DT a) (JJ six-point) (NN scale))))))) (. .)))
19178808	4	(ROOT (S (NP (JJ Controlled) (NNS Doc_19178808_891_902_Disease)) (VP (VBD was) (VP (VBN achieved) (PP (IN within) (NP (NP (DT a) (JJR shorter) (NN period)) (VP (VBG using) (NP (JJ laryngeal) (NN mask)) (S (VP (VBG using) (NP (NP (NP (JJR lower) (NNS rates)) (PP (IN of) (NP (JJ Doc_19178808_982_994_Chemical) (NN infusion)))) (CC and) (NP (NP (JJR lower) (JJ total) (NN dose)) (PP (IN of) (NP (NNS Doc_19178808_1028_1040_Chemical)))))))))))) (. .)))
19178808	5	(ROOT (S (PP (IN In) (NP (NN summary))) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ airway) (NN management)) (VP (VBG using) (NP (NNP FRLMA)) (PP (IN during) (NP (JJ controlled) (JJ Doc_19178808_1140_1151_Disease) (NN anesthesia))))) (VP (VP (VBD provided) (NP (JJR better) (JJ surgical) (NNS conditions)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NN quality)) (PP (IN of) (NP (JJ operative) (NN field) (CC and) (NNS Doc_19178808_1242_1252_Disease)))))))) (CC and) (VP (VBD allowed) (PP (IN for) (NP (NP (JJ convenient) (JJ induced) (NNS Doc_19178808_1288_1299_Disease)) (PP (IN with) (NP (NP (JJ low) (NNS doses)) (PP (IN of) (NP (NNS Doc_19178808_1318_1330_Chemical))))))) (PP (IN during) (NP (NP (NNP TIVA)) (PP (IN in) (NP (NNS patients))))) (S (VP (VBG undergoing) (NP (NNS FESS))))))))) (. .)))
19184102	0	(ROOT (S (VP (VB Doc_19184102_0_32_Disease) (PP (IN during) (NP (JJ Doc_19184102_40_49_Chemical) (NN therapy)))) (. .)))
19184102	1	(ROOT (S (S (NP (NP (NNP Doc_19184102_59_72_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19184102_74_77_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ effective) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (JJ many) (NNS types)) (PP (IN of) (NP (NNS Doc_19184102_127_135_Disease)))))))))) (, ,) (CC but) (S (NP (PRP$ its) (NN use)) (VP (MD can) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN body) (NN weight))))))))) (. .)))
19184102	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NP (NNS Doc_19184102_220_252_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19184102_254_259_Disease)) (-RRB- -RRB-))) (VP (VBG arising) (PP (IN in) (NP (NP (DT a) (NN child)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_19184102_294_301_Disease)) (PP (IN during) (NP (JJ Doc_19184102_309_312_Chemical) (NN treatment))))))))))))) (. .)))
19184102	3	(ROOT (S (NP (NNP Laboratory) (NNS data)) (VP (VBD revealed) (NP (NNS Doc_19184102_349_365_Disease)) (PP (IN with) (NP (NN insulin) (NN resistance)))) (. .)))
19184102	4	(ROOT (S (S (PP (IN After) (NP (NP (DT the) (NN withdrawal)) (PP (IN of) (NP (JJ Doc_19184102_415_418_Chemical) (NN therapy))))) (, ,) (NP (PRP$ our) (NN patient)) (VP (VBD showed) (NP (NP (DT a) (JJ significant) (NNS Doc_19184102_461_472_Disease)) (, ,) (NP (NP (DT a) (NN decrease)) (PP (IN of) (NP (NN body) (NN mass) (NN index)))) (, ,) (CC and) (NP (NP (NN normalization)) (PP (IN of) (NP (ADJP (JJ metabolic) (CC and) (JJ endocrine)) (NNS parameters))))))) (: ;) (S (ADVP (RB moreover)) (, ,) (NP (NN ultrasound) (NNS measurements)) (VP (VBD showed) (NP (DT a) (JJ complete) (NN normalization)))) (. .)))
19184102	5	(ROOT (S (S (NP (DT The) (JJ present) (NN case)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NNS Doc_19184102_660_667_Disease)) (, ,) (NP (NNS Doc_19184102_669_685_Disease)) (, ,) (NP (NN insulin) (NN resistance)) (, ,) (CC and) (NP (NP (JJ long-term) (NN treatment)) (PP (IN with) (NP (NNS Doc_19184102_736_739_Chemical))))) (VP (MD may) (VP (VB be) (VP (ADVP (DT all)) (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_19184102_786_791_Disease)))))))))))) (: ;) (S (NP (DT this) (NN side) (NN effect)) (VP (VBZ is) (ADJP (JJ reversible) (PP (IN after) (NP (JJ Doc_19184102_830_833_Chemical) (NN withdrawal)))))) (. .)))
19263707	0	(ROOT (NP (NP (NNP Doc_19263707_0_11_Chemical) (NNP induced) (NNP ANCA)) (NP (JJ positive) (NNS Doc_19263707_34_44_Disease)) (. .)))
19263707	1	(ROOT (S (NP (JJ Anti-thyroid) (NNS drugs)) (, ,) (PP (IN like) (NP (NNS Doc_19263707_71_82_Chemical) (CC and) (NNS Doc_19263707_87_103_Chemical))) (PRN (-LRB- -LRB-) (NP (NNP Doc_19263707_105_108_Chemical)) (-RRB- -RRB-)) (VP (VBP are) (ADVP (RB commonly)) (VP (VBN prescribed) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_19263707_155_170_Disease))))))) (. .)))
19263707	2	(ROOT (S (NP (PRP One)) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (NP (DT the) (NN side) (NNS effects)) (PP (IN of) (NP (JJ antithyroid) (NNS medications)))))))) (. .)))
19263707	3	(ROOT (NP (NP (JJ Antineutrophil) (JJ cytoplasmic) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NNP ANCA)) (-RRB- -RRB-)) (: --) (NP (NP (JJ associated) (NNS Doc_19263707_295_305_Disease)) (SBAR (S (VP (VBZ is) (NP (NP (DT a) (ADJP (RB potentially) (JJ life-threatening)) (JJ adverse) (NN effect)) (PP (IN of) (NP (NNS antithyroidmedications)))))))) (. .)))
19263707	4	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_19263707_407_422_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (NNP ANCA) (JJ positive) (NNS Doc_19263707_451_462_Chemical)) (VP (VBN induced) (NP (NNS Doc_19263707_471_481_Disease)))))))))) (. .)))
19263707	5	(ROOT (S (NP (DT The) (NN episode)) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (DT a) (JJ vasculitic) (NNS Doc_19263707_529_538_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ large) (JJ joint) (NNS Doc_19263707_567_576_Disease)) (, ,) (NP (NNS Doc_19263707_578_585_Disease) (CC and) (NNS Doc_19263707_590_601_Disease)) (CC but) (NP (DT no) (NNS Doc_19263707_609_639_Disease))))))))) (. .)))
19263707	6	(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN referred) (PP (TO to) (NP (PRP us))) (PP (IN for) (NP (JJ neurological) (NN evaluation))) (SBAR (IN because) (S (NP (PRP he)) (VP (VP (VBD had) (NP (NP (NN difficulty)) (PP (IN in) (S (VP (VBG getting) (PRT (RP up)) (PP (IN from) (S (VP (VBG squatting) (NP (NN position)))))))))) (CC and) (VP (VBD was) (VP (VBN suspected) (S (VP (TO to) (VP (VB have) (NP (NNS Doc_19263707_781_789_Disease)))))))))))) (. .)))
19263707	7	(ROOT (S (NP (NNS Doc_19263707_791_802_Chemical) (CC and) (NNS Doc_19263707_807_818_Chemical)) (VP (VBP have) (NP (NP (DT a) (JJR lower) (NN incidence)) (PP (IN of) (NP (JJ reported) (NNP ANCA) (JJ positive) (NN side) (NNS effects)))) (PP (IN than) (NP (NNP PUT)))) (. .)))
19263707	8	(ROOT (S (PP (TO To) (NP (NP (DT the) (JJS best)) (PP (IN of) (NP (PRP$ our) (NN knowledge))))) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (NNP ANCA) (JJ positive) (NN Doc_19263707_952_963_Chemical)) (VP (VBN induced) (NP (NP (JJ Doc_19263707_972_982_Disease) (NN case)) (VP (VBN reported) (PP (IN from) (NP (NNP India)))))))) (. .)))
19293073	0	(ROOT (NP (NP (NP (NNP Doc_19293073_0_7_Chemical)) (PP (IN for) (NP (NP (DT the) (JJ primary) (NN prevention)) (PP (IN of) (NP (JJ cardiovascular) (NNS events)))))) (: :) (NP (NP (DT an) (NN update)) (PP (IN of) (NP (NP (DT the) (NN evidence)) (PP (IN for) (NP (DT the) (NNP U.S.) (NNP Preventive) (NNPS Services) (NNP Task) (NNP Force)))))) (. .)))
19293073	1	(ROOT (S (NP (NNS Doc_19293073_144_166_Disease) (CC and) (NNS Doc_19293073_171_194_Disease)) (VP (VBP are) (NP (NP (VBG leading) (NNS causes)) (PP (IN of) (NP (NP (NNS Doc_19293073_217_222_Disease)) (PP (IN in) (NP (DT the) (NNP United) (NNPS States))))))) (. .)))
19293073	2	(ROOT (S (PP (IN In) (NP (CD 2002))) (, ,) (NP (NP (DT the) (NNP U.S.) (NNP Preventive) (NNP Services) (NNP Task) (NNP Force)) (PRN (-LRB- -LRB-) (NP (NNP USPSTF)) (-RRB- -RRB-))) (ADVP (RB strongly)) (VP (VBD recommended) (SBAR (IN that) (S (NP (NNS clinicians)) (VP (VB discuss) (NP (NNS Doc_19293073_348_355_Chemical)) (PP (IN with) (NP (NP (NNS adults)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (PP (IN at) (NP (NP (VBN increased) (NN risk)) (PP (IN for) (NP (NNS Doc_19293073_398_420_Disease)))))))))))))) (. .)))
19293073	3	(ROOT (S (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NNS benefits) (CC and) (NNS harms)) (PP (IN of) (S (VP (VBG taking) (NP (NNS Doc_19293073_477_484_Chemical)) (PP (IN for) (NP (NP (DT the) (JJ primary) (NN prevention)) (PP (IN of) (NP (NNS Doc_19293073_515_537_Disease) (, ,) (NNS Doc_19293073_539_546_Disease) (, ,) (CC and) (NNS Doc_19293073_552_557_Disease))))))))))) (. .)))
19293073	4	(ROOT (NP (NP (NNP DATA) (NNP SOURCES)) (: :) (NP (NP (NP (NNP MEDLINE) (CC and) (NNP Cochrane) (NNP Library)) (PRN (-LRB- -LRB-) (NP (NP (NN search) (NNS dates)) (, ,) (NP (NP (CD 1) (NNP January) (CD 2001)) (PP (TO to) (NP (CD 28))) (NP (NNP August) (CD 2008)))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ recent) (JJ systematic) (NNS reviews)) (, ,) (NP (NP (NN reference) (NNS lists)) (PP (IN of) (NP (JJ retrieved) (NNS articles)))) (, ,)) (CC and) (NP (NP (NNS suggestions)) (PP (IN from) (NP (NNS experts))))) (. .)))
19293073	5	(ROOT (FRAG (NP (NNP STUDY) (NNP SELECTION)) (: :) (S (NP (NP (NP (NP (JJ English-language) (NN randomized)) (, ,) (NP (NP (VBN controlled) (NNS trials)) (PRN (-LRB- -LRB-) (NP (NNP RCTs)) (-RRB- -RRB-)))) (: ;) (NP (NP (JJ case-control) (NNS studies)) (: ;) (NP (NNS meta-analyses))) (: ;) (CC and) (NP (NP (JJ systematic) (NNS reviews)) (PP (IN of) (NP (NP (NNS Doc_19293073_883_890_Chemical)) (PP (IN versus) (NP (NP (NN control)) (PP (IN for) (NP (NP (DT the) (JJ primary) (NN prevention)) (PP (IN of) (NP (NNS Doc_19293073_936_958_Disease))))))))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_19293073_960_963_Disease)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN selected) (S (VP (TO to) (VP (VB answer) (NP (NP (DT the) (JJ following) (NNS questions)) (: :) (SQ (VBZ Does) (NP (NNS Doc_19293073_1019_1026_Chemical)) (VP (VB decrease) (NP (NP (NP (JJ coronary) (NN heart) (NNS events)) (, ,) (NP (NNS Doc_19293073_1059_1066_Disease)) (, ,) (NP (NP (NNS Doc_19293073_1068_1073_Disease)) (PP (IN from) (NP (JJ coronary) (NN heart) (NNS events)))) (CC or) (NP (NNS Doc_19293073_1104_1110_Disease))) (, ,) (CC or) (NP (NP (JJ all-cause) (NN mortality)) (PP (IN in) (NP (NNS adults))))) (PP (IN without) (NP (VBN known) (NNS Doc_19293073_1159_1162_Disease)))))))))))) (. ?)))
19293073	6	(ROOT (SQ (NNP Does) (NP (NNS Doc_19293073_1169_1176_Chemical)) (VP (VB increase) (NP (NNS Doc_19293073_1186_1211_Disease) (CC or) (NNS Doc_19293073_1215_1234_Disease))) (. ?)))
19293073	7	(ROOT (NP (NP (NNP DATA) (NNP EXTRACTION)) (: :) (S (NP (DT All) (NNS studies)) (VP (VBD were) (VP (VP (VBN reviewed)) (, ,) (VP (VBN abstracted)) (, ,) (CC and) (VP (VBN rated) (PP (IN for) (NP (NN quality))) (PP (IN by) (S (VP (VBG using) (NP (JJ predefined) (NNP USPSTF) (NNS criteria))))))))) (. .)))
19293073	8	(ROOT (FRAG (NP (NNP DATA) (NNP SYNTHESIS)) (: :) (S (NP (NP (NNP New) (NN evidence)) (PP (IN from) (NP (NP (CD 1) (JJ good-quality) (NN RCT)) (, ,) (NP (CD 1) (JJ good-quality) (NNS meta-analysis)) (, ,) (CC and) (NP (NP (CD 2) (JJ fair-quality) (NNS subanalyses)) (PP (IN of) (NP (NNP RCTs))))))) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (JJ Doc_19293073_1492_1499_Chemical) (NN use)) (VP (VBZ reduces) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (JJ Doc_19293073_1526_1529_Disease) (NNS events)) (PP (IN in) (NP (NNS patients)))))) (PP (IN without) (NP (JJ known) (NNS Doc_19293073_1563_1566_Disease)))))))) (. .)))
19293073	9	(ROOT (S (NP (NP (NNS Men)) (PP (IN in) (NP (DT these) (NNS studies)))) (VP (VBD experienced) (SBAR (S (NP (JJR fewer) (NNS Doc_19293073_1607_1629_Disease) (CC and) (NNS women)) (VP (VBD experienced) (NP (JJR fewer) (NNS Doc_19293073_1658_1674_Disease)))))) (. .)))
19293073	10	(ROOT (S (NP (NNP Doc_19293073_1676_1683_Chemical)) (VP (VBZ does) (RB not) (VP (VB seem) (S (VP (TO to) (VP (VB affect) (NP (NP (JJ Doc_19293073_1708_1711_Disease) (NN mortality) (CC or) (JJ all-cause) (NN mortality)) (PP (IN in) (NP (CC either) (NNS men) (CC or) (NNS women))))))))) (. .)))
19293073	11	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NP (NNS Doc_19293073_1780_1787_Chemical)) (PP (IN for) (NP (JJ primary) (NN prevention)))))) (VP (VBZ increases) (NP (NP (DT the) (NN risk)) (PP (IN for) (NP (NP (JJ major) (JJ Doc_19293073_1840_1848_Disease) (NNS events)) (, ,) (NP (RB primarily) (JJ Doc_19293073_1867_1892_Disease) (NNS events)) (, ,)))) (PP (IN in) (NP (DT both) (NNS men) (CC and) (NNS women)))) (. .)))
19293073	12	(ROOT (S (NP (NNS Men)) (VP (VBP have) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN for) (NP (NP (NNS Doc_19293073_1955_1974_Disease)) (PP (IN with) (NP (JJ Doc_19293073_1980_1987_Chemical) (NN use))))))) (. .)))
19293073	13	(ROOT (S (NP (NP (DT A) (JJ new) (NN RCT)) (CC and) (NP (NNS meta-analysis))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN risk)) (PP (IN for) (NP (NP (NNS Doc_19293073_2047_2066_Disease)) (PP (IN in) (NP (NNS women)))))) (VP (VBZ is) (RB not) (ADJP (RB statistically) (RB significantly) (JJ increased)))))) (. .)))
19293073	14	(ROOT (S (NP (NP (NNP New) (NN evidence)) (PP (IN on) (NP (NP (NNS Doc_19293073_2151_2158_Chemical)) (PP (IN for) (NP (NP (DT the) (JJ primary) (NN prevention)) (PP (IN of) (NP (NNS Doc_19293073_2189_2192_Disease)))))))) (VP (VBZ is) (ADJP (JJ limited))) (. .)))
19293073	15	(ROOT (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NNS Doc_19293073_2217_2224_Chemical)))) (VP (VBD used) (PP (IN in) (NP (NP (DT the) (NNP RCTs) (NNP varied)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD prevented) (NP (NP (DT the) (NN estimation)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ appropriate)) (NN dose)) (PP (IN for) (NP (JJ primary) (NN prevention)))))))))))) (. .)))
19293073	16	(ROOT (S (NP (NP (JJ Several)) (PP (IN of) (NP (DT the) (NNPS RCTs)))) (VP (VBD were) (VP (VBN conducted) (PP (IN within) (NP (NP (NNS populations)) (PP (IN of) (NP (NP (NN health) (NNS professionals)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB potentially)) (VP (VBZ limits) (ADVP (RB generalizability))))))))))) (. .)))
19293073	17	(ROOT (S (NP (NNP Doc_19293073_2468_2475_Chemical)) (VP (VBZ reduces) (NP (NP (DT the) (NN risk)) (PP (IN for) (NP (NP (NNS Doc_19293073_2497_2518_Disease)) (PP (IN in) (NP (NNS men) (CC and) (NNS Doc_19293073_2530_2537_Disease)))))) (PP (IN in) (NP (NNS women)))) (. .)))
19293073	18	(ROOT (S (NP (JJ Doc_19293073_2548_2555_Chemical) (NN use)) (VP (VBZ increases) (NP (NP (DT the) (NN risk)) (PP (IN for) (NP (JJ serious) (JJ Doc_19293073_2591_2599_Disease) (NNS events))))) (. .)))
19338378	0	(ROOT (NP (NP (NP (JJ Reducing) (NN harm)) (VP (VBN associated) (PP (IN with) (NP (NN anticoagulation))))) (: :) (NP (NP (JJ practical) (NNS considerations)) (PP (IN of) (NP (NP (JJ Doc_19338378_75_85_Chemical) (NN therapy)) (PP (IN in) (NP (NN Doc_19338378_97_104_Chemical-induced) (NN thrombocytopenia)))))) (. .)))
19338378	1	(ROOT (S (NP (NNP Doc_19338378_131_141_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ hepatically) (JJ metabolized) (, ,) (JJ direct) (NN thrombin) (NN inhibitor)) (VP (VBN used) (PP (PP (IN for) (NP (NP (NNS prophylaxis) (CC or) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_19338378_235_245_Disease)) (PP (IN in) (NP (NP (NN Doc_19338378_249_256_Chemical-induced) (NN thrombocytopenia)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19338378_283_286_Disease)) (-RRB- -RRB-)))))))) (CC and) (PP (IN for) (S (NP (NP (NNS patients)) (PP (IN with) (CC or) (IN at) (NP (NP (NN risk)) (PP (IN of) (NP (NNS Doc_19338378_324_327_Disease)))))) (VP (VBG undergoing) (NP (NP (JJ percutaneous) (JJ coronary) (NN intervention)) (PRN (-LRB- -LRB-) (NP (NNP PCI)) (-RRB- -RRB-)))))))))) (. .)))
19338378	2	(ROOT (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN review)))) (VP (VBZ is) (S (VP (TO to) (VP (VB summarize) (NP (NP (JJ practical) (NNS considerations)) (PP (IN of) (NP (JJ Doc_19338378_454_464_Chemical) (NN therapy)))) (PP (IN in) (NP (NNS Doc_19338378_476_479_Disease))))))) (. .)))
19338378	3	(ROOT (SINV (S (NP (NP (DT The) (NNP US) (JJ FDA-recommended) (NNS Doc_19338378_504_514_Chemical) (NN dose)) (PP (IN in) (NP (NNS Doc_19338378_523_526_Disease)))) (VP (VBZ is) (NP (NP (CD 2) (NN microg/kg/min)) (PRN (-LRB- -LRB-) (VP (VBN reduced) (PP (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_19338378_572_590_Disease))))) (CC and) (PP (IN in) (NP (JJ paediatric) (NNS patients))))) (-RRB- -RRB-))))) (, ,) (VP (VBD adjusted) (S (VP (TO to) (VP (VB achieve) (NP (NP (VBN activated) (JJ partial) (NN thromboplastin) (NNS times)) (PRN (-LRB- -LRB-) (VP (VBZ aPTTs)) (-RRB- -RRB-))) (NP (CD 1.5-3) (NNS times)))))) (NP (NP (NN baseline)) (PRN (-LRB- -LRB-) (NP (QP (RB not) (CD >) (CD 100)) (NNS seconds)) (-RRB- -RRB-))) (. .)))
19338378	4	(ROOT (S (NP (NNP Contemporary) (NNS experiences)) (VP (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ reduced) (NNS doses)) (VP (VBP are) (ADVP (RB also)) (VP (VBN needed) (PP (IN in) (NP (NNS patients))) (PP (IN with) (NP (NP (NNS conditions)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ hepatic) (NN hypoperfusion)) (, ,) (NP (NNP e.g.) (NNP Doc_19338378_869_882_Disease)))))))))))) (, ,) (CC yet) (VP (VBP are) (ADJP (JJ unnecessary) (PP (IN for) (NP (JJ Doc_19338378_908_925_Disease) (, ,) (JJ adult) (NN age) (, ,) (NN sex) (, ,) (NN race/ethnicity) (CC or) (NNS Doc_19338378_961_968_Disease)))))) (. .)))
19338378	5	(ROOT (S (NP (NNP Doc_19338378_970_980_Chemical) (JJ 0.5-1) (CD .2) (NN microg/kg/min)) (ADVP (RB typically)) (VP (VBZ supports) (NP (JJ therapeutic) (NNS aPTTs))) (. .)))
19338378	6	(ROOT (S (NP (NP (DT The) (JJ FDA-recommended) (NN dose)) (PP (IN during) (NP (NNP PCI)))) (VP (VBZ is) (NP (NP (NP (CD 25) (NN microg/kg/min)) (-LRB- -LRB-) (NP (CD 350) (JJ microg/kg) (JJ initial) (NNS bolus)) (-RRB- -RRB-)) (, ,) (VP (VBN adjusted) (S (VP (TO to) (VP (VB achieve) (NP (NP (VBN activated) (VBG clotting) (NNS times)) (PRN (-LRB- -LRB-) (NP (NNP ACTs)) (-RRB- -RRB-)) (PP (IN of) (NP (CD 300-450) (NN sec)))))))))) (. .)))
19338378	7	(ROOT (S (S (PP (IN For) (NP (NNP PCI))) (, ,) (NP (NNS Doc_19338378_1205_1215_Chemical)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN investigated) (PP (IN in) (NP (JJ Doc_19338378_1245_1265_Disease) (NNS patients))))))) (: ;) (S (S (NP (NN dose) (NN adjustment)) (VP (VBZ is) (ADJP (JJ unnecessary) (PP (IN for) (NP (JJ adult) (NN age) (, ,) (NN sex) (, ,) (NN race/ethnicity) (CC or) (NNS Doc_19338378_1345_1352_Disease)))))) (, ,) (CC and) (S (NP (JJR lesser) (NNS doses)) (VP (MD may) (VP (VB be) (ADJP (JJ adequate) (PP (IN with) (NP (JJ concurrent) (NNP glycoprotein) (NNP IIb/IIIa) (NN inhibition)))))))) (. .)))
19338378	8	(ROOT (S (S (NP (NNP Doc_19338378_1437_1447_Chemical)) (VP (VBZ prolongs) (NP (DT the) (NNP International) (NNP Normalized) (NNP Ratio)))) (, ,) (CC and) (S (NP (NP (VBN published) (NNS approaches)) (PP (IN for) (S (VP (VBG monitoring) (NP (DT the) (NN Doc_19338378_1537_1547_Chemical-to-Doc_19338378_1551_1559_Chemical) (NN transition)))))) (VP (MD should) (VP (VB be) (VP (VBN followed))))) (. .)))
19338378	9	(ROOT (S (NP (NP (NNP Doc_19338378_1591_1605_Disease)) (PP (IN with) (NP (NNS Doc_19338378_1611_1621_Chemical)))) (VP (VBZ is) (NP (CD 0-10) (NN %)) (PP (IN in) (NP (NP (DT the) (JJ non-interventional) (NN setting)) (CC and) (NP (CD 0-5) (CD .8) (NN %)))) (ADVP (RB periprocedurally))) (. .)))
19338378	10	(ROOT (S (S (NP (NNP Doc_19338378_1694_1704_Chemical)) (VP (VBZ has) (NP (DT no) (JJ specific) (NN antidote)))) (, ,) (CC and) (S (SBAR (IN if) (S (NP (JJ excessive) (NN anticoagulation)) (VP (VBZ occurs)))) (, ,) (NP (JJ Doc_19338378_1772_1782_Chemical) (NN infusion)) (VP (MD should) (VP (VB be) (VP (VBN stopped) (CC or) (VBN reduced))))) (. .)))
19338378	11	(ROOT (S (NP (NP (JJ Improved) (NN familiarity)) (PP (IN of) (NP (NP (NN healthcare) (NNS professionals)) (PP (IN with) (NP (NP (JJ Doc_19338378_1876_1886_Chemical) (NN therapy)) (PP (IN in) (NP (NNS Doc_19338378_1898_1901_Disease)))))))) (, ,) (PP (VBG including) (PP (PP (IN in) (NP (JJ special) (NNS populations))) (CC and) (PP (IN during) (NP (NNP PCI))))) (, ,) (VP (MD may) (VP (VB facilitate) (NP (NP (NN reduction)) (PP (IN of) (NP (NP (NN harm)) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_19338378_2001_2004_Disease)) (PRN (-LRB- -LRB-) (NP (QP (CD e.g.) (JJR fewer)) (NNS Doc_19338378_2017_2027_Disease)) (-RRB- -RRB-)) (CC or) (NP (PRP$ its) (NN treatment)) (PRN (-LRB- -LRB-) (NP (NP (NNP e.g.)) (NP (JJR fewer) (JJ Doc_19338378_2058_2068_Chemical) (NN medication) (NNS errors))) (-RRB- -RRB-)))))))))) (. .)))
19392810	0	(ROOT (NP (NP (NN Doc_19392810_0_14_Disease) (CC and) (NN brain) (NNS Doc_19392810_25_40_Disease)) (PP (IN in) (NP (DT a) (NN Doc_19392810_46_52_Chemical-dependent) (NN male))) (PP (IN under) (NP (JJ Doc_19392810_74_83_Chemical) (NN maintenance) (NN therapy))) (. .)))
19392810	1	(ROOT (S (NP (EX There)) (VP (VBP are) (NP (NP (JJ several) (NNS complications)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ Doc_19392810_164_170_Chemical) (NN abuse)) (, ,) (SBAR (WHNP (NP (DT some)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (ADJP (JJ life-threatening)))))))))) (. .)))
19392810	2	(ROOT (S (NP (NNP Doc_19392810_214_223_Chemical)) (VP (MD may) (VP (VB aggravate) (NP (DT this) (NN problem)))) (. .)))
19392810	3	(ROOT (NP (DT A) (JJ clinical) (NN case) (NN description) (. .)))
19392810	4	(ROOT (S (NP (DT A) (JJ 33-year-old) (NN man)) (VP (VBD presented) (PP (IN with) (NP (JJ Doc_19392810_331_345_Disease) (CC and) (JJ cerebral) (NNS Doc_19392810_359_374_Disease))) (PP (IN after) (NP (JJ intravenous) (NNS Doc_19392810_393_399_Chemical)))) (. .)))
19392810	5	(ROOT (S (NP (PRP He)) (VP (VP (VBD had) (VP (VBN used) (NP (NNS Doc_19392810_413_419_Chemical)) (PP (IN since) (NP (NN age) (CD 20))))) (, ,) (CC and) (VP (VBD had) (VP (VBN used) (NP (CD 150) (NN mg) (NNS Doc_19392810_454_463_Chemical)) (ADVP (RB daily)) (PP (IN for) (NP (CD 6) (NNS months)))))) (. .)))
19392810	6	(ROOT (S (NP (PRP He)) (VP (VP (VBD was) (VP (VBN found) (NP (NNS unconsciousness)) (PP (IN at) (NP (NN home))))) (CC and) (VP (VBD was) (VP (VBN sent) (PP (TO to) (NP (PRP$ our) (NN hospital)))))) (. .)))
19392810	7	(ROOT (S (PP (IN In) (NP (DT the) (NNP ER))) (, ,) (NP (PRP$ his) (JJ opiate) (NN level)) (VP (VBD was) (NP (CD 4497) (NN ng/ml))) (. .)))
19392810	8	(ROOT (S (PP (IN In) (NP (DT the) (NNP ICU))) (, ,) (NP (PRP we)) (VP (VBD found) (NP (NNS Doc_19392810_616_630_Disease) (, ,) (NNS Doc_19392810_632_651_Disease) (CC and) (NNS Doc_19392810_656_681_Disease))) (. .)))
19392810	9	(ROOT (S (PP (IN After) (NP (NP (NN transfer)) (PP (TO to) (NP (DT an) (JJ internal) (NN ward))))) (, ,) (NP (PRP we)) (VP (VBD noted) (NP (NP (NNS Doc_19392810_728_735_Disease) (CC and) (NN weakness)) (PP (IN of) (NP (PRP$ his) (JJ left) (NNS limbs))))) (. .)))
19392810	10	(ROOT (S (PP (IN After) (NP (NNP MRI))) (, ,) (NP (PRP we)) (VP (VBD found) (NP (JJ cerebral) (NNS Doc_19392810_797_816_Disease))) (. .)))
19392810	11	(ROOT (S (NP (NP (DT Those)) (VP (VBG using) (NP (NNS Doc_19392810_842_851_Chemical) (CC and) (NNS Doc_19392810_856_862_Chemical)))) (ADVP (RB simultaneously)) (VP (MD may) (VP (VB increase) (NP (NP (NN risk)) (PP (IN of) (NP (NNS Doc_19392810_899_913_Disease) (CC and) (NNS Doc_19392810_918_933_Disease)))))) (. .)))
19392810	12	(ROOT (S (NP (NP (NNS Patients)) (PP (IN under) (NP (JJ Doc_19392810_950_959_Chemical) (NN maintenance) (NN therapy)))) (VP (MD should) (VP (VB be) (VP (VBN warned) (PP (VBG regarding) (NP (DT these) (JJ serious) (JJ adverse) (NNS events)))))) (. .)))
19392810	13	(ROOT (S (NP (NP (NNS Hypotheses)) (PP (IN of) (NP (NP (NN Doc_19392810_1051_1057_Chemical-related) (NNS Doc_19392810_1066_1080_Disease) (CC and) (NNS Doc_19392810_1085_1091_Disease)) (PP (IN in) (NP (JJ Doc_19392810_1095_1101_Chemical) (NNS abusers)))))) (VP (VBP are) (VP (VBN discussed))) (. .)))
19419794	0	(ROOT (NP (NP (VBN Increased) (NN vulnerability)) (PP (TO to) (NP (NP (JJ Doc_19419794_27_44_Chemical) (NN lesion)) (CC and) (NP (JJ reduced) (NN development)))) (PP (IN of) (NP (NP (NNS Doc_19419794_79_90_Disease)) (PP (IN in) (NP (NP (NNS mice)) (VP (VBG lacking) (NP (CD CB1) (JJ cannabinoid) (NNS receptors))))))) (. .)))
19419794	1	(ROOT (S (NP (NNP Motor) (NNP impairment)) (, ,) (S (VP (VBG Doc_19419794_152_160_Chemical) (NP (NP (PRN (-LRB- -LRB-) (NP (NNP DA)) (-RRB- -RRB-)) (JJ neuronal) (NN activity)) (CC and) (NP (NP (NNS Doc_19419794_188_201_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP PENK)) (-RRB- -RRB-))) (NP (NP (NN gene) (NN expression)) (PP (IN in) (NP (NP (DT the) (NN caudate-putamen)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19419794_249_252_Chemical)) (-RRB- -RRB-)))))))) (VP (VBD were) (VP (VP (VBN measured) (PP (IN in) (NP (NNS Doc_19419794_271_277_Chemical-lesioned)))) (CC and) (VP (VBN treated) (S (-LRB- -LRB-) (NP (NNS Doc_19419794_300_318_Chemical)) (-RRB- -RRB-) (NP (NNP CB1) (NNP KO) (CC and) (NNP WT) (NNS mice)))))) (. .)))
19419794	2	(ROOT (S (NP (NP (DT A) (NN lesion)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_19419794_360_366_Chemical))))) (VP (VBD produced) (NP (ADJP (RBR more) (JJ severe)) (NN motor) (NN deterioration)) (PP (IN in) (NP (NP (NNP CB1) (NNP KO) (NNS mice)) (VP (VBN accompanied) (PP (IN by) (NP (NP (NP (JJR more) (NN loss)) (PP (IN of) (NP (NNP DA) (NNS neurons)))) (CC and) (NP (NP (VBN increased) (NN PENK) (NN gene) (NN expression)) (PP (IN in) (NP (DT the) (NNP CPu)))))))))) (. .)))
19419794	3	(ROOT (S (NP (ADJP (JJ Oxidative/nitrosative) (CC and) (JJ neuroinflammatory)) (NNS parameters)) (VP (VBD were) (VP (VBN estimated) (PP (IN in) (NP (NP (DT the) (ADJP (JJ CPu) (CC and) (JJ cingulate)) (NN cortex)) (PRN (-LRB- -LRB-) (NP (NNP Cg)) (-RRB- -RRB-)))))) (. .)))
19419794	4	(ROOT (S (NP (NNP CB1) (NNP KO) (NNS mice)) (VP (VP (VBD exhibited) (NP (JJR higher) (JJ Doc_19419794_646_649_Chemical) (NNS levels))) (CC and) (VP (VBZ iNOS)) (NP (NN protein) (NN expression)) (PP (IN in) (NP (DT the) (NNP CPu) (CC and) (NNP Doc_19419794_700_702_Chemical))) (PP (VBN compared) (PP (TO to) (NP (NNP WT) (NNS mice))))) (. .)))
19419794	5	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN with) (NP (NP (NNS Doc_19419794_739_757_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 12) (NNS weeks)) (-RRB- -RRB-))))) (VP (VBD resulted) (PP (IN in) (NP (NP (ADJP (RBR less) (JJ severe)) (NNS Doc_19419794_793_804_Disease)) (PP (IN in) (NP (NNP CB1) (NNP KO))))) (PP (IN than) (PP (IN in) (NP (NNP WT) (NNS mice))))) (. .)))
19419794	6	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (JJ cannabinoid) (NN CB1) (NNS receptors)))) (VP (VP (VBD increased) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NNS Doc_19419794_922_938_Disease) (CC and) (NN DA) (NN lesion))))) (, ,) (CC and) (VP (VBD reduced) (NP (NN Doc_19419794_966_972_Chemical-induced) (NNS Doc_19419794_981_992_Disease))))))) (. .)))
19419794	7	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN activation)) (PP (IN of) (NP (CD CB1) (NNS receptors)))) (VP (VBZ offers) (NP (NP (NP (NN neuroprotection)) (PP (IN against) (NP (JJ dopaminergic) (NN lesion)))) (CC and) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN Doc_19419794_1123_1129_Chemical-induced) (NNS Doc_19419794_1138_1149_Disease))))))))) (. .)))
1943082	0	(ROOT (S (NP (NNP Hepatocellular) (NNP oxidant)) (VP (VBP stress) (NP (JJ following) (NNS Doc_1943082_40_78_Disease))) (. .)))
1943082	1	(ROOT (S (NP (NP (NNP Reperfusion)) (PP (IN of) (NP (NP (JJ ischemic) (NN intestine) (NNS results)) (PP (IN in) (NP (JJ acute) (NNS Doc_1943082_131_148_Disease)))))) (VP (VBD characterized) (PP (IN by) (NP (NP (NP (NN hepatocellular) (NN enzyme) (NN release)) (PP (IN into) (NP (NN plasma)))) (, ,) (NP (NP (NN reduction)) (PP (IN in) (NP (NN bile) (NN flow) (NN rate)))) (, ,) (CC and) (NP (NP (JJ neutrophil) (NN sequestration)) (PP (IN within) (NP (DT the) (NN liver))))))) (. .)))
1943082	2	(ROOT (S (NP (NP (DT The) (NN pathophysiology)) (VP (VBG underlying) (NP (DT this) (JJ acute) (NNS Doc_1943082_327_341_Disease)))) (VP (VBZ is) (ADJP (JJ unknown))) (. .)))
1943082	3	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN undertaken) (S (VP (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NNS oxidants)) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (DT the) (NNS Doc_1943082_434_448_Disease))))))))) (CC and) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (JJ relative) (NN value)) (PP (IN of) (NP (NP (JJ several) (JJ indirect) (NNS methods)) (PP (IN of) (S (VP (VBG assessing) (NP (JJ oxidant) (NN exposure)) (PP (IN in) (NP (NN vivo))))))))))))))) (. .)))
1943082	4	(ROOT (S (NP (NNS Rats)) (VP (VBD were) (VP (VBN subjected) (PP (TO to) (NP (DT a) (JJ standardized) (NNS Doc_1943082_590_628_Disease))))) (. .)))
1943082	5	(ROOT (S (NP (JJ Hepatic) (NN tissue)) (VP (VBD was) (VP (VP (VBN assayed) (PP (IN for) (NP (NN lipid) (NN peroxidation) (NNS products)))) (CC and) (VP (VBN oxidized) (CC and) (VBN Doc_1943082_706_725_Chemical)))) (. .)))
1943082	6	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NP (JJ hepatic) (NN tissue) (NN total) (NNS Doc_1943082_771_782_Chemical)) (PP (VBG following) (NP (NNS Doc_1943082_793_831_Disease))))))) (. .)))
1943082	7	(ROOT (S (NP (NP (JJ Oxidized) (NNS Doc_1943082_842_853_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1943082_855_859_Chemical)) (-RRB- -RRB-))) (VP (VBD increased) (ADVP (RB significantly)) (PP (VBG following) (NP (NP (CD 30)) (CC and) (NP (NP (CD 60) (NN min)) (PP (IN of) (NP (NN reperfusion))))))) (. .)))
1943082	8	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN increase)) (PP (IN in) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (NNS products)) (PP (IN of) (NP (NP (NN lipid) (NN peroxidation)) (VP (VBN associated) (PP (IN with) (NP (DT this) (NN injury)))))))))))) (. .)))
1943082	9	(ROOT (S (NP (NP (DT An) (NN increase)) (PP (IN in) (NP (NP (NNS Doc_1943082_1036_1040_Chemical)) (PP (IN within) (NP (NP (JJ hepatic) (NN tissue)) (PP (IN during) (NP (JJ intestinal) (NN reperfusion)))))))) (VP (VBZ suggests) (NP (NP (NN exposure)) (PP (IN of) (NP (NNS hepatocytes)))) (PP (TO to) (NP (DT an) (JJ oxidant) (NN stress)))) (. .)))
1943082	10	(ROOT (S (NP (NP (DT The) (NN lack)) (PP (IN of) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (NNS products)) (PP (IN of) (NP (NN lipid) (NN peroxidation)))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (DT the) (NN oxidant) (NN stress)) (VP (VBZ is) (PP (IN of) (NP (JJ insufficient) (NN magnitude))) (S (VP (TO to) (VP (VB result) (PP (IN in) (NP (JJ irreversible) (NN injury))) (S (VP (TO to) (VP (VB hepatocyte) (NP (NN cell) (NNS membranes)))))))))))) (. .)))
1943082	11	(ROOT (S (NP (DT These) (NNS data)) (ADVP (RB also)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN measurement)) (PP (IN of) (NP (NN tissue) (NNS Doc_1943082_1397_1401_Chemical)))) (VP (MD may) (VP (VB be) (NP (NP (DT a) (ADJP (RBR more) (JJ sensitive)) (NN indicator)) (PP (IN of) (NP (NP (JJ oxidant) (NN stress)) (PP (IN than) (NP (NP (NN measurement)) (PP (IN of) (NP (NP (NNS products)) (PP (IN of) (NP (NN lipid) (NN peroxidation))))))))))))))) (. .)))
19447152	0	(ROOT (NP (NP (NP (NNP Animal) (NN model)) (PP (IN of) (NP (NP (NNS Doc_19447152_16_21_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_19447152_33_40_Chemical))))))) (: :) (NP (NP (NN Evidence)) (PP (IN of) (NP (NP (JJ oxidative) (NN stress)) (PP (IN in) (NP (NP (JJ submitochondrial) (NNS particles)) (PP (IN of) (NP (DT the) (NN rat) (NN brain)))))))) (. .)))
19447152	1	(ROOT (S (NP (NP (DT The) (NN intracerebroventricular) (PRN (-LRB- -LRB-) (NP (NNP ICV)) (-RRB- -RRB-)) (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_19447152_171_178_Chemical)) (PRN (-LRB- -LRB-) (NP (DT a) (JJ Doc_19447152_182_187_Chemical) (NN /) (NNS Doc_19447152_188_192_Chemical-ATPase) (NN inhibitor)) (-RRB- -RRB-))) (PP (IN in) (NP (NNS rats)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (S (VP (TO to) (VP (VB mimic) (NP (NP (DT some) (NNS symptoms)) (PP (IN of) (NP (JJ human) (NNS Doc_19447152_270_283_Disease)))))))))) (. .)))
19447152	2	(ROOT (S (NP (JJ Clinical) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NNS Doc_19447152_318_334_Disease)) (VP (MD may) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (NNS Doc_19447152_353_378_Disease)))))))))) (. .)))
19447152	3	(ROOT (S (S (VP (VBN Herein))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (JJ behavioral) (CC and) (JJ biochemical) (NNS effects)) (VP (VBN induced) (PP (IN by) (NP (NP (DT the) (NNP ICV) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_19447152_480_487_Chemical)) (PP (IN in) (NP (NNS rats)))))))))) (. .)))
19447152	4	(ROOT (S (S (VP (TO To) (VP (VB achieve) (NP (DT this) (NN aim))))) (, ,) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NP (JJ Doc_19447152_533_540_Chemical) (NN injection)) (RRC (ADVP (RB immediately)) (PP (IN after)))) (CC and) (NP (NP (CD 7) (NNS days)) (PP (VBG following) (NP (NP (NP (DT a) (JJ single) (JJ Doc_19447152_599_602_Chemical) (NN administration)) (PRN (-LRB- -LRB-) (PP (IN at) (NP (NP (NP (NNS concentrations)) (PP (IN of) (NP (NP (CD 10)) (PRN (-LRB- -LRB-) (NP (CD -2)) (-RRB- -RRB-))))) (CC and) (NP (NP (CD 10)) (PRN (-LRB- -LRB-) (NP (CD -3)) (-RRB- -RRB-)) (NP (NNP M))))) (-RRB- -RRB-))) (PP (IN on) (NP (NN locomotion))))))))) (VP (VBD was) (VP (VBN measured) (S (VP (VBG using) (NP (DT the) (JJ open-field) (NN test)))))) (. .)))
19447152	5	(ROOT (S (ADVP (RB Additionally)) (, ,) (NP (NP (NP (JJ Doc_19447152_728_747_Chemical) (NN reactive) (NNS substances)) (PRN (-LRB- -LRB-) (NP (NNP TBARSs)) (-RRB- -RRB-))) (CC and) (NP (JJ Doc_19447152_781_791_Chemical) (NN production))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (JJ submitochondrial) (NNS particles)) (PP (IN of) (NP (DT the) (JJ prefrontal) (NN cortex) (, ,) (NNS hippocampus) (, ,) (NN striatum) (CC and) (NN amygdala))))))) (. .)))
19447152	6	(ROOT (S (S (NP (PRP$ Our) (NNS findings)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NNS Doc_19447152_940_947_Chemical)) (PP (IN at) (NP (NP (CD 10)) (PRN (-LRB- -LRB-) (NP (CD -2)) (-RRB- -RRB-)) (CC and) (NP (CD 10)) (PRN (-LRB- -LRB-) (NP (CD -3)) (-RRB- -RRB-))))) (VP (VBD M) (NP (JJ induced) (NN hyperlocomotion)) (PP (IN in) (NP (NNS rats)))))))) (, ,) (CC and) (S (NP (DT this) (NN response)) (VP (VBD remained) (PRT (RP up)) (PP (TO to) (NP (NP (CD 7) (NNS days)) (PP (VBG following) (NP (DT a) (JJ single) (NNP ICV) (NN injection))))))) (. .)))
19447152	7	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBD observed) (SBAR (IN that) (S (NP (NP (DT the) (JJ persistent) (NN increase)) (PP (IN in) (NP (DT the) (NN rat) (JJ spontaneous) (NN locomotion)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (VBN increased) (NN TBARS) (NNS levels)) (CC and) (NP (NP (JJ Doc_19447152_1211_1221_Chemical) (NN generation)) (PP (IN in) (NP (NP (JJ submitochondrial) (NNS particles)) (PP (IN in) (NP (DT the) (JJ prefrontal) (NN cortex) (, ,) (NN striatum) (CC and) (NN amygdala))))))))))))) (. .)))
19447152	8	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NN Doc_19447152_1327_1334_Chemical-induced) (NN Doc_19447152_1343_1348_Disease-like) (NN behavior)) (VP (MD may) (VP (VB provide) (NP (DT a) (ADJP (JJ useful) (JJ animal)) (NN model)) (S (VP (TO to) (VP (VB test) (NP (NP (DT the) (NNS hypothesis)) (PP (IN of) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (JJ oxidative) (NN stress)))))) (PP (IN in) (NP (NNS Doc_19447152_1462_1478_Disease)))))))) (. .)))
19515070	0	(ROOT (S (VP (VB Intraoperative) (NP (NN dialysis)) (PP (IN during) (NP (NP (NN liver) (NN transplantation)) (PP (IN with) (NP (NNS Doc_19515070_58_75_Chemical)))))) (. .)))
19515070	1	(ROOT (S (NP (NP (NNP Liver) (NNP transplantation)) (PP (IN for) (NP (NP (ADJP (RB acutely) (JJ ill)) (NNS patients)) (PP (IN with) (NP (NNS Doc_19515070_129_152_Disease)))))) (VP (VBZ carries) (NP (JJ high) (NN intraoperative) (CC and) (JJ immediate) (NN postoperative) (NNS risks))) (. .)))
19515070	2	(ROOT (S (S (NP (DT These)) (VP (VBP are) (VP (VBN increased) (PP (IN with) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ concomitant) (NNS Doc_19515070_269_288_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19515070_290_293_Disease)) (-RRB- -RRB-))))))))) (CC and) (S (NP (JJ intraoperative) (NN dialysis)) (VP (VBZ is) (ADVP (RB sometimes)) (VP (VBN required) (S (VP (TO to) (VP (VB allow) (NP (DT the) (NN transplant) (S (VP (TO to) (VP (VB proceed))))))))))) (. .)))
19515070	3	(ROOT (S (NP (NP (DT The) (NNS derangements)) (PP (IN in) (NP (NP (DT the) (NN procoagulant) (CC and) (NN anticoagulant) (NNS pathways)) (PP (IN during) (NP (NNS Doc_19515070_452_475_Disease)))))) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NP (NNS difficulties)) (PP (IN with) (NP (NN anticoagulation))))) (PP (IN during) (NP (NN dialysis))) (, ,) (SBAR (WHADVP (RB especially) (WRB when)) (S (VP (VBD continued) (PP (IN in) (NP (DT the) (VBG operating) (NN room)))))))) (. .)))
19515070	4	(ROOT (S (S (NP (JJ Systemic) (NN anticoagulation)) (VP (VBZ is) (ADJP (JJ unsafe)))) (CC and) (S (NP (NP (JJ regional) (JJ Doc_19515070_636_643_Chemical) (NN anticoagulation)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT a) (JJ functional) (NN liver)))))) (VP (VBZ carries) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ Doc_19515070_717_724_Chemical) (NNS Doc_19515070_725_733_Disease)))))) (. .)))
19515070	5	(ROOT (S (ADVP (RB Doc_19515070_735_752_Chemical)) (, ,) (NP (NP (DT a) (JJ new) (NN dialysate)) (PP (IN with) (NP (NNS Doc_19515070_775_786_Chemical)))) (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (NN anticoagulation))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (MD can) (RB not) (VP (VB tolerate) (NP (JJ Doc_19515070_851_858_Chemical) (CC or) (JJ regional) (NNS Doc_19515070_871_878_Chemical))))))))))) (. .)))
19515070	6	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (DT a) (JJ 40-year-old) (NN female)) (PP (IN with) (NP (NN Doc_19515070_926_939_Chemical-induced) (NNS Doc_19515070_948_971_Disease)))))) (PP (IN with) (NP (NP (JJ associated) (NNS Doc_19515070_988_991_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (JJ intraoperative) (JJ dialytic) (NN support)) (PP (IN during) (NP (NP (NN liver) (NN transplantation)) (VP (VBN anticoagulated) (PP (IN with) (NP (NNS Doc_19515070_1087_1104_Chemical))) (PP (IN during) (NP (DT the) (JJ entire) (NN procedure)))))))))))) (. .)))
19515070	7	(ROOT (S (NP (DT The) (NN patient)) (VP (VP (VBD tolerated) (ADVP (NP (DT the) (NN procedure)) (RB well)) (PP (IN without) (NP (NP (DT any) (NNS signs)) (PP (IN of) (NP (JJ Doc_19515070_1196_1203_Chemical) (NNS Doc_19515070_1204_1212_Disease)))))) (CC and) (VP (VBD maintained) (NP (JJ adequate) (NN anticoagulation)) (PP (IN for) (NP (NP (NN patency)) (PP (IN of) (NP (DT the) (NN dialysis) (NN circuit))))))) (. .)))
19515070	8	(ROOT (S (NP (JJ Doc_19515070_1290_1297_Chemical) (NN dialysate)) (VP (VBZ is) (NP (NP (DT a) (JJ safe) (NN alternative)) (PP (IN for) (NP (NP (JJ intradialytic) (NN support)) (PP (IN of) (NP (NP (NN liver) (NN transplantation)) (PP (IN in) (NP (NNS Doc_19515070_1384_1407_Disease))))))))) (. .)))
19531695	0	(ROOT (NP (NP (NP (NNP Doc_19531695_0_8_Disease)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ toxic) (JJ Doc_19531695_33_43_Chemical) (NN plasma) (NNS concentrations)))))) (: :) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (DT a) (JJ pharmacokinetic) (NN drug) (NN interaction)) (PP (IN with) (NP (NNS Doc_19531695_119_129_Chemical)))))) (. .)))
19531695	1	(ROOT (S (S (VP (TO To) (VP (VB describe) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NN Doc_19531695_164_174_Chemical-induced) (NNS Doc_19531695_183_191_Disease))))))) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ pharmacokinetic) (NN drug) (NN interaction)) (PP (IN with) (NP (NNS Doc_19531695_248_258_Chemical)))))) (. .)))
19531695	2	(ROOT (NP (NP (NNP CASE) (NNP SUMMARY)) (: :) (NP (NP (DT A) (JJ 69-year-old) (JJ white) (NN female)) (VP (VBN presented) (PP (TO to) (NP (DT the) (NN emergency) (NN department))) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS Doc_19531695_357_366_Disease) (CC and) (NNS Doc_19531695_371_379_Disease))))) (PP (IN over) (NP (DT the) (JJ past) (JJ several) (NNS days))))) (. .)))
19531695	3	(ROOT (S (S (PP (IN On) (NP (NN admission))) (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBG taking) (NP (QP (CD Doc_19531695_444_454_Chemical) (CD 12)) (NN mg)) (ADVP (RB twice)) (FRAG (ADVP (RB daily)) (, ,) (NP (NP (NNS Doc_19531695_474_482_Chemical)) (NP (CD 2) (NN mg/day))) (, ,) (NP (NP (NNS Doc_19531695_493_503_Chemical)) (NP (CD 1) (NN mg/day))) (, ,) (NP (NP (NNS Doc_19531695_514_527_Chemical)) (NP (CD 100) (NN microg/day))) (, ,) (NP (NP (NNS Doc_19531695_544_556_Chemical)) (NP (CD 40) (NN mg/day))) (, ,) (ADVP (RB Doc_19531695_568_578_Chemical)) (NP (CD 40) (NN mg/day)))))) (, ,) (CC and) (S (NP (NNP Doc_19531695_594_604_Chemical) (CD 100)) (VP (VBP mg) (ADVP (RB twice)) (ADVP (RB daily)))) (. .)))
19531695	4	(ROOT (S (NP (NNP Doc_19531695_625_635_Chemical)) (VP (VBD had) (VP (VBN been) (VP (VBN started) (PP (ADVP (NP (CD 2) (NNS weeks)) (RB prior)) (IN for) (NP (NNS Doc_19531695_671_690_Disease)))))) (. .)))
19531695	5	(ROOT (S (NP (NP (NNP Laboratory) (NN test) (NNS findings)) (PP (IN on) (NP (NN admission)))) (VP (VBD were) (ADJP (JJ notable)) (PP (RB only) (IN for) (NP (NP (DT a) (JJ Doc_19531695_754_764_Chemical) (NN plasma) (NN concentration)) (PP (IN of) (NP (NP (CD 1360) (NN microg/L)) (PRN (-LRB- -LRB-) (NP (NN reference) (NN range) (NNS 200-1000)) (-RRB- -RRB-))))))) (. .)))
19531695	6	(ROOT (S (NP (NP (DT A) (JJ metabolic) (NN drug) (NN interaction)) (PP (IN between) (NP (NNS Doc_19531695_868_878_Chemical) (CC and) (NNS Doc_19531695_883_893_Chemical))) (, ,) (SBAR (WHNP (WDT which)) (S (NP (DT the) (NN patient)) (VP (VBD had) (VP (VBN been) (VP (VBG taking) (PP (IN for) (NP (QP (JJR more) (IN than) (CD 5)) (NNS years)))))))) (, ,)) (VP (VBD was) (VP (VBN considered))) (. .)))
19531695	7	(ROOT (S (S (NP (NNP Doc_19531695_968_978_Chemical)) (VP (VBD was) (VP (VBN discontinued)))) (CC and) (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NNS Doc_19531695_1012_1022_Chemical)))) (VP (VBD was) (VP (VBN reduced) (PP (TO to) (NP (NP (CD 50) (NN mg)) (ADVP (RB twice) (JJ daily))))))) (. .)))
19531695	8	(ROOT (S (NP (PRP$ Her) (NNS Doc_19531695_1061_1069_Disease)) (VP (VBN resolved) (NP (CD 3) (NNS days) (RB later))) (. .)))
19531695	9	(ROOT (S (NP (NP (ADJP (JJ Doc_19531695_1105_1115_Chemical) (CC and) (JJ pharmacologically)) (JJ similar) (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP interact) (PP (IN with) (NP (JJ Doc_19531695_1172_1178_Chemical) (NNS channels))))))) (VP (MD may) (VP (VB cause) (NP (NP (NNS Doc_19531695_1198_1206_Disease)) (PP (IN in) (NP (ADJP (JJ susceptible)) (NNS patients)))))) (. .)))
19531695	10	(ROOT (S (NP (NP (DT A) (JJ MEDLINE) (NN search)) (PRN (-LRB- -LRB-) (ADJP (JJ 1966-January) (NP (CD 2009))) (-RRB- -RRB-))) (VP (VBD revealed) (NP (CD one)) (PP (IN in) (NP (JJ vivo) (JJ pharmacokinetic) (NN study))) (PP (IN on) (NP (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NNS Doc_19531695_1339_1349_Chemical)) (, ,) (NP (DT a) (NN CYP2D6) (NN substrate)) (, ,) (CC and) (NP (NP (NNS Doc_19531695_1375_1385_Chemical)) (, ,) (NP (DT a) (NN CYP2D6) (NN inhibitor)))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (CD 3) (NN case) (NNS reports)) (PP (IN of) (NP (NN Doc_19531695_1436_1446_Chemical-induced) (NNS Doc_19531695_1455_1463_Disease))))))) (. .)))
19531695	11	(ROOT (S (S (PP (VBG According) (PP (TO to) (NP (DT the) (NNP Naranjo) (NN probability) (NN scale)))) (, ,) (NP (NNS Doc_19531695_1509_1519_Chemical)) (VP (VBD was) (NP (NP (DT the) (JJ probable) (NN cause)) (PP (IN of) (NP (NP (DT the) (NN patient) (POS 's)) (NNS Doc_19531695_1560_1568_Disease)))))) (: ;) (S (NP (DT the) (NNP Horn) (NNP Drug) (NNP Interaction) (NNP Probability) (NNP Scale)) (VP (VBZ indicates) (NP (NP (DT a) (JJ possible) (JJ pharmacokinetic) (NN drug) (NN interaction)) (PP (IN between) (NP (NNS Doc_19531695_1676_1686_Chemical) (CC and) (NNS Doc_19531695_1691_1701_Chemical)))))) (. .)))
19531695	12	(ROOT (S (NP (JJ Supratherapeutic) (JJ Doc_19531695_1733_1743_Chemical) (NN plasma) (NNS concentrations)) (VP (MD may) (VP (VB cause) (NP (NNS Doc_19531695_1776_1784_Disease)))) (. .)))
19531695	13	(ROOT (S (SBAR (IN Because) (S (NP (NNS Doc_19531695_1794_1802_Disease)) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_19531695_1818_1828_Chemical)) (VP (VBZ is) (VP (VBN prescribed) (PP (IN with) (NP (NP (NNS Doc_19531695_1848_1858_Chemical)) (CC and) (NP (JJ other) (JJ potent) (NN CYP2D6) (NNS inhibitors)))))))))))) (, ,) (NP (JJ Doc_19531695_1895_1905_Chemical) (NN plasma) (NNS concentrations)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)) (PP (IN with) (NP (NP (NN commencement)) (PP (IN of) (NP (CD CYP2D6) (NNS inhibitors)))))))) (. .)))
19549709	0	(ROOT (S (NP (NP (NNP Efficacy)) (PP (IN of) (NP (NNS Doc_19549709_12_22_Chemical))) (PRN (-LRB- -LRB-) (NP (NNP Doc_19549709_24_30_Chemical)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (VBN advanced) (NNS Doc_19549709_58_63_Disease)))))) (ADVP (RB previously)) (VP (VBN treated) (PP (IN with) (NP (JJ chemotherapy) (UCP (ADVP (RB alone)) (CC or) (PP (IN with) (NP (NN chemotherapy) (CC and) (NN EGFR)))) (NNS inhibitors)))) (. .)))
19549709	1	(ROOT (S (NP (NNP Treatment) (NNS options)) (VP (VBP are) (ADJP (JJ scarce) (PP (IN in) (NP (ADJP (JJ pretreated)) (JJ advanced) (JJ Doc_19549709_213_239_Disease) (PRN (-LRB- -LRB-) (NP (NNP Doc_19549709_241_246_Disease)) (-RRB- -RRB-)) (NNS patients))))) (. .)))
19549709	2	(ROOT (S (NP (NP (NNP Doc_19549709_258_264_Chemical)) (, ,) (NP (NP (DT an) (JJ oral) (NN inhibitor)) (PP (IN of) (NP (NP (DT the) (JJ mammalian) (NN target)) (PP (IN of) (NP (NP (NNS Doc_19549709_311_320_Chemical)) (PRN (-LRB- -LRB-) (NP (NN mTOR)) (-RRB- -RRB-))))))) (, ,)) (VP (VBZ has) (VP (VBN shown) (S (VP (VB phase) (NP (PRP I)) (ADVP (RB efficacy)) (PP (IN in) (NP (NNS Doc_19549709_359_364_Disease))))))) (. .)))
19549709	3	(ROOT (S (NP (NNP Stage) (NNP IIIb) (CC or) (NNP IV) (NNP Doc_19549709_392_397_Disease) (NNS patients)) (, ,) (PP (IN with) (NP (NP (NP (NP (QP (CD two) (CC or) (JJR fewer)) (JJ prior) (NN chemotherapy) (NNS regimens)) (, ,) (NP (NP (CD one) (NNS Doc_19549709_459_467_Chemical)) (VP (VBN based)))) (PRN (-LRB- -LRB-) (NP (NN stratum) (CD 1)) (-RRB- -RRB-))) (CC or) (NP (NP (DT both) (ADJP (JJ chemotherapy) (CC and) (JJ epidermal)) (NN growth) (NN factor) (NN receptor) (JJ Doc_19549709_544_552_Chemical) (NN kinase) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN stratum) (CD 2)) (-RRB- -RRB-))))) (, ,) (VP (VBD received) (NP (QP (CD Doc_19549709_593_599_Chemical) (CD 10))) (PP (ADVP (RB mg/day)) (IN until) (NP (ADJP (JJ progression) (CC or) (JJ unacceptable)) (NNS Doc_19549709_644_652_Disease)))) (. .)))
19549709	4	(ROOT (S (NP (JJ Primary) (NN objective)) (VP (VBD was) (NP (NP (JJ overall) (NN response) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP ORR)) (-RRB- -RRB-)))) (. .)))
19549709	5	(ROOT (S (NP (NP (NNS Analyses)) (PP (IN of) (NP (NP (NNS markers)) (VP (VBN associated) (PP (IN with) (NP (DT the) (NN mTOR))))))) (ADVP (RB pathway)) (VP (VBD were) (VP (VBN carried) (PRT (RP out)) (PP (IN on) (NP (JJ archival) (NNS Doc_19549709_787_792_Disease))) (PP (IN from) (NP (NP (DT a) (NN subgroup)) (VP (VBG using) (NP (NP (NN immunohistochemistry)) (PRN (-LRB- -LRB-) (NP (NNP IHC)) (-RRB- -RRB-)) (CC and) (NP (JJ direct) (NN mutation) (NN sequencing)))))))) (. .)))
19549709	6	(ROOT (S (NP (JJ Eighty-five) (NNS patients)) (VP (VBD were) (VP (VP (VBN enrolled)) (, ,) (NP (NP (CD 42)) (PP (IN in) (NP (NNP stratum) (CD 1) (CC and) (CD 43))) (PP (IN in) (NP (NN stratum)))))) (. .)))
19549709	7	(ROOT (S (NP (NNP ORR)) (VP (VBD was) (NP (NP (CD 4.7) (NN %)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (CD 7.1) (NN %)) (NP (NN stratum) (CD 1))) (: ;) (NP (NP (ADJP (CD 2.3) (NN %)) (NN stratum)) (NP (CD 2)))) (-RRB- -RRB-)))) (. .)))
19549709	8	(ROOT (S (NP (JJ Overall) (NN disease) (NN control) (NN rate)) (VP (VBD was) (NP (CD 47.1) (NN %))) (. .)))
19549709	9	(ROOT (S (NP (NP (JJ Median) (JJ progression-free) (NNS survivals)) (PRN (-LRB- -LRB-) (NP (NNP PFSs)) (-RRB- -RRB-))) (VP (VBD were) (NP (NP (NP (CD 2.6)) (PRN (-LRB- -LRB-) (NP (NN stratum) (CD 1)) (-RRB- -RRB-))) (CC and) (NP (CD 2.7) (NNS months) (PRN (-LRB- -LRB-) (NP (NN stratum) (CD 2)) (-RRB- -RRB-))))) (. .)))
19549709	10	(ROOT (S (NP (NP (JJ Common) (NN >) (CC or) (NN =) (NN grade)) (NP (CD 3) (NNS events))) (VP (VBD were) (NP (NP (NN fatigue)) (, ,) (NP (NNS Doc_19549709_1173_1180_Disease)) (, ,) (NP (NNS Doc_19549709_1182_1192_Disease)) (, ,) (NP (NNS Doc_19549709_1194_1200_Disease)) (, ,) (CC and) (NP (NNS Doc_19549709_1206_1222_Disease)))) (. .)))
19549709	11	(ROOT (S (NP (NP (NP (NNP Doc_19549709_1224_1235_Disease)) (, ,) (UCP (ADVP (RB probably)) (CC or) (ADJP (RB possibly) (JJ related)))) (, ,) (RRC (ADVP (RB mainly)) (NP (NN grade) (CD 1/2))) (, ,)) (VP (VBD occurred) (PP (IN in) (NP (CD 25) (NN %)))) (. .)))
19549709	12	(ROOT (S (NP (NP (NNP Cox) (NN regression) (NN analysis)) (PP (IN of) (NP (NNP IHC) (NNS scores)))) (VP (VBD found) (SBAR (IN that) (S (NP (NP (RB only) (NNP phospho) (NNP AKT)) (PRN (-LRB- -LRB-) (NP (NN pAKT)) (-RRB- -RRB-))) (VP (VBD was) (NP (NP (DT a) (JJ significant) (JJ independent) (NN predictor)) (PP (IN of) (NP (NNP worse) (NNP PFS)))))))) (. .)))
19549709	13	(ROOT (S (NP (NNP Doc_19549709_1442_1448_Chemical) (CD 10)) (ADVP (RB mg/day)) (VP (VBD was) (ADJP (RB well) (JJ tolerated)) (, ,) (S (VP (VBG showing) (NP (JJ modest) (JJ clinical) (NN activity)) (PP (IN in) (NP (JJ pretreated) (NNS Doc_19549709_1526_1531_Disease)))))) (. .)))
19549709	14	(ROOT (S (NP (NP (NNP Evaluation)) (PP (IN of) (NP (NP (NNS Doc_19549709_1547_1553_Chemical)) (PP (CC plus) (NP (NP (JJ standard) (NN therapy)) (PP (IN for) (NP (JJ metastatic) (NNS Doc_19549709_1591_1596_Disease)))))))) (VP (VBZ continues)) (. .)))
19553912	0	(ROOT (NP (NP (NNP Doc_19553912_0_21_Disease)) (: :) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNS Doc_19553912_35_44_Chemical)))) (. .)))
19553912	1	(ROOT (S (NP (NNP Doc_19553912_46_67_Disease)) (VP (VBZ is) (NP (NP (DT a) (JJ common) (NN problem)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB hinder) (NP (NP (NP (NNS patients) (POS ')) (NN quality)) (PP (IN of) (NP (NN life)))))))))) (. .)))
19553912	2	(ROOT (S (NP (PRP It)) (VP (VP (VBZ occurs) (PP (IN in) (NP (NP (QP (CD 12) (TO to) (CD 76)) (NN %)) (PP (IN of) (NP (NNS patients)))))) (, ,) (CC and) (VP (VBZ is) (ADJP (ADJP (RBS most) (JJ common)) (PP (IN in) (NP (DT the) (JJ immediate) (NN posttransplant) (NN period)))))) (. .)))
19553912	3	(ROOT (S (NP (NP (DT A) (NN variety)) (PP (IN of) (NP (NNS factors)))) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (S (NP (DT that)) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_19553912_294_315_Disease)) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (NP (DT the) (NN level)) (PP (IN of) (NP (JJ renal) (NN function)))) (VP (VBZ is) (ADJP (RBS most) (JJ important))))))))))))) (. .)))
19553912	4	(ROOT (S (NP (NP (NNP Doc_19553912_373_382_Chemical)) (, ,) (NP (NP (DT a) (JJ mammalian) (NN target)) (PP (IN of) (NP (JJ Doc_19553912_406_415_Chemical) (NN inhibitor)))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN as) (S (VP (VBG playing) (NP (DT a) (JJ special) (NN role)) (PP (IN in) (NP (NNS Doc_19553912_476_497_Disease))))))))) (. .)))
19553912	5	(ROOT (S (NP (DT This) (NN review)) (VP (VBZ considers) (NP (NP (NNS Doc_19553912_521_527_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_19553912_544_553_Chemical)) (, ,) (PP (VBG including) (NP (NP (PRP$ its) (NN presentation)) (, ,) (NP (NNS mechanisms)) (, ,) (CC and) (NP (NN management))))))))) (. .)))
19655282	0	(ROOT (NP (NP (JJ Coronary) (JJ computerized) (NN tomography) (NN angiography)) (PP (IN for) (NP (JJ rapid) (NN discharge))) (PP (IN of) (NP (JJ low-risk) (NNS patients))) (PP (IN with) (NP (NN Doc_19655282_91_98_Chemical-associated) (NNS Doc_19655282_110_120_Disease))) (. .)))
19655282	1	(ROOT (S (NP (NP (JJS Most) (NNS patients)) (VP (VBG presenting) (PP (TO to) (NP (NP (NN emergency) (NNS departments)) (PRN (-LRB- -LRB-) (NP (NNP EDs)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN Doc_19655282_195_202_Chemical-associated) (NNS Doc_19655282_214_224_Disease))))) (VP (VP (VBP are) (VP (VBN admitted) (PP (IN for) (NP (QP (IN at) (JJS least) (CD 12)) (NNS hours))))) (CC and) (VP (VBP receive) (NP (NP (DT a) (`` ``) (NX (NX (NN rule)) (PP (IN out) (NP (JJ acute) (NNS Doc_19655282_290_307_Disease)))) ('' '') (NN protocol)) (, ,) (ADVP (RB often) (PP (IN with) (ADVP (NP (JJ noninvasive) (NN testing)) (RB prior))))) (S (VP (TO to) (VP (VB discharge)))))) (. .)))
19655282	2	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN without) (NP (JJ Doc_19655282_390_397_Chemical) (NN use))))) (, ,) (NP (NP (JJ coronary) (JJ computerized) (NN tomography) (NN angiography)) (PRN (-LRB- -LRB-) (NP (NNP CTA)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ useful) (PP (IN for) (S (VP (VBG identifying) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN at) (NP (JJ low) (NN risk)))))) (PP (IN for) (NP (NP (NNS Doc_19655282_534_548_Disease)) (SBAR (WHNP (WP who)) (S (VP (MD can) (VP (VB be) (VP (ADVP (RB safely)) (VBN discharged)))))))))))))))))) (. .)))
19655282	3	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ unclear)) (SBAR (IN whether) (S (NP (DT a) (JJ coronary) (NNP CTA) (NN strategy)) (VP (MD would) (VP (VB be) (NP (NP (NNS efficacious)) (PP (IN in) (NP (NN Doc_19655282_649_656_Chemical-associated) (NNS Doc_19655282_668_678_Disease)))) (, ,) (SBAR (IN as) (S (NP (NNS Doc_19655282_683_701_Disease)) (VP (MD may) (VP (VB account) (PP (IN for) (NP (NP (DT some)) (PP (IN of) (NP (DT the) (NNS Doc_19655282_730_738_Disease)))))))))))))) (. .)))
19655282	4	(ROOT (S (NP (PRP We)) (VP (VBD studied) (SBAR (IN whether) (S (NP (NP (DT a) (JJ negative) (JJ coronary) (NN CTA)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Doc_19655282_800_807_Chemical-associated) (NNS Doc_19655282_819_829_Disease)))))) (VP (MD could) (VP (VB identify) (S (NP (DT a) (NN subset)) (ADJP (JJ safe) (PP (IN for) (NP (NN discharge)))))))))) (. .)))
19655282	5	(ROOT (S (NP (PRP We)) (ADVP (RB prospectively)) (VP (VBN evaluated) (NP (NP (DT the) (NN safety)) (PP (IN of) (NP (JJ coronary) (NNP CTA)))) (PP (IN for) (NP (NP (JJ low-risk) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD presented) (PP (TO to) (NP (DT the) (NNP ED))) (PP (IN with) (NP (JJ cocaineassociated) (NNS Doc_19655282_1006_1016_Disease))) (PRN (-LRB- -LRB-) (NP (NP (JJ self-reported)) (CC or) (NP (JJ positive) (NN urine) (NN test))) (-RRB- -RRB-)))))))) (. .)))
19655282	6	(ROOT (S (NP (JJ Consecutive) (NNS patients)) (VP (VP (VBD received) (NP (DT either) (JJ immediate) (JJ coronary) (NN CTA)) (PP (IN in) (NP (DT the) (NNP ED))) (PRN (-LRB- -LRB-) (PP (IN without) (NP (JJ serial) (NNS markers))) (-RRB- -RRB-))) (CC or) (VP (VBD underwent) (NP (JJ coronary) (NN CTA)) (PP (IN after) (NP (DT a) (JJ brief) (NN observation) (NN period))) (PP (IN with) (NP (JJ serial) (JJ cardiac) (NN marker) (NNS measurements))))) (. .)))
19655282	7	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (JJ negative) (JJ coronary) (NN CTA)))) (PRN (-LRB- -LRB-) (S (NP (NN maximal)) (VP (VBZ stenosis) (NP (QP (JJR less) (IN than) (CD 50)) (NN %)))) (-RRB- -RRB-)) (VP (VBD were) (VP (VBN discharged))) (. .)))
19655282	8	(ROOT (S (NP (DT The) (JJ main) (NN outcome)) (VP (VBD was) (NP (JJ 30-day) (JJ cardiovascular) (NNS Doc_19655282_1381_1386_Disease) (CC or) (NNS Doc_19655282_1390_1411_Disease))) (. .)))
19655282	9	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 59) (NNS patients)) (PP (IN with) (NP (NN Doc_19655282_1450_1457_Chemical-associated) (NNS Doc_19655282_1469_1479_Disease)))))) (VP (VBD were) (VP (VBN evaluated))) (. .)))
19655282	10	(ROOT (S (NP (NNS Patients)) (VP (VP (VBD had) (NP (NP (DT a) (JJ mean) (NN age)) (PP (IN of) (NP (NP (QP (CD 45.6) (CD +)) (NNS /)) (: -) (NP (CD 6.6) (NN yrs)))))) (CC and) (VP (VBD were) (ADJP (ADJP (NP (CD 86) (NN %)) (JJ black)) (, ,) (ADJP (NP (CD 66) (NN %)) (JJ male))))) (. .)))
19655282	11	(ROOT (S (NP (JJ Seventy-nine) (NN percent)) (VP (VBD had) (NP (NP (DT a) (ADJP (JJ normal) (CC or) (JJ nonspecific)) (NN ECG)) (CC and) (NP (NP (CD 85) (NN %)) (VP (VBN had) (NP (DT a) (NNP TIMI) (NN score)) (S (VP (VBG <) (NP (CD 2)))))))) (. .)))
19655282	12	(ROOT (S (NP (CD Twenty) (NNS patients)) (VP (VBD received) (NP (JJ coronary) (NN CTA)) (ADVP (RB immediately)) (PP (IN in) (NP (NP (DT the) (NNP ED)) (, ,) (SBAR (WHNP (NP (CD 18)) (WHPP (IN of) (WHNP (WP whom)))) (S (VP (VBD were) (VP (VBN discharged) (PP (VBG following) (NP (NP (NNP CTA)) (PRN (-LRB- -LRB-) (NP (CD 90) (NN %)) (-RRB- -RRB-))))))))))) (. .)))
19655282	13	(ROOT (S (NP (NNP Thirty-nine)) (VP (VBD received) (NP (JJ coronary) (NN CTA)) (PP (IN after) (NP (DT a) (JJ brief) (NN observation) (NN period))) (, ,) (PP (IN with) (NP (NP (QP (CD 37) (CD discharged)) (NN home)) (PP (VBG following) (NP (NNP CTA))) (PRN (-LRB- -LRB-) (NP (CD 95) (NN %)) (-RRB- -RRB-))))) (. .)))
19655282	14	(ROOT (S (NP (CD Six) (NNS patients)) (VP (VBD had) (NP (NP (NP (NNS Doc_19655282_1891_1908_Disease)) (VP (VBN >))) (CC or) (SBAR (S (VP (SYM =) (NP (CD 50) (NN %))))))) (. .)))
19655282	15	(ROOT (S (PP (IN During) (NP (DT the) (JJ 30-day) (NN follow-up) (NN period))) (, ,) (S (NP (DT no) (NNS patients)) (VP (VBD died) (PP (IN of) (NP (NP (DT a) (JJ cardiovascular) (NN event)) (PRN (-LRB- -LRB-) (NP (NP (CD 0) (NN %)) (: ;) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (, ,) (NP (CD 0-6) (CD .1) (NN %)))) (-RRB- -RRB-)))))) (CC and) (S (NP (DT no) (NN patient)) (VP (VBD sustained) (NP (NP (DT a) (JJ nonfatal) (NNS Doc_19655282_2054_2075_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 0) (NN %)) (: ;) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (, ,) (NP (CD 0-6) (CD .1) (NN %)))) (-RRB- -RRB-))))) (. .)))
19655282	16	(ROOT (S (SBAR (IN Although) (S (NP (NN Doc_19655282_2120_2127_Chemical-associated) (NNS Doc_19655282_2139_2158_Disease)) (VP (MD can) (VP (VB result) (PP (IN from) (NP (JJ coronary) (NN vasoconstriction))))))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ Doc_19655282_2216_2223_Chemical) (JJ associated) (NNS Doc_19655282_2235_2245_Disease)) (, ,) (NP (DT a) (JJ non-ischemic) (NN ECG)) (, ,) (CC and) (NP (NP (DT a) (NNP TIMI) (NN risk) (NN score)) (NP (QP (CD <) (CD 2))))))) (VP (MD may) (VP (VB be) (VP (ADVP (RB safely)) (VBN discharged) (PP (IN from) (NP (DT the) (NNP ED))) (PP (IN after) (NP (NP (DT a) (JJ negative) (JJ coronary) (NN CTA)) (PP (IN with) (NP (NP (DT a) (JJ low) (NN risk)) (PP (IN of) (NP (JJ 30-day) (JJ adverse) (NNS events)))))))))) (. .)))
19681452	0	(ROOT (S (NP (NP (JJ Bilateral) (NNS Doc_19681452_10_33_Disease)) (PP (IN of) (NP (DT the) (NNS globus)))) (VP (VBZ pallidus) (PP (IN after) (NP (NNS Doc_19681452_63_70_Chemical) (CC and) (NNS Doc_19681452_75_82_Chemical) (NN intoxication)))) (. .)))
19681452	1	(ROOT (S (NP (NNP Doc_19681452_97_104_Chemical)) (VP (VBZ is) (NP (NP (DT a) (NN risk) (NN factor)) (PP (IN for) (NP (NP (DT both) (NN ischemic)) (CC and) (NP (NNS Doc_19681452_144_163_Disease)))))) (. .)))
19681452	2	(ROOT (S (NP (PRP We)) (VP (VBP present) (SBAR (S (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (DT a) (JJ 31-year-old) (NN man)) (PP (IN with) (NP (NP (JJ bilateral) (NNS Doc_19681452_221_229_Disease)) (PP (IN of) (NP (DT the) (NNS globus)))))))) (VP (VBZ pallidus) (SBAR (IN after) (S (NP (JJ excessive) (NNS Doc_19681452_269_276_Chemical) (CC and) (NN intranasal) (NNS Doc_19681452_292_299_Chemical)) (VP (VBP use)))))))) (. .)))
19681452	3	(ROOT (S (NP (JJ Drug-related) (NNS globus)) (VP (VBZ pallidus) (SBAR (S (NP (NNS Doc_19681452_334_345_Disease)) (VP (VBP are) (ADVP (RBS most) (RB often)) (VP (VBN associated) (PP (IN with) (NP (NN heroin)))))))) (. .)))
19681452	4	(ROOT (S (NP (NP (NNP Doc_19681452_385_417_Disease)) (PP (IN after) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_19681452_435_442_Chemical)))))) (, ,) (PP (IN without) (NP (JJ concurrent) (JJ Doc_19681452_463_469_Chemical) (NN use))) (, ,) (VP (VBP have) (ADVP (RB never)) (VP (VBN been) (VP (VBN reported)))) (. .)))
19681452	5	(ROOT (S (PP (IN In) (NP (PRP$ our) (NN patient))) (, ,) (NP (NP (JJ transient) (NNS Doc_19681452_527_545_Disease) (CC or) (NNS Doc_19681452_549_572_Disease)) (VP (VBN related) (PP (TO to) (NP (JJ Doc_19681452_584_591_Chemical) (NNP and/or) (NNP Doc_19681452_599_606_Chemical) (NN use))))) (VP (VBD were) (NP (NP (DT the) (ADJP (RBS most) (JJ likely)) (NNS causes)) (PP (IN of) (NP (NNS Doc_19681452_642_664_Disease))))) (. .)))
19715529	0	(ROOT (S (NP (RB Late) (NN fulminant)) (VP (VBP posterior) (NP (JJ reversible) (JJ Doc_19715529_36_50_Disease) (NN syndrome)) (PP (IN after) (NP (NN liver) (NN transplant)))) (. .)))
19715529	1	(ROOT (S (NP (NP (NNP Posterior) (NNP Doc_19715529_106_125_Disease)) (ADJP (JJ due) (PP (TO to) (NP (JJ calcineurin-inhibitor-related) (NNS Doc_19715529_163_176_Disease))))) (VP (VBZ is) (NP (NP (DT a) (ADJP (JJ rare) (CC but) (JJ severe)) (NN complication)) (SBAR (WHNP (WDT that)) (S (VP (VBZ results) (PP (IN from) (NP (NP (NN treatment)) (PP (IN with) (NP (JJ immunosuppressive) (NNS agents))) (PRN (-LRB- -LRB-) (NP (NP (RB primarily) (DT those)) (VP (VBN administered) (PP (IN after) (NP (DT a) (NN liver) (CC or) (NN kidney) (NN transplant))))) (-RRB- -RRB-))))))))) (. .)))
19715529	2	(ROOT (S (NP (NP (DT The) (JJ pathophysiologic) (NNS mechanisms)) (PP (IN of) (NP (DT that) (NN disorder)))) (VP (VBP remain) (ADJP (JJ unknown))) (. .)))
19715529	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT a) (JJ 46-year-old) (NN woman)))) (SBAR (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (DT a) (NN liver) (NN transplant)) (PP (IN in) (NP (PRP$ our) (NN center))) (PP (IN as) (NP (NP (NN treatment)) (PP (IN for) (NP (NNS Doc_19715529_512_531_Disease)))))))) (CC and) (SBAR (WHPP (IN in) (WHNP (WHNP (WP whom)) (PP (CC either) (NP (NP (DT a) (JJ fulminant) (NN course)) (PP (IN of) (NP (NP (NN posterior) (NNS Doc_19715529_583_602_Disease)) (CC or) (NP (NN posterior)))))))) (S (NP (JJ reversible) (JJ Doc_19715529_627_641_Disease) (NN syndrome)) (VP (VBD developed) (NP (CD 110) (NNS days)) (PP (IN after) (NP (NN transplant)))))))) (. .)))
19715529	4	(ROOT (S (PP (IN After) (NP (NP (DT an) (ADJP (ADVP (RB initially)) (JJ uneventful)) (NN course)) (PP (IN after) (NP (DT the) (NN transplant))))) (, ,) (NP (DT the) (NN patient)) (ADVP (RB rapidly)) (VP (VBD fell) (PP (IN into) (NP (JJ deep) (NNS Doc_19715529_782_786_Disease)))) (. .)))
19715529	5	(ROOT (S (NP (NNP Cerebral) (NNP MRI) (NNP scan)) (VP (VBD showed) (NP (NP (JJ typical) (NNS signs)) (PP (IN of) (NP (NN enhancement)))) (PP (IN in) (NP (DT the) (NN pontine) (CC and) (NN posterior) (NNS regions)))) (. .)))
19715529	6	(ROOT (S (S (VP (VBG Switching) (NP (DT the) (JJ immunosuppressive) (NN regimen)) (PP (IN from) (NP (NP (NNS Doc_19715529_934_944_Chemical)) (PP (TO to) (NP (NNS Doc_19715529_948_960_Chemical))))))) (VP (VBD did) (RB not) (VP (VB improve) (NP (DT the) (JJ clinical) (NN situation)))) (. .)))
19715529	7	(ROOT (S (NP (NP (DT The) (NN termination)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (DT any) (NN calcineurin) (NN inhibitor)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ complete) (NN resolution)) (PP (IN of) (NP (DT that) (NN complication)))))) (. .)))
19715529	8	(ROOT (S (NP (NP (NNP Posterior) (JJ reversible) (JJ Doc_19715529_1151_1165_Disease) (NN syndrome)) (PP (IN after) (NP (NN liver) (NN transplant)))) (VP (VBZ is) (ADJP (JJ rare))) (. .)))
19715529	9	(ROOT (S (NP (PRP We)) (VP (VBP recommend) (NP (NP (NP (DT a) (JJ complete) (NN cessation)) (PP (IN of) (NP (DT any) (NN calcineurin) (NN inhibitor)))) (CONJP (RB rather) (IN than)) (NP (DT a) (NN dose) (NN reduction)))) (. .)))
19728177	0	(ROOT (S (NP (NP (JJ Prolonged) (NNS Doc_19728177_10_21_Disease)) (PP (IN as) (NP (NP (DT a) (NN bridge)) (PP (TO to) (NP (NP (NN recovery)) (PP (IN for) (NP (NNS Doc_19728177_50_64_Disease) (CC and) (NNS Doc_19728177_69_94_Disease)))))))) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_19728177_111_136_Disease)))) (. .)))
19728177	1	(ROOT (S (VP (TO To) (VP (VP (VB review) (NP (JJ evidence-based) (NN treatment) (NNS options)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ Doc_19728177_210_224_Disease) (VBG complicating) (NNS Doc_19728177_238_263_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19728177_265_268_Disease)) (-RRB- -RRB-))))))) (CC and) (VP (VB discuss) (NP (NP (DT the) (JJ potential) (NNS applications)) (PP (IN of) (NP (NNS Doc_19728177_312_323_Disease))))))) (. .)))
19728177	2	(ROOT (NP (NP (JJ Case-based) (NNS observations)) (PP (IN from) (NP (DT a) (JJ medical) (JJ intensive) (NN care) (NN unit))) (PRN (-LRB- -LRB-) (NP (NNP MICU)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (DT a) (JJ tertiary) (NN care) (NN facility)) (PP (IN in) (NP (NP (DT a) (JJ 27-year-old) (NN female)) (PP (IN with) (NP (NP (NNS Doc_19728177_456_459_Disease)) (PP (IN from) (NP (NNS Doc_19728177_465_478_Chemical) (CC and) (NN resultant) (NNS Doc_19728177_493_507_Disease))))))))) (. .)))
19728177	3	(ROOT (S (NP (PRP$ Our) (NN patient)) (VP (VBD was) (VP (VBN admitted) (PP (TO to) (NP (DT the) (NN MICU))) (PP (IN after) (S (VP (VBG being) (VP (VBN found) (ADJP (JJ unresponsive) (PP (IN with) (NP (JJ presumed) (NNS Doc_19728177_600_608_Disease)))) (PP (IN from) (NP (NP (NNS Doc_19728177_614_627_Chemical)) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN ingested) (PP (IN over) (NP (DT a) (JJ 2-day) (NN period))))))))))))))) (. .)))
19728177	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (VP (VBN depressed) (PP (IN of) (NP (NP (JJ mental) (NN status)) (VP (VBG lasting) (ADVP (NP (QP (IN at) (JJS least) (CD 24)) (NN h)) (RB prior)) (PP (TO to) (NP (NN admission)))))))) (. .)))
19728177	5	(ROOT (S (NP (JJ Initial) (NN evaluation)) (VP (VBD confirmed) (NP (NNS Doc_19728177_782_785_Chemical)) (PP (IN from) (NP (NNS Doc_19728177_791_804_Chemical) (CC and) (NNS Doc_19728177_809_823_Disease)))) (. .)))
19728177	6	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (JJ Doc_19728177_854_866_Disease) (NN therapy) (, ,) (NN hyperventilation) (, ,) (NN sedation) (, ,) (CC and) (NN chemical) (NNS Doc_19728177_917_926_Disease))))) (. .)))
19728177	7	(ROOT (S (NP (PRP$ Her) (JJ intracranial) (NN pressure)) (VP (VBD remained) (SBAR (S (VP (VBD elevated) (PP (IN despite) (NP (JJ maximal) (JJ medical) (NN therapy))))))) (. .)))
19728177	8	(ROOT (S (NP (PRP We)) (ADVP (RB then)) (VP (VBD initiated) (NP (NP (NNS Doc_19728177_1023_1046_Disease)) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN continued) (PP (IN for) (NP (CD 5) (NNS days))))))))) (. .)))
19728177	9	(ROOT (S (PP (IN At) (NP (NN re-warming))) (, ,) (NP (NN patient)) (VP (VBD had) (NP (NP (NN resolution)) (PP (IN of) (NP (PRP$ her) (NNS Doc_19728177_1124_1138_Disease) (CC and) (NNS Doc_19728177_1143_1168_Disease))))) (. .)))
19728177	10	(ROOT (S (PP (IN At) (NP (NN discharge))) (, ,) (NP (PRP she)) (VP (VBD had) (NP (NP (JJ complete) (NN recovery)) (PP (IN of) (NP (JJ neurological) (CC and) (JJ hepatic) (NNS functions))))) (. .)))
19728177	11	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_19728177_1278_1281_Disease) (CC and) (NNS Doc_19728177_1286_1300_Disease)) (PP (IN from) (NP (JJ Doc_19728177_1306_1319_Chemical) (NNS Doc_19728177_1320_1328_Disease))))))) (, ,) (NP (JJ prolonged) (NNS Doc_19728177_1340_1363_Disease)) (VP (MD could) (ADVP (RB potentially)) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (NN life) (NN saving) (NN therapy)) (CC and) (NP (DT a) (NN bridge)))) (PP (TO to) (NP (JJ hepatic) (CC and) (JJ neurological) (NN recovery)))))) (. .)))
19728177	12	(ROOT (S (NP (NP (DT A) (JJ clinical) (NN trial)) (PP (IN of) (NP (NP (NNS Doc_19728177_1486_1497_Disease)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (DT this) (NN condition)))))))) (VP (VBZ is) (VP (VBN warranted))) (. .)))
19815465	0	(ROOT (S (NP (NNP Doc_19815465_0_28_Disease)) (VP (VBP are) (RB not) (ADJP (JJ specific) (PP (TO to) (NP (NNS Doc_19815465_49_59_Chemical))))) (. .)))
19815465	1	(ROOT (S (NP (DT This) (NN study)) (VP (VBD investigated) (NP (NP (DT the) (NNS Doc_19815465_89_103_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (JJ antiepileptic) (NN drug) (NNS Doc_19815465_143_153_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP VGB)) (-RRB- -RRB-))))))) (. .)))
19815465	2	(ROOT (S (NP (NP (CD Two) (CD hundred) (CD four) (NNS people)) (PP (IN with) (NP (NNS Doc_19815465_190_198_Disease)))) (VP (VBD were) (VP (VBN grouped) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NP (JJ antiepileptic) (NN drug) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NP (JJ current)) (, ,) (NP (JJ previous)) (, ,) (CC or) (NP (NP (DT no) (NN exposure)) (PP (TO to) (NP (NNP VGB))))) (-RRB- -RRB-)))))))) (. .)))
19815465	3	(ROOT (S (NP (NNS Groups)) (VP (VBD were) (VP (VBN matched) (PP (IN with) (NP (NN respect))) (PP (TO to) (NP (NN age) (, ,) (NN gender) (, ,) (CC and) (NN Doc_19815465_352_359_Disease) (NN frequency))))) (. .)))
19815465	4	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD underwent) (NP (NP (JJ objective) (NN assessment)) (PP (IN of) (NP (NP (JJ electrophysiological) (NN function)) (PRN (-LRB- -LRB-) (NP (JJ wide-field) (JJ multifocal) (NN electroretinography)) (-RRB- -RRB-)) (CC and) (NP (JJ conventional) (JJ visual) (NN field) (NN testing)) (PRN (-LRB- -LRB-) (NP (JJ static) (NN perimetry)) (-RRB- -RRB-)))))) (. .)))
19815465	5	(ROOT (S (NP (NNP Doc_19815465_550_585_Disease)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (S (NP (NP (CD 59) (NN %)) (PP (IN of) (NP (NNS patients)))) (ADVP (RB currently)) (VP (VBG taking) (NP (NP (NNP VGB)) (, ,) (NP (NP (CD 43) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (ADVP (RB previously)) (VP (VBD took) (NP (NP (NNP VGB)) (, ,) (CC and) (NP (NP (CD 24) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (DT no) (NN exposure))))))) (PP (TO to) (NP (NNP VGB))))))))))))))) (. .)))
19815465	6	(ROOT (S (NP (NP (NNP Assessment)) (PP (IN of) (NP (JJ retinal) (NN function)))) (VP (VBD revealed) (NP (JJ abnormal) (NNS responses)) (PP (PP (IN in) (NP (NP (NP (CD 48) (NN %)) (PP (IN of) (NP (JJ current) (NNP VGB) (NNS users)))) (CC and) (NP (NP (CD 22) (NN %)) (PP (IN of) (NP (JJ prior) (NNP VGB) (NNS users)))))) (, ,) (CC but) (PP (IN in) (NP (NP (NN none)) (PP (IN of) (NP (DT the) (NNS patients))))) (PP (IN without) (NP (JJ previous) (NN exposure)))) (PP (TO to) (NP (NNP VGB)))) (. .)))
19815465	7	(ROOT (S (NP (JJ Bilateral) (NNS Doc_19815465_913_939_Disease)) (VP (VBP are) (ADJP (JJ common) (PP (IN in) (NP (DT the) (JJ treated) (JJ Doc_19815465_966_974_Disease) (NN population)))) (, ,) (ADVP (RB irrespective) (PP (IN of) (NP (NN drug) (NN history))))) (. .)))
19815465	8	(ROOT (S (NP (NP (NNP Assessment)) (PP (IN by) (NP (JJ conventional) (JJ static) (NN perimetry)))) (VP (MD may) (RB neither) (VP (VB be) (ADJP (ADJP (RB sufficiently) (JJ sensitive)) (CC nor) (ADJP (JJ specific))) (S (VP (TO to) (VP (ADVP (RB reliably)) (VB identify) (NP (NP (NNS Doc_19815465_1133_1149_Disease)) (VP (VBN associated) (PP (IN with) (NP (NNP VGB)))))))))) (. .)))
19841052	0	(ROOT (NP (NP (NN Smoking)) (PP (IN of) (NP (NN crack) (NNS Doc_19841052_17_24_Chemical))) (PP (IN as) (NP (DT a) (NN risk) (NN factor))) (PP (IN for) (NP (NNS Doc_19841052_46_59_Disease))) (PP (IN among) (NP (NP (NNS people)) (SBAR (WHNP (WP who)) (S (VP (VBP use) (NP (NN injection) (NNS drugs))))))) (. .)))
19841052	1	(ROOT (S (NP (NNP Little)) (VP (VBZ is) (VP (VBN known) (PP (IN about) (NP (DT the) (JJ possible) (NN role))) (SBAR (IN that) (S (NP (NN smoking) (NN crack) (NNS Doc_19841052_169_176_Chemical)) (VP (VBZ has) (VP (PP (IN on) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_19841052_201_214_Disease))))))))))) (. .)))
19841052	2	(ROOT (S (PP (VBN Given) (NP (NP (DT the) (VBG increasing) (NN use)) (PP (IN of) (NP (NN crack) (NNS Doc_19841052_250_257_Chemical))))) (, ,) (NP (PRP we)) (VP (VBD sought) (S (VP (TO to) (VP (VB examine) (SBAR (IN whether) (S (NP (NP (NN use)) (PP (IN of) (NP (DT this) (JJ illicit) (NN drug)))) (VP (VBZ has) (VP (VBN become) (NP (NP (DT a) (NN risk) (NN factor)) (PP (IN for) (NP (NNS Doc_19841052_342_355_Disease)))))))))))) (. .)))
19841052	3	(ROOT (S (NP (PRP We)) (VP (VBD included) (NP (NNS data)) (PP (IN from) (NP (NP (NNS people)) (VP (VBG participating) (PP (IN in) (NP (NP (DT the) (NNP Vancouver) (NNP Injection) (NNP Drug) (NNP Users) (NNP Study)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD reported) (S (VP (VBG injecting) (NP (JJ illicit) (NNS drugs)) (ADVP (ADVP (IN at) (JJS least) (RB once)) (PP (IN in) (NP (DT the) (NN month)))) (PP (IN before) (NP (NN enrolment)))))) (, ,) (VP (VBD lived) (PP (IN in) (NP (DT the) (JJR greater) (NNP Vancouver) (NN area)))) (, ,) (VP (VBD were) (ADJP (JJ HIV-negative)) (PP (IN at) (NP (NN enrolment)))) (CC and) (VP (VBD completed) (NP (QP (IN at) (JJS least) (CD 1) (CD follow-up)) (NN study) (NN visit)))))))))))) (. .)))
19841052	4	(ROOT (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NN HIV) (NN seroconversion)) (PP (IN among) (NP (NP (JJ daily) (NNS smokers)) (PP (IN of) (NP (NN crack) (NNS Doc_19841052_732_739_Chemical)))))))) (VP (VBD changed) (PP (IN over) (NP (NN time))))))))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (NP (NP (NP (NP (NP (NNP Cox) (JJ proportional) (NNS hazards)) (VP (VBN regression) (CC and) (VBN divided) (NP (DT the) (NN study)) (PP (IN into) (NP (NP (CD 3) (NNS periods)) (: :) (NP (NNP May) (CD 1) (, ,) (CD 1996-Nov)))))) (. .) (NP (NP (NP (CD 30)) (, ,) (NP (NP (CD 1999)) (PRN (-LRB- -LRB-) (NP (NN period) (CD 1)) (-RRB- -RRB-))) (, ,)) (NP (NNP Dec.) (CD 1) (, ,) (CD 1999-Nov)))) (. .) (NP (NP (NP (CD 30)) (, ,) (NP (NP (CD 2002)) (PRN (-LRB- -LRB-) (NP (NN period) (CD 2)) (-RRB- -RRB-)))) (, ,) (CC and) (NP (NNP Dec.) (CD 1) (, ,) (CD 2002-Dec)))) (. .) (NP (NP (CD 30)) (, ,) (NP (CD 2005)))) (PRN (-LRB- -LRB-) (NP (NN period) (CD 3)) (-RRB- -RRB-)))) (. .)))
19841052	5	(ROOT (S (ADVP (RB Overall)) (, ,) (NP (CD 1048) (JJ eligible) (NN injection) (NN drug) (NNS users)) (VP (VBD were) (VP (VBN included) (PP (IN in) (NP (PRP$ our) (NN study))))) (. .)))
19841052	6	(ROOT (S (PP (IN Of) (NP (DT these))) (, ,) (NP (NNP 137)) (VP (VBD acquired) (NP (NNS Doc_19841052_1065_1078_Disease)) (PP (IN during) (NP (NN follow-up)))) (. .)))
19841052	7	(ROOT (S (NP (NP (DT The) (JJ mean) (NN proportion)) (PP (IN of) (NP (NP (NNS participants)) (SBAR (WHNP (WP who)) (S (VP (VBD reported) (NP (NP (JJ daily) (NN smoking)) (PP (IN of) (NP (NN crack) (NNS Doc_19841052_1169_1176_Chemical)))))))))) (VP (VBD increased) (PP (IN from) (NP (CD 11.6) (NN %))) (PP (IN in) (NP (NN period))) (NP (NP (QP (CD 1) (TO to) (CD 39.7)) (NN %)) (PP (IN in) (NP (NN period) (CD 3))))) (. .)))
19841052	8	(ROOT (S (PP (IN After) (S (VP (VBG adjusting) (PP (IN for) (NP (JJ potential) (NNS confounders)))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NN HIV) (NN seroconversion)) (PP (IN among) (NP (NP (NNS participants)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (NP (NP (JJ daily) (NNS smokers)) (PP (IN of) (NP (NN crack) (NNS Doc_19841052_1371_1378_Chemical)))))))))))) (VP (VBD increased) (PP (IN over) (NP (NP (NN time)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NN period)) (NP (CD 1))) (: :) (NP (NP (NP (NN hazard) (NN ratio) (NNP -LSB-) (NNP HR) (NNP -RSB-) (CD 1.03) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-)) (NP (CD 0.57-1) (CD .85))) (: ;) (NP (NP (NN period)) (NP (CD 2))) (: :) (NP (NP (NNP HR) (NNP 1.68)) (, ,) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (NP (CD 1.01-2) (CD .80)))) (: ;) (CC and) (NP (NN period) (CD 3))) (: :) (NP (NP (NNP HR) (NNP 2.74)) (, ,) (NP (ADJP (CD 95) (NN %)) (NNP CI)))) (NP (CD 1.06-7) (CD .11))) (-RRB- -RRB-)))))))) (. .)))
19841052	9	(ROOT (S (NP (NP (NN Smoking)) (PP (IN of) (NP (NN crack) (NNS Doc_19841052_1586_1593_Chemical)))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ independent) (NN risk) (NN factor)) (PP (IN for) (NP (NP (NN HIV) (NN seroconversion)) (PP (IN among) (NP (NP (NNS people)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (NP (NN injection) (NN drug) (NNS users))))))))))))))) (. .)))
19841052	10	(ROOT (S (NP (DT This) (NN finding)) (VP (VBZ points) (PP (TO to) (NP (NP (DT the) (JJ urgent) (NN need)) (PP (IN for) (NP (NP (JJ evidence-based) (JJ public) (NN health) (NNS initiatives)) (VP (VBN targeted) (PP (IN at) (NP (NP (NNS people)) (SBAR (WHNP (WP who)) (S (VP (VBP smoke) (NP (NN crack) (NNS Doc_19841052_1823_1830_Chemical))))))))))))) (. .)))
19914299	0	(ROOT (S (NP (NNP Doc_19914299_0_10_Chemical)) (VP (VBZ improves) (NP (NP (DT the) (NNS Doc_19914299_24_39_Disease)) (VP (VBN caused) (PP (IN by) (NP (DT the) (JJ chemotherapy) (NN agent) (NNS Doc_19914299_73_87_Chemical)))))) (. .)))
19914299	1	(ROOT (S (NP (NP (JJ Doc_19914299_89_95_Disease) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN been) (VP (VBN treated) (PP (IN with) (NP (JJ systemic) (NN adjuvant))))))))) (ADVP (RB chemotherapy)) (VP (VBP have) (VP (VBN described) (S (VP (VBG experiencing) (NP (NNS deteriorations)) (PP (IN in) (NP (NN cognition))))))) (. .)))
19914299	2	(ROOT (S (NP (NP (DT A) (ADJP (RB widely) (VBN used)) (JJ chemotherapeutic) (NN agent)) (, ,) (NP (JJ Doc_19914299_258_272_Chemical) (-LRB- -LRB-) (NNS Doc_19914299_274_278_Chemical) (-RRB- -RRB-)) (, ,)) (ADVP (RB readily)) (VP (VP (VBZ crosses) (NP (DT the) (JJ blood-brain) (NN barrier))) (CC and) (VP (ADVP (RB so)) (MD could) (VP (VB have) (NP (NP (DT a) (JJ direct) (NN effect)) (PP (IN on) (NP (NN brain) (NN function))))))) (. .)))
19914299	3	(ROOT (S (PP (IN In) (ADJP (JJ particular))) (NP (DT this) (JJ anti) (JJ mitotic) (NN drug)) (VP (MD could) (VP (VB reduce) (NP (NN cell) (NN proliferation)) (PP (IN in) (NP (NP (DT the) (JJ neurogenic) (NNS regions)) (PP (IN of) (NP (DT the) (JJ adult) (NN brain))))))) (. .)))
19914299	4	(ROOT (S (PP (IN In) (NP (NN contrast))) (NP (NNS reports)) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ hippocampal) (JJ dependent) (NNS neurogenesis) (CC and) (NN cognition)) (VP (VBP are) (VP (VBN enhanced) (PP (IN by) (NP (DT the) (NNP SSRI) (NN antidepressant) (NNS Doc_19914299_612_622_Chemical)))))))) (. .)))
19914299	5	(ROOT (S (PP (IN In) (NP (DT this) (NN investigation))) (NP (DT the) (NP (NP (NP (JJ behavioural) (NNS effects)) (PP (IN of) (NP (NP (JJ chronic) (PRN (-LRB- -LRB-) (NP (CD two) (NN week)) (-RRB- -RRB-)) (NN treatment)) (PP (IN with) (NP (NNS Doc_19914299_707_711_Chemical)))))) (CC and) (PRN (-LRB- -LRB-) (NP (CD three) (NNS weeks)) (-RRB- -RRB-)) (PP (IN with) (NP (NP (NNS Doc_19914299_735_745_Chemical)) (UCP (DT either) (ADVP (RB separately)) (CC or) (PP (IN in) (NP (NN combination)))))) (PP (IN with) (NP (NNS Doc_19914299_787_791_Chemical))))) (VP (VBD were) (VP (VBN tested) (PP (IN on) (NP (JJ adult) (NNP Lister) (NN hooded) (NNS rats))))) (. .)))
19914299	6	(ROOT (S (NP (JJ Behavioural) (NNS effects)) (VP (VBD were) (VP (VBN tested) (S (VP (VBG using) (S (NP (DT a) (NN context)) (ADJP (JJ dependent)) (S (VP (VBN conditioned) (NP (NP (JJ emotional) (NN response) (NN test)) (PRN (-LRB- -LRB-) (NP (NNP CER)) (-RRB- -RRB-)) (SBAR (WHNP (WDT which)) (S (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NNS animals)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_19914299_972_976_Chemical))))) (VP (VBD had) (NP (NP (DT a) (JJ significant) (NN reduction)) (PP (IN in) (NP (JJ freezing) (NN time)))) (PP (VBN compared) (PP (TO to) (NP (NNS controls)))))))))))))))))) (. .)))
19914299	7	(ROOT (S (NP (NP (DT A) (JJ separate) (NN group)) (PP (IN of) (NP (NNS animals)))) (VP (VBD was) (VP (VBN tested) (S (VP (VBG using) (NP (NP (DT a) (JJ hippocampal) (ADJP (JJ dependent) (NP (NP (JJ spatial) (JJ working) (NN memory) (NN test)) (, ,) (NP (DT the) (NN object)))) (NN location) (NN recognition) (NN test)) (PRN (-LRB- -LRB-) (NP (NNP OLR)) (-RRB- -RRB-))))))) (. .)))
19914299	8	(ROOT (S (S (NP (NP (NNS Animals)) (VP (VBN treated) (ADVP (RB only)) (PP (IN with) (NP (NNS Doc_19914299_1212_1216_Chemical))))) (VP (VBD showed) (NP (JJ significant) (NNS deficits)) (PP (IN in) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB carry) (PRT (RP out)) (NP (NP (DT the) (NNP OLR) (NN task)) (FRAG (CC but) (NP (NP (NP (NN co) (NN administration)) (PP (IN of) (NP (NNS Doc_19914299_1313_1323_Chemical)))) (VP (VBN improved) (NP (PRP$ their) (NN performance)))) (. .)))))))))) (NP (NNS Doc_19914299_1352_1356_Chemical)) (VP (ADVP (RB chemotherapy)) (VBD caused) (NP (DT a) (JJ significant) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (VBG proliferating) (NNS cells)) (PP (IN in) (NP (NP (DT the) (JJ sub) (JJ granular) (NN zone)) (PP (IN of) (NP (DT the) (JJ dentate) (NNS gyrus))))))))) (PP (VBN compared) (PP (TO to) (NP (NNS controls))))) (. .)))
19914299	9	(ROOT (S (NP (DT This) (NN reduction)) (VP (VBD was) (VP (VBN eliminated) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_19914299_1541_1551_Chemical)) (VP (VBD was) (ADVP (RB co)) (VP (VBN administered) (PP (IN with) (NP (NNS Doc_19914299_1577_1581_Chemical))))))))) (. .)))
19914299	10	(ROOT (S (NP (NP (NNP Doc_19914299_1583_1593_Chemical)) (PP (IN on) (NP (PRP$ its) (JJ own)))) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (VBG proliferating) (NN cell) (NN number)) (CC or) (NP (NN behaviour)))))) (. .)))
19914299	11	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NNS Doc_19914299_1690_1694_Chemical)) (VP (MD can) (ADVP (RB negatively)) (VP (VB affect) (NP (NP (DT both) (NN cell) (NN proliferation)) (CC and) (NP (NNS Doc_19914299_1745_1781_Disease))))))) (CC and) (SBAR (IN that) (S (NP (DT these) (NNS deficits)) (VP (MD can) (VP (VB be) (VP (VBN reversed) (PP (IN by) (NP (NP (DT the) (JJ simultaneous) (NN administration)) (PP (IN of) (NP (DT the) (JJ antidepressant) (NNS Doc_19914299_1879_1889_Chemical)))))))))))) (. .)))
19920070	0	(ROOT (S (NP (NP (JJ Liver-specific) (NN ablation)) (PP (IN of) (NP (NP (JJ integrin-linked) (NN kinase)) (PP (IN in) (NP (NNS mice)))))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (JJ enhanced)) (CC and) (NP (VBN prolonged) (NN cell) (NN proliferation))) (CC and) (NP (NP (NNS Doc_19920070_115_127_Disease)) (PP (IN after) (NP (JJ Doc_19920070_134_147_Chemical) (NN administration))))))) (. .)))
19920070	1	(ROOT (S (NP (PRP We)) (VP (VBP have) (ADVP (RB recently)) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (NN disruption)) (PP (IN of) (NP (NP (NP (NN extracellular) (NN matrix)) (PRN (-LRB- -LRB-) (NP (NNP ECM)) (-RRB- -RRB-))) (PRN (: /) (NP (NP (NN integrin) (NNS signaling)) (PP (IN via) (NP (NN elimination))) (PP (IN of) (NP (NP (NP (JJ integrin-linked) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NNP ILK)) (-RRB- -RRB-))) (PP (IN in) (NP (NNS hepatocytes)))))))))) (VP (VBZ interferes) (PP (IN with) (NP (NP (NNS signals)) (VP (VBG leading) (PP (TO to) (NP (NP (NN termination)) (PP (IN of) (NP (NNS Doc_19920070_372_390_Disease))))))))))))) (. .)))
19920070	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ investigates) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNP ILK)))) (PP (IN in) (NP (NP (NNS Doc_19920070_435_452_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_19920070_464_477_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19920070_479_481_Chemical)) (-RRB- -RRB-)))))))) (. .)))
19920070	3	(ROOT (S (S (NP (NP (NP (NP (NNP Wild-type)) (PRN (-LRB- -LRB-) (NP (NNP WT)) (-RRB- -RRB-))) (CC and) (NP (NNP ILK))) (: :) (NP (NN liver)) (: -)) (VP (VBZ /))) (: -) (S (NP (NNS mice)) (VP (VBD were) (NP (NP (VBN given) (NNS Doc_19920070_532_534_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.1) (NN %)) (PP (IN in) (NP (NN drinking) (NN water)))) (-RRB- -RRB-)) (PP (IN for) (NP (CD 10) (NNS days)))))) (. .)))
19920070	4	(ROOT (S (NP (NNS Livers)) (VP (VBD were) (VP (VBN harvested) (PP (IN on) (NP (NP (CD 2)) (, ,) (NP (CD 5)) (, ,) (CC and) (NP (CD 10) (NNS days)))) (PP (IN during) (NP (JJ Doc_19920070_623_625_Chemical) (NN administration))))) (. .)))
19920070	5	(ROOT (S (PP (IN In) (NP (NP (DT the) (JJ hepatocyte-specific) (NNP ILK/liver) (PRN (: -) (NP (NNP /)) (: -)) (NNS mice)) (, ,) (NP (DT the) (NN liver)))) (: :) (NP (NN body) (NN weight) (NN ratio)) (VP (VBD was) (NP (NP (QP (JJR more) (IN than) (RB double) (IN as))) (PP (VBN compared) (PP (TO to) (NP (NP (CD 0) (NN h)) (PP (IN at) (NP (NP (NN day) (CD 2)) (PRN (-LRB- -LRB-) (NP (QP (CD 2.5) (NNS times))) (-RRB- -RRB-)))))))) (, ,) (SBAR (IN while) (S (PP (IN at) (NP (NNS days) (CD 5) (CC and) (CD 10))) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN enlarged) (NP (CD three) (NNS times))))))) (. .)))
19920070	6	(ROOT (S (PP (IN In) (NP (DT the) (NNP WT) (NNS mice))) (, ,) (NP (DT the) (NN increase)) (VP (VP (VBD was) (ADJP (RB as) (VBN expected) (PP (IN from) (NP (NP (JJ previous) (NN literature)) (PRN (-LRB- -LRB-) (NP (QP (CD 1.8) (NNS times))) (-RRB- -RRB-)))))) (CC and) (VP (VBZ seems) (S (VP (TO to) (VP (VB have) (VP (VBN leveled) (PRT (RP off)) (PP (IN after) (NP (NN day) (CD 2))))))))) (. .)))
19920070	7	(ROOT (S (NP (EX There)) (VP (VBD were) (ADVP (RB slightly)) (VP (VBN increased) (S (VP (VBG proliferating) (NP (NN cell) (JJ nuclear) (NN antigen-positive) (NNS cells)) (PP (IN in) (NP (DT the) (NP (NNP ILK/liver)) (: -) (NP (NNP /)) (: -) (NP (NP (NNS animals)) (PP (IN at) (NP (NN day))))) (ADVP (NP (CD 2)) (RB as))) (PP (VBN compared) (PP (TO to) (NP (NP (NNP WT)) (PP (IN after) (NP (JJ Doc_19920070_1097_1099_Chemical) (NN administration)))))))))) (. .)))
19920070	8	(ROOT (S (PP (IN In) (NP (DT the) (NNP WT) (NNS animals))) (, ,) (NP (DT the) (JJ proliferative) (NN response)) (VP (VBD had) (VP (VBN come) (ADVP (RB back) (PP (TO to) (ADJP (JJ normal)))) (PP (IN by) (NP (NNS days) (CD 5) (CC and) (CD 10))))) (. .)))
19920070	9	(ROOT (S (NP (NP (NNS Hepatocytes)) (PP (IN of) (NP (DT the) (NNP ILK/liver) (PRN (: -) (NP (NNP /)) (: -)) (NNS mice)))) (VP (VBD continued) (S (VP (TO to) (VP (VB proliferate) (PRT (RP up)) (PP (IN until) (NP (NN day) (CD 10))))))) (. .)))
19920070	10	(ROOT (S (NP (JJ ILK/liver) (PRN (: -) (NP (NNP /)) (: -)) (NNS mice)) (ADVP (RB also)) (VP (VBD showed) (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (NP (JJ key) (NNS genes)) (VP (VBN involved) (PP (IN in) (NP (JJ hepatocyte) (NN proliferation))) (PP (IN at) (NP (JJ different) (NN time) (NNS points))) (PP (IN during) (NP (JJ Doc_19920070_1416_1418_Chemical) (NN administration)))))))) (. .)))
19920070	11	(ROOT (S (PP (IN In) (NP (NN summary))) (, ,) (NP (NNP ECM) (NNS proteins)) (VP (VB communicate) (PP (IN with) (NP (NP (DT the) (JJ signaling) (NN machinery)) (PP (IN of) (S (VP (VBG dividing) (NP (NP (NNS cells)) (PP (IN via) (NP (NNP ILK)))) (S (VP (TO to) (VP (VB regulate) (NP (NP (JJ hepatocyte) (NN proliferation) (CC and) (NN termination)) (PP (IN of) (NP (DT the) (JJ proliferative) (NN response))))))))))))) (. .)))
19920070	12	(ROOT (S (NP (NP (NN Lack)) (PP (IN of) (NP (NP (NNP ILK)) (PP (IN in) (NP (DT the) (NNS hepatocytes)))))) (VP (VBZ imparts) (NP (JJ prolonged) (NN proliferative) (NN response)) (PP (CONJP (RB not) (JJ only)) (PP (TO to) (NP (NP (NNS stimuli)) (VP (VBN related) (PP (TO to) (NP (NNS Doc_19920070_1714_1732_Disease)))))) (CONJP (CC but) (RB also)) (PP (TO to) (NP (NP (JJ xenobiotic) (NN chemical) (NNS mitogens)) (, ,) (PP (JJ such) (IN as) (S (VP (VBG Doc_19920070_1783_1785_Chemical)))))))) (. .)))
19967075	0	(ROOT (FRAG (NP (NP (NNP Decreased) (NNP Expression)) (PP (IN of) (NP (NNS Doc_19967075_24_26_Chemical)))) (: /) (NP (NP (NNP Doc_19967075_27_28_Chemical-ATPase) (, ,) (NNP NHE3) (, ,) (NNP NBC1) (, ,) (NNP AQP1) (CC and) (NNP Doc_19967075_58_61_Disease)) (PP (IN in) (NP (NN Doc_19967075_65_75_Chemical-induced) (NNS Doc_19967075_84_95_Disease)))) (. .)))
19967075	1	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBD was) (VP (VBN aimed) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT an) (VBN altered) (NN regulation)) (PP (IN of) (NP (NP (JJ tubular) (NNS transporters)) (PP (IN in) (NP (NN Doc_19967075_204_214_Chemical-induced) (NNS Doc_19967075_223_234_Disease)))))))))))))) (. .)))
19967075	2	(ROOT (S (S (NP (NP (JJ Sprague-Dawley) (JJ male) (NNS rats)) (PRN (-LRB- -LRB-) (NP (QP (CD 200) (CD ~)) (NN 250) (NN g)) (-RRB- -RRB-))) (VP (VBD were) (ADVP (RB subcutaneously)) (VP (VBN injected) (PP (IN with) (NP (NP (NP (NNS Doc_19967075_307_317_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 100) (NN mg/kg)) (PP (IN per) (NP (NN day)))) (-RRB- -RRB-))) (PP (IN for) (NP (CD 7) (NNS days)))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ tubular) (NNS transporters)))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NN immunoblotting) (CC and) (NN immunohistochemistry)))))) (. .)))
19967075	3	(ROOT (S (NP (NP (DT The) (NN mRNA) (CC and) (NN protein) (NN expression)) (PP (IN of) (NP (NNS Doc_19967075_487_490_Disease)))) (VP (VBD was) (VP (ADVP (RB also)) (VBN determined))) (. .)))
19967075	4	(ROOT (S (NP (NP (JJ Doc_19967075_512_522_Chemical-treated) (NNS rats)) (VP (VBN exhibited) (ADVP (RB significantly)))) (VP (VBD decreased) (NP (JJ Doc_19967075_570_580_Chemical) (NN clearance)) (ADVP (RB along)) (PP (IN with) (NP (VBN increased) (NN plasma) (NNS Doc_19967075_619_629_Chemical) (NNS levels)))) (. .)))
19967075	5	(ROOT (S (ADVP (RB Accordingly)) (, ,) (NP (NP (DT the) (JJ fractional) (NN excretion)) (PP (IN of) (NP (NNS Doc_19967075_679_685_Chemical)))) (VP (VBD increased)) (. .)))
19967075	6	(ROOT (S (NP (JJ Urine) (NN volume)) (VP (VBD was) (VP (VBN increased) (, ,) (SBAR (IN while) (S (NP (NP (NN urine) (NN osmolality)) (CC and) (NP (JJ free) (NN water) (NN reabsorption))) (VP (VBD were) (VP (VBN decreased))))))) (. .)))
19967075	7	(ROOT (FRAG (S (ADJP (JJ Immunoblotting) (CC and) (JJ immunohistochemistry)) (S (VP (VBN revealed) (NP (NP (VBN decreased) (NN expression)) (PP (IN of) (NP (NNS Doc_19967075_865_870_Chemical))))))) (: /) (NP (NP (NN Doc_19967075_871_875_Chemical-ATPase) (, ,) (NN NHE3) (, ,) (CD NBC1) (, ,) (CC and) (CD AQP1)) (PP (IN in) (NP (NP (DT the) (NN kidney)) (PP (IN of) (NP (VBG Doc_19967075_922_932_Chemical-treated) (NNS rats)))))) (. .)))
19967075	8	(ROOT (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NNP OAT1) (CC and) (NNP OAT3)))) (VP (VBD was) (VP (ADVP (RB also)) (VBN decreased))) (. .)))
19967075	9	(ROOT (S (NP (JJ Doc_19967075_999_1009_Chemical-induced) (NNS Doc_19967075_1018_1029_Disease)) (VP (MD may) (ADVP (ADVP (IN at) (JJS least)) (PP (IN in) (NP (NN part)))) (VP (VB be) (ADJP (RB causally) (VBN related) (PP (IN with) (NP (NP (DT a) (VBN decreased) (NN expression)) (PP (IN of) (NP (JJ Doc_19967075_1102_1107_Chemical) (NN /) (NNP Doc_19967075_1108_1112_Chemical-ATPase) (, ,) (NNP NHE3) (, ,) (NNP NBC1) (, ,) (NNP AQP1) (CC and) (NNP Doc_19967075_1142_1145_Disease)))))))) (. .)))
20009434	0	(ROOT (S (VP (VB Doc_20009434_0_19_Disease) (PP (IN after) (NP (NP (JJ high-dose) (JJ Doc_20009434_36_48_Chemical) (NN therapy)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NN ileostomy)))))))) (. .)))
20009434	1	(ROOT (S (NP (NP (JJ High-dose) (NNS Doc_20009434_96_108_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP HD-Doc_20009434_113_116_Chemical)) (-RRB- -RRB-))) (VP (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN treatment)) (PP (IN for) (NP (NNS Doc_20009434_148_164_Disease))))) (, ,) (CC but) (VP (MD can) (VP (VB cause) (NP (NN hepatic) (CC and) (NNS Doc_20009434_192_206_Disease)) (SBAR (WHADVP (WRB when)) (S (NP (PRP$ its) (NN clearance)) (VP (VBZ is) (VP (VBN delayed)))))))) (. .)))
20009434	2	(ROOT (S (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NNS Doc_20009434_258_277_Disease)))) (PP (IN after) (NP (NP (JJ Doc_20009434_284_290_Chemical) (NN therapy)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NN ileostomy))))))))) (, ,) (NP (DT The) (NN patient)) (VP (VBD was) (NP (NP (DT a) (JJ 3-year-old) (NN boy)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN received) (NP (NP (DT a) (JJ living-related) (NN liver) (NN transplantation)) (PP (IN for) (NP (NNS Doc_20009434_421_447_Disease)))))))))) (. .)))
20009434	3	(ROOT (S (PP (IN At) (NP (NP (NN day) (NNS 833)) (PP (IN after) (NP (DT the) (NN transplantation))))) (, ,) (NP (PRP he)) (VP (VBD was) (VP (VBN diagnosed) (PP (IN with) (NP (NP (NNS Doc_20009434_509_513_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_20009434_515_564_Disease)) (, ,) (NP (NNS Doc_20009434_566_597_Disease))) (-RRB- -RRB-)))))) (. .)))
20009434	4	(ROOT (S (PP (IN During) (NP (NN induction) (NN therapy))) (, ,) (NP (PRP he)) (VP (VP (VBZ Doc_20009434_629_655_Disease)) (CC and) (VP (ADVP (RB ileostomy)) (VBD was) (VP (VBN performed)))) (. .)))
20009434	5	(ROOT (S (NP (JJ Subsequent) (NN HD-Doc_20009434_699_702_Chemical) (NN therapy)) (VP (VBD caused) (NP (NP (NNS Doc_20009434_718_737_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD required) (NP (JJ continuous) (NNS hemodialysis))))))) (. .)))
20009434	6	(ROOT (S (NP (PRP We)) (VP (VBD supposed) (SBAR (IN that) (S (NP (NP (NNS Doc_20009434_794_819_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ substantial) (NN drainage)) (PP (IN from) (NP (DT the) (NN ileostoma))))))) (VP (VBD caused) (NP (NNS Doc_20009434_874_896_Disease)))))) (. .)))
20009434	7	(ROOT (S (PP (IN After) (NP (NP (NN recovery)) (PP (IN of) (NP (PRP$ his) (JJ renal) (NN function))))) (, ,) (NP (PRP we)) (VP (MD could) (ADVP (RB safely)) (VP (VB treat) (NP (NP (DT the) (NN patient)) (PP (IN with) (NP (NN HD-Doc_20009434_978_981_Chemical) (NN therapy)))) (PP (IN by) (NP (NP (VBG controlling) (NN drainage)) (PP (IN from) (NP (NP (NN ileostoma)) (PP (IN with) (NP (JJ total) (JJ parenteral) (NN nutrition))))))))) (. .)))
20024739	0	(ROOT (S (NP (NP (JJ Longitudinal) (NN association)) (PP (IN of) (NP (NNS Doc_20024739_28_35_Chemical)))) (VP (VBP use) (PP (IN with) (NP (NNS Doc_20024739_45_68_Disease) (CC and) (NNS Doc_20024739_73_111_Disease)))) (. .)))
20024739	1	(ROOT (S (NP (PRP We)) (VP (VBN evaluated) (NP (NP (NP (DT the) (NN association)) (PP (IN of) (NP (JJ Doc_20024739_145_152_Chemical) (NN consumption) (CC and) (NNS Doc_20024739_169_179_Disease)))) (, ,) (CC and) (NP (NP (PRP$ their) (NNS effects)) (PP (IN on) (NP (NP (NNS Doc_20024739_202_225_Disease)) (PP (IN among) (NP (NP (NNS women)) (PP (IN with) (NP (NNS Doc_20024739_243_246_Disease)))))))))) (. .)))
20024739	2	(ROOT (S (NP (DT The) (NN study)) (VP (VBD included) (NP (JJ 871) (NNS women)) (PP (IN with) (NP (NP (NNS Doc_20024739_282_285_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN recruited) (PP (IN from) (NP (CD 1993-1995))) (PP (IN in) (NP (CD four) (NNP US) (NNS cities)))))))))) (. .)))
20024739	3	(ROOT (S (S (NP (DT The) (NNS participants)) (VP (VBD had) (NP (NP (JJ physical) (NN examination)) (, ,) (NP (JJ medical) (NN record) (NN extraction)) (, ,) (CC and) (NP (NN venipuncture))))) (PRN (, ,) (S (NP (NNP CD4) (NNP +) (NNP T-cell)) (VP (VBZ counts) (NP (NP (NN determination)) (, ,) (NP (NP (NN measurement)) (PP (IN of) (NP (JJ Doc_20024739_475_485_Disease) (NNS symptoms))))) (PRN (-LRB- -LRB-) (S (VP (VBG using) (NP (DT the) (JJ self-report) (NN Center)) (PP (IN for) (NP (NNP Epidemiological) (NNP Studies-Doc_20024739_553_563_Disease) (NNP Scale))))) (-RRB- -RRB-)))) (, ,)) (CC and) (S (NP (NNS Doc_20024739_576_583_Chemical)) (VP (VBP use) (NP (NN assessment)) (PP (PP (IN at) (NP (NN enrollment))) (, ,) (CC and) (ADVP (RB semiannually)) (PP (IN until) (NP (NNP March) (CD 2000)))))) (. .)))
20024739	4	(ROOT (S (NP (NP (JJ Multilevel) (JJ random) (JJ coefficient) (JJ ordinal) (NNS models)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ multilevel) (NNS models)) (PP (IN with) (NP (JJ joint) (NNS responses))))) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (DT the) (NN analysis))))) (. .)))
20024739	5	(ROOT (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (JJ significant) (NN association)) (PP (IN between) (NP (NP (NN level)) (PP (IN of) (NP (JJ Doc_20024739_825_832_Chemical) (NN use)))))))) (CC and) (S (NP (NNP CD4) (NNP +) (NNP T-cell)) (VP (VBZ counts))) (. .)))
20024739	6	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (NNS participants)) (VP (VBD were) (ADJP (JJ stratified) (PP (IN by) (NP (ADJP (JJ antiretroviral)) (NN therapy) (PRN (-LRB- -LRB-) (NP (NNP ART)) (-RRB- -RRB-)) (NN use))))))) (, ,) (NP (NP (DT the) (NN association)) (PP (IN between) (NP (NP (NNS Doc_20024739_956_963_Chemical)) (CC and) (NP (NNP CD4) (NNP +) (NNP T-cell))))) (VP (VBD did) (RB not) (VP (VB reach) (NP (JJ statistical) (NN significance)))) (. .)))
20024739	7	(ROOT (S (NP (NP (DT The) (NN association)) (PP (IN between) (NP (JJ Doc_20024739_1044_1051_Chemical) (NN consumption) (CC and) (NNS Doc_20024739_1068_1078_Disease)))) (VP (VBD was) (ADJP (JJ significant)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-))) (. .)))
20024739	8	(ROOT (S (NP (NNP Doc_20024739_1106_1116_Disease)) (VP (VBD had) (NP (NP (DT a) (JJ significant) (JJ negative) (NN effect)) (PP (IN on) (NP (NP (CD CD4) (NNP +) (NNP T-cell) (NNS counts)) (PP (IN over) (NP (NN time)))))) (ADVP (RB regardless) (PP (IN of) (NP (NNP ART) (NN use))))) (. .)))
20024739	9	(ROOT (S (NP (PRP$ Our) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ Doc_20024739_1232_1239_Chemical) (NN consumption)) (VP (VBZ has) (NP (NP (DT a) (JJ direct) (NN association)) (PP (IN with) (NP (NNS Doc_20024739_1282_1292_Disease)))))))) (. .)))
20024739	10	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NNS Doc_20024739_1304_1314_Disease)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_20024739_1334_1357_Disease))))) (. .)))
20024739	11	(ROOT (S (NP (PRP$ Our) (NNS findings)) (VP (VBP have) (NP (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN provision)) (PP (IN of) (NP (NP (JJ Doc_20024739_1411_1418_Chemical) (NN use) (NNS interventions)) (CC and) (NP (JJ psychological) (NNS resources)))))) (S (VP (TO to) (VP (VB improve) (NP (NP (DT the) (NN health)) (PP (IN of) (NP (NNS women)))) (PP (IN with) (NP (NNS Doc_20024739_1501_1504_Disease))))))) (. .)))
20034406	0	(ROOT (S (NP (NP (NNP Chemokine) (NNP CCL2)) (CC and) (NP (PRP$ its) (NN receptor) (NN CCR2))) (VP (VBP are) (VP (VBN increased) (PP (IN in) (NP (NP (DT the) (NNS hippocampus)) (PP (VBG following) (NP (NN Doc_20034406_80_91_Chemical-induced) (NNS Doc_20034406_100_118_Disease))))))) (. .)))
20034406	1	(ROOT (S (NP (NNP Neuroinflammation)) (VP (VP (VBZ occurs) (PP (IN after) (NP (NNS Doc_20034406_163_171_Disease)))) (CC and) (VP (VBZ is) (VP (VBN implicated) (PP (IN in) (NP (NNS epileptogenesis)))))) (. .)))
20034406	2	(ROOT (S (S (NP (NNP CCR2)) (VP (VBZ is) (NP (NP (DT a) (JJ chemokine) (NN receptor)) (PP (IN for) (NP (NNP CCL2)))))) (CC and) (S (NP (PRP$ their) (NN interaction)) (VP (VBZ mediates) (NP (JJ monocyte) (NN infiltration)) (PP (IN in) (NP (NP (DT the) (JJ neuroinflammatory) (NN cascade)) (VP (VBN triggered) (PP (IN in) (NP (JJ different) (NNS Doc_20034406_357_374_Disease)))))))) (. .)))
20034406	3	(ROOT (S (PP (IN In) (NP (DT this) (NN work))) (NP (NN CCR2) (CC and) (NN CCL2) (NN expression)) (VP (VBD were) (VP (VBN examined) (PP (VBG following) (NP (NP (NNS Doc_20034406_438_456_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20034406_458_460_Disease)) (-RRB- -RRB-)) (VP (VBN induced) (PP (IN by) (NP (JJ Doc_20034406_473_484_Chemical) (NN injection)))))))) (. .)))
20034406	4	(ROOT (S (NP (NNP Doc_20034406_505_507_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (JJ Doc_20034406_523_534_Chemical) (NN injection))))) (. .)))
20034406	5	(ROOT (S (NP (NNP Control) (NNS rats)) (VP (VBD were) (VP (VBN injected) (PP (IN with) (NP (NP (NN saline)) (PP (RB instead) (IN of) (NP (NNS Doc_20034406_596_607_Chemical))))))) (. .)))
20034406	6	(ROOT (S (PP (NP (CD Five) (NNS days)) (IN after) (NP (NNS Doc_20034406_625_627_Disease))) (, ,) (NP (NP (NNP CCR2)) (VP (VBG staining) (PP (IN in) (NP (NP (NNS neurons)) (CC and) (NP (JJ glial) (NNS cells)))))) (VP (VBD was) (VP (VBN examined) (S (VP (VBG using) (NP (JJ imunohistochemical) (NNS analyses)))))) (. .)))
20034406	7	(ROOT (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (CD CCR2) (JJ positive) (NNS cells)))) (VP (VBD was) (VP (VBN determined) (S (VP (VBG using) (NP (JJ stereology) (NNS probes)) (PP (IN in) (NP (DT the) (NNS hippocampus))))))) (. .)))
20034406	8	(ROOT (S (NP (NP (CD CCL2) (NN expression)) (PP (IN in) (NP (DT the) (NNS hippocampus)))) (VP (VBD was) (VP (VBN examined) (PP (IN by) (NP (JJ molecular) (NN assay))))) (. .)))
20034406	9	(ROOT (S (NP (NNP Increased) (NNP CCR2)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (DT the) (NNS hippocampus))) (PP (IN after) (NP (NNS Doc_20034406_941_943_Disease))))) (. .)))
20034406	10	(ROOT (S (NP (NNP Doc_20034406_945_953_Disease)) (ADVP (RB also)) (VP (VBD resulted) (PP (IN in) (NP (NNS alterations))) (PP (TO to) (NP (DT the) (NN cell) (NNS types))) (S (VP (VBG expressing) (NP (NNP CCR2))))) (. .)))
20034406	11	(ROOT (S (NP (NP (VBN Increased) (NNS numbers)) (PP (IN of) (NP (NP (NNS neurons)) (SBAR (WHNP (WDT that)) (S (VP (VBD expressed) (NP (NNP CCR2)))))))) (VP (VBD was) (VP (VBN observed) (PP (VBG following) (NP (NNS Doc_20034406_1090_1092_Disease))))) (. .)))
20034406	12	(ROOT (S (NP (JJ Microglial) (NNS cells)) (VP (VBD were) (ADJP (ADJP (RBR more) (RB closely) (JJ apposed)) (PP (TO to) (NP (NP (DT the) (NN CCR2-labeled) (NNS cells)) (PP (IN in) (NP (JJ Doc_20034406_1166_1168_Disease) (NNS rats))))))) (. .)))
20034406	13	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NNS rats)) (SBAR (WHNP (WDT that)) (S (VP (VBD experienced) (NP (NNS Doc_20034406_1210_1212_Disease)))))) (VP (VBD exhibited) (NP (NNS CCR2-labeling)) (PP (IN in) (NP (NP (NNS populations)) (PP (IN of) (NP (JJ hypertrophied) (NNS astrocytes)))) (, ,) (ADVP (RB especially))) (PP (IN in) (NP (NN CA1) (CC and) (NN dentate) (NNS gyrus)))) (. .)))
20034406	14	(ROOT (S (NP (DT These) (NNP CCR2) (NNP +) (NNS astroctytes)) (VP (VBD were) (RB not) (VP (VBN observed) (PP (IN in) (NP (NN control) (NNS rats))))) (. .)))
20034406	15	(ROOT (S (NP (NP (NNP Examination)) (PP (IN of) (NP (NN CCL2) (NN expression)))) (VP (VBD showed) (SBAR (IN that) (S (NP (PRP it)) (VP (VBD was) (VP (VBN elevated) (PP (IN in) (NP (NP (DT the) (NNS hippocampus)) (PP (VBG following) (NP (NNS Doc_20034406_1465_1467_Disease)))))))))) (. .)))
20034406	16	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NNP CCR2) (CC and) (NNP CCL2)) (VP (VBP are) (VP (VBN up-regulated) (PP (IN in) (NP (DT the) (NNS hippocampus))) (PP (IN after) (NP (NN Doc_20034406_1556_1567_Chemical-induced) (NNS Doc_20034406_1576_1578_Disease)))))))) (. .)))
20034406	17	(ROOT (S (NP (NNP Doc_20034406_1580_1588_Disease)) (ADVP (RB also)) (VP (VBP result) (PP (IN in) (NP (NNS changes))) (PP (TO to) (NP (NP (NN CCR2) (NN receptor) (NN expression)) (PP (IN in) (NP (NNS neurons) (CC and) (NNS astrocytes)))))) (. .)))
20034406	18	(ROOT (S (NP (DT These) (NNS changes)) (VP (MD might) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (JJ detrimental) (NN neuroplasticity) (CC and) (NN neuroinflammatory) (NNS changes)) (SBAR (WHNP (WDT that)) (S (VP (VBP occur) (NP (JJ following) (NNS Doc_20034406_1781_1789_Disease)))))))))) (. .)))
20046642	0	(ROOT (S (NP (NNP Metallothionein) (NNP induction)) (VP (VBZ reduces) (NP (JJ caspase-3) (NN activity) (CC and) (NNP TNFalpha) (NNS levels)) (PP (IN with) (NP (NP (ADJP (JJ Doc_20046642_78_112_Disease) (CC and) (JJ intact)) (JJ hippocampal) (NNS neurons)) (PP (IN in) (NP (NN Doc_20046642_147_157_Chemical-treated) (NNS rats)))))) (. .)))
20046642	1	(ROOT (S (NP (JJ Hippocampal) (NN integrity)) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (JJ cognitive) (NNS functions))))) (. .)))
20046642	2	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NP (NN induction)) (PP (IN of) (NP (NP (NP (NP (NN metallothionein)) (PRN (-LRB- -LRB-) (NP (NNP MT)) (-RRB- -RRB-))) (PP (IN by) (NP (NNS Doc_20046642_288_295_Chemical)))) (CC and) (NP (NP (PRP$ its) (NN role)) (PP (IN in) (NP (NN neuroprotection))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN documented)))) (. .)))
20046642	3	(ROOT (NP (NP (NP (DT The) (JJ present) (NN study)) (VP (VBN aimed) (S (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NNP MT) (NN induction)))) (PP (IN on) (NP (NP (NNS Doc_20046642_414_424_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20046642_426_430_Chemical)) (-RRB- -RRB-))))))))) (: -) (NP (NP (JJ induced) (JJ hippocampal) (NNS Doc_20046642_452_473_Disease)) (PP (IN in) (NP (NNS rats)))) (. .)))
20046642	4	(ROOT (S (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (CD 60) (JJ male) (JJ Wistar) (NN albino) (NNS rats)))) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN divided) (PP (IN into) (NP (NP (CD four) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NNP 15/group)) (-RRB- -RRB-))))))) (: :) (S (NP (DT The) (NN control) (NN group)) (VP (VBD injected) (PP (IN with) (NP (NP (JJ single) (NNS doses)) (PP (IN of) (NP (NP (JJ normal) (NN saline)) (PRN (-LRB- -LRB-) (NP (NNP i.c.v)) (-RRB- -RRB-)) (VP (VBN followed) (PP (ADVP (NP (CD 24) (NN h)) (RBR later)) (IN by) (NP (JJ Doc_20046642_665_669_Chemical) (JJ solvent) (-LRB- -LRB-) (NN i.v) (-RRB- -RRB-)))))))))) (. .)))
20046642	5	(ROOT (S (NP (NP (DT The) (JJ second) (NN group)) (VP (VBN administered) (NP (NNS Doc_20046642_715_722_Chemical))) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 0.1) (NNS micromol/10)) (NP (JJ microl) (JJ normal) (NN saline)) (, ,) (ADVP (RB i.c.v))) (, ,) (ADVP (RB once))) (-RRB- -RRB-))) (ADVP (RB then)) (VP (VBZ Doc_20046642_780_784_Chemical) (ADJP (JJ solvent) (PRN (-LRB- -LRB-) (NP (NN i.v)) (-RRB- -RRB-)) (SBAR (IN after) (S (NP (CD 24) (NN h.) (JJ Third) (NN group)) (VP (VBD received) (NP (NP (NNS Doc_20046642_832_836_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 20) (NN mg/kg)) (, ,) (NP (NN i.v))) (, ,) (ADVP (RB once))) (-RRB- -RRB-)) (ADJP (CD 24) (JJ h))) (PP (IN after) (NP (NN injection))) (PP (IN with) (NP (NP (JJ normal) (NN saline)) (PRN (-LRB- -LRB-) (NP (NNP i.c.v)) (-RRB- -RRB-))))))))) (. .)))
20046642	6	(ROOT (S (NP (JJ Fourth) (NN group)) (VP (VBD received) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NNS Doc_20046642_947_954_Chemical))) (PRN (-LRB- -LRB-) (NP (NP (CD 0.1) (JJ micromol/10) (JJ microl) (JJ normal) (NN saline)) (, ,) (NP (NNP i.c.v))) (-RRB- -RRB-))) (NP (RB then)) (NP (NNS Doc_20046642_1006_1010_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 20) (NN mg/kg)) (, ,) (NP (NN i.v))) (, ,) (ADVP (RB once))) (-RRB- -RRB-)) (PP (IN after) (NP (CD 24) (NN h.))))))
20046642	7	(ROOT (SINV (S (NP (DT The) (JJ obtained) (NNS data)) (VP (VBD revealed) (SBAR (IN that) (S (NP (JJ Doc_20046642_1077_1081_Chemical) (NN administration)) (VP (VBD resulted) (PP (IN in) (NP (NP (NN deterioration)) (PP (IN of) (NP (NP (NN learning) (CC and) (JJ short-term) (NN memory)) (PRN (-LRB- -LRB-) (NP (NNP STM)) (-RRB- -RRB-)))))) (, ,) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (S (VP (VBG using) (NP (JJ radial) (NN arm) (NN water) (NN maze))))))))))))) (, ,) (VP (VBD accompanied) (PP (IN with) (NP (VBN decreased) (NN hippocampal) (NNS Doc_20046642_1247_1258_Chemical)))) (NP (NP (JJ reductase) (PRN (-LRB- -LRB-) (NP (NNP GR)) (-RRB- -RRB-)) (NN activity)) (CC and) (NP (JJ Doc_20046642_1287_1306_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_20046642_1308_1311_Chemical)) (-RRB- -RRB-)) (NN content))) (. .)))
20046642	8	(ROOT (S (ADVP (RB Also)) (, ,) (NP (JJ Doc_20046642_1328_1332_Chemical) (NN administration)) (VP (VBD increased) (NP (NP (NP (NP (NN serum) (NNS Doc_20046642_1364_1369_Disease)) (NP (JJ Doc_20046642_1370_1378_Disease) (NN factor-alpha))) (PRN (-LRB- -LRB-) (NP (NNP TNFalpha)) (-RRB- -RRB-)) (, ,) (NP (NNP hippocampal) (NNP MT)) (CC and) (NP (NP (NNS Doc_20046642_1423_1438_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20046642_1440_1443_Chemical)) (-RRB- -RRB-)) (NP (NNS contents)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ caspase-3) (NN activity)) (PP (IN in) (NP (NN addition))))) (PP (TO to) (NP (JJ histological) (NNS alterations)))) (. .)))
20046642	9	(ROOT (NP (NP (NP (JJ Doc_20046642_1525_1532_Chemical) (NN pretreatment)) (VP (VP (VBN counteracted) (NP (NP (NP (NN Doc_20046642_1559_1563_Chemical-induced) (NN inhibition)) (PP (IN of) (NP (NNP GR)))) (CC and) (NP (NP (NN depletion)) (PP (IN of) (NP (NNS Doc_20046642_1606_1609_Chemical)))))) (CC and) (VP (VBN resulted) (PP (IN in) (NP (NP (JJ significant) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NNP Doc_20046642_1665_1668_Chemical) (CC and) (NNP TNFalpha)))))))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (CD caspase-3)))) (. .)))
20046642	10	(ROOT (S (NP (DT The) (JJ histological) (NNS features)) (VP (VBD were) (VP (VBN improved) (PP (IN in) (NP (NP (NNS hippocampus)) (PP (IN of) (NP (NP (NNS rats)) (VP (VBN treated) (PP (IN with) (NP (JJ Doc_20046642_1796_1803_Chemical) (JJ +) (NNS Doc_20046642_1806_1810_Chemical))) (PP (VBN compared) (PP (TO to) (NP (JJ only) (NN Doc_20046642_1828_1832_Chemical-treated) (NNS animals))))))))))) (. .)))
20046642	11	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NNP MT) (NN induction) (NNS halts)) (VP (VBD Doc_20046642_1884_1888_Chemical-induced) (NP (JJ hippocampal) (NNS Doc_20046642_1909_1917_Disease)) (SBAR (IN as) (S (NP (PRP it)) (VP (VP (VBD prevented) (NP (NP (NNP GR) (NNP inhibition)) (CC and) (NP (JJ Doc_20046642_1952_1955_Chemical) (NN depletion)))) (CC and) (VP (VBN counteracted) (NP (NP (DT the) (VBN increased) (NNS levels)) (PP (IN of) (NP (NNP TNFalpha))) (, ,) (NP (NNS Doc_20046642_2017_2020_Chemical)) (CC and) (NP (NP (JJ caspase-3) (NN activity)) (PP (IN with) (NP (NP (JJ subsequent) (NN preservation)) (PP (IN of) (NP (NN cognition)))))))))))) (. .)))
20129423	0	(ROOT (NP (NP (NP (JJ Fatal) (NNS Doc_20129423_6_19_Chemical)) (VP (VBN induced) (S (VP (VB fulminant) (NP (JJ Doc_20129423_38_50_Disease) (PRN (-LRB- -LRB-) (NP (NNP Doc_20129423_52_68_Disease)) (-RRB- -RRB-)) (NNS Doc_20129423_70_81_Disease)))))) (: :) (NP (NP (NN emphasis)) (PP (IN on) (NP (JJ anatomical) (CC and) (JJ histological) (NNS characteristics))) (, ,) (NP (NP (NNS mechanisms) (CC and) (NNS genetics)) (PP (IN of) (NP (NN drug) (NNS Doc_20129423_172_188_Disease)))) (CC and) (NP (NN differential) (NN diagnosis))) (. .)))
20129423	1	(ROOT (S (NP (NP (DT The) (ADJP (RBS most) (JJ severe)) (JJ adverse) (NNS reactions)) (PP (TO to) (NP (NNS Doc_20129423_254_267_Chemical)))) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (JJ haemopoietic) (NN system)) (, ,) (NP (DT the) (NN liver)) (CC and) (NP (DT the) (JJ cardiovascular) (NN system))))))) (. .)))
20129423	2	(ROOT (S (NP (NP (DT A) (ADJP (ADVP (RB frequently)) (ADJP (JJ fatal)) (, ,) (ADJP (IN although) (JJ exceptionally))) (JJ rare) (NN side) (NN effect)) (PP (IN of) (NP (NNS Doc_20129423_419_432_Chemical)))) (VP (VBZ is) (VP (VBG Doc_20129423_436_447_Disease) (NP (JJ Doc_20129423_448_460_Disease) (PRN (-LRB- -LRB-) (NP (NNP Doc_20129423_462_478_Disease)) (-RRB- -RRB-)) (NNS Doc_20129423_480_491_Disease)))) (. .)))
20129423	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (S (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NNS Doc_20129423_513_541_Disease)))) (ADJP (JJ secondary) (PP (TO to) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_20129423_573_586_Chemical)))))))) (. .)))
20129423	4	(ROOT (S (S (NP (JJ Acute) (NNS Doc_20129423_594_622_Disease)) (VP (VBD was) (RB not) (VP (VBN suspected) (S (ADJP (JJ clinically)))))) (, ,) (CC and) (S (NP (DT the) (NN diagnosis)) (VP (VBD was) (VP (VBN made) (NP (NN post-mortem))))) (. .)))
20129423	5	(ROOT (S (NP (NNP Histology)) (VP (VBD revealed) (NP (NP (JJ diffuse) (NN infiltration)) (PP (IN of) (NP (DT the) (NN myocardium)))) (PP (IN by) (NP (NNS eosinophils) (CC and) (NNS lymphocytes))) (PP (IN with) (NP (JJ myocyte) (NN damage)))) (. .)))
20129423	6	(ROOT (S (ADVP (RB Clinically)) (, ,) (NP (NNS Doc_20129423_815_820_Disease)) (VP (VBD was) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_20129423_832_849_Disease))))) (. .)))
20129423	7	(ROOT (S (PP (TO To) (NP (NP (JJS best)) (PP (IN of) (NP (PRP$ our) (NN knowledge))))) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ second) (NN case)) (PP (IN of) (NP (NP (JJ fatal) (NNS Doc_20129423_909_922_Chemical)) (VP (VBN induced) (NP (NP (NNS Doc_20129423_931_942_Disease)) (VP (VBN reported) (PP (IN in) (NP (JJ English) (NN literature)))))))))) (. .)))
20169779	0	(ROOT (NP (NP (NNP Doc_20169779_0_26_Disease)) (PP (IN in) (NP (DT the) (JJ Doc_20169779_34_38_Chemical) (NN marmoset) (NN model))) (PP (IN of) (NP (NNS Doc_20169779_57_76_Disease))) (. .)))
20169779	1	(ROOT (S (NP (NNP Doc_20169779_90_115_Disease)) (VP (VBP are) (ADVP (RB increasingly)) (VP (VBN recognised) (PP (IN as) (NP (NP (DT a) (JJ significant) (NN problem)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_20169779_186_205_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20169779_207_209_Disease)) (-RRB- -RRB-)))))))))) (. .)))
20169779	2	(ROOT (S (NP (DT These) (NNS symptoms)) (VP (MD may) (VP (VB be) (ADJP (JJ due) (S (VP (TO to) (VP (`` `) (VB sensitisation) ('' ') (PP (VBG following) (NP (NP (VBN repeated) (JJ Doc_20169779_276_284_Chemical) (NN treatment)) (CC or) (NP (NP (DT a) (JJ direct) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_20169779_317_325_Chemical)) (PP (IN on) (NP (DT the) (NN disease) (NN state)))))))))))))) (. .)))
20169779	3	(ROOT (S (NP (DT The) (ADJP (JJ Doc_20169779_352_360_Chemical-treated) (JJ Doc_20169779_369_373_Chemical-lesioned)) (NN marmoset)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (NN model)) (PP (IN of) (NP (NP (NNS Doc_20169779_415_440_Disease)) (PP (IN in) (NP (JJ Doc_20169779_444_446_Disease) (NNS patients))))))))) (. .)))
20169779	4	(ROOT (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP compare) (S (NP (NP (DT the) (NN time) (NN course)) (PP (IN of) (NP (NN Doc_20169779_492_500_Chemical-induced) (NN motor) (NNS fluctuations) (CC and) (NN Doc_20169779_532_548_Disease-like) (NNS behaviors)))) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NN duration)) (PP (IN of) (NP (NN treatment) (CC and) (NN onset))))) (PP (IN of) (NP (NNS symptoms)))))))) (. .)))
20169779	5	(ROOT (S (NP (NNS Marmosets)) (VP (VBD were) (VP (VBN administered) (NP (NP (NP (NNS Doc_20169779_684_728_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2.0) (NN mg/kg) (NN s.c.)) (-RRB- -RRB-))) (PP (IN for) (NP (CD five) (NNS days)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (JJ stable) (NNS Doc_20169779_781_793_Disease))))))) (. .)))
20169779	6	(ROOT (S (NP (NP (NNP Doc_20169779_795_803_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 15) (NNS mg/kg) (CC and) (NNS Doc_20169779_818_829_Chemical)) (, ,) (NP (CD 3.75) (NN mg/kg))) (-RRB- -RRB-)) (NP (NN p.o.) (NN b.i.d)) (, ,)) (VP (VBD was) (VP (VBN administered) (PP (IN for) (NP (CD 30) (NNS days))))) (. .)))
20169779	7	(ROOT (S (NP (NNS Animals)) (VP (VBD were) (VP (VBN evaluated) (PP (PP (IN for) (NP (NP (NP (NNS Doc_20169779_912_935_Disease) (, ,) (NNS Doc_20169779_937_947_Disease) (CC and) (NNS on-time)) (PRN (-LRB- -LRB-) (NP (NN motor) (NNS fluctuations)) (-RRB- -RRB-))) (CC and) (NP (NP (NN Doc_20169779_985_1001_Disease-like) (NNS behaviors)) (PP (IN on) (NP (NNP Day) (CD 0)))))) (PRN (-LRB- -LRB-) (ADVP (RB prior) (S (VP (TO to) (VP (VB Doc_20169779_1036_1044_Chemical))))) (-RRB- -RRB-)) (CC and) (PP (IN on) (NP (NP (NNP Days) (CD 1) (, ,) (CD 7) (, ,) (CD 13) (, ,) (CD 27) (CC and) (CD 30)) (PP (IN of) (NP (NP (NN treatment)) (VP (VBG using) (S (VP (VP (VB post) (NP (ADJP (FW hoc) (FW DVD)) (NN analysis)) (PP (IN by) (NP (DT a) (VBN trained) (NN rater)))) (, ,) (NP (ADJP (JJ blind) (PP (TO to) (NP (DT the) (NN treatment)))) (NN day)))))))))))) (. .)))
20169779	8	(ROOT (S (NP (DT The) (JJ Doc_20169779_1180_1196_Disease-like) (NN behavior) (NN rating) (NN scale)) (VP (VBD demonstrated) (NP (NP (JJ high) (NN interrater) (NN reliability)) (PP (IN between) (NP (NP (CD three) (VBN trained) (NNS raters)) (PP (IN of) (NP (VBG differing) (JJ professional) (NNS backgrounds))))))) (. .)))
20169779	9	(ROOT (S (PP (IN As) (ADJP (JJ anticipated))) (, ,) (NP (NNS animals)) (VP (VBD exhibited) (NP (NP (DT a) (JJ progressive) (NN increase)) (PP (IN in) (NP (NN Doc_20169779_1393_1401_Chemical-induced) (NN motor) (NNS fluctuations) (, ,) (NNS Doc_20169779_1430_1440_Disease) (CC and) (NN wearing-off))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBN correlated) (PP (IN with) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (JJ Doc_20169779_1495_1503_Chemical) (NN therapy)))))))))) (. .)))
20169779	10	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (S (NP (NN Doc_20169779_1526_1534_Chemical-induced) (NN Doc_20169779_1543_1559_Disease-like) (NNS behaviors)) (VP (VBD were) (ADJP (JJ present) (PP (IN on) (NP (NP (NNP Day) (CD 1)) (PP (IN of) (NP (JJ Doc_20169779_1600_1608_Chemical) (NN treatment)))))))) (CC and) (S (NP (PRP$ their) (NN severity)) (VP (VBD did) (RB not) (VP (VB correlate) (PP (IN with) (NP (NP (NN duration)) (PP (IN of) (NP (NN treatment)))))))) (. .)))
20169779	11	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS Doc_20169779_1719_1745_Disease)) (PP (IN in) (NP (NNS Doc_20169779_1749_1751_Disease)))) (VP (VBP are) (ADVP (RBR more) (RB likely)) (NP (NP (DT an) (NN interaction)) (PP (IN between) (NP (NP (NNS Doc_20169779_1791_1799_Chemical)) (CC and) (NP (DT the) (NN disease) (NN state))))) (PP (IN than) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NN sensitisation))))) (PP (TO to) (NP (VBN repeated) (JJ dopaminergic) (NN therapy))))))) (. .)))
20192893	0	(ROOT (S (VP (VB Contrast) (NP (NN medium) (NN nephrotoxicity)) (PP (IN after) (NP (NP (JJ renal) (NN artery)) (CC and) (NP (JJ coronary) (NN angioplasty))))) (. .)))
20192893	1	(ROOT (S (NP (NP (NNP Doc_20192893_88_105_Disease)) (VP (VBN induced) (PP (IN by) (NP (ADJP (JJ iodinated)) (NN contrast) (NN medium) (PRN (-LRB- -LRB-) (NP (NNP CM)) (-RRB- -RRB-)) (NN administration))))) (VP (MD can) (VP (VB minimize) (NP (NP (DT the) (NN benefit)) (PP (IN of) (NP (DT the) (JJ interventional) (NN procedure)))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (NP (JJ renal) (NN angioplasty)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20192893_262_266_Chemical)) (-RRB- -RRB-)))))))) (. .)))
20192893	2	(ROOT (S (S (VP (TO To) (VP (VB compare) (NP (NP (DT the) (ADJP (JJ susceptibility) (TO to) (JJ nephrotoxic)) (NN effect)) (PP (IN of) (NP (NNP CM)))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (NNS Doc_20192893_359_363_Chemical)) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (NNS patients))))))))))) (VP (VBN submitted) (PP (TO to) (NP (NP (JJ percutaneous) (JJ coronary) (NN intervention)) (PRN (-LRB- -LRB-) (NP (NNP PCI)) (-RRB- -RRB-))))) (. .)))
20192893	3	(ROOT (S (NP (NP (NNP MATERIAL) (CC AND) (NNP METHODS)) (: :) (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 33) (NNS patients)) (VP (ADVP (RB successfully)) (VBN treated) (PP (IN with) (NP (NNS Doc_20192893_512_516_Chemical)))))))) (PRN (-LRB- -LRB-) (S (NP (JJ Doc_20192893_518_522_Chemical) (NN group)) (, ,) (S (VP (VB mean) (NP (NP (NN age)) (FRAG (NP (CD 70) (CD +)) (: /) (NP (NP (CD -12) (NNS years)) (, ,) (NP (CD 23) (NN female)) (, ,) (NP (NP (JJ basal) (NNS Doc_20192893_571_581_Chemical)) (NP (CD 1.46) (NNS +)))) (: /) (VP (VBN -0.79)))))) (, ,) (VP (VBP range) (NP (CD 0.7-4) (CD .9) (NN mg/dl)))) (-RRB- -RRB-)) (VP (VBD were) (VP (VBN compared) (PP (IN with) (NP (NP (CD 33) (NNS patients)) (VP (VBG undergoing) (NP (NP (NP (JJ successful) (NN PCI)) (PRN (-LRB- -LRB-) (NP (NNP PCI) (NN group)) (-RRB- -RRB-))) (, ,) (VP (VBN matched) (PP (IN for) (NP (NP (JJ basal) (NNS Doc_20192893_704_714_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1.44) (NNS +)) (: /) (NP (NP (CD -0.6)) (, ,) (NP (NN range) (CD 0.7-3) (NN .4) (NN mg/dl))) (-RRB- -RRB-)) (, ,) (NP (NN gender)) (, ,) (CC and) (NP (NN age))))))))))) (. .)))
20192893	4	(ROOT (S (PP (IN In) (NP (DT both) (NNS groups))) (NP (JJ postprocedural) (PRN (-LRB- -LRB-) (NP (QP (CD 48) (CD h))) (-RRB- -RRB-)) (JJ serum) (NNS Doc_20192893_810_820_Chemical)) (VP (VBD was) (VP (VBN measured))) (. .)))
20192893	5	(ROOT (S (NP (JJ Postprocedural) (JJ Doc_20192893_859_869_Chemical) (NN level)) (VP (VP (VBD decreased) (ADVP (RB nonsignificantly)) (PP (IN in) (NP (NP (DT the) (JJ Doc_20192893_910_914_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 1.46) (NNS +)) (: /) (NP (NP (CD -0.8)) (PP (IN vs.) (NP (NP (QP (CD 1.34) (CD +))) (PRN (: /) (NP (NP (CD -0.5) (NN mg/dl)) (, ,) (NP (NNP P) (NNP =) (NNP NS))))))) (-RRB- -RRB-))))) (CC and) (VP (VBD increased) (ADVP (RB significantly)) (PP (IN in) (NP (NP (DT the) (NNP PCI) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 1.44) (NNS +)) (: /) (NP (NP (CD -0.6)) (PP (IN vs.) (NP (NP (CD 1.57) (NNS +)) (PRN (: /) (NP (NP (CD -0.7) (NN mg/dl)) (, ,) (NP (NNP P) (NNP <) (NNP 0.02))))))) (-RRB- -RRB-)))))) (. .)))
20192893	6	(ROOT (S (NP (NP (NP (NNS Changes)) (PP (IN in) (NP (NP (NN serum) (NNS Doc_20192893_1066_1076_Chemical)) (PP (IN after) (NP (NN intervention)))))) (PRN (-LRB- -LRB-) (ADJP (JJ after-before)) (-RRB- -RRB-))) (VP (VBD were) (ADJP (RB significantly) (JJ different) (PP (IN between) (NP (DT the) (NNP Doc_20192893_1152_1156_Chemical) (CC and) (NNP PCI) (NNS groups)))) (PRN (-LRB- -LRB-) (FRAG (NP (CD -0.12) (CD +)) (: /) (NP (NP (CD -0.5)) (PP (IN vs.) (NP (CD 0.13) (NNS +)))) (: /) (VP (VP (VBN -0.3)) (, ,) (NP (NP (NNP P)) (S (VP (SYM =) (NP (CD 0.014))))))) (-RRB- -RRB-))) (. .)))
20192893	7	(ROOT (S (NP (DT This) (NN difference)) (VP (VBD was) (RB not) (VP (VBN related) (PP (PP (TO to) (NP (CC either) (DT a) (JJ different) (JJ clinical) (NN risk) (NN profile))) (CC or) (PP (TO to) (NP (NP (DT the) (NN volume)) (PP (IN of) (NP (NNP CM) (NNP administered)))))))) (. .)))
20192893	8	(ROOT (S (PP (IN In) (NP (DT this) (JJ preliminary) (NN study))) (NP (NP (NNS patients)) (VP (VBN submitted) (PP (TO to) (NP (NNS Doc_20192893_1384_1388_Chemical))))) (VP (VBD showed) (NP (DT a) (JJR lower) (NN susceptibility)) (PP (TO to) (NP (NP (NNS Doc_20192893_1422_1434_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNP CM) (NN administration))) (PP (IN than) (NP (NNP PCI) (NNS patients))))))) (. .)))
20192893	9	(ROOT (S (NP (NP (DT The) (NN effectiveness)) (PP (IN of) (NP (NP (NNS Doc_20192893_1504_1508_Chemical)) (PP (IN on) (NP (JJ renal) (NN function)))))) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (VP (ADVP (RB barely)) (VBN influenced) (PP (IN by) (NP (NNS Doc_20192893_1560_1571_Disease)))))))) (. .)))
2021990	0	(ROOT (S (NP (NNP Doc_2021990_0_15_Chemical)) (VP (VBZ prevents) (NP (NP (DT the) (JJ haemodynamic) (NNS changes)) (PP (IN of) (NP (NP (NNS Doc_2021990_53_63_Chemical)) (PP (IN in) (NP (NNP ICU) (NNS patients))))))) (. .)))
2021990	1	(ROOT (S (NP (NP (NNP Doc_2021990_81_91_Chemical)) (, ,) (NP (DT a) (ADJP (ADJP (QP (CD Doc_2021990_95_104_Chemical) (CD 2))) (PRN (-LRB- -LRB-) (NP (NNP H2)) (-RRB- -RRB-))) (NN antagonist)) (, ,)) (VP (VBZ produces) (S (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (JJ arterial) (NN pressure)))) (ADJP (JJ due) (S (VP (TO to) (VP (VB vasodilatation) (, ,) (ADVP (RB especially)) (PP (IN in) (NP (ADJP (RB critically) (JJ ill)) (NNS patients))))))))) (. .)))
2021990	2	(ROOT (S (NP (DT This)) (VP (MD may) (VP (VB be) (SBAR (IN because) (S (NP (NNS Doc_2021990_247_257_Chemical)) (VP (VBZ acts) (PP (IN as) (NP (DT a) (JJ Doc_2021990_268_277_Chemical) (NN agonist)))))))) (. .)))
2021990	3	(ROOT (S (NP (PRP We)) (, ,) (ADVP (RB therefore)) (, ,) (VP (VBD investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (DT the) (ADJP (QP (CD Doc_2021990_334_343_Chemical) (CD 1))) (PRN (-LRB- -LRB-) (NP (NNP H1)) (-RRB- -RRB-)) (NN receptor) (NN antagonist)) (, ,) (NP (NNS Doc_2021990_371_386_Chemical)) (, ,)))) (PP (IN on) (NP (NP (DT the) (JJ haemodynamic) (NNS changes)) (VP (VBN observed) (PP (IN after) (NP (NP (NNS Doc_2021990_431_441_Chemical)) (PP (IN in) (NP (NNP ICU) (NNS patients))))))))) (. .)))
2021990	4	(ROOT (S (NP (DT Each) (NN patient)) (VP (VBD was) (VP (VBN studied) (PP (IN on) (NP (CD two) (JJ separate) (NNS days))))) (. .)))
2021990	5	(ROOT (S (PP (IN In) (NP (DT a) (JJ random) (NN fashion))) (, ,) (S (NP (PRP they)) (VP (VBD received) (NP (QP (CD Doc_2021990_541_551_Chemical) (CD 200)) (NN mg) (NN iv)) (PP (IN on) (NP (CD one) (NN day))))) (, ,) (CC and) (S (PP (IN on) (NP (DT the) (JJ other))) (, ,) (NP (NP (DT a) (NN pretreatment)) (PP (IN of) (NP (NNP Doc_2021990_610_625_Chemical) (CD 40)))) (VP (VBP mg) (NP (NN iv)) (PP (IN with) (NP (NN Doc_2021990_640_650_Chemical) (CD 200) (NN mg) (NN iv))))) (. .)))
2021990	6	(ROOT (S (PP (IN In) (NP (DT the) (JJ non-pretreatment) (NN group))) (, ,) (NP (NP (JJ mean) (JJ arterial) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP MAP)) (-RRB- -RRB-))) (VP (VBD decreased) (PP (IN from) (NP (NP (NP (CD 107.4) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 8.4) (NN mmHg)) (PP (TO to) (NP (CD 86.7) (NNS +)))) (: /))) (: -) (ADJP (ADJP (CD 11.4) (JJ mmHg)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.01))) (-RRB- -RRB-))))) (NP (CD two) (NNS minutes)) (PP (IN after) (NP (NNS Doc_2021990_815_825_Chemical)))) (. .)))
2021990	7	(ROOT (S (ADVP (RB Also)) (, ,) (NP (NP (JJ systemic) (NN vascular) (NN resistance)) (PRN (-LRB- -LRB-) (NP (NNP SVR)) (-RRB- -RRB-))) (VP (VBD decreased) (PP (IN during) (NP (NP (DT the) (JJ eight-minute) (NN observation) (NN period)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.01))) (-RRB- -RRB-))))) (. .)))
2021990	8	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (PP (IN in) (NP (DT the) (JJ pretreatment) (NN group))) (, ,) (NP (JJ little) (JJ haemodynamic) (NN change)) (VP (VBD was) (VP (VBN seen))) (. .)))
2021990	9	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (DT an) (NNP H1) (NN antagonist)) (VP (MD may) (VP (VB be) (ADJP (JJ useful) (PP (IN in) (S (VP (VBG preventing) (NP (NP (NNS Doc_2021990_1080_1091_Disease)) (VP (VBN caused) (PP (IN by) (NP (NN iv) (NNS Doc_2021990_1105_1115_Chemical))))))))) (, ,) (SBAR (IN since) (S (NP (NP (DT the) (VBG vasodilating) (NN activity)) (PP (IN of) (NP (NNS Doc_2021990_1152_1162_Chemical)))) (VP (VBZ is) (VP (VBN mediated) (, ,) (PP (IN in) (NP (NN part))) (, ,) (PP (IN through) (NP (DT the) (NNP H1) (NN receptor)))))))))))) (. .)))
20408947	0	(ROOT (NP (NP (NP (NNP Medical) (CC and) (NNS Doc_20408947_12_23_Disease) (NNS outcomes)) (PP (IN for) (NP (NP (NNS patients) (NNS transplanted)) (PP (IN for) (NP (NN Doc_20408947_63_76_Chemical-induced) (NNS Doc_20408947_85_104_Disease)))))) (: :) (NP (DT a) (JJ case-control) (NN study)) (. .)))
20408947	1	(ROOT (S (NP (NNP Doc_20408947_140_153_Chemical-induced)) (ADVP (RB hepatotoxicity)) (VP (VBZ is) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (NN cause)) (PP (IN of) (NP (NP (NP (NNS Doc_20408947_205_224_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20408947_226_229_Disease)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (NNP UK))))))) (. .)))
20408947	2	(ROOT (S (NP (NNS Patients)) (ADVP (RB often)) (VP (VBP consume) (NP (DT the) (NN drug)) (PP (PP (IN with) (NP (JJ suicidal) (NN intent))) (CC or) (PP (IN with) (NP (NP (DT a) (NN background)) (PP (IN of) (NP (NN substance) (NN dependence))))))) (. .)))
20408947	3	(ROOT (FRAG (NP (NNS AIMS) (CC AND) (NNS METHODS)) (: :) (S (NP (PRP We)) (VP (VBD compared) (NP (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NNS Doc_20408947_387_408_Disease)))) (, ,) (NP (NP (NP (JJ Doc_20408947_410_421_Disease) (ADJP (JJ co-morbidity) (, ,) (JJ medical) (CC and) (JJ psychosocial)) (NNS outcomes)) (PP (IN of) (NP (NP (NP (DT all) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN undergone) (NP (NN liver) (NN transplantation)))))) (PRN (-LRB- -LRB-) (NP (NNP LT)) (-RRB- -RRB-))) (ADJP (JJ emergently) (PP (IN between) (NP (CD 1999-2004)))) (PP (IN for) (NP (NP (NN Doc_20408947_564_577_Chemical-induced) (NNS Doc_20408947_586_589_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 36))))) (-RRB- -RRB-)))) (PP (IN with) (NP (NN age) (: -) (CC and) (JJ sex-matched) (NNS patients))) (VP (VBG undergoing) (NP (NP (NNP emergent) (NNP LT)) (PP (IN for) (NP (JJ non-Doc_20408947_663_676_Chemical-induced) (NNS Doc_20408947_685_688_Disease)))))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 35))))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ elective) (NN LT)) (PP (IN for) (NP (NP (NNS Doc_20408947_716_737_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_20408947_739_742_Disease)) (, ,) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 34))))))) (-RRB- -RRB-)))))))) (. .)))
20408947	4	(ROOT (S (NP (NP (JJ Doc_20408947_760_773_Chemical-induced) (JJ Doc_20408947_782_785_Disease) (NNS patients)) (VP (VBG undergoing) (SBAR (S (NP (NNP LT)) (VP (VBD had) (NP (NP (DT a) (JJR greater) (NN severity)) (PP (IN of) (NP (JJ pre-LT) (NN illness))))))))) (VP (VBD reflected) (PP (IN by) (NP (NP (JJR higher) (JJ Acute) (NN Physiology) (CC and) (NNP Chronic) (NNP Health) (NNP Evaluation) (NNP II) (NNS scores) (CC and) (NN requirement)) (PP (IN for) (NP (NN organ) (NN support))))) (PP (VBN compared) (PP (IN with) (NP (DT the) (JJ other) (CD two) (NNS groups))))) (. .)))
20408947	5	(ROOT (S (NP (NP (CD Twenty)) (PRN (-LRB- -LRB-) (NP (CD 56) (NN %)) (-RRB- -RRB-))) (VP (VBD Doc_20408947_1010_1023_Chemical-induced) (SBAR (S (NP (JJ Doc_20408947_1032_1035_Disease) (NNS patients)) (VP (VBD had) (NP (DT a) (JJ formal) (NNS Doc_20408947_1058_1079_Disease)) (SBAR (IN before) (S (NP (NP (NP (NNP LT)) (PRN (-LRB- -LRB-) (NP (NP (NP (JJ non-Doc_20408947_1095_1108_Chemical-induced) (NNS Doc_20408947_1117_1120_Disease)) (SBAR (S (VP (SYM =) (NP (CD 0/35)))))) (, ,) (NP (NP (NNS Doc_20408947_1127_1130_Disease)) (SBAR (S (VP (SYM =) (NP (CD 2/34)))))) (, ;) (NP (NP (NNP P) (NNP <) (NNP 0.01)) (PP (IN for) (NP (DT all))))) (-RRB- -RRB-))) (CC and) (NP (NP (CD nine)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN %)) (-RRB- -RRB-)))) (VP (VBD had) (NP (DT a) (JJ previous) (NN suicide) (NN attempt))))))))) (. .)))
20408947	6	(ROOT (S (PP (IN During) (NP (NP (NN follow-up)) (PRN (-LRB- -LRB-) (NP (NP (NN median)) (NP (CD 5) (NNS years))) (-RRB- -RRB-)))) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN in) (NP (NN rejection)))) (PRN (-LRB- -LRB-) (NP (JJ acute) (CC and) (JJ chronic)) (-RRB- -RRB-)) (, ,) (NP (NN graft) (NN failure)) (CC or) (NP (NP (NN survival)) (PP (IN between) (NP (DT the) (NNS groups))))) (PRN (-LRB- -LRB-) (NP (NP (NN Doc_20408947_1353_1366_Chemical-induced) (NNS Doc_20408947_1375_1378_Disease)) (NP (NP (NP (CD 1) (NN year)) (ADJP (CD 87) (NN %))) (, ,) (NP (NP (NP (CD 5) (NNS years)) (ADJP (CD 75) (NN %))) (: ;) (NP (NP (JJ non-Doc_20408947_1408_1421_Chemical-induced) (NNS Doc_20408947_1430_1433_Disease)) (NP (NP (CD 88) (NN %)) (, ,) (NP (CD 78) (NN %)))) (: ;) (NP (NP (QP (CD Doc_20408947_1444_1447_Disease) (CD 93)) (NN %)) (, ,) (NP (CD 82) (NN %))) (: :) (NP (NP (NNP P) (NNP >)) (NP (CD 0.6) (NN log) (NN rank)))))) (-RRB- -RRB-)))) (. .)))
20408947	7	(ROOT (S (NP (CD Two) (NN Doc_20408947_1479_1492_Chemical-induced) (NN Doc_20408947_1501_1504_Disease) (NNS patients)) (VP (VBD reattempted) (NP (NP (NN suicide) (NN post-LT)) (PRN (-LRB- -LRB-) (S (NP (PRP one)) (VP (VBD died) (ADJP (NP (CD 8) (NNS years)) (JJ post-LT)))) (-RRB- -RRB-)))) (. .)))
20408947	8	(ROOT (S (PP (IN Despite) (NP (NP (DT a) (JJ high) (NN prevalence)) (PP (IN of) (NP (JJ Doc_20408947_1612_1623_Disease) (NN disturbance))))) (, ,) (NP (NP (NNS outcomes)) (PP (IN for) (NP (NP (NNS patients)) (JJ transplanted) (NN emergently) (PP (IN for) (NP (NN Doc_20408947_1687_1700_Chemical-induced) (NNS Doc_20408947_1709_1712_Disease)))))) (VP (VBD were) (ADJP (JJ comparable) (PP (TO to) (NP (NP (DT those) (NN transplanted)) (PP (IN for) (NP (JJ non-Doc_20408947_1759_1772_Chemical-induced) (NNS Doc_20408947_1781_1784_Disease) (CC and) (NN electively)))))) (PP (IN for) (NP (NNS Doc_20408947_1804_1807_Disease)))) (. .)))
20408947	9	(ROOT (S (NP (NP (JJ Multidisciplinary) (NNS approaches)) (PP (IN with) (NP (JJ long-term) (JJ Doc_20408947_1853_1864_Disease) (NN follow-up)))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (NP (JJ low) (JJ post-transplant) (NN suicide) (NNS rates)) (VP (VBN seen))) (CC and) (NP (NP (JJ low) (NNS rates)) (PP (IN of) (NP (NP (NN graft) (NN loss)) (PP (RB because) (IN of) (NP (NN non-compliance)))))))))) (. .)))
20431083	0	(ROOT (NP (NP (NP (JJ Antithrombotic) (NN drug) (NN use)) (, ,) (NP (JJ cerebral) (NNS microbleeds)) (, ,) (CC and) (NP (NNS Doc_20431083_51_75_Disease))) (: :) (NP (NP (DT a) (JJ systematic) (NN review)) (PP (IN of) (NP (JJ published) (CC and) (JJ unpublished) (NNS studies)))) (. .)))
20431083	1	(ROOT (NP (NP (NNP BACKGROUND) (CC AND) (NNP PURPOSE)) (: :) (S (S (NP (NP (NNS Doc_20431083_159_179_Disease)) (PRN (-LRB- -LRB-) (NP (NNP MB)) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (JJ potential) (NN risk) (NNS factors)) (PP (IN for) (NP (NP (NNS Doc_20431083_216_240_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20431083_242_245_Disease)) (-RRB- -RRB-))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ unclear)) (SBAR (IN if) (S (NP (PRP they)) (VP (VBP are) (NP (NP (DT a) (NN contraindication)) (PP (TO to) (S (VP (VBG using) (NP (JJ antithrombotic) (NNS drugs)))))))))))) (. .)))
20431083	2	(ROOT (S (NP (NNPS Insights)) (VP (MD could) (VP (VB be) (VP (VBN gained) (PP (IN by) (S (VP (VBG pooling) (S (NP (NP (NNS data)) (PP (IN on) (NP (NNP MB) (NN frequency)))) (ADJP (JJ stratified) (PP (IN by) (NP (NP (JJ antithrombotic) (NN use)) (PP (IN in) (NP (NP (NNS cohorts)) (PP (IN with) (NP (NP (NP (NP (NNS Doc_20431083_434_437_Disease) (CC and) (NNS Doc_20431083_442_457_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20431083_459_461_Disease)) (-RRB- -RRB-))) (PRN (: /) (NP (JJ transient) (JJ Doc_20431083_473_481_Disease) (NN attack)))) (PRN (-LRB- -LRB-) (NP (NNP Doc_20431083_490_493_Disease)) (-RRB- -RRB-)))))))))))))))) (. .)))
20431083	3	(ROOT (S (S (NP (PRP We)) (VP (VBD performed) (NP (NP (DT a) (JJ systematic) (NN review)) (PP (IN of) (NP (JJ published) (CC and) (JJ unpublished) (NNS data)))) (PP (IN from) (NP (NP (NNS cohorts)) (PP (IN with) (NP (NNS Doc_20431083_590_596_Disease) (CC or) (NNS Doc_20431083_600_603_Disease))))) (S (VP (TO to) (VP (VB compare) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNP MB)))) (PP (IN in))))))) (: :) (S (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (JJ antithrombotic) (NNS users)) (VP (VBP vs) (NP (JJ nonantithrombotic) (NNS users)) (PP (IN with) (NP (NNS Doc_20431083_695_698_Disease))))) (: ;) (S (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (JJ antithrombotic) (NNS users)) (VP (VBP vs) (NP (NNS nonusers)) (PP (IN with) (NP (JJ Doc_20431083_742_744_Disease) (JJ /) (NNS Doc_20431083_745_748_Disease))))) (: ;) (CC and) (S (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-)) (NP (NNS Doc_20431083_758_761_Disease)) (VP (VBP vs) (S (NP (JJ Doc_20431083_765_773_Disease) (NNS events)) (ADJP (JJ stratified) (PP (IN by) (NP (JJ antithrombotic) (NN use))))))) (. .)))
20431083	4	(ROOT (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD analyzed) (NP (JJ published) (CC and) (JJ unpublished) (NN follow-up) (NN data)) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_20431083_898_901_Disease)) (PP (IN in) (NP (JJ antithrombotic) (NNS users)))))) (PP (IN with) (NP (NNP MB))))))) (. .)))
20431083	5	(ROOT (S (S (PP (IN In) (NP (NP (DT a) (JJ pooled) (NN analysis)) (PP (IN of) (NP (NP (CD 1460) (NNS Doc_20431083_973_976_Disease)) (CC and) (NP (CD 3817) (JJ Doc_20431083_986_988_Disease) (JJ /) (NNS Doc_20431083_989_992_Disease)))))) (, ,) (NP (NNP MB)) (VP (VBD were) (ADJP (RBR more) (JJ frequent) (PP (IN in) (NP (JJ Doc_20431083_1019_1022_Disease) (NN vs) (NNS Doc_20431083_1026_1028_Disease)))) (PRN (: /) (NP (NP (NNS Doc_20431083_1029_1032_Disease)) (PP (IN in) (NP (DT all) (NN treatment) (NNS groups))))))) (, ,) (CC but) (S (NP (DT the) (NN excess)) (VP (VBD increased) (PP (IN from) (NP (NP (NP (CD 2.8)) (PRN (-LRB- -LRB-) (NP (NP (NNS odds) (NN ratio)) (: ;) (NP (NP (NN range)) (, ,) (NP (CD 2.3-3) (CD .5)))) (-RRB- -RRB-))) (PP (IN in) (NP (JJ nonantithrombotic) (NNS users))))) (PP (TO to) (NP (NP (NP (NP (CD 5.7)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (, ,) (NP (CD 3.4-9) (CD .7))) (-RRB- -RRB-))) (PP (IN in) (NP (JJ antiplatelet) (NNS users)))) (CC and) (NP (NP (NP (CD 8.0)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (, ,) (NP (CD 3.5-17) (CD .8))) (-RRB- -RRB-))) (PP (IN in) (NP (JJ Doc_20431083_1223_1231_Chemical) (NNS users)))))) (PRN (-LRB- -LRB-) (S (VP (VB P) (S (NP (NN difference)) (VP (SYM =) (NP (CD 0.01)))))) (-RRB- -RRB-)))) (. .)))
20431083	6	(ROOT (S (NP (EX There)) (VP (VBD was) (ADVP (RB also)) (NP (NP (DT an) (NN excess)) (PP (IN of) (NP (NP (NNP MB)) (PP (IN in) (NP (NP (JJ Doc_20431083_1293_1301_Chemical) (NNS users)) (VP (VBG vs) (NP (NNS nonusers)) (PP (IN with) (NP (NNS Doc_20431083_1325_1328_Disease))) (PRN (-LRB- -LRB-) (FRAG (NP (NP (NNP OR)) (, ,) (NP (CD 2.7))) (: ;) (NP (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (, ,) (NP (CD 1.6-4) (CD .4))) (: ;) (NP (NP (NNP P) (NNP <)) (NP (CD 0.001))))) (-RRB- -RRB-)) (FRAG (PP (CC but) (NP (NP (NN none)) (PP (IN in) (NP (NP (JJ Doc_20431083_1377_1385_Chemical) (NNS users)) (PP (IN with) (NP (NNS Doc_20431083_1397_1399_Disease))))))) (: /) (NP (NP (NP (NNP Doc_20431083_1400_1403_Disease) (-LRB- -LRB-) (NNP OR)) (, ,) (NP (CD 1.3))) (: ;) (NP (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (, ,) (NP (CD 0.9-1) (CD .7))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.33)))))) (: ;) (NP (NP (NNP P) (NN difference)) (SBAR (S (VP (SYM =) (NP (CD 0.01)))))))) (-RRB- -RRB-))))))))) (. .)))
20431083	7	(ROOT (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJR smaller) (NN excess)) (PP (IN of) (NP (NP (NNP MB)) (PP (IN in) (NP (JJ antiplatelet) (NNS users) (NN vs) (NNS nonusers)))))) (PP (IN with) (NP (NP (NNS Doc_20431083_1531_1534_Disease)) (PRN (-LRB- -LRB-) (ADVP (RB OR)) (, ,) (NP (NP (CD 1.7)) (: ;) (NP (NP (CD 95) (NN %)) (NP (NNP CI)))) (, ,) (NP (NP (CD 1.3-2) (CD .3)) (: ;) (NP (NNP P) (NNP <) (NNP 0.001))) (-RRB- -RRB-)))))) (, ,) (CC but) (S (NP (NNS findings)) (VP (VBD were) (ADJP (JJ similar) (SBAR (IN for) (FRAG (NP (NP (JJ antiplatelet) (NNS users)) (PP (IN with) (NP (NNS Doc_20431083_1626_1628_Disease)))) (: /) (NP (NP (NP (NNP Doc_20431083_1629_1632_Disease) (-LRB- -LRB-) (NNP OR)) (, ,) (NP (CD 1.4))) (: ;) (NP (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (, ,) (NP (CD 1.2-1) (CD .7))) (: ;) (NP (NP (NNP P) (NNP <)) (NP (CD 0.001))) (: ;) (NP (NP (NNP P) (NN difference)) (SBAR (S (VP (SYM =) (NP (CD 0.25)))))))) (-RRB- -RRB-)))))) (. .)))
20431083	8	(ROOT (S (PP (IN In) (NP (NP (JJ pooled) (NN follow-up) (NNS data)) (PP (IN for) (NP (CD 768) (JJ antithrombotic) (NNS users))))) (, ,) (NP (NP (NN presence)) (PP (IN of) (NP (NP (NNP MB)) (PP (IN at) (NP (NN baseline)))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (RB substantially) (VBN increased) (NN risk)) (PP (IN of) (NP (NP (JJ subsequent) (NNS Doc_20431083_1836_1839_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP OR) (, ,) (NNP 12.1)) (: ;) (NP (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (, ,) (NP (CD 3.4-42) (CD .5))) (: ;) (NP (NP (NNP P) (NNP <)) (NP (CD 0.001))))) (-RRB- -RRB-)))))))) (. .)))
20431083	9	(ROOT (S (NP (NP (DT The) (NN excess)) (PP (IN of) (NP (NP (NNP MB)) (PP (IN in) (NP (NP (JJ Doc_20431083_1912_1920_Chemical) (NNS users)) (PP (IN with) (NP (NP (NNS Doc_20431083_1932_1935_Disease)) (PP (VBN compared) (PP (TO to) (NP (JJ other) (NNS groups))))))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NNP MB)) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN Doc_20431083_1999_2007_Chemical-associated) (NNS Doc_20431083_2019_2022_Disease)))))))) (. .)))
20431083	10	(ROOT (S (S (NP (JJ Limited) (JJ prospective) (NNS data)) (VP (VBP corroborate) (NP (DT these) (NNS findings)))) (, ,) (CC but) (S (NP (JJR larger) (JJ prospective) (NNS studies)) (VP (VBP are) (ADVP (RB urgently)) (VP (VBN required)))) (. .)))
20447294	0	(ROOT (NP (NP (NNS Studies)) (PP (IN of) (NP (NP (NN synergy)) (PP (IN between) (NP (NP (NNS Doc_20447294_27_35_Chemical)) (CC and) (NP (DT a) (JJ novel) (JJ Doc_20447294_48_54_Chemical) (NN channel) (NN blocker)))))) (, ,) (NP (NNS Doc_20447294_72_79_Chemical)) (, ,) (PP (IN in) (NP (NP (NN rat) (NNS models)) (PP (IN of) (NP (NNS Doc_20447294_98_131_Disease))))) (. .)))
20447294	1	(ROOT (S (NP (DT This) (NN study)) (VP (VBD determined) (NP (NP (DT the) (JJ antihyperalgesic) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_20447294_197_204_Chemical)) (, ,) (NP (DT a) (JJ Doc_20447294_208_214_Chemical) (NN channel) (NN blocker))))) (PP (PP (IN with) (NP (NP (JJ antioxidant) (NNS properties)) (VP (VBN given) (ADVP (RB alone))))) (CC and) (PP (IN in) (S (VP (VBG combinations) (PP (IN with) (NP (NP (NNS Doc_20447294_296_304_Chemical)) (PP (IN in) (NP (NP (NN rat) (NNS models)) (PP (IN of) (NP (NNS Doc_20447294_322_355_Disease)))))))))))) (. .)))
20447294	2	(ROOT (S (NP (NP (JJ Dose) (NN response) (NNS curves)) (PP (IN for) (S (VP (VBG nonsedating) (NP (NP (NNS doses)) (PP (IN of) (NP (NNS Doc_20447294_411_419_Chemical) (CC and) (NNS Doc_20447294_424_431_Chemical)))) (PP (VBN given) (PP (ADVP (RB intraperitoneally)) (ADVP (RB alone) (CC and) (RB together)) (IN in) (NP (NNS combinations)))))))) (VP (VBD were) (VP (VBN constructed) (PP (IN for) (NP (NP (JJ antihyperalgesic) (NN effect)) (VP (VBG using) (NP (NN paw) (NN withdrawal)) (PP (IN from) (NP (NP (NP (JJ noxious) (NN heat)) (PP (IN in) (NP (CD two) (JJ Doc_20447294_582_590_Disease) (NNS models)))) (: :) (NP (NP (JJ carrageenan-induced) (NN paw) (NNS Doc_20447294_623_635_Disease) (CC and) (NNS Doc_20447294_640_654_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20447294_656_659_Chemical)) (-RRB- -RRB-))) (: -)))) (VP (VBN induced) (NP (NNS Doc_20447294_669_688_Disease))))))) (. .)))
20447294	3	(ROOT (S (NP (DT The) (JJ maximum) (VBG nonsedating) (NNS doses)) (VP (VP (VBD were)) (: :) (NP (NP (NP (NP (NNS Doc_20447294_735_743_Chemical)) (, ,) (NP (CD 3.2) (NN mg/kg))) (: ;) (NP (NP (NNS Doc_20447294_756_763_Chemical)) (NP (CD 10.0) (NN mg/kg))) (: ;) (NP (NP (CD 5.0) (JJ mg/kg) (NNS Doc_20447294_786_793_Chemical)) (PP (IN with) (NP (NNP Doc_20447294_799_807_Chemical) (CD 3.2))))) (VP (VBG mg/kg) (PP (IN in) (NP (NN combination)))))) (. .)))
20447294	4	(ROOT (S (NP (NP (DT The) (NNS doses)) (VP (VBN calculated) (S (VP (TO to) (VP (VB cause) (NP (NP (ADJP (CD 50) (NN %)) (NN reversal)) (PP (IN of) (NP (NNS Doc_20447294_880_892_Disease)))))))) (PRN (-LRB- -LRB-) (NP (NNP ED50)) (-RRB- -RRB-))) (VP (VBD were) (NP (NP (NP (NP (NNP 7.54)) (PRN (-LRB- -LRB-) (NP (NNP 1.81)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (CD 4.83)) (PRN (-LRB- -LRB-) (NP (CD 1.54)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (NN carrageenan) (NN model))))) (CC and) (NP (NP (NP (CD 44.18)) (PRN (-LRB- -LRB-) (NP (CD 1.37)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (CD 9.14)) (PRN (-LRB- -LRB-) (NP (CD 1.24)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NP (NP (DT the) (NN Doc_20447294_998_1001_Chemical-induced) (NNS Doc_20447294_1010_1020_Disease) (NN model)) (PP (IN for) (NP (NNS Doc_20447294_1031_1038_Chemical) (CC and) (NNS Doc_20447294_1043_1051_Chemical)))) (, ,) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (NP (NP (NN mg/kg)) (: ;) (NP (NP (NN mean)) (, ,) (NP (NNP SEM)))) (-RRB- -RRB-)))))))) (. .)))
20447294	5	(ROOT (S (NP (DT These) (NNS values)) (VP (VBD were) (NP (QP (JJR greater) (IN than) (DT the) (NN maximum)) (JJ nonsedating) (NNS doses))) (. .)))
20447294	6	(ROOT (S (NP (DT The) (NN ED50)) (VP (VBZ values) (PP (IN for) (NP (NP (NNS Doc_20447294_1168_1176_Chemical)) (SBAR (WHADVP (WRB when)) (S (S (VP (VBN given) (PP (IN in) (NP (NN combination))) (PP (IN with) (NP (NP (NNS Doc_20447294_1208_1215_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg)) (-RRB- -RRB-)))))) (VP (VBD were) (NP (NP (NP (QP (JJR less) (IN than) (DT the) (NN maximum)) (VBG nonsedating) (NN dose)) (: :) (NP (NP (NP (CD 0.56)) (PRN (-LRB- -LRB-) (NP (CD 1.55)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (NN carrageenan) (NN model))))) (CC and) (NP (NP (NP (CD 1.37)) (PRN (-LRB- -LRB-) (NP (CD 1.23)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (JJ Doc_20447294_1331_1341_Disease) (NN model)) (PRN (-LRB- -LRB-) (NP (NP (NN mg/kg)) (: ;) (NP (NP (NN mean)) (, ,) (NP (NNP SEM)))) (-RRB- -RRB-)))))))))))) (. .)))
20447294	7	(ROOT (S (NP (NP (DT The) (NN antinociception)) (PP (IN after) (NP (NP (NNS Doc_20447294_1394_1402_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 3.2) (NN mg/kg)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN increased) (PP (IN by) (NP (NP (ADJP (JJ co-administration) (PP (IN with) (NP (NP (NNS Doc_20447294_1455_1462_Chemical)) (PP (IN from) (NP (NP (QP (CD 28.0) (CC and) (CD 31.7)) (NN %)) (TO to) (NP (QP (CD 114.6) (CC and) (CD 56.9)) (NN %))))))) (NN reversal)) (PP (IN of) (NP (NP (NNS Doc_20447294_1514_1526_Disease)) (PP (IN in) (NP (NP (DT the) (ADJP (JJ inflammatory) (CC and) (JJ neuropathic)) (NNS models)) (, ,) (ADVP (RB respectively)))))) (PRN (-LRB- -LRB-) (S (NP (NNP P)) (VP (VBZ <) (NP (NP (CD 0.01)) (: ;) (NP (NP (JJ one-way) (NN analysis)) (PP (IN of) (NP (NP (JJ variance-significantly) (JJR greater)) (PP (IN than) (NP (NP (DT either) (NN drug)) (VP (VBN given) (ADVP (RB alone))))))))))) (-RRB- -RRB-)))))) (. .)))
20447294	8	(ROOT (S (NP (NP (DT The) (JJ maximum) (JJ antihyperalgesic) (NN effect)) (ADJP (JJ achievable) (PP (IN with) (S (VP (VBG nonsedating) (NP (NP (NNS doses)) (PP (IN of) (NP (NNS Doc_20447294_1763_1771_Chemical))))))))) (VP (MD may) (VP (VB be) (VP (VBN increased) (ADVP (RB significantly)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN drug)) (VP (VBZ is) (VP (VBN used) (PP (IN in) (NP (NN combination))) (PP (IN with) (NP (NNS Doc_20447294_1845_1852_Chemical)))))))))) (. .)))
20495512	0	(ROOT (NP (NP (JJ Doc_20495512_0_7_Chemical-induced) (NN thrombocytopenia)) (: :) (NP (DT a) (JJ practical) (NN review)) (. .)))
20495512	1	(ROOT (S (NP (NP (JJ Doc_20495512_54_61_Chemical-induced) (NN thrombocytopenia)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20495512_88_91_Disease)) (-RRB- -RRB-))) (VP (VBZ remains) (ADJP (JJ under-recognized) (PP (IN despite) (NP (PRP$ its) (ADJP (RB potentially) (VBG devastating)) (NNS outcomes))))) (. .)))
20495512	2	(ROOT (S (NP (PRP It)) (VP (VBZ begins) (SBAR (WHADVP (WRB when)) (S (NP (JJ Doc_20495512_179_186_Chemical) (NN exposure)) (VP (VBZ stimulates) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (NN Doc_20495512_224_231_Chemical-platelet) (NN factor)) (NP (NP (CD 4) (NNS antibodies)) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN turn))) (VP (VBZ triggers) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (JJ procoagulant) (NN platelet) (NNS particles))))))))))))))) (. .)))
20495512	3	(ROOT (S (NP (NP (NNS Doc_20495512_333_343_Disease) (CC and) (NNS Doc_20495512_348_364_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBP follow))))) (VP (VBP comprise) (NP (NP (DT the) (CD 2) (NN hallmark) (NNS traits)) (PP (IN of) (NP (NNS Doc_20495512_411_414_Disease))) (, ,) (PP (IN with) (NP (DT the) (JJ former))) (ADJP (RB largely) (JJ responsible))) (PP (IN for) (NP (JJ significant) (NNS Doc_20495512_468_490_Disease)))) (. .)))
20495512	4	(ROOT (S (NP (NP (DT The) (NN prevalence)) (PP (IN of) (NP (NNS Doc_20495512_510_513_Disease)))) (VP (VBZ varies) (PP (IN among) (NP (JJ several) (NNS subgroups))) (, ,) (PP (IN with) (NP (NP (JJR greater) (NN incidence)) (PP (IN in) (NP (NP (JJ surgical) (RB as)) (PP (VBN compared) (PP (IN with) (NP (JJ medical) (NNS populations))))))))) (. .)))
20495512	5	(ROOT (S (NP (NNP Doc_20495512_619_622_Disease)) (VP (MD must) (VP (VB be) (VP (VP (VBN acknowledged) (PP (IN for) (NP (NP (PRP$ its) (JJ intense) (NN predilection)) (PP (IN for) (NP (NNS Doc_20495512_677_687_Disease)))))) (CC and) (VP (VBN suspected) (SBAR (WHADVP (WRB whenever)) (S (NP (NNS Doc_20495512_711_721_Disease)) (VP (VBZ occurs) (PP (IN after) (NP (JJ Doc_20495512_735_742_Chemical) (NN exposure)))))))))) (. .)))
20495512	6	(ROOT (S (NP (NP (RB Early) (NN recognition)) (SBAR (WHNP (WDT that)) (S (VP (VBZ incorporates) (NP (DT the) (JJ clinical) (CC and) (JJ serologic) (NNS clues)))))) (VP (VBZ is) (ADJP (JJ paramount) (PP (TO to) (NP (NP (JJ timely) (NN institution)) (PP (IN of) (NP (NN treatment)))))) (, ,) (SBAR (IN as) (S (NP (PRP$ its) (NN delay)) (VP (MD may) (VP (VB result) (PP (IN in) (NP (JJ catastrophic) (NNS outcomes)))))))) (. .)))
20495512	7	(ROOT (S (NP (NP (DT The) (NN treatment)) (PP (IN of) (NP (NNS Doc_20495512_938_941_Disease)))) (VP (VBZ mandates) (NP (NP (NP (DT an) (JJ immediate) (NN cessation)) (PP (IN of) (NP (DT all) (JJ Doc_20495512_981_988_Chemical) (NN exposure)))) (CC and) (NP (NP (DT the) (NN institution)) (PP (IN of) (NP (DT an) (JJ antithrombotic) (NN therapy))))) (, ,) (S (VP (ADVP (RBS most) (RB commonly)) (VBG using) (NP (DT a) (JJ direct) (NN thrombin) (NN inhibitor))))) (. .)))
20495512	8	(ROOT (S (NP (NP (JJ Current) (`` ``) (JJ diagnostic) ('' '') (NNS tests)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB primarily)) (VP (VBP include) (NP (ADJP (JJ functional) (CC and) (JJ antigenic)) (NNS assays))))) (, ,)) (VP (VBP have) (NP (NP (JJR more)) (PP (IN of) (NP (NP (DT a) (NN confirmatory)) (PP (IN than) (NP (NP (JJ diagnostic) (NN role)) (PP (IN in) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (NNS Doc_20495512_1252_1255_Disease))))))))))) (. .)))
20495512	9	(ROOT (S (NP (JJ Special) (NN attention)) (VP (MD must) (VP (VB be) (VP (VBN paid) (PP (TO to) (NP (NP (JJ cardiac) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADVP (RB often)) (VP (VBN exposed) (PP (TO to) (NP (JJ Doc_20495512_1333_1340_Chemical) (JJ multiple) (NNS times))) (PP (IN during) (NP (NP (PRP$ their) (NN course)) (PP (IN of) (NP (NN treatment)))))))))))))) (. .)))
20495512	10	(ROOT (S (NP (JJ Direct) (NN thrombin) (NNS inhibitors)) (VP (VBP are) (NP (NP (JJ appropriate) (, ,) (JJ evidence-based) (NNS alternatives)) (PP (TO to) (NP (NP (NNS Doc_20495512_1465_1472_Chemical)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (NNS Doc_20495512_1503_1506_Disease)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBP need) (S (VP (TO to) (VP (VB undergo) (NP (JJ percutaneous) (JJ coronary) (NN intervention)))))))))))))))))) (. .)))
20495512	11	(ROOT (S (SBAR (IN As) (S (NP (NNS Doc_20495512_1567_1574_Chemical)) (VP (VBZ remains) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJS most)) (VP (ADVP (RB frequently)) (VBN used) (NP (JJ medications) (NN today)) (PP (IN with) (NP (NP (NN potential)) (PP (IN for) (NP (NP (NNS Doc_20495512_1652_1655_Disease)) (PP (IN with) (NP (DT every) (JJ Doc_20495512_1667_1674_Chemical) (NN exposure)))))))))))))) (, ,) (NP (NP (DT a) (JJ close) (NN vigilance)) (PP (IN of) (NP (JJ platelet) (NNS counts)))) (VP (MD must) (VP (VB be) (VP (VBN practiced) (SBAR (WHADVP (WRB whenever)) (S (NP (NNS Doc_20495512_1749_1756_Chemical)) (VP (VBZ is) (VP (VBN initiated)))))))) (. .)))
20513036	0	(ROOT (S (VP (VB Abductor) (NP (NNS Doc_20513036_9_18_Disease)) (PP (IN after) (NP (NP (NN botox) (NN injection)) (PP (IN for) (NP (NNS Doc_20513036_45_73_Disease)))))) (. .)))
20513036	1	(ROOT (NP (NP (NNS OBJECTIVES/HYPOTHESIS)) (: :) (NP (NP (NNP Botulinum) (NN toxin)) (PRN (-LRB- -LRB-) (NP (NNP Botox)) (-RRB- -RRB-)) (SBAR (S (NP (NP (NNS injections)) (PP (IN into) (NP (DT the) (JJ thyroarytenoid) (NNS muscles)))) (VP (VBP are) (NP (NP (DT the) (JJ current) (NN standard)) (PP (IN of) (NP (NP (NN care)) (PP (IN for) (NP (NP (NNS Doc_20513036_202_230_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20513036_232_236_Disease)) (-RRB- -RRB-))))))))))) (. .)))
20513036	2	(ROOT (S (NP (JJ Reported) (JJ adverse) (NNS effects)) (VP (VBP include) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (NNS breathiness) (, ,) (NNS Doc_20513036_297_308_Disease) (, ,) (CC and) (NN difficulty)))) (PP (IN with) (S (VP (VBG swallowing) (NP (NNS liquids)))))) (. .)))
20513036	3	(ROOT (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP report) (NP (NP (JJ multiple) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_20513036_383_411_Disease)) (PP (VBG following) (NP (NP (NNP Botox) (NNS injections)) (PP (IN for) (NP (NP (NNS Doc_20513036_443_447_Disease)) (, ,) (NP (NP (DT a) (NN complication)) (ADJP (RB previously) (VBN unreported))))))))))) (. .)))
20513036	4	(ROOT (NP (NP (NNP STUDY) (NNP DESIGN)) (: :) (NP (JJ Retrospective) (NN case) (NN series)) (. .)))
20513036	5	(ROOT (S (NP (NP (NNS Patients)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (NP (NNP Botox) (NNS injections)) (PP (IN for) (NP (JJ spasmodic) (NNS Doc_20513036_591_600_Disease))) (PP (IN between) (NP (NP (NNP January) (CD 2000)) (CC and) (NP (NNP October) (CD 2009)))))))) (VP (VBD were) (VP (VBN evaluated))) (. .)))
20513036	6	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NNS Doc_20513036_669_673_Disease)))) (VP (VBD were) (VP (VBN identified))) (. .)))
20513036	7	(ROOT (S (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NNS treatments)))) (VP (VBD received))) (CC and) (S (NP (JJ adverse) (NNS effects)) (VP (VBD were) (VP (VBN noted)))) (. .)))
20513036	8	(ROOT (S (PP (IN For) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Doc_20513036_775_803_Disease) (, ,) (NN age) (, ,) (NN sex) (, ,) (JJ Doc_20513036_815_824_Disease) (NNP Botox) (NN dose))))) (, ,) (NP (JJ prior) (JJ Botox) (NN dose) (, ,) (CC and) (NN course) (NN following) (NNS Doc_20513036_876_885_Disease)) (VP (VBD were) (VP (VBN noted))) (. .)))
20513036	9	(ROOT (S (PP (IN From) (S (NP (NP (DT a) (NN database)) (PP (IN of) (NP (JJ 452) (NNS patients)))) (VP (VBG receiving) (NP (NNP Botox))))) (, ,) (NP (JJ 352) (NNS patients)) (VP (VBD had) (VP (VBN been) (VP (VBN diagnosed) (PP (IN with) (NP (NNS Doc_20513036_993_997_Disease)))))) (. .)))
20513036	10	(ROOT (S (PP (IN Of) (NP (DT these) (JJ 352) (NNS patients))) (, ,) (S (NP (CD eight) (NNS patients)) (VP (VBD suffered) (NP (NNS Doc_20513036_1046_1074_Disease)))) (, ,) (CC and) (S (NP (CD two)) (VP (VBD suffered) (NP (DT this) (NN complication)) (ADVP (RB twice)))) (. .)))
20513036	11	(ROOT (S (NP (DT All) (VBN affected) (NNS patients)) (VP (VBD were) (NP (NP (NNS females)) (PP (IN over) (NP (NP (DT the) (NN age)) (PP (IN of) (NP (CD 50) (NNS years))))))) (. .)))
20513036	12	(ROOT (S (NP (JJS Most) (NNS patients)) (VP (VP (VBD had) (VP (VBN received) (NP (NNS treatments)) (ADVP (RB prior) (PP (TO to) (NP (NNS Doc_20513036_1226_1244_Disease)))))) (CC and) (VP (VBD continued) (S (VP (VBG receiving) (PP (IN after) (NP (NNS Doc_20513036_1275_1284_Disease))))))) (. .)))
20513036	13	(ROOT (S (S (NP (CD Seven) (NNS patients)) (VP (VBD recovered) (PP (IN after) (NP (NP (DT a) (JJ brief) (NN period)) (PP (IN of) (NP (NN activity) (NNS restrictions))))))) (, ,) (CC and) (S (NP (PRP one)) (VP (VBD underwent) (NP (DT a) (NN tracheotomy)))) (. .)))
20513036	14	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_20513036_1408_1426_Disease)) (PP (IN after) (NP (NP (NNP Botox) (NN injection)) (PP (IN for) (NP (NNS Doc_20513036_1453_1457_Disease)))))))) (VP (VBD was) (NP (CD 0.34) (NN %))) (. .)))
20513036	15	(ROOT (S (NP (JJ Bilateral) (NNS Doc_20513036_1492_1510_Disease)) (VP (VBZ is) (NP (NP (DT a) (JJ rare) (NN complication)) (PP (IN of) (NP (NP (NNP Botox) (NNS injections)) (PP (IN for) (NP (NNS Doc_20513036_1558_1562_Disease))))) (, ,) (VP (VBG causing) (NP (NN difficulty)) (PP (IN with) (S (VP (VBG breathing) (PP (IN upon) (NP (NN exertion))))))))) (. .)))
20513036	16	(ROOT (S (NP (NP (DT The) (JJ likely) (NN mechanism)) (PP (IN of) (NP (NNS Doc_20513036_1637_1646_Disease)))) (VP (VBZ is) (NP (NP (NN diffusion)) (PP (IN of) (NP (NP (NNP Botox)) (PP (IN around) (NP (NP (DT the) (JJ muscular) (NN process)) (PP (IN of) (NP (DT the) (ADJP (JJ arytenoid) (PP (TO to) (NP (DT the) (NN posterior)))) (JJ cricoarytenoid) (NNS muscles))))))))) (. .)))
20513036	17	(ROOT (S (S (NP (DT The) (NNS Doc_20513036_1759_1768_Disease)) (VP (VBZ is) (ADJP (JJ temporary)))) (, ,) (CC and) (S (NP (NP (NN watchful)) (VP (VBG waiting) (PP (IN with) (NP (NP (NN restriction)) (PP (IN of) (NP (NN activity))))))) (VP (VBZ is) (NP (DT the) (VBN recommended) (NN management)))) (. .)))
20566328	0	(ROOT (S (NP (NNP Doc_20566328_0_24_Disease)) (VP (VBZ contributes) (PP (TO to) (NP (NN Doc_20566328_40_47_Chemical-induced) (NNS Doc_20566328_56_75_Disease))) (: :) (NP (NP (NNP Prevention)) (PP (IN by) (NP (DT the) (JJ targeted) (NN antioxidant) (NN MitoQ))))) (. .)))
20566328	1	(ROOT (S (NP (NP (DT The) (NN goal)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB assess) (NP (NP (JJ mitochondrial) (NN function) (CC and) (NN ROS) (NN production)) (PP (IN in) (NP (NP (DT an) (JJ experimental) (NN model)) (PP (IN of) (NP (NN Doc_20566328_230_237_Chemical-induced) (NNS Doc_20566328_246_265_Disease)))))))))) (. .)))
20566328	2	(ROOT (S (NP (PRP We)) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (JJ Doc_20566328_288_295_Chemical) (NN abuse)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (JJ altered) (JJ mitochondrial) (NN function)) (SBAR (WHNP (WDT that)) (S (PP (IN in) (NP (NN turn))) (VP (MD may) (VP (VB cause) (NP (NNS Doc_20566328_368_396_Disease))))))))))))) (. .)))
20566328	3	(ROOT (S (NP (NP (CD Seven) (NNS days)) (PP (IN of) (NP (NP (JJ Doc_20566328_412_419_Chemical) (NN administration)) (PP (TO to) (NP (NP (NNS rats)) (VP (VBN led) (PP (TO to) (NP (DT an) (VBN increased) (NNS Doc_20566328_463_469_Chemical) (NN consumption))))))))) (VP (VBD detected) (PP (IN in) (NP (JJ cardiac) (NNS fibers))) (, ,) (ADVP (RB specifically)) (PP (IN through) (NP (NP (JJ complex) (NN I)) (CC and) (NP (JJ complex) (NNP III))))) (. .)))
20566328	4	(ROOT (S (NP (NNP ROS) (NNS levels)) (VP (VBD were) (VP (VBN increased) (, ,) (PP (ADVP (RB specifically)) (IN in) (NP (NN interfibrillar) (NN mitochondria))))) (. .)))
20566328	5	(ROOT (S (PP (IN In) (NP (NN parallel))) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (JJ Doc_20566328_666_669_Chemical) (NN synthesis)))) (, ,) (SBAR (IN whereas) (S (NP (DT no) (NN difference)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (JJ subsarcolemmal) (NN mitochondria)))))))) (. .)))
20566328	6	(ROOT (S (NP (NP (DT This) (VBG uncoupling) (NN effect)) (PP (IN on) (NP (JJ oxidative) (NN phosphorylation)))) (VP (VBD was) (RB not) (ADJP (JJ detectable) (PP (IN after) (NP (JJ short-term) (NN exposure)))) (PP (TO to) (NP (NNS Doc_20566328_848_855_Chemical))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT these) (NNS Doc_20566328_879_906_Disease)) (VP (VBD were) (NP (NP (DT a) (JJ late)) (CONJP (RB rather) (IN than)) (NP (DT a) (JJ primary) (NN event))) (PP (IN in) (NP (NP (DT the) (JJ pathological) (NN response)) (PP (TO to) (NP (NNS Doc_20566328_979_986_Chemical))))))))))) (. .)))
20566328	7	(ROOT (S (NP (NP (NNP MitoQ)) (, ,) (NP (DT a) (JJ mitochondrial-targeted) (NN antioxidant)) (, ,)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (ADVP (RB completely)) (VB prevent) (NP (NP (DT these) (NNS Doc_20566328_1071_1098_Disease)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS Doc_20566328_1110_1129_Disease)) (VP (VBN characterized) (ADVP (RB here)) (PP (IN by) (NP (NP (DT a) (NNS Doc_20566328_1154_1175_Disease)) (VP (VBN studied) (PP (IN with) (NP (DT a) (JJ conductance) (NN catheter))) (S (VP (TO to) (VP (VB obtain) (NP (JJ pressure-volume) (NNS data)))))))))))))))) (. .)))
20566328	8	(ROOT (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS results)) (VP (VP (VBP extend) (NP (JJ previous) (NNS studies))) (CC and) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN Doc_20566328_1319_1326_Chemical-induced) (NNS Doc_20566328_1335_1354_Disease)) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (DT a) (NNS Doc_20566328_1371_1391_Disease)))))))))) (. .)))
20589632	0	(ROOT (NP (NP (NP (JJ Doc_20589632_0_12_Chemical-induced) (JJ immune) (NNS Doc_20589632_28_44_Disease)) (PP (IN in) (NP (DT a) (JJ pediatric) (NN oncology) (NN patient)))) (VP (VBG presenting) (PP (IN as) (NP (DT an) (NNS Doc_20589632_94_130_Disease)))) (. .)))
20589632	1	(ROOT (S (NP (NP (DT A) (JJ 10-year-old) (NN male)) (PP (IN with) (NP (NNS Doc_20589632_156_170_Disease)))) (VP (VBD presented) (PP (IN with) (NP (NNS Doc_20589632_186_210_Disease)))) (. .)))
20589632	2	(ROOT (S (PP (IN During) (NP (JJ red) (NN cell) (NN transfusion))) (, ,) (NP (PRP he)) (VP (VBD developed) (NP (NNS Doc_20589632_254_268_Disease))) (. .)))
20589632	3	(ROOT (S (NP (NNP Transfusion) (NN reaction) (NN workup)) (VP (VBD was) (ADJP (JJ negative))) (. .)))
20589632	4	(ROOT (S (NP (NNP Doc_20589632_312_348_Disease)) (VP (VBD was) (VP (VBN suspected) (PP (RB because) (IN of) (NP (NP (JJ positive) (JJ direct) (NN antiglobulin) (NN test)) (, ,) (NP (JJ negative) (NN eluate)) (, ,) (CC and) (NP (NP (NNS microspherocytes)) (PP (IN on) (NP (NN smear) (NN pre)))) (: -) (CC and) (NP (NN post-transfusion)))))) (. .)))
20589632	5	(ROOT (S (NP (NP (NN Drug) (NNS studies)) (VP (VBG using) (NP (DT the) (JJ indirect) (NN antiglobulin) (NN test)))) (VP (VBD were) (ADJP (ADJP (RB strongly) (JJ positive) (PP (IN with) (NP (NNS Doc_20589632_561_573_Chemical) (CC and) (NNS Doc_20589632_578_590_Chemical-Doc_20589632_591_607_Chemical)))) (CC but) (ADJP (JJ negative) (PP (IN with) (NP (NNS Doc_20589632_626_642_Chemical)))))) (. .)))
20589632	6	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD recovered) (PP (IN after) (S (VP (VBG discontinuing) (NP (DT the) (NN drug))))) (, ,) (PP (IN with) (NP (NP (DT no) (NN recurrence)) (PP (IN in) (NP (CD 2) (NNS years)))))) (. .)))
20589632	7	(ROOT (S (NP (NP (JJ Other) (NNS causes)) (PP (IN of) (NP (NNS Doc_20589632_743_749_Disease)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ worse-than-expected) (NNS Doc_20589632_808_814_Disease))))) (PP (IN after) (NP (NN chemotherapy)))))) (. .)))
20589632	8	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NNS Doc_20589632_848_857_Disease)) (PP (IN during) (NP (NN transfusion)))) (VP (VBZ is) (RB not) (ADVP (RB always)) (NP (DT a) (NN transfusion) (NN reaction))) (. .)))
20595935	0	(ROOT (NP (NP (NP (JJ Doc_20595935_0_9_Chemical) (NN stimulation) (NN test)) (PP (IN in) (NP (NNS Doc_20595935_30_48_Disease)))) (: :) (NP (NP (NN loss)) (PP (IN of) (NP (NP (NN prolactin) (NN response)) (PP (IN in) (NP (ADJP (JJ anatomic) (CC or) (JJ functional)) (NN stalk) (NN effect)))))) (. .)))
20595935	1	(ROOT (S (NP (JJ Doc_20595935_122_131_Chemical) (NN stimulation) (NN test)) (VP (VBD was) (ADVP (RB previously)) (VP (VBN investigated) (PP (PP (IN as) (NP (NP (DT a) (NN tool)) (PP (IN for) (NP (NP (NN differential) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_20595935_217_235_Disease))))))) (, ,) (CC but) (PP (IN with) (NP (VBG conflicting) (NNS results)))))) (. .)))
20595935	2	(ROOT (S (NP (NNP Macroprolactinemia)) (VP (VBD was) (ADVP (RB never)) (VP (VBN considered) (PP (IN in) (NP (DT those) (JJ previous) (NNS studies))))) (. .)))
20595935	3	(ROOT (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBD aimed) (S (VP (TO to) (VP (VB re-investigate) (NP (NP (DT the) (JJ diagnostic) (NN value)) (PP (IN of) (NP (NNS Doc_20595935_391_400_Chemical)))) (PP (IN in) (NP (NP (DT a) (NN population)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (RB all) (VP (VBD screened) (PP (IN for) (NP (NN macroprolactinemia))))))))))))) (. .)))
20595935	4	(ROOT (S (NP (NP (NN Prolactin) (NNS responses)) (PP (TO to) (NP (NP (NNS Doc_20595935_486_495_Chemical)) (PP (IN in) (NP (NP (NP (CD 65) (JJ female) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (NN age)) (: :) (NP (NP (NNP 29.9) (NNP +) (NNP /)) (: -) (NP (CD 8.1) (NNS years)))) (-RRB- -RRB-))) (PP (IN with) (NP (NNS Doc_20595935_549_567_Disease)))))))) (VP (VBD were) (VP (VBN tested) (PP (IN in) (NP (DT a) (VBN descriptive) (, ,) (VBN matched) (JJ case-control) (NN study))))) (. .)))
20595935	5	(ROOT (S (S (S (VP (VBG Doc_20595935_635_644_Chemical) (NP (CD 80) (NN mg)))) (, ,) (NP (NNP p.o.)) (VP (VBD was) (VP (VBN administered)))) (, ,) (CC and) (S (ADVP (RB then)) (NP (NNP PRL) (NNS levels)) (VP (VBD were) (VP (VBN measured) (PP (IN at) (NP (JJ 8th) (CC and) (JJ 16th) (NNS hours))) (, ,) (PP (IN by) (NP (JJ immunometric) (NN chemiluminescence)))))) (. .)))
20595935	6	(ROOT (S (NP (JJ Doc_20595935_767_776_Chemical) (NNS responsiveness)) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NP (JJ peak) (NN percent) (NN change)) (PP (IN in) (NP (NP (JJ basal) (NN prolactin) (NNS levels)) (PRN (-LRB- -LRB-) (NP (NNP PRL)) (-RRB- -RRB-)))))))) (. .)))
20595935	7	(ROOT (S (NP (NNP Doc_20595935_872_881_Chemical)) (ADVP (RB significantly)) (VP (VBD increased) (NP (NNP PRL) (NNS levels)) (PP (IN in) (NP (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NP (NNP N.) (CD 8) (, ,) (CD PRL)) (: :) (NP (CD 183) (NN %))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_20595935_956_973_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP N.) (CD 8) (, ,) (CD PRL)) (: :) (NP (CD 7) (NN %))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_20595935_991_1008_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP N.) (CD 19) (, ,) (CD PRL)) (: :) (NP (CD 21) (NN %))) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN macroprolactinemia)) (PRN (-LRB- -LRB-) (NP (NP (NNP N.) (CD 23) (, ,) (CD PRL)) (: :) (NP (CD 126) (NN %))) (-RRB- -RRB-))) (PRN (, ,) (FRAG (CC but) (RB not) (PP (IN in) (NP (NP (NN pseudoprolactinoma)) (PRN (-LRB- -LRB-) (NP (NP (NNP N.) (CD 8) (, ,) (CD PRL)) (: :) (NP (CD 0.8) (NN %))) (-RRB- -RRB-))))) (, ,))) (CC and) (NP (NP (NN Doc_20595935_1120_1131_Chemical-induced) (NNS Doc_20595935_1140_1158_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP N.) (CD 7) (, ,) (CD PRL)) (: :) (NP (CD 3) (NN %))) (-RRB- -RRB-)))))) (. .)))
20595935	8	(ROOT (S (NP (NNP ROC) (NN curve) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (NNS unresponsiveness)) (PP (TO to) (NP (NP (NNS Doc_20595935_1229_1238_Chemical)) (VP (VBN defined) (PP (IN as) (NP (NP (NNP PRL) (NNP <)) (ADJP (CD 7) (NN %)) (, ,) (VP (VBN discriminated) (NP (NP (ADJP (JJ anatomical) (CC or) (JJ functional)) (NN stalk) (NN effect)) (PRN (-LRB- -LRB-) (NP (NP (NN sensitivity)) (: :) (NP (NP (NP (CD 74) (NN %)) (, ,) (NP (NN specificity))) (: :) (NP (NP (CD 73) (NN %)) (, ,) (NP (NNP AUC))) (: :) (NP (NP (CD 0.855) (NNS +)) (PRN (: /) (FRAG (NP (CD -0.04)) (, ,) (NP (NP (NNP P) (NNP <)) (NP (CD 0.001))) (, ,) (NP (NNP CI)) (: :))) (NP (CD 0.768-0) (CD .942))))) (-RRB- -RRB-)))))))))) (VP (VBN associated) (PP (IN with) (NP (NN pseudoprolactinoma) (CC or) (NN Doc_20595935_1432_1443_Chemical-induced) (NNS Doc_20595935_1452_1470_Disease))) (, ,) (ADVP (RB respectively)))))) (. .)))
20595935	9	(ROOT (S (NP (JJ Doc_20595935_1498_1507_Chemical) (NNS responsiveness)) (VP (VBZ is) (RB not) (NP (NP (DT a) (JJ reliable) (NN finding)) (PP (IN for) (NP (NP (DT the) (NN differential) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_20595935_1583_1601_Disease))))))) (. .)))
20595935	10	(ROOT (S (ADVP (RB However)) (, ,) (NP (JJ Doc_20595935_1612_1621_Chemical) (NNS unresponsiveness)) (VP (VBZ discriminates) (NP (NP (NN stalk) (NN effect)) (PRN (-LRB- -LRB-) (FW i.e.) (, ,) (ADJP (ADJP (JJ anatomically)) (CC or) (ADJP (RB functionally) (JJ inhibited) (NP (JJ dopaminergic) (NNS tonus)))) (-RRB- -RRB-))) (PP (IN from) (NP (NP (JJ other) (NNS causes)) (PP (IN of) (NP (NP (NNS Doc_20595935_1753_1771_Disease)) (PP (IN with) (NP (NP (VBG varying) (NNS degrees)) (PP (IN of) (NP (NNS responsiveness)))))))))) (. .)))
20682692	0	(ROOT (S (NP (NP (NNP Blockade)) (PP (IN of) (NP (NP (JJ endothelial-mesenchymal) (NN transition)) (PP (IN by) (NP (DT a) (JJ Smad3) (NN inhibitor)))))) (VP (VBZ delays) (NP (NP (DT the) (JJ early) (NN development)) (PP (IN of) (NP (NN Doc_20682692_100_114_Chemical-induced) (NNS Doc_20682692_123_143_Disease))))) (. .)))
20682692	1	(ROOT (S (NP (DT A) (NN multicenter) (, ,) (JJ controlled) (NN trial)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (JJ early) (NN blockade)) (PP (IN of) (NP (NP (DT the) (JJ renin-Doc_20682692_228_239_Chemical) (NN system)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (NN type) (CD 1)) (NNS Doc_20682692_271_279_Disease) (CC and) (NN normoalbuminuria)))))))) (VP (VBD did) (RB not) (VP (VB retard) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (NNS Doc_20682692_335_346_Disease)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (JJ other) (NN mechanism)) (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-))) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (NP (JJ early) (NNS Doc_20682692_425_445_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20682692_447_467_Disease)) (-RRB- -RRB-))))))))))))))))) (. .)))
20682692	2	(ROOT (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (NN endothelial-mesenchymal-transition)) (PRN (-LRB- -LRB-) (NP (NNP EndoMT)) (-RRB- -RRB-))) (VP (VBZ contributes) (PP (TO to) (NP (NP (DT the) (JJ early) (NN development)) (PP (IN of) (NP (NP (NNS Doc_20682692_591_618_Disease)) (PP (ADVP (RB independently)) (IN of) (NP (NP (NN microalbuminuria)) (PP (IN in) (NP (NNS mice))))))))) (PP (IN with) (NP (NP (NNS Doc_20682692_666_680_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20682692_682_685_Chemical)) (-RRB- -RRB-)) (: -) (NP (JJ induced) (NNS Doc_20682692_695_703_Disease))))))))) (. .)))
20682692	3	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (NNP blocking) (NNP EndoMT)) (VP (VBZ reduces) (NP (NP (DT the) (JJ early) (NN development)) (PP (IN of) (NP (NNS Doc_20682692_797_817_Disease)))))))) (. .)))
20682692	4	(ROOT (NP (NP (NNP RESEARCH) (NNP DESIGN) (CC AND) (NNP METHODS)) (: :) (S (NP (NNP EndoMT)) (VP (VBD was) (VP (VBN induced) (PP (PP (IN in) (NP (NP (NP (DT a) (NN mouse) (NN pancreatic) (NN microvascular) (NN endothelial) (NN cell) (NN line)) (PRN (-LRB- -LRB-) (NP (NNP MMEC)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (VBN advanced) (NN glycation) (NN end) (NNS products))))) (PRN (-LRB- -LRB-) (NP (NNP AGEs)) (-RRB- -RRB-)))) (CC and) (PP (IN in) (NP (NP (DT the) (JJ endothelial) (JJ lineage-traceble) (NN mouse) (NN line) (NN Tie2-Cre)) (: ;) (ADJP (JJ Loxp-EGFP) (PP (IN by) (NP (NP (NN administration)) (PP (IN of) (NP (NNP AGEs))))) (, ,) (PP (IN with) (NP (NP (JJ nonglycated) (NN mouse) (NN albumin)) (VP (VBG serving) (PP (IN as) (NP (DT a) (NN control))))))))))))) (. .)))
20682692	5	(ROOT (S (NP (JJ Phosphorylated) (NNS Smad3)) (VP (VBD was) (VP (VBN detected) (PP (IN by) (NP (NP (NN immunoprecipitation/Western) (VBG blotting)) (CC and) (NP (JJ confocal) (NN microscopy)))))) (. .)))
20682692	6	(ROOT (S (NP (NP (VBG Blocking) (NNS studies)) (VP (VBG using) (NP (NP (NP (NN receptor)) (PP (IN for) (NP (NNP AGE) (NNP siRNA)))) (CC and) (NP (NP (DT a) (JJ specific) (NN inhibitor)) (PP (IN of) (NP (NP (NNS Smad3)) (PRN (-LRB- -LRB-) (NP (NNP SIS3)) (-RRB- -RRB-)))))))) (VP (VBD were) (VP (VBN performed) (PP (PP (IN in) (NP (NNP MMECs))) (CC and) (PP (IN in) (NP (NP (NN Doc_20682692_1357_1360_Chemical-induced) (NNS Doc_20682692_1369_1389_Disease)) (PP (IN in) (NP (NP (NNS Tie2-Cre)) (: ;) (NP (NN Loxp-EGFP) (NNS mice))))))))) (. .)))
20682692	7	(ROOT (S (NP (NP (JJ Confocal) (NN microscopy)) (CC and) (NP (NNP real-time) (NNP PCR))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NNP AGEs)) (VP (VBN induced) (NP (NP (NNP EndoMT)) (PP (PP (IN in) (NP (NNP MMECs))) (CC and) (PP (IN in) (NP (NNS Tie2-Cre)))) (: ;) (NP (NN Loxp-EGFP) (NNS mice))))))) (. .)))
20682692	8	(ROOT (S (NP (NNP Immunoprecipitation/Western) (NNP blotting)) (VP (VP (VBD showed) (SBAR (IN that) (S (NP (NNS Smad3)) (VP (VBD was) (VP (VBN activated) (PP (IN by) (NP (NNP AGEs)))))))) (CC but) (VP (VBD was) (ADJP (JJ inhibited) (PP (IN by) (NP (NNP SIS3)))) (PP (PP (IN in) (NP (NNP MMECs))) (CC and) (PP (IN in) (NP (NN Doc_20682692_1663_1666_Chemical-induced) (NNS Doc_20682692_1675_1695_Disease)))))) (. .)))
20682692	9	(ROOT (S (NP (NP (JJ Confocal) (NN microscopy)) (CC and) (NP (NNP real-time) (NNP PCR))) (ADVP (RB further)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NNP SIS3)) (VP (VBD abrogated) (NP (NP (NNP EndoMT)) (, ,) (NP (NNS Doc_20682692_1784_1806_Disease)) (, ,) (CC and) (NP (NP (ADJP (JJ retarded)) (NN progression)) (PP (IN of) (NP (NNS Doc_20682692_1836_1847_Disease))))))))) (. .)))
20682692	10	(ROOT (S (NP (NNP EndoMT)) (VP (VBZ is) (NP (NP (DT a) (NN novel) (NN pathway)) (VP (VBG leading) (PP (TO to) (NP (NP (JJ early) (NN development)) (PP (IN of) (NP (NNS Doc_20682692_1920_1940_Disease)))))))) (. .)))
20682692	11	(ROOT (S (NP (NP (NNP Blockade)) (PP (IN of) (NP (NP (NNP EndoMT)) (PP (IN by) (NP (NNP SIS3)))))) (VP (MD may) (VP (VB provide) (NP (DT a) (JJ new) (NN strategy)) (S (VP (TO to) (VP (VB retard) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (JJ Doc_20682692_2025_2045_Disease) (CC and) (JJ other) (NNS Doc_20682692_2056_2078_Disease))))))))) (. .)))
20828385	0	(ROOT (NP (NP (JJ Cytostatic) (CC and) (JJ anti-angiogenic) (NNS effects)) (PP (IN of) (NP (NNS Doc_20828385_42_54_Chemical))) (PP (IN in) (NP (NNS Doc_20828385_58_89_Disease))) (. .)))
20828385	1	(ROOT (S (NP (NP (NNP Doc_20828385_91_111_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20828385_113_116_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (ADJP (JJ rare) (CC and) (JJ aggressive)) (NN type)) (PP (IN of) (NP (NNP B-cell) (CD non-Doc_20828385_162_180_Disease))))) (. .)))
20828385	2	(ROOT (S (S (NP (NNS Patients)) (VP (VBP become) (ADJP (RB progressively) (JJ refractory) (PP (TO to) (NP (JJ conventional) (NN chemotherapy)))))) (, ,) (CC and) (S (NP (PRP$ their) (NN prognosis)) (VP (VBZ is) (ADJP (JJ poor)))) (. .)))
20828385	3	(ROOT (S (S (ADVP (RB However)) (, ,) (NP (DT a) (ADJP (CD 38) (NN %)) (NN remission) (NN rate)) (VP (VBZ has) (VP (VBN been) (VP (ADVP (RB recently)) (VBN reported) (PP (IN in) (NP (NP (JJ refractory) (NNS Doc_20828385_353_356_Disease)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_20828385_370_382_Chemical)))))))))) (, ,) (NP (DT a) (NN mTOR)) (VP (VBP inhibitor.Here) (SBAR (S (NP (PRP we)) (VP (VBD had) (NP (DT the) (NN opportunity) (S (VP (TO to) (VP (VB study) (NP (NP (NP (DT a) (NN case)) (PP (IN of) (NP (JJ refractory) (NNS Doc_20828385_459_462_Disease))) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (JJ Doc_20828385_471_476_Disease) (NN regression)) (NP (CD two) (NNS months)) (PP (IN after) (NP (JJ Doc_20828385_505_517_Chemical) (NN treatment))))))) (, ,) (CC and) (NP (NP (DT a) (JJ progression-free) (NN survival)) (PP (IN of) (NP (CD 10) (NNS months))))))))))))) (. .)))
20828385	4	(ROOT (S (PP (IN In) (NP (DT this) (NN case))) (, ,) (NP (NN lymph) (NN node) (NNS biopsies)) (VP (VBD were) (VP (VBN performed) (ADVP (ADVP (RB before)) (CC and) (NP (CD six) (NNS months))) (PP (IN after) (NP (JJ Doc_20828385_652_664_Chemical) (NN therapy))))) (. .)))
20828385	5	(ROOT (S (NP (NP (NNP Comparison)) (PP (IN of) (NP (DT the) (CD two) (NNS biopsies)))) (VP (VBD showed) (SBAR (IN that) (S (NP (NNS Doc_20828385_717_729_Chemical)) (VP (VP (VBD inhibited) (NP (JJ Doc_20828385_740_745_Disease) (NN cell) (NN proliferation)) (PP (IN through) (NP (NN cell) (NN cycle) (NN arrest)))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (VB induce) (NP (DT any) (NN change)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ apoptotic) (JJ Doc_20828385_849_854_Disease) (NNS cells))))))))))) (. .)))
20828385	6	(ROOT (S (PP (ADVP (RB Apart)) (IN from) (NP (DT this) (JJ cytostatic) (NN effect))) (, ,) (NP (NNS Doc_20828385_897_909_Chemical)) (VP (VBD had) (NP (NP (DT an) (JJ antiangiogenic) (NN effect)) (PP (PP (IN with) (NP (NP (NN decrease)) (PP (IN of) (NP (JJ Doc_20828385_956_961_Disease) (JJ microvessel) (NN density))))) (CC and) (PP (IN of) (NP (NNP VEGF) (NN expression)))))) (. .)))
20828385	7	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (JJ numerous) (NN patchy)) (, ,) (NP (NP (JJ well-limited) (JJ fibrotic) (NNS areas)) (, ,) (NP (ADJP (JJ compatible) (PP (IN with) (NP (JJ post-Doc_20828385_1083_1091_Disease) (NN tissue)))) (NN repair))) (, ,)) (VP (VBD were) (VP (VBN found) (PP (IN after) (NP (JJ 6-month) (JJ Doc_20828385_1132_1144_Chemical) (NN therapy))))) (. .)))
20828385	8	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NNS Doc_20828385_1160_1172_Chemical)) (VP (VBD reduced) (NP (JJ Doc_20828385_1181_1186_Disease) (NN burden)) (PP (IN through) (NP (NP (JJ associated) (ADJP (JJ cytostatic) (CC and) (JJ anti-angiogenic)) (NNS effects.This)) (SBAR (S (NP (NP (JJ dual) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_20828385_1272_1284_Chemical)) (PP (IN on) (NP (JJ Doc_20828385_1288_1293_Disease) (NN tissue)))))) (VP (MD could) (VP (VB contribute) (PP (TO to) (NP (NP (PRP$ its) (ADJP (RB recently) (VBN reported)) (NN efficiency)) (PP (IN in) (NP (JJ refractory) (NNS Doc_20828385_1368_1371_Disease))) (ADJP (JJ resistant) (PP (TO to) (NP (JJ conventional) (NN chemotherapy))))))))))))) (. .)))
2083961	0	(ROOT (S (VP (VB Doc_2083961_0_19_Disease) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_2083961_27_37_Chemical))))) (. .)))
2083961	1	(ROOT (S (NP (NP (DT A) (JJ 23-year-old) (JJ male) (NN patient)) (PP (IN with) (NP (JJ bacteriologically) (VBN proven) (NNS Doc_2083961_96_118_Disease)))) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (DT the) (JJ various) (NNS regimens)) (PP (IN of) (NP (NP (JJ antituberculosis) (NNS drugs)) (PP (IN for) (NP (QP (RB nearly) (CD 15)) (NNS months))))))))) (. .)))
2083961	2	(ROOT (S (S (NP (NNP Doc_2083961_205_215_Chemical)) (VP (VBD was) (VP (VBN administered) (ADJP (JJ thrice)) (PP (IN as) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (CD 3-4) (NN drug) (NN regimen)))))))) (CC and) (S (NP (DT each) (NN time)) (NP (PRP he)) (VP (VBD developed) (NP (JJ untoward) (NN side) (NNS effects)) (PP (IN like) (NP (NNS Doc_2083961_325_331_Disease) (, ,) (NNS Doc_2083961_333_341_Disease) (CC and) (NN fever))) (PP (IN with) (NP (NNS chills) (CC and) (NNS Doc_2083961_368_374_Disease))))) (. .)))
2083961	3	(ROOT (S (NP (DT The) (JJ last) (JJ such) (NN episode)) (VP (VBD was) (PP (IN of) (NP (NNS Doc_2083961_405_424_Disease))) (PP (IN at) (SBAR (WHNP (WDT which)) (S (VP (VBP stage) (SBAR (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN seen) (PP (IN by) (NP (NP (DT the) (NNS authors)) (PP (IN of) (NP (DT this) (NN report)))))))))))))) (. .)))
2083961	4	(ROOT (S (NP (DT The) (NN patient)) (, ,) (ADVP (RB however)) (, ,) (VP (VBD made) (NP (DT a) (JJ full) (NN recovery))) (. .)))
20859899	0	(ROOT (S (NP (NNP Doc_20859899_0_7_Disease)) (VP (VBD caused) (PP (IN by) (NP (NNS Doc_20859899_18_30_Disease))) (PP (IN during) (NP (NP (NN use)) (PP (IN of) (NP (NP (DT a) (VBN combined) (NN therapy)) (PP (IN with) (NP (NP (DT the) (NN Doc_20859899_73_84_Chemical-converting) (NN enzyme) (NN inhibitor)) (CC and) (NP (NNS Doc_20859899_117_131_Chemical))))))))) (. .)))
20859899	1	(ROOT (S (NP (NP (DT A) (CD 76) (JJ year-old) (NN woman)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (JJ coronary) (NN artery) (NN bypass) (NN grafting)) (CC and) (NP (JJ prior) (NNS Doc_20859899_213_234_Disease))))))) (VP (VBD was) (VP (VBN transferred) (PP (TO to) (NP (DT the) (NN emergency) (NN room))) (PP (IN with) (NP (NP (NNS Doc_20859899_278_299_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ marked) (NNS Doc_20859899_314_325_Disease)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_20859899_336_348_Disease))))))))))) (. .)))
20859899	2	(ROOT (S (S (NP (NP (DT The) (NN concentration)) (PP (IN of) (NP (NN serum) (NNS Doc_20859899_377_386_Chemical)))) (VP (VBD was) (ADJP (JJ high)))) (, ,) (CC and) (S (NP (JJ normal) (NN sinus) (NN rhythm)) (VP (VBD was) (VP (VBN restored) (PP (IN after) (NP (NP (NN correction)) (PP (IN of) (NP (DT the) (NN serum) (NNS Doc_20859899_464_473_Chemical) (NN level)))))))) (. .)))
20859899	3	(ROOT (S (NP (NP (DT The) (NN cause)) (PP (IN of) (NP (NNS Doc_20859899_494_506_Disease)))) (VP (VBD was) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (NP (NP (JJ several) (NNS doses)) (PP (IN of) (NP (NP (NP (NNS Doc_20859899_545_559_Chemical)) (, ,) (NP (DT an) (JJ Doc_20859899_564_575_Chemical) (NN antagonist))) (, ,) (CONJP (IN in) (NN addition) (TO to)) (NP (NP (DT the) (JJ long-term) (NN intake)) (PP (IN of) (NP (NP (NNS Doc_20859899_627_635_Chemical)) (, ,) (NP (DT an) (NNP ACE) (NN inhibitor))))))))))))) (. .)))
20859899	4	(ROOT (S (NP (DT This) (NN case)) (VP (VBZ is) (NP (NP (DT a) (JJ good) (NN example)) (PP (IN of) (NP (NP (JJ electrolyte) (NN imbalance)) (VP (VBG causing) (NP (ADJP (JJ acute) (JJ life-threatening)) (NNS Doc_20859899_739_753_Disease))))))) (. .)))
20859899	5	(ROOT (S (NP (NNS Clinicians)) (VP (MD should) (VP (VB be) (ADJP (JJ alert)) (PP (PP (TO to) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NNS Doc_20859899_804_816_Disease))))) (, ,) (RB especially) (PP (IN in) (NP (NP (JJ elderly) (NNS patients)) (VP (VBG using) (NP (NP (NNP ACE/ARB)) (PP (IN in) (NP (NN combination)))) (PP (IN with) (NP (NP (NNS Doc_20859899_883_892_Chemical)) (VP (VBG sparing) (NP (NP (NNS agents)) (CC and) (SBAR (WHNP (WP who)) (S (VP (VBP have) (NP (JJ mild) (NNS Doc_20859899_926_943_Disease))))))))))))))) (. .)))
20927253	0	(ROOT (S (VP (VB Diffuse) (NP (NNS Doc_20927253_8_21_Disease)) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_20927253_46_57_Chemical)))))) (. .)))
20927253	1	(ROOT (S (S (NP (NNP Doc_20927253_71_83_Disease)) (VP (VBZ is) (VP (VBN caused) (PP (IN by) (NP (NN bone) (NN resorption))) (PP (IN in) (NP (NP (NN excess)) (PP (IN of) (NP (NN bone) (NN formation)))))))) (, ,) (CC and) (S (NP (NNP Doc_20927253_146_161_Chemical) (, ,)) (VP (VBP are) (VP (VBN used) (S (VP (TO to) (VP (VB inhibit) (NP (NN bone) (NN resorption)))))))) (. .)))
20927253	2	(ROOT (S (NP (NP (NNP Doc_20927253_200_211_Chemical)) (, ,) (NP (DT a) (NNS Doc_20927253_215_228_Chemical)) (, ,)) (VP (VBZ is) (ADJP (JJ effective) (PP (IN for) (NP (NP (CC both) (DT the) (NN treatment) (CC and) (NN prevention)) (PP (IN of) (NP (NP (NNS Doc_20927253_284_296_Disease)) (PP (IN in) (NP (JJ postmenopausal) (NNS women))))))))) (. .)))
20927253	3	(ROOT (S (NP (NN Side) (NNS effects)) (VP (VBP are) (ADJP (ADJP (RB relatively) (JJ few)) (CC and) (ADJP (ADVP (RB prominently)) (JJ gastrointestinal)))) (. .)))
20927253	4	(ROOT (S (NP (NNP Doc_20927253_388_408_Disease)) (VP (MD may) (VP (VB be) (NP (NP (DT an) (JJ important) (NN side) (NN effect)) (PP (IN in) (NP (DT these) (NNS patients)))))) (. .)))
20927253	5	(ROOT (S (NP (PRP We)) (VP (VBD presented) (SBAR (S (NP (DT a) (NN patient)) (VP (VBD admitted) (PP (TO to) (NP (NP (PRP$ our) (JJ out-patient) (NN clinic)) (PP (IN with) (NP (JJ diffuse) (NNS Doc_20927253_531_544_Disease))))) (PP (IN after) (NP (NP (CD three) (JJ consecutive) (NN administration)) (PP (IN of) (NP (NNS Doc_20927253_587_598_Chemical))))))))) (. .)))
20927253	6	(ROOT (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_20927253_643_655_Disease)))) (VP (MD can) (VP (VB report) (NP (NNS Doc_20927253_667_671_Disease)))))))) (, ,) (CC and) (S (NP (NN Doc_20927253_677_691_Chemical-related) (NNS Doc_20927253_700_704_Disease)) (VP (MD should) (ADVP (RB also)) (VP (VB be) (VP (VBN considered) (PP (IN before) (S (VP (VBG ascribing) (NP (DT this) (NN complaint)) (PP (TO to) (NP (NNS Doc_20927253_766_778_Disease)))))))))) (. .)))
20959502	0	(ROOT (NP (NP (JJ Cerebrospinal) (JJ fluid) (NN penetration)) (PP (IN of) (NP (NP (JJ high-dose) (NNS Doc_20959502_45_55_Chemical)) (PP (IN in) (NP (VBN suspected) (NNP Staphylococcus) (NN aureus) (NNS Doc_20959502_91_101_Disease))))) (. .)))
20959502	1	(ROOT (S (S (VP (TO To) (VP (VB report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NN Doc_20959502_134_145_Chemical-sensitive) (NNS Doc_20959502_156_195_Disease)))) (PP (IN with) (NP (VBN suspected) (NNP MSSA) (NNS Doc_20959502_216_226_Disease)))))) (VP (VBN treated) (PP (IN with) (NP (NP (JJ high-dose) (NNS Doc_20959502_250_260_Chemical)) (VP (VBN assessed) (PP (IN with) (NP (NP (JJ concurrent) (NN serum)) (CC and) (NP (JJ cerebrospinal) (NN fluid) (PRN (-LRB- -LRB-) (NP (NNP CSF)) (-RRB- -RRB-)) (NNS concentrations)))))))) (. .)))
20959502	2	(ROOT (NP (NP (NNP CASE) (NNP SUMMARY)) (: :) (NP (NP (DT A) (JJ 54-year-old) (NN male)) (VP (VBN presented) (PP (TO to) (NP (NP (NP (DT the) (NN emergency) (NN department)) (PP (IN with) (NP (JJ generalized) (NN weakness)))) (CC and) (NP (NP (VBN presumed) (JJ health-care-associated) (NNS Doc_20959502_471_480_Disease)) (VP (VBN shown) (PP (IN on) (NP (NN chest) (NN radiograph))))))))) (. .)))
20959502	3	(ROOT (S (NP (NNP Treatment)) (VP (VBD was) (ADVP (RB empirically)) (VP (VBN initiated) (PP (IN with) (NP (NP (NNS Doc_20959502_549_559_Chemical)) (, ,) (NP (NNS Doc_20959502_561_573_Chemical)) (, ,) (CC and) (NP (JJ Doc_20959502_579_591_Chemical) (JJ /) (NNS Doc_20959502_592_602_Chemical)))))) (. .)))
20959502	4	(ROOT (S (NP (NNP Blood) (NNS cultures)) (VP (VBD revealed) (S (NP (NNP S.) (NNP aureus)) (ADJP (JJ susceptible) (PP (TO to) (NP (NNS Doc_20959502_653_662_Chemical)))))) (. .)))
20959502	5	(ROOT (S (NP (JJ Empiric) (JJ antibiotic) (NN treatment)) (VP (VBD was) (VP (VBN narrowed) (S (VP (TO to) (VP (VB nafcillin) (PP (IN on) (NP (NN day) (CD 4)))))))) (. .)))
20959502	6	(ROOT (S (PP (IN On) (NP (NN day) (CD 8))) (, ,) (NP (DT the) (NN patient)) (VP (VBD developed) (NP (NP (NNS Doc_20959502_761_780_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NN serum) (NNS Doc_20959502_788_798_Chemical)) (NP (CD 1.9) (NN mg/dL))) (, ,) (VP (VBN increased) (PP (IN from) (NP (NP (CD 1.2) (NN mg/dL)) (NP (DT the) (JJ previous) (NN day)))))) (CC and) (NP (NP (CD 0.8) (NN mg/dL)) (PP (IN on) (NP (NN admission))))) (-RRB- -RRB-)))) (. .)))
20959502	7	(ROOT (S (NP (NP (DT The) (NN patient) (POS 's)) (NNP Glasgow) (NNP Doc_20959502_903_907_Disease) (NN Score)) (VP (VBD was) (NP (CD 3)) (, ,) (PP (IN with) (NP (NP (JJ normal) (NNS findings)) (VP (VBN shown) (PP (IN on) (NP (NP (JJ computed) (NN tomography) (NNS scan)) (PP (IN of) (NP (DT the) (NN head))) (NP (CD 72) (NNS hours)))) (PP (VBG following) (NP (NP (DT an) (NN episode)) (PP (IN of) (NP (NP (NNS Doc_20959502_1021_1035_Disease)) (PP (IN on) (NP (NN day) (CD 10))))))))))) (. .)))
20959502	8	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD experienced) (S (VP (VBG relapsing) (NP (NP (NNP MSSA) (NNP Doc_20959502_1086_1096_Disease)) (PP (IN on) (NP (NN day) (CD 9)))))) (, ,) (S (VP (VBG increasing) (NP (NP (DT the) (NN suspicion)) (PP (IN for) (NP (DT a) (ADJP (JJ central) (JJ nervous)) (NN system) (PRN (-LRB- -LRB-) (NP (NNP CNS)) (-RRB- -RRB-)) (NN Doc_20959502_1167_1176_Disease))))))) (. .)))
20959502	9	(ROOT (S (S (NP (NNP Doc_20959502_1178_1187_Chemical)) (VP (VBD was) (VP (VBN discontinued)))) (CC and) (S (NP (JJ Doc_20959502_1209_1219_Chemical) (CD 9) (NN mg/kg)) (ADVP (RB daily)) (VP (VP (VBD was) (VP (VBN initiated) (PP (IN for) (NP (VBN suspected) (NNS Doc_20959502_1262_1272_Disease))))) (CC and) (VP (VBD was) (VP (VBN continued) (PP (IN until) (NP (NP (DT the) (NN patient) (POS 's)) (NNS Doc_20959502_1311_1316_Disease))) (PP (IN on) (NP (NN day) (CD 16))))))) (. .)))
20959502	10	(ROOT (S (NP (JJ Doc_20959502_1328_1338_Chemical) (NN serum) (CC and) (NN CSF) (NN trough) (NNS concentrations)) (VP (VBD were) (NP (NP (CD 11.21) (NN ug/mL)) (CC and) (NP (NP (CD 0.52) (NN ug/mL)) (, ,) (ADVP (RB respectively)))) (, ,) (ADVP (RB prior) (PP (TO to) (NP (DT the) (JJ third) (NN dose))))) (. .)))
20959502	11	(ROOT (S (S (NP (JJ Lumbar) (NN puncture) (NNS results)) (VP (VBD were) (ADJP (JJ inconclusive)))) (CC and) (S (NP (DT no) (JJ further) (NN blood) (NNS cultures)) (VP (VBD were) (ADJP (JJ positive) (PP (IN for) (NP (NNP MSSA)))))) (. .)))
20959502	12	(ROOT (S (NP (JJ Doc_20959502_1543_1551_Chemical) (NN kinase) (NNS levels)) (VP (VP (VBD were) (ADJP (JJ normal)) (PP (RB prior) (PP (TO to) (NP (JJ Doc_20959502_1587_1597_Chemical) (NN therapy))))) (CC and) (VP (VBD were) (RB not) (VP (VBN reassessed)))) (. .)))
20959502	13	(ROOT (S (NP (NNP Doc_20959502_1643_1653_Chemical)) (VP (VBD was) (VP (VBN initiated) (PP (IN in) (NP (PRP$ our) (JJ patient) (JJ secondary))) (PP (TO to) (NP (NP (JJ possible) (ADJP (JJ Doc_20959502_1705_1714_Chemical-induced) (JJ acute)) (NNS Doc_20959502_1729_1751_Disease)) (CC and) (NP (VBG relapsing) (NNS Doc_20959502_1766_1776_Disease)))))) (. .)))
20959502	14	(ROOT (S (PP (IN At) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 9) (NN mg/kg))))) (, ,) (NP (NP (JJ resultant) (NN penetration)) (PP (IN of) (NP (CD 5) (NN %)))) (VP (VBD was) (ADJP (ADJP (JJR higher) (PP (IN than) (PP (IN in) (NP (JJ previous) (NNS reports))))) (, ,) (ADJP (RBR more) (JJ consistent))) (PP (IN with) (NP (JJ inflamed) (NNS meninges)))) (. .)))
20959502	15	(ROOT (S (NP (JJ High-dose) (NNS Doc_20959502_1928_1938_Chemical)) (VP (VP (MD may) (VP (VB be) (NP (NP (DT an) (JJ alternative) (NN option)) (PP (IN for) (NP (NP (NNP MSSA) (NNP Doc_20959502_1977_1987_Disease)) (PP (IN with) (CC or) (IN without) (NP (DT a) (NNP CNS) (NN source))))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN failed)))))))))) (CC or) (VP (MD can) (RB not) (VP (VB tolerate) (NP (JJ standard) (NN therapy))))) (. .)))
20959502	16	(ROOT (S (NP (NP (JJ Further) (JJ clinical) (NN evaluation)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ confirmed) (NNS Doc_20959502_2137_2147_Disease)))))) (VP (VBZ is) (VP (VBN warranted))) (. .)))
21195121	0	(ROOT (S (NP (NP (DT The) (NN role)) (PP (IN of) (NP (NP (NNS Doc_21195121_12_24_Chemical)) (PP (IN in) (NP (NNS Doc_21195121_28_39_Disease)))))) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_21195121_51_58_Chemical)) (PP (IN in) (NP (NNS rats)))))) (. .)))
21195121	1	(ROOT (S (NP (NNP Doc_21195121_68_75_Chemical)) (VP (VBZ is) (NP (NP (DT an) (JJ Doc_21195121_82_96_Chemical) (NN pesticide)) (CC and) (NP (NN scabicide)))) (. .)))
21195121	2	(ROOT (S (NP (PRP It)) (VP (VBZ evokes) (SBAR (S (NP (NNS Doc_21195121_132_143_Disease)) (ADVP (RB mainly)) (VP (VBZ trough) (NP (NP (DT the) (NN blockage)) (PP (IN of) (NP (JJ Doc_21195121_174_178_Chemical) (PRN (-LRB- -LRB-) (NP (NNP A)) (-RRB- -RRB-)) (NNS receptors)))))))) (. .)))
21195121	3	(ROOT (S (S (NP (NP (NP (NNP Doc_21195121_193_205_Chemical)) (PRN (-LRB- -LRB-) (INTJ (RB NO)) (-RRB- -RRB-))) (, ,) (NP (JJ gaseous) (NN neurotransmitter)) (, ,)) (VP (VBZ has) (NP (NP (NN contradictor) (NN role)) (PP (IN in) (NP (NP (NP (NNS epileptogenesis)) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ opposite) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_21195121_306_316_Chemical)) (, ,) (NP (NP (NN precursor)) (PP (IN of) (NP (DT NO) (NNS syntheses)))))))))) (PRN (-LRB- -LRB-) (NP (NNP NOS)) (-RRB- -RRB-))))))) (, ,) (CC and) (S (NP (NP (NNS Doc_21195121_355_361_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP NOS) (NN inhibitor)) (-RRB- -RRB-))) (VP (VBD observed) (PP (IN in) (NP (JJ different) (JJ Doc_21195121_400_408_Disease) (NNS models))))) (. .)))
21195121	4	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (JJ current) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (INTJ (RB NO))))) (PP (IN on) (NP (NP (DT the) (JJ behavioral) (CC and) (NNP EEG) (NNS characteristics)) (PP (IN of) (NP (NN Doc_21195121_526_533_Chemical-induced) (NNS Doc_21195121_542_550_Disease))))) (PP (IN in) (NP (JJ male) (NNP Wistar) (NN albino) (NNS rats))))))) (. .)))
21195121	5	(ROOT (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_21195121_601_611_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 600)) (, ,) (NP (CD 800)) (CC and) (NP (NP (CD 1000) (NN mg/kg)) (, ,) (NP (NN i.p.)))) (-RRB- -RRB-))) (PP (IN in) (NP (JJ dose-dependent) (NN manner)))))) (VP (VP (ADVP (RB significantly)) (VBD increased) (NP (JJ Doc_21195121_693_703_Disease) (NN incidence) (CC and) (NN severity))) (CC and) (VP (VBN shortened) (NP (JJ latency) (NN time)) (PP (TO to) (NP (NP (JJ first) (NNS Doc_21195121_763_773_Disease)) (VP (VBN elicited) (PP (IN by) (NP (NP (JJR lower) (JJ Doc_21195121_792_799_Chemical) (NN dose)) (PRN (-LRB- -LRB-) (NP (CD 4) (NN mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-))))))))) (. .)))
21195121	6	(ROOT (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NP (NNS Doc_21195121_857_863_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 500)) (, ,) (NP (CD 700)) (CC and) (NP (NP (CD 900) (NN mg/kg)) (, ,) (NP (NN i.p.)))) (-RRB- -RRB-))))) (VP (VBD decreased) (NP (NP (JJ Doc_21195121_905_915_Disease) (NN incidence)) (CC and) (NP (NN severity) (CC and) (JJ prolonged) (NN latency) (NN time))) (PP (TO to) (NP (NP (NNS Doc_21195121_969_979_Disease)) (PP (VBG following) (NP (NP (NN injection)) (PP (IN with) (NP (NP (DT a) (JJ Doc_21195121_1007_1017_Disease) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_21195121_1026_1033_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 8) (NN mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-))))))))))) (. .)))
21195121	7	(ROOT (S (NP (NNP EEG) (NNS analyses)) (VP (VBD showed) (NP (NP (NN increase)) (PP (IN of) (NP (NN number) (CC and) (NN duration))) (PP (IN of) (NP (JJ ictal) (NNS periods)))) (PP (IN in) (NP (NP (NNP EEG)) (PP (IN of) (NP (NP (NNS rats)) (VP (VBG receiving) (NP (NP (NNS Doc_21195121_1145_1155_Chemical)) (ADVP (RB prior) (PP (TO to) (NP (NNS Doc_21195121_1165_1172_Chemical) (CC and) (NN decrease)))) (PP (IN of) (NP (DT this) (NN number)))) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN pretreated) (PP (IN with) (NP (NNS Doc_21195121_1225_1231_Chemical)))))))))))) (. .)))
21195121	8	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP support) (NP (DT the) (NN conclusion)) (SBAR (IN that) (S (NP (NNP NO)) (VP (VBZ plays) (NP (NP (DT a) (NN role)) (PP (IN of) (NP (JJ endogenous) (NN convulsant)))) (PP (IN in) (NP (NP (NN rat) (NN model)) (PP (IN of) (NP (JJ Doc_21195121_1332_1339_Chemical) (NNS Doc_21195121_1340_1348_Disease))))))))) (. .)))
2131034	0	(ROOT (NP (NP (NP (JJ Severe) (NNS Doc_2131034_7_21_Disease) (CC and) (NN motor) (NN loss)) (PP (IN after) (NP (JJ intrathecal) (NN thiotepa) (NN combination) (NN chemotherapy)))) (: :) (NP (NP (NN description)) (PP (IN of) (NP (CD two) (NNS cases)))) (. .)))
2131034	1	(ROOT (S (NP (NP (CD Two) (NNS cases)) (PP (IN of) (NP (NP (JJ severe) (JJ delayed) (NNS Doc_2131034_144_163_Disease)) (VP (VBN related) (PP (TO to) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (JJ intrathecal) (PRN (-LRB- -LRB-) (NP (PRP IT)) (-RRB- -RRB-)) (NN combination)) (ADVP (RB chemotherapy)))))) (PP (VBG including) (NP (NP (NNS Doc_2131034_249_257_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP TSPA)) (-RRB- -RRB-)))))))) (VP (VBP are) (VP (VBN presented))) (. .)))
2131034	2	(ROOT (S (NP (DT Both) (NNS cases)) (VP (VBD developed) (NP (NNS Doc_2131034_301_318_Disease)) (PP (IN with) (NP (NP (NN motor) (NN predominance)) (PP (IN in) (NP (DT the) (JJR lower) (NNS extremities))))) (SBAR (NP (QP (CD 1) (CC and) (CD 6)) (NNS months)) (IN after) (S (NP (PRP IT)) (ADVP (RB chemotherapy)) (VP (VBD was) (VP (VBN administered)))))) (. .)))
2131034	3	(ROOT (S (NP (NNP Doc_2131034_423_444_Disease)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN with) (NP (NNS Doc_2131034_470_485_Chemical) (, ,) (NNS Doc_2131034_487_510_Chemical) (CC and) (NNS Doc_2131034_515_522_Chemical)))))) (. .)))
2131034	4	(ROOT (S (PP (TO To) (NP (PRP$ our) (NN knowledge))) (, ,) (ADVP (RB however)) (, ,) (NP (NP (NNS Doc_2131034_551_568_Disease)) (PP (VBG following) (NP (NP (NN administration)) (PP (IN of) (NP (DT these) (CD three) (NNS agents)))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (ADVP (RB previously)) (VBN described)))) (. .)))
2131034	5	(ROOT (S (PP (IN In) (NP (NP (NN spite)) (PP (IN of) (NP (NP (DT the) (NN fact)) (SBAR (IN that) (S (NP (NNS Doc_2131034_677_681_Chemical)) (VP (VBZ is) (NP (DT a) (JJ useful) (NNP IT) (NN agent))))))))) (, ,) (NP (NP (PRP$ its) (NN combination)) (PP (IN with) (NP (NNS Doc_2131034_725_728_Chemical) (, ,) (NNS Doc_2131034_730_735_Chemical) (CC and) (NN radiotherapy)))) (VP (MD could) (VP (VB cause) (NP (JJ severe) (NNS Doc_2131034_772_785_Disease)))) (. .)))
2131034	6	(ROOT (S (NP (DT This) (JJ unexpected) (NN complication)) (VP (VBZ indicates) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NP (JJ further) (NN toxicology) (NN research)) (PP (IN on) (NP (NNP IT-TSPA))))))) (. .)))
2173761	0	(ROOT (NP (NP (NNPS Effects)) (PP (IN of) (NP (NN cromakalim) (CC and) (NNS Doc_2173761_26_35_Chemical))) (PP (IN on) (NP (NP (JJ large) (ADJP (JJ epicardial) (CC and) (JJ small)) (JJ coronary) (NNS arteries)) (PP (IN in) (NP (JJ conscious) (NNS dogs))))) (. .)))
2173761	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NN i.v.) (NNS bolus)) (PP (PP (NP (NP (NN administration)) (PP (IN of) (NP (NP (NN cromakalim)) (PRN (-LRB- -LRB-) (NP (CD 1-10) (NN micrograms/kg)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_2173761_183_192_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 3-100) (NN micrograms/kg)) (-RRB- -RRB-))))) (IN on) (NP (ADJP (ADJP (ADJP (JJ large)) (PRN (-LRB- -LRB-) (NP (NN circumflex) (NN artery)) (-RRB- -RRB-))) (CC and) (ADJP (JJ small))) (JJ coronary) (NNS arteries))) (CC and) (PP (IN on) (NP (JJ systemic) (NNS hemodynamics))))))) (VP (VBD were) (VP (VBN investigated) (PP (PP (IN in) (NP (ADJP (RB chronically) (JJ instrumented)) (JJ conscious) (NNS dogs))) (CC and) (PP (VBN compared) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (NP (NNS Doc_2173761_387_400_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.03-10) (NN micrograms/kg)) (-RRB- -RRB-)))))))))) (. .)))
2173761	2	(ROOT (S (NP (NP (NNP Doc_2173761_426_439_Chemical)) (, ,) (VP (ADVP (RB up) (PP (TO to) (NP (CD 0.3)))) (VBG micrograms/kg)) (, ,)) (ADVP (RB selectively)) (VP (VBD increased) (NP (NP (NN circumflex) (NN artery) (NN diameter)) (PRN (-LRB- -LRB-) (NP (NNP CxAD)) (-RRB- -RRB-))) (PP (IN without) (S (ADVP (RB simultaneously)) (VP (VBG affecting) (NP (DT any) (JJ other) (NNS Doc_2173761_565_606_Disease)))))) (. .)))
2173761	3	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN cromakalim)) (CC and) (NP (NP (NNS Doc_2173761_636_645_Chemical)) (PP (IN at) (NP (NP (DT all) (NNS doses) (CC and) (NNS Doc_2173761_663_676_Chemical)) (PP (IN at) (NP (NNS doses))))) (UCP (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (NP (CD 0.3)) (VP (VBG micrograms/kg) (ADVP (RB simultaneously)))))) (CC and) (ADVP (RB dose-dependently))))) (VP (VBD increased) (NP (NP (NNP CxAD)) (, ,) (NP (JJ coronary) (NX (NX (NN blood) (NN flow)) (CC and) (NX (NN heart) (NN rate)))) (CC and) (NP (VBN decreased) (JJ coronary) (NN vascular) (NN resistance)) (CC and) (NP (JJ aortic) (NN pressure)))) (. .)))
2173761	4	(ROOT (S (NP (NNP Cromakalim)) (VP (VBD was) (ADVP (ADVP (RB approximately) (NP (CD 8))) (: -) (PP (TO to) (ADJP (JJ 9.5-fold)))) (ADJP (RBR more) (JJ potent)) (PP (IN than) (NP (NP (NNS Doc_2173761_928_937_Chemical)) (PP (IN in) (NP (VBG increasing) (NNP CxAD)))))) (. .)))
2173761	5	(ROOT (S (S (NP (NP (NNP Vasodilation)) (PP (IN of) (NP (NP (ADJP (JJ large) (CC and) (JJ small)) (JJ coronary) (NNS vessels)) (CC and) (NP (NP (NNS Doc_2173761_1011_1022_Disease)) (VP (VBN induced) (PP (IN by) (NP (NN cromakalim) (CC and) (NNS Doc_2173761_1049_1058_Chemical)))))))) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (JJ prior) (VBN combined) (JJ beta) (NN adrenergic)) (CC and) (NP (JJ muscarinic) (NNS receptors) (NN blockade))))))) (CC but) (S (NP (JJ drug-induced) (NNS Doc_2173761_1162_1173_Disease)) (VP (VBD was) (VP (VBN abolished)))) (. .)))
2173761	6	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (JJ circumflex) (NN artery) (NN blood) (NN flow)) (VP (VBD was) (VP (VBN maintained) (S (ADJP (JJ constant))))))) (, ,) (NP (NP (DT the) (NNS increases)) (PP (IN in) (NP (NP (NNP CxAD)) (VP (VBN induced) (PP (IN by) (NP (NP (NP (NNS Doc_2173761_1281_1291_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN micrograms/kg)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_2173761_1312_1321_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN micrograms/kg)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_2173761_1345_1358_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN micrograms/kg)) (-RRB- -RRB-))))))))) (VP (VBD were) (VP (VBN reduced) (PP (IN by) (NP (NP (NP (NP (CD 68) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 7)) (, ,) (NP (CD 54) (NNS +))) (: /))) (PRN (: -) (NP (NP (CD 9)) (CC and) (NP (CD 1) (NNS +))) (: /))) (: -) (ADJP (CD 1) (NN %)))) (, ,) (ADVP (RB respectively)))) (. .)))
2173761	7	(ROOT (S (ADVP (RB Thus)) (PRN (, ,) (SBAR (IN whereas) (S (NP (NP (NNS Doc_2173761_1455_1468_Chemical)) (ADJP (JJ preferentially) (CC and) (JJ flow-independently))) (VP (VBZ dilates) (NP (JJ large) (JJ coronary) (NNS arteries))))) (, ,)) (NP (NP (NN cromakalim)) (CC and) (NP (JJ Doc_2173761_1555_1571_Chemical) (ADJP (DT both) (JJ large) (CC and) (JJ small)) (JJ coronary) (NNS arteries)) (CC and) (NP (DT this) (NN effect))) (VP (VBZ is) (RB not) (ADJP (JJ dependent) (PP (IN upon) (NP (NP (DT the) (JJ simultaneous) (JJ beta) (JJ adrenoceptors-mediated) (NN rise)) (PP (IN in) (NP (JJ myocardial) (JJ metabolic) (NN demand))))))) (. .)))
2173761	8	(ROOT (S (ADVP (RB Finally)) (, ,) (NP (NP (NP (CD two) (NNS mechanisms)) (ADVP (IN at) (JJS least))) (, ,) (NP (JJ direct) (NN vasodilation) (CC and) (NN flow) (NNS dependency)) (, ,)) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (ADJP (JJ cromakalim) (: -) (CC and) (JJ Doc_2173761_1842_1851_Chemical-induced)) (NN increase)) (PP (IN in) (NP (NNP CxAD))))))) (. .)))
2217015	0	(ROOT (NP (NP (JJ Doc_2217015_0_14_Chemical-induced) (NNS Doc_2217015_23_34_Disease) (CC and) (NNS Doc_2217015_39_52_Disease)) (PP (IN in) (NP (JJ elderly) (NNS females))) (PP (IN with) (NP (NNS Doc_2217015_77_91_Disease))) (. .)))
2217015	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (ADJP (JJ Doc_2217015_103_117_Chemical-induced) (JJ non-oliguric)) (NNS Doc_2217015_139_152_Disease)) (CC and) (NP (NP (JJ severe) (NNS Doc_2217015_164_175_Disease)) (VP (VBG occurring) (ADVP (RB simultaneously)) (PP (IN in) (NP (CD two) (JJ elderly) (NNS females))))))) (. .)))
2217015	2	(ROOT (S (NP (DT The) (NNS Doc_2217015_229_240_Disease)) (VP (VBD was) (ADJP (JJ due) (S (VP (TO to) (VP (VB maturation) (NP (NP (NN arrest)) (PP (IN of) (NP (NP (DT the) (JJ myeloid) (NN series)) (PP (IN in) (NP (CD one) (NN patient))))))))))) (. .)))
2217015	3	(ROOT (S (S (NP (DT Both) (NNS patients)) (VP (VBD were) (NP (NNS Doc_2217015_327_343_Disease)))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ is) (RB not) (ADJP (JJ clear)) (SBAR (IN whether) (S (NP (DT this)) (VP (VBD was) (NP (NP (DT a) (VBG predisposing) (NN factor)) (PP (TO to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT these) (JJ adverse) (NNS reactions))))))))))) (. .)))
2217015	4	(ROOT (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (MD would) (VP (VB seem) (ADJP (JJ prudent) (S (RB not) (VP (TO to) (VP (VB use) (NP (NNS Doc_2217015_493_507_Chemical)) (PP (IN in) (NP (JJ Doc_2217015_511_522_Disease) (NNS patients))))))) (SBAR (IN until) (S (NP (DT the) (NNS Doc_2217015_542_556_Disease)) (VP (VBZ has) (VP (VBN been) (VP (VBN corrected)))))))) (. .)))
2239937	0	(ROOT (NP (NP (NNP Etiology)) (PP (IN of) (NP (NP (NNS Doc_2239937_12_25_Disease)) (PP (IN in) (NP (JJ hemodialysis) (NNS patients))))) (PP (IN on) (NP (JJ Doc_2239937_54_71_Chemical) (NN therapy))) (. .)))
2239937	1	(ROOT (S (NP (NP (NP (CD Fourteen)) (PP (IN of) (NP (CD 39) (NN dialysis) (NNS patients)))) (PRN (-LRB- -LRB-) (NP (CD 36) (NN %)) (-RRB- -RRB-))) (VP (VBD became) (ADJP (JJ hypercalcemic) (PP (IN after) (S (VP (VBG switching) (PP (TO to) (NP (NP (NNS Doc_2239937_160_177_Chemical)) (PP (IN as) (NP (PRP$ their) (JJ principal) (JJ Doc_2239937_197_206_Chemical) (NN binder)))))))))) (. .)))
2239937	2	(ROOT (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB identify) (NP (NP (NN risk) (NNS factors)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_2239937_284_297_Disease))))))))))) (, ,) (NP (NP (JJ indirect) (NNS parameters)) (PP (IN of) (NP (NP (JJ intestinal) (NN Doc_2239937_333_340_Chemical) (NN reabsorption) (CC and) (NN bone) (NN turnover) (NN rate)) (PP (IN in) (NP (DT these) (CD 14) (NNS patients)))))) (VP (VBD were) (VP (VBN compared) (PP (IN with) (NP (NP (NNS results)) (PP (IN in) (NP (NP (CD 14) (JJ eucalcemic) (NNS patients)) (VP (VBN matched) (PP (IN for) (NP (NP (NP (NN age)) (, ,) (NP (NN sex))) (, ,) (NP (NP (NN length)) (PP (IN of) (NP (NP (NN time)) (PP (IN on) (NP (NN dialysis)))))) (, ,) (CC and) (NP (NP (NN etiology)) (PP (IN of) (NP (NNS Doc_2239937_517_530_Disease))))))))))))) (. .)))
2239937	3	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (S (VP (VBG experiencing) (NP (JJ hypercalcemic) (NNS episodes)) (PP (IN with) (NP (NP (JJ peak) (JJ Doc_2239937_593_600_Chemical) (NNS values)) (PP (IN of) (NP (NP (QP (CD 2.7) (TO to) (CD 3.8)) (NN mmol/L)) (PRN (-LRB- -LRB-) (NP (QP (CD 10.7) (TO to) (CD 15.0)) (NNS mg/dL)) (-RRB- -RRB-))))))))))) (, ,) (NP (NP (NNS patients)) (PP (IN in) (NP (DT the) (JJ hypercalcemic) (NN group)))) (VP (VBD exhibited) (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ mean) (JJ Doc_2239937_732_739_Chemical) (NN concentration)) (VP (VBN obtained) (PP (IN during) (NP (CD 6) (NNS months))) (PP (IN before) (NP (DT the) (NN switch)))))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (DT the) (JJ mean) (NN value)) (VP (VBN obtained) (PP (IN during) (NP (NP (DT the) (CD 7) (NNS months)) (PP (IN of) (NP (NN observation))))) (PP (IN after) (NP (NP (DT the) (NN switch)) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 2.4)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (JJ 0.03) (PP (TO to) (NP (QP (CD 2.5) (CD +))))) (: /)) (: -) (FRAG (NP (NP (CD 0.03) (JJ mmol/L) (NNS -LSB-)) (NP (CD 9.7) (JJ +) (NNS /))) (: -) (NP (NP (NP (QP (CD 0.2) (TO to) (CD 10.2))) (NP (NNP +) (NNP /))) (: -) (NP (NP (CD 0.1) (JJ mg/dL) (NNS -RSB-)) (, ,) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.006))))))))))) (-RRB- -RRB-))))))))) (. .)))
2239937	4	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (JJ eucalcemic) (NNS patients)) (VP (VBD exhibited) (NP (DT no) (NN change)) (PP (IN in) (NP (NP (JJ mean) (JJ Doc_2239937_1035_1042_Chemical) (NNS values)) (PP (IN over) (NP (DT the) (JJ same) (NN time) (NN period))))) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 2.3)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADVP (ADVP (CD 0.05)) (PP (TO to) (NP (QP (CD 2.3) (CD +))))) (: /)) (: -) (FRAG (NP (CD 0.05) (NN mmol/L)) (NP (NP (NNP -LSB-) (NNP 9.2) (NNP +) (NNP /)) (: -) (NP (NP (QP (CD 0.2) (TO to) (CD 9.2))) (NP (NNP +) (NNP /))) (: -) (NP (CD 0.2) (JJ mg/dL) (NNS -RSB-)))))) (-RRB- -RRB-))) (. .)))
2239937	5	(ROOT (S (NP (NP (JJ Doc_2239937_1150_1155_Chemical) (NN dosage)) (, ,) (VP (VBN calculated) (ADVP (RB dietary)) (UCP (NP (JJ Doc_2239937_1183_1190_Chemical) (NN intake)) (, ,) (CC and) (VP (VBG circulating) (NP (NP (NNS levels)) (PP (IN of) (NP (JJ Doc_2239937_1225_1234_Chemical) (NNS metabolites)))))))) (VP (VBD were) (ADJP (JJ similar) (PP (IN in) (NP (DT both) (NNS groups))))) (. .)))
2239937	6	(ROOT (S (NP (NP (JJ Physical) (NN activity) (NN index)) (CC and) (NP (JJ predialysis) (JJ serum) (JJ Doc_2239937_1322_1333_Chemical) (NNS levels))) (ADVP (RB also)) (VP (VBD were) (ADJP (JJ similar) (PP (IN in) (NP (DT both) (NNS groups))))) (. .)))
2239937	7	(ROOT (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN difference)) (PP (IN in) (FRAG (NP (NP (NNS parameters)) (SBAR (S (VP (VBG reflecting) (NP (NP (NN bone) (NN turnover) (NNS rates)) (PP (IN between) (NP (NNS groups))))))) (. .)))) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-))))))
22836123	0	(ROOT (S (S (NP (JJ Late-onset) (NNS Doc_22836123_11_35_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_22836123_47_57_Chemical) (CC and) (NNS Doc_22836123_62_74_Chemical))))) (: :) (S (NP (DT a) (NN case)) (VP (VBP report))) (. .)))
22836123	1	(ROOT (S (NP (NP (NNP Doc_22836123_91_115_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_22836123_117_120_Disease)) (-RRB- -RRB-))) (VP (VP (VBZ is) (NP (NP (DT a) (JJ rare) (NN complication)) (PP (IN of) (NP (NP (NNS Doc_22836123_148_166_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_22836123_168_171_Disease)) (-RRB- -RRB-)))))) (CC but) (VP (MD can) (VP (VB be) (ADJP (JJ severe) (RB enough) (S (VP (TO to) (VP (VB require) (NP (ADJP (JJ temporary) (CC or) (JJ permanent)) (JJ renal) (NN replacement) (NN therapy))))))))) (. .)))
22836123	2	(ROOT (S (NP (ADJP (JJ Moderate) (PP (TO to) (NP (JJ high) (NN dose) (NNS Doc_22836123_281_295_Chemical)))) (NN use)) (VP (VBZ is) (VP (VBN recognized) (PP (IN as) (NP (NP (DT a) (JJ major) (NN risk) (NN factor)) (PP (IN for) (NP (NNS Doc_22836123_341_344_Disease))))))) (. .)))
22836123	3	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (JJ Doc_22836123_386_412_Disease) (NNS precipitated)))) (PP (IN by) (NP (NP (NNS Doc_22836123_429_441_Chemical)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_22836123_459_462_Disease))))))))) (. .)))
22836123	4	(ROOT (S (PP (IN In) (NP (DT this) (NN article))) (, ,) (NP (PRP we)) (VP (VBP report) (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_22836123_506_509_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_22836123_521_531_Chemical) (CC and) (NNS Doc_22836123_536_551_Chemical))))))) (. .)))
22836123	5	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN work)))) (VP (VBZ is) (S (VP (TO to) (VP (VB call) (NP (NN attention)) (PP (TO to) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ Doc_22836123_610_620_Chemical) (NN use))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_22836123_642_645_Disease))))))))) (. .)))
2320485	0	(ROOT (NP (NP (JJ Doc_2320485_0_10_Chemical-induced) (NNS Doc_2320485_19_35_Disease)) (PP (IN in) (NP (NP (DT a) (ADJP (CD 15) (NN year) (JJ old)) (NN presenting)) (ADJP (RB as) (JJ near-Doc_2320485_72_79_Disease)))) (. .)))
2320485	1	(ROOT (S (NP (NNP Doc_2320485_81_91_Chemical)) (VP (VBZ is) (NP (NP (DT an) (JJ antihypertensive) (NN medication)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ available)) (UCP (ADVP (RB generically)) (CC and) (PP (IN under) (NP (NP (DT the) (NN trade) (NN name) (NN Aldomet)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB widely)) (VP (VP (VBN prescribed) (PP (IN in) (NP (DT the) (JJ adult) (NN population)))) (CC and) (VP (ADVP (RB infrequently)) (VBN used) (PP (IN in) (NP (NNS children)))))))))))))))) (. .)))
2320485	2	(ROOT (S (NP (NNP Doc_2320485_275_285_Chemical)) (VP (VBZ causes) (NP (DT an) (NNS Doc_2320485_296_323_Disease)) (PP (IN in) (NP (NP (DT a) (JJ small) (NN percentage)) (PP (IN of) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP take) (NP (DT the) (NN drug)))))))))) (. .)))
2320485	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NN Doc_2320485_397_407_Chemical-induced) (NNS Doc_2320485_416_432_Disease)))) (PP (IN in) (NP (NP (DT a) (JJ 15-year-old) (NN boy)) (SBAR (WHNP (WP who)) (S (VP (VBD presented) (PP (TO to) (NP (DT the) (NN emergency) (NN department))) (PP (IN with) (ADJP (JJ near-Doc_2320485_506_513_Disease))))))))) (. .)))
2320485	4	(ROOT (S (NP (DT The) (NN boy)) (VP (VBD had) (VP (VBN been) (VP (VBN treated) (PP (IN with) (NP (JJ intravenous) (NNS Doc_2320485_557_567_Chemical))) (PP (IN during) (NP (DT a) (JJ Doc_2320485_577_583_Disease) (NN admission))) (PP (ADVP (NP (CD seven) (NNS weeks)) (RB prior)) (TO to) (NP (NN presentation)))))) (. .)))
2320485	5	(ROOT (S (NP (NNP Evaluation)) (VP (VBD revealed) (NP (NP (NP (DT a) (NN hemoglobin)) (PP (IN of) (NP (CD three) (NNS grams)))) (, ,) (NP (NP (QP (CD 3) (CD +)) (NP (NNP Coombs) (POS ')) (NN test)) (PP (IN with) (NP (JJ polyspecific) (JJ anti-human) (NN globulin) (CC and) (JJ monospecific) (NN IgG) (NNS reagents)))) (, ,) (CC and) (NP (NP (DT a) (JJ warm)) (VP (VBG reacting) (ADVP (RB autoantibody)))))) (. .)))
2320485	6	(ROOT (S (NP (NP (NNP Transfusion)) (CC and) (NP (JJ Doc_2320485_813_827_Chemical) (NN therapy))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ complete) (NN recovery)) (PP (IN of) (NP (DT the) (NN patient)))))) (. .)))
2320485	7	(ROOT (S (NP (NP (NN Emergency) (NNS physicians)) (VP (VBG treating) (NP (NNS children)))) (VP (MD must) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (DT this) (NN syndrome)))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB diagnose) (CC and) (VB treat) (NP (PRP it)) (ADVP (RB correctly)))))))) (. .)))
2320485	8	(ROOT (S (NP (NP (DT A) (JJ brief) (NN review)) (PP (IN of) (NP (JJ autoimmune) (CC and) (JJ drug-induced) (NNS Doc_2320485_1045_1062_Disease)))) (VP (VBZ is) (VP (VBN provided))) (. .)))
23433219	0	(ROOT (NP (NP (DT The) (NN risk) (CC and) (VBN associated) (NNS factors)) (PP (IN of) (NP (NP (JJ Doc_23433219_35_50_Chemical) (NNS Doc_23433219_51_60_Disease)) (PP (IN in) (NP (NP (NN Doc_23433219_64_79_Chemical-dependent) (NNS patients)) (PP (IN in) (NP (NNP Malaysia))))))) (. .)))
23433219	1	(ROOT (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN lifetime) (CC and) (JJ current) (NN Doc_23433219_201_216_Chemical-induced) (NNS Doc_23433219_225_234_Disease)))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ Doc_23433219_252_267_Chemical) (NN dependence))))))))) (. .)))
23433219	2	(ROOT (S (NP (NP (DT The) (NN association)) (PP (IN between) (NP (JJ psychiatric) (NN co-morbidity) (CC and) (NN Doc_23433219_333_348_Chemical-induced) (NNS Doc_23433219_357_366_Disease)))) (VP (VBD was) (VP (ADVP (RB also)) (VBN studied))) (. .)))
23433219	3	(ROOT (S (NP (DT This)) (VP (VBD was) (NP (NP (DT a) (JJ cross-sectional) (NN study)) (VP (VBN conducted) (ADVP (RB concurrently)) (PP (IN at) (NP (NP (DT a) (NN teaching) (NN hospital)) (CC and) (NP (DT a) (NN drug) (NN rehabilitation) (NN center)))) (PP (IN in) (NP (NNP Malaysia)))))) (. .)))
23433219	4	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NP (NNS Doc_23433219_550_565_Chemical)) (VP (VBN based) (PP (IN on) (NP (NNP DSM-IV))))))))) (VP (VBD were) (VP (VBN interviewed) (S (VP (VBG using) (NP (NP (NP (DT the) (NNP Mini) (NNP International) (NNP Neuropsychiatric) (NNP Interview)) (PRN (-LRB- -LRB-) (NP (NNP M.I.N.I.)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (NN Doc_23433219_670_685_Chemical-induced) (NNS Doc_23433219_694_703_Disease)) (CC and) (NP (JJ other) (NNS Doc_23433219_714_742_Disease))))))))) (. .)))
23433219	5	(ROOT (S (NP (NP (DT The) (NN information)) (PP (IN on) (NP (JJ sociodemographic) (NN background) (CC and) (NN drug) (NN use) (NN history)))) (VP (VBD was) (VP (VBN obtained) (PP (IN from) (NP (NN interview) (CC or) (JJ medical) (NNS records))))) (. .)))
23433219	6	(ROOT (S (PP (IN Of) (NP (JJ 292) (NNS subjects))) (, ,) (S (NP (NP (CD 47.9) (NN %)) (PP (IN of) (NP (DT the) (NNS subjects)))) (VP (VBD had) (NP (NP (DT a) (JJ past) (NN history)) (PP (IN of) (NP (NNS Doc_23433219_930_948_Disease)))))) (CC and) (S (NP (NP (CD 13.0) (NN %)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD were) (VP (VBG having) (NP (JJ current) (NNS Doc_23433219_995_1013_Disease))))) (. .)))
23433219	7	(ROOT (S (NP (NP (NP (NP (JJ Co-morbid) (JJ major) (NNS Doc_23433219_1031_1050_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP OR) (NNP =) (CD 7.18) (, ,) (CD 95)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 2.612-19) (CD .708))))))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_23433219_1082_1098_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP OR) (NNP =) (CD 13.807) (, ,) (CD 95)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 5.194-36) (CD .706))))))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_23433219_1132_1163_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP OR) (NNP =) (CD 12.619) (, ,) (CD 95)) (NP (NP (NNP CI)) (SBAR (S (VP (SYM =) (NP (CD 6.702-23) (CD .759))))))) (-RRB- -RRB-)))) (CC and) (NP (JJ heavy) (JJ Doc_23433219_1206_1221_Chemical) (NNS uses))) (VP (VBD were) (VP (ADVP (RB significantly)) (JJ associated) (PP (IN with) (NP (NN lifetime) (NN Doc_23433219_1271_1286_Chemical-induced) (NNS Doc_23433219_1295_1304_Disease))) (SBAR (IN after) (S (VP (VBN adjusted) (PP (IN for) (NP (JJ other) (NNS factors)))))))) (. .)))
23433219	8	(ROOT (S (NP (NP (NP (JJ Major) (NNS Doc_23433219_1345_1364_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP OR)) (SBAR (S (S (VP (SYM =) (NP (CD 2.870)))) (, ,) (VP (VBP CI) (S (VP (SYM =) (NP (CD 1.154-7) (CD .142)))))))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_23433219_1396_1427_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP OR) (NNP =) (CD 3.299) (, ,) (CD 95)) (VP (VBN CI) (S (VP (SYM =) (NP (CD 1.375-7) (CD .914)))))) (-RRB- -RRB-)))) (VP (VBD were) (NP (NP (DT the) (JJ only) (NNS factors)) (VP (VBN associated) (PP (IN with) (NP (JJ current) (NNS Doc_23433219_1504_1513_Disease)))))) (. .)))
23433219	9	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ high) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_23433219_1552_1561_Disease)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ Doc_23433219_1579_1594_Chemical) (NN dependence))))))))) (. .)))
23433219	10	(ROOT (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (JJ co-morbid) (NN affective) (NNS disorderDoc_23433219_1658_1682_Disease)))))) (, ,) (CC and) (S (NP (JJ heavy) (NNS Doc_23433219_1694_1709_Chemical)) (VP (VBP use))) (. .)))
23433219	11	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NP (DT all) (NNS cases)) (PP (IN of) (NP (JJ Doc_23433219_1751_1766_Chemical) (NN dependence)))) (VP (MD should) (VP (VB be) (VP (VBN screened) (PP (IN for) (NP (NNS Doc_23433219_1801_1819_Disease)))))))))) (. .)))
23535177	0	(ROOT (S (NP (JJ Cerebellar) (JJ sensory) (NN processing)) (VP (VBZ alterations) (NP (NN impact) (NN motor) (NN cortical) (NN plasticity)) (PP (IN in) (NP (NNS Doc_23535177_78_97_Disease))) (: :) (NP (NP (NNS clues)) (PP (IN from) (NP (JJ Doc_23535177_110_120_Disease) (NNS patients))))) (. .)))
23535177	1	(ROOT (S (NP (NP (DT The) (NN plasticity)) (PP (IN of) (NP (NP (NP (JJ primary) (NN motor) (NN cortex)) (PRN (-LRB- -LRB-) (NP (NNP M1)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_23535177_192_211_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23535177_213_215_Disease)) (-RRB- -RRB-)) (CC and) (NP (NN Doc_23535177_221_229_Chemical-induced) (NNS dyskinesias)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23535177_251_255_Disease)) (-RRB- -RRB-))))))))) (VP (VBZ is) (ADJP (RB severely) (JJ impaired))) (. .)))
23535177	2	(ROOT (S (NP (PRP We)) (ADVP (RB recently)) (VP (VBD reported) (PP (IN in) (NP (JJ young) (JJ healthy) (NNS subjects))) (SBAR (IN that) (S (NP (JJ inhibitory) (NN cerebellar) (NN stimulation)) (VP (VBD enhanced) (NP (NP (DT the) (NN sensorimotor) (NN plasticity)) (PP (IN of) (NP (NNP M1))) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (JJ paired) (NN associative) (NN stimulation)) (PRN (-LRB- -LRB-) (NP (NNP PAS)) (-RRB- -RRB-))))))))))))) (. .)))
23535177	3	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (DT the) (JJ deficient) (NN sensorimotor) (NN M1) (NN plasticity)) (PP (IN in) (NP (NP (CD 16) (NNS patients)) (PP (IN with) (NP (NNS Doc_23535177_556_560_Disease)))))) (VP (MD could) (VP (VB be) (VP (VBN reinstated) (PP (IN by) (NP (NP (DT a) (JJ single) (NN session)) (PP (IN of) (NP (NP (JJ real) (JJ inhibitory) (NN cerebellar) (NN stimulation)) (CONJP (CC but) (RB not)) (NP (NN sham) (NN stimulation)))))))))))) (. .)))
23535177	4	(ROOT (S (NP (DT This)) (VP (VBD was) (ADJP (JJ evident)) (SBAR (WHADVP (RB only) (WRB when)) (S (NP (DT a) (JJ sensory) (NN component)) (VP (VBD was) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN plasticity))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (JJ cerebellar) (JJ sensory) (NN processing) (NN function)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN resurgence)) (PP (IN of) (NP (NN M1) (NN plasticity)))))))))))))))) (. .)))
23535177	5	(ROOT (S (NP (NP (DT The) (NN benefit)) (PP (IN of) (NP (NP (JJ inhibitory) (NN cerebellar) (NN stimulation)) (PP (IN on) (NP (NNS Doc_23535177_916_920_Disease)))))) (VP (VBZ is) (VP (VBN known))) (. .)))
23535177	6	(ROOT (S (S (VP (TO To) (VP (VB explore) (SBAR (IN whether) (S (NP (DT this) (NN benefit)) (VP (VBZ is) (VP (VBN linked) (PP (TO to) (NP (NP (DT the) (NN restoration)) (PP (IN of) (NP (NP (NN sensorimotor) (NN plasticity)) (PP (IN of) (NP (NNP M1)))))))))))))) (, ,) (NP (PRP we)) (VP (VBD conducted) (NP (NP (DT an) (JJ additional) (NN study)) (VP (VBG looking) (PP (IN at) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NNS Doc_23535177_1081_1085_Disease)) (CC and) (NP (JJ PAS-induced) (NN plasticity)))))) (PP (IN after) (NP (NP (CD 10) (NNS sessions)) (PP (IN of) (NP (DT either) (JJ bilateral) (, ,) (JJ real) (JJ inhibitory) (NN cerebellar) (NN stimulation) (CC or) (NN sham) (NN stimulation)))))))) (. .)))
23535177	7	(ROOT (S (S (FRAG (NP (RB Only) (JJ real)) (CC and) (RB not)) (NP (NN sham) (NN stimulation)) (VP (VBD had) (NP (DT an) (JJ antidyskinetic) (NN effect)))) (CC and) (S (NP (PRP it)) (VP (VBD was) (VP (VBN paralleled) (PP (IN by) (NP (NP (DT a) (NN resurgence)) (PP (IN in) (NP (NP (DT the) (NN sensorimotor) (NN plasticity)) (PP (IN of) (NP (NNP M1)))))))))) (. .)))
23535177	8	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS alterations)) (PP (IN in) (NP (JJ cerebellar) (JJ sensory) (NN processing) (NN function)))) (, ,) (S (VP (VBG occurring) (ADJP (JJ secondary) (PP (TO to) (NP (NP (JJ abnormal) (JJ basal) (NN ganglia) (NNS signals)) (VP (VBG reaching) (NP (PRP it)))))))) (, ,) (VP (MD may) (VP (VB be) (NP (NP (DT an) (JJ important) (NN element)) (VP (VBG contributing) (PP (TO to) (NP (NP (NP (DT the) (JJ maladaptive) (NN sensorimotor) (NN plasticity)) (PP (IN of) (NP (NNP M1)))) (CC and) (NP (NP (DT the) (NN emergence)) (PP (IN of) (NP (NNS Doc_23535177_1612_1642_Disease))))))))))))) (. .)))
2358093	0	(ROOT (NP (NP (DT The) (JJ long-term) (NN safety)) (PP (IN of) (NP (NNS Doc_2358093_24_31_Chemical))) (PP (IN in) (NP (NP (NNS women)) (PP (IN with) (NP (NNS Doc_2358093_46_67_Disease))))) (. .)))
2358093	1	(ROOT (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (JJ short-term) (NN safety)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJR less) (PP (IN than))) (CC or) (ADJP (JJ equal) (PP (TO to) (NP (CD 6) (NNS months))))) (-RRB- -RRB-))) (PP (IN of) (NP (NNS Doc_2358093_136_143_Chemical)))) (VP (VBZ has) (VP (VBN been) (VP (VBN established) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS settings)))))))))) (, ,) (NP (DT no) (NN information)) (VP (VBZ exists) (PP (IN as) (PP (TO to) (NP (PRP$ its) (JJ long-term) (NN safety))))) (. .)))
2358093	2	(ROOT (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD investigated) (NP (NP (DT the) (JJ long-term) (NN safety)) (PP (IN of) (NP (NNS Doc_2358093_291_298_Chemical)))) (PP (IN by) (S (VP (VBG performing) (NP (NP (DT a) (NN retrospective) (NN chart) (NN review)) (PP (IN of) (NP (CD 60) (JJ female) (NNS patients)))) (PP (IN with) (NP (NP (NNS Doc_2358093_369_390_Disease)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_2358093_404_411_Chemical)) (PP (IN for) (NP (NP (DT a) (JJ continuous) (NN period)) (PP (IN of) (NP (NP (CD 6) (NNS months)) (CC or) (NP (JJR longer))))))))))))))) (. .)))
2358093	3	(ROOT (S (S (NP (NP (DT The) (JJ mean) (NN age)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD was) (NP (JJ 35.2) (NNS years)))) (CC and) (S (NP (NP (DT the) (JJ mean) (NN duration)) (PP (IN of) (NP (NN therapy)))) (VP (VBD was) (NP (JJ 59.7) (NNS months)))) (. .)))
2358093	4	(ROOT (S (NP (RB Virtually) (DT all) (NNS patients)) (VP (VBD experienced) (NP (QP (CD one) (CC or) (JJR more)) (JJ adverse) (NNS reactions))) (. .)))
2358093	5	(ROOT (S (NP (NP (NP (NP (NNP Doc_2358093_619_642_Disease)) (PRN (-LRB- -LRB-) (NP (CD 79) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_2358093_650_661_Disease)) (PRN (-LRB- -LRB-) (NP (CD 60) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (NN muscle)) (NP (NP (JJ cramps/Doc) (JJ _) (NNS 2358093_683_691_Disease)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN %)) (-RRB- -RRB-)))) (, ,) (CC and) (NP (JJ transaminase) (NNS elevations))) (PRN (-LRB- -LRB-) (NP (CD 40) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (NP (DT the) (ADJP (RBS most) (JJ common)) (NP (JJ adverse) (NNS reactions)))) (. .)))
2358093	6	(ROOT (S (NP (DT The) (NN drug)) (VP (VBD was) (VP (VBN discontinued) (ADJP (JJ due) (PP (TO to) (NP (JJ adverse) (NNS reactions)))) (PP (IN in) (NP (CD 8) (NNS patients))))) (. .)))
2358093	7	(ROOT (S (NP (DT No) (NN patient)) (VP (VBZ has) (VP (VBN died) (CC or) (VBN suffered) (NP (NP (DT any) (JJ apparent) (JJ long-term) (NN sequelae)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (RB directly) (JJ attributable)))))) (PP (TO to) (NP (DT the) (NN drug))))) (. .)))
2358093	8	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (, ,) (PP (IN despite) (NP (NP (DT a) (ADJP (RB relatively) (JJ high)) (NN incidence)) (PP (IN of) (NP (JJ adverse) (NNS reactions))))) (, ,) (NP (NNS Doc_2358093_1024_1031_Chemical)) (VP (VBZ has) (VP (VBN proven) (S (VP (TO to) (VP (VB be) (ADJP (RB remarkably) (JJ safe) (PP (IN over) (NP (DT the) (JJ long-term)))) (PP (IN in) (NP (NP (DT this) (NN group)) (PP (IN of) (NP (NNS patients))))))))))))) (. .)))
23666265	0	(ROOT (NP (NP (DT The) (NN function)) (PP (IN of) (NP (NNP P2X3) (NN receptor) (CC and) (NN NK1) (NN receptor) (NNS antagonists))) (PP (IN on) (NP (NN Doc_23666265_62_78_Chemical-induced) (NNS Doc_23666265_87_95_Disease))) (PP (IN in) (NP (NNS rats))) (. .)))
23666265	1	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT the) (NN study)))) (VP (VBZ is) (S (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NN P2X3) (CC and) (NN NK1) (NNS receptors) (NNS antagonists)))) (PP (IN on) (NP (NP (NP (NNS Doc_23666265_207_223_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23666265_225_228_Chemical)) (-RRB- -RRB-))) (: -) (NP (NP (JJ induced) (NNS Doc_23666265_238_246_Disease)) (PP (IN in) (NP (NNS rats)))))))))) (. .)))
23666265	2	(ROOT (S (NP (NP (CD Sixty) (JJ female) (NN Sprague-Dawley)) (PRN (-LRB- -LRB-) (NP (NNP SD)) (-RRB- -RRB-)) (NNS rats)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN divided) (PP (IN into) (NP (CD three) (NNS groups))))) (. .)))
23666265	3	(ROOT (S (S (NP (NP (DT The) (NNS rats)) (PP (IN in) (NP (DT the) (NN control) (NN group)))) (VP (VBD were) (ADVP (ADVP (RB intraperitoneally)) (PRN (-LRB- -LRB-) (NP (NNP i.p.)) (-RRB- -RRB-))) (VP (VBN injected) (PP (IN with) (NP (NP (ADJP (CD 0.9) (NN %)) (NN saline)) (PRN (-LRB- -LRB-) (NP (CD 4) (NN ml/kg)) (-RRB- -RRB-))))))) (: ;) (S (NP (NP (DT the) (NNS rats)) (PP (IN in) (NP (DT the) (NN model) (NN group)))) (VP (VBD were) (ADVP (RB i.p.)) (VP (VBN injected) (PP (IN with) (NP (NP (NNP CYP)) (PRN (-LRB- -LRB-) (NP (CD 150) (NN mg/kg)) (-RRB- -RRB-))))))) (: ;) (CC and) (S (NP (NP (DT the) (NNS rats)) (PP (IN in) (NP (DT the) (NN intervention) (NN group)))) (VP (VBD were) (ADVP (RB i.p.)) (VP (VBN injected) (PP (IN with) (NP (NNP CYP))) (PP (IN with) (NP (NP (ADVP (RB subsequently)) (NN perfusion)) (PP (IN of) (NP (NN bladder))))) (PP (IN with) (NP (NP (NNP P2X3) (CC and) (NNP NK1) (NNP receptors) (POS ')) (NNS antagonists) (, ,) (NNS Doc_23666265_658_665_Chemical) (CC and) (NNS Doc_23666265_670_678_Chemical)))))) (. .)))
23666265	4	(ROOT (S (NP (NP (JJ Spontaneous) (NNS Doc_23666265_692_706_Disease)) (PP (VBG following) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NNP CYP)))))) (VP (VBD were) (ADJP (JJ observed))) (. .)))
23666265	5	(ROOT (S (NP (NP (JJ Urodynamic) (NNS parameters)) (, ,) (NP (NN bladder) (JJ pressure-volume) (NN curve)) (, ,) (NP (NP (NP (JJ maximum) (NN voiding) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP MVP)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ maximum) (JJ cystometric) (NN capacity)) (PRN (-LRB- -LRB-) (NP (NNP MCC)) (-RRB- -RRB-)))) (, ,)) (VP (VBD were) (VP (VBN recorded))) (. .)))
23666265	6	(ROOT (S (NP (NP (JJ Pathological) (NNS changes)) (PP (IN in) (NP (NN bladder) (NN tissue)))) (VP (VBD were) (ADJP (JJ observed))) (. .)))
23666265	7	(ROOT (S (NP (NNP Immunofluorescence)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB detect) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN P2X3) (CC and) (NN NK1) (NNS receptors)))) (PP (IN in) (NP (NN bladder)))))))) (. .)))
23666265	8	(ROOT (S (NP (JJ Doc_23666265_1053_1069_Chemical) (NN treatment)) (VP (VBD increased) (NP (DT the) (JJ spontaneous) (JJ Doc_23666265_1106_1120_Disease) (NNS scores))) (. .)))
23666265	9	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_23666265_1146_1165_Disease)) (PP (IN during) (NP (NP (NN urine) (NN storage) (NN period)) (PP (IN of) (NP (NN model) (NN group)))))))) (VP (VBD was) (ADJP (RB significantly) (JJR higher)) (PP (IN than) (NP (NP (NP (NN intervention) (NN group)) (-LRB- -LRB-) (NP (NP (NNP X)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (SBAR (S (S (VP (SYM =) (NP (CD 7.619)))) (, ,) (VP (VBP P) (S (VP (SYM =) (NP (CD 0.007)))))))) (-RRB- -RRB-)) (CC and) (NP (NP (NN control) (NN group)) (-LRB- -LRB-) (NP (NP (NNP X)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (SBAR (S (S (VP (SYM =) (NP (CD 13.755)))) (, ,) (VP (VBP P) (S (VP (SYM =) (NP (CD 0.000)))))))) (-RRB- -RRB-))))) (. .)))
23666265	10	(ROOT (S (NP (NP (NNP MCC)) (PP (IN in) (NP (DT the) (NN model) (NN group)))) (VP (VBD was) (ADJP (JJR lower)) (PP (IN than) (NP (NP (DT the) (NN control) (CC and) (NN intervention) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-))))) (. .)))
23666265	11	(ROOT (S (NP (NP (NP (JJ Histological) (NNS changes)) (ADJP (JJ evident) (PP (IN in) (NP (NN model) (CC and) (NN intervention) (NNS groups) (NNS rats)))) (POS ')) (NN bladder)) (VP (VBD included) (NP (NP (NN Doc_23666265_1501_1506_Disease) (, ,) (NN vasodilation) (, ,) (CC and) (NN infiltration)) (PP (IN of) (NP (JJ inflammatory) (NNS cells))))) (. .)))
23666265	12	(ROOT (S (PP (IN In) (NP (NN model) (NN group))) (, ,) (S (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN P2X3) (NN receptor)))) (VP (VBD increased) (PP (IN in) (NP (NN urothelium) (CC and) (NN suburothelium))))) (, ,) (CC and) (S (NP (NNP NK1) (NN receptor)) (VP (VBD increased) (PP (IN in) (NP (NN suburothelium))) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (PRP them)) (PP (IN in) (NP (NN intervention) (NN group)))))) (VP (VBD was) (ADJP (JJR lower))))))) (. .)))
23666265	13	(ROOT (S (PP (IN In) (NP (JJ CYP-induced) (NNS Doc_23666265_1788_1796_Disease))) (, ,) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN P2X3) (CC and) (NN NK1) (NNS receptors)))) (VP (VP (VBD increased) (PP (IN in) (NP (NN urothelium)))) (CC and/or) (VP (VBP suburothelium))) (. .)))
23666265	14	(ROOT (S (NP (NP (NNP Perfusion)) (PP (IN of) (NP (NP (NN bladder)) (PP (IN with) (NP (NN P2X3) (CC and) (NN NK1) (NNS receptors) (NNS antagonists)))))) (VP (VBD ameliorated) (NP (DT the) (NN bladder) (NN function))) (. .)))
2383364	0	(ROOT (NP (NP (NP (JJ Patient) (NN tolerance) (NN study)) (PP (IN of) (NP (JJ topical) (NNS Doc_2383364_35_64_Chemical)))) (: :) (NP (NP (DT a) (JJ new) (JJ topical) (NN agent)) (PP (IN for) (NP (NNS burns)))) (. .)))
2383364	1	(ROOT (S (NP (JJ Effective) (JJ topical) (NN antimicrobial) (NNS agents)) (VP (VB decrease) (NP (NNS Doc_2383364_145_154_Disease) (CC and) (NN mortality)) (PP (IN in) (NP (JJ burn) (NNS patients)))) (. .)))
2383364	2	(ROOT (S (S (NP (NP (NP (NNP Doc_2383364_187_214_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2383364_216_219_Chemical)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ new) (JJ broad-spectrum) (NN antimicrobial) (NN agent)) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN evaluated) (SBAR (IN as) (S (NP (DT a) (JJ topical) (NN burn)) (VP (VBD wound) (S (VP (VBG dressing) (PP (IN in) (NP (NN cream) (NN form)))))))))))) (, ,) (CC but) (S (NP (JJ preliminary) (JJ clinical) (NNS trials)) (VP (VBD reported) (SBAR (IN that) (S (NP (PRP it)) (VP (VBD was) (ADJP (JJ painful) (PP (IN upon) (NP (NN application))))))))) (. .)))
2383364	3	(ROOT (S (NP (DT This) (NN study)) (VP (VBD compared) (NP (NP (JJ various) (NNS concentrations)) (PP (IN of) (NP (NNS Doc_2383364_456_459_Chemical)))) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (DT a) (JJ tolerable) (NN concentration)) (VP (MD could) (VP (VB be) (VP (VBN identified) (PP (IN with) (NP (NP (NN retention)) (PP (IN of) (NP (JJ antimicrobial) (NN efficacy)))))))))))))) (. .)))
2383364	4	(ROOT (S (NP (NP (JJ Twenty-nine) (JJ burn) (NNS patients)) (, ,) (NP (NP (DT each)) (PP (IN with) (NP (NP (NNS Doc_2383364_601_618_Disease)) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB be) (VP (ADVP (RB separately)) (VBN treated))))))))) (, ,)) (VP (VBD were) (VP (VBN given) (NP (NP (NNS pairs)) (PP (IN of) (NP (NNS treatments)))) (PP (IN at) (NP (NP (JJ successive) (JJ 12-h) (NNS intervals)) (PP (IN over) (NP (DT a) (JJ 3-day) (NN period))))))) (. .)))
2383364	5	(ROOT (S (NP (PRP One)) (VP (VBP burn) (SBAR (S (NP (NN site)) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (DT each)) (PP (IN of) (NP (CD four) (JJ different) (JJ Doc_2383364_789_792_Chemical) (NNS concentrations))))) (, ,) (PP (IN from) (NP (NP (CD 0.25) (ADJP (IN per) (NP (NP (QP (CD cent) (TO to) (CD 2))) (PP (IN per) (NP (NP (NN cent)) (, ,) (NP (PRP$ their) (NN vehicle)) (, ,) (CC and) (NP (NP (CD 1)) (PP (IN per) (NP (NP (NN cent) (NNS Doc_2383364_873_893_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2383364_895_899_Chemical)) (-RRB- -RRB-))))))))) (NN cream)) (, ,) (NP (NP (DT an) (JJ antimicrobial) (NN agent)) (VP (ADVP (RB frequently)) (VBN used) (PP (IN for) (NP (NP (JJ topical) (NN treatment)) (PP (IN of) (NP (JJ burn) (NNS wounds)))))))))))))) (. .)))
2383364	6	(ROOT (S (NP (DT The) (JJ other) (NN site)) (VP (VBD was) (ADVP (RB always)) (VP (VBN treated) (PP (IN with) (NP (JJ Doc_2383364_1024_1028_Chemical) (NN cream))))) (. .)))
2383364	7	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (NP (DT a) (JJ direct) (NN relationship)) (PP (IN between) (NP (JJ Doc_2383364_1076_1079_Chemical) (NN concentration)))) (CC and) (NP (NP (NP (NNS patients) (POS ')) (NNS ratings)) (PP (IN of) (NP (NP (NNS Doc_2383364_1119_1123_Disease)) (PP (IN on) (NP (DT an) (JJ analogue) (NN scale)))))))) (. .)))
2383364	8	(ROOT (S (S (NP (NP (DT The) (CD 0.25)) (PP (IN per) (NP (NN cent) (JJ Doc_2383364_1164_1167_Chemical) (NN cream)))) (VP (VBD was) (ADJP (ADJP (JJS closest)) (PP (TO to) (NP (NP (NNS Doc_2383364_1189_1193_Chemical)) (PP (IN in) (NP (JJ Doc_2383364_1197_1201_Disease) (NN tolerance)))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NP (NN none)) (PP (IN of) (NP (DT the) (NNS treatments)))) (VP (VBD differed) (ADJP (RB statistically) (PP (PP (IN from) (NP (NNS Doc_2383364_1273_1277_Chemical))) (CC or) (PP (IN from) (NP (DT each) (JJ other))))))) (. .)))
2383364	9	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN ease)) (PP (IN of) (NP (NP (NN application)) (PP (IN of) (NP (JJ Doc_2383364_1334_1337_Chemical) (NNS creams)))))) (VP (VBD was) (ADJP (RBR less) (JJ satisfactory)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NNS Doc_2383364_1380_1384_Chemical)))))) (. .)))
2383364	10	(ROOT (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN concluded) (SBAR (IN that) (S (NP (NP (QP (CD formulations) (IN at) (CC or) (IN below) (CD 0.5))) (PP (IN per) (NP (NN cent) (NNS Doc_2383364_1446_1449_Chemical)))) (VP (MD may) (VP (VB prove) (ADJP (JJ acceptable)) (PP (IN for) (NP (VBN wound) (NN care)))))))))) (, ,) (CC but) (S (NP (DT the) (NN vehicle) (NN system)) (VP (VBZ needs) (NP (JJ pharmaceutical) (NN improvement) (S (VP (TO to) (VP (VB render) (S (NP (PRP it)) (ADJP (ADJP (RBR more) (JJ tolerable)) (CC and) (ADJP (JJR easier) (S (VP (TO to) (VP (VB use))))))))))))) (. .)))
23846525	0	(ROOT (NP (NP (NP (JJ Acute) (NNS Doc_23846525_6_15_Disease)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_23846525_32_43_Chemical))))) (: :) (NP (NP (DT a) (NN case) (NN report) (CC and) (NN review)) (PP (IN of) (NP (DT the) (NN literature)))) (. .)))
23846525	1	(ROOT (S (S (NP (JJ Drug-induced) (NN hepatotoxicity)) (VP (VBZ is) (NP (NP (DT a) (JJ common) (NN cause)) (PP (IN of) (NP (JJ acute) (NNS Doc_23846525_144_153_Disease)))))) (, ,) (CC and) (S (NP (NP (DT the) (NN recognition)) (PP (IN of) (NP (DT the) (JJ responsible) (NN drug)))) (VP (MD may) (VP (VB be) (ADJP (JJ difficult))))) (. .)))
23846525	2	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (ADJP (JJ Doc_23846525_239_250_Chemical-related) (JJ acute)) (NNS Doc_23846525_265_274_Disease))))) (. .)))
23846525	3	(ROOT (S (NP (DT The) (NN diagnosis)) (VP (VBZ is) (ADVP (RB strongly)) (VP (VBN suggested) (PP (IN by) (NP (DT an) (ADJP (JJ accurate) (JJ medical)) (NN history) (CC and) (NN liver) (NN biopsy))))) (. .)))
23846525	4	(ROOT (S (NP (NP (NNS Reports)) (PP (IN about) (NP (NP (NNS cases)) (PP (IN of) (NP (ADJP (RB hepatotoxicity) (JJ due) (PP (TO to))) (NNS Doc_23846525_406_417_Chemical)))))) (VP (VBP are) (VP (VBG increasing) (PP (IN in) (NP (DT the) (JJ last) (JJ few) (NNS years))) (, ,) (PP (IN after) (NP (NP (DT the) (VBN increased) (NN use)) (PP (IN of) (NP (DT this) (NN drug))))))) (. .)))
23846525	5	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (PRP we)) (VP (VBP believe) (SBAR (IN that) (S (NP (NNS physicians)) (VP (MD should) (ADVP (RB carefully)) (VP (VB consider) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ drug-induced) (NNS Doc_23846525_587_601_Disease)))) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_23846525_607_618_Chemical)) (VP (VBZ is) (VP (VBN prescribed)))))))))) (. .)))
23864035	0	(ROOT (NP (NP (NP (NNS Doc_23864035_0_10_Chemical) (CC and) (NNS Doc_23864035_15_28_Chemical)) (PP (IN as) (NP (NP (NN salvage) (NN therapy)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ relapsed/refractory) (NNS Doc_23864035_85_101_Disease)))))))) (: :) (NP (NP (NN analysis)) (PP (IN of) (NP (JJ long-term) (JJ clinical) (NNS outcomes)))) (. .)))
23864035	1	(ROOT (NP (NP (NNP Doc_23864035_144_154_Chemical)) (PRN (-LRB- -LRB-) (NP (NN bort)) (-RRB- -RRB-)) (: -) (NP (NP (NNS Doc_23864035_162_175_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23864035_177_180_Chemical)) (-RRB- -RRB-)) (SBAR (S (VP (VBZ is) (NP (NP (DT an) (JJ effective) (NN therapy)) (PP (IN for) (NP (NP (JJ relapsed/refractory) (PRN (-LRB- -LRB-) (NP (NNP R/R)) (-RRB- -RRB-)) (NN Doc_23864035_236_252_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23864035_254_256_Disease)) (-RRB- -RRB-))))))))) (. .)))
23864035	2	(ROOT (S (NP (DT This) (NN retrospective) (NN study)) (VP (VBD investigated) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (NN bort)) (PRN (-LRB- -LRB-) (NP (NP (CD 1.3) (NN mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (PP (IN on) (NP (NP (NNS days) (CD 1)) (, ,) (NP (NP (CD 4) (, ,) (CD 8) (, ,) (CC and) (CD 11)) (NP (QP (DT every) (CD 3)) (NNS weeks)))))) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_23864035_377_380_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 20) (NN mg)) (PP (IN on) (NP (NP (DT the) (NN day)) (PP (IN of))))) (CC and) (NP (NP (DT the) (NN day)) (PP (IN after) (NP (NN bort))))) (-RRB- -RRB-))))) (PP (IN as) (NP (NP (NN salvage) (NN treatment)) (PP (IN in) (NP (NP (CD 85) (NNS patients)) (PP (IN with) (NP (NNP R/R) (NNP Doc_23864035_471_473_Disease))))))) (SBAR (IN after) (S (NP (JJ prior) (NNS autologous)) (VP (VBP stem) (NP (NP (NN cell) (NN transplantation)) (CC or) (NP (JJ conventional) (NN chemotherapy))))))) (. .)))
23864035	3	(ROOT (S (NP (NP (DT The) (JJ median) (NN number)) (PP (IN of) (NP (NP (JJ prior) (NNS lines)) (PP (IN of) (NP (NN therapy)))))) (VP (VBD was) (NP (CD 2))) (. .)))
23864035	4	(ROOT (S (NP (NP (JJ Eighty-seven) (NN percent)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD had) (VP (VBN received) (NP (NP (JJ immunomodulatory) (NNS drugs)) (VP (VBN included) (PP (IN in) (NP (NP (DT some) (NN line)) (PP (IN of) (NP (NN therapy))))) (PP (IN before) (ADJP (JJ bort-Doc_23864035_722_725_Chemical))))))) (. .)))
23864035	5	(ROOT (S (NP (NP (DT The) (JJ median) (NN number)) (PP (IN of) (NP (JJ bort-Doc_23864035_753_756_Chemical) (NNS cycles)))) (VP (VBD was) (NP (CD 6)) (, ,) (ADVP (RB up) (PP (TO to) (NP (NP (DT a) (NN maximum)) (PP (IN of) (NP (CD 12) (NNS cycles))))))) (. .)))
23864035	6	(ROOT (S (PP (IN On) (NP (DT an) (JJ intention-to-treat) (NN basis))) (, ,) (NP (NP (CD 55) (NN %)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD achieved) (NP (NP (ADVP (IN at) (JJS least)) (JJ partial) (NN response)) (, ,) (PP (VBG including) (NP (NP (ADJP (CD 19) (NN %)) (NNP CR)) (CC and) (NP (NP (CD 35) (NN %)) (VP (VBN achieved) (PP (IN at) (NP (ADJP (RBS least) (RB very) (JJ good)) (JJ partial) (NN response))))))))) (. .)))
23864035	7	(ROOT (S (NP (NP (JJ Median) (NNS durations)) (PP (IN of) (NP (NP (NN response)) (, ,) (NP (NP (NN time)) (PP (TO to) (NP (JJ next) (NN therapy)))) (CC and) (NP (JJ treatment-free) (NN interval))))) (VP (VBD were) (NP (NP (CD 8)) (, ,) (NP (CD 11.2)) (, ,) (CC and) (NP (CD 5.1) (NNS months))) (, ,) (ADVP (RB respectively))) (. .)))
23864035	8	(ROOT (S (NP (DT The) (ADJP (RBS most) (JJ relevant)) (JJ adverse) (NN event)) (VP (VBD was) (NP (NP (NNS Doc_23864035_1122_1143_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBD occurred) (PP (IN in) (NP (NP (CD 78) (NN %)) (PP (IN of) (NP (NP (DT the) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (NNP grade) (NNP II)) (, ,) (NP (NP (CD 38) (NN %)) (: ;) (NP (NNP grade) (NNP III))) (, ,) (NP (CD 21) (NN %))) (-RRB- -RRB-))))))) (CC and) (VP (VBD led) (PP (TO to) (NP (NN treatment) (NN discontinuation))) (PP (IN in) (NP (CD 6) (NN %))))))))) (. .)))
23864035	9	(ROOT (S (SBAR (IN With) (S (NP (DT a) (NN median)) (VP (VB follow) (PRT (RP up)) (PP (IN of) (NP (CD 22) (NNS months))) (, ,) (NP (JJ median) (NN time) (S (VP (TO to) (VP (VB progression)))))))) (, ,) (NP (NP (NP (JJ progression-free) (NN survival)) (PRN (-LRB- -LRB-) (NP (NNP PFS)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_23864035_1365_1381_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23864035_1383_1385_Disease)) (-RRB- -RRB-)))) (VP (VBD were) (NP (NP (CD 8.9)) (, ,) (NP (CD 8.7)) (, ,) (CC and) (NP (CD 22) (NNS months))) (, ,) (ADVP (RB respectively))) (. .)))
23864035	10	(ROOT (S (NP (NP (NNP Prolonged) (NNP PFS)) (CC and) (NP (NNS Doc_23864035_1449_1451_Disease))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (VP (VP (VBG achieving) (NP (NNP CR))) (CC and) (VP (VBG receiving) (NP (NP (JJ bort-Doc_23864035_1510_1513_Chemical) (DT a) (JJ single) (NN line)) (PP (IN of) (NP (JJ prior) (NN therapy)))))))))) (. .)))
23864035	11	(ROOT (S (NP (NNP Doc_23864035_1546_1554_Chemical)) (VP (VBD was) (NP (NP (DT an) (JJ effective) (NN salvage) (NN treatment)) (PP (IN for) (NP (JJ Doc_23864035_1594_1596_Disease) (NNS patients)))) (, ,) (ADVP (RB particularly) (PP (IN for) (NP (NP (DT those)) (PP (IN in) (NP (JJ first) (NN relapse))))))) (. .)))
23871786	0	(ROOT (S (NP (NP (JJ Pubertal) (NN exposure)) (PP (TO to) (NP (NNS Doc_23871786_21_32_Chemical)))) (VP (VP (VBZ increases) (NP (NN Doc_23871786_43_50_Disease-like) (NN behavior))) (CC and) (VP (VBZ decreases) (NP (NP (JJ acetylcholinesterase) (NN activity)) (PP (IN of) (NP (NP (NNS hippocampus)) (PP (IN in) (NP (JJ adult) (JJ male) (NNS mice)))))))) (. .)))
23871786	1	(ROOT (S (NP (NP (DT The) (JJ negative) (NNS effects)) (PP (IN of) (NP (NP (NP (NNS Doc_23871786_168_179_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23871786_181_184_Chemical)) (-RRB- -RRB-))) (PP (IN on) (NP (NN neurodevelopment) (CC and) (NNS behaviors)))))) (VP (VBP have) (VP (VBN been) (VP (ADVP (RB well)) (VBN established)))) (. .)))
23871786	2	(ROOT (S (NP (NP (NNP Acetylcholinesterase)) (PRN (-LRB- -LRB-) (NP (NNP AChE)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ regulatory) (NN enzyme)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NN Doc_23871786_320_327_Disease-like) (NN behavior))))))))) (. .)))
23871786	3	(ROOT (S (NP (DT This) (NN study)) (VP (VBD investigated) (NP (NP (JJ behavioral) (NNS phenotypes)) (CC and) (NP (JJ AChE) (NN activity))) (PP (IN in) (NP (NP (JJ male) (NNS mice)) (PP (VBG following) (NP (NP (JJ Doc_23871786_430_433_Chemical) (NN exposure)) (PP (IN during) (NP (NN puberty)))))))) (. .)))
23871786	4	(ROOT (S (PP (IN On) (NP (NP (NP (JJ postnatal) (NN day)) (PRN (-LRB- -LRB-) (NP (NNP PND)) (-RRB- -RRB-))) (NP (CD 35)))) (, ,) (NP (JJ male) (NNS mice)) (VP (VBD were) (VP (VBN exposed) (PP (TO to) (NP (NP (JJ 50mg) (NNS Doc_23871786_517_520_Chemical)) (PRN (: /) (NP (NP (NN kg) (NN diet)) (PP (IN per) (NP (NN day))))))) (PP (IN for) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (CD 35) (NNS days))))))) (. .)))
23871786	5	(ROOT (S (PP (IN On) (NP (NNP PND71))) (, ,) (NP (DT a) (JJ behavioral) (NN assay)) (VP (VBD was) (VP (VBN performed) (S (VP (VBG using) (NP (NP (DT the) (JJ elevated) (NN plus) (NN maze)) (PRN (-LRB- -LRB-) (NP (NNP EPM)) (-RRB- -RRB-)) (CC and) (NP (DT the) (NN light/dark) (NN test))))))) (. .)))
23871786	6	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NNP AChE) (NN activity)) (VP (VBD was) (VP (VBN measured) (PP (IN in) (NP (NP (DT the) (JJ prefrontal) (NN cortex)) (, ,) (NP (NNS Doc_23871786_731_743_Disease)) (, ,) (NP (NN cerebellum)) (CC and) (NP (NNS hippocampus)))))) (. .)))
23871786	7	(ROOT (S (NP (NP (NNS Results)) (PP (IN from) (NP (PRP$ our) (JJ behavioral) (NN phenotyping)))) (VP (VBD indicated) (SBAR (IN that) (S (NP (NN Doc_23871786_828_835_Disease-like) (NN behavior)) (VP (VBD was) (VP (VBN increased) (PP (IN in) (NP (NP (NNS mice)) (VP (VBN exposed) (PP (TO to) (NP (NNS Doc_23871786_883_886_Chemical))))))))))) (. .)))
23871786	8	(ROOT (S (NP (JJ AChE) (NN activity)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN decreased) (PP (IN in) (NP (NP (DT the) (NNS hippocampus)) (PP (IN of) (NP (NP (NNS mice)) (PP (IN with) (NP (NNS Doc_23871786_962_965_Chemical))))))) (PP (VBN compared) (PP (TO to) (NP (NN control) (NNS mice)))) (, ,) (SBAR (IN whereas) (S (NP (DT no) (NN difference)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (JJ prefrontal) (NN cortex)) (, ,) (NP (NNS Doc_23871786_1050_1062_Disease)) (CC and) (NP (NN cerebellum)))))))))) (. .)))
23871786	9	(ROOT (S (NP (PRP$ Our) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (NP (JJ pubertal) (JJ Doc_23871786_1113_1116_Chemical) (NN exposure)) (VP (VBD increased) (NP (NP (NN Doc_23871786_1136_1143_Disease-like) (NN behavior)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (VBN decreased) (JJ AChE) (NN activity)) (PP (IN of) (NP (NP (DT the) (NNS hippocampus)) (PP (IN in) (NP (JJ adult) (JJ male) (NNS mice))))))))))))))))) (. .)))
23871786	10	(ROOT (S (NP (JJ Further) (NNS studies)) (VP (VBP are) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (JJ cholinergic) (NN signaling)) (PP (IN of) (NP (NP (DT the) (NNS hippocampus)) (PP (IN in) (NP (NNP PBE) (NNP induced) (NN Doc_23871786_1356_1363_Disease-like) (NNS behaviors))))))))))) (. .)))
23872883	0	(ROOT (S (NP (NP (JJ Biochemical) (NNS effects)) (PP (IN of) (NP (NNP Solidago) (NNP virgaurea)))) (VP (VB extract) (PP (IN on) (NP (JJ experimental) (NNS Doc_23872883_66_80_Disease)))) (. .)))
23872883	1	(ROOT (S (NP (NP (NNP Doc_23872883_82_105_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23872883_107_111_Disease)) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (NP (DT the) (JJ major) (NN health) (NN problem)) (PP (IN of) (ADJP (JJ advanced)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (VBG developing) (NNS countries)) (PP (IN of) (NP (DT the) (NN world)))))) (. .)))
23872883	2	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (S (NP (NP (DT the) (JJ protective) (NN effect)) (PP (IN of) (NP (DT the) (NNP Solidago) (NN virgaurea)))) (VP (VB extract) (PP (IN on) (NP (NP (NN Doc_23872883_307_320_Chemical-induced) (NNS Doc_23872883_329_343_Disease)) (PP (IN in) (NP (NNS rats))))))))))) (. .)))
23872883	3	(ROOT (S (NP (NP (DT The) (JJ subcutaneous) (NN injection)) (PP (IN of) (NP (NNS Doc_23872883_383_396_Chemical))) (PRN (-LRB- -LRB-) (NP (CD 30) (NN mg/kg)) (-RRB- -RRB-)) (PP (IN into) (NP (NP (NNS rats)) (VP (ADVP (RB twice) (PP (IN at) (NP (NP (DT an) (NN interval)) (PP (IN of) (NP (NP (CD 24) (NN h)) (, ,) (PP (IN for) (NP (CD two) (JJ consecutive) (NNS days))) (, ,)))))) (VBN led) (PP (TO to) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (NN serum) (JJ Doc_23872883_513_520_Chemical) (NN dehydrogenase)) (, ,) (NP (JJ Doc_23872883_536_544_Chemical) (NN phosphokinase)) (, ,) (NP (JJ Doc_23872883_560_567_Chemical) (NN transaminase)) (, ,) (NP (JJ Doc_23872883_582_591_Chemical) (NN transaminase)) (, ,) (CC and) (NP (NP (NN Doc_23872883_610_621_Chemical-converting) (NN enzyme) (NNS activities)) (, ,) (NP (JJ total) (NNS Doc_23872883_658_669_Chemical)) (, ,) (NP (NNS Doc_23872883_671_684_Chemical)) (, ,) (NP (JJ free) (NN serum) (NNS Doc_23872883_697_707_Chemical)) (, ,) (NP (NP (NP (JJ cardiac) (NN tissue) (NNS Doc_23872883_724_739_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23872883_741_744_Chemical)) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ Doc_23872883_751_763_Chemical) (NNS levels))) (CC and) (NP (DT a) (JJ significant) (NN decrease))))))) (PP (IN in) (NP (NP (NNS levels)) (PP (IN of) (NP (NNS Doc_23872883_811_822_Chemical) (CC and) (NNS Doc_23872883_827_837_Chemical))))))))) (VP (VBP dismutase) (PP (IN in) (NP (NP (JJ cardiac) (NN tissue) (IN as)) (PP (VBN compared) (PP (TO to) (NP (NP (DT the) (JJ normal) (NN control) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-)))))))) (. .)))
23872883	4	(ROOT (S (NP (NP (NNP Pretreatment)) (PP (IN with) (NP (NP (NNP S.) (NNP virgaurea) (NNP extract)) (PP (IN for) (NP (NP (CD 5) (NNS weeks)) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 250) (NN mg/kg)) (VP (VBN followed) (PP (IN by) (NP (JJ Doc_23872883_1004_1017_Chemical) (NN injection))))))))))))) (ADVP (RB significantly)) (VP (VBD prevented) (NP (DT the) (ADJP (JJ observed)) (NNS alterations))) (. .)))
23872883	5	(ROOT (S (NP (NP (NNP Doc_23872883_1078_1087_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 50) (NN mg/kg/day)) (, ,) (NP (JJ given) (NN orally))) (-RRB- -RRB-)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NP (NN Doc_23872883_1134_1145_Chemical-converting) (NN enzyme)) (VP (VBN used) (PP (IN as) (NP (DT a) (JJ standard) (NN cardioprotective) (NN drug))))))) (, ,)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (JJ positive) (NN control)) (PP (IN in) (NP (DT this) (NN study))))))) (. .)))
23872883	6	(ROOT (S (NP (NP (DT The) (NNS data)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNP S.) (NNP virgaurea) (NNP extract)) (VP (VBZ exerts) (NP (PRP$ its) (JJ protective) (NN effect)) (PP (IN by) (S (VP (VP (VBG decreasing) (NP (JJ Doc_23872883_1359_1362_Chemical) (NN level))) (CC and) (VP (VBG increasing) (NP (NP (DT the) (JJ antioxidant) (NN status)) (PP (IN in) (NP (NN Doc_23872883_1410_1423_Chemical-treated) (NNS rats)))))))))))) (. .)))
23872883	7	(ROOT (S (NP (DT The) (NN study)) (VP (VBZ emphasizes) (S (NP (NP (DT the) (JJ beneficial) (NN action)) (PP (IN of) (NP (NNP S.) (NNP virgaurea)))) (VP (VB extract) (PP (IN as) (NP (DT a) (JJ cardioprotective) (NN agent)))))) (. .)))
23892921	0	(ROOT (NP (NP (NP (`` ``) (JJ Real-world) ('' '') (NNS data)) (PP (IN on) (NP (NP (DT the) (NN efficacy) (CC and) (NN safety)) (PP (IN of) (NP (NP (NNS Doc_23892921_48_60_Chemical) (CC and) (NNS Doc_23892921_65_78_Chemical)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ relapsed/refractory) (JJ multiple) (NNS Doc_23892921_125_132_Disease))))))))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN treated) (PP (VBG according) (PP (TO to) (NP (DT the) (JJ standard) (JJ clinical) (NN practice))))))))) (: :) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (DT the) (JJ Greek) (NNP Myeloma) (NNP Study) (NNP Group)))) (. .)))
23892921	1	(ROOT (S (S (NP (NP (NNS Doc_23892921_237_249_Chemical) (CC and) (NNS Doc_23892921_254_267_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP RD)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN standard)) (PP (IN of) (NP (NP (NN care)) (PP (IN for) (NP (NP (ADJP (RB relapsed/refractory) (JJ multiple)) (NNS Doc_23892921_328_335_Disease)) (PRN (-LRB- -LRB-) (NP (NNP RRMM)) (-RRB- -RRB-))))))))) (, ,) (CC but) (S (NP (EX there)) (VP (VBZ is) (VP (VBN limited) (NP (VBN published) (NNS data)) (PP (IN on) (NP (PRP$ its) (NN efficacy) (CC and) (NN safety))) (PP (IN in) (NP (NP (DT the) (`` ``) (JJ real) (NN world) ('' '')) (PRN (-LRB- -LRB-) (NP (NNP RW)) (-RRB- -RRB-)))) (, ,) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NNP International) (NNP Society)) (PP (IN of) (NP (NNPS Pharmacoeconomics) (CC and) (NNP Outcomes) (NNP Research) (NN definition))))))))) (. .)))
23892921	2	(ROOT (S (NP (PRP We)) (VP (VBD studied) (NP (NP (QP (CD 212) (CD RRMM)) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (NNP RD)) (PP (IN in) (NP (NNP RW))))))))) (. .)))
23892921	3	(ROOT (S (NP (NP (NP (JJ Objective) (NN response)) (-LRB- -LRB-) (NP (NNP >) (NNP PR)) (PRN (-LRB- -LRB-) (NP (JJ partial) (NN response)) (-RRB- -RRB-)) (-RRB- -RRB-)) (ADJP (NN rate))) (VP (VBD was) (NP (NP (CD 77.4) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NP (JJ complete) (NN response)) (PRN (-LRB- -LRB-) (NP (NNP CR)) (-RRB- -RRB-))) (, ,) (NP (CD 20.2) (NN %))) (-RRB- -RRB-)))) (. .)))
23892921	4	(ROOT (S (NP (NP (JJ Median) (NN time)) (PP (TO to) (NP (ADJP (JJS first) (CC and) (JJS best)) (NN response)))) (VP (VBD was) (NP (QP (CD 2) (CC and) (CD 5) (NNS months))) (, ,) (ADVP (RB respectively))) (. .)))
23892921	5	(ROOT (NP (NP (NP (JJ Median) (NN time)) (S (VP (TO to) (VP (VB CR) (SBAR (WHADVP (WRB when)) (S (NP (NNP RD)) (VP (VBD was) (VP (VBN given) (PP (IN as) (NP (NP (NNS 2nd)) (CC or) (NP (NNP >) (CD 2))))))))))) (PRN (-LRB- -LRB-) (NP (NN nd)) (-RRB- -RRB-))) (: -) (NP (NP (NN line) (NN treatment)) (PP (IN at) (NP (NP (CD 4) (CC and) (CD 11) (NNS months)) (, ,) (ADVP (RB respectively))))) (. .)))
23892921	6	(ROOT (S (NP (NP (NNP Quality)) (PP (IN of) (NP (NN response)))) (VP (VBD was) (ADJP (JJ independent) (PP (IN of) (NP (NP (JJ previous) (NNS lines)) (PP (IN of) (NP (NP (NNS therapies)) (CC or) (NP (JJ previous) (NN exposure))))))) (PP (TO to) (NP (NNS Doc_23892921_939_950_Chemical) (CC or) (NNS Doc_23892921_954_964_Chemical)))) (. .)))
23892921	7	(ROOT (S (S (NP (NP (JJ Median) (NN duration)) (PP (IN of) (NP (NN response)))) (VP (VBD was) (NP (CD 34.4) (NNS months)))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBD was) (ADJP (JJR higher)) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NNP RD)) (PP (IN until) (NP (NP (NN progression)) (PRN (-LRB- -LRB-) (VP (RB not) (VBN reached) (PP (FW versus) (NP (NP (CD 19) (NNS months)) (, ,) (NP (NP (NN p)) (NP (QP (CD <) (CD 0.001))))))) (-RRB- -RRB-))))))))))) (. .)))
23892921	8	(ROOT (S (NP (NP (NNP Improvement)) (PP (IN of) (NP (JJ humoral) (NN immunity)))) (VP (VBD occurred) (PP (PP (IN in) (NP (NP (CD 60) (NN %)) (PP (IN of) (NP (NNS responders))))) (PRN (-LRB- -LRB-) (S (VP (VB p) (NP (QP (CD <) (CD 0.001))))) (-RRB- -RRB-)) (CC and) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD achieved) (NP (JJ stable) (NN disease))))))))))) (. .)))
23892921	9	(ROOT (S (NP (JJ Adverse) (NNS events)) (VP (VBD were) (VP (VBN reported) (PP (IN in) (NP (NP (NP (CD 68.9) (NN %)) (PP (IN of) (NP (NNS patients)))) (PRN (-LRB- -LRB-) (VP (VBN myelosuppression) (PP (IN in) (NP (ADJP (CD 49.4) (NN %))))) (-RRB- -RRB-)) (CC and) (NP (NP (CD 12.7) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN needed) (NP (NN hospitalization)))))))))) (. .)))
23892921	10	(ROOT (S (NP (NNP Doc_23892921_1381_1402_Disease)) (VP (VBD was) (VP (VBN observed) (ADVP (RB only)) (PP (IN in) (NP (NP (CD 2.5) (NN %)) (PP (IN of) (NP (NNS patients) (CC and) (NNS Doc_23892921_1446_1466_Disease))))) (PP (IN in) (NP (CD 5.7) (NN %))))) (. .)))
23892921	11	(ROOT (S (NP (JJ Dose) (NNS reductions)) (VP (VBD were) (VP (VBN needed) (PP (IN in) (NP (NP (NP (CD 31) (NN %)) (PP (IN of) (NP (NNS patients)))) (CC and) (NP (NP (JJ permanent) (NN discontinuation)) (PP (IN in) (NP (CD 38.9) (NN %)))))))) (. .)))
23892921	12	(ROOT (S (NP (NP (JJ Median) (NN time)) (PP (TO to) (NP (NN treatment) (NN discontinuation)))) (VP (VBD was) (NP (CD 16.8) (NNS months))) (. .)))
23892921	13	(ROOT (S (NP (NP (NP (NNP Performance) (NN status)) (PRN (-LRB- -LRB-) (NP (NNP PS)) (-RRB- -RRB-))) (CC and) (NP (JJ initial) (JJ Doc_23892921_1660_1672_Chemical) (NN dose))) (VP (VBD predicted) (PP (IN for) (NP (NN treatment) (NN discontinuation)))) (. .)))
23892921	14	(ROOT (S (NP (JJ Extra-medullary) (NNS relapses)) (VP (VBD occurred) (PP (IN in) (NP (NP (CD 3.8) (NN %)) (PP (IN of) (NP (NNS patients)))))) (. .)))
23892921	15	(ROOT (S (S (NP (PRP$ Our) (NN study)) (VP (VBZ confirms) (SBAR (IN that) (S (NP (NNP RD)) (VP (VBZ is) (ADJP (JJ effective) (CC and) (JJ safe)) (PP (IN in) (NP (NP (NNP RRMM)) (PP (IN in) (NP (DT the) (NNP RW)))))))))) (: ;) (S (NP (PRP it)) (VP (VP (VBZ produces) (NP (JJ durable) (NNS responses)) (PP (RB especially) (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP continue) (PP (IN on) (NP (NN treatment))) (PP (IN till) (NP (NN progression))))))))) (CC and) (VP (VBZ improves) (NP (JJ humoral) (NN immunity)) (PP (RB even) (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ stable) (NN disease)))))))) (. .)))
23949582	0	(ROOT (NP (NP (NP (DT The) (JJ cytogenetic) (NN action)) (PP (IN of) (NP (NP (NNS Doc_23949582_26_36_Chemical)) (, ,) (NP (NNS Doc_23949582_38_43_Chemical)) (, ,) (CC and) (NP (NP (PRP$ their) (NN combination)) (PP (IN on) (NP (JJ peripheral) (NN rabbit) (NNS lymphocytes))))))) (: :) (NP (NP (DT an) (ADJP (PP (IN in) (NP (NN vivo/in))) (NN vitro)) (NN cytogenetic)) (NP (NN study))) (. .)))
23949582	1	(ROOT (S (NP (NP (NNP Doc_23949582_140_150_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23949582_152_155_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (VBG alkylating) (JJ Doc_23949582_174_182_Chemical) (NN mustard)) (, ,) (VP (VBN administrated) (PP (IN as) (NP (DT an) (JJ antineoplasmic) (NN agent)))))) (. .)))
23949582	2	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (PRP$ its) (JJ intense) (JJ urotoxic) (NN action))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NNS Doc_23949582_297_317_Disease))))))) (. .)))
23949582	3	(ROOT (S (NP (NP (DT This) (NN side) (NN effect)) (PP (IN of) (NP (NNS Doc_23949582_339_342_Chemical)))) (VP (VBZ raises) (NP (NP (DT the) (NN requirement)) (PP (IN for) (NP (NP (DT the) (NN co-administration)) (PP (IN with) (NP (NP (NP (NNS Doc_23949582_397_429_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23949582_431_436_Chemical)) (-RRB- -RRB-))) (VP (VBG aiming) (S (VP (TO to) (VP (VB avoid) (CC or) (VB minimize) (NP (DT this) (NN effect)))))))))))) (. .)))
23949582	4	(ROOT (S (NP (NNS Doc_23949582_479_482_Chemical) (CC and) (NNS Doc_23949582_487_492_Chemical)) (VP (VBD were) (VP (VBN administrated) (ADVP (RB separately)) (PP (IN on) (NP (NP (NN rabbit) (POS 's)) (NNS lymphocytes))) (PP (IN in) (NP (NP (NN vivo)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (ADVP (RB later)) (VP (VBN developed) (PP (IN in) (ADJP (NN vitro))))))))))) (. .)))
23949582	5	(ROOT (S (NP (NP (JJ Cytogenetic) (NNS markers)) (PP (IN for) (NP (NP (NP (JJ sister) (JJ chromatid) (NNS exchanges)) (PRN (-LRB- -LRB-) (NP (NNP SCEs)) (-RRB- -RRB-))) (, ,) (NP (NP (NN proliferation) (NN rate) (NN index)) (PRN (-LRB- -LRB-) (NP (NNP PRI)) (-RRB- -RRB-))) (CC and) (NP (NNP Mitotic) (NNP Index))))) (VP (VBD were) (VP (VBN recorded))) (. .)))
23949582	6	(ROOT (S (NP (NP (NP (NNP Doc_23949582_716_721_Chemical) (POS 's)) (NN action)) (, ,) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NP (NNS Doc_23949582_752_755_Chemical)) (SBAR (S (VP (VBZ reduces) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NNP SCEs))))))))))) (, ,)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (DT the) (NNP SCEs) (NNS recordings))))) (VP (VBD obtained) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_23949582_840_843_Chemical)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB alone))))))) (. .)))
23949582	7	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NP (DT this)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (JJ high) (NNS concentrations)) (PP (IN of) (NP (NNS Doc_23949582_916_921_Chemical)))) (VP (VBD were) (VP (VBN administered) (ADVP (RB alone)))))))))) (NP (NP (JJ significant) (NNS reductions)) (PP (IN of) (NP (DT the) (NNP PRI)))) (VP (VBD were) (VP (VBN noted) (, ,) (PP (IN than) (IN with) (NP (NP (NNS Doc_23949582_1002_1005_Chemical)) (VP (VBG acting) (PP (IN at) (NP (NP (DT the) (JJ same) (NN concentration)) (PP (IN on) (NP (DT the) (NNS lymphocytes)))))))))) (. .)))
23949582	8	(ROOT (S (NP (NNP Doc_23949582_1059_1064_Chemical)) (ADVP (RB significantly)) (VP (VBZ reduces) (NP (NP (NNP Doc_23949582_1087_1090_Chemical) (POS 's)) (NN genotoxicity)) (, ,) (SBAR (IN while) (S (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN in) (NP (JJ high) (NNS concentrations)))))) (NP (PRP it)) (VP (VBZ acts) (PP (IN in) (NP (NP (DT an) (JJ inhibitory) (NN fashion)) (PP (IN on) (NP (NP (DT the) (JJ cytostatic) (NN action)) (PP (IN of) (NP (DT the) (NN drug))))))))))) (. .)))
23952588	0	(ROOT (NP (NP (NN Risk) (NNS factors) (CC and) (NNS predictors)) (PP (IN of) (NP (NN Doc_23952588_31_39_Chemical-induced) (NNS Doc_23952588_48_58_Disease))) (PP (IN among) (NP (JJ multiethnic) (NNS Malaysians))) (PP (IN with) (NP (NNS Doc_23952588_93_112_Disease))) (. .)))
23952588	1	(ROOT (S (NP (NP (JJ Chronic) (JJ pulsatile) (JJ Doc_23952588_132_140_Chemical) (NN therapy)) (PP (IN for) (NP (NP (NNS Doc_23952588_153_172_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_23952588_174_176_Disease)) (-RRB- -RRB-))))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN motor) (NNS fluctuations) (CC and) (NNS Doc_23952588_229_239_Disease)))))) (. .)))
23952588	2	(ROOT (S (NP (PRP We)) (VP (VBD studied) (NP (NP (DT the) (NN prevalence) (CC and) (NNS predictors)) (PP (IN of) (NP (NN Doc_23952588_285_293_Chemical-induced) (NNS Doc_23952588_302_312_Disease)))) (PP (IN among) (NP (JJ multiethnic) (JJ Malaysian) (NNS patients))) (PP (IN with) (NP (NNS Doc_23952588_355_357_Disease)))) (. .)))
23952588	3	(ROOT (S (NP (DT This)) (VP (VBZ is) (NP (NP (DT a) (JJ cross-sectional) (NN study)) (PP (VBG involving) (NP (NP (CD 95) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_23952588_427_429_Disease)) (PP (IN on) (NP (NP (JJ uninterrupted) (JJ Doc_23952588_447_455_Chemical) (NN therapy)) (PP (IN for) (NP (QP (IN at) (JJS least) (CD 6)) (NNS months))))))))))) (. .)))
23952588	4	(ROOT (S (NP (NP (DT The) (NN instrument)) (VP (VBN used))) (VP (VBD was) (NP (DT the) (NNP UPDRS) (NNS questionnaires))) (. .)))
23952588	5	(ROOT (S (NP (NP (DT The) (NNS predictors)) (PP (IN of) (NP (NNS Doc_23952588_555_565_Disease)))) (VP (VBD were) (VP (VBN determined) (S (VP (VBG using) (NP (JJ multivariate) (JJ logistic) (NN regression) (NN analysis)))))) (. .)))
23952588	6	(ROOT (S (NP (DT The) (JJ mean) (NN age)) (VP (VBD was) (NP (NP (QP (CD 65.6) (CD +))) (NP (CD 8.5) (NNS years)))) (. .)))
23952588	7	(ROOT (S (NP (DT The) (JJ mean) (NN onset) (NN age)) (VP (VBD was) (NP (CD 58.5) (NNP +) (CD 9.8) (NNS years))) (. .)))
23952588	8	(ROOT (S (NP (DT The) (JJ median) (NN disease) (NN duration)) (VP (VBD was) (NP (NP (CD 6)) (PRN (-LRB- -LRB-) (NP (CD 7)) (-RRB- -RRB-)) (NP (NNS years)))) (. .)))
23952588	9	(ROOT (S (NP (NNP Doc_23952588_761_771_Disease)) (VP (VBD was) (ADJP (JJ present) (PP (IN in) (NP (NP (CD 44) (NN %)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 42))))) (-RRB- -RRB-))))) (PP (IN with) (NP (NP (JJ median) (JJ Doc_23952588_812_820_Chemical) (NN therapy)) (PP (IN of) (NP (CD 3) (NNS years)))))) (. .)))
23952588	10	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (CD 64.3) (NN %)) (NP (NP (JJ Chinese) (, ,) (ADJP (CD 31) (NN %)) (NNS Malays)) (, ,) (CC and) (NP (NP (ADJP (CD 3.7) (NN %)) (NNPS Indians)) (CC and) (NP (JJ other) (JJ ethnic) (NNS groups))))) (. .)))
23952588	11	(ROOT (S (NP (NP (JJ Eighty-one) (NN percent)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_23952588_957_967_Disease)))))) (VP (VBD had) (NP (JJ clinical) (NNS fluctuations))) (. .)))
23952588	12	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NNS Doc_23952588_1009_1019_Disease)))) (VP (VBD had) (NP (NP (NP (NP (NP (JJR lower) (NN onset) (NN age)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-))) (, ,) (NP (NP (JJR longer) (NN duration)) (PP (IN of) (NP (JJ Doc_23952588_1073_1081_Chemical) (NN therapy))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_23952588_1104_1127_Disease)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-))) (, ,) (NP (NP (JJR higher) (NN total)) (NP (NP (JJ daily) (JJ Doc_23952588_1161_1169_Chemical) (NN dose)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))) (, ,) (CC and) (NP (JJR higher) (JJ total) (NN UPDRS) (NNS scores))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.005))))) (-RRB- -RRB-))) (PP (IN than) (NP (NNS patients)))) (PP (IN without) (NP (NNS Doc_23952588_1254_1264_Disease)))) (. .)))
23952588	13	(ROOT (S (NP (NP (DT The) (CD three) (JJ significant) (NNS predictors)) (PP (IN of) (NP (NNS Doc_23952588_1302_1312_Disease)))) (VP (VBD were) (NP (NP (NN duration)) (PP (IN of) (NP (NP (JJ Doc_23952588_1330_1338_Chemical) (NN therapy)) (, ,) (NP (NN onset) (NN age)) (, ,) (CC and) (NP (JJ total) (JJ daily) (JJ Doc_23952588_1375_1383_Chemical) (NN dose)))))) (. .)))
23952588	14	(ROOT (S (NP (NP (DT The) (NN prevalence)) (PP (IN of) (NP (NP (NN Doc_23952588_1421_1429_Chemical-induced) (NNS Doc_23952588_1438_1448_Disease)) (PP (IN in) (NP (PRP$ our) (NNS patients)))))) (VP (VBD was) (NP (CD 44) (NN %))) (. .)))
23952588	15	(ROOT (S (NP (DT The) (RBS most) (JJ significant) (NNS predictors)) (VP (VBD were) (NP (NP (NN duration)) (PP (IN of) (NP (NP (JJ Doc_23952588_1523_1531_Chemical) (NN therapy)) (, ,) (NP (JJ total) (JJ daily) (JJ Doc_23952588_1553_1561_Chemical) (NN dose)) (, ,) (CC and) (NP (NN onset) (NN age)))))) (. .)))
2400986	0	(ROOT (NP (NP (NP (JJ Dose-dependent) (NNS Doc_2400986_15_28_Disease)) (PP (IN of) (NP (NP (JJ high-dose) (NNS Doc_2400986_42_50_Chemical)) (PP (IN in) (NP (NNS children)))))) (: :) (NP (DT a) (JJ clinical) (CC and) (JJ pharmacological) (NN study)) (. .)))
2400986	1	(ROOT (S (S (NP (NNP Doc_2400986_102_110_Chemical)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (NNS Doc_2400986_126_136_Disease)) (PP (IN in) (NP (NNS animals) (CC and) (NNS humans)))))))))) (, ,) (CC but) (S (NP (PRP$ its) (JJ acute) (NNS Doc_2400986_174_187_Disease)) (VP (VBZ remains) (VP (ADVP (RB poorly)) (VBN characterized) (PP (IN in) (NP (NNS children)))))) (. .)))
2400986	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (ADVP (RB here)) (NP (NP (DT a) (NN retrospective) (NN study)) (PP (IN of) (NP (NP (NP (CD 123) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ median) (NN age)) (, ,) (NP (CD 6.5) (NNS years)) (-RRB- -RRB-))) (VP (VBG receiving) (NP (NP (JJ high-dose) (NNS Doc_2400986_327_335_Chemical)) (PP (IN in) (NP (VBN combined) (NN chemotherapy)))))))) (PP (IN before) (NP (NP (NN bone) (NN marrow) (NN transplantation)) (PP (IN for) (NP (NP (JJ malignant) (JJ solid) (NNS Doc_2400986_416_422_Disease)) (, ,) (NP (NP (NNS Doc_2400986_424_436_Disease)) (VP (VBN excluded)))))))) (. .)))
2400986	3	(ROOT (S (NP (NNP Doc_2400986_447_455_Chemical)) (VP (VBD was) (VP (VBN given) (NP (NP (NN p.o.)) (, ,) (NP (NP (DT every) (CD 6) (NNS hours)) (PP (IN for) (NP (NP (CD 16) (NNS doses)) (PP (IN over) (NP (CD 4) (NNS days))))))))) (. .)))
2400986	4	(ROOT (NP (NP (NP (CD Two) (JJ total) (NNS doses)) (SBAR (S (VP (VBD were) (VP (ADVP (RB consecutively)) (VBN used)))))) (: :) (NP (NP (CD 16) (NN mg/kg)) (, ,) (ADVP (RB then) (NP (CD 600) (NNS mg/m2)))) (. .)))
2400986	5	(ROOT (S (NP (NP (DT The) (NN dose) (NN calculation)) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NN body)))))) (VP (VBP surface) (NP (NP (NN area) (NNS results)) (PP (IN in) (NP (NP (JJR higher) (NNS doses)) (PP (IN in) (NP (JJ young) (NNS children)))))) (PP (IN than) (PP (IN in) (NP (NP (JJR older) (NNS patients)) (PRN (-LRB- -LRB-) (NP (QP (CD 16) (TO to) (CD 28) (CD mg/kg))) (-RRB- -RRB-)))))) (. .)))
2400986	6	(ROOT (S (S (NP (JJ Ninety-six) (NNS patients)) (VP (VBD were) (RB not) (VP (VBN given) (NP (JJ anticonvulsive) (NNS prophylaxis))))) (: ;) (S (NP (NP (CD 7)) (PRN (-LRB- -LRB-) (NP (CD 7.5) (NN %)) (-RRB- -RRB-))) (VP (VBD developed) (NP (NNS Doc_2400986_799_807_Disease)) (PP (PP (IN during) (NP (NP (DT the) (CD 4) (NNS days)) (PP (IN of) (NP (DT the) (JJ Doc_2400986_833_841_Chemical) (NN course))))) (CC or) (PP (IN within) (NP (CD 24) (NN h)))) (PP (IN after) (NP (DT the) (JJ last) (NN dosing))))) (. .)))
2400986	7	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (DT the) (JJ total) (JJ Doc_2400986_902_910_Chemical) (NN dose)) (VP (VBD was) (VP (VBN taken) (PP (IN into) (NP (NN account))))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN difference)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (JJ Doc_2400986_987_1000_Disease) (NN incidence)) (PP (IN among) (NP (NP (NNS patients)) (PP (IN under) (NP (NP (CD 16) (NN mg/kg) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (IN of) (NP (CD 57))) (, ,) (NP (CD 1.7) (NN %))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS patients)) (PP (IN under) (NP (NP (NP (CD 600) (NNS mg/m2)) (PRN (-LRB- -LRB-) (NP (NP (CD 6)) (PP (IN of) (NP (CD 39))) (, ,) (NP (CD 15.4) (NN %))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.02))) (-RRB- -RRB-))))))))))))))) (. .)))
2400986	8	(ROOT (S (S (NP (JJ Twenty-seven) (NNS patients)) (VP (VBD were) (VP (VBN given) (NP (DT a) (JJ 600-mg/m2) (NNS Doc_2400986_1168_1176_Chemical)) (NP (JJ total) (NN dose)) (PP (IN with) (NP (NP (JJ continuous) (NN i.v.) (NN infusion)) (PP (IN of) (NP (NNS Doc_2400986_1221_1231_Chemical)))))))) (: ;) (S (NP (NN none)) (VP (VBD had) (NP (DT any) (JJ neurological) (NNS symptoms)))) (. .)))
2400986	9	(ROOT (S (NP (JJ Doc_2400986_1269_1277_Chemical) (NNS levels)) (VP (VBD were) (VP (VBN measured) (PP (IN by) (NP (NP (DT a) (NN gas) (NNS chromatographic-mass) (NN spectrometry) (NN assay)) (PP (IN in) (NP (NP (DT the) (NN plasma) (CC and) (NN cerebrospinal) (NN fluid)) (PP (IN of) (NP (CD 9) (NNS children))))))) (PP (IN without) (NP (NNS Doc_2400986_1408_1438_Disease))) (PP (IN under) (NP (NP (CD 600) (JJ mg/m2) (NNS Doc_2400986_1455_1463_Chemical)) (PP (IN with) (NP (NNS Doc_2400986_1469_1479_Chemical))))) (: :) (FRAG (NP (JJ Doc_2400986_1480_1488_Chemical) (JJ cerebrospinal) (NN fluid)) (: :) (S (NP (NN plasma) (NN ratio)) (VP (VBD was) (NP (CD 1.39))))))) (. .)))
2400986	10	(ROOT (S (NP (DT This)) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJ different)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.02))) (-RRB- -RRB-))) (PP (IN from) (NP (NP (DT the) (JJ cerebrospinal) (NN fluid)) (: :) (NP (NP (NN plasma) (NN ratio)) (VP (ADVP (RB previously)) (VBN defined) (PP (IN in) (NP (NP (NNS children)) (VP (VBG receiving) (NP (NP (DT a) (JJ 16-mg/kg) (JJ total) (NN dose)) (PP (IN of) (NP (NNS Doc_2400986_1692_1700_Chemical)))))))))))) (. .)))
2400986	11	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ shows) (SBAR (IN that) (S (NP (JJ Doc_2400986_1724_1732_Chemical) (NNS Doc_2400986_1733_1746_Disease)) (VP (VBZ is) (ADJP (JJ dose-dependent) (PP (IN in) (NP (NP (NNS children) (CC and) (NNS efficiently)) (VP (VBN prevented) (PP (IN by) (NP (NNS Doc_2400986_1806_1816_Chemical))))))))))) (. .)))
2400986	12	(ROOT (S (NP (NP (DT A) (JJ Doc_2400986_1820_1828_Chemical) (NN dose)) (VP (VBN calculated) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NN body) (NN surface) (NN area)))))) (, ,) (VP (VBG resulting) (PP (IN in) (NP (NP (JJR higher) (NNS doses)) (PP (IN in) (NP (JJ young) (NNS children)))))) (, ,)) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NNS Doc_2400986_1941_1964_Disease))) (, ,) (ADVP (JJ close) (PP (TO to) (NP (NP (JJ Doc_2400986_1975_1988_Disease) (NN incidence)) (VP (VBN observed) (PP (IN in) (NP (NNS adults))))))))) (. .)))
2400986	13	(ROOT (S (SBAR (IN Since) (S (NP (NN plasma) (NN pharmacokinetic) (NNS studies)) (VP (VBD showed) (NP (DT a) (JJR faster) (JJ Doc_2400986_2072_2080_Chemical) (NN clearance)) (PP (IN in) (NP (NNS children))) (PP (IN than) (PP (IN in) (NP (NNS adults))))))) (, ,) (NP (DT this) (JJ new) (NN dose)) (VP (MD may) (VP (VB approximate) (ADVP (RBR more) (RB closely)) (NP (NP (DT the) (JJ adult) (JJ systemic) (NN exposure)) (VP (VBN obtained) (PP (IN after) (NP (DT the) (JJ usual) (JJ 16-mg/kg) (JJ total) (NN dose))) (, ,) (PP (IN with) (NP (NP (JJ potential) (NNS inferences)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (JJ anticancer) (CC or) (JJ myeloablative) (NNS effects))))))))))) (. .)))
2400986	14	(ROOT (S (NP (NP (DT The) (JJ Doc_2400986_2315_2323_Chemical) (NN dose)) (PP (IN in) (NP (NP (NNS children) (CC and) (NNS infants)) (VP (VBG undergoing) (NP (NN bone) (NN marrow) (NN transplantation)))))) (VP (MD should) (VP (VB be) (VP (VBN reconsidered) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (JJ pharmacokinetic) (NNS studies)))))))) (. .)))
24040781	0	(ROOT (S (NP (NP (DT An) (JJ unexpected) (NN diagnosis)) (PP (IN in) (NP (NP (DT a) (JJ renal-transplant) (NN patient)) (PP (IN with) (NP (NNS Doc_24040781_59_70_Disease)))))) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_24040781_84_94_Chemical)) (: :) (NP (NNS Doc_24040781_96_110_Disease))))) (. .)))
24040781	1	(ROOT (S (NP (NNP Doc_24040781_112_123_Disease)) (VP (VBZ is) (NP (NP (DT an) (JJ expected) (NN complication)) (PP (IN in) (NP (NP (NN transplant) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ mammalian) (NN target)) (PP (IN of) (NP (NP (JJ Doc_24040781_208_217_Chemical) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NNP mTOR-i)) (-RRB- -RRB-))))))))))) (. .)))
24040781	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (JJ clinical) (NN suspicion)) (VP (MD should) (ADVP (RB always)) (VP (VB be) (VP (VBN supported) (PP (IN by) (NP (JJ histological) (NN evidence))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB investigate) (NP (NP (JJ potential) (JJ alternate) (NNS diagnoses)) (PP (JJ such) (IN as) (NP (NP (JJ acute) (CC or) (JJ chronic) (NN rejection)) (, ,) (NP (JJ interstitial) (NNS Doc_24040781_422_430_Disease) (CC and) (NNS Doc_24040781_435_450_Disease)) (, ,) (CC or) (NP (NN recurrent)) (CC or) (NP (IN de) (JJ novo) (NNS Doc_24040781_476_490_Disease)))))))))))) (. .)))
24040781	3	(ROOT (S (PP (IN In) (NP (DT this) (NN case))) (NP (PRP we)) (VP (VBP report) (NP (NP (DT the) (JJ unexpected) (NN diagnosis)) (PP (IN of) (NP (NP (NNS Doc_24040781_543_554_Disease)) (PP (IN in) (NP (DT a) (JJ renal-transplant) (NN patient)))))) (PP (IN with) (NP (NP (JJ pre-transplant) (NNS Doc_24040781_605_626_Disease)) (PP (IN of) (NP (JJ undetermined) (NN significance))) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_24040781_670_681_Disease)) (PP (IN after) (NP (NN conversion))) (PP (IN from) (NP (NP (NNS Doc_24040781_704_714_Chemical)) (PP (TO to) (NP (NNS Doc_24040781_718_728_Chemical))))))))))) (. .)))
24055495	0	(ROOT (S (NP (JJ Long-term) (JJ oral) (JJ Doc_24055495_15_24_Chemical) (NN treatment)) (VP (VBZ prevents) (NP (NP (NNS Doc_24055495_44_62_Disease)) (PP (IN in) (NP (NP (JJ male) (NNP Wistar) (NNS rats)) (VP (VBN treated) (ADVP (RB intracerebroventricularly)) (PP (IN with) (NP (NNS Doc_24055495_122_136_Chemical)))))))) (. .)))
24055495	1	(ROOT (S (NP (NP (NNP Basic)) (CC and) (NP (JJ clinical) (NN research))) (VP (VP (VBZ has) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (NNS Doc_24055495_188_196_Disease)) (PP (IN of) (NP (ADJP (JJ sporadic)) (JJ Doc_24055495_209_228_Disease) (PRN (-LRB- -LRB-) (NP (NN sAD)) (-RRB- -RRB-)) (NN type)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NN dysfunction)) (PP (IN of) (NP (DT the) (JJ insulin-receptor) (PRN (-LRB- -LRB-) (NP (NNP IR)) (-RRB- -RRB-)) (NN system))))) (PP (VBN followed) (PP (IN by) (NP (NP (VBN decreased) (JJ Doc_24055495_329_336_Chemical) (NN transport)) (PP (IN via) (NP (JJ Doc_24055495_351_358_Chemical) (NN transporter) (NN GLUT4)))))))))))) (CC and) (VP (VBD decreased) (NP (JJ Doc_24055495_391_398_Chemical) (NN metabolism)) (PP (IN in) (NP (NN brain) (NNS cells))))) (. .)))
24055495	2	(ROOT (S (NP (NP (DT An) (JJ alternative) (NN source)) (PP (IN of) (NP (NN energy)))) (VP (VBZ is) (NP (NP (NNS Doc_24055495_461_472_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN Doc_24055495_478_479_Chemical-4-epimer)) (PP (IN of) (NP (NNS Doc_24055495_492_501_Chemical)))) (-RRB- -RRB-)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN transported) (PP (IN into) (NP (DT the) (NN brain))) (PP (IN by) (NP (NP (JJ insulin-independent) (NN GLUT3) (NN transporter)) (SBAR (WHADVP (WRB where)) (S (NP (PRP it)) (VP (MD might) (VP (VB be) (VP (VBN metabolized) (PP (TO to) (NP (NP (NNS Doc_24055495_613_620_Chemical)) (PP (IN via) (NP (DT the) (NNP Leloir) (NN pathway)))))))))))))))))) (. .)))
24055495	3	(ROOT (S (S (NP (NP (ADJP (RB Exclusively) (JJ parenteral)) (JJ daily) (NNS injections)) (PP (IN of) (NP (NNS Doc_24055495_688_697_Chemical)))) (VP (VP (VB induce) (NP (NN memory) (NN deterioration)) (PP (IN in) (NP (NNS rodents)))) (CC and) (VP (VBP are) (VP (VBN used) (S (VP (TO to) (VP (VB generate) (NP (NN animal) (NN aging) (NN model))))))))) (, ,) (CC but) (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ oral) (JJ Doc_24055495_806_815_Chemical) (NN treatment)) (PP (IN on) (NP (JJ cognitive) (NNS functions)))))) (VP (VBP have) (ADVP (RB never)) (VP (VBN been) (VP (VBN tested))))) (. .)))
24055495	4	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ continuous) (JJ daily) (JJ oral) (NNS Doc_24055495_931_940_Chemical))) (PRN (-LRB- -LRB-) (NP (CD 200) (NN mg/kg/day)) (-RRB- -RRB-)) (NP (NP (NN treatment)) (PP (IN on) (NP (NP (NNS Doc_24055495_970_988_Disease)) (PP (IN in) (NP (NP (ADJP (ADJP (JJ Doc_24055495_992_1006_Chemical-induced)) (PRN (-LRB- -LRB-) (ADJP (JJ Doc_24055495_1016_1019_Chemical-icv)) (-RRB- -RRB-))) (NN rat) (NN model)) (PP (IN of) (NP (NN sAD))) (, ,) (VP (VBN tested) (PP (IN by) (NP (NNP Morris) (NNP Water) (NNP Maze) (CC and) (NNP Passive) (NNP Avoidance) (NN test))) (, ,) (ADVP (RB respectively))))))))))) (. .)))
24055495	5	(ROOT (S (NP (NP (CD One) (NN month)) (PP (IN of) (NP (NP (JJ oral) (JJ Doc_24055495_1131_1140_Chemical) (NN treatment)) (VP (VBN initiated) (ADVP (RB immediately)) (PP (IN after) (NP (DT the) (NN Doc_24055495_1183_1186_Chemical-icv) (NN administration))) (, ,) (ADVP (RB successfully)))))) (VP (VBD prevented) (NP (NP (NN development)) (PP (IN of) (NP (DT the) (NN Doc_24055495_1249_1252_Chemical-icv-induced) (NNS Doc_24055495_1265_1283_Disease))))) (. .)))
24055495	6	(ROOT (S (NP (NP (NNP Beneficial) (NN effect)) (PP (IN of) (NP (JJ oral) (NNS Doc_24055495_1311_1320_Chemical)))) (VP (VBD was) (ADJP (JJ independent) (PP (PP (IN of) (NP (DT the) (NN rat) (NN age))) (CC and) (PP (IN of) (NP (NP (DT the) (JJ Doc_24055495_1363_1372_Chemical) (NN dose)) (VP (VBG ranging) (PP (IN from) (NP (QP (CD 100) (TO to) (CD 300))) (ADVP (RB mg/kg/day))))))))) (. .)))
24055495	7	(ROOT (S (ADVP (RB Additionally)) (, ,) (NP (JJ oral) (JJ Doc_24055495_1432_1441_Chemical) (NN administration)) (VP (VBD led) (PP (TO to) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NNS Doc_24055495_1482_1491_Chemical))))) (PP (IN in) (NP (DT the) (NN blood)))) (. .)))
24055495	8	(ROOT (S (NP (NP (DT The) (NN increase)) (PP (IN of) (NP (NP (JJ Doc_24055495_1522_1531_Chemical) (NN concentration)) (PP (IN in) (NP (DT the) (JJ cerebrospinal) (NN fluid)))))) (VP (VBD was) (ADJP (ADJP (NP (QP (JJ several) (NNS times))) (JJR lower) (PP (IN after) (NP (JJ oral)))) (PP (IN than) (PP (IN after) (NP (NP (JJ parenteral) (NN administration)) (PP (IN of) (NP (DT the) (JJ same) (JJ Doc_24055495_1657_1666_Chemical) (NN dose)))))))) (. .)))
24055495	9	(ROOT (S (NP (JJ Oral) (JJ Doc_24055495_1678_1687_Chemical) (NN exposure)) (VP (VP (MD might) (VP (VB have) (NP (NP (JJ beneficial) (NNS effects)) (PP (IN on) (NP (NN learning) (CC and) (NN memory) (NN ability)))))) (CC and) (VP (MD could) (VP (VB be) (ADJP (JJ worth)) (S (VP (VBG investigating) (PP (IN for) (NP (NP (NN improvement)) (PP (IN of) (NP (NP (NNS Doc_24055495_1810_1828_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ Doc_24055495_1845_1852_Chemical) (NN hypometabolism)) (PP (IN in) (NP (NNS Doc_24055495_1871_1873_Disease))))))))))))))) (. .)))
24067251	0	(ROOT (NP (NP (NP (DT An) (NN investigation)) (PP (IN of) (NP (NP (DT the) (NN pattern)) (PP (IN of) (NP (NP (NNS Doc_24067251_35_48_Disease)) (PP (IN in) (NP (NP (JJ HIV-positive) (NNS persons)) (VP (VBN exposed) (PP (TO to) (NP (NNS Doc_24067251_84_113_Chemical))))))))))) (: :) (NP (NP (DT an) (NN examination)) (PP (IN of) (NP (NP (DT a) (JJ large) (NN population) (NN database)) (PRN (-LRB- -LRB-) (NP (NNP MHRA) (NN database)) (-RRB- -RRB-))))) (. .)))
24067251	1	(ROOT (S (NP (NP (DT The) (NN potential)) (PP (IN for) (NP (NNS Doc_24067251_196_205_Chemical) (S (VP (TO to) (VP (VB cause) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (NNS Doc_24067251_226_242_Disease)))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN established) (PP (IN from) (NP (ADJP (JJ mechanistic) (CC and) (JJ randomised)) (JJ clinical) (NNS trials)))))) (. .)))
24067251	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ exact) (NN pattern)) (PP (IN of) (NP (NN kidney) (NN involvement)))) (VP (VBZ is) (ADVP (RB still)) (ADJP (JJ uncertain))) (. .)))
24067251	3	(ROOT (S (NP (PRP We)) (VP (VP (VBD undertook) (NP (NP (DT a) (ADJP (JJ descriptive)) (NN analysis)) (PP (IN of) (NP (NP (JJ Yellow) (NN Card) (NNS records)) (PP (IN of) (NP (CD 407) (JJ HIV-positive) (NNS persons)))))) (S (VP (VBG taking) (NP (NP (NNS Doc_24067251_476_505_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24067251_507_510_Chemical)) (-RRB- -RRB-))) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (PRP$ their) (JJ antiretroviral) (NN therapy) (NN regimen)))))))) (CC and) (VP (VBD submitted) (PP (TO to) (NP (DT the) (NNP Medicines) (CC and) (NNP Healthcare) (NNP Products)))) (NP (NP (NNP Regulatory) (NNP Agency)) (PRN (-LRB- -LRB-) (NP (NNP MHRA)) (-RRB- -RRB-))) (PP (IN with) (NP (VBN suspected) (NN kidney) (JJ adverse) (NNS effects)))) (. .)))
24067251	4	(ROOT (S (NP (NP (NNS Reports)) (SBAR (WHNP (WDT that)) (S (VP (VB satisfy))))) (VP (VBD defined) (SBAR (S (NP (NNS criteria)) (VP (VBD were) (VP (VBN classified) (PP (IN as) (NP (NNS Doc_24067251_736_783_Disease) (CC and) (NNS Doc_24067251_788_804_Disease)))))))) (. .)))
24067251	5	(ROOT (S (PP (IN Of) (NP (NP (DT the) (CD 407) (JJ Yellow) (NN Card) (NNS records)) (VP (VBN analysed) (, ,) (NP (NP (QP (CD 106) (CD satisfied)) (NNS criteria)) (PP (IN for) (NP (NP (JJ TDF-related) (NNS Doc_24067251_886_900_Disease)) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (NP (CD 53)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (NP (NP (NNS features)) (PP (IN of) (NP (NN kidney) (NNS Doc_24067251_943_962_Disease))))))))))))) (, ,) (S (NP (NP (CD 35)) (PRN (-LRB- -LRB-) (NP (CD 33) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NP (NNS features)) (PP (IN of) (NP (NNS Doc_24067251_1004_1026_Disease)))))))))) (CC and) (S (NP (NP (CD 18)) (PRN (-LRB- -LRB-) (NP (CD 17) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (NP (NNS Doc_24067251_1044_1060_Disease)))) (. .)))
24067251	6	(ROOT (S (NP (DT The) (JJ median) (NNP TDF) (NN exposure)) (VP (VBD was) (NP (NP (JJ 316) (NNS days)) (PRN (-LRB- -LRB-) (NP (JJ interquartile) (NN range) (NN 120-740)) (-RRB- -RRB-)))) (. .)))
24067251	7	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NN hospitalisation)) (PP (IN for) (NP (NNP TDF) (NN kidney) (JJ adverse) (NNS effects)))))) (VP (VBD was) (ADJP (JJ high)) (, ,) (PP (ADVP (RB particularly)) (IN amongst) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS features)) (PP (IN of) (NP (NNS Doc_24067251_1251_1267_Disease)))))))) (. .)))
24067251	8	(ROOT (S (NP (NP (DT The) (NN pattern)) (PP (IN of) (NP (NP (NNS Doc_24067251_1284_1300_Disease)) (PP (IN in) (NP (DT this) (NN population) (NN series)))))) (VP (VBZ mirrors) (SBAR (IN that) (S (VP (VBD reported) (PP (IN in) (NP (JJ randomised) (JJ clinical) (NNS trials))))))) (. .)))
24067251	9	(ROOT (S (NP (NP (NNP Cessation)) (PP (IN of) (NP (NNP TDF)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (JJ complete) (NNS Doc_24067251_1426_1456_Disease)) (PP (IN in) (NP (NP (QP (RB up) (PDT half))) (PP (IN of) (NP (NP (DT the) (NNS patients)) (PP (IN in) (NP (DT this) (NN report))))))))))) (. .)))
24068571	0	(ROOT (S (NP (NP (NNP Incidence)) (PP (IN of) (NP (NNS Doc_24068571_13_35_Disease)))) (VP (VBZ is) (ADJP (JJ high) (RB even) (PP (IN in) (NP (DT a) (NN population))) (PP (IN without) (NP (VBN known) (NN risk) (NNS factors))))) (. .)))
24068571	1	(ROOT (S (NP (NNP Doc_24068571_102_124_Disease)) (VP (VBZ is) (NP (NP (DT a) (VBN recognized) (NN complication)) (PP (IN in) (NP (NP (NNS populations)) (PP (IN at) (NP (NN risk))))))) (. .)))
24068571	2	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBZ is) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (NP (JJ early) (NNS Doc_24068571_237_259_Disease)) (PP (IN in) (NP (DT a) (NN population)))))) (PP (IN without) (NP (NP (VBN known) (NN risk) (NNS factors)) (VP (VBN admitted) (PP (TO to) (NP (NP (DT the) (NNP ICU)) (PP (IN for) (NP (JJ postoperative) (NN monitoring))))) (PP (IN after) (NP (JJ elective) (JJ major) (NN surgery)))))))))) (. .)))
24068571	3	(ROOT (S (NP (NP (DT The) (JJ secondary) (NN outcome)) (VP (VBN investigated))) (VP (VBZ is) (S (VP (TO to) (VP (VB identify) (NP (JJ eventual) (JJ independent) (NN risk) (NNS factors)) (PP (IN among) (NP (NP (JJ demographic) (NNS data)) (CC and) (NP (NP (JJ anesthetic) (NNS drugs)) (VP (VBN used))))))))) (. .)))
24068571	4	(ROOT (S (NP (DT An) (JJ observational) (, ,) (JJ prospective) (NN study)) (VP (VBD was) (VP (VBN conducted) (PP (IN on) (NP (NP (DT a) (JJ consecutive) (NN cohort)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN admitted) (PP (TO to) (NP (PRP$ our) (NN ICU))) (PP (IN within) (CC and) (IN for) (NP (QP (IN at) (JJS least) (CD 24)) (NN h))) (PP (IN after) (NP (JJ major) (JJ surgical) (NNS procedures)))))))))) (. .)))
24068571	5	(ROOT (S (NP (NN Exclusion) (NNS criteria)) (VP (VBD were) (NP (DT any) (VBG preexisting) (VBG predisposing) (NN factor)) (PP (IN for) (NP (NP (NNS Doc_24068571_757_765_Disease)) (CC or) (NP (JJ other) (ADJP (RB potentially) (JJ confounding)) (NNS Doc_24068571_799_824_Disease))))) (. .)))
24068571	6	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN assessed) (ADVP (RB daily)) (S (VP (VBG using) (NP (NP (DT the) (NN confusion) (NN assessment) (NN method)) (PP (IN for) (NP (DT the) (NNP ICU) (NN scale)))) (PP (IN for) (NP (CD 3) (NNS days))) (PP (IN after) (NP (DT the) (JJ surgical) (NN procedure))))))) (. .)))
24068571	7	(ROOT (S (NP (RB Early) (JJ Doc_24068571_958_980_Disease) (JJ incidence) (NN risk) (NNS factors)) (VP (VBD were) (ADVP (RB then)) (VP (VBN assessed) (PP (IN through) (NP (CD three) (JJ different) (JJ multiple) (NN regression) (NNS models))))) (. .)))
24068571	8	(ROOT (S (PP (VBG According) (PP (TO to) (NP (NP (DT the) (NN confusion) (NN assessment) (NN method)) (PP (IN for) (NP (DT the) (NNP ICU) (NN scale)))))) (, ,) (NP (NP (CD 28) (NN %)) (PP (IN of) (NP (NNS patients)))) (VP (VBD were) (VP (VBN diagnosed) (PP (IN with) (NP (JJ early) (NNS Doc_24068571_1191_1213_Disease))))) (. .)))
24068571	9	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NNS Doc_24068571_1226_1237_Chemical)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (JJ eight-fold-higher) (NN risk)) (PP (IN for) (NP (NNS Doc_24068571_1302_1310_Disease))))) (PP (VBN compared) (PP (TO to) (NP (NP (NNS Doc_24068571_1323_1331_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 57.1) (NN %)) (PP (IN vs.) (NP (CD 7.1) (NN %)))) (, ,) (NP (NP (NNP RR)) (SBAR (S (VP (SYM =) (NP (CD 8.0)))))) (, ,) (NP (NP (NP (NNP X2)) (SBAR (S (VP (SYM =) (NP (CD 4.256)))))) (: ;) (NP (NP (NN df)) (SBAR (S (VP (SYM =) (NP (CD 1)))))) (: ;) (NP (NP (CD 0.05) (JJ <) (NN p) (NNS <)) (NP (CD 0.02))))) (-RRB- -RRB-))))))) (. .)))
24068571	10	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (NP (JJ early) (NNS Doc_24068571_1429_1451_Disease)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (ADJP (RB very) (JJ common)) (NN complication)) (PP (IN after) (NP (JJ major) (NN surgery))))))) (, ,) (PP (RB even) (IN in) (NP (NP (DT a) (NN population)) (PP (IN without) (NP (VBN known) (NN risk) (NNS factors))))))) (. .)))
24068571	11	(ROOT (S (NP (NNP Doc_24068571_1565_1576_Chemical)) (VP (VBD was) (ADVP (RB independently)) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (PRP$ its) (JJ relative) (NN risk))))))) (. .)))
24072398	0	(ROOT (S (NP (NP (DT A) (JJ single) (JJ neurotoxic) (NN dose)) (PP (IN of) (NP (NNS Doc_24072398_28_43_Chemical)))) (VP (VBZ induces) (NP (NP (DT a) (JJ long-lasting) (NN Doc_24072398_67_77_Disease-like) (NN behaviour)) (PP (IN in) (NP (NNS mice))))) (. .)))
24072398	1	(ROOT (S (NP (NP (NNP Doc_24072398_102_117_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24072398_119_123_Chemical)) (-RRB- -RRB-))) (VP (VBZ triggers) (SBAR (S (NP (NP (DT a) (NN disruption)) (PP (IN of) (NP (DT the) (JJ monoaminergic) (NN system) (CC and) (NNS Doc_24072398_179_183_Chemical) (NN abuse)))) (VP (VBZ leads) (PP (TO to) (NP (NP (JJ negative) (JJ emotional) (NNS states)) (PP (VBG including) (NP (NP (NNS Doc_24072398_235_254_Disease)) (PP (IN during) (NP (NN drug) (NN withdrawal))))))))))) (. .)))
24072398	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADVP (RB currently)) (ADJP (JJ unknown)) (SBAR (IN if) (S (NP (NP (DT the) (ADJP (JJ acute) (NN toxic)) (NN dosage)) (PP (IN of) (NP (NNS Doc_24072398_341_345_Chemical)))) (ADVP (RB also)) (VP (VBZ causes) (NP (NP (DT a) (JJ long-lasting) (NNS Doc_24072398_373_393_Disease)) (CC and) (NP (JJ persistent) (JJ monoaminergic) (NNS deficits))))))) (. .)))
24072398	3	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (PRP we)) (ADVP (RB now)) (VP (VBD assessed) (NP (DT the) (NN Doc_24072398_459_469_Disease-like) (NN behaviour)) (PP (IN in) (NP (NP (NNS mice)) (PP (IN at) (NP (JJ early) (CC and) (JJ long-term) (NNS periods))))) (PP (VBG following) (NP (NP (DT a) (JJ single) (JJ high) (JJ Doc_24072398_548_552_Chemical) (NN dose)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-))))) (. .)))
24072398	4	(ROOT (S (NP (NNP Doc_24072398_576_580_Chemical)) (VP (VBD did) (RB not) (VP (VP (VB alter) (NP (NP (DT the) (NN motor) (NN function) (CC and) (JJ procedural) (NN memory)) (PP (IN of) (NP (NNS mice)))) (SBAR (IN as) (S (VP (VBN assessed) (PP (IN by) (NP (NN swimming) (NN speed))))))) (CC and) (VP (VB escape) (ADVP (RB latency)) (S (VP (TO to) (VP (VB find) (NP (DT the) (NN platform)) (PP (IN in) (NP (NP (DT a) (JJ cued) (NN version)) (PP (IN of) (NP (DT the) (NN water) (NN maze) (NN task))))))))))) (. .)))
24072398	5	(ROOT (S (ADVP (RB However)) (, ,) (NP (NNS Doc_24072398_765_769_Chemical)) (ADVP (RB significantly)) (VP (VBD increased) (NP (DT the) (JJ immobility) (NN time)) (PP (IN in) (NP (DT the) (JJ tail) (NN suspension) (NN test))) (PP (IN at) (NP (NP (CD 3) (CC and) (CD 49) (NNS days)) (ADJP (JJ post-administration))))) (. .)))
24072398	6	(ROOT (S (NP (NP (DT This) (NN Doc_24072398_885_895_Disease-like) (NN profile)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_24072398_920_924_Chemical))))) (VP (VBD was) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT a) (JJ marked) (NN depletion)) (PP (IN of) (NP (JJ frontostriatal) (ADJP (JJ dopaminergic) (CC and) (JJ serotonergic)) (NNS neurotransmission))) (, ,) (VP (VBN indicated) (PP (IN by) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NNS Doc_24072398_1072_1080_Chemical) (, ,) (NNS Doc_24072398_1082_1087_Chemical) (CC and) (NNS Doc_24072398_1092_1095_Chemical)))))))) (, ,) (NP (JJ Doc_24072398_1097_1105_Chemical) (NN hydroxylase)) (CC and) (NP (NP (NNS Doc_24072398_1122_1131_Chemical)) (, ,) (UCP (VP (VBN observed) (PP (IN at) (NP (DT both) (CD 3)))) (CC and) (ADJP (NP (CD 49) (NNS days)) (JJ post-administration)))))))) (. .)))
24072398	7	(ROOT (S (PP (IN In) (NP (NN parallel))) (, ,) (S (NP (NP (DT another) (JJ neurochemical) (NN feature)) (PP (IN of) (NP (NP (NN depression)) (PRN (: --) (NP (JJ astroglial) (NN dysfunction)) (: --))))) (VP (VBD was) (ADJP (JJ unaffected) (PP (IN in) (NP (DT the) (NN cortex)))))) (CC and) (S (NP (NP (DT the) (JJ striatal) (NNS levels)) (PP (IN of) (NP (NP (DT the) (JJ astrocytic) (NN protein) (NN marker)) (, ,) (NP (JJ glial) (JJ fibrillary) (JJ acidic) (NN protein)) (, ,)))) (VP (VBD were) (ADVP (RB only)) (VP (ADVP (RB transiently)) (VBN increased) (PP (IN at) (NP (CD 3) (NNS days)))))) (. .)))
24072398	8	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP demonstrate) (PP (IN for) (NP (DT the) (JJ first) (NN time))) (SBAR (IN that) (S (NP (NP (DT a) (JJ single) (JJ high) (NN dose)) (PP (IN of) (NP (NNS Doc_24072398_1503_1507_Chemical)))) (VP (VBZ induces) (NP (NP (JJ long-lasting) (NN Doc_24072398_1529_1539_Disease-like) (NN behaviour)) (PP (IN in) (NP (NP (NNS mice)) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ persistent) (NN disruption)) (PP (IN of) (NP (JJ frontostriatal) (ADJP (JJ dopaminergic) (CC and) (JJ serotonergic)) (NNS homoeostasis))))))))))))) (. .)))
24088636	0	(ROOT (NP (CD Doc_24088636_0_9_Chemical-induced) (NNS Doc_24088636_18_34_Disease) (. .)))
24088636	1	(ROOT (S (NP (JJ Many) (JJ systemic) (NNS antimicrobials)) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (S (VP (TO to) (VP (VB cause) (NP (JJ ocular) (JJ adverse) (NNS effects)))))))) (. .)))
24088636	2	(ROOT (S (NP (DT This)) (VP (VBZ is) (ADJP (RB especially) (JJ relevant) (PP (IN in) (S (VP (VBG multidrug) (NP (NN therapy)) (SBAR (WHADVP (WRB where)) (S (NP (QP (JJR more) (IN than) (CD one)) (NN drug)) (VP (MD can) (VP (VB cause) (NP (DT a) (JJ similar) (NN ocular) (JJ adverse) (NN effect))))))))))) (. .)))
24088636	3	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (JJ progressive) (NNS Doc_24088636_270_284_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_24088636_301_310_Chemical) (NN therapy)))))))) (. .)))
24088636	4	(ROOT (S (NP (NP (NP (DT A) (JJ 45-year-old) (JJ male) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (PP (IN on) (NP (NN treatment))) (PP (IN with) (NP (NP (JJ multiple) (JJ second-line) (JJ anti-Doc_24088636_399_410_Disease) (NNS drugs)) (PP (VBG including) (NP (NP (NNS Doc_24088636_427_436_Chemical) (CC and) (NNS Doc_24088636_441_451_Chemical)) (PP (IN for) (NP (JJ extensively) (NNS Doc_24088636_468_495_Disease))))))))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_24088636_497_503_Disease)) (-RRB- -RRB-))) (VP (VBD presented) (PP (TO to) (NP (PRP us))) (PP (IN with) (NP (NP (JJ painless) (JJ progressive) (NNS Doc_24088636_547_561_Disease)) (PP (IN in) (NP (DT both) (NNS eyes)))))) (. .)))
24088636	5	(ROOT (S (S (NP (NNP Color) (NN vision)) (VP (VBD was) (ADJP (JJ defective)))) (CC and) (S (NP (JJ fundus) (NN examination)) (VP (VBD revealed) (NP (NNS Doc_24088636_635_651_Disease)) (PP (IN in) (NP (DT both) (NNS eyes))))) (. .)))
24088636	6	(ROOT (S (S (NP (JJ Doc_24088636_666_676_Chemical-induced) (NNS Doc_24088636_685_707_Disease)) (VP (VBD was) (VP (VBN suspected)))) (CC and) (S (NP (NN tablet) (NNS Doc_24088636_733_743_Chemical)) (VP (VBD was) (VP (VBN withdrawn)))) (. .)))
24088636	7	(ROOT (S (NP (NNP Doc_24088636_759_782_Disease)) (VP (VBD occurred) (PP (IN despite) (NP (NP (NN withdrawal)) (PP (IN of) (NP (NNS Doc_24088636_814_824_Chemical)))))) (. .)))
24088636	8	(ROOT (S (NP (NP (NNP Discontinuation)) (PP (IN of) (NP (NNS Doc_24088636_845_854_Chemical)))) (VP (VBD resulted) (PP (IN in) (NP (JJ marked) (NNS Doc_24088636_874_895_Disease)))) (. .)))
24088636	9	(ROOT (S (NP (PRP$ Our) (NN report)) (VP (VBZ emphasizes) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NP (NN monitoring)) (PP (IN of) (NP (JJ visual) (NN function)))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (JJ long-term) (JJ Doc_24088636_987_996_Chemical) (NN treatment)))))) (. .)))
24091473	0	(ROOT (NP (NP (NNP Resuscitation)) (PP (IN with) (NP (NP (NN lipid)) (, ,) (NP (NNS Doc_24091473_26_37_Chemical)) (, ,) (CC or) (NP (DT both)))) (PP (IN in) (NP (NN Doc_24091473_50_65_Chemical-induced) (NNS Doc_24091473_74_90_Disease))) (PP (IN in) (NP (JJ newborn) (NNS piglets))) (. .)))
24091473	1	(ROOT (S (NP (NP (DT The) (JJ optimal) (NN dosing) (NNS regimens)) (PP (IN of) (NP (NP (NN lipid) (NN emulsion)) (, ,) (NP (NNS Doc_24091473_170_181_Chemical)) (, ,) (CC or) (NP (DT both))))) (VP (VBP are) (RB not) (VP (ADVP (RB yet)) (VBN determined) (PP (IN in) (NP (NP (NNS neonates)) (PP (IN in) (NP (NP (NNS cases)) (PP (IN of) (NP (NP (JJ local) (JJ anaesthetic) (JJ systemic) (NNS Doc_24091473_265_273_Disease)) (PRN (-LRB- -LRB-) (NP (NNP LAST)) (-RRB- -RRB-)))))))))) (. .)))
24091473	2	(ROOT (S (NP (NN Newborn) (NNS piglets)) (VP (VBD received) (NP (NNS Doc_24091473_316_331_Chemical)) (SBAR (IN until) (S (NP (NNS Doc_24091473_338_361_Disease)) (VP (VBD occurred))))) (. .)))
24091473	3	(ROOT (S (S (NP (NNP Standard) (NN cardiopulmonary) (NN resuscitation)) (VP (VBD was) (VP (VBN started)))) (CC and) (S (NP (NP (NN electrocardiogram)) (PRN (-LRB- -LRB-) (NP (NNP ECG)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN monitored) (PP (IN for) (NP (NNS Doc_24091473_469_492_Disease) (, ,) (NNS Doc_24091473_494_506_Disease) (, ,) (CC or) (NNP QRS) (NNS prolongation)))))) (. .)))
24091473	4	(ROOT (S (NP (NNS Piglets)) (VP (VBD were) (ADVP (RB then)) (VP (ADVP (RB randomly)) (VBN allocated) (PP (TO to) (NP (NP (NP (CD four) (NNS groups)) (: :) (NP (NP (NN control)) (PRN (-LRB- -LRB-) (NP (NN saline)) (-RRB- -RRB-)) (, ,) (NP (NNP Intralipid) (NNP -LRB-))) (-RRB- -RRB-)) (ADJP (RB alone)) (, ,) (VP (VBN Doc_24091473_621_632_Chemical) (ADVP (RB alone))) (, ,) (CC or) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NNP Intralipd) (CC plus) (NNP Doc_24091473_675_686_Chemical)))))))) (. .)))
24091473	5	(ROOT (S (NP (NNP Resuscitation)) (VP (VP (VBD continued) (PP (IN for) (NP (CD 30) (NN min)))) (CC or) (VP (SBAR (IN until) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (NN return)) (PP (IN of) (NP (NP (JJ spontaneous) (NN circulation)) (PRN (-LRB- -LRB-) (NP (NNP ROSC)) (-RRB- -RRB-)) (VP (VP (VBN accompanied) (PP (IN by) (NP (DT a) (JJ mean) (JJ arterial) (NN pressure))) (PP (IN at))) (CC or) (VP (ADJP (JJ superior) (PP (TO to) (NP (DT the) (NN baseline) (NN pressure) (CC and) (JJ normal) (NNS sinus) (NN rhythm)))) (PP (IN for) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (CD 30) (NN min))))))))))))))) (. .)))
24091473	6	(ROOT (S (NP (NNP ROSC)) (VP (VBD was) (VP (VBN achieved) (PP (IN in) (NP (NP (RB only) (CD one)) (PP (IN of) (NP (DT the) (NN control) (NNS piglets))))) (PP (VBN compared) (PP (IN with) (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (JJ treated) (NNS piglets)))))))) (. .)))
24091473	7	(ROOT (S (NP (NNP Mortality)) (VP (VP (VBD was) (ADJP (RB not) (RB significantly) (JJ different)) (PP (IN between) (NP (DT the) (CD three) (NN treatment) (NNS groups)))) (, ,) (CC but) (VP (VBD was) (ADJP (RB significantly) (JJR lower)) (PP (IN in) (NP (NP (PDT all) (DT the) (NN treatment) (NNS groups)) (PP (VBN compared) (PP (IN with) (NP (NN control)))))))) (. .)))
24091473	8	(ROOT (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NNP ECG) (NNS abnormalities)))) (VP (VBD was) (NP (NP (CD zero)) (PP (IN in) (NP (DT the) (NNP Intralipid) (JJ only) (NN group)))) (, ,) (PP (CC but) (NP (CD 14) (CC and) (CD 17))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN in) (NP (NP (DT the) (NNS Doc_24091473_1282_1293_Chemical) (CC and) (NNS Doc_24091473_1298_1309_Chemical)) (PP (CC plus) (NP (NP (NN lipid) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-))))))) (. .)))
24091473	9	(ROOT (S (S (NP (NNP Lipid)) (VP (VBN emulsion) (PP (IN with) (CC or) (IN without) (NP (NNS Doc_24091473_1382_1393_Chemical))))) (, ,) (CC or) (S (NP (NNS Doc_24091473_1398_1409_Chemical)) (ADVP (RB alone)) (VP (VBD were) (ADJP (RB equally) (JJ effective) (PP (IN in) (S (VP (VBG achieving) (NP (DT a) (NN return)) (PP (TO to) (NP (NP (JJ spontaneous) (NN circulation)) (PP (IN in) (NP (NP (DT this) (NN model)) (PP (IN of) (NP (NNP LAST))))))))))))) (. .)))
24091473	10	(ROOT (S (NP (NP (JJ Doc_24091473_1511_1522_Chemical) (UCP (ADVP (RB alone)) (CC or) (PP (IN in))) (NN combination)) (PP (IN with) (NP (NN lipid)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN number)) (PP (IN of) (NP (NP (NNP ECG) (NNP abnormalities)) (PP (VBN compared) (PP (IN with) (NP (NN lipid) (NN emulsion)) (ADVP (RB alone)))))))))) (. .)))
24100055	0	(ROOT (S (NP (NP (NP (NNP Incidence)) (PP (IN of) (NP (NN Doc_24100055_13_20_Chemical-induced) (NNS Doc_24100055_29_53_Disease)))) (CC and) (NP (NP (JJ postoperative) (NN recovery)) (PP (IN of) (NP (NN platelet))))) (VP (VBP count) (PP (IN in) (NP (NP (NN liver) (NN graft) (NNS recipients)) (: :) (NP (DT a) (ADJP (JJ retrospective) (JJ cohort)) (NN analysis))))) (. .)))
24100055	1	(ROOT (S (NP (NP (NNP Doc_24100055_171_187_Disease)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ end-stage) (NNS Doc_24100055_215_228_Disease)))))) (VP (VBZ is) (NP (NP (DT a) (JJ common) (NN disorder)) (VP (VBN caused) (ADVP (RB mainly)) (PP (IN by) (NP (NP (JJ portal) (NNS Doc_24100055_274_286_Disease)) (, ,) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NN thrombopoetin)))) (, ,) (CC and) (NP (NNS Doc_24100055_321_332_Disease))))))) (. .)))
24100055	2	(ROOT (S (NP (NP (DT The) (NN impact)) (PP (IN of) (NP (NP (NP (JJ immune-mediated) (NN Doc_24100055_364_371_Chemical-induced) (NNS Doc_24100055_380_404_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24100055_406_417_Disease)) (-RRB- -RRB-))) (PP (IN as) (NP (NP (DT a) (NN cause)) (PP (IN of) (NP (NP (NNS Doc_24100055_433_449_Disease)) (PP (IN after) (NP (NN liver) (NN transplantation)))))))))) (VP (VBZ is) (RB not) (VP (ADVP (RB yet)) (VBN understood) (, ,) (PP (IN with) (NP (NP (JJ few) (NN literature) (NNS citations)) (VP (VBG reporting) (NP (JJ contradictory) (NNS results))))))) (. .)))
24100055	3	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (PRP$ our) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VP (VB demonstrate) (NP (NP (DT the) (JJ perioperative) (NN course)) (PP (IN of) (NP (NNS Doc_24100055_632_648_Disease)))) (PP (IN after) (NP (NN liver) (NN transplantation)))) (CC and) (VP (VB determine) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (JJ clinical) (NNS Doc_24100055_718_729_Disease))))))))) (. .)))
24100055	4	(ROOT (S (NP (PRP We)) (ADVP (RB retrospectively)) (VP (VP (VBN evaluated) (NP (NP (DT the) (JJ medical) (NNS records)) (PP (IN of) (NP (NP (JJ 205) (JJ consecutive) (NN adult) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (NP (JJ full-size) (NN liver) (NN transplantation)) (PP (IN between) (NP (NNP January) (CD 2006))))))))))) (CC and) (VP (ADJP (NP (NNP December) (CD 2010)) (JJ due)) (PP (TO to) (NP (ADJP (JJ end-stage) (CC or) (JJ malignant)) (NNS Doc_24100055_937_950_Disease))))) (. .)))
24100055	5	(ROOT (S (NP (NP (JJ Preoperative) (NN platelet) (NN count)) (, ,) (NP (NP (NP (JJ postoperative) (NN course)) (PP (IN of) (NP (NNS platelets)))) (, ,) (CC and) (NP (NP (JJ clinical) (NNS signs)) (PP (IN of) (NP (NNS Doc_24100055_1038_1049_Disease)))))) (VP (VBD were) (VP (VBN analyzed))) (. .)))
24100055	6	(ROOT (S (NP (NP (NP (DT A) (NN total)) (PP (IN of) (NP (CD 155)))) (PRN (-LRB- -LRB-) (NP (CD 75.6) (NN %)) (-RRB- -RRB-)) (PP (IN of) (NP (JJ 205) (NNS patients)))) (VP (VBD had) (NP (NP (NNS Doc_24100055_1117_1133_Disease)) (PP (IN before) (NP (NN transplantation)))) (, ,) (ADVP (RB significantly)) (VP (VBN influenced) (PP (IN by) (NP (NP (NNP Model)) (PP (IN of) (NP (JJ End-Stage) (JJ Doc_24100055_1205_1218_Disease) (NN score) (CC and) (NN liver) (NNS Doc_24100055_1235_1244_Disease))))))) (. .)))
24100055	7	(ROOT (S (S (NP (DT The) (NN platelet) (NN count)) (VP (VBD exceeded) (NP (CD 100,000) (JJ /) (NN uL)) (PP (IN in) (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (NNS patients))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 193))))) (-RRB- -RRB-)) (PP (IN at) (NP (NP (DT a) (NN medium)) (PP (IN of) (NP (NP (CD 7) (NN d.)) (PP (VBG Regarding) (NP (NNS Doc_24100055_1349_1355_Disease))))))))) (, ,) (NP (EX there)) (VP (VBD were) (ADVP (CD four)) (NP (NP (PRN (-LRB- -LRB-) (NP (CD 1.95) (NN %)) (-RRB- -RRB-)) (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN background)) (PP (IN of) (NP (NNS Doc_24100055_1411_1422_Disease))))))) (. .)))
24100055	8	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NNP HIT)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ end-stage) (NNS Doc_24100055_1485_1500_Disease)))))))) (VP (VBZ is) (ADJP (PRN (, ,) (PP (IN with) (NP (QP (RB about) (CD 1.95)) (NN %))) (, ,)) (JJ rare))) (. .)))
24100055	9	(ROOT (S (PP (IN For) (NP (NP (JJ further) (NN reduction)) (PP (IN of) (NP (NNS Doc_24100055_1554_1565_Disease))))) (, ,) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ intravenous) (NNS Doc_24100055_1590_1597_Chemical)))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (CC and) (S (NP (DT the) (JJ prophylactic) (NN anticoagulation)) (VP (MD should) (VP (VB be) (VP (VBN performed) (PP (IN with) (NP (JJ low-molecular-weight) (NNS Doc_24100055_1699_1706_Chemical))) (PP (IN after) (NP (NP (NN normalization)) (PP (IN of) (NP (JJ platelet) (NN count))))))))) (. .)))
24100257	0	(ROOT (NP (NP (NP (NNP Doc_24100257_0_18_Disease)) (PRN (-LRB- -LRB-) (NP (QP (CC or) (CD Doc_24100257_23_49_Disease))) (-RRB- -RRB-))) (ADJP (JJ secondary) (PP (TO to) (NP (NNS Doc_24100257_64_76_Chemical)))) (. .)))
24100257	1	(ROOT (S (NP (NP (JJ Doc_24100257_78_96_Disease) (-LRB- -LRB-) (NNS Doc_24100257_98_100_Disease) (-RRB- -RRB-)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NNS Doc_24100257_117_138_Disease)))) (, ,)) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (NP (JJ left) (JJ ventricle) (JJ apical) (NN ballooning)) (PP (IN with) (NP (JJ elevated) (JJ cardiac) (NNS biomarkers)))) (CC and) (NP (NP (JJ electrocardiographic) (NNS changes) (NN suggestive)) (PP (IN of) (NP (NP (DT an) (NNS Doc_24100257_276_299_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN ie)) (, ,) (NP (JJ ST-segment) (NN elevation)) (, ,) (NP (NNP T) (NN wave) (NNS inversions)) (, ,) (CC and) (NP (JJ pathologic) (NNP Q) (NNS waves))) (-RRB- -RRB-))))))))) (. .)))
24100257	2	(ROOT (S (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (JJ 54-year-old) (NN woman)))) (PP (IN with) (NP (NP (JJ medical) (NN history)) (PP (IN of) (NP (NNS Doc_24100257_433_454_Disease) (CC and) (NNS Doc_24100257_459_468_Disease))) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBN admitted) (PP (TO to) (NP (NP (DT the) (NN hospital)) (PP (IN for) (NP (JJ substernal) (NNS Doc_24100257_518_528_Disease))))))))))))) (CC and) (S (NP (NN electrocardiogram)) (VP (VBD demonstrated) (NP (QP (CD 1/2) (CD mm)) (JJ ST-segment) (NN elevation)) (PP (IN in) (NP (NP (NNP leads) (NNP II)) (, ,) (NP (NNP III)) (, ,) (NP (NN aVF) (, ,) (CD V5) (, ,) (CC and) (CD V6)) (CC and) (NP (JJ positive) (NN troponin) (NNP I.) (NNP Emergent)))) (SBAR (S (NP (JJ coronary) (NN angiogram)) (VP (VBD revealed) (NP (JJ normal) (JJ coronary) (NNS arteries)) (PP (IN with) (NP (ADJP (RB moderately) (JJ reduced)) (NN left) (NN ventricular) (NN ejection) (NN fraction))) (PP (IN with) (NP (NP (NNS Doc_24100257_777_802_Disease)) (ADJP (JJ consistent) (PP (IN with) (NP (NNS Doc_24100257_819_821_Disease))))))))))) (. .)))
24100257	3	(ROOT (S (NP (NP (JJ Detailed) (NN history)) (VP (VBN obtained) (ADVP (RB retrospectively)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (DT the) (NN patient)) (VP (VBD took) (NP (NNS Doc_24100257_896_908_Chemical)) (ADVP (RB sparingly)) (ADVP (RB only)) (SBAR (WHADVP (WRB when)) (S (NP (PRP she)) (VP (VBD had) (NP (NNS Doc_24100257_937_946_Disease))))))))) (. .)))
24100257	4	(ROOT (S (CC But) (PP (IN before) (NP (DT this) (NN event))) (, ,) (NP (PRP she)) (VP (VBD was) (VP (VBG taking) (NP (NNS Doc_24100257_986_998_Chemical)) (NP (CD 2-3) (NNS times) (RB daily)) (PP (IN for) (NP (NP (JJ several) (NNS days)) (PP (RB because) (IN of) (NP (DT a) (JJ persistent) (JJ Doc_24100257_1056_1064_Disease) (NNS Doc_24100257_1065_1073_Disease))))))) (. .)))
24100257	5	(ROOT (S (S (NP (PRP She)) (ADVP (RB otherwise)) (VP (VBD reported) (SBAR (IN that) (S (NP (PRP she)) (VP (VBZ is) (ADJP (RB quite) (JJ active))))))) (, ,) (NP (NNS rides)) (VP (VP (VBZ horses)) (, ,) (CC and) (VP (VBZ does) (NP (NP (NN show)) (VP (VBG jumping) (PP (IN without) (NP (NP (DT any) (NNS limitations)) (PP (IN in) (NP (PRP$ her) (JJ physical) (NN activity))))))))) (. .)))
24100257	6	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (DT any) (JJ recent) (NN stress)) (CC or) (NP (NNS Doc_24100257_1256_1274_Disease)))))) (. .)))
24100257	7	(ROOT (S (S (NP (JJ Extensive) (NN literature) (NN search)) (VP (VBD revealed) (NP (NP (JJ multiple) (NNS cases)) (PP (IN of) (NP (JJ Doc_24100257_1331_1346_Disease) (NN vasospasm) (JJ secondary)))) (PP (TO to) (NP (NNS Doc_24100257_1370_1382_Chemical))))) (, ,) (CC but) (S (NP (NP (NN none)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_24100257_1427_1429_Disease)))))) (. .)))
24114426	0	(ROOT (NP (NP (CD Doc_24114426_0_10_Disease) (, ,) (NN Doc_24114426_12_25_Disease) (, ,) (NN sleep) (, ,) (CC and) (NN memory)) (PP (IN in) (NP (ADJP (NN past) (CC and) (NN present)) (NN polydrug) (NNS users))) (PP (IN of) (NP (NP (NNS Doc_24114426_83_116_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_24114426_118_122_Chemical)) (, ,) (NP (NNS Doc_24114426_124_131_Chemical))) (-RRB- -RRB-)))) (. .)))
24114426	1	(ROOT (S (NP (NP (NNP Doc_24114426_145_152_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_24114426_154_187_Chemical)) (, ,) (NP (NNS Doc_24114426_189_193_Chemical))) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ worldwide) (JJ recreational) (NN drug)) (PP (IN of) (NP (NN abuse))))) (. .)))
24114426	2	(ROOT (S (ADVP (RB Unfortunately)) (, ,) (NP (NP (DT the) (NNS results)) (PP (IN from) (NP (NP (JJ human) (NN research)) (VP (VBG investigating) (NP (PRP$ its) (JJ psychological) (NNS effects)))))) (VP (VBP have) (VP (VBN been) (ADJP (JJ inconsistent)))) (. .)))
24114426	3	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBD aimed) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJS largest)) (PP (TO to) (NP (NP (NP (NN date)) (PP (IN in) (NP (NP (NN sample) (NN size)) (CC and) (NP (JJ 5HT-related) (NNS behaviors))))) (: ;) (NP (DT the) (ADJP (JJ first) (S (VP (TO to) (VP (VB compare) (NP (JJ present) (JJ Doc_24114426_482_489_Chemical) (NNS users)) (PP (IN with) (NP (JJ past) (NNS users))) (PP (IN after) (NP (NP (DT an) (NN abstinence)) (PP (IN of) (NP (QP (CD 4) (CC or) (JJR more)))))))))) (NNS years)) (, ,) (CC and) (NP (NP (DT the) (JJ first)) (SBAR (S (VP (TO to) (VP (VB include) (NP (JJ robust) (NNS controls)) (PP (IN for) (NP (JJ other) (JJ recreational) (NNS substances))))))))))))))) (. .)))
24114426	4	(ROOT (S (NP (NP (DT A) (NN sample)) (PP (IN of) (NP (NP (CD 997) (NNS participants)) (PRN (-LRB- -LRB-) (ADJP (NP (CD 52) (NN %)) (JJ male)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN recruited) (PP (TO to) (NP (NP (NP (CD four) (NN control) (NNS groups)) (-LRB- -LRB-) (NP (NP (NP (JJ non-drug)) (PRN (-LRB- -LRB-) (NP (NNP ND)) (-RRB- -RRB-))) (, ,) (NP (NP (NNP Doc_24114426_731_738_Chemical) (PRN (: /) (NP (NP (NP (NNS Doc_24114426_739_747_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP AN)) (-RRB- -RRB-))) (, ,) (NP (JJ cannabis/Doc) (JJ _) (NNS 24114426_763_770_Chemical))) (: /)) (NNP Doc_24114426_771_779_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CAN)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ non-Doc_24114426_791_798_Chemical) (VBG polydrug)) (PRN (-LRB- -LRB-) (NP (NNP PD)) (-RRB- -RRB-)))) (-RRB- -RRB-)) (, ,) (CC and) (NP (NP (CD two) (NNS Doc_24114426_823_830_Chemical)) (VP (VBG polydrug) (NP (NP (NP (NNS groups)) (-LRB- -LRB-) (NP (NP (JJ present) (-LRB- -LRB-) (NNS Doc_24114426_857_861_Chemical) (-RRB- -RRB-)) (CC and) (NP (JJ past) (NNS users)))) (PRN (-LRB- -LRB-) (NP (NNP EX-Doc_24114426_882_886_Chemical)) (-RRB- -RRB-))))))))) (. .)))
24114426	5	(ROOT (S (NP (NNS Participants)) (VP (VBD completed) (NP (NP (DT a) (NN drug) (NN history) (NN questionnaire)) (, ,) (NP (NNP Beck) (NNP Doc_24114426_947_957_Disease) (NNP Inventory)) (, ,) (NP (NNP Barratt) (NNPS Impulsiveness) (NNP Scale)) (, ,) (NP (NNP Pittsburgh) (NNP Sleep) (NNP Quality) (NNP Index)) (, ,) (CC and) (NP (NP (NNP Wechsler) (NNP Memory) (NNP Scale-Revised)) (SBAR (WHNP (WDT which)) (S (, ,) (PP (IN in) (NP (NN total))) (, ,) (VP (VBD provided) (NP (CD 13) (JJ psychometric) (NNS measures)))))))) (. .)))
24114426	6	(ROOT (S (SBAR (IN While) (S (NP (DT the) (NNP CAN) (CC and) (NNP PD) (NNS groups)) (VP (VBD tended) (S (VP (TO to) (VP (VB record) (NP (JJR greater) (NNS deficits)) (PP (IN than) (NP (DT the) (JJ non-drug) (NNS controls))))))))) (, ,) (NP (DT the) (JJ Doc_24114426_1219_1223_Chemical) (CC and) (JJ Doc_24114426_1228_1235_Chemical) (NNS groups)) (VP (VBD recorded) (NP (JJR greater) (NNS deficits)) (PP (IN than) (NP (PDT all) (DT the) (NN control) (NNS groups))) (PP (IN on) (NP (NP (CD ten)) (PP (IN of) (NP (DT the) (CD 13) (JJ psychometric) (NNS measures)))))) (. .)))
24114426	7	(ROOT (S (ADVP (RB Strikingly)) (, ,) (PP (IN despite) (NP (NP (VBN prolonged) (NN abstinence)) (PRN (-LRB- -LRB-) (NP (NP (NN mean)) (, ,) (NP (NP (CD 4.98)) (: ;) (NP (NN range))) (, ,) (NP (CD 4-9) (NNS years))) (-RRB- -RRB-)))) (, ,) (NP (JJ past) (JJ Doc_24114426_1415_1422_Chemical) (NNS users)) (VP (VBD showed) (NP (NP (JJ few) (NNS signs)) (PP (IN of) (NP (NN recovery))))) (. .)))
24114426	8	(ROOT (S (PP (VBN Compared) (PP (IN with) (NP (JJ present) (JJ Doc_24114426_1481_1488_Chemical) (NNS users)))) (, ,) (NP (DT the) (JJ past) (NNS users)) (VP (VBD showed) (NP (NP (NP (DT no) (NN change)) (PP (IN for) (NP (CD ten) (NNS measures)))) (, ,) (NP (NP (NNS Doc_24114426_1546_1566_Disease)) (PP (IN for) (NP (CD two) (NNS measures)))) (, ,) (CC and) (NP (NP (NN improvement)) (PP (IN on) (NP (RB just) (CD one) (NN measure)))))) (. .)))
24114426	9	(ROOT (S (PP (VBN Given) (NP (NP (NP (DT this) (NN record)) (PP (IN of) (NP (NNS Doc_24114426_1656_1671_Disease)))) (CC and) (NP (NP (ADJP (RB clinically) (JJ significant)) (NNS levels)) (PP (IN of) (NP (NNS Doc_24114426_1709_1719_Disease) (, ,) (NNS Doc_24114426_1721_1734_Disease) (, ,) (CC and) (NNS Doc_24114426_1740_1757_Disease)))))) (, ,) (NP (NP (DT the) (NN prognosis)) (PP (IN for) (NP (NP (DT the) (JJ current) (NN generation)) (PP (IN of) (NP (JJ Doc_24114426_1803_1810_Chemical) (NNS users)))))) (VP (VBZ is) (NP (NP (DT a) (JJ major) (NN cause)) (PP (IN for) (NP (NN concern))))) (. .)))
24126708	0	(ROOT (NP (NP (NNP Association)) (PP (IN of) (NP (JJ common) (JJ genetic) (NNS variants))) (PP (IN of) (NP (NP (CD HOMER1) (NN gene)) (PP (IN with) (NP (JJ Doc_24126708_59_67_Chemical) (JJ adverse) (NNS effects))))) (PP (IN in) (NP (JJ Doc_24126708_87_106_Disease) (NNS patients))) (. .)))
24126708	1	(ROOT (S (S (NP (NNP Doc_24126708_117_125_Chemical)) (VP (VBZ is) (NP (NP (DT the) (ADJP (RBS most) (JJ effective)) (JJ symptomatic) (NN therapy)) (PP (IN for) (NP (NNS Doc_24126708_172_191_Disease)))))) (, ,) (CC but) (S (NP (PRP$ its) (JJ chronic) (NN use)) (VP (MD could) (VP (VB lead) (PP (TO to) (NP (NP (JJ chronic) (JJ adverse) (NNS outcomes)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN motor) (NNS fluctuations)) (, ,) (NP (NNS Doc_24126708_281_291_Disease)) (CC and) (NP (NNS Doc_24126708_296_317_Disease))))))))) (. .)))
24126708	2	(ROOT (S (NP (NNP HOMER1)) (VP (VBZ is) (NP (NP (DT a) (NN protein)) (PP (IN with) (NP (NP (JJ pivotal) (NN function)) (PP (IN in) (NP (NP (JJ Doc_24126708_364_373_Chemical) (NN transmission)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN related) (PP (TO to) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (DT these) (NNS complications)))))))))))))))) (. .)))
24126708	3	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ investigates) (SBAR (IN whether) (S (NP (NP (NNS polymorphisms)) (PP (IN in) (NP (DT the) (NNP HOMER1) (NN gene) (NN promoter) (NN region)))) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (DT the) (JJ chronic) (NNS complications)) (PP (IN of) (NP (JJ Doc_24126708_603_611_Chemical) (NN therapy)))))))))))) (. .)))
24126708	4	(ROOT (S (NP (NP (QP (DT A) (NN total) (IN of) (CD 205)) (NNS patients)) (PP (IN with) (NP (NNS Doc_24126708_650_680_Disease)))) (VP (VBD were) (VP (VBN investigated))) (. .)))
24126708	5	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN genotyped) (PP (IN for) (NP (CD rs4704559) (, ,) (CD rs10942891) (CC and) (CD rs4704560))) (PP (IN by) (NP (JJ allelic) (NN discrimination))) (PP (IN with) (NP (JJ Taqman) (NNS assays))))) (. .)))
24126708	6	(ROOT (S (NP (DT The) (JJ rs4704559) (NNP G) (NN allele)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJR lower) (NN prevalence)) (PP (IN of) (NP (NP (NNS Doc_24126708_875_885_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (JJ prevalence) (NN ratio)) (PRN (-LRB- -LRB-) (NP (NNP PR)) (-RRB- -RRB-))) (ADJP (JJ =) (NP (CD 0.615)))) (, ,) (NP (NP (NP (ADJP (CD 95) (NN %)) (NN confidence) (NN interval)) (PRN (-LRB- -LRB-) (NP (NNP CI)) (-RRB- -RRB-))) (NP (CD 0.426-0) (CD .887))) (, ,) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.009))))))) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_24126708_971_992_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP PR)) (SBAR (S (VP (SYM =) (NP (CD 0.515)))))) (, ,) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (NP (CD 0.295-0) (CD .899))) (, ,) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.020))))))) (-RRB- -RRB-)))))))) (. .)))
24126708	7	(ROOT (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (CD HOMER1) (JJ rs4704559) (NNP G) (NN allele)) (VP (VBZ has) (NP (NP (DT a) (JJ protective) (NN role)) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ Doc_24126708_1127_1135_Chemical) (JJ adverse) (NNS effects)))))))))) (. .)))
24132704	0	(ROOT (S (NP (NNP Doc_24132704_0_6_Chemical)) (VP (VBZ improves) (NP (NP (NN lipid) (NN dysregulation)) (PP (IN in) (NP (JJ subacute) (JJ Doc_24132704_48_56_Chemical) (NN exposure)))) (PP (IN through) (NP (NP (CD ERK1/2) (NN pathway)) (PP (IN in) (NP (NN rat) (NN liver)))))) (. .)))
24132704	1	(ROOT (S (NP (NP (CD Doc_24132704_117_125_Chemical) (NNP Yis) (CD one)) (PP (IN of) (NP (DT the) (ADJP (RBS most) (RB broadly) (VBN used)) (NNS Doc_24132704_159_175_Chemical)))) (VP (VBZ insecticides) (PP (IN in) (NP (NN agriculture)))) (. .)))
24132704	2	(ROOT (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN exposure)) (PP (TO to) (NP (NNS Doc_24132704_240_248_Chemical)))) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NN lipid) (NN metabolism)))))))))) (. .)))
24132704	3	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (DT the) (JJ hypolipidemic) (NN effect)) (PP (IN of) (NP (NNS Doc_24132704_324_330_Chemical)))) (VP (VBZ has) (VP (VBN been) (VP (VBN established)))) (. .)))
24132704	4	(ROOT (S (NP (JJR Earlier) (NNS studies)) (VP (VBD revealed) (SBAR (S (NP (NP (DT the) (JJ major) (NN role)) (PP (IN of) (NP (NNP Extracellular)))) (VP (VBD signal-regulated) (NP (JJ kinase) (PRN (-LRB- -LRB-) (NP (NNP ERK)) (-RRB- -RRB-)) (NNS pathways)) (PP (IN in) (NP (ADJP (RB low-density) (JJ lipoprotein)) (NN receptor) (PRN (-LRB- -LRB-) (NP (NNP LDLr)) (-RRB- -RRB-)) (NN expression))))))) (. .)))
24132704	5	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB evaluate) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN lipid) (NN metabolism)) (, ,) (NP (NNP ERK)) (CC and) (NP (NNP LDLr) (NN expression))))))) (PP (IN in) (NP (NP (DT the) (NN liver)) (PP (IN of) (NP (NP (NNS rats)) (VP (VBN exposed) (S (VP (TO to) (VP (VB subacute) (NP (NNS Doc_24132704_654_662_Chemical)))))))))))))) (. .)))
24132704	6	(ROOT (S (S (ADVP (RB Furthermore)) (VP (VBG ameliorating) (NP (NP (NN effect)) (PP (IN of) (NP (NP (NNS Doc_24132704_699_705_Chemical)) (PP (IN on) (NP (NNS Doc_24132704_709_717_Chemical)))))))) (NP (ADJP (RB induced) (JJ disturbed)) (JJ Doc_24132704_736_747_Chemical) (NNS homeostasis)) (VP (VBD was) (VP (VBN studied))) (. .)))
24132704	7	(ROOT (S (NP (CD 24) (NNS Rats)) (VP (VBD were) (VP (VP (VBN divided) (PP (IN into) (NP (CD 4) (NNS groups)))) (CC and) (VP (VBN received) (PP (VBG following) (PP (NP (NP (NP (NNS treatments)) (PP (IN for) (NP (CD 4) (NNS weeks)))) (: ;) (NP (NP (NP (NN Corn) (NN oil)) (PRN (-LRB- -LRB-) (NP (NN control)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_24132704_884_892_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNS 15mg/kg)) (PP (IN per) (NP (NN day)))) (, ,) (ADVP (RB orally))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NNS Doc_24132704_923_929_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 12.5) (CC and) (CD 25mg/kg)) (PP (IN per) (NP (NN day)))) (, ,) (ADVP (RB intraperitoneally))) (-RRB- -RRB-))) (PP (IN in) (NP (NN combination)))))) (IN with) (NP (NP (NNS Doc_24132704_996_1004_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 15) (NN mg/kg)) (-RRB- -RRB-)))))))) (. .)))
24132704	8	(ROOT (S (NP (NP (DT The) (NNS levels)) (PP (IN of) (NP (NNP Doc_24132704_1031_1042_Chemical) (, ,) (NNP Doc_24132704_1044_1056_Chemical) (CC and) (NNP LDL))) (PP (IN in) (NP (NP (NN blood)) (PP (IN of) (NP (NNS rats)))))) (VP (VBD were) (VP (VBN analyzed))) (. .)))
24132704	9	(ROOT (S (ADVP (RB Moreover)) (NP (NP (NP (NN mRNA) (NNS levels)) (PP (IN of) (NP (NP (NNP LDLr) (CC and) (NNP ERK1/2)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN protein) (NNS levels)) (PP (IN of) (NP (NN total))))))) (CC and) (NP (NP (VBN activated) (NNS forms)) (PP (IN of) (NP (NNP ERK1/2))) (PP (IN in) (NP (NN rat) (NN liver))))) (VP (VBD were) (VP (VBN evaluated) (PP (IN by) (NP (NP (JJ Western) (VBG blotting)) (CC and) (NP (NP (JJ quantitative) (JJ real) (NN time) (NN polymerase)) (NP (NN chain) (NN reaction) (NN analysis))))))) (. .)))
24132704	10	(ROOT (S (NP (PRP$ Our) (NNS data)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (JJ subacute) (NN exposure)) (PP (TO to) (NP (NNS Doc_24132704_1364_1372_Chemical)))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (NNS concentrations)) (PP (IN of) (NP (NNP Doc_24132704_1415_1426_Chemical) (, ,) (NNP Doc_24132704_1428_1440_Chemical) (CC and) (NNP LDL)))))))) (. .)))
24132704	11	(ROOT (S (ADVP (RB Moreover)) (NP (NNS Doc_24132704_1459_1467_Chemical)) (VP (VBD decreased) (NP (JJ ERK1/2) (NN protein) (NN phosphorylation) (CC and) (NN LDLr) (NN transcript))) (. .)))
24132704	12	(ROOT (S (NP (NNP Doc_24132704_1530_1536_Chemical)) (VP (VBD reduced) (NP (NP (NP (NN inhibition)) (PP (IN of) (NP (NNP ERK) (NN activation) (CC and) (NN Doc_24132704_1578_1586_Chemical-induced) (NNS Doc_24132704_1595_1607_Disease)))) (CC and) (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (NNP LDLr) (NN transcript)))))) (. .)))
24132704	13	(ROOT (S (NP (NNP Doc_24132704_1662_1668_Chemical)) (VP (MD may) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (JJ novel) (JJ protective) (NN agent)) (PP (IN in) (NP (NN Doc_24132704_1718_1726_Chemical-induced) (NNS Doc_24132704_1735_1747_Disease))))) (PP (IN through) (S (VP (VBG modulating) (PP (IN of) (NP (NP (NNP ERK) (NN pathway) (CC and) (NN increase)) (PP (IN of) (NP (NNP LDLr) (NN expression))))))))))) (. .)))
24158386	0	(ROOT (S (NP (NNP Doc_24158386_0_5_Chemical)) (ADVP (RB chemotherapy)) (VP (VBZ is) (ADJP (JJ active) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ relapsed) (NNS Doc_24158386_58_74_Disease))))))) (. .)))
24158386	1	(ROOT (S (NP (NP (NNP Doc_24158386_76_92_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24158386_94_96_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (NP (DT a) (ADJP (RB relatively) (JJ chemosensitive)) (NNS Doc_24158386_129_139_Disease))) (. .)))
24158386	2	(ROOT (S (ADVP (RB However)) (, ,) (PP (IN for) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP relapse)))))) (, ,) (NP (NP (JJ high-dose) (NN chemotherapy)) (PP (IN with) (NP (NNS autologous)))) (VP (VBP stem) (SBAR (S (NP (NN cell) (NN transplant)) (VP (VBZ is) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN choice))) (SBAR (WHNP (WDT which)) (S (VP (VBZ relies) (PP (IN on) (NP (NP (JJ adequate) (NN disease) (NN control)) (PP (IN with) (NP (NN salvage) (NN chemotherapy))))))))))))) (. .)))
24158386	3	(ROOT (S (NP (NP (NNS Regimens)) (ADJP (RB commonly) (VBN used))) (ADVP (RB often)) (VP (VP (VBP require) (NP (JJ inpatient) (NN administration))) (CC and) (VP (MD can) (VP (VB be) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB deliver) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_24158386_429_437_Disease))))))))))) (. .)))
24158386	4	(ROOT (S (NP (NNS Doc_24158386_439_450_Chemical) (CC and) (NNS Doc_24158386_455_464_Chemical)) (VP (VP (VBP have) (NP (NP (NN activity)) (PP (IN in) (NP (JJ Doc_24158386_482_484_Disease) (, ,) (JJ non-overlapping) (NNS Doc_24158386_502_510_Disease)))) (PP (IN with) (NP (JJ first-line) (NNS chemotherapeutics)))) (, ,) (CC and) (VP (MD may) (VP (VB be) (VP (VBN delivered) (PP (IN in) (NP (DT an) (NN outpatient) (NN setting))))))) (. .)))
24158386	5	(ROOT (S (PP (IN In) (NP (NP (DT this) (ADJP (JJ retrospective) (JJ single-centre)) (NN analysis)) (, ,) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (JJ relapsed) (CC or) (JJ refractory) (NNS Doc_24158386_676_678_Disease)))) (VP (VBN treated) (PP (IN with) (NP (NP (QP (CD Doc_24158386_692_703_Chemical) (CD 1,000)) (NNP mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (NN day)) (PRN (-LRB- -LRB-) (NP (NNP D)) (-RRB- -RRB-)))) (NP (CD 1) (, ,) (CD D8) (CC and) (CD D15))) (: ;) (NP (QP (CD Doc_24158386_740_758_Chemical) (CD 1,000)) (NN mg) (NN D1-5)) (: ;) (CC and) (NP (QP (CD Doc_24158386_778_787_Chemical) (CD 100)) (NNP mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (NN D15))))) (, ,) (NP (NP (DT every) (CD 28) (NNS days)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24158386_820_825_Chemical)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN included))) (. .)))
24158386	6	(ROOT (S (NP (JJ Demographic) (, ,) (NN survival) (, ,) (NN response) (CC and) (NNS Doc_24158386_878_886_Disease) (NNS data)) (VP (VBD were) (VP (VBN recorded))) (. .)))
24158386	7	(ROOT (S (S (NP (JJ Forty-one) (JJ eligible) (NNS patients)) (VP (VBD were) (VP (VBN identified)))) (: :) (S (NP (NN median)) (VP (VBP age) (NP (CD 27)))) (. .)))
24158386	8	(ROOT (S (NP (NP (CD One) (CD hundred)) (CC and) (NP (NP (JJ twenty-two) (NNS cycles)) (PP (IN of) (NP (NNS Doc_24158386_1004_1009_Chemical))))) (VP (VBD were) (VP (VBN administered) (PP (IN in) (NP (NP (NN total)) (PRN (-LRB- -LRB-) (NP (NP (JJ median) (CD 3) (NNS cycles)) (: ;) (NP (NN range) (CD 1-6))) (-RRB- -RRB-)))))) (. .)))
24158386	9	(ROOT (S (NP (NP (CD Twenty)) (PP (IN of) (NP (JJ 41) (PRN (-LRB- -LRB-) (NP (CD 48) (NN %)) (-RRB- -RRB-)) (NNS patients)))) (VP (VBD received) (NP (NNS Doc_24158386_1105_1110_Chemical)) (PP (IN as) (NP (NP (JJ second-line) (NN treatment)) (CC and) (NP (NP (CD 11/41)) (PRN (-LRB- -LRB-) (NP (CD 27) (NN %)) (-RRB- -RRB-))))) (PP (IN as) (NP (JJ third-line) (NN therapy)))) (. .)))
24158386	10	(ROOT (S (NP (NP (NP (JJ Overall) (NN response) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP ORR)) (-RRB- -RRB-))) (PP (TO to) (NP (NP (NNS Doc_24158386_1207_1212_Chemical)) (PP (IN in) (NP (DT the) (JJ entire) (NN cohort)))))) (VP (VBD was) (NP (NP (CD 80) (NN %)) (PRN (-LRB- -LRB-) (S (VP (VB complete) (S (NP (NP (NN response)) (PRN (-LRB- -LRB-) (NP (NNP CR)) (-RRB- -RRB-)) (NP (CD 37) (NN %)) (, ,)) (NP (NP (JJ partial) (NN response)) (ADJP (CD 44) (NN %)))))) (-RRB- -RRB-)) (PP (IN with) (NP (NP (CD 14/15) (NN CR)) (VP (VBN confirmed) (PP (IN as) (NP (NP (DT a) (JJ metabolic) (NN CR)) (PP (IN on) (NP (NNP PET) (CC and) (NNP ORR))) (PP (IN of) (NP (NP (CD 85) (NN %)) (PP (IN in) (NP (DT the) (CD 20) (JJ second-line) (NNS patients)))))))))))) (. .)))
24158386	11	(ROOT (NP (NP (NP (DT The) (ADJP (RBS most) (JJ common)) (NN grade)) (SBAR (S (NP (CD 3/4) (NNS Doc_24158386_1419_1429_Disease)) (VP (VBD were) (ADJP (JJ haematological)))))) (: :) (NP (NP (NP (NNS Doc_24158386_1451_1462_Disease)) (ADJP (CD 54) (NN %))) (CC and) (NP (NP (NNS Doc_24158386_1472_1488_Disease)) (ADJP (CD 51) (NN %)))) (. .)))
24158386	12	(ROOT (S (NP (NP (JJ Median) (NN follow-up)) (PP (IN from) (NP (NP (DT the) (NN start)) (PP (IN of) (NP (NNS Doc_24158386_1530_1535_Chemical)))))) (VP (VBD was) (NP (CD 4.5) (NNS years))) (. .)))
24158386	13	(ROOT (S (PP (VBG Following) (NP (NNS Doc_24158386_1561_1566_Chemical))) (, ,) (S (NP (JJ 5-year) (JJ progression-free) (NN survival)) (VP (VBD was) (NP (NP (CD 46) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NP (ADJP (CD 95) (NN %)) (NN confidence) (NN interval)) (PRN (-LRB- -LRB-) (NP (NNP CI)) (-RRB- -RRB-))) (, ,) (NP (CD 30-62) (NN %))) (-RRB- -RRB-))))) (CC and) (S (NP (JJ 5-year) (JJ overall) (NN survival)) (VP (VBD was) (NP (NP (CD 59) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (, ,) (NP (CD 43-74) (NN %))) (-RRB- -RRB-))))) (. .)))
24158386	14	(ROOT (S (NP (NP (CD Fourteen)) (PP (IN of) (NP (CD 41) (NNS patients)))) (VP (VBD proceeded) (ADVP (RB directly)) (PP (TO to) (NP (JJ autologous) (NN transplant)))) (. .)))
24158386	15	(ROOT (S (NP (NNP Doc_24158386_1777_1782_Chemical)) (VP (VBZ is) (NP (NP (DT a) (NN salvage) (NN chemotherapy)) (PP (IN with) (NP (NP (ADJP (RB relatively) (JJ high)) (NN response) (NNS rates)) (, ,) (VP (VBG leading) (PP (TO to) (NP (NP (JJ successful) (NN transplantation)) (PP (IN in) (NP (JJ appropriate) (NNS patients)))))) (, ,) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ relapsed) (CC or) (JJ refractory) (NNS Doc_24158386_1952_1954_Disease))))))))) (. .)))
24190587	0	(ROOT (NP (NP (NP (NP (JJ Basal) (NN functioning)) (PP (IN of) (NP (DT the) (JJ hypothalamic-pituitary-adrenal) (PRN (-LRB- -LRB-) (NP (NNP HPA)) (-RRB- -RRB-)) (NNS axis)))) (CC and) (NP (NP (NNS Doc_24190587_71_93_Disease)) (PP (IN in) (NP (JJ recreational) (NNS Doc_24190587_110_117_Chemical))))) (VP (VBG polydrug) (NP (NNS users))) (. .)))
24190587	1	(ROOT (S (NP (NP (NNP Doc_24190587_145_152_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24190587_154_158_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ psychostimulant) (NN drug)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB increasingly)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_24190587_224_252_Disease))))))))) (. .)))
24190587	2	(ROOT (S (SBAR (IN While) (S (NP (DT some) (JJ recent) (NNS studies)) (VP (VBP suggest) (NP (NP (JJ acute) (NNS changes)) (PP (IN in) (NP (JJ neuroendocrine) (NN function))))))) (, ,) (NP (JJR less)) (VP (VBZ is) (VP (VBN known) (PP (IN about) (NP (NP (JJ long-term) (NNS changes)) (PP (IN in) (NP (NNP HPA) (NN functionality))))) (PP (IN in) (NP (JJ recreational) (NNS users))))) (. .)))
24190587	3	(ROOT (S (NP (DT The) (JJ current) (NN study)) (VP (VBZ is) (NP (DT the) (JJ first) (S (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NP (NN Doc_24190587_481_488_Chemical-polydrug) (NN use)) (PP (IN on) (NP (NNS Doc_24190587_505_527_Disease)))) (CC and) (NP (NP (JJ basal) (NN functioning)) (PP (IN of) (NP (DT the) (NNP HPA) (NNS axis))))))) (PP (IN through) (S (VP (VBG assessing) (NP (NP (DT the) (NN secretion)) (PP (IN of) (NP (NP (NNS Doc_24190587_601_609_Chemical)) (PP (IN across) (NP (DT the) (JJ diurnal) (NN period)))))))))))))) (. .)))
24190587	4	(ROOT (S (NP (NP (JJ Seventy-six) (NNS participants)) (PRN (-LRB- -LRB-) (NP (NP (CD 21) (NNS nonusers)) (, ,) (NP (CD 29) (JJ light) (NN Doc_24190587_693_700_Chemical-polydrug) (NNS users)) (, ,) (NP (CD 26) (JJ heavy) (NN Doc_24190587_726_733_Chemical-polydrug) (NNS users))) (-RRB- -RRB-))) (VP (VBD completed) (SBAR (S (NP (DT a) (NN substance)) (VP (VBP use) (NP (NP (NN inventory) (CC and) (NNS measures)) (PP (IN of) (NP (NP (NP (NNS Doc_24190587_802_824_Disease)) (PP (IN at) (NP (NN baseline)))) (, ,) (ADVP (RB then)) (NP (NP (CD two) (JJ consecutive) (NNS days)) (PP (IN of) (NP (NP (JJ Doc_24190587_867_875_Chemical) (NN sampling)) (PRN (-LRB- -LRB-) (PP (IN on) (NP (NP (NP (NN awakening)) (, ,) (NP (CD 30) (NN min) (NN post) (NN awakening)) (, ,)) (PP (IN between) (NP (NP (CD 1400) (CC and) (CD 1600) (NNS hours)) (CC and) (NP (NN pre) (NN bedtime)))))) (-RRB- -RRB-)))))))))))) (. .)))
24190587	5	(ROOT (S (PP (IN On) (NP (NN day) (CD 2))) (, ,) (NP (NNS participants)) (ADVP (RB also)) (VP (VBD attended) (NP (DT the) (NN laboratory) (S (VP (TO to) (VP (VB complete) (NP (DT a) (JJ 20-min) (NN multitasking) (NN stressor))))))) (. .)))
24190587	6	(ROOT (S (NP (DT Both) (NN user) (NNS groups)) (VP (VBD exhibited) (NP (NP (ADJP (RB significantly) (JJR greater)) (NNS levels)) (PP (IN of) (NP (NNS Doc_24190587_1133_1140_Disease) (CC and) (NNS Doc_24190587_1145_1155_Disease)))) (PP (IN than) (NP (NNS nonusers)))) (. .)))
24190587	7	(ROOT (S (PP (IN On) (NP (NN day) (CD 1))) (, ,) (NP (DT all) (NNS participants)) (VP (VBD exhibited) (NP (DT a) (JJ typical) (JJ Doc_24190587_1218_1226_Chemical) (NN profile)) (, ,) (SBAR (IN though) (S (NP (JJ light) (NNS users)) (VP (VBD had) (ADVP (RB significantly) (NP (JJ elevated) (NNS levels))) (VP (VBN pre-bed)))))) (. .)))
24190587	8	(ROOT (S (PP (IN On) (NP (NN day) (CD 2))) (, ,) (S (NP (JJ heavy) (NNS users)) (VP (VBD demonstrated) (NP (JJ elevated) (NNS levels)) (PP (IN upon) (NP (NN awakening))))) (CC and) (S (NP (DT all) (NN Doc_24190587_1372_1379_Chemical-polydrug) (NNS users)) (VP (VBD demonstrated) (NP (JJ elevated) (JJ pre-bed) (NNS levels)) (PP (VBN compared) (PP (TO to) (NP (NNS non-users)))))) (. .)))
24190587	9	(ROOT (S (NP (NP (NNP Significant)) (PP (IN between) (NP (NN group) (NNS differences)))) (VP (VBD were) (ADVP (RB also)) (VP (VBN observed) (PP (PP (IN in) (NP (NN afternoon) (NNS Doc_24190587_1525_1533_Chemical) (NNS levels))) (CC and) (PP (IN in) (NP (NP (JJ overall) (NNS Doc_24190587_1556_1564_Chemical)) (VP (VBN secretion) (PP (IN across) (NP (DT the) (NN day))))))))) (. .)))
24190587	10	(ROOT (S (NP (NP (DT The) (NNS increases)) (PP (IN in) (NP (NNS Doc_24190587_1621_1628_Disease) (CC and) (NNS Doc_24190587_1633_1643_Disease)))) (VP (VBP are) (PP (IN in) (NP (NP (NN line)) (PP (IN with) (NP (NP (JJ previous) (NNS observations)) (PP (IN in) (NP (JJ recreational) (NN Doc_24190587_1699_1706_Chemical-polydrug) (NNS users)))))))) (. .)))
24190587	11	(ROOT (S (S (NP (JJ Dysregulated) (JJ diurnal) (NNS Doc_24190587_1744_1752_Chemical)) (VP (MD may) (VP (VB be) (ADJP (JJ indicative) (PP (IN of) (NP (NP (JJ inappropriate) (NN anticipation)) (PP (IN of) (NP (JJ forthcoming) (NNS demands))))))))) (CC and) (S (NP (NNS Doc_24190587_1828_1842_Disease)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (DT the) (VBN increased) (ADJP (JJ psychological) (CC and) (JJ physical)) (NN morbidity)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ heavy) (JJ recreational) (NN use)) (PP (IN of) (NP (NNS Doc_24190587_1948_1955_Chemical))))))))))) (. .)))
24209900	0	(ROOT (NP (NP (ADJP (RB Doc_24209900_0_10_Chemical) (VBN related)) (NNS Doc_24209900_19_33_Disease)) (: :) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (DT a) (JJ timely) (NNP EEG) (NN evaluation)))) (. .)))
24209900	1	(ROOT (S (NP (NNP Doc_24209900_85_95_Chemical)) (VP (VBZ is) (NP (NP (DT an) (VBG alkylating) (NN agent)) (ADJP (JJ useful) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NP (NNS Doc_24209900_162_169_Disease)) (PP (VBG including) (NP (NNS Doc_24209900_180_188_Disease) (, ,) (NNS Doc_24209900_190_198_Disease) (, ,) (NNS gynecologic) (CC and) (NNS Doc_24209900_216_234_Disease)))))))))))) (. .)))
24209900	2	(ROOT (S (NP (NNP Doc_24209900_236_250_Disease)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (CD 10-40) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ high-dose) (NNP IV) (NNS Doc_24209900_314_324_Chemical)))))))))) (. .)))
24209900	3	(ROOT (S (VP (TO To) (VP (VB highlight) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (NN electroencephalogram)) (PRN (-LRB- -LRB-) (NP (NNP EEG)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (DT the) (JJ early) (NN detection) (CC and) (NN management)) (PP (IN of) (NP (JJ Doc_24209900_430_440_Chemical) (VBN related) (NNS Doc_24209900_449_463_Disease))))))) (. .)))
24209900	4	(ROOT (S (NP (NP (JJ Retrospective) (NN chart) (NN review)) (PP (VBG including) (NP (NP (JJ clinical) (NNS data)) (CC and) (NP (NNP EEG) (NNS recordings))))) (VP (VBD was) (VP (VBN done) (PP (IN on) (NP (NP (CD five) (NNS patients)) (, ,) (VP (VBN admitted) (PP (TO to) (NP (NP (NNP MD) (NNP Anderson) (NNP Doc_24209900_595_601_Disease) (NNP Center)) (PP (IN between) (NP (NNS years) (CD 2009) (CC and) (CD 2012)))))) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (JJ Doc_24209900_652_662_Chemical) (VBN related) (JJ acute) (NNS Doc_24209900_677_691_Disease))))))))) (. .)))
24209900	5	(ROOT (S (NP (DT All) (CD five) (NNS patients)) (VP (VBD experienced) (NP (NP (NNS symptoms)) (PP (IN of) (NP (NNS Doc_24209900_744_758_Disease)))) (PP (ADVP (RB soon)) (IN after) (NP (PRN (-LRB- -LRB-) (PP (IN within) (NP (CD 12) (JJ h-2) (NNS days))) (-RRB- -RRB-)) (NN receiving) (NNS Doc_24209900_801_811_Chemical)))) (. .)))
24209900	6	(ROOT (S (NP (CD Two) (NNS patients)) (VP (VBD developed) (NP (JJ generalized) (NNS Doc_24209900_848_859_Disease)) (SBAR (IN while) (S (NP (CD one) (NN patient)) (VP (VBD developed) (NP (NP (JJ continuous) (NN non-Doc_24209900_903_932_Disease)) (PRN (-LRB- -LRB-) (NP (NNP NCSE)) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (VP (VBD required) (NP (JJ ICU) (NN admission) (CC and) (NN intubation)))))))))) (. .)))
24209900	7	(ROOT (S (S (NP (NNP Initial) (NNP EEG)) (VP (VBD showed) (NP (NNS Doc_24209900_1003_1026_Disease)) (PP (IN in) (NP (CD three) (NNS patients))))) (: ;) (S (NP (NP (NN run)) (PP (IN of) (NP (NP (JJ triphasic) (NNS waves)) (PP (IN in) (NP (NP (CD one) (NN patient)) (CC and) (NP (JJ moderate) (NN degree) (NN diffuse))))))) (VP (VBD generalized) (S (VP (VBG slowing))))) (. .)))
24209900	8	(ROOT (S (NP (NP (JJ Mixed) (NN pattern)) (PP (IN with) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (DT both) (JJ sharps) (CC and) (JJ triphasic)) (NNS waves)))))) (VP (VBD were) (VP (ADVP (RB also)) (VBN noted))) (. .)))
24209900	9	(ROOT (S (NP (NP (NN Repeat) (NNS EEGs)) (PP (IN within) (NP (NP (NNS 24_h)) (PP (IN of) (NP (NN symptom) (NN onset)))))) (VP (VBD showed) (NP (NP (JJ marked) (NN improvement)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN correlated) (PP (IN with) (NP (JJ clinical) (NN improvement))))))))) (. .)))
24209900	10	(ROOT (S (NP (NP (NNP Severity)) (PP (IN of) (NP (JJ Doc_24209900_1356_1366_Chemical) (JJ related) (NNS Doc_24209900_1375_1389_Disease)))) (VP (VBZ correlates) (PP (IN with) (NP (NNP EEG) (NNS changes)))) (. .)))
24209900	11	(ROOT (S (NP (PRP We)) (VP (VBP suggest) (NP (NP (DT a) (JJ timely) (NNP EEG) (NN evaluation)) (PP (IN for) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NNS Doc_24209900_1477_1487_Chemical)) (SBAR (WHNP (WP who)) (S (VP (VBP develop) (NP (NP (NNS features)) (PP (IN of) (NP (NNS Doc_24209900_1512_1526_Disease))))))))))))) (. .)))
24220752	0	(ROOT (NP (NP (NNP Incidence)) (PP (IN of) (NP (JJ contrast-induced) (NNS Doc_24220752_30_41_Disease))) (PP (IN in) (NP (JJ hospitalised) (NNS patients))) (PP (IN with) (NP (NNS Doc_24220752_72_78_Disease))) (. .)))
24220752	1	(ROOT (S (S (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN frequency)) (PP (IN of)))))) (CC and) (S (NP (JJ possible) (NNS factors)) (VP (VBN related) (PP (TO to) (NP (NP (JJ contrast-induced) (NNS Doc_24220752_171_182_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24220752_184_187_Disease)) (-RRB- -RRB-)))) (PP (IN in) (NP (JJ hospitalised) (NNS patients))) (PP (IN with) (NP (NNS Doc_24220752_219_225_Disease))))) (. .)))
24220752	2	(ROOT (S (NP (CD Ninety) (JJ adult) (NNS patients)) (VP (VBD were) (VP (VBN enrolled))) (. .)))
24220752	3	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (NN risk) (NNS factors)) (PP (IN for) (NP (NNS Doc_24220752_304_323_Disease)))))) (VP (VBD were) (VP (VBN excluded))) (. .)))
24220752	4	(ROOT (S (NP (NNP Blood) (NNS samples)) (VP (VBD were) (VP (VBN examined) (NP (DT the) (NN day)) (PP (IN before) (NP (NP (NP (JJ contrast-enhanced) (JJ computed) (NN tomography)) (PRN (-LRB- -LRB-) (NP (NNP CT)) (-RRB- -RRB-))) (CC and) (NP (NP (NN serially)) (PP (IN for) (NP (CD 3) (NNS days)))))) (ADVP (RB thereafter)))) (. .)))
24220752	5	(ROOT (S (NP (NNP Doc_24220752_461_464_Disease)) (VP (VBD was) (VP (VBN defined) (SBAR (IN as) (S (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NP (NN serum) (NNS Doc_24220752_501_511_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Cr)) (-RRB- -RRB-))) (PP (IN of) (NP (CD 0.5)))))) (VP (VBP mg/dl) (NP (NP (QP (CC or) (JJR more))) (, ,) (CC or) (NP (NP (NN elevation)) (PP (IN of) (NP (NNS Doc_24220752_555_557_Chemical))))) (PP (TO to) (NP (NP (CD 25) (NN %)) (PP (IN over) (NP (NN baseline)))))))))) (. .)))
24220752	6	(ROOT (S (NP (NP (NNPS Relationships)) (PP (IN between) (NP (NP (NNS Doc_24220752_603_606_Disease)) (CC and) (NP (JJ possible) (NN risk) (NNS factors))))) (VP (VBD were) (VP (VBN investigated))) (. .)))
24220752	7	(ROOT (S (NP (NNP Doc_24220752_661_664_Disease)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (NP (CD 18/90)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN %)) (-RRB- -RRB-))) (NP (NNS patients)))))) (. .)))
24220752	8	(ROOT (S (NP (NNP Doc_24220752_704_707_Disease)) (VP (VBD developed) (PP (PP (IN in) (NP (NP (CD 25.5) (NN %) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (ADVP (RB chemotherapy))))))) (CC and) (PP (IN in) (NP (NP (NP (ADJP (CD 11) (NN %)) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD did) (RB not))))) (PRN (-LRB- -LRB-) (VP (VBN P) (S (VP (SYM =) (NP (CD 0.1))))) (-RRB- -RRB-)))))) (. .)))
24220752	9	(ROOT (S (S (NP (NNP Doc_24220752_808_811_Disease)) (ADVP (RBR more) (RB frequently)) (VP (VBD developed) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN undergone) (NP (NP (NNP CT)) (PP (IN within) (NP (CD 45) (NNS days)))) (PP (IN after) (NP (NP (DT the) (JJ last) (NN chemotherapy)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.005))) (-RRB- -RRB-)))))))))))) (: ;) (S (NP (PRP it)) (VP (VBD was) (NP (NP (ADVP (RB also)) (DT an) (JJ independent) (NN risk) (NN factor)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.017))) (-RRB- -RRB-))))) (. .)))
24220752	10	(ROOT (S (NP (NNP Doc_24220752_979_982_Disease)) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR more)) (PP (IN after) (NP (NN treatment)))) (PP (PP (IN with) (NP (NP (JJ bevacizumab/Doc) (JJ _) (NNS 24220752_1039_1049_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.021))) (-RRB- -RRB-)))) (CC and) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_24220752_1083_1095_Disease)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.044))) (-RRB- -RRB-)))))))) (. .)))
24220752	11	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_24220752_1139_1142_Disease)) (PP (IN after) (NP (NP (NNP CT)) (PP (IN in) (NP (JJ hospitalised) (JJ oncological) (NNS patients)))))))) (VP (VBD was) (NP (CD 20) (NN %))) (. .)))
24220752	12	(ROOT (S (NP (NNP Doc_24220752_1199_1202_Disease)) (VP (VBD developed) (ADJP (JJ 4.5-times) (ADVP (RBR more) (RB frequently)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_24220752_1256_1262_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN undergone) (NP (JJ recent) (NN chemotherapy)))))))))))) (. .)))
24220752	13	(ROOT (S (NP (NP (NNP Doc_24220752_1302_1314_Disease)) (CC and) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (JJ bevacizumab/Doc) (JJ _) (NNS 24220752_1350_1360_Chemical))))) (VP (MD may) (VP (VB be) (NP (NP (JJ additional) (NN risk) (NNS factors)) (PP (IN for) (NP (JJ Doc_24220752_1396_1399_Disease) (NN development)))))) (. .)))
24220752	14	(ROOT (NP (NNP KEY) (NNPS POINTS) (: :) (. .)))
24220752	15	(ROOT (S (NP (NP (NNP Doc_24220752_1427_1455_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24220752_1457_1460_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN concern)) (PP (IN for) (NP (NP (JJ oncological) (NNS patients)) (VP (VBG undergoing) (NP (NNP CT.))))))) (. .)))
24220752	16	(ROOT (S (NP (NNP Doc_24220752_1517_1520_Disease)) (VP (VBZ occurs) (ADVP (ADVP (RBR more) (RB often)) (SBAR (WHADVP (WRB when)) (S (NP (NNP CT)) (VP (VBZ is) (VP (VBN performed) (NP (QP (CD <) (CD 45)) (NNS days)) (PP (IN after) (NP (NN chemotherapy)))))) (. .)))) (. .)))
24220752	17	(ROOT (S (NP (NP (NN Doc_24220752_1591_1603_Disease) (CC and) (NN treatment)) (PP (IN with) (NP (NN bevacizumab)))) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (NP (JJ additional) (NN risk) (NNS factors)))))) (. .)))
24234943	0	(ROOT (S (NP (NP (NNP Syndrome)) (PP (IN of) (NP (NNS Doc_24234943_12_56_Disease)))) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_24234943_73_87_Chemical)))) (. .)))
24234943	1	(ROOT (S (S (VP (TO To) (VP (VB report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NNP Doc_24234943_120_167_Disease) (PRN (-LRB- -LRB-) (NP (NNP Doc_24234943_169_174_Disease)) (-RRB- -RRB-)) (NN secretion))))))) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_24234943_202_216_Chemical)))) (. .)))
24234943	2	(ROOT (NP (NP (NNP CASE) (NNP SUMMARY)) (: :) (NP (NP (DT A) (JJ 57-year) (JJ old) (NN female)) (PP (IN with) (NP (NN hyponatraemia)))) (. .)))
24234943	3	(ROOT (S (S (NP (PRP$ Her) (NNS medications)) (VP (VBD included) (NP (NNS Doc_24234943_298_312_Chemical)))) (, ,) (CC and) (S (NP (NNS symptoms)) (VP (VBD included) (NP (NNS Doc_24234943_336_342_Disease) (, ,) (NNS Doc_24234943_344_351_Disease) (CC and) (NNS Doc_24234943_356_365_Disease)))) (. .)))
24234943	4	(ROOT (S (S (NP (NP (DT The) (NN serum) (NNS Doc_24234943_377_383_Chemical)) (PP (IN at) (NP (DT this) (NN time)))) (VP (VBD was) (NP (CD 120) (NN mmol/L)))) (, ,) (NP (NN serum) (NN osmolality)) (VP (VBD was) (NP (NP (CD 263) (NN mosmol/kg) (, ,) (NN urine) (NN osmolality) (NN 410) (NN mosmol/kg) (CC and) (NN urine) (NNS Doc_24234943_490_496_Chemical)) (ADJP (CD 63) (JJ mmol/L))) (, ,) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT a) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_24234943_539_544_Disease))))))) (. .)))
24234943	5	(ROOT (S (S (NP (NNP Doc_24234943_546_560_Chemical)) (VP (VBD was) (VP (VBN ceased)))) (CC and) (S (NP (JJ fluid) (NN restriction)) (VP (VBD implemented))) (. .)))
24234943	6	(ROOT (S (PP (IN After) (NP (CD 4) (NNS days))) (NP (DT the) (NNS Doc_24234943_624_630_Chemical)) (VP (VBD increased) (PP (TO to) (NP (NP (CD 128) (ADJP (JJ mmol/L) (CC and) (JJ fluid)) (NN restriction)) (SBAR (S (VP (VBD was) (VP (VBN relaxed)))))))) (. .)))
24234943	7	(ROOT (S (PP (IN During) (NP (PRP$ her) (JJ further) (ADJP (NP (CD 3) (NNS weeks)) (JJ inpatient)) (NN admission))) (NP (DT the) (NN serum) (NNS Doc_24234943_747_753_Chemical)) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 134) (TO to) (CD 137)) (NN mmol/L))) (PP (IN during) (NP (NN treatment))) (PP (IN with) (NP (NNS Doc_24234943_806_817_Chemical)))) (. .)))
24234943	8	(ROOT (S (NP (NNP Doc_24234943_831_836_Disease)) (VP (VBZ has) (VP (VBN been) (VP (ADVP (RB widely)) (VBN reported) (PP (IN with) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (NNS antidepressants)))))))) (. .)))
24234943	9	(ROOT (S (NP (DT This) (NN case) (NN report)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NNS Doc_24234943_926_940_Chemical)) (VP (MD might) (VP (VB cause) (NP (ADJP (RB clinically) (JJ significant)) (NNS Doc_24234943_976_988_Disease))))))) (. .)))
24234943	10	(ROOT (S (NP (NNS Clinicians)) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NNS antidepressants)))))) (S (VP (TO to) (VP (VP (VB cause) (NP (NNS Doc_24234943_1076_1088_Disease))) (, ,) (CC and) (VP (VB take) (NP (JJ appropriate) (JJ corrective) (NN action)) (SBAR (WHADVP (WRB where)) (S (ADJP (JJ necessary)))))))))) (. .)))
24275640	0	(ROOT (S (NP (NNP Oxidative)) (VP (VBP stress) (PP (IN on) (NP (NP (NNS Doc_24275640_20_34_Disease)) (PP (IN after) (NP (NN treatment))))) (PP (IN with) (NP (NP (JJ single) (CC and) (JJ multiple) (NNS doses)) (PP (IN of) (NP (NNS Doc_24275640_85_96_Chemical)))))) (. .)))
24275640	1	(ROOT (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NP (NNS Doc_24275640_115_126_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24275640_128_131_Chemical)) (-RRB- -RRB-)) (: -) (NP (JJ induced) (NNS Doc_24275640_141_155_Disease))))) (VP (VBZ remains) (ADJP (JJ controversial))) (. .)))
24275640	2	(ROOT (S (S (NP (NP (JJ Wistar) (NNS rats)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 66))))) (-RRB- -RRB-))) (VP (VP (VBD received) (NP (JJ Doc_24275640_209_212_Chemical) (NNS injections)) (ADVP (RB intraperitoneally))) (CC and) (VP (VBD were) (VP (ADVP (RB randomly)) (VBN assigned) (PP (TO to) (NP (CD 2) (JJ experimental) (NNS protocols))))))) (: :) (S (S (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (NNS rats)) (VP (VBD were) (VP (VBN killed) (PP (IN before) (PRN (-LRB- -LRB-) (NP (NP (CD -24) (NN h)) (, ,) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 8))))))) (-RRB- -RRB-)))))) (CC and) (S (NP (NP (CD 24) (NN h)) (PP (IN after) (PRN (-LRB- -LRB-) (S (NP (CD +24)) (VP (VBP h) (, ,) (S (NP (NN n)) (VP (SYM =) (NP (CD 8)))))) (-RRB- -RRB-)) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (S (VP (VBG Doc_24275640_388_391_Chemical) (S (-LRB- -LRB-) (NP (CD 4) (JJ mg/kg) (NN body) (NN weight)) (-RRB- -RRB-) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (JJ Doc_24275640_431_434_Chemical) (JJ acute) (NN effect)) (CC and) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (NP (NNS rats))))))))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 58))))) (-RRB- -RRB-))) (VP (VP (VBD received) (NP (NP (CD 4) (NNS injections)) (PP (IN of) (NP (NP (NNS Doc_24275640_495_498_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 4) (CD mg/kg)) (NN body) (NN weight/week)) (-RRB- -RRB-)))))) (CC and) (VP (VBD were) (VP (VBN killed) (PP (IN before) (NP (NP (NP (DT the) (JJ first) (NN injection)) (PRN (-LRB- -LRB-) (NP (NNP M0)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 1) (NN week)) (PP (IN after) (NP (NP (DT each) (NN injection)) (PRN (-LRB- -LRB-) (NP (NP (NNP M1)) (, ,) (NP (NNP M2)) (, ,) (NP (NNP M3)) (, ,) (CC and) (NP (NNP M4))) (-RRB- -RRB-))))))) (S (VP (TO to) (VP (VB determine) (NP (DT the) (JJ chronological) (NNS effects)))))))))) (. .)))
24275640	3	(ROOT (S (NP (NP (NP (NNS Animals)) (VP (VBN used) (PP (IN at) (NP (NNP M0))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 8))))) (-RRB- -RRB-))) (VP (VBD were) (ADVP (RB also)) (VP (VBN used) (PP (IN at) (NP (NP (NN moment) (CD -24) (NN h)) (PP (IN of) (NP (JJ acute) (NN study))))))) (. .)))
24275640	4	(ROOT (S (NP (NP (NP (NP (NNP Cardiac) (JJ total) (NN antioxidant) (NN performance)) (PRN (-LRB- -LRB-) (NP (NNP TAP)) (-RRB- -RRB-))) (, ,) (NP (NN DNA) (NN damage)) (, ,)) (CC and) (NP (JJ morphology) (NNS analyses))) (VP (VBD were) (VP (VBN carried) (PRT (RP out)) (PP (IN at) (NP (DT each) (NN time) (NN point))))) (. .)))
24275640	5	(ROOT (S (NP (NP (JJ Single) (NN dose)) (PP (IN of) (NP (NNS Doc_24275640_874_877_Chemical)))) (VP (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (VBN increased) (NNS Doc_24275640_908_930_Disease)) (, ,) (NP (NNS Doc_24275640_932_940_Disease)) (, ,)) (CC and) (NP (NP (NN DNA) (NN damage)) (PRN (-LRB- -LRB-) (VP (VBN strand) (NP (NP (NNS breaks)) (PRN (-LRB- -LRB-) (NP (NNP SBs)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_24275640_982_1002_Chemical)))) (-RRB- -RRB-))))))) (CC and) (VP (VBD decreased) (NP (NNP TAP)))) (. .)))
24275640	6	(ROOT (S (NP (DT The) (JJ chronological) (NN study)) (VP (VBD showed) (NP (NP (NP (DT an) (NN effect)) (PP (IN of) (NP (NP (DT a) (JJ cumulative) (NN dose)) (PP (IN on) (NP (NN body) (NN weight)))))) (PRN (-LRB- -LRB-) (VP (VBN R) (S (VP (SYM =) (NP (CD -0.99)))) (, ,) (S (VP (VB p) (S (VP (SYM =) (NP (CD 0.011))))))) (-RRB- -RRB-)) (, ,) (NP (NP (NNS Doc_24275640_1124_1132_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN R)) (NP (NP (NNP =) (CD 1.00) (, ,) (CD p)) (SBAR (S (VP (SYM =) (NP (CD 0.004))))))) (-RRB- -RRB-)) (, ,) (NP (NNS Doc_24275640_1156_1159_Chemical))) (PRN (-LRB- -LRB-) (VP (VBN R) (S (VP (SYM =) (NP (CD 0.95)))) (, ,) (S (VP (VB p) (S (VP (SYM =) (NP (CD 0.049))))))) (-RRB- -RRB-)) (, ,) (CC and) (NP (NP (NNP DNA) (NNP SBs)) (PRN (-LRB- -LRB-) (VP (VBN R) (S (VP (SYM =) (NP (CD -0.95)))) (, ,) (S (VP (VB p) (S (VP (SYM =) (NP (CD 0.049))))))) (-RRB- -RRB-))))) (. .)))
24275640	7	(ROOT (S (NP (NNP DNA) (NNP SBs) (NN damage)) (VP (VBD was) (ADVP (RB negatively)) (VP (VBN associated) (PP (IN with) (NP (NP (NP (NNP TAP)) (PRN (-LRB- -LRB-) (VP (VBN R) (S (VP (SYM =) (NP (CD -0.98)))) (, ,) (S (VP (VB p) (S (VP (SYM =) (NP (CD 0.018))))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNS Doc_24275640_1297_1305_Disease)) (PRN (-LRB- -LRB-) (VP (VBN R) (S (VP (SYM =) (NP (CD -0.97)))) (, ,) (S (VP (VB p) (S (VP (SYM =) (NP (CD 0.027))))))) (-RRB- -RRB-))))))) (. .)))
24275640	8	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ oxidative) (NN damage)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ acute) (NNS Doc_24275640_1397_1411_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NNS Doc_24275640_1440_1443_Chemical))))) (ADVP (RB only)))))))))) (. .)))
24275640	9	(ROOT (S (NP (NP (VBN Increased) (NN resistance)) (PP (TO to) (NP (DT the) (JJ oxidative) (NN stress)))) (VP (VBZ is) (ADJP (JJ plausible) (PP (IN for) (NP (NP (DT the) (JJ multiple) (NN dose)) (PP (IN of) (NP (NNS Doc_24275640_1533_1536_Chemical))))))) (. .)))
24275640	10	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (JJ different) (NNS mechanisms)) (VP (MD may) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (JJ acute) (NNS Doc_24275640_1590_1598_Disease)) (PP (IN versus) (NP (JJ chronic) (NNS Doc_24275640_1614_1622_Disease)))))))) (. .)))
24283660	0	(ROOT (NP (NP (NP (JJ Doc_24283660_0_10_Chemical-related) (NNS Doc_24283660_19_26_Disease)) (PP (IN after) (NP (JJ pediatric) (NN liver) (NN transplantation)))) (: --) (NP (DT a) (JJ single-center) (NN experience)) (. .)))
24283660	1	(ROOT (S (S (VP (TO To) (VP (VB identify) (NP (NP (DT the) (NN risk) (NNS factors)) (PP (IN for) (NP (JJ new-onset) (NNS Doc_24283660_137_145_Disease)))) (PP (IN after) (NP (JJ pediatric) (NNP LT)))))) (CC and) (S (VP (TO to) (VP (VB assess) (NP (NP (PRP$ their) (JJ clinical) (NNS implications)) (CC and) (NP (JJ long-term) (NN prognosis)))))) (. .)))
24283660	2	(ROOT (S (NP (NP (DT The) (JJ clinical) (CC and) (NN laboratory) (NNS data)) (PP (IN of) (NP (NP (CD 27) (JJ consecutive) (NNS children)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (NNP LT)) (PP (IN from) (NP (NNP January) (CD 2007))) (PP (TO to) (NP (NNP December) (CD 2010))) (PP (IN in) (NP (PRP$ our) (NN center))))))))) (VP (VBD were) (VP (VBN analyzed) (ADVP (RB retrospectively)))) (. .)))
24283660	3	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN divided) (PP (IN into) (NP (NP (JJ Doc_24283660_416_424_Disease) (NN group)) (CC and) (NP (DT a) (JJ non-Doc_24283660_441_449_Disease) (NN group)))))) (. .)))
24283660	4	(ROOT (S (NP (JJ Pre-operative) (, ,) (NN intra-operative) (, ,) (CC and) (JJ post-operative) (NNS data)) (VP (VBD were) (VP (VBN collected))) (. .)))
24283660	5	(ROOT (S (NP (NNP Doc_24283660_529_537_Disease)) (VP (VBD occurred) (PP (IN in) (NP (NP (CD four) (NNS children)) (, ,) (NP (NP (DT an) (NN incidence)) (PP (IN of) (NP (CD 14.8) (NN %))))))) (. .)))
24283660	6	(ROOT (S (S (NP (DT All)) (VP (VBD exhibited) (NP (JJ generalized) (NNS Doc_24283660_614_635_Disease)) (PP (IN within) (NP (DT the) (JJ first) (CD two) (NNS wk))) (SBAR (IN after) (S (NP (NNP LT.) (NNP Univariate) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (NN risk) (NNS factors)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_24283660_735_743_Disease))) (PP (IN after) (NP (JJ pediatric) (NNP LT))))) (VP (VBD included) (NP (NN gender)))))))))) (PRN (, ,) (S (NP (JJ pediatric) (JJ end-stage) (NNS Doc_24283660_800_813_Disease)) (VP (VBP score) (SBAR (IN before) (S (NP (NP (NN surgery)) (, ,) (NP (NP (JJ Child-Pugh) (NN score)) (PP (IN before) (NP (NN surgery)))) (, ,)) (VP (VBP serum) (NP (JJ total) (NNS Doc_24283660_881_890_Chemical)) (PP (IN after) (NP (NN surgery)))))))) (, ,)) (CC and) (S (NP (NN trough) (NNS Doc_24283660_917_920_Chemical)) (VP (VBP level))) (. .)))
24283660	7	(ROOT (S (NP (JJ Multivariate) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN trough) (NNS Doc_24283660_969_972_Chemical) (NN level)) (VP (VBD was) (NP (NP (DT the) (JJ only) (JJ independent) (NN risk) (NN factor)) (VP (VBN associated) (PP (IN with) (NP (DT the) (NNS Doc_24283660_1036_1044_Disease))))))))) (. .)))
24283660	8	(ROOT (S (NP (NP (DT All) (NNS children)) (SBAR (WHNP (WP who)) (S (VP (VBD experienced) (NP (NNS Doc_24283660_1075_1083_Disease)))))) (VP (VP (VBD survived) (PP (IN with) (NP (JJ good) (NN graft) (NN function)))) (CC and) (VP (VBD remained) (NP (NNS Doc_24283660_1131_1138_Disease-free)) (PP (IN without) (NP (JJ anti-Doc_24283660_1157_1166_Disease) (NNS drugs))) (PP (IN over) (NP (NP (DT a) (JJ mean) (NN follow-up) (NN period)) (PP (IN of) (NP (CD 33.7) (NNS +))) (NP (CD 14.6) (NNS months)))))) (. .)))
24283660	9	(ROOT (S (NP (JJ High) (NN trough) (NN Doc_24283660_1237_1240_Chemical) (NN level)) (VP (VBD was) (NP (NP (DT the) (JJ predominant) (NN factor)) (SBAR (WHNP (WDT that)) (S (VP (VBD contributed) (PP (TO to) (NP (NP (NNS Doc_24283660_1294_1302_Disease)) (PP (IN in) (NP (DT the) (JJ early) (JJ post-operative) (NN period))))) (PP (IN after) (NP (JJ pediatric) (NNP LT.) (NNP High) (NNP PELD) (CC and) (NNP Child-Pugh) (NNS scores))) (SBAR (IN before) (S (NP (NP (NNP LT)) (CC and) (NP (JJ high) (JJ post-operative) (NN serum) (NN Tbil))) (VP (MD may) (VP (VB be) (NP (NP (JJ contributory) (NN risk) (NNS factors)) (PP (IN for) (NP (NN Doc_24283660_1472_1475_Chemical-related) (NNS Doc_24283660_1484_1492_Disease))))))))))))) (. .)))
24284476	0	(ROOT (NP (NP (DT The) (JJ flavonoid) (JJ Doc_24284476_14_22_Chemical) (NNS delays)) (VP (VBG forgetting) (PP (IN of) (NP (NP (JJ passive) (NN avoidance) (NN conditioning)) (PP (IN in) (NP (NNS rats)))))) (. .)))
24284476	1	(ROOT (S (NP (DT The) (JJ present) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (S (VP (TO to) (VP (VB study) (NP (NP (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (DT the) (JJ flavonoid) (NNS Doc_24284476_160_168_Chemical)))) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 20) (JJ mg/kg) (NN intraperitoneally)) (PRN (-LRB- -LRB-) (NP (NNP i.p.)) (-RRB- -RRB-)) (, ,) (NP (CD 1) (NN h))) (PP (IN before) (NP (NN acquisition)))) (-RRB- -RRB-)) (, ,) (PP (IN on) (NP (CD 24) (NN h) (NN retention) (NN performance)))) (CC and) (NP (NP (NNP forgetting)) (PP (IN of) (NP (DT a) (JJ step-through) (JJ passive) (NN avoidance) (NN task))))) (, ,) (PP (IN in) (NP (JJ young) (JJ male) (NNP Wistar) (NNS rats)))))))) (. .)))
24284476	2	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (NNS differences)) (PP (IN between) (NP (NP (ADJP (JJ saline) (: -) (CC and) (JJ Doc_24284476_390_398_Chemical-treated)) (NNS groups)) (PP (IN in) (NP (DT the) (CD 24) (NN h) (NN retention) (NN trial))))))) (. .)))
24284476	3	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NNS Doc_24284476_456_464_Chemical)) (VP (VBD did) (RB not) (VP (VB prevent) (S (NP (DT the) (NNS Doc_24284476_485_492_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_24284476_504_515_Chemical))) (PRN (-LRB- -LRB-) (NP (NP (NNS 1mg/kg)) (, ,) (NP (NN i.p.)) (, ,) (NP (CD 30) (NN min))) (PP (IN before) (NP (DT the) (NN acquisition))) (-RRB- -RRB-)))))) (. .)))
24284476	4	(ROOT (S (NP (NP (NP (DT The) (ADJP (JJ saline) (: -) (CC and) (JJ Doc_24284476_579_587_Chemical-treated)) (NNS rats)) (SBAR (WHNP (WDT that)) (S (VP (VBD did) (RB not) (VP (VB step) (PRT (RP through)) (PP (IN into) (NP (DT the) (JJ dark) (NN compartment))) (PP (IN during) (NP (DT the) (JJ cut-off) (NN time)))))))) (PRN (-LRB- -LRB-) (NP (QP (CD 540) (CD s))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN retested) (ADVP (RB weekly)) (PP (IN for) (NP (QP (IN up) (TO to) (CD eight)) (NNS weeks))))) (. .)))
24284476	5	(ROOT (S (PP (IN In) (NP (DT the) (JJ saline) (JJ treated) (NN group))) (, ,) (S (NP (NP (DT the) (JJ first) (JJ significant) (NN decline)) (PP (IN in) (NP (JJ passive) (NN avoidance) (NN response)))) (VP (VBD was) (VP (VBN observed) (PP (IN at) (NP (CD four) (NNS weeks)))))) (, ,) (CC and) (S (NP (JJ complete) (NNS Doc_24284476_859_870_Disease)) (VP (VBD was) (VP (VBN found) (NP (CD five) (NNS weeks)) (PP (IN after) (NP (NP (DT the) (NN acquisition)) (PP (IN of) (NP (DT the) (JJ passive) (NN avoidance) (NN task)))))))) (. .)))
24284476	6	(ROOT (S (PP (IN At) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (JJ experimental) (NN period))))) (, ,) (NP (NP (CD 60) (NN %)) (PP (IN of) (NP (NP (DT the) (NNS animals)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_24284476_1016_1024_Chemical))))))) (ADVP (RB still)) (VP (VBD did) (RB not) (VP (VB step) (PRT (RP through)))) (. .)))
24284476	7	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (S (LST (LS 1) (-RRB- -RRB-)) (NP (NNS Doc_24284476_1080_1088_Chemical)) (VP (VP (VBZ delays) (NP (DT the) (JJ long-term) (NN forgetting))) (CC but) (VP (VBD did) (RB not) (VP (VB modulate) (NP (NP (DT the) (CD 24) (NN h) (NN retention)) (PP (IN of) (NP (NN fear) (NN memory)))))))) (CC and) (S (NP (NP (LST (LS 2) (-RRB- -RRB-)) (DT the) (JJS obtained) (JJ beneficial) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_24284476_1217_1225_Chemical)) (PP (IN on) (NP (DT the) (JJ passive) (NN avoidance) (NN conditioning)))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (NNS mechanisms)) (SBAR (WHNP (WDT that)) (S (VP (VBP do) (RB not) (VP (VB implicate) (NP (PRP$ its) (NN action)) (PP (IN on) (NP (DT the) (JJ muscarinic) (JJ cholinergic) (NN system))))))))))))))) (. .)))
2429800	0	(ROOT (S (NP (JJ Doc_2429800_0_9_Chemical) (NNS antagonists) (CC and) (NNS Doc_2429800_26_40_Chemical-induced)) (VP (VBZ Doc_2429800_49_60_Disease) (PP (IN in) (NP (JJ cardiac) (JJ surgical) (NNS patients)))) (. .)))
2429800	1	(ROOT (S (NP (NP (JJ Hemodynamic) (NNS effects) (CC and) (NNS Doc_2429800_115_124_Chemical) (NN release)) (PP (IN by) (NP (NP (JJ bolus) (NN injection)) (PP (IN of) (NP (NP (CD 0.35) (NN mg/kg)) (PP (IN of) (NP (NNS Doc_2429800_169_183_Chemical)))))))) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (CD 24) (NNS patients))))) (. .)))
2429800	2	(ROOT (S (NP (NP (ADJP (JJ H1) (: -) (CC and) (JJ H2-Doc_2429800_224_233_Chemical)) (NNS antagonists)) (CC or) (NP (NN placebo))) (VP (VBD were) (VP (VBN given) (PP (IN before) (S (VP (VBG dosing) (PP (IN with) (NP (NP (NNS Doc_2429800_287_301_Chemical)) (PP (IN in) (NP (NP (NP (DT a) (JJ randomized) (JJ double-blind) (NN fashion)) (PP (TO to) (NP (CD four) (NNS groups)))) (: :) (NP (NN group) (CD 1)) (: --) (NP (NN placebo)) (: ;) (NP (NN group) (CD 2)) (: --) (NP (NP (NP (NNS Doc_2429800_382_392_Chemical)) (, ,) (NP (CD 4) (NN mg/kg)) (, ,)) (PP (CC plus) (NP (NN placebo)))) (: ;) (NP (NP (NN group)) (NP (CD 3))) (: --) (NP (NP (NP (NNS Doc_2429800_426_442_Chemical)) (, ,) (NP (CD 0.1) (NN mg/kg)) (, ,)) (PP (CC plus) (NP (NN placebo)))) (: ;) (CC and) (NP (NP (NN group) (CD 4)) (: --) (NP (NNP Doc_2429800_482_492_Chemical) (CC plus) (NNP Doc_2429800_498_514_Chemical)))))))))))) (. .)))
2429800	3	(ROOT (S (NP (JJ Doc_2429800_516_525_Chemical) (NN release)) (VP (VBD occurred) (PP (IN in) (NP (NP (JJS most) (NNS patients)) (, ,) (NP (DT the) (JJS highest) (NN level)))) (NP (CD 2) (NNS minutes)) (PP (IN after) (NP (JJ Doc_2429800_595_609_Chemical) (NN dosing)))) (. .)))
2429800	4	(ROOT (S (NP (NNP Group) (CD 1)) (VP (VBD had) (NP (NP (DT a) (JJ moderate) (JJ negative) (NN correlation)) (PP (IN between) (NP (NP (NP (NN plasma) (NN Doc_2429800_677_686_Chemical) (NN change) (CC and) (JJ systemic) (NN vascular) (NN resistance)) (-LRB- -LRB-) (NP (NP (NP (SYM r)) (SBAR (S (VP (SYM =) (NP (CD 0.58)))))) (: ;) (NP (NP (NNP P)) (NP (QP (JJR less) (IN than) (CD 0.05))))) (-RRB- -RRB-)) (ADJP (RB not) (JJ present))))) (PP (IN in) (NP (NN group) (CD 4)))) (. .)))
2429800	5	(ROOT (S (NP (NP (JJ Prior) (NN dosing)) (PP (IN with) (NP (NNS antagonists)))) (ADVP (RB partially)) (VP (VBD prevented) (NP (DT the) (NN fall)) (PP (IN in) (NP (JJ systemic) (NN vascular) (NN resistance)))) (. .)))
2429800	6	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (JJ hemodynamic) (NNS changes)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_2429800_940_954_Chemical) (NN dosing))))) (VP (VBP are) (ADVP (RB only)) (VP (ADVP (RB partially)) (VBN explained) (PP (IN by) (NP (JJ Doc_2429800_994_1003_Chemical) (NN release)))))))) (. .)))
2429800	7	(ROOT (S (S (VP (ADVP (RB Thus) (RB prior)) (VBG dosing) (PP (IN with) (NP (NNP H1))))) (: -) (CC and) (S (NP (NNS H2-antagonists)) (VP (VBZ provides) (NP (RB only) (JJ partial) (NN protection)))) (. .)))
24309294	0	(ROOT (S (NP (NNP Doc_24309294_0_15_Chemical-Doc_24309294_16_27_Chemical)) (VP (VBD restored) (NP (ADJP (JJ Doc_24309294_37_45_Chemical-induced) (JJ hippocampal)) (JJ long-term) (NN potentiation) (NN impairment)) (PP (IN in) (NP (NNS rats)))) (. .)))
24309294	1	(ROOT (S (NP (NP (NNP Doc_24309294_109_124_Chemical-Doc_24309294_125_136_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CCK-8)) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (DT a) (JJ typical) (JJ brain-gut) (NN peptide))))) (, ,)) (VP (VBZ exerts) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NP (JJ biological) (NNS activities)) (PP (IN on) (NP (DT the) (JJ central) (JJ nervous) (NN system))))))) (. .)))
24309294	2	(ROOT (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN reported) (SBAR (IN that) (S (NP (NNP CCK-8)) (VP (VP (ADVP (RB significantly)) (VBD alleviated) (NP (NN Doc_24309294_324_332_Chemical-induced) (NNS Doc_24309294_341_348_Disease))) (CC and) (VP (VBD reversed) (NP (NN spine) (NN density) (NNS decreases)) (PP (IN in) (NP (NP (DT the) (NN CA1) (NN region)) (PP (IN of) (NP (DT the) (NNS hippocampus))))) (PP (IN in) (NP (NN Doc_24309294_426_434_Chemical-treated) (NNS animals))))))))) (. .)))
24309294	3	(ROOT (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (UCP (ADJP (JJ CCK-8) (PP (IN on) (NP (NP (NP (JJ long-term) (NN potentiation)) (PRN (-LRB- -LRB-) (NP (NNP LTP)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (ADJP (JJ lateral) (JJ perforant)) (NN path)) (PRN (-LRB- -LRB-) (NP (NNP LPP)) (-RRB- -RRB-))))))) (: -) (NP (NP (JJ granule) (NN cell) (NN synapse)) (PP (IN of) (NP (NN rat))))) (JJ dentate) (NNS gyrus)) (PRN (-LRB- -LRB-) (NP (NNP DG)) (-RRB- -RRB-))))) (PP (IN in) (NP (JJ acute) (NN saline) (CC or) (NN Doc_24309294_629_637_Chemical-treated) (NNS rats)))) (. .)))
24309294	4	(ROOT (S (NP (NP (NNP Population) (NNS spikes)) (PRN (-LRB- -LRB-) (NP (NNP PS)) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN evoked) (PP (IN by) (NP (NP (NN stimulation)) (PP (IN of) (NP (DT the) (NNP LPP))))))))) (, ,)) (VP (VBD were) (VP (VBN recorded) (PP (IN in) (NP (DT the) (NNP DG) (NN region))))) (. .)))
24309294	5	(ROOT (S (NP (NP (NNP Acute) (NNP Doc_24309294_759_767_Chemical) (PRN (-LRB- -LRB-) (NP (NNP 30mg/kg)) (, ,) (NP (NNP s.c.)) (-RRB- -RRB-)) (NNP treatment)) (ADJP (RB significantly) (JJ attenuated))) (VP (VBP hippocampal) (SBAR (S (NP (NP (NNP LTP) (CC and) (NNP CCK-8)) (PRN (-LRB- -LRB-) (NP (NNP 1ug)) (, ,) (NP (NNP i.c.v.)) (-RRB- -RRB-))) (VP (VBD restored) (NP (NP (DT the) (NN amplitude)) (PP (IN of) (NP (NNP PS))) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN attenuated) (PP (IN by) (NP (JJ Doc_24309294_911_919_Chemical) (NN injection)))))))))))) (. .)))
24309294	6	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NP (NN microinjection)) (PP (IN of) (NP (NN CCK-8)))) (PRN (-LRB- -LRB-) (NP (NP (CD 0.1) (CC and) (CD 1ug)) (, ,) (NP (NN i.c.v.))) (-RRB- -RRB-))) (ADVP (RB also)) (ADVP (RB significantly)) (VP (VBD augmented) (NP (NP (NNP hippocampal) (NNP LTP)) (PP (IN in) (NP (JJ saline-treated) (PRN (-LRB- -LRB-) (NP (NNP 1ml/kg)) (, ,) (NP (NNP s.c.)) (-RRB- -RRB-)) (NNS rats))))) (. .)))
24309294	7	(ROOT (S (S (NP (NP (NN Pre-treatment)) (PP (IN of) (NP (DT the) (NNP CCK2) (NN receptor)))) (VP (VBP antagonist) (SBAR (S (NP (NP (NNP Doc_24309294_1120_1125_Chemical) (CD ,260)) (PRN (-LRB- -LRB-) (NP (NNP 10ug)) (, ,) (NP (NNP i.c.v)) (-RRB- -RRB-))) (VP (VBD reversed) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN CCK-8))))))))) (, ,) (CC but) (S (NP (DT the) (NNP CCK1) (NN receptor)) (VP (VBP antagonist) (SBAR (S (NP (NP (NNP L-364) (CD ,718)) (PRN (-LRB- -LRB-) (NP (NNP 10ug)) (, ,) (NP (NNP i.c.v)) (-RRB- -RRB-))) (VP (VBD did) (RB not)))))) (. .)))
24309294	8	(ROOT (S (NP (DT The) (JJ present) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NNP CCK-8)) (VP (VP (VBZ attenuates) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_24309294_1309_1317_Chemical)) (PP (IN on) (NP (JJ hippocampal) (NNP LTP)))))) (PP (IN through) (NP (CD CCK2) (NNS receptors)))) (CC and) (VP (VBP suggest) (NP (NP (DT an) (JJ ameliorative) (NN function)) (PP (IN of) (NP (NP (NN CCK-8)) (PP (IN on) (NP (NN Doc_24309294_1409_1417_Chemical-induced) (NNS Doc_24309294_1426_1443_Disease))))))))))) (. .)))
24333387	0	(ROOT (NP (NP (JJ Glial) (NN activation) (CC and) (NN post-Doc_24333387_26_48_Disease)) (: :) (NP (NP (DT the) (JJ key) (NNS events)) (PP (IN in) (NP (NP (NNS Doc_24333387_68_82_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP ICV)) (-RRB- -RRB-)) (VP (VBN induced) (NP (NP (NNS Doc_24333387_97_114_Disease)) (PP (IN in) (NP (NNS rats)))))))) (. .)))
24333387	1	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (JJ glial) (NN activation) (CC and) (NN post) (NN synaptic) (NNS Doc_24333387_192_200_Disease))) (PP (IN in) (NP (NP (NNP ICV) (NNP Doc_24333387_208_222_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24333387_224_227_Chemical)) (-RRB- -RRB-)) (VP (VBN induced) (NP (JJ Doc_24333387_237_252_Disease) (NNS rats)))))) (VP (VBD was) (VP (VBN explored))) (. .)))
24333387	2	(ROOT (S (PP (IN In) (NP (NP (NN experiment)) (VP (VBN set) (PRT (RP up)) (NP (CD 1))))) (: :) (NP (NNS Doc_24333387_296_310_Disease)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (NNP Morris) (NN water) (NN maze) (NN test)) (PP (IN on) (NP (CD 14-16) (NNS days))))) (PP (IN after) (NP (NNP Doc_24333387_367_370_Chemical) (PRN (-LRB- -LRB-) (NP (NP (NNP ICV)) (: ;) (NP (NNS 3mg/Kg))) (-RRB- -RRB-)) (NN administration))))) (. .)))
24333387	3	(ROOT (S (NP (NNP Doc_24333387_401_404_Chemical)) (VP (VBZ causes) (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (NNP GFAP) (, ,) (NNP CD11b) (CC and) (NNP TNF-a))) (VP (VBG indicating) (NP (JJ glial) (NN activation) (CC and) (NN neuroinflammation))))) (. .)))
24333387	4	(ROOT (S (NP (NNP Doc_24333387_509_512_Chemical)) (ADVP (RB also)) (VP (VP (ADVP (RB significantly)) (VBD increased) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NNP ROS)) (, ,) (NP (NP (NNS Doc_24333387_560_567_Chemical)) (, ,) (NP (NNS Doc_24333387_569_575_Chemical))))))) (CC and) (VP (VBD reduced) (NP (DT the) (JJ mitochondrial) (NN activity)) (PP (IN in) (NP (NP (JJ synaptosomal) (NN preparation)) (VP (VBG illustrating) (NP (JJ free) (JJ radical) (NN generation) (CC and) (NN excitotoxicity))))))) (. .)))
24333387	5	(ROOT (S (NP (NP (VBN Increased) (NN expression) (CC and) (NN activity)) (PP (IN of) (NP (NNS Caspase-3)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed) (PP (IN in) (NP (NP (NNS Doc_24333387_768_771_Chemical)) (VP (VBN treated) (NP (NP (NN rat)) (SBAR (WHNP (WDT which)) (S (VP (VB specify) (NP (JJ apoptotic) (NN cell) (NN death)) (PP (IN in) (NP (NNS hippocampus) (CC and) (NN cortex)))))))))))) (. .)))
24333387	6	(ROOT (S (NP (JJ Doc_24333387_846_849_Chemical) (NN treatment)) (VP (VBD showed) (NP (NP (NN decrease) (NN expression)) (PP (IN of) (NP (NN post) (NN synaptic) (NNS markers) (NNP CaMKIIa) (CC and) (NNP PSD-95)))) (, ,) (SBAR (IN while) (, ,) (S (NP (NP (NN expression)) (PP (IN of) (NP (NP (JJ pre) (JJ synaptic) (NNS markers)) (PRN (-LRB- -LRB-) (ADJP (JJ synaptophysin) (CC and) (JJ SNAP-25)) (-RRB- -RRB-))))) (VP (VBZ remains) (ADJP (JJ unaltered)) (S (VP (VBG indicating) (NP (JJ selective) (NN post) (NNS Doc_24333387_1046_1068_Disease)))))))) (. .)))
24333387	7	(ROOT (S (NP (NP (JJ Oral) (NN treatment)) (PP (IN with) (NP (NP (NNS Doc_24333387_1090_1099_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP 10mg/kg)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_24333387_1114_1123_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN mg/kg)) (-RRB- -RRB-))))) (ADVP (JJ daily) (PP (IN for) (NP (CD 13) (NNS days)))) (VP (VBD attenuated) (NP (NP (NNS Doc_24333387_1164_1167_Chemical)) (VP (VBN induced) (NP (NP (JJ glial) (NN activation)) (, ,) (NP (JJ apoptotic) (NN cell) (NN death)) (CC and) (NP (NN post) (NNS Doc_24333387_1224_1246_Disease))) (PP (IN in) (NP (NN rat) (NN brain)))))) (. .)))
24333387	8	(ROOT (SINV (ADVP (RB Further)) (, ,) (PP (IN in) (NP (NN experiment))) (VP (VBD set) (PRT (RP up))) (NP (NP (CD 2)) (: :) (SBAR (WHADVP (WRB where)) (S (NP (NN memory) (NN function)) (VP (VBD was) (RB not) (VP (VBN affected) (S (VP (VBG i.e.) (NP (CD 7-9) (NNS days)) (PP (IN after) (NP (JJ Doc_24333387_1353_1356_Chemical) (NN treatment)))))))))) (. .)))
24333387	9	(ROOT (S (NP (NP (DT The) (NN level)) (PP (IN of) (NP (NP (NNP GFAP)) (, ,) (NP (NNS CD11b)) (, ,) (NP (NNP TNF-a)) (, ,) (NP (NNP ROS)) (CC and) (NP (JJ Doc_24333387_1409_1416_Chemical) (NNS levels))))) (VP (VBD were) (VP (VBN increased))) (. .)))
24333387	10	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NP (JJ apoptotic) (NN marker)) (, ,) (NP (JJ synaptic) (NNS markers)) (, ,) (NP (JJ mitochondrial) (NN activity)) (CC and) (NP (JJ Doc_24333387_1522_1528_Chemical) (NNS levels))) (VP (VBD remained) (ADJP (JJ unaffected))) (. .)))
24333387	11	(ROOT (S (NP (JJ Collective) (NNS data)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NP (JJ neuroinflammatory) (NN process)) (CC and) (NP (JJ oxidative) (NN stress))) (VP (VP (VBZ occurs) (ADVP (RBR earlier) (PP (TO to) (NP (NNS apoptosis))))) (CC and) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NN memory) (NN function)))))))) (. .)))
24333387	12	(ROOT (S (NP (JJ Present) (NN study)) (ADVP (RB clearly)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (JJ glial) (NN activation) (CC and) (NN post) (NNS Doc_24333387_1762_1784_Disease)) (VP (VBP are) (NP (NP (DT the) (JJ key) (NNS factors)) (PP (IN in) (NP (NP (JJ Doc_24333387_1808_1811_Chemical) (JJ induced) (NNS Doc_24333387_1820_1837_Disease)) (CC and) (NP (JJ neuronal) (NN cell) (NN death))))))))) (. .)))
24341598	0	(ROOT (NP (NP (NNP Comparison)) (PP (IN of) (NP (NP (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_24341598_25_49_Chemical)) (PP (IN with) (NP (NP (NNS Doc_24341598_55_64_Chemical)) (PP (IN in) (NP (NN prevention))))))))) (PP (IN of) (NP (JJ contrast-induced) (NNS Doc_24341598_99_110_Disease))) (. .)))
24341598	1	(ROOT (S (NP (NP (NP (NNP INTRODUCTION) (CC AND) (NNP OBJECTIVE)) (: :) (NP (NNS Doc_24341598_140_168_Disease))) (PRN (-LRB- -LRB-) (NP (NNP Doc_24341598_170_173_Disease)) (-RRB- -RRB-))) (ADVP (RB significantly)) (VP (VBZ increases) (NP (NP (DT the) (NN morbidity) (CC and) (NN mortality)) (PP (IN of) (NP (NNS patients))))) (. .)))
24341598	2	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBZ is) (S (VP (TO to) (VP (VB investigate) (CC and) (VB compare) (NP (NP (DT the) (JJ protective) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_24341598_318_342_Chemical)) (PP (IN with) (NP (JJ Doc_24341598_348_366_Chemical) (NN infusion) (CC and) (NNS Doc_24341598_380_404_Chemical) (NN infusion)))))) (PP (IN with) (NP (NP (NNS Doc_24341598_419_428_Chemical)) (, ,) (NP (DT a) (JJ Doc_24341598_432_439_Chemical) (NN channel) (NN blocker)) (, ,))) (PP (IN in) (S (VP (VBG preventing) (NP (NNS Doc_24341598_471_474_Disease))))))))) (. .)))
24341598	3	(ROOT (NP (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (S (NP (PRP$ Our) (NN study)) (VP (VBD included) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN administered) (NP (NP (CD 30-60) (NN mL)) (PP (IN of) (NP (JJ iodinated) (NN contrast) (NN agent)))) (PP (IN for) (NP (NP (JJ percutaneous) (JJ coronary) (NN angiography)) (PRN (-LRB- -LRB-) (NP (NNP PCAG)) (-RRB- -RRB-)))) (, ,) (PP (DT all) (IN with) (NP (NP (JJ Doc_24341598_641_651_Chemical) (NNS values)) (PP (IN between) (NP (QP (CD 1.1) (CC and) (CD 3.1)) (NN mg/dL)))))))))))) (. .)))
24341598	4	(ROOT (S (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN divided) (PP (IN into) (NP (CD three) (NNS groups)))))) (CC and) (S (NP (DT each) (NN group)) (VP (VBD had) (NP (CD 20) (NNS patients)))) (. .)))
24341598	5	(ROOT (S (S (NP (NP (DT The) (JJ first) (NN group)) (PP (IN of) (NP (NNS patients)))) (VP (VBD was) (VP (VBN administered) (NP (NNS Doc_24341598_803_827_Chemical))))) (: ;) (S (NP (DT the) (JJ second) (NN group)) (VP (VBD was) (VP (VBN administered) (PP (ADVP (NP (DT a) (NN solution)) (IN that)) (IN of) (NP (NP (ADJP (CD 5) (NN %)) (NNS Doc_24341598_885_893_Chemical) (CC and) (NNS Doc_24341598_898_916_Chemical)) (, ,) (SBAR (IN while) (S (NP (DT the) (JJ third) (NN group)) (VP (VBD was) (VP (VBN administered) (NP (NNS Doc_24341598_957_981_Chemical)) (PP (IN before) (CC and) (IN after) (NP (DT the) (NN contrast) (NN injection)))))))))))) (. .)))
24341598	6	(ROOT (S (NP (DT The) (JJ third) (NN group)) (VP (VBD received) (NP (NP (DT an) (JJ additional) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_24341598_1075_1084_Chemical)) (NP (DT the) (NN day)) (ADVP (RB before) (CC and) (RB first) (NP (CD 2) (NNS days)))))) (PP (IN after) (NP (DT the) (NN contrast) (NN injection)))) (. .)))
24341598	7	(ROOT (S (NP (NP (NP (DT All)) (PP (IN of) (NP (NP (NP (DT the) (NNS patients) (POS ')) (NN plasma) (NN blood) (NNS Doc_24341598_1181_1194_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP BUN)) (-RRB- -RRB-))))) (CC and) (NP (JJ Doc_24341598_1205_1215_Chemical) (NNS levels))) (VP (VBD were) (VP (VBN measured) (PP (IN on) (NP (DT the) (JJ second) (CC and) (JJ seventh) (NN day))) (PP (IN after) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (JJ intravenous) (NN contrast) (NN material))))))) (. .)))
24341598	8	(ROOT (S (NP (DT The) (JJ basal) (JJ Doc_24341598_1345_1355_Chemical) (NNS levels)) (VP (VBD were) (ADJP (JJ similar) (PP (IN for) (NP (DT all) (CD three) (NNS groups)))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ >) (NP (CD 0.05))) (-RRB- -RRB-))) (. .)))
24341598	9	(ROOT (S (PP (IN Among) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 60) (NNS patients)) (VP (VBN included) (PP (IN in) (NP (DT the) (NN study)))))))) (, ,) (NP (CD 16) (NNS patients)) (VP (VBD developed) (NP (NP (NNS Doc_24341598_1483_1502_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24341598_1504_1507_Disease)) (-RRB- -RRB-))) (PP (IN on) (NP (DT the) (JJ second) (NN day))) (SBAR (IN after) (S (NP (NN contrast) (NN material)) (VP (VBD was) (VP (VBN injected) (PRN (-LRB- -LRB-) (NP (CD 26.6) (NN %)) (-RRB- -RRB-))))))) (. .)))
24341598	10	(ROOT (S (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_24341598_1610_1613_Disease)) (PP (IN on) (NP (DT the) (JJ second) (NN day))) (SBAR (IN after) (S (NP (NP (DT the) (NN injection)) (PP (IN in) (NP (DT the) (JJ first) (NN group)))) (VP (VBD was) (NP (NP (CD five)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN %)) (-RRB- -RRB-))) (, ,) (PP (IN in) (NP (DT the) (JJ second) (NN group)))))))))))) (VP (VBD was) (NP (NP (CD six)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN %)) (-RRB- -RRB-))))) (CC and) (S (NP (DT the) (JJ third) (NN group)) (VP (VBD was) (NP (NP (NP (CD five)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN %)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP p) (NNP >) (NNP 0.05)) (-RRB- -RRB-))))) (. .)))
24341598	11	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (JJ significant) (NN difference)) (PP (IN between) (NP (NNS Doc_24341598_1824_1848_Chemical) (, ,) (NNS Doc_24341598_1850_1868_Chemical) (CC and) (NNS Doc_24341598_1873_1897_Chemical)))) (PP (IN with) (NP (NP (JJ Doc_24341598_1903_1912_Chemical) (NN application)) (PP (IN in) (NP (NP (NN prevention)) (PP (IN of) (NP (NNS Doc_24341598_1942_1945_Disease)))))))) (. .)))
24345882	0	(ROOT (NP (NP (ADJP (JJ Neurocognitive) (CC and) (JJ neuroradiologic)) (JJ central) (JJ nervous) (NN system)) (NP (NP (JJ late) (NNS effects)) (PP (IN in) (NP (NP (NNS children)) (VP (VBN treated) (PP (IN on) (NP (NP (NP (NNP Pediatric) (NNP Oncology) (NNP Group) (PRN (-LRB- -LRB-) (NP (NNP POG)) (-RRB- -RRB-)) (NNS Doc_24345882_125_130_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ standard) (NN risk)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_24345882_151_156_Chemical)) (-LRB- -LRB-) (NP (JJR lesser) (NN risk)) (-RRB- -RRB-)))) (NP (NP (JJ Doc_24345882_171_199_Disease) (NNS protocols)) (PRN (-LRB- -LRB-) (NP (NNP ACCL0131)) (-RRB- -RRB-)) (: :) (NP (DT a) (JJ methotrexate) (NN consequence))))))) (. ?)))
24345882	1	(ROOT (NP (NP (DT A) (NN report)) (PP (IN from) (NP (NP (DT the) (NNP Children) (POS 's)) (NNP Oncology) (NNP Group))) (. .)))
24345882	2	(ROOT (S (NP (NP (NP (NNS Concerns)) (PP (IN about) (NP (JJ long-term) (NNS Doc_24345882_320_332_Chemical)))) (PRN (-LRB- -LRB-) (NP (NNP Doc_24345882_334_337_Chemical)) (-RRB- -RRB-))) (VP (VBZ Doc_24345882_339_352_Disease) (PP (IN in) (NP (NP (DT the) (NNS 1990s)) (VP (VBN led) (PP (TO to) (NP (NP (NNS modifications)) (PP (IN in) (NP (NP (JJ intrathecal) (PRN (-LRB- -LRB-) (NP (PRP IT)) (-RRB- -RRB-)) (NN therapy)) (, ,) (NP (NN leucovorin) (NN rescue)) (, ,) (CC and) (NP (NP (NN frequency)) (PP (IN of) (NP (JJ systemic) (JJ Doc_24345882_461_464_Chemical) (NN administration)))))))) (PP (IN in) (NP (NP (NNS children)) (PP (IN with) (NP (NNS Doc_24345882_497_525_Disease))))))))) (. .)))
24345882	3	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (JJ neurocognitive) (NNS outcomes)) (CC and) (NP (NP (JJ neuroradiologic) (NN evidence)) (PP (IN of) (NP (NNS Doc_24345882_598_617_Disease))))) (VP (VBD were) (VP (VBN compared) (PP (IN in) (NP (NP (NNS children)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ intense) (JJ central) (JJ nervous) (NN system)) (PRN (-LRB- -LRB-) (NP (NNP CNS)) (-RRB- -RRB-)) (: -) (NP (NP (NP (VBG directed) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NNP P9605)) (-RRB- -RRB-))) (CC versus) (NP (NP (DT those)) (VP (VBG receiving) (NP (JJR fewer) (JJ CNS-directed) (NN treatment) (NNS days)) (PP (IN during) (NP (NP (JJ intensive) (NN consolidation)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24345882_808_813_Chemical)) (-RRB- -RRB-)))))))))))))) (. .)))
24345882	4	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 66) (NNS children)) (PP (IN from) (NP (NP (CD 16) (NNP Pediatric) (NNP Oncology) (NNP Group) (NNS institutions)) (PP (IN with) (NP (NP (NP (`` ``) (JJ standard-risk) ('' '') (NNS Doc_24345882_906_934_Disease)) (, ,) (NP (NP (QP (CD 1.00) (TO to) (CD 9.99)) (NNS years)) (PP (IN at) (NP (NN diagnosis)))) (, ,)) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NNS Doc_24345882_989_1001_Disease)) (PP (IN at) (NP (NN diagnosis)))))))))))))) (VP (VBD were) (VP (VBN enrolled) (PP (IN on) (NP (NP (CD ACCL0131) (: :) (CD 28)) (PP (IN from) (NP (CD Doc_24345882_1050_1055_Chemical) (CC and) (CD 38))))) (PP (IN from) (NP (NNP P9605))))) (. .)))
24345882	5	(ROOT (S (NP (NP (JJ Magnetic) (NN resonance) (NN imaging) (NNS scans)) (CC and) (NP (JJ standard) (JJ neuropsychological) (NNS tests))) (VP (VBD were) (VP (VBN performed) (NP (QP (CD >) (CD 2.6)) (NNS years)) (PP (IN after) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (NN treatment))))))) (. .)))
24345882	6	(ROOT (S (NP (ADJP (RB Significantly) (JJR more)) (NNP P9605) (NNS patients)) (VP (VBD developed) (NP (NNS Doc_24345882_1244_1263_Disease)) (PP (VBN compared) (PP (IN with) (NP (NP (JJ Doc_24345882_1278_1283_Chemical) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 68) (NN %)) (, ,) (NP (NP (NP (NP (NP (ADJP (CD 95) (NN %)) (NN confidence) (NN interval)) (ADJP (NP (CD 49) (NN %)) (NP (CD -83) (NN %)))) (PP (IN vs.) (NP (ADJP (CD 22) (NN %)) (, ,) (ADJP (CD 95) (NN %)) (NN confidence) (NN interval))) (ADJP (CD 5) (NN %))) (NP (CD -44) (NN %))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.001)))))))) (-RRB- -RRB-)) (VP (VBN identified) (ADVP (RB as) (NP (RB late) (QP (RB as) (CD 7.7)) (NNS years))) (PP (IN after) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (NN treatment)))))))))) (. .)))
24345882	7	(ROOT (S (ADVP (RB Overall)) (, ,) (NP (NP (CD 40) (NN %)) (PP (IN of) (NP (NNS patients)))) (VP (VBD scored) (NP (QP (CD <) (CD 85))) (PP (IN on) (NP (DT either) (NNP Verbal) (CC or) (NNP Performance) (NNP IQ)))) (. .)))
24345882	8	(ROOT (S (S (NP (NP (NNP Children)) (PP (IN on) (NP (DT both) (NNS studies)))) (VP (VBD had) (NP (JJ significant) (NN attention) (NNS problems)))) (, ,) (CC but) (S (NP (NNP P9605) (NNS children)) (VP (VBD scored) (PP (IN below) (NP (NN average))) (PP (IN on) (NP (ADJP (RBR more) (JJ neurocognitive)) (NNS measures))) (PP (IN than) (NP (NP (DT those)) (VP (VBN treated) (PP (IN on) (NP (NP (NNS Doc_24345882_1668_1673_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 82) (NN %)) (, ,) (NP (NP (CD 14/17) (NNS measures)) (PP (IN vs.) (NP (CD 24) (NN %)))) (, ,) (NP (CD 4/17) (NNS measures))) (-RRB- -RRB-))))))))) (. .)))
24345882	9	(ROOT (S (NP (DT This)) (VP (VBZ supports) (NP (JJ ongoing) (NNS concerns)) (PP (IN about) (NP (NP (JJ intensive) (JJ Doc_24345882_1767_1770_Chemical) (NN exposure)) (PP (IN as) (NP (DT a) (JJ major) (NN contributor))))) (S (VP (TO to) (VP (VB CNS) (NP (JJ late) (NNS effects)))))) (. .)))
24434397	0	(ROOT (S (NP (NNP Doc_24434397_0_15_Chemical)) (VP (VBD overdosage-induced) (NP (JJ generalized) (NNS Doc_24434397_47_54_Disease)) (PP (IN in) (NP (NNS Doc_24434397_58_71_Disease)))) (. .)))
24434397	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (S (NP (NP (DT a) (JJ 45-year-old) (NN lady)) (PP (IN with) (NP (JJ chronic) (JJ Doc_24434397_115_129_Disease) (NN stage)))) (ADJP (CD 4) (JJ due))) (PP (TO to) (NP (JJ chronic) (NNS Doc_24434397_153_177_Disease)))) (. .)))
24434397	2	(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN admitted) (PP (TO to) (NP (NP (PRP$ our) (NN center)) (PP (IN for) (NP (JJ severe) (NNS Doc_24434397_221_227_Disease))))) (PP (JJ due) (TO to) (NP (NP (NNS Doc_24434397_235_246_Disease) (CC and) (NN deterioration)) (PP (IN of) (NP (JJ renal) (NN function))))))) (. .)))
24434397	3	(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN infused) (NP (NP (CD three) (NNS units)) (PP (IN of) (NP (JJ packed) (NNS cells)))) (PP (IN during) (NP (NP (DT a) (NN session)) (PP (IN of) (NP (NNS hemodialysis))))))) (. .)))
24434397	4	(ROOT (S (NP (NP (NP (NNP Doc_24434397_362_377_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP TNA)) (-RRB- -RRB-))) (ADJP (NP (CD 1) (NNS g)) (JJ 8-hourly))) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (PRP her))) (S (VP (TO to) (VP (VB control) (NP (NP (NNS Doc_24434397_432_440_Disease)) (PP (IN per) (NP (NN vaginum))))))))) (. .)))
24434397	5	(ROOT (S (PP (NP (CD Two) (NNS hours)) (IN after) (NP (NP (DT the) (JJ sixth) (NN dose)) (PP (IN of) (NP (NNP TNA))))) (, ,) (NP (PRP she)) (VP (VBD had) (NP (NP (DT an) (NN episode)) (PP (IN of) (NP (JJ generalized) (NNS Doc_24434397_527_551_Disease))))) (. .)))
24434397	6	(ROOT (S (NP (NNP TNA)) (VP (VBD was) (VP (VBN discontinued))) (. .)))
24434397	7	(ROOT (S (NP (NP (NNS Investigations)) (PP (IN of) (NP (DT the) (NN patient)))) (VP (VBD revealed) (NP (NP (DT no) (NN biochemical)) (CC or) (NP (NP (JJ structural) (JJ central) (NNS Doc_24434397_651_679_Disease)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB have) (VP (VBN provoked) (NP (DT the) (NNS Doc_24434397_709_720_Disease)))))))))) (. .)))
24434397	8	(ROOT (S (NP (PRP She)) (VP (VBD did) (RB not) (VP (VB require) (NP (DT any) (JJ further) (JJ dialytic) (NN support)))) (. .)))
24434397	9	(ROOT (S (NP (PRP She)) (VP (VBD had) (NP (NP (DT no) (JJ further) (NNS episodes)) (PP (IN of) (NP (NNS Doc_24434397_803_813_Disease)))) (PP (PP (IN till) (NP (NN dis-charge))) (CC and) (PP (IN during) (NP (NP (DT the) (CD two) (NNS months)) (PP (IN of) (NP (NN follow-up))))))) (. .)))
24434397	10	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (VBG precipitating) (NN cause)) (PP (IN of) (NP (NNS Doc_24434397_903_914_Disease)))) (VP (VBD was) (VP (VBN believed) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (NNS Doc_24434397_937_945_Disease)) (PP (IN of) (NP (NNP TNA))))))))) (. .)))
24438483	0	(ROOT (NP (NP (NP (NN Pre-treatment)) (PP (IN of) (NP (NN Doc_24438483_17_28_Chemical-induced) (NNS Doc_24438483_37_62_Disease)))) (VP (VBG using) (NP (NP (JJ different) (NN lipid) (NNS formulations)) (PP (IN of) (NP (NNS Doc_24438483_101_109_Chemical))))) (. .)))
24438483	1	(ROOT (S (S (NP (NP (NN Pre-treatment)) (PP (IN with) (NP (NN lipid) (NNS emulsions)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB increase) (NP (NP (JJ lethal) (NNS doses)) (PP (IN of) (NP (NNS Doc_24438483_201_212_Chemical))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN lipid) (NN content)) (PP (IN of) (NP (NNS Doc_24438483_239_247_Chemical)))) (VP (MD may) (VP (VB alleviate) (NP (NN Doc_24438483_262_273_Chemical-induced) (NNS Doc_24438483_282_296_Disease))))) (. .)))
24438483	2	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBZ is) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_24438483_353_361_Chemical)) (PP (IN in) (NP (ADJP (JJ intralipid) (CC or) (JJ medialipid)) (NNS emulsions)))))) (PP (IN on) (NP (NN Doc_24438483_403_414_Chemical-induced) (NNS Doc_24438483_423_437_Disease))))))) (. .)))
24438483	3	(ROOT (S (NP (NNS Rats)) (VP (VP (VBD were) (VP (VBN anaesthetised) (PP (IN with) (NP (NNS Doc_24438483_477_485_Chemical))))) (CC and) (VP (VBD were) (VP (VBN given) (NP (NP (NP (CD 0.5) (NN mg/kg/min) (NNS Doc_24438483_515_523_Chemical)) (PP (IN in) (NP (NP (NN intralipid)) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP P)) (-RRB- -RRB-))))) (, ,) (NP (NP (NNS Doc_24438483_549_557_Chemical)) (PP (IN in) (NP (NP (NN medialipid)) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP L)) (-RRB- -RRB-))))) (, ,) (CC or) (NP (NP (NP (NN saline)) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP C)) (-RRB- -RRB-))) (PP (IN over) (NP (CD 20) (NN min)))))))) (. .)))
24438483	4	(ROOT (S (ADVP (RB Thereafter)) (, ,) (NP (NP (CD 2) (NN mg/kg/min) (NNS Doc_24438483_640_651_Chemical)) (ADJP (CD 0.5) (NN %))) (VP (VBD was) (VP (VBN infused))) (. .)))
24438483	5	(ROOT (S (NP (PRP We)) (VP (VBD recorded) (NP (NN time)) (PP (TO to) (NP (NP (JJ first) (JJ Doc_24438483_696_707_Disease) (NN occurrence)) (, ,) (NP (NP (QP (CD respective) (NNS times) (TO to) (CD 25)) (NN %)) (CC and) (NP (NP (ADJP (CD 50) (NN %)) (NN reduction)) (PP (IN of) (NP (NP (DT the) (NN heart) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP HR)) (-RRB- -RRB-)) (CC and) (NP (JJ mean) (JJ arterial) (NN pressure)) (, ,))))) (CC and) (NP (NN time)))) (PP (TO to) (NP (NP (NNS Doc_24438483_825_833_Disease)) (CC and) (NP (NP (JJ total) (NN amount)) (PP (IN of) (NP (JJ Doc_24438483_854_865_Chemical) (NN consumption))))))) (. .)))
24438483	6	(ROOT (S (NP (NN Blood) (CC and) (NN tissue) (NNS samples)) (VP (VBD were) (VP (VBN collected) (PP (VBG following) (NP (NNS Doc_24438483_929_937_Disease))))) (. .)))
24438483	7	(ROOT (S (NP (NP (NP (DT The) (NN time)) (PP (TO to) (NP (JJ first) (JJ Doc_24438483_966_977_Disease) (NN occurrence)))) (, ,) (NP (NP (NN time)) (PP (TO to) (NP (NP (QP (CD 25) (NN %) (CC and) (CD 50) (NN %)) (NNS reductions)) (PP (IN in) (NP (NNP HR)))))) (, ,) (CC and) (NP (NP (NN time)) (PP (TO to) (NP (NNS Doc_24438483_1040_1048_Disease))))) (VP (VBD were) (ADVP (RB longer) (PP (IN in) (NP (NNP Group) (NNP P)))) (PP (IN than) (NP (DT the) (JJ other) (NNS groups)))) (. .)))
24438483	8	(ROOT (S (S (NP (NP (DT The) (JJ cumulative) (JJ Doc_24438483_1110_1121_Chemical) (NN dose)) (PP (VBN given) (PP (IN at) (NP (DT those) (NN time) (NNS points))))) (VP (VBD was) (ADJP (JJR higher)) (PP (IN in) (NP (NP (NNP Group) (NNP P.) (NNP Plasma)) (SBAR (S (NP (JJ Doc_24438483_1184_1195_Chemical) (NNS levels)) (VP (VBD were) (ADJP (ADJP (RB significantly) (JJR lower)) (PP (IN in) (NP (NNP Group) (NNP P)))) (SBAR (IN than) (S (PP (IN in) (NP (NNP Group) (NNP C.))) (NP (NP (JJ Doc_24438483_1256_1267_Chemical) (NNS levels)) (PP (IN in) (NP (DT the) (NN brain) (CC and) (NN heart)))) (VP (VBD were) (ADJP (ADJP (RB significantly) (JJR lower) (PP (IN in) (NP (NP (NNP Group) (NNP P)) (CC and) (NP (NNP Group) (NNP L))))) (PP (IN than) (PP (IN in) (NP (NNP Group) (NNP C.) (NNP CONCLUSION))))))))))))))) (: :) (S (NP (PRP We)) (VP (VBP conclude) (NP (DT that) (NN pre-treatment)) (PP (IN with) (NP (NP (NNS Doc_24438483_1411_1419_Chemical)) (PP (IN in) (NP (NN intralipid))))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (NNS Doc_24438483_1449_1457_Chemical)) (PP (IN in) (NP (ADJP (JJ medialipid) (CC or) (JJ saline)) (, ,) (ADJP (VBN delayed) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NP (JJ Doc_24438483_1504_1515_Chemical-induced) (JJ Doc_24438483_1524_1535_Disease) (NNS effects)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ reduced) (NN plasma) (NNS Doc_24438483_1570_1581_Chemical)))))) (NNS levels)))))))) (. .)))
24438483	9	(ROOT (S (NP (JJ Further) (NNS studies)) (VP (VBP are) (VP (VBN needed) (S (VP (TO to) (VP (VP (VB explore) (NP (NP (NN tissue) (NN Doc_24438483_1635_1646_Chemical) (NNS levels)) (PP (IN of) (NP (NP (NNS Doc_24438483_1657_1665_Chemical)) (PP (IN in) (NP (NN medialipid))))))) (CC and) (VP (VB adapt) (NP (DT these) (NNS results)) (PP (TO to) (NP (JJ clinical) (NN practice))))))))) (. .)))
24451297	0	(ROOT (S (VP (VB Drug-Induced) (S (NP (NNP Acute)) (ADJP (JJ Doc_24451297_19_31_Disease)) (PP (IN Within) (NP (CD 12) (NNS Hours))) (PP (IN After) (NP (NNP Doc_24451297_54_65_Chemical) (NNP Therapy))))) (. .)))
24451297	1	(ROOT (S (SBAR (IN Although) (S (NP (NNS Doc_24451297_84_91_Chemical)) (VP (VBP are) (ADVP (RB generally)) (NP (JJ well-tolerated) (NNS drugs))))) (, ,) (NP (NP (JJ recent) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_24451297_144_169_Disease)) (VP (VBN associated) (PP (IN with) (NP (PRP$ their) (NN use))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported)))) (. .)))
24451297	2	(ROOT (S (NP (DT A) (JJ 52-year-old) (JJ Chinese) (NN man)) (VP (VBD reported) (PP (IN with) (NP (NP (NNS Doc_24451297_256_268_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD appeared) (NP (CD 12) (NNS hours)) (PP (IN after) (S (VP (VBG beginning) (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_24451297_325_336_Chemical)))))))))))) (. .)))
24451297	3	(ROOT (S (NP (NNP Patient)) (VP (VBD presented) (PP (IN with) (NP (NP (NNS complaints)) (PP (IN of) (NP (NP (JJ increasing) (NNS Doc_24451297_386_392_Disease)) (, ,) (NP (NNS Doc_24451297_394_402_Disease)) (, ,) (CC and) (NP (JJ upper) (NNS Doc_24451297_414_428_Disease))))))) (. .)))
24451297	4	(ROOT (S (NP (PRP$ His) (NN laboratory) (NNS values)) (VP (VP (VBD showed) (S (NP (JJ elevated) (NNS Doc_24451297_468_476_Chemical)) (ADJP (JJ kinase)))) (CC and) (VP (VBZ transaminases))) (. .)))
24451297	5	(ROOT (S (NP (NP (NNP Testing)) (PP (IN for) (NP (NNS autoantibodies)))) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ negative))) (. .)))
24451297	6	(ROOT (S (NP (DT The) (NN liver) (NNS biochemistries)) (ADVP (RB eventually)) (VP (VBD normalized) (PP (IN within) (NP (NP (CD 3) (NNS weeks)) (PP (IN of) (S (VP (VBG stopping) (NP (DT the) (NNS Doc_24451297_627_638_Chemical)))))))) (. .)))
24451297	7	(ROOT (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NN prescribing)) (VP (VBZ statins)))) (, ,) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NNS Doc_24451297_696_710_Disease)))) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN into) (NP (NN account)))))) (. .)))
24459006	0	(ROOT (S (NP (NNP Doc_24459006_0_11_Chemical)) (VP (JJ associated) (NP (NNS Doc_24459006_23_38_Disease) (CC and) (NNS Doc_24459006_43_59_Disease))) (. .)))
24459006	1	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (JJ second) (NN case)) (PP (IN of) (NP (NP (NNS Doc_24459006_96_107_Chemical)) (VP (VBN associated) (NP (NP (NNS Doc_24459006_119_134_Disease)) (PP (IN with) (NP (NNS Doc_24459006_140_156_Disease) (CC and) (NN recovery)))) (PP (IN upon) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NN therapy)))))))))) (. .)))
24459006	2	(ROOT (S (NP (DT The) (NN patient)) (VP (VP (VBD began) (S (VP (TO to) (VP (VB have) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (JJ white) (NN blood) (NNS cells) (CC and) (NNS platelets)) (PP (IN within) (NP (NP (CD 48) (NN h)) (PP (IN of) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_24459006_305_316_Chemical)))))))))))))) (CC and) (VP (VBD began) (S (VP (TO to) (VP (VB recover) (PP (IN with) (NP (NP (CD 48) (NN h)) (PP (IN of) (NP (NN discontinuation)))))))))) (. .)))
24459006	3	(ROOT (S (NP (DT This) (NN case)) (VP (VBZ highlights) (SBAR (IN that) (S (NP (JJ drug-induced) (NNS Doc_24459006_407_423_Disease)) (VP (MD can) (VP (VB occur) (ADVP (RB unexpectedly)) (SBAR (IN as) (S (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (DT a) (ADJP (RB commonly) (VBN used)) (NN drug)))))) (VP (VBD thought) (S (VP (TO to) (VP (VB be) (ADJP (`` ``) (JJ safe) ('' ''))))))))))))) (. .)))
24459006	4	(ROOT (S (PP (VBG According) (PP (TO to) (NP (NP (NNP Naranjo) (POS 's)) (NN algorithm)))) (NP (NP (DT the) (NN likelihood)) (SBAR (IN that) (S (NP (NP (PRP$ our) (NN patient) (POS 's)) (NNS Doc_24459006_599_614_Disease) (CC and) (NNS Doc_24459006_619_635_Disease)) (VP (VBD occurred) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NN therapy))))) (PP (IN with) (NP (NNS Doc_24459006_673_684_Chemical))))))) (VP (VBZ is) (ADJP (JJ probable)) (, ,) (PP (IN with) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD six) (NNS points)))))) (. .)))
24459006	5	(ROOT (S (NP (PRP We)) (VP (VBP feel) (SBAR (IN that) (S (NP (NP (DT the) (NN weight)) (PP (IN of) (NP (NP (DT the) (JJ overall) (NN evidence)) (PP (IN of) (NP (DT this) (NN evidence)))))) (VP (VBZ is) (ADJP (JJ strong)))))) (. .)))
24459006	6	(ROOT (S (PP (IN In) (NP (NP (JJ particular) (DT the) (JJ temporal) (NN relationship)) (PP (IN of) (NP (NP (NNS Doc_24459006_845_868_Disease)) (PP (TO to) (NP (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NNS Doc_24459006_890_901_Chemical)))) (CC and) (NP (NP (DT the) (NN abatement)) (PP (IN of) (NP (NNS symptoms)))))))))) (NP (DT that)) (ADVP (RB rapidly)) (VP (VBD reversed) (ADVP (RB immediately)) (PP (VBG following) (NP (NN discontinuation)))) (. .)))
24464946	0	(ROOT (S (NP (NNP Two-dimensional)) (VP (VBP speckle) (S (VP (VBG tracking) (ADVP (RB echocardiography)) (PP (VBN combined) (PP (IN with) (NP (NP (JJ high-sensitive) (JJ cardiac) (NN troponin) (NN T)) (PP (IN in) (NP (NP (RB early) (NN detection) (CC and) (NN prediction)) (PP (IN of) (NP (NP (NNS Doc_24464946_135_149_Disease)) (PP (IN during) (NP (NN Doc_24464946_157_168_Chemical-based) (NN chemotherapy))))))))))))) (. .)))
24464946	1	(ROOT (S (S (VP (TO To) (VP (VB investigate) (SBAR (IN whether) (S (NP (NP (NNS alterations)) (PP (IN of) (NP (NP (NNS Doc_24464946_233_250_Disease)) (CC and) (NP (JJ high-sensitive) (JJ cardiac) (NN troponin))))) (VP (VBP T))))))) (PRN (-LRB- -LRB-) (VP (VB cTnT)) (-RRB- -RRB-)) (VP (MD could) (VP (VB predict) (NP (NP (JJ future) (NNS Doc_24464946_317_336_Disease)) (PP (IN in) (NP (NNS patients)))) (PP (IN after) (NP (JJ Doc_24464946_355_365_Chemical) (NN exposure))))) (. .)))
24464946	2	(ROOT (S (NP (NP (JJ Seventy-five) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_24464946_412_432_Disease)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_24464946_446_456_Chemical))))))) (VP (VBD were) (VP (VBN studied))) (. .)))
24464946	3	(ROOT (S (NP (NNP Blood) (NN collection) (CC and) (NN echocardiography)) (VP (VBD were) (VP (VBN performed) (PP (IN at) (NP (NP (NN baseline)) (, ,) (NP (NP (CD 1) (NN day)) (PP (IN after) (NP (DT the) (JJ third) (NN cycle)))) (, ,) (CC and) (NP (CD 1) (NN day)))) (PP (IN after) (NP (NP (NN completion)) (PP (IN of) (NP (NN chemotherapy))))))) (. .)))
24464946	4	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN studied) (S (VP (VBG using) (ADVP (RB echocardiography)) (PP (IN during) (NP (NN follow-up))))))) (. .)))
24464946	5	(ROOT (S (NP (NP (NP (NP (JJ Global) (NN longitudinal)) (PRN (-LRB- -LRB-) (NP (NNP GLS)) (-RRB- -RRB-))) (, ,) (NP (NP (NN circumferential)) (PRN (-LRB- -LRB-) (NP (NNP GCS)) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ radial) (NN strain))) (PRN (-LRB- -LRB-) (NP (NNP GRS)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN calculated) (S (VP (VBG using) (NP (JJ speckle) (NN tracking)) (ADVP (RB echocardiography)))))) (. .)))
24464946	6	(ROOT (S (NP (NNP Left) (NN ventricular) (NN ejection) (NN fraction)) (VP (VBD was) (VP (VBN analysed) (PP (IN by) (NP (JJ real-time) (CD 3D))) (ADVP (RB echocardiography)))) (. .)))
24464946	7	(ROOT (S (NP (NNP Doc_24464946_886_900_Disease)) (VP (VBD was) (VP (VBN defined) (PP (IN as) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NP (DT the) (NNP LVEF)) (PP (IN of) (NP (QP (CD >) (CD 5) (NN %) (TO to) (CD <) (CD 55) (NN %)))))))) (PP (IN with) (NP (NP (NP (NNS symptoms)) (PP (IN of) (NP (NNS Doc_24464946_972_985_Disease)))) (CC or) (NP (NP (DT an) (JJ asymptomatic) (NN reduction)) (PP (IN of) (NP (NP (DT the) (NNP LVEF)) (PP (IN of) (NP (QP (CD >) (CD 10) (NN %) (TO to) (CD <) (CD 55) (NN %))))))))))) (. .)))
24464946	8	(ROOT (S (NP (NP (CD Fourteen) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 18.67) (NN %)) (-RRB- -RRB-))) (VP (VBD developed) (NP (NNS Doc_24464946_1090_1104_Disease)) (PP (IN after) (NP (NN treatment)))) (. .)))
24464946	9	(ROOT (S (S (NP (NP (NP (NP (NNP GLS)) (PRN (-LRB- -LRB-) (NP (CD -18.48) (NNS +)) (NP (NP (CD 1.72) (NN %)) (PP (IN vs.) (NP (CD -15.96) (NNS +))) (ADJP (CD 1.6) (NN %))) (-RRB- -RRB-))) (, ,) (NP (NP (NNP GCS)) (PRN (-LRB- -LRB-) (NP (CD -20.93) (NNS +)) (NP (NP (CD 2.86) (NN %)) (PP (IN vs.) (NP (CD -19.20))) (ADJP (QP (CD +) (CD 3.21)) (NN %))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NNP GRS))) (PRN (-LRB- -LRB-) (NP (CD 39.23) (NNS +)) (NP (NP (CD 6.44) (NN %)) (PP (IN vs.) (NP (CD 34.98) (NNS +))) (ADJP (CD 6.2) (NN %))) (-RRB- -RRB-))) (VP (VBD were) (ADJP (RB markedly) (JJ reduced)))) (CC and) (S (NP (NN cTnT)) (VP (VBD was) (VP (VBG elevated) (PP (IN from) (NP (CD 0.0010))) (NP (NP (QP (CD +) (CD 0.0020) (TO to) (CD 0.0073) (CD +) (CD 0.0038)) (NN ng/mL)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (DT all) (CD <) (CD 0.01))) (-RRB- -RRB-))) (PP (IN at) (NP (NP (DT the) (NN completion)) (PP (IN of) (NP (NN chemotherapy))))) (PP (VBN compared) (PP (IN with) (NP (NN baseline) (NNS values))))))) (. .)))
24464946	10	(ROOT (S (NP (NP (DT A) (ADJP (QP (CD >) (CD 15.9)) (NN %)) (NN decrease)) (PP (IN in) (NP (NP (NP (NP (NNP GLS) (NNP -LSB-) (NNP sensitivity)) (, ,) (NP (CD 86) (NN %))) (: ;) (NP (NP (NN specificity)) (, ,) (NP (CD 75) (NN %))) (: ;) (NP (NP (NN area)) (PP (IN under) (NP (NP (NP (DT the) (NN curve)) (PRN (-LRB- -LRB-) (NP (NNP AUC)) (-RRB- -RRB-))) (ADJP (JJ =) (NP (CD 0.815)))))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.001) (NNS -RSB-))))))) (CC and) (NP (NP (DT a) (ADJP (QP (CD >) (CD 0.004))) (JJ ng/mL) (NN elevation)) (PP (IN in) (NP (NP (NP (NN cTnT)) (-LRB- -LRB-) (NP (NP (NP (NN sensitivity)) (, ,) (NP (CD 79) (NN %))) (: ;) (NP (NP (NN specificity)) (, ,) (NP (CD 64) (NN %))) (: ;) (NP (NP (NNP AUC)) (SBAR (S (VP (SYM =) (NP (CD 0.757)))))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.005))))))) (-RRB- -RRB-)) (PP (IN from) (NP (NP (NN baseline)) (PP (TO to) (NP (NP (DT the) (JJ third) (NN cycle)) (PP (IN of) (NP (NN chemotherapy))))))))))))) (VP (VBD predicted) (NP (JJ later) (NNS Doc_24464946_1686_1700_Disease))) (. .)))
24464946	11	(ROOT (S (NP (NP (DT The) (NN decrease)) (PP (IN in) (NP (NNP GLS)))) (VP (VBD remained) (NP (NP (DT the) (RB only) (JJ independent) (NN predictor)) (PP (IN of) (NP (NP (NNS Doc_24464946_1765_1779_Disease)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.000))) (-RRB- -RRB-)))))) (. .)))
24464946	12	(ROOT (S (NP (NP (NNP GLS)) (PP (VBN combined) (PP (IN with) (NP (NN cTnT))))) (VP (MD may) (VP (VB provide) (NP (DT a) (ADJP (JJ reliable) (CC and) (JJ non-invasive)) (NN method)) (S (VP (TO to) (VP (VB predict) (NP (NNS Doc_24464946_1887_1906_Disease)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NNS Doc_24464946_1929_1942_Chemical-based)) (ADVP (RB chemotherapy)))))))))) (. .)))
24535067	0	(ROOT (NP (NP (NP (NNP Prevention)) (PP (IN of) (NP (NP (NN Doc_24535067_14_23_Chemical-induced) (NNS Doc_24535067_32_41_Disease)) (: :) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ superior)))))))) (: :) (NP (NP (NNS Doc_24535067_62_70_Chemical)) (, ,) (NP (NNS Doc_24535067_72_81_Chemical)) (, ,) (CC or) (NP (DT a) (NN combination))) (. ?)))
24535067	1	(ROOT (NP (DT A) (JJ Retrospective) (JJ comparative) (NN study) (. .)))
24535067	2	(ROOT (S (PP (IN In) (NP (DT this) (NN retrospective) (JJ comparative) (NN study))) (, ,) (NP (PRP we)) (VP (VBD aimed) (S (VP (TO to) (VP (VB compare) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (NP (NNS Doc_24535067_230_238_Chemical)) (, ,) (NP (NNS Doc_24535067_240_249_Chemical)) (, ,) (CC and) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NNS Doc_24535067_272_280_Chemical) (CC and) (NNS Doc_24535067_285_294_Chemical))))))) (S (VP (TO to) (VP (VB prevent) (NP (NN Doc_24535067_306_315_Chemical-induced) (NNS Doc_24535067_324_333_Disease))))))))) (. .)))
24535067	3	(ROOT (NP (NP (NNP MATERIAL) (CC AND) (NNP METHODS)) (: :) (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN performed) (PP (VBN based) (PP (IN on) (NP (NN anesthesia) (NNS records))))))) (. .)))
24535067	4	(ROOT (S (PP (VBG Depending) (PP (IN on) (NP (NP (DT the) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD would) (VP (VB be) (VP (VBN given) (PP (IN before) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN anesthesia))))) (PP (IN with) (NP (NNS Doc_24535067_494_503_Chemical))))))))))) (, ,) (NP (DT the) (NNS patients)) (VP (VBD were) (VP (VBN separated) (PP (IN into) (NP (NP (CD 4) (NNS groups)) (: :) (NP (NP (NP (DT no) (NN pretreatment)) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP NP)) (-RRB- -RRB-))) (, ,) (NP (NP (QP (CD Doc_24535067_576_584_Chemical) (CD 1)) (NNS ug.kg-1)) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP F)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_24535067_606_615_Chemical)) (NP (CD 0.03) (NN mg.kg-1) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP M)) (-RRB- -RRB-)))) (, ,) (CC and) (NP (NP (NP (QP (CD Doc_24535067_644_653_Chemical) (CD 0.015)) (JJ mg.kg-1) (NN +) (NNS Doc_24535067_670_678_Chemical)) (ADJP (CD 0.5) (JJ ug.kg-1))) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP FM)) (-RRB- -RRB-)))))))) (. .)))
24535067	5	(ROOT (S (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (DT the) (JJ same) (JJ anesthetic) (NN procedure)))))) (VP (VBD were) (VP (VBN selected)))) (: :) (S (PP (NP (CD 2) (NNS minutes)) (IN after) (NP (NP (JJ intravenous) (NNS injections)) (PP (IN of) (NP (DT the) (JJ pretreatment) (NNS drugs))))) (, ,) (NP (NN anesthesia)) (VP (VBZ is) (VP (VBN induced) (PP (IN with) (NP (NP (CD 0.3) (JJ mg.kg-1) (NNS Doc_24535067_875_884_Chemical)) (VP (VBN injected) (ADVP (RB intravenously)) (PP (IN over) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (CD 20-30) (NNS seconds))))))))))) (. .)))
24535067	6	(ROOT (S (NP (NNP Doc_24535067_940_959_Disease)) (VP (VBP are) (VP (VBN evaluated) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN observed) (CC and) (VBN graded) (PP (VBG according) (PP (TO to) (NP (NP (JJ clinical) (NN severity)) (PP (IN during) (NP (NP (DT the) (CD 2) (NNS minutes)) (PP (IN after) (NP (JJ Doc_24535067_1064_1073_Chemical) (NN injection)))))))))))))) (. .)))
24535067	7	(ROOT (S (NP (NP (DT The) (NN severity)) (PP (IN of) (NP (NP (NNS Doc_24535067_1101_1105_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ Doc_24535067_1113_1122_Chemical) (NN injection)) (, ,) (NP (JJ mean) (JJ arterial) (NN pressure)) (, ,) (NP (NN heart) (NN rate)) (, ,) (CC and) (NP (JJ adverse) (NNS effects)))))))) (VP (VBD were) (VP (ADVP (RB also)) (VBN evaluated))) (. .)))
24535067	8	(ROOT (S (NP (NN Study) (NNS results)) (VP (VP (VBD showed) (SBAR (IN that) (S (NP (JJ Doc_24535067_1246_1255_Disease) (NN incidence)) (VP (VBD was) (NP (NP (CD 85) (NN %)) (, ,) (NP (CD 40) (NN %)) (, ,) (NP (CD 70) (NN %)) (, ,) (CC and) (NP (NP (CD 25) (NN %)) (PP (IN in) (NP (NP (NNP Group) (NNP NP)) (, ,) (NP (NNP Group) (NNP F)) (, ,) (NP (NNP Group) (NNP M)) (, ,) (CC and) (NP (NNP Group) (NNP FM)))))) (, ,) (ADVP (RB respectively)))))) (, ,) (CC and) (VP (VBD were) (ADJP (RB significantly) (JJR lower)) (PP (IN in) (NP (NP (NNP Group) (NNP F)) (CC and) (NP (NNP Group) (NNP FM)))))) (. .)))
24535067	9	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (NN pretreatment)) (PP (IN with) (NP (NNS Doc_24535067_1454_1462_Chemical) (CC or) (NN combination))) (PP (IN of) (NP (NNS Doc_24535067_1481_1489_Chemical) (CC and) (NNS Doc_24535067_1494_1503_Chemical)))) (VP (VBD was) (ADJP (JJ effective) (PP (IN in) (S (VP (VBG preventing) (NP (NN Doc_24535067_1532_1541_Chemical-induced) (NNS Doc_24535067_1550_1559_Disease)))))))))) (. .)))
2453942	0	(ROOT (NP (NP (JJ Convulsant) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_2453942_21_28_Chemical)) (CC and) (NP (JJ regional) (NN brain) (NN concentration)))) (PP (IN of) (NP (NNS Doc_2453942_65_69_Chemical) (CC and) (NNS Doc_2453942_74_82_Chemical))) (. .)))
2453942	1	(ROOT (S (NP (NP (NNP Doc_2453942_84_91_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2453942_93_120_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (JJ Doc_2453942_128_142_Chemical) (NN insecticide)) (PP (IN with) (NP (VBN known) (JJ Doc_2453942_166_176_Disease) (NNS effects))))) (. .)))
2453942	2	(ROOT (S (NP (NP (PRP$ Its) (NN mechanism)) (PP (IN of) (NP (NN action)))) (VP (VBZ is) (RB not) (VP (ADVP (RB well)) (VBN understood) (SBAR (IN although) (S (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (SBAR (IN that) (S (NP (NNS Doc_2453942_268_275_Chemical)) (VP (VBZ acts) (PP (IN as) (NP (NP (DT a) (JJ non-competitive) (NN antagonist)) (PP (IN at) (NP (NP (DT the) (NNS Doc_2453942_320_343_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2453942_345_349_Chemical)) (-RRB- -RRB-)) (: -) (NP (DT A) (NN receptor)))))))))))))))) (. .)))
2453942	3	(ROOT (S (NP (PRP We)) (VP (VBD studied) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NP (NNS Doc_2453942_388_395_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 150) (NN mg/kg)) (-RRB- -RRB-))) (PP (IN on) (NP (DT the) (JJ GABAergic) (CC and) (JJ dopaminergic) (NNS systems)))))) (PP (IN by) (S (VP (VBG measuring) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (NNS Doc_2453942_484_488_Chemical)) (, ,) (NP (NNS Doc_2453942_490_498_Chemical)) (CC and) (NP (PRP$ its) (NNS metabolites))))) (PP (IN in) (NP (CD 7) (NN brain) (NNS areas))) (PP (IN at) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NNS Doc_2453942_552_560_Disease))))))))) (. .)))
2453942	4	(ROOT (S (NP (DT All) (NNS animals)) (VP (VBD suffered) (NP (NN tonic) (NNS Doc_2453942_589_600_Disease)) (PP (IN at) (NP (NP (QP (CD 18.3) (CD +)) (NNS /)) (: -) (NP (CD 1.4) (NN min)))) (PP (IN after) (NP (JJ Doc_2453942_627_634_Chemical) (NN administration)))) (. .)))
2453942	5	(ROOT (S (NP (NP (DT The) (NN concentration)) (PP (IN of) (NP (NNS Doc_2453942_672_676_Chemical)))) (VP (VBD was) (ADVP (RB only)) (VP (ADVP (RB slightly) (CC but) (RB significantly)) (VBN decreased) (PP (IN in) (NP (DT the) (NN colliculi))) (PP (IN without) (NP (NP (NNS modifications)) (PP (IN in) (NP (DT the) (JJ other) (NNS areas))))))) (. .)))
2453942	6	(ROOT (S (S (NP (NP (DT The) (NN concentration)) (PP (IN of) (NP (NNS Doc_2453942_803_811_Chemical)))) (VP (VBD was) (VP (VBN increased) (PP (IN in) (NP (DT the) (NN mesencephalon)))))) (CC and) (S (NP (NP (DT that)) (PP (IN of) (NP (PRP$ its) (JJ metabolite) (NNS Doc_2453942_874_879_Chemical)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN increased) (PP (IN in) (NP (NP (DT the) (NN mesencephalon)) (CC and) (NP (DT the) (NN striatum))))))) (. .)))
24554916	0	(ROOT (NP (NP (JJ Cholestatic) (NN presentation)) (PP (IN of) (NP (JJ yellow) (JJ Doc_24554916_35_45_Chemical) (NN poisoning))) (. .)))
24554916	1	(ROOT (S (NP (NP (JJ Yellow) (NNS Doc_24554916_64_74_Chemical)) (, ,) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (JJ certain) (NN pesticide) (NNS pastes) (CC and) (NNS fireworks)))) (, ,)) (VP (VBZ is) (ADVP (RB well)) (VP (VBN known) (S (VP (TO to) (VP (VB cause) (ADVP (RB hepatotoxicity))))))) (. .)))
24554916	2	(ROOT (SINV (VP (VBG Poisoning) (PP (IN with) (NP (JJ yellow) (NNS Doc_24554916_192_202_Chemical)))) (VP (ADVP (RB classically)) (VBZ manifests) (PP (IN with) (NP (JJ acute) (NNS Doc_24554916_236_245_Disease)))) (NP (NP (VBG leading)) (PP (TO to) (NP (NP (NNS Doc_24554916_257_276_Disease)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB need) (NP (NN liver) (NN transplantation))))))))) (. .)))
24554916	3	(ROOT (S (NP (PRP We)) (VP (VBP present) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (JJ yellow) (JJ Doc_24554916_343_353_Chemical) (NN poisoning))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT a) (NN patient)) (VP (VBD presented) (PP (IN with) (NP (NP (JJ florid) (JJ clinical) (NNS features)) (PP (IN of) (NP (NNS Doc_24554916_426_437_Disease))))) (S (VP (VBG highlighting) (NP (DT the) (NN fact)) (SBAR (IN that) (S (NP (NNS Doc_24554916_465_476_Disease)) (VP (MD can) (ADVP (RB rarely)) (VP (VB be) (NP (NP (DT a) (JJ presenting) (NN feature)) (PP (IN of) (NP (JJ yellow) (JJ Doc_24554916_522_532_Chemical) (NN hepatotoxicity))))))))))))))) (. .)))
24571687	0	(ROOT (NP (NP (JJ Doc_24571687_0_17_Disease) (CC and) (JJ severe) (NNS Doc_24571687_29_40_Disease)) (PP (VBG following) (NP (NP (JJ intranasal) (NNS Doc_24571687_62_77_Chemical)) (PP (IN for) (NP (JJ pediatric) (JJ procedural) (NN sedation))))) (. .)))
24571687	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NN syncope) (CC and) (NNS Doc_24571687_135_146_Disease)) (PP (IN in) (NP (NP (DT an) (JJ 11-year-old) (NN girl)) (PP (VBG following) (NP (NP (NN administration)) (PP (IN of) (NP (NP (JJ intranasal) (NNS Doc_24571687_209_224_Chemical)) (PP (IN for) (NP (NP (NN sedation)) (PP (IN for) (NP (DT a) (JJ voiding) (NN cystourethrogram)))))))))))) (. .)))
24571687	2	(ROOT (S (PP (VBG Following) (NP (NP (JJ successful) (NN completion)) (PP (IN of) (NP (NP (NNP VCUG)) (CC and) (NP (DT a) (JJ 60-min) (NN recovery) (NN period)))))) (, ,) (NP (NP (NP (DT the) (NN patient) (POS 's)) (NN level)) (PP (IN of) (NP (NN consciousness) (CC and) (JJ vital) (NNS signs)))) (VP (VBD returned) (S (VP (TO to) (VP (VB presedation) (NP (NNS levels)))))) (. .)))
24571687	3	(ROOT (S (PP (IN Upon) (S (VP (VBG leaving) (NP (DT the) (NN sedation) (NN area))))) (, ,) (NP (DT the) (NN patient)) (VP (VBD collapsed) (, ,) (PP (IN with) (NP (DT no) (JJ apparent) (JJ inciting) (NN event)))) (. .)))
24571687	4	(ROOT (S (NP (DT The) (NN patient)) (ADVP (RB quickly)) (VP (VBD regained) (SBAR (S (NP (NP (NN consciousness)) (CC and) (NP (DT no) (NN injury))) (VP (VBD occurred))))) (. .)))
24571687	5	(ROOT (S (S (NP (DT The) (JJ primary) (NN abnormality)) (VP (VBD found) (SBAR (S (VP (VBD was) (NP (JJ persistent) (NNS Doc_24571687_625_636_Disease))))))) (, ,) (CC and) (S (NP (PRP she)) (VP (VBD was) (VP (VBN admitted) (PP (TO to) (NP (NP (DT the) (NN hospital)) (PP (IN for) (NP (JJ telemetric) (NN observation)))))))) (. .)))
24571687	6	(ROOT (S (S (NP (DT The) (NNS Doc_24571687_707_718_Disease)) (VP (VBD lasted) (NP (QP (CD ~) (CD 2)) (NN h)))) (, ,) (CC and) (S (NP (JJ further) (JJ cardiac) (NN workup)) (VP (VBD revealed) (NP (DT no) (JJ underlying) (NN abnormality)))) (. .)))
24571687	7	(ROOT (S (NP (ADJP (JJ Unanticipated) (CC and) (RB previously)) (JJ unreported) (NNS outcomes)) (VP (MD may) (VP (VB be) (VP (VBN witnessed) (SBAR (IN as) (S (NP (PRP we)) (VP (VBP expand) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ certain) (NNS sedatives)))) (PP (TO to) (NP (NP (JJ alternative) (NNS routes)) (PP (IN of) (NP (NN administration))))))))))) (. .)))
24582773	0	(ROOT (S (NP (JJ Paradoxical) (JJ severe) (NNS Doc_24582773_19_28_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ add-on) (JJ high-doses) (NNS Doc_24582773_58_68_Chemical)) (PP (IN in) (NP (NNS Doc_24582773_72_97_Disease)))))) (. .)))
24582773	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (DT a) (JJ 35-year-old) (NN patient)) (VP (VBG suffering) (PP (IN from) (NP (NP (NNS Doc_24582773_158_183_Disease)) (PP (IN since) (NP (NP (NP (DT the) (NN age)) (PP (IN of) (NP (NP (CD 19) (NNS years)) (, ,) (VP (VBN treated) (PP (IN by) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (JJ first-generation) (NNS antipsychotics))))))))) (, ,) (NP (NP (NNS Doc_24582773_272_286_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 100) (NN mg/day)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_24582773_304_311_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1200) (NN mg/day)) (-RRB- -RRB-))))))))))) (PRN (-LRB- -LRB-) (S (VP (VB serum) (S (NP (NNS Doc_24582773_333_340_Chemical)) (VP (SYM =) (NP (JJ 0.85) (NN mEq/l)))))) (-RRB- -RRB-))) (. .)))
24582773	2	(ROOT (S (NP (DT This) (NN patient)) (VP (VBD had) (NP (NP (NP (DT no) (JJ associated) (NNS Doc_24582773_385_405_Disease)) (-LRB- -LRB-) (NP (RB particularly) (DT no) (NNS Doc_24582773_423_442_Disease)) (-RRB- -RRB-)) (CC and) (NP (DT no) (NNS Doc_24582773_451_475_Disease)))) (. .)))
24582773	3	(ROOT (S (PP (IN Within) (NP (NP (DT the) (CD 48) (NN h)) (PP (VBG following) (NP (NP (DT the) (JJ gradual) (NN introduction)) (PP (IN of) (NP (NP (NNS Doc_24582773_531_541_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (IN up) (TO to) (CD 600) (CD mg/day))) (-RRB- -RRB-)))))))) (, ,) (NP (DT the) (NN patient)) (VP (VBD presented) (NP (JJ severe) (NNS Doc_24582773_591_600_Disease)) (PP (IN without) (NP (DT an) (JJ environmental) (NN explanation))) (, ,) (S (VP (VBG contrasting) (PP (IN with) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS Doc_24582773_684_698_Disease) (CC or) (NNS Doc_24582773_702_722_Disease)))))))))) (. .)))
24582773	4	(ROOT (S (NP (NP (DT The) (NNS diagnoses)) (PP (IN of) (NP (JJ Doc_24582773_741_746_Disease) (NN shift) (CC and) (NNS Doc_24582773_757_766_Disease)))) (VP (VBD were) (VP (VBN dismissed))) (. .)))
24582773	5	(ROOT (S (NP (NP (NP (DT The) (NN withdrawal)) (CC and) (NP (NP (DT the) (JJ gradual) (NN reintroduction)) (PP (IN of) (NP (NP (NNS Doc_24582773_832_842_Chemical)) (ADVP (NP (CD 2) (NNS weeks)) (RBR later)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBN led) (PP (TO to) (NP (DT another) (JJ severe) (NNS Doc_24582773_886_895_Disease)))))) (, ,)) (VP (VBD enabled) (S (NP (PRP us)) (VP (TO to) (VP (VB attribute) (NP (DT the) (NNS Doc_24582773_925_934_Disease)) (ADVP (RB specifically)) (PP (TO to) (NP (NNS Doc_24582773_951_961_Chemical))))))) (. .)))
24587916	0	(ROOT (NP (NP (JJ Antioxidant) (NNS effects)) (PP (IN of) (NP (JJ bovine) (NNS Doc_24587916_30_41_Chemical))) (PP (IN on) (NP (NN Doc_24587916_45_58_Chemical-induced) (NNS Doc_24587916_67_79_Disease))) (PP (IN in) (NP (NN rat))) (. .)))
24587916	1	(ROOT (NP (NP (NNP Doc_24587916_88_101_Chemical)) (: -) (NP (NP (-LRB- -LRB-) (NNP Doc_24587916_104_108_Chemical) (-RRB- -RRB-)) (VP (VBN induced) (SBAR (S (NP (NNS Doc_24587916_118_130_Disease)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (JJ enhanced) (NN oxidative) (NN stress))))))))) (. .)))
24587916	2	(ROOT (S (NP (NP (NNP Doc_24587916_177_188_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP LF)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (NN Doc_24587916_200_204_Chemical-binding) (NN glycoprotein)) (PP (IN with) (NP (JJ antihypertensive) (NNS properties))))) (. .)))
24587916	3	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (JJ chronic) (NN administration)) (PP (IN of) (NP (NNP LF)))))) (PP (IN on) (NP (JJ oxidative) (NN stress) (CC and) (NNS Doc_24587916_358_370_Disease))) (PP (IN upon) (NP (JJ Doc_24587916_376_379_Chemical) (NN administration)))) (. .)))
24587916	4	(ROOT (S (NP (NNP Male) (NNP Wistar) (NNS rats)) (VP (VBD were) (VP (VBN treated) (PP (IN by) (NP (NP (NP (NNS Doc_24587916_429_432_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 30) (CD u)) (NN g/kg/day) (NN subcutaneously)) (-RRB- -RRB-))) (CC or) (NP (NP (NN saline)) (PP (IN for) (NP (CD 14) (NNS days)))))))) (. .)))
24587916	5	(ROOT (S (NP (NP (NNP Oral) (NNP bovine) (NNP LF)) (PRN (-LRB- -LRB-) (NP (CD 30)) (, ,) (NP (CD 100)) (, ,) (NP (CD 300) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN given) (PP (IN from) (NP (NN day) (CD 8))) (PP (TO to) (NP (CD 14))) (PP (IN in) (NP (DT a) (NN reversal) (NN study))))) (. .)))
24587916	6	(ROOT (S (PP (IN In) (NP (DT a) (NN prevention) (NN study))) (, ,) (NP (NNS rats)) (VP (VBD received) (SBAR (S (NP (NP (CD 4) (NNS days)) (PP (IN of) (NP (NNP LF) (NN treatment)))) (VP (VP (VBD followed) (PP (IN by) (NP (NNS Doc_24587916_644_647_Chemical)))) (CC and) (VP (VBD continued) (PP (IN during) (NP (DT the) (NN test) (NN period)))))))) (. .)))
24587916	7	(ROOT (S (NP (NP (JJ Systolic) (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP SBP)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN measured) (S (VP (VBG using) (NP (JJ tail-cuff) (NN method)))))) (. .)))
24587916	8	(ROOT (S (NP (JJ Thymus) (NN weight)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (NN marker)) (PP (IN of) (NP (JJ glucocorticoid) (NN activity))))))) (. .)))
24587916	9	(ROOT (S (NP (NP (NNP Plasma) (NNP Doc_24587916_823_840_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_24587916_842_846_Chemical)) (-RRB- -RRB-)) (NNP concentration)) (CC and) (NP (ADJP (JJ ferric) (S (VP (VBG reducing) (NP (NP (JJ antioxidant) (NN power)) (PRN (-LRB- -LRB-) (NP (NNP FRAP)) (-RRB- -RRB-)))))) (NN value))) (VP (VBD were) (VP (VBN determined))) (. .)))
24587916	10	(ROOT (S (NP (NNP Doc_24587916_930_943_Chemical)) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (NNP SBP) (CC and) (NNP plasma) (NNP Doc_24587916_983_987_Chemical) (NN level)) (CC and) (NP (NNS Doc_24587916_998_1031_Disease)))) (. .)))
24587916	11	(ROOT (S (S (NP (NNP LF)) (VP (VBD lowered))) (PRN (-LRB- -LRB-) (S (NP (NNP P)) (VP (VBZ <) (NP (CD 0.01)))) (-RRB- -RRB-)) (CC and) (S (NP (NN dose)) (ADVP (RB dependently)) (VP (VBD prevented) (NP (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)) (JJ Doc_24587916_1098_1101_Chemical-induced) (NNS Doc_24587916_1110_1122_Disease)))) (. .)))
24587916	12	(ROOT (S (NP (NNP LF)) (VP (VP (VBD prevented) (NP (NN body) (NNS Doc_24587916_1142_1153_Disease))) (CC and) (VP (ADVP (RB significantly)) (VBD reduced) (NP (NP (DT the) (JJ elevated) (NN plasma) (NNS Doc_24587916_1200_1204_Chemical)) (CC and) (NP (VBN increased) (NN FRAP) (NNS values))))) (. .)))
24587916	13	(ROOT (S (NP (NP (JJ Chronic) (NN administration)) (PP (IN of) (NP (NNP LF)))) (ADVP (RB strongly)) (VP (VBD reduced) (NP (NP (NP (DT the) (NN blood) (NN pressure) (CC and) (NN production)) (PP (IN of) (NP (NNP ROS)))) (CC and) (NP (NP (VBN improved) (JJ antioxidant) (NN capacity)) (PP (IN in) (NP (NN Doc_24587916_1356_1359_Chemical-induced) (NNS Doc_24587916_1368_1380_Disease))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ oxidative) (NN stress)))))) (PP (IN as) (NP (NP (DT another) (NN mechanism)) (PP (IN of) (NP (NP (JJ antihypertensive) (NN action)) (PP (IN of) (NP (NNP LF)))))))))) (. .)))
24588023	0	(ROOT (NP (NP (NP (DT The) (NN association)) (PP (IN between) (NP (JJ Doc_24588023_24_39_Chemical) (CC and) (JJ Doc_24588023_44_54_Disease) (NNS Doc_24588023_55_63_Disease))) (PP (IN after) (NP (JJ cardiac) (NN surgery)))) (: :) (NP (NP (DT a) (JJ multivariate) (NN analysis)) (PP (IN in) (NP (CD 11) (CD 529) (NNS patients)))) (. .)))
24588023	1	(ROOT (S (PP (IN Because) (IN of) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NP (JJ contemporary) (NNS data)) (PP (VBG regarding) (NP (NP (NNS Doc_24588023_180_188_Disease)) (PP (IN after) (NP (JJ cardiac) (NN surgery))))))))) (, ,) (NP (PRP we)) (VP (VBD undertook) (SBAR (S (NP (NP (DT a) (NN retrospective) (NN analysis)) (PP (IN of) (NP (NNP prospectively)))) (VP (VBD collected) (NP (NNS data)) (PP (IN from) (NP (CD 11) (CD 529) (NNS patients))) (PP (IN in) (SBAR (WHNP (WP whom)) (S (NP (JJ cardiopulmonary) (NN bypass)) (VP (VBD was) (VP (VBN used) (PP (IN from) (NP (NNP January) (CD 2004))) (PP (TO to) (NP (NNP December) (CD 2010)))))))))))) (. .)))
24588023	2	(ROOT (S (NP (DT A) (JJ Doc_24588023_381_391_Disease) (NNS Doc_24588023_392_399_Disease)) (VP (VBD was) (VP (VBN defined) (PP (IN as) (NP (NP (DT a) (JJ transient) (NN episode)) (PP (IN of) (NP (NP (JJ disturbed) (NN brain) (NN function)) (VP (VBN characterised) (PP (IN by) (NP (JJ abnormal) (JJ involuntary) (NN motor) (NNS movements)))))))))) (. .)))
24588023	3	(ROOT (S (NP (JJ Multivariate) (NN regression) (NN analysis)) (VP (VBD was) (VP (VBN performed) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ independent) (NNS predictors)) (PP (IN of) (NP (JJ postoperative) (NNS Doc_24588023_617_625_Disease))))))))) (. .)))
24588023	4	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (ADJP (CD 100)) (PRN (-LRB- -LRB-) (NP (CD 0.9) (NN %)) (-RRB- -RRB-)) (NNS patients)))) (VP (VBD developed) (NP (JJ postoperative) (JJ Doc_24588023_682_692_Disease) (NNS Doc_24588023_693_701_Disease))) (. .)))
24588023	5	(ROOT (S (NP (JJ Generalised) (CC and) (JJ focal) (NNS Doc_24588023_725_733_Disease)) (VP (VBD were) (VP (VBN identified) (PP (IN in) (NP (CD 68) (CC and) (CD 32) (NNS patients))) (, ,) (ADVP (RB respectively)))) (. .)))
24588023	6	(ROOT (S (NP (NP (DT The) (NN median)) (PRN (-LRB- -LRB-) (NP (NNP IQR) (NN -LSB-) (NN range) (NNS -RSB-)) (-RRB- -RRB-))) (NP (NN time)) (PP (IN after) (NP (NP (NN surgery)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NNS Doc_24588023_840_847_Disease)) (VP (VBD occurred)))))) (VP (VBD was) (NP (NP (NP (CD 7)) (PRN (-LRB- -LRB-) (NP (CD 6-12) (NNP -LSB-) (NN 1-216) (NNS -RSB-)) (-RRB- -RRB-)) (NP (NN h))) (CC and) (NP (NP (CD 8)) (PRN (-LRB- -LRB-) (NP (CD 6-11) (NNP -LSB-) (NN 4-18) (NNS -RSB-)) (-RRB- -RRB-)) (NP (NN h)))) (, ,) (ADVP (RB respectively))) (. .)))
24588023	7	(ROOT (S (NP (NP (JJ Epileptiform) (NNS findings)) (PP (IN on) (NP (NN electroencephalography)))) (VP (VBD were) (VP (VBN seen) (PP (IN in) (NP (CD 19) (NNS patients))))) (. .)))
24588023	8	(ROOT (S (NP (NP (JJ Independent) (NNS predictors)) (PP (IN of) (NP (JJ postoperative) (NNS Doc_24588023_1031_1039_Disease)))) (VP (VBD included) (NP (NP (NN age)) (, ,) (NP (JJ female) (NN sex)) (, ,) (NP (JJ redo) (JJ cardiac) (NN surgery)) (, ,) (NP (NP (NN calcification)) (PP (IN of) (NP (JJ ascending) (NN aorta)))) (, ,) (NP (NNS Doc_24588023_1122_1146_Disease)) (, ,) (NP (JJ deep) (JJ hypothermic) (NNS Doc_24588023_1165_1183_Disease)) (, ,) (NP (NP (NN duration)) (PP (IN of) (NP (JJ aortic) (NN cross-clamp)))) (CC and) (NP (NNS Doc_24588023_1220_1235_Chemical)))) (. .)))
24588023	9	(ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VBN tested) (PP (IN in) (NP (DT a) (JJ multivariate) (NN regression) (NN analysis)))))) (, ,) (NP (NNS Doc_24588023_1288_1303_Chemical)) (VP (VBD was) (NP (NP (DT a) (JJ strong) (JJ independent) (NN predictor)) (PP (IN of) (NP (NP (NNS Doc_24588023_1342_1350_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP OR) (CD 14.3)) (, ,) (NP (NP (NP (CD 95) (NN %)) (SBAR (S (VP (VBP CI) (NP (CD 5.5-36) (CD .7)))))) (: ;) (NP (NP (NN p)) (NP (QP (CD <) (CD 0.001)))))) (-RRB- -RRB-)))))) (. .)))
24588023	10	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (JJ Doc_24588023_1404_1414_Disease) (NNS Doc_24588023_1415_1423_Disease)))) (VP (VBD had) (NP (ADVP (NP (CD 2.5) (NNS times)) (JJR higher)) (NP (JJ in-hospital) (NN mortality) (NNS rates)) (CC and) (RB twice) (NP (NP (DT the) (NN length)) (PP (IN of) (NP (NN hospital) (NN stay))))) (PP (VBN compared) (PP (IN with) (NP (NP (NNS patients)) (PP (IN without) (NP (JJ Doc_24588023_1542_1552_Disease) (NNS Doc_24588023_1553_1561_Disease))))))) (. .)))
24588023	11	(ROOT (S (NP (NP (JJ Mean) (PRN (-LRB- -LRB-) (NP (NNP IQR) (NN -LSB-) (NN range) (NNS -RSB-)) (-RRB- -RRB-)) (NN length)) (PP (IN of) (NP (NP (NN stay)) (PP (IN in) (NP (DT the) (JJ intensive) (NN care) (NN unit)))))) (VP (VBD was) (NP (NP (CD 115)) (PRN (-LRB- -LRB-) (NP (CD 49-228) (NNP -LSB-) (NN 32-481) (NNS -RSB-)) (-RRB- -RRB-)) (VP (VBN h) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ Doc_24588023_1669_1679_Disease) (NNS Doc_24588023_1680_1688_Disease))))) (PP (VBN compared) (PP (IN with) (NP (NP (CD 26)) (PRN (-LRB- -LRB-) (NP (CD 22-69) (NNP -LSB-) (NN 14-1080) (NNS -RSB-)) (-RRB- -RRB-)) (VP (VBN h) (PP (IN in) (NP (NNS patients))) (PP (IN without) (NP (NP (NNS Doc_24588023_1746_1754_Disease)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-))))))))))) (. .)))
24588023	12	(ROOT (S (NP (JJ Doc_24588023_1768_1778_Disease) (NNS Doc_24588023_1779_1787_Disease)) (VP (VBP are) (NP (NP (DT a) (JJ serious) (NNS Doc_24588023_1802_1828_Disease)) (PP (IN after) (NP (JJ cardiac) (NN surgery))))) (. .)))
24588023	13	(ROOT (S (SBAR (IN As) (S (NP (NNS Doc_24588023_1855_1870_Chemical)) (VP (VBZ is) (NP (DT the) (RB only) (JJ modifiable) (NN factor))))) (, ,) (NP (NP (PRP$ its) (NN administration)) (, ,) (VP (ADVP (RB particularly) (PP (IN in) (NP (NNS doses)))) (VBG exceeding) (NP (NP (CD 80) (NN mg.kg)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)))) (, ,)) (VP (MD should) (VP (VB be) (VP (VBN weighed) (PP (IN against) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ postoperative) (NNS Doc_24588023_2020_2028_Disease)))))))) (. .)))
24595967	0	(ROOT (S (VP (VB Dysfunctional) (NP (JJ overnight) (NN memory) (NN consolidation)) (PP (IN in) (NP (JJ Doc_24595967_48_55_Chemical) (NNS users)))) (. .)))
24595967	1	(ROOT (S (NP (NNP Sleep)) (VP (VBZ plays) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN consolidation) (CC and) (NN integration)) (PP (IN of) (NP (NN memory)))))) (PP (IN in) (NP (NP (DT a) (NN process)) (VP (VBN called) (NP (JJ overnight) (NN memory) (NN consolidation)))))) (. .)))
24595967	2	(ROOT (S (NP (JJ Previous) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ Doc_24595967_223_230_Chemical) (NNS users)) (VP (VBP have) (NP (ADJP (JJ marked) (CC and) (JJ persistent)) (NN neurocognitive) (CC and) (NN Doc_24595967_283_308_Disease)))))) (. .)))
24595967	3	(ROOT (S (NP (PRP We)) (VP (VBP extend) (NP (JJ past) (NN research)) (PP (IN by) (S (VP (VBG examining) (NP (JJ overnight) (NN memory) (NN consolidation)) (PP (IN among) (NP (NP (NP (JJ regular) (JJ Doc_24595967_392_399_Chemical) (NNS users)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 12))))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN drug)) (NP (ADJP (JJ naive) (JJ healthy)) (NNS controls))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 26))))) (-RRB- -RRB-))))))))) (. .)))
24595967	4	(ROOT (S (NP (NNP Doc_24595967_453_480_Disease)) (VP (VBD was) (VP (VBN evaluated) (PP (IN before) (CC and) (IN after) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (NN sleep))))) (, ,) (PP (IN with) (CC and) (IN without) (NP (NP (NN interference)) (ADVP (RB prior) (PP (TO to) (NP (NN testing)))))))) (. .)))
24595967	5	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBD assessed) (NP (JJ neurocognitive) (NNS performances)) (PP (IN across) (NP (NP (NNS tasks)) (PP (IN of) (NP (NN learning) (, ,) (NN memory) (CC and) (NN executive) (NNS functioning)))))) (. .)))
24595967	6	(ROOT (S (NP (JJ Doc_24595967_692_699_Chemical) (NNS users)) (VP (VBD demonstrated) (NP (NP (VBN impaired) (JJ overnight) (NN memory) (NN consolidation)) (, ,) (NP (NP (DT a) (NN finding)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (ADJP (RBR more) (JJ pronounced)) (PP (VBG following) (NP (JJ associative) (NN interference))))))))) (. .)))
24595967	7	(ROOT (S (ADVP (RB Additionally)) (, ,) (NP (JJ Doc_24595967_845_852_Chemical) (NNS users)) (VP (VBD demonstrated) (NP (NNS impairments)) (PP (IN on) (NP (NNS tasks))) (S (VP (VBG recruiting) (NP (ADJP (JJ frontostriatal) (CC and) (JJ hippocampal)) (JJ neural) (NN circuitry)))) (, ,) (PP (IN in) (NP (NP (DT the) (NNS domains)) (PP (IN of) (NP (NP (JJ proactive) (NN interference) (NN memory)) (, ,) (NP (JJ long-term) (NN memory)) (, ,) (NP (NN encoding)) (, ,) (NP (JJ working) (NN memory)) (CC and) (NP (JJ complex) (NN planning))))))) (. .)))
24595967	8	(ROOT (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN Doc_24595967_1083_1090_Chemical-associated) (NN dysfunction)) (PP (IN in) (NP (JJ fronto-temporal) (NN circuitry)))) (VP (MD may) (VP (VB underlie) (NP (JJ overnight) (NN consolidation) (NNS Doc_24595967_1180_1198_Disease)) (PP (IN in) (NP (JJ regular) (JJ Doc_24595967_1210_1217_Chemical) (NNS users)))))))) (. .)))
24614773	0	(ROOT (NP (NP (JJ Normoammonemic) (NNS Doc_24614773_15_29_Disease)) (: :) (NP (NP (RB solely) (JJ Doc_24614773_38_47_Chemical) (NNS induced)) (CC or) (NP (JJ multiple) (NNS mechanisms))) (. ?)))
24614773	1	(ROOT (S (NP (DT A) (JJ 77-year-old) (NN woman)) (VP (VBD presented) (PP (IN with) (NP (JJ subacute) (NN onset) (NN progressive) (NNS Doc_24614773_142_151_Disease) (, ,) (NNS Doc_24614773_153_163_Disease) (, ,) (NNS Doc_24614773_165_188_Disease) (CC and) (NNS Doc_24614773_193_202_Disease)))) (. .)))
24614773	2	(ROOT (S (PP (IN In) (NP (DT the) (VBG preceding) (NNS months))) (, ,) (NP (DT the) (NN patient)) (VP (VP (VBD had) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NNS admissions)) (PP (IN with) (NP (JJ transient) (NNS Doc_24614773_283_305_Disease)))))) (PP (IN with) (NP (JJ facial) (NN droop)))) (, ,) (CC and) (VP (VBD had) (VP (VBN been) (VP (VBN started) (PP (IN on) (NP (NP (NNS Doc_24614773_349_358_Chemical)) (PP (IN for) (NP (VBN presumed) (NNS Doc_24614773_372_391_Disease))))))))) (. .)))
24614773	3	(ROOT (S (S (NP (NNP Doc_24614773_393_402_Chemical)) (VP (VBD was) (VP (VBN withdrawn) (ADVP (RB soon)) (PP (IN after) (NP (NN admission)))))) (CC and) (S (NP (PRP$ her) (JJ cognitive) (NNS abilities)) (VP (VBP have) (ADVP (RB gradually)) (VP (VBN improved) (PP (IN over) (NP (NP (CD 3) (NNS months)) (PP (IN of) (NP (NN follow-up)))))))) (. .)))
24614773	4	(ROOT (S (S (NP (NP (JJ Doc_24614773_518_527_Chemical) (NNS levels)) (VP (VBN taken) (PP (RB prior) (PP (TO to) (NP (NN withdrawal)))))) (VP (VBD were) (ADJP (JJ subtherapeutic)))) (CC and) (S (NP (DT the) (NN patient)) (VP (VBD was) (ADJP (JJ normoammonaemic)))) (. .)))
24614773	5	(ROOT (S (NP (NP (NNP EEG)) (VP (VBN undertaken) (PP (IN during) (NP (JJ inpatient) (NN stay))))) (VP (VBD showed) (NP (NP (NNS changes)) (SBAR (S (NP (ADJP (JJ consistent) (PP (IN with) (NP (NP (NNS Doc_24614773_686_700_Disease)) (, ,) (CC and) (NP (JJ low) (NN titre) (NNS Doc_24614773_716_736_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24614773_738_742_Chemical)) (-RRB- -RRB-))))) (NN receptor) (NNS antibodies)) (VP (VBD were) (ADJP (JJ present) (PP (IN in) (NP (DT this) (NN patient))))))))) (. .)))
24614773	6	(ROOT (S (NP (NP (DT The) (JJ possible) (NNS aetiologies)) (PP (IN of) (NP (NP (NN Doc_24614773_822_831_Chemical-induced) (NNS Doc_24614773_840_854_Disease)) (CC and) (NP (JJ Doc_24614773_859_863_Chemical) (JJ receptor-associated) (NNS Doc_24614773_884_896_Disease))))) (VP (VBP present) (NP (DT a) (JJ diagnostic) (NN dilemma))) (. .)))
24614773	7	(ROOT (S (NP (PRP We)) (VP (VBP present) (SBAR (S (NP (DT a) (JJ putative) (NN combinatorial)) (VP (VBZ hypothesis) (S (VP (TO to) (VP (VB explain) (NP (NP (DT this) (NN patient) (POS 's)) (NNS symptoms))))))))) (. .)))
24618873	0	(ROOT (S (NP (NNP Doc_24618873_0_37_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ rapid) (NN infusion)) (PP (IN of) (NP (NNS Doc_24618873_67_76_Chemical)))))) (. .)))
24618873	1	(ROOT (S (NP (NNP Doc_24618873_78_87_Chemical)) (VP (VBZ is) (NP (NP (DT an) (NN opioid)) (SBAR (WHNP (WDT that)) (S (VP (VBZ gains) (NP (PRP$ its) (NN popularity)) (PP (IN for) (NP (DT the) (JJ effective) (JJ Doc_24618873_145_149_Disease) (NN control))) (PP (IN through) (S (VP (VBG acting) (PP (IN on) (NP (DT the) (NNS opioid-receptors))))))))))) (. .)))
24618873	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (JJ Doc_24618873_207_217_Disease) (NN relief)) (ADVP (RB sometimes)) (VP (VBZ brings) (PP (IN about) (NP (NP (JJ unfavourable) (NN side) (NNS effects)) (SBAR (WHNP (WDT that)) (S (ADVP (RB largely)) (VP (VBP limit) (NP (PRP$ its) (JJ clinical) (NN utility)))))))) (. .)))
24618873	3	(ROOT (S (NP (JJ Common) (NN side) (NNS effects)) (VP (VBP include) (NP (NNS Doc_24618873_343_349_Disease) (, ,) (NNS Doc_24618873_351_359_Disease) (CC and) (NNS Doc_24618873_364_375_Disease))) (. .)))
24618873	4	(ROOT (S (PP (IN In) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_24618873_394_427_Disease)))) (, ,) (CC and) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP need) (NP (JJ long-term) (JJ Doc_24618873_458_462_Disease) (NN control)))))))) (, ,) (NP (NNS Doc_24618873_472_481_Chemical)) (VP (MD may) (VP (VB cause) (NP (ADJP (RB excitatory) (JJ central)) (JJ nervous) (NN system) (PRN (-LRB- -LRB-) (NP (NNP CNS)) (-RRB- -RRB-)) (NNS effects)) (PP (IN through) (S (NP (NP (PRP$ its) (JJ neurotoxic) (NN metabolite)) (, ,) (NP (NNS Doc_24618873_575_587_Chemical)) (, ,)) (VP (VBG resulting) (PP (IN in) (NP (NNS Doc_24618873_602_614_Disease) (CC and) (NNS Doc_24618873_619_626_Disease) (NN attack)))))))) (. .)))
24618873	5	(ROOT (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (S (SBAR (IN though) (S (RB not) (ADJP (RB clinically) (JJ apparent)))) (, ,) (NP (NNS Doc_24618873_684_693_Chemical)) (ADVP (RB potentially)) (VP (VP (VBZ causes) (NP (JJ inhibitory) (NNS impacts)) (PP (IN on) (NP (DT the) (NNP CNS)))) (CC and) (VP (VBZ impairs) (NP (JJ normal) (NN cerebellar))))) (CC and) (S (NP (NN oculomotor)) (VP (VBP function) (PP (IN in) (NP (DT the) (JJ short) (NN term))))) (. .)))
24618873	6	(ROOT (S (PP (IN In) (NP (DT this) (NN case) (NN report))) (, ,) (NP (PRP we)) (VP (VB highlight) (NP (NP (NN opioid) (POS 's)) (JJ inhibitory) (NN side) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NN cerebellar) (NN structure)) (SBAR (WHNP (WDT that)) (S (VP (VBZ causes) (NP (NP (NNS Doc_24618873_923_932_Disease)) (, ,) (NP (NP (NNS Doc_24618873_934_944_Disease)) (, ,) (NP (VBN reduced) (JJ smooth) (NN pursuit) (NN gain)) (CC and) (NP (VBN decreased) (JJ saccadic) (NN velocity)))))))))) (. .)))
24641119	0	(ROOT (S (NP (NNP Doc_24641119_0_15_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_24641119_27_39_Chemical)))) (. .)))
24641119	1	(ROOT (S (NP (DT A) (JJ 27-year-old) (JJ male) (NN patient)) (VP (VBD presented) (PP (IN with) (NP (DT a) (NN maculopapular) (NNS Doc_24641119_99_107_Disease))) (PP (IN on) (NP (DT the) (JJ flexural) (NNS areas) (CC and) (NNS buttocks))) (PP (IN after) (S (VP (VBG using) (NP (JJ oral) (NNS Doc_24641119_160_172_Chemical)))))) (. .)))
24641119	2	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN diagnosed) (PP (IN with) (NP (JJ drug-induced) (NNS Doc_24641119_218_233_Disease))) (PP (VBN based) (PP (IN on) (NP (NP (PRP$ his) (NN history)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD included) (NP (JJ prior) (NN sensitivity)) (PP (TO to) (NP (NP (JJ topical) (NNS Doc_24641119_300_312_Chemical)) (, ,) (NP (DT a) (JJ physical) (NN examination)) (, ,) (CC and) (NP (JJ histopathological) (NNS findings)))))))))))) (. .)))
24641119	3	(ROOT (S (NP (NNP Doc_24641119_370_385_Disease)) (VP (VP (VBZ is) (NP (DT a) (NN drug))) (: -) (CC or) (VP (VB contact) (NP (NP (JJ allergen-related) (NN maculopapular) (NNS Doc_24641119_439_447_Disease)) (SBAR (WHNP (WDT that)) (S (ADVP (RB typically)) (VP (VBZ involves) (NP (DT the) (ADJP (JJ flexural) (CC and) (JJ gluteal)) (NNS areas)))))))) (. .)))
24641119	4	(ROOT (S (PP (TO To) (NP (NP (DT the) (JJS best)) (PP (IN of) (NP (PRP$ our) (NN knowledge))))) (, ,) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (VBN reported) (NN case)) (PP (IN of) (NP (NP (NN Doc_24641119_569_581_Chemical-induced) (NNS Doc_24641119_590_605_Disease)) (PP (IN in) (NP (DT the) (JJ English) (NN literature))))))) (. .)))
24653743	0	(ROOT (NP (NP (DT A) (NN Case)) (PP (IN of) (NP (NNP Sudden) (NNP Doc_24653743_17_30_Disease) (ADJP (JJ due) (TO to) (JJ Doc_24653743_38_50_Chemical-Induced)) (NNS Doc_24653743_59_78_Disease))) (. .)))
24653743	1	(ROOT (S (S (NP (DT An) (JJ 84-year-old) (NN male)) (VP (VBD received) (S (NP (NP (JJ oral) (NNS Doc_24653743_114_126_Chemical)) (, ,) (NP (NP (DT a) (JJ pure) (JJ Doc_24653743_135_141_Chemical) (NN channel) (NN blocker)) (PP (IN with) (NP (JJ slow) (NN recovery) (NNS kinetics)))) (, ,)) (VP (TO to) (VP (VB convert) (NP (PRP$ his) (JJ paroxysmal) (NNS Doc_24653743_213_232_Disease)) (PP (TO to) (NP (DT a) (JJ sinus) (NN rhythm)))))))) (: ;) (S (NP (DT the) (NN patient)) (VP (VBD developed) (NP (NNS Doc_24653743_274_294_Disease)) (NP (CD two) (NNS days) (RB later)))) (. .)))
24653743	2	(ROOT (S (NP (NP (DT The) (NNP Holter) (NN electrocardiogram)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN worn) (PP (IN by) (NP (NN chance))))))) (, ,)) (VP (VBD revealed) (NP (NNS Doc_24653743_376_394_Disease)) (PP (IN with) (NP (JJ gradually) (VBN prolonged) (NNP QT) (NNS intervals)))) (. .)))
24653743	3	(ROOT (S (S (NP (DT This) (NN drug)) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN absorbed) (PP (IN from) (NP (DT the) (JJ gastrointestinal) (NN tract)))))) (, ,) (CC and) (S (NP (NP (JJS most)) (PP (IN of) (NP (PRP it)))) (VP (VBZ is) (VP (VBN excreted) (PP (IN from) (NP (DT the) (NN kidney)))))) (. .)))
24653743	4	(ROOT (S (SBAR (IN Although) (S (S (NP (NP (DT the) (NN patient) (POS 's)) (JJ renal) (NN function)) (VP (VBD was) (RB not) (ADJP (RB highly) (JJ impaired)))) (CC and) (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NNS Doc_24653743_619_631_Chemical)))) (VP (VBD was) (ADJP (JJ low)))))) (, ,) (NP (NP (DT the) (NN plasma) (NN concentration)) (PP (IN of) (NP (NNS Doc_24653743_669_681_Chemical)))) (VP (MD may) (VP (VB have) (VP (VBN been) (ADJP (JJ high)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB produce) (NP (NNS Doc_24653743_720_739_Disease)) (PP (IN in) (NP (DT the) (NN octogenarian)))))))))) (. .)))
24653743	5	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT the) (JJ oral) (NN administration)) (PP (IN of) (NP (NN class) (NN IC) (NNS drugs)))) (, ,) (PP (VBG including) (NP (NNS Doc_24653743_823_835_Chemical))) (, ,) (VP (VBZ is) (ADJP (JJ effective) (S (VP (TO to) (VP (VB terminate) (NP (NNS Doc_24653743_863_882_Disease))))))))) (, ,) (NP (JJ careful) (NN consideration)) (VP (MD must) (VP (VB be) (VP (VBN taken) (PP (IN before) (S (VP (VBG giving) (NP (DT these) (NNS drugs)) (PP (TO to) (NP (NNS octogenarians))))))))) (. .)))
24658375	0	(ROOT (NP (NP (JJ Doc_24658375_0_23_Chemical-induced) (JJ inflammatory) (NNS Doc_24658375_45_53_Disease)) (PP (IN in) (NP (DT a) (NN patient))) (PP (IN with) (NP (NNS Doc_24658375_72_100_Disease))) (. .)))
24658375	1	(ROOT (S (NP (NP (NNP Doc_24658375_102_125_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24658375_127_131_Chemical)) (-RRB- -RRB-)) (, ,) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (NP (JJ standard) (NN therapy)) (PP (IN for) (NP (NP (NNS Doc_24658375_170_198_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24658375_200_203_Disease)) (-RRB- -RRB-))))))) (, ,)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (ADJP (ADJP (RB potentially) (JJ serious)) (CC but) (ADJP (JJ treatable))) (JJ adverse) (NNS effects))) (S (VP (VBG involving) (NP (JJ numerous) (NN organ) (NNS systems)))) (, ,) (PP (VBG including) (NP (JJ rare) (JJ skeletal) (NN muscle) (NN involvement))))) (. .)))
24658375	2	(ROOT (S (NP (NP (RB Only) (DT a) (NN handful)) (PP (IN of) (NP (NP (NNS cases)) (PP (IN of) (NP (NP (NN Doc_24658375_380_384_Chemical-induced) (NNS Doc_24658375_393_401_Disease)) (PP (IN in) (NP (NNS children)))))))) (VP (VBP have) (VP (VBN been) (VP (VP (VBN reported)) (, ,) (CC and) (VP (NP (NN none)) (PP (IN in) (NP (DT the) (JJ radiology) (NN literature))))))) (. .)))
24658375	3	(ROOT (S (NP (PRP We)) (VP (VBP present) (NP (PDT such) (DT a) (NN case)) (PP (IN in) (NP (NP (DT a) (JJ 15-year-old) (NN boy)) (PP (IN with) (NP (NP (NNS Doc_24658375_521_524_Disease)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NP (NN recognition)) (PP (IN of) (NP (NN imaging) (NNS findings)))) (VP (VP (VBD played) (NP (DT a) (JJ crucial) (NN role)) (PP (IN in) (S (VP (VBG making) (NP (DT the) (NN diagnosis)))))) (CC and) (VP (VBD facilitated) (NP (ADJP (JJ prompt) (, ,) (JJ effective)) (NN treatment))))))))))) (. .)))
24659727	0	(ROOT (NP (NP (NNP Tolerability)) (PP (IN of) (NP (NP (NNS Doc_24659727_16_25_Chemical)) (PP (IN in) (NP (NN combination))))) (PP (IN with) (NP (NP (NNS Doc_24659727_46_62_Chemical)) (PP (IN in) (NP (NP (NNS dogs)) (PP (IN with) (NP (NNS Doc_24659727_76_84_Disease))))))) (. .)))
24659727	1	(ROOT (S (NP (DT This) (NN retrospective) (NN study)) (VP (VBZ describes) (NP (NP (NNS Doc_24659727_121_129_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (NN protocol)) (PP (IN of) (NP (NP (NNS Doc_24659727_160_169_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24659727_171_175_Chemical)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_24659727_181_197_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24659727_199_202_Chemical)) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NNS dogs)) (PP (IN with) (NP (NNS Doc_24659727_217_225_Disease)))))))) (. .)))
24659727	2	(ROOT (S (S (NP (NNP Doc_24659727_227_231_Chemical)) (VP (VBD was) (VP (VBN administered) (PP (IN per) (NP (NP (NN os)) (PRN (-LRB- -LRB-) (NP (NNP PO)) (-RRB- -RRB-)))) (PP (IN at) (NP (NP (DT a) (JJ targeted) (NN dosage)) (PP (IN of) (NP (NP (CD 60) (NN mg/m)) (NP (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (NN body) (NN surface) (NN area)) (PP (IN on) (NP (NN day) (CD 0))))))))))) (PRN (, ,) (S (NP (NNS Doc_24659727_324_327_Chemical)) (VP (VBD was) (VP (VBN administered) (NP (NNP PO)) (PP (IN at) (NP (NP (DT a) (JJ targeted) (NN dosage)) (PP (IN of) (NP (NP (CD 250) (NN mg/m)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (VP (VBN divided) (PP (IN over) (NP (NP (NNS days) (CD 0)) (PP (IN through) (NP (CD 4))))))))))))) (, ,)) (CC and) (S (NP (DT all) (NNS dogs)) (VP (VBD received) (NP (JJ prophylactic) (NNS antibiotics)))) (. .)))
24659727	3	(ROOT (S (NP (CD Ninety) (NNS treatments)) (VP (VBD were) (VP (VBN given) (PP (TO to) (NP (NP (DT the) (CD 57) (NNS dogs)) (VP (VBN included) (PP (IN in) (NP (DT the) (NN study)))))))) (. .)))
24659727	4	(ROOT (S (S (NP (NNP Doc_24659727_530_541_Disease)) (VP (VBD was) (NP (DT the) (JJ principal) (JJ toxic) (NN effect)))) (, ,) (CC and) (S (NP (NP (DT the) (JJ overall) (NN frequency)) (PP (IN of) (NP (QP (CD grade) (CD 4)) (NNS Doc_24659727_611_622_Disease)))) (PP (IN after) (NP (NP (DT the) (JJ first) (NN treatment)) (PP (IN of) (NP (NNS Doc_24659727_652_656_Chemical))) (PRN (: /) (S (NP (NNS Doc_24659727_657_660_Chemical)) (VP (VBD was) (NP (CD 30) (NN %))))))) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %) (NN confidence) (NN interval)) (, ,) (NP (CD 19-43) (NN %))) (-RRB- -RRB-))) (. .)))
24659727	5	(ROOT (S (NP (NP (DT The) (JJ mean) (NN body) (NN weight)) (PP (IN of) (NP (NP (NNS dogs)) (PP (IN with) (NP (NP (QP (CD grade) (CD 4)) (NNS Doc_24659727_746_757_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 19.7) (NN kg) (NNS +)) (NP (CD 13.4) (NN kg))) (-RRB- -RRB-))))))) (VP (VBD was) (ADJP (RB significantly) (JJR less)) (PP (IN than) (NP (NP (DT the) (JJ mean) (NN body) (NN weight)) (PP (IN of) (NP (NP (NNS dogs)) (SBAR (WHNP (WDT that)) (S (VP (VBD did) (RB not) (VP (VB develop) (NP (NP (QP (CD grade) (CD 4)) (NNS Doc_24659727_864_875_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP 31.7) (NNP kg) (NNP +) (NNP 12.4) (NNP kg)) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .005))))))) (-RRB- -RRB-)))))))))))) (. .)))
24659727	6	(ROOT (S (NP (NP (CD One) (NN dog)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN %)) (-RRB- -RRB-))) (VP (VBD developed) (NP (NP (JJ hematologic) (NNS changes) (NN suggestive)) (PP (IN of) (NP (NN hepatotoxicity))))) (. .)))
24659727	7	(ROOT (S (NP (DT No) (NNS dogs)) (VP (VBD had) (NP (NP (NN evidence)) (PP (IN of) (NP (CC either) (NNS Doc_24659727_1011_1025_Disease) (CC or) (NNS Doc_24659727_1029_1049_Disease))))) (. .)))
24659727	8	(ROOT (S (NP (JJ Adverse) (JJ gastrointestinal) (NNS effects)) (VP (VBD were) (ADJP (JJ uncommon))) (. .)))
24659727	9	(ROOT (S (PP (IN On) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NP (DT the) (NNS findings)) (VP (VBN reported) (NP (NN herein))))))) (, ,) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 60) (NN mg/m))) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (PP (IN of) (NP (NP (NNS Doc_24659727_1169_1173_Chemical)) (VP (VBN combined) (PP (IN with) (NP (NP (CD 250) (NN mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (PP (IN of) (NP (NNS Doc_24659727_1203_1206_Chemical))) (PRN (-LRB- -LRB-) (VP (VBN divided) (PP (IN over) (NP (CD 5) (NNS days)))) (-RRB- -RRB-)))))))) (VP (VBP q) (SBAR (S (NP (CD 4) (NN wk)) (VP (VBZ is) (ADJP (JJ tolerable) (PP (IN in) (NP (NN Doc_24659727_1252_1257_Disease-bearing) (NNS dogs)))))))) (. .)))
24664478	0	(ROOT (NP (NP (NP (JJ Doc_24664478_0_10_Chemical) (NNS Doc_24664478_11_24_Disease)) (PP (IN with) (NP (JJ concurrent) (JJ intrathecal) (NN chemotherapy)))) (: :) (NP (NP (NNP Case) (NN report) (CC and) (NN review)) (PP (IN of) (NP (NN literature)))) (. .)))
24664478	1	(ROOT (S (NP (NP (JJ Severe) (JJ Doc_24664478_112_122_Chemical) (NNS Doc_24664478_123_136_Disease)) (PP (IN in) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (JJ concurrent) (NN intrathecal))))) (PRN (-LRB- -LRB-) (NP (PRP IT)) (-RRB- -RRB-))))) (ADVP (RB chemotherapy)) (VP (VBZ is) (VP (VBN reported))) (. .)))
24664478	2	(ROOT (S (NP (NP (DT A) (JJ 37-year-old) (NNP Caucasian) (NN woman)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS Doc_24664478_265_294_Disease)))))) (VP (VBD was) (VP (VBN admitted) (PP (IN for) (NP (NNS Doc_24664478_312_328_Disease))))) (. .)))
24664478	3	(ROOT (S (NP (PRP She)) (VP (VBD was) (ADVP (RB originally)) (VP (VBN treated) (PP (IN with) (NP (NP (NN induction)) (VP (ADVP (RB chemotherapy)) (VBN followed) (PP (IN by) (NP (DT an) (JJ autologous) (NN transplant)))))))) (. .)))
24664478	4	(ROOT (S (NP (PRP She)) (VP (VBD developed) (NP (NNS Doc_24664478_437_453_Disease)) (PP (ADVP (NP (CD 10) (NNS months)) (RBR later)) (IN with) (NP (NNS Doc_24664478_475_495_Disease)))) (. .)))
24664478	5	(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN re-induced) (PP (IN with) (NP (NP (QP (CD Doc_24664478_521_531_Chemical) (CD 1500)) (NN mg/m)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)))) (PP (IN on) (S (NP (NNS days) (CD 1) (, ,) (CD 3) (, ,) (CC and) (CD 5)) (PP (IN with) (NP (NP (CD 1) (NN dose)) (PP (IN of) (NP (PRP IT))))) (VP (VBG Doc_24664478_583_593_Chemical) (NP (NP (CD 100) (NN mg)) (PP (IN on) (NP (NN day) (CD 2)))) (SBAR (IN as) (S (NP (NP (JJ central) (JJ nervous) (NN system)) (PRN (-LRB- -LRB-) (NP (NNP CNS)) (-RRB- -RRB-))) (VP (VBZ prophylaxis))))))))) (. .)))
24664478	6	(ROOT (S (PP (IN At) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NN treatment))))) (, ,) (NP (PRP she)) (VP (VBD was) (PP (IN on) (NP (JJ continuous) (JJ renal) (NN replacement) (NN therapy))) (ADJP (JJ due) (PP (TO to) (NP (NP (NN sequelae)) (PP (IN of) (NP (NP (NNS Doc_24664478_748_768_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24664478_770_773_Disease)) (-RRB- -RRB-)))))))) (. .)))
24664478	7	(ROOT (S (NP (PRP She)) (VP (VP (VBD tolerated) (NP (NN therapy)) (ADVP (RB well))) (, ,) (VP (VBD entered) (NP (DT a) (JJ complete) (NN remission))) (, ,) (CC and) (VP (VBD recovered) (NP (PRP$ her) (JJ renal) (NN function)))) (. .)))
24664478	8	(ROOT (S (NP (PRP She)) (VP (VBD received) (NP (NP (DT a) (JJ second) (NN cycle)) (PP (IN of) (NP (NNS Doc_24664478_899_909_Chemical)))) (PP (IN without) (NP (JJ additional) (NNP IT) (NNS prophylaxis)) (ADVP (NP (CD one) (NN month)) (RBR later)))) (. .)))
24664478	9	(ROOT (S (NP (DT A) (NN week)) (PP (IN after) (NP (DT this) (JJ second) (NN cycle))) (, ,) (NP (PRP she)) (VP (VBD noted) (NP (NNS numbness)) (PP (IN in) (NP (PRP$ her) (JJR lower) (NNS extremities)))) (. .)))
24664478	10	(ROOT (S (S (ADJP (ADJP (RB Predominantly) (JJ sensory)) (, ,) (IN though) (ADJP (ADVP (RB also)) (JJ motor)) (CC and) (ADJP (JJ autonomic)))) (, ,) (NP (NNS Doc_24664478_1094_1115_Disease)) (VP (VP (VBD started) (PP (IN in) (NP (PRP$ her) (NNS feet)))) (, ,) (VP (VBD ascended) (ADVP (RB proximally)) (PP (TO to) (NP (DT the) (JJ mid-thoracic) (NN region)))) (, ,) (CC and) (ADVP (RB eventually)) (VP (VBD included) (NP (PRP$ her) (JJ distal) (JJ upper) (NNS extremities)))) (. .)))
24664478	11	(ROOT (S (NP (NP (NP (DT A) (JJ magnetic) (NN resonance) (NN imaging)) (PRN (-LRB- -LRB-) (NP (NNP MRI)) (-RRB- -RRB-))) (PP (IN of) (NP (PRP$ her) (NN spine)))) (VP (VBD demonstrated) (NP (NNS changes)) (PP (IN from) (NP (QP (CD C2) (TO to) (CD C6)) (ADJP (JJ consistent) (PP (IN with) (NP (NN subacute)))) (NNS Doc_24664478_1347_1368_Disease)))) (. .)))
24664478	12	(ROOT (S (NP (NNP Doc_24664478_1370_1380_Chemical)) (VP (VBD was) (VP (VBN felt) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (PRP$ her) (NNS symptoms))))))))) (. .)))
24664478	13	(ROOT (S (NP (PRP$ Her) (NNS Doc_24664478_1427_1437_Disease)) (VP (VP (VBD stabilized) (CC and) (VBD showed) (NP (JJ slight) (NN improvement))) (CC and) (VP (ADVP (RB ultimately)) (VBD received) (NP (NP (DT an) (JJ unrelated) (, ,) (JJ reduced-intensity) (JJ allogeneic) (NN transplant) (NN while)) (PP (IN in) (NP (JJ complete) (NN remission))))) (, ,) (CC but) (VP (VBD Doc_24664478_1590_1606_Disease) (NP (CD 10) (NNS weeks) (RB later)))) (. .)))
24664478	14	(ROOT (S (NP (PRP She)) (VP (VBZ is) (ADVP (RB currently)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (ADJP (JJS best) (JJ supportive)) (NN care)))))) (. .)))
24664478	15	(ROOT (S (PP (TO To) (NP (PRP$ our) (NN knowledge))) (, ,) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (VBN published) (NN case) (NN report)) (PP (IN of) (NP (NP (JJ severe) (NNS Doc_24664478_1749_1762_Disease)) (VP (VBN caused) (PP (IN by) (NP (NP (NNS Doc_24664478_1773_1783_Chemical)) (PP (IN in) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (JJ concurrent) (NNS IT)) (ADVP (RB chemotherapy)))))))))))))) (. .)))
24665854	0	(ROOT (NP (NP (JJ Doc_24665854_0_9_Chemical-induced) (JJ hyperammonemic) (NNS Doc_24665854_33_47_Disease)) (PP (IN in) (NP (DT a) (JJ renal) (JJ transplanted) (NN patient))) (. .)))
24665854	1	(ROOT (S (NP (NP (NNP Doc_24665854_81_107_Disease)) (PP (IN after) (NP (JJ renal) (NN transplantation)))) (VP (VBP constitute) (NP (NP (DT an) (JJ important) (NN cause)) (PP (IN of) (NP (NN morbidity) (CC and) (NN mortality))))) (. .)))
24665854	2	(ROOT (S (NP (PRP$ Their) (NN differential) (NN diagnosis)) (VP (VBZ is) (ADJP (JJ difficult) (CC and) (JJ essential)) (PP (IN for) (NP (NP (JJ subsequent) (NN patient) (POS 's)) (NN management)))) (. .)))
24665854	3	(ROOT (S (NP (JJ Doc_24665854_287_296_Chemical-induced) (JJ hyperammonemic) (NNS Doc_24665854_320_334_Disease)) (VP (VBZ is) (NP (NP (DT an) (ADJP (JJ uncommon) (CC but) (JJ serious)) (NN effect)) (PP (IN of) (NP (JJ Doc_24665854_372_381_Chemical) (NN treatment))))) (. .)))
24665854	4	(ROOT (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VBP describe) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (DT a) (JJ 15-year-old) (NN girl)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (PP (IN on) (NP (NP (DT a) (JJ long-term) (NN therapy)) (PP (IN with) (NP (NNS Doc_24665854_478_487_Chemical))))) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_24665854_495_503_Disease))))))))))) (CC and) (VP (VBD revealed) (NP (NNS Doc_24665854_517_539_Disease)) (PP (IN with) (NP (NP (NNS Doc_24665854_545_559_Disease)) (NP (CD 12) (NNS days)))) (PP (IN after) (NP (JJ renal) (NN transplantation))))) (. .)))
24665854	5	(ROOT (S (PP (IN After) (NP (NP (NNP withdraw)) (PP (IN of) (NP (NNS Doc_24665854_615_624_Chemical))))) (, ,) (NP (NP (NP (NNS patients) (POS ')) (NNS symptoms)) (VP (VBN resolved) (PP (IN within) (NP (CD 24) (NN h.) (NNS Clinicians))))) (VP (MD should) (VP (VB increase) (NP (PRP$ their) (NN awareness)) (PP (PP (IN for) (NP (NP (JJ potential) (NN complication)) (PP (IN of) (NP (NNS Doc_24665854_740_749_Chemical))))) (, ,) (RB especially) (PP (IN in) (NP (VBN transplanted) (NNS patients)))))) (. .)))
24671324	0	(ROOT (S (VP (VB Doc_24671324_0_21_Disease) (PP (IN after) (NP (NNS Doc_24671324_28_38_Chemical) (CC and) (NN Doc_24671324_43_56_Chemical-containing) (NN regimen))) (PP (IN in) (NP (NP (DT an) (JJ elderly) (NN patient)) (PP (IN of) (NP (NNS Doc_24671324_101_131_Disease)))))) (. .)))
24671324	1	(ROOT (S (NP (ADJP (JJ Doc_24671324_133_143_Chemical) (CC and) (JJ high-dose)) (NN Doc_24671324_158_171_Chemical-containing) (NNS regimens)) (VP (VBP are) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (ADJP (RB generally) (JJ tolerable) (PP (IN with) (NP (JJ few) (JJ severe) (NNS Doc_24671324_249_269_Disease)))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ B-cell) (NNS malignancies)))))))))) (. .)))
24671324	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NN information)) (VP (VBZ is) (VP (VBN limited) (PP (VBG concerning) (NP (NP (DT the) (NN safety)) (PP (IN of) (NP (NP (DT the) (NN regimen)) (PP (IN in) (NP (JJ elderly) (NNS patients))))))))) (. .)))
24671324	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (DT a) (JJ 76-year-old) (NN man)))) (PP (IN with) (NP (NP (NNS Doc_24671324_441_471_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD suffered) (NP (JJ necrotising) (NNS Doc_24671324_497_506_Disease)) (PP (IN without) (NP (NP (NNS Doc_24671324_515_526_Disease)) (PP (IN after) (NP (DT the) (NN combination) (NN treatment))))) (PP (IN with) (NP (NP (NNS Doc_24671324_564_574_Chemical)) (, ,) (NP (JJ high-dose) (NNS Doc_24671324_586_599_Chemical)) (CC and) (NP (NN rituximab)))))))))) (. .)))
24671324	4	(ROOT (S (PP (IN Despite) (NP (JJ immediate) (JJ intravenous) (JJ antimicrobial) (NN therapy))) (, ,) (NP (PRP he)) (VP (VBD succumbed) (NP (CD 23) (NN h)) (PP (IN after) (NP (DT the) (NN onset)))) (. .)))
24671324	5	(ROOT (S (S (NP (NNP Physicians)) (VP (MD should) (VP (VB recognise) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (JJ fatal) (NNS Doc_24671324_756_776_Disease)) (VP (VBN related) (PP (TO to) (NP (NP (NNS Doc_24671324_788_798_Chemical)) (PP (CC plus) (NP (NP (JJ high-dose) (NNS Doc_24671324_814_827_Chemical)) (PP (IN in) (NP (JJ elderly) (NNS patients)))))))))))))) (, ,) (CC and) (S (NP (PRP we)) (VP (VBP believe) (SBAR (S (NP (DT this) (NN case)) (VP (VBZ warrants) (NP (JJ further) (NN investigation))))))) (. .)))
24675088	0	(ROOT (NP (NP (DT An) (VBN integrated) (NN characterization)) (PP (IN of) (NP (NP (JJ serological) (, ,) (ADJP (JJ pathological) (, ,) (CC and) (JJ functional)) (NNS events)) (PP (IN in) (NP (NN Doc_24675088_86_97_Chemical-induced) (NNS Doc_24675088_106_120_Disease))))) (. .)))
24675088	1	(ROOT (S (S (NP (JJ Many) (JJ efficacious) (JJ Doc_24675088_139_145_Disease) (NNS treatments)) (VP (VBP cause) (NP (JJ significant) (NNS Doc_24675088_175_192_Disease)))) (, ,) (CC yet) (S (NP (NP (ADJP (JJ biomarkers) (CC or) (JJ functional)) (NNS indices)) (PP (IN of) (NP (JJ early) (NN damage))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD would) (VP (VB allow) (NP (NN monitoring) (CC and) (NN intervention)))))) (, ,)) (VP (VBP are) (VP (VBG lacking)))) (. .)))
24675088	2	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN utilized) (NP (NP (DT a) (NN rat) (NN model)) (PP (IN of) (NP (NP (JJ progressive) (NNS Doc_24675088_367_378_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24675088_380_383_Chemical)) (-RRB- -RRB-)) (: -) (NP (NP (JJ induced) (NNS Doc_24675088_393_407_Disease)) (, ,) (VP (VBG applying) (NP (JJ multiple) (NNS approaches)))) (, ,) (PP (VBG including) (NP (NP (JJ cardiac) (JJ magnetic) (NN resonance) (NN imaging)) (PRN (-LRB- -LRB-) (NP (NNP MRI)) (-RRB- -RRB-))))))) (, ,) (S (VP (TO to) (VP (VB provide) (NP (DT the) (ADJP (RBS most) (JJ comprehensive)) (NN characterization)) (PP (TO to) (NP (NP (NN date)) (PP (IN of) (NP (NP (DT the) (NN timecourse)) (PP (IN of) (NP (JJ serological) (, ,) (ADJP (JJ pathological) (, ,) (CC and) (JJ functional)) (NNS events))))))) (S (VP (VBG underlying) (NP (DT this) (NNS Doc_24675088_636_644_Disease))))))))) (. .)))
24675088	3	(ROOT (S (NP (NNP Hannover) (NNP Wistar) (NNS rats)) (VP (VBD were) (VP (VBN dosed) (PP (IN with) (NP (CD 1.25) (JJ mg/kg) (NNS Doc_24675088_694_697_Chemical))) (PP (ADVP (RB weekly)) (IN for) (NP (NP (CD 8) (NNS weeks)) (VP (VBN followed) (PRT (RP by)) (NP (DT a) (CD 4) (NN week) (JJ off-dosing) (`` ``) (NN recovery) ('' '') (NN period))))))) (. .)))
24675088	4	(ROOT (S (NP (NP (NNP Electron) (NN microscopy)) (PP (IN of) (NP (DT the) (NN myocardium)))) (VP (VP (VBD revealed) (NP (NN subcellular) (NN degeneration))) (CC and) (VP (VBD marked) (NP (JJ mitochondrial) (NNS changes)) (PP (IN after) (NP (DT a) (JJ single) (NN dose))))) (. .)))
24675088	5	(ROOT (S (NP (JJ Histopathological) (NN analysis)) (VP (VBD revealed) (NP (NP (JJ progressive) (NNS Doc_24675088_942_968_Disease)) (, ,) (NP (JJ Doc_24675088_970_981_Disease) (JJ /) (NN cytomegaly)) (, ,) (CC and) (NP (JJ extensive) (NN vacuolation))) (PP (IN after) (NP (CD two) (NNS doses)))) (. .)))
24675088	6	(ROOT (S (NP (NP (JJ Extensive) (NN replacement) (NNS Doc_24675088_1059_1067_Disease)) (PRN (-LRB- -LRB-) (VP (VBN quantified) (PP (IN by) (NP (NNP Sirius) (JJ red) (NN staining)))) (-RRB- -RRB-))) (VP (VBD developed) (PP (IN during) (NP (DT the) (JJ off-dosing) (NN period)))) (. .)))
24675088	7	(ROOT (S (NP (NP (NP (JJ Functional) (NNS indices)) (VP (VBN assessed) (PP (IN by) (NP (JJ cardiac) (NNP MRI))))) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (NP (JJ left) (NN ventricular) (NN ejection) (NN fraction)) (PRN (-LRB- -LRB-) (NP (NNP LVEF)) (-RRB- -RRB-)) (, ,) (NP (JJ cardiac) (NN output)) (, ,) (CC and) (NP (NNP E/A) (NN ratio)))) (-RRB- -RRB-))) (VP (VBD declined) (ADVP (RB progressively)) (, ,) (S (VP (VP (VBG reaching) (NP (JJ statistical) (NN significance)) (PP (IN after) (NP (CD two) (NNS doses)))) (CC and) (VP (VBG culminating) (PP (IN in) (NP (`` ``) (JJ clinical) ('' '') (NNS Doc_24675088_1376_1390_Disease))) (PP (IN by) (NP (CD 12) (NNS weeks))))))) (. .)))
24675088	8	(ROOT (S (NP (NP (NP (JJ Significant) (NNS increases)) (PP (IN in) (NP (NP (JJ peak) (JJ myocardial) (NN contrast) (NN enhancement)) (CC and) (NP (JJ serological) (JJ cardiac) (NN troponin) (NN I))))) (PRN (-LRB- -LRB-) (NP (NNP cTnI)) (-RRB- -RRB-))) (VP (VBN emerged) (PP (IN after) (NP (CD eight) (NNS doses))) (, ,) (ADVP (RB importantly) (S (VP (VBG preceding) (S (NP (DT the) (NNP LVEF) (NN decline)) (VP (TO to) (VP (VB <) (NP (CD 50) (NN %))))))))) (. .)))
24675088	9	(ROOT (S (NP (JJ Doc_24675088_1583_1591_Chemical) (NN I) (NNS levels)) (ADVP (RB positively)) (VP (VBD correlated) (PP (IN with) (NP (JJ delayed) (CC and) (JJ peak) (NNS Doc_24675088_1645_1655_Chemical))) (NP (NP (NN contrast) (NN enhancement)) (, ,) (ADJP (JJ histopathological) (JJ grading)) (, ,) (CC and) (NP (NNS Doc_24675088_1709_1730_Disease)))) (. .)))
24675088	10	(ROOT (S (PP (IN In) (NP (NN summary))) (, ,) (NP (NN subcellular) (NNS Doc_24675088_1756_1782_Disease)) (VP (VBD was) (NP (NP (DT the) (JJS earliest) (NN marker)) (, ,) (VP (VBN followed) (PP (IN by) (NP (JJ progressive) (JJ functional) (NN decline) (CC and) (NN histopathological) (NNS manifestations)))))) (. .)))
24675088	11	(ROOT (S (NP (NP (JJ Myocardial) (NN contrast) (NN enhancement)) (CC and) (NP (NP (NNS elevations)) (PP (IN in) (NP (NNS cTnI))))) (VP (VBD occurred) (ADVP (RB later))) (. .)))
24675088	12	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT all) (NNS indices)) (VP (VP (VBD predated) (NP (`` ``) (JJ clinical) ('' '') (NNS Doc_24675088_2001_2015_Disease))) (CC and) (VP (ADVP (RB thus)) (VBP warrant) (NP (NP (JJ further) (NN evaluation)) (PP (IN as) (NP (JJ predictive) (NNS biomarkers)))))) (. .)))
24684312	0	(ROOT (NP (NP (NP (JJ Intradermal) (NNS Doc_24684312_12_21_Chemical)) (CC and) (NP (JJ Doc_24684312_26_35_Chemical) (NNS injections))) (: :) (NP (NP (ADJP (JJ intra) (: -) (CC and) (JJ interindividual)) (NN variability)) (PP (IN of) (NP (JJ provoked) (NNS Doc_24684312_99_111_Disease) (CC and) (NNS Doc_24684312_116_125_Disease)))) (. .)))
24684312	1	(ROOT (S (NP (NP (JJ Intradermal) (NNS injections)) (PP (IN of) (NP (NNS Doc_24684312_153_162_Chemical) (CC and) (NNS Doc_24684312_167_176_Chemical)))) (VP (VBP are) (ADJP (JJ attractive) (S (VP (TO to) (VP (VB use) (PP (IN in) (NP (JJ human) (JJ Doc_24684312_208_225_Disease) (NNS models))) (SBAR (IN because) (S (NP (NNS Doc_24684312_241_253_Disease) (CC and) (NNS Doc_24684312_258_267_Disease)) (VP (VBP mimic) (NP (NP (VBN isolated) (NNS aspects)) (PP (IN of) (NP (JJ clinical) (NNS Doc_24684312_303_317_Disease)))))))))))) (. .)))
24684312	2	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN reproducibility)) (PP (IN of) (NP (DT these) (NNS models)))))))) (. .)))
24684312	3	(ROOT (S (NP (NP (CD Twenty) (JJ healthy) (JJ male) (NNS volunteers)) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (NP (NP (NN age)) (NP (CD 24) (NNS years))) (: ;) (NP (NP (NN range)) (NP (CD 18-38) (NNS years)))))) (-RRB- -RRB-))) (VP (VBD received) (NP (NP (JJ intradermal) (NNS injections)) (PP (IN of) (NP (NNS Doc_24684312_509_518_Chemical) (CC and) (NNS Doc_24684312_523_532_Chemical)))) (PP (IN in) (NP (DT the) (NN volar) (NN forearm)))) (. .)))
24684312	4	(ROOT (S (NP (NP (NNS Magnitudes)) (PP (IN of) (NP (NP (JJ secondary) (NN pinprick) (NNS Doc_24684312_588_600_Disease)) (CC and) (NP (JJ brush-evoked) (NNS Doc_24684312_618_627_Disease))))) (VP (VBD were) (VP (VBN investigated) (S (VP (VBG using) (NP (NP (NNP von) (NNP Frey) (NNS filaments)) (PRN (-LRB- -LRB-) (FRAG (ADJP (JJ gauges) (NP (CD 10) (, ,) (CD 15) (, ,) (CD 60) (CC and) (CD 100))) (ADJP (JJ g))) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_24684312_705_718_Disease))))))) (. .)))
24684312	5	(ROOT (S (NP (NP (NNS Areas)) (PP (IN of) (NP (JJ secondary) (NNS Doc_24684312_739_751_Disease) (CC and) (NNS Doc_24684312_756_765_Disease)))) (VP (VBD were) (VP (VBN quantified) (ADVP (RB immediately)) (PP (PP (IN after) (NP (NN injection))) (CC and) (PP (IN after) (NP (CD 15) (, ,) (CD 30) (CC and) (CD 60))) (NP (NN min))))) (. .)))
24684312	6	(ROOT (S (NP (NP (CD Two) (JJ identical) (NNS experiments)) (VP (VBN separated) (PP (IN by) (NP (QP (IN at) (JJS least) (CD 7)) (NNS days))))) (VP (VBD were) (VP (VBN performed))) (. .)))
24684312	7	(ROOT (S (NP (NP (NNP Reproducibility)) (PP (IN across) (CC and) (IN within) (NP (NP (NNS volunteers)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN inter) (NNS -)) (CC and) (NP (JJ intra-individual) (NN variation))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN assessed) (S (VP (VBG using) (NP (NP (JJ intraclass) (NN correlation) (NN coefficient)) (PRN (-LRB- -LRB-) (NP (NNP ICC)) (-RRB- -RRB-)) (CC and) (NP (NP (NN coefficient)) (PP (IN of) (NP (NP (NN variation)) (PRN (-LRB- -LRB-) (NP (NNP CV)) (-RRB- -RRB-)))))))))) (. .)))
24684312	8	(ROOT (S (NP (JJ Secondary) (NN pinprick) (NNS Doc_24684312_1123_1135_Disease)) (VP (VBD was) (VP (VBN observed) (PP (IN as) (NP (NP (DT a) (JJ marked) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ visual) (JJ analogue) (NN scale)) (PRN (-LRB- -LRB-) (NP (NNP VAS)) (-RRB- -RRB-)))))) (PP (NP (NN response)) (PP (TO to) (NP (NNP von) (NNP Frey) (ADJP (JJ gauges) (NP (CD 60) (CC and) (CD 100))) (NNS g))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-))) (PP (IN after) (NP (JJ Doc_24684312_1264_1273_Chemical) (NN injection))))) (. .)))
24684312	9	(ROOT (S (PP (IN For) (NP (NNS Doc_24684312_1289_1298_Chemical))) (, ,) (NP (JJ secondary) (NN pinprick) (NNS Doc_24684312_1319_1331_Disease)) (VP (VBD was) (VP (VBN detected) (PP (IN with) (NP (DT all) (NNP von) (NNP Frey) (NNS gauges))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))) (. .)))
24684312	10	(ROOT (S (NP (NNP Doc_24684312_1383_1392_Chemical)) (VP (VBD evoked) (NP (JJ reproducible) (NNP VAS) (NN response)) (PP (TO to) (NP (NP (DT all) (NNP von) (NNP Frey) (NNS gauges)) (PRN (-LRB- -LRB-) (NP (NNP ICC) (QP (CD >) (CD 0.60))) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_24684312_1466_1479_Disease)) (PRN (-LRB- -LRB-) (NP (NNP ICC) (QP (CD >) (CD 0.83))) (-RRB- -RRB-))))) (. .)))
24684312	11	(ROOT (S (NP (JJ Doc_24684312_1494_1503_Chemical) (NN injection)) (VP (VBD was) (ADJP (JJ reproducible) (PP (IN for) (NP (NP (JJ secondary) (NNS Doc_24684312_1545_1557_Disease)) (PRN (-LRB- -LRB-) (NP (NNP ICC) (QP (CD >) (CD 0.70))) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_24684312_1575_1584_Disease)) (PRN (-LRB- -LRB-) (NP (NNP ICC) (NNP >) (NNP 0.71)) (-RRB- -RRB-)))))) (. .)))
24684312	12	(ROOT (S (NP (NNP Intra-individual)) (ADVP (RB variability)) (VP (VBD was) (ADJP (ADJP (RB generally) (JJR lower) (PP (IN for) (NP (DT the) (NNP VAS) (NN response)))) (PP (TO to) (NP (NP (NNP von) (NNP Frey)) (CC and) (NP (NN brush))))) (PP (VBN compared) (PP (IN with) (NP (NP (NNS areas)) (PP (IN of) (NP (JJ secondary) (NNS Doc_24684312_1724_1736_Disease) (CC and) (NNS Doc_24684312_1741_1750_Disease))))))) (. .)))
24684312	13	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (S (NP (NNS Doc_24684312_1767_1776_Chemical) (CC and) (NNS Doc_24684312_1781_1790_Chemical)) (VP (VBP yield) (NP (NP (JJ reproducible) (NNS Doc_24684312_1810_1822_Disease)) (CC and) (NP (JJ allodynic) (NNS responses))))) (, ,) (CC and) (S (NP (DT the) (JJ present) (NN model)) (VP (VBZ is) (VP (ADVP (RB well)) (VBN suited) (PP (PP (IN for) (NP (JJ basic) (NN research))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN for))) (S (VP (VBG assessing) (NP (NP (DT the) (NN modulation)) (PP (IN of) (NP (JJ central) (NNS phenomena))))))))) (. .)))
24691439	0	(ROOT (S (NP (NNP Ocular-specific) (NNP ER)) (VP (VBP stress) (SBAR (S (NP (NN reduction)) (VP (VBZ rescues) (NP (NP (NNS Doc_24691439_44_52_Disease)) (PP (IN in) (NP (JJ murine) (JJ glucocorticoid-induced) (NNS Doc_24691439_86_94_Disease)))))))) (. .)))
24691439	1	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NNS glucocorticoids)))) (VP (VBZ induces) (NP (NP (NNS Doc_24691439_138_157_Disease)) (PP (IN in) (NP (DT some) (NNS patients))))) (. .)))
24691439	2	(ROOT (S (SBAR (IN If) (FRAG (ADJP (JJ untreated)))) (, ,) (NP (DT these) (NNS patients)) (VP (MD can) (VP (VB develop) (NP (NP (DT a) (NNS Doc_24691439_219_237_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBZ resembles) (NP (NP (NNS Doc_24691439_253_280_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24691439_282_286_Disease)) (-RRB- -RRB-))))))))) (. .)))
24691439	3	(ROOT (S (NP (NP (DT The) (VBG underlying) (NN pathology)) (PP (IN of) (NP (JJ glucocorticoid-induced) (NNS Doc_24691439_340_348_Disease)))) (VP (VBZ is) (RB not) (ADJP (ADJP (RB fully) (JJ understood)) (, ,) (ADJP (JJ due) (PP (IN in) (NP (NN part)))) (PP (TO to) (NP (NP (NN lack)) (PP (IN of) (NP (DT an) (JJ appropriate) (NN animal) (NN model))))))) (. .)))
24691439	4	(ROOT (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBD developed) (NP (NP (DT a) (JJ murine) (NN model)) (PP (IN of) (NP (JJ glucocorticoid-induced) (NNS Doc_24691439_486_494_Disease))) (SBAR (WHNP (WDT that)) (S (VP (VBZ exhibits) (NP (NP (JJ Doc_24691439_509_517_Disease) (NNS features)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN observed) (PP (IN in) (NP (NNS patients))))))))))))) (. .)))
24691439	5	(ROOT (NP (NP (NP (NNP Treatment)) (PP (IN of) (NP (NP (NNP WT) (NNS mice)) (PP (IN with) (NP (JJ topical) (NN ocular)))))) (ADJP (CD 0.1) (NN %)) (VP (ADVP (RB Doc_24691439_604_617_Chemical)) (VBN led) (PP (TO to) (NP (NP (NN elevation)) (PP (IN of) (NP (NP (NP (JJ intraocular) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP IOP)) (-RRB- -RRB-))) (, ,) (NP (ADJP (JJ functional) (CC and) (JJ Doc_24691439_681_716_Disease)) (NNS cells)) (, ,) (CC and) (NP (NNS Doc_24691439_728_747_Disease))))))) (, ,) (VP (VBG resembling) (NP (JJ glucocorticoid-induced) (NNS Doc_24691439_783_791_Disease))) (PP (IN in) (NP (JJ human) (NNS patients))) (. .)))
24691439	6	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NN Doc_24691439_824_837_Chemical-induced) (NNS Doc_24691439_846_865_Disease)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (JJ chronic) (NN ER) (NN stress)) (PP (IN of) (NP (NP (DT the) (NN trabecular) (NN meshwork)) (PRN (-LRB- -LRB-) (NP (NNP TM)) (-RRB- -RRB-)))))))) (. .)))
24691439	7	(ROOT (S (NP (NP (JJ Similar)) (PP (TO to) (NP (NP (NNS patients)) (, ,) (NP (NP (NN withdrawal)) (PP (IN of) (NP (NP (JJ Doc_24691439_972_985_Chemical) (NN treatment)) (VP (VBN reduced)))))))) (VP (VBD elevated) (SBAR (S (NP (NNP IOP) (CC and) (NNP ER)) (VP (VBP stress) (PP (IN in) (NP (DT this) (NN animal) (NN model))))))) (. .)))
24691439	8	(ROOT (S (S (NP (NNP Doc_24691439_1053_1066_Chemical)) (VP (VBN induced) (S (NP (NP (DT the) (JJ transcriptional) (NN factor) (NN CHOP)) (, ,) (NP (NP (DT a) (NN marker)) (PP (IN for) (NP (JJ chronic) (NNP ER) (NN stress)))) (, ,))) (PP (IN in) (NP (DT the) (JJ anterior) (NN segment) (NNS tissues))))) (, ,) (CC and) (S (NP (NNS Doc_24691439_1177_1190_Disease)) (VP (VP (VBD reduced) (NP (NNP ER) (NN stress)) (PP (IN in) (NP (DT these) (NNS tissues)))) (CC and) (VP (VBD prevented) (NP (NN Doc_24691439_1240_1253_Chemical-induced) (NNS Doc_24691439_1262_1281_Disease))))) (. .)))
24691439	9	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN reduction)) (PP (IN of) (NP (NP (NNP ER) (NN stress)) (PP (IN in) (NP (NP (DT the) (NNP TM)) (PP (IN with) (NP (NNS Doc_24691439_1334_1357_Chemical)))))))) (VP (VBD prevented) (NP (NN Doc_24691439_1368_1381_Chemical-induced) (NNS Doc_24691439_1390_1409_Disease)) (PP (IN in) (NP (NNP WT) (NNS mice)))) (. .)))
24691439	10	(ROOT (S (NP (PRP$ Our) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNP ER) (NN stress)) (VP (VP (VBZ contributes) (PP (TO to) (NP (JJ glucocorticoid-induced) (NNS Doc_24691439_1493_1512_Disease)))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (S (VP (VBG reducing) (NP (NNP ER) (NN stress)))) (VP (VBZ has) (NP (NP (NN potential)) (PP (IN as) (NP (NP (DT a) (JJ therapeutic) (NN strategy)) (PP (IN for) (S (VP (VBG treating) (NP (JJ glucocorticoid-induced) (NNS Doc_24691439_1625_1633_Disease)))))))))))))))) (. .)))
24709919	0	(ROOT (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (NNS Doc_24709919_11_23_Chemical)) (PP (IN on) (NP (JJ opioid-induced) (NNS Doc_24709919_42_54_Disease))))) (PP (IN in) (NP (NNS mice))) (. .)))
24709919	1	(ROOT (S (NP (NP (JJ Opioid-induced) (NNS Doc_24709919_79_91_Disease)) (PRN (-LRB- -LRB-) (NP (NNP OIH)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ nociceptive) (NN sensitization)) (VP (VBN caused) (PP (IN by) (NP (NP (DT the) (NN cessation)) (PP (IN of) (NP (JJ chronic) (JJ opioid) (NN use)))))))))) (. .)))
24709919	2	(ROOT (S (NP (NNP OIH)) (VP (MD can) (VP (VP (VB limit) (NP (NP (DT the) (JJ clinical) (NN use)) (PP (IN of) (NP (JJ opioid) (NNS analgesics))))) (CC and) (VP (VB complicate) (NP (NN withdrawal)) (PP (IN from) (NP (NNS Doc_24709919_274_290_Disease)))))) (. .)))
24709919	3	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNP Re)))) (, ,) (NP (NNS Doc_24709919_342_345_Chemical)) (, ,) (CC and) (NP (NP (JJ Rb1) (NNS Doc_24709919_355_367_Chemical)) (, ,) (NP (NP (DT the) (JJ bioactive) (NNS components)) (PP (IN of) (NP (NN ginseng)))) (, ,) (PP (IN on) (NP (NNP OIH)))))) (. .)))
24709919	4	(ROOT (S (NP (NNP OIH)) (VP (VBD was) (VP (VBN achieved) (PP (IN in) (NP (NNS mice))) (PP (IN after) (NP (NP (JJ subcutaneous) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_24709919_476_484_Chemical)) (PP (IN for) (NP (NP (CD 7) (JJ consecutive) (NNS days)) (NP (CD three) (NNS times)) (PP (IN per) (NP (NN day))))))))))) (. .)))
24709919	5	(ROOT (S (PP (IN During) (NP (NP (NN withdrawal)) (PRN (-LRB- -LRB-) (NP (NP (NNS days) (CD 8)) (CC and) (NP (CD 9))) (-RRB- -RRB-)))) (, ,) (NP (DT these) (NNS mice)) (VP (VBD were) (VP (VBN administered) (NP (NP (NNP Re)) (, ,) (NP (NNS Doc_24709919_596_599_Chemical)) (, ,) (CC or) (NP (NP (JJ Rb1) (NN intragastrically)) (NP (CD two) (NNS times)) (PP (IN per) (NP (NN day))))))) (. .)))
24709919	6	(ROOT (S (PP (IN On) (NP (NP (DT the) (NN test) (NN day)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 10)) (-RRB- -RRB-)))) (, ,) (NP (NNS mice)) (VP (VBD were) (VP (VBN subjected) (PP (TO to) (NP (NP (DT the) (JJ thermal) (NN sensitivity) (NN test)) (CC and) (NP (DT the) (NN Doc_24709919_730_741_Chemical-induced)))) (S (VP (VBG writhing) (NP (NN test)))))) (. .)))
24709919	7	(ROOT (S (NP (NP (NNP Re)) (PRN (-LRB- -LRB-) (NP (CD 300) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBD inhibited) (NP (NNP OIH)) (PP (IN in) (NP (PDT both) (NP (DT the) (JJ thermal) (NN sensitivity) (NN test)) (CC and) (NP (DT the) (NN Doc_24709919_839_850_Chemical-induced)))) (S (VP (VBG writhing) (NP (NN test))))) (. .)))
24709919	8	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NNS Doc_24709919_887_890_Chemical)) (CC and) (NP (JJ Rb1) (NNS Doc_24709919_899_911_Chemical))) (VP (VBD failed) (S (VP (TO to) (VP (VB prevent) (NP (NP (NNP OIH)) (PP (IN in) (NP (DT either) (NN test)))))))) (. .)))
24709919	9	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NNS Doc_24709919_963_966_Chemical)) (VP (VBD showed) (NP (DT a) (NN tendency) (S (VP (TO to) (VP (VB aggravate) (NP (NP (NNP OIH)) (PP (IN in) (NP (NP (DT the) (NN Doc_24709919_1009_1020_Chemical-induced)) (VP (VBG writhing) (NP (NN test))))))))))) (. .)))
24709919	10	(ROOT (S (NP (PRP$ Our) (NNS data)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NP (DT the) (NNS Doc_24709919_1072_1086_Chemical)) (, ,) (CONJP (CC but) (RB not)) (NP (NNS Doc_24709919_1096_1099_Chemical) (CC or) (NNS Rb1)) (, ,)) (VP (MD may) (VP (VB contribute) (PP (IN toward) (NP (NP (NN reversal)) (PP (IN of) (NP (NNP OIH)))))))))) (. .)))
24717468	0	(ROOT (NP (NP (DT A) (NN comparison)) (PP (IN of) (NP (NP (JJ severe) (JJ hemodynamic) (NNS disturbances)) (PP (IN between) (NP (NNS Doc_24717468_56_71_Chemical) (CC and) (NNS Doc_24717468_76_84_Chemical))))) (PP (IN for) (NP (NN sedation))) (PP (IN in) (NP (JJ neurocritical) (NN care) (NNS patients))) (. .)))
24717468	1	(ROOT (S (NP (NNS Doc_24717468_141_156_Chemical) (CC and) (NNS Doc_24717468_161_169_Chemical)) (VP (VBP are) (ADVP (RB commonly)) (VP (VBN used) (NP (NP (NNS sedatives)) (PP (IN in) (NP (JJ neurocritical) (NN care)))) (SBAR (IN as) (S (NP (PRP they)) (VP (VBP allow) (PP (IN for) (NP (JJ frequent) (JJ neurologic) (NNS examinations)))))))) (. .)))
24717468	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT both) (NNS agents)) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (JJ significant) (JJ hemodynamic) (NN side) (NNS effects))))) (. .)))
24717468	3	(ROOT (S (NP (NP (DT The) (JJ primary) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBZ is) (S (VP (TO to) (VP (VB compare) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (JJ severe) (JJ hemodynamic) (NNS effects)))) (PP (IN in) (NP (NP (JJ neurocritical) (NN care) (NNS patients)) (VP (VBG receiving) (NP (NNS Doc_24717468_487_502_Chemical) (CC and) (NNS Doc_24717468_507_515_Chemical))))))))) (. .)))
24717468	4	(ROOT (S (NP (NP (NNP Multicenter)) (, ,) (ADJP (JJ retrospective)) (, ,)) (VP (VBD propensity-matched) (NP (JJ cohort) (NN study))) (. .)))
24717468	5	(ROOT (S (NP (NNP Neurocritical)) (VP (VBP care) (NP (NNS units)) (PP (IN at) (NP (NP (CD two) (JJ academic) (JJ medical) (NNS centers)) (PP (IN with) (NP (NP (ADJP (JJ dedicated) (JJ neurocritical)) (NN care) (NNS teams)) (CC and) (NP (JJ board-certified) (NNS neurointensivists))))))) (. .)))
24717468	6	(ROOT (S (NP (NP (JJ Neurocritical) (NN care) (NNS patients)) (VP (VBN admitted) (PP (IN between) (NP (NP (NNP July) (CD 2009)) (CC and) (NP (NNP September) (CD 2012)))))) (VP (VBD were) (VP (VP (VBN evaluated)) (CC and) (ADVP (RB then)) (VP (VBN matched) (NP (CD 1:1)) (PP (VBN based) (PP (IN on) (NP (NP (NN propensity) (VBG scoring)) (PP (IN of) (NP (NN baseline) (NNS characteristics))))))))) (. .)))
24717468	7	(ROOT (S (NP (NNS Continuous)) (VP (VBN sedation) (PP (IN with) (NP (NNS Doc_24717468_948_963_Chemical) (CC or) (NNS Doc_24717468_967_975_Chemical)))) (. .)))
24717468	8	(ROOT (S (NP (NP (NP (NNP MEASUREMENTS) (CC AND) (NNP MAIN) (NNP RESULTS)) (: :) (NP (NP (DT A) (NN total)) (PP (IN of) (NP (JJ 342) (NNS patients))))) (PRN (-LRB- -LRB-) (NP (NP (CD 105) (NNS Doc_24717468_1037_1052_Chemical)) (CC and) (NP (JJ 237) (NNS Doc_24717468_1061_1069_Chemical))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN included) (PP (IN in) (NP (DT the) (NN analysis))) (, ,) (PP (IN with) (NP (NP (NP (CD 190) (VBN matched)) (PRN (-LRB- -LRB-) (NP (NP (CD 95)) (PP (IN in) (NP (DT each) (NN group)))) (-RRB- -RRB-))) (PP (IN by) (NP (NN propensity) (NN score))))))) (. .)))
24717468	9	(ROOT (S (NP (NP (DT The) (JJ primary) (NN outcome)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (NP (NP (DT a) (NN composite)) (PP (IN of) (NP (NP (JJ severe) (NNS Doc_24717468_1219_1230_Disease)) (PRN (-LRB- -LRB-) (NP (NP (JJ mean) (JJ arterial) (NN pressure) (NNS <)) (NP (CD 60) (NN mm) (NNP Hg))) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_24717468_1271_1282_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN heart) (NN rate) (NNS <)) (NP (CD 50) (NN beats/min))) (-RRB- -RRB-))))) (PP (IN during) (NP (JJ sedative) (NN infusion)))) (. .)))
24717468	10	(ROOT (S (NP (NP (DT No) (NN difference)) (PP (IN in) (NP (NP (DT the) (JJ primary) (JJ composite) (NN outcome)) (PP (IN in) (NP (PDT both) (NP (NP (DT the) (NN unmatched)) (PRN (-LRB- -LRB-) (NP (NP (CD 30) (NN %)) (VP (VBN vs) (NP (NP (CD 30) (NN %)) (, ,) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.94)))))))) (-RRB- -RRB-))) (CC or) (NP (NP (VBN matched) (NNS cohorts)) (PRN (-LRB- -LRB-) (NP (NP (CD 28) (NN %)) (VP (VBN vs) (NP (NP (CD 34) (NN %)) (, ,) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.35)))))))) (-RRB- -RRB-)))))))) (VP (MD could) (VP (VB be) (VP (VBN found)))) (. .)))
24717468	11	(ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VBD analyzed) (ADVP (RB separately))))) (, ,) (NP (DT no) (NNS differences)) (VP (MD could) (VP (VB be) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (JJ severe) (NNS Doc_24717468_1571_1582_Disease) (CC or) (NNS Doc_24717468_1586_1597_Disease))))) (PP (IN in) (NP (NP (RB either) (DT the) (NN unmatched)) (CC or) (NP (VBN matched) (NNS cohorts))))))) (. .)))
24717468	12	(ROOT (S (NP (JJ Severe) (NNS Doc_24717468_1662_1673_Disease) (CC and) (NNS Doc_24717468_1678_1689_Disease)) (VP (VBP occur) (PP (IN at) (NP (NP (JJ similar) (NN prevalence)) (PP (IN in) (NP (JJ neurocritical) (NN care) (NNS patients))) (SBAR (WHNP (WP who)) (S (VP (VBP receive) (NP (NNS Doc_24717468_1761_1776_Chemical) (CC or) (NNS Doc_24717468_1780_1788_Chemical)))))))) (. .)))
24717468	13	(ROOT (S (NP (NNS Providers)) (VP (MD should) (ADVP (RB similarly)) (VP (VB consider) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (NP (NNS Doc_24717468_1844_1855_Disease) (CC or) (NNS Doc_24717468_1859_1870_Disease)))) (PP (IN before) (S (VP (VBG starting) (NP (DT either) (NN sedative))))))) (. .)))
24727461	0	(ROOT (S (NP (JJ Doc_24727461_0_14_Chemical) (NNS ameliorates)) (VP (VBD oxidative) (NP (NN stress) (CC and) (NNS Doc_24727461_48_73_Disease)) (PP (IN in) (NP (NN Doc_24727461_77_88_Chemical-induced) (NNS Doc_24727461_97_111_Disease))) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (NNS Doc_24727461_125_138_Disease)))))) (. .)))
24727461	1	(ROOT (S (NP (JJ Oxidative) (NN stress)) (VP (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (JJ several) (NNS processes)) (PP (VBG including) (NP (NP (NNS Doc_24727461_200_206_Disease)) (, ,) (NP (VBG aging)) (CC and) (NP (NNS Doc_24727461_218_240_Disease)))))))) (, ,) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB potentiate) (NP (NP (DT the) (JJ therapeutic) (NN effect)) (PP (IN of) (NP (NP (NNS drugs)) (PP (JJ such) (IN as) (NP (NNS Doc_24727461_315_326_Chemical))))))))))))) (. .)))
24727461	2	(ROOT (S (NP (NNP Doc_24727461_328_339_Chemical)) (VP (VBZ causes) (NP (NP (JJ significant) (NNS Doc_24727461_359_373_Disease)) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ marked) (NNS increases)) (PP (IN in) (NP (JJ oxidative) (NN stress) (CC and) (NNS Doc_24727461_432_457_Disease)))))))) (. .)))
24727461	3	(ROOT (S (ADVP (RB Herein)) (, ,) (NP (PRP we)) (VP (VB investigate) (SBAR (IN whether) (S (NP (NN Doc_24727461_490_501_Chemical-associated) (NN chronic) (NNS Doc_24727461_521_537_Disease)) (VP (MD can) (VP (VB be) (VP (VBN ameliorated) (PP (IN with) (NP (NP (DT the) (JJ antioxidant) (NNS Doc_24727461_578_592_Chemical)) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (NNS Doc_24727461_606_619_Disease))))))))))))) (. .)))
24727461	4	(ROOT (S (NP (NP (JJ Thirty-six) (NNS rats)) (VP (VBG bearing) (NP (NP (NNS Doc_24727461_645_658_Disease)) (VP (VBN induced) (ADVP (RB chemically)))))) (VP (VBD were) (VP (VBN divided) (PP (IN into) (NP (NP (CD 4) (NNS groups)) (: :) (NP (NP (NN control)) (, ,) (NP (NP (NP (NNS Doc_24727461_715_729_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.5) (NN mg/kg)) (, ,) (NP (NNS 5days/week))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_24727461_754_765_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP 1mg/kg/week)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NNP Doc_24727461_785_796_Chemical) (CC plus) (NNP Doc_24727461_802_816_Chemical)))))))) (. .)))
24727461	5	(ROOT (S (S (NP (NNP Cardiac)) (VP (VBZ disturbances) (PP (IN at) (NP (NP (DT the) (JJ cellular) (CC and) (JJ mitochondrial) (NN level)) (, ,) (NP (JJ mitochondrial) (JJ electron) (NN transport) (NN chain) (NNP complexes) (NNP I-IV)) (CC and) (NP (JJ apoptosis-inducing) (NN factor)))))) (, ,) (CC and) (S (NP (JJ oxidative) (NN stress) (NNS markers)) (VP (VBP have) (VP (VBN been) (VP (VBN analyzed))))) (. .)))
24727461	6	(ROOT (S (NP (NNP Doc_24727461_1014_1028_Chemical)) (VP (VBD improved) (NP (NP (DT the) (NNS Doc_24727461_1042_1062_Disease)) (VP (VBN enhanced) (PP (IN by) (NP (NNS Doc_24727461_1075_1086_Chemical))) (PP (IN by) (S (ADVP (RB significantly)) (VP (VBG reducing) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (JJ altered) (NN mitochondria) (CC and) (NN oxidative) (NN damage)))))))))) (. .)))
24727461	7	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_24727461_1201_1215_Chemical)) (VP (VB improve) (NP (DT the) (JJ mitochondrial) (NN electron) (NN transport) (NN chain)))))) (. .)))
24727461	8	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NNS Doc_24727461_1297_1311_Chemical)) (VP (VB protect) (NP (NP (NN rat) (NN heart) (NN damage)) (VP (VBN provoked) (PP (IN by) (NP (JJ Doc_24727461_1349_1360_Chemical) (NNP decreasing) (NN oxidative) (NN damage) (CC and) (NN mitochondrial) (NNS alterations))))))))) (. .)))
24729111	0	(ROOT (NP (CD Doc_24729111_0_10_Chemical-induced) (NNS Doc_24729111_19_33_Disease) (. .)))
24729111	1	(ROOT (S (NP (DT A) (JJ 62-year-old) (NN man)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NNS Doc_24729111_71_82_Disease) (, ,) (NNS Doc_24729111_84_95_Disease) (CC and) (NNS Doc_24729111_100_119_Disease)) (PP (NP (CD 3) (NNS weeks)) (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (JJ Doc_24729111_148_158_Chemical) (NN therapy)) (PP (IN for) (NP (NNS Doc_24729111_171_190_Disease)))))))))))) (. .)))
24729111	2	(ROOT (S (S (NP (JJ Thyroid-stimulating) (NN hormone)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (RB 168) (JJ uIU/mL)))))))) (PRN (-LRB- -LRB-) (S (NP (NN nl) (. .) (NNP 0.3-5)) (VP (VBP uIU/mL))) (-RRB- -RRB-)) (CC and) (S (NP (NP (JJ free) (NNS Doc_24729111_275_284_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP FT4)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBG <) (NP (NP (CD 0.2) (NN ng/dL)) (PRN (-LRB- -LRB-) (NP (NNP nl) (. .)) (NP (NP (CD 0.8-1)) (NP (CD .8) (NN ng/dL))) (-RRB- -RRB-)))))) (. .)))
24729111	3	(ROOT (S (S (NP (PRP He)) (VP (VBD received) (NP (NP (JJ intravenous) (NNS fluids)) (, ,) (NP (NN vasopressor) (NN therapy)) (CC and) (NP (NN stress) (NN dose) (NNS Doc_24729111_395_403_Chemical))))) (: ;) (S (NP (PRP he)) (VP (VBD was) (VP (VBN intubated) (CC and) (VBN admitted) (PP (TO to) (NP (DT the) (JJ intensive) (NN care) (NN unit)))))) (. .)))
24729111	4	(ROOT (S (S (NP (PRP He)) (VP (VBD received) (NP (NP (CD 500) (NN ug)) (PP (IN of) (NP (JJ intravenous) (NNS Doc_24729111_497_510_Chemical)))) (PP (IN in) (NP (NP (DT the) (JJ first) (CD 18) (NN h)) (PP (IN of) (NP (NN therapy))))))) (, ,) (CC and) (S (NP (CD 150) (NN ug)) (VP (VBD intravenous) (ADVP (RB daily)) (ADVP (RB thereafter)))) (. .)))
24729111	5	(ROOT (S (S (NP (NP (JJ Haemodynamic) (NN improvement)) (, ,) (ADVP (IN along) (PP (IN with) (NP (NP (JJ complete) (NN recovery)) (PP (IN of) (NP (JJ mental) (NN status)))))) (, ,)) (VP (VBD occurred) (PP (IN after) (NP (CD 48) (NN h.))) (NP (CD Twelve) (NNS hours)) (PP (IN after) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NN therapy))))))) (, ,) (NP (NNP FT4)) (VP (VBD was) (NP (CD 0.96) (NN ng/dL))) (. .)))
24729111	6	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN maintained) (PP (IN on) (NP (NN Doc_24729111_772_785_Chemical) (CD 175) (-LRB- -LRB-) (JJ g) (NN POorally) (RB daily))))) (. .)))
24729111	7	(ROOT (S (NP (DT A) (NN thyroid) (NN ultrasound)) (VP (VBD showed) (NP (JJ diffuse) (NN heterogeneity))) (. .)))
24729111	8	(ROOT (S (NP (NP (DT The) (CD 24) (NN hour) (NN excretion)) (PP (IN of) (NP (NNS Doc_24729111_885_891_Chemical)))) (VP (VBD was) (VP (VBN 3657) (S (NP (-LRB- -LRB-) (NNP mcg) (-LRB- -LRB-) (NNP 25-756) (-LRB- -LRB-) (NNP mcg) (-RRB- -RRB-))))) (. .)))
24729111	9	(ROOT (S (NP (NP (DT The) (JJ only) (CD two) (NNS cases)) (PP (IN of) (NP (NP (NN Doc_24729111_944_954_Chemical-induced) (NNS Doc_24729111_963_977_Disease)) (PP (IN in) (NP (DT the) (NN literature)))))) (VP (VBP report) (NP (JJ patient) (NNS Doc_24729111_1011_1016_Disease)) (PP (IN despite) (NP (ADJP (JJ supportive)) (NN therapy) (CC and) (NN thyroid) (NN hormone) (NN replacement)))) (. .)))
24729111	10	(ROOT (S (NP (DT This) (NN case)) (VP (VBZ represents) (NP (NP (DT the) (ADJP (RBS most) (RB thoroughly) (JJ investigated)) (NN case)) (PP (IN of) (NP (NN Doc_24729111_1139_1149_Chemical-induced) (NNS Doc_24729111_1158_1172_Disease)))) (PP (IN with) (NP (NP (DT a) (NN history)) (ADJP (JJ significant) (PP (IN for) (NP (NNS Doc_24729111_1204_1231_Disease))))))) (. .)))
24733133	0	(ROOT (NP (NP (NN Use)) (PP (IN of) (NP (JJ Doc_24733133_7_17_Chemical) (CC and) (JJ catheter-directed) (NNS thrombolysis))) (PP (IN with) (NP (NN alteplase))) (PP (IN in) (NP (NP (DT an) (ADJP (RB oncology) (JJ patient) (PP (IN with) (NP (NNS Doc_24733133_96_103_Chemical-induced)))) (NN thrombocytopenia)) (PP (IN with) (NP (NNS thrombosis))))) (. .)))
24733133	1	(ROOT (S (NP (NP (DT The) (NN case)) (PP (IN of) (NP (NP (DT an) (JJ oncology) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD developed) (NP (NN Doc_24733133_201_208_Chemical-induced) (NN thrombocytopenia)) (PP (IN with) (NP (NP (NNS thrombosis)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24733133_251_255_Disease)) (-RRB- -RRB-))))) (CC and) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_24733133_278_288_Chemical)) (PP (CC plus) (NP (NP (JJ catheter-directed) (NNS thrombolysis)) (PRN (-LRB- -LRB-) (NP (NNP CDT)) (-RRB- -RRB-)))))) (PP (IN with) (NP (NN alteplase))))))))))) (VP (VBZ is) (VP (VBN presented))) (. .)))
24733133	2	(ROOT (S (NP (NP (DT A) (JJ 63-year-old) (NNP Caucasian) (NN man)) (PP (IN with) (NP (NP (NNS Doc_24733133_402_419_Disease)) (VP (VBG undergoing) (NP (JJ peripheral) (NN blood)))))) (VP (VBP stem) (SBAR (S (NP (NP (NN cell) (NN collection)) (PP (IN for) (NP (DT an) (NNS autologous)))) (VP (VBP stem) (SBAR (S (NP (NN cell) (NN transplant)) (VP (VBD developed) (NP (NP (NP (JJ extensive) (JJ bilateral) (JJ upper-extremity) (NNS Doc_24733133_554_576_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24733133_578_581_Disease)) (-RRB- -RRB-))) (CC and) (NP (JJ Doc_24733133_587_605_Disease) (ADJP (JJ secondary) (TO to) (JJ Doc_24733133_619_626_Chemical-induced)) (NNS Doc_24733133_635_651_Disease)))))))))) (. .)))
24733133	3	(ROOT (S (S (NP (NP (DT A) (JJ continuous) (NN i.v.) (NN infusion)) (PP (IN of) (NP (NNS Doc_24733133_683_693_Chemical)))) (VP (VBD was) (VP (VBN initiated)))) (, ,) (CC and) (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN managed) (PP (IN on) (NP (DT the) (JJ general) (JJ medical) (NN floor)))))) (. .)))
24733133	4	(ROOT (S (PP (IN After) (NP (NP (CD one) (NN week)) (PP (IN of) (NP (NN therapy))))) (, ,) (NP (PRP he)) (VP (VBD was) (VP (VBN transferred) (PP (TO to) (NP (DT the) (JJ intensive) (NN care) (NN unit))) (PP (IN with) (NP (NP (JJ cardiopulmonary) (NN compromise)) (VP (VBN related) (PP (TO to) (NP (ADJP (JJ superior) (JJ vena)) (NN cava) (PRN (-LRB- -LRB-) (NP (NNP SVC)) (-RRB- -RRB-)) (NN syndrome)))))))) (. .)))
24733133	5	(ROOT (S (S (NP (NP (DT A) (JJ percutaneous) (JJ mechanical) (NN thrombectomy)) (CC and) (NP (NP (NNP CDT)) (PP (IN with) (NP (NN alteplase))))) (VP (VBD were) (VP (VBN attempted)))) (, ,) (CC but) (S (NP (DT the) (NN procedure)) (VP (VBD was) (VP (VBN aborted) (S (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_24733133_1033_1042_Disease)))))))) (. .)))
24733133	6	(ROOT (S (S (NP (DT The) (NNS Doc_24733133_1048_1057_Disease)) (VP (VBD resolved) (NP (DT the) (JJ next) (NN day)))) (, ,) (CC and) (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN restarted) (PP (IN on) (NP (NNS Doc_24733133_1114_1124_Chemical)))))) (. .)))
24733133	7	(ROOT (S (NP (DT A) (JJ second) (JJ percutaneous) (JJ mechanical) (NN thrombectomy)) (VP (VBD was) (VP (VP (VBN performed) (NP (CD six) (NNS days) (RB later))) (CC and) (VP (VBN resulted) (PP (IN in) (NP (NP (JJ partial) (NN revascularization)) (PP (IN of) (NP (NP (DT the) (NNP SVC)) (CC and) (NP (JJ central) (NNS veins))))))))) (. .)))
24733133	8	(ROOT (S (S (NP (NP (ADJP (RB Postthrombectomy) (JJ continuous)) (NNP CDT)) (PP (IN with) (NP (NN alteplase)))) (VP (VBD was) (VP (VBN commenced) (SBAR (IN while) (S (NP (NNS Doc_24733133_1340_1350_Chemical)) (VP (VBD was) (VP (VBN withheld)))))))) (, ,) (CC and) (S (NP (NP (JJ complete) (NN patency)) (PP (IN of) (NP (NP (DT the) (NNP SVC)) (CC and) (NP (JJ central) (NNS veins))))) (VP (VBD was) (VP (VBN achieved) (PP (IN after) (NP (NP (CD three) (NNS days)) (PP (IN of) (NP (NN therapy)))))))) (. .)))
24733133	9	(ROOT (S (S (S (NP (NNP Alteplase)) (VP (VBD was) (VP (VBN discontinued)))) (, ,) (CC and) (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN reinitiated) (PP (IN on) (NP (NNS Doc_24733133_1520_1530_Chemical))))))) (: ;) (S (ADVP (RB ultimately)) (, ,) (NP (PRP he)) (VP (VBD was) (VP (VBN transitioned) (PP (TO to) (NP (NP (NNS Doc_24733133_1567_1575_Chemical)) (PP (IN for) (NP (JJ long-term) (NN anticoagulation)))))))) (. .)))
24733133	10	(ROOT (S (SBAR (IN Although) (S (NP (DT the) (NN patient)) (VP (VBD recovered)))) (, ,) (NP (PRP he)) (VP (VBD experienced) (NP (NP (JJ permanent) (NNS Doc_24733133_1664_1670_Disease) (CC and) (NNS Doc_24733133_1675_1687_Disease)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NNS Doc_24733133_1700_1723_Disease)))) (. .)))
24733133	11	(ROOT (S (NP (NP (DT A) (JJ 63-year-old) (NN man)) (PP (IN with) (NP (NP (NNS Doc_24733133_1760_1777_Disease) (CC and) (NNS Doc_24733133_1782_1794_Disease)) (ADJP (JJ secondary) (PP (TO to) (NP (NNS Doc_24733133_1808_1812_Disease))))))) (VP (VBD was) (ADVP (RB successfully)) (VP (VBN treated) (PP (IN with) (NP (NNP Doc_24733133_1843_1853_Chemical) (CC and) (NNP CDT))) (PP (IN with) (NP (NN alteplase))))) (. .)))
24739405	0	(ROOT (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (NNS Doc_24739405_11_33_Chemical)) (PP (IN in) (NP (JJ Doc_24739405_37_48_Chemical-induced) (JJ Doc_24739405_57_70_Disease) (NNS models))))) (PP (IN in) (NP (NNS mice))) (. .)))
24739405	1	(ROOT (S (VP (TO To) (VP (VB examine) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_24739405_124_146_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24739405_148_152_Chemical)) (-RRB- -RRB-))))) (PP (IN on) (NP (NP (NN animal) (NNS models)) (PP (IN of) (NP (NNS Doc_24739405_174_187_Disease))))))) (. .)))
24739405	2	(ROOT (S (NP (NP (CD Seventy) (JJ Swiss) (NN albino) (NN female) (NNS mice)) (PRN (-LRB- -LRB-) (NP (CD 25-35) (NNS g)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN divided) (PP (IN into) (NP (NP (CD 4) (NNS groups)) (: :) (NP (NP (NP (NNS Doc_24739405_269_280_Chemical-free)) (PRN (-LRB- -LRB-) (NP (NN control)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_24739405_297_308_Chemical)) (, ,) (NP (CD 50)) (, ,)) (CC and) (NP (CD 100) (JJ mg/kg) (NNS Doc_24739405_328_332_Chemical))))))) (. .)))
24739405	3	(ROOT (S (NP (DT The) (NNS Doc_24739405_338_342_Chemical)) (VP (VBD was) (VP (VBN administered) (NP (NP (NP (NN intraperitoneally)) (PRN (-LRB- -LRB-) (NP (NN ip)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 5) (NNS days)))))) (. .)))
24739405	4	(ROOT (S (NP (NP (NP (NNP Doc_24739405_395_406_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN mg/kg) (NN ip)) (-RRB- -RRB-))) (VP (VBN induced) (NP (NP (NP (JJ Doc_24739405_428_433_Disease) (NN locomotion)) (, ,) (NP (NNS Doc_24739405_446_457_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 1.5)) (S (VP (VBG mg/kg) (NP (JJ subcutaneously) (JJ -LSB-) (NN sc) (NNS -RSB-))))) (-RRB- -RRB-))) (VP (VBN induced) (S (VP (VBG climbing)))) (, ,) (CC and) (NP (NP (NP (NNS Doc_24739405_512_523_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1.5) (NN mg/kg) (NN sc)) (-RRB- -RRB-))) (VP (VBN induced) (NP (JJ Doc_24739405_547_556_Disease) (NNS tests))))))) (VP (VBD were) (VP (VBN used) (PP (IN as) (NP (NP (NN animal) (NNS models)) (PP (IN of) (NP (NNS Doc_24739405_593_606_Disease))))))) (. .)))
24739405	5	(ROOT (S (NP (DT The) (NN study)) (VP (VBD was) (VP (VBN conducted) (PP (IN at) (NP (NP (DT the) (NNP Animal) (NNP Experiment) (NNPS Laboratories)) (, ,) (NP (NP (NNP Department)) (PP (IN of) (NP (NNP Pharmacology)))) (, ,) (NP (NNP Medical) (NNP School)) (, ,) (NP (NNP Eskisehir) (NNP Osmangazi) (NNP University)) (, ,) (NP (NNP Eskisehir) (, ,) (NNP Turkey) (IN between) (NNP March)) (CC and) (NP (NNP May) (CD 2012)))))) (. .)))
24739405	6	(ROOT (S (NP (NNP Statistical) (NN analysis)) (VP (VBD was) (VP (VBN carried) (PP (IN out) (S (VP (VBG using) (NP (NP (NP (NNP Kruskal-Wallis) (NN test)) (PP (IN for) (NP (JJ Doc_24739405_860_865_Disease) (NN locomotion)))) (, ,) (CC and) (NP (NP (NNP one-way) (NNP ANOVA)) (PP (IN for) (NP (NN climbing) (CC and) (NN Doc_24739405_913_922_Disease) (NNS tests)))))))))) (. .)))
24739405	7	(ROOT (S (PP (IN In) (NP (DT the) (NN Doc_24739405_946_957_Chemical-induced) (NN locomotion) (NN test))) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (JJ significant) (NNS increases)) (PP (IN in) (NP (NP (DT all) (NNS movements)) (PP (VBN compared) (PP (IN with) (NP (DT the) (NN Doc_24739405_1051_1062_Chemical-free) (NN group)))))))) (. .)))
24739405	8	(ROOT (S (S (NP (DT Both) (NNP Doc_24739405_1080_1084_Chemical) (CD 50)) (VP (VBG mg/kg) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-)))) (, ,) (CC and) (S (NP (NP (CD 100) (NN mg/kg)) (PRN (-LRB- -LRB-) (NP (NNP p) (NNP <) (NNP 0.01)) (-RRB- -RRB-))) (ADVP (RB significantly)) (VP (VBD decreased) (NP (DT all) (NNS movements)) (PP (VBN compared) (PP (IN with) (NP (DT the) (NN Doc_24739405_1183_1194_Chemical-induced) (NN locomotion) (NN group)))))) (. .)))
24739405	9	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN difference)) (PP (IN between) (NP (NP (NNS groups)) (PP (IN in) (NP (DT the) (NN Doc_24739405_1278_1289_Chemical-induced) (NNS Doc_24739405_1298_1307_Disease) (NN test))) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (CD <) (CD 0.05))) (-RRB- -RRB-)))))) (. .)))
24739405	10	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (JJ significant) (NN difference)) (PP (IN between) (NP (NP (NNS groups)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (JJ total) (NN climbing) (NN time)) (PP (IN in) (NP (NP (DT the) (NN Doc_24739405_1413_1424_Chemical-induced)) (VP (VBG climbing) (NP (NN test))) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (CD >) (CD 0.05))) (-RRB- -RRB-)))))))))))) (. .)))
24739405	11	(ROOT (S (NP (PRP We)) (VP (VBD observed) (SBAR (IN that) (S (NP (NNS Doc_24739405_1486_1490_Chemical)) (VP (VBD reduced) (NP (NP (NN locomotor) (NN activity) (CC and) (VBN increased) (NNS Doc_24739405_1532_1541_Disease)) (PP (IN at) (NP (DT both) (NNS doses))))))) (, ,) (SBAR (IN while) (S (NP (PRP it)) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (S (VP (VBG climbing) (NP (NN behavior)))))))))) (. .)))
24739405	12	(ROOT (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_24739405_1618_1622_Chemical)) (VP (VP (VBZ displays) (NP (JJ typical) (NN Doc_24739405_1640_1651_Disease-like) (NNS effects))) (, ,) (CC and) (VP (MD may) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_24739405_1702_1715_Disease)))))))))))) (. .)))
24742750	0	(ROOT (S (NP (NP (NNP Availability)) (PP (IN of) (NP (JJ human) (JJ induced) (NN pluripotent)))) (VP (VBP stem) (NP (JJ cell-derived) (NNS cardiomyocytes)) (PP (IN in) (NP (NP (NN assessment)) (PP (IN of) (NP (NP (NN drug) (NN potential)) (PP (IN for) (NP (NNS Doc_24742750_111_126_Disease)))))))) (. .)))
24742750	1	(ROOT (S (NP (NP (NP (NNP Field) (JJ potential) (NN duration)) (PRN (-LRB- -LRB-) (NP (NNP FPD)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ human-induced) (NN pluripotent)))) (VP (VBP stem) (SBAR (S (NP (NP (JJ cell-derived) (NNS cardiomyocytes)) (PRN (-LRB- -LRB-) (NP (NNS hiPS-CMs)) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB express) (NP (NP (NNP QT) (NNP interval)) (PP (IN in) (NP (DT an) (NN electrocardiogram)))))))) (, ,)) (VP (VBZ is) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (NP (DT a) (JJ useful) (NN tool) (S (VP (TO to) (VP (VB predict) (NP (JJ Doc_24742750_331_335_Chemical) (NN channel) (CC and) (NN Doc_24742750_348_354_Chemical) (NN channel) (NN blocker) (NNS effects)) (PP (IN on) (NP (NNP QT) (NNP interval))))))))))))))) (. .)))
24742750	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (NN report)) (VP (VBG showing) (SBAR (IN that) (S (NP (DT this) (NN technique)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB predict) (NP (NP (JJ multichannel) (NN blocker) (NN potential)) (PP (IN for) (NP (NNS Doc_24742750_509_524_Disease))))))))))))))) (. .)))
24742750	3	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBZ is) (S (VP (TO to) (VP (VB show) (SBAR (IN that) (S (NP (NP (NNP FPD)) (PP (IN from) (NP (NNP MEA))) (PRN (-LRB- -LRB-) (NP (NNP Multielectrode) (NN array)) (-RRB- -RRB-)) (PP (IN of) (NP (NP (NNS hiPS-CMs)) (SBAR (S (VP (MD can) (VP (VB detect) (NP (NP (NNS Doc_24742750_623_638_Disease)) (VP (VBN induced) (PP (IN by) (NP (JJ multichannel) (NNS blockers))) (. .)) (SBAR (S (NP (NNS hiPS-CMs)) (VP (VBD were) (VP (VBN seeded) (PP (IN onto) (NP (NNP MEA) (CC and) (NNP FPD))))))))))))))) (VP (VBD was) (VP (VBN measured) (PP (IN for) (NP (NP (JJ 2min) (DT every) (NN 10min)) (PP (IN for) (NP (CD 30min))))) (PP (IN after) (NP (NP (NN drug) (NN exposure)) (PP (IN for) (NP (NP (DT the) (NN vehicle)) (CC and) (NP (DT each) (NN drug) (NN concentration)))))))))))))) (. .)))
24742750	4	(ROOT (S (NP (NNP IKr) (CC and) (NNP IKs)) (VP (VBZ blockers) (NP (NP (NP (JJ concentration-dependently) (VBN prolonged) (VBN corrected) (NN FPD)) (PRN (-LRB- -LRB-) (NP (NNP FPDc)) (-RRB- -RRB-))) (, ,) (SBAR (IN whereas) (S (NP (JJ Doc_24742750_907_913_Chemical) (NN channel)) (VP (VBZ blockers) (NP (JJ concentration-dependently) (NNP shortened) (NNP FPDc))))))) (. .)))
24742750	5	(ROOT (S (ADVP (RB Also)) (, ,) (NP (DT the) (NN multichannel)) (VP (VBZ blockers) (NP (NNS Doc_24742750_1005_1015_Chemical) (, ,) (NNS Doc_24742750_1017_1027_Chemical) (, ,) (NNS Doc_24742750_1029_1040_Chemical) (CC and) (NNS Doc_24742750_1045_1055_Chemical)) (PP (NP (JJ prolonged) (NNP FPDc)) (IN in) (NP (DT a) (NN concentration) (JJ dependent) (NN manner)))) (. .)))
24742750	6	(ROOT (S (ADVP (RB Finally)) (PRN (, ,) (SINV (NP (NP (DT the) (NN IKr) (NNS blockers) (, ,) (NNS Doc_24742750_1135_1146_Chemical) (CC and) (NNS Doc_24742750_1151_1161_Chemical)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN reported) (S (VP (TO to) (VP (VB cause) (NP (NP (NP (NNS Doc_24742750_1191_1209_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24742750_1211_1214_Disease)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ clinical) (NN practice)))))))))))) (, ,) (VP (VBD produced)) (NP (NP (JJ early) (NN afterdepolarization)) (PRN (-LRB- -LRB-) (NP (NNP EAD)) (-RRB- -RRB-))) (. .))) (NP (NP (NNS hiPS-CMs)) (VP (VBG using) (NP (NP (NNP MEA) (NN system)) (CC and) (NP (NNP FPDc))))) (VP (MD can) (VP (VB predict) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN drug) (NNS candidates)))) (PP (IN on) (NP (NNP QT) (NNP interval))))) (. .)))
24742750	7	(ROOT (S (NP (DT This) (NN study)) (ADVP (RB also)) (VP (VBZ shows) (SBAR (IN that) (S (NP (DT this) (NN assay)) (VP (MD can) (VP (VB help) (NP (NP (NNP detect) (NNP EAD)) (PP (IN for) (NP (NNS drugs)))) (PP (IN with) (NP (JJ Doc_24742750_1447_1450_Disease) (NN potential)))))))) (. .)))
24753331	0	(ROOT (NP (NP (JJ Dermal) (JJ developmental) (NNS Doc_24753331_21_29_Disease)) (PP (IN of) (NP (JJ Doc_24753331_33_46_Chemical) (NNS herbicides))) (PP (IN in) (NP (NNS rats))) (. .)))
24753331	1	(ROOT (S (NP (NNS Doc_24753331_79_86_Chemical) (CC and) (NNS Doc_24753331_91_98_Chemical)) (VP (VBP are) (NP (NP (NP (JJ Doc_24753331_103_116_Chemical) (NNS herbicides)) (CC and) (NP (VBN produced) (NN embryolethality))) (, ,) (NP (NP (NN teratogenicity)) (PRN (-LRB- -LRB-) (NP (NP (RB mainly) (NNS Doc_24753331_181_207_Disease)) (CC and) (NP (JJ wavy) (NNS ribs))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNS Doc_24753331_228_246_Disease)) (PP (IN in) (NP (NP (NNS rats)) (PP (IN in) (NP (JJ conventional) (JJ oral) (JJ developmental) (JJ Doc_24753331_290_298_Disease) (NNS studies)))))))) (. .)))
24753331	2	(ROOT (S (NP (NP (PRP$ Our) (NN objective)) (PP (IN in) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (DT the) (NNS compounds)) (VP (VB induce) (NP (NP (JJ developmental) (NNS Doc_24753331_398_406_Disease)) (PP (IN via) (NP (NP (DT the) (JJ dermal) (NN route)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (RBR more) (JJ relevant) (PP (TO to) (NP (JJ occupational) (NN exposure)))) (, ,) (ADVP (RB hence)) (S (ADVP (RB better)) (VP (VBG addressing) (NP (JJ human) (NN health) (NNS risks))))))))))))))))) (. .)))
24753331	3	(ROOT (S (S (NP (NNP Doc_24753331_531_538_Chemical)) (VP (VBD was) (VP (VBN administered) (ADVP (RB dermally)) (PP (TO to) (NP (NNS rats))) (PP (IN at) (NP (NP (CD 30) (, ,) (CD 100) (, ,) (CC and) (CD 300)) (VP (VBG mg/kg) (PP (IN during) (NP (NNS organogenesis))))))))) (, ,) (CC and) (S (NP (NNS Doc_24753331_625_632_Chemical)) (VP (VBD was) (VP (VBN administered) (PP (IN at) (NP (NP (CD 200)) (, ,) (NP (CD 400)) (, ,) (CC and) (NP (NP (CD 800) (NN mg/kg)) (-LRB- -LRB-) (NP (DT the) (JJ maximum) (JJ applicable) (NN dose) (NN level)) (-RRB- -RRB-))))))) (. .)))
24753331	4	(ROOT (S (NP (NNS Fetuses)) (VP (VBD were) (VP (VP (VBN obtained) (PP (IN by) (NP (DT a) (NNP Cesarean) (NN section)))) (CC and) (VP (VBN examined) (PP (IN for) (NP (NP (JJ external)) (, ,) (NP (NNS Doc_24753331_785_819_Disease))))))) (. .)))
24753331	5	(ROOT (S (NP (NP (JJ Dermal) (NN exposure)) (PP (IN of) (NP (NP (NNS rats)) (PP (TO to) (NP (NP (NNS Doc_24753331_857_864_Chemical)) (PP (IN at) (NP (CD 300) (NN mg/kg)))))))) (VP (VBD produced) (NP (NP (NNS patterns)) (PP (IN of) (NP (NP (JJ developmental) (NNS Doc_24753331_913_921_Disease)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBG resulting) (PP (IN from) (NP (JJ oral) (NN exposure))))))))))) (. .)))
24753331	6	(ROOT (S (NP (NNP Doc_24753331_969_977_Disease)) (VP (VBD included) (NP (NN embryolethality) (, ,) (NN teratogenicity) (, ,) (CC and) (NN Doc_24753331_1024_1042_Disease))) (. .)))
24753331	7	(ROOT (S (S (NP (NP (JJ Dermal) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_24753331_1069_1076_Chemical)) (PP (IN at) (NP (CD 800) (NN mg/kg)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (NNS Doc_24753331_1128_1143_Disease) (CC and) (NNS Doc_24753331_1148_1173_Disease))))))) (, ,) (CC but) (S (NP (JJ retarded) (JJ fetal) (NN growth)) (VP (VBD was) (RB not) (ADJP (JJ observed)) (SBAR (IN as) (S (NP (PRP it)) (VP (VBD was) (VP (VBG following) (NP (JJ oral) (NN exposure)) (PP (TO to) (NP (NNS Doc_24753331_1255_1262_Chemical))))))))) (. .)))
24753331	8	(ROOT (S (PP (VBN Based) (PP (IN on) (NP (DT the) (NNS results)))) (, ,) (NP (NNS Doc_24753331_1299_1306_Chemical) (CC and) (NNS Doc_24753331_1311_1318_Chemical)) (VP (VBD were) (ADJP (JJ teratogenic) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (ADVP (RB dermally)) (PP (TO to) (NP (JJ pregnant) (NNS rats))))))) (SBAR (IN as) (S (VP (VBD were) (NP (NP (DT the) (NNS compounds)) (VP (VBN administered) (ADVP (RB orally)))))))) (. .)))
24753331	9	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (NN investigation)) (PP (IN of) (NP (NP (DT the) (NN mechanism)) (CC and) (NP (PRP$ its) (JJ human) (NN relevancy))))) (VP (VBP become) (ADJP (RBR more) (JJ important))) (. .)))
24778426	0	(ROOT (S (NP (NP (NNS Rates)) (PP (IN of) (NP (NP (NNS Doc_24778426_9_23_Disease)) (PP (IN in) (NP (NNP Doc_24778426_27_33_Disease) (NNPS Patients) (NNP Receiving)))))) (VP (VBZ Doc_24778426_53_62_Chemical) (PP (IN With) (CC and) (IN Without) (NP (NNS Doc_24778426_80_88_Chemical)))) (. .)))
24778426	1	(ROOT (S (NP (NNP Doc_24778426_102_111_Chemical)) (VP (VBZ is) (NP (DT a) (ADJP (RB widely) (VBN used)) (NN antineoplastic))) (. .)))
24778426	2	(ROOT (S (NP (NP (CD One)) (PP (IN of) (NP (NP (DT the) (JJ major) (NNS complications)) (PP (IN of) (NP (JJ Doc_24778426_179_188_Chemical) (NN use)))))) (VP (VBZ is) (VP (VBG dose-limiting) (ADVP (RB nephrotoxicity)))) (. .)))
24778426	3	(ROOT (S (NP (EX There)) (VP (VBP are) (NP (JJ many) (NNS strategies) (S (VP (TO to) (VP (VB prevent) (NP (NP (DT this) (NNS Doc_24778426_268_276_Disease)) (, ,) (PP (VBG including) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_24778426_299_307_Chemical)))))) (PP (IN as) (NP (NP (DT a) (NN nephroprotectant)) (PP (IN in) (NP (NN combination))))) (PP (IN with) (NP (NN hydration)))))))) (. .)))
24778426	4	(ROOT (S (NP (PRP We)) (VP (VBD aimed) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NNS rates)) (PP (IN of) (NP (NN Doc_24778426_406_415_Chemical-induced) (NN nephrotoxicity)))) (PP (IN in) (NP (NP (JJ Doc_24778426_442_448_Disease) (NNS patients)) (VP (VBG receiving) (NP (JJ single-agent) (NNS Doc_24778426_481_490_Chemical)) (PP (IN with) (CC and) (IN without) (NP (NNS Doc_24778426_508_516_Chemical)))))))))) (. .)))
24778426	5	(ROOT (S (NP (DT This) (JJ single-center) (NN retrospective) (NN analysis)) (VP (VBD was) (NP (NP (DT a) (JJ quasi) (NN experiment)) (VP (VBN created) (PP (IN by) (NP (DT the) (JJ national) (JJ Doc_24778426_616_624_Chemical) (NN shortage)))))) (. .)))
24778426	6	(ROOT (S (NP (NNP Data)) (VP (VBD were) (VP (VBN collected) (PP (IN on) (NP (JJ adult) (JJ Doc_24778426_664_670_Disease) (NNS patients))) (S (VP (VBG receiving) (NP (JJ single-agent) (NNS Doc_24778426_703_712_Chemical)) (PP (IN as) (NP (NP (DT an) (NN outpatient)) (PP (IN from) (NP (NNP January) (CD 2011))))) (PP (TO to) (NP (NNP September) (CD 2012))))))) (. .)))
24778426	7	(ROOT (S (NP (DT The) (JJ primary) (NN outcome)) (VP (VBD was) (NP (NP (NNS Doc_24778426_791_810_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24778426_812_815_Disease)) (-RRB- -RRB-)))) (. .)))
24778426	8	(ROOT (S (S (NP (PRP We)) (VP (VBN evaluated) (NP (NP (JJ 143) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (JJ single-agent) (NNS Doc_24778426_879_888_Chemical)))))))) (: ;) (S (NP (NP (CD 97.2) (NN %)) (PP (IN of) (NP (NNS patients)))) (VP (VBD had) (NP (NP (NNS Doc_24778426_912_932_Disease)) (PP (IN as) (NP (PRP$ their) (JJ primary) (NN malignancy)))))) (. .)))
24778426	9	(ROOT (S (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBD did) (RB not) (VP (VB receive) (NP (NNS Doc_24778426_991_999_Chemical))))))) (VP (VBD were) (ADJP (RBR more) (JJ likely) (S (VP (TO to) (VP (VB develop) (ADVP (RB nephrotoxicity)))))))) (: :) (S (NP (NNS odds) (NN ratio)) (VP (VBP -LSB-) (S (NP (NNP OR) (NNP -RSB-)) (VP (SYM =) (NP (CD 2.646)))) (PRN (-LRB- -LRB-) (S (NP (CD 95) (NN %)) (VP (VBP CI) (NP (NP (NNP =) (CD 1.008) (, ,) (CD 6.944)) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.048))))))))) (-RRB- -RRB-)))) (. .)))
24778426	10	(ROOT (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (DT the) (NP (CD 100) (NN mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (NN dosing)) (CC and) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS Doc_24778426_1183_1195_Disease))))))))))))) (ADVP (RB also)) (VP (VBD had) (NP (NP (NP (NP (DT a) (JJR higher) (NN likelihood)) (PP (IN of) (S (VP (VBG developing) (ADVP (RB nephrotoxicity)))))) (: :) (NP (NP (NP (NNP OR)) (SBAR (S (VP (SYM =) (NP (CD 11.494)))))) (PRN (-LRB- -LRB-) (NP (CD 95) (NN %)) (NP (NP (NNP CI) (NNP =) (CD 4.149) (, ,) (CD 32.258)) (: ;) (NP (NNP P) (NNP <) (NNP 0.0001))) (-RRB- -RRB-))) (CC and) (NP (NP (NNP OR)) (SBAR (S (VP (SYM =) (NP (CD 3.219))))))) (PRN (-LRB- -LRB-) (NP (CD 95) (NN %)) (NP (NP (NNP CI) (NNP =) (CD 1.228) (, ,) (CD 8.439)) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.017))))))) (-RRB- -RRB-))) (, ,) (ADVP (RB respectively))) (. .)))
24778426	11	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (NP (JJ limited) (NNS quantities)) (PP (IN of) (NP (NNS Doc_24778426_1409_1417_Chemical)))) (VP (VBP are) (ADJP (JJ available))))) (, ,) (NP (PRP it)) (VP (MD should) (ADVP (RB preferentially)) (VP (VB be) (VP (VBN given) (PP (TO to) (NP (NP (NNS patients)) (PP (IN at) (NP (NP (ADJP (RB particularly) (JJ high)) (NN risk)) (PP (IN of) (NP (NN nephrotoxicity)))))))))) (. .)))
24778426	12	(ROOT (S (NP (PRP$ Our) (NN analysis)) (VP (VP (VBZ suggests) (SBAR (IN that) (S (S (NP (DT those) (NNS patients)) (VP (VBG receiving) (S (NP (NP (DT the) (JJ dosing) (NN schedule)) (PP (IN of) (NP (NP (CD 100) (NN mg/m)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))))) (NP (NNS Doc_24778426_1611_1620_Chemical))) (NP (QP (DT every) (CD 3)) (NNS weeks)))) (CC and) (S (NP (NP (DT those)) (PP (IN with) (NP (NNS Doc_24778426_1650_1662_Disease)))) (VP (VBP are) (PP (IN at) (NP (NP (DT the) (JJS greatest) (NN risk)) (PP (IN of) (NP (NN nephrotoxicity)))))))))) (CC and) (VP (MD would) (VP (VB benefit) (PP (IN from) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NNS Doc_24778426_1745_1753_Chemical)))))))) (. .)))
24802403	0	(ROOT (S (NP (NNP Doc_24802403_0_9_Chemical)) (VP (VBZ protects) (PP (IN against) (NP (NP (JJ Doc_24802403_27_35_Disease) (, ,) (NN learning) (CC and) (NNS Doc_24802403_50_68_Disease) (CC and) (NN oxidative) (NN damage)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_24802403_101_119_Chemical-induced)) (VP (VBG kindling) (PP (IN in) (NP (NNS mice)))))))))) (. .)))
24802403	1	(ROOT (S (NP (NP (NNP Doc_24802403_146_166_Disease)) (, ,) (NP (NP (DT the) (ADJP (RBS most) (JJ common) (CC and) (JJ severe)) (NN comorbidity)) (PP (IN of) (NP (NNS Doc_24802403_210_218_Disease)))) (, ,)) (ADVP (RB greatly)) (VP (VBZ diminishes) (NP (NP (DT the) (NN quality)) (PP (IN of) (NP (NN life))))) (. .)))
24802403	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (JJ current) (JJ therapeutic) (NNS interventions)) (PP (IN for) (NP (NNS Doc_24802403_307_315_Disease)))) (VP (MD can) (ADVP (RB also)) (VP (VB cause) (NP (JJ untoward) (NN cognitive) (NNS effects)))) (. .)))
24802403	3	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT an) (JJ urgent) (NN need)) (PP (IN for) (NP (NP (JJ new) (NNS kinds)) (PP (IN of) (NP (NP (NNS agents)) (VP (VBG targeting) (NP (CC both) (NNS Doc_24802403_428_436_Disease) (CC and) (NNS Doc_24802403_441_459_Disease))))))))) (. .)))
24802403	4	(ROOT (S (S (NP (JJ Oxidative) (NN stress)) (VP (VBZ is) (VP (VBN considered) (S (VP (TO to) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NNS epileptogenesis) (CC and) (NNS Doc_24802403_541_559_Disease))))))))) (, ,) (CC and) (S (NP (NNS antioxidants)) (VP (VBP have) (NP (DT a) (JJ putative) (JJ antiepileptic) (NN potential)))) (. .)))
24802403	5	(ROOT (S (NP (NP (NNP Doc_24802403_619_628_Chemical)) (, ,) (NP (DT the) (ADJP (RBS most) (RB commonly) (JJ prescribed)) (JJ antidiabetic) (JJ oral) (NN drug)) (, ,)) (VP (VBZ has) (NP (JJ antioxidant) (NNS properties))) (. .)))
24802403	6	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (JJ ameliorative) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_24802403_775_784_Chemical)) (PP (IN on) (NP (NNS Doc_24802403_788_796_Disease) (, ,) (NNS Doc_24802403_798_818_Disease) (CC and) (NN brain) (NN oxidative) (NN stress) (NNS markers))) (VP (VBN observed) (PP (IN in) (NP (NN Doc_24802403_866_884_Chemical-induced) (NN kindling) (NNS animals)))))))))))) (. .)))
24802403	7	(ROOT (S (NP (JJ Male) (NN C57BL/6) (NNS mice)) (VP (VBD were) (VP (VBN administered) (PP (IN with) (NP (NP (JJ subconvulsive) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_24802403_974_992_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 37) (NN mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-)) (NP (DT every) (JJ other) (NN day)))))) (PP (IN for) (NP (CD 14) (NNS injections))))) (. .)))
24802403	8	(ROOT (S (NP (NNP Doc_24802403_1045_1054_Chemical)) (VP (VBD was) (VP (VBN injected) (ADVP (RB intraperitoneally)) (PP (IN in) (NP (NP (NN dose)) (PP (IN of) (NP (NP (NNS 200mg/kg)) (ADVP (IN along) (PP (IN with) (NP (JJ alternate-day) (NNS Doc_24802403_1131_1134_Chemical)))))))))) (. .)))
24802403	9	(ROOT (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NNS Doc_24802403_1150_1159_Chemical)) (VP (VP (VBD suppressed) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (NN kindling))))) (, ,) (VP (VBD ameliorated) (NP (DT the) (NNS Doc_24802403_1216_1236_Disease))) (CC and) (VP (VBD decreased) (NP (NN brain) (NN oxidative) (NN stress))))))) (. .)))
24802403	10	(ROOT (S (ADVP (RB Thus)) (NP (DT the) (JJ present) (NN study)) (VP (VBD concluded) (SBAR (IN that) (S (NP (NNS Doc_24802403_1313_1322_Chemical)) (VP (MD may) (VP (VB be) (NP (NP (DT a) (JJ potential) (NN agent)) (PP (IN for) (NP (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_24802403_1369_1377_Disease)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT a) (JJ protective) (NN medicine)) (PP (IN against) (NP (NP (NNS Doc_24802403_1419_1439_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_24802403_1451_1459_Disease))))))))))))))) (. .)))
24812279	0	(ROOT (S (NP (NNP P53) (NNP inhibition)) (VP (VBZ exacerbates) (NP (JJ late-stage) (JJ Doc_24812279_38_51_Chemical) (NNS Doc_24812279_52_66_Disease))) (. .)))
24812279	1	(ROOT (S (NP (NP (NNP Doc_24812279_74_85_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24812279_87_90_Chemical)) (-RRB- -RRB-))) (VP (VP (VBZ is) (NP (DT an) (ADJP (JJ effective) (JJ anti-Doc_24812279_113_119_Disease)) (NN therapeutic))) (, ,) (CC but) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (ADJP (DT both) (JJ acute) (CC and) (JJ late-stage)) (NNS Doc_24812279_182_196_Disease)))))) (. .)))
24812279	2	(ROOT (S (NP (NNP Children)) (VP (VBP are) (ADJP (RB particularly) (JJ sensitive) (PP (TO to) (NP (NN Doc_24812279_237_240_Chemical-induced) (NNS Doc_24812279_249_262_Disease))))) (. .)))
24812279	3	(ROOT (S (ADVP (RB Here)) (, ,) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NP (NN p53) (NN inhibition)) (PP (IN on) (ADJP (JJ acute))) (PP (IN vs.) (NP (JJ late-stage) (JJ Doc_24812279_323_326_Chemical) (NNS Doc_24812279_327_341_Disease)))))) (VP (VBD was) (VP (VBN examined) (PP (IN in) (NP (DT a) (JJ juvenile) (NN model))))) (. .)))
24812279	4	(ROOT (NP (NP (NNP METHODS) (CC AND) (NNP RESULTS)) (: :) (NP (NP (NP (JJ Two-week-old) (NN MHC-CB7) (NNS mice)) (PRN (-LRB- -LRB-) (SBAR (WHNP (WDT which)) (S (VP (VBP express) (NP (NP (JJ dominant-interfering) (NN p53)) (PP (IN in) (NP (NNS cardiomyocytes))))))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (PRP$ their) (JJ non-transgenic) (-LRB- -LRB-) (JJ Doc_24812279_508_515_Chemical) (-RRB- -RRB-) (NNS littermates)) (VP (VBN received) (NP (NP (JJ weekly) (JJ Doc_24812279_545_548_Chemical) (NNS injections)) (PP (IN for) (NP (CD 5) (NNS weeks)))))) (-LRB- -LRB-) (NP (CD 25) (JJ mg/kg) (JJ cumulative) (NN dose)) (-RRB- -RRB-))) (. .)))
24812279	5	(ROOT (S (PP (NP (CD One) (NN week)) (IN after) (NP (NP (DT the) (JJ last) (JJ Doc_24812279_624_627_Chemical) (NN treatment)) (PRN (-LRB- -LRB-) (NP (JJ acute) (NN stage)) (-RRB- -RRB-)))) (, ,) (NP (NN MHC-CB7) (NNS mice)) (VP (VBD exhibited) (NP (NP (VBN improved) (JJ cardiac) (NN function)) (CC and) (NP (NP (JJR lower) (NNS levels)) (PP (IN of) (NP (JJ cardiomyocyte) (NNS apoptosis))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (DT the) (JJ NON-TXG) (NNS mice))))))) (. .)))
24812279	6	(ROOT (S (S (ADVP (RB Surprisingly)) (, ,) (PP (IN by) (NP (NP (CD 13) (NNS weeks)) (PP (VBG following) (NP (NP (DT the) (JJ last) (JJ Doc_24812279_828_831_Chemical) (NN treatment)) (PRN (-LRB- -LRB-) (NP (JJ late) (NN stage)) (-RRB- -RRB-)))))) (, ,) (NP (NNP MHC-CB7)) (VP (VBD exhibited) (NP (NP (NP (DT a) (JJ progressive) (NN decrease)) (PP (IN in) (NP (JJ cardiac) (NN function)))) (CC and) (NP (NP (JJR higher) (NNS rates)) (PP (IN of) (NP (JJ cardiomyocyte) (NNS apoptosis))))) (SBAR (WHADVP (WRB when)) (FRAG (PP (VBN compared) (PP (IN with) (NP (JJ NON-TXG) (NNS mice)))) (. .))))) (NP (NN p53) (NN inhibition)) (VP (VBD blocked) (NP (NP (JJ transient) (NN Doc_24812279_1027_1030_Chemical-induced) (NN STAT3) (NN activation)) (PP (IN in) (NP (NP (NN MHC-CB7) (NNS mice)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (JJ enhanced) (NN induction)) (PP (IN of) (NP (NP (DT the) (NNP DNA) (NN repair) (NNS proteins) (NN Ku70)) (CC and) (NP (NNS Ku80)))))))))))))) (. .)))
24812279	7	(ROOT (S (NP (NP (NNS Mice)) (PP (IN with) (NP (NP (JJ cardiomyocyte-restricted) (NN deletion)) (PP (IN of) (NP (NNP STAT3)))))) (VP (VBD exhibited) (NP (NP (JJR worse) (JJ cardiac) (NN function)) (, ,) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (JJ cardiomyocyte) (NNS apoptosis)))) (, ,) (CC and) (NP (NP (DT a) (JJR greater) (NN induction)) (PP (IN of) (NP (NP (NNS Ku70) (CC and) (NNS Ku80)) (PP (IN in) (NP (NN response))))))) (PP (TO to) (NP (JJ Doc_24812279_1345_1348_Chemical) (NN treatment))) (PP (IN during) (NP (DT the) (JJ acute) (NN stage))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (NN control) (NNS animals))))))) (. .)))
24812279	8	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP support) (NP (NP (DT a) (NN model)) (SBAR (WHADVP (WRB wherein)) (S (NP (NP (DT a) (JJ p53-dependent) (NN cardioprotective) (NN pathway)) (, ,) (VP (VBN mediated) (PP (IN via) (NP (NN STAT3) (NN activation)))) (, ,)) (VP (VBZ mitigates) (NP (ADJP (JJ Doc_24812279_1548_1551_Chemical-induced) (JJ myocardial)) (NN stress)) (PP (IN during) (NP (NN drug) (NN delivery)))))))) (. .)))
24812279	9	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (DT these) (NNS data)) (VP (VBP suggest) (NP (NP (DT an) (NN explanation)) (PP (IN as) (TO to) (SBAR (WHADVP (WRB how)) (S (NP (NN p53) (NN inhibition)) (VP (MD can) (VP (VB result) (PP (IN in) (NP (NN cardioprotection))) (PP (PP (IN during) (NP (NN drug) (NN treatment))) (CC and) (, ,) (ADVP (RB paradoxically)) (, ,) (ADVP (NP (JJ enhanced) (NNS Doc_24812279_1754_1768_Disease)) (RB long)) (PP (IN after) (NP (NP (DT the) (NN cessation)) (PP (IN of) (NP (NN drug) (NN treatment))))))))))))) (. .)))
24816962	0	(ROOT (NP (NP (JJ Doc_24816962_0_13_Chemical-induced) (NNS Doc_24816962_22_36_Disease)) (: :) (NP (DT an) (JJ uncommon) (NN scenario)) (. .)))
24816962	1	(ROOT (S (NP (NNP Doc_24816962_60_73_Chemical)) (VP (MD can) (VP (VB produce) (NP (JJ neurological) (NNS complications)) (SBAR (IN although) (S (NP (PRP it)) (VP (VBZ is) (RB not) (NP (DT a) (JJ common) (NN scenario))))))) (. .)))
24816962	2	(ROOT (S (NP (PRP We)) (VP (VBP present) (NP (NP (DT a) (NN case)) (SBAR (WHADVP (WRB where)) (S (NP (DT a) (NN patient)) (VP (VBD developed) (NP (NP (NNS features)) (PP (IN of) (NP (NP (NNS Doc_24816962_207_221_Disease)) (PP (VBG following) (NP (VBN prolonged) (NNS Doc_24816962_242_255_Chemical) (NN intake))))))))))) (. .)))
24816962	3	(ROOT (S (NP (JJ Magnetic) (NN resonance) (NN imaging)) (PRN (-LRB- -LRB-) (NP (NNP MRI)) (-RRB- -RRB-)) (NP (NN brain)) (VP (VBD showed) (NP (NP (JJ abnormal) (NN signal) (NN intensity)) (PP (VBG involving) (NP (NP (DT both) (JJ dentate) (NN nuclei)) (PP (IN of) (NP (NP (NN cerebellum) (CC and) (NN splenium)) (PP (IN of) (NP (NN corpus) (NN callosum))))))))) (. .)))
24816962	4	(ROOT (S (NP (NP (DT The) (NN diagnosis)) (PP (IN of) (NP (JJ Doc_24816962_430_443_Chemical) (NN toxicity)))) (VP (VBD was) (VP (VP (VBN made) (PP (IN by) (NP (DT the) (NNP MRI) (NNS findings)))) (CC and) (VP (VBN supported) (S (ADJP (JJ clinically)))))) (. .)))
24840785	0	(ROOT (S (NP (JJ Doc_24840785_0_9_Chemical-induced) (JJ Doc_24840785_18_22_Chemical) (NN overload)) (VP (VP (VBZ causes) (NP (NNS Doc_24840785_39_49_Disease))) (CC and) (VP (VBZ triggers) (NP (NNS apoptosis)) (PP (IN through) (NP (NP (JJ p38) (NN MAPK)) (VP (VBG signaling) (ADVP (RB pathway)) (PP (IN in) (NP (NNS rats)))))))) (. .)))
24840785	1	(ROOT (S (NP (NNP Doc_24840785_117_126_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ major) (JJ bioactive) (NNS Doc_24840785_148_168_Chemical)) (PP (IN with) (NP (NP (JJ high) (NN content)) (VP (VBN derived) (PP (IN from) (NP (JJ herbal) (NN aconitum) (NNS plants)))))))) (. .)))
24840785	2	(ROOT (S (NP (VBG Emerging) (NN evidence)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (JJ voltage-dependent) (JJ Doc_24840785_275_280_Chemical) (NNS channels)) (VP (VBP have) (NP (NP (JJ pivotal) (NNS roles)) (PP (IN in) (NP (NP (DT the) (NNS Doc_24840785_316_330_Disease)) (PP (IN of) (NP (NNS Doc_24840785_334_343_Chemical)))))))))) (. .)))
24840785	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT no) (NNS reports)) (VP (VBP are) (ADJP (JJ available) (PP (IN on) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (NNS Doc_24840785_394_400_Chemical)) (PP (IN in) (NP (JJ Doc_24840785_404_413_Chemical) (NNS Doc_24840785_414_423_Disease))))))))) (. .)))
24840785	4	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD explored) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NP (JJ pathological) (NNS Doc_24840785_483_489_Chemical)) (VP (VBG signaling) (PP (IN in) (NP (JJ Doc_24840785_503_512_Chemical) (NNS Doc_24840785_513_522_Disease))) (PP (IN in) (UCP (ADJP (NN vitro)) (CC and) (PP (IN in) (NP (NN vivo)))))))))) (. .)))
24840785	5	(ROOT (S (NP (PRP We)) (VP (VP (VBD found) (NP (DT that) (JJ Doc_24840785_559_565_Chemical) (NN overload) (NN lead)) (PP (TO to) (NP (NP (JJ accelerated) (VBG beating) (NN rhythm)) (PP (IN in) (NP (JJ adult) (NN rat) (NN ventricular) (NNS myocytes)))))) (CC and) (VP (VBD caused) (NP (NNS Doc_24840785_655_665_Disease)) (PP (IN in) (NP (JJ conscious) (ADJP (RB freely) (JJ moving)) (NNS rats))))) (. .)))
24840785	6	(ROOT (S (S (VP (TO To) (VP (VB investigate) (NP (NP (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_24840785_725_734_Chemical)) (PP (IN on) (NP (NNS Doc_24840785_738_755_Disease))))))))) (, ,) (NP (PRP we)) (VP (VBD performed) (NP (JJ Doc_24840785_770_782_Disease) (NN assay)) (PP (IN in) (NP (NP (NP (JJ neonatal) (NN rat) (NN ventricular) (NNS myocytes)) (PRN (-LRB- -LRB-) (NP (NNP NRVMs)) (-RRB- -RRB-))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ measured) (JJ Doc_24840785_855_862_Chemical) (NN dehydrogenase) (NN level)) (PP (IN in) (NP (NP (DT the) (NN culture) (NN medium)) (PP (IN of) (NP (NP (NNS NRVMs) (CC and) (NNS activities)) (PP (IN of) (NP (JJ serum) (JJ cardiac) (NNS enzymes)))))))))) (PP (IN in) (NP (NNS rats)))) (. .)))
24840785	7	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (NNS Doc_24840785_987_996_Chemical)) (VP (VBD resulted) (PP (IN in) (NP (NP (NNS Doc_24840785_1009_1026_Disease)) (CC and) (NP (VBN reduced) (NNP NRVMs) (NN viability) (NN dose-dependently)))))))) (. .)))
24840785	8	(ROOT (S (S (VP (TO To) (VP (VB confirm) (NP (DT the) (JJ pro-apoptotic) (NNS effects))))) (, ,) (NP (PRP we)) (VP (VBD performed) (NP (NP (NN flow) (JJ cytometric) (NN detection)) (, ,) (NP (JJ cardiac) (NN histology)) (, ,) (NP (NN transmission) (NN electron) (NN microscopy)) (CC and) (NP (NN terminal) (JJ deoxynucleotidyl) (JJ transferase-mediated) (NN Doc_24840785_1254_1258_Chemical-Doc_24840785_1259_1265_Chemical) (NN nick) (NN end))) (S (VP (VBG labeling) (ADVP (RB assay))))) (. .)))
24840785	9	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (NNP Doc_24840785_1315_1324_Chemical) (NNP stimulated)) (VP (VBZ apoptosis) (ADJP (JJ time-dependently)))))) (. .)))
24840785	10	(ROOT (S (NP (NP (DT The) (NN expression) (NN analysis)) (PP (IN of) (NP (JJ Doc_24840785_1391_1397_Chemical) (NN handling) (NNS proteins)))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NNS Doc_24840785_1434_1443_Chemical)) (VP (VBD promoted) (NP (JJ Doc_24840785_1453_1459_Chemical) (NN overload)) (PP (IN through) (NP (NP (DT the) (NN expression) (NN regulation)) (PP (IN of) (NP (JJ Doc_24840785_1506_1512_Chemical) (NN handling) (NNS proteins))))))))) (. .)))
24840785	11	(ROOT (S (S (NP (NP (DT The) (NN expression) (NN analysis)) (PP (IN of) (NP (JJ apoptosis-related) (NNS proteins)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (JJ pro-apoptotic) (NN protein) (NN expression)) (VP (VBD was) (VP (VBN upregulated))))))) (, ,) (CC and) (S (NP (JJ anti-apoptotic) (NN protein) (NN BCL-2) (NN expression)) (VP (VBD was) (VP (VBN downregulated)))) (. .)))
24840785	12	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (VBN increased) (NN phosphorylation)) (PP (IN of) (NP (NP (NN MAPK) (NN family) (NNS members)) (, ,) (RB especially) (NP (DT the) (NNP P-P38) (NNP /) (NNP P38) (NN ratio))))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (JJ cardiac) (NNS tissues))))) (. .)))
24840785	13	(ROOT (S (ADVP (RB Hence)) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_24840785_1869_1878_Chemical)) (VP (VP (ADVP (RB significantly)) (VBZ aggravates) (NP (JJ Doc_24840785_1904_1910_Chemical) (NN overload) (CC and) (NNS causes) (NNS Doc_24840785_1931_1941_Disease))) (CC and) (VP (ADVP (RB finally)) (VBZ promotes) (NP (NP (JJ apoptotic) (NN development)) (PP (IN via) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NNP P38) (JJ mitogen-activated) (NN protein) (NN kinase))))))))))) (. .)))
24842192	0	(ROOT (S (NP (NP (JJ Chronic) (NN treatment)) (PP (IN with) (NP (NNS Doc_24842192_23_32_Chemical)))) (VP (VP (VBZ suppresses) (NP (JJ toll-like) (NN receptor) (CD 4) (NNS signaling))) (CC and) (VP (VBZ attenuates) (NP (JJ Doc_24842192_90_118_Disease) (VBG following) (NNS Doc_24842192_129_150_Disease)))) (. .)))
24842192	1	(ROOT (S (NP (NP (JJ Acute) (NN treatment)) (PP (IN with) (NP (NNS Doc_24842192_173_182_Chemical)))) (VP (VBZ has) (NP (NP (DT a) (JJ protective) (NN effect)) (PP (IN in) (NP (NNS Doc_24842192_210_231_Disease)))) (PP (IN by) (NP (NP (NN suppression)) (PP (IN of) (NP (NP (NP (JJ Doc_24842192_250_262_Disease) (NNS responses)) (ADJP (JJ due) (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (NN Doc_24842192_294_297_Chemical-activated) (NN protein) (NN kinase))))))) (PRN (-LRB- -LRB-) (NP (NNP AMPK)) (-RRB- -RRB-))))))) (. .)))
24842192	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (JJ chronic) (ADJP (JJ pre-treatment) (PP (IN with) (NP (NP (NP (NNS Doc_24842192_394_403_Chemical)) (PP (IN on) (NP (NNS Doc_24842192_407_426_Disease)))) (CC and) (NP (NP (JJ toll-like) (NN receptor)) (NP (NP (CD 4)) (PRN (-LRB- -LRB-) (NP (NNP TLR4)) (-RRB- -RRB-))))))) (NNS activities)) (PP (VBG following) (NP (NP (NNS Doc_24842192_480_501_Disease)) (CC and) (NP (NP (PRP$ their) (NN relation)) (PP (IN with) (NP (NNP AMPK))))))))) (VP (VBD were) (VP (VBN assessed))) (. .)))
24842192	3	(ROOT (S (S (NP (NNP Male) (NNP Wistar) (NNS rats)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN assigned) (PP (TO to) (NP (NP (CD one)) (PP (IN of) (NP (NP (CD 5) (NNS groups)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 6))))) (-RRB- -RRB-))))))))) (: :) (S (NP (JJ normal) (NN control) (CC and) (NNS groups)) (VP (VBD were) (VP (VBN injected) (NP (NNS Doc_24842192_652_665_Chemical)) (PP (IN after) (NP (JJ chronic) (NN pre-treatment))) (PP (IN with) (NP (CD 0))) (, ,) (NP (NP (CD 25) (, ,) (CD 50) (, ,) (CC or) (CD 100mg/kg)) (PP (IN of) (NP (NNS Doc_24842192_725_734_Chemical) (RB twice) (RB daily) (IN for) (CD 14) (NNS days))))))) (. .)))
24842192	4	(ROOT (S (NP (NP (NNP Doc_24842192_760_773_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP 100mg/kg)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN injected) (ADVP (RB subcutaneously)) (PP (IN on) (NP (NP (DT the) (NN 13th)) (CC and) (NP (JJ 14th) (NNS days)))) (S (VP (TO to) (VP (VB induce) (NP (NNS Doc_24842192_849_876_Disease))))))) (. .)))
24842192	5	(ROOT (S (NP (NNP Doc_24842192_878_891_Chemical)) (ADVP (RB alone)) (VP (VBD decreased) (RB left) (VP (VB ventricular) (NP (NP (JJ systolic) (NN pressure) (CC and) (NN myocardial) (NN contractility)) (VP (VBN indexed) (PP (IN as) (NP (NNP LVdp/dtmax) (CC and) (NNP LVdp/dtmin))))))) (. .)))
24842192	6	(ROOT (S (NP (DT The) (NNS Doc_24842192_1014_1042_Disease)) (VP (VBD was) (ADJP (RB significantly) (JJR lower)) (PP (IN in) (NP (NP (DT the) (NNS groups)) (VP (VBN treated) (PP (IN with) (NP (NP (CD 25) (CC and) (CD 50mg/kg)) (PP (IN of) (NP (NNS Doc_24842192_1112_1121_Chemical))))))))) (. .)))
24842192	7	(ROOT (SINV (S (NP (NNP Doc_24842192_1123_1132_Chemical) (NNP markedly)) (VP (VBD lowered) (NP (NN Doc_24842192_1150_1163_Chemical-induced) (NN elevation)) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NNP TLR4) (NNP mRNA))))))) (, ,) (VP (VBD myeloid) (NP (NN differentiation) (NN protein))) (NP (NP (CD 88)) (PRN (-LRB- -LRB-) (NP (NNP MyD88)) (-RRB- -RRB-)) (, ,) (NP (NP (NP (JJ Doc_24842192_1254_1259_Disease) (JJ Doc_24842192_1260_1268_Disease) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NNP TNF-a)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (NN interleukin) (CD 6)) (PRN (-LRB- -LRB-) (NP (NNP IL-6)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (NN heart) (NNS tissues)))))) (. .)))
24842192	8	(ROOT (S (NP (JJ Similar) (NNS changes)) (VP (VBD were) (ADVP (RB also)) (VP (VBN seen) (PP (IN in) (NP (NP (DT the) (NN serum) (NNS levels)) (PP (IN of) (NP (NNP TNF-a) (CC and) (NNP IL-6))))))) (. .)))
24842192	9	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJR lower) (NNS doses)) (PP (IN of) (NP (CD 25) (CC and) (CD 50mg/kg)))) (VP (VBD were) (ADJP (RBR more) (JJ effective)) (PP (IN than) (NP (CD 100mg/kg)))) (. .)))
24842192	10	(ROOT (S (NP (NP (NP (NNP Phosphorylated) (NNP AMPKa)) (PRN (-LRB- -LRB-) (ADJP (JJ p-AMPK)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (NN myocardium)))) (VP (VBD was) (ADJP (RB significantly) (JJ elevated) (PP (PP (IN by) (NP (NP (NNS 25mg/kg)) (PP (IN of) (NP (NP (NNS Doc_24842192_1575_1584_Chemical)) (, ,) (ADVP (RB slightly) (PP (IN by) (NP (CD 50mg/kg)))))))) (, ,) (CC but) (RB not) (PP (IN by) (NP (CD 100mg/kg)))))) (. .)))
24842192	11	(ROOT (S (NP (NP (JJ Chronic) (NN pre-treatment)) (PP (IN with) (NP (NNS Doc_24842192_1655_1664_Chemical)))) (VP (VBZ reduces) (NP (ADJP (JJ post-Doc_24842192_1678_1719_Disease) (CC and) (JJ suppresses)) (JJ Doc_24842192_1735_1747_Disease) (NNS responses)) (, ,) (ADVP (RB possibly)) (PP (IN through) (NP (NP (NN inhibition)) (PP (IN of) (NP (CD TLR4) (NNS activities)))))) (. .)))
24842192	12	(ROOT (S (NP (DT This) (NN mechanism)) (VP (MD can) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (DT a) (NN target))) (S (VP (TO to) (VP (VB protect) (NP (JJ infarcted) (NN myocardium)))))))) (. .)))
2484903	0	(ROOT (NP (NP (NP (JJ Unusual) (NNS complications)) (PP (IN of) (NP (JJ antithyroid) (NN drug) (NN therapy)))) (: :) (NP (NP (CD four) (NN case) (NNS reports) (CC and) (NN review)) (PP (IN of) (NP (NN literature)))) (. .)))
2484903	1	(ROOT (S (NP (NP (NP (CD Two) (NNS cases)) (PP (IN of) (NP (ADJP (JJ Doc_2484903_108_124_Chemical-associated) (JJ acute)) (NNS Doc_2484903_142_151_Disease)))) (, ,) (NP (NP (CD one) (NN case)) (PP (IN of) (NP (ADJP (JJ fatal) (JJ Doc_2484903_171_182_Chemical-associated)) (NN hepatocellular) (NNS Doc_2484903_209_217_Disease)))) (CC and) (NP (NP (CD one) (NN case)) (PP (IN of) (NP (NN Doc_2484903_234_250_Chemical-associated) (NNS Doc_2484903_262_281_Disease))))) (VP (VBP are) (VP (VBN described))) (. .)))
2484903	2	(ROOT (S (NP (NP (DT The) (NN literature)) (VP (VBN related) (PP (TO to) (NP (NP (JJ antithyroid) (NN drug) (NN side) (NNS effects)) (CC and) (NP (DT the) (NNS mechanisms)))) (PP (IN for) (NP (PRP$ their) (NN occurrence))))) (VP (VBP are) (VP (VP (VBN reviewed)) (CC and) (VP (NP (NP (DT the) (NN efficacy) (CC and) (NNS complications)) (PP (IN of) (NP (NN thyroidectomy) (CC and) (NNS Doc_2484903_462_473_Chemical)))) (PP (VBN compared) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (JJ antithyroid) (NNS drugs))))))))) (. .)))
2484903	3	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (PP (IN in) (NP (JJS most) (NNS circumstances))) (NP (CD 131I)) (VP (VBZ is) (NP (NP (DT the) (NN therapy)) (PP (IN of) (NP (NP (NN choice)) (PP (IN for) (NP (NNS Doc_2484903_591_606_Disease))))))))))) (. .)))
24881749	0	(ROOT (S (NP (NNP Doc_24881749_0_30_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NN combination) (NN therapy)) (PP (IN with) (NP (NNS Doc_24881749_67_80_Chemical) (CC and) (NNS Doc_24881749_85_93_Chemical))))) (PP (IN in) (NP (NP (DT a) (JJ Japanese) (NN patient)) (PP (IN with) (NP (NNS Doc_24881749_121_141_Disease))))) (PP (IN at) (NP (NP (DT the) (NN terminal) (NN stage)) (PP (IN of) (NP (JJ recurrent) (NNS Doc_24881749_177_190_Disease)))))) (. .)))
24881749	1	(ROOT (S (NP (PRP We)) (VP (VBP herein) (VP (VB describe) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT an) (JJ 81-year-old) (JJ Japanese) (NN woman)))) (PP (IN with) (NP (NP (NNS Doc_24881749_258_288_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD occurred) (NP (CD 36) (NNS days)) (PP (IN after) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NP (NN combination) (NN therapy)) (PP (IN with) (NP (NP (NNS Doc_24881749_360_368_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 75) (NN mg/day)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_24881749_385_398_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 12.5) (NN mg/day)) (-RRB- -RRB-)))))))) (PP (IN for) (NP (NNS Doc_24881749_417_437_Disease)))))))))) (. .)))
24881749	2	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (VP (VBN been) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_24881749_473_481_Chemical) (CC or) (NNS Doc_24881749_485_498_Chemical))) (PP (ADVP (RB alone)) (IN without) (NP (DT any) (JJ adverse) (NNS effects))) (PP (IN before) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (DT the) (NN combination) (NN therapy)))))))) (. .)))
24881749	3	(ROOT (S (NP (PRP She)) (ADVP (RB also)) (VP (VBD had) (NP (JJ advanced) (NNS Doc_24881749_609_622_Disease)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN combination) (NN therapy)) (VP (VBD was) (VP (VBN initiated)))))) (. .)))
24881749	4	(ROOT (S (PP (TO To) (NP (NP (DT the) (JJS best)) (PP (IN of) (NP (PRP$ our) (NN knowledge))))) (, ,) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (NNS Doc_24881749_715_745_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NP (NN combination) (NN therapy)) (PP (IN with) (NP (NNS Doc_24881749_778_791_Chemical) (CC and) (NNS Doc_24881749_796_804_Chemical))))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (ADVP (RB previously)) (VBN reported)))) (. .)))
24881749	5	(ROOT (S (NP (NNP Doc_24881749_839_852_Chemical)) (VP (MD should) (VP (VB be) (VP (VBN administered) (ADVP (ADVP (RB very) (RB carefully)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (JJ neuroleptic) (NNS drugs)))) (, ,) (ADVP (RB particularly)))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (DT a) (VBG worsening) (JJ general) (NN condition)))))))) (. .)))
24894748	0	(ROOT (S (NP (DT A) (NN Doc_24894748_2_12_Chemical-Doc_24894748_13_24_Chemical) (NN combination)) (VP (VBN induced) (NP (NNS Doc_24894748_45_56_Disease))) (. .)))
24894748	1	(ROOT (S (S (VP (TO To) (VP (VB report) (NP (DT a) (JJ sinus) (NNS Doc_24894748_76_87_Disease))))) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_24894748_99_109_Chemical)) (CC and) (NP (NP (JJ Doc_24894748_114_125_Chemical) (JJ drug-drug) (NN interaction)) (CC and) (NP (PRP$ its) (NN management)))))) (. .)))
24894748	2	(ROOT (S (NP (NP (DT A) (ADJP (CD 63) (JJ year-old)) (NNP Caucasian) (NN man)) (PP (IN on) (NP (NP (QP (CD Doc_24894748_199_209_Chemical) (CD 200)) (NN mg/day)) (PP (IN for) (NP (JJ stable) (NNS Doc_24894748_232_255_Disease)))))) (VP (VBD was) (VP (VBN prescribed) (NP (NP (DT a) (JJ 90-day) (NN course)) (PP (IN of) (NP (NP (JJ oral) (JJ Doc_24894748_295_306_Chemical) (CD 250) (NN mg/day)) (PP (IN for) (NP (NNS Doc_24894748_322_335_Disease)))))))) (. .)))
24894748	3	(ROOT (S (PP (IN On) (NP (NP (DT the) (JJ 49th) (NN day)) (PP (IN of) (NP (JJ Doc_24894748_356_367_Chemical) (NN therapy))))) (, ,) (NP (PRP he)) (VP (VP (VBD was) (VP (VBN brought) (PP (TO to) (NP (NP (DT the) (NN emergency) (NN room)) (PP (IN for) (NP (NP (DT a) (NN decrease)) (PP (IN of) (NP (NP (PRP$ his) (JJ global) (NN health) (NN status)) (, ,) (NP (NNS Doc_24894748_458_467_Disease)))))))))) (CC and) (VP (VBZ falls))) (. .)))
24894748	4	(ROOT (S (NP (DT The) (NN electrocardiogram)) (VP (VBD revealed) (NP (DT a) (CD 37) (NN beats/min) (NN sinus) (NNS Doc_24894748_531_542_Disease))) (. .)))
24894748	5	(ROOT (S (NP (NP (DT A) (NN score)) (PP (IN of) (NP (NP (CD 7)) (PP (IN on) (NP (DT the) (NNP Naranjo) (NNP Doc_24894748_572_593_Disease) (NN probability) (NN scale)))))) (VP (VBZ indicates) (NP (NP (NP (DT a) (JJ probable) (NN relationship)) (PP (IN between) (NP (NP (DT the) (NN patient) (POS 's)) (JJ sinus) (NNS Doc_24894748_674_685_Disease)))) (CC and) (NP (NP (DT the) (NN drug) (NN interaction)) (PP (IN between) (NP (NNS Doc_24894748_719_729_Chemical) (CC and) (NNS Doc_24894748_734_745_Chemical)))))) (. .)))
24894748	6	(ROOT (S (NP (DT The) (NN heart) (NN rate)) (VP (VBD ameliorated) (ADVP (RB first)) (PP (IN with) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NNS Doc_24894748_811_821_Chemical)))))))) (. .)))
24894748	7	(ROOT (S (S (NP (PRP It)) (VP (VBD was) (ADVP (RB subsequently)) (VP (VBN changed) (PP (TO to) (NP (NNS Doc_24894748_854_864_Chemical)))))) (CC and) (S (NP (DT the) (NN heart) (NN rate)) (VP (VBD remained) (ADJP (JJ normal)))) (. .)))
24894748	8	(ROOT (S (PP (IN By) (S (VP (VBG inhibiting) (NP (DT the) (JJ cytochrome) (QP (CD P450) (CD 2D6)))))) (, ,) (NP (NNS Doc_24894748_940_951_Chemical)) (VP (VBD had) (VP (VBN decreased) (NP (NP (NNP Doc_24894748_966_976_Chemical) (POS 's)) (NN clearance)) (, ,) (S (VP (VBG leading) (PP (IN in) (NP (NP (JJ Doc_24894748_1001_1011_Chemical) (NN accumulation)) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN resulted) (PP (IN in) (NP (ADJP (RB clinically) (JJ significant)) (NN sinus) (NNS Doc_24894748_1076_1087_Disease))))))))))))) (. .)))
24897009	0	(ROOT (NP (NP (NP (NNP Optochiasmatic)) (CC and) (NP (NNS Doc_24897009_19_40_Disease))) (ADJP (JJ due) (PP (TO to) (NP (JJ Doc_24897009_48_58_Chemical) (NN overtreatment)))) (. .)))
24897009	1	(ROOT (S (NP (NNP Doc_24897009_74_84_Chemical)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB cause) (NP (NP (NNS Doc_24897009_103_119_Disease)) (CC and) (PRN (, ,) (ADVP (RBR more)) (ADVP (RB rarely)) (, ,)) (NP (JJ axonal) (NNS Doc_24897009_145_159_Disease)))))))) (. .)))
24897009	2	(ROOT (S (NP (PRP We)) (VP (VBP characterize) (NP (NP (DT the) (JJ clinical)) (, ,) (ADJP (JJ neurophysiological)) (, ,) (CC and) (NP (NP (VBG neuroimaging) (NNS findings)) (PP (IN in) (NP (DT a) (JJ 72-year-old) (NN man))) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_24897009_272_283_Disease) (CC and) (NNS paresthesias)) (PP (IN after) (NP (NP (CD 11) (NNS weeks)) (PP (IN of) (NP (NN exposure))))) (PP (TO to) (NP (NP (DT a) (JJ supratherapeutic) (NN dose)) (PP (IN of) (NP (NNS Doc_24897009_358_368_Chemical))))))))))) (. .)))
24897009	3	(ROOT (S (NP (DT This) (NN case)) (VP (VBZ demonstrates) (NP (NP (NP (DT the) (JJ selective) (NN vulnerability)) (PP (IN of) (NP (DT the) (JJ anterior) (JJ visual) (NNS pathways)))) (CC and) (NP (NP (JJ peripheral) (NNS nerves)) (PP (TO to) (NP (JJ Doc_24897009_478_488_Chemical) (NNS Doc_24897009_489_497_Disease)))))) (. .)))
24902786	0	(ROOT (S (NP (NNP Doc_24902786_0_12_Chemical)) (VP (VBZ ameliorates) (NP (NP (NN Doc_24902786_25_39_Chemical-induced) (NNS Doc_24902786_48_65_Disease)) (PP (IN in) (NP (JJ male) (NNS rats))))) (. .)))
24902786	1	(ROOT (X (S (VP (TO To) (VP (VB study) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_24902786_109_121_Chemical)) (PP (IN on) (NP (NP (NNS Doc_24902786_125_139_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24902786_141_144_Chemical)) (-RRB- -RRB-)))))))))) (: -) (NP (NP (VBG induced) (NNS Doc_24902786_154_171_Disease)) (PP (IN in) (NP (JJ male) (NNS rats)))) (. .)))
24902786	2	(ROOT (S (S (NP (JJ Adult) (JJ male) (NN Wistar) (NNS rats)) (VP (VBD were) (ADVP (ADVP (RB intracerebroventricularly)) (PRN (-LRB- -LRB-) (NP (NN icv)) (-RRB- -RRB-))) (VP (VBN infused) (PP (IN with) (NP (NP (NNS Doc_24902786_268_271_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 750) (CD ug))) (-RRB- -RRB-)))) (PP (IN on) (NP (NP (QP (CD d) (CD 1))) (CC and) (NP (QP (CD d) (CD 3)))))))) (, ,) (CC and) (S (NP (DT a) (JJ passive) (NN avoidance) (NN task)) (VP (VBD was) (VP (VBN assessed) (NP (CD 2) (NNS weeks)) (PP (IN after) (NP (NP (DT the) (JJ first) (NN injection)) (PP (IN of) (NP (NNS Doc_24902786_376_379_Chemical)))))))) (. .)))
24902786	3	(ROOT (S (S (NP (NN Castration) (NN surgery)) (VP (VBD was) (VP (VBN performed) (PP (IN in) (NP (NP (DT another) (NN group)) (PP (IN of) (NP (NNS rats)))))))) (, ,) (CC and) (S (NP (DT the) (JJ passive) (NN avoidance) (NN task)) (VP (VBD was) (VP (VBN assessed) (NP (CD 4) (NNS weeks)) (PP (IN after) (NP (DT the) (NN operation)))))) (. .)))
24902786	4	(ROOT (S (NP (NP (NP (NNP Doc_24902786_513_525_Chemical)) (-LRB- -LRB-) (NP (NP (NP (NP (CD 1)) (VP (VBG mg.kg))) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (. .) (NP (NP (SYM d)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)) (, ,) (NP (NN sc)))) (-RRB- -RRB-)) (PRN (, ,) (S (NP (DT the) (JJ Doc_24902786_555_563_Chemical) (NN receptor)) (VP (VBP antagonist) (NP (NP (NP (NNS Doc_24902786_584_593_Chemical)) (-LRB- -LRB-) (NP (NP (NP (NP (CD 10)) (VP (VBG mg.kg))) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (. .) (NP (NP (SYM d)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)) (, ,) (NP (NN ip)))) (-RRB- -RRB-)) (, ,) (NP (NP (NP (DT the) (JJ Doc_24902786_624_632_Chemical) (NN receptor) (NN antagonist) (NNS Doc_24902786_653_662_Chemical)) (-LRB- -LRB-) (NP (NP (NP (NP (CD 1)) (VP (VBG mg.kg))) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (. .) (NP (NP (SYM d)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)) (, ,) (NP (NN ip)))) (-RRB- -RRB-)) (CC or) (NP (NP (DT the) (JJ aromatase) (NN inhibitor) (NNS Doc_24902786_714_723_Chemical)) (-LRB- -LRB-) (NP (NP (NP (NP (CD 4)) (VP (VBG mg.kg))) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (. .) (NP (NP (SYM d)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)) (, ,) (NP (NN ip)))) (-RRB- -RRB-)))))))) (VP (VBD were) (VP (VBN administered) (PP (IN for) (NP (QP (CD 6) (CD d)))) (PP (IN after) (NP (NP (DT the) (JJ first) (NN injection)) (PP (IN of) (NP (NNS Doc_24902786_803_806_Chemical))))))) (. .)))
24902786	5	(ROOT (S (NP (JJ Doc_24902786_817_820_Chemical) (NN administration) (CC and) (NN castration) (NNS markedly)) (VP (VBD decreased) (NP (NP (NP (DT both) (NN STL1)) (PRN (-LRB- -LRB-) (NP (DT the) (JJ short) (NN memory)) (-RRB- -RRB-))) (CC and) (NP (NP (NNP STL2)) (PRN (-LRB- -LRB-) (NP (DT the) (JJ long) (NN memory)) (-RRB- -RRB-)))) (PP (IN in) (NP (JJ passive) (NN avoidance) (NNS tests)))) (. .)))
24902786	6	(ROOT (S (NP (JJ Doc_24902786_954_966_Chemical) (NN replacement)) (ADVP (RB almost)) (VP (VBD restored) (NP (NP (NP (DT the) (NN STL1) (CC and) (NN STL2)) (PP (IN in) (NP (JJ castrated) (NNS rats)))) (, ,) (CC and) (NP (NP (ADJP (RB significantly) (JJ prolonged)) (DT the) (NN STL1)) (CC and) (NP (NP (NNP STL2)) (PP (IN in) (NP (NN Doc_24902786_1081_1084_Chemical-treated) (NNS rats))))))) (. .)))
24902786	7	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NNS Doc_24902786_1117_1126_Chemical) (, ,) (NNS Doc_24902786_1128_1137_Chemical) (CC or) (NNS Doc_24902786_1141_1150_Chemical)))) (VP (VP (ADVP (RB significantly)) (VBZ impaired) (NP (NP (DT the) (NN memory)) (PP (IN in) (NP (JJ intact) (NNS rats))))) (, ,) (CC and) (ADVP (RB significantly)) (VP (VBD attenuated) (NP (DT the) (JJ Doc_24902786_1234_1246_Chemical) (NN replacement)) (PP (IN in) (S (VP (VBG improving) (NP (ADJP (JJ Doc_24902786_1272_1275_Chemical) (: -) (CC and) (JJ castration-induced)) (NNS Doc_24902786_1300_1317_Disease))))))) (. .)))
24902786	8	(ROOT (S (NP (JJ Doc_24902786_1331_1343_Chemical) (NN administration)) (VP (VBZ ameliorates) (NP (NP (ADJP (JJ Doc_24902786_1371_1374_Chemical) (: -) (CC and) (JJ castration-induced)) (NNS Doc_24902786_1399_1416_Disease)) (PP (IN in) (NP (JJ male) (NNP Wistar) (NNS rats))))) (. .)))
24911645	0	(ROOT (S (NP (NP (JJ Behavioral) (CC and) (JJ neurochemical) (NNS studies)) (PP (IN in) (NP (NNS mice)))) (VP (VBD pretreated) (PP (IN with) (NP (JJ garcinielliptone) (NNP FC))) (PP (IN in) (NP (NN Doc_24911645_84_95_Chemical-induced) (NNS Doc_24911645_104_112_Disease)))) (. .)))
24911645	1	(ROOT (S (NP (NP (JJ Doc_24911645_114_133_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_24911645_135_138_Chemical)) (-RRB- -RRB-)) (ADJP (VBN isolated) (PP (IN from) (NP (JJ hexanic) (NN fraction) (NN seed)))) (NN extract)) (PP (IN of) (NP (NNP species) (NNP Platonia)))) (VP (VBZ insignis) (NP (NNP Mart))) (. .)))
24911645	2	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (ADVP (RB widely)) (VBN used) (PP (IN in) (NP (NN folk) (NN medicine))) (S (VP (TO to) (VP (VB treat) (SBAR (S (NP (NP (NNS Doc_24911645_263_276_Disease)) (PP (IN in) (NP (NP (DT both) (NNS humans) (CC and) (NNS animals)) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NN seed) (NN decoction))))) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NNS diarrheas) (CC and) (NNS Doc_24911645_371_392_Disease))))))))))))))) (. .)))
24911645	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (NN research)) (PP (IN on) (NP (NP (JJ Doc_24911645_427_430_Chemical) (NNS effects)) (PP (IN in) (NP (NP (DT the) (JJ central) (JJ nervous) (NN system)) (PP (IN of) (NP (NNS rodents))))))))) (. .)))
24911645	4	(ROOT (S (NP (NP (DT The) (JJ present) (NN study)) (VP (VBN aimed) (S (VP (TO to) (VP (VB evaluate) (NP (DT the) (JJ Doc_24911645_521_524_Chemical) (NNS effects)) (PP (IN at) (NP (NP (NNS doses)) (PP (IN of) (NP (CD 25) (, ,) (CD 50) (CC or) (CD 75))) (VP (VBG mg/kg) (PP (IN on) (NP (JJ Doc_24911645_567_574_Disease) (NNS parameters))) (S (VP (TO to) (VP (VB determine) (PP (PP (NP (NP (PRP$ their) (JJ anticonvulsant) (NN activity)) (CC and) (NP (PRP$ its) (NNS effects))) (IN on) (NP (JJ Doc_24911645_648_658_Chemical) (PRN (-LRB- -LRB-) (NP (NP (JJ Doc_24911645_660_679_Chemical) (-LRB- -LRB-) (NNS Doc_24911645_681_685_Chemical) (-RRB- -RRB-)) (, ,) (NP (NNS Doc_24911645_688_697_Chemical) (, ,) (NNS Doc_24911645_699_708_Chemical) (CC and) (NNS Doc_24911645_713_724_Chemical))) (-RRB- -RRB-)) (NNS levels))) (CONJP (RB as) (RB well) (IN as)) (PP (IN on) (NP (NP (JJ acetylcholinesterase) (PRN (-LRB- -LRB-) (NP (NNP AChE)) (-RRB- -RRB-)) (NN activity)) (PP (IN in) (NP (NNS mice))))))))))))))))) (VP (VBZ hippocampus) (PP (IN after) (NP (NNS Doc_24911645_810_818_Disease)))) (. .)))
24911645	5	(ROOT (S (NP (NNP Doc_24911645_820_823_Chemical)) (VP (VBD produced) (NP (DT an) (JJ increased) (NN latency)) (PP (PP (TO to) (NP (JJ first) (NNS Doc_24911645_863_870_Disease))) (, ,) (PP (IN at) (NP (NP (NP (NNS doses) (NNS 25mg/kg)) (PRN (-LRB- -LRB-) (NP (QP (CD 20.12) (CD +)) (NN 2.20) (NN min)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS 50mg/kg)) (PRN (-LRB- -LRB-) (NP (QP (CD 20.95) (CD +)) (NN 2.21) (NN min)) (-RRB- -RRB-))) (CC or) (NP (CD 75) (NN mg/kg) (PRN (-LRB- -LRB-) (NP (QP (CD 23.43) (CD +)) (NN 1.99) (NN min)) (-RRB- -RRB-)))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (JJ seized) (NNS mice))))))) (. .)))
24911645	6	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ Doc_24911645_1012_1016_Chemical) (NN content)) (PP (IN of) (NP (NP (NNS mice) (NNS hippocampus)) (VP (VBN treated) (PP (IN with) (NP (NNP GFC75) (CC plus) (NNP P400))))))) (VP (VBD showed) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (CD 46.90) (NN %)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (JJ seized) (NNS mice))))))) (. .)))
24911645	7	(ROOT (S (PP (IN In) (NP (NNS Doc_24911645_1138_1147_Chemical) (, ,) (NNS Doc_24911645_1149_1158_Chemical) (CC and) (NNS Doc_24911645_1163_1172_Chemical))) (NP (NNS levels)) (VP (VBD detected) (NP (NP (DT a) (NN decrease)) (PP (IN of) (NP (NP (CD 5.21) (NN %)) (, ,) (NP (CD 13.55) (NN %)) (CC and) (NP (CD 21.80) (NN %))))) (, ,) (PP (ADVP (RB respectively)) (IN in) (NP (NP (NNS mice) (NNS hippocampus)) (VP (VBN treated) (PP (IN with) (NP (NNP GFC75) (CC plus) (NNP P400))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (JJ seized) (NNS mice)))))))))) (. .)))
24911645	8	(ROOT (S (NP (NP (JJ Hippocampus) (NNS mice)) (VP (VBN treated) (PP (IN with) (NP (NNP GFC75) (CC plus) (NNP P400))))) (VP (VBD showed) (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ AChE) (NN activity)) (PRN (-LRB- -LRB-) (NP (CD 63.30) (NN %)) (-RRB- -RRB-)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (JJ seized) (NNS mice))))))) (. .)))
24911645	9	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_24911645_1472_1475_Chemical)) (VP (MD can) (VP (VP (VB exert) (NP (JJ anticonvulsant) (NN activity))) (CC and) (VP (VP (VB reduce) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NP (NN installation)) (PP (IN of) (NP (NN Doc_24911645_1554_1565_Chemical-induced) (NNS Doc_24911645_1574_1592_Disease)))))) (, ,) (SBAR (IN as) (S (VP (VBD demonstrated) (PP (IN by) (NP (NP (NN increase)) (PP (IN in) (NP (NN latency))))) (PP (TO to) (NP (JJ first) (NNS Doc_24911645_1642_1649_Disease))))))) (CC and) (VP (VB decrease) (PP (IN in) (NP (NP (NN mortality) (NN rate)) (PP (IN of) (NP (NNS animals)))))))))))) (. .)))
24911645	10	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_24911645_1730_1733_Chemical)) (VP (MD may) (VP (VP (VB influence) (PP (IN in) (NP (NNS epileptogenesis)))) (CC and) (VP (VB promote) (NP (NP (JJ anticonvulsant) (NNS actions)) (PP (IN in) (NP (JJ Doc_24911645_1805_1816_Chemical) (NN model)))) (PP (IN by) (NP (VBG modulating) (UCP (NP (NP (DT the) (NNS Doc_24911645_1841_1845_Chemical)) (CC and) (NP (JJ Doc_24911645_1850_1859_Chemical) (NNS contents))) (CC and) (RRC (PP (IN of) (NP (NNP AChE) (NN activity))) (PP (IN in) (NP (JJ seized) (NNS mice))))) (NNS hippocampus))))))))) (. .)))
24911645	11	(ROOT (S (S (NP (DT This) (NN compound)) (VP (MD may) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB produce) (NP (JJ neuronal) (NN protection))))))))) (CC and) (S (NP (PRP it)) (VP (MD can) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (DT an) (JJ anticonvulsant) (NN agent))))))) (. .)))
24923469	0	(ROOT (NP (NP (NP (NP (NNP Standard) (NN operating) (NNS procedures)) (PP (IN for) (NP (JJ antibiotic) (NN therapy)))) (CC and) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NNS Doc_24923469_75_94_Disease))))) (: :) (NP (DT a) (JJ prospective) (, ,) (JJ clinical) (, ,) (JJ non-interventional) (, ,) (JJ observational) (NN study)) (. .)))
24923469	1	(ROOT (S (NP (NP (NNP Doc_24923469_176_195_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24923469_197_200_Disease)) (-RRB- -RRB-))) (VP (VBZ occurs) (PP (IN in) (NP (NP (NP (CD 7) (NN %)) (PP (IN of) (NP (NNP hospitalized)))) (CC and) (NP (NP (CD 66) (NN %)) (PP (IN of) (NP (NNP Intensive) (NNP Care) (NNP Unit) (PRN (-LRB- -LRB-) (NP (NNP ICU)) (-RRB- -RRB-)) (NNS patients))))))) (. .)))
24923469	2	(ROOT (S (NP (PRP It)) (VP (VBZ increases) (NP (NP (NN mortality)) (, ,) (NP (NP (NN hospital) (NN length)) (PP (IN of) (NP (NN stay)))) (, ,) (CC and) (NP (NNS costs)))) (. .)))
24923469	3	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate)))) (, ,) (SBAR (IN whether) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP (NN adherence)) (PP (TO to) (NP (NP (NP (NP (NNS guidelines)) (-LRB- -LRB-) (NP (JJ standard) (NN operating) (NNS procedures)) (PRN (-LRB- -LRB-) (NP (NNP SOP)) (-RRB- -RRB-)) (-RRB- -RRB-)) (PP (IN for) (NP (ADJP (RB potentially) (JJ nephrotoxic)) (NNS antibiotics)))) (CC and) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NNS Doc_24923469_544_547_Disease))))))))))))) (. .)))
24923469	4	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN as) (NP (DT a) (JJ prospective) (, ,) (JJ clinical) (, ,) (JJ non-interventional) (, ,) (JJ observational) (NN study))))) (. .)))
24923469	5	(ROOT (S (NP (NNP Data) (NN collection)) (VP (VBD was) (VP (VBN performed) (PP (IN over) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 170) (NNS days)) (PP (IN in) (NP (CD three) (NNS ICUs))))))) (PP (IN at) (NP (NP (NNS Doc_24923469_726_733_Chemical)) (: -) (NP (NNP Universitaetsmedizin) (NNP Berlin)))))) (. .)))
24923469	6	(ROOT (S (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (JJ 675) (NNS patients)))) (VP (VBD were) (VP (VBN included)))) (: ;) (S (NP (NP (CD 163)) (PP (IN of) (NP (DT these)))) (VP (VP (VBD had) (NP (NP (NN therapy)) (PP (IN with) (NP (NNS Doc_24923469_834_844_Chemical) (, ,) (NNS Doc_24923469_846_856_Chemical) (, ,) (CC or) (NNS Doc_24923469_861_871_Chemical))))) (: ;) (VP (VBD were) (ADJP (JJ >)) (NP (CD 18) (NNS years))) (: ;) (CC and) (VP (VBN treated) (PP (IN in) (NP (NP (DT the) (NNP ICU)) (PP (IN for) (NP (QP (CD >) (CD 24)) (NNS hours)))))))) (. .)))
24923469	7	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (DT an) (NN adherence)) (PP (TO to) (NP (NP (NNP SOP) (NNP >)) (ADJP (CD 70) (NN %))))))) (VP (VBD were) (VP (VBN classified) (PP (IN into) (NP (NP (NP (DT the) (JJ high) (NN adherence) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP HAG)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT an) (NN adherence)) (PP (IN of) (NP (QP (CD <) (CD 70)) (NN %)))))))) (PP (IN into) (NP (NP (DT the) (JJ low) (NN adherence) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP LAG)) (-RRB- -RRB-)))))) (. .)))
24923469	8	(ROOT (S (NP (NNP Doc_24923469_1093_1096_Disease)) (VP (VBD was) (VP (VBN defined) (PP (VBG according) (PP (TO to) (NP (JJ RIFLE) (NNS criteria)))))) (. .)))
24923469	9	(ROOT (S (NP (NP (NNP Adherence)) (PP (TO to) (NP (NNP SOPs)))) (VP (VBD was) (VP (VBN evaluated) (PP (IN by) (NP (NN retrospective) (NN expert) (NN audit))))) (. .)))
24923469	10	(ROOT (S (NP (NP (NNP Development)) (PP (IN of) (NP (NNS Doc_24923469_1216_1219_Disease)))) (VP (VBD was) (VP (VBN compared) (PP (IN between) (NP (NP (NNS groups)) (PP (IN with) (NP (NP (JJ exact) (ADJP (JJ Chi2-test) (CC and) (JJ multivariate)) (NN logistic) (NN regression) (NN analysis)) (PRN (-LRB- -LRB-) (NP (JJ two-sided) (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-)))))))) (. .)))
24923469	11	(ROOT (S (NP (NNP LAG)) (VP (VBD consisted) (PP (IN of) (NP (NP (NP (CD 75) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 46) (NN %)) (-RRB- -RRB-))) (PP (IN versus) (NP (NP (CD 88) (NNP HAG) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 54) (NN %)) (-RRB- -RRB-))))))) (. .)))
24923469	12	(ROOT (S (NP (NNP Doc_24923469_1410_1413_Disease)) (VP (VBD occurred) (ADVP (ADVP (RB significantly) (RBR more) (RB often)) (PP (IN in) (NP (NNP LAG)))) (PP (IN with) (NP (NP (CD 36) (NN %)) (PP (IN versus) (NP (NP (CD 21) (NN %)) (PP (IN in) (NP (NNP HAG))))))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.035))) (-RRB- -RRB-))) (. .)))
24923469	13	(ROOT (S (NP (NNP Basic) (NNS characteristics)) (VP (VBD were) (ADJP (JJ comparable)) (, ,) (PP (IN except) (NP (NP (DT an) (VBN increased) (NN rate)) (PP (IN of) (NP (NP (JJ soft) (NNS Doc_24923469_1567_1584_Disease)) (PP (IN in) (NP (NNP LAG)))))))) (. .)))
24923469	14	(ROOT (S (NP (JJ Multivariate) (NN analysis)) (VP (VBD revealed) (NP (NP (DT an) (NNS odds) (NN ratio)) (PP (IN of) (NP (NP (JJ 2.5-fold)) (PP (IN for) (NP (NNS Doc_24923469_1654_1657_Chemical)))))) (S (VP (TO to) (VP (VB develop) (NP (NNS Doc_24923469_1669_1672_Disease)) (PP (VBN compared) (PP (IN with) (NP (NP (NNP HAG)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (SBAR (S (NP (NN confidence)) (VP (VBP interval) (NP (NP (QP (CD 1.195) (TO to) (CD 5.124))) (, ,) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.039))))))))))) (-RRB- -RRB-))))))))) (. .)))
24923469	15	(ROOT (S (NP (NP (NNP Low) (NNP adherence)) (PP (TO to) (NP (NP (NNP SOPs)) (PP (IN for) (NP (ADJP (RB potentially) (JJ nephrotoxic)) (NNS antibiotics)))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJR higher) (NN occurrence)) (PP (IN of) (NP (NNS Doc_24923469_1861_1864_Disease))))))) (. .)))
24923469	16	(ROOT (NP (NP (NNP TRIAL) (NNP REGISTRATION)) (: :) (NP (NNP Current) (NNP Controlled) (NNPS Trials) (NNP ISRCTN54598675)) (. .)))
24923469	17	(ROOT (NP (NP (NNP Registered) (CD 17)) (NP (NNP August) (CD 2007)) (. .)))
24927617	0	(ROOT (S (NP (NP (NNP Doc_24927617_0_14_Disease)) (PP (IN in) (NP (JJ Doc_24927617_18_46_Disease) (NN patient)))) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_24927617_68_78_Chemical) (CC and) (NNS Doc_24927617_83_94_Chemical)))) (. .)))
24927617	1	(ROOT (S (NP (NP (DT A) (JJ 46-year) (JJ old) (NN man)) (PP (IN with) (NP (DT a) (NNS Doc_24927617_121_156_Disease)))) (VP (VBD received) (NP (JJ triple) (NN therapy)) (PP (IN with) (NP (NNS Doc_24927617_186_195_Chemical) (, ,) (NNS Doc_24927617_197_217_Chemical) (CC and) (NNS Doc_24927617_222_232_Chemical)))) (. .)))
24927617	2	(ROOT (S (NP (DT The) (NN patient)) (ADVP (RB also)) (VP (VBD received) (NP (NNS Doc_24927617_260_271_Chemical))) (. .)))
24927617	3	(ROOT (S (PP (NP (CD One) (NN month)) (IN after) (S (VP (VBG starting) (NP (DT the) (JJ antiviral) (NN therapy))))) (, ,) (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN admitted) (PP (TO to) (NP (DT the) (NN hospital))) (SBAR (IN because) (S (NP (PRP he)) (VP (VBD developed) (NP (NNS Doc_24927617_383_397_Disease))))))) (. .)))
24927617	4	(ROOT (S (PP (IN At) (NP (NP (NN admission) (NNS Doc_24927617_412_423_Chemical)) (CC and) (NP (DT all)))) (NP (JJ antiviral) (NNS drugs)) (VP (VBD were) (VP (VBN discontinued) (SBAR (IN because) (S (NP (NP (NNS Doc_24927617_474_482_Disease)) (ADJP (JJ due) (PP (TO to) (NP (DT a) (JJ drug-drug) (NN interaction))))) (VP (VBD was) (VP (VBN suspected))))))) (. .)))
24927617	5	(ROOT (S (NP (NP (DT The) (JJ Doc_24927617_533_541_Chemical) (NN kinase)) (VP (VBN peaked) (PP (IN at) (NP (NP (CD 62,246) (NNS IU/L)) (CC and) (NP (DT the) (NN patient)))))) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (JJ intravenous) (JJ normal) (NN saline))))) (. .)))
24927617	6	(ROOT (S (NP (NP (DT The) (NN patient) (POS 's)) (JJ renal) (NN function)) (VP (VBD remained) (ADJP (JJ unaffected))) (. .)))
24927617	7	(ROOT (S (PP (NP (CD Fourteen) (NNS days)) (IN after) (NP (NN hospitalization))) (, ,) (S (NP (JJ Doc_24927617_718_726_Chemical) (NN kinase) (NN level)) (VP (VBD had) (VP (VBN returned) (PP (TO to) (NP (QP (CD 230) (CD IU/L))))))) (CC and) (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN discharged)))) (. .)))
24927617	8	(ROOT (S (NP (NNP Doc_24927617_797_807_Chemical)) (VP (VBD was) (VP (VBN considered) (NP (NP (DT the) (ADJP (JJ probable) (JJ causative)) (NN agent)) (PP (IN of) (NP (DT an) (NN interaction)))) (PP (IN with) (NP (NNS Doc_24927617_875_886_Chemical))) (PP (VBG according) (PP (TO to) (NP (DT the) (NNP Drug) (NNP Interaction) (NNP Probability) (NNP Scale)))))) (. .)))
24927617	9	(ROOT (S (NP (DT The) (NN interaction)) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ CYP3A4-mediated) (JJ Doc_24927617_996_1007_Chemical) (NN clearance))))))) (. .)))
24927617	10	(ROOT (S (NP (JJ Doc_24927617_1019_1030_Chemical) (NN plasma) (NN concentration)) (VP (VBD increased) (SBAR (S (NP (NP (CD 30) (NNS times)) (PP (IN in) (NP (DT this) (NN patient) (CC and) (NN statin) (NN induced) (NNS Doc_24927617_1106_1121_Disease)))) (VP (VBZ is) (ADJP (VBN related) (PP (TO to) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (DT the) (NN statin)) (PP (IN in) (NP (NN blood)))))))))))) (. .)))
24927617	11	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (PP (IN with) (NP (DT this) (NN case))) (NP (PRP we)) (VP (VBP illustrate) (SBAR (IN that) (S (NP (NNS Doc_24927617_1227_1237_Chemical) (CONJP (RB as) (RB well) (IN as)) (NNS statins)) (VP (VBP are) (ADJP (JJ susceptible) (PP (TO to) (NP (JJ clinical) (JJ relevant) (JJ drug-drug) (NNS interactions)))))))) (. .)))
24928523	0	(ROOT (S (NP (NP (NP (NNP Combination)) (PP (IN of) (NP (NNS Doc_24928523_15_25_Chemical) (, ,) (NNS Doc_24928523_27_38_Chemical) (, ,) (CC and) (NNS Doc_24928523_44_57_Chemical)))) (PRN (-LRB- -LRB-) (NP (NNP VTD)) (-RRB- -RRB-)) (PP (IN as) (NP (NP (DT a) (NN consolidation) (NN therapy)) (PP (IN after) (NP (NNS autologous)))))) (VP (VBP stem) (NP (NP (NN cell) (NN transplantation)) (PP (IN for) (NP (NP (JJ symptomatic) (NNS Doc_24928523_150_166_Disease)) (PP (IN in) (NP (JJ Japanese) (NNS patients))))))) (. .)))
24928523	1	(ROOT (S (NP (NP (NN Consolidation) (NN therapy)) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_24928523_229_245_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24928523_247_249_Disease)) (-RRB- -RRB-))))))) (VP (VBZ has) (VP (VBN been) (ADJP (RB widely) (VBN adopted) (S (VP (TO to) (VP (VB improve) (S (NP (NN treatment) (NN response) (NN following) (NNS autologous)) (VP (VB stem) (NP (NN cell) (NN transplantation)))))))))) (. .)))
24928523	2	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (ADVP (RB retrospectively)) (VP (VBD analyzed) (NP (NP (DT the) (NN safety) (CC and) (NN efficacy)) (PP (IN of) (NP (NP (NN combination) (NN regimen)) (PP (IN of) (NP (NNS Doc_24928523_446_456_Chemical) (, ,) (NNS Doc_24928523_458_469_Chemical) (, ,) (CC and) (NNS Doc_24928523_475_488_Chemical))))) (PRN (-LRB- -LRB-) (NP (NNP VTD)) (-RRB- -RRB-))) (PP (IN as) (NP (NN consolidation) (NN therapy))) (PP (IN in) (NP (NP (CD 24) (JJ Japanese) (NNS patients)) (PP (IN with) (NP (ADJP (RB newly) (JJ diagnosed)) (NNS Doc_24928523_565_567_Disease)))))) (. .)))
24928523	3	(ROOT (S (NP (NNP VTD)) (VP (VBD consisted) (PP (IN of) (NP (NP (NNS Doc_24928523_586_596_Chemical)) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 1.3) (NN mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_24928523_626_639_Chemical)) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 40) (NN mg/day)) (PP (IN on) (NP (NP (NNS days) (CD 1)) (, ,) (NP (NP (CD 8) (, ,) (CD 15) (, ,) (CC and) (CD 22)) (PP (IN of) (NP (DT a) (JJ 35-day) (NN cycle)))) (, ,)))))))))))))) (PP (IN with) (NP (JJ daily) (JJ oral) (NNS Doc_24928523_723_734_Chemical))) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 100) (NN mg/day)))))) (. .)))
24928523	4	(ROOT (S (S (NP (NNP Grade) (NNP 3-4) (NNS Doc_24928523_770_781_Disease) (CC and) (NNS Doc_24928523_786_802_Disease)) (VP (VBD were) (VP (VBN documented) (PP (IN in) (NP (NP (QP (CD four) (CC and) (CD three)) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 17)) (CC and) (NP (CD 13) (NN %))) (-RRB- -RRB-)))) (, ,) (ADVP (RB respectively))))) (, ,) (CC but) (S (NP (NP (NN drug) (NN dose) (NN reduction)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_24928523_906_915_Disease))))) (VP (VBD was) (RB not) (VP (VBN required) (PP (IN in) (NP (DT any) (NN case)))))) (. .)))
24928523	5	(ROOT (S (S (NP (NNP Doc_24928523_946_967_Disease)) (VP (VBD was) (ADJP (JJ common)) (PRN (-LRB- -LRB-) (NP (CD 63) (NN %)) (-RRB- -RRB-)))) (, ,) (CC but) (S (NP (JJ severe) (NN grade) (NN 3-4) (NNS Doc_24928523_1008_1029_Disease)) (VP (VBD was) (RB not) (ADJP (JJ observed)))) (. .)))
24928523	6	(ROOT (S (NP (NP (ADJP (RB Very) (JJ good)) (JJ partial) (NN response)) (CC or) (NP (NP (JJR better) (NN response)) (PRN (-LRB- -LRB-) (NP (NNP >) (NNP VGPR)) (-RRB- -RRB-)))) (VP (VBZ rates) (SBAR (IN before) (CC and) (RB after) (S (NP (NN consolidation) (NN therapy)) (VP (VBD were) (NP (NP (CD 54)) (CC and) (NP (CD 79) (NN %))) (, ,) (ADVP (RB respectively)))))) (. .)))
24928523	7	(ROOT (S (NP (NNS Patients)) (VP (VBD had) (NP (NP (DT a) (JJ significant) (NN probability)) (PP (IN of) (S (VP (VBG improving) (PP (IN from) (NP (NNP <VGPR before consolidation therapy to >) (NNP VGPR))) (PP (IN after) (NP (NN consolidation) (NN therapy))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.041))))) (-RRB- -RRB-))))))) (. .)))
24928523	8	(ROOT (S (NP (DT The) (NNP VTD) (NN regimen)) (VP (MD may) (VP (VB be) (ADJP (JJ safe) (CC and) (JJ effective)) (PP (IN as) (NP (NP (DT a) (NN consolidation) (NN therapy)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_24928523_1410_1412_Disease)) (PP (IN in) (NP (JJ Japanese) (NN population))))))))))) (. .)))
24971338	0	(ROOT (NP (NP (NP (ADJP (JJ Conversion) (PP (TO to) (NP (JJ Doc_24971338_14_23_Chemical) (NNS ameliorates)))) (NN Doc_24971338_36_48_Chemical-induced) (NNS Doc_24971338_57_68_Disease)) (PP (IN in) (NP (DT the) (NN rat)))) (: :) (NP (NP (NN focus)) (PP (IN on) (NP (NP (NN serum) (, ,) (NN urine) (, ,) (NN gene) (, ,) (CC and) (NN protein)) (NP (JJ renal) (NN expression) (NNS biomarkers))))) (. .)))
24971338	1	(ROOT (S (S (NP (NP (NNS Protocols)) (PP (IN of) (NP (NP (NN conversion)) (PP (IN from) (NP (NP (NP (NNS Doc_24971338_180_193_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24971338_195_198_Chemical)) (-RRB- -RRB-))) (PP (TO to) (NP (NP (NNS Doc_24971338_203_212_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_24971338_214_217_Chemical)) (-RRB- -RRB-))))))))) (VP (VBP have) (VP (VBN been) (VP (ADVP (RB widely)) (VBN used) (PP (IN in) (NP (NN immunotherapy))) (PP (IN after) (NP (NN transplantation))) (S (VP (TO to) (VP (VB prevent) (NP (NN Doc_24971338_291_294_Chemical-induced) (NNS Doc_24971338_303_314_Disease))))))))) (, ,) (CC but) (S (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (VP (VBG underlying) (NP (DT these) (NNS protocols)))) (VP (VBP remain) (NP (JJ nuclear)))) (. .)))
24971338	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBD aimed) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (JJ molecular) (NNS pathways) (CC and) (NN putative) (NNS biomarkers)) (PP (IN of) (NP (NN Doc_24971338_467_470_Chemical-to-Doc_24971338_474_477_Chemical) (NN conversion)))) (PP (IN in) (NP (DT a) (NN rat) (NN model))))))) (. .)))
24971338	3	(ROOT (S (NP (NP (CD Four) (NN animal) (NNS groups)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 6))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN tested) (PP (IN during) (NP (NP (NP (CD 9) (NNS weeks)) (: :) (NP (NP (NN control)) (, ,) (NP (NNS Doc_24971338_569_572_Chemical)) (, ,) (NP (NNS Doc_24971338_574_577_Chemical)) (, ,) (CC and) (NP (NN conversion)))) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_24971338_595_598_Chemical)) (PP (IN for) (NP (CD 3) (NNS weeks))) (VP (VBN followed) (PP (IN by) (NP (NP (NNS Doc_24971338_623_626_Chemical)) (PP (IN for) (NP (CD 6) (NNS weeks))))))) (-RRB- -RRB-)))))) (. .)))
24971338	4	(ROOT (S (NP (NP (NN Classical) (CC and) (NN emergent) (NN serum)) (, ,) (NP (JJ urinary) (, ,) (CC and) (NN kidney) (NN tissue) (PRN (-LRB- -LRB-) (NP (NN gene) (CC and) (NN protein) (NN expression)) (-RRB- -RRB-)) (NNS markers))) (VP (VBD were) (VP (VBN assessed))) (. .)))
24971338	5	(ROOT (S (NP (NNP Doc_24971338_751_764_Disease)) (VP (VBD were) (VP (VBN analyzed) (PP (IN in) (NP (NP (NNS Doc_24971338_782_793_Chemical) (CC and) (NNS Doc_24971338_798_803_Chemical)) (, ,) (NP (JJ periodic) (NN acid-Schiff)) (, ,) (CC and) (NP (NP (NNP Masson) (POS 's)) (JJ trichrome) (NNS stains)))))) (. .)))
24971338	6	(ROOT (S (NP (JJ Doc_24971338_858_861_Chemical-treated) (NNS rats)) (VP (VBD presented) (NP (NP (NNP Doc_24971338_885_896_Disease) (CC and) (NNP NGAL)) (PRN (-LRB- -LRB-) (NP (JJ serum) (CC and) (JJ urinary)) (-RRB- -RRB-))) (PP (IN as) (NP (NP (DT the) (JJS best) (NNS markers)) (PP (IN of) (NP (NNS Doc_24971338_949_965_Disease)))))) (. .)))
24971338	7	(ROOT (S (NP (JJ Short) (JJ Doc_24971338_973_976_Chemical) (NN treatment)) (VP (VBD presented) (NP (NP (JJ slight)) (CC or) (RB even) (NP (NP (NNS Doc_24971338_1012_1033_Disease)) (CC and) (NP (NNP TGF-b) (, ,) (NNP NF))) (: -) (NP (NP (NN kb) (, ,) (NN mTOR) (, ,) (NN PCNA) (, ,) (NN TP53) (, ,) (NN KIM-1) (, ,) (CC and) (NN CTGF)) (PP (IN as) (NP (JJ relevant) (NN gene) (CC and) (NN protein) (NNS changes)))))) (. .)))
24971338	8	(ROOT (NP (NP (NP (JJ Prolonged) (JJ Doc_24971338_1135_1138_Chemical) (NN exposure)) (VP (VBN aggravated) (NP (NNS Doc_24971338_1159_1171_Disease)) (, ,) (PP (PP (IN without) (NP (NP (JJ clear) (NNS changes)) (PP (IN on) (NP (DT the) (JJ traditional) (NNS markers))))) (, ,) (CC but) (PP (IN with) (NP (NP (NNS changes)) (PP (IN in) (NP (NNP serums) (NNP TGF)))))))) (: -) (NP (NP (QP (NP (SYM b)) (CC and) (NP (NN IL-7) (, ,) (JJ TBARs) (NN clearance)))) (, ,) (CC and) (NP (NP (NN kidney) (NNS TGF-b)) (CC and) (NP (NN mTOR)))) (. .)))
24971338	9	(ROOT (SINV (ADJP (JJ Conversion) (PP (TO to) (NP (NNS Doc_24971338_1325_1328_Chemical)))) (VP (VBD prevented)) (NP (NP (NN Doc_24971338_1339_1342_Chemical-induced) (NNS Doc_24971338_1351_1373_Disease)) (PRN (-LRB- -LRB-) (NP (NN absent/mild) (NN grade) (NNS lesions)) (-RRB- -RRB-)) (, ,) (SBAR (IN while) (S (NP (NP (NNP NGAL)) (PRN (-LRB- -LRB-) (NP (NNP serum) (CC versus) (NNP urine)) (-RRB- -RRB-))) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (ADJP (JJ feasible)) (NN biomarker)) (PP (IN of) (NP (JJ Doc_24971338_1471_1474_Chemical) (NN replacement)))) (PP (TO to) (NP (NNS Doc_24971338_1490_1493_Chemical)))))))))) (. .)))
24975837	0	(ROOT (S (NP (NP (NNP Kinin) (NN B2) (NN receptor) (NN deletion)) (CC and) (NP (NN blockage))) (VP (VBZ ameliorates) (NP (NN Doc_24975837_52_61_Chemical-induced) (NNS Doc_24975837_70_88_Disease))) (. .)))
24975837	1	(ROOT (S (S (NP (JJ Doc_24975837_90_99_Chemical) (NN treatment)) (VP (VBZ has) (VP (VBN been) (VP (VBN adopted) (PP (IN in) (NP (DT some) (NNS chemotherapies))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (DT this) (NN drug)) (VP (MD can) (VP (VB induce) (NP (NNS Doc_24975837_181_200_Disease)) (PP (IN due) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VP (ADVP (RB negatively)) (VB affect) (NP (JJ renal) (NN function))) (, ,) (VP (VB augment) (NP (NP (NN serum) (NNS levels)) (PP (IN of) (NP (NNS Doc_24975837_278_288_Chemical) (CC and) (NNS Doc_24975837_293_297_Chemical))))) (, ,) (VP (VB increase) (NP (DT the) (JJ Doc_24975837_312_334_Disease) (NN score))) (CC and) (VP (VB up-regulate) (NP (NP (NNS cytokines)) (PRN (-LRB- -LRB-) (NP (NNP e.g.)) (, ,) (NP (NNP IL-1b) (CC and) (NNP TNF-a)) (-RRB- -RRB-)))))))))))) (. .)))
24975837	2	(ROOT (S (S (NP (DT The) (NN kinin) (NN B2) (NN receptor)) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN inflammation) (NN process)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (JJ cytokine) (NN expression)))))))))) (, ,) (CC and) (S (NP (PRP$ its) (NN deletion)) (VP (VBD resulted) (PP (IN in) (NP (DT an) (NN improvement))) (PP (IN in) (NP (DT the) (JJ Doc_24975837_566_586_Disease) (NN status))))) (. .)))
24975837	3	(ROOT (S (S (VP (TO To) (VP (VB examine) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (DT the) (JJ kinin) (NN B2) (NN receptor)) (PP (IN in) (NP (NN Doc_24975837_643_652_Chemical-induced) (NNS Doc_24975837_661_680_Disease))))))))) (, ,) (NP (NN kinin) (NN B2) (NN receptor) (NN knockout) (NNS mice)) (VP (VBD were) (VP (VBN challenged) (PP (IN with) (NP (NNS Doc_24975837_735_744_Chemical))))) (. .)))
24975837	4	(ROOT (S (ADVP (RB Additionally)) (, ,) (NP (NNP WT) (NNS mice)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (DT a) (NN B2) (NN receptor) (NN antagonist))) (PP (IN after) (NP (JJ Doc_24975837_817_826_Chemical) (NN administration))))) (. .)))
24975837	5	(ROOT (S (NP (NN B2) (NN receptor-deficient) (NNS mice)) (VP (VBD were) (ADJP (RBR less) (JJ sensitive) (PP (TO to) (NP (NP (DT this) (NN drug)) (PP (IN than) (NP (DT the) (NNP WT) (NNS mice)))))) (, ,) (PP (IN as) (NP (UCP (VP (VBN shown) (PP (IN by) (NP (NP (JJ reduced) (NNS Doc_24975837_941_952_Disease)) (, ,) (NP (NP (JJR better) (NN preservation)) (PP (IN of) (NP (NN kidney) (NN function)))) (, ,))) (PP (IN down) (NP (NP (NN regulation)) (PP (IN of) (NP (JJ inflammatory) (NNS cytokines)))))) (CC and) (ADJP (JJR less))) (NNS Doc_24975837_1045_1067_Disease)))) (. .)))
24975837	6	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (NN treatment)) (PP (IN with) (NP (DT the) (JJ kinin) (NN B2) (NN receptor) (NN antagonist)))) (ADVP (RB effectively)) (VP (VBD reduced) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN serum) (NNS Doc_24975837_1167_1177_Chemical) (CC and) (NN blood) (NNS Doc_24975837_1188_1192_Chemical)))) (PP (IN after) (NP (JJ Doc_24975837_1199_1208_Chemical) (NN administration)))) (. .)))
24975837	7	(ROOT (S (ADVP (RB Thus)) (, ,) (S (NP (PRP$ our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (NN kinin) (NN B2) (NN receptor)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NN Doc_24975837_1290_1299_Chemical-induced) (NNS Doc_24975837_1308_1327_Disease))) (PP (IN by) (S (VP (VBG mediating) (NP (DT the) (JJ necrotic) (NN process))))))))))) (CC and) (S (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ inflammatory) (NNS cytokines)) (, ,) (VP (ADVP (RB thus)) (VBG resulting) (PRT (RP in)))))) (VP (VBD declined) (NP (JJ renal) (NN function)))) (. .)))
24975837	8	(ROOT (S (NP (DT These) (NNS results)) (VP (VB highlight) (NP (DT the) (JJ kinin) (NN B2) (NN receptor) (NN antagonist) (NN treatment)) (PP (IN in) (NP (NP (NN amelioration)) (PP (IN of) (NP (NP (NN nephrotoxicity)) (VP (VBN induced) (PP (IN by) (NP (JJ Doc_24975837_1563_1572_Chemical) (NN therapy))))))))) (. .)))
24999722	0	(ROOT (NP (NP (NN Safety) (CC and) (NN efficacy)) (PP (IN of) (NP (JJ Doc_24999722_23_45_Chemical) (JJ intravitreal) (NN implant))) (PRN (-LRB- -LRB-) (NP (CD 0.59) (NNS mg)) (-RRB- -RRB-)) (PP (IN in) (NP (NNS Doc_24999722_80_108_Disease))) (. .)))
24999722	1	(ROOT (S (VP (TO To) (VP (VB report) (NP (NP (DT the) (NN treatment) (NNS outcomes)) (PP (IN of) (NP (NP (DT the) (JJ Doc_24999722_159_181_Chemical) (JJ intravitreal) (NN implant)) (PRN (-LRB- -LRB-) (NP (CD 0.59) (NNS mg)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_24999722_230_258_Disease)) (SBAR (WHNP (WP$ whose) (NN disease)) (S (VP (VBZ is) (ADJP (JJ refractory) (CC or) (JJ intolerant)) (PP (TO to) (NP (JJ conventional) (JJ immunomodulatory) (NN therapy)))))))))))) (. .)))
24999722	2	(ROOT (NP (NP (DT A) (NN retrospective) (NN case) (NN series)) (VP (VBG involving) (NP (NP (CD 11) (JJ Doc_24999722_393_421_Disease) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 11) (NNS eyes)) (-RRB- -RRB-)))) (. .)))
24999722	3	(ROOT (S (NP (NP (CD Eleven) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 11) (NNS eyes)) (-RRB- -RRB-))) (VP (VBD underwent) (NP (NN surgery)) (PP (IN for) (NP (NP (JJ Doc_24999722_490_512_Chemical) (NN implant)) (PRN (-LRB- -LRB-) (NP (CD 0.59) (NNS mg)) (-RRB- -RRB-))))) (. .)))
24999722	4	(ROOT (S (NP (NP (NNP Treatment) (NNP outcomes)) (PP (IN of) (NP (NN interest)))) (VP (VBD were) (VP (VBN noted) (PP (PP (IN at) (NP (NN baseline))) (, ,) (PP (IN before) (NP (JJ Doc_24999722_594_616_Chemical) (NN implant))) (, ,) (CC and) (RB then) (PP (IN at) (NP (NP (CD 6) (NNS months)) (, ,) (NP (CD 1) (NN year)) (, ,) (NP (CD 2) (NNS years)) (, ,) (NP (CD 3) (NNS years)) (, ,) (CC and) (NP (IN beyond) (CD 3) (NNS years))))))) (. .)))
24999722	5	(ROOT (S (NP (NNP Disease) (NN activity) (NNS markers)) (, ,) (PP (VBG including) (NP (NP (NNS signs)) (PP (IN of) (NP (NNS Doc_24999722_739_758_Disease))))) (, ,) (NP (NP (NN evidence)) (PP (IN of) (NP (JJ Doc_24999722_772_790_Disease) (, ,) (JJ Swedish) (JJ interactive) (NN threshold) (NN algorithm-short)))) (VP (VBP wavelength) (SBAR (S (NP (NP (JJ automated) (NN perimetry) (NNP Humphrey) (JJ visual) (NN field) (NN analysis)) (, ,) (NP (JJ electroretinographic) (NNS parameters)) (, ,) (CC and) (NP (JJ optical) (NN coherence) (NN tomography))) (VP (VBD were) (VP (VBN recorded)))))) (. .)))
24999722	6	(ROOT (S (NP (NP (NNP Data)) (PP (IN on) (NP (NP (NN occurrence)) (PP (IN of) (NP (NP (NNS Doc_24999722_1004_1012_Disease)) (CC and) (NP (VBN raised) (JJ intraocular) (NN pressure))))))) (VP (VBD were) (VP (VBN collected) (PP (IN in) (NP (DT all) (NNS eyes))))) (. .)))
24999722	7	(ROOT (S (NP (NNP Intraocular) (NNP Doc_24999722_1094_1106_Disease)) (VP (VBD was) (ADJP (JJ present) (PP (IN in) (NP (NP (NNP 54.5)) (, ,) (NP (CD 9.9)) (, ,) (NP (CD 11.1)) (, ,) (CC and) (NP (NP (CD 0) (NN %)) (PP (IN of) (NP (NNS patients))))))) (PP (IN at) (NP (NP (NN baseline)) (, ,) (NP (CD 6) (NNS months)) (, ,) (NP (CD 1) (NN year)) (, ,) (NP (CD 2) (NNS years)) (, ,) (NP (CD 3) (NNS years)) (, ,) (CC and) (NP (IN beyond) (CD 3) (NNS years)))) (PP (IN after) (S (VP (VBG receiving) (NP (DT the) (NN implant))))) (, ,) (ADVP (RB respectively))) (. .)))
24999722	8	(ROOT (S (NP (JJ Active) (NNS Doc_24999722_1276_1286_Disease)) (VP (VBD was) (VP (VBN noted) (PP (IN in) (NP (ADJP (CD 36.3) (NN %)) (NNS patients))) (PP (IN at) (NP (NP (NN baseline)) (CC and) (NP (CD 0) (NN %)))) (PP (IN at) (NP (NP (CD 3) (NNS years)) (PP (IN of) (NP (NN follow-up))))))) (. .)))
24999722	9	(ROOT (S (NP (NP (NP (NP (QP (JJR More) (IN than) (CD 20)) (NN %)) (PRN (-LRB- -LRB-) (NP (QP (CD 47.61-67) (CD .2)) (NN %)) (-RRB- -RRB-))) (NN reduction)) (PP (IN in) (NP (JJ central) (JJ retinal) (NN thickness)))) (VP (VBD was) (VP (VBN noted) (PP (IN in) (NP (NP (DT all) (NNS patients)) (PP (IN with) (NP (NNS Doc_24999722_1457_1478_Disease))))) (PP (IN at) (NP (NP (CD 6) (NNS months)) (, ,) (NP (CD 1) (NN year)) (, ,) (NP (CD 2) (NNS years)) (, ,) (CC and) (NP (CD 3) (NNS years) (JJ postimplant)))))) (. .)))
24999722	10	(ROOT (S (PP (IN At) (NP (NN baseline))) (, ,) (NP (ADJP (CD 54.5) (NN %)) (NNS patients)) (VP (VBD were) (PP (IN on) (NP (JJ immunomodulatory) (NNS agents)))) (. .)))
24999722	11	(ROOT (S (NP (DT This) (NN percentage)) (VP (VBD decreased) (PP (TO to) (NP (NP (CD 45.45)) (, ,) (NP (CD 44.4)) (, ,) (CC and) (NP (CD 14.28) (NN %)))) (PP (IN at) (NP (NP (CD 1) (NN year)) (, ,) (NP (CD 2) (NNS years)) (, ,) (CC and) (NP (NP (CD 3) (NNS years)) (NP (NN postimplant)) (, ,) (ADVP (RB respectively)))))) (. .)))
24999722	12	(ROOT (S (NP (JJ Adverse) (NNS events)) (VP (VBD included) (NP (NP (NP (NNS Doc_24999722_1731_1761_Disease)) (PRN (-LRB- -LRB-) (ADJP (CD 54.5) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ Doc_24999722_1774_1782_Disease) (NN formation)) (PRN (-LRB- -LRB-) (NP (CD 100) (NN %)) (-RRB- -RRB-))))) (. .)))
24999722	13	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ Doc_24999722_1835_1857_Chemical) (NN implant)) (PRN (-LRB- -LRB-) (NP (CD 0.59) (NNS mg)) (-RRB- -RRB-))) (VP (VBZ helps) (S (VP (TO to) (VP (VB control) (NP (NNS Doc_24999722_1893_1905_Disease)) (PP (IN in) (NP (NP (ADJP (RB otherwise) (JJ treatment-refractory)) (NNS cases)) (PP (IN of) (NP (NNS Doc_24999722_1949_1977_Disease)))))))))))) (. .)))
24999722	14	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ significant) (NN side) (NNS effects)) (PP (IN of) (NP (NNS Doc_24999722_2029_2037_Disease) (CC and) (NNS Doc_24999722_2042_2061_Disease))))) (S (VP (VBG requiring) (NP (NN treatment)))))) (. .)))
25006369	0	(ROOT (NP (NP (JJ Optimal) (VBG precurarizing) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_25006369_30_40_Chemical)) (PP (TO to) (NP (NN decrease) (NNS Doc_25006369_53_66_Disease) (CC and) (NNS Doc_25006369_71_78_Disease))))) (PP (VBG following) (NP (JJ Doc_25006369_89_104_Chemical) (NN administration))) (. .)))
25006369	1	(ROOT (S (NP (NNP Doc_25006369_133_148_Chemical)) (ADVP (RB commonly)) (VP (VBZ produces) (NP (NP (JJ frequent) (JJ adverse) (NNS effects)) (, ,) (PP (VBG including) (NP (NNS Doc_25006369_203_223_Disease) (CC and) (NNS Doc_25006369_228_235_Disease))))) (. .)))
25006369	2	(ROOT (S (NP (NP (DT The) (JJ current) (NN study)) (VP (VP (VBN identified) (NP (NP (DT the) (JJ optimal) (NN dose)) (PP (IN of) (NP (NNS Doc_25006369_286_296_Chemical)))) (S (VP (TO to) (VP (VB prevent) (NP (NN Doc_25006369_308_323_Chemical-induced) (NNS Doc_25006369_332_345_Disease) (CC and) (NNS Doc_25006369_350_357_Disease)))))) (CC and) (VP (VBN evaluated) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (NNS Doc_25006369_389_399_Chemical)))) (PP (IN on) (NP (NP (DT the) (NN speed)) (PP (IN of) (NP (NN onset)))))))) (VP (VBD produced) (PP (IN by) (NP (NNS Doc_25006369_434_449_Chemical)))) (. .)))
25006369	3	(ROOT (S (NP (DT This) (JJ randomized) (, ,) (JJ double-blinded) (NN study)) (VP (VBD was) (VP (VBN conducted) (PP (IN in) (NP (NP (CD 100) (NNS patients)) (VP (ADVP (RB randomly)) (VBN allocated) (PP (IN into) (NP (NP (CD five) (NNS groups)) (PP (IN of) (NP (NP (CD 20) (NNS patients)) (NP (DT each))))))))))) (. .)))
25006369	4	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN randomized) (S (VP (TO to) (VP (VB receive) (NP (NP (CD 0.02) (, ,) (CD 0.03) (, ,) (CD 0.04) (, ,) (CD 0.05) (CC and) (CD 0.06) (NN mg/kg) (NNS Doc_25006369_659_669_Chemical)) (PP (IN as) (NP (DT a) (VBG precurarizing) (NN dose))))))))) (. .)))
25006369	5	(ROOT (S (NP (NP (NNP Neuromuscular)) (VP (VBG monitoring) (PP (IN after) (NP (DT each) (VBG precurarizing) (NN dose))))) (VP (VBD was) (VP (VBN recorded) (PP (IN from) (NP (NP (DT the) (NN adductor) (NNS pollicis) (NN muscle)) (VP (VBG using) (ADVP (RB acceleromyography)) (PP (IN with) (NP (NP (JJ train-of-four) (NN stimulation)) (PP (IN of) (NP (DT the) (NN ulnar) (NN nerve)))))))))) (. .)))
25006369	6	(ROOT (S (NP (DT All) (NNS patients)) (VP (VP (VBD received) (NP (QP (CD Doc_25006369_894_909_Chemical) (CD 1.5))) (S (VP (VBG mg/kg) (PP (IN at) (NP (CD 2) (NNS minutes))) (PP (IN after) (NP (DT the) (NN precurarization)))))) (, ,) (CC and) (VP (VBD were) (VP (VBN assessed) (NP (NP (DT the) (NN incidence) (CC and) (NN severity)) (PP (IN of) (NP (NNS Doc_25006369_1008_1022_Disease)))) (, ,) (SBAR (IN while) (S (NP (NNS Doc_25006369_1030_1037_Disease)) (VP (VBD was) (VP (VBN assessed) (PP (IN at) (NP (CD 24) (NNS hours))) (PP (IN after) (NP (NN surgery)))))))))) (. .)))
25006369	7	(ROOT (S (NP (NP (DT The) (NN incidence) (CC and) (NN severity)) (PP (IN of) (NP (JJ visible) (NNS Doc_25006369_1125_1145_Disease)))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR less)) (PP (IN with) (S (VP (VBG increasing) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (VBG precurarizing) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_25006369_1221_1231_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))))))))))) (. .)))
25006369	8	(ROOT (S (S (NP (NP (DT Those)) (PP (IN of) (NP (NNS Doc_25006369_1254_1261_Disease)))) (VP (VBP tend) (S (VP (TO to) (VP (VB decrease) (PP (VBG according) (PP (TO to) (S (VP (VBG increasing) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (VBG precurarizing) (NN dose)) (PP (IN of) (NP (NNS Doc_25006369_1339_1349_Chemical))))))))))))))) (, ,) (CC but) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN significance)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.072))) (-RRB- -RRB-))))) (. .)))
25006369	9	(ROOT (S (NP (NP (DT The) (NN onset) (NN time)) (PP (IN of) (NP (NNS Doc_25006369_1412_1427_Chemical)))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR longer)) (PP (IN with) (S (VP (VBG increasing) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (VBG precurarizing) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_25006369_1505_1515_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))))))))))) (. .)))
25006369	10	(ROOT (S (NP (NP (NNP Precurarization)) (PP (IN with) (NP (CD 0.04) (JJ mg/kg) (NNS Doc_25006369_1574_1584_Chemical)))) (VP (VBD was) (NP (NP (DT the) (JJ optimal) (NN dose)) (VP (VBG considering) (NP (NP (DT the) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN incidence) (CC and) (NN severity)) (PP (IN of) (NP (NP (NP (NNS Doc_25006369_1665_1678_Disease) (CC and) (NNS Doc_25006369_1683_1690_Disease)) (PP (IN with) (NP (JJ acceptable) (NN onset) (NN time)))) (, ,) (CC and) (NP (DT the) (ADJP (JJ safe) (CC and) (JJ effective)) (NN precurarization)))))))))) (. .)))
25006961	0	(ROOT (S (NP (NP (NNP Absence)) (PP (IN of) (NP (NNP PKC-alpha)))) (VP (VBZ attenuates) (NP (NN Doc_25006961_32_39_Chemical-induced) (NNS Doc_25006961_48_78_Disease))) (. .)))
25006961	1	(ROOT (S (NP (NP (NNP Doc_25006961_80_87_Chemical)) (, ,) (NP (DT an) (JJ effective) (NN antipsychotic)) (, ,)) (VP (VBZ induces) (NP (NP (NP (NNS Doc_25006961_125_155_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_25006961_157_160_Disease)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (CD 40) (NN %)) (PP (IN of) (NP (NNS patients))))))) (. .)))
25006961	2	(ROOT (S (NP (NP (DT The) (VBN decreased) (NN capacity)) (SBAR (S (VP (TO to) (VP (VB concentrate) (NP (NN urine))))))) (VP (VBZ is) (ADJP (RB likely) (JJ due) (PP (TO to) (NP (NNS Doc_25006961_244_251_Chemical)))) (S (ADVP (RB acutely)) (VP (VP (VBG disrupting) (NP (DT the) (JJ Doc_25006961_275_279_Chemical) (NN pathway))) (CC and) (VP (VBG chronically) (S (VP (VBG reducing) (NP (NP (NP (JJ Doc_25006961_313_317_Chemical) (NN transporter)) (PRN (-LRB- -LRB-) (NP (NNP UT-A1)) (-RRB- -RRB-))) (CC and) (NP (NP (NN water) (NN channel)) (PRN (-LRB- -LRB-) (NP (NNP AQP2)) (-RRB- -RRB-))) (NP (NP (NN expression)) (PP (IN in) (NP (DT the) (JJ inner) (NN medulla))))))))))) (. .)))
25006961	3	(ROOT (SINV (VP (VBG Targeting) (NP (NP (DT an) (NN alternative)) (VP (VBG signaling) (ADVP (RB pathway))))) (, ,) (PP (JJ such) (IN as) (NP (JJ PKC-mediated) (NNS signaling))) (, ,) (VP (MD may) (VP (VB be))) (NP (NP (DT an) (JJ effective) (NN method)) (PP (IN of) (S (VP (VBG treating) (NP (NN Doc_25006961_511_518_Chemical-induced) (NNS Doc_25006961_527_535_Disease)))))) (. .)))
25006961	4	(ROOT (S (NP (NP (NP (JJ PKC-alpha) (JJ null) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NNP PKCa) (NNP KO)) (-RRB- -RRB-))) (CC and) (NP (JJ strain-matched) (JJ wild) (NN type) (PRN (-LRB- -LRB-) (NP (NNP WT)) (-RRB- -RRB-)) (NNS controls))) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_25006961_628_635_Chemical)) (PP (IN for) (NP (CD 0))) (, ,) (NP (QP (CD 3) (CC or) (CD 5)) (NNS days)))))) (. .)))
25006961	5	(ROOT (S (NP (NNP WT) (NNS mice)) (VP (VP (VBD had) (VP (VBN increased) (NP (NN urine) (NN output)))) (CC and) (VP (VBD lowered) (NP (NN urine) (NN osmolality)) (PP (IN after) (NP (NP (CD 3) (CC and) (CD 5) (NNS days)) (PP (IN of) (NP (NN treatment))))) (SBAR (IN whereas) (S (NP (NNP PKCa) (NNP KO) (NNS mice)) (VP (VBD had) (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NN urine) (NN output) (CC or) (NN concentration))))))))) (. .)))
25006961	6	(ROOT (S (S (NP (JJ Western) (NN blot) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (CD AQP2) (NN expression)) (PP (IN in) (NP (JJ medullary) (NNS tissues)))) (VP (VBD was) (VP (VBN lowered) (PP (IN after) (NP (NP (CD 3) (CC and) (CD 5) (NNS days)) (PP (IN in) (NP (NNP WT) (NNS mice))))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NNP AQP2)) (VP (VBD was) (ADJP (JJ unchanged) (PP (IN in) (NP (NNP PKCa) (NNP KO)))))) (. .)))
25006961	7	(ROOT (S (NP (JJ Similar) (NNS results)) (VP (VBD were) (VP (VBN observed) (PP (IN with) (NP (NN UT-A1) (NN expression))))) (. .)))
25006961	8	(ROOT (S (NP (NNS Animals)) (VP (VBD were) (ADVP (RB also)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_25006961_1061_1068_Chemical)) (PP (IN for) (NP (CD 6) (NNS weeks))))))) (. .)))
25006961	9	(ROOT (S (NP (NNP Doc_25006961_1082_1089_Chemical-treated) (NNP WT) (NNS mice)) (VP (VBD had) (NP (NP (JJ 19-fold) (VBN increased) (NN urine) (NN output)) (SBAR (IN whereas) (S (NP (NNP treated) (NNP PKCa) (NNP KO) (NNS animals)) (VP (VBD had) (NP (NP (DT a) (JJ 4-fold) (NN increase)) (PP (IN in) (NP (NN output))))))))) (. .)))
25006961	10	(ROOT (S (NP (NP (NN AQP2) (CC and) (NN UT-A1) (NN expression)) (SBAR (S (VP (VBD was) (VP (VBN lowered) (PP (IN in) (NP (ADJP (CD 6) (NN week) (JJ Doc_25006961_1254_1261_Chemical-treated)) (NN WT) (NNS animals))) (SBAR (IN whereas) (S (PP (IN in) (NP (JJ treated) (NNP PKCa) (NNP KO) (NNS mice))) (, ,) (NP (NNP AQP2)) (VP (VBD was) (ADVP (RB only)) (VP (VBN reduced) (PP (IN by) (NP (ADJP (JJ 2-fold) (CC and) (JJ UT-A1)) (NN expression)))))))))))) (VP (VBD was) (ADJP (JJ unaffected))) (. .)))
25006961	11	(ROOT (S (NP (ADVP (RB Urinary)) (NNS Doc_25006961_1391_1397_Chemical) (, ,) (NNS Doc_25006961_1399_1408_Chemical) (CC and) (NNS Doc_25006961_1413_1420_Chemical)) (VP (VBD were) (VP (VBN elevated) (PP (PP (IN in) (NP (NNP Doc_25006961_1438_1445_Chemical-fed) (NNP WT))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (JJ Doc_25006961_1464_1471_Chemical-fed) (NNP PKCa) (NNP KO) (NNS mice)))))) (. .)))
25006961	12	(ROOT (S (NP (PRP$ Our) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN ablation)) (PP (IN of) (NP (NNP PKCa)))) (VP (VP (VBZ preserves) (NP (NNP AQP2) (CC and) (NN UT-A1) (NN protein) (NN expression) (CC and) (NN localization)) (PP (IN in) (NP (NN Doc_25006961_1590_1597_Chemical-induced) (NNS Doc_25006961_1606_1609_Disease)))) (, ,) (CC and) (VP (VBZ prevents) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (DT the) (JJ severe) (NNS Doc_25006961_1654_1662_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_25006961_1679_1686_Chemical) (NN therapy)))))))))))) (. .)))
25031906	0	(ROOT (SQ (VBZ Is) (NP (NNP Dysguesia)) (VP (VBG Going) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (NN Rare)) (CC or) (NP (NP (DT a) (JJ Common) (NN Side-effect)) (PP (IN of) (NP (NNS Doc_25031906_59_69_Chemical))))))))) (. ?)))
25031906	1	(ROOT (S (NP (NP (DT A) (ADJP (RB very) (JJ rare)) (NN side-effect)) (PP (IN of) (NP (NNS Doc_25031906_98_108_Chemical)))) (VP (VBZ is) (ADJP (JJ dysguesia))) (. .)))
25031906	2	(ROOT (S (NP (NP (DT A) (NN review)) (PP (IN of) (NP (DT the) (NN literature)))) (VP (VBD produced) (NP (RB only) (CD one) (NN case))) (. .)))
25031906	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN about) (NP (NP (DT a) (NN female)) (PP (IN with) (NP (JJ essential) (NNS Doc_25031906_221_233_Disease)))))) (PP (IN on) (NP (NP (NN drug) (NN treatment)) (PP (IN with) (NP (JJ Doc_25031906_257_267_Chemical) (VBN developed) (NNS Doc_25031906_278_301_Disease)))))) (. .)))
25031906	4	(ROOT (S (NP (NNP Condition)) (ADVP (RB moderately)) (VP (VBD improved) (PP (IN on) (NP (NP (NN stoppage)) (PP (IN of) (NP (DT the) (NN drug))))) (PP (IN for) (NP (CD 25) (NNS days)))) (. .)))
25031906	5	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NNS Doc_25031906_387_397_Chemical)) (VP (MD can) (VP (VB cause) (NP (NN dysguesia))))))) (. .)))
25031906	6	(ROOT (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VP (VB describe) (NP (DT the) (JJ clinical) (NN presentation))) (CC and) (VP (VB review) (NP (DT the) (JJ relevant) (NN literature)) (PP (IN on) (NP (NNS Doc_25031906_501_511_Chemical) (CC and) (NN dysguesia))))) (. .)))
25041770	0	(ROOT (NP (NP (NNP Doc_25041770_0_14_Disease)) (PP (IN in) (NP (NN association))) (PP (IN with) (NP (NNS Doc_25041770_35_46_Chemical) (CC and) (NN dosage) (NN increment))) (PP (IN in) (NP (NNS Doc_25041770_71_85_Chemical))) (. .)))
25041770	1	(ROOT (S (NP (NNP Doc_25041770_87_101_Chemical)) (VP (VBZ is) (NP (NP (DT the) (ADJP (RBS most) (VBN documented)) (NN cytochrome)) (PP (NP (NP (QP (CD P450) (CD 3A4))) (PRN (-LRB- -LRB-) (NP (NNP CYP3A4)) (-RRB- -RRB-))) (NP (NN inhibitor) (S (VP (TO to) (VP (VB cause) (NP (DT an) (JJ adverse) (NN interaction)) (PP (IN with) (NP (NNS Doc_25041770_201_212_Chemical)))))))))) (. .)))
25041770	2	(ROOT (S (NP (DT This) (JJ particular) (NN case)) (VP (VBZ is) (PP (IN of) (NP (NN interest))) (SBAR (IN as) (S (NP (NNS Doc_25041770_253_267_Disease)) (ADVP (RB only)) (VP (VBD occurred) (PP (IN after) (NP (DT an) (NN increase))) (PP (IN in) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NNS Doc_25041770_315_329_Chemical))))))))) (. .)))
25041770	3	(ROOT (S (NP (NP (DT The) (NN patient)) (VP (VBN developed))) (VP (VBD raised) (NP (JJ cardiac) (NNS biomarkers)) (PP (IN without) (NP (DT any) (JJ obvious) (JJ cardiac) (NNS issues))) (, ,) (NP (NP (DT a) (NN phenomenon)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN linked) (PP (TO to) (NP (NNS Doc_25041770_452_466_Disease))) (ADVP (RB previously))))))))) (. .)))
25041770	4	(ROOT (S (PP (TO To) (NP (NN date))) (, ,) (NP (EX there)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT no) (JJ reported) (NN effect)) (PP (IN of) (NP (NNS Doc_25041770_525_539_Disease)))) (PP (IN on) (NP (NP (DT the) (NN structure) (CC and) (NN function)) (PP (IN of) (NP (JJ cardiac) (NN muscle))))))) (. .)))
25041770	5	(ROOT (S (NP (NNS Clinicians)) (VP (VBP need) (S (VP (TO to) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (S (VP (VBG prescribing) (NP (NP (JJ concomitant) (NNS medications)) (SBAR (WHNP (WDT that)) (S (VP (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_25041770_682_690_Disease))))) (CC or) (VP (VB inhibit) (NP (DT the) (NNP CYP3A4) (NN enzyme))))))))))))))) (. .)))
25041770	6	(ROOT (S (NP (PRP$ Our) (NN case)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN troponin) (NN elevation)) (VP (MD could) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (JJ statin) (JJ induced) (NNS Doc_25041770_803_817_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB warrant) (NP (JJ further) (NNS studies)))))))))))))) (. .)))
25054547	0	(ROOT (S (S (NP (NP (NNP Characterization)) (PP (IN of) (NP (DT a) (NN novel)))) (VP (VBP BCHE) (NP (`` ``) (JJ silent) ('' '') (NN allele)))) (: :) (S (NP (NP (NN point) (NN mutation)) (PRN (-LRB- -LRB-) (NP (NNP p.Val204Asp)) (-RRB- -RRB-))) (VP (VBZ causes) (NP (JJ Doc_25054547_86_102_Disease) (CC and) (JJ prolonged) (NNS Doc_25054547_117_122_Disease)) (PP (IN with) (NP (NNS Doc_25054547_128_141_Chemical))))) (. .)))
25054547	1	(ROOT (S (NP (NNP Doc_25054547_143_175_Disease)) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (JJ prolonged) (NNS Doc_25054547_206_211_Disease))) (PP (IN after) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NP (NN muscle) (NNS relaxants)) (PRN (-LRB- -LRB-) (NP (JJ Doc_25054547_247_260_Chemical) (CC or) (JJ Doc_25054547_264_274_Chemical)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN mutations) (PP (IN in) (NP (DT the) (NNP BCHE) (NN gene))))))))))))))) (. .)))
25054547	2	(ROOT (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NNS Doc_25054547_351_380_Disease)))) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NNS Doc_25054547_405_418_Chemical)) (VP (VBG leading) (PP (TO to) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (NP (DT a) (ADJP (JJ novel) (JJ BCHE)) (NN variant)) (PRN (-LRB- -LRB-) (NP (NP (NN c.) (CD 695T) (NNP >) (NNP A)) (, ,) (NP (NNS p.Val204Asp))) (-RRB- -RRB-)))))))))))) (. .)))
25054547	3	(ROOT (S (NP (NP (NN Inhibition) (NNS studies)) (, ,) (NP (JJ kinetic) (NN analysis)) (CC and) (NP (JJ molecular) (NNS dynamics))) (VP (VBD were) (VP (VBN undertaken) (S (VP (TO to) (VP (VB understand) (SBAR (WHADVP (WRB how)) (S (NP (DT this) (NN mutation)) (VP (VP (VBZ disrupts) (NP (DT the) (JJ catalytic) (NN triad))) (CC and) (VP (VBZ determines) (NP (DT a) (`` ``) (JJ silent) ('' '') (NN phenotype))))))))))) (. .)))
25054547	4	(ROOT (S (NP (NP (NNP Low) (NN activity)) (PP (IN of) (NP (NP (NP (JJ patient) (NN plasma) (NN butyrylcholinesterase)) (PP (IN with) (NP (NP (NNS Doc_25054547_725_743_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_25054547_745_748_Chemical)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_25054547_754_768_Chemical)) (, ,)))) (CC and) (NP (NP (NNS values)) (PP (IN of) (NP (JJ Doc_25054547_784_793_Chemical) (CC and) (JJ Doc_25054547_798_806_Chemical) (NNS numbers))))))) (VP (VBP fit) (PP (IN with) (NP (JJ heterozygous) (JJ atypical) (JJ silent) (NN genotype)))) (. .)))
25054547	5	(ROOT (S (NP (NP (JJ Electrophoretic) (NN analysis)) (PP (IN of) (NP (NP (NNP plasma) (NNP BChE)) (PP (IN of) (NP (NP (DT the) (NN proband)) (CC and) (NP (PRP$ his) (NN mother))))))) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP (NN patient)) (VP (VBZ has) (NP (NP (DT a) (VBN reduced) (NN amount)) (PP (IN of) (NP (NP (JJ tetrameric) (NN enzyme)) (PP (IN in) (NP (NN plasma))))))))) (CC and) (SBAR (IN that) (S (S (NP (JJ minor) (JJ fast-moving) (NN BChE) (NNS components)) (: :) (NP (NP (NN monomer)) (, ,) (NP (NN dimer)) (, ,))) (CC and) (S (NP (JJ monomer-albumin) (NN conjugate)) (VP (VBP are) (ADJP (VBG missing)))))))) (. .)))
25054547	6	(ROOT (S (NP (JJ Kinetic) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (NNS p.Val204Asp)) (VP (VBZ /) (ADJP (JJ p.Asp70Gly-p)))))) (. .)))
25054547	7	(ROOT (S (NP (NNP Ala539Thr) (NNP BChE)) (VP (VBZ displays) (NP (NP (DT a) (JJ pure) (NNP Michaelian) (NN behavior)) (PP (IN with) (NP (NNP BTC)))) (PP (IN as) (NP (DT the) (NN substrate)))) (. .)))
25054547	8	(ROOT (S (S (NP (DT Both) (JJ catalytic) (NNS parameters)) (VP (VBN Km) (S (VP (SYM =) (NP (CD 265) (NN uM)))) (PP (PP (IN for) (NP (NNP BTC))) (, ,) (ADVP (NP (CD two) (NNS times)) (RBR higher)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (JJ atypical) (NN enzyme)))))))) (, ,) (CC and) (S (NP (DT a) (JJ low) (NN Vmax)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NN activity)) (PP (IN against) (NP (NNS Doc_25054547_1409_1422_Chemical)))))))))) (. .)))
25054547	9	(ROOT (S (NP (JJ Doc_25054547_1424_1441_Disease) (PRN (-LRB- -LRB-) (NP (NNP Doc_25054547_1443_1445_Disease)) (-RRB- -RRB-)) (NNS simulations)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (JJ overall) (NN effect)) (PP (IN of) (NP (DT the) (NN mutation) (NN p.Val204Asp)))) (VP (VBZ is) (NP (NP (NP (NN disruption)) (PP (IN of) (NP (NP (JJ Doc_25054547_1535_1543_Chemical) (NN bonding)) (PP (IN between) (NP (NNS Doc_25054547_1560_1563_Chemical223) (CC and) (NNS Doc_25054547_1571_1574_Chemical441)))))) (, ,) (NP (VBG leading) (NNS Ser198)) (CC and) (NP (NNS His438) (S (VP (TO to) (VP (VB move) (PRT (RP away)) (PP (IN from) (NP (NP (DT each) (JJ other)) (PP (IN with) (NP (NP (JJ subsequent) (NN disruption)) (PP (IN of) (NP (DT the) (JJ catalytic) (JJ triad) (NN functionality))))))) (ADVP (RB regardless) (PP (IN of) (NP (NP (DT the) (NN type)) (PP (IN of) (NP (NN substrate))))))))))))))) (. .)))
25054547	10	(ROOT (S (NP (NNP Doc_25054547_1735_1737_Disease)) (ADVP (RB also)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ enzyme) (NN volume)) (VP (VBZ is) (VP (VBN increased))))) (, ,) (S (VP (VBG suggesting) (NP (DT a) (JJ pre-denaturation) (NN state))))) (. .)))
25054547	11	(ROOT (S (NP (DT This)) (VP (VBZ fits) (PP (IN with) (NP (NP (DT the) (VBN reduced) (NN concentration)) (PP (IN of) (NP (JJ p.Ala204Asp) (JJ /) (NN p.Asp70Gly-p)))))) (. .)))
25054547	12	(ROOT (S (NP (NP (JJ Ala539Thr) (JJ tetrameric) (NN enzyme)) (PP (IN in) (NP (NP (DT the) (NN plasma)) (CC and) (NP (NP (JJ non-detectable) (JJ fast) (NNS moving-bands)) (PP (IN on) (NP (NNS electrophoresis))))))) (VP (VBZ gels)) (. .)))
25071004	0	(ROOT (NP (NP (NP (JJ Delayed) (NNS Doc_25071004_8_14_Disease)) (PP (IN after) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (JJ injectable) (NNS Doc_25071004_47_57_Chemical)) (PP (IN in) (NP (NP (DT the) (JJ Democratic) (NN Republic)) (PP (IN of) (NP (DT the) (NNP Congo)))))))))) (: :) (NP (DT a) (JJ manageable) (NN issue)) (. .)))
25071004	1	(ROOT (S (NP (NP (NNS Cases)) (PP (IN of) (NP (JJ delayed) (NNS Doc_25071004_136_152_Disease)))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN after) (NP (NN treatment))) (PP (IN with) (NP (NP (NP (JJ injectable) (NNS Doc_25071004_205_215_Chemical)) (, ,) (NP (NP (DT the) (JJ current) (NNP World) (NNP Health) (NNP Organization)) (PRN (-LRB- -LRB-) (NP (NNP WHO)) (-RRB- -RRB-)))) (: -) (NP (NP (VBD recommended) (JJ first-line) (NN drug)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ severe) (NNS Doc_25071004_317_324_Disease))))))))))) (. .)))
25071004	2	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 350) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (QP ($ 215) (CD -LSB-) (CD 61.4)) (NN %)) (JJ -RSB-) (QP (CD <) (CD 5)) (NNS years)) (PP (IN of) (NP (NP (NN age) (CC and) (CD 135) (NNP -LSB-) (CD 38.6) (NN %) (NN -RSB-) (NNS >)) (NP (CD 5) (NNS years)) (PP (IN of) (NP (NN age)))))) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN followed-up) (PP (IN after) (NP (NN treatment))) (PP (IN with) (NP (NP (JJ injectable) (NNS Doc_25071004_463_473_Chemical)) (PP (IN for) (NP (JJ severe) (NNS Doc_25071004_485_492_Disease))))) (PP (IN in) (NP (NP (NNS hospitals) (CC and) (NN health) (NNS centers)) (PP (IN of) (NP (NP (DT the) (JJ Democratic) (NN Republic)) (PP (IN of) (NP (DT the) (NNP Congo))))))))) (. .)))
25071004	3	(ROOT (S (NP (NP (JJ Complete) (NN series)) (PP (IN of) (NP (JJ hemoglobin) (PRN (-LRB- -LRB-) (NP (NNP Hb)) (-RRB- -RRB-)) (NNS measurements)))) (VP (VBD were) (ADJP (JJ available) (PP (IN for) (NP (CD 201) (NNS patients))))) (. .)))
25071004	4	(ROOT (S (NP (NP (DT A) (NN decrease)) (PP (IN in) (NP (NP (NNP Hb) (NNS levels)) (PP (IN between) (NP (CD 2) (CC and) (CD 5)))))) (ADVP (RB g/dL)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (ADJP (CD 23)) (PRN (-LRB- -LRB-) (ADJP (CD 11.4) (NN %)) (-RRB- -RRB-)) (NNS patients))) (PP (IN during) (NP (DT the) (NN follow-up) (NN period))))) (. .)))
25071004	5	(ROOT (S (PP (IN For) (NP (CD five) (NNS patients))) (, ,) (NP (NNP Hb) (NNS levels)) (VP (VBD decreased) (PP (IN below) (NP (CD 5) (NN g/dL))) (PP (IN during) (NP (QP (IN at) (JJS least) (CD one)) (NN follow-up) (NN visit)))) (. .)))
25071004	6	(ROOT (S (NP (NP (DT All) (NNS cases)) (PP (IN of) (NP (JJ delayed) (NNS Doc_25071004_867_873_Disease)))) (VP (VBD were) (UCP (ADJP (RB clinically) (JJ manageable)) (CC and) (VP (VBN resolved) (PP (IN within) (NP (CD one))))) (NP (NN month))) (. .)))
25080425	0	(ROOT (S (NP (NP (NN Regulation)) (PP (IN of) (NP (NP (NP (NN signal) (NN transducer) (CC and) (NN activator)) (PP (IN of) (NP (NN transcription) (CD 3)))) (CC and) (NP (NP (JJ apoptotic) (NNS pathways)) (PP (IN by) (NP (NNS Doc_25080425_91_98_Chemical))))))) (VP (VBZ attenuates) (NP (NP (ADJP (JJ Doc_25080425_110_123_Chemical-induced) (JJ acute)) (NNS Doc_25080425_138_155_Disease)) (PP (IN in) (NP (NNS rats))))) (. .)))
25080425	1	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (JJ cardioprotective) (NNS effects)) (PP (IN of) (NP (NNS Doc_25080425_243_250_Chemical)))) (PP (IN on) (NP (NP (NNS Doc_25080425_254_279_Disease)) (VP (VBN induced) (ADVP (RB experimentally)) (PP (IN in) (NP (NP (NNS rats)) (VP (VBG focusing) (PP (IN on) (NP (NP (NP (NN regulation)) (PP (IN of) (NP (NN signal) (NN transducer) (CC and) (NN activator))) (PP (IN of) (NP (NP (NN transcription) (CD 3)) (PRN (-LRB- -LRB-) (NP (NNP STAT3)) (-RRB- -RRB-))))) (CC and) (NP (NP (JJ apoptotic) (NNS pathways)) (PP (IN as) (NP (DT the) (JJ potential) (NN mechanism)))))) (S (VP (VBG underlying) (NP (DT the) (NN drug) (NN effect))))))))))))))) (. .)))
25080425	2	(ROOT (S (NP (NNP Male) (NNP Sprague) (NNP Dawley) (NNS rats)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (JJ Doc_25080425_517_524_Chemical) (PRN (-LRB- -LRB-) (NP (NP (CD 100)) (, ,) (NP (CD 200)) (, ,) (CC and) (NP (CD 400) (NN mg/kg))) (-RRB- -RRB-)) (NN orally)) (PP (IN for) (NP (CD 40) (NNS days))))))) (. .)))
25080425	3	(ROOT (S (NP (JJ Acute) (NNS Doc_25080425_577_603_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN in) (NP (NNS rats))) (PP (IN by) (NP (NP (JJ subcutaneous) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_25080425_653_666_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 85) (NN mg/kg)) (-RRB- -RRB-)))))) (, ,) (PP (IN for) (NP (CD two) (JJ consecutive) (NNS days))))) (. .)))
25080425	4	(ROOT (S (NP (NP (JJ Serum) (JJ cardiac) (NN marker) (NN enzyme)) (, ,) (NP (JJ histopathological) (NNS variables)) (CC and) (NP (NP (NN expression)) (PP (IN of) (NP (NN protein) (NNS levels))))) (VP (VBD were) (VP (VBN analyzed))) (. .)))
25080425	5	(ROOT (S (NP (NP (JJ Oral) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_25080425_833_840_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 200) (CC and) (CD 400) (CD mg/kg))) (-RRB- -RRB-))))) (VP (VP (ADVP (RB significantly)) (VBD reduced) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (JJ cardiac) (NN marker) (NN enzyme)))) (PP (IN in) (NP (DT the) (NN serum)))) (CC and) (VP (VBD prevented) (NP (JJ left) (NN ventricular) (NN remodeling)))) (. .)))
25080425	6	(ROOT (S (NP (JJ Western) (NN blot) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NN Doc_25080425_1008_1021_Chemical-induced) (NN phosphorylation)) (PP (IN of) (NP (NNP STAT3)))) (VP (VBD was) (VP (VP (VBN maintained)) (CC or) (VP (ADVP (RBR further)) (VBN enhanced) (PP (IN by) (NP (NP (JJ Doc_25080425_1093_1100_Chemical) (NN treatment)) (PP (IN in) (NP (NN myocardium))))))))))) (. .)))
25080425	7	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NNS Doc_25080425_1139_1146_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 200)) (CC and) (NP (CD 400) (NN mg/kg))) (-RRB- -RRB-)) (NP (NN treatment)) (VP (VBD increased) (NP (NP (DT the) (NN ventricular) (NN expression)) (PP (IN of) (NP (NP (ADJP (JJ Bcl-2) (CC and) (JJ reduced)) (DT the) (NN level)) (PP (IN of) (NP (NNP Bax)))))) (, ,) (S (ADVP (RB therefore)) (VP (VBG causing) (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN ratio)) (PP (IN of) (NP (NNP Bcl-2) (NNP /) (NNP Bax)))))))) (. .)))
25080425	8	(ROOT (S (NP (NP (DT The) (JJ protective) (NN role)) (PP (IN of) (NP (NP (NNS Doc_25080425_1344_1351_Chemical)) (PP (IN on) (NP (NNS Doc_25080425_1355_1372_Disease)))))) (VP (VBD was) (ADVP (RBR further)) (VP (VBN confirmed) (PP (IN by) (NP (JJ histopathological) (NN examination))))) (. .)))
25080425	9	(ROOT (S (PP (IN In) (NP (NN summary))) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (JJ Doc_25080425_1465_1472_Chemical) (NN pretreatment)) (VP (VBD attenuated) (NP (NP (NN Doc_25080425_1497_1510_Chemical-induced) (NNS Doc_25080425_1519_1544_Disease)) (PP (IN via) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NNP STAT3)) (CC and) (NP (JJ apoptotic) (NNS pathways))))))))))) (. .)))
25084821	0	(ROOT (NP (NP (JJ Doc_25084821_0_10_Chemical-induced) (NNS Doc_25084821_19_30_Disease)) (PP (IN in) (NP (DT a) (JJ Doc_25084821_36_43_Disease) (NN patient))) (PP (IN with) (NP (NNS Doc_25084821_57_81_Disease))) (. .)))
25084821	1	(ROOT (S (NP (NNP Doc_25084821_94_104_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ Doc_25084821_110_127_Chemical) (NN derivative)) (, ,) (ADJP (JJ similar) (PP (TO to) (NP (NNS Doc_25084821_151_160_Chemical)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (NP (NP (DT the) (JJS highest) (NN risk)) (PP (IN of) (S (VP (VBG causing) (NP (NP (NNS Doc_25084821_200_216_Disease)) (, ,) (RB especially) (NP (NNS Doc_25084821_229_240_Disease)))))))))))) (. .)))
25084821	2	(ROOT (S (S (NP (EX There)) (VP (VBP are) (NP (NP (DT some) (NN case) (NNS reports)) (PP (IN about) (NP (NP (DT this) (NN side) (NN effect)) (PP (IN of) (NP (NNS Doc_25084821_296_306_Chemical)))))))) (, ,) (CC but) (S (NP (JJ possible) (NN risk) (NNS factors)) (VP (VBP are) (ADVP (RB seldom)) (VP (VBN discussed) (CC and) (VBN identified)))) (. .)))
25084821	3	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_25084821_396_420_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD developed) (NP (NNS Doc_25084821_436_447_Disease)) (PP (IN after) (NP (NN treatment))) (PP (IN with) (NP (NNS Doc_25084821_469_479_Chemical))))))))))) (VP (VBZ is) (VP (VBN described) (ADVP (RB here)))) (. .)))
25084821	4	(ROOT (FRAG (NP (NNP CASE) (NNP REPORT)) (: :) (S (NP (NP (DT A) (JJ 62-year-old) (JJ Taiwanese) (NN widow)) (PP (IN with) (NP (NNS Doc_25084821_547_563_Disease)))) (VP (VBD was) (VP (VBN diagnosed) (PP (IN with) (NP (NP (NNS Doc_25084821_583_607_Disease)) (PP (IN at) (NP (NN age) (CD 60)))))))) (. .)))
25084821	5	(ROOT (S (NP (PRP She)) (VP (VBD developed) (NP (NNS Doc_25084821_633_643_Disease)) (PP (IN after) (S (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_25084821_669_679_Chemical)))))))) (. .)))
25084821	6	(ROOT (S (SBAR (IN After) (S (NP (NNS Doc_25084821_687_697_Chemical)) (VP (VBD was) (VP (VBN discontinued))))) (, ,) (NP (PRP$ her) (JJ white) (NN blood) (NN cell)) (VP (VBP count) (VP (VBN returned) (PP (TO to) (ADJP (JJ normal))))) (. .)))
25084821	7	(ROOT (S (SBAR (IN Although) (S (NP (NNS Doc_25084821_785_796_Disease)) (VP (VBZ is) (RB not) (NP (NP (DT a) (JJ common) (NN side) (NN effect)) (PP (IN of) (NP (NNS Doc_25084821_828_838_Chemical))))))) (, ,) (NP (NNS physicians)) (VP (MD should) (VP (VB be) (ADJP (JJ cautious) (PP (IN about) (NP (PRP$ its) (NN presentation) (CC and) (VBN associated) (NN risk) (NNS factors)))))) (. .)))
25084821	8	(ROOT (S (S (NP (NNP Doc_25084821_922_941_Disease)) (VP (MD may) (VP (VB be) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (JJ possible) (NN risk) (NNS factors))))))) (, ,) (CC and) (S (NP (JJ concomitant) (NN fever)) (VP (MD may) (VP (VB be) (NP (NP (DT a) (JJ diagnostic) (NN marker)) (PP (IN for) (NP (JJ adverse) (NN reaction)))) (PP (TO to) (NP (NNS Doc_25084821_1056_1066_Chemical)))))) (. .)))
25096313	0	(ROOT (S (NP (JJ Lateral) (NN antebrachial)) (VP (VBZ cutaneous) (NP (NNS Doc_25096313_31_41_Disease)) (PP (IN after) (NP (NP (JJ Doc_25096313_48_55_Chemical) (NN injection)) (PP (IN at) (NP (JJ lateral) (NN epicondyle)))))) (. .)))
25096313	1	(ROOT (NP (NP (NNP BACKGROUND) (CC AND) (NNP OBJECTIVES)) (: :) (NP (NP (DT This) (NN report)) (VP (VBN aimed) (S (VP (TO to) (VP (VB present) (NP (NP (NP (DT a) (NN case)) (PP (IN of) (NP (JJ lateral) (JJ antebrachial) (NNS cutaneous) (NNS Doc_25096313_186_196_Disease)))) (PRN (-LRB- -LRB-) (NP (NNP LACNP)) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (VP (VBD occurred) (PP (IN after) (NP (NP (DT a) (JJ Doc_25096313_227_234_Chemical) (NN injection)) (PP (IN in) (NP (DT the) (JJ lateral) (NN epicondyle))))) (S (VP (TO to) (VP (VB treat) (NP (NNS Doc_25096313_280_301_Disease)) (PP (IN in) (NP (DT a) (JJ 40-year-old) (NN woman))))))))))))))) (. .)))
25096313	2	(ROOT (NP (NP (NNP MATERIAL) (CC AND) (NNP METHOD)) (: :) (S (S (NP (DT A) (JJ 40-year-old) (NN woman)) (VP (VBD presented) (PP (IN with) (NP (NNS Doc_25096313_382_401_Disease) (CC and) (NN paresthesia))) (PP (IN over) (NP (PRP$ her) (JJ right) (JJ lateral) (NN forearm))))) (: ;) (S (NP (DT the) (NN paresthesia)) (VP (VBD had) (VP (VBN occurred) (PP (IN after) (NP (NP (DT a) (JJ Doc_25096313_487_494_Chemical) (NN injection)) (PP (IN in) (NP (NP (DT the) (JJ right) (JJ lateral) (NN epicondyle)) (ADVP (NP (CD 3) (NNS months)) (IN before)))))))))) (. .)))
25096313	3	(ROOT (S (NP (NP (PRP$ Her) (NN sensation)) (PP (IN of) (NP (JJ light) (NN touch) (CC and) (NNS Doc_25096313_587_591_Disease)))) (VP (VBD was) (VP (VBN diminished) (PP (IN over) (NP (NP (DT the) (JJ lateral) (NN side)) (PP (IN of) (NP (DT the) (JJ right) (NN forearm) (CC and) (NN wrist) (NN area))))))) (. .)))
25096313	4	(ROOT (S (NP (NP (DT The) (JJ sensory) (NN action) (NN potential) (NN amplitude)) (PP (IN of) (NP (NP (NP (DT the) (JJ right) (JJ lateral) (JJ antebrachial) (NNS cutaneous) (NN nerve)) (PRN (-LRB- -LRB-) (NP (NNP LACN)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (QP (CD 6.2) (CD uV))) (-RRB- -RRB-))))) (VP (VBD was) (ADJP (JJR lower)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NP (DT the) (NN left)) (PRN (-LRB- -LRB-) (NP (QP (CD 13.1) (CD uV))) (-RRB- -RRB-))))))) (. .)))
25096313	5	(ROOT (S (NP (NP (DT The) (NN difference)) (PP (IN of) (NP (NP (NN amplitude)) (PP (IN between) (NP (DT both) (NNS sides)))))) (VP (VBD was) (ADJP (JJ significant)) (SBAR (IN because) (S (NP (EX there)) (VP (VBD was) (ADJP (JJR more)) (PP (IN than) (NP (DT a) (ADJP (CD 50) (NN %)) (NN reduction))))))) (. .)))
25096313	6	(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN diagnosed) (PP (IN with) (NP (NP (JJ right) (NNS LACNP)) (PRN (-LRB- -LRB-) (NP (RB mainly) (JJ axonal) (NN involvement)) (-RRB- -RRB-)))) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NP (DT the) (JJ clinical) (NN manifestation)) (CC and) (NP (DT the) (JJ electrodiagnostic) (NNS findings)))))))) (. .)))
25096313	7	(ROOT (S (NP (PRP$ Her) (NNS symptoms)) (VP (VP (VBD improved) (PP (IN through) (NP (JJ physical) (NN therapy)))) (CC but) (VP (VBD persisted) (PP (TO to) (NP (DT some) (NN degree))))) (. .)))
25096313	8	(ROOT (S (NP (DT This) (NN report)) (VP (VBZ describes) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (DT a) (NN woman)) (PP (IN with) (NP (NNP LACNP))))) (SBAR (WHNP (WDT that)) (S (VP (VBN developed) (PP (IN after) (NP (NP (DT a) (JJ Doc_25096313_1238_1245_Chemical) (NN injection)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_25096313_1277_1298_Disease)))))))))))) (. .)))
25096313	9	(ROOT (S (NP (NP (DT An) (JJ electrodiagnostic) (NN study)) (, ,) (PP (VBG including) (NP (NP (DT a) (NN nerve) (NN conduction) (NN study)) (PP (IN of) (NP (DT the) (NNP LACN))))) (, ,)) (VP (VBD was) (ADJP (JJ helpful) (S (VP (VP (TO to) (VP (VB diagnose) (NP (JJ right) (NNS LACNP)))) (CC and) (VP (TO to) (VP (VB find) (NP (NP (DT the) (NN passage)) (PP (IN of) (NP (NP (DT the) (NN LACN)) (PP (IN on) (NP (DT the) (JJ lateral) (NN epicondyle)))))))))))) (. .)))
25119790	0	(ROOT (NP (NP (NP (NNP Doc_25119790_0_8_Chemical)) (VP (VBZ prevents) (NP (JJ maleate-induced) (NN nephrotoxicity)))) (: :) (NP (NP (NN relation)) (PP (TO to) (NP (NP (JJ hemodynamic) (NNS alterations)) (, ,) (NP (JJ oxidative) (NN stress)) (, ,) (NP (JJ mitochondrial) (JJ Doc_25119790_119_125_Chemical) (NN consumption)) (CC and) (NP (NN activity)))) (PP (IN of) (NP (ADJP (RB respiratory) (JJ complex)) (NN I.))))))
25119790	1	(ROOT (S (NP (NP (DT The) (JJ potential) (JJ protective) (NN effect)) (PP (IN of) (NP (DT the) (JJ dietary) (JJ antioxidant) (NNS Doc_25119790_236_244_Chemical))) (PRN (-LRB- -LRB-) (NP (NP (CD 120) (NN mg/Kg/day)) (PP (IN for) (NP (CD 6) (NNS days)))) (-RRB- -RRB-)) (PP (IN against) (NP (NP (DT the) (NNS Doc_25119790_284_296_Disease)) (VP (VBN induced) (PP (IN by) (NP (NN maleate))))))) (VP (VBD was) (VP (VBN evaluated))) (. .)))
25119790	2	(ROOT (S (NP (NP (NNP Tubular) (NNP Doc_25119790_339_350_Disease)) (CC and) (NP (JJ oxidative) (NN stress))) (VP (VBD were) (VP (VBN induced) (PP (IN by) (NP (NP (DT a) (JJ single) (NN injection)) (PP (IN of) (NP (NP (NP (NNS Doc_25119790_410_417_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 400) (NN mg/kg)) (-RRB- -RRB-))) (PP (IN in) (NP (NNS rats))))))))) (. .)))
25119790	3	(ROOT (S (S (NP (JJ Doc_25119790_439_446_Chemical-induced) (NNS Doc_25119790_455_467_Disease)) (VP (VBD included) (NP (NN increase)) (PP (IN in) (NP (JJ renal) (NN vascular) (NN resistance))))) (CC and) (S (PP (IN in) (NP (NP (DT the) (JJ urinary) (NN excretion)) (PP (IN of) (NP (NP (JJ total) (NN protein) (, ,) (JJ Doc_25119790_562_569_Chemical) (, ,) (JJ Doc_25119790_571_577_Chemical) (, ,) (JJ neutrophil) (JJ gelatinase-associated) (NN lipocalin)) (PRN (-LRB- -LRB-) (NP (NNP NGAL)) (-RRB- -RRB-)) (CC and) (NP (JJ Doc_25119790_633_641_Chemical) (NN b-D-glucosaminidase)) (PRN (-LRB- -LRB-) (NP (NNP NAG)) (-RRB- -RRB-)))))) (, ,) (NP (NP (NN upregulation)) (PP (IN of) (NP (NP (NP (JJ Doc_25119790_685_698_Disease) (NN molecule)) (PRN (-LRB- -LRB-) (NP (NNP KIM)) (-RRB- -RRB-)) (NP (CD -1))) (, ,) (NP (NP (NN decrease)) (PP (IN in) (NP (JJ renal) (NN blood) (NN flow)))) (CC and) (NP (NP (JJ claudin-2) (NN expression) (NNS besides)) (PP (IN of) (NP (NP (NNS Doc_25119790_782_790_Disease) (CC and) (NNS apoptosis)) (PP (IN of) (NP (NP (JJ tubular) (NNS cells)) (PP (IN on) (NP (CD 24) (NNP h.) (NNP Oxidative) (NN stress))))))))))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (S (VP (VBG measuring) (NP (NP (NP (DT the) (NN oxidation)) (PP (IN of) (NP (NNS lipids) (CC and) (NNS proteins)))) (CC and) (NP (NP (NN diminution)) (PP (IN in) (NP (JJ renal) (JJ Nrf2) (NNS levels))))))))))) (. .)))
25119790	4	(ROOT (S (NP (NNPS Studies)) (VP (VBD were) (ADVP (RB also)) (VP (VBN conducted) (PP (PP (IN in) (NP (JJ renal) (JJ epithelial) (NN LLC-PK1) (NNS cells))) (CC and) (PP (IN in) (NP (NP (NN mitochondria)) (VP (VBN isolated) (PP (IN from) (NP (NP (NNS kidneys)) (PP (IN of) (NP (PDT all) (DT the) (JJ experimental) (NNS groups))))))))))) (. .)))
25119790	5	(ROOT (S (VP (VP (VB Maleate) (NP (JJ induced) (NN cell) (NN damage))) (CC and) (VP (VB reactive) (NP (NP (JJ Doc_25119790_1127_1133_Chemical) (NNS species)) (PRN (-LRB- -LRB-) (NP (NNP ROS)) (-RRB- -RRB-)))) (NP (NN production)) (PP (IN in) (NP (NP (NN LLC-PK1) (NNS cells)) (PP (IN in) (NP (NN culture)))))) (. .)))
25119790	6	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ maleate) (NN treatment)) (VP (VBD reduced) (NP (JJ Doc_25119790_1227_1233_Chemical) (NN consumption)) (PP (IN in) (NP (NP (NN Doc_25119790_1249_1252_Chemical-stimulated) (NN mitochondria)) (CC and) (NP (JJ diminished) (JJ respiratory) (NN control) (NN index)))) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (JJ Doc_25119790_1329_1335_Chemical) (JJ /) (NNS Doc_25119790_1336_1345_Chemical)) (PP (IN as) (NP (NN substrate))))))) (. .)))
25119790	7	(ROOT (S (NP (NP (DT The) (NNS activities)) (PP (IN of) (NP (DT both) (JJ complex) (NN I) (CC and) (NN aconitase)))) (VP (VBD were) (VP (ADVP (RB also)) (VBN diminished))) (. .)))
25119790	8	(ROOT (S (NP (PDT All) (DT the) (JJ above-described) (NNS alterations)) (VP (VBD were) (VP (VBN prevented) (PP (IN by) (NP (NNS Doc_25119790_1483_1491_Chemical))))) (. .)))
25119790	9	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (NNS Doc_25119790_1514_1522_Chemical)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB attenuate) (PP (PP (IN in) (NP (JJ vivo) (JJ maleate-induced) (NNS Doc_25119790_1568_1579_Disease))) (CC and) (PP (IN in) (NP (JJ vitro) (NN cell) (NN damage))))))))))))) (. .)))
25119790	10	(ROOT (S (S (NP (NP (NNP The)) (PP (IN in) (NP (NN vivo) (NN protection)))) (VP (VBD was) (VP (VBN associated) (PP (TO to) (NP (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (JJ oxidative) (NN stress) (CC and) (NN preservation))) (PP (IN of) (NP (JJ mitochondrial) (JJ Doc_25119790_1716_1722_Chemical) (NN consumption)))) (CC and) (NP (NP (NN activity)) (PP (IN of) (NP (ADJP (RB respiratory) (JJ complex)) (NN I))))))))) (, ,) (CC and) (S (NP (DT the) (ADJP (IN in) (NN vitro)) (NN protection)) (VP (VBD was) (VP (VBN associated) (PP (TO to) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (NNP ROS) (NN production)))))))) (. .)))
2553470	0	(ROOT (NP (NP (JJ Anticonvulsant) (NNS actions)) (PP (IN of) (NP (NP (NNS Doc_2553470_26_32_Chemical)) (PP (IN on) (NP (DT the) (NN Doc_2553470_40_47_Chemical-Doc_2553470_48_59_Chemical) (NN model))))) (PP (IN of) (NP (NP (NNS Doc_2553470_69_87_Disease)) (PP (IN in) (NP (NNS rats))))) (. .)))
2553470	1	(ROOT (S (NP (NP (NNP Doc_2553470_97_103_Chemical)) (, ,) (NP (DT a) (NP (NP (JJ noncompetitive) (NNS Doc_2553470_122_142_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2553470_144_148_Chemical)) (-RRB- -RRB-))) (NN receptor) (NN antagonist)) (, ,)) (VP (VBD was) (VP (VBN tested) (PP (IN for) (NP (JJ anticonvulsant) (NNS effects))) (PP (IN in) (NP (NP (NNS rats)) (VP (VBG using) (NP (NP (CD two) (JJ Doc_2553470_227_234_Disease) (NNS models)) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NNS Doc_2553470_263_270_Chemical) (CC and) (NNS Doc_2553470_275_286_Chemical)))) (CC and) (NP (NP (NN administration)) (PP (IN of) (NP (NP (DT a) (JJ high) (NN dose)) (PP (IN of) (NP (NNS Doc_2553470_324_335_Chemical))))))) (ADVP (RB alone))))))) (. .)))
2553470	2	(ROOT (S (NP (CD Three) (JJ major) (NNS results)) (VP (VBP are) (VP (VBN reported))) (. .)))
2553470	3	(ROOT (S (ADVP (RB First)) (, ,) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NNS Doc_2553470_402_408_Chemical)))) (VP (VBD produced) (NP (DT an) (ADJP (JJ effective) (CC and) (JJ dose-dependent)) (NN anticonvulsant) (NN action)) (PP (PP (IN with) (NP (DT the) (NN Doc_2553470_481_488_Chemical-Doc_2553470_489_500_Chemical) (NN model))) (CONJP (CC but) (RB not)) (PP (IN with) (NP (NP (NNS rats)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_2553470_538_549_Chemical))) (ADVP (RB alone)))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ different) (JJ biochemical) (NNS mechanisms)) (VP (VBP control) (NP (NP (NNS Doc_2553470_614_622_Disease)) (PP (IN in) (NP (DT these) (CD two) (NNS models)))))))))) (. .)))
2553470	4	(ROOT (S (ADVP (LS Second)) (, ,) (NP (NP (DT the) (JJ anticonvulsant) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_2553470_681_687_Chemical)) (PP (IN in) (NP (DT the) (NN Doc_2553470_695_702_Chemical-Doc_2553470_703_714_Chemical) (NN model)))))) (ADVP (RB only)) (VP (VBN occurred) (PP (IN after) (NP (NP (JJ initial) (NNS periods)) (PP (IN of) (NP (JJ Doc_2553470_760_767_Disease) (NN activity)))))) (. .)))
2553470	5	(ROOT (S (NP (DT This) (NN observation)) (VP (VBZ is) (VP (VBN suggested) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (RB in) (JJ vivo) (NN demonstration)) (PP (IN of) (NP (NP (DT the) (NN conclusion)) (VP (VBN derived) (PP (IN from) (NP (ADJP (IN in) (NN vitro)) (NNS experiments))) (SBAR (IN that) (S (NP (NNP Doc_2553470_896_902_Chemical) (NNP binding)) (VP (VBZ requires) (NP (NP (JJ agonist-induced) (NN opening)) (PP (IN of) (NP (NP (DT the) (NN channel) (NNS sites)) (PP (IN of) (NP (DT the) (JJ Doc_2553470_972_976_Chemical) (NN receptor)))))))))))))))))) (. .)))
2553470	6	(ROOT (S (ADVP (LS Third)) (, ,) (SBAR (IN although) (S (NP (PRP it)) (VP (VBZ is) (ADJP (RB relatively) (JJ easy)) (S (VP (TO to) (VP (VB block) (NP (NP (NNS Doc_2553470_1034_1042_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_2553470_1054_1061_Chemical) (CC and) (NNS Doc_2553470_1066_1077_Chemical))) (PP (IN by) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NNS anticonvulsants)) (ADVP (RB prior) (PP (TO to) (NP (NNS Doc_2553470_1124_1135_Chemical)))))))))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (RBR more) (JJ difficult) (S (VP (TO to) (VP (VP (VB terminate) (NP (JJ ongoing) (NNS Doc_2553470_1179_1197_Disease))) (CC and) (VP (VB block) (NP (NP (DT the) (NN lethality)) (PP (IN of) (NP (DT the) (NNS Doc_2553470_1229_1237_Disease)))))))))) (. .)))
2553470	7	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NNS Doc_2553470_1257_1263_Chemical) (CD 30) (CC or) (CD 60)))) (VP (VBP min) (SBAR (IN after) (S (NP (NP (NNS Doc_2553470_1283_1294_Chemical)) (, ,) (VP (VBN i.e.) (, ,) (PP (IN during) (NP (NNS Doc_2553470_1309_1327_Disease)))) (, ,)) (VP (VP (ADVP (RB gradually)) (VBD reduced) (NP (JJ electrical) (CC and) (JJ behavioral) (NNS Doc_2553470_1373_1380_Disease) (NN activity))) (CC and) (VP (ADVP (RB greatly)) (VBD enhanced) (NP (DT the) (NN survival) (NN rate))))))) (. .)))
2553470	8	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN activation)) (PP (IN of) (NP (JJ Doc_2553470_1471_1475_Chemical) (NNS receptors)))) (VP (VBZ plays) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NNS Doc_2553470_1513_1531_Disease) (CC and) (NNS Doc_2553470_1536_1548_Disease)))) (PP (IN in) (NP (DT the) (NN Doc_2553470_1556_1563_Chemical-Doc_2553470_1564_1575_Chemical) (NN model))))))) (. .)))
2553470	9	(ROOT (S (NP (DT This)) (VP (VBD was) (VP (RBR further) (VBN supported) (PP (IN by) (NP (NP (NNS results)) (VP (VBG showing) (SBAR (IN that) (S (NP (NP (JJ nonconvulsive) (NNS doses)) (PP (IN of) (NP (NNS Doc_2553470_1657_1661_Chemical) (CC and) (NNS Doc_2553470_1666_1677_Chemical)))) (VP (VBD were) (ADJP (JJ synergistic)) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NNS Doc_2553470_1709_1727_Disease)) (CC and) (NP (JJ subsequent) (NN mortality)))))))))))))) (. .)))
256433	0	(ROOT (S (NP (JJ Continuous) (NN infusion) (NNS Doc_256433_20_30_Chemical)) (VP (VBD combined) (PP (IN with) (NP (NP (NNS Doc_256433_45_58_Chemical)) (PP (IN for) (NP (NNS Doc_256433_63_73_Disease))))) (PP (IN in) (NP (JJ Doc_256433_77_83_Disease) (NNS patients)))) (. .)))
256433	1	(ROOT (S (NP (NP (DT The) (NN cure) (NN rate)) (PP (IN of) (NP (NP (NNS Doc_256433_111_121_Disease)) (PP (IN in) (NP (JJ Doc_256433_125_131_Disease) (NNS patients)))))) (VP (VBZ is) (ADVP (RB adversely)) (VP (VBN affected) (PP (IN by) (NP (NP (NNS Doc_256433_166_177_Disease)) (PRN (-LRB- -LRB-) (NP (QP (JJR less) (IN than) (CD 1,000) (CD /)) (NNS mm3)) (-RRB- -RRB-)))))) (. .)))
256433	2	(ROOT (S (PP (IN In) (ADJP (JJ particular))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ severe) (NNS Doc_256433_237_248_Disease)) (PRN (-LRB- -LRB-) (NP (QP (JJR less) (IN than) (CD 100/mm3))) (-RRB- -RRB-))))) (VP (VBP have) (VP (VBN shown) (NP (DT a) (JJ poor) (NN response)) (PP (TO to) (NP (NNS antibiotics))))) (. .)))
256433	3	(ROOT (S (S (VP (TO To) (VP (VB overcome) (NP (NP (DT the) (JJ adverse) (NNS effects)) (PP (IN of) (NP (NNS Doc_256433_347_358_Disease))))))) (, ,) (NP (NNS Doc_256433_360_370_Chemical)) (VP (VBD was) (VP (VP (VBN given) (PP (IN by) (NP (JJ continuous) (NN infusion)))) (CC and) (VP (VBN combined) (PP (IN with) (NP (JJ intermittent) (NNS Doc_256433_435_448_Chemical)))))) (. .)))
256433	4	(ROOT (S (S (NP (NNP Doc_256433_450_460_Chemical)) (VP (VBD was) (VP (VBN given) (PP (TO to) (NP (NP (DT a) (JJ total) (JJ daily) (NN dose)) (PP (IN of) (NP (CD 300) (NNS mg/m2)))))))) (CC and) (S (NP (NNS Doc_256433_510_523_Chemical)) (VP (VBD was) (VP (VBN given) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 5) (NN gm))))) (NP (DT every) (CD four) (NNS hours))))) (. .)))
256433	5	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (CD 125) (JJ Doc_256433_585_595_Disease) (NNS episodes)) (PP (IN in) (NP (NP (QP (CD 116) (CD Doc_256433_612_618_Disease)) (NNS patients)) (VP (VBG receiving) (NP (JJ myelosuppressive) (NN chemotherapy))))))) (. .)))
256433	6	(ROOT (S (NP (DT The) (JJ overall) (NN cure) (NN rate)) (VP (VBD was) (NP (CD 70) (NN %))) (. .)))
256433	7	(ROOT (S (S (NP (NNP Doc_256433_700_709_Disease)) (VP (VBD was) (NP (DT the) (ADJP (RBS most) (JJ common)) (NNS Doc_256433_730_739_Disease)))) (CC and) (S (NP (NP (CD 61) (NN %)) (PP (IN of) (NP (CD 59) (NNS episodes)))) (VP (VBD were) (VP (VBN cured)))) (. .)))
256433	8	(ROOT (S (S (NP (JJ Gram-negative) (NNS bacilli)) (VP (VBD were) (NP (DT the) (RBS most) (JJ common) (NN causative) (NNS organisms)))) (CC and) (S (NP (NP (CD 69) (NN %)) (PP (IN of) (NP (DT these) (NNS Doc_256433_855_865_Disease)))) (VP (VBD were) (VP (VBN cured)))) (. .)))
256433	9	(ROOT (S (NP (DT The) (ADJP (RBS most) (JJ common)) (NN pathogen)) (VP (VBD was) (NP (NP (NNS Doc_256433_907_928_Disease)) (CC and) (NP (DT this))) (, ,) (PP (ADVP (RB together)) (IN with) (NP (NP (JJ Doc_256433_953_964_Disease) (NNS coli) (CC and) (NNS Doc_256433_974_996_Disease)) (, ,) (VP (VBN accounted) (PP (IN for) (NP (NP (CD 74) (NN %)) (PP (IN of) (NP (DT all) (JJ gram-negative) (NNS Doc_256433_1037_1057_Disease))))))))) (. .)))
256433	10	(ROOT (S (NP (NNP Response)) (VP (VBD was) (RB not) (VP (VBN influenced) (PP (IN by) (NP (DT the) (JJ initial) (JJ neutrophil) (NN count))) (, ,) (PP (IN with) (NP (NP (DT a) (CD 62) (NN %) (NN cure) (NN rate)) (PP (IN for) (NP (NP (CD 39) (NNS episodes)) (VP (VBN associated) (PP (IN with) (NP (JJ severe) (NNS Doc_256433_1180_1191_Disease)))))))))) (. .)))
256433	11	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (NN failure)) (PP (IN of) (NP (DT the) (JJ neutrophil) (NN count) (S (VP (TO to) (VP (VB increase) (PP (IN during) (NP (NN therapy))))))))) (ADVP (RB adversely)) (VP (VBD affected) (NP (NN response))) (. .)))
256433	12	(ROOT (S (S (NP (NNP Doc_256433_1290_1298_Disease)) (VP (VBD was) (NP (NP (DT the) (JJ major) (NN side) (NN effect)) (VP (VBN recognized))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBD occurred) (PP (IN in) (NP (NP (CD 11) (NN %)) (PP (IN of) (NP (NNS episodes))))))) (. .)))
256433	13	(ROOT (S (NP (NP (JJ Major) (NNS Doc_256433_1379_1387_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN serum) (NNS Doc_256433_1395_1405_Chemical)) (NP (QP (JJR greater) (IN than) (CD 2.5)) (NN mg/dl))) (CC or) (NP (NP (NNP BUN)) (NP (QP (JJR greater) (IN than) (CD 50)) (NN mg/dl)))) (-RRB- -RRB-))) (VP (VBD occurred) (PP (IN in) (NP (QP (RB only) (CD 2)) (NN %)))) (. .)))
256433	14	(ROOT (S (NP (NNP Doc_256433_1480_1488_Disease)) (VP (VBD was) (RB not) (VP (VBN related) (PP (TO to) (NP (NP (NN duration)) (PP (IN of) (NP (NN therapy) (CC or) (NN serum) (NNS Doc_256433_1537_1547_Chemical) (NN concentration))))))) (. .)))
256433	15	(ROOT (S (NP (DT This) (JJ antibiotic) (NN regimen)) (VP (VBD showed) (NP (DT both) (JJ therapeutic) (ADJP (JJ efficacy) (CC and) (JJ acceptable)) (NNS Doc_256433_1635_1649_Disease)) (PP (IN for) (NP (DT these) (NNS patients)))) (. .)))
25907210	0	(ROOT (S (S (NP (NP (NNP Incidence)) (PP (IN of) (NP (NP (JJ solid) (NNS Doc_25907210_19_26_Disease)) (PP (IN among) (NP (NN pesticide) (NNS applicators)))))) (VP (VBD exposed) (PP (TO to) (NP (DT the) (JJ Doc_25907210_70_85_Chemical) (JJ insecticide) (NNS Doc_25907210_98_106_Chemical))) (PP (IN in) (NP (DT the) (NNP Agricultural) (NNP Health) (NNP Study))))) (: :) (S (NP (DT an) (VBN updated) (NN analysis))) (. .)))
25907210	1	(ROOT (S (S (NP (NP (NNP Doc_25907210_173_181_Chemical)) (, ,) (NP (NP (DT a) (JJ common) (JJ Doc_25907210_192_207_Chemical) (NN insecticide)) (PP (IN with) (NP (JJ genotoxic) (NNS properties)))) (, ,)) (VP (VBD was) (ADVP (RB previously)) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_25907210_278_289_Disease)) (PP (IN in) (NP (DT the) (NP (NP (NNP Agricultural) (NNP Health) (NNP Study)) (PRN (-LRB- -LRB-) (NP (NNP AHS)) (-RRB- -RRB-))) (NN cohort)))))))) (, ,) (CC but) (S (NP (JJ few) (JJ other) (NN epidemiological) (NNS studies)) (VP (VBP have) (VP (VBN examined) (S (VP (VBG Doc_25907210_389_397_Chemical-associated) (NP (JJ Doc_25907210_409_415_Disease) (NN risk))))))) (. .)))
25907210	2	(ROOT (S (NP (PRP We)) (VP (VBD used) (NP (VBN updated) (JJ Doc_25907210_438_446_Chemical) (NN exposure) (CC and) (NN Doc_25907210_460_466_Disease) (NN incidence) (NN information)) (S (VP (TO to) (VP (VB evaluate) (NP (NP (JJ solid) (NN tumour) (NN risk)) (PP (IN in) (NP (DT the) (NNP AHS)))))))) (. .)))
25907210	3	(ROOT (S (S (NP (NP (JJ Male) (NN pesticide) (NNS applicators)) (PP (IN in) (NP (NNP Iowa) (CC and) (NNP North) (NNP Carolina)))) (VP (VBD reported) (SBAR (S (NP (NN lifetime) (NNS Doc_25907210_612_620_Chemical)) (VP (VBP use) (PP (IN at) (NP (NP (NN enrolment)) (PRN (-LRB- -LRB-) (NP (CD 1993-1997)) (-RRB- -RRB-)) (CC and) (NP (NN follow-up)) (PRN (-LRB- -LRB-) (NP (CD 1998-2005)) (-RRB- -RRB-))))))))) (: ;) (S (NP (JJ Doc_25907210_677_683_Disease) (NN incidence)) (VP (VBD was) (VP (VBN assessed) (PP (IN through) (NP (NP (NP (NP (CD 2010)) (PRN (-LRB- -LRB-) (NP (NNP North) (NNP Carolina)) (-RRB- -RRB-))) (PRN (: /) (NP (CD 2011)))) (PRN (-LRB- -LRB-) (NP (NNP Iowa)) (-RRB- -RRB-))))))) (. .)))
25907210	4	(ROOT (S (PP (IN Among) (NP (NP (NNS applicators)) (PP (IN with) (NP (NP (NN usage) (NN information)) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB evaluate) (NP (JJ exposure-response) (NNS patterns)))))))))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (JJ Poisson) (NN regression)) (S (VP (TO to) (VP (VB estimate) (NP (NP (NP (VBN adjusted) (NN rate) (NNS ratios)) (PRN (-LRB- -LRB-) (NP (NNP RRs)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (PP (IN for) (NP (NP (JJ Doc_25907210_921_927_Disease) (NNS sites)) (PP (IN with) (NP (NP (QP (CD >) (CD 10)) (VBN exposed) (NNS cases)) (PP (IN for) (NP (DT both) (NN lifetime)))))))) (PRN (-LRB- -LRB-) (NP (NNP LT)) (-RRB- -RRB-))) (NP (NN exposure) (NNS days)) (CC and) (NP (NP (NP (JJ intensity-weighted) (PRN (-LRB- -LRB-) (NP (NNP IW)) (-RRB- -RRB-)) (NN lifetime)) (NP (NN exposure) (NNS days))) (PRN (-LRB- -LRB-) (NP (NP (NN accounting)) (PP (IN for) (NP (NP (NNS factors)) (VP (VBG impacting) (NP (NN exposure)))))) (-RRB- -RRB-)))))))) (. .)))
25907210	5	(ROOT (S (NP (PRP We)) (VP (VBD observed) (NP (NP (JJ elevated) (JJ Doc_25907210_1120_1131_Disease) (NNS risks)) (PRN (-LRB- -LRB-) (NP (NNP N) (NNP =) (NNP 283)) (-RRB- -RRB-))) (PP (IN among) (NP (NNS applicators))) (PP (IN with) (NP (NP (DT the) (JJS greatest) (NN number)) (PP (IN of) (NP (NP (NP (NNP LT)) (-LRB- -LRB-) (NP (NP (NP (NNP RR)) (SBAR (S (VP (SYM =) (NP (CD 1.60)))))) (: ;) (NP (NP (CD 95) (NN %)) (RRC (ADVP (RB CI)) (NP (QP (CD 1.11) (TO to) (CD 2.31))))) (: ;) (NP (NP (NNP Ptrend)) (SBAR (S (VP (SYM =) (NP (CD 0.02))))))) (-RRB- -RRB-)) (CC and) (NP (NP (NNP IW) (NNS days)) (PP (IN of) (NP (NP (JJ Doc_25907210_1254_1262_Chemical) (NN use)) (PRN (-LRB- -LRB-) (NP (NP (NNP RR) (NNP =) (NNP 1.41)) (: ;) (NP (NP (NP (CD 95) (NN %)) (RRC (ADVP (RB CI)) (NP (QP (CD 0.98) (TO to) (CD 2.04))))) (: ;) (NP (NP (NNP Ptrend)) (SBAR (S (VP (SYM =) (NP (CD 0.08)))))))) (-RRB- -RRB-)))))))))) (. .)))
25907210	6	(ROOT (S (NP (JJ Doc_25907210_1312_1325_Disease) (PRN (-LRB- -LRB-) (NP (NNP N) (QP (CD =) (CD 94))) (-RRB- -RRB-)) (NNS risks)) (VP (VBD were) (NP (NP (JJ non-significantly) (NNS elevated)) (PRN (-LRB- -LRB-) (NP (NP (JJ RRLT) (NNS days)) (NP (NP (QP (CD =) (CD 1.77))) (: ;) (NP (NP (CD 95) (NN %)) (NP (NP (NP (NNP CI) (CD 0.90)) (PP (TO to) (NP (CD 3.51)))) (: ;) (NP (NP (NNP Ptrend)) (SBAR (S (VP (SYM =) (NP (CD 0.09)))))) (: ;) (NP (NP (JJ RRIW) (NNS days)) (NP (CD 1.37))) (: ;) (NP (NP (CD 95) (NN %)) (RRC (ADVP (RB CI)) (NP (QP (CD 0.64) (TO to) (CD 2.92))))) (: ;) (NP (NP (NNP Ptrend)) (SBAR (S (VP (SYM =) (NP (CD 0.50)))))))))) (-RRB- -RRB-))) (, ,) (SBAR (IN as) (S (VP (VBD were) (NP (NP (NNS risks)) (PP (IN for) (NP (NP (JJ aggressive) (NNS Doc_25907210_1502_1517_Disease)) (PRN (-LRB- -LRB-) (NP (NNP N) (QP (CD =) (CD 656))) (-RRB- -RRB-))))))))) (. .)))
25907210	7	(ROOT (S (NP (NP (PRP$ Our) (VBN updated) (NN evaluation)) (PP (IN of) (NP (NNS Doc_25907210_1566_1574_Chemical)))) (VP (VBZ provides) (NP (NP (JJ additional) (NN evidence)) (PP (IN of) (NP (NP (DT an) (NN association)) (PP (IN with) (NP (JJ Doc_25907210_1627_1638_Disease) (NN risk))))))) (. .)))
25907210	8	(ROOT (S (NP (NP (ADJP (RB Newly) (VBN identified)) (NNS links)) (PP (TO to) (NP (NNS Doc_25907210_1671_1684_Disease) (CC and) (NNS associations))) (PP (IN with) (NP (JJ aggressive) (NNS Doc_25907210_1718_1733_Disease)))) (VP (VBP require) (NP (JJ further) (NN evaluation))) (. .)))
25951420	0	(ROOT (S (NP (NP (NNS Associations)) (PP (IN of) (NP (NP (NNS Doc_25951420_16_21_Chemical)) (CC and) (NP (NNP PM2) (CD .5))))) (VP (VBZ Concentrations) (PP (IN With) (NP (NNS Doc_25951420_52_71_Disease))) (PP (IN Among) (NP (NP (NNS Participants)) (PP (IN in) (NP (DT the) (NNP Agricultural) (NNP Health) (NNP Study)))))) (. .)))
25951420	1	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ describes) (NP (NP (NNS associations)) (PP (IN of) (NP (NP (NNS Doc_25951420_173_178_Chemical)) (CC and) (NP (JJ fine) (NN particulate) (NN matter))))) (PP (IN with) (NP (NP (NNS Doc_25951420_212_231_Disease)) (VP (VBN observed) (PP (IN among) (NP (NP (NNS farmers)) (PP (IN in) (NP (NNP North) (NNP Carolina) (CC and) (NNP Iowa))))))))) (. .)))
25951420	2	(ROOT (S (NP (PRP We)) (VP (VBD used) (NP (JJ logistic) (NN regression)) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NNS associations)) (PP (IN of) (NP (DT these) (NNS pollutants)))) (PP (IN with) (NP (JJ self-reported) (, ,) (JJ doctor-diagnosed) (NNS Doc_25951420_407_426_Disease))))))) (. .)))
25951420	3	(ROOT (S (NP (NNP Daily)) (VP (VBD predicted) (SBAR (S (NP (NN pollutant) (NNS concentrations)) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VP (VB derive) (NP (NP (NNS surrogates)) (PP (IN of) (NP (JJ long-term) (NN exposure))))) (CC and) (VP (VB link) (S (NP (PRP them)) (VP (TO to) (VP (VB study) (NP (NP (NNS participants) (POS ')) (JJ geocoded) (NNS addresses)))))))))))))) (. .)))
25951420	4	(ROOT (S (NP (PRP We)) (VP (VBD observed) (NP (NP (JJ positive) (NNS associations)) (PP (IN of) (NP (NP (NNS Doc_25951420_625_644_Disease)) (PP (IN with) (NP (NP (NNS Doc_25951420_650_655_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS odds)) (NP (NP (NP (NN ratio)) (SBAR (S (VP (SYM =) (NP (CD 1.39)))))) (: ;) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (: :) (NP (QP (CD 0.98) (TO to) (CD 1.98)))))) (-RRB- -RRB-)) (CC and) (NP (JJ fine) (NN particulate) (NN matter)) (PRN (-LRB- -LRB-) (NP (NP (NNS odds) (NN ratio)) (NP (NP (QP (CD =) (CD 1.34))) (: ;) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (: :) (NP (QP (CD 0.93) (TO to) (CD 1.93)))))) (-RRB- -RRB-))))))) (PP (PP (IN in) (NP (NNP North) (NNP Carolina))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NNP Iowa))))) (. .)))
25951420	5	(ROOT (S (NP (NP (DT The) (NN plausibility)) (PP (IN of) (NP (NP (DT an) (NN effect)) (PP (IN of) (NP (NP (JJ ambient) (NNS concentrations)) (PP (IN of) (NP (NP (DT these) (NNS pollutants)) (PP (IN on) (NP (JJ Doc_25951420_895_914_Disease) (NN risk)))))))))) (VP (VBZ is) (VP (VBN supported) (PP (IN by) (NP (JJ experimental) (NNS data))) (S (VP (VBG demonstrating) (NP (NNS Doc_25951420_968_998_Disease)) (PP (IN at) (NP (JJ relevant) (NNS concentrations))))))) (. .)))
25951420	6	(ROOT (S (S (NP (JJ Additional) (NNS studies)) (VP (VBP are) (VP (VBN needed) (S (VP (VP (TO to) (VP (VB address) (NP (NNS uncertainties)) (ADVP (VBN related) (PP (TO to) (NP (NN confounding)))))) (CC and) (VP (TO to) (VP (VB examine) (NP (NP (JJ temporal) (NNS aspects)) (PP (IN of) (NP (DT the) (NNS associations))))))))))) (NP (PRP we)) (VP (VBD observed)) (. .)))
25986755	0	(ROOT (S (NP (NP (ADJP (RB Low) (JJ functional)) (NN programming)) (PP (IN of) (NP (JJ renal) (NN AT2R)))) (VP (VBZ mediates) (NP (NP (DT the) (JJ developmental) (NN origin)) (PP (IN of) (NP (NP (NNS Doc_25986755_78_96_Disease)) (PP (IN in) (NP (NP (JJ adult) (NN offspring)) (VP (VBN induced) (PP (IN by) (NP (JJ prenatal) (JJ Doc_25986755_136_144_Chemical) (NN exposure)))))))))) (. .)))
25986755	1	(ROOT (S (NP (PRP$ Our) (JJ previous) (NN study)) (VP (VBZ has) (VP (VBN indicated) (SBAR (IN that) (S (NP (NP (JJ prenatal) (JJ Doc_25986755_214_222_Chemical) (NN exposure)) (PRN (-LRB- -LRB-) (NP (NNP PCE)) (-RRB- -RRB-))) (VP (MD could) (VP (VB induce) (NP (NP (NP (NNS Doc_25986755_251_282_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_25986755_284_288_Disease)) (-RRB- -RRB-))) (PP (IN of) (NP (NN offspring)))))))))) (. .)))
25986755	2	(ROOT (S (NP (JJ Recent) (NN research)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NNS Doc_25986755_335_339_Disease)) (VP (VBZ is) (NP (NP (DT a) (NN risk) (NN factor)) (PP (IN for) (NP (NNS Doc_25986755_361_379_Disease)))))))) (. .)))
25986755	3	(ROOT (S (ADVP (RB However)) (, ,) (SBAR (IN whether) (S (NP (NNP PCE)) (VP (MD could) (VP (VB induce) (NP (NP (NNS Doc_25986755_415_433_Disease)) (CC and) (NP (PRP$ its) (VBG underlying) (NNS mechanisms))))))) (VP (VB remain) (ADJP (JJ unknown))) (. .)))
25986755	4	(ROOT (S (NP (DT This) (NN study)) (VP (VBD aimed) (S (VP (TO to) (VP (VB demonstrate) (NP (DT the) (NN induction)) (PP (TO to) (NP (NP (NNS Doc_25986755_529_547_Disease)) (PP (IN in) (NP (JJ adult) (NN offspring))))) (PP (IN by) (NP (NP (NNP PCE)) (CC and) (NP (PRP$ its) (JJ intrauterine) (NN programming) (NNS mechanisms)))))))) (. .)))
25986755	5	(ROOT (S (S (NP (NP (DT A) (NN rat) (NN model)) (PP (IN of) (NP (NNS Doc_25986755_634_638_Disease)))) (VP (VBD was) (VP (VBN established) (PP (IN by) (NP (NNP PCE)))))) (, ,) (NP (NP (JJ male) (NNS fetuses) (CC and) (NN adult) (NN offspring)) (PP (IN at) (NP (NP (DT the) (NN age)) (PP (IN of) (NP (NN postnatal) (NN week) (CD 24)))))) (VP (VBD were) (VP (VBN euthanized))) (. .)))
25986755	6	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (DT the) (JJ adult) (NN offspring) (NNS kidneys)) (PP (IN in) (NP (DT the) (NNP PCE) (NN group)))) (VP (VBD exhibited) (NP (NP (NNS Doc_25986755_826_844_Disease)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ interstitial) (NNS Doc_25986755_869_877_Disease))) (, ,) (S (VP (VBN accompanied) (PP (IN by) (NP (NP (JJ elevated) (NNS levels)) (PP (IN of) (NP (NP (NN serum) (NNS Doc_25986755_919_929_Chemical)) (CC and) (NP (NN urine) (NN protein)))))))))))) (. .)))
25986755	7	(ROOT (FRAG (NP (NP (NNP Renal) (NNP angiotensin) (NNP II) (NN receptor) (NN type)) (SBAR (WHNP (WHNP (CD 2)) (PRN (-LRB- -LRB-) (NP (NNP AT2R)) (-RRB- -RRB-))) (S (NP (NP (NN gene) (NN expression)) (PP (IN in) (NP (JJ adult) (NN offspring)))) (VP (VBD was) (VP (VBN reduced) (PP (IN by) (NP (NNP PCE))) (, ,) (SBAR (IN whereas) (S (NP (DT the) (JJ renal) (NNP angiotensin) (NNP II) (NN receptor) (NN type)) (VP (VBZ 1a) (NP (-LRB- -LRB-) (NNS AT1aR) (-RRB- -RRB-)))))))))) (: /) (S (NP (CD AT2R) (NN expression) (NN ratio)) (VP (VBD was) (VP (VBN increased)))) (. .)))
25986755	8	(ROOT (S (NP (NP (DT The) (JJ fetal) (NNS kidneys)) (PP (IN in) (NP (DT the) (NNP PCE) (NN group)))) (VP (VBD displayed) (NP (NP (NP (DT an) (NNP enlarged) (NNP Bowman) (POS 's)) (NN space)) (CC and) (NP (NP (DT a) (JJ shrunken) (NN glomerular) (NN tuft)) (, ,) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT a) (VBN reduced) (NN cortex) (NN width)) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (DT the) (JJ nephrogenic) (JJ zone/cortical) (NN zone) (NN ratio)))))))))) (. .)))
25986755	9	(ROOT (S (NP (NP (NNP Observation)) (PP (IN by) (NP (JJ electronic) (NN microscope)))) (VP (VBD revealed) (SBAR (S (NP (NP (NP (JJ structural) (NN damage)) (PP (IN of) (NP (NNS podocytes)))) (: ;) (NP (NP (DT the) (VBN reduced) (NN expression) (NN level)) (PP (IN of) (NP (JJ podocyte) (NN marker) (NNS genes) (, ,) (NNS nephrin) (CC and) (NNS Doc_25986755_1491_1498_Chemical)))) (, ,)) (VP (VBD was) (ADVP (RB also)) (VP (VBN detected) (PP (IN by) (NP (NN q-PCR)))))))) (. .)))
25986755	10	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (CD AT2R) (NN gene) (CC and) (NN protein) (NNS expressions)) (PP (IN in) (NP (JJ fetal) (NNS kidneys)))) (VP (VBD were) (VP (VBN inhibited) (PP (IN by) (NP (NP (NNP PCE)) (, ,) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN repression)) (PP (IN of) (NP (NP (DT the) (NN gene) (NN expression)) (PP (IN of) (NP (NP (NP (NP (JJ glial-cell-line-derived) (JJ neurotrophic) (NN factor)) (PRN (-LRB- -LRB-) (NP (NNP GDNF)) (-RRB- -RRB-))) (PRN (: /) (NP (JJ Doc_25986755_1720_1728_Chemical) (JJ kinase) (NN receptor)))) (PRN (-LRB- -LRB-) (NP (NN c-Ret)) (-RRB- -RRB-)))))))) (S (VP (VBG signaling) (ADVP (RB pathway))))))))) (. .)))
25986755	11	(ROOT (S (S (NP (DT These) (NNS results)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NNP PCE)) (VP (MD could) (VP (VB induce) (NP (NP (NP (NNS Doc_25986755_1821_1830_Disease)) (PP (IN of) (NP (JJ fetal) (NNS kidneys)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS Doc_25986755_1859_1877_Disease)) (PP (IN of) (NP (JJ adult) (NN offspring))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (ADJP (JJ low) (JJ functional)) (NN programming)) (PP (IN of) (NP (JJ renal) (NN AT2R)))) (VP (MD might) (VP (VB mediate) (NP (NP (DT the) (JJ developmental) (NN origin)) (PP (IN of) (NP (JJ adult) (NNS Doc_25986755_1995_2013_Disease))))))) (. .)))
26002693	0	(ROOT (S (ADVP (RB Doc_26002693_0_13_Chemical)) (, ,) (NP (NP (NNS Doc_26002693_15_18_Disease)) (CC and) (NP (NP (DT the) (NN t)) (PRN (-LRB- -LRB-) (NP (CD 9:22)) (-RRB- -RRB-)))) (VP (VBP translocation) (: :) (NP (DT A) (NN reality) (NN check))) (. .)))
26002693	1	(ROOT (S (NP (NP (JJ Epidemiological) (NNS studies)) (PP (IN of) (NP (NNS Doc_26002693_106_119_Chemical)))) (VP (VBP have) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS exposures)) (PP (TO to) (NP (NNS humans)))) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_26002693_178_202_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_26002693_204_207_Disease)) (-RRB- -RRB-)))))))))) (. .)))
26002693	2	(ROOT (S (S (NP (NNP Doc_26002693_210_213_Disease)) (VP (VBZ has) (NP (NP (DT a) (JJ well-documented) (NN association)) (PP (IN with) (NP (VBG ionizing) (NN radiation)))))) (, ,) (CC but) (S (NP (NP (NNS reports)) (PP (IN of) (NP (NP (NNS associations)) (PP (IN with) (NP (NN chemical) (NNS exposures)))))) (VP (VBP have) (VP (VBN been) (VP (VBN questioned))))) (. .)))
26002693	3	(ROOT (S (S (NP (VBG Ionizing) (NN radiation)) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG inducing) (NP (NP (DT the) (JJ requisite) (ADJP (JJ Doc_26002693_403_406_Disease-associated) (JJ t)) (PRN (-LRB- -LRB-) (NP (CD 9:22)) (-RRB- -RRB-)) (NN translocation)) (PRN (-LRB- -LRB-) (NP (NNP Doc_26002693_441_464_Disease)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (JJ appropriate) (NNS cells)) (PP (IN in) (NP (NNP vitro))))))))))) (CC but) (, ,) (S (ADVP (RB thus) (RB far)) (, ,) (NP (NNS chemicals)) (VP (VBP have) (RB not) (VP (VBN shown) (NP (DT this) (NN capacity))))) (. .)))
26002693	4	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN proposed) (SBAR (IN that) (S (NP (NNS Doc_26002693_573_586_Chemical)) (VP (VBZ metabolites) (VP (VB be) (VP (ADVP (RB so)) (VBN tested) (PP (IN as) (NP (NP (DT a) (NN reality) (NN check)) (PP (IN on) (NP (DT the) (JJ epidemiological) (NNS reports)))))))))))) (. .)))
26002693	5	(ROOT (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB conduct) (NP (JJ reliable) (NN testing)) (PP (IN in) (NP (DT this) (NN regard))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ essential)) (SBAR (IN that) (S (NP (NP (DT a) (JJ positive) (NN control)) (PP (IN for) (NP (NN induction)))) (VP (VB be) (ADJP (JJ available)))))) (. .)))
26002693	6	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN used) (S (VP (VBG ionizing) (NP (NN radiation)) (S (VP (TO to) (VP (VB develop) (NP (PDT such) (DT a) (NN control))))))))) (. .)))
26002693	7	(ROOT (S (NP (NNS Results)) (VP (VBD described) (ADVP (RB here)) (VP (VB demonstrate) (SBAR (IN that) (S (NP (DT this) (NN agent)) (VP (VP (VBZ does) (PP (IN in) (NP (NN fact))) (S (VP (VB induce) (NP (NP (JJ pathogenic) (NN t) (PRN (-LRB- -LRB-) (NP (CD 9:22)) (-RRB- -RRB-)) (NNS translocations)) (PP (IN in) (NP (NP (DT a) (JJ human) (JJ myeloid) (NN cell) (NN line)) (PP (IN in) (NP (NNP vitro))))))))) (, ,) (CC but) (VP (VBZ does) (ADVP (RB so)) (PP (IN at) (NP (JJ low) (NNS frequencies))))))))) (. .)))
26002693	8	(ROOT (S (NP (NP (NNS Conditions)) (SBAR (WHNP (WDT that)) (S (VP (MD will) (VP (VB be) (VP (VBN required) (PP (IN for) (NP (NP (NNS studies)) (PP (IN of) (NP (NNS Doc_26002693_1067_1080_Chemical))))))))))) (VP (VBP are) (VP (VBN discussed))) (. .)))
26033014	0	(ROOT (NP (NP (NP (JJ Doc_26033014_0_6_Disease) (NN incidence) (CC and) (NNS Doc_26033014_21_32_Chemical) (NN use)) (PP (IN in) (NP (DT the) (NNP Agricultural) (NNP Health) (NNP Study)))) (: :) (NP (DT An) (NN update)) (. .)))
26033014	1	(ROOT (S (NP (NP (NNP Doc_26033014_94_105_Chemical)) (, ,) (NP (DT a) (ADJP (RB widely) (VBN used)) (NN herbicide)) (, ,)) (VP (VBZ is) (VP (VBN classified) (PP (IN as) (NP (NP (DT a) (NNP Group) (NNP C) (NN carcinogen)) (PP (IN by) (NP (DT the) (NNP U.S.) (NNP Environmental) (NNP Protection) (NNP Agency))))) (PP (VBN based) (PP (IN on) (NP (NP (VBN increased) (NNS Doc_26033014_233_248_Disease)) (PP (IN in) (NP (JJ female) (NNS rats)))))))) (. .)))
26033014	2	(ROOT (S (NP (NP (JJ Epidemiologic) (NNS studies)) (PP (IN of) (NP (NP (DT the) (NN health) (NNS effects)) (PP (IN of) (NP (NNS Doc_26033014_312_323_Chemical)))))) (VP (VBP have) (VP (VBN been) (VP (VBN limited)))) (. .)))
26033014	3	(ROOT (S (S (NP (NP (DT The) (NNP Agricultural) (NNP Health) (NNP Study)) (PRN (-LRB- -LRB-) (NP (NNP AHS)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ prospective) (NN cohort) (NN study)) (PP (VBG including) (NP (NP (JJ licensed) (JJ private) (CC and) (JJ commercial) (NN pesticide) (NNS applicators)) (PP (IN in) (NP (NNP Iowa)))))))) (CC and) (S (NP (NNP North) (NNP Carolina)) (VP (VBD enrolled) (NP (CD 1993-1997)))) (. .)))
26033014	4	(ROOT (S (S (NP (PRP We)) (VP (VBN evaluated) (NP (JJ Doc_26033014_533_539_Disease) (NN incidence)) (PP (IN through) (NP (NP (CD 2010/2011)) (PRN (-LRB- -LRB-) (NP (NNP NC/IA)) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 49,616) (NNS applicators))))) (, ,) (NP (NP (CD 53) (NN %)) (PP (IN of) (NP (WP whom)))) (VP (VBD reported) (S (ADVP (RB ever)) (VP (VBG using) (NP (NNS Doc_26033014_632_643_Chemical))))) (. .)))
26033014	5	(ROOT (S (NP (PRP We)) (VP (VBD used) (NP (JJ Poisson) (NN regression)) (S (VP (TO to) (VP (VB evaluate) (NP (NP (NNS relations)) (PP (IN between) (NP (NP (CD two) (NNS metrics)) (PP (IN of) (NP (NP (NP (JJ Doc_26033014_717_728_Chemical) (NN use)) (PRN (-LRB- -LRB-) (NP (NP (NN lifetime) (NNS days)) (, ,) (NP (JJ intensity-weighted) (NN lifetime) (NNS days))) (-RRB- -RRB-))) (CC and) (NP (JJ Doc_26033014_787_793_Disease) (NN incidence))))))))))) (. .)))
26033014	6	(ROOT (S (NP (PRP We)) (VP (VBD saw) (NP (NP (NP (NP (DT no) (NN association)) (PP (IN between) (NP (JJ Doc_26033014_835_846_Chemical) (NN use) (CC and) (NN incidence))) (PP (IN of) (NP (NP (DT all) (NNS Doc_26033014_872_879_Disease)) (VP (VBN combined))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 5,701)))) (PP (IN with) (NP (DT a) (JJ 5-year) (NN lag)))) (-RRB- -RRB-))) (CC or) (NP (ADJP (RBS most) (JJ site-specific)) (NNS Doc_26033014_941_948_Disease)))) (. .)))
26033014	7	(ROOT (S (PP (IN For) (NP (NNS Doc_26033014_954_966_Disease))) (, ,) (PP (IN in) (NP (NP (NNS analyses)) (VP (VBN restricted) (PP (TO to) (NP (VBN exposed) (NNS workers)))))) (, ,) (NP (NP (NNS elevations)) (VP (VBN observed) (PP (IN at) (NP (NP (JJR higher) (NNS categories)) (PP (IN of) (NP (NN use))))))) (VP (VBD were) (RB not) (ADJP (RB statistically) (JJ significant))) (. .)))
26033014	8	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (NNS trends)) (PP (IN for) (NP (NP (DT both) (NN lifetime)) (CC and) (NP (NP (JJ intensity-weighted) (NN lifetime) (NNS days)) (PP (IN of) (NP (JJ Doc_26033014_1169_1179_Chemical) (NN use))))))) (VP (VBD were) (ADJP (ADJP (JJ positive)) (CC and) (ADJP (RB statistically) (JJ significant))) (PP (IN with) (NP (DT an) (JJ unexposed) (NN reference) (NN group)))) (. .)))
26033014	9	(ROOT (S (S (NP (DT A) (JJ similar) (NN pattern)) (VP (VBD was) (VP (VBN observed) (PP (IN for) (NP (NNS Doc_26033014_1298_1322_Disease)))))) (, ,) (CC but) (S (NP (DT no) (JJ other) (NNS Doc_26033014_1337_1345_Disease)) (VP (VBZ subtypes))) (. .)))
26033014	10	(ROOT (S (NP (NP (DT An) (JJR earlier) (NN suggestion)) (PP (IN of) (NP (NP (JJ Doc_26033014_1381_1402_Disease) (NN risk)) (PP (IN at) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (JJ Doc_26033014_1426_1437_Chemical) (NN use)) (PP (IN in) (NP (DT this) (NN cohort)))))))))) (VP (VBD was) (RB not) (VP (VBN confirmed) (PP (IN in) (NP (DT this) (NN update))))) (. .)))
26033014	11	(ROOT (S (NP (NP (DT This) (NN suggestion)) (PP (IN of) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP (NNS Doc_26033014_1533_1544_Chemical) (CC and) (NNS Doc_26033014_1549_1561_Disease)) (PP (IN among) (NP (NN pesticide) (NNS applicators)))))))) (VP (VBZ is) (NP (NP (DT a) (NN novel) (NN finding) (CC and) (NNS echoes) (NN observation)) (PP (IN of) (NP (NP (VBN increased) (NNS Doc_26033014_1645_1660_Disease)) (PP (IN in) (NP (DT some) (NN animal) (NNS studies))))))) (. .)))
26033014	12	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (PRP$ our) (NNS findings)) (PP (IN for) (NP (DT both) (NNS Doc_26033014_1716_1728_Disease) (CC and) (NNS Doc_26033014_1733_1757_Disease) (NN warrant)))) (VP (VBZ follow-up) (S (VP (TO to) (VP (ADVP (RBR better)) (VB differentiate) (NP (NP (NNS effects)) (PP (IN of) (NP (NP (JJ Doc_26033014_1811_1822_Chemical) (NN use)) (PP (IN from) (NP (JJ other) (NNS factors)))))))))) (. .)))
26115410	0	(ROOT (NP (NP (NP (NNPS Mechanisms) (NNP Underlying) (NNP Latent) (NNP Disease) (NNP Risk) (NNP Associated)) (PP (IN with) (NP (NNP Early-Life) (NNP Doc_26115410_69_76_Chemical) (NNP Exposure)))) (: :) (NP (NP (NNP Current) (NNP Research) (NNP Trends)) (CC and) (NP (NNP Scientific) (NNP Gaps))) (. .)))
26115410	1	(ROOT (S (NP (NP (NP (NNS Millions)) (PP (IN of) (NP (NP (NNS individuals)) (ADVP (RB worldwide))))) (, ,) (NP (NP (RB particularly) (DT those) (NN living)) (PP (IN in) (NP (JJ rural) (CC and) (JJ developing) (NNS areas)))) (, ,)) (VP (VBP are) (VP (VBN exposed) (PP (TO to) (NP (NP (JJ harmful) (NNS levels)) (PP (IN of) (NP (NP (NP (JJ inorganic) (NNS Doc_26115410_279_286_Chemical)) (PRN (-LRB- -LRB-) (NP (NN iAs)) (-RRB- -RRB-))) (PP (IN in) (NP (PRP$ their) (NN drinking) (NN water))))))))) (. .)))
26115410	2	(ROOT (S (NP (NNP Inorganic)) (PP (IN As) (NP (NP (NN exposure)) (PP (IN during) (NP (JJ key) (JJ developmental) (NNS periods))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ adverse) (NN health) (NNS effects))))) (PP (VBG including) (NP (NP (DT those)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ evident) (PP (IN in) (ADJP (JJ adulthood))))))))))) (. .)))
26115410	3	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (JJ considerable) (NN interest)) (PP (IN in) (S (VP (VBG identifying) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (SBAR (WHNP (WDT that)) (S (VP (VBP relate) (NP (JJ early-life) (NN iAs) (NN exposure)) (PP (PP (TO to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT these) (NN latent) (NNS diseases))))) (, ,) (RB particularly) (PP (IN in) (NP (NP (NN relationship)) (PP (TO to) (NP (NNS Doc_26115410_659_665_Disease))))))))))))))) (. .)))
26115410	4	(ROOT (S (NP (DT This) (NN work)) (VP (VBZ summarizes) (NP (NN research)) (PP (IN on) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (SBAR (WHNP (WDT that)) (S (VP (VB underlie) (NP (NP (DT the) (VBN increased) (NN risk)) (PP (IN of) (NP (NP (JJ Doc_26115410_773_779_Disease) (NN development)) (PP (IN in) (NP (NN adulthood))))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (JJ early-life) (NN iAs) (NN exposure)))))))))))))) (. .)))
26115410	5	(ROOT (S (S (NP (NNP Epigenetic)) (VP (VBG reprogramming) (SBAR (IN that) (S (NP (NP (ADJP (JJ imparts) (JJ functional)) (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (, ,) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_26115410_962_968_Disease))))))) (VP (VBP stem) (NP (NNS cells))))))) (, ,) (CC and) (S (NP (NN immunomodulation)) (VP (VBP are) (NP (NP (JJ plausible) (VBG underlying) (NNS mechanisms)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (JJ early-life) (NN iAs) (NN exposure)) (VP (VBZ elicits) (NP (ADJP (JJ latent) (JJ carcinogenic)) (NNS effects)))))))) (. .)))
26115410	6	(ROOT (S (NP (NN Evidence)) (VP (VBZ is) (NP (NP (VBG mounting)) (SBAR (WHNP (WDT that)) (S (VP (VBZ relates) (NP (JJ early-life) (NN iAs) (NN exposure) (CC and) (NNS Doc_26115410_1183_1189_Disease) (NN development)) (ADVP (RB later) (PP (IN in) (NP (NN life))))))))) (. .)))
26115410	7	(ROOT (S (NP (JJ Future) (NN research)) (VP (MD should) (VP (VB include) (NP (NP (NN animal) (NNS studies)) (SBAR (WHNP (WDT that)) (S (VP (VBP address) (NP (NP (JJ mechanistic) (NNS hypotheses) (CC and) (NNS studies)) (PP (IN of) (NP (JJ human) (NNS populations))) (SBAR (WHNP (WDT that)) (S (VP (VB integrate) (NP (NP (JJ early-life) (NN exposure)) (, ,) (NP (JJ molecular) (NNS alterations)) (, ,) (CC and) (NP (NN latent) (NN disease) (NNS outcomes))))))))))))) (. .)))
2614930	0	(ROOT (S (NP (NNP Doc_2614930_0_10_Chemical)) (VP (VBN induced) (NP (NNS Doc_2614930_19_30_Disease)) (PP (IN in) (NP (DT a) (NN patient))) (PP (IN with) (NP (NNS Doc_2614930_49_69_Disease)))) (. .)))
2614930	1	(ROOT (S (NP (NP (DT An) (ADJP (CD 80) (NN year) (JJ old)) (NNS Doc_2614930_86_99_Disease)) (PP (IN with) (NP (NP (NN evidence)) (PP (IN of) (NP (NNS Doc_2614930_117_152_Disease)))))) (VP (VBD was) (VP (VBN admitted) (PP (IN with) (NP (NNS Doc_2614930_171_181_Disease))))) (. .)))
2614930	2	(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NP (NNS Doc_2614930_204_218_Disease)) (PP (IN at) (NP (NP (DT a) (NN ventricular) (NN rate)) (PP (IN of) (NP (CD 70/min))))) (SBAR (WHNP (WDT which)) (S (VP (VBD slowed) (PRT (RP down)) (PP (TO to) (NP (CD 30-40) (JJ /) (NN min))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NP (NNS Doc_2614930_287_297_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 60) (CD mg))) (-RRB- -RRB-))) (PP (IN in) (NP (CD 3)))) (VP (VBD divided) (NP (NP (NNS doses)) (, ,) (SBAR (WHPP (IN during) (WHNP (WDT which))) (S (NP (PRP he)) (VP (VBD was) (VP (VBN paced) (PP (IN at) (NP (NP (DT a) (NN rate)) (PP (IN of) (NP (CD 70/min)))))))))))))))))))))) (. .)))
2614930	3	(ROOT (S (NP (DT This)) (VP (VBZ is) (ADJP (JJ inconsistent) (PP (IN with) (NP (DT the) (JJ well-established) (NN finding)))) (SBAR (IN that) (S (NP (NNS Doc_2614930_433_443_Chemical)) (VP (VBZ induces) (NP (NP (NNS Doc_2614930_452_463_Disease)) (PP (IN in) (NP (ADJP (ADVP (RB normally)) (JJ innervated)) (NNS hearts)))))))) (. .)))
2614930	4	(ROOT (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (NNS hearts)) (VP (VBN deprived) (PP (IN of) (NP (ADJP (JJ compensatory) (JJ sympathetic)) (NN drive)))))) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NNS Doc_2614930_573_584_Disease))))) (. .)))
2625524	0	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_2625524_14_25_Chemical)) (PP (IN in) (NP (NNS Doc_2625524_29_36_Chemical) (CC and) (NNS Doc_2625524_41_52_Chemical)))))) (VP (VBP intoxication)) (. .)))
2625524	1	(ROOT (S (NP (NP (DT The) (NN effectiveness)) (PP (IN of) (NP (NP (JJ Doc_2625524_88_99_Chemical) (NN pretreatment)) (PP (IN in) (S (VP (VBG preventing) (NP (NP (DT the) (JJ toxic) (NNS effects)) (PP (IN of) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NNS Doc_2625524_162_173_Chemical) (CC and) (NNS Doc_2625524_178_185_Chemical)))))))))))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (NNS rats))))) (. .)))
2625524	2	(ROOT (S (PP (IN In) (NP (DT this) (NN model))) (, ,) (NP (JJ toxic) (NNS effects)) (VP (VBD were) (VP (VBN induced) (PP (IN by) (NP (NP (NP (JJ intraperitoneal) (PRN (-LRB- -LRB-) (NP (NNP i.p.)) (-RRB- -RRB-)) (NN injection)) (PP (IN of) (NP (NP (QP (CD Doc_2625524_288_299_Chemical) (CD 75)) (NN mg/kg)) (PRN (-LRB- -LRB-) (NP (NP (CD 100) (NN %)) (NP (JJ Doc_2625524_315_320_Disease) (NN rate))) (-RRB- -RRB-))))) (CC or) (NP (NP (NNS Doc_2625524_330_337_Chemical)) (NP (CD 70) (NN mg/kg) (PRN (-LRB- -LRB-) (NP (NP (CD 82) (NN %)) (NP (JJ Doc_2625524_352_357_Disease) (NN rate))) (-RRB- -RRB-)))))))) (. .)))
2625524	3	(ROOT (S (NP (NNP Doc_2625524_365_376_Chemical)) (VP (VP (VBD failed) (S (VP (TO to) (VP (VB prevent) (NP (NN Doc_2625524_395_406_Chemical-induced) (NNS Doc_2625524_415_423_Disease)))))) (, ,) (CC but) (VP (VBD did) (ADVP (RBR lower)) (NP (DT the) (NN mortality) (NN rate)) (PP (IN at) (NP (NP (JJS most) (NNS doses)) (VP (VBN tested)))))) (. .)))
2625524	4	(ROOT (S (S (NP (NNP Doc_2625524_480_491_Chemical)) (VP (VBD decreased) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NN Doc_2625524_519_526_Chemical-induced) (NNS Doc_2625524_535_543_Disease)))) (PP (IN at) (NP (DT the) (CD two) (JJS highest) (NNS doses))))) (, ,) (CC but) (S (NP (NP (DT the) (NN lowering)) (PP (IN of) (NP (DT the) (NN mortality) (NN rate)))) (VP (VBD did) (RB not) (VP (VB reach) (NP (JJ statistical) (NN significance)) (PP (IN at) (NP (DT any) (NN dose)))))) (. .)))
2625524	5	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP suggest) (NP (NP (DT a) (JJ protective) (NN role)) (PP (IN for) (NP (NP (DT the) (JJ central) (JJ Doc_2625524_714_722_Chemical) (NN blocker) (NNS Doc_2625524_731_742_Chemical)) (PP (IN against) (NP (NP (NNS Doc_2625524_751_756_Disease)) (PP (IN from) (NP (JJ high-dose) (JJ Doc_2625524_772_783_Chemical) (NN exposure)))))))) (PP (IN without) (S (VP (VBG reducing) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_2625524_827_835_Disease)))))))) (. .)))
2625524	6	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NNS Doc_2625524_850_861_Chemical)) (VP (VBD demonstrated) (NP (DT an) (NN ability) (S (VP (TO to) (VP (VB reduce) (NP (NN Doc_2625524_896_903_Chemical-induced) (NNS Doc_2625524_912_920_Disease)) (PP (IN without) (S (ADVP (RB significantly)) (VP (VBG reducing) (NP (NN mortality)))))))))) (. .)))
2650911	0	(ROOT (NP (NP (JJ Autoradiographic) (NN evidence)) (PP (IN of) (NP (JJ Doc_2650911_29_37_Chemical) (VBG binding) (NNS sites))) (PP (IN in) (NP (NNS nuclei))) (PP (IN of) (NP (NNS Doc_2650911_65_84_Chemical))) (VP (VBN induced) (NP (NN hamster) (NNS Doc_2650911_101_117_Disease))) (. .)))
2650911	1	(ROOT (S (NP (JJ Doc_2650911_119_127_Chemical) (JJ binding) (NNS sites)) (VP (VBD were) (VP (VBN demonstrated) (PP (IN by) (NP (NP (NP (NN autoradiography)) (PP (IN in) (NP (CD one) (NN transplantable)))) (CC and) (NP (NP (CD five) (JJ primary) (NNS Doc_2650911_218_237_Chemical)) (VP (VBN induced) (NP (NP (NNS Doc_2650911_246_262_Disease)) (PP (IN in) (NP (CD three) (NNS hamsters)))))))))) (. .)))
2650911	2	(ROOT (S (S (NP (NP (NN Radiolabelling)) (, ,) (PP (VBG following) (NP (NP (DT the) (RB in) (JJ vivo) (NN injection)) (PP (IN of) (NP (NNS Doc_2650911_333_353_Chemical))))) (, ,)) (VP (VBD was) (VP (VBN increased) (ADVP (RB only)) (PP (IN over) (NP (NP (DT the) (NN nuclei)) (PP (IN of) (NP (JJ Doc_2650911_393_398_Disease) (NNS cells)))))))) (: ;) (S (NP (JJ stereologic) (NN analysis)) (VP (VBD revealed) (X (NP (DT a) (CD 4.5)) (: -) (PP (TO to) (ADJP (JJ 6.7-times)))) (NP (NP (JJR higher) (NN concentration)) (PP (IN of) (NP (NP (JJ reduced) (JJ Doc_2650911_488_494_Chemical) (NNS grains)) (PP (IN over) (NP (NP (NNS nuclei)) (PP (IN than) (NP (NP (NN cytoplasm)) (PP (IN of) (NP (DT these) (NNS cells)))))))))))) (. .)))
2650911	3	(ROOT (S (PP (IN Despite) (NP (NP (JJ rapid) (JJ tubular) (NN excretion)) (PP (IN of) (NP (NP (NNS Doc_2650911_580_589_Chemical)) (SBAR (WHNP (WDT which)) (S (VP (VBN peaked) (PP (IN in) (NP (QP (JJR less) (IN than) (CD 1)) (NN h)))))))))) (, ,) (NP (DT the) (JJ normal) (NNS cells)) (VP (VBD did) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB bind) (NP (DT the) (NN ligand))))))) (. .)))
2650911	4	(ROOT (S (NP (DT This)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (VBN published) (NN report)) (VP (VBG documenting) (NP (DT the) (JJ preferential)) (PP (IN in) (NP (NP (NN vivo) (VBG binding)) (PP (IN of) (NP (NP (NNS Doc_2650911_756_764_Chemical)) (PP (TO to) (NP (NP (NNS nuclei)) (PP (IN of) (NP (NP (NNS cells)) (PP (IN in) (NP (JJ Doc_2650911_787_795_Chemical) (JJ induced) (NN hamster) (NNS Doc_2650911_812_828_Disease)))))))))))))) (. .)))
2710809	0	(ROOT (S (VP (VB Doc_2710809_0_11_Disease) (ADJP (JJ due) (S (VP (TO to) (VP (VB biperiden)))))) (. .)))
2710809	1	(ROOT (S (PP (IN In) (NP (NP (DT a) (JJ 38-year-old) (JJ male) (NN patient) (NN suffering)) (PP (IN from) (NP (DT a) (JJ severe) (NNS Doc_2710809_84_117_Disease))))) (, ,) (NP (NP (JJ intravenous) (NN application)) (PP (IN of) (NP (CD 10) (NN mg) (NNS Doc_2710809_152_169_Chemical)))) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (JJ long-lasting) (JJ paradoxical) (NN reaction)) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ considerable) (NNS Doc_2710809_243_254_Disease)) (, ,) (NP (NNS Doc_2710809_256_266_Disease)) (, ,) (CC and) (NP (NNS Doc_2710809_272_281_Disease)))))))) (. .)))
2710809	2	(ROOT (S (NP (DT The) (NN heart) (NN rate)) (VP (VBD was) (ADVP (RB back) (PP (TO to) (ADJP (JJ normal)))) (PP (IN within) (NP (NP (CD 12) (NNS hours)) (PP (IN upon) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_2710809_356_369_Chemical))))))) (PP (IN under) (NP (NP (JJ cardiac) (NN monitoring)) (PP (IN in) (NP (DT an) (JJ intensive) (NN care) (NN unit)))))) (. .)))
2710809	3	(ROOT (S (NP (NP (NNP Doc_2710809_422_433_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_2710809_445_454_Chemical))))) (VP (VBZ is) (VP (VBN attributed) (PP (PP (TO to) (NP (NP (DT the) (NN speed)) (PP (IN of) (NP (NN injection))))) (CC and) (PP (TO to) (NP (NP (DT a) (JJ dose-related) (JJ dual) (NN effect)) (PP (IN of) (NP (NN Doc_2710809_532_540_Chemical-like) (NNS drugs)))))) (PP (IN on) (NP (JJ muscarine) (NNS receptors))))) (. .)))
2718706	0	(ROOT (S (NP (JJ Deliberate) (NNS Doc_2718706_11_22_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_2718706_34_43_Chemical))) (PP (IN with) (NP (NNS Doc_2718706_49_58_Chemical) (, ,) (NNS Doc_2718706_60_69_Chemical) (CC or) (NNS Doc_2718706_73_83_Chemical))) (PP (IN for) (NP (JJ middle-ear) (NN surgery)))) (. .)))
2718706	1	(ROOT (S (NP (NP (DT The) (NN feasibility)) (PP (IN of) (S (VP (VBG using) (NP (NP (NNS Doc_2718706_133_142_Chemical)) (, ,) (NP (DT an) (ADJP (NN alpha) (: -) (CC and) (JJ beta-adrenergic)) (JJ blocking) (NN agent)) (, ,)) (PP (IN as) (NP (NP (DT a) (JJ Doc_2718706_195_206_Disease) (NN agent)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NN inhalation) (NNS anaesthetics)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_2718706_258_267_Chemical)) (, ,) (NP (NNS Doc_2718706_269_278_Chemical) (CC or) (NNS Doc_2718706_282_292_Chemical))) (-RRB- -RRB-)))))))))))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (NP (CD 23) (JJ adult) (NNS patients)) (VP (VBG undergoing) (NP (JJ middle-ear) (NN surgery))))))) (. .)))
2718706	2	(ROOT (S (NP (DT The) (JJ mean) (JJ arterial) (NN pressure)) (VP (VBD was) (VP (VBN decreased) (PP (IN from) (NP (NP (NP (CD 86) (NNS +)) (PRN (: /) (VP (VBG -) (NP (CD 5)) (PRN (-LRB- -LRB-) (S (NP (NNP s.e.)) (VP (VBP mean))) (-RRB- -RRB-)) (S (VP (VBG mmHg) (PP (TO to) (NP (QP (CD 52) (CD +))))))) (: /))) (: -) (NP (NP (NP (CD 1) (NN mmHg) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 11.5)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (JJ 0.7) (PP (TO to) (NP (CD 6.9) (NNS +)))) (: /)) (: -) (FRAG (NP (CD 0.1)) (NP (NN kPa))))) (-RRB- -RRB-))) (SBAR (IN for) (FRAG (FRAG (ADJP (NP (CD 98)) (JJ +)) (: /)) (: -) (FRAG (NP (NP (CD 10) (NN min)) (PP (IN in) (NP (DT the) (JJ Doc_2718706_506_515_Chemical) (PRN (-LRB- -LRB-) (NP (NNP H)) (-RRB- -RRB-)) (NN group)))) (, ,) (PP (IN from) (NP (CD 79) (NNS +))) (: /))))) (: -) (NP (NP (QP (CD 5) (TO to) (CD 53)) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 1) (NN mmHg) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 10.5)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (JJ 0.7) (PP (TO to) (NP (CD 7.1) (NNS +)))) (: /)) (: -) (FRAG (NP (CD 0.1)) (NP (NN kPa))))) (-RRB- -RRB-))) (PP (IN for) (NP (CD 129) (NNS +)))) (: /))) (: -) (NP (NP (CD 11) (NN min)) (PP (PP (IN in) (NP (DT the) (JJ Doc_2718706_618_627_Chemical) (PRN (-LRB- -LRB-) (NP (NNP E)) (-RRB- -RRB-)) (NN group))) (, ,) (CC and) (PP (IN from) (NP (NP (NP (CD 80) (JJ +) (NNS /)) (PRN (: -) (NP (QP (CD 4) (TO to) (CD 49)) (NNS +)) (: /))) (PRN (: -) (NP (NP (NP (CD 1) (NN mmHg)) (-LRB- -LRB-) (NP (NP (NP (QP (CD 10.7) (CD +)) (NNS /)) (PRN (: -) (NP (QP (CD 0.5) (TO to) (CD 6.5)) (NNS +)) (: /))) (: -) (NP (QP (CD 0.1) (CD kPa)))) (-RRB- -RRB-)) (PP (IN for) (NP (CD 135) (NNS +)))) (: /)))))) (: -) (NP (NP (CD 15) (NN min)) (PP (IN in) (NP (DT the) (JJ Doc_2718706_734_744_Chemical) (PRN (-LRB- -LRB-) (NNP I) (-RRB- -RRB-)) (NN group))))))))) (. .)))
2718706	3	(ROOT (S (NP (NP (DT The) (JJ mean) (NNP H) (NN concentration)) (PP (IN during) (NP (NP (NNS Doc_2718706_788_799_Disease)) (PP (IN in) (NP (DT the) (JJ inspiratory) (NN gas)))))) (VP (VBD was) (NP (NP (CD 0.7) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 0.1) (CD vol) (NN %)) (, ,) (NP (NP (NP (DT the) (JJ mean) (NN E) (NN concentration)) (NP (QP (CD 1.6) (CD +)) (NNS /))) (: -) (NP (QP (CD 0.2) (CD vol)) (NN %))) (, ,) (CC and) (NP (NP (DT the) (JJ mean) (NN I) (NN concentration)) (NP (CD 1.0) (NNS +)))) (: /)) (: -) (NP (CD 0.1) (CD vol) (NN %)))) (. .)))
2718706	4	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NNS patients)) (VP (VBD received) (NP (NNS Doc_2718706_970_978_Chemical) (CC and) (NNS Doc_2718706_983_997_Chemical))) (. .)))
2718706	5	(ROOT (S (NP (NP (DT The) (JJ initial) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_2718706_1019_1028_Chemical)) (PP (IN for) (S (VP (VBG lowering) (NP (NN blood) (NN pressure)))))))) (VP (VBD was) (NP (JJ similar) (, ,) (JJ 0.52-0) (CD .59) (NN mg/kg)) (, ,) (PP (IN in) (NP (PDT all) (DT the) (NNS groups)))) (. .)))
2718706	6	(ROOT (S (PP (IN During) (NP (NNS Doc_2718706_1113_1124_Disease))) (, ,) (NP (DT the) (NN heart) (NN rate)) (VP (VBD was) (ADJP (JJ stable) (PP (IN without) (NP (NN tachy) (: -) (CC or) (NN Doc_2718706_1170_1181_Disease))))) (. .)))
2718706	7	(ROOT (S (NP (NP (DT The) (VBG operating) (NNS conditions)) (PP (VBG regarding) (NP (NN bleeding)))) (VP (VP (VBD were) (VP (VBN estimated) (PP (IN in) (NP (DT a) (JJ double-blind) (NN manner))))) (, ,) (CC and) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PP (IN between) (NP (DT the) (NNS groups)))))) (. .)))
2718706	8	(ROOT (S (PP (IN During) (NP (NNS Doc_2718706_1328_1339_Disease))) (, ,) (NP (DT the) (NN serum) (NNS Doc_2718706_1351_1361_Chemical) (NN concentration)) (VP (VP (VBD rose) (ADVP (RB significantly)) (PP (IN in) (NP (NP (DT all) (NNS groups)) (PP (IN from) (NP (DT the) (NNS values))))) (PP (IN before) (NP (NNS Doc_2718706_1432_1443_Disease)))) (CC and) (VP (VBD returned) (ADVP (RB postoperatively)) (PP (TO to) (NP (NP (DT the) (JJ initial) (NN level)) (PP (IN in) (NP (DT the) (JJ other) (NNS groups))) (, ,) (PP (IN except) (NP (DT the) (JJ Doc_2718706_1526_1536_Chemical) (NN group))))))) (. .)))
2718706	9	(ROOT (S (PP (IN After) (NP (NNS Doc_2718706_1550_1561_Disease))) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN rebound) (NN phenomenon)) (PP (IN in) (NP (DT either) (NN blood) (NN pressure) (CC or) (NN heart) (NN rate))))) (. .)))
2718706	10	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_2718706_1662_1671_Chemical)) (VP (VBZ induces) (ADVP (RB easily)) (NP (JJ adjustable) (NNS Doc_2718706_1698_1709_Disease)) (PP (IN without) (NP (NNS Doc_2718706_1718_1742_Disease) (CC and) (NN rebound) (NNS Doc_2718706_1755_1767_Disease))))))) (. .)))
2765447	0	(ROOT (S (VP (VB Doc_2765447_0_10_Disease) (NP (JJ following) (JJ intravenous) (NNS Doc_2765447_33_44_Chemical)) (ADVP (RB angiography))) (. .)))
2765447	1	(ROOT (S (NP (NNP Doc_2765447_58_79_Disease)) (VP (VBD followed) (NP (JJ intravenous) (JJ Doc_2765447_101_112_Chemical) (NN injection)) (PP (IN for) (NP (NNS fundus))) (PP (ADVP (RB angiography)) (IN in) (NP (DT a) (JJ 47-year-old) (NN male)))) (. .)))
2765447	2	(ROOT (S (PP (IN Despite) (NP (NNS precautions))) (NP (DT this) (JJ adverse) (NN reaction)) (VP (VBD recurred) (PP (IN on) (NP (NN re-exposure))) (PP (TO to) (NP (JJ intravenous) (NNS Doc_2765447_250_261_Chemical)))) (. .)))
2767010	0	(ROOT (NP (NP (NNP Pharmacology)) (PP (IN of) (NP (NP (NNS Doc_2767010_16_24_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ Doc_2767010_26_35_Chemical) (NN prodrug)) (-RRB- -RRB-)))) (. .)))
2767010	1	(ROOT (S (NP (NP (NNP Doc_2767010_46_54_Chemical)) (, ,) (NP (NP (DT the) (NNS Doc_2767010_60_84_Chemical)) (PP (IN of) (NP (NNS Doc_2767010_88_125_Chemical)))) (, ,)) (VP (VBZ is) (NP (NP (DT a) (NN prodrug)) (PP (IN of) (NP (NP (NNS Doc_2767010_143_152_Chemical)) (PP (IN with) (NP (ADJP (JJ advantageous) (JJ physicochemical)) (NNS properties))))))) (. .)))
2767010	2	(ROOT (S (NP (NNP Doc_2767010_199_207_Chemical)) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN converted) (ADVP (RB enzymatically)) (PP (TO to) (NP (NP (NNS Doc_2767010_246_255_Chemical)) (PP (IN in) (NP (NN vivo))))))) (. .)))
2767010	3	(ROOT (S (NP (NNS Doc_2767010_265_273_Chemical) (CC and) (NNS Doc_2767010_278_294_Chemical)) (VP (VBP have) (NP (NP (NN equivalent) (NN anticonvulsant) (NN activity)) (PP (IN against) (NP (NP (NNS Doc_2767010_343_351_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ maximal) (NN electroshock)) (PRN (-LRB- -LRB-) (NP (NNP MES)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (NNS mice)) (PP (VBG following) (NP (NP (NN i.p.)) (, ,) (NP (JJ oral)) (, ,) (CC or) (NP (NN i.v.) (NN administration))))))))))) (. .)))
2767010	4	(ROOT (S (NP (DT The) (CD ED50) (NNS doses)) (VP (VBD were) (NP (NP (NP (CD 16) (NN mg/kg)) (PP (IN for) (NP (NN i.v.) (NNS Doc_2767010_482_490_Chemical)))) (CC and) (NP (NP (CD 8) (NN mg/kg)) (PP (IN for) (NP (NN i.v.) (NNS Doc_2767010_512_528_Chemical)))))) (. .)))
2767010	5	(ROOT (S (NP (NNS Doc_2767010_530_538_Chemical) (CC and) (NNS Doc_2767010_543_559_Chemical)) (VP (VBP have) (NP (NP (JJ similar) (JJ antiarrhythmic) (NN activity)) (PP (IN against) (NP (NP (NN Doc_2767010_605_612_Chemical-induced) (NNS Doc_2767010_621_644_Disease)) (PP (IN in) (NP (JJ anesthetized) (NNS dogs))))))) (. .)))
2767010	6	(ROOT (S (NP (NP (DT The) (JJ total) (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_2767010_686_694_Chemical) (CC or) (NNS Doc_2767010_698_714_Chemical)) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB convert) (NP (DT the) (NNS Doc_2767010_740_750_Disease)) (PP (TO to) (NP (DT a) (JJ normal) (NNS sinus) (NN rhythm)))))))))) (VP (VBD were) (NP (NP (NP (CD 24) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 6)) (CC and) (NP (CD 14) (NNS +))) (: /))) (: -) (NP (CD 3) (NN mg/kg)) (, ,)) (ADVP (RB respectively))) (. .)))
2767010	7	(ROOT (S (NP (JJ Only) (NNS Doc_2767010_829_845_Chemical)) (VP (VBD displayed) (PP (IN in) (NP (NP (ADJP (NN vitro) (JJ antiarrhythmic)) (NN activity)) (PP (IN against) (NP (NN Doc_2767010_897_911_Chemical-induced) (NNS Doc_2767010_920_931_Disease))))) (PP (IN in) (NP (NN guinea) (NN pig) (NN right) (NN atria)))) (. .)))
2767010	8	(ROOT (S (PP (IN In) (NP (JJ anesthetized) (NNS dogs))) (, ,) (S (NP (NP (DT a) (JJ high) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_2767010_996_1004_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 31) (NN mg/kg)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN infused) (PP (IN over) (NP (NP (CD 15)) (, ,) (NP (CD 20)) (, ,) (CC and) (NP (CD 30) (NN min))))))) (CC and) (S (NP (DT the) (NNS responses)) (VP (VBD were) (PP (VBN compared) (PP (TO to) (NP (NP (DT an) (NN equimolar) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_2767010_1108_1124_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 21) (NN mg/kg)) (-RRB- -RRB-))))))))) (. .)))
2767010	9	(ROOT (S (NP (DT The) (JJ Doc_2767010_1141_1149_Chemical) (CC and) (JJ Doc_2767010_1154_1170_Chemical) (NNS treatments)) (VP (VBD produced) (NP (NP (JJ similar) (JJ marked) (NNS Doc_2767010_1206_1244_Disease)) (CC and) (NP (NP (JJ contractile) (NN force)) (PRN (-LRB- -LRB-) (NP (NNP LVdP/dt)) (-RRB- -RRB-))))) (. .)))
2767010	10	(ROOT (S (NP (NP (DT The) (JJ maximum) (NNS effects)) (PP (IN of) (NP (DT each) (NN treatment)))) (VP (VBD occurred) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (JJ maximum) (JJ Doc_2767010_1348_1364_Chemical) (NNS levels)))))) (. .)))
2767010	11	(ROOT (S (NP (NP (JJ Acute) (JJ Doc_2767010_1379_1387_Disease) (NNS studies)) (PP (IN of) (NP (NNS Doc_2767010_1399_1407_Chemical) (CC and) (NNS Doc_2767010_1412_1428_Chemical)))) (VP (VBD were) (VP (VBN carried) (PRT (RP out)) (PP (IN in) (NP (NNS mice) (, ,) (NNS rats) (, ,) (NNS rabbits) (, ,) (CC and) (NNS dogs))) (PP (IN by) (NP (NP (NN i.v.)) (, ,) (NP (NN i.m.)) (, ,) (CC and) (NP (NP (NN i.p.) (NNS routes)) (PP (IN of) (NP (NN administration)))))))) (. .)))
2767010	12	(ROOT (S (NP (NP (DT The) (JJ systemic) (JJ toxic) (NNS signs)) (PP (IN of) (NP (DT both) (NNS agents)))) (VP (VP (VBD were) (ADJP (JJ similar))) (CC and) (VP (VBD occurred) (PP (IN at) (NP (ADJP (RB approximately) (JJ equivalent)) (NNS doses))))) (. .)))
2767010	13	(ROOT (S (ADVP (RB Importantly)) (, ,) (NP (NP (DT the) (JJ local) (NN irritation)) (PP (IN of) (NP (NNS Doc_2767010_1667_1675_Chemical)))) (VP (VBD was) (ADJP (ADVP (RB markedly) (RBR less)) (SBAR (IN than) (FRAG (NP (JJ Doc_2767010_1699_1715_Chemical) (JJ following) (NN i.m.)) (NP (NN administration)) (. .)))) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-)))))
2782734	0	(ROOT (S (NP (NNS Tachyphylaxis) (S (VP (TO to) (VP (VB systemic) (PRN (CC but) (S (RB not) (VP (TO to) (VP (VB airway) (NP (NNS responses)) (PP (IN during) (NP (VBN prolonged) (NN therapy))))))) (PP (IN with) (NP (JJ high) (NN dose))))))) (VP (VBD inhaled) (NP (NNS Doc_2782734_102_112_Chemical)) (PP (IN in) (NP (NNS asthmatics)))) (. .)))
2782734	1	(ROOT (S (NP (NP (JJ High) (NNS doses)) (PP (IN of) (NP (JJ inhaled) (NNS Doc_2782734_150_160_Chemical)))) (VP (VP (VBP produce) (NP (JJ substantial) (NNS improvements)) (PP (IN in) (NP (NP (JJ airway) (NN response)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_2782734_230_236_Disease)))))))) (, ,) (CC and) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (JJ dose-dependent) (JJ systemic) (JJ beta-adrenoceptor) (NNS responses)))))) (. .)))
2782734	2	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (NNS tachyphylaxis)) (VP (VBZ occurs) (PP (IN during) (NP (NP (VBN prolonged) (NN treatment)) (PP (IN with) (NP (JJ high) (NN dose) (NN inhaled) (NNS Doc_2782734_446_456_Chemical)))))))))))) (. .)))
2782734	3	(ROOT (S (NP (NP (CD Twelve) (JJ Doc_2782734_465_474_Disease) (NNS patients)) (PRN (-LRB- -LRB-) (FRAG (FRAG (NP (CD FEV1)) (, ,) (NP (CD 81) (CD +)) (: /)) (: -) (FRAG (ADJP (CD 4) (NN %)) (ADJP (JJ predicted)))) (-RRB- -RRB-))) (, ,) (S (VP (VBG requiring) (NP (RB only) (JJ occasional) (NN inhaled) (NNS beta-agonists)) (PP (IN as) (NP (PRP$ their) (JJ sole) (NN therapy))))) (, ,) (VP (VBD were) (VP (VBN given) (NP (NP (DT a) (JJ 14-day) (NN treatment)) (PP (IN with) (NP (JJ high) (NN dose)))) (NP (NP (NP (NP (JJ inhaled) (NNS Doc_2782734_637_647_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2782734_649_652_Disease)) (-RRB- -RRB-))) (, ,) (NP (NP (CD 4,000) (NNS micrograms)) (NP (NP (JJ daily) (, ,) (JJ low) (NN dose) (NN inhaled) (NNS Doc_2782734_696_706_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP LDS)) (-RRB- -RRB-)))) (, ,) (ADVP (NP (CD 800) (NNS micrograms)) (RB daily))) (, ,) (CC or) (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (NNP PI)) (-RRB- -RRB-)))) (PP (IN by) (NP (NP (JJ metered-dose) (NN inhaler)) (PP (IN in) (NP (DT a) (JJ double-blind) (, ,) (JJ randomized) (NN crossover) (NN design))))))) (. .)))
2782734	4	(ROOT (S (PP (IN During) (NP (UCP (NP (DT the) (JJ 14-day) (NN run-in)) (CC and) (PP (IN during) (NP (NN washout)))) (NNS periods))) (, ,) (S (NP (JJ inhaled) (NNS beta-agonists)) (VP (VBD were) (VP (VBN withheld)))) (CC and) (S (NP (NNS Doc_2782734_917_936_Chemical)) (VP (VBD was) (VP (VBN substituted) (PP (IN for) (NP (NN rescue) (NNS purposes)))))) (. .)))
2782734	5	(ROOT (S (PP (IN At) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT each) (JJ 14-day) (NN treatment))))) (, ,) (S (NP (NP (DT a) (JJ dose-response) (NN curve)) (PRN (-LRB- -LRB-) (NP (NNP DRC)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN performed)))) (, ,) (CC and) (S (NP (NP (NP (NP (JJ airway) (PRN (-LRB- -LRB-) (NP (NNP FEV1)) (, ,) (NP (NNP FEF25-75)) (-RRB- -RRB-)) (NN chronotropic)) (PRN (-LRB- -LRB-) (NP (NNP HR)) (-RRB- -RRB-))) (, ,) (NP (NNS Doc_2782734_1101_1107_Disease)) (, ,)) (CC and) (NP (ADJP (ADJP (JJ metabolic)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_2782734_1124_1125_Chemical)) (, ,) (NP (NNS Doc_2782734_1127_1130_Chemical))) (-RRB- -RRB-))) (NNS responses))) (VP (VBD were) (VP (VBN measured) (PP (IN at) (NP (NP (DT each) (NN step)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (QP (CD 100) (TO to) (CD 4,000)) (NNS micrograms))) (-RRB- -RRB-))))))) (. .)))
2782734	6	(ROOT (S (NP (NNP Treatment)) (VP (VBD had) (NP (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NN baseline) (NNS values))))) (. .)))
2782734	7	(ROOT (S (S (NP (EX There)) (VP (VBD were) (NP (NP (JJ dose-dependent) (NNS increases)) (PP (IN in) (NP (NNP FEV1) (CC and) (NNP FEF25-75))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))))) (, ,) (CC and) (S (NP (NP (NN pretreatment)) (PP (IN with) (NP (NNS Doc_2782734_1357_1360_Disease)))) (VP (VBD did) (RB not) (VP (VB displace) (NP (DT the) (NNP DRC)) (PP (TO to) (NP (DT the) (NN right)))))) (. .)))
2782734	8	(ROOT (S (NP (NP (NNP DRC)) (PP (IN for) (NP (NP (NP (NNP HR)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (, ,) (NP (NP (NNP K)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNS Doc_2782734_1459_1462_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.005))) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN attenuated) (PP (IN after) (NP (NN treatment))) (PP (IN with) (NP (NP (NNS Doc_2782734_1520_1523_Chemical)) (PP (VBN compared) (PP (IN with) (NP (NNP PI)))))))) (. .)))
2782734	9	(ROOT (S (NP (EX There)) (VP (VBD were) (ADVP (RB also)) (NP (NP (NP (NNS differences)) (PP (IN between) (NP (NNP Doc_2782734_1578_1581_Disease) (CC and) (NNP LDS))) (PP (IN for) (NP (NP (NNP HR)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))))) (CC and) (NP (NP (NNS Doc_2782734_1621_1624_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-)) (NP (NNS responses))))) (. .)))
2782734	10	(ROOT (NP (NP (NN Frequency) (CC and) (NN severity)) (PP (IN of) (NP (NP (NP (NP (JJ subjective) (JJ adverse) (NNS effects)) (SBAR (S (VP (VBD were) (ADVP (RB also)) (VP (VBN reduced) (PP (IN after) (NP (NNS Doc_2782734_1732_1735_Disease)))))))) (: :) (NP (NP (NNS Doc_2782734_1737_1743_Disease)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-)) (, ,) (NP (NP (NNS palpitations)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-)))) (. .)) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-))))))
2818777	0	(ROOT (S (NP (NNP Doc_2818777_0_9_Chemical)) (VP (VBN induced) (NP (JJ fatal) (NNS Doc_2818777_24_38_Disease))) (. .)))
2818777	1	(ROOT (S (NP (DT A) (ADJP (NP (CD 61) (NN year)) (JJ old)) (NN female)) (VP (VBD developed) (NP (JJ fatal) (NNS Doc_2818777_77_92_Disease)) (PP (IN after) (NP (JJ Doc_2818777_99_108_Chemical) (NN administration)))) (. .)))
2818777	2	(ROOT (S (NP (DT A) (JJ typical) (NN multisystem) (JJ clinical) (NN pattern)) (VP (VBZ precedes) (NP (NP (DT the) (NNS manifestations)) (PP (IN of) (NP (NNS Doc_2818777_195_209_Disease))))) (. .)))
2818777	3	(ROOT (S (NP (DT The) (ADJP (JJ hematologic) (, ,) (JJ biochemical) (CC and) (JJ pathologic)) (NNS features)) (VP (VBP indicate) (S (NP (DT a) (VBN mixed) (NNS Doc_2818777_281_302_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NN drug) (NNS Doc_2818777_315_331_Disease)))))) (. .)))
2818777	4	(ROOT (S (PP (IN In) (S (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NP (NNS Doc_2818777_356_365_Chemical)) (SBAR (WHNP (WP who)) (S (VP (VBZ presents) (NP (DT a) (JJ viral-like) (NN illness))))))))) (, ,) (NP (NP (RB early) (NN recognition) (CC and) (NN discontinuation)) (PP (IN of) (NP (DT the) (NN drug)))) (VP (VBP are) (ADJP (JJ mandatory))) (. .)))
2884595	0	(ROOT (NP (NP (NNP Treatment)) (PP (IN of) (NP (JJ lethal) (NN pertussis) (NN vaccine) (NN reaction))) (PP (IN with) (NP (JJ Doc_2884595_52_61_Chemical) (NN H1) (NNS antagonists))) (. .)))
2884595	1	(ROOT (S (NP (PRP We)) (VP (VBD studied) (NP (NN mortality)) (PP (IN after) (NP (NN pertussis) (NN immunization))) (PP (IN in) (NP (DT the) (NN mouse)))) (. .)))
2884595	2	(ROOT (S (PP (IN Without) (NP (NN treatment))) (, ,) (NP (NP (CD 73)) (PP (IN of) (NP (NP (CD 92) (NNS animals)) (PRN (-LRB- -LRB-) (NP (CD 80) (NN %)) (-RRB- -RRB-))))) (VP (VBD died) (PP (IN after) (NP (NP (NN injection)) (PP (IN of) (NP (NP (JJ bovine) (NN serum) (NN albumin)) (PRN (-LRB- -LRB-) (NP (NNP BSA)) (-RRB- -RRB-)))))) (PP (IN on) (NP (NP (NN day) (CD +7)) (PP (IN of) (NP (NN pertussis) (NN immunization)))))) (. .)))
2884595	3	(ROOT (S (PP (IN After) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NP (CD 3) (NN mg)) (PP (IN of) (NP (NP (NNS Doc_2884595_304_318_Chemical)) (, ,) (NP (CD 2) (NN mg) (NNS Doc_2884595_325_334_Chemical)) (, ,) (CC or) (NP (CD 2) (NN mg) (NNS Doc_2884595_344_360_Chemical)))))))) (, ,) (NP (NP (QP (RB only) (CD 5))) (PP (IN of) (NP (CD 105) (NNS animals))) (PRN (-LRB- -LRB-) (NP (CD 5) (NN %)) (-RRB- -RRB-))) (VP (VBD died) (PP (IN after) (S (VP (VBG receiving) (NP (NNP BSA)) (PP (IN on) (NP (NN day) (CD +7))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-)))))) (. .)))
2884595	4	(ROOT (S (NP (NP (NNP Blockade)) (PP (IN of) (NP (JJ Doc_2884595_457_466_Chemical) (NN H1) (NNS receptors)))) (VP (MD may) (VP (VB reduce) (NP (NN mortality)) (PP (IN in) (NP (NP (NN pertussis) (JJ immunization-induced) (NNS Doc_2884595_535_549_Disease)) (PP (IN in) (NP (NNS mice))))))) (. .)))
2904523	0	(ROOT (NP (NP (NP (NN Support)) (PP (IN for) (NP (NN Doc_2904523_12_22_Chemical-Doc_2904523_23_35_Disease) (NNS hypothesis)))) (: :) (NP (NP (CD 18) (NN hour) (NN pressor) (NN effect)) (PP (IN after) (NP (CD 6) (NNS hours) (NNS Doc_2904523_85_95_Chemical) (NN infusion)))) (. .)))
2904523	1	(ROOT (S (PP (IN In) (NP (DT a) (JJ double) (JJ blind) (, ,) (JJ crossover) (NN study))) (NP (NP (NP (CD 6) (NN h) (NNS infusions)) (PP (IN of) (NP (NP (NNS Doc_2904523_158_168_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 15) (NN ng/kg/min)) (: ;) (NP (NP (CD 1) (NN ng)) (SBAR (S (VP (SYM =) (NP (CD 5.458) (NN pmol))))))) (-RRB- -RRB-))))) (, ,) (NP (NP (NP (NNS Doc_2904523_204_217_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 30) (NN ng/kg/min)) (: ;) (NP (NP (CD 1) (NN ng)) (SBAR (S (VP (SYM =) (NP (CD 5.911) (NN pmol))))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (DT a) (ADJP (CD 5) (NN %)) (JJ Doc_2904523_262_270_Chemical) (NN solution)) (PRN (-LRB- -LRB-) (NP (QP (CD 5.4) (CD ml/h))) (-RRB- -RRB-)))) (, ,)) (VP (VBD were) (VP (VBN given) (PP (TO to) (NP (NP (CD ten) (JJ healthy) (NNS volunteers)) (PP (IN in) (NP (JJ random) (NN order))))) (NP (CD 2) (NNS weeks) (RB apart)))) (. .)))
2904523	2	(ROOT (S (PP (IN By) (NP (NP (NNS means)) (PP (IN of) (NP (JJ intra-arterial) (JJ ambulatory) (NN monitoring))))) (NP (DT the) (JJ haemodynamic) (NNS effects)) (VP (VBD were) (VP (VBN followed) (PP (IN for) (NP (CD 18) (NN h))) (SBAR (IN after) (S (NP (DT the) (NNS infusions)) (VP (VBD were) (VP (VBN stopped))))))) (. .)))
2904523	3	(ROOT (S (NP (NP (NNP Doc_2904523_491_501_Chemical)) (, ,) (CONJP (CC but) (RB not)) (NP (NNS Doc_2904523_511_524_Chemical)) (, ,)) (VP (VBD caused) (NP (DT a) (JJ delayed) (CC and) (JJ protracted) (NN pressor) (NN effect))) (. .)))
2904523	4	(ROOT (S (S (PP (IN Over) (NP (DT the) (JJ total) (NN postinfusion) (NN period))) (NP (UCP (JJ systolic) (CC and) (JJ diastolic)) (NN arterial) (NN pressure)) (VP (VBD were) (NP (NP (CD 6)) (PRN (-LRB- -LRB-) (NP ($ SEM) (CD 2)) (-RRB- -RRB-))) (ADVP (RB %)))) (CC and) (S (NP (NP (CD 7)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (VP (VBD %) (, ,) (ADVP (RB respectively)) (, ,) (PP (ADVP (JJR higher)) (IN than) (IN after) (NP (NP (JJ Doc_2904523_710_718_Chemical) (NN infusion)) (PRN (-LRB- -LRB-) (NP (NP (NNP ANOVA)) (, ,) (ADVP (RB p) (NP (QP (JJR less) (IN than) (CD 0.001))))) (-RRB- -RRB-)))))) (. .)))
2904523	5	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (`` ``) (NN stress) ('' '') (NNS levels)) (PP (IN of) (NP (NP (NP (NNS Doc_2904523_781_791_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 230) (NN pg/ml)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 6) (NN h)))))) (VP (VBP cause) (NP (DT a) (JJ delayed) (CC and) (JJ protracted) (NN pressor) (NN effect))) (. .)))
2904523	6	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP are) (NP (NP (JJ strong) (NN support)) (PP (IN for) (NP (NP (DT the) (NN Doc_2904523_901_911_Chemical-Doc_2904523_912_924_Disease) (NNS hypothesis)) (PP (IN in) (NP (NN man))))))) (. .)))
2907577	0	(ROOT (NP (NP (NN Effect)) (PP (IN of) (NP (NP (NNS Doc_2907577_10_24_Chemical)) (PP (IN on) (NP (NN Doc_2907577_28_38_Chemical-induced) (NNS Doc_2907577_47_66_Disease))))) (PP (IN in) (NP (DT the) (NN rat))) (. .)))
2907577	1	(ROOT (S (NP (JJ Doc_2907577_79_88_Chemical) (NNS antagonists)) (VP (VBP have) (VP (VBN been) (ADVP (RB previously)) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (PP (IN of) (NP (NN benefit))) (PP (IN in) (NP (NP (DT some) (ADJP (JJ ischaemic) (CC and) (JJ nephrotoxic)) (NNS models)) (PP (IN of) (NP (NP (NNS Doc_2907577_189_208_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2907577_210_213_Disease)) (-RRB- -RRB-)))))))))))) (. .)))
2907577	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (CD three) (NNS Doc_2907577_259_273_Chemical)) (PP (IN with) (NP (NP (JJ different) (NNS potencies)) (PP (IN as) (NP (NNS Doc_2907577_302_311_Chemical) (NNS antagonists) (NNS Doc_2907577_324_344_Chemical) (, ,) (NNS Doc_2907577_346_358_Chemical) (CC and) (NNS Doc_2907577_363_375_Chemical)))))))) (, ,) (VP (VBD were) (VP (VBN examined) (PP (IN in) (NP (NP (NNS rats)) (VP (VBG developing) (NP (NNS Doc_2907577_410_429_Disease)) (PP (IN after) (NP (NP (CD 4) (JJ daily) (NNS injections)) (PP (IN of) (NP (NP (NNS Doc_2907577_458_468_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 200) (NN mg) (NN kg-1)) (-RRB- -RRB-))))))))))) (. .)))
2907577	3	(ROOT (S (NP (JJ Renal) (NN function)) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (ADJP (ADJP (ADJP (ADJP (JJ biochemical)) (PRN (-LRB- -LRB-) (NP (NP (NN plasma) (NNS Doc_2907577_535_539_Chemical)) (CC and) (NP (NNS Doc_2907577_544_554_Chemical))) (-RRB- -RRB-))) (, ,) (ADJP (ADJP (JJ functional)) (PRN (-LRB- -LRB-) (NP (NP (NN urine) (NN analysis)) (CC and) (NP (JJ Doc_2907577_588_628_Chemical) (NNS clearances))) (-RRB- -RRB-))) (CC and) (ADJP (JJ morphological))) (PRN (-LRB- -LRB-) (NP (NP (NN degree)) (PP (IN of) (NP (NNS Doc_2907577_670_678_Disease)))) (-RRB- -RRB-))) (NNS indices))))) (. .)))
2907577	4	(ROOT (S (NP (DT The) (JJ various) (NN drug) (NNS treatments)) (VP (VBD produced) (NP (NP (NP (NNS improvements)) (PP (IN in) (NP (DT some)))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (DT all)) (, ,) (NP (NP (NNS measurements)) (PP (IN of) (NP (JJ renal) (NN function))))))) (. .)))
2907577	5	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT any) (NN improvement)) (VP (VBN produced) (PP (IN by) (NP (NN drug) (NN treatment))))) (VP (VBD was) (ADVP (RB largely)) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (DT a) (JJ beneficial) (NN effect)) (VP (VBN exerted) (PP (IN by) (NP (NP (PRP$ its) (NN vehicle)) (PRN (-LRB- -LRB-) (NP (JJ Doc_2907577_913_932_Chemical) (CC and) (JJ Doc_2907577_937_941_Chemical)) (-RRB- -RRB-))))))))) (. .)))
2907577	6	(ROOT (S (NP (NP (DT The) (NN lack)) (PP (IN of) (NP (NP (DT any) (JJ consistent) (JJ protective) (NN effect)) (VP (VBN noted) (PP (IN with) (NP (NP (DT the) (NNS Doc_2907577_1004_1018_Chemical)) (VP (VBN tested) (PP (IN in) (NP (DT the) (JJ present) (NN study)))))))))) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NNS Doc_2907577_1062_1071_Chemical)) (VP (VBZ plays) (NP (RB little)) (NP (NP (PRN (, ,) (IN if) (DT any) (, ,)) (JJ pathophysiological) (NN role)) (PP (IN in) (NP (NN Doc_2907577_1121_1131_Chemical-induced) (NNS Doc_2907577_1140_1143_Disease)))))))) (. .)))
2931989	0	(ROOT (S (NP (JJ Adverse) (NN ocular) (NNS reactions)) (ADVP (RB possibly)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_2931989_50_62_Chemical)))) (. .)))
2931989	1	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (CD 261) (JJ adverse) (NN ocular) (NNS reactions)))) (VP (VBD occurred) (PP (IN in) (NP (NP (JJ 237) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (NNS Doc_2931989_142_154_Chemical)) (, ,) (NP (NP (DT a) (ADJP (RB commonly) (VBN used)) (NN drug)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ severe) (JJ cystic) (NN acne))))))))))))) (. .)))
2931989	2	(ROOT (S (NP (NP (NNS Blepharoconjunctivitis)) (, ,) (NP (NP (JJ subjective) (NNS complaints)) (PP (IN of) (NP (NNS Doc_2931989_266_274_Disease)))) (, ,)) (VP (VBD blurred) (SBAR (S (NP (NP (NN vision)) (, ,) (NP (NN contact) (NN lens) (NN intolerance)) (, ,) (CC and) (NP (NNS Doc_2931989_322_337_Disease))) (VP (VBP are) (NP (JJ reversible) (NN side) (NNS effects)))))) (. .)))
2931989	3	(ROOT (S (S (NP (ADJP (RBR More) (JJ serious)) (JJ ocular) (JJ adverse) (NNS reactions)) (VP (VBP include) (NP (NP (NNS Doc_2931989_413_424_Disease)) (, ,) (NP (JJ Doc_2931989_426_437_Disease) (NNS cerebri)) (, ,) (CC and) (NP (ADJP (JJ white) (CC or) (JJ gray)) (JJ subepithelial) (JJ corneal) (NNS opacities))))) (: ;) (S (NP (NP (DT all)) (PP (IN of) (NP (DT these)))) (VP (VBP are) (ADJP (JJ reversible) (SBAR (IN if) (S (NP (DT the) (NN drug)) (VP (VBZ is) (VP (VBN discontinued)))))))) (. .)))
2931989	4	(ROOT (S (NP (NP (JJ Reported) (NNS cases)) (PP (IN of) (NP (VBN decreased) (JJ dark) (NN adaptation)))) (VP (VBP are) (PP (IN under) (NP (NN investigation)))) (. .)))
2931989	5	(ROOT (S (NP (NNP Doc_2931989_624_636_Chemical)) (VP (VBZ is) (VP (VBN contraindicated) (PP (IN in) (NP (NP (NN pregnancy)) (PP (RB because) (IN of) (NP (DT the) (JJ many) (JJ reported) (NNS Doc_2931989_698_722_Disease))))) (PP (IN after) (NP (JJ maternal) (NN use) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (NP (NNS Doc_2931989_753_790_Disease)) (, ,) (CC and) (NP (NNS Doc_2931989_796_818_Disease)))) (-RRB- -RRB-)))))) (. .)))
2933998	0	(ROOT (NP (NP (NNS Doc_2933998_0_10_Chemical) (CC and) (NNS Doc_2933998_15_26_Chemical)) (PP (IN in) (NP (NNS Doc_2933998_30_46_Disease))) (. .)))
2933998	1	(ROOT (NP (NP (DT A) (NN double-blind)) (, ,) (NP (JJ placebo-controlled) (, ,) (JJ cross-over) (NN study)) (. .)))
2933998	2	(ROOT (S (NP (NP (NNP Doc_2933998_102_112_Chemical)) (, ,) (NP (DT a) (JJ new) (JJ beta-2) (NN adrenoceptor) (NN stimulant)) (, ,)) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (NP (DT a) (JJ double-blind) (, ,) (JJ placebo-controlled) (, ,) (JJ cross-over) (NN trial)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_2933998_236_252_Disease))))))))) (. .)))
2933998	3	(ROOT (S (NP (NP (JJ Oral) (NNS Doc_2933998_259_269_Chemical)) (ADJP (NP (CD 50) (NNS micrograms)) (JJ b.d.))) (, ,) (S (VP (VBG Doc_2933998_290_300_Chemical) (NP (ADJP (NP (CD 100) (NNS micrograms)) (JJ b.d.)) (, ,) (CC and) (NN Doc_2933998_326_337_Chemical) (CD 5) (NN mg) (NN t.i.d.)))) (, ,) (VP (VBD were) (PP (VBN compared) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (ADVP (RB randomly)) (PP (IN in) (NP (JJ 1-week) (NN treatment) (NNS periods)))))))) (. .)))
2933998	4	(ROOT (S (NP (DT The) (RBS best) (JJ clinical) (NN effect)) (VP (VBD was) (VP (VBN found) (PP (IN with) (NP (NNS Doc_2933998_454_465_Chemical))))) (. .)))
2933998	5	(ROOT (S (NP (NP (DT Both) (ADJP (JJ anti-Doc_2933998_477_486_Disease) (CC and) (JJ tremorgenic)) (NNS effects)) (PP (IN of) (NP (NNS Doc_2933998_514_524_Chemical)))) (VP (VBD were) (ADJP (JJ dose-related))) (. .)))
2933998	6	(ROOT (S (S (NP (NNP Doc_2933998_544_554_Chemical)) (VP (VBD appeared) (ADJP (JJ effective)) (PP (IN in) (NP (NP (DT the) (NNS doses)) (VP (VBN tested)))))) (, ,) (CC and) (S (NP (DT a) (RB twice) (JJ daily) (NN regimen)) (VP (MD would) (VP (VB appear) (S (VP (TO to) (VP (VB be) (ADJP (JJ suitable) (PP (IN with) (NP (DT this) (NN drug)))))))))) (. .)))
2974281	0	(ROOT (NP (NP (JJ Subacute) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_2974281_20_31_Chemical)) (CC and) (NP (NNP B) (CD 24/76)))) (PP (IN on) (NP (NP (NN Doc_2974281_47_60_Chemical-induced) (NN rat) (NNS Doc_2974281_73_90_Disease)) (PP (IN in) (NP (NN correlation))))) (PP (IN with) (NP (NN blood) (NN pressure))) (. .)))
2974281	1	(ROOT (S (NP (PRP We)) (VP (VBD compared) (NP (NP (DT the) (JJ potential) (JJ beta-receptor) (NN blocker)) (, ,) (ADJP (NP (NNP B) (CD 24/76)) (NP (NP (QP (CD i.e.) (CD 1))) (: -) (NP (NP (PRN (-LRB- -LRB-) (ADJP (JJ 2,4-dichlorophenoxy)) (-RRB- -RRB-)) (JJ -3) (NN -LSB-)) (PP (NP (NP (CD 2-3) (CD ,4)) (: -) (NP (NN dimethoxyphenyl)) (-RRB- -RRB-)) (NP (NP (NN ethanolamino) (NNS -RSB-)) (: -) (S (VP (VB prop) (ADJP (JJ an-2-ol))))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ beta) (JJ 1-adrenoceptor) (NNS blocking)) (CC and) (NP (JJ beta) (JJ 2-adrenoceptor) (JJ stimulating) (NNS properties))))))))) (PP (IN with) (NP (NNS Doc_2974281_372_383_Chemical)))) (. .)))
2974281	2	(ROOT (S (NP (DT The) (NNS studies)) (VP (VBD were) (VP (VBN performed) (S (VP (VBG using) (NP (NP (DT an) (JJ experimental) (NN model)) (PP (IN of) (NP (NN Doc_2974281_443_456_Chemical-induced) (NNS Doc_2974281_465_482_Disease)))) (PP (IN in) (NP (NNS rats))))))) (. .)))
2974281	3	(ROOT (S (NP (NP (DT A) (NN correlation)) (PP (IN of) (NP (DT the) (NN blood) (NN pressure)))) (VP (VBD was) (RB neither) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NN development) (NN nor)) (PP (IN in) (NP (DT the) (NN attempt))))) (S (VP (TO to) (VP (VB suppress) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_2974281_615_632_Disease)))) (PP (IN with) (NP (DT the) (CD two) (JJ beta-receptor) (NNS blockers)))))))) (. .)))
2974281	4	(ROOT (S (NP (DT Both) (NNS beta-blockers)) (VP (VBD influenced) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_2974281_719_730_Disease)))) (PP (TO to) (NP (DT a) (ADJP (ADJP (JJ different)) (, ,) (CC but) (ADJP (RB not) (JJ reproducible))) (NN extent)))) (. .)))
2974281	5	(ROOT (S (S (NP (PRP It)) (VP (VBD was) (ADJP (JJ possible) (S (VP (TO to) (VP (VB suppress) (NP (NP (DT the) (VBN increased) (JJ Doc_2974281_818_827_Chemical) (NN decarboxylase) (NN activity)) (PP (IN with) (NP (NP (DT both) (NNS beta-blockers)) (PP (IN in) (NP (JJ Doc_2974281_878_891_Disease) (NNS hearts)))))))))))) (, ,) (CC but) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (DT the) (NN heart) (NN mass)))))) (. .)))
2974281	6	(ROOT (S (NP (CC Neither) (NP (NNS Doc_2974281_951_962_Chemical)) (CC nor) (NP (NNP B) (CD 24/76))) (VP (MD could) (VP (VB stop) (NP (DT the) (NNS changes)) (PP (IN in) (NP (NP (DT the) (JJ characteristic) (NN myosin) (NN isoenzyme) (NN pattern)) (PP (IN of) (NP (DT the) (JJ Doc_2974281_1052_1065_Disease) (NN rat) (NN heart))))))) (. .)))
2974281	7	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (DT the) (NNS investigations)) (VP (VBD did) (RB not) (VP (VB provide) (NP (DT any) (NN evidence)) (SBAR (IN that) (S (NP (NP (DT the) (JJ beta-receptor) (NNS blockers) (NNS Doc_2974281_1163_1174_Chemical)) (CC and) (NP (NNP B) (CD 24/76))) (VP (VBP have) (NP (DT the) (NN potency) (S (VP (TO to) (VP (VB prevent) (NP (NNS Doc_2974281_1215_1228_Chemical)) (PP (IN from) (NP (VBG producing) (NNS Doc_2974281_1244_1261_Disease)))))))))))) (. .)))
2983630	0	(ROOT (NP (NP (VBN Increased) (JJ anxiogenic) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_2983630_32_40_Chemical)) (PP (IN in) (NP (NNS Doc_2983630_44_59_Disease))))) (. .)))
2983630	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (JJ oral) (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_2983630_99_107_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg/kg)) (-RRB- -RRB-))) (PP (IN on) (NP (NP (JJ behavioral) (NNS ratings)) (, ,) (NP (JJ somatic) (NNS symptoms)) (, ,) (NP (NN blood) (NN pressure)) (CC and) (NP (NN plasma) (NNS levels)))) (PP (IN of) (NP (NP (NP (NNS Doc_2983630_196_233_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2983630_235_239_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NNS Doc_2983630_245_253_Chemical))))))))) (VP (VBD were) (VP (VBN determined) (PP (IN in) (NP (NP (CD 17) (JJ healthy) (NNS subjects)) (CC and) (NP (CD 21) (NNS patients)))) (S (VP (VBG meeting) (NP (JJ DSM-III) (NNS criteria)) (PP (IN for) (NP (NP (NNS Doc_2983630_338_349_Disease)) (PP (IN with) (NP (JJ Doc_2983630_355_360_Disease) (NNS attacks) (CC or) (NNS Doc_2983630_372_386_Disease))))))))) (. .)))
2983630	2	(ROOT (S (NP (NNP Doc_2983630_388_396_Chemical)) (VP (VBD produced) (NP (ADJP (RB significantly) (JJR greater)) (NNS increases)) (PP (IN in) (NP (NP (JJ subject-rated) (NNS Doc_2983630_455_462_Disease)) (, ,) (NP (NN nervousness)) (, ,) (NP (NN fear)) (, ,) (NP (NNS Doc_2983630_483_489_Disease)) (, ,) (NP (NNS palpitations)) (, ,) (NP (NNS restlessness)) (, ,) (CC and) (NP (NNS Doc_2983630_523_530_Disease)))) (PP (IN in) (NP (DT the) (NNS patients))) (PP (VBN compared) (PP (IN with) (NP (JJ healthy) (NNS subjects))))) (. .)))
2983630	3	(ROOT (S (PP (IN In) (NP (NP (DT the) (NNS patients)) (, ,) (CONJP (CC but) (RB not)) (NP (DT the) (JJ healthy) (NNS subjects)))) (, ,) (NP (DT these) (NNS symptoms)) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN correlated) (PP (IN with) (NP (NN plasma) (NNS Doc_2983630_683_691_Chemical) (NNS levels))))) (. .)))
2983630	4	(ROOT (S (NP (NP (JJ Seventy-one) (NN percent)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD reported) (SBAR (IN that) (S (NP (NP (DT the) (JJ behavioral) (NNS effects)) (PP (IN of) (NP (NNS Doc_2983630_776_784_Chemical)))) (VP (VBD were) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN experienced) (PP (IN during) (NP (JJ Doc_2983630_826_831_Disease) (NNS attacks))))))))))) (. .)))
2983630	5	(ROOT (S (NP (NNP Doc_2983630_841_849_Chemical)) (VP (VBD did) (RB not) (VP (VB alter) (NP (JJ plasma) (JJ Doc_2983630_871_875_Chemical) (NNS levels)) (PP (IN in) (NP (CC either) (DT the) (JJ healthy) (NNS subjects) (CC or) (NNS patients))))) (. .)))
2983630	6	(ROOT (S (NP (NNP Doc_2983630_927_935_Chemical)) (VP (VBD increased) (NP (JJ plasma) (JJ Doc_2983630_953_961_Chemical) (NNS levels)) (ADVP (RB equally)) (PP (IN in) (NP (DT the) (ADJP (JJ patient) (CC and) (JJ healthy)) (NNS groups)))) (. .)))
2983630	7	(ROOT (S (SBAR (IN Because) (S (NP (NNS Doc_2983630_1020_1028_Chemical)) (VP (VBZ is) (NP (DT an) (JJ Doc_2983630_1035_1044_Chemical) (NN receptor) (NN antagonist))))) (, ,) (NP (DT these) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT some) (JJ Doc_2983630_1098_1112_Disease) (NNS patients)) (VP (MD may) (VP (VB have) (NP (NP (NNS abnormalities)) (PP (IN in) (NP (NP (JJ neuronal) (NNS systems)) (VP (VBG involving) (NP (NNS Doc_2983630_1175_1184_Chemical))))))))))) (. .)))
2983630	8	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NNS Doc_2983630_1200_1217_Disease)))) (VP (MD may) (VP (VB benefit) (PP (IN by) (S (VP (VBG avoiding) (NP (NN Doc_2983630_1242_1250_Chemical-containing) (NNS foods) (CC and) (NNS beverages))))))) (. .)))
3074291	0	(ROOT (NP (NP (NNP Comparison)) (PP (IN of) (NP (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NNS Doc_3074291_28_46_Chemical)))) (CC and) (NP (PP (IN of) (NP (JJ slow-release) (NNS Doc_3074291_67_79_Chemical))) (PP (IN on) (NP (JJ nocturnal) (NN asthma)))))) (. .)))
3074291	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (DT a) (JJ new) (JJ inhaled) (JJ antimuscarinic) (NN drug)) (, ,) (NP (NNS Doc_3074291_151_169_Chemical)) (, ,) (CC and) (PP (IN of) (NP (DT a) (JJ slow-release) (JJ Doc_3074291_193_205_Chemical) (NN preparation))) (PP (IN upon) (NP (JJ nocturnal) (NN asthma)))))) (VP (VBD were) (VP (VBN compared) (PP (IN in) (NP (DT a) (JJ placebo-controlled) (JJ double-blind) (NN study))))) (. .)))
3074291	2	(ROOT (S (S (NP (CD Two) (NNS samples)) (VP (VBD were) (VP (VBN studied)))) (: :) (S (NP (CD 12) (NNS patients)) (VP (VBD received) (NP (NNS Doc_3074291_345_355_Chemical)) (PP (IN at) (NP (NP (NP (CD 600) (NNS micrograms)) (PRN (-LRB- -LRB-) (NP (CD 6) (NNS subjects)) (-RRB- -RRB-))) (CC or) (NP (NP (ADVP (IN at) (NP (CD 400) (NNS micrograms))) (NN t.i.d.)) (PRN (-LRB- -LRB-) (NP (CD 6) (NNS subjects)) (-RRB- -RRB-))))) (SBAR (IN whereas) (S (NP (NP (CD 11) (VBN received) (NNS Doc_3074291_448_460_Chemical)) (PP (IN at) (NP (CD 300) (JJ mg) (NN b.i.d.) (NN Morning) (NNS dipping))) (, ,) (VP (VBN assessed) (PP (IN by) (NP (NP (DT the) (NN fall)) (PP (IN in) (NP (JJ peak) (NN flow))))) (ADVP (RB overnight))) (, ,)) (VP (VBD was) (VP (ADVP (RB significantly)) (VBN reduced) (PP (IN in) (NP (NP (DT the) (NNS periods)) (SBAR (WHADVP (WRB when)) (S (NP (DT either) (JJ active) (NN drug)) (VP (VBD was) (VP (VBN taken))))))) (, ,) (SBAR (IN whereas) (S (NP (DT no) (NN difference)) (VP (VBD was) (VP (VBN noticed) (PP (IN during) (NP (DT the) (NN placebo) (NN administration))))))))))))) (. .)))
3074291	3	(ROOT (S (NP (DT No) (JJ significant) (NN difference)) (VP (VBD was) (VP (VBN noticed) (PP (PP (IN between) (NP (NP (NNS results)) (VP (VBN obtained) (PP (IN with) (NP (DT either) (JJ active) (NN drug)))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN with) (NP (NP (DT either) (NN dosage)) (PP (IN of) (NP (NNS Doc_3074291_806_816_Chemical)))))))) (. .)))
3074291	4	(ROOT (S (NP (DT No) (NN subject)) (VP (VBD reported) (NP (NP (NN side) (NNS effects)) (PP (IN of) (NP (NNS Doc_3074291_854_864_Chemical)))) (, ,) (PP (ADVP (IN as)) (VBN compared) (PP (TO to) (NP (NP (CD three) (NNS subjects)) (VP (VBG reporting) (NP (NNS Doc_3074291_906_912_Disease) (, ,) (NNS Doc_3074291_914_922_Disease) (CC and) (NNS Doc_3074291_927_934_Disease)) (PP (IN after) (NP (NNS Doc_3074291_941_953_Chemical)))))))) (. .)))
3074291	5	(ROOT (S (NP (NNP Doc_3074291_955_965_Chemical)) (VP (VP (VBZ proves) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ valuable) (NN alternative)) (PP (TO to) (NP (NP (NNS Doc_3074291_1005_1017_Chemical)) (PP (IN in) (NP (JJ nocturnal) (NN asthma)))))) (, ,) (SBAR (IN since) (S (NP (PRP it)) (VP (VBZ is) (ADJP (ADJP (RB equally) (JJ potent)) (, ,) (ADJP (JJR safer)))))))))) (CC and) (VP (VBZ does) (RB not) (VP (VB require) (NP (NP (DT the) (NN titration)) (PP (IN of) (NP (NN dosage))))))) (. .)))
3083835	0	(ROOT (NP (CD Doc_3083835_0_10_Chemical) (NNS Doc_3083835_11_22_Disease) (. .)))
3083835	1	(ROOT (S (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (JJ oral) (JJ Doc_3083835_39_49_Chemical) (NNS Doc_3083835_50_61_Disease)))) (VP (VBZ is) (VP (VBN described)))) (, ,) (CC and) (S (NP (NP (DT the) (NN terminology)) (, ,) (NP (NN occurrence)) (, ,) (NP (JJ clinical) (NNS manifestations)) (, ,) (NP (NNS pathogenesis)) (, ,) (NP (NN prevention)) (, ,) (CC and) (NP (NP (NN treatment)) (PP (IN of) (NP (NNS Doc_3083835_177_188_Disease))))) (VP (VBP are) (VP (VBN reviewed)))) (. .)))
3083835	2	(ROOT (S (NP (NNP Emergency) (NNS physicians)) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (JJ oral) (JJ Doc_3083835_248_258_Chemical) (NNS Doc_3083835_259_270_Disease)))) (SBAR (IN in) (NN order) (S (VP (VP (TO to) (VP (VB prevent) (NP (PRP$ its) (NN occurrence)) (PP (IN by) (S (VP (VBG prescribing) (NP (DT the) (JJ antibiotic) (NN judiciously) (CC and) (NN knowledgeably))))))) (CC and) (VP (TO to) (VP (VB offer) (NP (JJ optimal) (JJ medical) (NN therapy)) (SBAR (IN once) (S (NP (DT this) (JJ life-threatening) (NN reaction)) (VP (VBZ has) (VP (VBN begun)))))))))))) (. .)))
3084231	0	(ROOT (NP (NP (JJ Reversible) (NN Doc_3084231_11_24_Chemical-induced) (NNS Doc_3084231_33_41_Disease)) (: :) (NP (DT a) (NN case) (NN report)) (. .)))
3084231	1	(ROOT (S (NP (JJ Reversible) (NN Doc_3084231_69_82_Chemical-induced) (NNS Doc_3084231_91_99_Disease)) (VP (VBD was) (VP (VBN documented) (PP (IN in) (NP (DT a) (JJ 21-year-old) (NN man))) (PP (IN with) (NP (NP (NNS Doc_3084231_141_149_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (DT a) (JJ 3-year) (NN history)) (PP (IN of) (NP (NP (JJ insidious) (JJ progressive) (NNS Doc_3084231_200_237_Disease)) (VP (VBN documented) (PP (IN by) (NP (JJ serial) (JJ neuropsychological) (NNS studies)))))))))))))) (. .)))
3084231	2	(ROOT (S (NP (NP (NN Repeat) (NN neuropsychological)) (VP (VBG testing) (NP (CD 7) (NNS weeks)) (PP (IN after) (NP (NP (NN discontinuation)) (PP (IN of) (NP (DT the) (NN drug))))))) (VP (VBD revealed) (NP (JJ dramatic) (NN improvement)) (PP (IN in) (NP (NP (NNP IQ)) (, ,) (NP (NN memory)) (, ,) (NP (NN naming)) (, ,) (CC and) (NP (NP (JJ other) (NNS tasks)) (ADJP (JJ commensurate) (PP (IN with) (NP (JJ clinical) (NN recovery))))))) (PP (IN in) (NP (PRP$ his) (JJ intellectual) (NN capacity)))) (. .)))
3084231	3	(ROOT (S (NP (NP (JJ Possible) (JJ pathophysiological) (NNS mechanisms)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB have) (VP (VBN been) (VP (VBN operative) (PP (IN in) (NP (DT this) (NN case)))))))))) (VP (VBP include) (: :) (NP (NP (NP (DT a) (JJ direct) (JJ central) (JJ nervous) (NN system)) (PRN (-LRB- -LRB-) (NP (NNP CNS)) (-RRB- -RRB-))) (NP (NP (NP (JJ toxic) (NN effect)) (PP (IN of) (NP (NNS Doc_3084231_643_656_Chemical)))) (: ;) (NP (NP (DT a) (JJ paradoxical) (JJ epileptogenic) (NN effect)) (VP (VBN secondary) (PP (TO to) (NP (DT the) (NN drug)))))) (: ;) (CC and) (NP (NP (DT an) (JJ indirect) (NNP CNS) (JJ toxic) (NN effect)) (VP (VBN mediated) (PP (IN through) (NP (NN Doc_3084231_766_779_Chemical-induced) (NNS Doc_3084231_788_802_Disease))))))) (. .)))
3088653	0	(ROOT (NP (NP (NNP Reversal)) (PP (IN of) (NP (NN Doc_3088653_12_23_Chemical-induced) (NNS Doc_3088653_32_39_Disease))) (PP (IN of) (NP (JJ passive) (NN avoidance))) (PP (IN by) (NP (NN pre) (: -) (CC and) (JJ post-training) (NNS Doc_3088653_87_95_Chemical))) (. .)))
3088653	1	(ROOT (S (PP (IN In) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (CD five) (NNS experiments))))) (, ,) (NP (NP (DT the) (VBG modulating) (NN role)) (PP (IN of) (NP (NP (NNS Doc_3088653_153_161_Chemical)) (PP (IN on) (NP (NP (DT a) (NN Doc_3088653_167_178_Chemical-induced) (NNS Doc_3088653_187_204_Disease)) (PP (IN in) (NP (DT a) (JJ passive) (NN avoidance) (NN paradigm)))))))) (VP (VBD was) (VP (VBN investigated) (PP (IN in) (NP (NNS mice))))) (. .)))
3088653	2	(ROOT (S (NP (NP (NP (NNP Doc_3088653_263_274_Chemical)) (, ,) (CONJP (CC but) (RB not)) (NP (NP (NNS Doc_3088653_284_302_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (CC and) (NP (CD 3) (NN mg/kg))) (-RRB- -RRB-)))) (, ,) (VP (VBN induced))) (ADVP (NP (DT an) (NN Doc_3088653_331_338_Disease)) (RB as)) (VP (VBN measured) (PP (IN by) (NP (NN latency) (CC and) (NN duration) (NNS parameters)))) (. .)))
3088653	3	(ROOT (S (NP (NP (NNP Doc_3088653_387_395_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.3)) (, ,) (NP (CD 1)) (, ,) (NP (CD 3)) (, ,) (CC and) (NP (CD 10) (NN mg/kg))) (-RRB- -RRB-))) (VP (VBD injected) (ADVP (RB prior) (PP (TO to) (NP (NP (NN training)) (VP (VBN attenuated) (NP (DT the) (NNS Doc_3088653_464_481_Disease)) (PP (IN with) (NP (NP (DT a) (NN peak)) (PP (IN of) (NP (NN activity))))) (PP (IN at) (NP (CD 3) (NN mg/kg)))))))) (. .)))
3088653	4	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NNS Doc_3088653_532_540_Chemical)))) (VP (MD could) (VP (VB be) (VP (VBN antagonized) (PP (IN with) (NP (NP (NNS Doc_3088653_567_575_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (, ,) (NP (CD 3)) (, ,) (CC and) (NP (CD 10) (NN mg/kg))) (-RRB- -RRB-)))) (, ,) (S (VP (VBG demonstrating) (NP (NP (DT the) (JJ opioid) (NN specificity)) (PP (IN of) (NP (DT the) (JJ Doc_3088653_642_650_Chemical) (NN effect))))))))) (. .)))
3088653	5	(ROOT (S (NP (NP (JJ Post-training) (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_3088653_691_699_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN mg/kg)) (-RRB- -RRB-))) (PP (PP (IN as) (NP (DT a) (JJ single))) (CC or) (PP (IN as) (NP (DT a) (NN split) (NN dose))))))) (ADVP (RB also)) (VP (VBD attenuated) (NP (DT the) (NN Doc_3088653_761_772_Chemical-induced) (NNS Doc_3088653_781_788_Disease))) (. .)))
3088653	6	(ROOT (S (NP (NNP Control) (NNS experiments)) (VP (VBD indicated) (SBAR (IN that) (S (NP (CC neither) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ Doc_3088653_848_852_Disease) (NN sensitivity)) (PRN (-LRB- -LRB-) (NP (JJ pre-training) (NNS Doc_3088653_879_887_Chemical)) (-RRB- -RRB-))))) (CC nor) (NP (NP (DT an) (JJ induced) (NN aversive) (NN state)) (PRN (-LRB- -LRB-) (NP (JJ post-training) (NNS Doc_3088653_934_942_Chemical)) (-RRB- -RRB-))))) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (NP (NNS Doc_3088653_990_998_Chemical)) (PP (IN on) (NP (DT the) (NN Doc_3088653_1006_1017_Chemical-induced) (NNS Doc_3088653_1026_1043_Disease))))))))))))))) (. .)))
3088653	7	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP extend) (NP (NP (JJ previous) (NNS findings)) (VP (VBG implicating) (NP (NP (DT a) (JJ cholinergic-opioid) (NN interaction)) (PP (IN in) (NP (NN memory) (NNS processes))))))) (. .)))
3088653	8	(ROOT (S (NP (NP (DT A) (JJ possible) (NN mechanism)) (PP (IN for) (NP (NP (DT this) (NN interaction)) (VP (VBG involving) (NP (DT the) (JJ septo-hippocampal) (JJ cholinergic) (NN pathway)))))) (VP (VBZ is) (VP (VBN discussed))) (. .)))
3109094	0	(ROOT (S (NP (NP (NNP Electron) (JJ microscopic) (NNS investigations)) (PP (IN of) (NP (DT the) (NN Doc_3109094_43_59_Chemical-induced)))) (VP (VBZ lesions) (PP (IN of) (NP (NP (DT the) (JJ urinary) (NN bladder)) (PP (IN of) (NP (NP (DT the) (NN rat)) (CC and) (NP (PRP$ their) (NN prevention)))))) (PP (IN by) (NP (NNS Doc_3109094_134_139_Chemical)))) (. .)))
3109094	1	(ROOT (S (NP (NNP Fully)) (VP (VBD developed) (SBAR (S (NP (NN Doc_3109094_157_173_Chemical-induced) (NNS Doc_3109094_182_190_Disease)) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (ADJP (RB nearly) (JJ complete)) (NN detachment)) (PP (IN of) (NP (NP (DT the) (NN urothelium)) (, ,) (NP (NP (JJ severe) (NNS Doc_3109094_264_280_Disease)) (VP (VBG owing) (S (VP (TO to) (VP (VB damage) (PP (TO to) (NP (NP (DT the) (NN microvascular) (NN bed)) (CC and) (NP (JJ focal) (NNS Doc_3109094_332_347_Disease)))))))))))))))))) (. .)))
3109094	2	(ROOT (S (NP (NP (DT The) (JJ initial) (NN response)) (PP (TO to) (NP (NP (DT the) (JJ primary) (NN attack)) (PP (IN by) (NP (DT the) (JJ Doc_3109094_399_415_Chemical) (NNS metabolites)))))) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (NP (NP (NN fragmentation)) (PP (IN of) (NP (DT the) (JJ luminal) (NN membrane)))))))) (. .)))
3109094	3	(ROOT (NP (NP (DT This) (NNS damages)) (NP (NP (DT the) (JJ cellular) (NN barrier)) (PP (IN against) (NP (DT the) (JJ hypertonic) (NN urine)))) (. .)))
3109094	4	(ROOT (S (NP (NP (JJ Subsequent) (NNS breaks)) (PP (PP (IN in) (NP (NP (DT the) (JJ lateral) (NN cell) (NNS membranes)) (PP (IN of) (NP (DT the) (JJ superficial) (NNS cells))))) (CC and) (PP (IN in) (NP (NP (PDT all) (DT the) (NN plasma) (NNS membranes)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ intermediate) (CC and) (JJ basal)) (NNS cells)) (, ,) (NP (NN intercellular) (CC and) (NN intracellular) (NNS Doc_3109094_717_722_Disease)) (CC and) (NP (NP (NN disintegration)) (PP (IN of) (NP (DT the) (NNS desmosomes) (CC and) (NNS hemidesmosomes)))))))))) (VP (VBP lead) (PP (TO to) (NP (NP (JJ progressive) (NN degeneration) (CC and) (NN detachment)) (PP (IN of) (NP (DT the) (JJ epithelial) (NNS cells))))) (PP (IN with) (NP (NP (NN exposure) (CC and) (NN splitting)) (PP (IN of) (NP (DT the) (JJ basal) (NN membrane)))))) (. .)))
3109094	5	(ROOT (S (NP (NP (DT The) (JJ morphological) (NNS changes)) (PP (IN of) (NP (NP (DT the) (JJ endothelial) (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBN become) (S (ADJP (RBR more) (JJ pronounced))) (PP (IN in) (NP (NP (NP (DT the) (JJ later) (NNS stages)) (PP (IN of) (NP (DT the) (NN experiment)))) (, ,) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NP (NN blood) (NNS vessels)) (ADVP (RB regardless) (PP (IN of) (NP (PRP$ their) (NN diameter))))))) (CC and) (NP (NP (DT the) (JJ location-dependent) (NN extent)) (PP (IN of) (NP (DT the) (NN damage)))))))))))) (VP (VBP indicate) (NP (NP (DT a) (JJ direct) (NN type)) (PP (IN of) (NP (NN damage))) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN preceded) (PP (IN by) (NP (NP (DT a) (JJ mediator-induced) (NN increase)) (PP (IN in) (NP (NP (NN permeability)) (, ,) (NP (NP (DT the) (JJ morphological) (NN correlate)) (PP (IN of) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (NNS gaps)) (PP (IN in) (NP (NP (DT the) (JJ interendothelial) (NN cell) (NNS connections)) (PP (IN on) (NP (DT the) (NNS venules))))))))))))))))))))))) (. .)))
3109094	6	(ROOT (S (NP (DT These) (NNS changes)) (VP (MD can) (VP (VB be) (VP (ADVP (RB effectively)) (VBN prevented) (PP (IN by) (NP (NNS Doc_3109094_1396_1401_Chemical)))))) (. .)))
3109094	7	(ROOT (S (NP (NP (DT The) (JJ only) (NN sign)) (PP (IN of) (NP (DT a) (JJ possible) (NN involvement)))) (VP (VBZ is) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (JJ specific) (NNS granules)) (PP (IN with) (NP (NP (DT a) (VBN presumed) (JJ lysosomal) (NN function)) (PP (IN in) (NP (DT the) (JJ superficial) (NNS cells))))))))))) (. .)))
3125850	0	(ROOT (S (VP (VP (VB Increase) (PP (IN in) (NP (JJ intragastric) (NN pressure))) (PP (IN during) (NP (NP (NN Doc_3125850_41_54_Chemical-induced) (NNS Doc_3125850_63_84_Disease)) (PP (IN in) (NP (NNS children)))))) (: :) (VP (ADJP (JJ inhibition)) (PP (IN by) (NP (NNS Doc_3125850_112_122_Chemical))))) (. .)))
3125850	1	(ROOT (S (NP (NP (NNS Changes)) (PP (IN in) (NP (NP (JJ intragastric) (NN pressure)) (PP (IN after) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NNP Doc_3125850_185_198_Chemical) (CD 1.5)))))))) (VP (VBP mg) (SBAR (S (NP (JJ kg-1) (NN i.v.)) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (NP (NP (NP (CD 32) (NNS children)) (PRN (-LRB- -LRB-) (NP (JJ mean) (NN age) (NN 6.9) (NN yr)) (-RRB- -RRB-))) (VP (VBN pretreated) (PP (IN with) (NP (NP (DT either) (JJ physiological) (NN saline)) (CC or) (NP (NNS Doc_3125850_309_319_Chemical)))))) (ADJP (NP (CD 50) (NNS micrograms)) (JJ kg-1))))))))) (. .)))
3125850	2	(ROOT (S (NP (NNP Anaesthesia)) (VP (VBD was) (VP (VBN induced) (PP (IN with) (NP (NP (NNS Doc_3125850_369_380_Chemical)) (ADJP (NP (CD 5) (NNS mg)) (JJ kg-1)))))) (. .)))
3125850	3	(ROOT (S (NP (NP (DT The) (NN incidence) (CC and) (NN intensity)) (PP (IN of) (NP (NP (NNS Doc_3125850_423_444_Disease)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_3125850_455_468_Chemical))))))) (VP (VBD were) (ADJP (ADJP (RB significantly) (JJR greater)) (PP (IN in) (ADVP (NP (DT the) (NN control)) (IN than)))) (PP (IN in) (NP (DT the) (JJ Doc_3125850_523_533_Chemical) (NN group)))) (. .)))
3125850	4	(ROOT (S (NP (NP (DT The) (JJ intragastric) (NN pressure)) (PP (IN during) (NP (NNS Doc_3125850_574_595_Disease)))) (VP (VBD was) (ADJP (ADJP (ADJP (RB significantly) (JJR higher) (PP (IN in) (NP (DT the) (NN control) (NN group)))) (PRN (-LRB- -LRB-) (NP (NP (CD 16) (JJ +) (NNS /)) (: -) (NP (NP (CD 0.7)) (PRN (-LRB- -LRB-) (NP (NNP SEM)) (-RRB- -RRB-)) (NP (NN cm) (NNS Doc_3125850_663_666_Chemical)))) (-RRB- -RRB-))) (PP (IN than) (PP (IN in) (NP (NP (DT the) (JJ Doc_3125850_680_690_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (NP (CD 7.7) (JJ +) (NNS /)) (: -) (NP (NP (CD 1.5)) (PRN (-LRB- -LRB-) (NP (NNP SEM)) (-RRB- -RRB-)) (NP (NN cm) (NNS Doc_3125850_719_722_Chemical)))) (-RRB- -RRB-))))))) (. .)))
3125850	5	(ROOT (S (NP (NP (DT The) (NN increase)) (PP (IN in) (NP (JJ intragastric) (NN pressure)))) (VP (VBD was) (ADJP (RB directly) (JJ related) (PP (TO to) (NP (NP (DT the) (NN intensity)) (PP (IN of) (NP (NNS Doc_3125850_804_825_Disease)))))) (PRN (-LRB- -LRB-) (NP (NP (NN regression) (NN line)) (: :) (NP (NP (NN y)) (SBAR (S (VP (SYM =) (NP (CD 0.5) (NNP +) (CD 4.78) (NNS x))))))) (PP (IN with) (NP (NP (SYM r)) (PP (IN of) (NP (CD 0.78))))) (-RRB- -RRB-))) (. .)))
3125850	6	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (JJ intragastric) (NN pressure)) (VP (VBZ increases) (ADVP (RB significantly)) (PP (IN during) (NP (NP (NNS Doc_3125850_951_972_Disease)) (VP (VBN caused) (PP (IN by) (NP (NP (NNS Doc_3125850_983_996_Chemical)) (PP (IN in) (NP (JJ healthy) (NNS children))))))))))))) (. .)))
3125850	7	(ROOT (S (S (NP (NP (NNP Doc_3125850_1018_1028_Chemical)) (ADJP (NP (CD 50) (NNS micrograms)) (JJ kg-1))) (ADVP (RB effectively)) (VP (VBZ inhibits) (NP (NP (DT the) (NN incidence) (CC and) (NN intensity)) (PP (IN of) (NP (NN Doc_3125850_1100_1113_Chemical-induced) (NNS Doc_3125850_1122_1143_Disease)))))) (: ;) (S (ADVP (RB moreover)) (, ,) (NP (JJ intragastric) (NN pressure)) (VP (VBZ remains) (PP (IN at) (NP (PRP$ its) (NN control) (NN value))))) (. .)))
3155884	0	(ROOT (S (NP (JJ Acute) (NN insulin) (NN treatment)) (VP (VBZ normalizes) (NP (DT the) (NN resistance)) (PP (TO to) (NP (NP (DT the) (JJ Doc_3155884_57_68_Disease) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_3155884_79_92_Chemical)) (PP (IN in) (NP (JJ Doc_3155884_96_110_Chemical) (JJ Doc_3155884_111_119_Disease) (NNS rats)))))))) (. .)))
3155884	1	(ROOT (S (NP (NP (DT A) (JJ morphometric) (NN study)) (PP (IN of) (NP (NNS Doc_3155884_150_163_Chemical)))) (VP (VBN induced) (NP (NNS Doc_3155884_172_191_Disease))) (. .)))
3155884	2	(ROOT (S (NP (NP (DT The) (JJ acute) (NN effect)) (PP (IN of) (NP (NP (NN insulin) (NN treatment)) (PP (IN on) (NP (NP (DT the) (JJR earlier) (VBN reported) (JJ protective) (NN effect)) (PP (IN of) (NP (NP (JJ Doc_3155884_276_290_Chemical) (NNS Doc_3155884_291_307_Disease)) (NP (NP (DT the) (JJ Doc_3155884_312_323_Disease) (NN effect)) (PP (IN of) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_3155884_348_361_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3155884_363_366_Chemical)) (-RRB- -RRB-)))))))))))))) (VP (VBD was) (VP (VBN investigated) (PP (IN in) (NP (NNS rats))))) (. .)))
3155884	3	(ROOT (S (PP (PP (ADVP (RB Thirty)) (TO to) (NP (CD 135) (NN min))) (PP (IN after) (NP (NP (DT the) (NN injection)) (PP (IN of) (NP (JJ crystalline) (NN insulin)))))) (, ,) (S (NP (NNS Doc_3155884_456_459_Chemical)) (VP (VBD was) (VP (VBN given) (ADVP (RB subcutaneously))))) (CC and) (S (SBAR (WHADVP (WRB when)) (S (NP (NP (JJ Doc_3155884_494_497_Chemical) (JJ induced) (NNS Doc_3155884_506_514_Disease)) (PP (IN in) (NP (DT the) (NN myocardium)))) (VP (VBD was) (ADVP (RB morphometrically)) (VP (VBN analyzed) (NP (CD 7) (NNS days) (RB later)))))) (, ,) (NP (NP (NP (DT a) (ADJP (RB highly) (JJ significant)) (NN correlation)) (PRN (-LRB- -LRB-) (NP (NP (NNP r) (NNP =) (CD 0.83) (, ,) (CD 2)) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.006)))))) (-RRB- -RRB-))) (PP (TO to) (NP (NP (DT the) (NN slope)) (PP (IN of) (NP (NP (DT the) (NN fall)) (PP (IN in) (NP (NN blood) (NNS Doc_3155884_668_675_Chemical))))))) (PP (IN after) (NP (NN insulin) (NN treatment)))) (VP (VBD appeared))) (. .)))
3155884	4	(ROOT (S (NP (NP (DT The) (JJ myocardial) (NN content)) (PP (IN of) (NP (NNS Doc_3155884_736_750_Chemical)))) (VP (VBD was) (VP (VBN estimated) (PP (IN in) (NP (DT these) (CD 8) (NN day) (NNS Doc_3155884_780_788_Disease) (NNS rats))))) (. .)))
3155884	5	(ROOT (S (NP (DT The) (JJ Doc_3155884_799_813_Chemical) (NN content)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN increased) (SBAR (IN while) (S (NP (NNS Doc_3155884_856_867_Chemical)) (VP (VBD remained) (ADJP (JJ unchanged))))))) (. .)))
3155884	6	(ROOT (S (NP (NP (DT An) (JJ enhanced) (ADJP (JJ sympathetic) (JJ nervous)) (NN system) (NN activity)) (PP (IN with) (NP (NP (DT a) (JJ consequent) (JJ down) (NN regulation)) (PP (IN of) (NP (DT the) (JJ myocardial) (JJ beta-adrenergic) (NNS receptors)))))) (VP (MD could) (, ,) (ADVP (RB therefore)) (, ,) (VP (VB explain) (NP (DT this) (JJ Doc_3155884_1045_1058_Chemical) (NN resistance)))) (. .)))
3155884	7	(ROOT (S (NP (NP (DT The) (JJ rapid) (NN reversion)) (PP (IN after) (NP (NN insulin) (NN treatment)))) (VP (VBZ excludes) (NP (DT the) (NN possibility)) (SBAR (IN that) (S (NP (NP (NNS Doc_3155884_1145_1159_Chemical)) (PP (IN in) (NP (PRP itself)))) (VP (VBZ causes) (NP (DT the) (JJ Doc_3155884_1181_1184_Chemical) (NN resistance) (CC and) (NNS points)) (PP (IN towards) (NP (NP (DT a) (JJ direct) (NN insulin) (NN effect)) (PP (IN on) (NP (NP (JJ myocardial) (JJ Doc_3155884_1253_1266_Chemical) (NN sensitivity)) (PP (IN in) (NP (JJ Doc_3155884_1282_1290_Disease) (NNS rats))))))))))) (. .)))
3155884	8	(ROOT (S (NP (DT The) (NN phenomenon)) (VP (VP (VBD described) (SBAR (S (VP (MD might) (VP (VB elucidate) (NP (JJ pathogenetic) (NNS mechanisms)) (PP (IN behind) (NP (JJ toxic) (JJ myocardial) (NN cell) (NN degeneration)))))))) (CC and) (VP (MD may) (ADVP (RB possibly)) (VP (VB have) (NP (NP (NN relevance)) (PP (IN for) (NP (NP (JJ acute) (NNS Doc_3155884_1446_1474_Disease)) (PP (IN in) (NP (JJ Doc_3155884_1478_1486_Disease) (NNS patients))))))))) (. .)))
3191389	0	(ROOT (S (NP (NP (JJ Differential) (NNS effects)) (PP (IN of) (NP (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)) (PP (IN on) (NP (NNS Doc_3191389_65_73_Disease)))))) (VP (VBD produced) (PP (IN by) (NP (NNS Doc_3191389_86_97_Chemical))) (PP (IN in) (NP (NNS rats)))) (. .)))
3191389	1	(ROOT (S (NP (DT The) (JJ muscarinic) (JJ cholinergic) (NN agonist) (NNS Doc_3191389_142_153_Chemical)) (VP (VBZ induces) (PP (IN in) (NP (NP (JJ rats) (NNS Doc_3191389_170_178_Disease) (CC and) (NNS Doc_3191389_183_201_Disease)) (VP (VBN followed) (PP (IN by) (NP (JJ widespread) (NN damage))) (PP (TO to) (NP (DT the) (NN forebrain))))))) (. .)))
3191389	2	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (CD 5) (JJ non-steroidal) (NN anti-inflammatory) (NNS drugs) (, ,) (NNS Doc_3191389_351_368_Chemical) (, ,) (NNS Doc_3191389_370_384_Chemical) (, ,) (NNS Doc_3191389_386_398_Chemical) (, ,) (NNS Doc_3191389_400_409_Chemical) (CC and) (NNS Doc_3191389_414_428_Chemical))))))) (, ,) (PP (IN on) (NP (NP (NNS Doc_3191389_433_441_Disease)) (VP (VBN produced) (PP (IN by) (NP (NNS Doc_3191389_454_465_Chemical)))))))) (. .)))
3191389	3	(ROOT (S (NP (NP (NNP Pretreatment)) (PP (IN of) (NP (NP (NP (NNS rats)) (PP (IN with) (NP (NP (JJ Doc_3191389_493_510_Chemical) (, ,) (NNP ED50) (CD 103) (NN mg/kg)) (PRN (-LRB- -LRB-) (NP (CD 60-174)) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (NNS Doc_3191389_541_555_Chemical)) (, ,) (NP (CD 59) (NN mg/kg) (PRN (-LRB- -LRB-) (NP (CD 50-70)) (-RRB- -RRB-))))))) (VP (VBD converted) (NP (NP (DT the) (JJ non-convulsant) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_3191389_611_622_Chemical)) (, ,) (NP (CD 200) (NN mg/kg)) (, ,)))) (PP (TO to) (NP (DT a) (JJ convulsant) (NN one)))) (. .)))
3191389	4	(ROOT (S (ADVP (RB Doc_3191389_656_668_Chemical)) (, ,) (NP (NP (CD 1-10) (NN mg/kg)) (, ,) (CC and) (NP (NNS Doc_3191389_686_695_Chemical)) (, ,) (NP (CD 10-100) (NN mg/kg)) (, ,)) (VP (VBD failed) (PP (TO to) (NP (NP (JJ modulate) (NNS Doc_3191389_730_738_Disease)) (VP (VBN produced) (PP (IN by) (NP (NNS Doc_3191389_751_762_Chemical))))))) (. .)))
3191389	5	(ROOT (S (NP (NP (NNP Doc_3191389_764_778_Chemical)) (, ,) (NP (NP (NP (CD 26)) (PRN (-LRB- -LRB-) (NP (CD 22-30)) (-RRB- -RRB-))) (VP (VBG mg/kg))) (, ,)) (VP (VBD prevented) (NP (JJ Doc_3191389_808_816_Disease) (CC and) (JJ protected) (NNS rats)) (PP (IN from) (NP (NP (NN Doc_3191389_841_848_Disease-related) (NNS Doc_3191389_857_869_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_3191389_881_892_Chemical)) (, ,) (NP (CD 380) (NN mg/kg)))))))) (. .)))
3191389	6	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)) (ADVP (RB differentially)) (VP (VBP modulate) (NP (NP (DT the) (NN threshold)) (PP (IN for) (NP (NN Doc_3191389_1013_1024_Chemical-induced) (NNS Doc_3191389_1033_1041_Disease)))))))) (. .)))
3289726	0	(ROOT (S (VP (VB Doc_3289726_0_28_Disease) (PP (IN after) (NP (NP (JJ high-dose) (JJ Doc_3289726_45_54_Chemical) (NN therapy)) (PP (IN for) (NP (NNS Doc_3289726_67_83_Disease)))))) (. .)))
3289726	1	(ROOT (S (NP (NP (NNP Doc_3289726_85_94_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3289726_96_105_Chemical)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (JJ many) (JJ solid) (NNS Doc_3289726_152_158_Disease)) (CC and) (NP (NNS Doc_3289726_163_187_Disease))))))))) (. .)))
3289726	2	(ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VP (VBN used) (PP (IN in) (NP (JJ high) (NNS doses)))) (CC and) (VP (PP (IN in) (NP (NN conjunction))) (PP (IN with) (NP (JJ autologous) (NN bone) (NN marrow) (NN transplantation))))))) (, ,) (NP (DT this) (NN agent)) (VP (VBZ has) (NP (NP (NN activity)) (PP (IN against) (NP (NP (JJ several) (JJ treatment-resistant) (NNS Doc_3289726_337_344_Disease)) (PP (VBG including) (NP (NNS Doc_3289726_355_371_Disease))))))) (. .)))
3289726	3	(ROOT (S (PP (IN In) (NP (NP (CD six)) (PP (IN of) (NP (NP (CD eight) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 75) (NN %)) (-RRB- -RRB-)) (SBAR (WHNP (WP who)) (S (NP (PRP we)) (VP (VBN treated) (PP (IN for) (NP (ADJP (JJ recurrent) (CC or) (JJ resistant)) (NNS Doc_3289726_446_452_Disease)))))))))) (, ,) (NP (NNS Doc_3289726_454_492_Disease)) (VP (VBD occurred)) (. .)))
3289726	4	(ROOT (S (NP (DT This)) (VP (VBD developed) (NP (NP (DT a) (NN median)) (PP (IN of) (NP (CD 9) (NNS days)))) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (JJ high-dose) (JJ Doc_3289726_567_576_Chemical) (NN therapy)))))) (. .)))
3289726	5	(ROOT (S (NP (JJ Significant) (JJ clinical) (NNS manifestations)) (VP (VBP have) (VP (VBN included) (NP (NP (NP (NNS Doc_3289726_636_645_Disease)) (, ,) (NP (NNS Doc_3289726_647_658_Disease)) (, ,) (NP (NNS Doc_3289726_660_670_Disease)) (, ,) (NP (NP (NN exacerbation)) (PP (IN of) (NP (NN motor) (NNS deficits))))) (, ,) (CC and) (NP (NP (JJ sharp) (NN increase)) (PP (IN in) (NP (JJ Doc_3289726_726_733_Disease) (NN activity))))))) (. .)))
3289726	6	(ROOT (S (NP (DT These) (NNS abnormalities)) (VP (VBD resolved) (ADVP (RB rapidly)) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (JJ high-dose) (JJ intravenous) (JJ Doc_3289726_823_836_Chemical) (NN therapy)))))) (. .)))
3289726	7	(ROOT (S (PP (IN In) (NP (DT all) (NNS patients))) (, ,) (NP (JJ computerized) (ADJP (ADJP (JJ tomographic)) (PRN (-LRB- -LRB-) (NP (NNP CT)) (-RRB- -RRB-))) (NN brain) (NNS scans)) (VP (VBD demonstrated) (NP (NN stability)) (PP (IN in) (NP (JJ Doc_3289726_931_936_Disease) (NN size) (CC and) (NN peritumor) (NNS Doc_3289726_956_961_Disease))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (JJ pretransplant) (NNS scans))))))) (. .)))
3289726	8	(ROOT (S (NP (DT This) (NN complication)) (VP (VBZ appears) (S (VP (TO to) (VP (VB represent) (NP (NP (DT a) (JJ significant) (JJ new) (NNS Doc_3289726_1059_1067_Disease)) (PP (IN of) (NP (NP (JJ high-dose) (JJ Doc_3289726_1081_1090_Chemical) (NN therapy)) (PP (IN for) (NP (NNS Doc_3289726_1103_1119_Disease)))))))))) (. .)))
3297909	0	(ROOT (NP (NP (JJ Progressive) (NNS Doc_3297909_12_28_Disease)) (PP (IN after) (NP (JJ Doc_3297909_35_48_Chemical) (NN administration))) (. .)))
3297909	1	(ROOT (S (NP (DT A) (JJ 27-yr-old) (NN man)) (VP (VBD developed) (NP (JJ Doc_3297909_91_99_Disease) (CD 2) (NNS wk)) (PP (IN after) (NP (NN exposure))) (PP (TO to) (NP (NNS Doc_3297909_123_136_Chemical)))) (. .)))
3297909	2	(ROOT (S (NP (NNP Doc_3297909_138_149_Disease)) (VP (VBD persisted) (PP (IN for) (NP (NP (CD 3) (NN yr)) (, ,) (SBAR (WHPP (IN at) (WHNP (WDT which) (NN time))) (S (NP (DT a) (NN liver) (NN transplant)) (VP (VBD was) (VP (VBN performed)))))))) (. .)))
3297909	3	(ROOT (S (NP (NP (CD Two) (NN liver) (NN biopsy) (NNS specimens)) (CC and) (NP (DT the) (JJ hepatectomy) (NN specimen))) (VP (VBD were) (ADJP (JJ remarkable) (PP (IN for) (NP (NP (ADJP (RB almost) (JJ complete)) (NN disappearance)) (PP (IN of) (NP (NN interlobular) (NN bile) (NNS ducts))))))) (. .)))
3297909	4	(ROOT (S (S (NP (JJ Prominent) (NNS Doc_3297909_362_370_Disease) (CC and) (NN hepatocellular) (NNS regeneration)) (VP (VBD were) (ADVP (RB also)) (ADJP (JJ present)))) (: ;) (S (ADVP (RB however)) (, ,) (NP (DT the) (NN lobular) (NN architecture)) (VP (VBD was) (VP (VBN preserved)))) (. .)))
3297909	5	(ROOT (S (NP (DT This) (NN case)) (VP (VBZ represents) (NP (NP (DT an) (NN example)) (PP (IN of) (NP (ADJP (`` ``) (JJ idiosyncratic) ('' '') (JJ drug-induced)) (NNS Doc_3297909_535_547_Disease))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT the) (JJ primary) (NN target)) (PP (IN of) (NP (NN injury)))) (VP (VBZ is) (NP (DT the) (NN bile) (NN duct))))))) (. .)))
3297909	6	(ROOT (S (NP (NP (DT An) (JJ autoimmune) (NNS pathogenesis)) (PP (IN of) (NP (DT the) (NN bile) (NN duct) (NN destruction)))) (VP (VBZ is) (VP (VBN suggested))) (. .)))
3323259	0	(ROOT (NP (NP (NP (JJ Differential) (NNS effects)) (PP (IN of) (NP (JJ Doc_3323259_24_51_Chemical) (NN channel) (NNS blockers)))) (: :) (NP (JJ therapeutic) (NNS implications)) (. .)))
3323259	1	(ROOT (S (NP (NP (VBG Increasing) (NN recognition)) (PP (IN of) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NP (NNS Doc_3323259_140_147_Chemical)) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (NNS Doc_3323259_171_193_Disease)))))))))) (VP (VBZ has) (VP (VBN stimulated) (NP (NN research)) (PP (IN into) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ Doc_3323259_234_241_Chemical) (NN channel))))) (S (VP (VBG blocking) (NP (NNS agents)) (PP (IN for) (NP (NP (NN treatment)) (PP (IN of) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS Doc_3323259_296_319_Disease))))))))))) (. .)))
3323259	2	(ROOT (S (NP (NP (DT The) (JJ favorable) (NN efficacy)) (CC and) (NP (NP (JJ tolerability) (NNS profiles)) (PP (IN of) (NP (DT these) (NNS agents))))) (VP (VBP make) (S (NP (PRP them)) (NP (JJ attractive) (JJ therapeutic) (NNS modalities)))) (. .)))
3323259	3	(ROOT (S (NP (NP (JJ Clinical) (NNS applications)) (PP (IN of) (NP (JJ Doc_3323259_456_463_Chemical) (NN channel)))) (VP (VBZ blockers) (VP (VB parallel) (NP (PRP$ their) (NN tissue)) (ADVP (RB selectivity)))) (. .)))
3323259	4	(ROOT (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (NNS Doc_3323259_531_540_Chemical) (CC and) (NNS Doc_3323259_545_554_Chemical))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADJP (RB roughly) (JJ equipotent) (PP (IN in) (NP (PRP$ their) (NNS actions)))) (PP (IN on) (NP (DT the) (NN heart) (CC and) (NN vascular) (JJ smooth) (NN muscle)))))))) (, ,) (NP (DT the) (JJ Doc_3323259_647_670_Chemical) (NN channel) (NNS blockers)) (VP (VBP are) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (JJ potent) (JJ peripheral) (NN vasodilator) (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP exert) (NP (NP (JJ minimal) (JJ electrophysiologic) (NNS effects)) (PP (IN on) (NP (JJ cardiac) (NN nodal) (CC or) (NN conduction) (NN tissue))))))))))) (. .)))
3323259	5	(ROOT (S (SBAR (IN As) (S (NP (DT the) (JJ first) (NNS Doc_3323259_838_853_Chemical)) (ADJP (JJ available) (PP (IN for) (NP (NP (NN use)) (PP (IN in) (NP (DT the) (NNP United) (NNPS States)))))))) (, ,) (NP (NNS Doc_3323259_894_904_Chemical)) (VP (VBZ controls) (NP (NNS Doc_3323259_914_920_Disease) (CC and) (NNS Doc_3323259_925_937_Disease)) (PP (IN with) (NP (NP (JJ minimal) (NNS Doc_3323259_951_961_Disease)) (PP (IN of) (NP (JJ cardiac) (NN function)))))) (. .)))
3323259	6	(ROOT (S (NP (NP (JJ Additional) (NNS members)) (PP (IN of) (NP (NP (DT this) (NN group)) (PP (IN of) (NP (JJ Doc_3323259_1019_1026_Chemical) (NN channel) (NNS blockers)))))) (VP (VBP have) (VP (VBN been) (VP (VBN studied) (PP (IN for) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS indications)) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (PRP they)) (VP (MD may) (VP (VB offer) (NP (NNS advantages)) (PP (IN over) (NP (JJ current) (NN therapy)))))))))))))) (. .)))
3323259	7	(ROOT (SINV (ADVP (RB Once) (CC or) (RB twice)) (ADJP (NP (JJ daily) (NNP dosage)) (JJ possible) (PP (IN with) (NP (NNS Doc_3323259_1190_1202_Chemical) (CC and) (NNS Doc_3323259_1207_1218_Chemical)))) (VP (VBZ offers)) (NP (NP (DT a) (JJ convenient) (NN administration) (NN schedule)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ encourages) (NP (JJ patient) (NN compliance)) (PP (IN in) (NP (NP (JJ long-term) (NN therapy)) (PP (IN of) (NP (NNS Doc_3323259_1324_1336_Disease))))))))) (. .)))
3323259	8	(ROOT (S (NP (NP (DT The) (JJ coronary) (NN vasodilating) (NNS properties)) (PP (IN of) (NP (NNS Doc_3323259_1378_1389_Chemical)))) (VP (VBP have) (VP (VBN led) (PP (TO to) (NP (NP (DT the) (NN investigation)) (PP (IN of) (NP (NP (DT this) (NN agent)) (PP (IN for) (NP (NN use))))))) (PP (IN in) (NP (NNS Doc_3323259_1445_1451_Disease))))) (. .)))
3323259	9	(ROOT (S (NP (NP (NNP Selectivity)) (PP (IN for) (NP (DT the) (NN cerebrovascular) (NN bed)))) (VP (VBZ makes) (S (NP (NNS Doc_3323259_1499_1509_Chemical)) (ADJP (RB potentially) (JJ useful) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_3323259_1549_1572_Disease) (, ,) (NNS Doc_3323259_1574_1591_Disease) (, ,) (NNS Doc_3323259_1593_1601_Disease) (, ,) (CC and) (NNS Doc_3323259_1607_1613_Disease)))))))) (. .)))
3323259	10	(ROOT (S (PP (IN In) (NP (NN general))) (, ,) (NP (DT the) (JJ Doc_3323259_1631_1654_Chemical) (NN channel) (NNS blockers)) (VP (VBP are) (ADVP (RB usually)) (ADJP (RB well) (JJ tolerated)) (, ,) (PP (IN with) (S (NP (NP (NNS Doc_3323259_1705_1713_Disease)) (, ,) (NP (JJ facial) (NN flushing)) (, ,) (NP (NNS palpitations)) (, ,) (NP (NNS Doc_3323259_1746_1751_Disease)) (, ,) (NP (NNS Doc_3323259_1753_1759_Disease)) (, ,) (NP (NNS Doc_3323259_1761_1769_Disease)) (, ,) (CC and) (NP (NNS Doc_3323259_1775_1784_Disease))) (VP (VBG being) (NP (DT the) (ADJP (RBR more) (JJ common)) (NP (JJ adverse) (NNS effects))))))) (. .)))
3323599	0	(ROOT (NP (NP (DT The) (NN enhancement)) (PP (IN of) (NP (JJ Doc_3323599_19_34_Chemical) (NNS Doc_3323599_35_44_Disease))) (PP (IN by) (NP (NP (DT the) (NN co-administration)) (PP (IN of) (NP (NNS Doc_3323599_73_82_Chemical))))) (. .)))
3323599	1	(ROOT (S (NP (NP (DT An) (JJ experimental) (NN model)) (PP (IN of) (NP (NP (NNS Doc_3323599_109_145_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3323599_147_151_Disease)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN developed) (PP (IN in) (NP (NNS rats))) (PP (IN by) (NP (NP (DT the) (VBN combined) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_3323599_209_234_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3323599_236_240_Chemical)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_3323599_246_263_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP PS)) (-RRB- -RRB-)))))))) (. .)))
3323599	2	(ROOT (S (NP (NP (JJ Male) (JJ Sprague-Dawley) (NNS rats)) (, ,) (VP (VBN uninephrectomized) (NP (CD three) (NNS weeks) (RB before))) (, ,)) (VP (VBD received) (NP (NP (JJ daily) (NNS injections)) (PP (IN of) (NP (NP (JJ subcutaneous) (NNS AMNS)) (PRN (-LRB- -LRB-) (NP (NP (CD 1) (NNS mg/100)) (NP (NN g) (NN body) (NN wt))) (-RRB- -RRB-)) (CC and) (NP (NNP intravenous) (NNP PS)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 2) (JJ separated)) (NNS doses)) (PP (IN of) (NP (CD 2.5) (JJ mg/100) (NNP g) (NN body) (NN wt)))) (-RRB- -RRB-))))) (PP (IN for) (NP (CD four) (NNS days)))) (. .)))
3323599	3	(ROOT (S (NP (NP (DT The) (NN series)) (PP (IN of) (NP (NNS injections)))) (VP (VBD were) (VP (VBN repeated) (NP (DT another) (CD three) (NNS times)) (PP (IN at) (NP (CD 10) (NN day) (NNS intervals))))) (. .)))
3323599	4	(ROOT (S (NP (DT The) (NNS animals)) (VP (VBD were) (VP (VBN sacrificed) (PP (IN on) (NP (NP (NNS days)) (NP (CD 24) (, ,) (CD 52) (, ,) (CC and) (CD 80)))))) (. .)))
3323599	5	(ROOT (S (NP (PRP They)) (VP (VBD developed) (NP (NNS Doc_3323599_627_645_Disease) (CC and) (NNS Doc_3323599_650_671_Disease))) (. .)))
3323599	6	(ROOT (S (NP (NP (DT The) (JJ time-course) (NN curve)) (PP (IN of) (NP (JJ Doc_3323599_698_708_Chemical) (NN clearance)))) (VP (VBD dropped) (CC and) (VBD showed) (NP (JJ significant) (NN difference)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.01))) (-RRB- -RRB-)) (PP (IN from) (NP (NP (DT that)) (PP (IN of) (NP (NP (DT each) (NN control) (NN group)) (, ,) (NP (JJ such) (RB as)) (, ,) (NP (NNP AMNS) (RB alone)) (, ,) (NP (NNP PS) (RB alone)) (CC or) (NP (JJ saline) (NNS injected))))))) (. .)))
3323599	7	(ROOT (S (NP (PRP$ Their) (NNS glomeruli)) (VP (VBD showed) (NP (NP (NNS changes)) (PP (IN of) (NP (JJ progressive) (NNS Doc_3323599_909_913_Disease))))) (. .)))
3323599	8	(ROOT (S (NP (NP (DT The) (JJ ultrastructural) (NNS studies)) (PP (IN in) (NP (DT the) (JJ initial) (NN stage)))) (VP (VP (VBD revealed) (NP (NP (JJ significant) (NN lack)) (PP (IN of) (NP (NP (NNS particles)) (PP (IN of) (NP (JJ perfused) (JJ Doc_3323599_1015_1024_Chemical) (NN red)))))) (PP (IN on) (NP (DT the) (NN lamina) (NN rara) (NN externa)))) (CC and) (VP (VBD marked) (NP (NNS changes)) (PP (IN in) (NP (JJ epithelial) (NN cell) (NN cytoplasm))))) (. .)))
3323599	9	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN suggested) (SBAR (IN that) (S (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NNP PS)))) (VP (VP (VBZ enhances) (NP (NP (DT the) (NNS Doc_3323599_1175_1183_Disease)) (PP (IN of) (NP (NP (NNS AMNS)) (PP (IN on) (NP (DT the) (NNS glomerulus))))))) (CC and) (VP (ADVP (RB readily)) (VBZ produces) (NP (JJ progressive) (NNS Doc_3323599_1243_1247_Disease)) (PP (IN in) (NP (NP (NNS rats)) (VP (VBG resulting) (PP (IN in) (NP (DT the) (NNS Doc_3323599_1273_1296_Disease)))))))))))) (. .)))
3339945	0	(ROOT (NP (NP (JJ Doc_3339945_0_12_Chemical) (NNS Doc_3339945_13_26_Disease)) (PP (IN in) (NP (JJ pregnant) (NNS rats))) (. .)))
3339945	1	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN investigation)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NNS Doc_3339945_108_121_Disease)) (PP (IN of) (NP (NNS Doc_3339945_125_137_Chemical)))) (VP (VBZ is) (VP (VBN altered) (PP (IN in) (NP (JJ advanced) (NN pregnancy))))))))))) (. .)))
3339945	2	(ROOT (S (NP (NP (JJ Sprague-Dawley) (NNS rats)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (NP (CD 20) (NNS days)) (NP (NP (ADJP (JJ pregnant) (CC and) (JJ nonpregnant)) (NNS rats)) (PP (IN of) (NP (DT the) (JJ same) (NN age) (CC and) (NN strain)))))))) (VP (VBD received) (NP (NP (NNS infusions)) (PP (IN of) (NP (NNS Doc_3339945_289_302_Chemical)))) (PP (IN until) (NP (NP (NN onset)) (PP (IN of) (NP (JJ maximal) (NNS Doc_3339945_326_334_Disease))) (SBAR (WHNP (WDT which)) (S (VP (VBD occurred) (PP (IN after) (NP (NP (CD 28) (CC and) (CD 30) (NNS minutes)) (ADVP (RB respectively)))))))))) (. .)))
3339945	3	(ROOT (S (S (NP (NP (JJ Doc_3339945_388_400_Chemical) (NNS concentrations)) (PP (IN at) (NP (NP (DT this) (NN endpoint)) (PP (IN in) (NP (NP (NP (NN serum)) (PRN (-LRB- -LRB-) (NP (NN total)) (-RRB- -RRB-))) (CC and) (NP (NNP CSF))))))) (VP (VBD were) (ADJP (JJ similar)))) (CC but) (S (NP (NP (NP (NN serum)) (PRN (-LRB- -LRB-) (ADJP (JJ free)) (-RRB- -RRB-))) (CC and) (NP (NN brain) (NNS concentrations))) (VP (VBD were) (ADJP (RB slightly) (JJ different)) (PP (IN in) (NP (JJ pregnant) (NNS rats))))) (. .)))
3339945	4	(ROOT (S (NP (NP (JJ Doc_3339945_555_567_Chemical) (NN serum) (NN protein) (NNS binding)) (VP (VBN determined) (PP (IN by) (NP (NN equilibrium) (NN dialysis))))) (VP (VBD was) (ADJP (JJR lower)) (PP (IN in) (NP (JJ pregnant) (NNS rats)))) (. .)))
3339945	5	(ROOT (S (NP (NP (JJ Fetal) (NN serum) (NNS concentrations)) (PP (IN at) (NP (NP (NN onset)) (PP (IN of) (NP (NP (NNS Doc_3339945_692_700_Disease)) (PP (IN in) (NP (DT the) (NN mother)))))))) (VP (VP (VBD were) (ADJP (JJ similar) (S (VP (TO to) (VP (VB maternal) (NP (NN brain) (CC and) (NN CSF) (NNS concentrations))))))) (CC and) (VP (VBD correlated) (ADVP (RB significantly)) (PP (IN with) (NP (DT the) (JJ former))))) (. .)))
3339945	6	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (JJ advanced) (NN pregnancy)) (VP (VBZ has) (NP (NP (DT a) (JJ negligible) (NN effect)) (PP (IN on) (NP (DT the) (JJ Doc_3339945_886_896_Disease) (NN response)))) (PP (TO to) (NP (NP (NNS Doc_3339945_909_921_Chemical)) (PP (IN in) (NP (NNS rats)))))))))) (. .)))
3375885	0	(ROOT (S (NP (NNP Doc_3375885_0_12_Disease)) (VP (VP (VBN induced) (PP (IN by) (NP (NNS Doc_3375885_24_36_Chemical) (CC and) (NNS Doc_3375885_41_49_Chemical)))) (CC and) (VP (VBN reversed) (PP (IN by) (NP (NNS Doc_3375885_66_81_Chemical))))) (. .)))
3375885	1	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN described) (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (JJ severe) (NNS Doc_3375885_123_143_Disease)) (CC and) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ Doc_3375885_161_175_Chemical) (NNS Doc_3375885_176_187_Disease))) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (JJ Doc_3375885_196_208_Disease) (CC and) (JJ inappropriate) (NNS Doc_3375885_227_244_Disease)) (VP (VBD were) (VP (VBN caused) (PP (IN by) (NP (DT both) (NNS Doc_3375885_265_277_Chemical) (CC and) (NNS Doc_3375885_282_290_Chemical))) (, ,) (PP (IN without) (NP (JJ major) (NNS Doc_3375885_306_331_Disease)))))))))))) (. .)))
3375885	2	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ likely)) (SBAR (IN that) (S (NP (VBG preexisting) (NNS Doc_3375885_363_376_Disease)) (VP (VBD predisposed) (NP (DT this) (NN patient)) (PP (TO to) (NP (NN type) (NNS Doc_3375885_410_435_Disease))) (PP (IN with) (NP (JJ Doc_3375885_441_454_Chemical) (NN synthetase) (NNS inhibitors))))))) (. .)))
3375885	3	(ROOT (S (SBAR (IN Because) (S (NP (PRP he)) (VP (VBD was) (ADJP (JJ unable) (S (VP (TO to) (VP (VB discontinue) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NN drug) (NN therapy))))))))) (, ,) (NP (NNS Doc_3375885_560_575_Chemical)) (VP (VBD was) (VP (VBN added) (, ,) (S (VP (VP (VBG correcting) (NP (DT the) (NNS Doc_3375885_602_614_Disease))) (CC and) (VP (VBG allowing) (NP (JJ Doc_3375885_628_640_Chemical) (NN therapy)) (S (VP (TO to) (VP (VB be) (VP (VBN continued) (ADVP (RB safely))))))))))) (. .)))
3383127	0	(ROOT (FRAG (ADJP (JJ Doc_3383127_0_11_Disease) (PP (IN as) (NP (NP (DT a) (NN manifestation)) (PP (IN of) (NP (NP (NNS Doc_3383127_34_48_Disease)) (PP (IN in) (NP (CD three) (NNS patients)))))))) (S (VP (VBG receiving) (NP (NNS Doc_3383127_77_86_Chemical) (CC and) (NNS Doc_3383127_91_105_Chemical)))) (. .)))
3383127	1	(ROOT (S (NP (NP (NNP Doc_3383127_107_123_Disease)) (, ,) (PP (VBG including) (NP (NNS Doc_3383127_135_146_Disease))) (, ,)) (VP (VBD developed) (PP (IN in) (NP (NP (CD three) (NNS patients)) (PP (IN with) (NP (JJ advanced) (NNS Doc_3383127_190_210_Disease))))) (SBAR (IN while) (S (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_3383127_236_245_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3383127_247_251_Chemical)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_3383127_257_271_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3383127_273_277_Chemical)) (-RRB- -RRB-))))))))) (. .)))
3383127	2	(ROOT (S (PP (IN In) (NP (CD two) (NNS patients))) (, ,) (NP (NNS Doc_3383127_297_308_Disease)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (JJ severe) (NNS Doc_3383127_336_364_Disease))))) (. .)))
3383127	3	(ROOT (S (NP (DT All) (CD three) (NNS patients)) (VP (VBD required) (NP (NN therapy) (NN discontinuation))) (. .)))
3383127	4	(ROOT (S (NP (NNP Cardiac) (NNS enzymes)) (VP (VBD remained) (ADJP (JJ normal)) (PP (IN despite) (NP (JJ transient) (JJ electrocardiographic) (PRN (-LRB- -LRB-) (NP (NNP EKG)) (-RRB- -RRB-)) (NNS changes)))) (. .)))
3383127	5	(ROOT (S (NP (NP (NP (DT The) (NN presentation) (CC and) (JJ cardiac) (NN evaluation)) (PRN (-LRB- -LRB-) (NP (NP (NN hemodynamic)) (, ,) (NP (NN echocardiographic)) (, ,) (CC and) (NP (NN scintigraphic))) (-RRB- -RRB-))) (PP (IN of) (NP (DT these) (NNS patients)))) (VP (VBP suggest) (NP (NP (JJ new) (NNS manifestations)) (PP (IN of) (NP (JJ Doc_3383127_645_649_Chemical) (NNS Doc_3383127_650_664_Disease))) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (VP (VBN influenced) (PP (IN by) (NP (NNS Doc_3383127_691_695_Chemical)))))))))) (. .)))
3383127	6	(ROOT (S (NP (DT The) (JJ possible) (JJ pathophysiologic) (NNS mechanisms)) (VP (VBP are) (VP (VBN discussed))) (. .)))
3409843	0	(ROOT (S (NP (NP (JJ Fatal) (NNS Doc_3409843_6_21_Disease)) (PP (IN in) (NP (DT a) (NN patient)))) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_3409843_48_61_Chemical)))) (. .)))
3409843	1	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (JJ fatal) (NNS Doc_3409843_79_94_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ Doc_3409843_102_115_Chemical) (NN treatment)) (PP (IN in) (NP (DT an) (JJ Doc_3409843_132_141_Disease) (NN woman))))))))) (VP (VBZ is) (VP (VBN reported))) (. .)))
3409843	2	(ROOT (S (PP (IN Despite) (NP (NP (NNS concerns)) (PP (IN of) (NP (NP (JJ fatal) (NN bone) (NNS Doc_3409843_192_207_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_3409843_215_228_Chemical)))))))) (, ,) (NP (DT this)) (VP (VBZ is) (NP (RB only) (DT the) (ADJP (RB fourth) (VBN documented) (CC and) (VBN published)) (NN report))) (. .)))
3409843	3	(ROOT (S (S (NP (NNP Doc_3409843_287_300_Chemical)) (VP (VBZ is) (NP (DT a) (JJ safe) (NN drug)))) (, ,) (CC but) (S (NP (NNS physicians) (CC and) (NNS patients)) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (NP (DT the) (ADJP (ADJP (RB exceedingly) (JJ rare)) (CC but) (ADJP (RB potentially) (JJ fatal))) (NN side) (NNS effects)) (, ,) (VP (ADVP (RBR better)) (VBN prevented) (PP (IN by) (NP (JJ clinical))) (PP (IN than) (PP (IN by) (NP (NN laboratory) (NN monitoring))))))))))) (. .)))
3423103	0	(ROOT (NP (NP (NNP Participation)) (PP (IN of) (NP (NP (DT a) (JJ bulbospinal) (JJ serotonergic) (NN pathway)) (PP (IN in) (NP (DT the) (NN rat) (NN brain))))) (PP (IN in) (NP (NN Doc_3423103_72_81_Chemical-induced) (NNS Doc_3423103_90_101_Disease) (CC and) (NNS Doc_3423103_106_117_Disease))) (. .)))
3423103	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NN microinjection)) (PP (IN of) (NP (NP (NP (NNS Doc_3423103_152_161_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 1-10) (NNS micrograms)) (PP (IN in) (NP (CD 1) (NN microliter)))) (-RRB- -RRB-))) (PP (IN into) (NP (DT a) (NN region)))))))) (ADVP (JJ adjacent) (PP (TO to) (NP (NP (DT the) (JJ ventrolateral) (NN surface)) (PP (IN of) (NP (NP (DT the) (NN medulla) (NN oblongata)) (PP (IN on) (NP (JJ cardiovascular) (NN function)))))))) (VP (VBD were) (VP (VBN assessed) (PP (IN in) (NP (NN Doc_3423103_317_325_Chemical-anesthetized) (NNS rats))))) (. .)))
3423103	2	(ROOT (S (NP (NP (NP (JJ Intramedullary) (NN administration)) (PP (IN of) (NP (NNS Doc_3423103_378_387_Chemical)))) (, ,) (CONJP (CC but) (RB not)) (NP (JJ saline) (NN vehicle)) (, ,)) (VP (VBD caused) (NP (DT a) (JJ dose-dependent) (NN decrease)) (PP (IN in) (NP (PDT both) (NP (DT the) (JJ mean) (JJ arterial) (NN pressure)) (CC and) (NP (DT the) (NN heart) (NN rate))))) (. .)))
3423103	3	(ROOT (S (NP (DT The) (NN Doc_3423103_505_514_Chemical-induced) (NNS Doc_3423103_523_534_Disease)) (VP (VBD was) (VP (VBN antagonized) (PP (IN by) (NP (NP (JJ prior) (JJ spinal) (NN transection)) (, ,) (CONJP (CC but) (RB not)) (NP (JJ bilateral) (NN vagotomy)))))) (. .)))
3423103	4	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (DT the) (NN Doc_3423103_631_640_Chemical-induced) (NNS Doc_3423103_649_660_Disease)) (VP (VBD was) (VP (VBN antagonized) (PP (IN by) (NP (NP (JJ prior) (JJ bilateral) (NN vagotomy)) (, ,) (CONJP (CC but) (RB not)) (NP (JJ spinal) (NN transection)))))) (. .)))
3423103	5	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (JJ selective) (NN destruction)) (PP (IN of) (NP (DT the) (JJ spinal) (JJ Doc_3423103_783_787_Chemical) (NNS nerves))) (, ,) (VP (VBN produced) (PP (IN by) (NP (NP (JJ bilateral) (JJ spinal) (NN injection)) (PP (IN of) (NP (NNS Doc_3423103_838_861_Chemical)))))) (, ,)) (VP (VBD reduced) (NP (NP (DT the) (NN magnitude)) (PP (IN of) (NP (NP (DT the) (NN vasodepressor)) (CC or) (NP (DT the) (JJ bradycardiac) (NNS responses))))) (PP (TO to) (NP (NP (NNS Doc_3423103_939_948_Chemical)) (VP (VBN microinjected) (PP (IN into) (NP (NP (DT the) (NN area)) (PP (IN near) (NP (NP (DT the) (JJ ventrolateral) (NN surface)) (PP (IN of) (NP (NP (DT the) (NN medulla) (NN oblongata)) (PP (IN in) (NP (NNS rats))))))))))))) (. .)))
3423103	6	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (DT a) (JJ bulbospinal) (JJ serotonergic) (NN pathway)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (NN development)) (PP (IN of) (NP (NN Doc_3423103_1130_1139_Chemical-induced) (NNS Doc_3423103_1148_1159_Disease) (CC and) (NNS Doc_3423103_1164_1175_Disease)))))))))) (. .)))
3423103	7	(ROOT (S (NP (DT The) (JJ induced) (NNS Doc_3423103_1189_1200_Disease)) (VP (VBZ is) (VP (VBN brought) (PP (IN about) (IN by) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (JJ sympathetic) (NN efferent) (NN activity))))) (, ,) (SBAR (IN whereas) (S (NP (DT the) (JJ induced) (NNS Doc_3423103_1286_1297_Disease)) (VP (VBD was) (ADJP (JJ due) (PP (TO to) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ vagal) (NN efferent) (NN activity))))))))))) (. .)))
3439580	0	(ROOT (S (NP (NP (NNP Doc_3439580_0_12_Disease)) (PP (IN in) (NP (NNS Doc_3439580_16_29_Disease)))) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_3439580_41_51_Chemical)))) (. .)))
3439580	1	(ROOT (S (NP (NNP Doc_3439580_53_65_Disease)) (VP (VBZ is) (NP (NP (DT a) (JJ well-known) (NN finding)) (PP (IN in) (NP (NP (DT some) (NNS patients)) (PP (IN with) (NP (NNS Doc_3439580_112_125_Disease))))))) (. .)))
3439580	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ has) (RB not) (ADVP (RB previously)) (VP (VBN been) (VP (VBN described) (PP (IN in) (NP (NN association))) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_3439580_204_214_Chemical)))))))) (. .)))
3439580	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (NP (JJ severe) (NNS Doc_3439580_251_263_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN blood) (NN pressure)) (NP (CD 190/160))) (-RRB- -RRB-))) (PP (IN in) (NP (DT a) (JJ 4-year-old) (NN girl)))))) (PP (IN with) (NP (NP (NNS Doc_3439580_315_328_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBN given) (NP (NNS Doc_3439580_343_353_Chemical)) (S (VP (TO to) (VP (VB control) (NP (DT a) (NNS Doc_3439580_367_384_Disease)))))))))))) (. .)))
3439580	4	(ROOT (S (NP (PRP It)) (VP (VBD was) (VP (VBN determined) (ADVP (RB later)) (SBAR (IN that) (S (NP (NP (DT this) (NN patient) (POS 's)) (NNS Doc_3439580_430_435_Disease)) (VP (VBD was) (VP (VBN recurring) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (PRP$ her) (JJ Doc_3439580_469_481_Disease) (NN episode))))))))))) (. .)))
3439580	5	(ROOT (S (SBAR (IN Since) (S (NP (PRP she)) (VP (VBD had) (NP (NP (DT no) (NN blood) (NN pressure) (NN elevation)) (PP (IN at) (NP (NP (JJ initial) (NN diagnosis)) (CC and) (NP (NP (NN none) (VBG following) (NN discontinuation)) (PP (IN of) (NP (DT the) (NNS Doc_3439580_596_606_Chemical))) (PRN (-LRB- -LRB-) (SBAR (WHADVP (WRB when)) (S (NP (PRP she)) (VP (VBD was) (PP (IN in) (NP (JJ florid) (NN relapse)))))) (-RRB- -RRB-))))))))) (, ,) (NP (PRP we)) (VP (VBP believe) (SBAR (IN that) (S (NP (NP (DT this) (NN drug)) (PP (RB rather) (IN than) (NP (PRP$ her) (JJ underlying) (NN disease)))) (ADVP (RB alone)) (VP (VBD caused) (NP (PRP$ her) (NNS Doc_3439580_719_731_Disease)))))) (. .)))
3439580	6	(ROOT (S (NP (NP (DT The) (NN mechanism)) (PP (IN for) (NP (DT this) (NN reaction)))) (VP (VBZ is) (VP (VBN believed) (S (VP (TO to) (VP (VB be) (VP (VBN increased) (NP (NP (NNS levels)) (PP (IN of) (NP (JJ vasoactive) (NNS Doc_3439580_814_828_Chemical)))) (PP (JJ due) (TO to) (NP (NP (NN interference)) (PP (IN of) (NP (PRP$ their) (JJ physiologic) (NN inactivation))))) (PP (IN by) (NP (NNS Doc_3439580_886_896_Chemical))))))))) (. .)))
3439580	7	(ROOT (S (PP (IN From) (NP (DT this) (NN experience))) (, ,) (NP (PRP we)) (VP (VBP urge) (NP (JJ extreme) (NN caution)) (PP (IN in) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PP (IN in) (NP (NP (NNS children)) (PP (IN with) (NP (JJ active) (NNS Doc_3439580_1008_1021_Disease)))))))))) (. .)))
3475563	0	(ROOT (NP (NP (NNP Rechallenge)) (PP (IN of) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_3475563_38_68_Disease)) (PP (IN with) (NP (NNS Doc_3475563_74_101_Chemical)))))))) (. .)))
3475563	1	(ROOT (S (PP (IN Of) (NP (NP (CD 158) (JJ Doc_3475563_110_119_Disease) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN placed) (PP (IN on) (NP (JJ inhaled) (NNS Doc_3475563_156_170_Chemical))))))))) (, ,) (NP (NP (CD 15)) (PRN (-LRB- -LRB-) (NP (CD 9.5) (NN %)) (-RRB- -RRB-))) (VP (VBD developed) (NP (NP (NP (DT either) (NNS Doc_3475563_199_226_Disease)) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (DT both)) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-))))) (. .)))
3475563	2	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (PRP$ their) (JJ adverse) (NNS reactions)) (VP (VBD subsided)))) (, ,) (NP (NP (CD seven)) (PP (IN of) (NP (DT these) (CD 15) (NNS patients)))) (VP (VBD were) (VP (VBN rechallenged) (PP (IN with) (NP (JJ inhaled) (NNS Doc_3475563_342_356_Chemical))))) (. .)))
3475563	3	(ROOT (S (NP (DT These)) (VP (VBD included) (NP (NP (CD five) (NNS cases)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (NNS hoarseness)) (CC and) (NP (NP (CD three)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_3475563_433_444_Disease)))))))))))) (. .)))
3475563	4	(ROOT (S (NP (CD One) (NN patient)) (VP (VBD had) (NP (DT both))) (. .)))
3475563	5	(ROOT (S (S (NP (NNP Doc_3475563_468_479_Disease)) (VP (VBD did) (RB not) (VP (VB recur)))) (, ,) (CC but) (S (NP (NP (NP (CD 60) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 3/5)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS hoarseness)))))) (VP (VBD had) (NP (NN recurrence)))) (. .)))
3475563	6	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NNS patients)) (VP (MD may) (VP (VB be) (VP (VBN restarted) (PP (IN on) (NP (JJ inhaled) (NNS Doc_3475563_607_621_Chemical))) (SBAR (WHADVP (WRB when)) (S (NP (NNP clinically)) (VP (VBD indicated)))) (: ;) (ADVP (RB however)) (, ,) (PP (RB because) (IN of) (NP (NP (DT the) (JJ high) (NN recurrence) (NN rate)) (, ,) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP develop) (SBAR (S (NP (NNS hoarseness)) (VP (MD should) (RB not) (VP (VB be) (ADJP (JJ re-challenged)))))))))))))))))) (. .)))
3475563	7	(ROOT (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (JJ oral) (NNS Doc_3475563_780_790_Chemical)) (CC and) (NP (JJ topical) (NNS Doc_3475563_803_817_Chemical))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (S (VP (VBG developing) (NP (NNS hoarseness) (CC or) (NNS Doc_3475563_868_879_Disease)))))))) (. .)))
3533179	0	(ROOT (NP (NP (JJ Doc_3533179_0_16_Chemical) (NNS Doc_3533179_17_31_Disease)) (: :) (NP (NP (DT an) (NN analysis)) (PP (IN of) (S (VP (VBG dosing) (PP (IN as) (NP (DT a) (NN risk) (NN factor))))))) (. .)))
3533179	1	(ROOT (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBP undergo) (NP (NN bone) (NN marrow) (NN transplantation)))))) (VP (VBP are) (ADVP (RB generally)) (VP (VBN immunosuppressed) (PP (IN with) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_3533179_168_184_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3533179_186_189_Chemical)) (-RRB- -RRB-)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB usually)) (VP (VBN calculated) (PP (VBN based) (PP (IN on) (NP (NP (DT the) (NN patient) (POS 's)) (NN weight)))))))))))))) (. .)))
3533179	2	(ROOT (S (S (PP (IN At) (NP (NP (DT these) (JJ high) (NNS doses)) (PP (IN of) (NP (NNS Doc_3533179_273_276_Chemical))))) (, ,) (NP (JJ serious) (NNS Doc_3533179_286_300_Disease)) (VP (MD may) (VP (VB occur)))) (, ,) (CC but) (S (NP (NP (JJ definitive) (NN risk) (NNS factors)) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ such) (NNS Doc_3533179_368_382_Disease)))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN described))))) (. .)))
3533179	3	(ROOT (S (SBAR (IN Since) (S (NP (JJ chemotherapeutic) (NN agent) (NNS Doc_3533179_437_445_Disease)) (ADVP (RB generally)) (VP (VBZ correlates) (PP (IN with) (NP (NP (NN dose)) (PP (IN per) (NP (NN body) (NN surface) (NN area)))))))) (, ,) (NP (PRP we)) (ADVP (RB retrospectively)) (VP (VBD calculated) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NNS Doc_3533179_542_545_Chemical)))) (PP (IN in) (NP (NP (NNS patients)) (VBN transplanted) (PP (IN at) (NP (PRP$ our) (NN institution))) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ Doc_3533179_628_631_Chemical) (NNS Doc_3533179_632_646_Disease)))) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN dose)) (PP (IN per) (NP (NN body) (NN surface) (NN area)))))))))))))) (. .)))
3533179	4	(ROOT (S (NP (NP (JJ Eighty) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (S (VP (TO to) (VP (VB receive) (NP (NP (NNP Doc_3533179_731_734_Chemical) (CD 50)) (VP (VBN mg/kg/d) (PP (IN for) (NP (NP (CD four) (NNS days)) (PP (IN as) (NP (NP (NN preparation)) (PP (IN for) (NP (NN marrow) (NN grafting)))))))))))))))) (VP (VBD underwent) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 84) (NNS transplants)))) (PP (IN for) (NP (NP (NNS Doc_3533179_835_850_Disease)) (, ,) (NP (NNS Doc_3533179_852_876_Disease)) (, ,) (CC or) (NP (JJ severe) (NNS Doc_3533179_888_922_Disease))))) (. .)))
3533179	5	(ROOT (S (NP (NP (CD Fourteen)) (PP (IN of) (NP (JJ 84) (PRN (-LRB- -LRB-) (NP (CD 17) (NN %)) (-RRB- -RRB-)) (NNS patients)))) (VP (VBD had) (NP (NP (NNS symptoms) (CC and) (NNS signs)) (ADJP (JJ consistent) (PP (IN with) (NP (JJ Doc_3533179_993_996_Chemical) (NNS Doc_3533179_997_1011_Disease))))) (PP (IN within) (NP (NP (CD ten) (NNS days)) (PP (IN of) (S (VP (VBG receiving) (NP (NP (QP (CD 1) (TO to) (CD 4)) (NNS doses)) (PP (IN of) (NP (NNS Doc_3533179_1057_1060_Chemical)))))))))) (. .)))
3533179	6	(ROOT (S (NP (NP (CD Six)) (PP (IN of) (NP (DT the) (CD 14) (NNS patients)))) (VP (VBD died) (PP (IN with) (NP (NNS Doc_3533179_1095_1119_Disease)))) (. .)))
3533179	7	(ROOT (S (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_3533179_1133_1136_Chemical)) (PP (IN per) (NP (NN body) (NN surface) (NN area)))))) (VP (VBD was) (VP (VBN calculated) (PP (IN for) (NP (DT all) (NNS patients)))))) (CC and) (S (NP (DT the) (NNS patients)) (VP (VBD were) (VP (VBN divided) (PP (IN into) (NP (NP (CD two) (NNS groups)) (VP (VBN based) (PP (IN on) (NP (NP (NP (JJ daily) (NNS Doc_3533179_1252_1255_Chemical)) (NP (NN dose))) (: :) (ADJP (ADJP (ADJP (NP (NNP Group) (CD 1) (, ,) (CD Doc_3533179_1271_1274_Chemical)) (JJR less)) (PP (IN than))) (CC or) (ADJP (JJ equal) (PP (TO to) (NP (CD 1.55) (NNS g/m2/d))))) (: ;) (NP (NNP Group) (CD 2)) (, ,) (NP (NP (NNS Doc_3533179_1319_1322_Chemical)) (NP (QP (JJR greater) (IN than) (CD 1.55)) (NNS g/m2/d))))))))))) (. .)))
3533179	8	(ROOT (S (NP (NP (NNP Doc_3533179_1349_1363_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (NNS Doc_3533179_1398_1401_Chemical)))))))))))) (VP (VBD occurred) (PP (PP (IN in) (NP (NP (NP (CD 1/32)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (NNP Group) (CD 1))))))) (CC and) (PP (IN in) (NP (NP (CD 13/52)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN %)) (-RRB- -RRB-)))) (NP (NNS patients))) (PP (IN in) (NP (NNP Group) (CD 2))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.025))) (-RRB- -RRB-))) (. .)))
3533179	9	(ROOT (S (NP (NNP Doc_3533179_1507_1531_Disease)) (VP (VP (VBD caused)) (CC or) (VP (VBD contributed) (PP (TO to) (NP (NN death))) (PP (IN in) (NP (NP (CD 0/32) (NNS patients)) (PP (IN in) (NP (NNP Group) (CD 1))) (PP (NP (NP (QP (CD v) (CD 6/52))) (PRN (-LRB- -LRB-) (NP (CD 12) (NN %)) (-RRB- -RRB-))) (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (NNP Group) (CD 2))))))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.25))) (-RRB- -RRB-)))) (. .)))
3533179	10	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN engraftment)) (PP (IN of) (NP (NP (JJ evaluable) (NNS patients)) (PP (IN in) (NP (NP (DT the) (CD two) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR greater) (IN than) (CD 0.5))) (-RRB- -RRB-)))))))))))) (. .)))
3533179	11	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (DT the) (JJ Doc_3533179_1781_1784_Chemical) (NNS Doc_3533179_1785_1799_Disease)) (VP (VBZ correlates) (PP (IN with) (NP (JJ Doc_3533179_1816_1819_Chemical) (NN dosage))) (SBAR (SBAR (IN as) (S (VP (VBN calculated) (PP (IN by) (NP (NN body) (NN surface) (NN area)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_3533179_1886_1901_Disease) (CC and) (NNS Doc_3533179_1906_1924_Disease)))) (VP (MD can) (VP (VB be) (VP (ADVP (RB effectively)) (VBN prepared) (PP (IN for) (NP (NN bone) (NN marrow))) (S (VP (VBG grafting) (PP (IN at) (NP (NP (DT a) (JJ Doc_3533179_1983_1986_Chemical) (NN dose)) (PP (IN of) (NP (NP (CD 1.55) (NNS g/m2/d)) (PP (IN for) (NP (CD four) (NNS days))))))) (PP (IN with) (NP (NP (DT a) (JJR lower) (NN incidence)) (PP (IN of) (NP (NNS Doc_3533179_2047_2061_Disease))))) (PP (IN than) (NP (NP (NNS patients)) (SBAR (WP$ whose) (S (NP (JJ Doc_3533179_2082_2085_Chemical) (NN dosage)) (VP (VBZ is) (VP (VBN calculated) (PP (VBN based) (PP (IN on) (NP (NN weight)))))))))))))))))))))) (. .)))
3533179	12	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ reaffirms) (NP (DT the) (NN principle)) (SBAR (IN that) (S (NP (NN drug) (NNS Doc_3533179_2169_2177_Disease)) (VP (VBZ correlates) (PP (IN with) (NP (NP (NN dose)) (PP (IN per) (NP (NN body) (NN surface) (NN area))))))))) (. .)))
3538855	0	(ROOT (NP (NP (NNS Studies)) (PP (IN of) (NP (NN risk) (NNS factors))) (PP (IN for) (NP (JJ Doc_3538855_28_42_Chemical) (NN nephrotoxicity))) (. .)))
3538855	1	(ROOT (S (NP (NP (DT The) (NN epidemiology)) (PP (IN of) (NP (NNS Doc_3538855_79_93_Chemical-induced)))) (ADVP (RB nephrotoxicity)) (VP (VBZ is) (RB not) (VP (ADVP (RB fully)) (VBN understood))) (. .)))
3538855	2	(ROOT (S (S (NP (NP (JJ Experimental) (NNS studies)) (PP (IN in) (NP (JJ healthy) (JJ human) (NNS volunteers)))) (VP (VBP indicate) (S (NP (NNS Doc_3538855_200_215_Chemical)) (VP (VB cause) (NP (JJ proximal) (JJ tubular) (NN damage)) (PP (IN in) (NP (JJS most) (NNS patients))))))) (, ,) (CC but) (S (ADVP (RB rarely)) (, ,) (SBAR (IN if) (FRAG (ADVP (RB ever)))) (, ,) (VP (VBP cause) (NP (NNS Doc_3538855_291_324_Disease)))) (. .)))
3538855	3	(ROOT (S (NP (NP (JJ Clinical) (NNS trials)) (PP (IN of) (NP (NP (NNS Doc_3538855_345_360_Chemical)) (PP (IN in) (NP (ADJP (ADVP (RB seriously)) (JJ ill)) (NNS patients)))))) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (JJ relative) (NN risk)) (PP (IN for) (S (VP (VBG developing) (NP (NNS Doc_3538855_434_453_Disease)) (PP (IN during) (NP (NN therapy))))))) (VP (VBZ ranges) (PP (IN from) (NP (QP (CD 8) (TO to) (CD 10))))))) (CC and) (SBAR (IN that) (S (NP (DT the) (JJ attributable) (NN risk)) (VP (VBZ is) (NP (QP (CD 70) (NN %) (TO to) (CD 80) (NN %)))))))) (. .)))
3538855	4	(ROOT (S (NP (NP (JJ Further) (NN analysis)) (PP (IN of) (NP (DT these) (NNS data)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (NN therapy)) (, ,) (NP (JJ plasma) (JJ Doc_3538855_612_626_Chemical) (NNS levels)) (, ,) (NP (NNS Doc_3538855_635_648_Disease)) (, ,) (NP (JJ advanced) (NN age)) (, ,) (NP (JJ high) (JJ initial) (JJ estimated) (JJ Doc_3538855_687_697_Chemical) (NN clearance)) (CC and) (PRN (, ,) (ADVP (RB possibly)) (, ,)) (NP (JJ female) (NN gender))))) (ADVP (DT all)) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN for) (NP (NN nephrotoxicity)))))))) (. .)))
3538855	5	(ROOT (S (NP (NP (JJ Other) (NNS causes)) (PP (IN of) (NP (NNS Doc_3538855_795_814_Disease))) (, ,) (PP (JJ such) (IN as) (NP (NNS Doc_3538855_824_829_Disease))) (, ,)) (VP (VBP appear) (S (VP (TO to) (VP (VB have) (NP (DT an) (JJ additive) (NN effect)))))) (. .)))
3538855	6	(ROOT (S (NP (JJ Predictive) (NNS models)) (VP (VBP have) (VP (VBN been) (VP (VBN developed) (PP (IN from) (NP (NP (DT these) (NNS analyses)) (SBAR (WHNP (WDT that)) (S (VP (MD should) (VP (VB be) (ADJP (JJ useful) (PP (IN for) (S (VP (VBG identifying) (NP (NNS patients)) (PP (IN at) (NP (JJ high) (NN risk)))))))))))))))) (. .)))
3538855	7	(ROOT (S (NP (DT These) (NNS models)) (VP (MD may) (ADVP (RB also)) (VP (VB be) (ADJP (JJ useful) (PP (IN in) (S (VP (VBG developing) (NP (NNS insights)) (PP (IN into) (NP (NP (DT the) (NN pathophysiology)) (PP (IN of) (NP (NN Doc_3538855_1068_1082_Chemical-induced) (NN nephrotoxicity))))))))))) (. .)))
35781	0	(ROOT (NP (NP (JJ Central) (NN action)) (PP (IN of) (NP (JJ narcotic) (NNS analgesics))) (. .)))
35781	1	(ROOT (NP (NNP Part) (NNP IV) (. .)))
35781	2	(ROOT (S (NP (NNP Noradrenergic)) (VP (VBZ influences) (PP (IN on) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NNS analgesics)) (PP (IN in) (NP (NNS rats)))))))) (. .)))
35781	3	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NNS Doc_35781_126_135_Chemical) (, ,) (NNS Doc_35781_137_148_Chemical) (CC and) (NNS Doc_35781_153_167_Chemical))) (PP (PP (IN on) (NP (NP (NNS Doc_35781_171_180_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_35781_192_200_Chemical) (, ,) (NNS Doc_35781_202_209_Chemical) (, ,) (NNS Doc_35781_211_219_Chemical) (CC and) (NNS Doc_35781_224_235_Chemical)))))) (, ,) (CC and) (PP (IN on) (NP (NP (JJ cataleptic) (NN effect)) (PP (IN of) (NP (NNS Doc_35781_265_273_Chemical) (, ,) (NNS Doc_35781_275_281_Chemical) (CC and) (NNS Doc_35781_286_294_Chemical))))))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (NNS rats))))) (. .)))
35781	4	(ROOT (S (NP (NP (DT The) (JJ biochemical) (NNS assays)) (PP (IN on) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (NP (CD four) (NNS analgesics)) (PP (IN on) (NP (NP (DT the) (NN brain) (NN concentration) (CC and) (NN turnover)) (PP (IN of) (NP (NP (NNS Doc_35781_418_431_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP NA)) (-RRB- -RRB-))))))))))) (VP (VBD were) (VP (ADVP (RB also)) (VBN performed))) (. .)))
35781	5	(ROOT (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (NP (NP (CD three) (NNS drugs)) (VP (VBG stimulating) (NP (JJ central) (NNP NA) (NNS receptors)))) (VP (VBD failed) (S (VP (TO to) (VP (VB affect) (NP (NP (DT the) (JJ analgesic) (NN ED50)) (PP (IN of) (NP (DT all) (JJ antinociceptive) (NNS agents))))))))))))) (CC and) (S (NP (PRP they)) (VP (VBD enhanced) (NP (NP (NNS Doc_35781_605_614_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_35781_626_634_Chemical) (CC and) (NNS Doc_35781_639_647_Chemical))))))) (. .)))
35781	6	(ROOT (S (NP (JJ Doc_35781_649_656_Chemical) (NNS Doc_35781_657_666_Disease)) (VP (VBD was) (VP (VP (VBN increased) (PP (IN by) (NP (NNS Doc_35781_684_693_Chemical)))) (CC and) (VP (VBN decreased) (PP (IN by) (NP (NNS Doc_35781_711_722_Chemical) (CC and) (NNS Doc_35781_727_741_Chemical)))))) (. .)))
35781	7	(ROOT (S (S (NP (NP (DT The) (NN brain) (NN concentration)) (PP (IN of) (NP (NNP NA)))) (VP (VBD was) (RB not) (VP (VBN changed) (PP (IN by) (NP (NNS Doc_35781_792_800_Chemical) (CC and) (NNS Doc_35781_805_813_Chemical)))))) (, ,) (CC but) (S (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_35781_839_846_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 45) (NN mg/kg)) (-RRB- -RRB-))))))) (ADVP (RB slightly)) (VP (VBD enhanced) (NP (PRP it)))) (. .)))
35781	8	(ROOT (S (NP (JJ Doc_35781_880_891_Chemical) (NN dose-dependently)) (VP (VBD decreased) (NP (NP (DT the) (NN brain) (NN level)) (PP (IN of) (NP (NNP NA))))) (. .)))
35781	9	(ROOT (S (NP (NP (DT The) (NN rate)) (PP (IN of) (NP (NNP NA) (NN turnover)))) (VP (VBD was) (RB not) (VP (VBN altered) (PP (IN by) (NP (NNS analgesics))) (PP (IN except) (IN for) (NP (NP (DT the) (JJR higher) (NN dose)) (PP (IN of) (NP (NP (NP (NNS Doc_35781_1026_1034_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.2) (NN mg/kg)) (-RRB- -RRB-))) (PP (VBG following) (SBAR (WHNP (WDT which)) (S (NP (NP (DT the) (NN disappearance)) (PP (IN of) (NP (NP (NNP NA)) (PP (IN from) (NP (DT the) (NN brain)))))) (VP (VBD was) (VP (VBN diminished)))))))))))) (. .)))
35781	10	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP are) (VP (VBN discussed) (PP (IN in) (NP (NP (DT the) (NN light)) (PP (IN of) (NP (JJ various) (CC and) (JJ non-uniform) (NNS data))))) (PP (IN from) (NP (DT the) (NN literature))))) (. .)))
35781	11	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN suggested) (SBAR (IN that) (S (PP (IN in) (NP (NNS rats))) (NP (DT the) (NN brain) (NN NA)) (VP (VBZ plays) (NP (NP (DT a) (ADJP (RBR less) (JJ important)) (NN function)) (PP (IN than) (NP (NP (DT the) (JJ other) (NNS Doc_35781_1299_1309_Chemical)) (PP (IN in) (NP (NP (DT the) (JJ behavioural) (NN activity)) (PP (IN of) (NP (JJ potent) (NNS analgesics))))))))))))) (. .)))
3685052	0	(ROOT (NP (NP (NP (JJ Doc_3685052_0_9_Chemical) (JJ Doc_3685052_10_17_Disease) (NNS thresholds)) (PP (IN in) (NP (NP (NNS mice)) (VP (VBN treated) (ADVP (RB neonatally)) (PP (IN with) (NP (NP (DT a) (JJ single) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_3685052_83_103_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3685052_105_108_Chemical)) (-RRB- -RRB-)))))))))) (: :) (NP (NP (NN evaluation)) (PP (IN of) (NP (NP (JJ experimental) (NNS parameters)) (PP (IN in) (NP (JJ Doc_3685052_152_161_Chemical) (JJ Doc_3685052_162_169_Disease) (NN testing)))))) (. .)))
3685052	1	(ROOT (S (ADVP (RB Monosodium)) (NP (NP (JJ Doc_3685052_190_199_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_3685052_201_204_Chemical)) (-RRB- -RRB-)) (NN administration)) (PP (TO to) (NP (JJ neonatal) (NNS rodents)))) (VP (VBZ produces) (NP (NNS Doc_3685052_250_261_Disease) (CC and) (NNS results)) (PP (IN in) (NP (JJ numerous) (NN biochemical) (CC and) (NNS Doc_3685052_302_321_Disease)))) (. .)))
3685052	2	(ROOT (S (NP (DT These) (NNS studies)) (VP (VBD were) (VP (VBN undertaken) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (JJ neonatal) (NN administration)) (PP (IN of) (NP (NNS Doc_3685052_396_399_Chemical)))) (VP (VBD produced) (NP (JJ permanent) (NNS alterations)) (PP (IN in) (NP (JJ Doc_3685052_434_441_Disease) (NN susceptibility))) (, ,) (SBAR (IN since) (S (NP (JJ previous) (NNS investigations)) (VP (VBD were) (ADJP (JJ inconclusive))))))))))))) (. .)))
3685052	3	(ROOT (S (NP (CD Doc_3685052_507_524_Chemical) (JJ Doc_3685052_525_532_Disease) (NN screening) (NN technique)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB evaluate) (NP (JJ Doc_3685052_574_581_Disease) (NN susceptibility)) (PP (IN in) (NP (NP (JJ adult) (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (NP (NP (JJ neonatal) (NNS injections)) (PP (IN of) (NP (NP (NNS Doc_3685052_648_651_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 4) (NN mg/g)) (CC and) (NP (CD 1) (NN mg/g))) (-RRB- -RRB-))))))))))))))) (. .)))
3685052	4	(ROOT (S (NP (JJ Doc_3685052_673_676_Chemical) (NN treatment)) (VP (VP (VBD resulted) (PP (IN in) (NP (JJ significant) (NNS reductions))) (PP (IN in) (NP (JJ whole) (NN brain) (NN weight)))) (CC but) (VP (VBD did) (RB not) (VP (VB alter) (NP (JJ Doc_3685052_762_769_Disease) (NN threshold))))) (. .)))
3685052	5	(ROOT (S (NP (DT A) (NP (NP (NNS Doc_3685052_783_791_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg)) (-RRB- -RRB-))) (NN challenge)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ ineffective)) (PP (IN in) (S (VP (VBG altering) (NP (NP (DT the) (JJ Doc_3685052_849_856_Disease) (NNS thresholds)) (PP (IN of) (NP (NP (DT either) (NN control)) (PP (IN of) (NP (NN Doc_3685052_889_892_Chemical-treated) (NNS mice)))))))))) (. .)))
3685052	6	(ROOT (S (S (NP (NNP Doc_3685052_907_922_Chemical)) (VP (VBD produced) (NP (NP (NNS Doc_3685052_932_943_Disease)) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN correlated) (PP (IN with) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (JJ Doc_3685052_986_995_Chemical) (NN exposure)))))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NP (DT the) (NN relationship)) (PP (IN of) (NP (NP (NNS Doc_3685052_1035_1046_Disease)) (PP (TO to) (NP (JJ Doc_3685052_1050_1057_Disease) (NN induction)))))) (VP (VBD was) (ADJP (JJ unclear)))) (. .)))
3685052	7	(ROOT (S (NP (JJ Doc_3685052_1081_1090_Chemical) (JJ Doc_3685052_1091_1098_Disease) (NN testing)) (VP (VBD proved) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (ADJP (JJ rapid) (CC and) (JJ reliable)) (NN technique)) (PP (IN with) (SBAR (WHNP (WDT which)) (S (VP (TO to) (VP (VB evaluate) (NP (NNS Doc_3685052_1174_1181_Disease)) (ADVP (RB susceptibility)))))))))))) (. .)))
3708328	0	(ROOT (S (NP (NP (NNP Susceptibility)) (PP (TO to) (NP (NNS Doc_3708328_18_26_Disease)))) (VP (VBD produced) (PP (IN by) (NP (NP (NNS Doc_3708328_39_50_Chemical)) (PP (IN in) (NP (NNS rats))))) (PP (IN after) (NP (NP (NN microinjection)) (PP (IN of) (NP (NNS Doc_3708328_83_92_Chemical) (CC or) (NNS Doc_3708328_96_112_Chemical))))) (PP (IN into) (NP (DT the) (NN substantia) (NN nigra)))) (. .)))
3708328	1	(ROOT (S (NP (NP (NNP Doc_3708328_140_151_Chemical)) (, ,) (VP (VBN given) (ADVP (RB intraperitoneally)) (PP (TO to) (NP (NNS rats)))) (, ,)) (VP (VP (VBZ reproduces) (NP (NP (DT the) (JJ neuropathological) (NN sequelae)) (PP (IN of) (NP (NNS Doc_3708328_231_253_Disease))))) (CC and) (VP (VBZ provides) (NP (DT a) (JJ relevant) (NN animal) (NN model)) (PP (IN for) (S (VP (VBG studying) (NP (NP (NNS mechanisms)) (PP (IN of) (NP (NP (NN buildup)) (PP (IN of) (NP (JJ Doc_3708328_329_339_Disease) (NN activity) (CC and) (NNS pathways) (NN operative)))))) (PP (IN in) (NP (NP (DT the) (NN generalization) (CC and) (NN propagation)) (PP (IN of) (NP (NP (NNS Doc_3708328_413_421_Disease)) (PP (IN within) (NP (DT the) (NN forebrain)))))))))))) (. .)))
3708328	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (DT the) (NNS effects)) (PP (IN of) (S (VP (VBG manipulating) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (DT the) (NNS Doc_3708328_514_537_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3708328_539_543_Chemical)) (-RRB- -RRB-)))))))) (: -) (NP (NP (JJ mediated) (JJ synaptic) (NN inhibition)) (PP (IN within) (NP (NP (DT the) (NN substantia) (NN nigra)) (PP (IN on) (NP (NP (NNS Doc_3708328_605_613_Disease)) (VP (VBN produced) (PP (IN by) (NP (NP (NNS Doc_3708328_626_637_Chemical)) (PP (IN in) (NP (NNS rats))))))))))) (, ,)) (VP (VBD were) (VP (VBN investigated))) (. .)))
3708328	3	(ROOT (S (PP (IN In) (NP (NP (NNS animals)) (VP (VBN pretreated) (PP (IN with) (NP (NP (NNS microinjections)) (PP (IN of) (NP (NNS Doc_3708328_712_721_Chemical)))))))) (, ,) (NP (NP (CD 150) (NNS micrograms)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NP (NN activity)) (PP (IN of) (NP (NP (DT the) (NN Doc_3708328_771_775_Chemical-synthesizing) (NN enzyme)) (, ,) (NP (JJ Doc_3708328_797_812_Chemical) (NN decarboxylase)) (, ,)))))) (PP (IN into) (NP (DT the) (NN substantia) (NN nigra) (NNS pars) (NN reticulata))) (PRN (-LRB- -LRB-) (NP (NNP SNR)) (-RRB- -RRB-)) (, ,) (NP (NP (JJ bilaterally) (, ,) (JJ non-convulsant) (NNS doses)) (PP (IN of) (NP (NNS Doc_3708328_914_925_Chemical)))) (, ,) (NP (NP (QP (CD 100) (CC and) (CD 200))) (NP (NN mg/kg))) (, ,)) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ severe) (NN motor) (NN limbic) (NNS Doc_3708328_978_986_Disease)) (CC and) (NP (NNS Doc_3708328_991_1009_Disease))))) (. .)))
3708328	4	(ROOT (S (NP (NP (NNP Electroencephalographic)) (CC and) (NP (JJ behavioral) (NN monitoring))) (VP (VBD revealed) (NP (NP (DT a) (JJ profound) (NN reduction)) (PP (IN of) (NP (DT the) (NN threshold)))) (PP (IN for) (NP (NN Doc_3708328_1112_1123_Chemical-induced) (NNS Doc_3708328_1132_1143_Disease)))) (. .)))
3708328	5	(ROOT (S (NP (NP (JJ Morphological) (NN analysis)) (PP (IN of) (NP (NP (JJ frontal) (NN forebrain) (NNS sections)) (PP (IN with) (NP (JJ light) (NN microscopy)))))) (VP (VBD revealed) (NP (NN Doc_3708328_1229_1236_Disease-related) (NN damage)) (PP (TO to) (NP (NP (DT the) (JJ hippocampal) (NN formation)) (, ,) (NP (NNS thalamus)) (, ,) (NP (NN amygdala)) (, ,) (NP (JJ olfactory) (NN cortex)) (, ,) (NP (NN substantia) (NN nigra)) (CC and) (NP (NN neocortex)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB typically)) (ADJP (JJ observed) (PP (IN with) (NP (NP (NNS Doc_3708328_1385_1396_Chemical)) (PP (IN in) (NP (NNS doses)))))) (S (VP (VBG exceeding) (NP (CD 350) (NN mg/kg)))))))) (. .)))
3708328	6	(ROOT (S (NP (NP (JJ Bilateral) (JJ intrastriatal) (NNS injections)) (PP (IN of) (NP (NNS Doc_3708328_1465_1474_Chemical)))) (VP (VBD did) (RB not) (VP (VB augment) (NP (NP (NNS Doc_3708328_1491_1499_Disease)) (VP (VBN produced) (PP (IN by) (NP (NP (NNS Doc_3708328_1512_1523_Chemical)) (, ,) (NP (CD 200) (NN mg/kg)))))))) (. .)))
3708328	7	(ROOT (S (NP (NP (NNP Application)) (PP (IN of) (NP (NP (DT an) (JJ irreversible) (NN inhibitor)) (PP (IN of) (NP (JJ Doc_3708328_1580_1584_Chemical) (NN transaminase)))))) (, ,) (S (NP (NP (NP (NNS Doc_3708328_1599_1615_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3708328_1617_1645_Chemical)) (-RRB- -RRB-))) (, ,) (NP (CD 5) (NNS micrograms)) (, ,)) (PP (IN into) (NP (DT the) (NNP SNR))) (, ,) (ADVP (RB bilaterally))) (, ,) (VP (VBD suppressed) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NP (JJ electrographic) (CC and) (JJ behavioral) (NNS Doc_3708328_1748_1756_Disease)) (VP (VBN produced) (PP (IN by) (NP (NP (NNS Doc_3708328_1769_1780_Chemical)) (, ,) (NP (CD 380) (NN mg/kg))))))))) (. .)))
3708328	8	(ROOT (S (NP (DT This) (NN treatment)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB protect) (NP (NNS animals)) (PP (IN from) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NNS Doc_3708328_1870_1882_Disease)))))))))) (. .)))
3708328	9	(ROOT (S (NP (NP (NNS Microinjections)) (PP (IN of) (NP (NP (NP (NNS Doc_3708328_1903_1919_Chemical)) (, ,) (NP (CD 5) (NNS micrograms)) (, ,)) (PP (IN into) (NP (DT the) (JJ dorsal) (NN striatum)))))) (, ,) (ADVP (RB bilaterally)) (, ,) (VP (VBD failed) (S (VP (TO to) (VP (VB prevent) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNS Doc_3708328_2011_2022_Disease)) (VP (VBN produced) (PP (IN by) (NP (NP (NNS Doc_3708328_2035_2046_Chemical)) (, ,) (NP (CD 380) (NN mg/kg)))))))))))) (. .)))
3708328	10	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (NN threshold)) (PP (IN for) (NP (NP (NN Doc_3708328_2106_2117_Chemical-induced) (NNS Doc_3708328_2126_2134_Disease)) (PP (IN in) (NP (NNS rats)))))) (VP (VBZ is) (VP (VBN subjected) (PP (TO to) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ Doc_3708328_2181_2185_Chemical-mediated) (JJ synaptic)) (NN inhibition)) (PP (IN within) (NP (DT the) (NN substantia) (NN nigra)))))))))))) (. .)))
3711722	0	(ROOT (NP (NP (NP (NNP Human)) (CC and) (NP (JJ canine) (NN ventricular) (NN vasoactive) (NN intestinal) (NN polypeptide))) (: :) (NP (NP (NN decrease)) (PP (IN with) (NP (NNS Doc_3711722_78_91_Disease)))) (. .)))
3711722	1	(ROOT (S (NP (NP (JJ Vasoactive) (JJ intestinal) (NN polypeptide)) (PRN (-LRB- -LRB-) (NP (NNP VIP)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ systemic) (CC and) (JJ coronary) (NN vasodilator)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB have) (NP (JJ positive) (JJ inotropic) (NNS properties)))))))) (. .)))
3711722	2	(ROOT (S (NP (NP (JJ Myocardial) (NNS levels)) (PP (IN of) (NP (NNP VIP)))) (VP (VBD were) (VP (VBN assayed) (PP (IN before) (CC and) (IN after) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNS Doc_3711722_291_304_Disease)) (PP (IN in) (NP (CD two) (JJ canine) (NNS models))))))))) (. .)))
3711722	3	(ROOT (S (S (PP (IN In) (NP (DT the) (JJ first))) (, ,) (NP (JJ Doc_3711722_341_347_Chemical) (NNS Doc_3711722_348_362_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN in) (NP (CD eight) (NNS dogs)))))) (: ;) (S (NP (NNP VIP)) (PRN (-LRB- -LRB-) (PP (IN by) (NP (NN radioimmunoassay))) (-RRB- -RRB-)) (VP (VBD decreased) (PP (IN from) (NP (NP (NP (CD 35) (VBG +) (NNS /)) (PRN (: -) (NP (NP (NP (CD 11) (JJ pg/mg) (NN protein)) (PRN (-LRB- -LRB-) (NP (JJ mean) (JJ +) (NNS /)) (, -) (NP (NNP SD)) (-RRB- -RRB-))) (PP (TO to) (NP (CD 5) (NNS +)))) (: /))) (: -) (NP (NP (CD 4) (VBG pg/mg) (NN protein)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))))))) (. .)))
3711722	4	(ROOT (S (PP (IN In) (NP (NP (CD six) (NNS dogs)) (PP (IN with) (NP (NN Doc_3711722_531_542_Chemical-induced) (NNS Doc_3711722_551_564_Disease))))) (, ,) (NP (NNP VIP)) (VP (VBD decreased) (PP (IN from) (NP (NP (NP (CD 31) (VBG +) (NNS /)) (PRN (: -) (NP (QP (CD 7) (TO to) (CD 11)) (NNS +)) (: /))) (: -) (NP (NP (CD 4) (VBG pg/mg) (NN protein)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-)))))) (. .)))
3711722	5	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NNP VIP) (NN content)) (PP (IN of) (NP (NP (JJ left) (NN ventricular) (NN muscle)) (PP (IN of) (NP (NP (JJ resected) (VBG failing) (NNS hearts)) (PP (IN in) (NP (NP (CD 10) (NNS patients)) (VP (VBG receiving) (NP (DT a) (NN heart) (NN transplant)))))))))) (VP (VBD was) (VP (VBN compared) (PP (IN with) (NP (NP (DT the) (JJ papillary) (NNS muscles)) (PP (IN in) (NP (NP (CD 14) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD five)) (PP (IN with) (NP (NP (NNS Doc_3711722_829_846_Disease)) (, ,) (NP (NP (CD nine)) (PP (IN with) (NP (NNS Doc_3711722_858_881_Disease))))))) (-RRB- -RRB-)))))) (S (VP (VBG receiving) (NP (JJ mitral) (NN valve) (NNS prostheses)))))) (. .)))
3711722	6	(ROOT (S (NP (DT The) (JJS lowest) (NNP myocardial) (NNP Doc_3711722_940_943_Chemical) (NN concentration)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NNS hearts)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (NNS Doc_3711722_999_1015_Disease)) (PRN (-LRB- -LRB-) (NP (CD one) (NN patient) (NN receiving)) (NP (NP (DT a) (NN transplant)) (CC and) (NP (CD three) (NN receiving) (NN mitral) (NNS prostheses))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD 6.3) (NNP +) (NNS /)) (, -) (NP (CD 1.9) (NN pg/mg) (NN protein)) (-RRB- -RRB-)))))))))) (. .)))
3711722	7	(ROOT (S (NP (NP (DT The) (JJ other) (NNS patients)) (VP (VBG undergoing) (NP (NN transplantation)))) (VP (VBD had) (NP (NP (NP (DT an) (JJ average) (NN ejection) (NN fraction)) (PP (IN of) (NP (NP (CD 17) (NN %) (QP (CD +) (CD /))) (PRN (: -) (NP (NP (NP (CD 6) (NN %)) (CC and) (NP (DT a) (NNP VIP) (NN level))) (PP (IN of) (NP (CD 8.8) (NNS +)))) (: /))))) (: -) (NP (NP (CD 3.9)) (VP (VBG pg/mg) (NP (NN protein)))))) (. .)))
3711722	8	(ROOT (S (S (NP (NP (DT The) (NNS hearts)) (PP (IN without) (NP (NP (NNS Doc_3711722_1278_1301_Disease)) (PRN (-LRB- -LRB-) (NP (NP (JJ average) (NN ejection) (NN fraction)) (PP (IN of) (NP (NP (DT this) (NN group) (CD 62) (NN %) (NN +) (NN /)) (: -) (ADJP (CD 10) (NN %))))) (-RRB- -RRB-))))) (VP (VBD had) (NP (NP (NP (DT a) (NNP VIP) (NN concentration)) (PP (IN of) (NP (CD 14.1) (JJ +) (NNS /)))) (: -) (NP (NP (CD 7.9)) (VP (VBG pg/mg) (NP (NN protein))))))) (, ,) (CC and) (S (NP (DT this)) (VP (VBD was) (ADJP (ADJP (JJR greater)) (PP (IN than) (PP (IN in) (NP (NP (NNS hearts)) (PP (IN of) (NP (DT the) (NNS patients))))))) (PP (IN with) (NP (NP (NNS Doc_3711722_1468_1484_Disease)) (CC and) (NP (NP (DT the) (NNS hearts)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (DT a) (NN transplant)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))))))))))) (. .)))
3711722	9	(ROOT (S (NP (JJ Myocardial) (NNS Doc_3711722_1566_1580_Chemical)) (VP (VBD were) (ADVP (RB also)) (VP (VBN determined) (PP (IN in) (NP (NP (CD 14) (NNS subjects)) (: ;) (NP (NP (NP (DT a) (JJ weak) (NN correlation)) (PRN (-LRB- -LRB-) (NP (NP (NP (SYM r)) (SBAR (S (VP (SYM =) (NP (CD 0.57)))))) (, ,) (ADVP (RB P)) (NP (NP (JJR less)) (PP (IN than) (NP (CD 0.05))))) (-RRB- -RRB-))) (PP (IN between) (NP (NP (NP (DT the) (NN tissue)) (UCP (NP (NP (NNS concentrations)) (PP (IN of) (NP (NNP VIP)))) (CC and) (S (NP (NNS Doc_3711722_1711_1725_Chemical)) (VP (VBD was) (VP (VBN noted)))) (. .))) (PRN (-LRB- -LRB-) (S (NP (NNP ABSTRACT)) (VP (VBD TRUNCATED) (NP (QP (CD AT) (CD 250)) (NNS WORDS)))) (-RRB- -RRB-)))))))))))
3746148	0	(ROOT (S (NP (NP (JJ Non-invasive) (NN detection)) (PP (IN of) (NP (NP (NNS Doc_3746148_26_49_Disease)) (PP (IN by) (NP (NN body)))))) (VP (VBP surface) (NP (JJ electrocardiographic) (NN mapping)) (PP (IN after) (NP (JJ Doc_3746148_101_113_Chemical) (NN infusion)))) (. .)))
3746148	1	(ROOT (S (NP (NP (NP (JJ Electrocardiographic) (NNS changes)) (PP (IN after) (NP (JJ Doc_3746148_159_171_Chemical) (NN infusion)))) (PRN (-LRB- -LRB-) (NP (CD 0.568) (NN mg/kg/4) (NN min)) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN studied) (PP (IN in) (NP (NP (CD 41) (NNS patients)) (PP (IN with) (NP (NNS Doc_3746148_234_257_Disease)))))) (CC and) (VP (VBN compared) (PP (IN with) (NP (NP (DT those)) (PP (IN after) (NP (JJ submaximal) (JJ treadmill) (NN exercise))))) (PP (IN by) (NP (NP (NN use)) (PP (IN of) (NP (DT the) (NN body) (NN surface) (NN mapping) (NN technique)))))))) (. .)))
3746148	2	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN divided) (PP (IN into) (NP (NP (NP (CD three) (NNS groups)) (: ;) (NP (NP (CD 19) (NNS patients)) (PP (IN without) (NP (NP (NNS Doc_3746148_425_446_Disease)) (PRN (-LRB- -LRB-) (NP (NN non-MI) (NN group)) (-RRB- -RRB-)))))) (, ,) (NP (NP (CD 14)) (PP (IN with) (NP (NP (NN anterior) (NNS Doc_3746148_480_490_Disease)) (PRN (-LRB- -LRB-) (NP (NNP ANT-MI)) (-RRB- -RRB-))))) (CC and) (NP (NP (CD eight)) (PP (IN with) (NP (NP (JJ inferior) (NNS Doc_3746148_524_534_Disease)) (PRN (-LRB- -LRB-) (NP (NNP INF-MI)) (-RRB- -RRB-))))))))) (. .)))
3746148	3	(ROOT (S (NP (NP (NP (JJ Eighty-seven) (NN unipolar) (NNS electrocardiograms)) (PRN (-LRB- -LRB-) (NP (NNP ECGs)) (-RRB- -RRB-))) (VP (VBN distributed) (PP (IN over) (NP (DT the) (JJ entire) (JJ thoracic) (NN surface))))) (VP (VBD were) (VP (ADVP (RB simultaneously)) (VBN recorded))) (. .)))
3746148	4	(ROOT (S (PP (IN After) (NP (NNS Doc_3746148_674_686_Chemical))) (, ,) (NP (NP (JJ ischemic) (JJ ST-segment) (NNS Doc_3746148_708_718_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.05) (NN mV)) (CC or) (NP (JJR more))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (NP (CD 84) (NN %)) (PP (IN of) (NP (DT the) (JJ non-MI) (NN group)))) (, ,) (NP (NP (CD 29) (NN %)) (PP (IN of) (NP (DT the) (JJ ANT-MI) (NN group)))) (, ,) (NP (NP (CD 63) (NN %)) (PP (IN of) (NP (DT the) (JJ INF-MI) (NN group)))) (CC and) (NP (NP (CD 61) (NN %)) (PP (IN of) (NP (DT the) (JJ total) (NN population)))))))) (. .)))
3746148	5	(ROOT (S (NP (JJ Exercise-induced) (NNP ST) (NNS Doc_3746148_880_890_Disease)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (NP (CD 84) (NN %)) (PP (IN of) (NP (DT the) (JJ non-MI) (NN group)))) (, ,) (NP (NP (CD 43) (NN %)) (PP (IN of) (NP (DT the) (JJ ANT-MI) (NN group)))) (, ,) (NP (NP (CD 38) (NN %)) (PP (IN of) (NP (DT the) (JJ INF-MI) (NN group)))) (CC and) (NP (NP (CD 61) (NN %)) (PP (IN of) (NP (DT the) (NN total)))))))) (. .)))
3746148	6	(ROOT (S (PP (IN For) (NP (JJ individual) (NNS patients))) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (JJ obvious) (NNS differences)) (PP (IN between) (NP (NP (DT the) (NN body) (NN surface) (NN distribution)) (PP (IN of) (NP (NP (NNP ST) (NNP Doc_3746148_1106_1116_Disease)) (PP (IN in) (NP (DT both) (NNS tests))))))))) (. .)))
3746148	7	(ROOT (S (NP (NP (DT The) (NN increase)) (PP (IN in) (NP (NP (NN pressure) (NN rate) (NN product)) (PP (IN after) (NP (NNS Doc_3746148_1176_1188_Chemical)))))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR less)) (PP (IN than) (NP (DT that)))) (PP (IN during) (NP (DT the) (JJ treadmill) (NN exercise)))) (. .)))
3746148	8	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (NN Doc_3746148_1279_1291_Chemical-induced) (NNS Doc_3746148_1300_1319_Disease)) (VP (VBZ is) (VP (VBN caused) (PP (IN by) (NP (NP (DT the) (JJ inhomogenous) (NN distribution)) (PP (IN of) (NP (JJ myocardial) (NN blood) (NN flow)))))))))) (. .)))
3746148	9	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (DT the) (NNP Doc_3746148_1410_1422_Chemical) (NNP ECG) (NN test)) (VP (VBZ is) (ADJP (RB as) (JJ useful) (PP (IN as) (NP (NP (DT the) (NN exercise) (NNP ECG) (NN test)) (PP (IN for) (NP (NP (DT the) (NN assessment)) (PP (IN of) (NP (NNS Doc_3746148_1492_1515_Disease)))))))))))) (. .)))
3798047	0	(ROOT (S (VP (VB Doc_3798047_0_11_Disease) (PP (IN after) (NP (JJ high-dose) (JJ intravenous) (JJ Doc_3798047_40_58_Chemical) (NN therapy)))) (. .)))
3798047	1	(ROOT (S (PP (IN In) (NP (NP (CD 5) (JJ consecutive) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_3798047_99_119_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (NP (NP (JJ intravenous) (JJ high-dose) (NNS Doc_3798047_155_173_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP MP)) (-RRB- -RRB-))) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NP (CD 1) (NN g) (RB daily)) (PP (IN for) (NP (QP (CD 2) (CC or) (CD 3)) (JJ consecutive) (NNS days)))) (-RRB- -RRB-)))))))))) (, ,) (NP (NP (DT a) (NN decline)) (PP (IN in) (NP (NN pulse) (NN rate)))) (VP (VBD was) (ADJP (ADJP (JJ observed)) (, ,) (ADJP (RBS most) (JJ pronounced))) (PP (IN on) (NP (NN day) (CD 4)))) (. .)))
3798047	2	(ROOT (S (PP (IN In) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (CD 5) (NNS patients))))) (NP (DT the) (NNS Doc_3798047_321_332_Disease)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NNS complaints)) (PP (IN of) (NP (JJ substernal) (NN pressure))))))) (. .)))
3798047	3	(ROOT (S (NP (NP (NNP Reversal)) (PP (TO to) (NP (JJ normal) (NN heart) (NN rate)))) (VP (VBD was) (VP (VBN found) (PP (IN on) (NP (NN day) (CD 7))))) (. .)))
3798047	4	(ROOT (S (NP (JJ Electrocardiographic) (NNS registrations)) (VP (VBD showed) (NP (JJ sinus) (NNS Doc_3798047_486_497_Disease)) (PP (IN in) (NP (DT all) (NNS cases)))) (. .)))
3798047	5	(ROOT (S (NP (NP (DT No) (JJ significant) (NNS changes)) (PP (IN in) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NNS electrolytes)))))) (VP (VBD were) (VP (VBN found))) (. .)))
3798047	6	(ROOT (S (NP (NP (JJ Careful) (NN observation)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ high-dose) (NNS MP)))))) (VP (VBZ is) (VP (VBN recommended))) (. .)))
3798047	7	(ROOT (S (NP (NNP High-dose) (NNP MP)) (VP (MD may) (VP (VB be) (VP (VBN contraindicated) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ known) (NNS Doc_3798047_718_731_Disease)))))))) (. .)))
3812624	0	(ROOT (S (NP (NP (CD Two) (NNS cases)) (PP (IN of) (NP (NN downbeat) (NNS Doc_3812624_22_31_Disease) (CC and) (NNS oscillopsia)))) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_3812624_64_77_Chemical)))) (. .)))
3812624	1	(ROOT (S (NP (NNP Doc_3812624_79_97_Disease)) (VP (VP (VBZ is) (ADVP (RB often)) (VP (VBN associated) (PP (IN with) (NP (JJ structural) (NNS lesions))) (PP (IN at) (NP (DT the) (JJ craniocervical) (NN junction))))) (, ,) (CC but) (VP (VBZ has) (ADVP (RB occasionally)) (VP (VBN been) (VP (VBN reported) (PP (IN as) (NP (NP (DT a) (NN manifestation)) (PP (IN of) (NP (JJ metabolic) (NN imbalance) (CC or) (NN drug) (NN intoxication))))))))) (. .)))
3812624	2	(ROOT (S (NP (PRP We)) (VP (VBD recorded) (NP (NP (DT the) (NN eye) (NNS movements)) (PP (IN of) (NP (CD two) (NNS patients)))) (PP (IN with) (NP (NP (ADJP (JJ reversible) (JJ downbeat)) (NNS Doc_3812624_344_353_Disease)) (VP (VBN related) (PP (TO to) (NP (JJ Doc_3812624_365_378_Chemical) (NN therapy))))))) (. .)))
3812624	3	(ROOT (S (NP (NP (DT The) (NNS Doc_3812624_392_401_Disease)) (PP (IN of) (NP (DT both) (NNS patients)))) (VP (VBN resolved) (PP (IN after) (NP (NP (NN reduction)) (PP (IN of) (NP (DT the) (JJ serum) (JJ Doc_3812624_457_470_Chemical) (NNS levels)))))) (. .)))
3812624	4	(ROOT (S (NP (NP (JJ Neuroradiologic) (NNS investigations)) (PP (VBG including) (NP (NP (JJ magnetic) (NN resonance) (NN imaging) (NNS scans)) (PP (IN in) (NP (DT both) (NNS patients)))))) (VP (VBD showed) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NNS Doc_3812624_592_616_Disease))))) (. .)))
3812624	5	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NN downbeat) (NNS Doc_3812624_644_653_Disease))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG taking) (NP (JJ anticonvulsant) (NNS medications)))))))) (, ,) (NP (NN consideration)) (VP (MD should) (VP (VB be) (VP (VBN given) (PP (TO to) (NP (NP (NN reduction)) (PP (IN in) (NP (NN dose))))) (SBAR (IN before) (S (NP (JJ further) (NN investigation)) (VP (VBZ is) (VP (VBN undertaken)))))))) (. .)))
3831029	0	(ROOT (NP (NP (NNP Improvement)) (PP (IN by) (NP (NNS Doc_3831029_15_25_Chemical))) (PRN (-LRB- -LRB-) (NP (NNP Doc_3831029_27_33_Chemical)) (-RRB- -RRB-)) (PP (IN of) (NP (NP (NN Doc_3831029_38_51_Chemical-induced) (NNS Doc_3831029_60_75_Disease)) (PP (IN in) (NP (DT the) (NN dog) (NN heart-lung) (NN preparation))))) (. .)))
3831029	1	(ROOT (S (NP (NP (DT The) (NN efficacy)) (PP (IN of) (NP (NP (NNS Doc_3831029_127_137_Chemical)) (, ,) (NP (DT an) (ADJP (RB orally) (JJ active)) (JJ beta) (JJ 1-adrenoceptor) (NN agonist)) (, ,) (PP (IN in) (NP (VBG improving) (NNS Doc_3831029_198_213_Disease)))))) (VP (VBD was) (VP (VBN assessed) (PP (IN in) (NP (NN dog) (NN heart-lung) (NNS preparations))))) (. .)))
3831029	2	(ROOT (S (NP (NNP Cardiac) (NNS functions)) (VP (VBD Doc_3831029_277_286_Disease) (PP (IN by) (NP (NP (NNS Doc_3831029_290_303_Chemical)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (CD 118)) (NP (NNP +) (NNP /))) (: -) (NP (NP (CD 28) (NN mg)) (: ;) (NP (NP (JJ mean) (NN value)) (NP (NNP +) (NNP /))) (: -) (NP (NNP SD)))) (-RRB- -RRB-)))) (PP (JJ such)) (SBAR (IN that) (S (S (NP (NP (JJ cardiac) (NN output) (CC and) (NN maximum) (NN rate)) (PP (IN of) (NP (NP (NN rise)) (PP (IN of) (NP (NP (JJ left) (NN ventricular) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP LV) (NNP dP/dt) (NNP max)) (-RRB- -RRB-))))))) (VP (VBD had) (VP (VBN been) (VP (VBN reduced) (PP (IN by) (NP (QP (RB about) (CD 35)) (NN %))))))) (CC and) (S (NP (NP (CD 26) (NN %)) (PP (IN of) (NP (DT the) (JJ respective) (NNS controls)))) (VP (VBD were) (VP (VBN improved) (PP (IN by) (NP (NP (NP (NNS Doc_3831029_515_525_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10-300) (NNS micrograms)) (-RRB- -RRB-))) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))))))))))) (. .)))
3831029	3	(ROOT (S (PP (IN With) (NP (CD 100) (JJ micrograms) (NNS Doc_3831029_594_604_Chemical))) (, ,) (NP (NP (ADJP (RB almost) (JJ complete)) (NN restoration)) (PP (IN of) (NP (JJ cardiac) (NN performance)))) (VP (VBD was) (VP (VP (VBN attained)) (, ,) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ slight) (NN increase)) (PP (IN in) (NP (NN heart) (NN rate)))))))) (. .)))
3831029	4	(ROOT (S (NP (DT No) (NNS Doc_3831029_723_734_Disease)) (VP (VBD were) (VP (VBN induced) (PP (IN by) (NP (NP (DT these) (NNS doses)) (PP (IN of) (NP (NNS Doc_3831029_766_776_Chemical))))))) (. .)))
3831029	5	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP warrant) (NP (NP (JJ clinical) (NNS trials)) (PP (IN of) (NP (NP (NNS Doc_3831029_817_827_Chemical)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_3831029_848_863_Disease))))))))) (. .)))
3832950	0	(ROOT (S (VP (VB Doc_3832950_0_10_Chemical) (ADVP (RB monotherapy)) (PP (IN for) (NP (NP (NNS Doc_3832950_27_35_Disease)) (PP (IN in) (NP (NN childhood)))))) (. .)))
3832950	1	(ROOT (S (NP (NP (NP (CD Sixty) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (JJ age-range) (NN one) (NN month)) (PP (TO to) (NP (CD 14) (NNS years)))) (-RRB- -RRB-))) (PP (IN with) (NP (NP (JJ other) (NNS types)) (PP (IN of) (NP (NP (NNS Doc_3832950_119_127_Disease)) (PP (IN than) (NP (NNS Doc_3832950_133_149_Disease)))))))) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_3832950_168_178_Chemical))))) (. .)))
3832950	2	(ROOT (S (NP (NP (NNP Disappearance)) (PP (IN of) (NP (NP (NNS Doc_3832950_197_205_Disease) (CC and) (NNS normalization)) (PP (IN of) (NP (JJ abnormal) (NNP EEG))) (PP (IN with) (NP (NP (NN disappearance)) (PP (IN of) (NP (NNS Doc_3832950_262_270_Disease)))))))) (VP (VBD were) (VP (VBN recognized) (PP (IN in) (NP (NP (CD 77) (NN %)) (CC and) (NP (CD 50) (NN %)))) (, ,) (ADVP (RB respectively)))) (. .)))
3832950	3	(ROOT (S (NP (NNP Doc_3832950_317_325_Disease)) (VP (VBD disappeared) (PP (IN in) (NP (NP (CD 71) (NN %)) (PP (IN of) (NP (DT the) (NNS patients))))) (PP (IN with) (NP (NP (JJ generalized) (NNS Doc_3832950_378_386_Disease)) (CC and) (NP (NP (CD 89) (NN %)) (PP (IN of) (NP (JJ partial) (NNS Doc_3832950_406_414_Disease))))))) (. .)))
3832950	4	(ROOT (S (NP (NP (NNP Improvement)) (PP (IN of) (NP (JJ abnormal) (NNP EEG)))) (VP (VBD was) (VP (VBN noticed) (PP (PP (IN in) (NP (NP (CD 76) (NN %)) (PP (IN of) (NP (JJ diffuse) (NNS paroxysms))))) (CC and) (PP (IN in) (NP (NP (CD 67) (NN %)) (PP (IN of) (NP (JJ focal) (NNS paroxysms)))))))) (. .)))
3832950	5	(ROOT (S (S (PP (IN In) (NP (JJ excellent) (NNS cases))) (, ,) (NP (JJ mean) (JJ effective) (NNS dosages)) (VP (VBD were) (NP (NP (QP (CD 0.086) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 0.021) (NN mg/kg/day)) (PP (IN in) (NP (NP (NNS infants)) (CC and) (NP (CD 0.057) (NNS +))))) (: /))))) (: -) (S (NP (NP (CD 0.022) (NN mg/kg/day)) (PP (IN in) (NP (NP (NNS schoolchildren)) (, ,) (NP (DT this) (NN difference))))) (VP (VBD was) (ADJP (RB statistically) (JJ significant)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.005))) (-RRB- -RRB-)))) (. .)))
3832950	6	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NN side) (NNS effects)) (PP (JJ such) (IN as) (NP (NNS drowsiness) (CC and) (NNS Doc_3832950_769_775_Disease)))))) (VP (VBD was) (NP (QP (RB only) (CD 5)) (NN %))) (. .)))
3833372	0	(ROOT (NP (NP (VBG Postmarketing) (NN study)) (PP (IN of) (NP (JJ Doc_3833372_23_50_Chemical) (NN antihypertensive) (NN therapy))) (. .)))
3833372	1	(ROOT (S (NP (DT A) (VBG postmarketing) (NN surveillance) (NN study)) (VP (VBD was) (VP (VBN conducted) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN safety) (CC and) (NN efficacy)) (PP (IN of) (NP (NP (DT a) (JJ fixed-ratio) (NN combination)) (VP (VBG containing) (NP (NP (CD 10) (NN mg)) (PP (IN of) (NP (NP (NNS Doc_3833372_212_227_Chemical)) (CC and) (NP (CD 25) (NN mg)))) (PP (IN of) (NP (NNS Doc_3833372_241_260_Chemical))) (, ,) (VP (VBN administered) (ADVP (RB twice) (RB daily)) (PP (IN for) (NP (NP (CD one) (NN month)) (PP (TO to) (NP (JJ Doc_3833372_304_316_Disease) (NNS patients)))))))))))))))) (. .)))
3833372	2	(ROOT (S (NP (NP (NNP Data)) (PP (IN on) (NP (CD 9,037) (NNS patients)))) (VP (VBD were) (VP (VBN collected) (PP (IN by) (NP (CD 1,455))) (S (VP (VBG participating) (NP (NNS physicians)))))) (. .)))
3833372	3	(ROOT (S (NP (CD Mean) (JJ systolic) (NN blood) (NN pressure)) (VP (VBD decreased) (SBAR (S (NP (NP (CD 25) (NN mmHg)) (CC and) (NP (JJ mean) (JJ diastolic) (NN blood) (NN pressure))) (VP (VBD declined) (NP (CD 15) (NN mmHg)) (PP (IN after) (NP (NP (CD one) (NN month)) (PP (IN of) (NP (JJ Doc_3833372_517_544_Chemical) (NN therapy))))) (PRN (-LRB- -LRB-) (ADVP (RB P)) (ADJP (JJR less) (PP (IN than) (NP (NP (CD 0.01)) (, ,) (NP (DT both) (NNS comparisons))))) (-RRB- -RRB-)))))) (. .)))
3833372	4	(ROOT (S (NP (NP (NNP Age)) (, ,) (NP (NN race)) (, ,) (CC and) (NP (NN sex))) (VP (VBD appeared) (S (VP (TO to) (VP (VB have) (NP (NP (DT no) (NN influence)) (PP (IN on) (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NN blood) (NN pressure)))))))))) (. .)))
3833372	5	(ROOT (S (NP (NP (DT The) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (DT the) (NN drug)))) (VP (VBD was) (ADJP (JJR greater)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (RBR more) (JJ severe)) (NNS Doc_3833372_756_768_Disease)))))) (. .)))
3833372	6	(ROOT (S (ADVP (RB Overall)) (, ,) (NP (CD 1,453) (NNS patients)) (VP (VBD experienced) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 2,658) (JJ adverse) (NNS events)) (, ,) (NP (DT the) (RBS most) (JJ common) (JJ being) (NN fatigue)) (, ,) (NP (NNS Doc_3833372_870_879_Disease)) (, ,) (CC and) (NP (NNS Doc_3833372_885_893_Disease)))))) (. .)))
3833372	7	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN in) (NP (CD 590) (NNS patients)))) (VP (VBD was) (VP (VBN discontinued) (PP (RB because) (IN of) (NP (JJ adverse) (NNS events))))) (. .)))
3864191	0	(ROOT (NP (NP (NP (JJ Doc_3864191_0_10_Chemical) (NNS Doc_3864191_11_22_Disease)) (PP (IN in) (NP (DT the) (NNP Gunn) (NN rat)))) (: :) (NP (NP (JJ potential) (NN role)) (PP (IN of) (NP (NNS Doc_3864191_58_72_Chemical)))) (. .)))
3864191	1	(ROOT (S (NP (PRP We)) (VP (VBD examined) (NP (NP (DT the) (JJ potential) (NN role)) (PP (IN of) (NP (NP (NNS Doc_3864191_108_122_Chemical)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ analgesic) (NNS Doc_3864191_155_166_Disease)))))))) (PP (IN in) (NP (NP (DT the) (JJ Gunn) (NN strain)) (PP (IN of) (NP (NN rat)))))) (. .)))
3864191	2	(ROOT (S (NP (DT The) (JJ homozygous) (NNP Gunn) (NNS rats)) (VP (VBP have) (VP (VBN Doc_3864191_224_255_Disease) (S (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ Doc_3864191_278_288_Chemical) (NN transferase))))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (VBN marked) (JJ Doc_3864191_320_329_Chemical) (NN deposition)) (PP (IN in) (NP (JJ renal) (NN medulla) (CC and) (NN papilla))))))))) (. .)))
3864191	3	(ROOT (S (NP (DT These) (NNS rats)) (VP (VBP are) (ADVP (RB also)) (ADJP (RB highly) (JJ susceptible) (S (VP (TO to) (VP (VB develop) (NP (NNS Doc_3864191_421_439_Disease)) (PP (IN with) (NP (JJ analgesic) (NN administration)))))))) (. .)))
3864191	4	(ROOT (S (NP (PRP We)) (VP (VBD used) (NP (NP (NP (NNS homozygous)) (PRN (-LRB- -LRB-) (NP (NN jj)) (-RRB- -RRB-))) (CC and) (NP (ADJP (RB phenotypically) (JJ normal)) (NN heterozygous) (PRN (-LRB- -LRB-) (NP (NN jJ)) (-RRB- -RRB-)) (NNS animals)))) (. .)))
3864191	5	(ROOT (S (S (NP (NP (CD Four) (NNS groups)) (PP (IN of) (NP (NP (NNS rats)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 7))))) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN studied)))) (: :) (S (NP (NN jj) (CC and) (NN jJ) (NNS rats)) (VP (VBD treated) (ADVP (RB either)) (PP (IN with) (NP (NNP Doc_3864191_625_632_Chemical) (CD 300))) (S (VP (VBG mg/kg) (NP (NP (DT every) (JJ other) (NN day)) (CC or) (NP (JJ sham-treated))))))) (. .)))
3864191	6	(ROOT (S (PP (IN After) (NP (CD one))) (NP (NN week)) (, ,) (NP (NP (NNS slices)) (PP (IN of) (NP (NP (NN cortex)) (, ,) (SBAR (WHNP (NP (JJ outer) (CC and) (JJ inner) (NN medulla)) (PP (IN from) (NP (CD one) (NN kidney)))) (S (VP (VBD were) (VP (VBN incubated) (PP (IN in) (NP (NN buffer) (CC and) (NN Doc_3864191_779_792_Chemical) (NN synthesis)))))))))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NN radioimmunoassay))))) (. .)))
3864191	7	(ROOT (S (NP (DT The) (JJ other) (NN kidney)) (VP (VBD was) (VP (VBN examined) (ADVP (RB histologically)))) (. .)))
3864191	8	(ROOT (S (NP (NP (DT A) (JJ marked) (NN corticomedullary) (NN gradient)) (PP (IN of) (NP (JJ Doc_3864191_923_936_Chemical) (NN synthesis)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (DT all) (NNS groups))))) (. .)))
3864191	9	(ROOT (S (NP (NNP Doc_3864191_975_979_Chemical) (NNP synthesis)) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (PP (IN in) (NP (JJ outer) (NN medulla))) (, ,) (CC but) (RB not) (PP (NP (NP (NN cortex) (CC or) (JJ inner) (NN medulla)) (, ,) (PP (IN of) (NP (NP (NN jj)) (PRN (-LRB- -LRB-) (NP (CD 38) (NNP +) (NNS /)) (, -) (NP (CD 6) (NN ng/mg) (NN prot)) (-RRB- -RRB-))))) (IN than) (NP (NP (NP (NN jJ) (NNS rats)) (PRN (-LRB- -LRB-) (NP (CD 15) (NNP +) (NNS /)) (, -) (NP (CD 3)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.01))) (-RRB- -RRB-))))))) (. .)))
3864191	10	(ROOT (S (S (NP (JJ Doc_3864191_1138_1145_Chemical) (NN treatment)) (VP (VBD reduced) (NP (JJ Doc_3864191_1164_1168_Chemical) (NN synthesis)) (PP (IN in) (NP (DT all) (NNS regions))))) (, ,) (CC but) (S (NP (JJ outer) (NN medullary) (NNS Doc_3864191_1215_1219_Chemical)) (VP (VBD remained) (NP (JJR higher)) (PP (IN in) (NP (NP (NN jj)) (PRN (-LRB- -LRB-) (NP (CD 18) (NNP +) (NNS /)) (, -) (NP (CD 3)) (-RRB- -RRB-)))) (PP (IN than) (NP (NP (NP (NN jJ) (NNS rats)) (PRN (-LRB- -LRB-) (NP (CD 9) (NNP +) (NNS /)) (, -) (NP (CD 2)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-)))))) (. .)))
3864191	11	(ROOT (S (NP (NNP Doc_3864191_1296_1306_Chemical)) (VP (VBD was) (ADVP (RB also)) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN in) (NP (NP (DT the) (JJ outer) (NN medulla)) (PP (IN of) (NP (NN jj) (NNS rats)))))) (PP (IN with) (CC and) (IN without) (NP (NP (JJ Doc_3864191_1386_1393_Chemical) (NN administration)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))))) (. .)))
3864191	12	(ROOT (S (NP (NP (DT The) (NNS changes)) (PP (IN in) (NP (JJ renal) (JJ Doc_3864191_1450_1463_Chemical) (NN synthesis)))) (VP (VBD were) (VP (VP (VBN accompanied) (PP (IN by) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NNS Doc_3864191_1506_1518_Disease)) (PP (IN in) (NP (NN Doc_3864191_1522_1529_Chemical-treated) (NN jj)))))))) (CONJP (CC but) (RB not)) (VP (ADVP (NP (CD jJ) (NNS rats)) (RB as)) (VBN evidenced) (PP (IN by))) (: :) (VP (VBN increased) (NP (NP (NP (NP (NN incidence) (CC and) (NN severity)) (PP (IN of) (NP (NNS Doc_3864191_1610_1619_Disease)))) (PRN (-LRB- -LRB-) (S (VP (VB p) (NP (QP (JJR less) (IN than) (CD 0.01))))) (-RRB- -RRB-))) (: ;) (NP (NP (VBN increased) (NN serum) (NNS Doc_3864191_1656_1666_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))) (: ;) (CC and) (NP (NP (NN increase)) (PP (IN in) (NP (NP (JJ outer) (ADJP (RB medullary) (JJ histopathologic)) (NNS lesions)) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (QP (JJR less) (IN than) (CD 0.005))) (PP (VBN compared) (PP (TO to) (NP (DT either) (JJ sham-treated) (NN jj) (CC or) (NN Doc_3864191_1800_1807_Chemical-treated) (NN jJ))))) (-RRB- -RRB-))))))))) (. .)))
3864191	13	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (JJ enhanced) (JJ Doc_3864191_1857_1870_Chemical) (NN synthesis)) (VP (VBZ contributes) (PP (TO to) (NP (NP (NN maintenance)) (PP (IN of) (NP (JJ renal) (NN function) (CC and) (NN morphological) (NN integrity)))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ Doc_3864191_1978_1991_Chemical) (NN synthesis)))) (VP (MD may) (VP (VB lead) (S (VP (TO to) (VP (VB pathological) (NP (NP (JJ renal) (NN medullary) (NNS lesions)) (CC and) (NP (NP (NN deterioration)) (PP (IN of) (NP (JJ renal) (NN function)))))))))))))) (. .)))
3895875	0	(ROOT (NP (NP (JJ Prophylactic) (NNS Doc_3895875_13_22_Chemical)) (PP (IN in) (NP (NP (DT the) (JJ early) (NN phase)) (PP (IN of) (NP (VBN suspected) (NNS Doc_3895875_55_76_Disease))))) (. .)))
3895875	1	(ROOT (S (NP (NP (CD Four) (CD hundred) (CD two) (NNS patients)) (PP (IN with) (NP (NP (VBN suspected) (NNS Doc_3895875_119_140_Disease)) (VP (VBN seen) (PP (IN within) (NP (NP (CD 6) (NNS hours)) (PP (IN of) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NNS symptoms))))))))))) (VP (VBD entered) (NP (NP (DT a) (JJ double-blind) (JJ randomized) (NN trial)) (PP (IN of) (NP (JJ Doc_3895875_229_238_Chemical) (NN vs) (NN placebo))))) (. .)))
3895875	2	(ROOT (S (PP (IN During) (NP (NP (DT the) (CD 1) (NN hour)) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (DT the) (NN drug))))))) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (JJ Doc_3895875_319_343_Disease) (CC or) (JJ sustained) (NNS Doc_3895875_357_380_Disease)) (PP (IN among) (NP (NP (DT the) (CD 204) (NNS patients)) (PP (IN with) (NP (NNS Doc_3895875_409_436_Disease)))))))) (VP (VP (VBD was) (ADJP (JJ low))) (, ,) (NP (CD 1.5) (NN %))) (. .)))
3895875	3	(ROOT (S (NP (NP (NNP Doc_3895875_452_461_Chemical)) (, ,) (VP (VBN given) (PP (IN in) (NP (NP (DT a) (CD 300) (NN mg) (NN dose)) (VP (ADVP (RB intramuscularly)) (VBN followed) (PP (IN by) (NP (CD 100) (NN mg) (NN intravenously))))))) (, ,)) (VP (VBD did) (RB not) (VP (VB prevent) (NP (JJ sustained) (NNS Doc_3895875_562_585_Disease)) (, ,) (SBAR (IN although) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_3895875_661_680_Disease)) (PP (IN between) (NP (NP (CD 15) (CC and) (CD 45) (NNS minutes)) (PP (IN after) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_3895875_735_744_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-)))))))))))))))))))) (. .)))
3895875	4	(ROOT (S (NP (NP (DT The) (JJ average) (NN plasma) (NN Doc_3895875_784_793_Chemical) (NN level)) (NP (CD 10) (NNS minutes)) (PP (IN after) (NP (NP (NN administration)) (PP (IN for) (NP (NP (NNS patients)) (PP (IN without) (NP (DT a) (NNS Doc_3895875_855_876_Disease)))))))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN than) (NP (NP (DT that)) (PP (IN for) (NP (NNS patients)))))) (PP (IN with) (NP (DT an) (JJ acute) (NNS Doc_3895875_939_949_Disease)))) (. .)))
3895875	5	(ROOT (S (NP (NP (DT The) (JJ mean) (NN plasma) (NN Doc_3895875_967_976_Chemical) (NN level)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN on) (NP (JJ beta-blocking) (NNS agents)))))) (VP (VBD was) (ADJP (RB no) (JJ different) (PP (IN from) (NP (NP (DT that)) (PP (IN in) (NP (NNS patients)))))) (PP (RB not) (IN on) (NP (NP (NN beta)) (VP (VBG blocking) (NP (NNS agents)))))) (. .)))
3895875	6	(ROOT (S (PP (IN During) (NP (DT the) (JJ 1-hour) (NN study) (NN period))) (, ,) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ central) (JJ nervous) (NN system) (NN side) (NNS effects)))) (VP (VBD was) (ADJP (RB significantly) (JJR greater)) (PP (IN in) (NP (NP (DT the) (JJ Doc_3895875_1205_1214_Chemical) (NN group)) (, ,) (NP (NP (NP (NNS Doc_3895875_1222_1233_Disease)) (VP (VBN occurred) (PP (IN in) (NP (CD 11) (NNS patients))))) (, ,) (NP (NP (CD nine)) (PP (IN of) (SBAR (WHNP (WP whom)) (S (VP (VBD had) (VP (VBN received) (NP (NNS Doc_3895875_1285_1294_Chemical)))))))) (, ,) (CC and) (NP (NP (CD four) (NNS patients)) (VP (VBN died) (PP (IN from) (NP (NP (NNS Doc_3895875_1324_1332_Disease)) (, ,) (SBAR (WHNP (CD three) (WHPP (IN of) (WHNP (WP whom)))) (S (VP (VBD had) (VP (VBN had) (NP (NNS Doc_3895875_1356_1365_Chemical)))))))))))))) (. .)))
3895875	7	(ROOT (S (NP (PRP We)) (VP (MD can) (RB not) (VP (VB advocate) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (JJ Doc_3895875_1408_1417_Chemical) (NN prophylactically)))) (PP (IN in) (NP (NP (DT the) (JJ early) (NNS hours)) (PP (IN of) (NP (VBN suspected) (NNS Doc_3895875_1467_1488_Disease))))))) (. .)))
3925479	0	(ROOT (NP (NP (NN Evidence)) (PP (IN for) (NP (DT a) (JJ cholinergic) (NN role))) (PP (IN in) (NP (NN Doc_3925479_35_46_Chemical-induced) (NNS Doc_3925479_55_64_Disease))) (. .)))
3925479	1	(ROOT (S (NP (NP (NNS Experiments)) (PP (IN in) (NP (NNS mice)))) (VP (VBD tested) (NP (JJ previous) (NN evidence)) (SBAR (SBAR (IN that) (S (NP (NP (NN activation)) (PP (IN of) (NP (JJ cholinergic) (NNS systems)))) (VP (VBZ promotes) (NP (NNS Doc_3925479_159_168_Disease))))) (CC and) (SBAR (IN that) (S (NP (JJ cholinergic) (NNS mechanisms)) (VP (VBP need) (S (VP (TO to) (VP (VB be) (ADJP (JJ intact) (PP (IN for) (NP (NP (JJ full) (NN expression)) (PP (IN of) (NP (JJ neuroleptic-induced) (NNS Doc_3925479_262_271_Disease)))))))))))))) (. .)))
3925479	2	(ROOT (S (NP (NP (JJ Large) (NNS doses)) (PP (IN of) (NP (NP (DT the) (NN cholinomimetic)) (, ,) (NP (NNS Doc_3925479_308_319_Chemical)) (, ,)))) (VP (MD could) (VP (VB induce) (NP (NNS Doc_3925479_334_343_Disease)) (SBAR (WHADVP (WRB when)) (S (NP (JJ peripheral) (JJ cholinergic) (NNS receptors)) (VP (VBD were) (VP (VBN blocked))))))) (. .)))
3925479	3	(ROOT (S (NP (NP (NNP Low) (NNS doses)) (PP (IN of) (NP (NNS Doc_3925479_409_420_Chemical)))) (VP (VBD caused) (NP (NP (DT a) (JJ pronounced) (NN enhancement)) (PP (IN of) (NP (NP (DT the) (NNS Doc_3925479_460_469_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (DT the) (JJ dopaminergic) (NN blocker)) (, ,) (NP (NNS Doc_3925479_516_527_Chemical)))))))))))) (. .)))
3925479	4	(ROOT (S (NP (NP (DT A) (JJ muscarinic) (NN receptor) (NN blocker)) (, ,) (NP (NNS Doc_3925479_560_568_Chemical)) (, ,)) (VP (VBD disrupted) (NP (NN Doc_3925479_580_591_Chemical-induced) (NNS Doc_3925479_600_609_Disease))) (. .)))
3925479	5	(ROOT (S (NP (NP (JJ Intracranial) (NN injection)) (PP (IN of) (NP (NP (DT an) (NN Doc_3925479_640_653_Chemical-synthesis) (NN inhibitor)) (, ,) (NP (NNS Doc_3925479_675_688_Chemical)) (, ,)))) (VP (VBD prevented) (NP (NP (DT the) (NNS Doc_3925479_704_713_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB usually)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_3925479_741_752_Chemical))))))))) (. .)))
3925479	6	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (NP (DT the) (NNS hypothesis)) (SBAR (IN that) (S (NP (NP (DT the) (NNS Doc_3925479_801_810_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN produced) (PP (IN by) (NP (NP (NNS neuroleptics)) (PP (JJ such) (IN as) (NP (NNS Doc_3925479_852_863_Chemical)))))))))) (VP (VBZ is) (ADVP (RB actually)) (VP (VBN mediated) (PP (IN by) (NP (JJ intrinsic) (JJ central) (JJ cholinergic) (NNS systems)))))))) (. .)))
3925479	7	(ROOT (S (ADVP (RB Alternatively)) (, ,) (NP (NP (NN activation)) (PP (IN of) (NP (JJ central) (JJ cholinergic) (NNS systems)))) (VP (MD could) (VP (VB promote) (NP (NNS Doc_3925479_998_1007_Disease)) (PP (IN by) (NP (NP (NN suppression)) (PP (IN of) (NP (JJ dopaminergic) (NNS systems))))))) (. .)))
3975902	0	(ROOT (S (NP (NP (NNS Doc_3975902_0_26_Disease) (CC and) (NNS Doc_3975902_31_47_Disease)) (PP (TO to) (NP (NNS Doc_3975902_51_71_Chemical)))) (VP (VBN induced) (PP (IN by) (NP (JJ chronic) (JJ Doc_3975902_91_106_Chemical) (NN ingestion)))) (. .)))
3975902	1	(ROOT (S (NP (NNP Doc_3975902_118_124_Chemical-supplemented) (NNP Long-Evans)) (VP (VBD hooded) (SBAR (S (NP (NNS rats)) (VP (VBD were) (VP (VBN characterized) (PP (IN by) (NP (NP (DT a) (JJ persistent) (NNS Doc_3975902_196_208_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (ADJP (JJ evident) (PP (IN after) (NP (NP (CD 1) (NN month)) (PP (IN of) (NP (NNP Doc_3975902_243_249_Chemical) (PRN (-LRB- -LRB-) (NP (NP (CD 100) (JJ micrograms/ml) (NN mineral)) (NP (JJ fortified) (NN water))) (-RRB- -RRB-)) (NN treatment)))))))))))))))) (. .)))
3975902	2	(ROOT (S (NP (NP (NNP Analysis)) (PP (IN of) (PP (IN in) (NP (NP (NN vivo) (NNS Doc_3975902_325_348_Disease)) (, ,) (NP (NN contractility)) (, ,) (CC and) (NP (NP (JJ metabolic) (NNS characteristics)) (PP (IN at) (NP (CD 16) (NNS months)))))))) (VP (VBD revealed) (NP (JJ other) (JJ significant) (NN Doc_3975902_435_441_Chemical-induced) (NNS disturbances)) (PP (IN within) (NP (DT the) (JJ cardiovascular) (NN system)))) (. .)))
3975902	3	(ROOT (S (NP (NP (DT The) (ADJP (RBS most) (JJ distinctive)) (NN aspect)) (PP (IN of) (NP (DT the) (JJ Doc_3975902_532_538_Chemical) (NN effect)))) (VP (VBD was) (NP (NP (DT a) (JJ demonstrated) (NNS Doc_3975902_565_581_Disease)) (PP (IN of) (NP (NP (DT the) (JJ cardiovascular) (NN system)) (PP (TO to) (NP (NNS Doc_3975902_614_634_Chemical))))))) (. .)))
3975902	4	(ROOT (S (PP (IN Under) (NP (JJ Doc_3975902_642_653_Chemical) (NN anesthesia))) (, ,) (NP (NP (RB virtually) (DT all)) (PP (IN of) (NP (DT the) (JJ myocardial) (JJ contractile) (NNS indices)))) (VP (VBD were) (VP (VBN depressed) (ADVP (RB significantly)) (PP (IN in) (NP (NP (NN Doc_3975902_750_756_Chemical-exposed) (NNS rats)) (ADVP (JJ relative) (PP (TO to) (NP (DT the) (JJ corresponding) (JJ control-fed) (NNS rats)))))))) (. .)))
3975902	5	(ROOT (S (NP (NP (DT The) (NN lack)) (PP (IN of) (NP (NP (DT a) (JJ similar) (NN response)) (PP (TO to) (NP (NNS Doc_3975902_852_860_Chemical) (CC and) (NNS Doc_3975902_865_873_Chemical) (NN anesthesia)))))) (VP (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (DT the) (JJ cardiovascular) (NNS actions)) (PP (IN of) (NP (NP (NNS Doc_3975902_929_949_Chemical)) (PP (IN in) (NP (NN Doc_3975902_953_959_Chemical-treated) (NNS rats)))))) (VP (VBD were) (VP (VBN linked) (ADVP (RB specifically)) (PP (TO to) (NP (DT this) (NN anesthetic)))))))) (, ,) (CC and) (VP (VBD were) (ADJP (RB not) (JJ representative)) (PP (IN of) (NP (DT a) (JJ generalized) (JJ anesthetic) (NN response))))) (. .)))
3975902	6	(ROOT (S (NP (NP (JJ Other) (JJ myocardial) (ADJP (JJ pathophysiologic) (CC and) (JJ metabolic)) (NNS changes)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_3975902_1151_1157_Chemical))))) (VP (VBD were) (ADJP (JJ manifest)) (, ,) (S (VP (ADVP (RB irrespective) (PP (IN of) (NP (DT the) (NN anesthetic)))) (VBN employed)))) (. .)))
3975902	7	(ROOT (S (NP (NP (DT The) (JJ contractile) (NN element) (NN shortening) (NN velocity)) (PP (IN of) (NP (DT the) (JJ cardiac) (NN muscle) (NNS fibers)))) (VP (VBD was) (ADJP (RB significantly) (JJR slower)) (PP (IN in) (NP (NP (DT both) (NNS groups)) (PP (IN of) (NP (NP (NN Doc_3975902_1330_1336_Chemical-treated) (NNS rats)) (ADVP (JJ relative) (PP (TO to) (NP (DT the) (NN control) (NNS groups)))))))) (, ,) (ADVP (RB irrespective) (PP (IN of) (NP (DT the) (JJ anesthetic) (NN regimen))))) (. .)))
3975902	8	(ROOT (S (ADVP (RB Similarly)) (, ,) (NP (NP (JJ significant) (NNS disturbances)) (PP (IN in) (NP (JJ myocardial) (NN energy) (NN metabolism)))) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (NP (DT the) (NN Doc_3975902_1511_1517_Chemical-exposed) (NNS rats)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (ADJP (JJ consistent)) (PP (IN with) (NP (DT the) (VBN reduced) (NN contractile) (NN element) (NN shortening) (NN velocity)))))))))) (. .)))
3975902	9	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN excitability)) (PP (IN of) (NP (DT the) (JJ cardiac) (NN conduction) (NN system)))) (VP (VBD was) (VP (VBN depressed) (ADVP (RB preferentially)) (PP (IN in) (NP (NP (DT the) (NN atrioventricular) (NN nodal) (NN region)) (PP (IN of) (NP (NP (NNS hearts)) (PP (IN from) (NP (NN Doc_3975902_1755_1761_Chemical-exposed) (NNS rats))))))))) (. .)))
3975902	10	(ROOT (S (ADVP (RB Overall)) (, ,) (NP (NP (NP (DT the) (JJ altered) (JJ cardiac) (NN contractility)) (CC and) (NP (JJ excitability) (NNS characteristics))) (, ,) (NP (DT the) (JJ myocardial) (JJ metabolic) (NNS disturbances)) (, ,) (CC and) (NP (NP (DT the) (NNS Doc_3975902_1900_1916_Disease)) (PP (IN of) (NP (NP (DT the) (JJ cardiovascular) (NN system)) (PP (TO to) (NP (NNS Doc_3975902_1949_1969_Chemical))))))) (VP (VBP suggest) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NP (DT a) (JJ heretofore) (JJ undescribed) (NNS Doc_3975902_2020_2044_Disease)) (VP (VBN induced) (PP (IN by) (NP (JJ chronic) (JJ Doc_3975902_2064_2070_Chemical) (NN exposure)))))))) (. .)))
3975902	11	(ROOT (S (NP (DT These) (JJ experimental) (NNS findings)) (VP (VBP represent) (NP (DT the) (JJ first) (NN indication)) (SBAR (IN that) (S (NP (JJ life-long) (JJ Doc_3975902_2155_2161_Chemical) (NN ingestion)) (VP (MD may) (VP (VB have) (NP (NP (JJ significant) (JJ adverse) (NNS effects)) (PP (IN on) (NP (DT the) (JJ mammalian) (JJ cardiovascular) (NN system))))))))) (. .)))
3987172	0	(ROOT (NP (NP (JJ Doc_3987172_0_11_Chemical) (NN antagonism)) (PP (IN of) (NP (NN Doc_3987172_26_45_Chemical-induced) (NNS Doc_3987172_54_66_Disease))) (. .)))
3987172	1	(ROOT (S (NP (JJ Doc_3987172_68_87_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_3987172_89_92_Chemical)) (-RRB- -RRB-)) (NNS Doc_3987172_94_102_Disease)) (VP (MD can) (VP (VB cause) (NP (NP (JJ severe) (NNS Doc_3987172_120_132_Disease)) (, ,) (NP (NNS Doc_3987172_134_158_Disease)) (, ,) (CC and) (NP (NNS Doc_3987172_164_169_Disease))))) (. .)))
3987172	2	(ROOT (S (NP (PRP We)) (VP (VBD studied) (NP (NP (DT the) (NN efficacy) (CC and) (NN safety)) (PP (IN of) (NP (NNS Doc_3987172_209_220_Chemical)))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN Doc_3987172_241_244_Chemical-induced) (NNS Doc_3987172_253_265_Disease)))))) (. .)))
3987172	3	(ROOT (S (NP (NNS Subjects)) (VP (VBD received) (NP (NNS Doc_3987172_285_296_Chemical)) (PP (CC either) (PP (IN by) (NP (NP (NN mouth)) (PP (IN for) (NP (NP (CD 48) (NNS hours)) (PP (IN before) (NP (NNS Doc_3987172_333_336_Chemical))))))) (CC or) (PP (IN as) (NP (DT a) (JJ rapid) (JJ intravenous) (NN infusion)))) (PP (IN after) (NP (NNS Doc_3987172_378_381_Chemical)))) (. .)))
3987172	4	(ROOT (S (S (NP (NP (NNP Doc_3987172_383_386_Chemical)) (, ,) (NP (CD 75) (NN mg) (RB alone)) (, ,)) (VP (VBD increased) (NP (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 31)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (NP (QP (CD 14) (CD mm)) (NN Hg)) (JJ systolic)) (, ,) (NP (CD 20) (CD +)) (: /)) (: -) (FRAG (ADJP (NP (CD 5) (NNS mm)) (JJ Hg)) (ADJP (JJ diastolic))))) (-RRB- -RRB-)))) (, ,) (CC and) (S (NP (JJ Doc_3987172_484_495_Chemical) (NN pretreatment)) (VP (VBD antagonized) (NP (DT this) (NN increase)) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 12)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (NP (QP (CD 10) (CD mm)) (NN Hg)) (JJ systolic)) (, ,) (NP (CD 10) (CD +)) (: /)) (: -) (FRAG (ADJP (NP (CD 7) (NNS mm)) (JJ Hg)) (ADJP (JJ diastolic))))) (-RRB- -RRB-)))) (. .)))
3987172	5	(ROOT (S (NP (NP (JJ Intravenous) (NNS Doc_3987172_601_612_Chemical)) (PP (IN after) (NP (NNS Doc_3987172_619_622_Chemical)))) (ADVP (RB also)) (VP (VBD decreased) (NP (NN blood) (NN pressure))) (. .)))
3987172	6	(ROOT (S (NP (NP (NNP Left) (NN ventricular) (NN function)) (PRN (-LRB- -LRB-) (VP (VBN assessed) (PP (IN by) (NP (NN echocardiography)))) (-RRB- -RRB-))) (VP (VBD showed) (SBAR (IN that) (S (NP (NNS Doc_3987172_723_726_Chemical)) (VP (VBD increased) (NP (DT the) (JJ Doc_3987172_741_747_Disease) (NN volume)) (NP (NP (NP (CD 30) (NN %)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NP (CD 62.5) (JJ +) (NNS /)) (PRN (: -) (NP (QP (CD 20.9) (TO to) (CD 80.8)) (NNS +)) (: /)) (: -) (NP (CD 22.4) (NN ml)))) (-RRB- -RRB-))) (, ,) (NP (NP (NP (DT the) (NN ejection) (NN fraction)) (ADJP (CD 9) (NN %))) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NP (NP (CD 64) (NN %) (QP (CD +) (CD /))) (PRN (: -) (NP (QP (CD 10) (NN %) (TO to) (CD 70) (NN %)) (NNS +)) (: /))) (: -) (ADJP (CD 7) (NN %)))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ cardiac) (NN output)) (NP (NP (CD 14) (NN %)) (PRN (-LRB- -LRB-) (FRAG (FRAG (PP (IN from) (NP (CD 3.6))) (NP (CD +)) (: /)) (: -) (FRAG (FRAG (ADJP (JJ 0.6) (PP (TO to) (NP (QP (CD 4.1) (CD +))))) (: /)) (: -) (FRAG (NP (CD 1.0)) (NP (NNP L/min))))) (-RRB- -RRB-))))))))) (. .)))
3987172	7	(ROOT (S (NP (JJ Intravenous) (NNS Doc_3987172_936_947_Chemical)) (VP (VBD reversed) (NP (DT these) (NNS effects))) (. .)))
3987172	8	(ROOT (S (NP (JJ Systemic) (NN vascular) (NN resistance)) (VP (VBD was) (VP (VP (VBN increased) (PP (IN by) (NP (NP (NNS Doc_3987172_1018_1021_Chemical)) (ADJP (CD 28) (NN %))))) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NP (CD 1710) (JJ +) (NNS /)) (PRN (: -) (NP (QP (CD 200) (TO to) (CD 2190)) (NNS +)) (: /)) (: -) (NP (CD 700) (JJ dyne) (NNP X) (NNS sec/cm5)))) (-RRB- -RRB-)) (CC and) (VP (VBD was) (VP (ADVP (RBR further)) (VBN increased) (PP (IN by) (NP (NP (QP (CD Doc_3987172_1106_1117_Chemical) (CD 22)) (NN %)) (PRN (-LRB- -LRB-) (FRAG (FRAG (PP (TO to) (NP (CD 2660))) (NP (CD +)) (: /)) (: -) (FRAG (NP (CD 1200) (NN dyne)) (NP (NNP X) (NNPS sec/cm5)))) (-RRB- -RRB-)))))))) (. .)))
3987172	9	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP (NNS Doc_3987172_1174_1177_Chemical)) (VP (VBZ increases) (NP (NN blood) (NN pressure)) (PP (IN by) (S (VP (VBG increasing) (NP (JJ systemic) (NN vascular) (NN resistance) (CC and) (JJ cardiac) (NN output)))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NNS Doc_3987172_1275_1286_Chemical)) (VP (VBZ antagonizes) (NP (DT this) (NN increase)) (PP (IN by) (S (VP (VBG reversing) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_3987172_1340_1343_Chemical)) (PP (IN on) (NP (JJ cardiac) (NN output)))))))))))))) (. .)))
3987172	10	(ROOT (S (NP (DT That) (NNS Doc_3987172_1368_1379_Chemical)) (VP (VBZ antagonizes) (SBAR (S (NP (NP (DT the) (NN pressor) (NN effect)) (PP (IN of) (NP (NNS Doc_3987172_1414_1417_Chemical)))) (VP (VBZ is) (PP (IN in) (NP (NN contrast))) (PP (TO to) (NP (NP (DT the) (NN interaction)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NNS Doc_3987172_1461_1472_Chemical)) (VP (VBZ enhances) (NP (NP (DT the) (NN pressor) (NN effect)) (PP (IN of) (NP (NNS Doc_3987172_1504_1518_Chemical))))))))))))) (. .)))
3987172	11	(ROOT (S (NP (DT This)) (VP (VBZ is) (ADVP (RB probably)) (SBAR (IN because) (S (NP (NNS Doc_3987172_1545_1548_Chemical)) (VP (VBZ has) (VP (ADVP (NP (QP (JJR less) (IN beta) (CD 2)) (NN activity)) (IN than)) (VBZ does) (NP (NNS Doc_3987172_1584_1598_Chemical))))))) (. .)))
3990093	0	(ROOT (S (VP (VB Mesangial) (NP (NN function) (CC and) (NNS Doc_3990093_23_43_Disease)) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (JJ Doc_3990093_57_72_Chemical) (NNS Doc_3990093_73_82_Disease)))))) (. .)))
3990093	1	(ROOT (S (NP (NP (DT The) (JJ possible) (NN relationship)) (PP (IN between) (NP (NNS Doc_3990093_118_139_Disease) (CC and) (NN development))) (PP (IN of) (NP (NNS Doc_3990093_159_179_Disease)))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (DT the) (JJ Doc_3990093_199_224_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_3990093_226_229_Chemical)) (-RRB- -RRB-)) (NN model))))) (. .)))
3990093	2	(ROOT (S (S (NP (CD Five) (JJ male) (NN Wistar) (NNS rats)) (VP (VBD received) (NP (VBN repeated) (NN subcutaneous) (NNS Doc_3990093_291_294_Chemical) (NNS injections)))) (: ;) (S (NP (CD five) (NNS controls)) (VP (VBD received) (NP (NN saline)) (ADVP (RB only)))) (. .)))
3990093	3	(ROOT (S (S (PP (IN After) (NP (CD 4) (NNS weeks))) (NP (DT the) (JJ Doc_3990093_361_364_Chemical) (NNS rats)) (VP (VBD were) (ADJP (RB severely) (JJ proteinuric)) (PRN (-LRB- -LRB-) (NP (NP (CD 190) (JJ +) (NNS /)) (: -) (NP (CD 80) (JJ mg/24) (NN hr))) (-RRB- -RRB-)))) (, ,) (CC and) (S (NP (DT all) (NNS rats)) (VP (VBD were) (VP (VBN given) (NP (NP (JJ colloidal) (NNS Doc_3990093_453_459_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CC)) (-RRB- -RRB-))) (ADVP (RB intravenously))))) (. .)))
3990093	4	(ROOT (S (S (PP (IN At) (NP (CD 5) (NNS months))) (NP (NNS Doc_3990093_492_512_Disease)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (QP (CD 7.6) (CD +)) (NNS /)) (: -) (NP (NP (CD 3.4) (NN %)) (PP (IN of) (NP (NP (DT the) (NN glomeruli)) (PP (IN of) (NP (JJ Doc_3990093_559_562_Chemical) (NNS rats))))))))))) (: ;) (S (NP (NP (NNS glomeruli)) (PP (IN of) (NP (DT the) (NNS controls)))) (VP (VBD were) (ADJP (JJ normal)))) (. .)))
3990093	5	(ROOT (S (NP (NP (NNP Glomeruli)) (PP (IN of) (NP (JJ Doc_3990093_621_624_Chemical) (NNS rats)))) (VP (VBD contained) (NP (ADJP (RB significantly) (JJR more)) (NN CC)) (PP (IN than) (NP (NP (NNS glomeruli)) (PP (IN of) (NP (NNS controls)))))) (. .)))
3990093	6	(ROOT (S (NP (NP (NNP Glomeruli)) (PP (IN with) (NP (NNS Doc_3990093_705_714_Disease)))) (VP (VBD contained) (NP (ADJP (RB significantly) (JJR more)) (NN CC)) (PP (IN than) (NP (JJ non-sclerotic) (NNS glomeruli))) (PP (IN in) (NP (DT the) (JJ same) (NNS kidneys)))) (. .)))
3990093	7	(ROOT (S (NP (NNP CC)) (VP (VBD was) (ADJP (RB preferentially) (JJ localized) (PP (IN within) (NP (NP (DT the) (JJ sclerotic) (NNS areas)) (PP (IN of) (NP (DT the) (VBN affected) (NN glomeruli))))))) (. .)))
3990093	8	(ROOT (S (SBAR (IN Since) (S (NP (NP (JJ mesangial) (NN CC) (NN clearance)) (PP (IN from) (NP (DT the) (NN mesangium)))) (VP (VBD did) (RB not) (VP (VB change) (PP (IN during) (NP (JJ chronic) (JJ Doc_3990093_961_964_Chemical) (NN treatment))))))) (, ,) (NP (PRP we)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (DT this) (JJ preferential) (NNP CC) (NN localization)) (PP (IN within) (NP (DT the) (NNS lesions)))) (VP (VBZ is) (VP (VBN caused) (PP (IN by) (NP (DT an) (VBN increased) (NNP CC) (NN uptake))) (ADVP (RB shortly)) (PP (IN after) (NP (NN injection))) (PP (IN in) (NP (JJ apparent) (JJ vulnerable) (NNS areas))) (SBAR (WHADVP (WRB where)) (S (NP (NNS Doc_3990093_1141_1150_Disease)) (VP (MD will) (VP (VB develop) (ADVP (RB subsequently))))))))))) (. .)))
3990093	9	(ROOT (S (NP (JJ Cluster) (NN analysis)) (VP (VBD showed) (NP (NP (DT a) (JJ random) (NN distribution)) (PP (IN of) (NP (NP (NNS lesions)) (PP (IN in) (NP (NP (DT the) (JJ Doc_3990093_1242_1245_Chemical) (NN glomeruli)) (PP (IN in) (NP (NN concordance)))))))) (PP (IN with) (NP (NP (DT the) (JJ random) (NN localization)) (PP (IN of) (NP (JJ mesangial) (NNS areas))))) (PP (IN with) (NP (NP (NN dysfunction)) (PP (IN in) (NP (DT this) (NN model)))))) (. .)))
3990093	10	(ROOT (S (PP (VBG Similar) (PP (TO to) (NP (NP (DT the) (JJ remnant) (NN kidney) (NN model)) (PP (IN in) (NP (JJ Doc_3990093_1390_1393_Chemical) (NNS Doc_3990093_1394_1403_Disease)))))) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_3990093_1423_1443_Disease)))) (VP (MD may) (VP (VB be) (VP (VBN related) (PP (TO to) (`` ``) (NP (JJ mesangial) (NN overloading)))))) (. .) ('' '')))
4010471	0	(ROOT (S (VP (VB Relationship) (PP (IN between) (NP (NP (NN Doc_4010471_21_29_Chemical-induced) (NNS Doc_4010471_38_46_Disease)) (CC and) (NP (JJ hippocampal) (JJ nicotinic) (NNS receptors))))) (. .)))
4010471	1	(ROOT (S (NP (DT A) (NN controversy)) (VP (VBZ has) (VP (VBN existed) (PP (IN for) (NP (NP (JJ several) (NNS years)) (PP (VBG concerning) (NP (NP (DT the) (JJ physiological) (NN relevance)) (PP (IN of) (NP (NP (DT the) (JJ nicotinic) (NN receptor)) (VP (VBN measured) (PP (IN by) (NP (JJ Doc_4010471_205_223_Chemical) (VBG binding)))))))))))) (. .)))
4010471	2	(ROOT (S (S (VP (VBG Using) (NP (NP (NNS mice)) (VP (VBN derived) (PP (IN from) (NP (NP (DT a) (JJ classical) (NN F2)) (CC and) (NP (JJ backcross) (JJ genetic) (NN design)))))))) (, ,) (NP (NP (DT a) (NN relationship)) (PP (IN between) (NP (NP (NN Doc_4010471_325_333_Chemical-induced) (NNS Doc_4010471_342_350_Disease)) (CC and) (NP (JJ alpha-bungarotoxin) (JJ nicotinic) (NN receptor) (NN concentration))))) (VP (VBD was) (VP (VBN found))) (. .)))
4010471	3	(ROOT (S (NP (NP (NNS Mice)) (ADJP (JJ sensitive) (PP (TO to) (NP (NP (DT the) (JJ convulsant) (NNS effects)) (PP (IN of) (NP (NNS Doc_4010471_462_470_Chemical))))))) (VP (VBD had) (NP (NP (JJR greater) (JJ alpha-bungarotoxin) (NNS binding)) (PP (IN in) (NP (DT the) (NNS hippocampus)))) (PP (IN than) (NP (JJ Doc_4010471_534_541_Disease) (JJ insensitive) (NNS mice)))) (. .)))
4010471	4	(ROOT (S (NP (NP (DT The) (VBG binding) (NNS sites)) (PP (IN from) (NP (JJ Doc_4010471_583_590_Disease) (ADJP (JJ sensitive) (CC and) (JJ resistant)) (NNS mice)))) (VP (VBD were) (ADVP (RB equally)) (VP (VBN affected) (PP (IN by) (NP (NN treatment))) (PP (IN with) (NP (NNS Doc_4010471_660_674_Chemical) (, ,) (NN trypsin) (CC or) (NN heat))))) (. .)))
4010471	5	(ROOT (S (ADVP (RB Thus)) (NP (PRP it)) (VP (VBZ appears) (SBAR (IN that) (S (NP (NP (DT the) (NN difference)) (PP (IN between) (NP (JJ Doc_4010471_737_744_Disease) (ADJP (JJ sensitive) (CC and) (JJ insensitive)) (NNS animals)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (NN difference)) (PP (IN in) (NP (JJ hippocampal) (JJ nicotinic) (NN receptor) (NN concentration)))))) (SBAR (IN as) (S (VP (VBN measured) (PP (IN with) (NP (JJ alpha-bungarotoxin) (VBG binding))))))))))) (. .)))
4082192	0	(ROOT (NP (NP (NP (DT The) (NN role)) (PP (IN of) (NP (NP (NNS Doc_4082192_12_25_Chemical)) (PP (IN in) (NP (NN Doc_4082192_29_42_Chemical-induced) (NN nephrotoxicity)))))) (: :) (NP (NP (NN effect)) (PP (IN of) (NP (NP (NP (NNS Doc_4082192_77_105_Chemical)) (PP (IN on) (NP (NNS Doc_4082192_109_122_Chemical)))) (CC and) (NP (NP (JJ Doc_4082192_127_140_Chemical) (NN nephrotoxicity) (CC and) (NN metabolism)) (PP (IN in) (NP (NNP Fischer) (CD 344) (NNS rats))))))) (. .)))
4082192	1	(ROOT (S (NP (NP (NNP Doc_4082192_192_205_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_4082192_207_211_Chemical)) (-RRB- -RRB-))) (VP (VBZ produces) (NP (NP (JJ proximal) (NNS Doc_4082192_231_247_Disease)) (PP (IN in) (NP (NNP Fischer) (NNP 344) (PRN (-LRB- -LRB-) (NP (NNP F344)) (-RRB- -RRB-)) (NNS rats))))) (. .)))
4082192	2	(ROOT (S (ADVP (RB Recently)) (, ,) (NP (NP (NNS Doc_4082192_286_299_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_4082192_301_304_Chemical)) (-RRB- -RRB-)) (, ,) (NP (DT a) (VBN known) (JJ potent) (NN nephrotoxicant)) (, ,)) (VP (VBD was) (VP (VBN identified) (PP (IN as) (NP (NP (DT a) (NN metabolite)) (PP (IN of) (NP (NP (NNS Doc_4082192_372_376_Chemical)) (PP (IN in) (NP (CD F344) (NNS rats))))))))) (. .)))
4082192	3	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (JJ Doc_4082192_437_440_Chemical) (NN formation)) (VP (VBZ is) (NP (NP (DT a) (JJ requisite) (NN step)) (PP (IN in) (NP (NN Doc_4082192_474_478_Chemical-induced) (NN nephrotoxicity))))))))))) (. .)))
4082192	4	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (NP (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NNS Doc_4082192_528_556_Chemical)))) (PRN (-LRB- -LRB-) (NP (NNP Doc_4082192_558_562_Chemical)) (-RRB- -RRB-)) (, ,) (NP (DT an) (JJ acylamidase) (NN inhibitor)) (, ,) (PP (IN on) (NP (NNS Doc_4082192_594_598_Chemical)))) (CC and) (NP (NP (JJ Doc_4082192_603_606_Chemical) (NN nephrotoxicity)) (CC and) (NP (NN metabolism)))) (VP (VBD was) (VP (VBN determined))) (. .)))
4082192	5	(ROOT (S (NP (NP (NNP BNPP)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (TO to) (CD 8) (CD mM))) (-RRB- -RRB-))) (VP (VBD reduced) (NP (JJ Doc_4082192_678_682_Chemical) (NN deacetylation) (CC and) (NN covalent)) (NP (NP (ADJP (JJ binding) (PP (IN in) (NP (NNP F344)))) (JJ renal) (JJ cortical) (NNS homogenates)) (PP (IN in) (NP (DT a) (JJ concentration-dependent) (NN manner))))) (. .)))
4082192	6	(ROOT (S (NP (NP (NNP Pretreatment)) (PP (IN of) (NP (NP (NNS animals)) (PP (IN with) (NP (NNP BNPP)))))) (ADVP (RB prior) (PP (TO to) (NP (NNS Doc_4082192_833_837_Chemical) (CC or) (NNS Doc_4082192_841_844_Chemical) (NN administration)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (JJ marked) (NN reduction)) (PP (IN of) (NP (NNP Doc_4082192_892_896_Chemical) (PRN (-LRB- -LRB-) (NP (CD 900) (NN mg/kg)) (-RRB- -RRB-)) (NN nephrotoxicity)))) (CONJP (CC but) (RB not)) (NP (JJ Doc_4082192_932_935_Chemical) (NN nephrotoxicity))))) (. .)))
4082192	7	(ROOT (S (NP (DT This) (NN result)) (VP (VBD was) (RB not) (ADJP (JJ due) (PP (TO to) (NP (NP (NP (VBN altered) (NN disposition)) (PP (IN of) (NP (DT either) (NNS Doc_4082192_1009_1013_Chemical)))) (CC or) (NP (NP (JJ acetylated) (NNS metabolites)) (PP (IN in) (NP (NP (NN plasma) (CC or) (JJ renal) (NN cortical)) (CC and) (NP (JJ hepatic) (NN tissue))))))))) (. .)))
4082192	8	(ROOT (S (ADVP (RB Rather)) (, ,) (NP (NNP BNPP) (NNP pretreatment)) (VP (VBD reduced) (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (NP (NNS Doc_4082192_1138_1142_Chemical)) (VP (VBN excreted) (PP (IN as) (NP (NNS Doc_4082192_1155_1158_Chemical))) (PP (IN by) (NP (NP (CD 64)) (CC and) (NP (CD 75) (NN %)))) (PP (IN after) (NP (NP (JJ Doc_4082192_1179_1183_Chemical) (NNS doses)) (PP (IN of) (NP (QP (CD 750) (CC and) (CD 900)) (NN mg/kg)))))))))) (. .)))
4082192	9	(ROOT (S (NP (NNP BNPP)) (VP (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (NP (DT the) (NN excretion)) (PP (IN of) (NP (NNS Doc_4082192_1248_1252_Chemical)))) (CC or) (NP (NP (DT any)) (PP (IN of) (NP (PRP$ its) (JJ non-deacetylated) (NNS metabolites))))))) (CC nor) (VP (VBD did) (S (NP (NNP BNPP)) (VP (VB alter) (NP (NP (NN excretion)) (PP (IN of) (NP (NP (NNS Doc_4082192_1328_1331_Chemical)) (CC or) (NP (PRP$ its) (NNS metabolites))))) (PP (IN after) (NP (NP (JJ Doc_4082192_1357_1360_Chemical) (NNS doses)) (PP (IN of) (NP (QP (CD 150) (CC and) (CD 300)) (NN mg/kg))))))))) (. .)))
4082192	10	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (JJ BNPP-induced) (NN reduction)) (PP (IN in) (NP (NN Doc_4082192_1430_1434_Chemical-induced) (NN nephrotoxicity)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ Doc_4082192_1493_1497_Chemical) (NN deacetylation)))))))))) (. .)))
4082192	11	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (NP (JJ Doc_4082192_1534_1537_Chemical) (NN formation)) (, ,) (PP (IN in) (NP (NN vivo))) (, ,)) (VP (VBZ accounts) (, ,) (ADVP (ADVP (IN at) (JJS least)) (PP (IN in) (NP (NN part)))) (, ,) (PP (IN for) (NP (NN Doc_4082192_1590_1594_Chemical-induced) (NNS Doc_4082192_1603_1625_Disease)))))))) (. .)))
4082466	0	(ROOT (NP (NP (JJ Doc_4082466_0_8_Chemical-induced) (NNS Doc_4082466_17_25_Disease)) (PP (IN in) (NP (JJ newborn) (NNS infants))) (. .)))
4082466	1	(ROOT (S (NP (CD Two) (NNS neonates)) (VP (VBD suffered) (PP (IN from) (NP (JJ generalized) (NNS Doc_4082466_85_93_Disease))) (PP (IN during) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (NP (JJ intravenous) (NNS Doc_4082466_127_143_Chemical)) (PP (IN for) (NP (JJ post-operative) (NNS Doc_4082466_163_172_Disease)))))))) (. .)))
4082466	2	(ROOT (S (NP (PRP They)) (VP (VBD received) (S (NP (NP (NNS Doc_4082466_188_196_Chemical)) (PP (IN in) (NP (NP (NNS doses)) (PP (IN of) (NP (NP (CD 32) (NN micrograms/kg/hr)) (CC and) (NP (CD 40) (NN micrograms/kg/hr))))))) (ADJP (JJR larger) (PP (IN than) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (CD 10) (NNS neonates)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD received) (NP (CD 6-24) (NN micrograms/kg/hr))) (CC and) (VP (VBD had) (NP (DT no) (NNS Doc_4082466_334_342_Disease))))))))))))) (. .)))
4082466	3	(ROOT (S (NP (NP (NNP Plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NNS Doc_4082466_369_377_Chemical)) (PP (IN in) (NP (DT these) (NNS neonates)))))) (VP (VBD was) (ADJP (JJ excessive)) (PRN (-LRB- -LRB-) (NP (NP (CD 60)) (CC and) (NP (CD 90) (NN mg/ml))) (-RRB- -RRB-))) (. .)))
4082466	4	(ROOT (S (S (NP (NP (JJ Other) (JJ known) (NNS reasons)) (PP (IN for) (NP (NNS Doc_4082466_453_461_Disease)))) (VP (VBD were) (VP (VBN ruled) (PRT (RP out))))) (CC and) (S (NP (DT the) (NNS Doc_4082466_485_496_Disease)) (VP (VP (VBD stopped) (NP (DT a) (JJ few) (NNS hours)) (PP (IN after) (NP (NP (NN cessation)) (PP (IN of) (NP (NNS Doc_4082466_536_544_Chemical)))))) (CC and) (VP (VBD did) (RB not) (VP (VB reoccur) (PP (IN in) (NP (DT the) (JJ subsequent) (CD 8) (NNS months))))))) (. .)))
4082466	5	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN suggested) (SBAR (IN that) (S (NP (JJ post-operative) (JJ intravenous) (NNS Doc_4082466_641_649_Chemical)) (VP (MD should) (RB not) (VP (VB exceed) (NP (NP (CD 20) (NN micrograms/kg/ml)) (PP (IN in) (NP (NNS neonates)))))))))) (. .)))
439781	0	(ROOT (S (NP (NP (NNP Doc_439781_0_12_Chemical) (NNP induced) (NNP Doc_439781_21_32_Disease)) (PP (IN in) (NP (NNS Doc_439781_36_42_Chemical) (CC and) (NN volume)))) (VP (VBD depleted) (NP (NNS rats))) (. .)))
439781	1	(ROOT (S (PP (IN After) (NP (NP (DT a) (JJ single) (JJ oral) (NN dose)) (PP (IN of) (NP (NP (NP (CD 4) (JJ mg/kg) (NNS Doc_439781_105_117_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP IDM)) (-RRB- -RRB-))) (PP (TO to) (NP (NNS Doc_439781_127_133_Chemical) (CC and) (NN volume))) (VP (VBN depleted) (NP (NNS rats))))))) (NP (NP (NP (NN plasma) (NN renin) (NN activity)) (PRN (-LRB- -LRB-) (NP (NNP PRA)) (-RRB- -RRB-))) (CC and) (NP (JJ systolic) (NN blood) (NN pressure))) (VP (VBD fell) (ADVP (RB significantly)) (PP (IN within) (NP (CD four) (NNS hours)))) (. .)))
439781	2	(ROOT (S (PP (IN In) (NP (JJ Doc_439781_256_262_Chemical) (JJ repleted) (NNS animals))) (NP (NNS Doc_439781_280_292_Chemical)) (VP (VBD did) (RB not) (VP (VB change) (NP (NP (JJ systolic) (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP BP)) (-RRB- -RRB-))) (SBAR (IN although) (S (NP (NN plasma) (NN renin) (NN activity)) (VP (VBD was) (VP (VBN decreased))))))) (. .)))
439781	3	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (NNS Doc_439781_389_401_Chemical)) (PP (IN by) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ Doc_439781_419_432_Chemical) (NN synthesis)))))) (VP (MD may) (VP (VB diminish) (NP (NP (DT the) (NN blood) (NN pressure)) (VP (VBG maintaining) (NP (NP (NN effect)) (PP (IN of) (NP (NP (DT the) (JJ stimulated) (JJ renin-Doc_439781_518_529_Chemical) (NN system)) (PP (IN in) (NP (NNS Doc_439781_540_546_Chemical) (CC and) (NN volume) (NN depletion)))))))))) (. .)))
44072	0	(ROOT (FRAG (PP (IN On) (NP (NP (DT the) (JJ antiarrhythmic) (NN activity)) (PP (IN of) (NP (NP (CD one) (NNS Doc_44072_38_62_Chemical) (JJ derivative)) (PP (IN of) (NP (NNS Doc_44072_77_134_Chemical))))))) (. .)))
44072	1	(ROOT (S (NP (NP (DT The) (JJ antiarrhythmic) (NN activity)) (PP (IN of) (NP (DT the) (JJ compound) (NNS Doc_44072_180_288_Chemical))) (, ,) (VP (VBN referred) (PP (TO to) (NP (QP (RB as) (CD P11))))) (, ,)) (VP (VBZ is) (VP (VBN studied) (PP (PP (IN on) (NP (NP (JJ anaesthesized) (NNS cats)) (CC and) (NP (NNP Wistar) (NN albino) (NNS rats)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN on) (NP (JJ non-anaesthesized) (NNS rabbits)))))) (. .)))
44072	2	(ROOT (S (NP (NP (CD Four) (NNS types)) (PP (IN of) (NP (JJ experimental) (NNS Doc_44072_435_445_Disease)))) (VP (VBP are) (VP (VBN used) (: --) (PP (PP (IN with) (NP (NNS Doc_44072_461_466_Chemical))) (, ,) (PP (IN with) (NP (NNS Doc_44072_473_483_Chemical-Doc_44072_484_494_Chemical))) (, ,) (PP (IN with) (NP (NNS Doc_44072_501_515_Chemical))) (CC and) (PP (IN with) (NP (NNS Doc_44072_525_534_Chemical)))))) (. .)))
44072	3	(ROOT (S (NP (DT The) (JJ compound) (NN P11)) (VP (VBZ is) (VP (VBN introduced) (PP (IN in) (NP (NP (NP (NNS doses)) (PP (IN of) (NP (CD 0.25)))) (CC and) (NP (NP (CD 0.50) (VBG mg/kg) (NN intravenously)) (CC and) (NP (CD 10) (VBG mg/kg) (NN orally))))))) (. .)))
44072	4	(ROOT (S (NP (DT The) (NN compound)) (VP (VBZ manifests) (NP (JJ antiarrhythmic) (NN activity)) (PP (IN in) (NP (NP (DT all) (NNS models)) (PP (IN of) (NP (NP (JJ experimental) (NNS Doc_44072_711_721_Disease)) (VP (VBN used)))))) (, ,) (S (VP (VBG causing) (NP (NP (JJS greatest) (NNS inhibition)) (PP (IN on) (NP (NP (DT the) (NNS Doc_44072_763_773_Disease)) (VP (VBN induced) (PP (PP (IN by) (NP (NP (NNS Doc_44072_785_795_Chemical-Doc_44072_796_806_Chemical)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (CD 90)) (PP (IN per) (NP (NN cent))))) (-RRB- -RRB-)))) (CC and) (PP (IN with) (NP (NP (NNS Doc_44072_833_838_Chemical)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (CD 84)) (PP (IN per) (NP (NN cent))))) (-RRB- -RRB-)))))))))))) (. .)))
44072	5	(ROOT (S (NP (NP (DT The) (NNS results)) (VP (VBN obtained))) (VP (VBP are) (VP (VBN associated) (PP (PP (IN with) (NP (DT the) (NN beta-adrenoblocking))) (CC and) (PP (IN with) (NP (NP (DT the) (JJ membrane-stabilizing) (NN action)) (PP (IN of) (NP (DT the) (NN compound)))))))) (. .)))
448423	0	(ROOT (S (NP (JJ Recurrent) (NNS Doc_448423_10_33_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_448423_50_67_Chemical) (NN therapy) (CC and) (NNS Doc_448423_80_109_Disease)))) (. .)))
448423	1	(ROOT (S (NP (NNP Case)) (VP (VBP report)) (. .)))
448423	2	(ROOT (S (NP (NP (NNP Doc_448423_124_149_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_448423_151_155_Chemical)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB prevent) (S (VP (VBG rebleeding) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_448423_210_233_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_448423_235_238_Disease)) (-RRB- -RRB-)))))))))))))) (. .)))
448423	3	(ROOT (S (SBAR (IN Although) (S (NP (DT this) (NN agent)) (VP (VBZ does) (VP (VB decrease) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NN rebleeding)))))))) (, ,) (NP (JJ several) (NNS reports)) (VP (VBP have) (VP (VBN described) (NP (NP (JJ Doc_448423_335_345_Disease) (NNS complications)) (PP (IN of) (NP (JJ Doc_448423_363_367_Chemical) (NN therapy)))))) (. .)))
448423	4	(ROOT (S (NP (DT These) (NNS complications)) (VP (VBP have) (VP (VBN included) (NP (NP (JJ clinical) (NN deterioration) (CC and) (NNS Doc_448423_438_470_Disease)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_448423_488_491_Disease) (, ,) (NN arteriolar) (CC and) (NN capillary) (NN fibrin) (NNS thrombi)))))) (PP (IN in) (NP (NNS patients))) (PP (IN with) (NP (NP (JJ fibrinolytic) (NNS syndromes)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_448423_586_590_Chemical)) (, ,) (CC or) (NP (JJ other) (JJ Doc_448423_601_615_Disease) (NNS phenomena))))))))) (. .)))
448423	5	(ROOT (S (SBAR (IN Since) (S (NP (NN intravascular) (NN fibrin) (NNS thrombi)) (VP (VBP are) (ADVP (RB often)) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_448423_698_720_Disease))))))))) (, ,) (NP (NNS Doc_448423_722_726_Chemical)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (NN fibrin) (NNS thrombi))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ disseminated) (NNS Doc_448423_820_845_Disease)) (CC or) (NP (JJ other) (`` ``) (NNS Doc_448423_856_882_Disease))))))))) (. .) ('' '')))
448423	6	(ROOT (S (NP (DT This) (NN report)) (VP (VBZ describes) (S (NP (JJ subtotal) (NNS Doc_448423_916_940_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NP (NNS Doc_448423_948_958_Disease)) (PP (IN of) (NP (DT a) (JJ normal) (JJ renal) (NN artery)))))))) (. .)))
448423	7	(ROOT (S (NP (DT This) (NN occlusion)) (VP (VBD occurred) (PP (IN after) (NP (JJ Doc_448423_1015_1019_Chemical) (NN therapy))) (PP (IN in) (NP (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NNS Doc_448423_1046_1049_Disease)))) (CC and) (NP (NP (JJ histopathological) (NN documentation)) (PP (IN of) (NP (JJ recurrent) (NNS Doc_448423_1099_1102_Disease))))))) (. .)))
448423	8	(ROOT (S (NP (DT The) (JJ corresponding) (JJ clinical) (NN event)) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (JJ marked) (NNS Doc_448423_1165_1177_Disease) (CC and) (NNS Doc_448423_1182_1215_Disease))))) (. .)))
4631913	0	(ROOT (NP (NP (NN Effect)) (PP (IN of) (NP (NNS Doc_4631913_10_29_Chemical))) (PP (IN on) (NP (NP (NNS Doc_4631913_33_55_Disease)) (PP (IN in) (NP (NNS monkeys))))) (. .)))
4631913	1	(ROOT (S (PP (IN In) (NP (JJ rhesus) (NNS monkeys))) (, ,) (SBAR (X (X (NP (NP (JJ intravenous) (NN challenge)) (PP (IN with) (NP (CD 0.6)))) (NP (SYM x)) (NP (NP (NP (CD 10)) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-))) (PP (TO to) (NP (CD 2.2))))) (NP (SYM x))) (S (NP (NP (CD 10)) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-)) (NNS Doc_4631913_142_174_Disease)) (VP (VBD caused) (NP (NP (NP (JJ acute) (NN illness)) (PP (IN of) (NP (QP (CD 4) (TO to) (CD 5)) (NNS days))) (POS ')) (NN duration)) (PP (IN with) (NP (JJ spontaneous) (NN recovery))) (PP (IN in) (NP (NP (CD 13)) (PP (IN of) (NP (CD 15) (NNS monkeys)))))))) (: ;) (NP (NN blood) (NNS cultures)) (VP (VBD became) (NP (QP (JJ negative) (CD 3) (TO to) (CD 17)) (NNS days)) (PP (IN after) (NP (NN challenge)))) (. .)))
4631913	2	(ROOT (S (NP (NNP Doc_4631913_329_341_Disease)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (DT all) (NNS monkeys))))) (. .)))
4631913	3	(ROOT (S (NP (NP (NNS Intravenous)) (CC or) (NP (NP (JJ intratracheal) (NN inoculation)) (PP (IN of) (NP (NP (QP (CD 2.0) (TO to) (CD 2.5)) (NN mg)) (PP (IN of) (NP (NNS Doc_4631913_432_451_Chemical))))))) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (NNS Doc_4631913_468_478_Disease)) (PP (IN in) (NP (QP (CD 4) (TO to) (CD 5)) (NNS days))))))) (. .)))
4631913	4	(ROOT (S (X (X (NP (NP (JJ Intravenous) (NN inoculation)) (PP (IN of) (NP (CD 4.2)))) (NP (SYM x)) (NP (NP (NP (CD 10)) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-))) (PP (TO to) (NP (CD 7.8))))) (NP (SYM x))) (NP (NP (CD 10)) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-)) (NNS Doc_4631913_551_557_Chemical)) (VP (VBZ type) (NP (CD 6) (NNP Pseudomonas) (NNS organisms)) (PP (IN in) (NP (NP (NNS monkeys)) (VP (VBN given) (NP (NNS Doc_4631913_604_623_Chemical)) (NP (NP (CD 4) (NNS days)) (VP (ADVP (RB previously)) (VBN resulted) (PP (IN in) (NP (NP (JJ fatal) (NNS Doc_4631913_660_669_Disease)) (PP (IN in) (NP (NP (CD 11)) (PP (IN of) (NP (CD 14) (NNS monkeys))))))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN none)) (PP (IN of) (NP (CD four) (NN receiving) (NNS Pseudomonas)))) (ADVP (RB alone)) (VP (VBD died)))))))))) (. .)))
4631913	5	(ROOT (S (NP (DT These) (NNS studies)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (DT an) (NN Doc_4631913_776_790_Chemical-induced) (NNS Doc_4631913_799_809_Disease)) (VP (VBZ predisposes) (PP (TO to) (NP (JJ severe) (NNS Doc_4631913_832_850_Disease)))))) (CC and) (SBAR (IN that) (S (NP (JJ such) (NNS monkeys)) (VP (MD may) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (JJ biological) (NN model)) (PP (IN for) (NP (NP (NN study)) (PP (IN of) (NP (NP (JJ comparative) (NN efficacy)) (PP (IN of) (NP (JJ antimicrobial) (NNS agents))))))))))))))) (. .)))
48835	0	(ROOT (S (VP (VBN Modification) (PP (IN by) (NP (NP (NNS Doc_48835_16_27_Chemical)) (PP (IN of) (NP (NP (JJ cardiovascular) (NNS effects)) (PP (IN of) (NP (JJ induced) (NN hypoglycaemia)))))))) (. .)))
48835	1	(ROOT (S (NP (NP (DT The) (JJ cardiovascular) (NNS effects)) (PP (IN of) (NP (NN hypoglycaemia))) (, ,) (PP (IN with) (CC and) (IN without) (NP (NN beta-blockade))) (, ,)) (VP (VBD were) (VP (VBN compared) (PP (IN in) (NP (CD fourteen) (JJ healthy) (NNS men))))) (. .)))
48835	2	(ROOT (S (S (NP (CD Eight)) (VP (VBD received) (NP (NN insulin)) (ADVP (RB alone)))) (, ,) (CC and) (S (NP (NP (CD eight)) (, ,) (PP (VBG including) (NP (NP (CD two)) (PP (IN of) (NP (DT the) (JJ original) (JJ insulin-only) (NN group))))) (, ,)) (VP (VBD were) (VP (VBN given) (NP (NNS Doc_48835_298_309_Chemical) (CC and) (NN insulin))))) (. .)))
48835	3	(ROOT (S (PP (IN In) (NP (DT the) (NN insulin-group))) (NP (NP (DT the) (NN period)) (PP (IN of) (NP (NN hypoglycaemia)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN heart-rate)))) (CC and) (NP (NP (DT a) (NN fall)) (PP (IN in) (NP (JJ diastolic) (NN blood-pressure)))))))) (. .)))
48835	4	(ROOT (S (PP (IN In) (NP (DT the) (NN Doc_48835_465_476_Chemical-insulin) (NN group))) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN fall)) (PP (IN in) (NP (NP (NP (NN heart-rate)) (PP (IN in) (NP (JJS most) (NNS subjects)))) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ diastolic) (NN pressure)))))))) (. .)))
48835	5	(ROOT (S (NP (JJ Typical) (NN S-T/T) (NNS changes)) (VP (VBD occurred) (PP (IN in) (NP (DT the) (NN insulin-group))) (PP (CC but) (IN in) (NP (NP (NN none)) (PP (IN of) (NP (DT the) (NN Doc_48835_661_672_Chemical-insulin) (NN group)))))) (. .)))
48835	6	(ROOT (S (NP (NP (NNP Doc_48835_688_700_Disease)) (PP (IN in) (NP (NP (NNS diabetics)) (ADJP (JJ prone) (PP (TO to) (NP (NN hypoglycaemia) (NNS attacks))))))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN treated) (PP (IN with) (NP (NNS beta-blockers))) (SBAR (IN because) (S (NP (DT these) (NNS drugs)) (VP (MD may) (VP (VB cause) (NP (DT a) (JJ sharp) (NN rise)) (PP (IN in) (NP (NP (NN blood-pressure)) (PP (IN in) (NP (JJ such) (NNS patients)))))))))))) (. .)))
573555	0	(ROOT (NP (NP (NP (JJ Long-term) (JJ Doc_573555_10_21_Chemical) (NN therapy)) (PP (IN in) (NP (NN pregnancy)))) (: :) (NP (NP (NN maternal)) (CC and) (NP (JJ fetal) (NN outcome))) (. .)))
573555	1	(ROOT (S (NP (NP (NNP Doc_573555_72_83_Chemical)) (, ,) (NP (DT a) (JJ beta-adrenergic) (JJ blocking) (NN agent)) (, ,)) (VP (VBZ has) (VP (VBN found) (NP (DT an) (JJ important) (NN position)) (PP (IN in) (NP (NP (DT the) (NN practice)) (PP (IN of) (NP (NN medicine))))))) (. .)))
573555	2	(ROOT (S (NP (NP (PRP$ Its) (NN use)) (PP (IN in) (NP (NN pregnancy)))) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ is) (NP (DT an) (JJ open) (NN question)) (SBAR (IN as) (S (NP (NP (DT a) (NN number)) (PP (IN of) (NP (JJ detrimental) (NN side) (NNS effects)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (DT the) (NN fetus) (CC and) (NN neonate))))))))) (. .)))
573555	3	(ROOT (S (NP (NP (CD Ten) (NNS patients)) (CC and) (NP (CD 12) (NNS pregnancies))) (VP (VBP are) (VP (VBN reported) (SBAR (WHADVP (WRB where)) (S (NP (JJ chronic) (NNS Doc_573555_375_386_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN administered)))))))) (. .)))
573555	4	(ROOT (S (NP (NP (CD Five) (NNS patients)) (PP (IN with) (NP (NP (JJ serial) (NNS pregnancies)) (PP (IN with) (CC and) (IN without) (NP (JJ Doc_573555_465_476_Chemical) (NN therapy)))))) (VP (VBP are) (ADVP (RB also)) (VP (VBN examined))) (. .)))
573555	5	(ROOT (S (NP (JJ Maternal) (, ,) (NN fetal) (, ,) (CC and) (NN neonatal) (NNS complications)) (VP (VBP are) (VP (VBN examined))) (. .)))
573555	6	(ROOT (S (NP (DT An) (NN attempt)) (VP (VBZ is) (VP (VBN made) (S (VP (TO to) (VP (VB differentiate) (NP (JJ drug-related) (NNS complications)) (PP (IN from) (NP (NP (JJ maternal) (NN disease)) (: --) (NP (JJ related) (NNS complications))))))))) (. .)))
573555	7	(ROOT (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (ADVP (RB previously)) (VP (VBD reported) (NP (NNS Doc_573555_708_720_Disease) (, ,) (NNS Doc_573555_722_740_Disease) (, ,) (NNS Doc_573555_742_754_Disease) (, ,) (JJ neonatal) (NNS Doc_573555_765_770_Disease))))))) (, ,) (CC and) (S (NP (NNS Doc_573555_776_787_Disease)) (VP (VP (VBP are) (RB not) (ADJP (JJ invariable))) (CC and) (VP (MD can) (RB not) (VP (VB be) (ADJP (RB statistically) (JJ correlated) (PP (IN with) (NP (JJ chronic) (JJ Doc_573555_859_870_Chemical) (NN therapy)))))))) (. .)))
573555	8	(ROOT (S (NP (NNP Doc_573555_880_898_Disease)) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ significant) (PP (IN in) (NP (NP (DT both)) (PP (IN of) (NP (PRP$ our) (NN series)))))))))) (. .)))
6106951	0	(ROOT (S (NP (NNP Central)) (VP (VBP excitatory) (NP (NP (NNS actions)) (PP (IN of) (NP (NNS Doc_6106951_30_40_Chemical))))) (. .)))
6106951	1	(ROOT (S (NP (NP (JJ Toxic) (NNS actions)) (PP (IN of) (NP (NP (NNS Doc_6106951_59_69_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP FZP)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (NNS cats) (, ,) (NNS mice) (CC and) (NNS rats))))) (. .)))
6106951	2	(ROOT (S (NP (JJ High) (NNS doses)) (VP (VBD caused) (SBAR (S (NP (NP (DT an) (JJ apparent) (JJ central) (NN excitation)) (, ,) (VP (ADVP (RBS most) (RB clearly)) (VBN seen) (PP (IN as) (NP (JJ clonic) (NNS Doc_6106951_191_202_Disease)))) (, ,)) (VP (VBN superimposed) (PP (IN on) (NP (JJ general) (NNS Doc_6106951_228_238_Disease))))))) (. .)))
6106951	3	(ROOT (S (PP (VBG Following) (NP (DT a) (JJ lethal) (NN dose))) (, ,) (NP (NNS Doc_6106951_265_270_Disease)) (VP (VBD was) (ADVP (RB always)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_6106951_298_309_Disease))))) (. .)))
6106951	4	(ROOT (S (S (VP (VBG Comparing) (NP (DT the) (JJ relative) (NN sensitivity)) (PP (TO to) (NP (JJ central) (NNS Doc_6106951_357_367_Disease) (CC and) (NN excitation))))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NNS rats)) (VP (VBD were) (ADJP (RBS least) (JJ likely) (S (VP (TO to) (VP (VB have) (NP (NNS Doc_6106951_428_439_Disease)) (PP (IN at) (NP (NP (NNS doses)) (SBAR (WHNP (WDT that)) (S (VP (VBD did) (RB not) (ADVP (RB first)) (VP (VB cause) (NP (NNS Doc_6106951_474_495_Disease)))))))) (, ,) (SBAR (IN while) (S (NP (NNS cats)) (ADVP (RBS most) (RB clearly)) (VP (VBD showed) (NP (JJ marked) (JJ central) (NN excitatory) (NNS actions))))))))))))) (. .)))
6106951	5	(ROOT (S (NP (NP (NNS Signs)) (PP (IN of) (NP (NP (NNP FZP) (NN toxocity)) (PP (IN in) (NP (NNS cats)))))) (VP (VBD included) (NP (NP (NNS Doc_6106951_602_622_Disease)) (, ,) (NP (JJ extreme) (NNS Doc_6106951_632_653_Disease)) (, ,) (NP (NN retching)) (, ,) (NP (NN muscle) (NNS Doc_6106951_672_679_Disease)) (CC and) (NP (NNS Doc_6106951_684_695_Disease)))) (. .)))
6106951	6	(ROOT (S (NP (NP (NP (DT An) (NN interaction)) (PP (IN between) (NP (NNP FZP) (CC and) (NNP Doc_6106951_728_745_Chemical)))) (PRN (-LRB- -LRB-) (NP (NNP Doc_6106951_747_750_Chemical)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN shown) (PP (IN by) (S (VP (VBG pretreating) (NP (NNS mice)) (PP (IN with) (NP (NNP FZP))) (PP (IN before) (NP (JJ Doc_6106951_798_801_Chemical) (NN challenge)))))))) (. .)))
6106951	7	(ROOT (S (PP (IN As) (NP (NP (DT a) (NN function)) (PP (IN of) (NP (NN dose))))) (, ,) (NP (NNP FZP)) (ADVP (RB first)) (VP (VBN protected) (PP (IN against) (NP (NNS Doc_6106951_864_875_Disease) (CC and) (NNS Doc_6106951_880_885_Disease)))) (. .)))
6106951	8	(ROOT (S (PP (IN At) (NP (JJR higher) (NNS doses))) (, ,) (ADVP (RB however)) (, ,) (NP (NNS Doc_6106951_913_924_Disease)) (ADVP (RB again)) (VP (VBD emerged)) (. .)))
6106951	9	(ROOT (S (NP (NP (DT These) (NNS doses)) (PP (IN of) (NP (NNP FZP)))) (VP (VBD were) (ADJP (JJR lower)) (PP (IN than) (NP (NP (DT those)) (SBAR (WHNP (WDT that)) (S (VP (MD would) (ADVP (RB alone)) (VP (VB cause) (NP (NNS Doc_6106951_1004_1015_Disease))))))))) (. .)))
6106951	10	(ROOT (S (NP (DT These) (NNS results)) (VP (MD may) (VP (VB be) (ADJP (JJ relevant) (PP (TO to) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNP FZP)))))) (PP (IN in) (NP (NP (JJ clinical) (NNS situations)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (EX there)) (VP (VBZ is) (NP (NP (VBN increased) (JJ neural) (NN excitability)) (, ,) (PP (JJ such) (IN as) (NP (NP (NNS Doc_6106951_1145_1153_Disease)) (CC or) (NP (JJ sedative-hypnotic) (NN drug) (NN withdrawal)))))))))))) (. .)))
611664	0	(ROOT (S (VP (VB Use) (PP (IN of) (NP (NP (NNS Doc_611664_7_18_Chemical)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_611664_39_73_Disease)))))))) (. .)))
611664	1	(ROOT (S (NP (NP (CD Five) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_611664_94_128_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (ADJP (JJ physiologic) (CC and) (JJ biochemical)) (NN evidence)) (PP (IN of) (NP (JJ severe) (NNS Doc_611664_184_205_Disease)))))))))) (VP (VBD were) (VP (VBN included) (PP (IN in) (NP (DT the) (NN study))))) (. .)))
611664	2	(ROOT (S (NP (PRP They)) (ADVP (NP (DT all) (NN exhibited)) (RB markedly)) (VP (VP (VBD reduced) (NP (NP (NN plasma) (NNS Doc_611664_277_291_Chemical)) (CC and) (NP (NN plasma) (NN renin) (NN activity))) (PP (IN in) (NP (DT both) (NN recumbent) (CC and) (NN upright) (NNS positions)))) (CC and) (VP (VBD had) (NP (JJ marked) (NNS Doc_611664_373_389_Disease)) (PP (TO to) (NP (NP (DT the) (NN pressor) (NNS effects)) (PP (IN of) (NP (JJ infused) (NNS Doc_611664_424_438_Chemical))))))) (. .)))
611664	3	(ROOT (S (NP (NP (NP (NNP Treatment)) (PP (IN with) (NP (NP (NNS Doc_611664_455_465_Chemical)) (VP (VBN administered) (ADVP (RB intravenously)))))) (PRN (-LRB- -LRB-) (NP (CD 1-5) (NNS mg)) (-RRB- -RRB-))) (VP (VBD produced) (NP (NNS Doc_611664_511_557_Disease)) (PP (IN in) (NP (NP (CD 4)) (PP (IN of) (NP (DT the) (CD 5) (NNS individuals))))) (PP (IN with) (NP (NP (NNS rises)) (VP (VBG ranging) (PP (IN from) (NP (QP (CD 11/6) (TO to) (CD 22/11)) (NN mmHg))))))) (. .)))
611664	4	(ROOT (S (NP (NP (JJ Chronic) (JJ oral) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_611664_659_670_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 40-160) (NN mg/day)) (-RRB- -RRB-))))) (ADVP (RB also)) (VP (VBD elevated) (SBAR (S (NP (NP (DT the) (NN blood) (NNS pressures)) (PP (IN of) (NP (NP (DT these) (NNS individuals)) (PP (IN with) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (DT the) (NN order)) (PP (IN of) (NP (CD 20-35/15) (CD -25)))))))))) (VP (VBP mmg) (S (VP (VBG being) (ADJP (JJ observed)))))))) (. .)))
611664	5	(ROOT (S (PP (IN In) (NP (CD 1) (NN patient))) (, ,) (S (NP (JJ marked) (NNS Doc_611664_826_838_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_611664_854_865_Chemical)))))) (CC and) (S (NP (DT the) (NN drug)) (VP (VBD had) (S (VP (TO to) (VP (VB be) (VP (VBN withdrawn))))))) (. .)))
611664	6	(ROOT (S (S (NP (PRP It)) (ADVP (RB otherwise)) (VP (VBD was) (ADJP (RB well) (JJ tolerated)))) (CC and) (S (NP (DT no) (JJ important) (NN side) (NNS effects)) (VP (VBD were) (ADJP (JJ observed)))) (. .)))
611664	7	(ROOT (S (NP (NNP Treatment)) (VP (VBZ has) (VP (VBN been) (VP (VBN continued) (PP (IN in) (NP (NP (CD 3) (NNS individuals)) (PP (IN for) (NP (CD 6-13) (NNS months))))) (PP (IN with) (NP (NP (NN persistence)) (PP (IN of) (NP (DT the) (NN pressor) (NN effect))))) (, ,) (SBAR (IN although) (S (NP (EX there)) (VP (VBZ appears) (S (VP (TO to) (VP (VB have) (VP (VBN been) (NP (NP (DT some) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NN response)))))) (PP (IN with) (NP (NN time))))))))))))) (. .)))
611664	8	(ROOT (S (NP (NP (JJ Hemodynamic) (NNS measurements)) (PP (IN in) (NP (NP (CD 1)) (PP (IN of) (NP (DT the) (NNS patients)))))) (VP (VBD demonstrated) (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ total) (JJ peripheral) (NN resistance)) (CC and) (NP (RB essentially) (DT no) (NN change)))) (PP (IN in) (NP (NP (JJ cardiac) (NN output)) (PP (VBG following) (NP (JJ Doc_611664_1322_1333_Chemical) (NN therapy)))))) (. .)))
611664	9	(ROOT (S (NP (DT The) (NNS studies)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_611664_1368_1379_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ useful) (NN drug)) (PP (IN in) (NP (NP (VBN selected) (NNS patients)) (PP (IN with) (NP (JJ severe) (NNS Doc_611664_1430_1464_Disease)))))))))) (. .)))
612112	0	(ROOT (NP (NP (JJ Total) (JJ intravenous) (NN anesthesia)) (PP (IN with) (NP (NNS Doc_612112_34_43_Chemical))) (. .)))
612112	1	(ROOT (FRAG (NP (NNP III)) (. .)))
612112	2	(ROOT (NP (NP (DT Some) (NNS observations)) (PP (IN in) (NP (NNS adults))) (. .)))
612112	3	(ROOT (S (NP (DT An) (NN investigation)) (VP (VBD was) (VP (VBN undertaken) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (NP (NNS Doc_612112_138_147_Chemical)) (VP (VBN required) (S (VP (TO to) (VP (VB maintain) (NP (NN sleep)) (PP (IN in) (NP (NP (NNS adults)) (VP (VBG undergoing) (NP (NN surgery)) (PP (IN under) (NP (JJ regional) (JJ local) (NN anesthesia)))))))))))))))))) (. .)))
612112	4	(ROOT (S (S (NP (NP (NNP Premedication)) (PP (IN of) (NP (NN Doc_612112_254_262_Chemical) (CD 10) (NN mg) (CC and) (JJ Doc_612112_273_281_Chemical) (CD 0.5) (NN mg)))) (VP (VBD was) (VP (VBN given)))) (, ,) (CC and) (S (NP (NN sleep)) (VP (VBD was) (VP (VBN induced) (CC and) (VBN maintained) (PP (IN by) (NP (NP (JJ intermittent) (JJ intravenous) (NNS injections)) (PP (IN of) (NP (NN Doc_612112_379_388_Chemical) (CD 0.1) (NN /) (NN mg/kg))))) (, ,) (PP (VBN given) (SBAR (WHADVP (WRB whenever)) (S (NP (DT the) (NN patient)) (VP (MD would) (VP (VB open) (NP (PRP$ his) (NNS eyes)) (PP (IN on) (NP (NN request))))))))))) (. .)))
612112	5	(ROOT (S (S (NP (NP (DT A) (JJ mean) (JJ overall) (NN dose)) (PP (IN of) (NP (NNP Doc_612112_482_491_Chemical) (NNP 17.4) (NNP microgram/kg/min) (. .)))) (VP (VBD was) (VP (VBN required) (S (VP (TO to) (VP (VB maintain) (NP (NN sleep)))))))) (, ,) (CC but) (S (NP (JJ great) (JJ individual) (NN variation)) (VP (VBD occurred) (, ,) (PP (IN with) (NP (NP (JJR older) (NNS patients)) (VP (VBG requiring) (NP (JJR less) (NN drug))))))) (. .)))
612112	6	(ROOT (S (NP (DT The) (NN investigation)) (VP (VBD was) (VP (VBN discontinued) (PP (IN after) (NP (NP (CD 18) (NNS patients)) (PP (RB because) (IN of) (NP (NP (DT the) (NN frequency) (CC and) (NN intensity)) (PP (IN of) (NP (NP (NNS side-effects)) (, ,) (NP (RB particularly) (NNS Doc_612112_751_755_Disease)) (CC and) (NP (NN myoclonia)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD caused) (NP (DT the) (NN technique) (S (VP (TO to) (VP (VB be) (VP (VBN abandoned) (PP (IN in) (NP (CD two) (NNS cases))))))))))))))) (. .)))
612112	7	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN considered) (ADJP (JJ unlikely)) (SBAR (IN that) (S (NP (NNS Doc_612112_859_868_Chemical)) (VP (MD will) (VP (VB prove) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (NN hypnotic)) (PP (IN of) (NP (NP (NN choice)) (PP (IN for) (NP (NP (DT a) (RB totally) (JJ intravenous) (JJ anesthetic) (NN technique)) (PP (IN in) (NP (NP (NNS adults)) (PP (RB because) (IN of) (NP (NP (DT the) (JJ high) (NN incidence)) (PP (IN of) (NP (NN myoclonia))))))))))))))) (PP (IN after) (NP (VBN prolonged) (NN administration))))))))) (. .)))
612112	8	(ROOT (S (PP (IN In) (NP (JJ several) (NNS patients))) (NP (JJ uncontrollable) (NN muscle) (NNS movements)) (VP (VBD persisted) (PP (IN for) (NP (JJ many) (NNS minutes))) (PP (IN after) (NP (NP (JJ complete) (NN recovery)) (PP (IN of) (NP (NN consciousness)))))) (. .)))
6299641	0	(ROOT (NP (NP (NN Evidence)) (PP (IN for) (NP (JJ cardiac) (JJ beta) (NN 2-adrenoceptors))) (PP (IN in) (NP (NN man))) (. .)))
6299641	1	(ROOT (S (NP (PRP We)) (VP (VBD compared) (NP (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NP (JJ single) (NNS doses)) (PP (IN of) (NP (CD 50) (NN mg) (NNS Doc_6299641_99_107_Chemical)))) (PRN (-LRB- -LRB-) (NP (NN cardioselective)) (-RRB- -RRB-)) (, ,) (NP (NP (CD 40) (NN mg) (NNS Doc_6299641_133_144_Chemical)) (PRN (-LRB- -LRB-) (NP (NN nonselective)) (-RRB- -RRB-))) (, ,)))) (CC and) (NP (NP (NN placebo)) (PP (IN on) (NP (DT both) (NN exercise)))) (: -) (CC and) (NP (NP (NN Doc_6299641_195_208_Chemical-induced) (NNS Doc_6299641_217_228_Disease)) (PP (IN in) (NP (CD two) (NNS experiments))))) (S (VP (VBG involving) (NP (CD nine) (JJ normal) (NNS subjects))))) (. .)))
6299641	2	(ROOT (S (S (NP (JJ Maximal) (NN exercise) (NN heart) (NN rate)) (VP (VBD was) (VP (VBN reduced) (PP (IN from) (NP (NP (NP (NP (QP (CD 187) (CD +)) (NNS /)) (PRN (: -) (NP (NP (NP (CD 4)) (PRN (-LRB- -LRB-) (NP (NNP SEM)) (-RRB- -RRB-))) (PP (IN after) (NP (QP (CD placebo) (TO to) (CD 146)) (NNS +)))) (: /))) (PRN (: -) (NP (NP (CD 7) (NN bpm)) (PP (IN after) (NP (NP (NNS Doc_6299641_377_385_Chemical)) (CC and) (NP (CD 138) (NNS +))))) (: /))) (: -) (NP (NP (CD 6) (NN bpm)) (PP (IN after) (NP (NNS Doc_6299641_410_421_Chemical))))))))) (, ,) (CC but) (S (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (NNS differences)) (PP (IN between) (NP (DT the) (NNS drugs)))))) (. .)))
6299641	3	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN on) (NP (JJ Doc_6299641_487_500_Chemical) (NNS Doc_6299641_501_512_Disease)))) (VP (VBD were) (VP (VBN determined) (PP (IN before) (CC and) (IN after) (NP (NP (NNS Doc_6299641_546_554_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.04) (NN mg/kg) (NN IV)) (-RRB- -RRB-)))))) (. .)))
6299641	4	(ROOT (S (S (NP (NNP Doc_6299641_572_585_Chemical) (NNP sensitivity)) (VP (VBD was) (VP (VBN determined) (PP (IN as) (NP (NP (DT the) (JJ intravenous) (NN dose)) (SBAR (WHNP (WDT that)) (S (VP (VBD increased) (NP (NN heart) (NN rate)) (PP (IN by) (NP (NP (CD 25) (NN bpm)) (PRN (-LRB- -LRB-) (NP (NNP CD25)) (-RRB- -RRB-)))))))))))) (CC and) (S (NP (DT this)) (VP (VBD was) (VP (VBN increased) (PP (IN from) (NP (NP (NP (NP (QP (CD 1.8) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 0.3) (NNS micrograms)) (PP (IN after) (NP (QP (CD placebo) (TO to) (CD 38.9)) (NNS +)))) (: /))) (PRN (: -) (NP (NP (CD 8.3) (NNS micrograms)) (PP (IN after) (NP (NP (NNS Doc_6299641_778_789_Chemical)) (CC and) (NP (CD 8.3) (NNS +))))) (: /))) (: -) (NP (NP (CD 1.7) (NNS micrograms)) (PP (IN after) (NP (NNS Doc_6299641_823_831_Chemical))))))))) (. .)))
6299641	5	(ROOT (S (NP (NP (DT The) (NN difference)) (PP (IN in) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT the) (CD two)))))) (VP (VBD was) (ADJP (JJ significant))) (. .)))
6299641	6	(ROOT (S (S (PP (IN After) (NP (NNS Doc_6299641_897_905_Chemical))) (NP (DT the) (NN CD25)) (VP (VBD was) (ADJP (JJ unchanged) (PP (IN after) (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (CD 2.3) (NNP +) (NNS /)) (, -) (NP (CD 0.3) (NNS micrograms)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_6299641_972_980_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 7.7) (NNP +) (NNS /)) (, -) (NP (CD 1.3) (NNS micrograms)) (-RRB- -RRB-))))))) (: ;) (S (NP (PRP it)) (VP (VP (VBD was) (VP (VBN reduced) (PP (IN after) (NP (NP (NNS Doc_6299641_1028_1039_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 24.8) (NNP +) (NNS /)) (, -) (NP (CD 5.0) (NNS micrograms)) (-RRB- -RRB-)))))) (, ,) (CC but) (VP (VBD remained) (ADJP (JJ different)) (PP (IN from) (NP (NNS Doc_6299641_1095_1103_Chemical)))))) (. .)))
6299641	7	(ROOT (S (S (NP (NP (DT This) (NN change)) (PP (IN with) (NP (JJ Doc_6299641_1122_1133_Chemical) (NN sensitivity)))) (VP (VBD was) (VP (VBN calculated) (PP (IN as) (NP (DT the) (JJ apparent) (NN Ka)))))) (, ,) (NP (DT this)) (VP (VBD was) (ADJP (JJ unchanged) (PP (IN by) (NP (NP (NNS Doc_6299641_1203_1211_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 11.7) (NNP +) (NNS /)) (: -) (NP (NP (CD 2.1) (CC and) (CD 10.1) (NN +) (NNS /)) (: -) (NP (CD 2.5) (NN ml/ng))) (-RRB- -RRB-)))))) (. .)))
6299641	8	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (DT the) (NNS hypothesis)))) (SBAR (IN that) (S (NP (JJ exercise-induced) (NNS Doc_6299641_1319_1330_Disease)) (VP (VBZ results) (ADVP (RB largely)) (PP (IN from) (NP (NP (NP (JJ beta) (JJ 1-receptor) (NN activation)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN blocked) (PP (IN by) (NP (ADJP (DT both) (JJ cardioselective) (CC and) (JJ nonselective)) (NNS drugs))) (, ,) (SBAR (IN whereas) (S (NP (NNS Doc_6299641_1451_1464_Chemical)) (VP (VBZ activates) (NP (DT both) (JJ beta) (CD 1)))))))))) (: -) (CC and) (NP (NP (NN beta)) (ADJP (JJ 2-receptors) (RB so) (SBAR (IN that) (S (PP (IN after) (NP (JJ cardioselective) (NN blockade))) (NP (EX there)) (VP (VBZ remains) (NP (NP (DT a) (JJ beta) (NN 2-component)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN blocked) (PP (IN with) (NP (DT a) (JJ nonselective) (NN drug)))))))))))))))))))) (. .)))
6299641	9	(ROOT (S (SBAR (IN While) (S (NP (EX there)) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (NP (NP (JJ beta) (NN 2-receptors)) (PP (IN in) (NP (DT the) (JJ human) (NN heart)))))))))) (, ,) (NP (PRP$ their) (JJ physiologic) (CC or) (JJ pathologic) (NNS roles)) (VP (VBP remain) (S (VP (TO to) (VP (VB be) (VP (VBN defined)))))) (. .)))
6305660	0	(ROOT (NP (NP (NNS Hormones) (CC and) (NN risk)) (PP (IN of) (NP (NNS Doc_6305660_21_34_Disease))) (. .)))
6305660	1	(ROOT (S (NP (DT This) (NN paper)) (VP (VBZ reports) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (NP (CD 50) (JJ menopausal) (NNS women)) (VP (VBG receiving) (NP (JJ hormonal) (NN replacement) (NN therapy))))))))) (. .)))
6305660	2	(ROOT (S (S (NP (NP (DT The) (NN majority)) (PRN (-LRB- -LRB-) (NP (CD 29)) (-RRB- -RRB-))) (VP (VBD had) (NP (JJ surgical) (NN menopause)))) (: ;) (S (NP (PRP$ their) (JJ mean) (NN age)) (VP (VBD was) (NP (CD 45.7) (NNS years)))) (. .)))
6305660	3	(ROOT (S (NP (PRP It)) (VP (VBD was) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (NNS Doc_6305660_239_249_Chemical)) (VP (MD could) (VP (VB equilibrate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT the) (JJ estrogenic) (NN stimulation)))) (PP (IN on) (NP (NP (DT the) (ADJP (JJ mammary) (CC and) (JJ endometrial)) (NN target) (NNS tissues)) (PP (IN of) (NP (NP (NNS women)) (PP (IN on) (NP (JJ hormonal) (NN replacement) (NN therapy))))))))))))) (. .)))
6305660	4	(ROOT (S (NP (DT The) (NN treatment) (NN schedule)) (VP (VBD consisted) (PP (IN of) (NP (NP (NP (JJ conjugated) (NNS Doc_6305660_445_454_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6305660_456_464_Chemical)) (-RRB- -RRB-))) (ADJP (CD 1.25) (JJ mg/day)))) (PP (IN for) (NP (NP (CD 21) (NNS days)) (CC and) (NP (NNS Doc_6305660_494_521_Chemical)))) (NP (NP (CD 10) (NN mg/day)) (PP (IN for) (NP (NP (CD 10) (NNS days)) (PP (IN in) (NP (DT each) (NN month))))))) (. .)))
6305660	5	(ROOT (S (NP (DT The) (JJ mean) (NN treatment) (NN period)) (VP (VBD was) (NP (CD 18) (NNS months))) (. .)))
6305660	6	(ROOT (S (PP (IN During) (NP (DT the) (NN follow-up) (NN period))) (, ,) (NP (NN attention)) (VP (VBD was) (ADVP (NP (NNS Doc_6305660_643_671_Disease)) (RB as)) (VP (VBN evidenced) (PP (IN by) (NP (NP (NN symptomatology)) (, ,) (NP (JJ physical) (NN examination)) (, ,) (CC and) (NP (NN plate) (NN thermography)))))) (. .)))
6305660	7	(ROOT (S (S (NP (NNP Doc_6305660_750_760_Disease)) (VP (VBD was) (VP (VBN reported) (PP (IN by) (NP (CD 21) (NNS patients)))))) (, ,) (CC and) (S (NP (JJ physical) (NN examination)) (VP (VBD revealed) (NP (DT a) (JJ light) (NNS Doc_6305660_832_859_Disease)) (PP (IN in) (NP (NP (CD 12) (NNS women)) (CC and) (NP (DT a) (JJ moderate) (NN increase)))) (PP (IN in) (NP (NP (NN breast) (NN nodularity)) (PP (IN in) (NP (CD 2) (NNS women))))))) (. .)))
6305660	8	(ROOT (S (NP (NNP Themography)) (VP (VBD confirmed) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (DT an) (JJ excessive) (NN breast) (NN stimulation)))) (PP (PP (IN in) (NP (NP (CD 1) (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VBD complained) (PP (IN of) (NP (JJ moderate) (NNS Doc_6305660_1038_1048_Disease)))))))) (CC and) (PP (IN in) (NP (NP (CD 5)) (PP (IN of) (NP (DT the) (CD 7) (NNS women))) (SBAR (WHNP (WP who)) (S (VP (VBD complained) (PP (IN of) (NP (JJ severe) (NNS Doc_6305660_1098_1108_Disease)))))))))) (. .)))
6305660	9	(ROOT (S (NP (NNP Normalization)) (VP (VBD was) (VP (VBN obtained) (PP (IN by) (S (VP (VBG halving) (NP (DT the) (JJ Doc_6305660_1152_1160_Chemical) (NN dose))))))) (. .)))
6305660	10	(ROOT (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ hormonal) (NN replacement) (NN therapy)) (VP (MD can) (VP (VB be) (VP (ADVP (RB safely)) (VBN prescribed) (SBAR (IN if) (S (NP (DT the) (JJ following) (NNS criteria)) (VP (VBP are) (ADJP (JJ satisfied)))))))))))) (: :) (S (NP (NP (LST (LS 1) (-RRB- -RRB-)) (NP (JJ preliminary) (NN evaluation)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN from) (NP (DT a) (JJ clinical) (, ,) (JJ metabolic) (, ,) (JJ cytologic) (, ,) (CC and) (NN mammographic) (NN perspective)))))) (: ;) (NP (LST (LS 2) (-RRB- -RRB-)) (NP (JJ cyclic) (NN treatment) (NN schedule) (, ,)) (PP (IN with) (NP (NP (DT a) (JJ progestative) (NN phase)) (PP (IN of) (NP (CD 10) (NNS days)))))) (: ;) (CC and) (NP (LST (LS 3) (-RRB- -RRB-)) (NP (JJ periodic) (JJ complete) (NN follow-up) (, ,)) (PP (IN with) (NP (NP (ADJP (JJ accurate) (JJ thermographic)) (NN evaluation)) (PP (IN of) (NP (DT the) (NN breast))))))) (VP (VBP target) (NP (NNS tissues)))) (. .)))
6310832	0	(ROOT (S (NP (NP (RB Early) (NNS Doc_6310832_6_16_Disease)) (PP (IN in) (NP (NN kidney) (, ,) (NN heart) (, ,) (CC and) (NN liver) (NN transplant)))) (VP (VBZ recipients) (PP (IN on) (NP (NNS Doc_6310832_70_82_Chemical)))) (. .)))
6310832	1	(ROOT (S (NP (NP (JJ Eighty-one) (NNS renal)) (, ,) (NP (CD seventeen) (NN heart)) (, ,) (CC and) (NP (JJ twenty-four) (NN liver) (NN transplant) (NNS patients))) (VP (VBD were) (VP (VBN followed) (PP (IN for) (NP (NNS Doc_6310832_179_188_Disease))))) (. .)))
6310832	2	(ROOT (S (NP (CD Seventeen) (JJ renal) (NNS patients)) (VP (VBD received) (NP (NP (NNS Doc_6310832_224_236_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6310832_238_241_Chemical)) (-RRB- -RRB-)) (CC and) (NP (NP (NNS Doc_6310832_247_257_Chemical)) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT a) (JJ randomized) (NN trial)) (PP (IN of) (NP (NN immunosuppression))))))))) (PP (IN with) (NP (CD 21) (JJ Doc_6310832_317_344_Chemical-treated) (JJ renal) (NN transplant) (NNS patients)))) (. .)))
6310832	3	(ROOT (S (NP (DT All) (NNS others)) (VP (VBD received) (NP (NNS Doc_6310832_400_412_Chemical) (CC and) (NNS Doc_6310832_417_427_Chemical))) (. .)))
6310832	4	(ROOT (S (NP (DT The) (JJ randomized) (JJ Doc_6310832_444_447_Chemical) (NNS patients)) (VP (VBD had) (NP (NP (ADJP (ADJP (ADJP (RBR more) (JJ Doc_6310832_466_484_Disease)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))) (CC and) (ADJP (JJR more))) (NNS Doc_6310832_513_532_Disease)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.02))) (-RRB- -RRB-))) (PP (IN than) (NP (DT the) (JJ randomized) (JJ Doc_6310832_572_584_Chemical) (NNS patients)))) (. .)))
6310832	5	(ROOT (S (NP (NNP Heart) (CC and) (NN liver) (NNS patients)) (VP (VBD had) (NP (ADJP (ADJP (RBR more) (JJ Doc_6310832_629_639_Disease) (PP (IN than) (NP (JJ Doc_6310832_645_657_Chemical) (JJ renal) (NNS patients)))) (CC but) (ADJP (JJR fewer))) (NNS Doc_6310832_683_693_Disease)) (PP (IN than) (NP (DT the) (JJ Doc_6310832_703_706_Chemical) (JJ renal) (NNS patients)))) (. .)))
6310832	6	(ROOT (S (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (JJ infectious) (NNS deaths)) (PP (IN in) (NP (NP (JJ renal) (NN transplant) (NNS patients)) (PP (IN on) (NP (NNS Doc_6310832_787_799_Chemical) (CC or) (NNS Doc_6310832_803_806_Chemical)))))))) (, ,) (CC but) (S (NP (NNS Doc_6310832_812_821_Disease)) (VP (VBD played) (NP (DT a) (JJ major) (NN role)) (PP (PP (IN in) (NP (NP (CD 3)) (PP (RB out) (IN of) (NP (CD 6) (JJ cardiac) (NN transplant) (NNS deaths))))) (CC and) (PP (IN in) (NP (NP (CD 8)) (PP (RB out) (IN of) (NP (CD 9) (NN liver) (NN transplant) (NNS deaths)))))))) (. .)))
6310832	7	(ROOT (S (NP (NP (JJ Renal) (NNS patients)) (PP (IN on) (NP (NNS Doc_6310832_943_955_Chemical)))) (VP (VBD had) (NP (DT the) (NNS Doc_6310832_964_982_Disease))) (. .)))
6310832	8	(ROOT (S (NP (NP (NNP Analysis)) (PP (IN of) (NP (NP (NN site)) (PP (IN of) (NP (NNS Doc_6310832_1004_1013_Disease)))))) (VP (VBD showed) (NP (NP (NP (DT a) (NN preponderance)) (PP (IN of) (NP (NP (NNS Doc_6310832_1040_1060_Disease)) (PP (IN in) (NP (NN liver) (NNS patients)))))) (, ,) (NP (NP (NNS Doc_6310832_1080_1104_Disease)) (PP (IN in) (NP (NN heart) (NNS patients)))) (, ,) (CC and) (NP (NP (NNS Doc_6310832_1128_1152_Disease)) (PP (IN in) (NP (JJ renal) (NNS patients)))))) (. .)))
6310832	9	(ROOT (S (NP (NNP Doc_6310832_1172_1192_Disease)) (VP (VBD were) (ADJP (RBR less) (JJ common) (PP (IN in) (S (VP (VBG Doc_6310832_1213_1225_Chemical-treated) (NP (JJ renal) (NNS patients)) (ADVP (IN than) (PP (IN in) (NP (NN Doc_6310832_1257_1260_Chemical-treated) (NNS patients)))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))))))) (. .)))
6310832	10	(ROOT (S (S (NP (JJ Doc_6310832_1298_1301_Chemical) (NNS patients)) (VP (VBD had) (NP (ADJP (RB significantly) (JJR more)) (NNS Doc_6310832_1334_1359_Disease)) (PP (IN than) (NP (NP (DT all) (JJ other) (NN transplant) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.005))) (-RRB- -RRB-)))))) (, ,) (CC and) (S (NP (JJ systemic) (NNS Doc_6310832_1427_1444_Disease)) (VP (VBD occurred) (ADVP (RB only)) (PP (IN in) (NP (DT the) (NN liver) (NN transplant) (NN group))))) (. .)))
6310832	11	(ROOT (S (S (NP (NP (NP (NNS Cytomegalovirus)) (PRN (-LRB- -LRB-) (NP (NNP CMV)) (-RRB- -RRB-))) (ADJP (JJ shedding) (CC or) (JJ serological))) (VP (VBZ rises) (PP (IN in) (NP (NN antibody) (NN titer))))) (, ,) (CC or) (S (NP (DT both)) (VP (VBD occurred) (PP (IN in) (NP (NP (NP (CD 78) (NN %)) (PP (IN of) (NP (JJ Doc_6310832_1588_1600_Chemical) (NNS patients)))) (CC and) (NP (NP (CD 76) (NN %)) (PP (IN of) (NP (JJ Doc_6310832_1621_1624_Chemical) (NNS patients)))))))) (. .)))
6310832	12	(ROOT (S (PP (IN Of) (NP (DT the) (JJ Doc_6310832_1642_1654_Chemical) (NNS patients))) (, ,) (NP (CD 15) (NN %)) (VP (VBD had) (NP (NP (NNS symptoms)) (VP (VBN related) (PP (TO to) (NP (NNS Doc_6310832_1693_1706_Disease)))))) (. .)))
6310832	13	(ROOT (S (NP (NP (JJ Serological) (NN evidence)) (PP (IN for) (NP (NNS Doc_6310832_1733_1761_Disease)))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (CD 20) (NN %)) (PP (IN of) (NP (NP (CD 65) (JJ Doc_6310832_1785_1797_Chemical) (NNS patients)) (VP (VBN studied)))))))) (. .)))
6310832	14	(ROOT (S (S (NP (NNP Three)) (VP (VBD had) (VP (VBN associated) (NP (NNS symptoms))))) (, ,) (CC and) (S (NP (PRP one)) (VP (VBD developed) (NP (DT a) (NNS Doc_6310832_1867_1875_Disease)))) (. .)))
6316193	0	(ROOT (NP (NP (JJ Structure-activity) (CC and) (JJ dose-effect) (NNS relationships)) (PP (IN of) (NP (NP (DT the) (NN antagonism)) (PP (IN of) (NP (NN Doc_6316193_70_80_Chemical-induced) (NNS Doc_6316193_89_97_Disease))))) (PP (IN by) (NP (NNS Doc_6316193_101_116_Chemical) (, ,) (NNS fragments) (CC and) (NNS analogues))) (PP (IN of) (NP (NP (NNS Doc_6316193_145_160_Chemical)) (PP (IN in) (NP (NNS mice))))) (. .)))
6316193	1	(ROOT (S (NP (NP (JJ Intraperitoneal) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_6316193_204_246_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CCK-8-SE)) (-RRB- -RRB-)) (CC and) (NP (JJ nonsulphated) (JJ Doc_6316193_275_290_Chemical) (NN octapeptide)) (PRN (-LRB- -LRB-) (NP (NNP CCK-8-NS)) (-RRB- -RRB-))))) (VP (VBD enhanced) (NP (NP (DT the) (NN latency)) (PP (IN of) (NP (NP (NNS Doc_6316193_338_346_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_6316193_358_368_Chemical)) (PP (IN in) (NP (NNS mice)))))))))) (. .)))
6316193	2	(ROOT (S (NP (NP (NNS Experiments)) (PP (IN with) (NP (ADJP (JJ Doc_6316193_395_396_Chemical) (: -) (CC and) (JJ Doc_6316193_402_403_Chemical-terminal)) (NNS fragments)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (DT the) (NN Doc_6316193_441_442_Chemical-terminal) (NN tetrapeptide)) (PRN (-LRB- -LRB-) (NP (NNP CCK-5-8)) (-RRB- -RRB-))) (VP (VBD was) (NP (NP (DT the) (JJ active) (NN centre)) (PP (IN of) (NP (DT the) (NNP CCK) (NNP Doc_6316193_508_519_Chemical) (NN molecule)))))))) (. .)))
6316193	3	(ROOT (S (NP (NP (DT The) (NNS analogues)) (ADJP (JJ CCK-8-SE) (CC and) (JJ CCK-8-NS))) (PRN (-LRB- -LRB-) (S (NP (NN dose)) (VP (VBP range) (SBAR (S (NP (NP (CD 0.2-6) (NNP .4) (NNP mumol/kg) (-RRB- -RRB-)) (CC and) (NP (JJ Doc_6316193_600_609_Chemical) (NN dose))) (VP (VBP range) (NP (CD 0.1-0) (CD .8) (NN mumol/kg))))))) (-RRB- -RRB-)) (VP (VBD showed) (NP (JJ bell-shaped) (JJ dose-effect) (NNS curves)) (, ,) (PP (IN with) (NP (NP (DT the) (JJS greatest) (JJ maximum) (NN inhibition)) (PP (IN for) (NP (NN CCK-8-NS)))))) (. .)))
6316193	4	(ROOT (S (NP (DT The) (JJ peptide) (NN CCK-5-8)) (VP (VBD had) (NP (NP (JJ weak) (NN anticonvulsant) (NN activity)) (PP (IN in) (NP (NN comparison)))) (PP (TO to) (NP (NP (DT the) (NNS octapeptides)) (, ,) (NP (CD 3.2) (NN mumol/kg)) (CC and) (NP (NP (NP (JJR larger) (NNS doses)) (PP (IN of) (NP (DT the) (NN reference) (NN drug)))) (, ,) (NP (NNS Doc_6316193_870_878_Chemical)) (, ,) (VP (ADVP (RB totally)) (VBN prevented) (NP (NP (NN Doc_6316193_898_908_Chemical-induced) (NNS Doc_6316193_917_925_Disease)) (CC and) (NP (NN mortality)))))))) (. .)))
6316193	5	(ROOT (S (NP (NP (DT The) (JJ maximum) (NN effect)) (PP (IN of) (NP (NP (DT the) (NNS peptides)) (VP (VBN tested))))) (VP (VBD was) (ADJP (JJR less)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NNS Doc_6316193_1005_1013_Chemical)))))) (. .)))
6316193	6	(ROOT (S (NP (NP (NNS Experiments)) (PP (IN with) (NP (NP (NNS analogues) (CC and) (NNS derivatives)) (PP (IN of) (NP (NN CCK-5-8)))))) (VP (VBD demonstrated) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (NP (DT the) (JJ Doc_6316193_1112_1123_Chemical) (NNS derivatives)) (PP (IN of) (NP (NN CCK-5-8)))))) (VP (VBD were) (VP (VBN enhanced))))) (CC and) (SBAR (IN that) (S (NP (PRP they)) (VP (VBD were) (VP (VBN equipotent) (PP (IN with) (NP (NN CCK-8-SE))))))))) (. .)))
6316193	7	(ROOT (S (PP (IN Of) (NP (DT the) (NN CCK-2-8) (NNS analogues))) (, ,) (NP (NP (NP (NNP Ser)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6316193_1236_1240_Chemical)) (-RRB- -RRB-))) (ADJP (JJ 7-Ac-CCK-2-8-SE) (CC and) (JJ Thr))) (PRN (-LRB- -LRB-) (NP (NNP Doc_6316193_1265_1269_Chemical)) (-RRB- -RRB-)) (NP (ADJP (ADJP (JJ 7-Ac-CCK-2-8-SE)) (CC and) (ADJP (ADJP (JJ Hyp)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6316193_1294_1298_Chemical)) (-RRB- -RRB-))) (: -)) (NNS Ac-CCK-2-8-SE)) (VP (VBD were) (ADJP (RB slightly) (RBR more) (JJ active)) (PP (IN than) (NP (NN CCK-8-SE)))) (. .)))
6321816	0	(ROOT (S (VP (VB Doc_6321816_0_11_Chemical) (PP (IN as) (NP (DT a) (JJ possible) (NN contributor))) (PP (TO to) (NP (NNS Doc_6321816_41_53_Disease)))) (. .)))
6321816	1	(ROOT (S (NP (NP (DT The) (NN role)) (PP (IN of) (NP (NP (NNS Doc_6321816_67_78_Chemical)) (PP (IN as) (NP (NP (DT a) (NN pressor) (NN agent)) (PP (TO to) (NP (DT the) (JJ Doc_6321816_105_117_Disease) (NN process)))))))) (VP (VBD was) (VP (VBN examined))) (. .)))
6321816	2	(ROOT (S (NP (NNP Doc_6321816_140_151_Chemical)) (VP (VBZ plays) (NP (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (NN Doc_6321816_194_198_Chemical-salt) (NNS Doc_6321816_204_216_Disease)))))) (, ,) (SBAR (IN since) (S (NP (NP (DT the) (NN elevation)) (PP (IN of) (NP (NN blood) (NN pressure)))) (VP (VBD was) (RB not) (ADJP (JJ substantial) (PP (IN in) (NP (NP (DT the) (NNS rats)) (PP (IN with) (NP (NN Doc_6321816_293_300_Chemical-treated) (NNS Doc_6321816_309_327_Disease)))))) (PP (IN after) (NP (NN Doc_6321816_334_338_Chemical-salt) (NN treatment))))))) (. .)))
6321816	3	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NP (NNS Doc_6321816_373_378_Chemical)) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (NP (NP (JJ antidiuretic) (NN action)) (PP (CC but) (NP (JJ minimal) (NN vasopressor) (NN effect)))))))))) (VP (VBD failed) (S (VP (TO to) (VP (VB increase) (NP (NN blood) (NN pressure)) (PP (TO to) (NP (NP (DT the) (NNS levels)) (VP (VBN observed) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_6321816_521_524_Chemical)))))))))))) (. .)))
6321816	4	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NN pressor) (NN action)) (PP (IN of) (NP (NNS Doc_6321816_561_572_Chemical)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ important)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (DT this) (NN model)) (PP (IN of) (NP (NNS Doc_6321816_633_645_Disease))))))) (, ,) (SBAR (IN since) (S (NP (NP (DT the) (JJ enhanced) (NN pressor) (NNS responsiveness)) (PP (TO to) (NP (DT the) (NN hormone)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (JJ initial) (NN stage)) (PP (IN of) (NP (NNS Doc_6321816_741_753_Disease))))))))))))) (. .)))
6321816	5	(ROOT (S (NP (NP (VBN Increased) (NN secretion)) (PP (IN of) (NP (NP (NNS Doc_6321816_778_789_Chemical)) (PP (IN from) (NP (NNS neurohypophysis)))))) (ADVP (RB also)) (VP (VBZ promotes) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NP (DT the) (NN hormone)) (PP (IN as) (NP (NP (DT a) (JJ pathogenetic) (NN factor)) (PP (IN in) (NP (NNS Doc_6321816_881_893_Disease))))))))) (. .)))
6321816	6	(ROOT (S (NP (NP (DT An) (JJ unproportional) (NN release)) (PP (IN of) (NP (NP (NNS Doc_6321816_924_935_Chemical)) (PP (VBN compared) (PP (TO to) (NP (NN plasma))))))) (ADVP (RB osmolality)) (VP (MD may) (VP (VB be) (VP (VBN induced) (PP (IN by) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT an) (NN adjusting) (NN control)) (PP (IN of) (NP (NP (NNP angiotensin) (NNP II) (NNP forming)) (CC and) (NP (NP (NN receptor) (VBG binding) (NN capacity)) (PP (IN for) (NP (JJ Doc_6321816_1080_1086_Chemical) (NN balance))) (PP (IN in) (NP (DT the) (NN brain))))))))))))) (. .)))
6321816	7	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNS Doc_6321816_1130_1141_Chemical)))) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN determined) (PP (IN in) (NP (JJ human) (JJ essential) (NNS Doc_6321816_1186_1198_Disease)))))))) (. .)))
6453500	0	(ROOT (S (NP (NNP Doc_6453500_0_15_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_6453500_27_37_Chemical)) (PP (IN in) (NP (DT a) (JJ non-alcoholic)))))) (. .)))
6453500	1	(ROOT (S (NP (DT A) (JJ reversible) (NNS Doc_6453500_71_89_Disease)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (DT a) (JJ non-alcoholic) (NN woman)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_6453500_141_151_Chemical)))))))) (. .)))
6453500	2	(ROOT (S (NP (DT The) (JJ causative) (NN relationship)) (VP (VBD was) (VP (VBN proven) (PP (IN by) (NP (NN challenge))))) (. .)))
6517710	0	(ROOT (NP (NP (NNP Doc_6517710_0_17_Disease)) (VP (VBG involving) (NP (NP (DT the) (NN heart)) (PP (IN of) (NP (NP (NN F-344) (NNS rats)) (VP (VBG ingesting) (NP (NNS Doc_6517710_62_86_Chemical))))))) (. .)))
6517710	1	(ROOT (S (NP (NNP Doc_6517710_88_112_Chemical)) (VP (VBZ is) (ADJP (JJ toxic) (PP (IN for) (NP (NP (DT the) (NN heart)) (PP (IN of) (NP (NN F-344) (NNS rats))))))) (. .)))
6517710	2	(ROOT (S (NP (NP (NNS Rats)) (VP (VBN treated) (PP (IN with) (NP (NP (CD 500) (NN ppm) (NNS Doc_6517710_177_201_Chemical)) (PP (IN in) (NP (DT the) (NN diet))))))) (ADVP (DT all)) (VP (VBD developed) (NP (NP (DT a) (JJ high) (NN incidence)) (PP (IN of) (NP (JJ left) (NNS Doc_6517710_253_270_Disease))))) (. .)))
6517710	3	(ROOT (S (NP (DT The) (NN lesion)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_6517710_303_322_Disease) (CC and) (NNS Doc_6517710_327_337_Disease)) (CC and) (NP (JJ focal) (NNS Doc_6517710_348_371_Disease)))))) (. .)))
6517710	4	(ROOT (S (NP (NNS Rats)) (VP (VBD died) (PP (IN from) (NP (NP (NP (NNS Doc_6517710_388_407_Disease)) (PP (IN with) (NP (JJ severe) (NNS acute)))) (CC and) (NP (NP (JJ chronic) (NN congestion)) (PP (IN of) (NP (NP (DT the) (NNS lungs)) (, ,) (NP (NN liver)) (, ,) (CC and) (NP (JJ other) (NNS organs)))))))) (. .)))
6517710	5	(ROOT (S (NP (NP (CD Seventy) (NN percent)) (PP (IN of) (NP (NP (NNS rats)) (VP (VBN given) (NP (NP (CD 250) (NN ppm) (NNS Doc_6517710_526_550_Chemical)) (CC and) (NP (CD 1,000) (NN ppm) (NNS Doc_6517710_565_579_Chemical))) (PP (ADVP (RB simultaneously)) (IN in) (NP (DT the) (NN diet))))))) (VP (VBD had) (NP (NP (NNS Doc_6517710_611_621_Disease)) (PP (IN of) (NP (NP (DT the) (NN atria)) (PP (IN of) (NP (DT the) (NN heart)))))) (, ,) (SBAR (IN while) (S (NP (NP (JJ untreated) (NN control) (NNS rats)) (PP (IN in) (NP (DT this) (NN laboratory)))) (VP (VBD did) (RB not) (VP (VB have) (NP (NNS Doc_6517710_710_727_Disease))))))) (. .)))
6517710	6	(ROOT (S (NP (NP (NNP Doc_6517710_729_743_Chemical)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NNS Doc_6517710_764_788_Chemical)))))) (VP (VBD appeared) (S (VP (TO to) (VP (VB have) (NP (DT no) (JJ additional) (NN effect)))))) (. .)))
6529939	0	(ROOT (S (NP (NP (JJ Alternating) (NNS sinus) (NN rhythm)) (CC and) (NP (JJ intermittent) (NNS Doc_6529939_42_58_Disease))) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_6529939_70_81_Chemical)))) (. .)))
6529939	1	(ROOT (S (NP (NP (VBG Alternating) (JJ sinus) (NN rhythm)) (CC and) (NP (NP (JJ intermittent) (NN sinoatrial)) (PRN (-LRB- -LRB-) (NP (NNP S-A)) (-RRB- -RRB-)) (NP (NN block)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (DT a) (JJ 57-year-old) (NN woman))) (, ,) (PP (IN under) (NP (NP (NN treatment)) (PP (IN for) (NP (NP (NNS Doc_6529939_205_211_Disease)) (PP (IN with) (NP (CD 80) (NN mg) (NNS Doc_6529939_223_234_Chemical))) (ADVP (RB daily)))))))) (. .)))
6529939	2	(ROOT (S (NP (DT The) (NN electrocardiogram)) (VP (VBD showed) (NP (NP (NN alternation)) (PP (IN of) (NP (NP (ADJP (JJ long) (CC and) (JJ short)) (JJ P-P) (NNS intervals)) (CC and) (NP (JJ occasional) (NNS pauses)))))) (. .)))
6529939	3	(ROOT (S (S (NP (DT These) (NN pauses)) (VP (VP (VBD were) (VP (ADVP (RB always)) (VBN preceded) (PP (IN by) (NP (DT the) (JJ short) (JJ P-P) (NNS intervals))))) (CC and) (VP (VBD were) (VP (ADVP (RB usually)) (VBN followed) (PP (IN by) (NP (CD one))))))) (CC or) (S (NP (NP (CD two) (JJ P-P) (NNS intervals)) (PP (IN of) (NP (CD 0.92-0) (CD .95)))) (VP (VBZ s) (VP (VBG representing) (NP (DT the) (JJ basic) (NN sinus) (NN cycle))))) (. .)))
6529939	4	(ROOT (S (PP (VBG Following) (NP (DT these) (JJ basic) (NNS sinus) (NNS cycles))) (, ,) (NP (JJ alternating) (NN rhythm)) (VP (VBD started) (PP (IN with) (NP (DT the) (JJR longer) (NNP P-P) (NN interval)))) (. .)))
6529939	5	(ROOT (S (NP (DT The) (JJ long) (JJ P-P) (NNS intervals)) (VP (VBD ranged) (PP (IN between) (NP (NP (CD 1.04-1) (CD .12) (NNS s)) (CC and) (NP (NP (DT the) (JJ short) (JJ P-P) (NNS intervals)) (PP (IN between) (NP (CD 0.80-0) (CD .84) (NNS s)))))) (, ,) (ADVP (RB respectively))) (. .)))
6529939	6	(ROOT (S (NP (NP (DT The) (NN duration)) (PP (IN of) (NP (DT the) (NN pauses)))) (VP (VBD were) (ADJP (ADJP (JJ equal)) (CC or) (ADJP (RB almost) (JJ equal))) (PP (PP (TO to) (NP (NP (CD one)) (JJ short) (IN plus) (NP (CD one) (JJ long) (NNP P-P) (NN interval)))) (CC or) (PP (TO to) (NP (RB twice) (DT the) (JJ basic) (NNS sinus))) (NP (NN cycle)))) (. .)))
6529939	7	(ROOT (S (PP (IN In) (S (NP (PRP one)) (VP (VBG recording) (NP (NP (DT a) (JJ short) (NN period)) (PP (IN of) (NP (JJ regular) (NNS sinus) (NN rhythm)))) (PP (IN with) (NP (JJ intermittent) (CD 2/1)))))) (NP (JJ S-A) (NN block)) (VP (VBD was) (ADJP (JJ observed))) (. .)))
6529939	8	(ROOT (S (NP (NP (DT This) (JJ short) (NN period)) (PP (IN of) (NP (JJ sinus) (NN rhythm)))) (VP (VBD was) (VP (VBN interrupted) (PP (IN by) (NP (NP (JJ sudden) (NN prolongation)) (PP (IN of) (NP (DT the) (JJ P-P) (NN interval))))) (S (VP (VBG starting) (NP (DT the) (JJ alternative) (NN rhythm)))))) (. .)))
6529939	9	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (JJ small) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN shape)) (PP (IN of) (NP (NP (DT the) (NNP P) (NNS waves)) (CC and) (NP (JJ P-R) (NNS intervals)))))))) (. .)))
6529939	10	(ROOT (S (NP (NP (JJ S-A) (NN conduction)) (PP (IN through) (NP (NP (CD two) (NNS pathways)) (, ,) (NP (DT the) (ADJP (JJ first) (PP (PP (IN with) (NP (NP (CD 2/1) (NN block)) (SBAR (S (NP (NP (DT the) (NN second)) (VP (VBG having) (NP (CD 0.12-0) (CD .14)))) (VP (VBZ s) (NP (JJR longer) (NN conduction) (NN time))))))) (CC and) (PP (IN with) (NP (JJ occasional) (CD 2/1))))) (NN block))))) (VP (VBD was) (VP (VBN proposed) (PP (IN for) (NP (NP (NP (DT the) (NN explanation)) (PP (IN of) (NP (DT the) (NNP alternating) (NNP P-P) (NN interval)))) (CC and) (NP (NP (JJ other) (JJ electrocardiographic) (NNS features)) (VP (VBN seen))))))) (. .)))
6529939	11	(ROOT (S (NP (NP (QP (CD Doc_6529939_1395_1403_Chemical) (CD 1)) (NN mg)) (VP (VBN given) (ADVP (RB intravenously)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NN shortening)) (PP (IN of) (NP (DT all) (JJ P-P) (NNS intervals))))) (PP (IN without) (S (VP (VBG changing) (NP (DT the) (NN rhythm)))))) (. .)))
6529939	12	(ROOT (S (S (NP (DT The) (JJ abnormal) (NN rhythm)) (VP (VBD disappeared) (PP (IN with) (NP (NP (DT the) (NN withdrawal)) (PP (IN of) (NP (NNS Doc_6529939_1557_1568_Chemical))))))) (CC and) (S (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN drug)) (VP (VBD was) (VP (VBN restarted))))) (NP (DT a) (CD 2/1) (JJ S-A) (NN block)) (VP (VBD was) (VP (VBN seen)))) (. .)))
6529939	13	(ROOT (S (NP (DT This)) (VP (VBD was) (VP (VBN accepted) (PP (IN as) (NP (NP (NN evidence)) (PP (IN for) (NP (NNS Doc_6529939_1661_1672_Chemical))))) (S (VP (VBG being) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (DT this) (NNS Doc_6529939_1697_1716_Disease)))))))) (. .)))
6585590	0	(ROOT (NP (NP (JJ Antitumor) (NN effect)) (, ,) (NP (NNS Doc_6585590_18_32_Disease)) (, ,) (CC and) (NP (NP (NN nephrotoxicity)) (PP (IN of) (NP (NP (NNS Doc_6585590_56_67_Chemical)) (PP (IN in) (NP (DT the) (NNP IgM) (JJ solid) (JJ immunocytoma-bearing) (JJ LOU/M/WSL) (NN rat)))))) (. .)))
6585590	1	(ROOT (S (NP (NP (JJ Antitumor) (NN activity)) (, ,) (NP (NNS Doc_6585590_141_155_Disease)) (, ,) (CC and) (NP (NP (NN nephrotoxicity)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_6585590_187_198_Chemical)))))) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (NP (JJ LOU/M/WSL) (JJ inbred) (NNS rats)) (NP (DT each)))) (S (VP (VBG bearing) (NP (DT a) (JJ transplantable) (JJ solid) (NN IgM) (NN immunocytoma)))))) (. .)))
6585590	2	(ROOT (S (NP (NP (NNS Animals)) (PP (IN with) (NP (NP (DT a) (NNS Doc_6585590_306_311_Disease)) (PRN (-LRB- -LRB-) (NP (NN diameter) (, ,) (NN 15.8) (NN +) (NN /)) (, -) (NP (CD 3.3) (NNS mm)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NN iv) (NNS injections)) (PP (IN of) (NP (NNS Doc_6585590_375_386_Chemical))))) (PP (IN on) (NP (NP (CD 5) (JJ consecutive) (NNS days)) (, ,) (VP (VBN followed) (PP (IN by) (NP (NP (CD 1) (JJ weekly) (NN injection)) (PP (IN for) (NP (NP (CD 7) (NNS weeks)) (PRN (-LRB- -LRB-) (NP (NP (NN dose) (NN range)) (, ,) (NP (CD 0.015-4) (CD .0) (NN mg/kg) (NN body) (NNS wt))) (-RRB- -RRB-))))))))))) (. .)))
6585590	3	(ROOT (FRAG (NP (NP (JJ Doc_6585590_492_497_Disease) (NN regression)) (SBAR (S (VP (VBD was) (VP (VBN observed) (PP (IN with) (NP (CD 0.5) (NN mg) (NNS Doc_6585590_534_545_Chemical)))))))) (: /) (VP (VBP kg)) (. .)))
6585590	4	(ROOT (S (NP (NP (JJ Complete) (NN disappearance)) (PP (IN of) (NP (DT the) (NNS Doc_6585590_580_585_Disease)))) (VP (VBD was) (VP (VBN induced) (PP (IN with) (NP (CD 1.0) (JJ mg) (NNP Doc_6585590_610_621_Chemical) (NNP /) (NN kg))))) (. .)))
6585590	5	(ROOT (S (NP (NP (JJ Histologic) (NN evidence)) (PP (IN of) (NP (NNS Doc_6585590_649_663_Disease)))) (VP (VBD scored) (SBAR (IN as) (S (NP (NNP grade) (NNP III)) (VP (VBD was) (ADVP (RB only)) (VP (VBN observed) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 1.0) (JJ mg) (NNP Doc_6585590_722_733_Chemical) (NNP /) (NN kg)))))))))) (. .)))
6585590	6	(ROOT (S (NP (NP (JJ Light) (JJ microscopic) (NN evidence)) (PP (IN of) (NP (NNS Doc_6585590_768_780_Disease)))) (VP (VBD was) (VP (VBN seen) (PP (IN above) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 0.5) (JJ mg) (JJ Doc_6585590_813_824_Chemical) (NN /) (NN kg)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD resulted) (PP (IN in) (NP (NP (NNS Doc_6585590_847_858_Disease)) (CC and) (NP (ADJP (RB very) (JJ low)) (NN serum) (NN albumin) (NNS levels))))))))))))) (. .)))
6585590	7	(ROOT (UCP (S (PP (IN In) (NP (DT the) (NN group))) (NP (DT that)) (VP (VBD received) (NP (NP (NP (CD 1.0) (NN mg) (NNS Doc_6585590_928_939_Chemical)) (PRN (: /) (NP (NP (NN kg)) (, ,) (NP (NP (DT the) (NN serum) (NN albumin) (NN level)) (VP (VBN decreased) (PP (IN from) (NP (QP (CD 33.6) (CD +))))))) (: /))) (PRN (: -) (NP (QP (CD 4.1) (TO to) (CD 1.5)) (NNS +)) (: /))))) (: -) (NP (CD 0.5) (NN g/liter)) (. .)))
6585590	8	(ROOT (S (NP (NNS Ascites) (CC and) (NNS hydrothorax)) (VP (VBD were) (VP (VBN observed) (ADVP (RB simultaneously)))) (. .)))
6585590	9	(ROOT (S (NP (DT The) (JJ same) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (PP (IN with) (NP (NP (JJ non-Doc_6585590_1119_1124_Disease-bearing) (NNS rats)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT no) (JJ major) (NNS differences)) (VP (VBD were) (ADJP (JJ observed))))))))) (. .)))
6585590	10	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NP (NN antitumor) (NN activity)) (, ,) (NP (NNS Doc_6585590_1219_1233_Disease)) (, ,) (CC and) (NP (NN nephrotoxicity))) (VP (VBD were) (VP (VBN studied) (ADVP (RB simultaneously)) (PP (IN in) (NP (DT the) (JJ same) (JJ LOU/M/WSL) (NN rat))))) (. .)))
6585590	11	(ROOT (S (S (ADJP (RB Doc_6585590_1309_1320_Disease) (JJ due) (PP (TO to) (NP (NP (NNS Doc_6585590_1328_1340_Disease)) (VP (VBN led) (PP (TO to) (NP (ADJP (RB extremely) (JJ low)) (JJ serum) (NN albumin) (NNS levels)))))))) (, ,) (IN so) (S (NP (NNS ascites) (CC and) (NNS hydrothorax)) (VP (VBD were) (RB not) (ADVP (RB necessarily)) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (DT the) (ADJP (JJ observed)) (NNS Doc_6585590_1462_1476_Disease)))))) (. .)))
6615679	0	(ROOT (S (NP (JJ Intraoperative) (NNS Doc_6615679_15_26_Disease) (CC and) (NNS Doc_6615679_31_42_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_6615679_59_66_Chemical)) (CC and) (NP (JJ Doc_6615679_71_82_Chemical) (NN eye) (NNS drops))))) (. .)))
6615679	1	(ROOT (S (NP (NP (DT A) (JJ 69-yr-old) (NN man)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD was) (ADVP (RB concurrently)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_6615679_151_170_Chemical)) (CC and) (NP (JJ Doc_6615679_175_190_Chemical) (NN eye) (NNS drops))))))))) (, ,)) (VP (VP (VBD developed) (NP (DT a) (NNS Doc_6615679_214_225_Disease))) (CC and) (VP (VBD became) (NP (NNS Doc_6615679_237_248_Disease)) (PP (IN during) (NP (JJ Doc_6615679_256_265_Chemical) (NN anaesthesia))))) (. .)))
6615679	2	(ROOT (S (NP (DT Both) (NNS Doc_6615679_284_291_Chemical) (CC and) (NNS Doc_6615679_296_307_Chemical)) (VP (VBD were) (ADVP (RB subsequently)) (VP (VBN identified) (PP (IN in) (NP (NP (DT a) (JJ 24-h) (NN collection)) (PP (IN of) (NP (NN urine))))))) (. .)))
6615679	3	(ROOT (S (S (NP (NP (NNP Doc_6615679_368_375_Chemical)) (PRN (-LRB- -LRB-) (FRAG (CONJP (CC but) (RB not)) (NP (NNS Doc_6615679_385_396_Chemical))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (DT a) (NN sample)) (PP (IN of) (NP (NP (NN plasma)) (VP (VBN removed) (PP (IN during) (NP (NN surgery))))))))))) (: ;) (S (NP (NP (DT the) (NN plasma) (NN concentration)) (PP (IN of) (NP (NP (NNS Doc_6615679_485_492_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2.6) (NN ng) (NN ml-1)) (-RRB- -RRB-))))) (VP (VBD was) (ADJP (JJ consistent) (PP (IN with) (NP (JJ partial) (JJ beta-adrenoceptor) (NN blockade)))))) (. .)))
6615679	4	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN postulated) (SBAR (IN that) (S (NP (DT this) (NN action)) (VP (MD may) (VP (VB have) (VP (VBN been) (VP (VBN enhanced) (PP (IN during) (NP (JJ Doc_6615679_627_636_Chemical) (NN anaesthesia))) (PP (IN with) (NP (NN resultant) (NNS Doc_6615679_664_675_Disease) (CC and) (NNS Doc_6615679_680_691_Disease))))))))))) (. .)))
6615679	5	(ROOT (S (NP (NNP Doc_6615679_693_704_Chemical)) (VP (MD may) (VP (VB have) (VP (VBN had) (NP (DT a) (JJ contributory) (NN effect))))) (. .)))
6627074	0	(ROOT (NP (NP (JJ Doc_6627074_0_15_Chemical) (NN apnoea)) (: :) (NP (NP (VBN attempted) (NN reversal)) (PP (IN with) (NP (NNS anticholinesterases)))) (. .)))
6627074	1	(ROOT (S (NP (NNS Anticholinesterases)) (VP (VBD were) (VP (VBN administered) (PP (IN in) (NP (DT an) (NN attempt))) (S (VP (TO to) (VP (VB antagonize) (NP (VBN prolonged) (NNS Doc_6627074_145_167_Disease)) (PP (VBG following) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_6627074_200_215_Chemical)) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (ADVP (RB later)) (VBN found) (S (VP (TO to) (VP (VB be) (NP (NP (NNS homozygous)) (PP (IN for) (NP (JJ atypical) (NN plasma) (NN cholinesterase))))))))))))))))))) (. .)))
6627074	2	(ROOT (S (NP (NP (QP (CD Doc_6627074_294_305_Chemical) (CD 10)) (NN mg)) (, ,) (VP (VBN given) (NP (CD 74) (NN min)) (PP (IN after) (NP (NNS Doc_6627074_332_347_Chemical))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (JJ train-of-four) (NN stimulation)) (VP (VBD was) (ADJP (JJ characteristic) (PP (IN of) (NP (NNP phase) (NNP II) (NN block)))))))) (, ,)) (VP (VBD produced) (NP (NP (JJ partial) (NN antagonism)) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (RB not) (VP (VBN sustained))))))) (. .)))
6627074	3	(ROOT (S (NP (NP (JJ Repeated) (NNS doses)) (PP (IN of) (NP (NP (QP (CD Doc_6627074_489_500_Chemical) (TO to) (CD 70)) (NN mg)) (CC and) (NP (QP (CD Doc_6627074_514_525_Chemical) (TO to) (CD 2.5)) (NN mg))))) (VP (VBD did) (RB not) (VP (VB antagonize) (CC or) (VB augment) (NP (DT the) (NN block)))) (. .)))
6627074	4	(ROOT (S (NP (JJ Spontaneous) (NN respiration)) (VP (VBD recommenced) (NP (QP (CD 200) (CD min))) (PP (IN after) (NP (JJ Doc_6627074_627_642_Chemical) (NN administration)))) (. .)))
6627074	5	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (NNS anticholinesterases)) (VP (VBP are) (ADVP (RB only)) (ADJP (RB partially) (JJ effective) (PP (IN in) (S (VP (VBG restoring) (NP (NP (NN neuromuscular) (NN function)) (PP (IN in) (NP (JJ Doc_6627074_768_783_Chemical) (NN apnoea)))) (PP (IN despite) (NP (NP (NN muscle) (NN twitch) (NN activity)) (ADJP (JJ typical)) (PP (IN of) (NP (NNP phase) (NNP II) (NN block)))))))))))))) (. .)))
6631522	0	(ROOT (NP (NP (NN Effect)) (PP (IN of) (NP (NP (NNS Doc_6631522_10_21_Chemical)) (PP (IN on) (NP (JJ Doc_6631522_25_56_Chemical) (NNS Doc_6631522_57_80_Disease) (CC and) (NN echocardiography))))) (PP (IN in) (NP (NNS dogs))) (. .)))
6631522	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (JJ serial) (NN treatment)) (PP (PP (IN with) (NP (NP (NNS Doc_6631522_148_159_Chemical)) (PP (IN on) (NP (NP (JJ dynamic) (NNS Doc_6631522_171_194_Disease)) (PP (IN with) (NP (NP (NNS Doc_6631522_200_231_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6631522_233_238_Chemical) (NNP HA)) (-RRB- -RRB-)))))))) (, ,) (CC and) (PP (IN on) (NP (NP (JJ global) (JJ left-ventricular) (NN function)) (VP (VBN determined) (ADVP (RB echocardiographically))))))))) (, ,) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (CD nine) (JJ mongrel) (NNS dogs))))))) (. .)))
6631522	2	(ROOT (S (NP (JJ Total) (NN extractable) (NN myocardial) (NN lipid)) (VP (VBD was) (VP (VBN compared) (NP (NP (NN postmortem)) (PP (IN between) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NN control) (NNS dogs) (CC and) (NN Doc_6631522_459_470_Chemical-treated) (NNS dogs)))))))) (. .)))
6631522	3	(ROOT (S (NP (DT A) (ADJP (JJ significant) (CC and) (RB then)) (JJ progressive) (NNS Doc_6631522_520_546_Disease)) (VP (VBD was) (VP (VBN observed) (PP (IN at) (NP (NP (DT a) (JJ cumulative) (JJ Doc_6631522_576_587_Chemical) (NN dose)) (PP (IN of) (NP (CD 4) (NN mg/kg))))))) (. .)))
6631522	4	(ROOT (S (NP (NP (DT A) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ myocardial) (NN t1/2)) (PP (IN of) (NP (DT the) (NNP I-131) (NNP HA)))))) (VP (VBD was) (VP (VBN observed) (ADVP (RB only)) (PP (IN at) (NP (NP (DT a) (JJR higher) (JJ cumulative) (NN dose)) (, ,) (NP (CD 10) (NN mg/kg)))))) (. .)))
6631522	5	(ROOT (S (NP (NP (DT No) (JJ significant) (NN alteration)) (PP (IN in) (NP (JJ total) (JJ extractable) (JJ myocardial) (NNS lipids)))) (VP (VBD was) (VP (VBN observed) (PP (IN between) (NP (NP (NN control) (NNS dogs)) (CC and) (NP (NP (DT those)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_6631522_846_857_Chemical))))))))) (. .)))
6631522	6	(ROOT (S (NP (PRP$ Our) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NNS changes)) (VP (VBG leading) (PP (TO to) (NP (NP (DT an) (NN alteration)) (PP (IN of) (NP (JJ myocardial) (JJ dynamic) (NN imaging))))) (PP (IN with) (NP (NNP I-131) (NNP HA))))) (VP (VBP are) (RB not) (NP (NP (DT the) (JJ initiating) (NN factor)) (PP (IN in) (NP (JJ Doc_6631522_999_1010_Chemical) (NNS Doc_6631522_1011_1025_Disease)))))))) (. .)))
6673474	0	(ROOT (S (VP (VB Hemodynamics) (CC and) (VB myocardial) (NP (NN metabolism)) (PP (IN under) (NP (ADJP (JJ deliberate)) (NNS Doc_6673474_56_67_Disease)))) (. .)))
6673474	1	(ROOT (NP (NP (DT An) (JJ experimental) (NN study)) (PP (IN in) (NP (NNS dogs))) (. .)))
6673474	2	(ROOT (S (NP (NP (JJ Coronary) (NN blood) (NN flow)) (, ,) (NP (JJ cardiac) (NN work)) (CC and) (NP (NN metabolism))) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (NP (NNS dogs)) (PP (IN under) (NP (NP (NNS Doc_6673474_176_196_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6673474_198_201_Chemical)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_6673474_207_218_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6673474_220_223_Chemical)) (-RRB- -RRB-)))))) (S (VP (VB deliberate) (NP (NP (NNS Doc_6673474_236_247_Disease)) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 20) (NN %) (CC and) (CD 40) (NN %)) (JJ mean) (NN pressure) (NN decrease)) (PP (IN from) (NP (NN baseline)))) (-RRB- -RRB-))))))) (. .)))
6673474	3	(ROOT (S (S (VP (VBG Regarding) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ drug-induced) (NNS Doc_6673474_338_349_Disease)))) (PP (IN on) (NP (NP (JJ coronary) (NN blood) (NN flow)) (, ,) (NP (NP (JJ aortic) (CC and) (JJ coronary) (JJ sinus) (JJ metabolic) (NNS data)) (PRN (-LRB- -LRB-) (NP (NNP pH)) (, ,) (NP (NNP Doc_6673474_420_423_Chemical)) (, ,) (NP (NNP Doc_6673474_425_429_Chemical)) (-RRB- -RRB-)) (SBAR (S (NP (PRP we)) (VP (MD could) (VP (VB confirm) (SBAR (IN that) (S (NP (JJ Doc_6673474_453_466_Chemical) (NNS Doc_6673474_467_478_Disease)) (VP (MD could) (VP (VB be) (VP (ADVP (RB safely)) (VBN used) (PP (TO to) (NP (CD 30) (NN %))) (S (VP (VB mean) (NP (NP (NN blood) (NN pressure) (NN decrease)) (PP (IN from) (NP (NN control)))))))))))))))))))) (, ,) (NP (NP (NN trimetaphan) (NNS Doc_6673474_562_573_Disease)) (PP (TO to) (NP (CD 20) (NN %)))) (VP (VBP mean) (NP (NN blood) (NN pressure) (NN decrease))) (. .)))
6673474	4	(ROOT (S (NP (NNP Cardiac) (NN work)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN reduced) (PP (IN during) (NP (NNP SNP) (NNP Doc_6673474_661_672_Disease))))) (. .)))
6673474	5	(ROOT (S (NP (NP (JJ Myocardial) (JJ Doc_6673474_685_687_Chemical) (NN consumption)) (CC and) (NP (JJ Doc_6673474_704_706_Chemical) (NN availability))) (VP (VBD were) (ADJP (RB directly) (JJ dependent)) (PP (IN on) (NP (DT the) (JJ coronary) (NN perfusion)))) (. .)))
6673474	6	(ROOT (S (NP (NP (JJ Careful) (NN invasive) (NN monitoring)) (PP (PP (IN of) (NP (NP (DT the) (NN blood) (NN pressure)) (, ,) (NP (NN blood) (NNS gases)))) (CC and) (PP (IN of) (NP (DT the) (NNP ECG) (NNP ST-T) (NN segment))))) (VP (VBZ is) (NP (JJ mandatory))) (. .)))
6687006	0	(ROOT (S (NP (NP (NN Evidence)) (PP (IN for) (NP (NP (DT a) (JJ selective) (NN brain) (NN noradrenergic) (NN involvement)) (PP (IN in) (NP (DT the) (NN locomotor)))))) (VP (VBZ stimulant) (NP (NP (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_6687006_95_106_Chemical)) (PP (IN in) (NP (DT the) (NN rat))))))) (. .)))
6687006	1	(ROOT (S (NP (JJ Male) (NNS rats)) (VP (VBD received) (NP (NP (DT the) (JJ Doc_6687006_142_155_Chemical) (NN neurotoxin) (NNS Doc_6687006_167_171_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN mg/kg)) (-RRB- -RRB-))) (PP (ADVP (NP (CD 7) (NNS days)) (RB prior)) (TO to) (NP (NP (NN injection)) (PP (IN of) (NP (NP (NNS Doc_6687006_212_225_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 10) (CC or) (CD 40)) (NN mumol/kg) (NN i.p.)) (-RRB- -RRB-))))))) (. .)))
6687006	2	(ROOT (S (NP (NP (DT The) (NNS Doc_6687006_256_269_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_6687006_281_294_Chemical)))) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mumol/kg)) (-RRB- -RRB-))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN reduced) (PP (IN by) (NP (JJ Doc_6687006_338_342_Chemical) (NN pretreatment))))) (. .)))
6687006	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (VBN increased) (NNS rearings)) (CC and) (NP (DT the) (NN Doc_6687006_397_408_Chemical-induced) (NNS stereotypies))) (VP (VBD were) (RB not) (VP (VBN blocked) (PP (IN by) (NP (NN pretreatment))) (PP (IN with) (NP (NNS Doc_6687006_468_472_Chemical))))) (. .)))
6687006	4	(ROOT (S (NP (NP (DT The) (NN reduction)) (PP (IN of) (NP (NP (JJ Doc_6687006_491_502_Chemical) (NNS Doc_6687006_503_516_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_6687006_528_532_Chemical))))))) (VP (VBD was) (VP (VBN blocked) (PP (IN by) (NP (NN pretreatment))) (PP (IN with) (NP (NP (DT the) (NN Doc_6687006_570_583_Chemical-uptake)) (VP (VBG blocking) (NP (NP (NN agent)) (, ,) (NP (NNS Doc_6687006_607_618_Chemical)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ prevents) (NP (NP (DT the) (JJ Doc_6687006_639_649_Disease) (NN action)) (PP (IN of) (NP (NNS Doc_6687006_660_664_Chemical))))))))))))) (. .)))
6687006	5	(ROOT (S (NP (DT The) (JJ present) (NNS results)) (VP (VBP suggest) (NP (NP (DT a) (JJ selective) (NN involvement)) (PP (IN of) (NP (NP (JJ central) (JJ noradrenergic) (NNS neurones)) (PP (IN in) (NP (NP (DT the) (NN locomotor) (NN stimulant) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_6687006_789_800_Chemical)) (PP (IN in) (NP (DT the) (NN rat))))))))))) (. .)))
6695685	0	(ROOT (S (VP (VB Accelerated) (NP (NNS Doc_6695685_12_30_Disease)) (PP (IN during) (NP (JJ oral) (JJ Doc_6695685_43_52_Chemical) (NN therapy)))) (. .)))
6695685	1	(ROOT (S (NP (DT This) (NN study)) (VP (VBD examined) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (JJ Doc_6695685_99_133_Disease) (CC and) (JJ accelerated) (NNS Doc_6695685_150_168_Disease)))) (PP (IN in) (NP (NP (CD 59) (NNS patients)) (VP (VBG receiving) (NP (JJ oral) (NNS Doc_6695685_199_208_Chemical)))))) (. .)))
6695685	2	(ROOT (S (NP (JJ Accelerated) (NNS Doc_6695685_222_240_Disease) (CC and) (NNS Doc_6695685_245_260_Disease)) (VP (VBD were) (ADJP (JJ frequent) (PP (IN in) (NP (NNS patients)))) (PP (IN with) (NP (NP (NNS Doc_6695685_292_325_Disease)) (, ,) (RB particularly) (NP (NNP AV) (JJ nodal) (NN reentry))))) (. .)))
6695685	3	(ROOT (S (NP (NP (JJ Doc_6695685_358_367_Chemical) (NN administration)) (PP (TO to) (NP (DT these) (NNS patients)))) (VP (VBD led) (PP (TO to) (NP (DT an) (JJ asymptomatic) (NN increase))) (PP (IN in) (NP (NP (NN activity)) (PP (IN of) (NP (DT these) (JJ junctional) (NNS pacemakers)))))) (. .)))
6695685	4	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ various) (NN chest) (NNS Doc_6695685_508_522_Disease))))) (, ,) (NP (NNS Doc_6695685_524_533_Chemical)) (VP (VP (RB neither) (VBD increased) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NNS Doc_6695685_569_587_Disease))))) (CC nor) (VP (VBD suppressed) (NP (PRP$ their) (NN role)) (PP (IN as) (NP (NN escape) (NNS rhythms))) (PP (IN under) (NP (ADJP (RB physiologically) (JJ appropriate)) (NNS circumstances))))) (. .)))
6728873	0	(ROOT (S (NP (NNP Interstrain)) (VP (VBD variation) (PP (IN in) (NP (JJ acute) (JJ Doc_6728873_31_36_Disease) (NN response))) (PP (TO to) (NP (NP (NNS Doc_6728873_49_57_Chemical)) (PP (IN among) (NP (JJ inbred) (NNS mice)))))) (. .)))
6728873	1	(ROOT (S (NP (NP (JJ Acute) (JJ Doc_6728873_83_88_Disease) (JJ dosage-dependent) (JJ behavioral) (NNS effects)) (PP (IN of) (NP (NNS Doc_6728873_128_136_Chemical)))) (VP (VBD were) (VP (VBN compared) (PP (IN in) (NP (JJ adult) (NNS males))) (PP (IN from) (NP (NP (CD seven) (JJ inbred) (NN mouse) (NNS strains)) (PRN (-LRB- -LRB-) (NP (NP (NNP A/J)) (, ,) (NP (NNP BALB/cJ) (, ,) (NNP CBA/J) (, ,) (NNP C3H/HeJ) (, ,) (NNP C57BL/6J) (, ,) (NNP DBA/2J) (, ,) (NNP SWR/J))) (-RRB- -RRB-)))))) (. .)))
6728873	2	(ROOT (S (NP (NP (NNP C57BL/6J)) (, ,) (VP (VBN chosen) (PP (IN as) (NP (DT a) (`` ``) (NN prototypic) ('' '') (NN mouse) (NN strain)))) (, ,)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (NP (JJ behavioral) (NNS responses)) (PP (TO to) (NP (NP (NP (DT a) (JJ broad) (NN range)) (PRN (-LRB- -LRB-) (NP (CD 5-500) (NN mg/kg)) (-RRB- -RRB-))) (PP (IN of) (NP (JJ Doc_6728873_381_389_Chemical) (NNS doses)))))))))) (. .)))
6728873	3	(ROOT (S (NP (NP (CD Five) (JJ phenotypic) (NNS characteristics)) (PRN (: --) (RRC (NP (NP (NN locomotor) (NN activity)) (, ,) (NP (JJ righting) (NN ability)) (, ,) (NP (JJ clonic) (JJ Doc_6728873_475_482_Disease) (NN induction)) (, ,) (NP (JJ stress-induced) (NN lethality)) (, ,) (NP (NNS Doc_6728873_520_525_Disease))) (PP (IN without) (NP (JJ external) (NN stress)))) (: --))) (VP (VBD were) (VP (VBN scored) (PP (IN at) (NP (NP (JJ various) (JJ Doc_6728873_574_582_Chemical) (NNS doses)) (PP (IN in) (NP (JJ drug-naive) (NNS animals))))) (PP (IN under) (NP (ADJP (RB empirically) (JJ optimized) (, ,) (RB rigidly) (JJ constant)) (JJ experimental) (NNS conditions))))) (. .)))
6728873	4	(ROOT (S (NP (NP (NNS Mice)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 12)))) (PP (IN for) (NP (DT each) (NN point)))) (-RRB- -RRB-))) (VP (VBD received) (NP (NP (JJ single) (NNP IP) (NNS injections)) (PP (IN of) (NP (NP (DT a) (VBN fixed) (JJ volume/g) (NN body) (NN weight)) (PP (IN of) (NP (JJ physiological) (NN saline) (NN carrier)))))) (PP (IN with) (CC or) (IN without) (NP (NNS Doc_6728873_821_829_Chemical))) (PP (IN in) (NP (NP (NNS doses)) (VP (VBG ranging) (PP (IN from) (NP (CD 125-500) (NN mg/kg))))))) (. .)))
6728873	5	(ROOT (S (NP (NP (NN Loss)) (PP (IN of) (NP (JJ righting) (NN ability)))) (VP (VBD was) (VP (VBN scored) (PP (IN at) (NP (NP (CD 1)) (, ,) (NP (CD 3)) (, ,) (NP (CD 5) (NN min) (NN post) (NN dosing)) (CC and) (ADVP (IN at) (NP (QP (CD 5) (CD min)) (NNS intervals)) (ADVP (RB thereafter) (PP (IN for) (NP (CD 20))))) (NP (NN min)))))) (. .)))
6728873	6	(ROOT (S (PP (IN In) (NP (DT the) (JJ same) (NNS animals))) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NNS Doc_6728873_1014_1029_Disease)))) (VP (VBD was) (VP (VBN scored) (PP (IN as) (PP (TO to) (NP (NP (NN time)) (PP (IN of) (NP (NN onset) (CC and) (NN severity)))))) (PP (IN for) (NP (CD 20) (NN min))) (PP (IN after) (NP (NN drug) (NN administration))))) (. .)))
6728873	7	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (DT these)) (VP (VBD proceeded) (PP (TO to) (NP (NN tonic) (NNS Doc_6728873_1142_1150_Disease)))))) (, ,) (NP (NNS Doc_6728873_1152_1157_Disease)) (VP (VBD occurred) (PP (IN in) (NP (QP (JJR less) (IN than) (CD 20)) (NN min)))) (. .)))
6728873	8	(ROOT (S (S (NP (NP (NNS Animals)) (VP (VBG surviving) (PP (IN for) (NP (CD 20) (NN min))))) (VP (VBD were) (ADVP (RB immediately)) (VP (VBN stressed) (PP (IN by) (NP (NP (DT a) (JJ swim) (NN test)) (PP (IN in) (NP (CD 25) (NNP degrees) (NNP C) (NN water)))))))) (, ,) (CC and) (S (NP (NN Doc_6728873_1285_1290_Disease-producing) (NN tonic) (NNS Doc_6728873_1307_1315_Disease)) (VP (VBD were) (VP (VBN scored) (PP (IN for) (NP (CD 2) (NN min)))))) (. .)))
6728873	9	(ROOT (S (PP (IN In) (NP (JJ other) (NNS animals))) (NP (NN locomotor) (NN activity)) (VP (VBD was) (VP (VBN measured) (NP (QP (CD 15) (CC or) (CD 60)) (NN min)) (PP (IN after) (NP (JJ Doc_6728873_1407_1415_Chemical) (NN administration))))) (. .)))
6728873	10	(ROOT (S (PP (IN By) (NP (NP (DT any) (JJ single) (JJ behavioral) (NN criterion)) (CC or) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (DT these) (NNS criteria)))))) (, ,) (NP (NP (JJ marked) (NNS differences)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (JJ Doc_6728873_1537_1542_Disease) (JJ Doc_6728873_1543_1551_Chemical) (NNS doses)))))) (VP (VBD were) (VP (VBN observed) (PP (IN between) (NP (NNS strains))))) (. .)))
6728873	11	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ behavioral) (JJ Doc_6728873_1628_1636_Disease) (NN testing)) (PP (IN of) (NP (NP (NNS Doc_6728873_1648_1662_Chemical)) (PP (IN in) (NP (DT a) (JJ single) (NN mouse) (NN strain)))))) (VP (MD may) (VP (VP (VB be) (ADJP (JJ misleading))) (CC and) (VP (VB suggest) (SBAR (IN that) (S (NP (NP (JJ Doc_6728873_1723_1728_Disease) (NNS responses)) (PP (IN of) (NP (NP (DT the) (JJ central) (JJ nervous) (NN system)) (PP (TO to) (NP (NP (DT this) (NN class)) (PP (IN of) (NP (NNS compounds)))))))) (VP (VBP are) (ADJP (RB genetically) (JJ influenced) (PP (IN in) (NP (NNS mammals))))))))))))) (. .)))
6806735	0	(ROOT (NP (NP (NNP Treatment)) (PP (IN of) (NP (NP (NNS Doc_6806735_13_27_Disease)) (PP (IN with) (NP (DT a) (NN combination))))) (PP (IN of) (NP (NNS Doc_6806735_50_62_Chemical) (, ,) (NNS Doc_6806735_64_74_Chemical) (, ,) (NNS Doc_6806735_76_92_Chemical) (CC and) (NNS Doc_6806735_97_115_Chemical))) (. .)))
6806735	1	(ROOT (S (PP (IN During) (NP (DT the) (JJ last) (CD 2 1/2) (NNS years))) (, ,) (NP (NP (CD 38) (NNS patients)) (PP (IN with) (NP (NNS Doc_6806735_163_177_Disease)))) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NP (NP (NNS Doc_6806735_213_224_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CPDD)) (-RRB- -RRB-))) (, ,) (NP (NP (CD 50) (NNS mg/m2)) (, ,) (NP (NNS Doc_6806735_243_253_Chemical)) (, ,) (NP (CD 30) (NNS mg/m2)) (, ,) (NP (NNS Doc_6806735_265_281_Chemical)) (, ,) (NP (CD 300) (NNS mg/m2)) (, ,) (PP (IN on) (NP (NN day) (CD 1)))) (: ;) (CC and) (NP (NP (JJ Doc_6806735_308_326_Chemical) (-LRB- -LRB-) (NNS Doc_6806735_328_331_Chemical) (-RRB- -RRB-)) (, ,) (NP (CD 6) (VBG mg/kg) (NN daily)) (, ,) (PP (IN for) (NP (CD 14) (NNS days)))))))))) (. .)))
6806735	2	(ROOT (S (S (NP (DT Each) (NN course)) (VP (VBD was) (VP (VBN repeated) (ADVP (RB monthly)))) (. .)) (NP (CD 2) (NNS patients)) (VP (VBD had) (VP (NN stage) (NP (NP (NNP II)) (, ,) (NP (CD 14) (NN stage) (NNP III)) (CC and) (NP (NP (CD 22) (NN stage)) (SBAR (S (NP (NP (NNP IV) (NNP disease) (. .)) (SBAR (S (NP (NP (CD 14)) (PP (IN of) (NP (DT the) (CD 38) (NNS patients)))) (VP (VBD were) (ADVP (RB previously)) (VP (VBN treated) (PP (IN with) (NP (NP (NN chemotherapy)) (, ,) (NP (NP (CD 1)) (PP (IN with) (NP (NN radiation)))) (, ,) (NP (NP (CD 6)) (PP (IN with) (NP (DT both) (NN chemotherapy) (CC and) (NN radiation)))) (, ,) (CC and) (NP (NP (NP (CD 17)) (SBAR (S (VP (VBD did) (RB not) (VP (VB have) (NP (NP (DT any) (NN treatment)) (PP (IN before) (NP (JJ CPDD) (NN combination))))))))) (. .) (NP (NP (CD 31)) (PP (IN of) (NP (DT the) (CD 38) (NNS cases))))))))))) (PRN (-LRB- -LRB-) (NP (CD 81.5) (NN %)) (-RRB- -RRB-))) (VP (VBD demonstrated) (NP (NP (JJ objective) (NNS responses)) (VP (VBG lasting) (PP (IN for) (NP (CD 2) (NNS months) (QP (CC or) (JJR more))))))))))))) (. .)))
6806735	3	(ROOT (S (NP (DT These) (NNS responses)) (VP (VBD were) (ADJP (ADJP (JJ partial) (PP (IN in) (NP (CD 19)))) (CC and) (ADJP (JJ complete) (PP (IN in) (NP (CD 12) (NNS cases)))))) (. .)))
6806735	4	(ROOT (S (NP (NNP Doc_6806735_792_812_Disease)) (VP (VBD was) (UCP (ADJP (JJ moderate)) (CC and) (PP (IN with) (NP (NP (JJ reversible) (NNS Doc_6806735_846_852_Disease)) (VP (VBG developing) (PP (IN in) (NP (NP (CD 71) (NN %)) (PP (IN of) (NP (NNS patients)))))))))) (. .)))
6806735	5	(ROOT (S (NP (NP (JJ Gastrointestinal) (NN side) (NNS effects)) (PP (IN from) (NP (NNP CPDD)))) (VP (VBD were) (ADJP (JJ universal))) (. .)))
6806735	6	(ROOT (S (NP (NNP HMM) (NNP Doc_6806735_944_969_Disease)) (VP (VBD necessitated) (NP (NP (NN discontinuation)) (PP (IN of) (NP (DT the) (NN drug)))) (PP (IN in) (NP (CD 5) (NNS patients)))) (. .)))
6806735	7	(ROOT (S (NP (NNP Severe)) (ADVP (RB nephrotoxicity)) (VP (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (CD 2) (NNS patients))))) (CC but) (VP (VBD was) (ADJP (JJ reversible)))) (. .)))
6806735	8	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (DT no) (JJ drug-related) (NNS Doc_6806735_1122_1128_Disease))) (. .)))
6884395	0	(ROOT (NP (NP (NNP Nontraumatic)) (VP (VBG dissecting) (NP (NNS Doc_6884395_24_54_Disease))) (. .)))
6884395	1	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (JJ nontraumatic) (JJ dissecting) (NNS Doc_6884395_90_120_Disease)) (PP (IN in) (NP (NP (NN association)) (PP (IN with) (NP (NP (NNS Doc_6884395_141_153_Disease)) (, ,) (NP (NN smoke)) (, ,) (CC and) (NP (JJ oral) (NNS contraceptives))))))))) (VP (VBZ is) (VP (VBN reported) (PP (IN in) (NP (NP (DT a) (JJ young) (JJ female) (NN patient)) (PP (IN with) (NP (DT a) (NNS Doc_6884395_231_249_Disease))))))) (. .)))
689020	0	(ROOT (NP (NP (DT A) (NN method)) (PP (IN for) (NP (NP (NP (DT the) (NN measurement)) (PP (IN of) (NP (NNS Doc_689020_32_38_Disease)))) (, ,) (CC and) (NP (NP (DT a) (NN comparison)) (PP (IN of) (NP (DT the) (NNS effects)))))) (PP (IN of) (NP (JJ tocolytic) (NNS beta-mimetics))) (. .)))
689020	1	(ROOT (S (NP (NP (DT A) (NN method)) (VP (VBG permitting) (NP (NP (NN measurement)) (PP (IN of) (NP (NN finger) (NNS Doc_689020_142_148_Disease)))) (PP (IN as) (NP (DT a) (JJ displacement-time) (NN curve))))) (VP (VBZ is) (VP (VBN described) (, ,) (S (VP (VBG using) (NP (DT a) (NN test) (NN system)) (PP (IN with) (NP (JJ simple) (NN amplitude) (NN calibration))))))) (. .)))
689020	2	(ROOT (S (NP (NP (DT The) (NN coordinates)) (PP (IN of) (NP (NP (DT the) (NN inversion) (NNS points)) (PP (IN of) (NP (DT the) (JJ displacement-time) (NNS curves)))))) (VP (VBD were) (VP (VBN transferred) (PP (IN through) (NP (JJ graphical) (NN input) (NN equipment))) (PP (TO to) (NP (JJ punched) (NN tape))))) (. .)))
689020	3	(ROOT (S (PP (IN By) (NP (NP (NNS means)) (PP (IN of) (NP (DT a) (NN computer) (NN program))))) (, ,) (NP (NP (NNS periods) (CC and) (NNS amplitudes)) (PP (IN of) (NP (JJ Doc_689020_445_451_Disease) (NNS oscillations)))) (VP (VBD were) (VP (VBN calculated) (CC and) (VBN classified))) (. .)))
689020	4	(ROOT (S (NP (NP (DT The) (NN event) (NN frequency)) (PP (IN for) (NP (NP (DT each) (NN class)) (PP (IN of) (NP (NNS periods) (CC and) (NNS amplitudes)))))) (VP (VBD was) (VP (VBN determined))) (. .)))
689020	5	(ROOT (S (NP (NP (DT The) (NNS actions)) (PP (IN of) (NP (NN Doc_689020_589_598_Chemical-Doc_689020_599_611_Chemical) (, ,) (NN Doc_689020_613_621_Chemical-Doc_689020_622_625_Chemical) (CC and) (NN placebo))) (PP (VBN given) (PP (TO to) (NP (NP (CD 10) (JJ healthy) (NNS subjects)) (PP (IN by) (NP (NP (JJ intravenous) (NN infusion)) (PP (IN in) (NP (DT a) (JJ double-blind) (NN crossover) (NN study))))))))) (VP (VBD were) (VP (VBN tested) (PP (IN by) (NP (DT this) (NN method))))) (. .)))
689020	6	(ROOT (S (PP (IN At) (NP (JJ therapeutic) (NNS doses))) (NP (DT both) (NNS substances)) (VP (VBD raised) (NP (DT the) (JJ mean) (JJ Doc_689020_806_812_Disease) (NN amplitude)) (PP (TO to) (NP (QP (RB about) (CD three)))) (PP (CC times) (NP (DT the) (NN control) (NN level)))) (. .)))
689020	7	(ROOT (S (PP (IN At) (NP (DT the) (JJ same) (NN time))) (, ,) (NP (NP (NP (DT the) (JJ mean) (NN period)) (PP (IN within) (NP (NP (DT each) (NN class)) (PP (IN of) (NP (NP (NNS amplitudes)) (VP (VBN shortened) (PP (IN by) (NP (CD 10))))))))) (: --) (NP (CD 20) (NN ms)) (, ,) (SBAR (IN whereas) (S (NP (DT the) (JJ mean) (NNS periods)) (VP (VBN calculated) (PP (IN from) (NP (DT all) (NNS oscillations))))))) (ADVP (RB together)) (VP (VBD did) (RB not) (VP (VB change) (ADVP (RB significantly)))) (. .)))
689020	8	(ROOT (S (PP (IN After) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (NN Doc_689020_1067_1076_Chemical-Doc_689020_1077_1089_Chemical) (NN infusion))))) (, ,) (NP (JJ Doc_689020_1100_1106_Disease) (NNS amplitudes)) (VP (VBD decreased) (ADJP (RB significantly) (JJR faster)) (PP (IN than) (NP (DT those) (JJ following) (JJ Doc_689020_1170_1182_Chemical) (NN infusion)))) (. .)))
6893265	0	(ROOT (NP (CD Doc_6893265_0_16_Chemical-induced) (NNS Doc_6893265_25_39_Disease) (. .)))
6893265	1	(ROOT (S (NP (NP (CD Two) (NNS cases)) (PP (IN of) (NP (NN Doc_6893265_54_70_Chemical-induced) (NNS Doc_6893265_79_91_Disease)))) (VP (VBP have) (VP (VBN been) (VP (VBN observed)))) (. .)))
6893265	2	(ROOT (S (S (NP (DT The) (JJ first) (NN case)) (VP (VBZ is) (PP (IN of) (NP (NP (DT an) (JJ acute) (NN type)) (PP (IN of) (NP (NN damage))) (, ,) (VP (VBN proven) (PP (IN by) (NP (NN rechallenge)))))))) (: ;) (S (NP (DT the) (NN second)) (VP (VBZ presents) (NP (NP (DT a) (JJ clinical) (CC and) (JJ histologic) (NN picture)) (VP (VBG resembling) (NP (NNS Doc_6893265_246_270_Disease)) (, ,) (PP (IN with) (NP (JJ spontaneous) (NN remission))))))) (. .)))
6985297	0	(ROOT (S (NP (NP (NNS Studies)) (PP (IN on) (NP (DT the) (NNS Doc_6985297_15_26_Disease)))) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_6985297_38_46_Chemical)))) (. .)))
6985297	1	(ROOT (S (NP (NP (NNP Doc_6985297_48_56_Chemical)) (, ,) (NP (NP (DT a) (JJ novel) (JJ active) (NN compound)) (PP (IN for) (NP (NP (JJ prophylactic) (NN treatment)) (PP (IN of) (NP (NNS Doc_6985297_112_127_Disease)))))) (, ,)) (VP (VBN induced) (NP (NP (NP (JJ persistent) (NNS Doc_6985297_148_159_Disease)) (CC and) (NP (DT a) (JJ non-specific) (JJ anti-tachycardial) (NN effect))) (, ,) (NP (NP (DT the) (NNS mechanisms)) (PP (IN of) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN investigated) (PP (IN in) (UCP (ADJP (NN vitro)) (CC and) (PP (IN in) (NP (NN vivo))))))))))))) (. .)))
6985297	2	(ROOT (SINV (PP (IN In) (NP (NP (JJ vitro) (NN perfusion)) (PP (IN of) (NP (NP (NNS Doc_6985297_291_299_Chemical)) (PP (IN in) (NP (DT the) (JJ life-support) (NN medium))))))) (VP (PP (IN for) (NP (NP (VBN isolated) (JJ sino-atrial) (NN tissue)) (PP (IN from) (NP (NN rabbit) (NN heart))))) (, ,) (VBD caused) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN action) (NN potential))) (PRN (-LRB- -LRB-) (NP (NNP AP)) (-RRB- -RRB-)) (NP (NP (NP (JJ spike) (NN frequency)) (PRN (-LRB- -LRB-) (VP (VBN recorded) (PP (IN by) (NP (JJ Doc_6985297_451_454_Chemical) (NNS microelectrodes)))) (-RRB- -RRB-))) (VP (VBG starting) (PP (IN at) (NP (NP (NNS doses)) (PP (IN of) (NP (NP (CD 5) (NNP X) (CD 10)) (PRN (-LRB- -LRB-) (NP (CD -6)) (-RRB- -RRB-)))))))))) (NP (NNP M.))))
6985297	3	(ROOT (S (NP (DT This) (NN effect)) (VP (VBD was) (ADJP (ADJP (JJ dose-dependent) (IN up)) (PP (TO to) (NP (NP (NNS concentrations)) (PP (IN of) (NP (NP (CD 5) (NNP X) (CD 10)) (PRN (-LRB- -LRB-) (NP (CD -5)) (-RRB- -RRB-))))))) (NP (NP (NNP M)) (, ,) (NP (NP (NN whereupon) (NN blockade)) (PP (IN of) (NP (NP (JJ sinus) (NN activity)) (VP (VBN set) (PP (IN in)))))))) (. .)))
6985297	4	(ROOT (SINV (VP (VBG Doc_6985297_621_629_Chemical) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 5)))))) (VP (VBZ X) (NP (CD 10))) (PRN (-LRB- -LRB-) (NP (CD -6)) (-RRB- -RRB-)) (NP (NP (NP (NP (NNP M)) (, ,) (VP (VBN induced) (NP (NP (NP (DT a) (JJ concomitant) (NN reduction)) (PP (IN in) (NP (NNP AP) (NN amplitude)))) (PRN (-LRB- -LRB-) (VP (VBG falling) (PP (IN from) (NP (NP (CD 71) (JJ +) (NNS /)) (PRN (: -) (NP (QP (CD 8) (CD mV) (TO to) (CD 47) (CD +))) (: /)) (: -) (NP (CD 6) (NN mV))))) (-RRB- -RRB-)) (, ,) (NP (NP (NP (JJ maximum) (JJ systolic) (NN depolarization) (NN velocity)) (PRN (-LRB- -LRB-) (NP (NN phase) (CD 0)) (-RRB- -RRB-)) (SBAR (WHNP (WDT which)) (S (VP (VBD fell) (SBAR (FRAG (FRAG (PP (IN from) (NP (CD 1.85))) (NP (CD +)) (: /)) (: -) (FRAG (ADJP (NP (CD 0.35)) (JJ V/s) (PP (TO to) (NP (CD 0.84) (NNS +)))) (: /)))))))) (PRN (: -) (NP (NP (NP (CD 0.28) (NNS V/s)) (, ,) (ADVP (RB together))) (PP (IN with) (NP (NP (JJ maximum) (JJ diastolic) (NN depolarization) (NN velocity)) (PRN (-LRB- -LRB-) (NP (NN phase) (CD 4)) (-RRB- -RRB-)))) (SBAR (WHNP (WDT which)) (S (VP (VBD fell) (PP (IN from) (NP (CD 38) (NNS +))))))) (: /)))))) (PRN (: -) (NP (NP (CD 3) (NNS mV/s)) (PP (TO to) (NP (CD 24) (NNS +)))) (: /))) (: -) (NP (CD 5) (NNS mV/s))) (. .)))
6985297	5	(ROOT (S (PP (IN In) (NP (NP (NN vivo) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_6985297_990_998_Chemical)) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 5) (NN mg/kg) (PRN (-LRB- -LRB-) (NP (NNP i.v.)) (-RRB- -RRB-))) (PP (IN into) (NP (NP (CD 6) (JJ anaesthetized) (NNS dogs)) (SBAR (WHNP (WDT which)) (S (VP (VBD had) (VP (VBN undergone) (NP (NP (NN ablation)) (PP (IN of) (NP (PDT all) (DT the) (JJ extrinsic) (JJ cardiac) (NN afferent) (NN nerve) (NN supply)))))))))))))))))) (, ,) (ADVP (RB together) (PP (IN with) (NP (DT a) (JJ bilateral) (NN medullo-adrenalectomy)))) (, ,) (VP (VBD caused) (NP (NP (NP (DT a) (JJ marked) (NN reduction)) (PP (IN in) (NP (NN heart) (NN rate))) (SBAR (WHNP (WDT which)) (S (VP (VBD fell) (SBAR (FRAG (FRAG (PP (IN from) (NP (CD 98.7))) (NP (CD +)) (: /)) (: -) (FRAG (ADJP (NP (CD 4.2)) (JJ beats/min) (PP (TO to) (NP (CD 76) (NNS +)))) (: /)))))))) (: -) (NP (NP (CD 5.3) (NN beats/min)) (VP (VBN sustained) (PP (IN for) (NP (QP (JJR more) (IN than) (CD 45)) (NN min))))))) (. .)))
6985297	6	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (NNS Doc_6985297_1339_1347_Chemical)) (VP (VBZ reduces) (NP (NN heart) (NN rate)) (PP (IN by) (S (VP (VBG acting) (ADVP (RB directly)) (PP (IN on) (NP (DT the) (JJ sinus) (NN node))))))))))) (. .)))
6985297	7	(ROOT (S (NP (NP (DT This) (NN effect)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (NN flattening)) (PP (IN of) (NP (DT the) (NN phase) (CD 0)))) (CC and) (NP (NP (NN phase)) (NP (CD 4) (NN slope)) (, ,) (ADVP (RB together))))) (PP (IN with) (NP (DT a) (JJR longer) (NNP AP) (NN duration)))))) (, ,)) (VP (MD may) (VP (VB be) (ADJP (JJ due)) (PP (PP (TO to) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN time) (NNS constants)) (PP (IN of) (NP (NP (JJ slow) (JJ inward) (JJ ionic) (NNS currents)) (PRN (-LRB- -LRB-) (VP (ADVP (RB already)) (VBN demonstrated) (ADVP (RB elsewhere))) (-RRB- -RRB-)))))))) (, ,) (CONJP (CC but) (RB also)) (PP (TO to) (NP (NP (DT an) (VBN increased) (NN time)) (ADJP (JJ constant) (PP (IN for) (NP (NP (NN deactivation)) (PP (IN of) (NP (NP (DT the) (JJ outward) (JJ Doc_6985297_1701_1710_Chemical) (NN current)) (PRN (-LRB- -LRB-) (NP (NNP Ip)) (-RRB- -RRB-)))))))))))) (. .)))
6985498	0	(ROOT (NP (NP (NNS Doc_6985498_0_9_Disease) (CC and) (NNS Doc_6985498_14_36_Disease)) (PP (IN after) (NP (NN anesthesia))) (PP (IN with) (NP (NNS Doc_6985498_59_73_Chemical))) (. .)))
6985498	1	(ROOT (S (NP (NP (DT A) (JJ 69-year-old) (NN man)) (VP (VBN operated) (PP (IN for) (NP (JJ acute) (NNS Doc_6985498_112_125_Disease))) (PP (IN under) (NP (JJ Doc_6985498_132_146_Chemical) (NN anesthesia))))) (VP (VBD developed) (ADVP (RB postoperatively)) (NP (DT a) (NNS Doc_6985498_186_216_Disease) (CC and) (NNS Doc_6985498_221_243_Disease))) (. .)))
6985498	2	(ROOT (S (NP (JJ Massive) (NNS Doc_6985498_253_261_Disease)) (VP (VBD appeared) (PP (IN during) (NP (NP (NN surgery)) (SBAR (WHNP (WDT which)) (S (VP (VBD lasted) (PP (IN for) (NP (CD six) (NNS hours))))))))) (. .)))
6985498	3	(ROOT (S (NP (NP (JJ Postoperative) (NN evolution)) (PP (IN under) (NP (ADJP (JJ supportive)) (NN therapy)))) (VP (VBD was) (ADJP (JJ favourable))) (. .)))
6985498	4	(ROOT (S (NP (JJ Complete) (NN recovery)) (VP (VBD was) (VP (VBN confirmed) (PP (IN by) (NP (NP (VBN repeated) (NNS controls)) (VP (VBN performed) (PP (IN over) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (CD one))))) (NP (NN year)) (PP (IN after) (NP (NN surgery)))))))) (. .)))
7018927	0	(ROOT (NP (NP (JJ Pituitary) (NN response)) (PP (TO to) (S (VP (VBG luteinizing) (NP (JJ hormone-releasing) (NN hormone)) (PP (IN during) (NP (NN Doc_7018927_67_78_Chemical-induced) (NNS Doc_7018927_87_105_Disease)))))) (. .)))
7018927	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (DT a) (JJ 6-hour) (NN infusion)) (PP (IN with) (NP (NP (NP (NNS Doc_7018927_145_156_Chemical)) (PP (IN on) (NP (NN serum) (NN prolactin)))) (CC and) (NP (JJ luteinizing) (NN hormone) (PRN (-LRB- -LRB-) (NP (NNP LH)) (-RRB- -RRB-)) (NNS levels))))))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (JJ male) (NNS subjects))))))) (. .)))
7018927	2	(ROOT (S (PP (NP (CD Five) (NNS hours)) (IN after) (S (VP (VBG starting) (NP (DT the) (NNS infusions))))) (, ,) (NP (NP (NP (DT a) (NN study)) (PP (IN of) (NP (NP (DT the) (JJ pituitary) (NNS responses)) (PP (TO to) (NP (JJ LH-releasing) (NN hormone)))))) (PRN (-LRB- -LRB-) (NP (NNP LH-RH)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN carried) (PRT (RP out)))) (. .)))
7018927	3	(ROOT (S (NP (NNP Control) (NNS patients)) (VP (VBD received) (NP (NP (NNS infusions)) (PP (IN of) (NP (ADJP (CD 0.9) (NN %)) (JJ Doc_7018927_422_426_Chemical) (NN solution))))) (. .)))
7018927	4	(ROOT (S (PP (IN During) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (JJ Doc_7018927_458_469_Chemical) (NNS infusions))))) (, ,) (NP (JJ significant) (NNS Doc_7018927_493_511_Disease)) (VP (VBD was) (VP (VBN found) (, ,) (PP (PP (ADVP (RB together)) (IN with) (NP (NP (DT an) (JJ abolished) (NN pituitary) (NN response)) (PP (TO to) (NP (NNP LH-RH))))) (, ,) (RB as) (PP (VBN compared) (PP (IN with) (NP (NP (NNS responses)) (PP (IN of) (NP (NN control) (NNS subjects))))))))) (. .)))
7121659	0	(ROOT (S (NP (NP (NP (NP (VBG Doc_7121659_0_14_Chemical) (NNS antibodies)) (PP (IN in) (NP (JJ acute) (NN Doc_7121659_35_45_Chemical-associated) (NNS Doc_7121659_57_70_Disease)))) (. .) (NP (NP (CD 5) (NNS patients)) (PP (IN with) (NP (NNS Doc_7121659_88_107_Disease))))) (PRN (-LRB- -LRB-) (NP (NP (CD 3)) (PP (IN with) (NP (NNS Doc_7121659_116_128_Disease) (CC and) (NNS Doc_7121659_133_142_Disease)))) (-RRB- -RRB-))) (VP (VBN induced) (PP (IN by) (NP (NP (DT the) (NN reintroduction)) (PP (IN of) (NP (NP (NNS Doc_7121659_177_187_Chemical)) (SBAR (S (VP (VBP are) (VP (VBN described)))))))))) (. .)))
7121659	1	(ROOT (S (NP (DT No) (NN correlation)) (VP (VBD was) (VP (VBN found) (PP (IN between) (NP (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (JJ clinical) (NNS manifestations)))) (CC and) (NP (NP (DT the) (JJ total) (NN dose)) (VP (VBN taken) (PP (IN by) (NP (DT the) (NNS patients))))))))) (. .)))
7121659	2	(ROOT (S (PP (IN In) (NP (QP (DT all) (CC but) (CD 1)) (NN patient))) (, ,) (NP (JJ Doc_7121659_340_354_Chemical) (NNS antibodies)) (VP (VBD were) (VP (VBN detected))) (. .)))
7121659	3	(ROOT (S (NP (NP (NNS Antibodies)) (VP (VBN suggested) (S (VP (TO to) (VP (VB be) (PP (IN of) (NP (DT the) (NNP IgM) (NN class)))))))) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (DT all) (CD 3) (NNS patients))) (PP (IN with) (NP (NNS Doc_7121659_462_485_Disease))))) (. .)))
7121659	4	(ROOT (S (NP (NP (DT The) (NN pattern)) (PP (IN of) (NP (JJ non-specific) (NNS Doc_7121659_515_537_Disease)))) (VP (VBD found) (SBAR (IN in) (S (NP (NP (DT the) (CD 2) (JJ biopsied) (NNS patients)) (, ,) (ADJP (JJ indistinguishable) (PP (IN from) (NP (NP (DT that)) (PP (IN of) (NP (JJ Doc_7121659_603_611_Disease) (NN origin)))))) (, ,)) (VP (VBD raised) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (DT a) (JJ vascular-mediated) (NN damage)))))))) (. .)))
7121659	5	(ROOT (S (PP (IN In) (NP (CD 3) (NNS patients))) (, ,) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (DT a) (VBG triggering) (JJ immunoallergic) (NN mechanism)))) (VP (VBZ is) (VP (VBN discussed))) (. .)))
7147232	0	(ROOT (S (NP (NP (NNP Cardiovascular) (NNS effects)) (PP (IN of) (NP (NNS Doc_7147232_26_37_Disease)))) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_7147232_49_71_Chemical) (CC and) (NNS Doc_7147232_76_96_Chemical))) (PP (IN on) (NP (NNS dogs))) (PP (IN with) (NP (JJ denervated) (NNS hearts)))) (. .)))
7147232	1	(ROOT (S (NP (NP (NP (NNP Doc_7147232_129_151_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7147232_153_156_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_7147232_162_182_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7147232_184_187_Chemical)) (-RRB- -RRB-)))) (VP (VBP are) (VP (VBN administered) (PP (TO to) (NP (NNS patients))) (S (VP (TO to) (VP (VB induce) (CC and) (VB control) (NP (NNS Doc_7147232_240_251_Disease)) (PP (IN during) (NP (NN anesthesia)))))))) (. .)))
7147232	2	(ROOT (S (S (NP (NNP Doc_7147232_271_274_Chemical)) (VP (VBZ is) (VP (VBN authorized) (PP (IN for) (NP (NP (JJ clinical) (NN use)) (PP (IN in) (NP (NNP USA) (CC and) (NNP UK)))))))) (, ,) (CC and) (S (NP (NNS Doc_7147232_325_328_Chemical)) (VP (VBZ is) (ADJP (RB clinically) (VBN used) (PP (IN in) (NP (NP (JJ other) (NNS countries)) (PP (JJ such) (IN as) (NP (NNP Japan)))))))) (. .)))
7147232	3	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (SBAR (WHADVP (WRB how)) (S (NP (DT these) (CD two) (NNS drugs)) (VP (VBP act) (PP (IN on) (NP (NP (DT the) (JJ cardiovascular) (NNS systems)) (PP (IN of) (NP (NP (CD 20) (NNS dogs)) (SBAR (WHNP (WP$ whose) (NNS hearts)) (S (VP (VBD had) (VP (VBN been) (VP (VBN denervated) (PP (IN by) (NP (NP (DT a) (NN procedure)) (SBAR (S (NP (PRP we)) (VP (VBD had) (VP (VBN devised)))))))))))))))))))) (. .)))
7147232	4	(ROOT (S (NP (NP (NP (NNP Doc_7147232_527_530_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NNS dogs)) (-RRB- -RRB-))) (CC or) (NP (NP (NNS Doc_7147232_544_547_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NNS dogs)) (-RRB- -RRB-)))) (VP (VBD was) (VP (VBN administered) (S (VP (TO to) (VP (VB reduce) (NP (JJ mean) (JJ arterial) (NN pressure)) (PP (IN by) (NP (NP (QP (CD 30) (NN %) (TO to) (CD 70) (NN %))) (PP (IN of) (NP (NN control)))))))))) (. .)))
7147232	5	(ROOT (S (ADVP (IN Before)) (, ,) (PP (PP (IN during)) (CC and) (PP (IN after) (NP (JJ induced) (NNS Doc_7147232_667_678_Disease)))) (, ,) (NP (PRP we)) (VP (VBD measured) (NP (JJ major) (NNS Doc_7147232_698_723_Disease))) (. .)))
7147232	6	(ROOT (S (S (NP (NP (NNP Doc_7147232_725_736_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_7147232_748_751_Chemical))))) (VP (VBD was) (VP (VBN accompanied) (PP (IN by) (NP (JJ significant) (NNS decreases))) (PP (IN in) (NP (NP (NP (JJ mean) (JJ pulmonary) (JJ arterial) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (, ,) (NP (NP (NP (JJ central) (NNS venous) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ left) (NN ventricular) (JJ end-diastolic) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ total) (JJ peripheral) (NN resistance)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (, ,) (NP (NP (NN rate) (NN pressure) (NN product)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ total) (NN body) (NNS Doc_7147232_1059_1065_Chemical)) (NP (NP (NN consumption)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-)))) (, ,) (CC and) (NP (NP (NN heart) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))))))))) (: ;) (S (NP (PDT all) (DT these) (NNS variables)) (VP (VBD returned) (ADJP (JJ normal) (PP (IN within) (NP (CD 30) (NN min)))) (SBAR (IN after) (S (NP (NNS Doc_7147232_1190_1193_Chemical)) (VP (VBD was) (VP (VBN stopped))))))) (. .)))
7147232	7	(ROOT (S (NP (NNP Cardiac) (NN output)) (VP (VBD did) (RB not) (VP (VB change))) (. .)))
7147232	8	(ROOT (SINV (PP (IN During) (NP (NP (NNS Doc_7147232_1245_1256_Disease)) (VP (VBN produced) (PP (IN by) (NP (JJ Doc_7147232_1269_1272_Chemical) (JJ similar) (NNS decreases)))))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (JJ mean) (JJ pulmonary) (NN arterial))))) (NP (NP (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.01))) (-RRB- -RRB-)) (, ,) (NP (NP (NP (JJ central) (NNS venous) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ left) (NN ventricular) (JJ end-diastolic) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.01))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ total) (JJ peripheral) (NN resistance)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (, ,) (NP (NP (NN rate) (NN pressure) (NN product)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ Doc_7147232_1562_1568_Chemical) (NN content) (NN difference)) (PP (IN between) (NP (NP (ADJP (JJ arterial) (CC and) (JJ mixed)) (JJ venous) (NN blood)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-)))))) (, ,) (SBAR (IN while) (S (NP (NP (NP (NN heart) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ cardiac) (NN output)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN increased)))))) (. .)))
7147232	9	(ROOT (S (NP (NP (NNS Recoveries)) (PP (IN of) (NP (NP (NN heart) (NN rate)) (CC and) (NP (JJ left) (NN ventricular) (JJ end-diastolic) (NN pressure))))) (VP (VBD were) (RB not) (VP (VBN shown) (PP (IN within) (NP (CD 60) (NN min))) (SBAR (IN after) (S (NP (NNS Doc_7147232_1843_1846_Chemical)) (VP (VBD had) (VP (VBN been) (VP (VBN stopped)))))))) (. .)))
7147232	10	(ROOT (S (NP (DT Both) (NNS Doc_7147232_1870_1873_Chemical) (CC and) (NNS Doc_7147232_1878_1881_Chemical)) (VP (MD should) (VP (VB act) (PP (IN on) (NP (NP (DT the) (NN pacemaker) (NN tissue)) (PP (IN of) (NP (DT the) (NN heart))))))) (. .)))
7173007	0	(ROOT (NP (NP (JJ Comparative) (NN study)) (: :) (NP (NP (NP (NNS Doc_7173007_19_30_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7173007_32_43_Chemical)) (-RRB- -RRB-))) (, ,) (NP (NP (NNP Vasurix) (NNP Doc_7173007_54_64_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7173007_66_77_Chemical)) (-RRB- -RRB-))) (, ,) (NP (NP (NNP Dimer-X)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7173007_89_98_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NNS Doc_7173007_104_112_Chemical)) (PRN (-LRB- -LRB-) (NP (NN ioxaglate)) (-RRB- -RRB-))) (PP (IN in) (NP (NN hysterosalpingography))))) (. .)))
7173007	1	(ROOT (S (NP (NP (NN Side) (NNS effects)) (PP (IN of) (NP (NP (NN hysterosalpingography)) (PP (IN with) (NP (JJ Dimer-X) (, ,) (NNP Hexabrix) (, ,) (NNP Vasurix) (NNS Doc_7173007_221_231_Chemical) (CC and) (NNS Doc_7173007_236_247_Chemical))) (PP (IN in) (NP (CD 142) (JJ consecutive) (NNS patients))) (, ,) (VP (VBG receiving) (NP (CD one))) (PP (IN of) (NP (DT the) (CD four)))))) (VP (VBD tested) (SBAR (S (NP (NNS media)) (VP (VBD were) (VP (VBN evaluated) (PP (IN from) (NP (NNS replies))) (PP (TO to) (NP (JJ postal) (NNS questionnaires)))))))) (. .)))
7173007	2	(ROOT (S (NP (DT The) (JJ Dimer-X) (NN group)) (VP (VBD had) (NP (NP (DT a) (JJR higher) (NN incidence)) (PP (IN of) (NP (NNS Doc_7173007_414_420_Disease) (CC and) (NNS Doc_7173007_425_434_Disease))))) (. .)))
7173007	3	(ROOT (S (NP (DT The) (JJ Doc_7173007_440_451_Chemical) (NN group)) (VP (VBD had) (NP (NP (DT a) (JJR higher) (NN incidence)) (PP (IN of) (NP (NNS Doc_7173007_484_498_Disease))))) (. .)))
7173007	4	(ROOT (S (NP (DT These) (NNS differences)) (VP (VBP occur) (ADVP (RB especially)) (PP (IN in) (NP (DT the) (NN age) (NNS groups))) (PP (IN under) (NP (CD 30) (NNS years)))) (. .)))
7173007	5	(ROOT (S (NP (NNP Hexabrix) (CC and) (NNP Vasurix) (NNS Doc_7173007_590_600_Chemical)) (VP (VBP are) (VP (VBN considered) (NP (NP (DT the) (JJS best) (NN contrast) (NNS media)) (PP (PP (IN for) (NP (NN hysterosalpingography))) (CC and) (RB perhaps) (RB because) (PP (IN of) (NP (PRP$ its) (JJ low) (NNS Doc_7173007_697_705_Disease)))) (SBAR (S (NP (NNP Hexabrix)) (VP (MD should) (VP (VB be) (VP (VBN preferred))))))))) (. .)))
7176945	0	(ROOT (NP (NP (JJ Post-Doc_7176945_5_18_Chemical) (NNS pains)) (PP (IN in) (NP (JJ Nigerian) (JJ surgical) (NNS patients))) (. .)))
7176945	1	(ROOT (S (ADVP (JJ Contrary) (PP (TO to) (NP (NP (DT an) (JJR earlier) (NN report)) (PP (IN by) (NP (NNS Doc_7176945_89_94_Chemical)))))) (, ,) (NP (JJ Doc_7176945_96_103_Chemical) (NNS Doc_7176945_104_108_Disease)) (VP (VBZ occurs) (PP (IN in) (NP (JJ African) (NNS negroes)))) (. .)))
7176945	2	(ROOT (S (NP (PRP$ Its) (NN incidence)) (VP (VBD was) (VP (VBN determined) (PP (IN in) (NP (NP (DT a) (JJ prospective) (NN study)) (PP (VBG involving) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 100) (JJ Nigerian) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 50) (NNS out-patients)) (CC and) (NP (CD 50) (NNS in-patients))) (-RRB- -RRB-)))))))))) (. .)))
7176945	3	(ROOT (S (NP (NP (QP (RB About) (CD 62)) (NN %)) (PP (IN of) (NP (DT the) (NNS out-patients)))) (VP (VBD developed) (NP (JJ Doc_7176945_309_316_Chemical) (NNS Doc_7176945_317_321_Disease)) (PP (IN as)) (PP (VBN compared) (PP (IN with) (NP (NP (QP (RB about) (CD 26)) (NN %)) (PP (IN among) (NP (DT the) (NNS in-patients))))))) (. .)))
7176945	4	(ROOT (S (NP (NP (NP (DT The) (NN abolition)) (PP (IN of) (NP (NNS Doc_7176945_389_410_Disease)))) (PRN (-LRB- -LRB-) (PP (IN by) (NP (CD 0.075))) (NP (NP (VBG mg/kg) (NN dose)) (PP (IN of) (NP (NNS Doc_7176945_434_444_Chemical)))) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB influence) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (JJ Doc_7176945_482_489_Chemical) (NNS Doc_7176945_490_494_Disease)))))) (. .)))
7176945	5	(ROOT (S (NP (DT Neither) (NP (NP (NP (NP (DT the) (NN type)) (PP (IN of) (NP (NP (NN induction) (NN agent)) (PRN (-LRB- -LRB-) (NP (NNP Althesin) (CC or) (NNP Doc_7176945_545_556_Chemical)) (-RRB- -RRB-))))) (CC nor) (NP (NP (DT the) (NN salt) (NN preparation)) (PP (IN of) (NP (NP (NNS Doc_7176945_586_599_Chemical)) (VP (VBN used)))))) (-LRB- -LRB-) (NP (NNS Doc_7176945_606_614_Chemical) (CC or) (NNS Doc_7176945_618_625_Chemical)) (-RRB- -RRB-))) (, ,) (VP (VBD affected) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ Doc_7176945_654_661_Chemical) (NNS Doc_7176945_662_666_Disease))))) (. .)))
7248895	0	(ROOT (NP (NP (JJ Invasive) (NNS Doc_7248895_9_38_Disease)) (PP (VBG following) (NP (NP (JJ Doc_7248895_49_65_Chemical) (NN therapy)) (PP (IN for) (NP (JJ nonmalignant) (NN disease))))) (. .)))
7248895	1	(ROOT (S (NP (NP (DT A) (JJ 47-year-old) (NN woman)) (PP (IN with) (NP (NP (JJ right) (NNS hydroureteronephrosis)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_7248895_160_195_Disease))))))) (VP (VBD had) (NP (JJ gross) (NNS Doc_7248895_206_215_Disease)) (PP (IN after) (S (VP (VBG being) (VP (VBN treated) (PP (IN for) (NP (NP (ADJP (NP (CD five) (NNS years)) (JJ wtih)) (NNS Doc_7248895_256_272_Chemical)) (PP (IN for) (NP (NNS Doc_7248895_277_296_Disease)))))))))) (. .)))
7248895	2	(ROOT (S (NP (DT A) (NN right)) (ADVP (RB nephroureterectomy)) (VP (VBD was) (VP (VBN required) (PP (IN for) (NP (NP (NN control)) (PP (IN of) (NP (NNS Doc_7248895_353_361_Disease))))))) (. .)))
7248895	3	(ROOT (S (NP (DT The) (JJ pathology) (NN specimen)) (VP (VBD contained) (NP (ADJP (RB clinically) (JJ occult)) (JJ invasive) (NNS Doc_7248895_423_452_Disease))) (. .)))
7248895	4	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NNS Doc_7248895_478_494_Chemical) (S (VP (TO to) (VP (VB cause) (S (NP (NNS Doc_7248895_504_524_Disease) (CC and) (NN urine) (NN cytologic) (NNS abnormalities)) (ADJP (JJ indistinguishable) (PP (IN from) (NP (JJ high) (NN grade) (NNS Doc_7248895_593_602_Disease))))))))))) (VP (VBZ is) (ADJP (RB well) (VBN known))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADVP (RBR less) (RB widely)) (VP (VBN appreciated) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_7248895_680_689_Disease)) (PP (IN of) (NP (DT the) (JJ urinary) (NN tract))))))))))) (. .)))
7248895	5	(ROOT (S (NP (NP (NNP Doc_7248895_712_729_Disease)) (PP (IN of) (NP (NP (DT the) (JJ urinary) (NN bladder)) (CC and) (NP (CD one) (NNS Doc_7248895_761_786_Disease))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NN association))) (PP (IN with) (NP (PRP$ its) (NN use)))))) (. .)))
7248895	6	(ROOT (S (NP (DT The) (JJ present) (NN case)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (NNS Doc_7248895_865_894_Disease)) (VP (VBN reported) (PP (IN in) (NP (NN association))) (PP (IN with) (NP (JJ Doc_7248895_924_940_Chemical) (NN treatment)))))) (. .)))
7248895	7	(ROOT (S (NP (PRP It)) (VP (VBZ is) (NP (NP (DT the) (JJ third) (NNS Doc_7248895_968_988_Disease)) (VP (VBN reported) (PP (IN in) (NP (NN association))) (PP (IN with) (NP (NP (JJ Doc_7248895_1018_1034_Chemical) (NN treatment)) (PP (IN for) (NP (JJ nonmalignant) (NN disease)))))))) (. .)))
7248895	8	(ROOT (S (NP (NP (DT The) (NN association)) (PP (IN of) (NP (NP (DT the) (NNS Doc_7248895_1094_1099_Disease)) (PP (IN with) (NP (VBG preexisting) (NNS hydroureteronephrosis)))))) (VP (VBZ suggests) (NP (NP (DT that) (JJ Doc_7248895_1153_1159_Disease) (ADJP (JJ prolonged) (CC and) (JJ intensified)) (NN exposure)) (PP (IN of) (NP (NP (JJ upper) (JJ urinary) (NN tract) (NN epithelium)) (PP (TO to) (NP (NNS Doc_7248895_1232_1248_Chemical))))))) (. .)))
7248895	9	(ROOT (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (NP (NP (NNS candidates)) (PP (IN for) (NP (JJ long-term) (JJ Doc_7248895_1292_1308_Chemical) (NN treatment)))))))) (VP (MD should) (VP (VB be) (VP (ADVP (RB routinely)) (VBN evaluated) (NP (NNS Doc_7248895_1349_1373_Disease))))) (. .)))
7315949	0	(ROOT (S (NP (NP (JJ Medial) (NNS changes)) (PP (IN in) (NP (JJ arterial) (NNS Doc_7315949_27_32_Disease)))) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_7315949_44_60_Chemical)))) (. .)))
7315949	1	(ROOT (S (PP (IN In) (NP (JJ normal) (NNS rats))) (, ,) (NP (NP (DT the) (NNS media)) (PP (IN of) (NP (NP (JJ small) (NNS arteries)) (PRN (-LRB- -LRB-) (NP (CD 0.4)) (: --) (NP (NP (CD 0.2) (NN mm)) (PP (IN in) (NP (NN diameter)))) (-RRB- -RRB-))))) (ADVP (RB previously)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB contain) (NP (NP (NN intracellular) (NNS vacuoles)) (, ,) (VP (VBN identified) (ADVP (RB ultrastructurally)) (PP (IN as) (NP (NP (NNS herniations)) (PP (IN of) (NP (NP (CD one) (JJ smooth) (NN muscle) (NN cell)) (PP (IN into) (NP (DT another)))))))))))))) (. .)))
7315949	2	(ROOT (S (NP (NP (DT The) (NNS hypothesis)) (SBAR (IN that) (S (NP (JJ intense) (NN vasoconstriction)) (VP (MD would) (VP (VB increase) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ such) (NNS vacuoles))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN tested)))) (. .)))
7315949	3	(ROOT (S (PP (IN In) (NP (NP (DT the) (NNS media)) (PP (IN of) (NP (NP (DT the) (JJ saphenous) (NN artery)) (CC and) (NP (PRP$ its) (JJ distal) (NN branch)))))) (, ,) (NP (NP (NN vasoconstriction)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_7315949_465_481_Chemical))))) (VP (VBD produced) (NP (JJ many) (JJ cell-to-cell) (NNS hernias)) (PP (IN within) (NP (CD 15) (NNS minutes)))) (. .)))
7315949	4	(ROOT (S (PP (IN At) (NP (CD 1) (NN day))) (NP (PRP$ their) (NN number)) (VP (VBD was) (VP (VBN reduced) (PP (TO to) (NP (NP (QP (RB about) (CD 1/10))) (PP (IN of) (NP (DT the) (JJ original) (NN number))))))) (. .)))
7315949	5	(ROOT (S (PP (IN By) (NP (CD 7) (NNS days))) (NP (DT the) (NN vessel)) (VP (VBD was) (ADVP (RB almost)) (VP (VBN restored) (PP (TO to) (ADJP (JJ normal))))) (. .)))
7315949	6	(ROOT (S (NP (NP (JJ Triple) (NN stimulation)) (PP (IN over) (NP (CD 1) (NN day)))) (VP (VBN induced) (NP (JJR more) (JJ severe) (NNS changes)) (PP (IN in) (NP (DT the) (NNS media)))) (. .)))
7315949	7	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ smooth) (NN muscle) (NNS cells)) (VP (VBP are) (ADJP (JJ susceptible) (S (VP (TO to) (VP (VB damage) (PP (IN in) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (PRP$ their) (JJ specific) (NN function))))))))))))) (. .)))
7315949	8	(ROOT (S (NP (DT The) (JJ experimental) (NNS data)) (VP (VBP are) (VP (VBN discussed) (PP (IN in) (NP (NN relation))) (PP (TO to) (NP (NP (JJ medial) (NNS changes)) (VP (VBN observed) (PP (IN in) (NP (NP (JJ other) (NNS instances)) (PP (IN of) (NP (JJ arterial) (NNS Doc_7315949_954_959_Disease)))))))))) (. .)))
7315949	9	(ROOT (S (NP (NP (JJ Endothelial) (NNS changes)) (SBAR (WHNP (WDT that)) (S (VP (VBN developed) (PP (IN in) (NP (DT the) (JJ same) (JJ experimental) (NN model))))))) (VP (VBD were) (VP (VBN described) (PP (IN in) (NP (DT a) (JJ previous) (NN paper))))) (. .)))
733189	0	(ROOT (NP (NP (NP (ADJP (JJ Doc_733189_0_24_Disease) (CC and) (JJ choriocapillaris)) (NN occlusion)) (PP (VBG following) (NP (NP (DT the) (NN injection)) (PP (IN of) (NP (NP (JJ long-acting) (JJ corticosteroid) (NNS suspensions)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (NNS drugs)))))))))) (: :) (NP (NP (NNP I.) (NNP Clinical)) (NP (NNS studies))) (. .)))
733189	1	(ROOT (S (NP (NP (CD Two) (JJ well-documented) (NNS cases)) (PP (IN of) (NP (JJ bilateral) (JJ retinal) (NN artery) (CC and) (NN choriocapillaris) (NNS occlusions))) (PP (IN with) (NP (NP (NNS Doc_733189_267_276_Disease)) (VP (VBG following) (ADVP (NN head) (CC and) (NN neck)) (NP (NP (JJ soft-tissue) (NN injection)) (PP (IN with) (NP (NP (NNS Doc_733189_328_354_Chemical)) (PP (IN in) (NP (NN combination)))))) (PP (IN with) (NP (NNS Doc_733189_375_384_Chemical) (, ,) (NNS Doc_733189_386_397_Chemical) (, ,) (CC or) (NNS Doc_733189_402_412_Chemical))))))) (VP (VBP are) (VP (VBN reported))) (. .)))
733189	2	(ROOT (S (NP (CD One) (NN case)) (VP (VBD had) (NP (RB only) (DT a) (JJ unilateral) (NN injection))) (. .)))
733189	3	(ROOT (S (NP (DT The) (JJ acute) (NNS observations)) (VP (VBD included) (NP (NP (JJ hazy) (NN sensorium)) (, ,) (NP (JJ superior) (JJ gaze) (NN palsy)) (, ,) (NP (NNS Doc_733189_538_561_Disease)) (, ,) (CC and) (NP (NNS Doc_733189_567_591_Disease))) (PP (IN with) (NP (NNS Doc_733189_597_602_Disease)))) (. .)))
733189	4	(ROOT (S (NP (JJ Follow-up) (NNS changes)) (VP (VBD showed) (NP (NP (JJ marked) (NNS Doc_733189_636_647_Disease)) (, ,) (NP (JJ constricted) (JJ visual) (NNS fields)) (, ,) (NP (JJ optic) (NN nerve) (NN pallor)) (, ,) (NP (NN vascular) (NN attenuation)) (, ,) (CC and) (NP (NNS Doc_733189_722_743_Disease)))) (. .)))
733189	5	(ROOT (S (S (NP (DT The) (NN literature)) (VP (VBZ is) (VP (VBN reviewed)))) (, ,) (CC and) (S (NP (JJ possible) (NNS causes)) (VP (VBP are) (VP (VBN discussed)))) (. .)))
7369302	0	(ROOT (NP (NP (NNS Abnormalities)) (PP (IN of) (NP (NP (DT the) (NN pupil)) (CC and) (NP (JJ visual-evoked) (NN potential)))) (PP (IN in) (NP (JJ quinine) (NNS Doc_7369302_66_75_Disease))) (. .)))
7369302	1	(ROOT (S (NP (NP (NNP Doc_7369302_77_92_Disease)) (PP (IN with) (NP (NP (DT a) (JJ transient) (NN tonic) (NN pupillary) (NN response)) (, ,) (NP (NN denervation) (NN supersensitivity)) (, ,) (CC and) (NP (JJ abnormal) (JJ visual-evoked) (NNS potentials))))) (VP (VBD developed) (PP (IN in) (NP (DT a) (JJ 54-year-old) (NN man))) (PP (IN after) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS Doc_7369302_252_267_Chemical)) (PP (IN for) (NP (NN leg) (NNS cramps)))))))) (. .)))
7369302	2	(ROOT (S (NP (PRP He)) (ADVP (RB later)) (VP (VBD recovered) (NP (JJ normal) (JJ visual) (NN acuity))) (. .)))
7369302	3	(ROOT (S (NP (NP (DT A) (JJ transient) (NN tonic) (NN pupillary) (NN response)) (, ,) (NP (NP (NP (NN denervation) (NN supersensitivity)) (, ,) (CC and) (NP (NP (JJ abnormal) (JJ visual-evoked) (NNS potentials)) (PP (IN in) (NP (JJ Doc_7369302_434_441_Chemical) (NNS Doc_7369302_442_450_Disease)))) (, ,)) (PP (TO to) (NP (PRP$ our) (NN knowledge)))) (, ,)) (VP (VBP have) (RB not) (VP (VBN been) (VP (ADVP (RB previously)) (VBN reported)))) (. .)))
7378868	0	(ROOT (S (NP (JJ Doc_7378868_0_13_Chemical-induced) (NNS Doc_7378868_22_35_Disease) (CC and) (NNS Doc_7378868_40_47_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ atypical) (JJ cholinesterase) (: :) (NN case) (NN report)))) (. .)))
7378868	1	(ROOT (S (NP (DT An) (JJ 11-year-old) (NN boy)) (VP (VBD was) (VP (VBN given) (NP (NP (NNS Doc_7378868_131_140_Chemical) (, ,) (NNS Doc_7378868_142_155_Chemical) (CC and) (NNS Doc_7378868_160_166_Chemical)) (, ,) (NP (NNP Doc_7378868_168_179_Chemical) (CD 0.4) (NN mg)) (CC and) (NP (NNS Doc_7378868_191_204_Chemical))) (NP (NP (CD 100) (NN mg)) (PP (IN for) (NP (NP (NN induction)) (PP (IN of) (NP (NN anaesthesia)))))))) (. .)))
7378868	2	(ROOT (S (PP (IN In) (NP (NP (NN response)) (PP (TO to) (NP (DT this))))) (NP (DT a) (VBN marked) (NNS Doc_7378868_271_284_Disease)) (VP (VBD occurred) (SBAR (WHNP (WDT which)) (S (VP (VBD lasted) (SBAR (IN for) (S (NP (NP (CD two) (NNS minutes)) (CC and) (NP (DT the) (NN anaesthesia))) (VP (VBD were) (VP (VBN terminated))))))))) (. .)))
7378868	3	(ROOT (S (S (NP (NP (CD Four) (NNS hours)) (PP (IN of) (NP (NN apnoea)))) (VP (VBD ensued))) (CC and) (S (NP (PRP he)) (VP (VBD suffered) (NP (NP (JJ generalized) (JJ severe) (NNS Doc_7378868_423_430_Disease)) (VP (VBG lasting) (PP (IN for) (NP (CD one))) (NP (NN week)))))) (. .)))
7378868	4	(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NP (JJ atypical) (NN plasma) (NN cholinesterase)) (PP (IN with) (NP (NP (DT a) (JJ Doc_7378868_512_521_Chemical) (NN number)) (PP (IN of) (NP (CD 12))))) (, ,) (VP (VBG indicating) (ADVP (RB homozygocity))))))))) (. .)))
7378868	5	(ROOT (S (NP (DT This)) (VP (VBD was) (VP (VBN verified) (PP (IN by) (NP (NP (NN study)) (PP (IN of) (NP (DT the) (NN family))))))) (. .)))
7378868	6	(ROOT (S (NP (DT The) (NN case)) (VP (VBZ shows) (SBAR (IN that) (S (NP (JJ prolonged) (NNS Doc_7378868_633_645_Disease) (CC and) (NNS Doc_7378868_650_657_Disease)) (VP (MD may) (VP (VB occur) (PP (IN after) (NP (NP (NNS Doc_7378868_674_687_Chemical)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ atypical) (NN cholinesterase))))))) (PP (IN despite) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NNS Doc_7378868_755_766_Chemical)))))))))) (. .)))
7411769	0	(ROOT (NP (NP (JJ Doc_7411769_0_12_Chemical-induced) (NNS Doc_7411769_21_33_Disease)) (PP (IN in) (NP (CD three) (NNS patients))) (PP (IN with) (NP (JJ gouty) (NNS Doc_7411769_63_72_Disease))) (. .)))
7411769	1	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (CD three) (NNS patients)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (JJ severe) (, ,) (NN life-threatening) (NNS Doc_7411769_134_146_Disease) (CC and) (NNS Doc_7411769_151_170_Disease)) (VP (VBD developed) (PP (IN after) (NP (NP (NN treatment)) (PP (IN of) (NP (NNS Doc_7411769_200_221_Disease))))) (PP (IN with) (NP (NNS Doc_7411769_227_239_Chemical)))))))) (. .)))
7411769	2	(ROOT (S (NP (DT This) (NN complication)) (VP (MD may) (VP (VB result) (PP (IN from) (NP (NP (DT an) (NN inhibition)) (PP (IN of) (NP (NP (JJ Doc_7411769_292_305_Chemical) (NN synthesis)) (CC and) (NP (JJ consequent) (NNS Doc_7411769_331_362_Disease)))))))) (. .)))
7411769	3	(ROOT (S (NP (NP (JJ Careful) (NN attention)) (PP (TO to) (NP (NP (JJ renal) (NN function) (CC and) (NNS Doc_7411769_404_413_Chemical) (NN balance)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NNS Doc_7411769_444_456_Chemical)) (CC or) (NP (JJ other) (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents)))))))) (, ,) (UCP (ADJP (RB particularly) (PP (IN in) (NP (NP (DT those) (NNS patients)) (PP (IN with) (NP (NNS Doc_7411769_541_558_Disease)))))) (CC or) (VP (VBG preexisting) (NP (NNS Doc_7411769_574_587_Disease)))) (, ,)) (VP (MD will) (VP (VB help) (VP (VB prevent) (NP (DT this) (ADJP (RB potentially) (JJ serious)) (NN complication))))) (. .)))
7457821	0	(ROOT (NP (NP (NNP Doc_7457821_0_9_Chemical)) (: :) (NP (DT a) (JJ foreshortened) (JJ clinical) (NN trial)) (. .)))
7457821	1	(ROOT (S (NP (NP (DT A) (JJ clinical) (NN evaluation)) (PP (IN of) (NP (NP (NNS Doc_7457821_68_77_Chemical)) (PP (IN for) (NP (NN outpatient)))))) (ADVP (RB cystoscopy)) (VP (VBD was) (VP (VBN embarked) (PP (RB upon)))) (. .)))
7457821	2	(ROOT (S (NP (JJ Unpremedicated) (NNS patients)) (VP (VBD were) (VP (VBN given) (NP (NNS Doc_7457821_158_166_Chemical)) (NP (NP (CD 1) (NN microgram/kg)) (VP (VBN followed) (PP (IN by) (NP (NNP Doc_7457821_194_203_Chemical) (CD 0.3) (NN mg/kg))))))) (. .)))
7457821	3	(ROOT (S (NP (NNP Anaesthesia)) (VP (VBD was) (VP (VBN maintained) (PP (IN with) (NP (NP (JJ intermittent) (NNS Doc_7457821_260_269_Chemical)) (PP (IN in) (NP (CD 2-4) (NN mg) (NNS doses))))))) (. .)))
7457821	4	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VP (VBN interviewed) (ADVP (RB personally) (RB later)) (NP (DT the) (JJ same) (NN day))) (, ,) (CC and) (VP (PP (IN by) (NP (NN questionnaire))) (ADVP (NP (QP (CD three) (TO to) (CD four)) (NNS weeks)) (RB later))))) (. .)))
7457821	5	(ROOT (S (NP (DT The) (NN trial)) (VP (VBD was) (VP (VBN discontinued) (PP (IN after) (NP (NP (CD 20) (NNS cases)) (PP (RB because) (IN of) (NP (NP (DT an) (ADJP (JJ unacceptable)) (NN incidence)) (PP (IN of) (NP (NN side) (NNS effects))))))))) (. .)))
7457821	6	(ROOT (S (NP (NP (NNP Doc_7457821_488_499_Disease)) (VP (VBN occurred) (PP (IN in) (NP (NP (CD 68) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (CC and) (NP (CD 50) (NN %)))))))) (VP (VBD had) (NP (NP (NN redness)) (, ,) (NP (NNS Doc_7457821_549_553_Disease)) (CC or) (NP (NP (VBG swelling)) (VP (VBN related) (PP (TO to) (NP (DT the) (NN injection) (NN site)))))) (, ,) (PP (IN in) (NP (NP (DT some) (NNS cases)) (VP (VBG lasting) (PRT (RP up)) (PP (TO to) (NP (CD three) (NNS weeks))) (PP (IN after) (NP (NN anaesthesia))))))) (. .)))
7457821	7	(ROOT (S (S (NP (NNP Doc_7457821_656_674_Disease)) (VP (VBD occurred) (PP (IN in) (NP (NP (CD 50) (NN %)) (PP (IN of) (NP (NNS patients))))))) (: ;) (S (NP (CD 30) (NN %)) (VP (VBD experienced) (ADJP (RB respiratory) (JJ upset)) (, ,) (S (NP (PRP one)) (ADJP (RB sufficiently) (JJ severe)) (S (VP (TO to) (VP (VB necessitate) (S (VP (VBG abandoning) (NP (DT the) (NN technique)))))))))) (. .)))
7457821	8	(ROOT (S (NP (NP (NNS Doc_7457821_804_810_Disease) (CC and) (NNS Doc_7457821_815_823_Disease)) (VP (VBN occurred) (PP (IN in) (NP (NP (CD 40) (NN %)) (CC and) (NP (CD 25) (NN %)))))) (VP (VBD had) (NP (JJ disturbing) (NN emergence) (NNS Doc_7457821_873_882_Disease))) (. .)))
7477981	0	(ROOT (S (NP (JJ Doc_7477981_0_8_Chemical-induced) (NNS Doc_7477981_17_28_Disease)) (VP (VBP are) (VP (VBN improved) (PP (IN by) (NP (NNS Doc_7477981_45_55_Chemical))))) (. .)))
7477981	1	(ROOT (S (NP (PRP We)) (VP (VBN evaluated) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NNS Doc_7477981_86_102_Disease) (CC and) (NNS Doc_7477981_107_118_Disease)))) (PP (IN in) (NP (NP (CD seven) (NN Doc_7477981_128_136_Chemical-responsive) (NNS patients)) (PP (IN with) (NP (NNS Doc_7477981_162_181_Disease))))) (PP (IN after) (NP (NP (DT an) (JJ acute) (NN challenge)) (PP (IN with) (NP (NP (NP (DT the) (VBN mixed) (JJ Doc_7477981_222_230_Chemical) (NN agonist)) (PRN (, ,) (FRAG (NP (NNS Doc_7477981_240_251_Chemical)) (, ,) (PP (IN before) (CC and) (IN after) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_7477981_292_302_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (NN mg) (RB twice)) (PP (IN per) (NP (NN day)))) (-RRB- -RRB-))) (PP (IN for) (NP (CD 11) (NNS +))))))) (: /)) (, -))) (NP (CD 1) (NNS days))))))) (. .)))
7477981	2	(ROOT (S (PP (IN After) (NP (JJ Doc_7477981_350_360_Chemical) (NN treatment))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (ADJP (CD 47) (NN %)) (NN improvement)) (PRN (-LRB- -LRB-) (NP (NNP p) (NNP <) (NNP 0.05)) (-RRB- -RRB-)) (PP (IN of) (NP (NN Doc_7477981_426_437_Chemical-induced) (NNS Doc_7477981_446_457_Disease)))) (PP (IN without) (NP (NP (NN modification)) (PP (IN of) (NP (JJ Doc_7477981_482_494_Disease) (NNS Doc_7477981_495_511_Disease)))))) (. .)))
7477981	3	(ROOT (S (NP (DT The) (NNS Doc_7477981_517_528_Disease)) (VP (VBD were) (VP (VBN reduced) (ADVP (RB predominantly)) (PP (IN in) (NP (DT the) (JJR lower) (NNS limbs))) (PP (PP (IN during) (NP (NP (DT the) (NN onset) (CC and) (NN disappearance)) (PP (IN of) (NP (NP (NNS Doc_7477981_613_633_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN onset) (NNS -)) (CC and) (NP (JJ end-of-dose) (NNS Doc_7477981_658_669_Disease))) (-RRB- -RRB-)))))) (CC and) (PP (IN in) (NP (DT the) (JJ upper) (NNS limbs)))) (PP (IN during) (NP (JJ choreic) (JJ mid-dose) (NNS Doc_7477981_718_729_Disease))))) (. .)))
7477981	4	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (VBN increased) (NN brain) (JJ serotoninergic) (NN transmission)) (PP (IN with) (NP (NNS Doc_7477981_805_815_Chemical)))) (VP (MD may) (VP (VB reduce) (NP (NP (NNS Doc_7477981_827_835_Chemical)) (: -) (CC or) (NP (JJ Doc_7477981_840_848_Chemical) (JJ agonist-induced) (NNS Doc_7477981_865_876_Disease))) (PP (IN without) (NP (VBG aggravating) (JJ Doc_7477981_897_909_Disease) (NNS Doc_7477981_910_926_Disease)))))))) (. .)))
7479194	0	(ROOT (NP (NP (DT A) (JJ large) (JJ population-based) (NN follow-up) (NN study)) (PP (IN of) (NP (NNS Doc_7479194_44_73_Chemical) (, ,) (NNS Doc_7479194_75_87_Chemical) (, ,) (CC and) (NNS Doc_7479194_93_103_Chemical))) (PP (IN for) (NP (JJ uncommon) (JJ serious) (NNS Doc_7479194_125_138_Disease))) (. .)))
7479194	1	(ROOT (S (NP (PRP We)) (VP (VBD conducted) (NP (NP (DT a) (JJ population-based) (JJ 45-day) (NN follow-up) (NN study)) (PP (IN of) (NP (NP (NP (CD 232,390) (NNS people)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN prescribed) (NP (NP (NNS Doc_7479194_233_262_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7479194_264_267_Chemical-SMZ)) (-RRB- -RRB-)))))))) (, ,) (ADVP (NP (CD 266,951) (JJ prescribed) (NNS Doc_7479194_293_305_Chemical)) (RB alone)) (, ,) (CC and) (NP (CD 196,397) (JJ prescribed) (NNS Doc_7479194_336_346_Chemical))))) (, ,) (S (VP (TO to) (VP (VB estimate) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (JJ serious) (NN liver)) (, ,) (NP (NN blood)) (, ,) (NP (NN skin)) (, ,) (CC and) (NP (NNS Doc_7479194_404_419_Disease)))) (VP (VBG resulting) (PP (IN in) (NP (NP (NN referral) (CC or) (NN hospitalization)) (VP (VBN associated) (PP (IN with) (NP (DT these) (NNS drugs)))))))))))) (. .)))
7479194	2	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD were) (VP (VBN based) (PP (IN on) (NP (NP (NN information)) (VP (VBN recorded) (PP (IN on) (NP (NN office) (NNS computers))) (PP (IN by) (NP (NP (VBN selected) (JJ general) (NNS practitioners)) (PP (IN in) (NP (DT the) (NNP United) (NNP Kingdom))))) (, ,) (ADVP (RB together)) (PP (IN with) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (JJ clinical) (NNS records)))))))))) (. .)))
7479194	3	(ROOT (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (ADJP (RB clinically) (JJ important)) (NNS Doc_7479194_691_715_Disease)))) (VP (VBD was) (ADJP (JJ similar) (PP (IN for) (NP (NP (NP (NP (NNS persons)) (VP (VBN prescribed) (S (ADJP (JJ Doc_7479194_751_754_Chemical-SMZ))))) (PRN (-LRB- -LRB-) (NP (QP (CD 5.2) (IN /) (CD 100,000))) (-RRB- -RRB-))) (CC and) (NP (NP (DT those) (JJ prescribed) (VBG Doc_7479194_794_806_Chemical) (RB alone)) (PRN (-LRB- -LRB-) (NP (QP (CD 3.8) (IN /) (CD 100,000))) (-RRB- -RRB-))))))) (. .)))
7479194	4	(ROOT (S (NP (NP (DT The) (NN risk)) (PP (IN for) (NP (DT those) (JJ prescribed) (NNS Doc_7479194_858_868_Chemical)))) (VP (VBD was) (ADJP (ADJP (RB somewhat) (JJR lower)) (PRN (-LRB- -LRB-) (FRAG (X (SYM 2.0)) (: /) (NP (CD 100,000))) (-RRB- -RRB-)))) (. .)))
7479194	5	(ROOT (S (S (NP (RB Only) (CD five) (NNS patients)) (VP (VBD experienced) (NP (NP (NNS Doc_7479194_934_949_Disease)) (, ,) (SBAR (WHNP (CD one) (WHPP (IN of) (WHNP (WP whom)))) (S (VP (VBD was) (VP (VBN exposed) (PP (TO to) (NP (NNS Doc_7479194_978_981_Chemical-SMZ)))))))))) (: ;) (S (PP (IN of) (NP (NP (CD seven)) (PP (IN with) (NP (NNS Doc_7479194_1001_1020_Disease) (CC and) (NNS Doc_7479194_1025_1049_Disease))))) (, ,) (NP (CD four)) (VP (VBD were) (VP (VBN exposed) (PP (TO to) (NP (NNS Doc_7479194_1072_1075_Chemical-SMZ)))))) (. .)))
7479194	6	(ROOT (S (NP (NP (DT The) (CD one) (NN case)) (PP (IN of) (NP (NNS Doc_7479194_1097_1123_Disease)))) (VP (VBD occurred) (PP (IN in) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD took) (NP (NNS Doc_7479194_1155_1165_Chemical)))))))) (. .)))
7479194	7	(ROOT (S (ADVP (RB Finally)) (, ,) (NP (NP (QP (RB only) (CD five)) (NNS cases)) (PP (IN of) (NP (JJ acute) (JJ parenchymal) (NNS Doc_7479194_1213_1226_Disease)))) (VP (VBD occurred) (, ,) (S (NP (NN none)) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (VP (VBN caused) (PP (IN by) (NP (DT a) (NN study) (NN drug)))))))))) (. .)))
7479194	8	(ROOT (S (NP (PRP We)) (VP (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (DT the) (JJ serious) (NNS diseases)) (VP (VBN studied))))) (VP (VBZ is) (ADJP (JJ small) (PP (IN for) (NP (DT the) (CD three) (NNS agents)))))))) (, ,) (CC and) (VP (VBZ compares) (ADVP (RB reasonably)) (PP (IN with) (NP (NP (DT the) (NN risk)) (PP (IN for) (NP (JJ many) (JJ other) (NNS antibiotics))))))) (. .)))
7492040	0	(ROOT (NP (NP (JJ Clinical) (NN safety)) (PP (IN of) (NP (NNS Doc_7492040_19_28_Chemical))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Doc_7492040_46_53_Chemical-associated) (NNS Doc_7492040_65_86_Disease))))) (. .)))
7492040	1	(ROOT (NP (NP (NNP STUDY) (NNP OBJECTIVE)) (: :) (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NN safety)) (PP (IN of) (NP (NP (NNS Doc_7492040_131_140_Chemical)) (PP (IN in) (NP (NP (DT the) (NN setting)) (PP (IN of) (NP (NP (NN Doc_7492040_159_166_Chemical-induced) (NNS Doc_7492040_175_196_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7492040_198_200_Disease)) (-RRB- -RRB-)))))))))))) (. .)))
7492040	2	(ROOT (NP (NP (DT A) (NN retrospective)) (, ,) (NP (NN multicenter) (NN study)) (. .)))
7492040	3	(ROOT (NP (NP (JJ Twenty-nine) (NN university)) (, ,) (NP (NP (JJ university-affiliated) (, ,) (CC or) (NN community) (NNS hospitals)) (PP (IN during) (NP (NP (DT a) (JJ 6-year) (NN period)) (PRN (-LRB- -LRB-) (NP (NP (NN total)) (PP (IN of) (NP (CD 117) (JJ cumulative) (NNS hospital-years)))) (-RRB- -RRB-))))) (. .)))
7492040	4	(ROOT (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (NN Doc_7492040_419_426_Chemical-associated) (NNS Doc_7492040_438_440_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NNS Doc_7492040_454_463_Chemical)) (PP (IN in) (NP (DT the) (NN emergency) (NN department)))))))) (. .)))
7492040	5	(ROOT (S (PP (IN Of) (NP (NP (CD 29) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NNS Doc_7492040_530_539_Chemical)) (PP (IN in) (NP (NP (DT the) (NN setting)) (PP (IN of) (NP (NN Doc_7492040_558_565_Chemical-associated) (NNS Doc_7492040_577_579_Disease)))))))))) (, ,) (NP (DT no) (NN patient)) (VP (VP (VBD died)) (: ;) (VP (VBD exhibited) (NP (NP (NNS bradydysrhythmias)) (, ,) (NP (NNS Doc_7492040_627_650_Disease)) (, ,) (CC or) (NP (NNS Doc_7492040_655_679_Disease)))) (: ;) (CC or) (VP (VBD experienced) (NP (NNS Doc_7492040_696_704_Disease)) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_7492040_729_738_Chemical))))) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %) (NN confidence) (NN interval)) (, ,) (NP (CD 0) (NN %))) (PP (TO to) (NP (CD 11) (NN %))) (-RRB- -RRB-)))) (. .)))
7492040	6	(ROOT (S (PP (IN Despite) (NP (NP (JJ theoretical) (NNS concerns)) (SBAR (IN that) (S (NP (NNS Doc_7492040_823_832_Chemical)) (VP (MD may) (VP (VB enhance) (NP (JJ Doc_7492040_845_852_Chemical) (NN toxicity)))))))) (, ,) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS Doc_7492040_874_883_Chemical)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Doc_7492040_901_908_Chemical-associated) (NNS Doc_7492040_920_922_Disease)))))))) (VP (VBD was) (RB not) (VP (VBN associated) (PP (IN with) (NP (JJ significant) (NNS Doc_7492040_959_1008_Disease))))) (. .)))
753803	0	(ROOT (NP (NP (NP (JJ Experimental) (JJ progressive) (NNS Doc_753803_25_43_Disease)) (CC and) (NP (NP (PRP$ its) (NN treatment)) (PP (IN with) (NP (JJ high) (NNS doses))))) (VP (VBG anabolizing) (NP (NNS agents))) (. .)))
753803	1	(ROOT (S (NP (PRP We)) (VP (VBP are) (ADVP (RB still)) (NP (NP (DT a) (JJ long) (NN way)) (PP (IN from) (S (VP (VBG discovering) (NP (NP (DT an) (JJ unequivocal) (JJ pathogenetic) (NN interpretation)) (PP (IN of) (NP (JJ progressive) (NNS Doc_753803_197_215_Disease)))) (PP (IN in) (NP (NN man)))))))) (. .)))
753803	2	(ROOT (S (S (NP (JJ Noteworthy) (NNS efforts)) (VP (VBP have) (VP (VBN been) (VP (VBN made) (PP (IN in) (NP (DT the) (JJ experimental) (NN field))))))) (: ;) (S (NP (NP (DT a) (JJ recessive) (JJ autosomic) (NN form)) (VP (VBN found) (PP (IN in) (NP (DT the) (NN mouse))))) (VP (VBZ seems) (S (VP (TO to) (VP (VB bear) (NP (NP (DT the) (JJS closest) (NN resemblance)) (PP (TO to) (NP (DT the) (JJ human) (NN form)))) (PP (IN from) (NP (NP (DT the) (JJ genetic) (NN point)) (PP (IN of) (NP (NN view)))))))))) (. .)))
753803	3	(ROOT (S (S (ADJP (RB Doc_753803_419_427_Disease) (JJ due) (PP (TO to) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NNS Doc_753803_443_452_Chemical) (CC and) (NNS Doc_753803_457_465_Disease)) (VP (VBN induced) (PP (IN by) (NP (JJ certain) (NNS viruses)))))))))) (VP (VBP have) (ADVP (ADVP (RB much) (PP (IN in) (NP (JJ common) (NN anatomically)))) (CC and) (ADVP (RB pathologically) (PP (IN with) (NP (DT the) (JJ human) (NN form)))))) (. .)))
753803	4	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBN induced) (NP (NP (NNS Doc_753803_586_598_Disease)) (PP (IN in) (NP (DT the) (NN rat)))) (PP (IN by) (S (VP (VBG giving) (NP (PRP it)) (NP (NP (DT a) (NN diet)) (VP (VBG lacking) (PP (IN in) (NP (NNS Doc_753803_641_650_Chemical))))))))) (. .)))
753803	5	(ROOT (S (NP (NP (DT The) (JJ pharmacological) (NNS characteristics)) (PP (IN of) (NP (NP (NNS Doc_753803_691_700_Chemical)) (CC and) (NP (NP (DT the) (JJ degenerative) (NNS changes)) (VP (VBN brought) (IN about) (PP (IN by) (NP (PRP$ its) (NN deficiency)))))))) (PRN (, ,) (ADVP (RB especially)) (PP (IN in) (NP (DT the) (NNS muscles))) (, ,)) (VP (VBP are) (VP (VBN illustrated))) (. .)))
753803	6	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB thus)) (VP (VBN confirmed) (SBAR (IN that) (S (NP (NP (DT the) (JJ histological) (NNS characteristics)) (PP (IN of) (NP (NP (JJ Doc_753803_869_878_Disease) (NN rat) (NN muscle)) (VP (VBN induced) (ADVP (RB experimentally)))))) (VP (VBP are) (ADJP (RB extraordinarily) (JJ similar) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (JJ human) (NNS Doc_753803_959_967_Disease)))))) (SBAR (IN as) (S (VP (VBD confirmed) (PP (IN during) (NP (NP (NNS biopsies)) (VP (VBN performed) (PP (IN at) (NP (NP (DT the) (NNP Orthopaedic) (NNP Traumatological) (NNP Centre)) (, ,) (NP (NNP Florence))))))))))))))) (. .)))
753803	7	(ROOT (S (NP (NP (DT The) (JJ encouraging) (NNS results)) (VP (VBN obtained) (PP (IN in) (NP (NP (JJ various) (NN authoratative) (NNS departments)) (PP (IN in) (NP (JJ Doc_753803_1133_1142_Disease) (NNS patients))))) (PP (IN by) (S (VP (VBG using) (NP (VBG anabolizing) (NNS Doc_753803_1173_1181_Chemical))))))) (VP (VBP have) (VP (VBN encouraged) (NP (DT the) (NNS authors)) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (JJ beneficial) (NNS effects)) (PP (IN of) (NP (NP (CD one) (JJ anabolizing) (NN agent)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_753803_1274_1282_Chemical)) (, ,) (NP (NNS Doc_753803_1284_1288_Chemical))) (-RRB- -RRB-))))) (PP (IN at) (NP (NP (JJ high) (NNS doses)) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN rendered) (NP (NNS Doc_753803_1321_1330_Disease)) (PP (IN by) (NP (NP (DT a) (NN diet) (NN deficient)) (PP (IN in) (NP (NNS Doc_753803_1354_1363_Chemical))))))))))))))) (. .)))
753803	8	(ROOT (S (S (PP (IN In) (NP (DT this) (NN way))) (NP (PRP they)) (VP (VBD obtained) (NP (NP (JJ appreciable) (NNS changes)) (PP (IN in) (NP (NP (NN body) (NN weight)) (PRN (-LRB- -LRB-) (VP (VBN increased) (PP (IN from) (NP (QP (CD 50) (TO to) (CD 70)) (NN g))) (PP (IN after) (NP (JJ forty) (NNS days))) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 5) (NN mg)) (PP (IN per) (NP (NP (NN day)) (PP (IN of) (NP (JJ anabolizing) (NN agent)))))))))) (-RRB- -RRB-))))))) (, ,) (CC but) (S (ADVP (RBS most) (PP (IN of) (NP (DT all)))) (NP (PRP they)) (VP (VBD found) (NP (JJ histological) (NNS changes)) (PP (JJ due) (TO to) (NP (NP (`` ``) (JJ regenerative) ('' '') (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN muscle) (NN tissue)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB however)) (VP (VBD maintained) (NP (PRP$ its) (JJ Doc_753803_1648_1657_Disease) (NNS characteristics)) (PP (IN in) (NP (NP (DT the) (NN control) (NNS animals)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (RB not) (VP (VBN treated) (PP (IN with) (NP (DT the) (VBG anabolizing) (NN agent)))))))))))))))))) (. .)))
753803	9	(ROOT (S (S (NP (DT The) (NNS authors)) (VP (VBP conclude) (PP (IN by) (S (VP (VBG affirming) (NP (NP (DT the) (JJ undoubted) (NN efficacy)) (PP (IN of) (NP (NP (DT the) (VBG anabolizing) (NNS Doc_753803_1823_1831_Chemical)) (PP (IN in) (NP (JJ experimental) (NNS Doc_753803_1848_1865_Disease))))))))))) (, ,) (CC but) (S (NP (PRP they)) (VP (VBP have) (VP (VBN reservations) (PP (IN as) (PP (TO to) (NP (NP (DT the) (NN transfer)) (PP (IN of) (NP (DT the) (NNS results)))))) (PP (IN into) (NP (DT the) (JJ human) (NN field)))))) (, ,) (SBAR (SBAR (WHADVP (WRB where)) (S (NP (JJ high) (NN dosage)) (VP (MD can) (RB not) (VP (VB be) (VP (VBN carried) (PRT (RP out)) (ADVP (RB continuously)) (PP (RB because) (IN of) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT the) (NN drug))))) (PP (IN on) (NP (NN virility)))))))) (: ;) (SBAR (IN because) (S (NP (DT the) (NNS Doc_753803_2063_2076_Disease)) (ADVP (RB too) (RB often)) (VP (VBZ occurs) (PP (IN at) (NP (DT an) (JJ irreversible) (NN stage) (NNS vis-a-vis))) (NP (NP (DT the) (`` ``) (NN regeneration) ('' '')) (PP (IN of) (NP (DT the) (NN muscle) (NN tissue))))))) (: ;) (CC and) (SBAR (ADVP (RB finally)) (IN because) (S (NP (DT the) (JJ Doc_753803_2194_2214_Disease) (NN agent)) (VP (VBZ is) (ADVP (RB certainly) (NP (RB not) (DT the) (NN lack)) (PP (IN of) (NP (NP (NNS Doc_753803_2250_2259_Chemical)) (PP (CC but) (NP (NN something)))))) (ADJP (RB as) (RB yet) (JJ unknown)))))) (. .)))
7644931	0	(ROOT (NP (NP (NP (JJ Doc_7644931_0_10_Chemical) (JJ 3-hour) (NN infusion)) (VP (VP (VBN given) (ADVP (RB alone))) (CC and) (VP (VBN combined) (PP (IN with) (NP (NNS Doc_7644931_57_68_Chemical)))))) (: :) (NP (NP (JJ preliminary) (NNS results)) (PP (IN of) (NP (JJ dose-escalation) (NNS trials)))) (. .)))
7644931	1	(ROOT (S (NP (NP (NP (NNP Doc_7644931_117_127_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_7644931_129_134_Chemical)) (: ;) (NP (NNP Bristol-Myers) (NNP Squibb) (NNP Company))) (, ,) (NP (NP (NNP Princeton)) (, ,) (NP (NNP NJ))) (-RRB- -RRB-))) (PP (IN by) (NP (JJ 3-hour) (NN infusion)))) (VP (VBD was) (VP (VBN combined) (PP (IN with) (NP (NP (NNS Doc_7644931_218_229_Chemical)) (PP (IN in) (NP (NP (DT a) (NN phase) (NNP I/II) (NN study)) (VP (VBN directed) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_7644931_278_304_Disease)))))))))))) (. .)))
7644931	2	(ROOT (S (NP (NNP Doc_7644931_306_317_Chemical)) (VP (VBD was) (VP (VBN given) (PP (IN at) (NP (NP (DT a) (JJ fixed) (NN target) (NN area)) (PP (IN under) (NP (NP (DT the) (JJ concentration-time) (NN curve)) (PP (IN of) (NP (CD 6.0))))))) (PP (IN by) (NP (DT the) (NNP Calvert) (NN formula))) (, ,) (SBAR (IN whereas) (S (NP (NNS Doc_7644931_425_435_Chemical)) (VP (VBD was) (VP (VBN escalated) (PP (IN in) (NP (JJ patient) (NNS cohorts))) (PP (IN from) (NP (CD 150) (NNS mg/m2))) (PRN (-LRB- -LRB-) (S (NP (NN dose)) (VP (VBP level) (NP (PRP I)))) (-RRB- -RRB-)) (PP (TO to) (NP (NP (CD 175)) (, ,) (NP (CD 200)) (, ,) (NP (CD 225)) (, ,) (CC and) (NP (CD 250) (NNS mg/m2)))))))))) (. .)))
7644931	3	(ROOT (S (NP (DT The) (CD 225) (JJ mg/m2) (NN level)) (VP (VBD was) (VP (VBN expanded) (PP (IN for) (NP (NP (DT the) (NN phase) (NNP II) (NN study)) (PP (IN since) (NP (NP (DT the) (JJS highest) (NN level)) (VP (VBN achieved) (NP (NP (PRN (-LRB- -LRB-) (NP (CD 250) (NNS mg/m2)) (-RRB- -RRB-)) (JJ required) (NN modification)) (PP (RB because) (IN of) (NP (JJ nonhematologic) (NNS Doc_7644931_681_691_Disease))) (PRN (-LRB- -LRB-) (NP (JJ Doc_7644931_693_703_Disease) (CC and) (JJ Doc_7644931_708_726_Disease)) (-RRB- -RRB-)))))))))) (. .)))
7644931	4	(ROOT (S (NP (JJ Therapeutic) (NNS effects)) (VP (VBD were) (VP (VBN noted) (PP (IN at) (NP (DT all) (NN dose) (NNS levels))) (, ,) (PP (IN with) (NP (NP (JJ objective) (NNS responses)) (PP (IN in) (NP (NP (NP (CD 17)) (PRN (-LRB- -LRB-) (NP (NP (CD two) (NNS complete)) (CC and) (NP (CD 15) (JJ partial) (NNS regressions))) (-RRB- -RRB-))) (PP (IN of) (NP (CD 41) (ADJP (RB previously) (JJ untreated)) (NNS patients))))))))) (. .)))
7644931	5	(ROOT (S (NP (NNP Doc_7644931_890_900_Disease)) (VP (VBD were) (VP (VBN compared) (PP (IN with) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (NP (DT a) (NN phase) (NN I) (NN trial)) (PP (IN of) (NP (NNS Doc_7644931_963_973_Chemical))))))))) (PP (ADVP (RB alone)) (IN at) (NP (JJ identical) (NN dose) (NNS levels))))) (. .)))
7644931	6	(ROOT (S (S (NP (NNP Doc_7644931_1006_1017_Chemical)) (VP (VBD did) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB add) (PP (TO to) (NP (NP (DT the) (NNS Doc_7644931_1047_1069_Disease)) (VP (VBN observed)))))))))) (, ,) (CC and) (S (NP (DT the) (JJ Doc_7644931_1088_1098_Chemical) (JJ /) (NNS Doc_7644931_1099_1110_Chemical) (NN combination)) (VP (MD could) (VP (VB be) (VP (VBN dosed) (NP (DT every) (CD 3) (NNS weeks)))))) (. .)))
7661171	0	(ROOT (NP (NP (DT The) (JJ dose-dependent) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_7661171_29_40_Chemical)) (PP (IN on) (NP (NN Doc_7661171_44_56_Chemical-induced) (NNS Doc_7661171_65_82_Disease))))) (PP (IN in) (NP (RB well) (CD compensated) (NNS Doc_7661171_103_112_Disease))) (. .)))
7661171	1	(ROOT (S (NP (NP (NNP Doc_7661171_114_125_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 200) (NNS micrograms)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (ADVP (RB acutely)) (VB counteract) (NP (NP (DT the) (NN Doc_7661171_184_196_Chemical-induced) (NNS Doc_7661171_205_222_Disease)) (PP (IN in) (NP (ADJP (RB well) (VBN compensated)) (JJ cirrhotic) (NNS patients)))))))))) (. .)))
7661171	2	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT the) (JJ prophylactic) (NN value)) (PP (IN of) (NP (NNS Doc_7661171_331_342_Chemical)))) (VP (VBD was) (ADJP (JJ dose-dependent))))))))) (. .)))
7661171	3	(ROOT (S (NP (NP (NNS Parameters)) (PP (IN of) (NP (NP (JJ renal) (NNS hemodynamics)) (CC and) (NP (JJ tubular) (NNS Doc_7661171_408_414_Chemical) (CC and) (NN water) (NN handling))))) (VP (VBD were) (VP (VBN assessed) (PP (IN by) (NP (NP (NN clearance) (NNS techniques)) (PP (IN in) (NP (CD 26) (ADJP (RB well) (JJ compensated)) (JJ cirrhotic) (NNS patients))))) (PP (IN before) (CC and) (IN after) (NP (NP (DT an) (JJ oral) (NN combination)) (PP (IN of) (NP (NP (NP (CD 50) (NN mg)) (PP (IN of) (NP (NNS Doc_7661171_563_575_Chemical)))) (CC and) (NP (NP (JJ various) (NNS doses)) (PP (IN of) (NP (NNS Doc_7661171_597_608_Chemical)))))))))) (. .)))
7661171	4	(ROOT (S (NP (DT The) (JJ 200-micrograms) (NN dose)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (ADVP (RB totally)) (VB abolish) (NP (NP (DT the) (JJ deleterious) (JJ renal) (NNS effects)) (PP (IN of) (NP (NNS Doc_7661171_695_707_Chemical)))) (, ,) (SBAR (IN whereas) (S (NP (DT the) (JJ 800-micrograms) (NN dose)) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ significant) (VBG worsening)) (PP (IN of) (NP (NP (JJ renal) (NNS hemodynamics)) (CC and) (NP (JJ Doc_7661171_801_807_Chemical) (NN retention)))))))))))))) (. .)))
7661171	5	(ROOT (S (NP (DT These) (NNS changes)) (VP (VP (VBD were) (ADJP (JJ maximal) (PP (IN in) (NP (DT the) (NN hour)))) (PP (ADVP (RB immediately)) (IN after) (NP (NNS medications)))) (CC and) (ADVP (RB slowly)) (VP (VBD returned) (PP (IN toward) (NP (JJ base-line) (NNS levels))) (ADVP (RB thereafter)))) (. .)))
7661171	6	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ renal) (JJ protective) (NNS effects)) (PP (IN of) (NP (NNS Doc_7661171_1003_1014_Chemical)))) (VP (VBZ is) (ADJP (JJ dose-dependent)))))) (. .)))
7661171	7	(ROOT (S (ADVP (RB However)) (, ,) (SBAR (IN until) (S (NP (NP (DT this) (JJ apparent) (NN ability)) (PP (IN of) (NP (NP (CD 200) (NNS micrograms)) (PP (IN of) (NP (NNS Doc_7661171_1092_1103_Chemical) (S (VP (TO to) (VP (VB prevent) (NP (NP (DT the) (JJ adverse) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_7661171_1138_1150_Chemical)) (PP (IN on) (NP (JJ renal) (NN function)))))))))))))) (VP (VBZ is) (VP (VBN confirmed) (PP (IN with) (NP (JJ chronic) (JJ frequent) (NN dosing))))))) (, ,) (NP (PRP it)) (VP (MD would) (VP (VB be) (ADJP (JJ prudent) (S (VP (TO to) (VP (VB avoid) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NN therapy)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_7661171_1297_1306_Disease))))))))))) (. .)))
7671401	0	(ROOT (S (NP (NP (VBN Increased) (NN frequency) (CC and) (NN severity)) (PP (IN of) (NP (NNS Doc_7671401_36_48_Disease)))) (VP (VBN related) (PP (TO to) (NP (JJ long-term) (NN therapy))) (PP (IN with) (NP (NP (NN Doc_7671401_83_94_Chemical-converting) (NN enzyme) (NN inhibitor)) (PP (IN in) (NP (CD two) (NNS patients)))))) (. .)))
7671401	1	(ROOT (S (NP (NP (JJ Adverse) (NNS reactions)) (PP (TO to) (NP (NNS drugs)))) (VP (VBP are) (ADVP (RB well)) (VP (VBN recognized) (PP (IN as) (NP (NP (NP (DT a) (NN cause)) (PP (IN of) (NP (JJ acute) (CC or) (JJ chronic) (NNS Doc_7671401_218_227_Disease)))) (, ,) (CC and) (NP (NNS Doc_7671401_233_245_Disease)))))) (. .)))
7671401	2	(ROOT (S (S (NP (NP (JJ Angiotensin-converting) (NN enzyme) (PRN (-LRB- -LRB-) (NP (NNP ACE)) (-RRB- -RRB-)) (NNS inhibitors)) (, ,) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NNS Doc_7671401_309_321_Disease) (CC and) (NNS Doc_7671401_326_350_Disease)))))) (, ,)) (VP (VBD were) (VP (VBN introduced) (PP (IN in) (NP (NNP Europe))) (PP (IN in) (NP (NP (DT the) (NN middle)) (PP (IN of) (NP (DT the) (NNS eighties)))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (VBZ has) (VP (VBN increased) (ADVP (RB progressively))))) (. .)))
7671401	3	(ROOT (S (PP (RB Soon) (IN after) (NP (NP (DT the) (NN introduction)) (PP (IN of) (NP (NNP ACE) (NNS inhibitors))))) (, ,) (NP (NP (JJ acute) (NNS bouts)) (PP (IN of) (NP (NNS Doc_7671401_527_539_Disease)))) (VP (VBD were) (VP (VBN reported) (PP (IN in) (NP (NN association))) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT these) (NNS drugs))))))) (. .)))
7671401	4	(ROOT (S (NP (PRP We)) (VP (VBP wish) (S (VP (TO to) (VP (VB draw) (NP (NN attention)) (PP (TO to) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (JJ adverse) (NNS reactions))))) (PP (PP (TO to) (NP (NP (NNP ACE) (NNS inhibitors)) (PP (IN after) (NP (JJ long-term) (NN use))))) (CC and) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ pre-existing) (NNS Doc_7671401_736_748_Disease)))))))))) (. .)))
7727612	0	(ROOT (S (NP (NNP Doc_7727612_0_9_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ Doc_7727612_26_35_Chemical) (NN therapy)) (PP (IN in) (NP (CD very-Doc_7727612_52_76_Disease)))))) (. .)))
7727612	1	(ROOT (S (NP (NNP Doc_7727612_78_87_Chemical)) (VP (VBZ is) (VP (VBG being) (VP (VBN used) (PP (IN with) (NP (NP (VBG increasing) (NN frequency)) (PP (IN as) (NP (NP (DT a) (NN sedative)) (PP (IN in) (NP (NP (DT the) (NN newborn)) (CC and) (NP (DT the) (JJ young) (NN infant))))))))))) (. .)))
7727612	2	(ROOT (S (NP (NN Concern)) (VP (VBZ has) (VP (VBN been) (VP (VBN raised) (PP (IN with) (NP (NN regard))) (PP (PP (TO to) (NP (NP (DT the) (NN safety)) (PP (IN of) (NP (NP (NNS Doc_7727612_232_241_Chemical)) (PP (IN in) (NP (DT this) (NN age) (NN group))))))) (, ,) (RB especially) (PP (IN in) (NP (JJ very-low-birth-weight) (PRN (-LRB- -LRB-) (NP (NP (NNP VLBW)) (: ;) (NP (NNP <) (CD 1,500) (NN g))) (-RRB- -RRB-)) (NNS infants))))))) (. .)))
7727612	3	(ROOT (S (NP (NP (CD Three) (JJ young) (NNS infants)) (, ,) (NP (NP (NP (DT all)) (PP (IN of) (NP (NN birth) (NN weight) (NNS <)))) (NP (CD 1,500) (NN g))) (, ,)) (VP (VBD experienced) (NP (NP (NNS Doc_7727612_388_397_Disease)) (PP (VBG following) (NP (NP (DT the) (JJ intravenous) (NN administration)) (PP (IN of) (NP (NNS Doc_7727612_442_451_Chemical))))))) (. .)))
7727612	4	(ROOT (S (NP (NP (DT The) (JJ potential) (JJ Doc_7727612_467_477_Disease) (NNS effects)) (PP (IN of) (NP (NP (NP (DT the) (NN drug)) (PRN (-LRB- -LRB-) (PP (CC and) (NP (PRP$ its) (NN vehicle))) (-RRB- -RRB-))) (PP (IN in) (NP (DT this) (NN population)))))) (VP (VBP are) (VP (VBN discussed))) (. .)))
7727612	5	(ROOT (S (NP (JJ Injectable) (NNS Doc_7727612_561_570_Chemical)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NP (NN caution)) (PP (IN in) (NP (JJ VLBW) (NNS infants)))))))) (. .)))
7739955	0	(ROOT (S (NP (NNS Transvenous)) (ADVP (RB right)) (VP (VBP ventricular) (NP (NN pacing)) (PP (IN during) (NP (NP (JJ cardiopulmonary) (NN resuscitation)) (PP (IN of) (NP (NP (JJ pediatric) (NNS patients)) (PP (IN with) (NP (JJ acute) (NNS Doc_7739955_107_121_Disease)))))))) (. .)))
7739955	1	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (DT the) (JJ cardiopulmonary) (NN resuscitation) (NNS efforts)) (PP (IN on) (NP (NP (CD five) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD presented) (PP (IN in) (NP (NNS Doc_7739955_211_236_Disease))) (PP (IN from) (NP (NNS Doc_7739955_242_264_Disease))))))))) (. .)))
7739955	2	(ROOT (S (S (NP (CD Three) (NNS patients)) (VP (VBD had) (NP (JJ acute) (NNS Doc_7739955_291_308_Disease)))) (PRN (, ,) (S (NP (PRP one)) (VP (VBD had) (NP (DT a) (ADJP (JJ Doc_7739955_320_333_Chemical-induced) (JJ acute)) (NNS Doc_7739955_348_372_Disease)))) (, ,)) (CC and) (S (NP (PRP one)) (VP (VBD had) (NP (NP (JJ cardiac) (NNS Doc_7739955_394_407_Disease)) (VP (VBG resulting) (PP (IN in) (NP (JJ acute) (NNS Doc_7739955_427_444_Disease))))))) (. .)))
7739955	3	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD were) (ADVP (RB continuously)) (VP (VBN monitored) (PP (IN with) (NP (NP (JJ central) (NNS venous)) (CC and) (NP (JJ arterial) (NNS catheters)))) (PP (IN in) (NP (NN addition))) (PP (TO to) (NP (JJ routine) (NN noninvasive) (NN monitoring))))) (. .)))
7739955	4	(ROOT (S (NP (NP (NP (DT An) (NN introducer) (NN sheath)) (, ,) (NP (DT a) (NN pacemaker)) (, ,)) (CC and) (NP (ADJP (JJ sterile)) (NN pacing) (NNS wires))) (VP (VBD were) (VP (VBN made) (S (ADJP (RB readily) (JJ available))) (PP (IN for) (NP (DT the) (NNS patients))) (, ,) (SINV (MD should) (NP (DT the) (NN need)) (VP (VB arise) (S (VP (TO to) (VP (VB terminate) (NP (ADJP (JJ resistant)) (NNS Doc_7739955_728_748_Disease))))))))) (. .)))
7739955	5	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD developed) (NP (NP (NNS Doc_7739955_773_797_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ extreme) (NNS Doc_7739955_822_833_Disease) (CC and) (NNS Doc_7739955_838_850_Disease))) (PP (IN within) (NP (NP (DT the) (JJ first) (CD 48) (NNS hours)) (PP (IN of) (NP (PRP$ their) (NN admission))))) (PP (TO to) (NP (NP (DT the) (JJ pediatric) (JJ intensive) (NN care) (NN unit)) (PRN (-LRB- -LRB-) (NP (NNP PICU)) (-RRB- -RRB-))))))) (. .)))
7739955	6	(ROOT (S (NP (NNP Right) (NN ventricular) (NN pacemaker) (NNS wires)) (VP (VBD were) (VP (VBN inserted) (PP (IN in) (NP (NP (DT all)) (PP (IN of) (NP (PRP them))))) (PP (IN during) (NP (NP (JJ cardiopulmonary) (NN resuscitation)) (PRN (-LRB- -LRB-) (NP (NNP CPR)) (-RRB- -RRB-)))))) (. .)))
7739955	7	(ROOT (S (PP (IN In) (NP (CD four) (NNS patients))) (, ,) (NP (JJ cardiac) (NN pacing)) (VP (VBD was) (VP (VBN used) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (JJ temporary) (NN captured) (NN rhythm) (CC and) (NN restoration)) (PP (IN of) (NP (PRP$ their) (JJ cardiac) (NN output))))))))) (. .)))
7739955	8	(ROOT (S (NP (DT These) (NNS patients)) (VP (VBD had) (NP (NP (DT a) (JJ second) (NN event)) (PP (IN of) (NP (NNS Doc_7739955_1210_1224_Disease)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NNS Doc_7739955_1239_1244_Disease))) (, ,) (PP (IN within) (NP (QP (CD 10) (TO to) (CD 60)) (NNS minutes)))))) (. .)))
7739955	9	(ROOT (S (PP (IN In) (NP (CD one) (NN patient))) (, ,) (NP (JJ cardiac) (NN pacing)) (VP (VBD was) (RB not) (VP (VBN used) (, ,) (SBAR (IN because) (S (NP (PRP he)) (VP (VBD converted) (PP (TO to) (NP (JJ normal) (NNS sinus) (NN rhythm))) (PP (IN by) (NP (JJ electrical) (NN defibrillation))) (PP (IN within) (NP (NP (CD three) (NNS minutes)) (PP (IN of) (NP (NNP initiating) (NNP CPR)))))))))) (. .)))
7739955	10	(ROOT (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (JJ cardiac) (NN pacing)) (PP (IN during) (NP (NP (JJ resuscitative) (NNS efforts)) (PP (IN in) (NP (NP (JJ pediatric) (NNS patients)) (VP (VBG suffering) (PP (IN from) (NP (NNS Doc_7739955_1527_1555_Disease))))))))) (VP (MD may) (RB not) (VP (VB have) (NP (NP (JJ long-term) (NN value)) (PP (IN in) (CC and) (IN of) (NP (PRP itself)))))))))) (: ;) (S (ADVP (RB however)) (, ,) (SBAR (IN if) (S (NP (JJ temporary) (JJ hemodynamic) (NN stability)) (VP (VBZ is) (VP (VBN achieved) (PP (IN by) (NP (DT this) (NN procedure))))))) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB provide) (NP (NP (JJ additional) (NN time)) (VP (VBN needed) (S (VP (TO to) (VP (VB institute) (NP (JJ other) (JJ therapeutic) (NNS modalities)))))))))) (. .)))
7931490	0	(ROOT (S (NP (NP (NN Efficacy) (CC and) (NN safety)) (PP (IN of) (NP (NP (NP (NNS Doc_7931490_23_34_Chemical)) (, ,) (NP (DT a) (JJ selective) (NN Doc_7931490_48_67_Chemical-3) (NN receptor) (NN antagonist)) (, ,)) (PP (IN in) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (NNS Doc_7931490_112_118_Disease) (CC and) (NNS Doc_7931490_123_131_Disease)))))))) (VP (VBN induced) (PP (IN by) (NP (JJ high-dose) (NNS Doc_7931490_153_162_Chemical)))) (. .)))
7931490	1	(ROOT (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (JJ antiemetic) (NNS effects) (CC and) (NN safety) (NN profile)) (PP (IN of) (NP (NP (CD four) (JJ different) (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_7931490_252_263_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Kytril)) (: ;) (NP (NP (NNP SmithKline) (NNP Beecham) (NNP Pharmaceuticals)) (, ,) (NP (NNP Philadelphia) (, ,) (NNP PA))) (-RRB- -RRB-))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN as) (NP (DT a) (JJ single) (JJ intravenous) (PRN (-LRB- -LRB-) (NP (NNP IV)) (-RRB- -RRB-)) (NN dose))) (PP (IN for) (NP (NP (NNS prophylaxis)) (PP (IN of) (NP (NN Doc_7931490_398_407_Chemical-induced) (NNS Doc_7931490_416_422_Disease) (CC and) (NNS Doc_7931490_427_435_Disease)))))))))) (. .)))
7931490	2	(ROOT (FRAG (NP (NNS PATIENTS) (CC AND) (NNS METHODS)) (: :) (S (NP (NP (NP (CD One) (CD hundred) (NN eighty-four) (JJ chemotherapy-naive) (NNS patients)) (VP (VBG receiving) (NP (JJ high-dose) (NNS Doc_7931490_531_540_Chemical)))) (PRN (-LRB- -LRB-) (NP (QP (CD 81) (TO to) (CD 120)) (NNS mg/m2)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN randomized) (S (VP (TO to) (VP (VB receive) (NP (NP (CD one)) (PP (IN of) (NP (NP (CD four) (JJ Doc_7931490_598_609_Chemical) (NNS doses)) (PRN (-LRB- -LRB-) (NP (NP (CD 5)) (, ,) (NP (CD 10)) (, ,) (NP (CD 20)) (, ,) (CC or) (NP (CD 40) (NN micrograms/kg))) (-RRB- -RRB-)) (VP (VBN administered) (PP (IN before) (NP (NN chemotherapy))))))))))))) (. .)))
7931490	3	(ROOT (S (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN observed) (PP (IN on) (NP (NP (DT an) (JJ inpatient) (NN basis)) (PP (IN for) (NP (QP (CD 18) (TO to) (CD 24)) (NNS hours)))))))) (, ,) (CC and) (S (NP (NP (JJ vital) (NNS signs)) (, ,) (NP (NNS Doc_7931490_765_771_Disease)) (, ,) (NP (NNS Doc_7931490_773_781_Disease)) (, ,) (NP (NN retching)) (, ,) (CC and) (NP (NN appetite))) (VP (VBD were) (VP (VBN assessed)))) (. .)))
7931490	4	(ROOT (S (NP (NNP Safety) (NNS analyses)) (VP (VBD included) (NP (NP (NN incidence)) (PP (IN of) (NP (JJ adverse) (NNS experiences) (CC and) (NN laboratory) (NN parameter) (NNS changes))))) (. .)))
7931490	5	(ROOT (S (S (PP (IN After) (NP (NP (JJ Doc_7931490_928_939_Chemical) (NNS doses)) (PP (IN of) (NP (NP (CD 5)) (, ,) (NP (CD 10)) (, ,) (NP (CD 20)) (, ,) (CC and) (NP (CD 40) (NN micrograms/kg)))))) (, ,) (NP (NP (DT a) (JJ major) (NN response)) (PRN (-LRB- -LRB-) (NP (NP (NNP <) (CC or) (NNP =)) (NP (CD two) (NNS Doc_7931490_1011_1019_Disease) (CC or) (NN retching) (NNS episodes)) (, ,) (CC and) (NP (DT no) (JJ antiemetic) (NN rescue))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN recorded) (PP (IN in) (NP (NP (CD 23) (NN %)) (, ,) (NP (CD 57) (NN %)) (, ,) (NP (CD 58) (NN %)) (, ,) (CC and) (NP (NP (CD 60) (NN %)) (PP (IN of) (NP (NNS patients)))))) (, ,) (ADVP (RB respectively))))) (, ,) (CC and) (S (NP (NP (DT a) (JJ complete) (NN response)) (PRN (-LRB- -LRB-) (NP (DT no) (ADJP (ADJP (JJ Doc_7931490_1162_1170_Disease) (CC or) (JJ retching)) (, ,) (CC and) (ADJP (RB no) (JJ antiemetic))) (NN rescue)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (CD 18) (NN %)) (, ,) (NP (CD 41) (NN %)) (, ,) (NP (CD 40) (NN %)) (, ,) (CC and) (NP (NP (CD 47) (NN %)) (PP (IN of) (NP (NNS patients)))))) (, ,) (ADVP (RB respectively))) (. .)))
7931490	6	(ROOT (S (S (NP (EX There)) (VP (VBD was) (NP (DT a) (ADJP (RB statistically) (JJR longer)) (NN time)) (PP (TO to) (NP (NP (JJ first) (NN episode)) (PP (IN of) (NP (NP (NNS Doc_7931490_1321_1352_Disease)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD .0001))) (-RRB- -RRB-)))))))) (, ,) (CC and) (S (NP (JJR fewer) (NNS patients)) (VP (VBD were) (VP (VBN administered) (NP (NP (JJ additional) (JJ antiemetic) (NN medication)) (PP (IN in) (NP (DT the) (JJ 10-micrograms/kg) (JJ dosing) (NNS groups)))) (PP (IN than) (PP (IN in) (NP (DT the) (JJ 5-micrograms/kg) (NN dosing) (NN group))))))) (. .)))
7931490	7	(ROOT (S (SBAR (IN As) (S (NP (JJ Doc_7931490_1519_1530_Chemical) (NN dose)) (VP (VBD increased)))) (, ,) (NP (NN appetite) (NN return)) (VP (VBD increased) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD .040))) (-RRB- -RRB-))) (. .)))
7931490	8	(ROOT (S (NP (NNP Doc_7931490_1585_1593_Disease)) (VP (VBD was) (NP (NP (DT the) (ADJP (ADVP (RBS most) (RB frequently)) (VBN reported)) (JJ adverse) (NN event)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN %)) (-RRB- -RRB-)))) (. .)))
7931490	9	(ROOT (S (NP (NP (DT A) (JJ single) (CD 10) (NNS -)) (, ,) (NP (NP (QP (CD 20) (CD -))) (, ,) (CC or) (NP (NP (JJ 40-micrograms/kg) (NN dose)) (PP (IN of) (NP (NNS Doc_7931490_1707_1718_Chemical)))))) (VP (VBD was) (ADJP (JJ effective) (PP (IN in) (NP (NP (VBG controlling) (NNS Doc_7931490_1748_1756_Disease)) (PP (IN in) (NP (NP (QP (CD 57) (NN %) (TO to) (CD 60) (NN %))) (PP (IN of) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD received) (NP (NNS Doc_7931490_1796_1805_Chemical)) (PP (IN at) (S (VP (VBG doses) (NP (QP (JJR greater) (IN than) (CD 81)) (NNS mg/m2)))))) (CC and) (VP (ADVP (RB totally)) (VBD prevented) (NP (NNS Doc_7931490_1859_1867_Disease)) (PP (IN in) (NP (NP (QP (CD 40) (NN %) (TO to) (CD 47) (NN %))) (PP (IN of) (NP (NNS patients))))))))))))))))) (. .)))
7931490	10	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (ADJP (RB statistically) (JJ significant)) (NNS differences)) (PP (IN in) (NP (NP (NP (NN efficacy)) (PP (IN between) (NP (DT the) (JJ 10-micrograms/kg) (NN dose)))) (CC and) (NP (DT the) (CD 20)) (: -) (CC and) (NP (JJ 40-micrograms/kg) (NNS doses)))))) (. .)))
7931490	11	(ROOT (S (NP (NNP Doc_7931490_2033_2044_Chemical)) (VP (VBD was) (ADVP (RB well)) (VP (VBN tolerated) (PP (IN at) (NP (DT all) (NNS doses))))) (. .)))
7949506	0	(ROOT (NP (NP (JJ Adverse) (NN interaction)) (PP (IN between) (NP (NNS Doc_7949506_28_37_Chemical) (CC and) (NNS Doc_7949506_42_51_Chemical))) (. .)))
7949506	1	(ROOT (S (VP (TO To) (VP (VB report) (NP (NP (CD two) (NNS cases)) (PP (IN of) (NP (NP (DT a) (JJ possible) (JJ adverse) (NN interaction)) (PP (IN between) (NP (NNS Doc_7949506_126_135_Chemical) (CC and) (NNS Doc_7949506_140_149_Chemical)))))) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NP (NNS Doc_7949506_163_190_Disease)) (PP (IN in) (NP (DT both) (NNS patients)))) (CC and) (NP (NP (JJ severe) (NNS Doc_7949506_219_230_Disease)) (PP (IN in) (NP (CD one) (NN patient)))))))))) (. .)))
7949506	2	(ROOT (FRAG (NP (NN CASE) (NNS SUMMARIES)) (: :) (S (NP (NP (DT A) (JJ 54-year-old) (NN woman)) (PP (IN with) (NP (NNS Doc_7949506_288_306_Disease)))) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NN Doc_7949506_324_333_Chemical) (CD 480) (NN mg/d) (CC and) (JJ Doc_7949506_347_361_Chemical) (CD 100) (NN mg/d)))))) (. .)))
7949506	3	(ROOT (S (PP (IN After) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (DT a) (JJ minimal) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_7949506_412_421_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.15) (NN mg) (NN bid)) (-RRB- -RRB-)))))))) (, ,) (NP (PRP she)) (VP (VBD developed) (NP (NP (NP (JJ complete) (NNS Doc_7949506_460_468_Disease)) (CC and) (NP (JJ severe) (NNS Doc_7949506_480_491_Disease))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBN resolved) (PP (IN upon) (NP (NP (NN cessation)) (PP (IN of) (NP (DT all) (NNS medications)))))))))) (. .)))
7949506	4	(ROOT (S (NP (DT A) (JJ 65-year-old) (NN woman)) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (JJ extended-release) (NNS Doc_7949506_597_606_Chemical)) (ADJP (NP (CD 240)) (JJ mg/d)))))) (. .)))
7949506	5	(ROOT (S (PP (IN After) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN Doc_7949506_639_648_Chemical) (CD 0.15) (NN mg) (NN bid))))) (NP (PRP she)) (VP (VBD developed) (NP (NP (JJ complete) (NNS Doc_7949506_684_692_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBN resolved) (SBAR (IN after) (S (NP (DT all) (NN therapy)) (VP (VBD was) (VP (VBN stopped)))))))))) (. .)))
7949506	6	(ROOT (S (NP (NP (DT An) (JJ adverse) (NN interaction)) (PP (IN between) (NP (NNS Doc_7949506_783_792_Chemical) (CC and) (NNS Doc_7949506_797_806_Chemical)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN reported) (ADVP (RB previously))))) (. .)))
7949506	7	(ROOT (S (NP (PRP We)) (VP (VP (VB describe) (NP (CD two) (JJ such) (NNS cases))) (CC and) (VP (VB discuss) (NP (NP (DT the) (JJ various) (NNS mechanisms)) (SBAR (WHNP (WDT that)) (S (VP (MD might) (VP (VB cause) (NP (PDT such) (DT an) (NN interaction))))))))) (. .)))
7949506	8	(ROOT (S (NP (NNS Clinicians)) (VP (MD should) (VP (VB be) (ADJP (VBN acquainted) (PP (IN with) (NP (NP (DT this) (ADJP (RB possibly) (JJ fatal)) (NN interaction)) (PP (IN between) (NP (CD two) (ADJP (RB commonly) (VBN used)) (JJ antihypertensive) (NNS drugs)))))))) (. .)))
7949506	9	(ROOT (S (NP (NN Caution)) (VP (VBZ is) (VP (VBN recommended) (PP (PP (IN in) (S (VP (VBG combining) (NP (NP (NNS Doc_7949506_1109_1118_Chemical)) (CC and) (NP (JJ Doc_7949506_1123_1132_Chemical) (NN therapy)))))) (, ,) (RB even) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP do) (RB not) (VP (VB have) (NP (NNS sinus) (CC or) (NNS Doc_7949506_1184_1203_Disease))))))))))) (. .)))
7949506	10	(ROOT (S (NP (DT The) (CD two) (NNS drugs)) (VP (MD may) (VP (VB act) (ADVP (RB synergistically)) (PP (IN on) (NP (PDT both) (NP (DT the) (NNP AV) (NN node)) (CC and) (NP (DT the) (JJ peripheral) (NN circulation)))))) (. .)))
7967231	0	(ROOT (NP (NP (NP (JJ Pharmacological) (NNS studies)) (PP (IN on) (NP (DT a) (JJ new) (JJ Doc_7967231_33_62_Chemical) (NN antagonist) (, ,) (NNP S-312-d) (. .) (NN 5th) (NN communication)))) (: :) (NP (NP (JJ anticonvulsant) (NNS effects)) (PP (IN in) (NP (NNS mice)))) (. .)))
7967231	1	(ROOT (S (S (NP (NP (NNP Doc_7967231_135_140_Chemical)) (, ,) (NP (UCP (ADJP (JJ S-312-d)) (, ,) (CONJP (CC but) (RB not)) (NP (JJ Doc_7967231_159_166_Chemical) (, ,) (JJ L-type) (JJ Doc_7967231_175_182_Chemical) (NN channel))) (NNS antagonists)) (, ,)) (VP (VBD showed) (NP (JJ anticonvulsant) (NNS effects)) (PP (IN on) (NP (DT the) (JJ audiogenic) (NN tonic) (NNS Doc_7967231_258_269_Disease))) (PP (IN in) (NP (CD DBA/2) (NNS mice))))) (: ;) (CC and) (S (NP (PRP$ their) (NN ED50) (NNS values)) (VP (VBD were) (NP (NP (NP (CD 18.4)) (PRN (-LRB- -LRB-) (NP (QP (CD 12.8-27) (CD .1))) (-RRB- -RRB-))) (VP (VBG mg/kg) (PRN (, ,) (S (NP (NP (NN p.o.)) (CC and) (NP (NP (CD 15.0)) (PRN (-LRB- -LRB-) (NP (QP (CD 10.2-23) (CD .7))) (-RRB- -RRB-)))) (VP (VBG mg/kg) (, ,) (ADVP (RB p.o.)) (, ,) (ADVP (RB respectively)) (, ,) (SBAR (IN while) (S (NP (NP (DT that)) (PP (IN of) (NP (NNS Doc_7967231_403_414_Chemical)))) (VP (VBD was) (NP (NP (NP (CD 34.0)) (PRN (-LRB- -LRB-) (NP (QP (CD 26.0-44) (CD .8))) (-RRB- -RRB-))) (VP (VBG mg/kg)))))))) (, ,)) (NP (NP (NN p.o.)) (SBAR (S (SBAR (IN Although) (S (NP (NP (JJ moderate) (NN anticonvulsant) (NNS effects)) (PP (IN of) (NP (NP (NNS S-312-d)) (PP (IN in) (NP (JJR higher) (NNS doses)))))) (VP (VBD were) (VP (VBN observed) (PP (IN against) (NP (NP (DT the) (JJ clonic) (NNS Doc_7967231_549_560_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_7967231_572_590_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 85) (NN mg/kg)) (, ,) (NP (NNP s.c.)) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_7967231_611_620_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN mg/kg)) (, ,) (NP (NNP s.c.)) (-RRB- -RRB-))))))))))) (, ,) (NP (DT no) (NNS effects)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (NNS Doc_7967231_667_678_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_7967231_690_710_Chemical) (, ,) (NNS Doc_7967231_712_722_Chemical) (, ,) (CC or) (NN electroshock))) (PP (IN in) (NP (NNP Slc))) (: :) (NP (NN ddY) (NNS mice)))))))))))))) (. .)))
7967231	2	(ROOT (S (NP (NNP S-312-d)) (VP (MD may) (VP (VB be) (ADJP (JJ useful) (PP (IN in) (NP (NP (DT the) (NN therapy)) (PP (IN of) (NP (NP (JJ certain) (NNS types)) (PP (IN of) (NP (JJ human) (NNS Doc_7967231_820_828_Disease)))))))))) (. .)))
8096565	0	(ROOT (S (VP (VB Doc_8096565_0_32_Disease) (PP (IN with) (NP (NNS Doc_8096565_38_49_Chemical)))) (. .)))
8096565	1	(ROOT (S (PP (IN For) (NP (NNS Doc_8096565_55_66_Chemical))) (, ,) (NP (NP (NNS tightness)) (PP (IN in) (NP (NP (DT the) (NN chest)) (VP (VBN caused) (PP (IN by) (NP (DT an) (JJ unknown) (NN mechanism))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (CD 3-5) (NN %)) (PP (IN of) (NP (NNS users)))))))) (. .)))
8096565	2	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (DT a) (JJ 47-year-old) (NN woman)) (PP (IN with) (NP (DT an) (NNS Doc_8096565_198_225_Disease))) (SBAR (IN after) (S (NP (NP (NN administration)) (PP (IN of) (NP (NNP Doc_8096565_250_261_Chemical) (CD 6)))) (VP (VBP mg) (ADVP (RB subcutaneously)) (PP (IN for) (NP (NNS Doc_8096565_286_302_Disease))))))) (. .)))
8096565	3	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (JJ underlying) (NNS Doc_8096565_345_368_Disease) (CC or) (NNS Doc_8096565_372_391_Disease))))) (. .)))
8096565	4	(ROOT (S (NP (PRP She)) (VP (VBD recovered) (PP (IN without) (NP (NNS complications)))) (. .)))
8135424	0	(ROOT (S (NP (NNP Doc_8135424_0_10_Chemical)) (VP (VBZ induces) (NP (NNS Doc_8135424_19_27_Disease) (CC and) (NNS Doc_8135424_32_37_Disease)) (PP (IN in) (NP (VBN mixed) (NN Doc_8135424_47_54_Chemical-Doc_8135424_55_63_Chemical) (NNS intoxications)))) (. .)))
8135424	1	(ROOT (FRAG (NP (NNP STUDY) (NNP HYPOTHESIS)) (: :) (S (NP (NP (NNP Administration)) (PP (IN of) (NP (DT the) (JJ Doc_8135424_119_133_Chemical) (JJ antagonist) (NNS Doc_8135424_145_155_Chemical)))) (VP (MD may) (VP (VB unmask) (NP (NP (NNS Doc_8135424_167_175_Disease)) (PP (IN in) (NP (VBN mixed) (NN Doc_8135424_185_192_Chemical-Doc_8135424_193_207_Chemical) (NN intoxication))))))) (. .)))
8135424	2	(ROOT (S (NP (NNP Male) (NNP Sprague-Dawley) (NNS rats)) (VP (VBD received) (NP (NP (NP (CD 100)) (VP (VBG mg/kg) (NP (NNP Doc_8135424_274_281_Chemical) (NNP IP)) (ADVP (RB alone)))) (, ,) (NP (NP (CD 5) (VBG mg/kg) (NNS Doc_8135424_300_308_Chemical)) (ADVP (RB alone))) (, ,) (CC or) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NNS Doc_8135424_336_344_Chemical) (CC and) (NNS Doc_8135424_349_356_Chemical)))))) (. .)))
8135424	3	(ROOT (S (NP (CD Three) (NNS minutes) (RB later)) (, ,) (NP (NNS groups)) (VP (VBD were) (VP (VBN challenged) (PP (IN with) (NP (NP (NN vehicle)) (CC or) (NP (NNS Doc_8135424_418_428_Chemical) (CD 5) (CC or) (CD 10)))) (S (VP (VBG mg/kg) (NP (NNP IP)))))) (. .)))
8135424	4	(ROOT (S (NP (NP (NNP Animal) (NN behavior)) (, ,) (NP (NP (NP (NNS Doc_8135424_464_472_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN time)) (PP (TO to) (NP (QP (CC and) (CD incidence))))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_8135424_498_503_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN time)) (PP (TO to) (NP (QP (CC and) (CD incidence))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ cortical) (NNP EEG) (NNS tracings)))) (VP (VBD were) (VP (VBN recorded))) (. .)))
8135424	5	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NP (NNS Doc_8135424_603_613_Chemical)) (PP (TO to) (NP (NP (NNS animals)) (PP (IN after) (NP (PRP they)))))))) (VP (VBD had) (VP (VBN received) (NP (NP (DT a) (NN combination) (NN dose)) (PP (IN of) (NP (NNS Doc_8135424_671_678_Chemical) (CC and) (NNS Doc_8135424_683_691_Chemical)))))) (. .)))
8135424	6	(ROOT (S (PP (IN In) (NP (NN group) (CD 1))) (, ,) (NP (NNS animals)) (VP (VBD received) (SBAR (S (NP (NNS Doc_8135424_731_738_Chemical)) (VP (VBD followed) (PP (IN by) (NP (NN vehicle))))))) (. .)))
8135424	7	(ROOT (S (NP (DT This)) (VP (VBD resulted) (PP (IN in) (NP (NP (CD 100) (NN %)) (VP (VBG developing) (NP (NNS Doc_8135424_793_801_Disease) (CC and) (NNS Doc_8135424_806_811_Disease)))))) (. .)))
8135424	8	(ROOT (S (NP (NNP Group) (CD 2)) (VP (VBD received) (NP (NP (NNS Doc_8135424_830_838_Chemical)) (VP (ADVP (RB alone)) (VBN followed) (PP (IN by) (NP (NN vehicle)))))) (. .)))
8135424	9	(ROOT (S (NP (NNS Animals)) (VP (VBD became) (SBAR (S (NP (NN somnolent) (CC and) (NN none)) (VP (VBD died))))) (. .)))
8135424	10	(ROOT (S (NP (NNP Group) (CD 3)) (VP (VBD received) (SBAR (S (NP (NNS Doc_8135424_923_931_Chemical)) (VP (VBD followed) (PP (IN by) (NP (CD 5) (JJ mg/kg) (NNS Doc_8135424_952_962_Chemical))))))) (. .)))
8135424	11	(ROOT (S (NP (NNS Animals)) (VP (VBD became) (S (S (ADJP (JJ somnolent)) (PP (IN after) (NP (NNS Doc_8135424_995_1003_Chemical)))) (CC and) (S (ADVP (RB then)) (ADJP (JJ active) (PP (IN after) (NP (JJ Doc_8135424_1026_1036_Chemical) (NN administration))))))) (. .)))
8135424	12	(ROOT (S (PP (IN In) (NP (NN group) (CD 4))) (, ,) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NNS Doc_8135424_1082_1089_Chemical) (CC and) (NNS Doc_8135424_1094_1102_Chemical)))) (VP (VBD was) (VP (VBN administered) (ADVP (RB simultaneously)))) (. .)))
8135424	13	(ROOT (S (NP (DT This)) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT no) (NN overt)) (CC or) (NP (JJ EEG-detectable) (NNS Doc_8135424_1180_1188_Disease))) (CC and) (NP (NP (DT a) (ADJP (CD 50) (NN %)) (NN incidence)) (PP (IN of) (NP (NNS Doc_8135424_1212_1217_Disease))))))) (. .)))
8135424	14	(ROOT (S (NP (NNP Group) (CD 5)) (VP (VBD received) (NP (NP (DT a) (JJ similar) (NN combination)) (PP (IN of) (NP (NNS Doc_8135424_1261_1268_Chemical) (CC and) (NNS Doc_8135424_1273_1281_Chemical)))) (, ,) (PP (VBN followed) (PP (ADVP (RB later)) (IN by) (NP (CD 5) (JJ mg/kg) (NNS Doc_8135424_1309_1319_Chemical))))) (. .)))
8135424	15	(ROOT (S (NP (DT This)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_8135424_1364_1372_Disease)) (, ,) (NP (CD 90) (NN %)))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .01))) (-RRB- -RRB-)) (, ,) (CC and) (NP (NP (NNS Doc_8135424_1393_1398_Disease)) (, ,) (NP (NP (CD 100) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <)) (CC or) (NP (NNP =) (CD .01))) (-RRB- -RRB-)))))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NN group) (CD 4))))) (. .)))
8135424	16	(ROOT (S (NP (NNP Group) (CD 6)) (VP (VBD received) (NP (NNS Doc_8135424_1461_1468_Chemical) (CC and) (NNS Doc_8135424_1473_1481_Chemical)) (PP (VBN followed) (PP (IN by) (NP (CD 10) (JJ mg/kg) (NNS Doc_8135424_1503_1513_Chemical))))) (. .)))
8135424	17	(ROOT (S (NP (DT This)) (ADVP (RB also)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_8135424_1563_1571_Disease)) (, ,) (NP (CD 90) (NN %)))) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <)) (CC or) (NP (NNP =) (CD .01))) (-RRB- -RRB-)) (, ,) (CC and) (NP (NP (NNS Doc_8135424_1597_1602_Disease)) (, ,) (NP (NP (CD 90) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <)) (CC or) (NP (NNP =) (CD .05))) (-RRB- -RRB-)))))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NN group) (CD 4))))) (. .)))
8135424	18	(ROOT (S (NP (NNP Doc_8135424_1659_1669_Chemical)) (VP (MD can) (VP (VP (VB unmask) (NP (NNS Doc_8135424_1681_1689_Disease))) (CC and) (VP (VB increase) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_8135424_1720_1725_Disease)))) (PP (IN in) (NP (NP (DT a) (NN model)) (PP (IN of) (NP (VBN combined) (NN Doc_8135424_1749_1756_Chemical-Doc_8135424_1757_1765_Chemical) (NNS intoxications)))))))) (. .)))
8160791	0	(ROOT (NP (NP (NNPS Mechanisms)) (PP (IN for) (NP (JJ protective) (NNS effects))) (PP (IN of) (NP (NP (JJ free) (JJ radical) (NNS scavengers)) (PP (IN on) (NP (NN Doc_8160791_64_74_Chemical-mediated) (NNS Doc_8160791_84_95_Disease))))) (PP (IN in) (NP (NNS rats))) (. .)))
8160791	1	(ROOT (S (NP (NNPS Studies)) (VP (VBD were) (VP (VBN performed) (S (VP (TO to) (VP (VB examine) (NP (DT the) (NNS mechanisms)) (PP (IN for) (NP (NP (DT the) (JJ protective) (NNS effects)) (PP (IN of) (NP (JJ free) (JJ radical) (NNS scavengers))))) (PP (IN on) (NP (NP (NNS Doc_8160791_211_221_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8160791_223_225_Chemical)) (-RRB- -RRB-)) (: -) (NP (JJ mediated) (NNS Doc_8160791_236_247_Disease))))))))) (. .)))
8160791	2	(ROOT (NP (NP (NNP Administration)) (PP (IN of) (NP (NP (NNS Doc_8160791_267_269_Chemical)) (PP (IN at) (NP (NP (CD 40) (VBG mg/kg) (NN sc)) (PP (IN for) (NP (CD 13) (NNS days))))))) (PP (TO to) (NP (NNS rats))) (VP (VBN induced) (NP (NP (NP (NP (DT a) (JJ significant) (NNS Doc_8160791_327_356_Disease)) (PRN (-LRB- -LRB-) (NP (NNP RBF)) (-RRB- -RRB-))) (CC and) (NP (NP (NN inulin) (NN clearance)) (PRN (-LRB- -LRB-) (NP (NNP CIn)) (-RRB- -RRB-)))) (CONJP (RB as) (RB well) (IN as)) (NP (JJ marked) (NNS Doc_8160791_408_422_Disease)))) (. .)))
8160791	3	(ROOT (S (NP (NP (DT A) (JJ significant) (NN reduction)) (PP (IN in) (NP (NP (NP (JJ urinary) (NNS Doc_8160791_459_495_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8160791_497_501_Chemical)) (-RRB- -RRB-)) (NP (NN excretion))) (CC and) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (JJ renal) (JJ cortical) (NN renin)) (CC and) (NP (JJ endothelin-1) (NNS contents)))))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN observed) (PP (IN in) (NP (NN Doc_8160791_612_614_Chemical-mediated) (NNS Doc_8160791_624_635_Disease))))) (. .)))
8160791	4	(ROOT (S (NP (NP (NP (JJ Doc_8160791_637_647_Chemical) (NN dismutase)) (PRN (-LRB- -LRB-) (NP (NNP SOD)) (-RRB- -RRB-))) (CC or) (NP (NP (NNS Doc_8160791_667_683_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8160791_685_689_Chemical)) (-RRB- -RRB-)))) (ADVP (RB significantly)) (VP (VBD lessened) (NP (DT the) (NN Doc_8160791_718_720_Chemical-induced) (NN decrement)) (PP (IN in) (NP (NNP CIn)))) (. .)))
8160791	5	(ROOT (S (NP (NP (DT The) (JJ SOD-induced) (NN increase)) (PP (IN in) (NP (NN glomerular) (NN filtration) (NN rate)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT a) (JJ marked) (NN improvement)) (PP (IN in) (NP (NNP RBF)))) (, ,) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ urinary) (JJ Doc_8160791_874_878_Chemical) (NN excretion)))) (, ,) (CC and) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (JJ renal) (NN renin)) (CC and) (NP (JJ endothelin-1) (NN content))))))))) (. .)))
8160791	6	(ROOT (S (NP (NNP SOD)) (VP (VBD did) (RB not) (VP (VB attenuate) (NP (DT the) (NNS Doc_8160791_972_986_Disease)))) (. .)))
8160791	7	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (S (NP (NNS Doc_8160791_1001_1005_Chemical)) (ADVP (RB significantly)) (VP (VBD reduced) (NP (DT the) (NN Doc_8160791_1032_1046_Disease) (CC and) (NN lipid) (NN peroxidation)))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBD did) (RB not) (VP (VB affect) (NP (JJ renal) (NNS hemodynamics) (CC and) (NN vasoactive) (NNS substances))))) (. .)))
8160791	8	(ROOT (S (NP (CC Neither) (NP (NNP SOD)) (CC nor) (NP (NNS Doc_8160791_1155_1159_Chemical))) (VP (VBD affected) (NP (DT the) (JJ renal) (JJ cortical) (JJ Doc_8160791_1188_1190_Chemical) (NN content)) (PP (IN in) (NP (NN Doc_8160791_1202_1204_Chemical-treated) (NNS rats)))) (. .)))
8160791	9	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (S (LST (LS 1) (-RRB- -RRB-)) (NP (DT both) (NNP SOD) (CC and) (NNP Doc_8160791_1262_1266_Chemical)) (VP (VBP have) (NP (NP (JJ protective) (NNS effects)) (PP (IN on) (NP (NP (NN Doc_8160791_1294_1296_Chemical-mediated) (NNS Doc_8160791_1306_1317_Disease)) (, ,) (NP (LST (LS 2) (-RRB- -RRB-)) (NP (DT the) (NNS mechanisms)) (PP (IN for) (NP (NP (DT the) (JJ protective) (NNS effects)) (SBAR (S (VP (VBP differ) (PP (IN for) (NP (NNP SOD) (CC and) (NNP Doc_8160791_1383_1387_Chemical)))))))))))))) (, ,) (CC and) (S (LST (LS 3) (-RRB- -RRB-)) (NP (JJ Doc_8160791_1396_1406_Chemical) (NNS anions)) (VP (VBP play) (NP (NP (DT a) (JJ critical) (NN role)) (PP (IN in) (NP (JJ Doc_8160791_1438_1440_Chemical-induced) (JJ renal) (NN vasoconstriction))))))))) (. .)))
816141	0	(ROOT (S (VP (VB Doc_816141_0_11_Chemical-induced) (NP (JJ immune) (NNS Doc_816141_27_43_Disease))) (. .)))
816141	1	(ROOT (S (NP (NP (DT A) (NN patient)) (PP (IN with) (NP (NNS Doc_816141_60_73_Disease)))) (VP (VBD developed) (NP (JJ Coombs-positive) (NNS Doc_816141_100_116_Disease)) (PP (IN while) (S (VP (VBG receiving) (NP (JJ Doc_816141_133_144_Chemical) (NN therapy)))))) (. .)))
816141	2	(ROOT (S (NP (DT An) (JJ anti-Doc_816141_162_173_Chemical) (NNP IgG) (NN antibody)) (VP (VBD was) (VP (VBN detected) (PP (PP (IN in) (NP (NP (DT the) (NN patient) (POS 's)) (NN serum))) (CC and) (PP (IN in) (NP (DT the) (NNS eluates)))) (PP (IN from) (NP (PRP$ her) (NNS erythrocytes))))) (. .)))
816141	3	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ nonimmunologic) (VBG binding)) (PP (IN of) (NP (NP (JJ normal)) (CC and) (NP (NP (NP (NN patient) (POS 's)) (NN serum) (NNS proteins)) (TO to) (NP (PRP$ her) (ADJP (JJ own) (CC and) (JJ Doc_816141_355_366_Chemical-coated)) (JJ normal) (JJ red) (NNS cells)))))) (VP (VBD was) (VP (VBN demonstrated))) (. .)))
816141	4	(ROOT (S (NP (NP (NN Skin) (NNS tests)) (CC and) (NP (ADJP (IN in) (NN vitro)) (JJ lymphocyte) (NN stimulation))) (VP (VBD revealed) (SBAR (IN that) (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN sensitized) (PP (PP (TO to) (NP (NNS Doc_816141_500_511_Chemical))) (CC and) (PP (ADVP (RB also)) (TO to) (NP (NNS Doc_816141_524_534_Chemical))))))))) (. .)))
816141	5	(ROOT (S (NP (NP (JJ Careful) (NN investigation)) (PP (IN of) (NP (JJ drug-induced) (NNS Doc_816141_574_591_Disease)))) (VP (VBZ reveals) (NP (NP (DT the) (NN complexity)) (PP (IN of) (NP (NP (DT the) (JJ immune) (NNS mechanisms)) (VP (VBN involved)))))) (. .)))
8184922	0	(ROOT (S (NP (NP (NNP Assessment)) (PP (IN of) (NP (JJ cardiomyocyte) (NN DNA)))) (VP (VBZ synthesis) (PP (IN during) (NP (NP (NNS Doc_8184922_49_60_Disease)) (PP (IN in) (NP (JJ adult) (NNS mice)))))) (. .)))
8184922	1	(ROOT (S (NP (NP (DT The) (NN ability)) (PP (IN of) (NP (NNS cardiomyocytes) (S (VP (TO to) (VP (VB synthesize) (NP (NP (NNP DNA)) (PP (IN in) (NP (NN response)))) (S (VP (TO to) (VP (ADVP (RB experimentally)) (VB induced) (NP (NNS Doc_8184922_162_181_Disease))))))))))) (VP (VBD was) (VP (VBN assessed) (PP (IN in) (NP (JJ adult) (NNS mice))))) (. .)))
8184922	2	(ROOT (S (NP (NP (NNP Doc_8184922_210_223_Chemical)) (VP (VBN delivered) (PP (IN by) (NP (NP (JJ osmotic) (NN minipump) (NN implantation)) (PP (IN in) (NP (JJ adult) (JJ C3Heb/FeJ) (NNS mice))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (CD 46) (NN %)) (NN increase)) (PP (IN in) (NP (NP (NN heart) (NN weight)) (CC and) (NP (DT a) (CD 19.3) (NN %) (NN increase)))))) (PP (IN in) (NP (JJ cardiomyocyte) (NN area)))) (. .)))
8184922	3	(ROOT (S (NP (NP (DT No) (NN DNA) (NN synthesis)) (, ,) (SBAR (IN as) (S (VP (VBN assessed) (PP (IN by) (NP (NP (JJ autoradiographic) (NN analysis)) (PP (IN of) (NP (VBN isolated) (NNS cardiomyocytes)))))))) (, ,)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NN control) (CC or) (NN Doc_8184922_492_504_Disease) (NNS hearts))))) (. .)))
8184922	4	(ROOT (S (NP (NP (DT A) (NN survey)) (PP (IN of) (NP (NP (CD 15) (JJ independent) (JJ inbred) (NNS strains)) (PP (IN of) (NP (NNS mice)))))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NN ventricular)) (VP (VBP cardiomyocyte) (SBAR (S (NP (JJ nuclear) (NN number)) (VP (VBD ranged) (PP (IN from) (NP (CD 3))) (PP (TO to) (NP (ADJP (CD 13) (NN %)) (NNS Doc_8184922_639_651_Chemical))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ cardiomyocyte) (NN terminal) (NN differentiation)) (VP (VBZ is) (VP (VBN influenced) (ADVP (RB directly) (CC or) (RB indirectly)) (PP (IN by) (NP (JJ genetic) (NN background)))))))))))))))) (. .)))
8184922	5	(ROOT (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN capacity)) (PP (IN for) (NP (JJ reactive) (NN DNA) (NN synthesis)))) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ subject) (PP (TO to) (NP (JJ genetic) (NN regulation)))))))))) (, ,) (NP (NNS Doc_8184922_869_888_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN in) (NP (NP (DT the) (NNS strains)) (PP (IN of) (NP (NP (NNS mice)) (VP (VBG comprising) (NP (NP (DT the) (NNS extremes)) (PP (IN of) (NP (DT the) (JJ nuclear) (NN number) (NN survey))))))))))) (. .)))
8184922	6	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ adult) (NN mouse) (NN atrial)) (CC and) (NP (NN ventricular) (NNS cardiomyocytes))) (VP (VBP do) (RB not) (VP (VB synthesize) (NP (NP (NNP DNA)) (PP (IN in) (NP (NN response)))) (PP (TO to) (NP (NN Doc_8184922_1090_1103_Chemical-induced) (NNS Doc_8184922_1112_1131_Disease)))))))) (. .)))
8188982	0	(ROOT (NP (NP (JJ Central) (JJ cardiovascular) (NNS effects)) (PP (IN of) (NP (NNP Doc_8188982_34_37_Chemical) (CC and) (NNP ANP))) (PP (IN in) (NP (UCP (ADJP (JJ normotensive)) (CC and) (ADVP (RB spontaneously))) (JJ Doc_8188982_80_92_Disease) (NNS rats))) (. .)))
8188982	1	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (UCP (S (VP (TO to) (VP (VB compare) (NP (NP (NN influence)) (PP (IN of) (NP (NP (JJ central) (NNS Doc_8188982_168_188_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8188982_190_193_Chemical)) (-RRB- -RRB-)))))))) (CC and) (PP (IN of) (NP (NP (NP (JJ atrial) (JJ natriuretic) (NN peptide)) (PRN (-LRB- -LRB-) (NP (NNP ANP)) (-RRB- -RRB-))) (PP (IN on) (NP (NP (NN control)) (PP (IN of) (NP (NP (JJ arterial) (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP MAP)) (-RRB- -RRB-)) (CC and) (NP (NN heart) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP HR)) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (NN normotensive)) (PRN (-LRB- -LRB-) (NP (NNP WKY)) (-RRB- -RRB-))) (CC and) (NP (ADVP (RB spontaneously)) (NNP Doc_8188982_339_351_Disease) (PRN (-LRB- -LRB-) (NP (NNP SHR)) (-RRB- -RRB-)) (NNS rats)))))))) (. .)))
8188982	2	(ROOT (S (NP (NP (CD Three) (NN series)) (PP (IN of) (NP (NNS experiments)))) (VP (VBD were) (VP (VBN performed) (PP (IN on) (NP (NP (CD 30) (NN WKY)) (CC and) (NP (CD 30) (NN SHR)))) (, ,) (ADJP (RB chronically) (JJ instrumented) (PP (IN with) (NP (NP (NN guide) (NNS tubes)) (PP (IN in) (NP (NP (NP (DT the) (JJ lateral) (NN ventricle)) (PRN (-LRB- -LRB-) (NP (NNP LV)) (-RRB- -RRB-))) (CC and) (NP (ADJP (JJ arterial) (CC and) (JJ venous)) (NNS catheters))))))))) (. .)))
8188982	3	(ROOT (S (NP (NNP MAP) (CC and) (NNP HR)) (VP (VBD were) (VP (VBN monitored) (PP (IN before) (CC and) (IN after) (NP (NP (NP (NN i.v.) (NNS injections)) (PP (IN of) (NP (NP (DT either) (NN vehicle)) (CC or) (NP (CD 1))))) (, ,) (NP (NP (QP (CD 10) (CC and) (CD 50)) (NN ng)) (PP (IN of) (NP (NNS Doc_8188982_635_638_Chemical)))) (CC and) (NP (NP (CD 25) (, ,) (CD 125) (CC and) (CD 500) (NNS ng)) (PP (IN of) (NP (NNP ANP)))))))) (. .)))
8188982	4	(ROOT (S (NP (NP (NNP Sensitivity)) (PP (IN of) (NP (NP (JJ cardiac) (NN component)) (PP (IN of) (NP (NP (NP (NN baroreflex)) (PRN (-LRB- -LRB-) (NP (NNP CCB)) (-RRB- -RRB-))) (, ,) (VP (VBN expressed) (PP (IN as) (NP (NP (DT a) (NN slope)) (PP (IN of) (NP (DT the) (NN regression) (NN line))))))))))) (VP (VBD was) (VP (VP (VBN determined) (PP (IN from) (NP (NP (NNS relationships)) (PP (IN between) (NP (NP (JJ systolic) (JJ arterial) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP SAP)) (-RRB- -RRB-)) (CC and) (NP (NNP HR) (NN period)) (PRN (-LRB- -LRB-) (NP (NNP HRp)) (-RRB- -RRB-)))))) (PP (IN during) (NP (NP (NNS Doc_8188982_870_883_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8188982_885_888_Chemical)) (-RRB- -RRB-))))) (: -) (VP (VBN induced) (NP (NP (NNS Doc_8188982_898_910_Disease) (CC and) (NNS Doc_8188982_915_935_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP SN)) (-RRB- -RRB-)))) (: -) (VP (VBN induced)) (NP (NNS Doc_8188982_949_960_Disease)))) (. .)))
8188982	5	(ROOT (S (NP (NNP CCB)) (VP (VBD was) (VP (VBN measured) (PP (IN before) (CC and) (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (NP (DT either) (NN vehicle)) (, ,) (NP (NNS Doc_8188982_1030_1033_Chemical)) (, ,) (NP (NNP ANP)) (, ,) (CC or) (NP (DT both) (NNS peptides)))) (ADVP (RB together)))))) (. .)))
8188982	6	(ROOT (S (NP (NNP Doc_8188982_1067_1083_Disease)) (VP (VBD occurred) (SBAR (IN after) (S (NP (NP (NNP LV) (NN administration)) (PP (IN of) (NP (CD 1) (, ,) (CD 10) (CC and) (CD 50)))) (VP (VBP ng) (PP (IN of) (NP (NP (NP (NNS Doc_8188982_1139_1142_Chemical)) (PP (IN in) (NP (NNP WKY)))) (CC and) (NP (NP (QP (IN of) (CD 10) (CC and) (CD 50)) (NN ng)) (PP (IN in) (NP (NNP SHR)))))))))) (. .)))
8188982	7	(ROOT (S (S (NP (NNP ANP)) (VP (VBD did) (RB not) (VP (VB cause) (NP (JJ significant) (NNS changes)) (PP (IN in) (NP (NP (NNP MAP)) (PP (IN in) (NP (DT both) (NNS strains) (RB as))))) (PP (VBN compared) (PP (TO to) (NP (NN vehicle))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBD abolished) (S (NP (NNP Doc_8188982_1280_1283_Chemical-induced) (NNP MAP)) (VP (VB increase) (PP (IN in) (NP (NNP WKY) (CC and) (NNP SHR))))))) (. .)))
8188982	8	(ROOT (S (NP (NNP CCB)) (VP (VBD was) (VP (VBN reduced) (PP (IN in) (NP (NNP WKY) (CC and) (NNP SHR))) (PP (IN after) (NP (NP (NNP LV) (NN administration)) (PP (IN of) (NP (NNS Doc_8188982_1379_1382_Chemical))))) (PP (IN during) (NP (JJ SN-induced) (NNS Doc_8188982_1401_1412_Disease))))) (. .)))
8188982	9	(ROOT (S (PP (IN In) (NP (NP (NP (NNP SHR)) (PRN (CC but) (PP (RB not) (IN in) (NP (NNP WKY) (NN administration))))) (PP (IN of) (NP (NNP ANP))))) (, ,) (NP (NP (NNS Doc_8188982_1459_1462_Chemical)) (CC and) (NP (JJ Doc_8188982_1467_1470_Chemical) (JJ +) (NNS Doc_8188982_1473_1476_Chemical))) (VP (VBD decreased) (NP (NNS Doc_8188982_1487_1490_Chemical)) (PP (IN during) (NP (NNP Doc_8188982_1498_1501_Chemical-induced) (NNP MAP) (NNP elevation)))) (. .)))
8188982	10	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNP centrally)) (VP (VP (VBD applied) (NP (NNP Doc_8188982_1569_1572_Chemical) (CC and) (NNP ANP) (NN exert) (NN differential) (NNS effects)) (PP (IN on) (NP (NP (NN blood) (NN pressure) (CC and) (NN baroreflex) (NN control)) (PP (IN of) (NP (NN heart) (NN rate))))) (PP (IN in) (NP (NNP WKY) (CC and) (NNP SHR)))) (CC and) (VP (VBP suggest) (NP (NP (NN interaction)) (PP (IN of) (NP (NP (DT these) (CD two) (NNS peptides)) (PP (IN in) (NP (NP (NN blood) (NN pressure) (NN regulation)) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (JJ central) (JJ nervous) (NN system))))))))))))))) (. .)))
8308951	0	(ROOT (S (S (NP (NP (JJ Cutaneous) (NN exposure)) (PP (TO to) (NP (NN Doc_8308951_22_30_Chemical-like) (NN anticoagulant)))) (VP (VBG causing) (NP (DT an) (NNS Doc_8308951_61_85_Disease)))) (: :) (S (NP (DT a) (NN case)) (VP (VBP report))) (. .)))
8308951	1	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (JJ intercerebral) (NNS Doc_8308951_126_134_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NN Doc_8308951_142_150_Chemical-induced) (NNS Doc_8308951_159_171_Disease))))))) (VP (VBZ is) (VP (VBN presented))) (. .)))
8308951	2	(ROOT (S (NP (DT The) (JJ 39-year-old) (NN woman)) (VP (VBD had) (VP (VBN spread) (NP (DT a) (NN Doc_8308951_221_229_Chemical-type) (NN rat) (NN poison)) (PP (IN around) (NP (PRP$ her) (NN house) (NN weekly))) (S (VP (VBG using) (NP (PRP$ her) (JJ bare) (NNS hands)))) (, ,) (PP (IN with) (NP (DT no) (JJ washing) (NN post) (NN application))))) (. .)))
8308951	3	(ROOT (S (NP (NP (JJ Percutaneous) (NN absorption)) (PP (IN of) (NP (JJ Doc_8308951_353_361_Chemical) (VBG causing) (NNS Doc_8308951_370_382_Disease))) (, ,) (VP (VBN reported) (NP (CD three) (NNS times)) (PP (IN in) (NP (DT the) (NN past)))) (, ,)) (VP (VBZ is) (NP (DT a) (JJ significant) (NN risk)) (SBAR (IN if) (S (NP (NP (JJ protective) (NNS measures)) (, ,) (PP (JJ such) (IN as) (NP (NNS gloves))) (, ,)) (VP (VBP are) (RB not) (VP (VBN used)))))) (. .)))
8308951	4	(ROOT (S (NP (NP (DT An) (JJ adverse) (NN drug) (NN interaction)) (PP (IN with) (NP (NNS Doc_8308951_527_536_Chemical))) (, ,) (SBAR (WHNP (WDT which)) (S (NP (PRP she)) (VP (VBD took) (ADVP (RB occasionally))))) (, ,)) (VP (MD may) (VP (VB have) (VP (VBN exacerbated) (NP (DT the) (NNS Doc_8308951_592_604_Disease))))) (. .)))
8312343	0	(ROOT (S (NP (NNP Pediatric) (NN heart)) (VP (VBZ transplantation) (PP (IN without) (NP (JJ chronic) (NN maintenance) (NNS Doc_8312343_60_68_Chemical)))) (. .)))
8312343	1	(ROOT (S (PP (IN From) (NP (NP (CD 1986)) (PP (TO to) (NP (NNP February) (CD 1993))))) (, ,) (NP (NP (CD 40) (NNS children)) (VP (VBN aged) (PP (NP (CD 2) (NNS months)) (PP (TO to) (NP (CD 18) (NNS years))) (PRN (-LRB- -LRB-) (NP (NP (JJ average) (NN age) (NNP 10.4) (NNP +) (NNP /)) (: -) (NP (CD 5.8) (NNS years))) (-RRB- -RRB-))))) (VP (VBD underwent) (NP (NN heart) (NN transplantation))) (. .)))
8312343	2	(ROOT (S (NP (NP (NNS Indications)) (PP (IN for) (NP (NN transplantation)))) (VP (VBD were) (NP (NP (NP (JJ idiopathic) (NNS Doc_8312343_250_264_Disease)) (PRN (-LRB- -LRB-) (NP (CD 52) (NN %)) (-RRB- -RRB-)) (, ,) (NP (NNS Doc_8312343_272_296_Disease))) (PRN (-LRB- -LRB-) (NP (CD 35) (NN %)) (-RRB- -RRB-))) (PP (IN with) (CC and) (IN without) (NP (NP (NP (JJ prior) (NN repair)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 71) (NN %)) (CC and) (NP (CD 29) (NN %))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_8312343_362_389_Disease)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_8312343_396_418_Disease)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN %)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ Doc_8312343_429_440_Chemical) (NNS Doc_8312343_441_455_Disease)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN %)) (-RRB- -RRB-)))))) (. .)))
8312343	3	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN managed) (PP (IN with) (NP (NNS Doc_8312343_489_501_Chemical) (CC and) (NNS Doc_8312343_506_518_Chemical))))) (. .)))
8312343	4	(ROOT (S (NP (NP (DT No) (NNS prophylaxis)) (PP (IN with) (NP (JJ antilymphocyte) (NN globulin)))) (VP (VBD was) (VP (VBN used))) (. .)))
8312343	5	(ROOT (S (S (NP (NNP Doc_8312343_574_582_Chemical)) (VP (VBD were) (VP (VBN given) (PP (TO to) (NP (NP (CD 39) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN for) (NP (JJ refractory) (NN rejection)))))))))) (, ,) (CC but) (S (NP (NN weaning)) (VP (VBD was) (ADJP (ADJP (RB always) (JJ attempted)) (CC and) (ADJP (ADJP (RB generally) (JJ successful)) (PRN (-LRB- -LRB-) (NP (CD 64) (NN %)) (-RRB- -RRB-)))))) (. .)))
8312343	6	(ROOT (S (NP (NP (CD Five) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 14) (NN %)) (-RRB- -RRB-))) (VP (VBD received) (NP (NN maintenance) (NNS Doc_8312343_745_753_Chemical))) (. .)))
8312343	7	(ROOT (S (NP (NP (CD Four) (NNS patients)) (VP (VBN died) (PP (IN in) (NP (NP (DT the) (JJ perioperative) (NN period)) (CC and) (NP (CD one)))))) (VP (VBD died) (NP (CD 4) (NNS months) (RB later))) (. .)))
8312343	8	(ROOT (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (DT no) (NNS deaths)) (ADVP (VBN related) (PP (TO to) (NP (NN rejection) (CC or) (NNS Doc_8312343_881_890_Disease)))))) (. .)))
8312343	9	(ROOT (S (NP (NNP Average) (NNP follow-up)) (VP (VBD was) (NP (NP (CD 36) (JJ +) (NNS /)) (: -) (NP (CD 19) (NNS months) (PRN (-LRB- -LRB-) (NP (NP (NN range) (CD 1)) (PP (TO to) (NP (CD 65) (NNS months)))) (-RRB- -RRB-))))) (. .)))
8312343	10	(ROOT (S (NP (JJ Cumulative) (NN survival)) (VP (VBZ is) (NP (NP (CD 88) (NN %)) (PP (IN at) (NP (CD 5) (NNS years))))) (. .)))
8312343	11	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (NP (QP (JJR less) (IN than) (CD 7)) (NNS years)) (IN of) (NP (NN age))))) (, ,) (NP (NN rejection)) (VP (VBD was) (VP (VBN monitored) (ADVP (RB noninvasively)))) (. .)))
8312343	12	(ROOT (S (PP (IN In) (NP (DT the) (JJ first) (NN postoperative))) (NP (NN month)) (, ,) (NP (NP (CD 89) (NN %)) (PP (IN of) (NP (NNS patients)))) (VP (VBD were) (VP (VBN treated) (PP (IN for) (NP (NN rejection))))) (. .)))
8312343	13	(ROOT (S (NP (NP (NNP Freedom)) (PP (IN from) (NP (JJ serious) (NNS Doc_8312343_1170_1180_Disease)))) (VP (VBD was) (NP (NP (CD 83) (NN %)) (PP (IN at) (NP (NP (CD 1) (NN month)) (CC and) (NP (CD 65) (NN %))))) (PP (IN at) (NP (CD 1))) (NP (NN year))) (. .)))
8312343	14	(ROOT (S (NP (NNP Doc_8312343_1219_1245_Disease)) (VP (VBD were) (VP (VBN treated) (ADVP (RB successfully)) (PP (IN with) (NP (NP (NNS Doc_8312343_1277_1288_Chemical)) (PP (IN in) (NP (CD 11) (NNS patients))))))) (. .)))
8312343	15	(ROOT (S (NP (DT No) (NNS Doc_8312343_1308_1328_Disease)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (NNS children)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (NN transplantation)) (PP (VBN compared) (PP (IN with) (NP (DT a) (NN control) (NN population))))))))))) (. .)))
8312343	16	(ROOT (S (S (NP (NP (CD Twenty-one) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 60) (NN %)) (-RRB- -RRB-))) (VP (VBP have) (VP (VBN undergone) (NP (JJ annual) (NNS catheterizations))))) (CC and) (S (NP (NP (DT no) (NN sign)) (PP (IN of) (NP (NN graft) (NNS Doc_8312343_1506_1521_Disease)))) (VP (VBZ has) (VP (VBN been) (VP (VBN observed))))) (. .)))
8312343	17	(ROOT (S (S (NP (NNP Doc_8312343_1541_1549_Disease)) (VP (VBD occurred) (PP (IN in) (NP (NP (CD five) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 14) (NN %)) (-RRB- -RRB-)))))) (CC and) (S (NP (NNS Doc_8312343_1586_1598_Disease)) (VP (VBD was) (VP (VBN treated) (PP (IN in) (NP (NP (CD 10) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 28) (NN %)) (-RRB- -RRB-))))))) (. .)))
8312343	18	(ROOT (NP (S (S (NP (DT No) (NN patient)) (VP (VBD was) (VP (VBN disabled)))) (CC and) (S (NP (DT no) (JJ lymphoproliferative) (NN disorder)) (VP (VBD was) (NP (NP (NNP observed) (. .)) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-))))))))
8312983	0	(ROOT (S (VP (VB Delirium) (PP (IN during) (NP (JJ Doc_8312983_16_26_Chemical) (NN treatment)))) (. .)))
8312983	1	(ROOT (S (NP (DT A) (NN case)) (VP (VBP report)) (. .)))
8312983	2	(ROOT (S (NP (NP (DT The) (NN correlation)) (PP (IN between) (NP (NP (JJ high) (JJ serum) (JJ tricyclic) (NN antidepressant) (NNS concentrations)) (CC and) (NP (JJ central) (JJ nervous) (NN system) (NN side) (NNS effects))))) (VP (VBZ has) (VP (VBN been) (VP (ADVP (RB well)) (VBN established)))) (. .)))
8312983	3	(ROOT (S (NP (QP (RB Only) (DT a) (JJ few)) (NNS reports)) (VP (VBP exist) (, ,) (ADVP (RB however)) (, ,) (PP (IN on) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (DT the) (NN serum) (NNS concentrations)) (PP (IN of) (NP (NP (NP (JJ selective) (JJ Doc_8312983_296_305_Chemical) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NNP SSRIs)) (-RRB- -RRB-))) (CC and) (NP (PRP$ their) (JJ toxic) (NNS effects))))))))) (. .)))
8312983	4	(ROOT (S (PP (IN In) (NP (DT some) (NNS cases))) (, ,) (NP (NP (DT a) (JJ high) (NN serum) (NN concentration)) (PP (IN of) (NP (NP (NP (NNS Doc_8312983_404_414_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD >) (CD 600)) (NNS nmol/L)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ elderly) (NNS patients)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (VBN increased) (NN somnolence) (CC and) (NN movement) (NNS difficulties)))))) (. .)))
8312983	5	(ROOT (S (NP (NP (JJ Widespread) (NNS Doc_8312983_534_553_Disease)) (, ,) (PP (JJ such) (IN as) (NP (NNS Doc_8312983_563_571_Disease))) (, ,)) (VP (VBP have) (RB not) (VP (VBN been) (VP (ADVP (RB previously)) (VBN linked) (PP (IN with) (NP (NP (JJ high) (NN blood) (NNS levels)) (PP (IN of) (NP (NNP SSRIs)))))))) (. .)))
8312983	6	(ROOT (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP describe) (NP (DT a) (ADJP (JJ patient) (PP (IN with) (NP (NP (JJ Doc_8312983_681_708_Disease) (ADJP (JJ connected) (PP (IN with) (NP (DT a) (JJ high) (NN serum)))) (JJ total) (NNS Doc_8312983_743_753_Chemical)) (PRN (-LRB- -LRB-) (NP (NNS Doc_8312983_755_765_Chemical) (IN plus) (NN Doc_8312983_771_790_Chemical)) (-RRB- -RRB-))))) (NN concentration))) (. .)))
8318674	0	(ROOT (NP (NP (NP (NNS Doc_8318674_0_15_Disease) (CC and) (NNS Doc_8318674_20_25_Disease)) (PP (IN after) (NP (NP (JJ high-dose) (NNS Doc_8318674_42_51_Chemical-C)) (PP (IN for) (NP (NNS Doc_8318674_58_66_Disease)))))) (: ;) (NP (NP (JJ possible) (NN role)) (PP (IN of) (NP (NNP TNF-alpha) (CC and) (NNP PAF)))) (. .)))
8318674	1	(ROOT (S (NP (NP (CD Four)) (PP (RB out) (IN of) (NP (NP (CD 23) (JJ consecutive) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ high-dose) (NNS Doc_8318674_163_168_Chemical)) (PP (IN for) (NP (NP (NNS Doc_8318674_173_182_Disease)) (PP (IN in) (NP (PRP$ our) (NN institution))))))))))) (VP (VBD developed) (NP (DT a) (ADJP (RB strikingly) (JJ similar)) (NN syndrome)) (PP (IN during) (NP (DT the) (NN perfusion)))) (. .)))
8318674	2	(ROOT (S (NP (PRP It)) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NNS Doc_8318674_301_306_Disease) (, ,) (NNS Doc_8318674_308_316_Disease) (, ,) (NNS Doc_8318674_318_323_Disease) (, ,) (NNS Doc_8318674_325_340_Disease) (, ,) (NNS Doc_8318674_342_361_Disease) (, ,) (NNS Doc_8318674_363_381_Disease) (, ,) (NNS Doc_8318674_383_394_Disease) (CC and) (NNS Doc_8318674_399_411_Disease))))))) (. .)))
8318674	3	(ROOT (S (NP (JJ Thorough) (JJ bacteriological) (NN screening)) (VP (VBD failed) (S (VP (TO to) (VP (VB provide) (NP (NP (NN evidence)) (PP (IN of) (NP (NNS Doc_8318674_478_487_Disease)))))))) (. .)))
8318674	4	(ROOT (S (NP (NP (JJ Sequential) (JJ biological) (NNS assays)) (PP (IN of) (NP (NNP IL-1) (, ,) (NNP IL-2) (, ,) (NNP TNF) (CC and) (NNP PAF)))) (VP (VBD were) (VP (VBN performed) (PP (IN during) (NP (JJ Doc_8318674_567_572_Chemical) (NN infusion))) (PP (TO to) (NP (CD ten) (NNS patients))) (, ,) (PP (VBG including) (NP (NP (DT the) (CD four)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (DT the) (NN syndrome))))))))) (. .)))
8318674	5	(ROOT (S (NP (NP (NNP TNF)) (CC and) (NP (NNP PAF) (NN activity))) (VP (VBD was) (VP (VBN found) (PP (PP (IN in) (NP (NP (DT the) (NN serum)) (PP (IN of) (ADVP (RB respectively)) (NP (NP (CD two) (CC and) (CD four)) (PP (IN of) (NP (DT the) (NNS cases))))))) (, ,) (CC but) (RB not) (PP (IN in) (NP (DT the) (CD six) (NNS controls)))))) (. .)))
8318674	6	(ROOT (S (SBAR (IN As) (S (NP (NNP TNF) (CC and) (NNP PAF)) (VP (VBP are) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_8318674_826_838_Disease) (CC and) (NN adult) (NNS Doc_8318674_849_878_Disease))))))))))))) (, ,) (NP (PRP we)) (VP (VBP hypothesize) (SBAR (IN that) (S (NP (JJ high-dose) (NNS Doc_8318674_910_915_Chemical)) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (JJ cytokine) (NN release))))))))) (. .)))
8392553	0	(ROOT (NP (NP (JJ Protective) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_8392553_21_31_Chemical)) (PP (IN against) (NP (NN Doc_8392553_40_51_Chemical-induced) (NNS Doc_8392553_60_74_Disease))))) (PP (IN in) (NP (NNS rats))) (. .)))
8392553	1	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_8392553_115_125_Chemical)) (, ,) (NP (DT a) (JJ Doc_8392553_129_156_Chemical) (NN antagonist)) (, ,)))) (PP (IN on) (NP (NP (NN Doc_8392553_172_183_Chemical-induced) (NNS Doc_8392553_192_206_Disease)) (PP (IN in) (NP (NNS rats)))))) (. .)))
8392553	2	(ROOT (S (PP (IN With) (NP (JJ 2-week) (JJ chronic) (JJ Doc_8392553_236_247_Chemical) (NN infusion))) (, ,) (S (NP (NP (CD 16)) (PP (IN of) (NP (CD 30) (NNS rats)))) (VP (VBD died) (PP (IN within) (NP (CD 4) (NNS days))))) (, ,) (CC and) (S (NP (NP (JJ severe) (NNS Doc_8392553_303_319_Disease) (CC and) (NNS Doc_8392553_324_332_Disease)) (PP (IN of) (NP (DT the) (JJ left) (NNS ventricles)))) (VP (VBD were) (ADJP (JJ observed)))) (. .)))
8392553	3	(ROOT (S (S (PP (IN In) (NP (NN Doc_8392553_374_385_Chemical-treated) (NNS rats))) (, ,) (NP (NP (JJ left) (NN atrial)) (CC and) (NP (NP (JJ left) (NN ventricular) (NN papillary) (NN muscle) (NN contractile) (NNS responses)) (PP (TO to) (NP (NNS Doc_8392553_475_488_Chemical))))) (VP (VBD were) (VP (VBN reduced)))) (, ,) (CC but) (S (NP (NP (NNS responses)) (PP (TO to) (NP (NNS Doc_8392553_520_527_Chemical)))) (VP (VBD were) (UCP (ADJP (JJ normal)) (CC or) (VP (VBN enhanced) (PP (VBN compared) (PP (TO to) (NP (NNS controls)))))))) (. .)))
8392553	4	(ROOT (S (NP (NP (NNP Left) (NNP ventricular) (NNP alpha)) (CC and) (NP (JJ beta) (NN adrenoceptor) (NNS densities))) (VP (VBD were) (ADVP (RB also)) (VP (VBN reduced) (PP (VBN compared) (PP (TO to) (NP (NNS controls)))))) (. .)))
8392553	5	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN with) (NP (NNS Doc_8392553_684_694_Chemical)))) (VP (VP (VBD prevented) (NP (NP (NN Doc_8392553_705_716_Chemical-induced) (NNS Doc_8392553_725_730_Disease)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .05))) (-RRB- -RRB-)))) (, ,) (CC and) (VP (VBD attenuated) (NP (NP (DT the) (NNS Doc_8392553_761_789_Disease) (CC and) (NNS Doc_8392553_794_802_Disease)) (, ,) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner)))))) (. .)))
8392553	6	(ROOT (S (S (NP (NP (CD Left) (ADJP (JJ atrial) (CC and) (VBN left)) (JJ ventricular) (JJ papillary) (NN muscle) (NN contractile) (NNS responses)) (PP (TO to) (NP (NNS Doc_8392553_907_920_Chemical)))) (VP (VBD were) (VP (VBN reduced) (PP (VBN compared) (PP (TO to) (NP (NP (NNS controls)) (PP (IN in) (NP (NP (NNS groups)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_8392553_978_988_Chemical))) (ADVP (RB alone))))))))))) (, ,) (CC but) (S (PP (VBN combined) (PP (IN with) (NP (NNS Doc_8392553_1014_1025_Chemical)))) (, ,) (NP (NNS Doc_8392553_1027_1037_Chemical)) (VP (VP (VBD restored) (NP (JJ left) (JJ atrial) (NNS responses))) (CC and) (VP (VBD enhanced) (RB left) (VP (VB ventricular) (NP (JJ papillary) (NNS responses)) (PP (TO to) (NP (NNS Doc_8392553_1122_1135_Chemical))))))) (. .)))
8392553	7	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (NP (NNS Doc_8392553_1155_1165_Chemical)) (VP (VBD did) (RB not) (VP (VB prevent) (NP (NP (NN Doc_8392553_1182_1193_Chemical-induced) (NN down-regulation)) (PP (IN of) (NP (ADJP (NN alpha) (CC and) (NN beta)) (NNS adrenoceptors)))))) (. .)))
8392553	8	(ROOT (S (ADVP (RB Interestingly)) (, ,) (NP (NP (NNS Doc_8392553_1266_1276_Chemical)) (, ,) (VP (VBN infused) (ADVP (RB alone))) (, ,)) (VP (VBD resulted) (PP (IN in) (NP (NP (VBN decreased) (JJ adrenergic) (NN receptor) (NNS densities)) (PP (IN in) (NP (DT the) (JJ left) (NN ventricle)))))) (. .)))
8392553	9	(ROOT (S (NP (NNP Doc_8392553_1368_1378_Chemical)) (ADVP (RB also)) (VP (VBD did) (RB not) (VP (VB prevent) (NP (DT the) (VBN enhanced) (NNS responses)) (PP (TO to) (NP (NP (NNS Doc_8392553_1426_1433_Chemical)) (VP (VBN seen) (PP (IN in) (NP (DT the) (NN Doc_8392553_1446_1457_Chemical-treated) (NNS animals)))))) (, ,) (SBAR (IN although) (S (NP (NP (DT the) (JJ high) (NN dose)) (PP (IN of) (NP (NNS Doc_8392553_1501_1511_Chemical)))) (ADVP (RB partially)) (VP (VBD attenuated) (NP (DT the) (JJ maximal) (NN response)) (PP (TO to) (NP (NNS Doc_8392553_1557_1564_Chemical))) (PP (VBN compared) (PP (TO to) (NP (NN Doc_8392553_1577_1588_Chemical-treated) (NNS animals))))))))) (. .)))
8392553	10	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NNS Doc_8392553_1621_1631_Chemical)) (VP (VBD attenuated) (NP (NN Doc_8392553_1643_1654_Chemical-induced) (NNS Doc_8392553_1663_1677_Disease)) (, ,) (PP (ADVP (RB possibly)) (IN through) (NP (PRP$ its) (NN effect))) (PP (IN on) (NP (DT the) (JJ adrenergic) (NN pathway)))) (. .)))
851038	0	(ROOT (NP (NP (JJ Kaliuretic) (NN effect)) (PP (IN of) (NP (JJ Doc_851038_21_27_Chemical) (NN treatment))) (PP (IN in) (NP (JJ Doc_851038_41_53_Disease) (NNS patients))) (. .)))
851038	1	(ROOT (S (NP (NP (NNP Doc_851038_64_75_Disease)) (, ,) (ADJP (RB sometimes) (JJ severe)) (, ,)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (DT some) (JJ Doc_851038_116_122_Chemical-treated) (JJ Doc_851038_131_143_Disease) (NNS patients))))) (. .)))
851038	2	(ROOT (S (NP (NP (DT The) (NN influence)) (PP (IN of) (NP (NP (NNS Doc_851038_171_177_Chemical)) (PP (IN on) (NP (NP (DT the) (JJ renal) (NN excretion)) (PP (IN of) (NP (NNS Doc_851038_204_213_Chemical)))))))) (VP (VBD was) (VP (VBN studied) (PP (PP (IN in) (NP (NP (CD 3) (NNS patients)) (PP (IN with) (NP (NNS Doc_851038_245_256_Disease))))) (CC and) (PP (IN in) (NP (CD 5) (JJ normokalemic) (NNS patients)))) (PP (IN by) (NP (NP (NN determination)) (PP (IN of) (NP (NP (NP (JJ renal) (NN plasma) (NN flow)) (, ,) (NP (NN glomerular) (NN filtration) (NN rate)) (, ,) (NP (NP (NN plasma) (NN concentration)) (PP (IN of) (NP (NNS Doc_851038_379_388_Chemical)))) (CC and) (NP (NNS Doc_851038_393_399_Chemical))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ urinary) (NN excretion)) (PP (IN of) (NP (NNS Doc_851038_432_441_Chemical) (, ,) (NNS Doc_851038_443_449_Chemical) (CC and) (NNS Doc_851038_454_465_Chemical)))))))))) (. .)))
851038	3	(ROOT (S (NP (JJ Doc_851038_467_473_Chemical) (NN intake)) (VP (VBD was) (VP (VP (VBN found) (S (VP (TO to) (VP (VB cause) (NP (NP (DT an) (VBN increased) (NN excretion)) (PP (IN of) (NP (NNS Doc_851038_526_535_Chemical)))))))) (, ,) (CC and) (VP (ADVP (RB sometimes)) (PP (PP (ADVP (RB also)) (IN of) (NP (NP (NNS Doc_851038_559_565_Chemical)) (, ,) (PP (IN in) (NP (DT the) (NNS Doc_851038_574_585_Disease))))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (DT the) (JJ normokalemic) (NNS patients))))))) (. .)))
851038	4	(ROOT (S (NP (NP (DT This) (NN effect)) (PP (IN on) (NP (DT the) (JJ renal) (NN function)))) (VP (MD could) (VP (VB be) (VP (VBN prohibited) (PP (IN by) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (DT a) (JJ peripheral) (NN dopa) (NN decarbodylase) (NN inhibitor)))))))) (. .)))
851038	5	(ROOT (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (WHADVP (WRB why)) (S (NP (DT this) (NN effect)) (VP (VBD occurred) (PP (PP (IN in) (NP (DT some) (NNS individuals))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NNS others)))))))))) (, ,) (CC but) (S (NP (PRP$ our) (NNS results)) (VP (VBP indicate) (NP (NP (NP (DT a) (NN correlation)) (PP (IN between) (NP (JJ Doc_851038_873_884_Chemical) (NN production)))) (CC and) (NP (NP (DT this) (JJ renal) (NN effect)) (PP (IN of) (NP (NNS Doc_851038_921_927_Chemical))))))) (. .)))
8511251	0	(ROOT (NP (NNP Doc_8511251_0_7_Chemical) (NNP induced) (NNP Doc_8511251_16_35_Disease) (. .)))
8511251	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NNS Doc_8511251_57_76_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_8511251_88_95_Chemical)))))))) (. .)))
8511251	2	(ROOT (S (NP (NP (DT The) (NNS Doc_8511251_101_109_Disease)) (VP (ADVP (RB probably)) (VBN induced) (PP (IN by) (NP (NNS Doc_8511251_130_151_Disease))))) (VP (VBD was) (VP (VBN reversed) (PP (IN by) (NP (NNS Doc_8511251_168_181_Chemical) (CC and) (NNS Doc_8511251_186_193_Chemical))) (S (VP (VBG blocking) (NP (NNS agents)))))) (. .)))
8603459	0	(ROOT (S (NP (JJ Doc_8603459_0_11_Chemical-induced) (NNS Doc_8603459_20_34_Disease)) (VP (VBD monitored) (PP (IN by) (NP (NNP ECG))) (PP (IN in) (S (ADVP (RB freely)) (VP (VBG moving) (NP (NNS mice)))))) (. .)))
8603459	1	(ROOT (S (NP (DT A) (JJ new) (NN model)) (VP (TO to) (VP (VB test) (NP (JJ potential) (NNS protectors)))) (. .)))
8603459	2	(ROOT (S (PP (IN In) (NP (NN laboratory) (NNS animals))) (, ,) (NP (NN histology)) (VP (VBZ is) (ADVP (RBS most) (RB commonly)) (VP (VBN used) (S (VP (TO to) (VP (VB study) (NP (NN Doc_8603459_181_192_Chemical-induced) (NNS Doc_8603459_201_215_Disease))))))) (. .)))
8603459	3	(ROOT (S (ADVP (RB However)) (, ,) (PP (IN for) (S (VP (VBG monitoring) (PP (IN during) (NP (NN treatment)))))) (, ,) (NP (NP (JJ large) (NNS numbers)) (PP (IN of) (NP (NNS animals)))) (VP (VBP are) (VP (VBN needed))) (. .)))
8603459	4	(ROOT (S (ADVP (RB Recently)) (NP (PRP we)) (VP (VBD developed) (NP (DT a) (JJ new) (NN method)) (S (VP (TO to) (VP (VB measure) (NP (NNP ECG) (NNS values)) (PP (IN in) (S (ADVP (RB freely)) (VP (VBG moving) (NP (NNS mice)) (PP (IN by) (NP (NN telemetry)))))))))) (. .)))
8603459	5	(ROOT (S (PP (IN With) (NP (DT this) (NN model))) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ chronic) (JJ Doc_8603459_443_454_Chemical) (NN administration)))) (PP (IN on) (NP (NP (NP (DT the) (NNP ECG)) (PP (IN of) (NP (ADJP (RB freely) (JJ moving)) (JJ BALB/c) (NNS mice)))) (CC and) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NP (NNS Doc_8603459_530_538_Chemical)) (PP (IN as) (NP (DT a) (JJ protective) (NN agent))))))))) (. .)))
8603459	6	(ROOT (S (NP (DT The) (NNP ST) (NN interval)) (ADVP (RB significantly)) (VP (VBD widened) (PP (IN from) (NP (NP (CD 15.0) (JJ +) (NNS /)) (PRN (: -) (NP (QP (CD 1.5) (TO to) (CD 56.8)) (NNS +)) (: /)) (: -) (NP (NP (QP (CD 11.8) (CD ms))) (PP (IN in) (NP (NP (NN week) (CD 10)) (PRN (-LRB- -LRB-) (NP (NP (CD 7) (JJ weekly) (NNS doses)) (PP (IN of) (NP (CD 4) (JJ mg/kg) (NNS Doc_8603459_676_687_Chemical))) (VP (VBN given) (NP (NN i.v.)) (NP (NP (IN plus) (CD 3) (NNS weeks)) (PP (IN of) (NP (NN observation)))))) (-RRB- -RRB-)))))))) (. .)))
8603459	7	(ROOT (S (NP (NP (DT The) (NNP ECG)) (PP (IN of) (NP (DT the) (NN control) (NNS animals)))) (VP (VBD did) (RB not) (VP (VB change) (PP (IN during) (NP (DT the) (JJ entire) (NN study))))) (. .)))
8603459	8	(ROOT (S (PP (IN After) (NP (NN sacrifice))) (S (NP (NP (DT the) (NNS hearts)) (PP (IN of) (NP (NN Doc_8603459_830_841_Chemical-treated) (NNS animals)))) (VP (VBD were) (ADJP (JJ enlarged)))) (CC and) (S (NP (DT the) (NN atria)) (VP (VBD were) (NP (NNS Doc_8603459_891_903_Disease)))) (. .)))
8603459	9	(ROOT (S (PP (IN As) (NP (NP (DT this) (NN schedule)) (VP (VBN exerted) (NP (JJR more) (NNS Doc_8603459_935_943_Disease)) (SBAR (IN than) (S (VP (VBD needed) (S (VP (TO to) (VP (VB investigate) (NP (JJ protective) (NNS agents))))))))))) (, ,) (NP (NP (DT the) (NN protection)) (PP (IN of) (NP (NNS Doc_8603459_1008_1016_Chemical)))) (VP (VBD was) (VP (VBN determined) (S (VP (VBG using) (NP (DT a) (NN dose) (NN schedule)) (PP (IN with) (NP (NP (JJR lower) (JJ general) (NNS Doc_8603459_1073_1081_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 6) (JJ weekly) (NNS doses)) (PP (IN of) (NP (CD 4) (JJ mg/kg) (NNS Doc_8603459_1109_1120_Chemical))) (VP (VBN given) (NP (NN i.v.)) (NP (NP (IN plus) (CD 2) (NNS weeks)) (PP (IN of) (NP (NN observation)))))) (-RRB- -RRB-)))))))) (. .)))
8603459	10	(ROOT (S (PP (IN On) (NP (DT this) (NN schedule))) (, ,) (NP (NP (DT the) (NNS animals) (POS ')) (NNS hearts)) (VP (VBD appeared) (ADJP (JJ normal)) (SBAR (IN after) (S (NP (NP (NN sacrifice) (CC and) (NNS Doc_8603459_1236_1244_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 50) (NN mg/kg)) (VP (VBN given) (NP (NN i.p.)) (NP (NP (CD 1) (NN h)) (PP (IN before) (NP (NNS Doc_8603459_1277_1288_Chemical)))))) (-RRB- -RRB-))) (VP (VBD provided) (NP (RB almost) (JJ full) (NN protection)))))) (. .)))
8603459	11	(ROOT (S (NP (DT These) (NNS data)) (VP (VBD were) (VP (VBN confirmed) (PP (IN by) (NP (NN histology))))) (. .)))
8603459	12	(ROOT (S (NP (DT The) (NNS results)) (VP (VP (VBP indicate) (SBAR (IN that) (S (NP (DT this) (JJ new) (NN model)) (VP (VBZ is) (ADJP (RB very) (JJ sensitive)))))) (CC and) (VP (VBZ enables) (NP (NP (NN monitoring)) (PP (IN of) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_8603459_1467_1481_Disease)))))) (PP (IN with) (NP (NN time))))) (. .)))
8603459	13	(ROOT (S (NP (NP (DT These) (NNS findings) (NN result)) (PP (IN in) (NP (NP (DT a) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (VBZ allows) (NP (NP (DT the) (NN testing)) (PP (IN of) (NP (NP (NNS protectors)) (PP (IN against) (NP (NN Doc_8603459_1572_1583_Chemical-induced) (NNS Doc_8603459_1592_1606_Disease)))))) (PP (IN as)))))))) (VP (VBD demonstrated) (PP (IN by) (NP (NP (DT the) (NN protection)) (VP (VBN provided) (PP (IN by) (NP (NNS Doc_8603459_1653_1661_Chemical))))))) (. .)))
8659767	0	(ROOT (S (NP (NNP Doc_8659767_0_11_Chemical)) (ADVP (RB dysrhythmogenicity)) (VP (VBZ is) (RB not) (VP (VBN enhanced) (PP (IN by) (NP (NP (JJ subtoxic) (NNS Doc_8659767_59_70_Chemical)) (PP (IN in) (NP (NNS dogs))))))) (. .)))
8659767	1	(ROOT (S (SBAR (IN Since) (S (NP (NNS Doc_8659767_86_97_Chemical) (CC and) (NNS Doc_8659767_102_113_Chemical)) (VP (MD may) (DT both) (VP (VB precipitate) (NP (NNS Doc_8659767_135_147_Disease)))))) (, ,) (S (VP (VBG circulating) (NP (NNS Doc_8659767_161_172_Chemical)) (PP (IN during) (NP (JJ regional) (NN anesthesia))))) (VP (MD could) (VP (VB potentiate) (NP (NP (JJ dysrhythmogenic) (NNS effects)) (PP (IN of) (NP (NNS Doc_8659767_244_255_Chemical)))))) (. .)))
8659767	2	(ROOT (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD examined) (SBAR (IN whether) (S (NP (NNS Doc_8659767_287_298_Chemical)) (VP (VBZ alters) (NP (NP (DT the) (NN dysrhythmogenicity)) (PP (IN of) (NP (NP (JJ subsequent) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_8659767_361_372_Chemical)) (PP (PP (IN in) (NP (JJ conscious) (, ,) (JJ healthy) (NNS dogs))) (CC and) (PP (IN in) (NP (NP (JJ anesthetized) (NNS dogs)) (PP (IN with) (NP (NNS Doc_8659767_430_451_Disease))))))))))))))) (. .)))
8659767	3	(ROOT (S (NP (JJ Forty-one) (JJ conscious) (NNS dogs)) (VP (VBD received) (SBAR (FRAG (NP (CD 10) (CD micrograms.kg-1)) (. .) (NP (JJ min-1) (NNS Doc_8659767_512_523_Chemical)) (. .))))))
8659767	4	(ROOT (S (NP (CD Seventeen) (NNS animals)) (VP (VBD responded) (PP (IN with) (NP (NP (NNS Doc_8659767_558_581_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8659767_583_585_Disease)) (-RRB- -RRB-)))) (PP (IN within) (NP (CD 3) (NN min)))) (. .)))
8659767	5	(ROOT (S (PP (IN After) (NP (CD 3) (NN h))) (, ,) (NP (DT these) (NNS responders)) (ADVP (RB randomly)) (VP (VBD received) (NP (NP (QP (CD 1) (CC or) (CD 2)) (JJ mg/kg) (NNS Doc_8659767_660_671_Chemical)) (CC or) (NP (ADJP (JJ saline) (PP (IN over) (NP (NP (CD 5) (NN min)) (, ,) (VP (VBN followed) (PP (IN by) (NP (CD 10) (CD micrograms.kg-1))) (. .))))) (JJ min-1) (NNS Doc_8659767_731_742_Chemical)))) (. .)))
8659767	6	(ROOT (S (PP (IN In) (NP (DT the) (JJ Doc_8659767_751_762_Chemical) (NNS groups))) (, ,) (NP (NNS Doc_8659767_771_782_Chemical)) (VP (VBD caused) (NP (JJR fewer) (JJ prodysrhythmic) (NNS effects)) (PP (IN than) (PP (IN without) (NP (NNS Doc_8659767_832_843_Chemical))))) (. .)))
8659767	7	(ROOT (S (S (NP (NNP Doc_8659767_845_847_Disease)) (VP (VBD appeared) (PP (PP (IN in) (NP (JJR fewer) (NNS dogs))) (CC and) (PP (IN at) (NP (DT a) (JJ later) (NN time)))))) (, ,) (CC and) (S (NP (EX there)) (VP (VBD were) (UCP (NP (JJR more) (JJ sinoatrial) (NNS beats)) (CC and) (ADJP (RBR less) (JJ ectopies))))) (. .)))
8659767	8	(ROOT (FRAG (NP (NNP Doc_8659767_948_959_Chemical) (NNP shortened) (NNP QT)) (ADJP (JJR less) (PP (IN after) (NP (NNS Doc_8659767_984_995_Chemical)))) (ADVP (IN than) (PP (IN in) (NP (NN control) (NNS animals)))) (. .)))
8659767	9	(ROOT (S (NP (NP (CD One) (NN day)) (PP (IN after) (NP (NP (JJ experimental) (NNS Doc_8659767_1048_1069_Disease)) (, ,) (NP (NP (NP (CD six) (JJ additional) (NN Doc_8659767_1086_1095_Chemical-anesthetized) (NNS dogs)) (VP (VBN received) (S (ADJP (CD 4) (JJ micrograms.kg-1))))) (. .) (NP (NP (JJ min-1) (NNS Doc_8659767_1147_1158_Chemical)) (PP (IN until) (NP (NNS Doc_8659767_1165_1167_Disease)))))))) (VP (VBD appeared)) (. .)))
8659767	10	(ROOT (S (PP (IN After) (NP (CD 45) (NN min))) (, ,) (NP (CD 1) (JJ mg/kg) (NNS Doc_8659767_1200_1211_Chemical)) (VP (VBD was) (VP (VBN injected) (PP (IN over) (NP (NP (CD 5) (NN min)) (, ,) (VP (ADVP (RB again)) (VBN followed) (PP (IN by) (NP (CD 4) (NNP micrograms.kg-1) (. .) (JJ min-1) (NNS Doc_8659767_1279_1290_Chemical)))))))) (. .)))
8659767	11	(ROOT (S (PP (IN In) (NP (DT these) (NNS dogs))) (, ,) (NP (NP (DT the) (JJ prodysrhythmic) (NN response)) (PP (TO to) (NP (NNS Doc_8659767_1338_1349_Chemical)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN mitigated) (PP (IN by) (NP (VBG preceding) (NNS Doc_8659767_1382_1393_Chemical))))) (. .)))
8659767	12	(ROOT (S (NP (NNP Doc_8659767_1395_1406_Chemical)) (VP (VBZ antagonizes) (S (NP (NP (JJ Doc_8659767_1419_1430_Chemical) (NN dysrhythmogenicity)) (PP (IN in) (NP (JJ conscious) (NNS dogs)))) (ADJP (JJ susceptible) (PP (PP (TO to) (NP (NNS Doc_8659767_1483_1485_Disease))) (CC and) (PP (IN in) (NP (NP (JJ anesthetized) (NNS dogs)) (PP (IN with) (NP (JJ spontaneous) (NNS Doc_8659767_1528_1552_Disease))))))))) (. .)))
8659767	13	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (DT no) (NN evidence)) (SBAR (IN that) (S (NP (JJ systemic) (JJ subtoxic) (JJ Doc_8659767_1598_1609_Chemical) (NN administration)) (VP (VBZ enhances) (NP (NP (DT the) (NN dysrhythmogenicity)) (PP (IN of) (NP (JJ subsequent) (NNS Doc_8659767_1671_1682_Chemical)))))))) (. .)))
8667442	0	(ROOT (S (NP (NNP Doc_8667442_0_20_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_8667442_32_42_Chemical)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NNS Doc_8667442_61_79_Disease)))))))) (. .)))
8667442	1	(ROOT (S (NP (NNP Doc_8667442_81_101_Disease)) (VP (VBD was) (ADVP (RB first)) (VP (VBN described) (PP (ADVP (NP (CD 70) (NNS years)) (RB ago)) (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_8667442_170_190_Disease))))))) (PP (IN with) (NP (NP (JJ large) (NNS amounts)) (PP (IN of) (NP (NNS Doc_8667442_213_220_Chemical) (CC and) (NNS alkali))))))) (. .)))
8667442	2	(ROOT (S (SBAR (IN Although) (S (PP (IN with) (NP (NP (JJ current) (JJ Doc_8667442_255_260_Disease) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NP (NN H-2) (NNS blockers)) (, ,) (NP (NNS Doc_8667442_284_294_Chemical)) (, ,) (CC and) (NP (NNS Doc_8667442_300_310_Chemical))) (-RRB- -RRB-)))) (, ,) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NNS Doc_8667442_330_350_Disease)))) (VP (VBZ has) (VP (VBN decreased) (ADVP (RB significantly)))))) (, ,) (NP (NP (DT the) (JJ classic) (NN triad)) (PP (IN of) (NP (NNS Doc_8667442_401_414_Disease) (, ,) (NNS Doc_8667442_416_425_Disease) (, ,) (CC and) (NNS Doc_8667442_431_447_Disease)))) (VP (VBZ remains) (NP (DT the) (NNS Doc_8667442_460_484_Disease))) (. .)))
8667442	3	(ROOT (S (NP (NNP Doc_8667442_486_506_Disease)) (VP (MD can) (VP (VB present) (NP (ADJP (ADJP (JJ serious)) (CC and) (ADJP (RB occasionally) (JJ life-threatening))) (NN illness)) (SBAR (IN unless) (S (VP (VP (VBD diagnosed)) (CC and) (VP (VBD treated) (ADVP (RB appropriately)))))))) (. .)))
8667442	4	(ROOT (S (NP (DT This) (NN article)) (VP (VBZ presents) (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_8667442_650_668_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_8667442_690_707_Chemical) (CC and) (NNS Doc_8667442_712_722_Chemical))) (S (VP (VBG resulting) (PP (IN in) (NP (CD two) (NNS admissions))) (PP (TO to) (NP (NP (DT the) (NN hospital)) (PP (IN for) (NP (NNS Doc_8667442_771_791_Disease)))))))))))))) (. .)))
8667442	5	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (ADVP (RB successfully)) (VP (VBN treated) (PP (PP (IN with) (NP (NP (JJ intravenous) (NNS Doc_8667442_847_858_Chemical)) (PP (IN on) (NP (PRP$ his) (JJ first) (NN admission))))) (CC and) (PP (IN with) (NP (NP (NNS Doc_8667442_891_905_Chemical)) (PP (IN on) (NP (DT the) (NN second)))))))) (. .)))
8667442	6	(ROOT (S (NP (DT This)) (VP (VBZ illustrates) (NP (JJ intravenous) (NNS Doc_8667442_950_961_Chemical)) (PP (IN as) (NP (NP (DT a) (JJ valuable) (JJ therapeutic) (NN tool)) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_8667442_998_1018_Disease)) (VP (VBZ presents) (PP (IN as) (NP (JJ hypercalcemic) (NN emergency))))))))) (. .)))
8701013	0	(ROOT (NP (CD Doc_8701013_0_10_Chemical-associated) (NNS Doc_8701013_22_30_Disease) (. .)))
8701013	1	(ROOT (NP (NP (DT A) (NN series)) (PP (IN of) (NP (CD six) (NNS cases))) (. .)))
8701013	2	(ROOT (S (NP (NNP Doc_8701013_55_65_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ Doc_8701013_71_80_Chemical) (NN H2-receptor) (NN antagonist)) (VP (VP (VBN used) (PP (IN in) (NP (NP (JJ inpatient) (NNS settings)) (PP (IN for) (NP (NP (NN prevention)) (PP (IN of) (NP (NN stress) (NNS Doc_8701013_156_162_Disease)))))))) (CC and) (VP (VBZ is) (VP (VBG showing) (NP (NP (VBG increasing) (NN popularity)) (PP (RB because) (IN of) (NP (PRP$ its) (JJ low) (NN cost))))))))) (. .)))
8701013	3	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT all)) (PP (IN of) (NP (DT the) (ADJP (RB currently) (JJ available)) (NN H2-receptor) (NNS antagonists)))) (VP (VBP have) (VP (VBN shown) (NP (DT the) (NN propensity) (S (VP (TO to) (VP (VB cause) (NP (NNS Doc_8701013_324_332_Disease)))))))))) (, ,) (NP (RB only) (CD two)) (ADVP (RB previously)) (VP (VBD reported) (SBAR (S (NP (NNS cases)) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_8701013_395_405_Chemical))))))))) (. .)))
8701013	4	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBP report) (PP (IN on) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN Doc_8701013_442_452_Chemical-associated) (NNS Doc_8701013_464_472_Disease))))) (PP (IN in) (NP (NP (JJ hospitalized) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD cleared) (ADVP (RB completely)) (PP (IN upon) (NP (NP (NN removal)) (PP (IN of) (NP (NNS Doc_8701013_537_547_Chemical))))))))))) (. .)))
8701013	5	(ROOT (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NNS Doc_8701013_573_583_Chemical)))) (VP (VBP are) (VP (VBN reviewed) (, ,) (PP (IN with) (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NP (PRP$ its) (NN metabolism)) (PP (IN in) (NP (NP (DT the) (JJ elderly) (NN population)) (VP (VBN seen)))))))))) (. .)))
8701013	6	(ROOT (S (NP (NP (DT The) (NNS implications)) (PP (IN of) (S (VP (VBG using) (NP (NNS Doc_8701013_689_699_Chemical)) (PP (IN in) (NP (JJ elderly) (NNS persons))))))) (VP (VBP are) (VP (VBN discussed))) (. .)))
8748050	0	(ROOT (SBARQ (WHNP (NP (CD Doc_8748050_0_14_Disease)) (PP (IN during) (NP (JJ Doc_8748050_22_35_Chemical) (NN therapy)) (: :))) (SQ (VBP are) (NP (NP (NNS Doc_8748050_49_79_Disease)) (CC and) (NP (JJ Doc_8748050_84_93_Chemical) (NN syndrome) (NN spectrum) (NNS disorders)))) (. ?)))
8748050	1	(ROOT (S (NP (DT This) (NN report)) (VP (VBZ describes) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NNS Doc_8748050_155_169_Disease)) (VP (VBN developed) (PP (IN in) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (JJ Doc_8748050_197_210_Chemical) (NN therapy))))) (, ,) (PP (IN during) (NP (NP (DT a) (NN remission)) (PP (IN of) (NP (NNS Doc_8748050_242_261_Disease)))))))))) (. .)))
8748050	2	(ROOT (S (NP (DT This) (NN patient)) (VP (MD could) (VP (VB have) (VP (VBN been) (VP (VBN diagnosed) (PP (IN as) (S (VP (VBG having) (NP (NP (NP (DT either) (NNS Doc_8748050_319_349_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8748050_351_354_Disease)) (-RRB- -RRB-))) (CC or) (NP (NP (JJ Doc_8748050_359_368_Chemical) (NN syndrome)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8748050_379_381_Disease)) (-RRB- -RRB-))))))))))) (. .)))
8748050	3	(ROOT (S (NP (NP (DT The) (JJ major) (NN determinant)) (PP (IN of) (NP (DT the) (NNS symptoms)))) (VP (MD may) (VP (VB have) (VP (VBN been) (NP (NP (NNP Doc_8748050_436_444_Chemical) (NNP /) (NNS Doc_8748050_445_454_Chemical) (NN imbalance)) (PP (IN in) (NP (DT the) (JJ central) (JJ nervous) (NN system))))))) (. .)))
8748050	4	(ROOT (S (NP (NP (DT The) (NN Doc_8748050_500_503_Disease-like) (NNS Doc_8748050_509_523_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBZ develops) (PP (IN in) (NP (NN association))) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS antidepressants))))))))) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NNS Doc_8748050_600_603_Disease) (CC and) (NNS Doc_8748050_608_610_Disease)) (VP (VBP are) (NP (NP (NN spectrum) (NNS disorders)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS drugs)) (PP (IN with) (NP (ADJP (DT both) (JJ antidopaminergic) (CC and) (JJ serotonergic)) (NNS effects))))))))))) (. .)))
8755612	0	(ROOT (S (NP (NP (NNP Doc_8755612_0_18_Disease)) (PP (IN of) (NP (JJ Doc_8755612_22_27_Disease) (NN growth) (CC and) (NNS Doc_8755612_39_50_Disease)))) (VP (VBZ phenotypes) (PP (IN in) (NP (DT an) (NN Doc_8755612_68_76_Chemical-induced) (NNS Doc_8755612_85_90_Disease)))) (. .)))
8755612	1	(ROOT (S (NP (NP (JJ Chronic) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_8755612_118_126_Chemical)) (PP (TO to) (NP (DT the) (NNP Fischer) (CD 344) (-LRB- -LRB-) (NNP F344) (-RRB- -RRB-) (NN rat)))))) (VP (VBZ induces) (NP (NP (NN growth)) (PP (IN of) (NP (JJ large) (, ,) (JJ Doc_8755612_182_193_Disease) (NNS Doc_8755612_194_210_Disease))))) (. .)))
8755612	2	(ROOT (S (NP (NP (CD Ten) (NNS weeks)) (PP (IN of) (NP (NNP Doc_8755612_225_243_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_8755612_245_248_Chemical)) (-RRB- -RRB-)) (NN treatment)))) (VP (VBD caused) (NP (JJ female) (NN F344) (NN rat) (NNS pituitaries)) (S (VP (VP (TO to) (VP (VB grow) (PP (TO to) (NP (NP (NP (DT an) (NN average)) (PP (IN of) (NP (NP (QP (CD 109.2) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 6.3) (NN mg) (PRN (-LRB- -LRB-) (NP (JJ mean) (JJ +) (NNS /)) (, -) (NP (NNP SE)) (-RRB- -RRB-))) (PP (IN versus) (NP (QP (CD 11.3) (CD +))))) (: /))))) (: -) (NP (NP (CD 1.4) (NN mg)) (PP (IN for) (NP (JJ untreated) (NNS rats)))))))) (, ,) (CC and) (VP (TO to) (VP (VB become) (ADJP (RB highly) (JJ Doc_8755612_415_426_Disease))))))) (. .)))
8755612	3	(ROOT (S (NP (DT The) (JJ same) (JJ Doc_8755612_437_440_Chemical) (NN treatment)) (VP (VBD produced) (NP (NP (DT no) (JJ significant) (NN growth)) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 8.9)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (ADJP (CD 0.5) (JJ mg)) (PP (IN for) (NP (NP (JJ treated) (NNS females)) (PP (IN versus) (NP (CD 8.7) (NNS +)))))) (: /)) (: -) (FRAG (NP (CD 1.1)) (PP (IN for) (NP (JJ untreated) (NNS females)))))) (-RRB- -RRB-)) (CC or) (NP (NP (JJ morphological) (NNS changes)) (PP (IN in) (NP (NNP Brown) (NNP Norway))))) (PRN (-LRB- -LRB-) (NP (NNP BN)) (-RRB- -RRB-)) (VP (VB rat) (NP (NNS pituitaries)))) (. .)))
8755612	4	(ROOT (S (NP (NP (DT An) (NN F1) (NN hybrid)) (PP (IN of) (NP (NNP F344) (CC and) (NNP BN)))) (VP (VBD exhibited) (NP (JJ significant) (NN pituitary) (NN growth)) (PP (IN after) (NP (NP (CD 10) (NNS weeks)) (PP (IN of) (NP (JJ Doc_8755612_708_711_Chemical) (NN treatment))))) (PP (IN with) (NP (NP (NP (NP (DT an) (JJ average) (NN mass)) (PP (IN of) (NP (QP (CD 26.3) (CD +)) (NNS /)))) (PRN (: -) (NP (NP (CD 0.7) (NN mg)) (PP (VBN compared) (PP (IN with) (NP (CD 8.6) (NNS +))))) (: /))) (: -) (NP (NP (CD 0.9) (NN mg)) (PP (IN for) (NP (JJ untreated) (NNS rats))))))) (. .)))
8755612	5	(ROOT (S (ADVP (RB Surprisingly)) (, ,) (NP (DT the) (CD F1) (JJ hybrid) (NNS Doc_8755612_839_845_Disease)) (VP (VP (VBD were) (RB not) (VP (VBN Doc_8755612_855_866_Disease))) (CC and) (VP (VBD had) (NP (NP (NN hemoglobin) (NN content) (CC and) (NN outward) (NN appearance)) (ADJP (JJ identical) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NNP BN))))))))) (. .)))
8755612	6	(ROOT (S (NP (NP (NNP Expression)) (PP (IN of) (NP (NP (DT both) (NN growth)) (CC and) (NP (JJ morphological) (NNS changes))))) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (JJ multiple) (NNS genes))))) (. .)))
8755612	7	(ROOT (S (ADVP (RB However)) (, ,) (SBAR (IN while) (S (NP (NN Doc_8755612_1035_1038_Chemical-induced) (NN pituitary) (NN growth)) (VP (VBD exhibited) (NP (JJ quantitative) (, ,) (NN additive) (NN inheritance))))) (, ,) (NP (DT the) (JJ Doc_8755612_1114_1125_Disease) (NN phenotype)) (VP (VBD exhibited) (NP (ADJP (JJ recessive) (, ,) (JJ epistatic)) (NN inheritance))) (. .)))
8755612	8	(ROOT (S (S (NP (NP (QP (RB Only) (CD 5))) (PP (IN of) (NP (DT the) (QP (CD 160) (CD F2)) (NNS pituitaries)))) (VP (VBD exhibited) (NP (DT the) (JJ Doc_8755612_1227_1238_Disease) (NN phenotype)))) (: ;) (S (S (NP (NP (CD 36)) (PP (IN of) (NP (DT the) (QP (CD 160) (CD F2)) (NNS pituitaries)))) (VP (VBD were) (PP (IN in) (NP (NP (DT the) (NN F344) (NN range)) (PP (IN of) (NP (NN mass))))))) (, ,) (CC but) (S (NP (NP (CD 31)) (PP (IN of) (NP (DT these)))) (VP (VBD were) (RB not) (ADJP (JJ Doc_8755612_1336_1347_Disease)) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (DT the) (JJ Doc_8755612_1369_1380_Disease) (NN phenotype)) (VP (VBZ is) (RB not) (ADVP (RB merely)) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (JJ extensive) (NN growth)))))))))))) (. .)))
8755612	9	(ROOT (S (NP (DT The) (NNP Doc_8755612_1444_1455_Disease) (NNP F2) (NNS pituitaries)) (VP (VBD were) (NP (NP (DT all)) (PP (IN among) (NP (NP (DT the) (RBS most) (JJ massive)) (, ,) (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT some)) (PP (IN of) (NP (DT the) (NNS genes)))) (VP (VB regulate) (NP (DT both) (NNS phenotypes)))))))))) (. .)))
8808730	0	(ROOT (S (NP (NP (VBN Increased) (NN expression)) (PP (IN of) (NP (JJ neuronal) (NNS Doc_8808730_33_45_Chemical)))) (VP (VBP synthase) (PP (IN in) (NP (NP (NN bladder) (NN afferent) (NNS pathways)) (PP (VBG following) (NP (JJ chronic) (NNS Doc_8808730_102_120_Disease)))))) (. .)))
8808730	1	(ROOT (S (NP (JJ Immunocytochemical) (NNS techniques)) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB examine) (NP (NP (NNS alterations)) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ neuronal) (JJ Doc_8808730_215_227_Chemical) (NN synthase)) (PRN (-LRB- -LRB-) (NP (NNP NOS)) (-RRB- -RRB-))))))) (PP (IN in) (NP (NP (NN bladder) (NNS pathways)) (PP (VBG following) (NP (NP (JJ acute) (CC and) (JJ chronic) (NN irritation)) (PP (IN of) (NP (NP (DT the) (JJ urinary) (NN tract)) (PP (IN of) (NP (DT the) (NN rat)))))))))))))) (. .)))
8808730	2	(ROOT (S (NP (NNP Doc_8808730_335_352_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_8808730_368_384_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CYP)) (-RRB- -RRB-)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN metabolized) (PP (TO to) (NP (NP (NNS Doc_8808730_415_423_Chemical)) (, ,) (NP (NP (DT an) (NN irritant)) (VP (VBN eliminated) (PP (IN in) (NP (DT the) (NN urine))))))))))))))) (. .)))
8808730	3	(ROOT (S (NP (NP (NNP Injection)) (PP (IN of) (NP (NP (NP (NNP CYP)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (JJ n) (NP (NNP =) (CD 10) (, ,) (CD 75))) (NN mg/kg)) (, ,) (NP (NN i.p.))) (-RRB- -RRB-))) (PP (ADVP (NP (CD 2) (NNS hours)) (RB prior)) (TO to) (NP (NP (NN perfusion)) (PRN (-LRB- -LRB-) (NP (JJ acute) (NN treatment)) (-RRB- -RRB-)))) (PP (IN of) (NP (DT the) (NNS animals)))))) (VP (VBD increased) (NP (NP (NP (NP (NNP Fos-immunoreactivity)) (PRN (-LRB- -LRB-) (NP (NNP IR)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS neurons)) (PP (IN in) (NP (NP (DT the) (JJ dorsal) (NN commissure)) (, ,) (NP (JJ dorsal) (NN horn)) (, ,) (CC and) (NP (NP (JJ autonomic) (NNS regions)) (PP (IN of) (NP (JJ spinal) (NNS segments))))))))) (PRN (-LRB- -LRB-) (ADJP (JJ L1-L2) (CC and) (JJ L6-S1)) (-RRB- -RRB-)) (SBAR (WHNP (WDT which)) (S (VP (VBP receive) (NP (JJ afferent) (NNS inputs)) (PP (IN from) (NP (NP (DT the) (NN bladder)) (, ,) (NP (NN urethra)) (, ,) (CC and) (NP (NN ureter))))))))) (. .)))
8808730	4	(ROOT (S (NP (NP (NN Fos-IR)) (PP (IN in) (NP (DT the) (JJ spinal) (NN cord)))) (VP (VBD was) (RB not) (VP (VBN changed) (PP (IN in) (NP (NP (NNS rats)) (VP (VBG receiving) (NP (NP (JJ chronic) (NN CYP) (NN treatment)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 15)))))) (, ,) (NP (NP (CD 75) (NN mg/kg)) (, ,) (NP (NN i.p.))) (, ,) (NP (NP (DT every) (JJ 3rd) (NN day)) (PP (IN for) (NP (CD 2) (NNS weeks))))) (-RRB- -RRB-)))))))) (. .)))
8808730	5	(ROOT (S (PP (PP (IN In) (NP (NN control) (NNS animals))) (CC and) (PP (IN in) (NP (NP (NNS animals)) (VP (VBN treated) (ADVP (RB acutely)) (PP (IN with) (NP (NNP CYP))))))) (, ,) (NP (NP (NP (RB only) (JJ small) (NNS numbers)) (PP (IN of) (NP (NN NOS-IR) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (CD 0.5-0) (NNP .7) (NN cell) (NNS profiles/sections)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (NP (DT the) (ADJP (JJ L6-S1) (JJ dorsal)) (NN root) (NN ganglia)) (PRN (-LRB- -LRB-) (NP (NNP DRG)) (-RRB- -RRB-)))))) (. .)))
8808730	6	(ROOT (S (NP (NP (NP (JJ Chronic) (JJ Doc_8808730_1103_1106_Chemical) (NN administration)) (ADVP (RB significantly))) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <)) (CC or) (NP (NNP =) (CD .002))) (-RRB- -RRB-))) (VP (VBD increased) (NP (NN bladder) (NN weight)) (PP (IN by) (NP (NP (CD 60) (NN %)) (CC and) (NP (NP (JJ increased)) (PRN (-LRB- -LRB-) (X (NP (CD 7)) (: -) (PP (TO to) (ADJP (JJ 11-fold)))) (-RRB- -RRB-)) (SBAR (S (NP (NP (DT the) (NNS numbers)) (PP (IN of) (NP (NNP NOS-immunoreactive) (PRN (-LRB- -LRB-) (NP (NNP IR)) (-RRB- -RRB-)) (NN afferent)))) (VP (VBZ neurons) (PP (IN in) (NP (DT the) (NNP L6-S1) (NNP DRG)))))))))) (. .)))
8808730	7	(ROOT (S (S (NP (NP (DT A) (JJ small) (NN increase)) (PRN (-LRB- -LRB-) (ADJP (JJ 1.5-fold)) (-RRB- -RRB-))) (ADVP (RB also)) (VP (VBD occurred) (PP (IN in) (NP (DT the) (NNP L1) (NNP DRG))))) (, ,) (CC but) (S (NP (DT no) (NN change)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (DT the) (NNP L2) (CC and) (NNP L5) (NNP DRG)))))) (. .)))
8808730	8	(ROOT (S (S (NP (NP (JJ Bladder) (NN afferent) (NNS cells)) (PP (IN in) (NP (NP (DT the) (NNP L6-S1) (NNP DRG)) (VP (VBN labeled) (PP (IN by) (NP (NP (NNP Fluorogold)) (PRN (-LRB- -LRB-) (NP (CD 40) (NNS microliters)) (-RRB- -RRB-)) (VP (VBN injected) (PP (IN into) (NP (DT the) (NN bladder) (NN wall)))))))))) (VP (VBD did) (RB not) (VP (VB exhibit) (NP (NN NOS-IR)) (PP (IN in) (NP (NN control) (NNS animals)))))) (: ;) (S (ADVP (RB however)) (, ,) (PP (VBG following) (NP (JJ chronic) (NNP CYP) (NN administration))) (, ,) (NP (NP (DT a) (JJ significant) (NN percentage)) (PP (IN of) (NP (NN bladder) (NN afferent) (NNS neurons)))) (VP (VBD were) (UCP (ADJP (JJ NOS-IR)) (: :) (NP (NP (NP (NNP L6)) (PRN (-LRB- -LRB-) (NP (NP (NNP 19.8) (NNP +) (NNP /)) (: -) (NP (CD 4.6) (NN %))) (-RRB- -RRB-))) (CC and) (NP (NP (NNP S1)) (PRN (-LRB- -LRB-) (NP (CD 25.3) (NNP +) (NNS /)) (, -) (NP (CD 2.9) (NN %)) (-RRB- -RRB-))))))) (. .)))
8808730	9	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ neuronal) (NN gene) (NN expression)) (PP (IN in) (NP (JJ visceral) (JJ sensory) (NNS pathways)))) (VP (MD can) (VP (VB be) (VP (VBN upregulated) (PP (IN by) (NP (NP (NN chemical) (NN irritation)) (PP (IN of) (NP (NP (JJ afferent) (NNS receptors)) (PP (IN in) (NP (DT the) (JJ urinary) (NN tract) (NN and/or))))))) (SBAR (IN that) (S (NP (NP (JJ pathological) (NNS changes)) (PP (IN in) (NP (DT the) (JJ urinary) (NN tract)))) (VP (MD can) (VP (VB initiate) (NP (NP (NN chemical) (NNS signals)) (SBAR (WHNP (WDT that)) (S (VP (VBP alter) (NP (NP (DT the) (JJ chemical) (NNS properties)) (PP (IN of) (NP (JJ visceral) (NN afferent) (NNS neurons)))))))))))))))))) (. .)))
8819482	0	(ROOT (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (DT a) (JJ new) (JJ Doc_8819482_17_24_Chemical) (NN antagonist)) (, ,) (NP (NNS Doc_8819482_37_43_Chemical)) (, ,))) (PP (IN on) (NP (NN Doc_8819482_48_61_Chemical-induced) (NNS Doc_8819482_70_89_Disease))) (PP (IN in) (NP (NP (NNS dogs)) (PP (IN with) (NP (JJ partial) (NNS Doc_8819482_111_128_Disease))))) (. .)))
8819482	1	(ROOT (S (S (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (NNS Doc_8819482_141_147_Chemical)) (PP (IN on) (NP (NP (NNS Doc_8819482_151_164_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8819482_166_169_Chemical)) (-RRB- -RRB-)) (: -) (NP (JJ induced) (NNS Doc_8819482_179_198_Disease))))))) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (NP (NNS dogs)) (PP (IN with) (NP (NP (JJ partial) (NNS Doc_8819482_233_250_Disease)) (PP (IN of) (NP (DT the) (JJ left) (NN circumflex) (JJ coronary) (NN artery)))))))))) (CC and) (S (NP (NNS findings)) (VP (VBD were) (VP (VBN compared) (PP (IN with) (NP (NP (DT those)) (PP (IN for) (NP (NNS Doc_8819482_332_342_Chemical) (CC or) (NNS Doc_8819482_346_355_Chemical)))))))) (. .)))
8819482	2	(ROOT (S (PP (IN In) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_8819482_376_400_Disease))))) (, ,) (NP (NP (JJ 3-min) (NNS periods)) (PP (IN of) (NP (NP (JJ intracoronary) (JJ Doc_8819482_433_436_Chemical) (NN infusion)) (PRN (-LRB- -LRB-) (NP (CD 10) (NNS ng/kg/min)) (-RRB- -RRB-))))) (VP (VBD increased) (NP (NP (NN heart) (NN rate) (CC and) (NN maximal) (NN rate)) (PP (IN of) (NP (NP (JJ left) (NN ventricular) (NN pressure) (NN rise)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD resulted) (PP (IN in) (NP (DT a) (NN decrease))) (PP (IN in) (NP (NP (NN percentage) (NN segmental) (NN shortening) (CC and) (NN ST-segment) (NN elevation)) (PP (IN of) (NP (DT the) (JJ epicardial) (NN electrocardiogram)))))))))))) (. .)))
8819482	3	(ROOT (S (SBAR (IN After) (S (NP (NP (DT the) (NN control) (NNS Doc_8819482_678_681_Chemical) (NN infusion)) (PP (IN with) (NP (NNS Doc_8819482_696_704_Disease)))) (VP (VBD was) (VP (VBN performed))))) (, ,) (NP (NP (JJ equihypotensive) (NNS doses)) (PP (IN of) (NP (NP (NP (NNS Doc_8819482_745_751_Chemical)) (-LRB- -LRB-) (NP (NP (QP (CD 3) (CC and) (CD 10)) (NN micrograms/kg/min)) (, ,) (VP (VBN n) (S (VP (SYM =) (NP (CD 7)))))) (-RRB- -RRB-)) (, ,) (NP (NP (NNS Doc_8819482_789_799_Chemical)) (-LRB- -LRB-) (NP (NP (QP (CD 1) (CC and) (CD 3)) (NN micrograms/kg/min)) (, ,) (VP (VBN n) (S (VP (SYM =) (NP (CD 9)))))) (-RRB- -RRB-)) (CC or) (NP (NP (NNS Doc_8819482_838_847_Chemical)) (PRN (-LRB- -LRB-) (S (NP (CD 10) (CC and) (CD 30)) (VP (VBP micrograms/kg/min) (, ,) (S (NP (NN n)) (VP (SYM =) (NP (CD 7)))))) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN infused) (NP (CD 5) (NN min)) (PP (IN before) (CC and) (IN during) (NP (DT the) (JJ second) (CC and) (JJ third) (NNS Doc_8819482_943_946_Chemical) (NN infusion))))) (. .)))
8819482	4	(ROOT (S (NP (NP (DT Both) (NNS Doc_8819482_962_968_Chemical) (CC and) (NNS Doc_8819482_973_982_Chemical)) (, ,) (CONJP (CC but) (RB not)) (NP (NNS Doc_8819482_992_1002_Chemical)) (, ,)) (ADVP (RB significantly)) (VP (VBD reduced) (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (NN heart) (NN rate)) (VP (VBN induced) (PP (IN by) (NP (JJ Doc_8819482_1064_1067_Chemical) (NN infusion))))))) (. .)))
8819482	5	(ROOT (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (NNS Doc_8819482_1093_1103_Chemical))))) (, ,) (NP (NP (NNS Doc_8819482_1105_1111_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NNS micrograms/kg/min)) (-RRB- -RRB-))) (VP (VBD prevented) (NP (DT the) (NN decrease)) (PP (IN in) (NP (NP (NP (NN percentage) (JJ segmental) (NN shortening)) (PP (IN from) (NP (NP (NP (NP (CD 32) (JJ +) (NNS /)) (PRN (: -) (NP (QP (CD 12) (NN %) (TO to) (CD 115)) (NNS +)) (: /))) (PRN (: -) (NP (NP (NP (CD 26) (NN %)) (PP (IN of) (NP (NP (DT the) (NN control) (NN value)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .01))) (-RRB- -RRB-))))) (CC and) (NP (NP (JJ ST-segment) (NN elevation)) (PP (IN from) (NP (CD 5.6) (NNS +))))) (: /))) (PRN (: -) (NP (QP (CD 1.0) (CD mV) (TO to) (CD 1.6) (CD +))) (: /))))) (: -) (NP (NP (CD 1.3) (NN mV) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .01))) (-RRB- -RRB-))) (PP (IN at) (NP (CD 3) (NN min)))))) (PP (IN after) (NP (NP (JJ Doc_8819482_1343_1346_Chemical) (NN infusion)) (PP (IN with) (NP (NNS Doc_8819482_1361_1369_Disease)))))) (. .)))
8819482	6	(ROOT (S (NP (NP (NNP Doc_8819482_1371_1380_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 30) (NNS micrograms/kg/min)) (-RRB- -RRB-))) (ADVP (RB also)) (VP (VBD prevented) (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NP (NP (NP (NN percentage) (NN segmental)) (VP (VBG shortening) (PP (IN from) (NP (NP (NP (CD 34) (JJ +) (NNS /)) (PRN (: -) (NP (QP (CD 14) (NN %) (TO to) (CD 63)) (NNS +)) (: /))) (PRN (: -) (NP (NP (NP (CD 18) (NN %)) (PP (IN of) (NP (NP (DT the) (NN control) (NN value)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .05))) (-RRB- -RRB-))))) (CC and) (NP (NP (JJ ST-segment) (NN elevation)) (PP (IN from) (NP (CD 4.7) (NNS +))))) (: /)))))) (PRN (: -) (NP (NP (CD 0.7)) (VP (VBN mV) (PP (TO to) (NP (QP (CD 2.1) (CD +)))))) (: /))) (: -) (NP (NP (CD 0.7) (NN mV) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .01))) (-RRB- -RRB-))) (PP (IN at) (NP (CD 3) (NN min))))))) (PP (IN after) (NP (JJ Doc_8819482_1616_1619_Chemical) (NN infusion))) (PP (IN with) (NP (NNS Doc_8819482_1634_1642_Disease)))) (. .)))
8819482	7	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NNS Doc_8819482_1665_1671_Chemical)) (VP (VP (VBZ improves) (NP (NNS Doc_8819482_1681_1700_Disease)) (PP (IN during) (NP (NP (JJ Doc_8819482_1708_1711_Chemical) (NN infusion)) (PP (IN with) (NP (NNS Doc_8819482_1726_1734_Disease)))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ negative) (JJ chronotropic) (NN property)) (PP (IN of) (NP (NNS Doc_8819482_1790_1796_Chemical)))) (VP (VBZ plays) (NP (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ beneficial) (NNS effects)) (PP (IN of) (NP (NNS Doc_8819482_1845_1851_Chemical)))))))))))))) (. .)))
8825380	0	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (JJ recombinant) (JJ human) (JJ insulin-like) (NN growth)))) (VP (VBD factor-I) (PP (IN on) (NP (JJ chronic) (JJ Doc_8825380_72_97_Chemical) (NNS Doc_8825380_98_109_Disease))) (PP (IN in) (NP (NNS rats)))) (. .)))
8825380	1	(ROOT (S (NP (PRP We)) (ADVP (RB recently)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (JJ recombinant) (NN hGH)) (VP (VBZ exacerbates) (NP (NP (JJ renal) (UCP (ADJP (JJ functional)) (CC and) (NP (NP (NNS Doc_8825380_198_215_Disease)) (PP (IN in) (NP (NP (JJ chronic) (NNS Doc_8825380_227_252_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8825380_254_257_Chemical)) (-RRB- -RRB-)))))) (NNS Doc_8825380_259_270_Disease)) (, ,) (NP (NP (DT an) (JJ experimental) (NN model)) (PP (IN of) (NP (NNS Doc_8825380_297_315_Disease))))))))) (. .)))
8825380	2	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD examined) (SBAR (IN whether) (S (NP (NP (JJ recombinant) (NN human)) (PRN (-LRB- -LRB-) (NP (NN rh)) (-RRB- -RRB-))) (ADVP (RB IGF-I)) (VP (VBZ is) (NP (NP (DT a) (JJR safer) (NN alternative)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_8825380_421_435_Disease)) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (JJ chronic) (JJ Doc_8825380_457_460_Chemical) (NNS Doc_8825380_461_472_Disease)))))))))))))) (. .)))
8825380	3	(ROOT (S (NP (DT The) (NNS Doc_8825380_478_492_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (CD seven) (JJ serial) (NNS injections)) (PP (IN of) (NP (NP (NNS Doc_8825380_535_538_Chemical)) (PP (IN over) (NP (CD 12) (NN wk))))))))) (. .)))
8825380	4	(ROOT (S (NP (NP (JJ Experimental) (NNS animals)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 6))))) (-RRB- -RRB-))) (VP (VBD received) (NP (NP (NN rhIGF-I)) (, ,) (NP (NP (NP (CD 400)) (VP (VBN micrograms/d) (, ,) (SBAR (IN whereas) (S (NP (NP (NN control) (NNS rats)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 6))))) (-RRB- -RRB-))) (VP (VBD received) (NP (DT the) (NN vehicle))))))) (. .) (NP (NP (JJ rhIGF-I) (JJ improved) (NNS Doc_8825380_684_695_Disease)) (PP (IN by) (NP (NP (CD 14) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP p) (NNP <) (NNP 0.05)) (-RRB- -RRB-))))))) (, ,) (PP (IN without) (S (VP (VBG altering) (NP (NN hematocrit) (CC or) (NN blood) (NN pressure)) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (NNS Doc_8825380_774_787_Disease))))))))) (. .)))
8825380	5	(ROOT (S (NP (JJ Urinary) (NN protein) (NN excretion)) (VP (VBD was) (ADJP (JJ unaltered) (PP (IN by) (NP (NN rhIGF-I) (NN treatment)))) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (JJ chronic) (JJ Doc_8825380_871_874_Chemical) (NNS Doc_8825380_875_886_Disease)))))) (. .)))
8825380	6	(ROOT (S (PP (IN After) (NP (CD 12) (NN wk))) (PRN (, ,) (S (NP (DT the) (NN inulin) (NN clearance)) (VP (VBD was) (ADJP (JJR higher)) (PP (IN in) (NP (JJ rhIGF-I-treated) (NNS rats))))) (, ,)) (NP (NP (NP (CD 0.48) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 0.08)) (CC versus) (NP (CD 0.24) (NNS +))) (: /))) (: -) (NP (NP (CD 0.06) (JJ mL/min/100) (NN g)) (PP (IN of) (NP (NP (NN body) (NN weight)) (PP (IN in) (NP (CD untreated) (JJ Doc_8825380_1034_1037_Chemical) (JJ Doc_8825380_1038_1049_Disease) (NNS animals)))))) (, ,)) (VP (VBP p) (NP (CD <) (CD 0.05))) (. .)))
8825380	7	(ROOT (S (NP (NP (DT The) (NN improvement)) (PP (IN in) (NP (NNP GFR)))) (VP (VP (VBD was) (RB not) (VP (VBN associated) (PP (IN with) (NP (JJ enhanced) (NNS Doc_8825380_1125_1147_Disease))))) (CC or) (VP (VBD increased) (NP (NNS Doc_8825380_1161_1189_Disease) (, ,) (NNS Doc_8825380_1191_1216_Disease) (, ,) (CC or) (JJ renal) (NN cortical) (NNS Doc_8825380_1236_1251_Chemical)) (ADJP (JJ content)))) (. .)))
8825380	8	(ROOT (S (PP (IN In) (NP (NP (NNS rats)) (PP (IN with) (NP (JJ Doc_8825380_1274_1277_Chemical) (NNS Doc_8825380_1278_1289_Disease))))) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NN rhIGF-I)))) (VP (VBD increased) (NP (NP (NNP IGF-I)) (CC and) (NP (NNP GH) (NN receptor) (NN gene) (NN expression))) (, ,) (PP (IN without) (S (VP (VBG altering) (NP (NP (DT the) (JJ steady) (NN state) (NN level)) (PP (IN of) (NP (JJ IGF-I) (NN receptor) (NN mRNA)))))))) (. .)))
8825380	9	(ROOT (S (PP (IN In) (NP (NP (JJ normal) (NNS rats)) (PP (IN with) (NP (JJ intact) (NNS kidneys))))) (PRN (, ,) (SINV (VP (VBG rhIGF-I) (NP (NN administration))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 4))))) (-RRB- -RRB-)) (VP (VBD did) (RB not) (VP (VB alter))) (NP (NP (NNS Doc_8825380_1511_1522_Disease)) (, ,) (NP (NP (NP (NN blood) (NN pressure)) (, ,) (NP (NNS Doc_8825380_1540_1551_Disease)) (, ,) (NP (NNP GFR)) (, ,) (NP (NN glomerular) (NN planar) (NN area)) (, ,) (NP (JJ renal) (JJ cortical) (JJ Doc_8825380_1597_1612_Chemical) (NN content)) (, ,) (CC or) (NP (NN glomerular))) (CC or) (NP (NP (JJ tubulointerstitial) (NN damage)) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (ADJP (JJ untreated)) (NNS animals)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 4))))) (-RRB- -RRB-)))))))) (. .))) (NP (NN rhIGF-I) (NN treatment)) (VP (VP (VBD reduced) (NP (DT the) (JJ steady) (NN state)) (NP (JJ renal) (JJ IGF-I) (NN mRNA) (NN level))) (CC but) (VP (VBD did) (RB not) (VP (VB modify) (NP (NP (NN gene) (NN expression)) (PP (IN of) (NP (DT the) (NNP IGF-I) (CC or) (NNP GH) (NNS receptors))))))) (. .)))
8825380	10	(ROOT (S (S (NP (PRP We)) (VP (VBP conclude) (NP (NP (DT that)) (: :) (NP (LST (LS 1) (-RRB- -RRB-)) (NP (NN administration)) (PP (IN of) (NP (NP (NN rhIGF-I)) (VP (VBZ improves) (NP (NN growth) (CC and) (NN GFR)) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (JJ chronic) (JJ Doc_8825380_1930_1933_Chemical) (NNS Doc_8825380_1934_1945_Disease))))))))) (CC and) (NP (LST (LS 2) (-RRB- -RRB-)) (VBN unlike) (NN rhGH))))) (, ,) (NP (NP (JJ long-term) (NN use)) (PP (IN of) (NP (NN rhIGF-I)))) (VP (VBZ does) (RB not) (VP (VB worsen) (NP (JJ renal) (NNS functional) (CC and) (NNS Doc_8825380_2028_2045_Disease)) (PP (IN in) (NP (DT this) (NN disease) (NN model))))) (. .)))
8829135	0	(ROOT (S (NP (NP (NNP Doc_8829135_0_11_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8829135_13_20_Chemical)) (-RRB- -RRB-))) (VP (VBZ reverses) (NP (NP (NP (NN Doc_8829135_31_42_Chemical-induced) (NNS Doc_8829135_51_58_Disease)) (PP (IN of) (NP (DT a) (JJ passive) (NN avoidance) (NN response)))) (: :) (NP (NP (VBN delayed) (NN emergence)) (PP (IN of) (NP (DT the) (NN memory) (NN retention) (NNS effects)))))) (. .)))
8829135	1	(ROOT (S (NP (NNP Doc_8829135_143_154_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ novel) (JJ Doc_8829135_166_177_Chemical) (NN derivative)) (SBAR (WHNP (WDT which)) (S (VP (VBZ attenuates) (S (NP (NNS Doc_8829135_206_217_Chemical-induced)) (VP (VBG learning) (CC and) (VBG post-training) (NP (NN consolidation) (NNS deficits))))))))) (. .)))
8829135	2	(ROOT (S (PP (VBN Given) (SBAR (IN that) (S (NP (NNS Doc_8829135_288_299_Chemical)) (VP (VBZ inhibits) (NP (JJ passive) (NN avoidance) (NN retention)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (PP (IN during) (NP (NN training))) (CC or) (PP (IN in) (NP (DT a) (JJ defined) (JJ 10-12h) (JJ post-training) (NN period))))))))))) (, ,) (NP (PRP we)) (VP (VBN evaluated) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NNS Doc_8829135_437_448_Chemical)))) (PP (TO to) (NP (NP (JJ attenuate) (NNS Doc_8829135_462_469_Disease)) (VP (VBN induced) (PP (IN by) (NP (JJ dopaminergic) (NN agonism))))))) (. .)))
8829135	3	(ROOT (S (S (NP (DT A) (JJ step-down) (JJ passive) (NN avoidance) (NN paradigm)) (VP (VBD was) (VP (VBN employed)))) (CC and) (S (NP (NP (NP (NNS Doc_8829135_559_570_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN mg/kg)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_8829135_585_596_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.5) (NN mg/kg)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN given) (ADVP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NN combination)))) (PP (PP (IN during) (NP (NN training))) (CC and) (PP (IN at) (NP (NP (DT the) (JJ 10-12h) (JJ post-training) (NN period)) (PP (IN of) (NP (NN consolidation))))))))) (. .)))
8829135	4	(ROOT (S (NP (NP (NNP Co-administration)) (PP (IN of) (NP (NP (NNS Doc_8829135_738_749_Chemical) (CC and) (NNS Doc_8829135_754_765_Chemical)) (PP (IN during) (NP (NN training) (CC or) (NNS 10h)))))) (ADVP (RB thereafter)) (VP (VBD produced) (NP (DT no) (JJ significant) (JJ anti-Doc_8829135_829_836_Disease) (NN effect))) (. .)))
8829135	5	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NNS Doc_8829135_872_883_Chemical)) (PP (IN during) (NP (NN training)))))) (ADVP (RB completely)) (VP (VBD reversed) (SBAR (S (NP (NP (DT the) (NNS Doc_8829135_924_931_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_8829135_943_954_Chemical)) (PP (IN at) (NP (NP (DT the) (JJ 10h) (JJ post-training) (NN time)) (CC and) (NP (DT the) (NN converse)))))))) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ true)))))) (. .)))
8829135	6	(ROOT (S (NP (DT These) (NNS effects)) (VP (VBD were) (RB not) (VP (VBN mediated) (PP (IN by) (NP (DT a) (JJ dopaminergic) (NN mechanism))) (SBAR (IN as) (S (NP (NP (NNS Doc_8829135_1080_1091_Chemical)) (, ,) (PP (IN at) (NP (NN millimolar) (NNS concentrations))) (, ,)) (VP (VBD failed) (S (VP (TO to) (VP (VB displace) (S (NP (DT either) (NNS Doc_8829135_1149_1162_Chemical) (CC or) (NNS Doc_8829135_1166_1179_Chemical)) (ADJP (JJ binding)))))) (PP (IN from) (NP (NNP D1) (CC or) (NNP D2) (JJ Doc_8829135_1202_1210_Chemical) (NN receptor) (NNS subtypes))) (, ,) (ADVP (RB respectively))))))) (. .)))
8829135	7	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN suggested) (SBAR (IN that) (S (NP (NNS Doc_8829135_1265_1276_Chemical)) (VP (VBZ augments) (NP (JJ molecular) (NNS processes)) (PP (IN in) (NP (NP (DT the) (JJ early) (NNS stages)) (PP (IN of) (NP (NP (NNS events)) (SBAR (WHNP (WDT which)) (S (ADVP (RB ultimately)) (VP (VBP lead) (PP (TO to) (NP (NP (NN consolidation)) (PP (IN of) (NP (NN memory))))))))))))))))) (. .)))
891494	0	(ROOT (NP (NP (NP (JJ Doc_891494_0_9_Chemical) (NNS Doc_891494_10_24_Disease)) (PP (IN as) (NP (ADJP (JJ probable) (JJ idiosyncratic)) (NN reaction)))) (: :) (NP (NN case) (NN report)) (. .)))
891494	1	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (JJ Doc_891494_84_93_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_891494_95_98_Chemical)) (-RRB- -RRB-)) (NNS Doc_891494_100_114_Disease))) (PP (IN with) (NP (NP (VBG increasing) (NNS Doc_891494_131_139_Disease)) (CC and) (NP (NP (NNP EEG)) (CC and) (NP (JJ mental) (NNS changes)))))) (VP (VBZ is) (VP (VBN described))) (. .)))
891494	2	(ROOT (S (PP (IN Despite) (NP (NP (JJ adequate) (JJ oral) (NN dosage)) (PP (IN of) (NP (NP (NNS Doc_891494_213_216_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg/daily)) (-RRB- -RRB-)))))) (NP (DT the) (NN plasma) (NN level)) (VP (VBD was) (ADJP (RB very) (JJ low)) (PRN (-LRB- -LRB-) (ADJP (QP (CD 2.8) (CD microgramg/ml))) (-RRB- -RRB-))) (. .)))
891494	3	(ROOT (S (NP (DT The) (NNS Doc_891494_288_302_Disease)) (VP (VBD was) (ADVP (RB probably)) (NP (NP (DT an) (ADJP (ADJP (JJ idiosyncratic)) (CC and) (ADJP (RB not) (JJ toxic)))) (CC or) (NP (NNS Doc_891494_350_367_Disease)))) (. .)))
891494	4	(ROOT (S (S (PP (IN In) (NP (NN fact))) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (JJ free) (NNS Doc_891494_403_406_Chemical)))) (VP (VBD was) (ADJP (JJ normal)))) (, ,) (S (NP (DT the) (NN patient)) (VP (VBD presented) (NP (DT a) (NNS Doc_891494_443_469_Disease)) (PP (IN during) (NP (JJ Doc_891494_477_480_Chemical) (NN treatment))))) (, ,) (S (NP (DT the) (NN protidogram)) (VP (VBD was) (ADJP (JJ normal)))) (, ,) (CC and) (S (NP (DT an) (JJ intradermic) (JJ Doc_891494_539_542_Chemical) (NN injection)) (VP (VBD had) (NP (DT no) (JJ local) (NN effect)))) (. .)))
891494	5	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBP conclude) (SBAR (IN that) (S (PP (IN in) (S (NP (DT a) (NN patient)) (VP (VBG starting) (NP (JJ Doc_891494_622_625_Chemical) (NN treatment))))) (NP (NP (DT an) (JJ unexpected) (NN increase)) (PP (IN in) (NP (NP (NNS Doc_891494_662_670_Disease)) (, ,) (PP (IN with) (NP (NP (NNP EEG)) (CC and) (NP (NP (JJ mental) (NNS changes)) (VP (VBG occurring) (ADVP (RB simultaneously)))))) (, ,)))) (VP (MD should) (VP (VB alert) (NP (DT the) (NN physician)) (PP (TO to) (NP (DT the) (JJ possible) (NN need))) (PP (IN for) (S (VP (VBG eliminating) (NP (NNS Doc_891494_790_793_Chemical)) (PP (IN from) (NP (DT the) (JJ therapeutic) (NN regimen)))))) (, ,) (SBAR (RB even) (IN if) (S (NP (NN plasma) (NNS concentrations)) (VP (VBP are) (ADJP (JJ low)))))))))) (. .)))
89511	0	(ROOT (NP (NP (NP (NN Prevention) (CC and) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_89511_28_47_Disease)) (PP (IN in) (NP (JJ climacteric) (NNS women)))))) (VP (VBG receiving) (NP (JJ Doc_89511_79_88_Chemical) (NN therapy))) (. .)))
89511	1	(ROOT (S (NP (DT The) (NN treatment) (NNS regimens)) (VP (VBP are) (VP (VBN described) (PP (IN in) (NP (NP (CD 74) (NNS patients)) (PP (IN with) (NP (NNS Doc_89511_155_174_Disease))))) (PP (IN among) (NP (NP (CD 850) (JJ climacteric) (NNS women)) (VP (VBG receiving) (NP (JJ Doc_89511_213_222_Chemical) (NN therapy))))))) (. .)))
89511	2	(ROOT (S (NP (NNP Doc_89511_232_250_Disease)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (JJ unopposed) (JJ Doc_89511_281_290_Chemical) (NN therapy))) (PP (IN without) (NP (NN progestagen))))) (. .)))
89511	3	(ROOT (S (NP (NP (CD Two) (NNS courses)) (PP (IN of) (NP (NP (CD 21) (NNS days)) (PP (IN of) (NP (CD 5) (NN mg) (NNS Doc_89511_351_365_Chemical)))))) (ADVP (RB daily)) (VP (VBD caused) (NP (NN reversion)) (PP (TO to) (ADJP (JJ normal))) (PP (IN in) (NP (PDT all) (NP (NP (CD 57) (NNS cases)) (PP (IN of) (NP (NNS Doc_89511_418_436_Disease)))) (CC and) (NP (NP (CD 6)) (PP (IN of) (NP (NP (DT the) (CD 8) (NNS cases)) (PP (IN of) (NP (VBG Doc_89511_461_481_Disease)))))) (. .) (NP (NP (CD 4) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_89511_494_515_Disease)) (VP (VBN referred) (PP (IN from) (NP (NP (RB elsewhere)) (VP (VBN demonstrated) (NP (NP (DT the) (NNS problems)) (PP (IN of) (NP (NP (ADJP (JJ inappropriate) (CC and) (JJ unsupervised)) (JJ unopposed) (JJ Doc_89511_610_619_Chemical) (NN therapy)) (CC and) (NP (NP (DT the) (NN difficulty)) (PP (IN in) (NP (JJ distinguishing) (JJ severe) (NNS Doc_89511_672_683_Disease))))))) (PP (IN from) (NP (NNS Doc_89511_689_699_Disease))))))))))))) (. .)))
89511	4	(ROOT (S (NP (NP (JJ Cyclical) (JJ low-dose) (JJ Doc_89511_719_728_Chemical) (NN therapy)) (PP (IN with) (NP (NP (CD 7)) (: --) (NP (NP (CD 13) (NNS days)) (PP (IN of) (NP (NNS Doc_89511_756_767_Chemical))))))) (VP (VBZ does) (RB not) (VP (VB seem) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_89511_806_842_Disease))))))))) (. .)))
895432	0	(ROOT (NP (NP (NNPS Effects)) (PP (IN of) (NP (NN exercise))) (PP (IN on) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NN Doc_895432_39_52_Chemical-induced) (NNS Doc_895432_61_82_Disease))))) (. .)))
895432	1	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (NN exercise)) (PP (IN on) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NN Doc_895432_126_139_Chemical-induced) (NNS Doc_895432_148_169_Disease)))))))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (JJ male) (NNS rats))))) (. .)))
895432	2	(ROOT (S (NP (JJ Ninety-three) (NNS rats)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN divided) (PP (IN into) (NP (CD three) (NNS groups))))) (. .)))
895432	3	(ROOT (S (NP (NP (NP (DT The) (NN exercise-Doc_895432_268_281_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP E-1)) (-RRB- -RRB-))) (CC and) (NP (NP (NN exercise) (NN control)) (PRN (-LRB- -LRB-) (NP (NNP EC)) (-RRB- -RRB-)) (NP (NNS groups)))) (VP (VBD exercised) (ADVP (RB daily)) (PP (IN for) (NP (NP (CD thirty) (NNS days)) (PP (IN on) (NP (NP (DT a) (NN treadmill)) (PP (IN at) (NP (NP (CD 1) (NN mph)) (, ,) (NP (ADJP (CD 2) (NN %)) (NN grade)))))))) (SBAR (IN while) (S (NP (NP (NNS animals)) (PP (IN of) (NP (DT the) (JJ sedentary-Doc_895432_418_431_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_895432_433_436_Chemical)) (-RRB- -RRB-)) (NN group)))) (VP (VBD remained) (ADVP (RB sedentary)))))) (. .)))
895432	4	(ROOT (S (NP (CD Eight) (NNS animals)) (VP (VBD were) (VP (VBN assigned) (PP (TO to) (NP (NP (DT the) (NN sedentary) (NN control) (PRN (-LRB- -LRB-) (NP (NNP SC)) (-RRB- -RRB-)) (NN group)) (SBAR (WHNP (WDT which)) (S (VP (VBD remained) (ADVP (RB sedentary)) (PP (IN throughout) (NP (DT the) (JJ experimental) (NN period)))))))))) (. .)))
895432	5	(ROOT (S (NP (NP (JJ Forty-eight) (NNS hours)) (PP (IN after) (NP (NP (DT the) (JJ final) (NN exercise) (NN period)) (, ,) (NP (NNS Doc_895432_640_643_Chemical)) (CC and) (NP (JJ E-I) (NNS animals))))) (VP (VBD received) (NP (NP (DT a) (JJ single) (NNS subcutaneous) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_895432_704_717_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 250) (CD mg/kg)) (NN body) (NN weight)) (-RRB- -RRB-)))))) (. .)))
895432	6	(ROOT (S (NP (NP (NNS Animals)) (PP (IN of) (NP (DT the) (JJ Doc_895432_758_761_Chemical) (NN group)))) (VP (VBD exhibited) (ADVP (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (NNP Pp) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))) (NP (JJR greater) (NN mortality)) (PP (IN from) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_895432_850_863_Chemical))))) (PP (IN than) (NP (NP (NNS animals)) (PP (IN of) (NP (DT the) (JJ E-I) (NN group)))))) (. .)))
895432	7	(ROOT (S (NP (NP (NNP Serum) (NNP CPK) (NN activity)) (PP (IN for) (NP (JJ E-I) (NNS animals)))) (VP (VBD was) (ADVP (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))) (ADJP (ADJP (JJR greater)) (PP (IN than) (PP (IN for) (NP (NP (NNS animals)) (PP (IN in) (NP (DT the) (NNP Doc_895432_999_1002_Chemical) (CC and) (NNP EC) (NNS groups))) (NP (CD twenty) (NNS hours)))))) (PP (VBG following) (NP (JJ Doc_895432_1040_1053_Chemical) (NN injection)))) (. .)))
895432	8	(ROOT (S (NP (DT No) (ADJP (RB statistically) (JJ significant)) (NNS differences)) (VP (VBD were) (VP (VBN observed) (PP (IN between) (NP (NP (DT the) (CD two) (NNS Doc_895432_1136_1149_Chemical)) (VP (VBN treated) (NP (NP (NP (NNS groups)) (PP (IN for) (NP (NP (NN severity)) (PP (IN of) (NP (DT the) (JJ induced) (NNS lesions)))))) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN heart) (NN weight)))) (, ,) (CC or) (NP (NP (NN heart) (NN weight)) (PP (TO to) (NP (NN body) (NN weight) (NNS ratios)))))))))) (. .)))
895432	9	(ROOT (S (NP (DT The) (NNS results)) (VP (VP (VBD indicated) (SBAR (IN that) (S (NP (NN exercise)) (VP (VBD reduced) (NP (NP (DT the) (NN mortality)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ large) (NNS dosages)) (PP (IN of) (NP (NNS Doc_895432_1372_1385_Chemical))))))))))))) (CC but) (VP (VBD had) (NP (NP (RB little)) (PP (IN on) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (DT the) (NNS Doc_895432_1424_1434_Disease)))))))) (. .)))
8957205	0	(ROOT (S (NP (NP (JJ Human) (JJ corticotropin-releasing) (NN hormone)) (CC and) (NP (JJ thyrotropin-releasing) (NN hormone))) (VP (VBP modulate) (NP (NP (DT the) (JJ hypercapnic) (NN ventilatory) (NN response)) (PP (IN in) (NP (NNS humans))))) (. .)))
8957205	1	(ROOT (S (NP (NP (NP (JJ Human) (JJ corticotropin-releasing) (NN hormone)) (PRN (-LRB- -LRB-) (NP (NN hCRH)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ thyrotropin-releasing) (NN hormone)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8957205_209_212_Chemical)) (-RRB- -RRB-)))) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB stimulate) (NP (NN ventilation)) (PP (IN after) (NP (NP (NN i.v.) (NN administration)) (PP (IN in) (NP (NNS humans)))))))))) (. .)))
8957205	2	(ROOT (S (PP (IN In) (NP (DT a) (JJ placebo-controlled) (, ,) (JJ single-blind) (NN study))) (NP (PRP we)) (VP (VBD aimed) (S (VP (TO to) (VP (VB clarify) (SBAR (IN if) (S (NP (DT both) (NNS peptides)) (VP (VBP act) (PP (IN by) (S (VP (VBG altering) (NP (JJ central) (NN chemosensitivity)))))))))))) (. .)))
8957205	3	(ROOT (S (NP (CD Two) (JJ subsequent) (NN Doc_8957205_424_427_Chemical-rebreathing) (NNS tests)) (VP (VBD were) (VP (VBN performed) (PP (IN in) (NP (JJ healthy) (JJ young) (NNS volunteers))))) (. .)))
8957205	4	(ROOT (S (S (PP (IN During) (NP (DT the) (JJ first) (NN test))) (NP (ADJP (CD 0.9) (NN %)) (NNS Doc_8957205_517_521_Chemical)) (VP (VBD was) (VP (VBN given) (NP (NN i.v.))))) (: ;) (S (PP (IN during) (NP (DT the) (JJ second) (NN test))) (NP (NP (CD 200) (NNS micrograms)) (PP (IN of) (NP (NP (NP (NN hCRH)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 12))))) (-RRB- -RRB-))) (CC or) (NP (NP (CD 400) (NNS micrograms)) (PP (IN of) (NP (NNS Doc_8957205_614_617_Chemical)))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 6))))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN administered) (SBAR (S (NP (NNP i.v.) (NNP Nine) (NNS subjects)) (VP (VBD received) (NP (ADJP (CD 0.9) (NN %)) (JJ Doc_8957205_676_680_Chemical) (NN i.v.)) (PP (IN during) (NP (DT both) (VBG rebreathing) (NNS manoeuvres))))))))) (. .)))
8957205	5	(ROOT (S (NP (NP (DT The) (NN Doc_8957205_726_729_Chemical-response) (NNS curves)) (PP (IN for) (NP (DT the) (CD two) (NNS tests)))) (VP (VBD were) (VP (VBN compared) (PP (IN within) (NP (DT the) (JJ same) (NN subject))))) (. .)))
8957205	6	(ROOT (S (PP (IN In) (NP (DT the) (JJ hCRH) (NN group))) (NP (NP (DT a) (JJ marked) (JJ parallel) (NN shift)) (PP (IN of) (NP (NP (DT the) (NN Doc_8957205_852_855_Chemical-response) (NN curve)) (PP (TO to) (NP (DT the) (NN left)))))) (VP (VBD was) (VP (VBN observed) (PP (IN after) (NP (NP (NN hCRH)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-)))))) (. .)))
8957205	7	(ROOT (S (NP (DT The) (JJ same) (NN effect)) (VP (VP (VBD occurred) (NP (JJ following) (NNS Doc_8957205_954_957_Chemical))) (CC but) (VP (VBD was) (ADJP (ADJP (RBR less) (JJ striking)) (PRN (-LRB- -LRB-) (ADVP (RB P)) (ADJP (JJ =) (NP (CD 0.05))) (-RRB- -RRB-))))) (. .)))
8957205	8	(ROOT (S (NP (NN hCRH) (CC and) (NNS Doc_8957205_1001_1004_Chemical)) (VP (VBD caused) (NP (DT a) (NN reduction)) (PP (IN in) (NP (DT the) (JJ Doc_8957205_1031_1034_Chemical) (NN threshold)))) (. .)))
8957205	9	(ROOT (S (NP (NP (DT The) (NN Doc_8957205_1050_1053_Chemical-response) (NNS curves)) (PP (IN in) (NP (DT the) (NN control) (NN group)))) (VP (VBD were) (ADJP (RB nearly) (JJ identical))) (. .)))
8957205	10	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (NP (NP (DT an) (JJ additive) (NN effect)) (PP (IN of) (NP (NP (DT both)) (VP (VBG releasing) (NP (NNS hormones)) (PP (IN on) (NP (NP (DT the) (JJ hypercapnic) (NN ventilatory) (NN response)) (PP (IN in) (NP (NP (NNS humans)) (, ,) (ADVP (RB presumably)) (NP (NP (JJ independent)) (PP (IN of) (NP (JJ central) (NN chemosensitivity))))))))))))) (. .)))
8985298	0	(ROOT (S (NP (NNP Doc_8985298_0_10_Chemical)) (VP (VBZ is) (ADJP (JJ effective) (PP (IN in) (S (VP (VBG suppressing) (NP (NP (NP (JJ Doc_8985298_39_50_Disease) (NN virus) (NN DNA)) (PP (IN in) (NP (JJ Chinese) (JJ Doc_8985298_72_83_Disease) (NN surface) (NN antigen) (NNS carriers)))) (: :) (NP (DT a) (JJ placebo-controlled) (NN trial)))))))) (. .)))
8985298	1	(ROOT (S (NP (NNP Doc_8985298_138_148_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ novel) (JJ Doc_8985298_160_182_Chemical) (NN analogue)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (NP (JJ potent) (NN inhibitory) (NNS effects)) (PP (PP (IN on) (NP (NP (JJ Doc_8985298_230_241_Disease) (NN virus) (NN replication)) (PP (IN in) (NP (NNP vitro))))) (CC and) (PP (IN in) (NP (NN vivo))))))))) (. .)))
8985298	2	(ROOT (S (NP (PRP We)) (VP (VBD performed) (NP (DT a) (JJ single-blind) (, ,) (JJ placebo-controlled) (NN study)) (S (VP (TO to) (VP (VB assess) (NP (PRP$ its) (NN effectiveness) (CC and) (NN safety)) (PP (IN in) (NP (JJ Chinese) (NNP Doc_8985298_386_397_Disease) (NN surface) (NN antigen) (-LRB- -LRB-) (NNP HBsAg) (-RRB- -RRB-) (NNS carriers))))))) (. .)))
8985298	3	(ROOT (S (NP (JJ Forty-two) (JJ Chinese) (NN HBsAg) (NNS carriers)) (VP (VBD were) (VP (VBN randomized) (S (VP (TO to) (VP (VB receive) (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (CD 6) (NNS patients)) (-RRB- -RRB-)) (CC or) (NP (NP (JJ Doc_8985298_516_526_Chemical) (NN orally)) (PP (IN in) (NP (NP (NNS dosages)) (PP (IN of) (NP (NP (CD 25) (NN mg)) (, ,) (NP (CD 100) (NN mg)) (, ,) (CC or) (NP (CD 300) (NN mg) (RB daily)) (PRN (-LRB- -LRB-) (NP (NP (CD 12) (NNS patients)) (PP (IN for) (NP (DT each) (NN dosage)))) (-RRB- -RRB-))))))))))))) (. .)))
8985298	4	(ROOT (S (NP (DT The) (NN drug)) (VP (VBD was) (VP (VBN given) (PP (IN for) (NP (CD 4) (NNS weeks))))) (. .)))
8985298	5	(ROOT (S (NP (DT The) (NNS patients)) (VP (VBD were) (ADVP (RB closely)) (VP (VBN monitored) (NP (NNP clinically) (, ,) (NN biochemically) (, ,) (CC and) (NN serologically)) (PP (NP (QP (IN up) (TO to) (CD 4)) (NNS weeks)) (IN after) (NP (NN drug) (NN treatment))))) (. .)))
8985298	6	(ROOT (SINV (ADVP (RB All) (NP (CD 36) (NNS patients))) (VP (VBG receiving) (NP (NNS Doc_8985298_785_795_Chemical))) (VP (VBD had) (NP (DT a) (JJ Doc_8985298_802_825_Disease) (NN virus))) (PRN (-LRB- -LRB-) (NP (NNP HBV)) (-RRB- -RRB-)) (NP (NP (NN DNA) (NNS values)) (PP (IN of) (NP (NP (QP (CD >) (CD 90)) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <) (NNP .001)) (PP (VBN compared) (PP (IN with) (NP (NN placebo))))) (-RRB- -RRB-))))) (. .)))
8985298	7	(ROOT (S (SBAR (IN Although) (S (NP (NP (CD 25) (NN mg)) (PP (IN of) (NP (NNS Doc_8985298_909_919_Chemical)))) (VP (VBD was) (ADJP (RB slightly) (RBR less) (JJ effective)) (PP (IN than) (NP (NP (CD 100) (NN mg)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD .011))) (-RRB- -RRB-)) (CC and) (NP (CD 300) (NN mg)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD .005))) (-RRB- -RRB-))))))) (, ,) (NP (PRP it)) (ADVP (RB still)) (VP (VBD induced) (NP (NP (CD 94) (NN %) (NN suppression)) (PP (IN of) (NP (NNP HBV) (NNP DNA)))) (PP (IN after) (NP (NP (DT the) (JJ fourth) (NN week)) (PP (IN of) (NP (NN therapy)))))) (. .)))
8985298	8	(ROOT (S (NP (NNP HBV) (NNP DNA) (NNS values)) (VP (VBD returned) (S (VP (TO to) (VP (VB pretreatment) (NP (NNS levels)) (PP (IN within) (NP (NP (CD 4) (NNS weeks)) (PP (IN of) (NP (NP (NN cessation)) (PP (IN of) (NP (NN therapy))))))))))) (. .)))
8985298	9	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN change)) (PP (PP (IN in) (NP (DT the) (JJ Doc_8985298_1186_1197_Disease) (JJ e) (NN antigen) (NN status))) (CC or) (PP (IN in) (NP (JJ aminotransferase) (NNS levels)))))) (. .)))
8985298	10	(ROOT (S (NP (DT No) (JJ serious) (JJ adverse) (NNS events)) (VP (VBD were) (ADJP (JJ observed))) (. .)))
8985298	11	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NP (DT a) (JJ 4-week) (NN course)) (PP (IN of) (NP (NNS Doc_8985298_1321_1331_Chemical)))) (VP (VBD was) (ADJP (JJ safe) (CC and) (JJ effective)) (PP (IN in) (NP (NP (NN suppression)) (PP (IN of) (NP (NP (NNP HBV) (NNP DNA)) (PP (IN in) (NP (JJ Chinese) (NN HBsAg) (NNS carriers)))))))) (. .)))
8985298	12	(ROOT (S (NP (DT The) (NN suppression)) (VP (VBD was) (ADJP (ADJP (QP (CD >) (CD 90)) (NN %)) (CC but) (ADJP (JJ reversible)))) (. .)))
8985298	13	(ROOT (S (NP (NP (NNS Studies)) (PP (IN with) (NP (JJ long-term) (JJ Doc_8985298_1472_1482_Chemical) (NN administration)))) (VP (MD should) (VP (VB be) (VP (VBN performed) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (VBN prolonged) (NN suppression)) (PP (IN of) (NP (NNP HBV) (NNP DNA)))) (VP (MD can) (VP (VB be) (VP (VBN achieved)))))))))))) (. .)))
8996419	0	(ROOT (S (NP (NP (JJ Population-based) (NN study)) (PP (IN of) (NP (NP (NN risk)) (PP (IN of) (NP (NNS Doc_8996419_34_56_Disease)))))) (VP (VBN associated) (PP (IN with) (NP (JJ various) (NNS Doc_8996419_81_100_Chemical)))) (. .)))
8996419	1	(ROOT (S (NP (NP (CD Four) (NNS studies)) (VP (VBN published) (PP (IN since) (NP (NP (NNP December)) (, ,) (NP (CD 1995)) (, ,))))) (VP (VBD reported) (SBAR (IN that) (S (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_8996419_190_212_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8996419_214_217_Disease)) (-RRB- -RRB-))))) (VP (VBD was) (ADJP (JJR higher)) (PP (IN in) (NP (NP (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VBD used) (NP (NP (NP (NNS Doc_8996419_248_267_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP OCs)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (DT the) (JJ third-generation) (JJ Doc_8996419_306_318_Chemical) (NN gestodene)) (CC or) (NP (NNS Doc_8996419_332_343_Chemical))) (PP (IN than) (IN in) (NP (NP (NNS users)) (PP (IN of) (NP (NNP OCs))))) (S (VP (VBG containing) (NP (JJ second-generation) (NNS progestagens))))))))))))))) (. .)))
8996419	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (VBG confounding) (CC and) (NN bias)) (PP (IN in) (NP (NP (DT the) (NN design)) (PP (IN of) (NP (DT these) (NNS studies)))))) (VP (MD may) (VP (VB have) (VP (VBN affected) (NP (DT the) (NNS findings))))) (. .)))
8996419	3	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (PRP$ our) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB re-examine) (NP (NP (DT the) (NN association)) (PP (IN between) (NP (NP (NN risk)) (PP (IN of) (NP (NNS Doc_8996419_572_575_Disease) (CC and) (NN OC) (NN use)))))) (PP (IN with) (NP (NP (DT a) (JJ different) (NN study) (NN design)) (CC and) (NP (NN analysis)))) (S (VP (TO to) (VP (VB avoid) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (NN bias) (CC and) (NN confounding)) (PP (IN of) (NP (DT the) (JJR earlier) (NNS studies))))))))))))) (. .)))
8996419	4	(ROOT (S (NP (PRP We)) (VP (VBD used) (NP (NP (NN computer) (NNS records)) (PP (IN of) (NP (NNS patients)))) (PP (IN from) (NP (NP (JJ 143) (JJ general) (NNS practices)) (PP (IN in) (NP (DT the) (NNP UK)))))) (. .)))
8996419	5	(ROOT (S (NP (DT The) (NN study)) (VP (VBD was) (VP (VBN based) (PP (IN on) (NP (NP (DT the) (JJ medical) (NNS records)) (PP (IN of) (NP (NP (QP (RB about) (CD 540,000)) (NNS women)) (VP (VBN born) (PP (IN between) (NP (CD 1941) (CC and) (CD 1981)))))))))) (. .)))
8996419	6	(ROOT (S (NP (NP (DT All) (NNS women)) (SBAR (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (DT a) (VBN recorded) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_8996419_916_936_Disease))) (, ,) (NP (NP (NNS Doc_8996419_938_955_Disease)) (VP (RB not) (ADVP (RB otherwise)) (VBN specified))) (, ,) (CC or) (NP (NP (NNS Doc_8996419_984_1001_Disease)) (PP (IN during) (NP (DT the) (NN study) (NN period)))))))) (, ,) (CC and) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN been) (VP (VBN treated) (PP (IN with) (NP (DT an) (NN anticoagulant)))))))))) (VP (VBD were) (VP (VBN identified) (PP (IN as) (NP (NP (JJ potential) (NNS cases)) (PP (IN of) (NP (NNS Doc_8996419_1112_1115_Disease))))))) (. .)))
8996419	7	(ROOT (S (S (NP (PRP We)) (VP (VBD did) (NP (DT a) (JJ cohort) (NN analysis)) (S (VP (TO to) (VP (VB estimate) (CC and) (VB compare) (NP (NP (NN incidence)) (PP (IN of) (NP (NNS Doc_8996419_1179_1182_Disease)))) (PP (IN in) (NP (NP (NNS users)) (PP (IN of) (NP (DT the) (JJ main) (NNP OC) (NNS preparations)))))))))) (, ,) (CC and) (S (NP (DT a) (JJ nested) (NN case-control)) (VP (VBP study) (S (VP (TO to) (VP (VB calculate) (NP (NP (DT the) (NNS odds) (NNS ratios)) (PP (IN of) (NP (NP (NNS Doc_8996419_1285_1288_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (NN use)) (PP (IN of) (NP (NP (JJ different) (NNS types)) (PP (IN of) (NP (NNP OC))))))) (, ,) (PP (IN after) (NP (NP (NN adjustment)) (PP (IN for) (NP (JJ potential) (VBG confounding) (NNS factors)))))))))))))) (. .)))
8996419	8	(ROOT (S (PP (IN In) (NP (DT the) (JJ case-control) (NN study))) (, ,) (NP (PRP we)) (VP (VBD matched) (NP (NNS cases)) (PP (TO to) (NP (NNS controls))) (PP (IN by) (NP (NP (JJ exact) (NN year)) (PP (IN of) (NP (NP (NN birth)) (, ,) (NP (NN practice)) (, ,) (CC and) (NP (NP (JJ current) (NN use)) (PP (IN of) (NP (NNP OCs))))))))) (. .)))
8996419	9	(ROOT (S (NP (PRP We)) (VP (VBD used) (NP (NP (DT a) (JJ multiple) (JJ logistic) (NN regression) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (VBD included) (SBAR (S (NP (NP (JJ body-mass) (NN index)) (, ,) (NP (NP (NN number)) (PP (IN of) (NP (NNS cycles)))) (, ,)) (VP (VBP change) (PP (IN in) (NP (NP (NN type)) (PP (IN of) (NP (NP (NNP OC)) (VP (VBN prescribed) (PP (IN within) (NP (NP (CD 3) (NNS months)) (PP (IN of) (NP (NP (DT the) (NN event)) (, ,) (NP (JJ previous) (NN pregnancy)) (, ,) (CC and) (NP (JJ concurrent) (NN disease))))))))))))))))))) (. .)))
8996419	10	(ROOT (S (NP (CD 85) (NNS women)) (VP (VBD met) (NP (DT the) (NN inclusion) (NNS criteria)) (PP (IN for) (NP (NP (NNS Doc_8996419_1751_1754_Disease)) (, ,) (SBAR (WHNP (CD two) (WHPP (IN of) (WHNP (WP whom)))) (S (VP (VBD were) (NP (NP (NNS users)) (PP (IN of) (NP (JJ progestagen-only) (NNP OCs)))))))))) (. .)))
8996419	11	(ROOT (S (PP (IN Of) (NP (NP (DT the) (CD 83) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_8996419_1823_1826_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (NN use)) (PP (IN of) (NP (VBN combined) (NN OCs)))))))))) (, ,) (NP (CD 43)) (VP (VBD were) (VP (VBN recorded) (PP (IN as) (NP (NP (NNS Doc_8996419_1884_1904_Disease)) (, ,) (NP (NP (CD 35)) (PP (IN as) (NP (NNS Doc_8996419_1912_1932_Disease)))) (, ,) (CC and) (NP (NP (CD five)) (PP (IN as) (NP (NP (NNS Doc_8996419_1946_1963_Disease)) (VP (RB not) (ADVP (RB otherwise)) (VBN specified))))))))) (. .)))
8996419	12	(ROOT (S (NP (NP (DT The) (JJ crude) (NN rate)) (PP (IN of) (NP (NP (NNS Doc_8996419_2007_2010_Disease)) (PP (IN per) (NP (CD 10,000) (NNS woman-years)))))) (VP (VBD was) (NP (NP (NP (CD 4.10)) (PP (IN in) (NP (NP (JJ current) (NNS users)) (PP (IN of) (NP (DT any) (NNP OC)))))) (, ,) (NP (NP (CD 3.10)) (PP (IN in) (NP (NP (NNS users)) (PP (IN of) (NP (JJ second-generation) (NNP OCs)))))) (, ,) (CC and) (NP (NP (CD 4.96)) (PP (IN in) (NP (NP (NNS users)) (PP (IN of) (NP (JJ third-generation) (NNS preparations)))))))) (. .)))
8996419	13	(ROOT (S (PP (IN After) (NP (NP (NN adjustment)) (PP (IN for) (NP (NN age))))) (, ,) (NP (NP (DT the) (NN rate) (NN ratio)) (PP (IN of) (NP (NP (NNS Doc_8996419_2207_2210_Disease)) (PP (IN in) (NP (NP (NNS users)) (PP (IN of) (NP (NN third-generation)))))))) (ADVP (JJ relative) (PP (TO to) (NP (JJ second-generation) (NNP OCs)))) (VP (VBD was) (ADJP (JJ 1.68)) (PRN (-LRB- -LRB-) (S (NP (CD 95) (NN %)) (VP (VBP CI) (NP (CD 1.04-2) (CD .75)))) (-RRB- -RRB-))) (. .)))
8996419	14	(ROOT (S (NP (JJ Logistic) (NN regression)) (VP (VBD showed) (NP (DT no) (JJ significant) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_8996419_2371_2374_Disease)) (PP (IN between) (NP (NP (NNS users)) (PP (IN of) (NP (JJ third-generation) (CC and) (JJ second-generation) (NNS OCs)))))))))) (. .)))
8996419	15	(ROOT (S (PP (IN Among) (NP (NP (NNS users)) (PP (IN of) (NP (JJ third-generation) (NNS progestagens))))) (, ,) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_8996419_2494_2497_Disease)))) (VP (VBD was) (VP (RBR higher) (PP (IN in) (NP (NP (NNS users)) (PP (IN of) (NP (NP (NNS Doc_8996419_2521_2532_Chemical)) (PP (IN with) (NP (CD 20) (NN g) (NNS Doc_8996419_2543_2560_Chemical))))))) (PP (IN than) (IN in) (NP (NP (NNS users)) (PP (IN of) (NP (NNS Doc_8996419_2578_2587_Chemical) (CC or) (NNS Doc_8996419_2591_2602_Chemical))))) (PP (IN with) (NP (CD 30) (NN g) (NNS Doc_8996419_2613_2630_Chemical))))) (. .)))
8996419	16	(ROOT (S (PP (IN With) (NP (NP (DT all) (JJ second-generation) (NN OCs)) (PP (IN as) (NP (DT the) (NN reference))))) (, ,) (NP (NP (DT the) (NNS odds) (NNS ratios)) (PP (IN for) (NP (NNS Doc_8996419_2701_2704_Disease)))) (VP (VBD were) (NP (NP (NP (NNP 3.49)) (PRN (-LRB- -LRB-) (NP (QP (CD 1.21-10) (CD .12))) (-RRB- -RRB-))) (PP (IN for) (NP (NP (NP (NNS Doc_8996419_2732_2743_Chemical)) (PP (CC plus) (NP (CD 20) (NN g) (NNS Doc_8996419_2754_2771_Chemical)))) (CC and) (NP (NP (NP (CD 1.18)) (PRN (-LRB- -LRB-) (NP (QP (CD 0.66-2) (CD .17))) (-RRB- -RRB-))) (PP (IN for) (NP (DT the) (JJ other) (JJ third-generation) (NNS progestagens)))))))) (. .)))
8996419	17	(ROOT (S (NP (NP (DT The) (ADJP (RB previously) (VBN reported)) (NN increase)) (PP (IN in) (NP (NNS odds) (NN ratio))) (VP (VBN associated) (PP (IN with) (NP (JJ third-generation) (NNP OCs))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (JJ second-generation) (NNS products)))))))) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB have) (VP (VBN been) (NP (NP (DT the) (NN result)) (PP (IN of) (NP (JJ residual) (NN confounding)))) (PP (IN by) (NP (NN age))))))))) (. .)))
8996419	18	(ROOT (S (NP (NP (DT The) (VBN increased) (NNS odds) (NN ratio)) (VP (VBN associated) (PP (IN with) (NP (NP (NNS products)) (VP (VBG containing) (NP (CD 20) (JJ micrograms) (NNS Doc_8996419_3125_3142_Chemical) (CC and) (NNS Doc_8996419_3147_3158_Chemical)) (PP (VBN compared) (PP (IN with) (NP (DT the) (CD 30) (NN micrograms) (NN product))))))))) (VP (VP (VBZ is) (ADJP (RB biologically) (JJ implausible))) (, ,) (CC and) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VP (VB be) (NP (NP (DT the) (NN result)) (PP (IN of) (NP (JJ preferential) (NN prescribing))))) (CC and) (PRN (, ,) (ADVP (RB thus)) (, ,)) (VP (VB confounding)))))))) (. .)))
9061777	0	(ROOT (S (NP (NNP Doc_9061777_0_6_Chemical)) (VP (VP (VBZ augments) (NP (ADJP (JJ Doc_9061777_16_27_Chemical-induced) (JJ electrographic)) (NNS Doc_9061777_51_58_Disease))) (CC but) (VP (VBZ protects) (PP (IN against) (NP (NP (NNS Doc_9061777_80_92_Disease)) (PP (IN in) (NP (NP (NNP rats) (. .)) (NP (CD 1)))))))) (. .)))
9061777	1	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBD examined) (NP (NP (DT the) (JJ anticonvulsant) (NNS effects)) (PP (IN of) (NP (NNS Doc_9061777_156_162_Chemical)))) (PP (IN on) (NP (DT the) (NN Doc_9061777_170_181_Chemical-induced) (NNS Doc_9061777_190_197_Disease) (NN model)))) (. .)))
9061777	2	(ROOT (S (NP (NP (JJ Intraperitoneal) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_9061777_234_245_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 400) (NN mg/kg)) (-RRB- -RRB-))))) (VP (VBN induced) (NP (NNS Doc_9061777_266_290_Disease))) (. .)))
9061777	3	(ROOT (S (S (NP (NP (NP (NNP Doc_9061777_292_303_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg/kg)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_9061777_319_332_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg)) (-RRB- -RRB-)))) (VP (VBD prevented) (NP (NP (NN development)) (PP (IN of) (NP (JJ Doc_9061777_368_379_Chemical-induced) (JJ behavioral) (NNS Doc_9061777_399_406_Disease)))))) (CC but) (S (NP (NP (NNS Doc_9061777_411_417_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.5) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBD did) (NP (QP (ADVP (RB not) (. .)) (CD 2))))) (. .)))
9061777	4	(ROOT (S (NP (NP (DT An) (JJ electrical) (NNS Doc_9061777_456_463_Disease)) (VP (VBN measured) (PP (IN with) (NP (JJ hippocampal) (NNP EEG))))) (VP (VBD appeared) (PP (IN in) (NP (DT the) (NN Doc_9061777_510_521_Chemical-treated) (NN group)))) (. .)))
9061777	5	(ROOT (S (NP (NNS Doc_9061777_537_548_Chemical) (CC and) (NNS Doc_9061777_553_566_Chemical)) (VP (VBD blocked) (SBAR (S (NP (DT the) (ADJP (JJ Doc_9061777_579_590_Chemical-induced) (NP (NP (JJ electrographic) (NNS Doc_9061777_614_621_Disease)) (, ,) (NP (NNS Doc_9061777_623_629_Chemical)))) (NN treatment)) (VP (VBD augmented) (NP (NP (DT the) (JJ electrographic) (NNS Doc_9061777_669_676_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNP Doc_9061777_688_699_Chemical) (. .)) (NP (CD 3)))))))))) (. .)))
9061777	6	(ROOT (S (NP (NN Brain) (NN damage)) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (S (VP (VBG examining) (NP (DT the) (NNS hippocampus)) (ADVP (RB microscopically))))))) (. .)))
9061777	7	(ROOT (S (NP (NNP Doc_9061777_776_787_Chemical)) (VP (VBD produced) (NP (NNS Doc_9061777_797_811_Disease)) (PP (IN in) (NP (NP (DT the) (NNS hippocampus)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD showed) (NP (JJ pyknotic) (NNS changes)))))))) (. .)))
9061777	8	(ROOT (S (NP (JJ Doc_9061777_863_876_Chemical) (, ,) (NNS Doc_9061777_878_889_Chemical) (CC and) (NNS Doc_9061777_894_900_Chemical)) (VP (VBD protected) (NP (DT the) (NNS Doc_9061777_915_927_Disease)) (PP (IN by) (NP (NNS Doc_9061777_931_942_Chemical))) (, ,) (SBAR (IN though) (S (PP (IN in) (NP (DT the) (NN Doc_9061777_958_964_Chemical-treated) (NN group))) (, ,) (NP (NP (DT the) (JJ pyramidal) (NNS cells)) (PP (IN of) (NP (NNS hippocampus)))) (VP (VBD appeared) (NP (JJR darker)) (PP (IN than) (ADJP (JJ normal))))))) (. .)))
9061777	9	(ROOT (S (PP (IN In) (NP (DT all) (NNS treatments))) (, ,) (NP (NP (JJ granule) (NNS cells)) (PP (IN of) (NP (DT the) (JJ dentate) (NNS gyrus)))) (VP (VBD were) (ADVP (RB not) (ADJP (JJ affected) (. .))) (NP (CD 4))) (. .)))
9061777	10	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NNS Doc_9061777_1148_1166_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_9061777_1178_1189_Chemical))))) (VP (VBZ is) (VP (VP (VBN initiated) (PP (IN by) (NP (JJ cholinergic) (NN overstimulation)))) (CC and) (VP (VBN propagated) (PP (IN by) (NP (NP (JJ glutamatergic) (NN transmission)) (, ,) (SBAR (WHNP (NP (DT the) (NN elevation)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (MD may) (VP (VB cause) (NP (NNS Doc_9061777_1313_1325_Disease)) (PP (IN through) (NP (DT an) (JJ excitatory) (JJ Doc_9061777_1348_1352_Chemical) (JJ receptor-mediated) (NN mechanism))))))))))))))) (. .)))
9071336	0	(ROOT (S (UCP (NP (NP (NNP Doc_9071336_0_10_Chemical)) (, ,) (VP (VBN Doc_9071336_12_26_Chemical))) (, ,) (CC and) (FRAG (NP (NP (NP (NNS Doc_9071336_32_44_Chemical)) (PP (IN in) (NP (JJ metastatic) (NNS Doc_9071336_59_72_Disease)))) (: :) (NP (NP (NN BRE-26)) (, ,) (NP (DT a) (NN phase) (NNP II) (NN trial))) (. .)))) (NP (NP (NNS Doc_9071336_100_114_Chemical)) (PP (CC plus) (NP (NP (NNS Doc_9071336_120_132_Chemical) (CC and) (NNS Doc_9071336_137_147_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_9071336_149_154_Chemical)) (: ;) (NP (NNP Bristol-Myers) (NNP Squibb) (NNP Company))) (, ,) (NP (NP (NNP Princeton)) (, ,) (NP (NNP NJ))) (-RRB- -RRB-))))) (VP (VBP are) (NP (NP (JJ effective) (NN salvage) (NNS therapies)) (PP (IN for) (NP (JJ metastatic) (JJ Doc_9071336_248_261_Disease) (NNS patients))))) (. .)))
9071336	1	(ROOT (S (NP (NNS Doc_9071336_272_282_Chemical) (CC and) (NNS Doc_9071336_287_301_Chemical)) (VP (VBP have) (NP (NP (JJ additive) (NNS Doc_9071336_316_328_Disease)) (PP (IN in) (NP (NN MCF-7) (NN cell) (NNS lines))))) (. .)))
9071336	2	(ROOT (S (NP (PRP We)) (VP (VBD performed) (NP (NP (DT a) (NN phase) (NNP II) (NN trial)) (PP (IN of) (NP (NP (QP (CD Doc_9071336_383_393_Chemical) (CD 175)) (NNS mg/m2)) (PP (IN over) (NP (NP (CD 3) (NNS hours)) (PP (IN on) (NP (NP (NN day)) (SBAR (S (NP (PRP I)) (VP (VBD followed) (PP (IN by) (NP (NP (QP (CD Doc_9071336_438_450_Chemical) (CD 300)) (NN mg)) (PP (IN over) (NP (CD 1) (NN hour))))) (PP (IN before) (NP (NP (QP (CD Doc_9071336_477_491_Chemical) (CD 350)) (NNS mg/m2)) (PP (IN on) (NP (NNS days) (CD 1) (TO to) (CD 3))))) (NP (DT every) (CD 28) (NNS days))))))))) (PRN (-LRB- -LRB-) (NP (NNP TFL)) (-RRB- -RRB-))))) (PP (IN in) (NP (NNS women))) (PP (IN with) (NP (JJ metastatic) (NNS Doc_9071336_562_575_Disease)))) (. .)))
9071336	3	(ROOT (S (S (NP (NNP Analysis)) (VP (VBZ is) (VP (VBN reported) (PP (IN on) (NP (NP (CD 37) (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN minimum)) (PP (IN of) (NP (CD 6) (NNS months) (NN follow-up))))) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (QP (DT a) (NN total) (IN of) (CD 192)) (NNS cycles)) (PP (IN of) (NP (NNS Doc_9071336_688_691_Chemical)))))))))))) (: :) (S (NP (NP (CD nine) (NNS cycles)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (QP (CD grade) (CD 3/4)) (NNS Doc_9071336_741_752_Disease))) (S (VP (VBG requiring) (NP (NN hospitalization))))))) (: ;) (S (NP (NP (CD seven)) (PRN (-LRB- -LRB-) (NP (CD 4) (NN %)) (-RRB- -RRB-))) (VP (VBZ cycles) (PP (IN in) (NP (NP (CD two) (NNS patients)) (VP (VBN required) (S (NP (JJ granulocyte) (JJ colony-stimulating) (NN factor)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_9071336_868_879_Disease)))))))))) (: ;) (S (NP (DT no) (NN patient)) (VP (VBD required) (NP (JJ platelet) (NNS transfusions)))) (. .)))
9071336	4	(ROOT (S (NP (QP (CD Grade) (CD 3/4)) (JJ nonhematologic) (NNS Doc_9071336_949_959_Disease)) (VP (VBD were) (ADJP (JJ uncommon))) (. .)))
9071336	5	(ROOT (S (PP (IN Among) (NP (NP (DT the) (CD 34) (NNS patients) (NN evaluable)) (PP (IN for) (NP (NN response))))) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (CD three) (JJ complete) (NNS responses)) (PRN (-LRB- -LRB-) (NP (CD 9) (NN %)) (-RRB- -RRB-)) (CC and) (NP (NP (NP (CD 18) (JJ partial) (NNS responses)) (PRN (-LRB- -LRB-) (NP (CD 53) (NN %)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (DT an) (JJ overall) (NN response) (NN rate)) (PP (IN of) (NP (CD 62) (NN %)))))))) (. .)))
9071336	6	(ROOT (S (PP (IN Of) (NP (NP (DT the) (CD 19) (JJ evaluable) (NNS patients)) (PP (IN with) (NP (JJ prior) (JJ Doc_9071336_1170_1181_Chemical) (NN exposure))))) (, ,) (NP (NP (CD 11)) (PRN (-LRB- -LRB-) (NP (CD 58) (NN %)) (-RRB- -RRB-))) (VP (VBD responded) (PP (VBN compared) (PP (IN with) (NP (NP (CD nine)) (PP (IN of) (NP (NP (CD 15)) (PRN (-LRB- -LRB-) (NP (CD 60) (NN %)) (-RRB- -RRB-))))))) (PP (IN without) (NP (JJ prior) (NNS Doc_9071336_1256_1267_Chemical)))) (. .)))
9071336	7	(ROOT (S (NP (NNP Plasma) (NNP Doc_9071336_1276_1286_Chemical) (NNS concentrations)) (VP (VBD were) (VP (VBN measured) (PP (PP (IN at) (NP (NP (DT the) (NN completion)) (PP (IN of) (NP (JJ Doc_9071336_1337_1347_Chemical) (NN infusion))))) (CC and) (PP (IN at) (NP (NP (CD 24) (NNS hours)) (PP (IN in) (NP (CD 19) (NNS patients)))))))) (. .)))
9071336	8	(ROOT (S (NP (NNP TFL)) (VP (VBZ is) (NP (NP (DT an) (JJ active) (, ,) (JJ well-tolerated) (NN regimen)) (PP (IN in) (NP (JJ metastatic) (NNS Doc_9071336_1444_1457_Disease))))) (. .)))
9125676	0	(ROOT (NP (NP (NN Efficacy) (CC and) (NN proarrhythmia)) (PP (IN with) (NP (DT the) (NN use))) (PP (IN of) (NP (NP (NNS Doc_9125676_43_54_Chemical)) (PP (IN for) (NP (JJ sustained) (NNS Doc_9125676_69_97_Disease))))) (. .)))
9125676	1	(ROOT (S (NP (DT This) (NN study)) (ADVP (RB prospectively)) (VP (VBN evaluated) (NP (NP (DT the) (JJ clinical) (NN efficacy)) (, ,) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_9125676_174_193_Disease)))) (, ,) (CC and) (NP (DT the) (JJ presumable) (NN risk) (NNS factors))) (PP (IN for) (NP (NP (NNS Doc_9125676_231_250_Disease)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_9125676_276_287_Chemical)) (PP (IN for) (NP (JJ sustained) (NNS Doc_9125676_302_330_Disease))))))))))) (. .)))
9125676	2	(ROOT (S (NP (NP (NP (JJ Eighty-one) (JJ consecutive) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 54)) (PP (IN with) (NP (NNS Doc_9125676_373_396_Disease))) (, ,) (CC and) (NP (NP (CD 20)) (PP (IN with) (NP (NNS Doc_9125676_410_432_Disease))))) (-RRB- -RRB-))) (PP (IN with) (NP (JJ inducible) (VBN sustained) (NNS Doc_9125676_459_482_Disease) (CC or) (NNS Doc_9125676_486_510_Disease)))) (VP (VBD received) (NP (JJ oral) (NNS Doc_9125676_525_536_Chemical)) (S (VP (TO to) (VP (VB prevent) (NP (NP (NN induction)) (PP (IN of) (NP (DT the) (NNS Doc_9125676_565_592_Disease)))))))) (. .)))
9125676	3	(ROOT (S (PP (IN During) (NP (NP (JJ oral) (NN loading)) (PP (IN with) (NP (NNS Doc_9125676_619_630_Chemical))))) (, ,) (NP (ADJP (ADJP (JJ continuous) (JJ electrocardiographic)) (PRN (-LRB- -LRB-) (NP (NNP ECG)) (-RRB- -RRB-))) (NN monitoring)) (VP (VBD was) (VP (VBN performed))) (. .)))
9125676	4	(ROOT (S (NP (NP (DT Those) (NNS patients)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (NNS Doc_9125676_719_730_Chemical)) (VP (VBD prevented) (NP (NP (NN induction)) (PP (IN of) (NP (NNS Doc_9125676_754_777_Disease) (CC or) (NNS Doc_9125676_781_805_Disease)))))))) (VP (VBD were) (VP (VP (VBN discharged) (PP (IN with) (NP (DT the) (NN drug)))) (CC and) (VP (VBN followed) (PRT (RP up)) (PP (IN on) (NP (DT an) (NN outpatient) (NN basis))) (PP (IN for) (NP (NP (QP (CD 21) (CD +)) (NNS /)) (: -) (NP (CD 18) (NNS months))))))) (. .)))
9125676	5	(ROOT (S (S (NP (NP (NNP Induction)) (PP (IN of) (NP (DT the) (NNS Doc_9125676_914_941_Disease)))) (VP (VBD was) (VP (VBN prevented) (PP (IN by) (NP (NP (JJ oral) (NNS Doc_9125676_964_975_Chemical)) (PP (IN in) (NP (ADJP (CD 35)) (PRN (-LRB- -LRB-) (NP (CD 43) (NN %)) (-RRB- -RRB-)) (NNS patients)))))))) (: ;) (S (NP (DT the) (NNS Doc_9125676_1002_1029_Disease)) (VP (VBD remained) (NP (ADJP (JJ inducible) (PP (IN in) (NP (NP (CD 40)) (PRN (-LRB- -LRB-) (NP (CD 49) (NN %)) (-RRB- -RRB-))))) (NNS patients)))) (: ;) (CC and) (S (NP (NP (CD two)) (PRN (-LRB- -LRB-) (NP (CD 2.5) (NN %)) (-RRB- -RRB-)) (NNS patients)) (VP (VBD did) (RB not) (VP (VB tolerate) (NP (NP (RB even) (CD 40) (NN mg)) (PP (IN of) (NP (NNS Doc_9125676_1126_1137_Chemical)))) (ADVP (RB once) (RB daily))))) (. .)))
9125676	6	(ROOT (S (NP (NP (CD Four)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN %)) (-RRB- -RRB-)) (NNS patients)) (VP (VBD had) (PP (IN from) (NP (NP (NNS Doc_9125676_1178_1197_Disease)) (PP (IN during) (NP (NP (DT the) (JJ initial) (JJ oral) (NN treatment)) (PP (IN with) (NP (NNS Doc_9125676_1237_1248_Chemical)))))))) (. .)))
9125676	7	(ROOT (S (NP (NP (NP (DT Neither) (NNP ECG) (NNP -LSB-) (JJ sinus-cycle) (NN length)) (PRN (-LRB- -LRB-) (NP (NNP SCL)) (-RRB- -RRB-))) (, ,) (NP (NP (NNP QT)) (CC or) (NP (NNP QTc) (NNP interval))) (, ,) (CC or) (NP (NP (NNP U) (NN wave) (NNP -RSB-)) (CC nor) (NP (JJ clinical) (NNS parameters)))) (VP (VBD identified) (NP (NNS patients)) (PP (IN at) (NP (NN risk))) (PP (IN for) (NP (NNS Doc_9125676_1376_1395_Disease)))) (. .)))
9125676	8	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ oral) (NN dose)) (PP (IN of) (NP (NNS Doc_9125676_1423_1434_Chemical)))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR lower)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_9125676_1476_1495_Disease)))))) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 200)) (JJ +)) (: /)) (: -) (FRAG (FRAG (NP (CD 46)) (PP (FW vs.) (NP (CD 328) (NNS +)))) (: /) (FRAG (: -) (ADVP (RB 53)) (NP (NP (NN mg/day)) (: ;) (NP (NP (NN p)) (SBAR (S (VP (SYM =) (NP (CD 0.0017)))))))))) (-RRB- -RRB-))) (. .)))
9125676	9	(ROOT (S (NP (NP (NN Risk) (NNS factors)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_9125676_1592_1611_Disease))))))) (VP (VBD were) (NP (NP (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (DT an) (NNP U) (NN wave)))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.049))))) (-RRB- -RRB-)) (, ,) (NP (NP (JJ female) (NN gender)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.015))))) (-RRB- -RRB-)))) (, ,) (CC and) (NP (NP (NP (JJ significant) (JJ dose-corrected) (NNS changes)) (PP (IN of) (NP (NP (NNP SCL)) (, ,) (NP (NNP QT) (NNP interval)) (, ,) (CC and) (NP (NNP QTc) (NNP interval))))) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (CD <) (CD 0.05))) (-RRB- -RRB-))))) (. .)))
9125676	10	(ROOT (S (PP (IN During) (NP (NN follow-up))) (, ,) (S (NP (NP (CD seven)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN %)) (-RRB- -RRB-)) (NNS patients)) (VP (VBD had) (NP (DT a) (JJ nonfatal) (JJ Doc_9125676_1828_1851_Disease) (NN recurrence)))) (, ,) (CC and) (S (NP (NP (CD two)) (PRN (-LRB- -LRB-) (NP (CD 6) (NN %)) (-RRB- -RRB-)) (NNS patients)) (VP (VBD died) (ADVP (RB suddenly)))) (. .)))
9125676	11	(ROOT (S (NP (NP (CD One) (JJ female) (NN patient)) (PP (IN with) (NP (JJ stable) (NNS Doc_9125676_1932_1947_Disease)))) (VP (VBD had) (NP (JJ recurrent) (NNS Doc_9125676_1962_1981_Disease)) (PP (IN after) (NP (NP (CD 2) (NNS years)) (PP (IN of) (NP (JJ successful) (NN treatment))))) (PP (IN with) (NP (NNS Doc_9125676_2025_2036_Chemical)))) (. .)))
9125676	12	(ROOT (S (NP (NNP Doc_9125676_2038_2057_Disease)) (VP (VBD occurred) (ADVP (RB early) (PP (IN during) (NP (NN treatment)) (ADVP (RB even)))) (PP (IN with) (NP (NP (JJ low) (NNS doses)) (PP (IN of) (NP (JJ oral) (NNS Doc_9125676_2118_2129_Chemical)))))) (. .)))
9125676	13	(ROOT (S (NP (NP (JJ Pronounced) (NNS changes)) (PP (IN in) (NP (NP (NP (DT the) (NN surface) (NN ECG)) (PRN (-LRB- -LRB-) (NP (NP (NN cycle) (NN length)) (, ,) (NP (NNP QT)) (, ,) (CC and) (NP (NNP QTc))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN relation)) (PP (TO to) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (JJ oral) (NNS Doc_9125676_2229_2240_Chemical)))))))))) (VP (MD might) (VP (VB identify) (NP (NP (DT a) (NN subgroup)) (PP (IN of) (NP (NNS patients)))) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN for) (NP (NNS Doc_9125676_2306_2325_Disease))))))) (. .)))
9125676	14	(ROOT (S (NP (NP (JJ Other) (NNP ECG) (NNS parameters)) (PP (IN before) (NP (NP (DT the) (NN application)) (PP (IN of) (NP (NNS Doc_9125676_2374_2385_Chemical)))))) (VP (VBD did) (RB not) (VP (VB identify) (NP (NNS patients)) (PP (IN at) (NP (NP (VBN increased) (NN risk)) (PP (IN for) (NP (NNS Doc_9125676_2434_2453_Disease))))))) (. .)))
9125676	15	(ROOT (S (NP (NP (JJ Recurrence) (NNS rates)) (PP (IN of) (NP (NNS Doc_9125676_2475_2503_Disease)))) (VP (VBP are) (ADJP (JJ high) (PP (IN despite) (NP (NP (JJ complete) (NN suppression)) (PP (IN of) (NP (DT the) (NNS Doc_9125676_2549_2559_Disease)))))) (PP (IN during) (NP (JJ programmed) (NN stimulation)))) (. .)))
9125676	16	(ROOT (S (ADVP (RB Therefore)) (NP (NP (JJ programmed) (JJ electrical) (NN stimulation)) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NNS Doc_9125676_2650_2661_Chemical)))))) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (PP (IN of) (NP (JJ limited) (JJ prognostic) (NN value))))))) (. .)))
9128918	0	(ROOT (S (NP (NP (JJ Chronic) (NNS Doc_9128918_8_26_Disease) (CC and) (NNS changes)) (PP (IN in) (NP (NNS Doc_9128918_42_50_Chemical)))) (VP (VBZ neurons)) (. .)))
9128918	1	(ROOT (S (NP (DT The) (JJ tuberoinfundibular) (NN dopaminergic) (PRN (-LRB- -LRB-) (NP (NNP TIDA)) (-RRB- -RRB-)) (NN system)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB inhibit) (NP (JJ prolactin) (PRN (-LRB- -LRB-) (NP (NNP PRL)) (-RRB- -RRB-)) (NNS secretion))))))) (. .)))
9128918	2	(ROOT (S (PP (IN In) (NP (JJ young) (NNS animals))) (NP (DT this) (NN system)) (VP (VBZ responds) (PP (TO to) (NP (NP (JJ acute) (NNS elevations)) (PP (IN in) (NP (NNP serum) (NNP PRL))))) (PP (IN by) (S (VP (VBG increasing) (NP (PRP$ its) (NN activity)))))) (. .)))
9128918	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT this) (NNS responsiveness)) (VP (VBZ is) (VP (VBN lost) (PP (IN in) (NP (NP (VBG aging) (NNS rats)) (PP (IN with) (NP (RB chronically) (JJ high) (NN serum) (NN PRL) (NNS levels))))))) (. .)))
9128918	4	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VP (VB induce) (NP (NNS Doc_9128918_387_405_Disease)) (PP (IN in) (NP (NP (NNS rats)) (PP (IN for) (NP (NP (JJ extended) (NNS periods)) (PP (IN of) (NP (NN time)))))))) (CC and) (VP (VB examine) (NP (PRP$ its) (NNS effects)) (PP (IN on) (NP (NP (JJ dopaminergic) (NNS systems)) (PP (IN in) (NP (DT the) (NN brain)))))))))) (. .)))
9128918	5	(ROOT (S (S (NP (NNP Doc_9128918_505_523_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NN treatment))) (PP (IN with) (NP (NP (NNS Doc_9128918_554_565_Chemical)) (, ,) (NP (DT a) (JJ Doc_9128918_569_577_Chemical) (NN receptor) (NN antagonist))))))) (, ,) (CC and) (S (NP (NP (NP (NNP Palkovits) (POS ')) (NN microdissection) (NN technique)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ high-performance) (JJ liquid) (NN chromatography)))))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB measure) (NP (NN neurotransmitter) (NNS concentrations)) (PP (IN in) (NP (NP (JJ several) (NNS areas)) (PP (IN of) (NP (DT the) (NN brain))))))))))) (. .)))
9128918	6	(ROOT (S (PP (IN After) (NP (NP (CD 6) (NNS months)) (PP (IN of) (NP (NNS Doc_9128918_800_818_Disease))))) (, ,) (NP (NP (NNS Doc_9128918_820_828_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP DA)) (-RRB- -RRB-))) (VP (VBZ concentrations) (PP (IN in) (NP (NP (DT the) (JJ median) (NN eminence)) (PRN (-LRB- -LRB-) (NP (NNP ME)) (-RRB- -RRB-)) (VP (VBN increased) (PP (IN by) (NP (NP (CD 84) (NN %)) (PP (IN over) (NP (DT the) (NN control) (NN group))))))))) (. .)))
9128918	7	(ROOT (S (NP (NP (CD Nine) (NNS months)) (PP (IN of) (NP (NNS Doc_9128918_933_951_Disease)))) (VP (VBD produced) (NP (NP (DT a) (ADJP (CD 50) (NN %)) (NN increase)) (PP (IN in) (NP (NNP DA) (NNS concentrations)))) (PP (IN in) (NP (DT the) (NNP ME))) (PP (IN over) (NP (DT the) (NN control) (NN group)))) (. .)))
9128918	8	(ROOT (S (ADVP (RB However)) (, ,) (NP (NNP DA) (NN response)) (VP (VBD was) (VP (VBN lost) (SBAR (IN if) (S (NP (DT a) (JJ 9-month) (JJ long) (NN Doc_9128918_1079_1090_Chemical-induced) (NNS Doc_9128918_1099_1117_Disease)) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (DT a) (CD 1 1/2) (JJ month-long) (ADJP (ADJP (RB extremely) (JJ high) (NN increase)) (PP (IN in) (NP (NNP serum) (NNP PRL)))) (NNS levels)) (VP (VBN produced) (PP (IN by) (NP (NP (NN implantation)) (PP (IN of) (NP (NNP MMQ) (NNS cells))))) (PP (IN under) (NP (DT the) (NN kidney) (NN capsule)))))))))))) (. .)))
9128918	9	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NNP DA)))))) (, ,) (NP (NP (NNS Doc_9128918_1302_1316_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP NE)) (-RRB- -RRB-)) (, ,) (NP (NP (NNS Doc_9128918_1323_1332_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9128918_1334_1338_Chemical)) (-RRB- -RRB-)))) (, ,) (CC or) (NP (NP (NP (PRP$ their) (NNS metabolites)) (PP (IN in) (NP (DT the) (NNS Doc_9128918_1369_1384_Disease))) (PRN (-LRB- -LRB-) (NP (NNP Doc_9128918_1386_1388_Disease)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ medial) (JJ preoptic) (NN area)) (PRN (-LRB- -LRB-) (NP (NNP MPA)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ caudate) (NN putamen)) (PRN (-LRB- -LRB-) (NP (NNP CP)) (-RRB- -RRB-))) (, ,) (NP (NP (NN substantia) (NN nigra)) (PRN (-LRB- -LRB-) (NP (NNP SN)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN zona) (NN incerta)) (PRN (-LRB- -LRB-) (NP (NNP ZI)) (-RRB- -RRB-)))))) (, ,) (PP (IN except) (PP (IN for) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (NNS Doc_9128918_1512_1538_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9128918_1540_1546_Chemical)) (-RRB- -RRB-))))))) (PP (IN in) (NP (DT the) (NNS Doc_9128918_1555_1557_Disease))) (PP (IN after) (NP (NP (JJ 6-months)) (PP (IN of) (NP (NP (NNS Doc_9128918_1576_1594_Disease)) (CC and) (NP (DT an) (NN increase)))))) (PP (IN in) (NP (NNP DA) (NNS concentrations))) (PP (IN in) (NP (DT the) (NNS Doc_9128918_1639_1641_Disease))) (PP (IN after) (NP (NP (JJ 9-months)) (PP (IN of) (NP (NNS Doc_9128918_1660_1678_Disease))))) (. .)))
9128918	10	(ROOT (S (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NNS Doc_9128918_1711_1729_Disease)) (ADVP (RB specifically)) (VP (VBZ affects) (NP (NNP TIDA) (NNS neurons))))))) (CC and) (S (NP (DT these) (NNS effects)) (VP (VBP vary))) (, ,) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (NN duration) (CC and) (NN intensity)) (PP (IN of) (NP (NNS Doc_9128918_1831_1849_Disease)))))) (. .)))
9128918	11	(ROOT (S (NP (NP (DT The) (JJ age-related) (NN decrease)) (PP (IN in) (NP (JJ hypothalamic) (JJ Doc_9128918_1892_1900_Chemical) (NN function)))) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (NNS increases)) (PP (IN in) (NP (NNP PRL) (NN secretion)))))))) (. .)))
9132810	0	(ROOT (NP (NP (JJ Treatment-related) (NNS Doc_9132810_18_62_Disease)) (PP (IN with) (NP (JJ characteristic) (NN contrast) (NN enhancement))) (PP (IN of) (NP (DT the) (JJ white) (NN matter))) (. .)))
9132810	1	(ROOT (S (NP (DT This) (NN report)) (VP (VBZ describes) (NP (NP (JJ unique) (NN contrast) (NN enhancement)) (PP (IN of) (NP (NP (DT the) (JJ white) (NN matter)) (PP (IN on) (NP (NP (JJ T1-weighted) (JJ magnetic) (NN resonance) (NNS images)) (PP (IN of) (NP (CD two) (NNS patients)))))))) (PP (IN with) (NP (NP (NNS Doc_9132810_257_301_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBN developed) (PP (IN from) (NP (NP (NNS Doc_9132810_324_352_Disease)) (VP (VBN treated) (PP (IN with) (NP (JJ high-dose) (NNS Doc_9132810_376_388_Chemical)))))))))))) (. .)))
9132810	2	(ROOT (S (PP (IN In) (NP (DT both) (NNS patients))) (, ,) (NP (DT the) (NN enhancement)) (VP (VBD was) (ADJP (RBR more) (JJ pronounced) (PP (IN near) (NP (NP (DT the) (NN base)) (PP (IN of) (NP (DT the) (NN brain)))))) (PP (IN than) (PP (IN at) (NP (DT the) (NN vertex))))) (. .)))
9132810	3	(ROOT (S (NP (NP (NNP Necropsy)) (PP (IN of) (NP (DT the) (JJ first) (NN case)))) (VP (VBD revealed) (NP (NNS Doc_9132810_527_579_Disease))) (. .)))
9132810	4	(ROOT (S (NP (NP (JJ Possible) (NNS mechanisms)) (VP (VBG causing) (NP (PDT such) (DT a) (NNS Doc_9132810_616_635_Disease)))) (VP (VBP are) (VP (VBN discussed))) (. .)))
9158667	0	(ROOT (NP (NP (JJ Doc_9158667_0_10_Disease) (NNS complications)) (PP (IN in) (NP (NNS Doc_9158667_28_56_Disease))) (PP (IN during) (NP (JJ Doc_9158667_64_87_Chemical) (NN therapy))) (. .)))
9158667	1	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (NNS Doc_9158667_107_126_Disease)) (, ,) (ADJP (JJ due) (PP (TO to) (NP (NP (NN occlusion)) (PP (IN of) (NP (NP (JJ renal) (NNS vessels)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_9158667_180_208_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9158667_210_213_Disease)) (-RRB- -RRB-)) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NNS Doc_9158667_228_251_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9158667_253_257_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NNS Doc_9158667_263_278_Chemical))))))))))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (ADVP (RB recently))))) (. .)))
9158667	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NNS Doc_9158667_328_347_Disease)) (PP (IN in) (NP (NP (DT an) (JJ Doc_9158667_354_357_Disease) (NN patient)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_9158667_379_383_Chemical))) (ADVP (RB alone))))))))) (. .)))
9158667	3	(ROOT (S (NP (DT This) (NN case)) (ADVP (RB further)) (VP (VBZ supports) (NP (NP (DT the) (NN concern)) (PP (IN about) (NP (NP (JJ Doc_9158667_436_450_Disease) (NNS complications)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ Doc_9158667_481_485_Chemical) (NN therapy)) (PP (IN in) (NP (JJ Doc_9158667_497_500_Disease) (NNS patients)))))))))) (. .)))
9158667	4	(ROOT (S (NP (NP (DT The) (NNS patients)) (, ,) (NP (DT a) (JJ 43-year-old) (NN man)) (, ,)) (VP (VP (VBD presented) (NP (NP (PDT all) (DT the) (NNS signs) (CC and) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_9158667_584_587_Disease))))) (CC and) (VP (VBD was) (VP (VBN included) (PP (IN in) (NP (DT a) (NN treatment) (NN protocol))) (PP (IN with) (NP (NNS Doc_9158667_634_638_Chemical)))))) (. .)))
9158667	5	(ROOT (S (PP (IN After) (NP (NP (CD 10) (NNS days)) (PP (IN of) (NP (NN treatment))))) (, ,) (NP (PRP he)) (VP (VBD developed) (NP (NP (NP (NNS Doc_9158667_681_700_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (ADJP (RB completely) (JJ reversible)) (SBAR (IN after) (S (NP (NP (JJ complete) (NN remission)) (PP (IN of) (NP (NNS Doc_9158667_760_763_Disease)))) (VP (VBD was) (VP (VBN achieved))))))))) (CC and) (NP (NP (NN therapy)) (VP (VBN discontinued))))) (. .)))
9158667	6	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NNS Doc_9158667_820_824_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ valid) (JJ therapeutic) (NN choice)) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_9158667_873_876_Disease)))))) (, ,) (SBAR (IN although) (S (NP (DT the) (NN procoagulant) (NN tendency)) (VP (VBZ is) (RB not) (VP (ADVP (RB completely)) (VBN corrected))))))))) (. .)))
9158667	7	(ROOT (S (NP (JJ Doc_9158667_942_952_Disease) (NNS events)) (, ,) (ADVP (RB however)) (, ,) (VP (MD could) (VP (VB be) (VP (VBN avoided) (PP (IN by) (S (VP (VBG using) (NP (JJ low-dose) (NN heparin)))))))) (. .)))
9197951	0	(ROOT (S (S (NP (JJ Pupillary) (NNS changes)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ stimulant-induced) (NNS Doc_9197951_71_76_Disease))))))) (: :) (S (NP (DT a) (NN case)) (VP (VBP report))) (. .)))
9197951	1	(ROOT (S (NP (NP (DT A) (JJ 30-year-old) (NN Doc_9197951_107_114_Chemical-dependent) (NN man)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (NP (NP (DT a) (ADJP (JJ subject) (PP (IN in) (NP (NP (DT a) (NN study)) (VP (VBG evaluating) (NP (NP (DT the) (VBG anticraving) (NN efficacy)) (PP (IN of) (NP (DT the) (NN stimulant)))))))) (NN medication) (NNS Doc_9197951_222_236_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP DEP)) (-RRB- -RRB-))))))) (VP (VBD became) (NP (NNS Doc_9197951_250_255_Disease)) (PP (IN during) (NP (PRP$ his) (JJ second) (NN week))) (PP (IN on) (NP (DT the) (NN study) (NN drug)))) (. .)))
9197951	2	(ROOT (S (NP (NNP Pupillometric)) (VP (VBZ changes) (SBAR (IN while) (S (PP (IN on) (NP (NNP DEP))) (, ,) (S (ADVP (RB especially)) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (DT the) (JJ total) (NN power)) (PP (IN of) (NP (NNS Doc_9197951_375_396_Disease))))))) (, ,) (VP (VBD were) (ADJP (RB dramatically) (JJ different)) (SBAR (IN than) (S (NP (DT those)) (VP (VBD observed) (PP (IN in) (NP (NP (DT the) (CD eight) (JJ other) (NN study) (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBD did) (RB not) (VP (VB become) (NP (NNS Doc_9197951_499_504_Disease))))))))))))))) (. .)))
9197951	3	(ROOT (S (NP (NP (DT The) (JJ large) (NNS changes)) (PP (IN in) (NP (NP (JJ total) (NN power)) (PP (IN of) (NP (NNS Doc_9197951_542_563_Disease)))))) (VP (VBD occurred) (NP (DT a) (JJ few) (NNS days)) (SBAR (IN before) (S (NP (DT the) (NN patient)) (VP (VBD became) (ADJP (RB fully) (JJ Doc_9197951_616_621_Disease)))))) (. .)))
9197951	4	(ROOT (S (NP (NP (JJ Such) (JJ medication-associated) (NNS changes)) (PP (IN in) (NP (NP (DT the) (JJ total) (NN power)) (PP (IN of) (NP (NNS Doc_9197951_680_701_Disease)))))) (VP (MD might) (VP (VB be) (PP (IN of) (NP (NN utility))) (PP (IN in) (S (VP (VBG identifying) (NP (NNS persons)) (PP (IN at) (NP (NP (NN risk)) (PP (IN for) (NP (JJ Doc_9197951_757_762_Disease-like) (JJ adverse) (NNS effects))))) (PP (IN during) (NP (NP (DT the) (JJ medical) (NN use)) (PP (IN of) (NP (NP (NN psychomotor) (NNS stimulants)) (CC or) (NP (JJ sympathomimetic) (NNS agents))))))))))) (. .)))
920167	0	(ROOT (S (NP (NNP Fetal)) (VP (VBZ risks) (ADJP (JJ due) (PP (TO to) (NP (JJ Doc_920167_19_27_Chemical) (NN therapy)))) (PP (IN during) (NP (NN pregnancy)))) (. .)))
920167	1	(ROOT (S (NP (NP (CD Two) (NNS mothers)) (PP (IN with) (NP (NN heart) (NN valve) (NNS prosthesis)))) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_920167_112_120_Chemical))) (PP (IN during) (NP (NN pregnancy))))) (. .)))
920167	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ first) (NN case))) (NP (DT a) (NN caesarean) (NN section)) (VP (VBD was) (VP (VBN done) (NP (CD one) (NN week)) (PP (IN after) (NP (NP (NN replacement)) (PP (IN of) (NP (NP (NNS Doc_920167_216_224_Chemical)) (PP (IN with) (NP (NN heparin))))))))) (. .)))
920167	3	(ROOT (S (NP (DT The) (NN baby)) (VP (VBD died) (PP (IN of) (NP (NNS Doc_920167_256_289_Disease)))) (. .)))
920167	4	(ROOT (S (NP (DT The) (JJ second) (NN mother)) (VP (VBD had) (NP (NP (DT a) (JJ male) (NN infant)) (PP (IN by) (NP (NN caesarean) (NN section))))) (. .)))
920167	5	(ROOT (S (NP (DT The) (NN baby)) (VP (VBD showed) (NP (NN Doc_920167_365_373_Chemical-induced) (NNS Doc_920167_382_393_Disease)) (PP (IN with) (NP (NP (JJ nasal) (NNS Doc_920167_405_415_Disease) (CC and) (NNS Doc_920167_420_438_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_920167_440_465_Disease)) (-RRB- -RRB-))))) (. .)))
920167	6	(ROOT (S (S (NP (NP (JJ Nasal) (NNS Doc_920167_474_484_Disease)) (PP (IN with) (CC or) (IN without) (NP (NNS Doc_920167_501_519_Disease)))) (VP (VBZ has) (ADVP (RB now)) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (CD 11) (NNS infants)) (VP (VBN born) (PP (TO to) (NP (NP (NNS mothers)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_920167_585_593_Chemical))) (PP (IN during) (NP (DT the) (JJ first) (NN trimester))))))))))))) (, ,) (CC and) (S (NP (DT a) (JJ causal) (NN association)) (VP (VBZ is) (ADJP (JJ probable)))) (. .)))
920167	7	(ROOT (S (PP (IN In) (NP (NP (NN view)) (PP (IN of) (NP (NP (DT the) (NNS risks)) (PP (TO to) (NP (NP (DT both) (NN mother) (CC and) (NN fetus)) (PP (IN in) (NP (NP (NNS women)) (PP (IN with) (NP (JJ prosthetic) (JJ cardiac) (NNS valves))))))))))) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (JJ therapeutic) (NN abortion)) (VP (VB be) (VP (VBN advised) (PP (IN as) (NP (DT the) (JJ first) (NN alternative))))))))) (. .)))
9272404	0	(ROOT (NP (NP (DT The) (JJ negative) (JJ mucosal) (NN potential)) (: :) (S (VP (VBG separating) (NP (NP (JJ central) (CC and) (JJ peripheral) (NNS effects)) (PP (IN of) (NP (NNP NSAIDs)))) (PP (IN in) (NP (NN man))))) (. .)))
9272404	1	(ROOT (S (NP (PRP We)) (VP (VBD wanted) (S (VP (TO to) (VP (VB test) (SBAR (IN whether) (S (NP (NP (NN assessment)) (PP (IN of) (NP (PDT both) (NP (NP (DT a) (JJ central) (NNS Doc_9272404_158_162_Disease-related) (NN signal)) (PRN (-LRB- -LRB-) (NP (JJ chemo-somatosensory) (JJ evoked) (NN potential)) (, ,) (NP (NNP CSSEP)) (-RRB- -RRB-))) (CC and) (NP (NP (DT a) (JJR concomitantly) (VBN recorded) (JJ peripheral) (NN signal)) (PRN (-LRB- -LRB-) (NP (NP (JJ negative) (JJ mucosal) (NN potential)) (, ,) (NP (NNS Doc_9272404_300_303_Chemical))) (-RRB- -RRB-)))))) (VP (VBZ allows) (PP (IN for) (NP (NP (NN separation)) (PP (IN of) (NP (NP (JJ central) (CC and) (JJ peripheral) (NNS effects)) (PP (IN of) (NP (NNP NSAIDs)))))))))))))) (. .)))
9272404	2	(ROOT (S (PP (IN For) (NP (DT this) (NN purpose))) (, ,) (NP (JJ experimental) (NNS conditions)) (VP (VBD were) (VP (VBN created) (PP (IN in) (SBAR (WHNP (WDT which)) (S (NP (NNP NSAIDs)) (VP (VBD had) (ADVP (RB previously)) (VP (VBN been) (VP (VBN observed) (S (VP (TO to) (VP (VB produce) (NP (NP (NNS effects)) (PP (IN on) (NP (NN phasic) (CC and) (NNS Doc_9272404_505_515_Disease)))) (PP (IN by) (NP (DT either) (JJ central) (CC or) (JJ peripheral) (NNS mechanisms)))))))))))))) (. .)))
9272404	3	(ROOT (S (PP (VBG According) (PP (TO to) (NP (DT a) (JJ double-blind) (, ,) (JJ randomised) (, ,) (JJ controlled) (, ,) (JJ threefold) (NN cross-over) (NN design)))) (, ,) (NP (NP (CD 18) (JJ healthy) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NP (CD 11) (NNS males)) (, ,) (NP (NP (CD 7) (NNS females)) (: ;) (NP (NP (JJ mean) (NN age)) (NP (CD 26) (NNS years))))) (-RRB- -RRB-))) (VP (VBD received) (NP (NP (DT either) (NN placebo)) (, ,) (NP (CD 400) (NN mg) (NNS Doc_9272404_744_753_Chemical)) (, ,) (CC or) (NP (CD 800) (NN mg) (NNS Doc_9272404_765_774_Chemical)))) (. .)))
9272404	4	(ROOT (S (S (NP (NNP Phasic) (NNP Doc_9272404_783_787_Disease)) (VP (VBD was) (VP (VBN applied) (PP (IN by) (NP (NP (NNS means)) (PP (IN of) (NP (NP (JJ short) (NNS pulses)) (PP (IN of) (NP (NNS Doc_9272404_828_831_Chemical))))))) (PP (TO to) (NP (NP (DT the) (JJ nasal) (NN mucosa)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN stimulus) (NN duration)) (NP (CD 500) (NN ms))) (, ,) (ADVP (RB interval)) (NP (NP (QP (RB approximately) (CD 60))) (NP (PRP s)))) (-RRB- -RRB-))))))) (, ,) (CC and) (S (NP (NNS Doc_9272404_913_923_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN in) (NP (DT the) (JJ nasal) (NN cavity))) (PP (IN by) (NP (NP (NNS means)) (PP (IN of) (NP (NP (JJ dry) (NN air)) (PP (IN of) (NP (NP (JJ controlled) (NN temperature) (, ,) (NN humidity) (CC and) (NN flow) (NN rate)) (PRN (-LRB- -LRB-) (NP (CD 22) (NNS degrees)) (NP (NP (NNP C)) (, ,) (NP (NP (CD 0) (NN %)) (NP (JJ relative) (NN humidity))) (, ,) (NP (CD 145) (NNS ml.s-1))) (-RRB- -RRB-))))))))))) (. .)))
9272404	5	(ROOT (S (NP (NP (DT Both) (NNPS CSSEPs)) (PP (IN as) (NP (JJ central) (CC and) (NNP NMPs))) (PP (IN as) (NP (NP (JJ peripheral) (NNS correlates)) (PP (IN of) (NP (NNS Doc_9272404_1136_1140_Disease)))))) (VP (VBD were) (VP (VBN obtained) (PP (IN in) (NP (NN response))) (PP (TO to) (NP (DT the) (JJ Doc_9272404_1174_1177_Chemical) (NNS stimuli))))) (. .)))
9272404	6	(ROOT (S (ADVP (RB Additionally)) (, ,) (NP (DT the) (NNS subjects)) (VP (VBD rated) (NP (NP (DT the) (NN intensity)) (PP (IN of) (NP (NP (DT both) (NN phasic)) (CC and) (NP (NNS Doc_9272404_1253_1263_Disease))))) (PP (IN by) (NP (NP (NNS means)) (PP (IN of) (NP (JJ visual) (JJ analogue) (NNS scales)))))) (. .)))
9272404	7	(ROOT (S (SBAR (IN As) (S (VP (VBD described) (ADVP (RBR earlier))))) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_9272404_1349_1358_Chemical)))) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (JJ Doc_9272404_1389_1399_Disease) (NN but-relative))))) (PP (TO to) (NP (NP (JJ placebo-an) (NN increase)) (PP (IN in) (NP (NP (NNS correlates)) (PP (IN of) (NP (JJ phasic) (NNS Doc_9272404_1460_1464_Disease))))))) (, ,) (S (VP (VBG indicating) (NP (NP (DT a) (JJ specific) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_9272404_1498_1507_Chemical)) (PP (IN on) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (DT the) (JJ Doc_9272404_1539_1543_Disease) (NNS stimuli)))))))) (PP (IN under) (NP (DT these) (JJ special) (JJ experimental) (NNS conditions))))))) (. .)))
9272404	8	(ROOT (S (PP (VBN Based) (PP (IN on) (NP (NP (DT the) (JJ similar) (NN behaviour)) (PP (IN of) (NP (NNP CSSEP) (CC and) (NNP NMP)))))) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN concluded) (SBAR (IN that) (S (NP (NP (DT the) (JJ pharmacological) (NN process)) (VP (VBG underlying) (NP (DT this) (NN phenomenon)))) (VP (VBD was) (ADJP (JJ localised) (PP (IN in) (NP (DT the) (NN periphery))))))))) (. .)))
9272404	9	(ROOT (S (PP (IN By) (NP (NP (NNS means)) (PP (IN of) (NP (NP (DT the) (JJ simultaneous) (NN recording)) (PP (IN of) (NP (JJ interrelated) (JJ peripheral) (CC and) (JJ central) (JJ electrophysiologic) (NNS correlates))) (PP (IN of) (NP (NN nociception))))))) (, ,) (NP (PRP it)) (VP (VBD was) (ADJP (JJ possible) (S (VP (TO to) (VP (VB separate) (NP (NP (JJ central) (CC and) (JJ peripheral) (NNS effects)) (PP (IN of) (NP (DT an) (NNP NSAID))))))))) (. .)))
9272404	10	(ROOT (S (NP (NP (DT The) (JJ major) (NN advantage)) (PP (IN of) (NP (DT this) (JJ Doc_9272404_1979_1983_Disease) (NN model)))) (VP (VBZ is) (NP (NP (DT the) (NN possibility)) (PP (IN of) (S (VP (VBG obtaining) (NP (NP (JJ peripheral) (NN Doc_9272404_2033_2037_Disease-related) (NN activity)) (VP (ADVP (RB directly)) (VBG using) (NP (NP (DT a) (ADJP (JJ non-invasive)) (NN technique)) (PP (IN in) (NP (NNS humans))))))))))) (. .)))
931801	0	(ROOT (NP (NP (NN Effect)) (PP (IN of) (NP (NP (NNS Doc_931801_10_22_Chemical)) (PP (IN on) (NP (JJ basic) (JJ antibiotic-induced) (NNS Doc_931801_51_63_Disease))))) (PP (IN in) (NP (NNS rats))) (. .)))
931801	1	(ROOT (S (NP (JJ Dehydrated) (NNS rats)) (ADVP (RB regularly)) (VP (VBP develop) (NP (NP (NNS Doc_931801_107_126_Disease)) (PP (VBG following) (NP (NP (JJ single) (NN injection)) (PP (IN of) (NP (NP (JJ Doc_931801_157_171_Chemical) (NNS antibiotics)) (VP (VBN combined) (PP (PP (IN with) (NP (NN dextran))) (CC or) (PP (IN of) (NP (NNS antibiotics))) (ADVP (RB only)))))))))) (. .)))
931801	2	(ROOT (S (NP (NP (JJ Oral) (NN administration)) (PP (IN of) (NP (NNS Doc_931801_253_296_Chemical)))) (VP (VBD protected) (NP (NNS rats)) (PP (IN against) (NP (NP (NNS Doc_931801_320_333_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_931801_345_354_Chemical-dextran))))))) (. .)))
931801	3	(ROOT (S (NP (DT The) (JJ protective) (NN effect)) (VP (VBD was) (ADJP (JJ prevalent) (PP (PP (IN among) (NP (NNS Doc_931801_406_418_Chemical))) (, ,) (CC and) (ADVP (RB also)) (PP (TO to) (NP (JJ other) (NNS Doc_931801_438_452_Chemical) (, ,) (NNS Doc_931801_454_470_Chemical) (CC and) (NNS Doc_931801_475_492_Chemical))))) (, ,) (SBAR (IN although) (S (VP (PP (PP (TO to) (NP (DT a) (JJR lesser) (NN degree))) (, ,) (CC but) (RB not) (PP (TO to) (NP (NP (DT a) (JJ Doc_931801_536_546_Chemical) (, ,) (JJ Doc_931801_548_562_Chemical) (, ,) (JJ substances) (JJ inthe) (JJ Doc_931801_581_584_Chemical) (NN cycle)) (CC and) (NP (JJ other) (JJ acidic) (NNS compounds))))))))) (. .)))
931801	4	(ROOT (S (NP (NNP Doc_931801_619_631_Chemical)) (VP (VBD were) (ADJP (JJ effective) (PP (IN against) (NP (NP (NNS Doc_931801_655_667_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ peptide) (NNS antibiotics)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ various) (JJ Doc_931801_718_732_Chemical) (NNS antibitocis))))))))) (. .)))
931801	5	(ROOT (S (NP (NNS Dose-responses)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (JJ protective) (NN effect)) (PP (IN of) (NP (NNS Doc_931801_803_815_Chemical))))))) (. .)))
931801	6	(ROOT (S (PP (IN With) (NP (NP (DT a) (NN D-glucarate)) (PP (IN of) (NP (NP (DT a) (VBN fixed) (NN size)) (PP (IN of) (NP (NN dose))))))) (, ,) (NP (NP (RB approximately) (DT the) (JJ same) (NN degree)) (PP (IN of) (NP (NN protection)))) (VP (VBD was) (VP (VBN obtained) (PP (IN against) (NP (NP (NNS Doc_931801_926_939_Disease)) (VP (VBN induced) (PP (IN by) (NP (JJ different) (JJ basic) (NNS antibiotics))) (PP (IN despite) (NP (NP (JJ large) (NNS disparities)) (PP (IN in) (NP (NP (NN administration) (NNS doses)) (PP (IN of) (NP (JJ different) (NNS antibiotics)))))))))))) (. .)))
931801	7	(ROOT (S (NP (NNP Doc_931801_1055_1067_Chemical)) (VP (VBD had) (NP (DT the) (NN ability) (S (VP (VP (TO to) (VP (VB prevent) (NP (NNS Doc_931801_1095_1107_Disease)))) (CONJP (CC but) (RB not)) (VP (TO to) (VP (VB cure) (NP (PRP it)))))))) (. .)))
931801	8	(ROOT (S (NP (NNS Rats)) (VP (VBD excreted) (NP (JJ acidic) (NN urine)) (SBAR (WHADVP (WRB when)) (S (NP (PRP they)) (VP (VBD were) (VP (VBN spared) (PP (IN from) (NP (JJ renal) (NNS lesions))) (PP (IN by) (NP (NNS Doc_931801_1199_1214_Chemical)))))))) (. .)))
931801	9	(ROOT (S (NP (NP (DT The) (NN reduction) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_931801_1240_1252_Chemical)) (PP (IN against) (NP (NP (NN nephrotoxicity)) (PP (IN of) (NP (JJ basic) (NNS antibiotics)))))))) (VP (VBD was) (VP (VBN discussed))) (. .)))
9323412	0	(ROOT (S (VP (VB Acute) (NP (NP (JJ severe) (NNS Doc_9323412_13_23_Disease)) (PP (VBG following) (NP (JJ peri-operative) (NN ondansetron))))) (. .)))
9323412	1	(ROOT (S (NP (NP (DT A) (JJ 41-year-old) (NN woman)) (PP (IN with) (NP (NP (DT a) (JJ strong) (NN history)) (PP (IN of) (NP (NNS Doc_9323412_107_140_Disease)))))) (VP (VBD presented) (PP (IN for) (NP (JJ abdominal) (NN hysterectomy))) (NP (CD 3) (NNS months)) (PP (IN after) (NP (NP (DT a) (JJ previous) (NN anaesthetic)) (SBAR (WHADVP (WRB where)) (S (NP (NN ondansetron) (NNS prophylaxis)) (VP (VBD had) (VP (VBN been) (VP (VBN used))))))))) (. .)))
9323412	2	(ROOT (S (NP (PRP She)) (VP (VBD had) (VP (VBN developed) (NP (DT a) (JJ severe) (JJ acute) (JJ major) (NNS Doc_9323412_300_319_Disease)) (ADVP (RB almost) (RB immediately) (RB thereafter)) (, ,) (S (ADJP (RB possibly) (VBN related) (PP (TO to) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT a) (JJ Doc_9323412_384_393_Chemical) (NN antagonist))))))))) (. .)))
9323412	3	(ROOT (S (NP (NP (CD Nine) (NNS years)) (PP (IN before) (NP (PRP she)))) (VP (VBD had) (VP (VBN experienced) (NP (DT a) (JJ self-limited) (JJ puerperal) (NNS Doc_9323412_469_487_Disease)))) (. .)))
9323412	4	(ROOT (S (NP (NP (NNP Anaesthesia)) (PP (IN with) (NP (NP (DT a) (JJ Doc_9323412_508_516_Chemical) (NN infusion) (CC and) (NN avoidance)) (PP (IN of) (NP (JJ Doc_9323412_543_552_Chemical) (NNS antagonists)))))) (VP (VBD provided) (NP (DT a) (ADJP (JJ Doc_9323412_576_582_Disease-free) (JJ postoperative)) (NN course)) (PP (IN without) (NP (NP (NN exacerbation)) (PP (IN of) (NP (DT the) (NNS Doc_9323412_637_656_Disease)))))) (. .)))
9382023	0	(ROOT (S (NP (NP (JJ Doc_9382023_0_12_Disease) (NN response)) (PP (IN during) (NP (NNS Doc_9382023_29_39_Chemical)))) (VP (VBP stress) (ADVP (RB echocardiography))) (. .)))
9382023	1	(ROOT (S (PP (IN Among) (NP (CD 3,129) (JJ Doc_9382023_77_87_Chemical) (NN stress) (JJ echocardiographic) (NNS studies))) (, ,) (NP (NP (DT a) (JJ Doc_9382023_124_136_Disease) (NN response)) (, ,) (VP (VBN defined) (PP (IN as) (NP (NP (JJ systolic) (NN blood) (NN pressure) (PRN (-LRB- -LRB-) (NP (NNP BP)) (-RRB- -RRB-)) (NNS >)) (CC or) (NP (QP (CD =) (CD 220)) (NNP mm) (NNP Hg) (NNP and/or) (NNP diastolic) (NNP BP) (NNPS >)) (CC or) (NP (QP (CD =) (CD 110)) (JJ mm) (NNS Hg))))) (, ,)) (VP (VBD occurred) (PP (IN in) (NP (NP (CD 30) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN %)) (-RRB- -RRB-))))) (. .)))
9382023	2	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (DT this) (NN response)))) (ADVP (RBR more) (RB often)) (VP (VP (VBD had) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS Doc_9382023_328_340_Disease))))) (CC and) (VP (VBD had) (NP (NP (JJR higher) (NNS resting)) (ADJP (JJ systolic) (CC and) (JJ diastolic))) (NP (NNP BP)) (PP (IN before) (NP (JJ Doc_9382023_397_407_Chemical) (NN infusion))))) (. .)))
9428298	0	(ROOT (NP (NP (NP (ADJP (RB Continuously) (JJ nebulized)) (NNS Doc_9428298_23_32_Chemical)) (PP (IN in) (NP (NP (JJ severe) (NNS exacerbations)) (PP (IN of) (NP (NP (NNS Doc_9428298_60_66_Disease)) (PP (IN in) (NP (NNS adults)))))))) (: :) (NP (DT a) (JJ case-controlled) (NN study)) (. .)))
9428298	1	(ROOT (S (NP (NP (DT A) (ADJP (JJ retrospective) (, ,) (JJ case-controlled)) (NN analysis)) (VP (VBG comparing) (NP (NNS patients)))) (VP (VBD admitted) (PP (TO to) (NP (DT a) (JJ medical) (JJ intensive) (NN care) (NN unit))) (PP (IN with) (NP (NP (JJ severe) (NNS exacerbations)) (PP (IN of) (NP (NP (NNS Doc_9428298_235_241_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (ADJP (RB continuously) (JJ nebulized)) (NNS Doc_9428298_278_287_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CNA)) (-RRB- -RRB-)) (PP (IN versus) (NP (NP (NP (JJ intermittent) (NNS Doc_9428298_314_323_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP INA)) (-RRB- -RRB-))) (SBAR (S (NP (NNS treatments)) (VP (VBZ is) (VP (VBN reported)))))))))))))))) (. .)))
9428298	2	(ROOT (S (NP (NP (CD Forty) (VBN matched) (NNS pairs)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_9428298_391_397_Disease)))))) (VP (VBP are) (VP (VBN compared))) (. .)))
9428298	3	(ROOT (S (NP (NNP CNA)) (VP (VBD was) (VP (VBN administered) (PP (IN for) (NP (NP (DT a) (NN mean)) (PP (IN of) (NP (NP (QP (CD 11) (CD +)) (NNS /)) (: -) (NP (CD 10) (NN hr)))))))) (. .)))
9428298	4	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NNS Doc_9428298_478_498_Disease)))) (VP (VBD was) (ADJP (JJ similar) (PP (IN between) (NP (NNS groups))))) (. .)))
9428298	5	(ROOT (S (NP (NNP Symptomatic) (NNP Doc_9428298_539_550_Disease)) (VP (VBD did) (RB not) (VP (VB occur))) (. .)))
9428298	6	(ROOT (S (NP (NNP CNA) (NNS patients)) (VP (VBD had) (NP (JJR higher) (NN heart) (NNS rates)) (PP (IN during) (NP (NP (NN treatment)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB reflect) (NP (NP (NN severity)) (PP (IN of) (NP (NN illness))))))))))) (. .)))
9428298	7	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NN intubation)))) (VP (VBD was) (ADJP (JJ similar))) (. .)))
9428298	8	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NNP CNA) (CC and) (NNP INA)) (VP (VBD demonstrated) (NP (JJ similar) (NNS profiles)) (PP (IN with) (NP (NN regard))) (PP (TO to) (NP (NP (NN safety)) (, ,) (NP (NN morbidity)) (, ,) (CC and) (NP (NN mortality)))))))) (. .)))
946593	0	(ROOT (NP (NP (JJ Doc_946593_0_10_Disease) (JJ following) (JJ intrathecal) (NNS Doc_946593_33_45_Chemical)) (: :) (NP (NP (NN report)) (PP (IN of) (NP (NP (DT a) (NN case) (CC and) (NN review)) (PP (IN of) (NP (DT the) (NN literature)))))) (. .)))
946593	1	(ROOT (S (NP (NP (DT A) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (NNS Doc_946593_118_128_Disease)) (PP (VBG following) (NP (NP (DT the) (JJ intrathecal) (NN instillation)) (PP (IN of) (NP (NNS Doc_946593_171_183_Chemical)))))))))) (VP (VBZ is) (VP (VBN discribed))) (. .)))
946593	2	(ROOT (S (NP (NP (DT The) (CD ten) (ADJP (RB previously) (VBN reported)) (NNS cases)) (PP (IN of) (NP (DT this) (JJ unusual) (NN complication)))) (VP (VBP are) (VP (VBN reviewed))) (. .)))
946593	3	(ROOT (S (NP (DT The) (JJ following) (NNS factors)) (VP (VBP appear) (S (VP (VP (TO to) (VP (VB predispose) (PP (TO to) (NP (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT this) (NN complication)))) (: :) (NP (NP (JJ abnormal) (JJ cerebrospinal) (NNS dynamics)) (VP (VBN related) (PP (TO to) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_946593_418_449_Disease))))))) (, ,) (CC and) (NP (NP (JJ epidural) (JJ cerebrospinal) (NN leakage)) (: ;) (NP (NP (JJ elevated) (JJ cerebrospinal) (JJ fluid) (JJ Doc_946593_516_528_Chemical) (NN concentration)) (VP (VBN related) (PP (TO to) (NP (JJ abnormal) (JJ cerebrospinal) (NN fluid) (NNS dynamics)))))))))) (CC and) (VP (TO to) (VP (VB inappropriately) (NP (JJ high) (JJ Doc_946593_620_632_Chemical) (NNS doses)) (PP (VBN based) (PP (IN on) (NP (NP (NP (NN body) (NN surface) (NN area) (NNS calculations)) (PP (IN in) (NP (JJR older) (NNS children) (CC and) (NNS adults)))) (: ;) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ Doc_946593_725_735_Disease) (NNS preservatives)) (PP (IN in) (NP (ADJP (RB commercially) (JJ available)) (NP (JJ Doc_946593_776_788_Chemical) (NNS preparations)) (CC and) (NNS diluents)))))) (: ;) (CC and) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (JJ Doc_946593_831_843_Chemical) (NNS diluents)) (PP (IN of) (NP (NP (JJ unphysiologic) (NN pH)) (, ,) (NP (JJ ionic) (NN content)) (CC and) (NP (NN osmolarity))))))))))))))) (. .)))
946593	4	(ROOT (S (NP (NP (DT The) (NN role)) (PP (IN of) (NP (NP (JJ Doc_946593_916_928_Chemical) (NNS contaminants)) (, ,) (NP (JJ local) (JJ Doc_946593_949_955_Chemical) (NN deficiency)) (, ,) (CC and) (NP (NP (JJ cranial) (NN irradiation)) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (JJ intrathecal) (JJ Doc_946593_1027_1039_Chemical) (NNS Doc_946593_1040_1048_Disease))))))))) (VP (VBZ is) (ADJP (JJ unclear))) (. .)))
946593	5	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NNS Doc_946593_1078_1091_Disease)))) (VP (MD may) (VP (VB be) (VP (VBN reduced) (PP (PP (IN by) (S (VP (VBG employing) (NP (NP (JJR lower) (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_946593_1135_1147_Chemical)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_946593_1167_1198_Disease))))))))))) (, ,) (PP (IN in) (NP (JJR older) (NNS children) (CC and) (NNS adults))) (, ,) (CC and) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_946593_1253_1269_Disease))))))))) (. .)))
946593	6	(ROOT (S (NP (NP (RB Only) (JJ preservative-free) (NNS Doc_946593_1294_1306_Chemical)) (PP (IN in) (NP (NP (NP (NNP Elliott) (POS 's)) (NNP B) (NN Solution)) (PP (IN at) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (QP (RB not) (JJR more) (IN than) (CD 1)) (NN mg/ml)))))))) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (JJ intrathecal) (NN administration)))))) (. .)))
946593	7	(ROOT (S (NP (NP (JJ Periodic) (NN monitoring)) (PP (IN of) (NP (JJ cerebruspinal) (JJ fluid) (JJ Doc_946593_1465_1477_Chemical) (NNS levels)))) (VP (MD may) (VP (VB be) (NP (NP (JJ predictive)) (PP (IN of) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ serious) (NNS Doc_946593_1533_1546_Disease)))))))) (. .)))
9538487	0	(ROOT (S (NP (NNP Doc_9538487_0_28_Disease)) (VP (VBD precipitated) (PP (IN by) (NP (NN Doc_9538487_45_52_Chemical-induced) (NNS Doc_9538487_61_91_Disease)))) (. .)))
9538487	1	(ROOT (S (NP (NP (DT A) (JJ 45-year-old) (NN man)) (, ,) (PP (IN with) (NP (NP (DT a) (JJ 10-year) (NN history)) (PP (IN of) (NP (NP (NNS Doc_9538487_138_154_Disease)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_9538487_168_175_Chemical)))))))) (, ,)) (VP (VBD was) (VP (VBN admitted) (PP (IN with) (NP (JJ Doc_9538487_195_207_Disease) (, ,) (JJ nonketotic) (NNS Doc_9538487_220_224_Disease))))) (. .)))
9538487	2	(ROOT (S (NP (PRP He)) (VP (VBD gave) (NP (NP (DT a) (JJ five-year) (NN history)) (PP (IN of) (NP (NP (NNS Doc_9538487_257_265_Disease) (CC and) (NNS Doc_9538487_270_280_Disease)) (, ,) (SBAR (WHPP (IN during) (WHNP (WDT which))) (S (NP (NN time) (NNS urinalysis)) (VP (VBD had) (VP (VBN been) (ADJP (JJ negative)) (PP (IN for) (NP (NNS Doc_9538487_333_340_Chemical))))))))))) (. .)))
9538487	3	(ROOT (S (PP (IN After) (NP (NP (NN recovery)) (PP (IN from) (NP (NN hyperglycaemia))))) (, ,) (NP (PRP he)) (VP (VBD remained) (NP (NP (ADJP (JJ polyuric) (PP (IN despite) (NP (JJ normal) (NN blood) (NNS Doc_9538487_420_427_Chemical)))) (NNS concentrations)) (: ;) (NP (NP (NN water) (NN deprivation)) (VP (VBG testing) (NP (JJ indicated) (NNS Doc_9538487_480_510_Disease)) (, ,) (S (ADVP (RB likely)) (VP (TO to) (VP (VB be) (ADJP (JJ Doc_9538487_525_532_Chemical-induced))))))))) (. .)))
9538487	4	(ROOT (S (NP (PRP We)) (VP (VBP hypothesize) (SBAR (IN that) (S (SBAR (WHADVP (WRB when)) (S (NP (DT this) (NN man)) (VP (VBD developed) (NP (QP (CD Doc_9538487_586_590_Disease) (CD 2)) (NNS Doc_9538487_593_601_Disease))))) (, ,) (NP (NP (JJ chronic) (NNS Doc_9538487_611_619_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_9538487_627_657_Disease))))) (VP (VBD was) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB precipitate) (NP (NNS Doc_9538487_688_712_Disease)))))))))) (. .)))
9570197	0	(ROOT (S (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (DT the) (JJ intracoronary) (NN infusion)) (PP (IN of) (NP (NP (NNS Doc_9570197_41_48_Chemical)) (PP (IN on) (NP (NP (JJ left) (NN ventricular)) (ADJP (JJ systolic) (CC and) (JJ diastolic))))))))) (VP (VBP function) (PP (IN in) (NP (NNS humans)))) (. .)))
9570197	1	(ROOT (S (PP (IN In) (NP (NNS dogs))) (, ,) (NP (NP (DT a) (JJ large) (NN amount)) (PP (IN of) (NP (JJ intravenous) (NNS Doc_9570197_163_170_Chemical)))) (VP (VBZ causes) (NP (NP (NP (DT a) (JJ profound) (NN deterioration)) (PP (IN of) (NP (ADJP (JJ left)) (NN ventricular) (PRN (-LRB- -LRB-) (NP (NNP LV)) (-RRB- -RRB-)) (JJ systolic) (NN function)))) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NNP LV) (JJ end-diastolic) (NN pressure)))))) (. .)))
9570197	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN done) (S (VP (TO to) (VP (VB assess) (NP (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (NP (DT a) (JJ high) (JJ intracoronary) (JJ Doc_9570197_360_367_Chemical) (NN concentration)) (PP (IN on) (NP (NNP LV)))))) (ADJP (JJ systolic) (CC and) (JJ diastolic)) (NN function)) (PP (IN in) (NP (NNS humans)))))))) (. .)))
9570197	3	(ROOT (FRAG (NP (NNS METHODS) (CC AND) (NNS RESULTS)) (: :) (S (SBAR (IN In) (S (NP (NP (CD 20) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 14) (NNS men) (CC and) (CD 6) (NNS women)) (VP (VBN aged) (NP (QP (CD 39) (TO to) (CD 72)) (NNS years)))) (-RRB- -RRB-))) (VP (VBD referred) (PP (IN for) (NP (JJ cardiac) (NN catheterization))) (PP (IN for) (NP (NP (DT the) (NN evaluation)) (PP (IN of) (NP (NNS Doc_9570197_567_577_Disease)))))))) (, ,) (NP (PRP we)) (VP (VBD measured) (NP (NP (NP (NP (NN heart) (NN rate)) (, ,) (NP (JJ systemic) (JJ arterial) (NN pressure)) (, ,) (NP (NNP LV) (NN pressure)) (CC and) (NP (PRP$ its) (JJ first) (NN derivative))) (PRN (-LRB- -LRB-) (NP (NN dP/dt)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNP LV) (NNS volumes)) (CC and) (NP (NN ejection) (NN fraction)))) (PP (IN before) (CC and) (IN during) (NP (DT the) (JJ final) (QP (CD 2) (TO to) (CD 3)) (NNS minutes))) (PP (IN of) (NP (NP (NP (DT a) (JJ 15-minute) (NN intracoronary) (NN infusion)) (PP (IN of) (NP (NN saline)))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 10) (, ,) (NN control) (NNS subjects))))) (-RRB- -RRB-)) (CC or) (NP (NP (NNS Doc_9570197_833_854_Chemical)) (PRN (NP (CD 1) (NNS mg/min))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 10))))) (-RRB- -RRB-))))))) (. .)))
9570197	4	(ROOT (S (NP (DT No) (NN variable)) (VP (VBD changed) (PP (IN with) (NP (NN saline)))) (. .)))
9570197	5	(ROOT (S (PP (IN With) (NP (NNS Doc_9570197_910_917_Chemical))) (, ,) (NP (NP (DT the) (NN drug) (NN concentration)) (PP (IN in) (NP (NP (NN blood)) (VP (VBN obtained) (PP (IN from) (NP (DT the) (JJ coronary) (NNS sinus))))))) (VP (VBD was) (NP (NP (CD 3.0) (NNS +)) (PRN (: /) (S (NP (NP (NP (CD -0.4)) (PRN (-LRB- -LRB-) (NP (JJ mean) (JJ +) (NNS /)) (, -) (NP (NNP SD)) (-RRB- -RRB-))) (ADJP (JJ mg/L) (, ,) (JJ similar))) (PP (IN in) (NP (NN magnitude))))) (PP (TO to) (NP (NP (DT the) (NN blood) (NNS Doc_9570197_1050_1057_Chemical) (NN concentration)) (VP (VBN reported) (PP (IN in) (NP (NP (NNS abusers) (VBG dying)) (PP (IN of) (NP (JJ Doc_9570197_1101_1108_Chemical) (NN intoxication)))))))))) (. .)))
9570197	6	(ROOT (S (S (NP (NNP Doc_9570197_1123_1130_Chemical)) (VP (VBN induced) (NP (NP (DT no) (JJ significant) (NN change)) (PP (IN in) (NP (NP (NN heart) (NN rate)) (, ,) (NP (NNP LV) (NNP dP/dt)) (PRN (-LRB- -LRB-) (NP (JJ positive) (CC or) (JJ negative)) (-RRB- -RRB-)) (, ,) (CC or) (NP (NNP LV) (JJ end-diastolic) (NN volume))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBD caused) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ systolic) (CC and) (JJ mean) (NN arterial) (NNS pressures)) (, ,) (NP (NNP LV) (JJ end-diastolic) (NN pressure)) (, ,) (CC and) (NP (NNP LV) (JJ end-systolic) (NN volume))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NNP LV) (NN ejection) (NN fraction))))))) (. .)))
9570197	7	(ROOT (S (PP (IN In) (NP (NNS humans))) (, ,) (NP (NP (DT the) (JJ intracoronary) (NN infusion)) (PP (IN of) (NP (NP (NNS Doc_9570197_1460_1467_Chemical)) (ADJP (JJ sufficient) (PP (IN in) (NP (NN amount) (S (VP (TO to) (VP (VB achieve) (NP (DT a) (JJ high) (NN drug) (NN concentration)) (PP (IN in) (NP (JJ coronary) (NNS sinus) (NN blood)))))))))))) (VP (VBZ causes) (NP (NP (NP (DT a) (NN deterioration)) (PP (IN of) (NP (NNP LV)))) (ADJP (JJ systolic) (CC and) (JJ diastolic)) (NN performance))) (. .)))
9578276	0	(ROOT (S (NP (NP (VBG Ascending) (NN dose) (NN tolerance) (NN study)) (PP (IN of) (NP (NN intramuscular) (NNS Doc_9578276_48_58_Chemical)))) (VP (VBN administered) (PP (IN after) (NP (JJ normal) (JJ vaginal) (NN birth)))) (. .)))
9578276	1	(ROOT (S (S (VP (TO To) (VP (VB determine) (NP (DT the) (NN maximum))))) (VP (VBD tolerated) (NP (NP (NP (NN dose)) (PRN (-LRB- -LRB-) (NP (NNP MTD)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS Doc_9578276_160_170_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (JJ long-acting) (JJ synthetic) (NN analogue)) (PP (IN of) (NP (NNS Doc_9578276_208_216_Chemical)))) (-RRB- -RRB-))))) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (ADVP (RB immediately)) (PP (IN after) (NP (NP (JJ vaginal) (NN delivery)) (PP (IN at) (NP (NN term))))))))) (. .)))
9578276	2	(ROOT (NP (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (S (NP (NNS Doc_9578276_304_314_Chemical)) (VP (VBD was) (VP (VBN given) (PP (IN as) (NP (DT an) (NN intramuscular) (NN injection))) (PP (ADVP (RB immediately)) (IN after) (NP (NP (DT the) (NN birth)) (PP (IN of) (NP (NP (DT the) (NN infant)) (PP (IN in) (NP (NP (CD 45) (JJ healthy) (NNS women)) (PP (IN with) (NP (JJ normal) (NN singleton) (NNS pregnancies))))))) (SBAR (WHNP (WP who)) (S (VP (VBN delivered) (ADVP (RB vaginally)) (PP (IN at) (NP (NN term))))))))))) (. .)))
9578276	3	(ROOT (S (NP (NP (JJ Dosage) (NNS groups)) (PP (IN of) (NP (UCP (NP (CD 15)) (, ,) (NP (CD 30)) (, ,) (NP (CD 50)) (, ,) (NP (CD 75)) (, ,) (NP (CD 100)) (, ,) (NP (CD 125)) (, ,) (NP (CD 150)) (, ,) (NP (CD 175)) (CC or) (ADJP (NP (CD 200)) (JJ microg))) (NNS Doc_9578276_550_560_Chemical)))) (VP (VBD were) (VP (VBN assigned) (PP (TO to) (NP (NP (NNS blocks)) (PP (IN of) (NP (CD three) (NNS women))))) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (JJ continual) (NN reassessment) (NN method)) (PRN (-LRB- -LRB-) (NP (NNP CRM)) (-RRB- -RRB-))))))) (. .)))
9578276	4	(ROOT (S (NP (DT All) (NN dosage) (NNS groups)) (VP (VBD consisted) (PP (IN of) (NP (CD three) (NNS women))) (, ,) (PP (IN except) (NP (NP (NP (DT those)) (PP (IN with) (NP (CD 100) (NN microg)))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 6))))) (-RRB- -RRB-)) (CC and) (NP (NP (CD 200) (NN microg)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 18))))) (-RRB- -RRB-)))))) (. .)))
9578276	5	(ROOT (S (NP (NNP Recorded)) (VP (VBD were) (NP (NP (NP (JJ dose-limiting) (JJ adverse) (NNS events)) (: :) (ADJP (JJ hyper) (: -) (CC or) (JJ Doc_9578276_819_830_Disease))) (PRN (-LRB- -LRB-) (NP (CD three)) (-RRB- -RRB-)) (, ,) (NP (NP (JJ severe) (NNS Doc_9578276_847_861_Disease)) (PRN (-LRB- -LRB-) (NP (CD 0)) (-RRB- -RRB-)) (, ,) (NP (NP (NNS Doc_9578276_867_875_Disease)) (PRN (-LRB- -LRB-) (NP (CD 0)) (-RRB- -RRB-)))) (CC and) (NP (NP (VBG retained) (NN placenta)) (PRN (-LRB- -LRB-) (NP (CD four)) (-RRB- -RRB-))))) (. .)))
9578276	6	(ROOT (NP (NP (NP (JJ Serious) (JJ adverse) (NNS events)) (VP (VBN occurred) (PP (IN in) (NP (CD seven) (NNS women))))) (: :) (NP (NP (CD six) (NNS cases)) (PP (IN with) (NP (NP (NP (NNP Doc_9578276_973_983_Disease) (NNP >)) (CC or) (NP (NNP =) (CD 1000) (NN ml))) (, ,) (NP (NP (CD four) (NNS cases)) (PP (IN of) (NP (JJ manual) (NN placenta) (NN removal)))) (, ,) (NP (NP (CD five) (NNS cases)) (PP (IN of) (NP (JJ additional) (NNS oxytocics) (NN administration)))) (CC and) (NP (NP (CD five) (NNS cases)) (PP (IN of) (NP (NN blood) (NN transfusion))))))) (. .)))
9578276	7	(ROOT (S (NP (JJ Maximum) (NNS Doc_9578276_1134_1144_Disease)) (VP (VBD was) (NP (NP (NP (JJS greatest)) (PP (IN at) (NP (NP (DT the) (JJ upper)) (CC and) (NP (JJR lower) (NN dose) (NNS levels))))) (, ,) (CC and) (NP (NP (JJS lowest)) (PP (IN in) (NP (DT the) (CD 70-125) (NN microg) (NN dose) (NN range)))))) (. .)))
9578276	8	(ROOT (S (NP (NP (CD Four)) (PP (RB out) (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN with) (NP (NNP Doc_9578276_1265_1275_Disease) (NNPS >) (CC or) (NNP =) (NNP 1000) (NN ml)))))) (VP (VBD occurred) (PP (IN in) (NP (DT the) (CD 200) (NN microg) (NN group)))) (. .)))
9578276	9	(ROOT (S (NP (NP (DT The) (NN majority)) (PP (IN of) (NP (NP (JJ additional) (NN administration)) (PP (IN of) (NP (NP (NNS oxytocics)) (PRN (-LRB- -LRB-) (NP (CD 4/5)) (-RRB- -RRB-)) (CC and) (NP (NN blood) (NN transfusion)) (PRN (-LRB- -LRB-) (NP (CD 3/5)) (-RRB- -RRB-))))))) (VP (VBD occurred) (PP (IN in) (NP (NP (DT the) (NN dose) (NNS groups)) (PP (IN of) (NP (CD 200) (NN microg)))))) (. .)))
9578276	10	(ROOT (S (NP (DT All)) (VP (VBD retained) (SBAR (S (NP (NN placentae)) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NN group)) (PP (IN of) (NP (CD 200) (NN microg)))))))))) (. .)))
9578276	11	(ROOT (S (NP (DT The) (NNP MTD)) (VP (VBD was) (VP (VBN calculated) (S (VP (TO to) (VP (VB be) (PP (IN at) (NP (CD 200) (JJ microg) (NNS Doc_9578276_1574_1584_Chemical)))))))) (. .)))
9646784	0	(ROOT (NP (NP (JJ Doc_9646784_0_7_Chemical-induced) (NNS Doc_9646784_16_32_Disease)) (, ,) (NP (JJ paradoxical) (NNS Doc_9646784_46_61_Disease)) (, ,) (CC and) (NP (NP (JJ other) (NN side) (NNS effects)) (PP (IN of) (NP (JJ Doc_9646784_89_96_Chemical) (NN therapy)))) (. .)))
9646784	1	(ROOT (S (SBAR (IN Although) (S (NP (JJ several) (JJ new) (NN anticoagulant) (NNS drugs)) (VP (VBP are) (PP (IN in) (NP (NN development)))))) (, ,) (NP (NNS Doc_9646784_167_174_Chemical)) (VP (VBZ remains) (NP (NP (DT the) (NN drug)) (PP (IN of) (NP (NP (NN choice)) (PP (IN for) (NP (ADJP (RBS most) (JJ anticoagulation)) (NNS needs))))))) (. .)))
9646784	2	(ROOT (S (S (NP (NP (DT The) (JJ clinical) (NNS effects)) (PP (IN of) (NP (NNS Doc_9646784_258_265_Chemical)))) (VP (VBP are) (ADJP (JJ meritorious)))) (, ,) (CC but) (S (NP (NN side) (NNS effects)) (VP (VBP do) (VP (VB exist)))) (. .)))
9646784	3	(ROOT (S (NP (NP (JJ Important) (JJ untoward) (NNS effects)) (PP (IN of) (NP (NP (JJ Doc_9646784_340_347_Chemical) (NN therapy)) (PP (VBG including) (NP (NP (NN Doc_9646784_366_373_Chemical-induced) (NNS Doc_9646784_382_398_Disease)) (, ,) (NP (NN Doc_9646784_400_407_Chemical-associated) (NNS Doc_9646784_419_431_Disease)) (, ,) (NP (NNS Doc_9646784_433_445_Disease)) (, ,) (NP (NN skin) (NNS reactions)) (, ,) (NP (NP (NNS Doc_9646784_463_481_Disease)) (PP (JJ other) (IN than) (NP (NNS Doc_9646784_493_509_Disease) (CC and) (NNS Doc_9646784_514_522_Disease))))))))) (VP (MD will) (VP (VB be) (VP (VBN discussed) (PP (IN in) (NP (DT this) (NN article)))))) (. .)))
9725303	0	(ROOT (NP (NP (JJ Nonopaque) (NN crystal) (NN deposition)) (VP (VBG causing) (NP (NP (NNS Doc_9725303_37_57_Disease)) (PP (IN in) (NP (NNS patients)))) (PP (IN with) (NP (NP (NNS Doc_9725303_75_78_Disease)) (VP (VBG undergoing) (NP (JJ Doc_9725303_90_99_Chemical) (NN therapy)))))) (. .)))
9725303	1	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT the) (JJ unique) (NNP CT) (NNS features)) (PP (IN of) (NP (JJ ureteric) (NNS calculi)))) (PP (IN in) (NP (NP (CD six) (JJ Doc_9725303_182_194_Disease) (NNS patients)) (VP (VBG receiving) (NP (NP (NNS Doc_9725303_214_223_Chemical)) (, ,) (NP (DT the) (ADJP (RBS most) (RB commonly) (VBN used)) (NN Doc_9725303_248_251_Disease) (NN protease) (NN inhibitor)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (NNS Doc_9725303_323_335_Disease)))))))))))))) (. .)))
9725303	2	(ROOT (S (NP (NP (NNP Doc_9725303_349_369_Disease)) (VP (VBN caused) (PP (IN by) (NP (JJ precipitated) (JJ Doc_9725303_393_402_Chemical) (NNS crystals))))) (VP (MD may) (VP (VB be) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB diagnose) (PP (IN with) (NP (JJ unenhanced) (NNP CT.))))))))) (. .)))
9725303	3	(ROOT (S (S (NP (DT The) (NNS calculi)) (VP (VBP are) (RB not) (ADJP (JJ opaque)))) (, ,) (CC and) (S (NP (NP (JJ secondary) (NNS signs)) (PP (IN of) (NP (NNS Doc_9725303_512_523_Disease)))) (VP (VP (MD may) (VP (VB be) (ADJP (JJ absent) (CC or) (JJ minimal)))) (CC and) (VP (MD should) (VP (VB be) (VP (VBN sought) (ADVP (RB carefully))))))) (. .)))
9725303	4	(ROOT (S (NP (NNS Images)) (VP (MD may) (VP (VB need) (S (VP (TO to) (VP (VB be) (VP (VBN obtained) (S (VP (VBG using) (NP (JJ i.v.) (NN contrast) (NN material)) (S (VP (TO to) (VP (VB enable) (NP (NP (NN diagnosis)) (PP (IN of) (NP (NP (NNS Doc_9725303_664_694_Disease)) (PP (IN in) (NP (NNS patients)))))) (PP (IN with) (NP (NP (NNS Doc_9725303_712_725_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBP receive) (NP (JJ Doc_9725303_738_747_Chemical) (NN therapy)))))))))))))))))) (. .)))
9759693	0	(ROOT (S (NP (NNS Doc_9759693_0_16_Disease) (CC and) (NNS Doc_9759693_21_32_Chemical)) (VP (VBP use)) (. .)))
9759693	1	(ROOT (S (NP (NP (NNP Doc_9759693_38_59_Chemical)) (, ,) (NP (DT a) (JJ Doc_9759693_63_74_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_9759693_76_95_Chemical-1)) (-RRB- -RRB-)) (NN receptor) (NN agonist)) (, ,)) (VP (VBZ is) (NP (NP (DT an) (JJ antimigraine) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN reported) (S (VP (TO to) (VP (VB act) (PP (IN by) (S (ADVP (RB selectively)) (VP (VBG constricting) (NP (JJ intracranial) (NNS arteries)))))))))))))) (. .)))
9759693	2	(ROOT (S (ADVP (RB Recently)) (, ,) (NP (NP (NN vasopressor) (NNS responses)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ distinct) (PP (IN from) (NP (DT the) (JJ cranial) (NN circulation)))))))) (VP (VBP have) (VP (VBN been) (VP (VBN demonstrated) (S (VP (TO to) (VP (VB occur) (PP (IN in) (NP (NP (DT the) (JJ systemic) (, ,) (NNP pulmonary) (, ,)) (CC and) (NP (JJ coronary) (NNS circulations)))))))))) (. .)))
9759693	3	(ROOT (S (NP (NNS Cases)) (VP (VBP have) (VP (VBN been) (VP (VBN published) (PP (IN of) (NP (NNS Doc_9759693_411_429_Disease) (, ,) (NNS Doc_9759693_431_450_Disease) (, ,) (CC and) (NNS Doc_9759693_456_477_Disease))) (S (VP (VBG occurring) (PP (IN after) (NP (JJ Doc_9759693_494_505_Chemical) (NN use)))))))) (. .)))
9759693	4	(ROOT (S (NP (PRP We)) (VP (VBP report) (PP (IN on) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (CD 8) (JJ serious) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_9759693_562_578_Disease)) (PP (IN in) (NP (NNS patients))))))))) (PP (IN with) (NP (NP (NNS Doc_9759693_596_604_Disease)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_9759693_618_629_Chemical))))))) (. .)))
9782254	0	(ROOT (S (ADVP (ADVP (RB Pallidotomy)) (PP (IN with) (FRAG (NP (NP (DT the) (NN gamma) (NN knife)) (: :) (NP (DT a) (JJ positive) (NN experience)) (. .))))) (NP (NP (CD 51) (NNS patients)) (PP (IN with) (NP (JJ medically) (JJ refractory) (NNS Doc_9782254_95_114_Disease)))) (VP (VP (VBD underwent) (NP (NP (JJ stereotactic) (JJ posteromedial) (NN pallidotomy)) (PP (IN between) (NP (NNP August) (CD 1993))))) (CC and) (VP (NP (NNP February) (CD 1997)) (PP (IN for) (NP (NP (NN treatment)) (PP (IN of) (NP (NNS Doc_9782254_219_231_Disease) (, ,) (NNS Doc_9782254_233_241_Disease) (, ,) (CC and) (NN Doc_9782254_247_253_Chemical-induced) (NNS Doc_9782254_262_273_Disease))))))) (. .)))
9782254	1	(ROOT (S (PP (IN In) (NP (CD 29) (NNS patients))) (, ,) (S (NP (DT the) (NNS pallidotomies)) (VP (VBD were) (VP (VBN performed) (PP (IN with) (NP (DT the) (NNP Leksell) (NNP Gamma) (NNP Knife)))))) (CC and) (S (PP (IN in) (NP (CD 22))) (NP (PRP they)) (VP (VBD were) (VP (VBN performed) (PP (IN with) (NP (DT the) (JJ standard) (JJ radiofrequency) (PRN (-LRB- -LRB-) (NP (NNP RF)) (-RRB- -RRB-)) (NN method)))))) (. .)))
9782254	2	(ROOT (S (NP (NP (JJ Clinical) (NN assessment)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ blinded) (NNS ratings)) (PP (IN of) (NP (NNP Unified) (NNP Doc_9782254_487_506_Disease) (NNP Rating) (NNP Scale) (PRN (-LRB- -LRB-) (NP (NNP UPDRS)) (-RRB- -RRB-)) (NNS scores))))) (VP (VBD were) (VP (VBN carried) (PP (IN out) (NP (NN pre) (: -) (CC and) (NN postoperatively))))) (. .)))
9782254	3	(ROOT (S (NP (NP (NN Mean) (NN follow-up) (NN time)) (SBAR (S (VP (VBZ is) (NP (NP (CD 20.6) (NNS months) (PRN (-LRB- -LRB-) (NP (NN range) (CD 6-48)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT all)) (SBAR (IN except) (S (NP (CD 4) (NNS patients)) (VP (VBP have) (VP (VBN been) (VP (VBN followed) (NP (QP (JJR more) (IN than) (CD one)) (NN year)))))))) (. .) (NP (NP (CD 85) (NN percent)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_9782254_719_730_Disease)))))))))))) (VP (VBD were) (VP (VBN relieved) (PP (IN of) (NP (NNS symptoms))) (, ,) (ADVP (RB regardless) (PP (IN of) (SBAR (IN whether) (S (NP (DT the) (NNS pallidotomies)) (VP (VBD were) (VP (VBN performed) (PP (IN with) (NP (NP (DT the) (NNP Gamma) (NNP Knife)) (CC or) (NP (JJ radiofrequency) (NNS methods)))))))))))) (. .)))
9782254	4	(ROOT (S (NP (NP (QP (RB About) (CD 2/3))) (PP (IN of) (NP (NP (DT the) (NNS patients)) (PP (IN in) (NP (NP (DT both) (NNP Gamma) (NNP Knife)) (CC and) (NP (JJ radiofrequency) (NNS groups))))))) (VP (VBD showed) (NP (NP (NP (NNS improvements)) (PP (IN in) (NP (NNS Doc_9782254_956_968_Disease) (CC and) (NNS Doc_9782254_973_981_Disease))) (, ,) (SBAR (IN although) (FRAG (WHADVP (WRB when))))) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (NN group)) (SBAR (S (NP (CC neither) (NP (DT the) (NNP Gamma) (NNP Knife)) (CC nor) (NP (DT the) (JJ radiofrequency) (NN group))) (VP (VBD showed) (NP (ADJP (RB statistically) (JJ significant)) (NNS improvements)) (PP (IN in) (NP (NNP UPDRS) (NNS scores))))))))))) (. .)))
9782254	5	(ROOT (S (NP (NP (NP (CD One) (NN patient)) (PP (IN in) (NP (DT the) (NNP Gamma) (NNP Knife) (NN group)))) (PRN (-LRB- -LRB-) (NP (CD 3.4) (NN %)) (-RRB- -RRB-))) (VP (VBD developed) (SBAR (S (S (NP (DT a) (NNS homonymous)) (VP (VBZ Doc_9782254_1202_1213_Disease) (NP (NP (CD 9) (NNS months)) (PP (VBG following) (NP (NN treatment)))))) (CC and) (S (NP (NP (NP (CD 5) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 27.7) (NN %)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (JJ radiofrequency) (NN group)))) (VP (VBD became) (NP (ADJP (RB transiently) (VBN confused)) (NN postoperatively))))))) (. .)))
9782254	6	(ROOT (S (NP (DT No) (JJ other) (NNS complications)) (VP (VBD were) (VP (VBN seen))) (. .)))
9782254	7	(ROOT (S (NP (NNP Gamma) (NNP Knife)) (ADVP (RB pallidotomy)) (VP (VBZ is) (ADJP (RB as) (JJ effective) (PP (IN as) (ADJP (ADJP (RB radiofrequency) (JJ pallidotomy)) (PP (IN in) (S (VP (VBG controlling) (NP (NP (JJ certain)) (PP (IN of) (NP (NP (DT the) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_9782254_1485_1504_Disease))))))))))))) (. .)))
9782254	8	(ROOT (S (NP (PRP It)) (VP (MD may) (VP (VB be) (NP (NP (DT the) (ADJP (RB only) (JJ practical)) (NN technique)) (ADJP (JJ available) (PP (IN in) (NP (JJ certain) (NNS patients)))))) (, ,) (PP (JJ such) (IN as) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP take) (NP (NNS anticoagulants))))))) (, ,) (VP (VB have) (NP (NP (JJ Doc_9782254_1620_1628_Disease) (NNS diatheses)) (CC or) (NP (JJ serious) (JJ systemic) (JJ medical) (NNS illnesses))))) (. .)))
9782254	9	(ROOT (S (NP (PRP It)) (VP (VBZ is) (NP (NP (DT a) (JJ viable) (NN option)) (PP (IN for) (NP (JJ other) (NNS patients)))) (ADVP (RB as) (RB well))) (. .)))
978847	0	(ROOT (S (NP (NNP Centrally)) (VP (VBD mediated) (NP (NP (JJ cardiovascular) (NNS effects)) (PP (IN of) (NP (NP (JJ intracisternal) (NN application)) (PP (IN of) (NP (NNS Doc_978847_75_84_Chemical)))))) (PP (IN in) (NP (JJ anesthetized) (NNS rats)))) (. .)))
978847	1	(ROOT (S (NP (NP (DT The) (NN pressor) (NN response)) (PP (TO to) (NP (DT the) (JJ intracisternal) (PRN (-LRB- -LRB-) (NP (NNP i.c.)) (-RRB- -RRB-)) (NN injection))) (PP (IN of) (NP (NP (NP (NNS Doc_978847_170_179_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (CD mug))) (-RRB- -RRB-))) (PP (IN in) (NP (JJ anesthetized) (NNS rats)))))) (VP (VBD was) (VP (VBN analyzed))) (. .)))
978847	2	(ROOT (S (S (NP (DT This) (NN response)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN reduced) (PP (IN by) (NP (DT the) (JJ intravenous) (PRN (-LRB- -LRB-) (NP (NNP i.v.)) (-RRB- -RRB-)) (NN injection))) (PP (IN of) (NP (NP (NP (NNS Doc_978847_302_314_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 5) (CD mg))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_978847_323_336_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 10) (CD mg))) (-RRB- -RRB-))) (CC or) (NP (NP (NNS Doc_978847_348_360_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 5) (CD mg))) (-RRB- -RRB-)))))))) (, ,) (CC and) (ADVP (RB conversely)) (, ,) (S (ADJP (JJ potentiated) (PP (IN by) (NP (NP (NN i.v.) (NNS Doc_978847_405_424_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.3) (NNS mg)) (-RRB- -RRB-)))))) (, ,) (SBAR (IN while) (S (NP (JJ Doc_978847_441_452_Chemical) (PRN (-LRB- -LRB-) (NP (QP (CD 0.5) (CD mg))) (-RRB- -RRB-)) (NNS i.v.)) (ADVP (RB selectively)) (VP (VBD inhibited) (NP (NP (NP (DT the) (NN enlargement)) (PP (IN of) (NP (NN pulse) (NN pressure)))) (CC and) (NP (NP (DT the) (NNS Doc_978847_531_542_Disease)) (PP (VBG following) (NP (NP (NN i.c.) (NNS Doc_978847_558_567_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (CD mug))) (-RRB- -RRB-))))))))) (. .)))
978847	3	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NP (NP (DT the) (NN pressor) (NN response)) (PP (TO to) (NP (NN i.c.) (NNS Doc_978847_625_634_Chemical)))) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (CD mug))) (-RRB- -RRB-))) (VP (VBD was) (ADVP (RB almost) (RB completely)) (VP (VP (VBN blocked) (PP (IN by) (NP (NP (NN i.c.) (NNS Doc_978847_681_689_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 3) (CD mug))) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_978847_701_714_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 500) (CD mug))) (-RRB- -RRB-))))) (, ,) (CC and) (ADVP (RB significantly)) (VP (VP (VBN reduced) (PP (IN by) (NP (NP (NN i.c.) (NNS Doc_978847_760_774_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 50) (CD mug))) (-RRB- -RRB-))))) (CC but) (VP (ADVP (RB significantly)) (VBN potentiated) (PP (IN by) (NP (NP (NN i.c.) (NNS Doc_978847_822_841_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 30) (CD mug))) (-RRB- -RRB-)))))))) (. .)))
978847	4	(ROOT (S (NP (NP (NP (DT The) (NN pressor) (NN response)) (PP (TO to) (NP (NN i.c.) (NNS Doc_978847_881_890_Chemical)))) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (CD mug))) (-RRB- -RRB-))) (VP (VP (VBD remained) (ADJP (JJ unchanged) (PP (IN after) (S (VP (VBG sectioning) (PP (IN of) (NP (DT the) (JJ bilateral) (JJ cervical) (JJ vagal) (NNS nerves)))))))) (CC but) (VP (VBD disappeared) (PP (IN after) (NP (NP (NN sectioning)) (PP (IN of) (NP (NP (DT the) (JJ spinal) (NN cord)) (PRN (-LRB- -LRB-) (NP (NNP C7-C8)) (-RRB- -RRB-)))))))) (. .)))
978847	5	(ROOT (S (PP (IN From) (NP (DT the) (JJ above) (NN result))) (NP (PRP it)) (VP (VBZ is) (VP (VBN suggested) (SBAR (SBAR (IN that) (S (NP (DT the) (NN pressor) (NN response)) (VP (TO to) (VP (VB i.c.) (NP (JJ Doc_978847_1107_1116_Chemical) (JJ ortral) (CC and) (JJ peripheral) (NN adrenergic) (NNS mechanisms)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (DT the) (JJ sympathetic) (NN trunk)) (VP (VBZ is) (NP (DT the) (JJ main) (NN pathway)))))))) (. .)))
9831002	0	(ROOT (S (VP (VB Doc_9831002_0_30_Disease) (CC and) (VB Doc_9831002_35_50_Chemical)) (. .)))
9831002	1	(ROOT (S (NP (NP (DT A) (JJ 1-year-old) (NN female)) (VP (VBN presented) (PP (IN with) (NP (NNS Doc_9831002_87_117_Disease))))) (ADVP (RB probably)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_9831002_137_152_Chemical)))) (. .)))
9831002	2	(ROOT (S (NP (PRP She)) (VP (VBD had) (NP (NP (NNS defects)) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ supratentorial) (NN brain)) (PP (VBG including) (NP (NP (DT the) (JJ basal) (NN ganglia)) (CC and) (NP (DT the) (NN striatum))))) (-LRB- -LRB-) (NP (JJ multicystic) (NNS Doc_9831002_256_272_Disease)) (-RRB- -RRB-)) (ADJP (JJ due) (PP (TO to) (NP (JJ severe) (JJ perinatal) (NNS Doc_9831002_298_329_Disease)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ possible) (NN predisposing) (NN factor)) (VP (VBG causing) (NP (NNS Doc_9831002_397_427_Disease))))))))))))))) (. .)))
9831002	3	(ROOT (S (NP (DT A) (JJ dopaminergic) (NN blockade) (NN mechanism)) (ADVP (RB generally)) (VP (VBZ is) (VP (VBN accepted) (PP (IN as) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (DT this) (NN syndrome))))))) (. .)))
9831002	4	(ROOT (S (ADVP (RB However)) (, ,) (S (NP (NNS Doc_9831002_532_547_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ Doc_9831002_553_561_Chemical) (NN agonist)) (PP (IN via) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (NN uptake)) (PP (IN of) (NP (NNS Doc_9831002_602_610_Chemical)))))))))) (, ,) (CC and) (ADVP (RB therefore)) (S (NP (NP (JJ dopaminergic) (NNS systems)) (PP (IN in) (NP (NP (NP (DT the) (NN brainstem)) (-LRB- -LRB-) (NP (RB mainly) (DT the) (NN midbrain)) (-RRB- -RRB-)) (CC and) (NP (DT the) (JJ spinal) (NN cord))))) (VP (VBD were) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (DT this) (NN syndrome))))))))))) (. .)))
9831002	5	(ROOT (S (NP (DT A) (JJ relative) (NN Doc_9831002_777_800_Chemical-ergic) (NN deficiency)) (VP (MD might) (VP (VB occur) (SBAR (IN because) (S (NP (NP (NNS Doc_9831002_838_846_Chemical)) (, ,) (NP (DT a) (NN Doc_9831002_850_873_Chemical-mimetic) (NN agent)) (, ,)) (VP (VBD was) (ADJP (RB strikingly) (JJ effective))))))) (. .)))
9831002	6	(ROOT (S (NP (DT This)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (JJ reported) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_9831002_955_985_Disease)) (VP (ADVP (RB probably)) (VBN caused) (PP (IN by) (NP (NNS Doc_9831002_1005_1020_Chemical)))))))) (. .)))
9869655	0	(ROOT (NP (NP (JJ Differential) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_9869655_24_48_Chemical)) (PP (IN on) (NP (NP (DT the) (ADJP (JJ neutral) (CC and) (JJ acidic)) (NNS pathways)) (PP (IN of) (NP (JJ Doc_9869655_87_96_Chemical) (NN synthesis))))))) (PP (IN in) (NP (DT the) (NN rat))) (. .)))
9869655	1	(ROOT (S (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (NP (NNS Doc_9869655_130_154_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9869655_156_158_Chemical)) (-RRB- -RRB-))) (PP (IN on) (NP (DT the) (UCP (ADJP (JJ neutral)) (CC and) (NP (NP (JJ acidic) (JJ biosynthetic) (NNS pathways)) (PP (IN of) (NP (NP (NNS Doc_9869655_211_220_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP BS)) (-RRB- -RRB-)))))) (NN synthesis)))))) (VP (VBD were) (VP (VBN evaluated) (PP (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (DT an) (ADJP (JJ intact) (JJ enterohepatic)) (NN circulation))))) (CC and) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (JJ long-term) (NN bile) (NN diversion)))))) (S (VP (TO to) (VP (VB induce) (NP (NNP BS) (NN synthesis))))))) (. .)))
9869655	2	(ROOT (S (PP (IN For) (NP (DT this) (NN purpose))) (, ,) (NP (NP (JJ Doc_9869655_384_393_Chemical) (NN pool) (NN composition)) (, ,) (NP (NP (NN synthesis)) (PP (IN of) (NP (NP (JJ individual) (NN BS)) (PP (PP (IN in) (NP (NP (NN vivo)) (, ,) (NP (JJ hepatic) (NNS activities)) (, ,) (CC and) (NP (NP (NN expression) (NNS levels)) (PP (IN of) (NP (NP (NP (NNS Doc_9869655_493_504_Chemical)) (ADJP (ADJP (ADJP (JJ 7alpha-hydroxylase)) (PRN (-LRB- -LRB-) (NP (NNP CYP7A)) (-RRB- -RRB-))) (, ,) (CC and) (ADJP (RB Doc_9869655_537_543_Chemical) (JJ 27-hydroxylase)))) (PRN (-LRB- -LRB-) (NP (NNP CYP27)) (-RRB- -RRB-))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN of) (NP (JJ other) (NNS enzymes)))))) (VP (VBN involved) (PP (IN in) (NP (NNP BS) (NNP synthesis))))) (, ,)) (VP (VBD were) (VP (VBN analyzed) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NNS Doc_9869655_657_659_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN mg/kg)) (, ,) (NP (CD 3) (NNS days))) (-RRB- -RRB-))) (CC or) (NP (PRP$ its) (NN vehicle))))))))) (. .)))
9869655	3	(ROOT (S (S (NP (NNP BS) (NN pool) (NN size)) (VP (VBD was) (VP (VBN decreased) (PP (IN by) (NP (CD 27) (NN %)))))) (CC but) (S (NP (JJ total) (NN BS) (NN synthesis)) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NNS Doc_9869655_771_773_Chemical)) (PP (IN in) (NP (JJ intact) (NNS rats)))))))) (. .)))
9869655	4	(ROOT (S (NP (NP (NNS Synthesis)) (PP (IN of) (NP (NN cholate)))) (VP (VBD was) (VP (VBN reduced) (PP (IN by) (NP (NP (CD 68) (NN %)) (PP (IN in) (NP (NN Doc_9869655_833_835_Chemical-treated) (NNS rats))))) (, ,) (SBAR (IN while) (S (NP (NP (DT that)) (PP (IN of) (NP (NNS Doc_9869655_864_881_Chemical)))) (VP (VBD was) (VP (VBN increased) (PP (IN by) (NP (CD 60) (NN %))))))))) (. .)))
9869655	5	(ROOT (S (NP (NP (DT The) (ADJP (RB recently) (VBN identified)) (NN Delta22-isomer)) (PP (IN of) (NP (NN beta-muricholate)))) (VP (VP (VBD contributed) (PP (IN for) (NP (NP (QP (CD 5.4) (NN %) (CC and) (CD 18.3) (NN %))) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT the) (NN pool)) (PP (IN in) (NP (NN control) (CC and) (NN Doc_9869655_1033_1035_Chemical-treated) (NNS rats))))) (, ,) (ADVP (RB respectively))) (, ,) (CC but) (VP (MD could) (RB not) (VP (VB be) (VP (VBN detected) (PP (IN in) (NP (NN bile))) (PP (IN after) (NP (NP (NN exhaustion)) (PP (IN of) (NP (DT the) (NN pool))))))))) (. .)))
9869655	6	(ROOT (S (S (NP (NP (DT A) (JJ clear) (NN reduction)) (PP (IN of) (NP (NNP BS) (NNP synthesis)))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (JJ bile-diverted) (NNS rats)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_9869655_1207_1209_Chemical))))))))) (, ,) (CC yet) (S (ADVP (RB biliary)) (NP (NNP BS) (NNP composition)) (VP (VBD was) (ADVP (RB only)) (VP (ADVP (RB minimally)) (VBN affected)))) (. .)))
9869655	7	(ROOT (S (NP (NP (NN Activity)) (PP (IN of) (NP (NNP CYP7A)))) (VP (VBD was) (VP (VBN decreased) (PP (IN by) (NP (NP (NNS Doc_9869655_1302_1304_Chemical)) (PP (IN in) (NP (ADJP (DT both) (JJ intact) (CC and) (JJ bile-diverted)) (NNS rats))))) (, ,) (SBAR (IN whereas) (S (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT the) (NN CYP27)))) (VP (VBD was) (RB not) (VP (VBN affected))))))) (. .)))
9869655	8	(ROOT (S (S (NP (NP (JJ Hepatic) (NN mRNA) (NNS levels)) (PP (IN of) (NP (NNP CYP7A)))) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN reduced) (PP (IN by) (NP (NP (NNS Doc_9869655_1455_1457_Chemical)) (PP (IN in) (NP (JJ bile-diverted) (NNS rats))))) (ADVP (RB only))))) (: ;) (S (NP (NNP CYP27) (NN mRNA) (NNS levels)) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NNS Doc_9869655_1525_1527_Chemical)))))) (. .)))
9869655	9	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN mRNA) (NNS levels)) (PP (IN of) (NP (JJ Doc_9869655_1557_1563_Chemical) (ADJP (JJ 12alpha-hydroxylase) (CC and) (JJ lithocholate)) (NNS 6beta-hydroxylase)))) (VP (VBD were) (VP (VP (VBN increased) (PP (IN by) (NP (NN bile) (NN diversion)))) (CC and) (VP (VBN suppressed) (PP (IN by) (NP (NNS Doc_9869655_1670_1672_Chemical)))))) (. .)))
9869655	10	(ROOT (S (S (NP (DT This) (NN study)) (VP (VBZ shows) (NP (NP (DT that) (NNS Doc_9869655_1696_1720_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9869655_1722_1724_Chemical)) (-RRB- -RRB-))))) (: -) (S (NP (NP (JJ induced) (NNS Doc_9869655_1734_1758_Disease)) (PP (IN in) (NP (NNS rats)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ selective) (NN inhibition)) (PP (IN of) (NP (NP (DT the) (JJ neutral) (NN pathway)) (PP (IN of) (NP (NNP Doc_9869655_1833_1842_Chemical) (PRN (-LRB- -LRB-) (NP (NNP BS)) (-RRB- -RRB-)) (NN synthesis)))))))))) (. .)))
9869655	11	(ROOT (S (NP (NP (JJ Simultaneous) (NN impairment)) (PP (IN of) (NP (NP (JJ other) (NNS enzymes)) (PP (IN in) (NP (DT the) (NNP BS) (JJ biosynthetic) (NN pathways)))))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (JJ overall) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_9869655_1969_1971_Chemical)) (PP (IN on) (NP (NNP BS) (NNP synthesis))))))))) (. .)))
9881641	0	(ROOT (S (NP (JJ Doc_9881641_0_13_Chemical-sensitive) (NNS Doc_9881641_24_35_Disease)) (VP (VBD produced) (PP (IN by) (NP (NP (NNS Doc_9881641_48_58_Chemical)) (VP (VBN assessed) (PP (IN in) (NP (DT the) (NN rat))))))) (. .)))
9881641	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_9881641_95_105_Chemical)) (, ,) (NP (NP (DT a) (JJ basic) (JJ 35-Doc_9881641_118_128_Chemical) (NN peptide)) (VP (VBN isolated) (PP (IN from) (NP (NP (DT the) (NN venom)) (PP (IN of) (NP (DT a) (JJ lizard) (NN salivary) (NN gland))))) (, ,) (PP (IN on) (NP (JJ arterial) (NN blood) (NN pressure) (CC and) (NN heart) (NN rate)))))))) (VP (VBD were) (VP (VBN examined) (PP (IN in) (NP (DT the) (NN rat))) (, ,) (S (VP (VBG focusing) (PP (IN on) (NP (DT the) (NN possibility))) (NP (NP (DT that) (NN activation)) (PP (IN of) (NP (NP (NP (JJ Doc_9881641_304_307_Chemical) (JJ sensitive) (JJ Doc_9881641_318_319_Chemical) (NNS +)) (-LRB- -LRB-) (NP (NNS Doc_9881641_322_323_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9881641_324_327_Chemical)) (-RRB- -RRB-)) (-RRB- -RRB-)) (SBAR (S (NP (NNS channels)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (DT the) (NNS responses)))))))))))))) (. .)))
9881641	2	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD were) (ADVP (RB also)) (PP (VBN compared) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (NP (JJ vasoactive) (JJ intestinal) (NN polypeptide)) (PRN (-LRB- -LRB-) (NP (NNP VIP)) (-RRB- -RRB-)))))))) (. .)))
9881641	3	(ROOT (S (NP (NNP Doc_9881641_455_465_Chemical)) (VP (VBD produced) (NP (NNS Doc_9881641_475_486_Disease)) (PP (IN in) (NP (NP (DT a) (JJ dose-dependent) (NN manner)) (PP (IN with) (NP (ADJP (RB approximately) (JJ similar)) (NN potency) (CC and) (NN duration))))) (PP (TO to) (NP (NNP VIP)))) (. .)))
9881641	4	(ROOT (S (NP (NP (NNP Doc_9881641_570_581_Disease)) (VP (VBN induced) (PP (IN by) (NP (DT both) (NNS peptides))))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN attenuated) (PP (IN by) (NP (NP (NNS Doc_9881641_639_652_Chemical)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD abolished) (NP (DT a) (JJ levcromakalim-produced) (NN decrease)) (PP (IN in) (NP (JJ arterial) (NN blood) (NN pressure)))))))))) (. .)))
9881641	5	(ROOT (S (NP (NNP Oxyhemoglobin)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN Doc_9881641_761_771_Chemical-induced) (NNS Doc_9881641_780_791_Disease)) (, ,) (SBAR (IN whereas) (S (NP (PRP it)) (VP (VBN shortened) (S (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (NNS Doc_9881641_830_843_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9881641_845_848_Chemical)) (-RRB- -RRB-))))) (: -) (VP (VBD produced) (NP (NNS Doc_9881641_859_870_Disease))))))))) (. .)))
9881641	6	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN Doc_9881641_900_910_Chemical-produced) (NNS Doc_9881641_920_931_Disease)) (VP (VBZ is) (ADVP (RB partly)) (NP (NP (ADJP (JJ attributable) (PP (TO to) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN Doc_9881641_976_989_Chemical-sensitive) (NNS Doc_9881641_1000_1002_Chemical)))))) (NNS channels)) (PRN (-LRB- -LRB-) (NP (NP (JJ Doc_9881641_1013_1014_Chemical) (-LRB- -LRB-) (NNS Doc_9881641_1015_1018_Chemical) (-RRB- -RRB-)) (NP (NNS channels))) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB presumably)) (VP (VBP exist) (PP (IN on) (NP (JJ arterial) (JJ smooth) (NN muscle) (NNS cells))))))))))) (. .)))
9881641	7	(ROOT (S (NP (JJ EDRF) (PRN (-LRB- -LRB-) (NP (JJ endothelium-derived) (JJ relaxing) (NN factor)) (-RRB- -RRB-)) (JJ /) (NNS Doc_9881641_1130_1142_Chemical)) (VP (VBZ does) (RB not) (VP (VB seem) (S (VP (TO to) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (DT the) (JJ peptide-produced) (NNS Doc_9881641_1207_1218_Disease)))))))) (. .)))
9889429	0	(ROOT (NP (NP (JJ Long-term) (NN efficacy) (CC and) (JJ adverse) (NN event)) (PP (IN of) (NP (JJ Doc_9889429_40_50_Chemical) (JJ sustained-release) (NNS tablets))) (PP (IN for) (NP (NN Doc_9889429_81_94_Chemical-induced) (NNS Doc_9889429_103_115_Disease))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_9889429_133_142_Disease))))) (. .)))
9889429	1	(ROOT (S (NP (NP (JJ Thirteen) (JJ Doc_9889429_153_162_Disease) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_9889429_177_189_Disease)) (PP (IN during) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (JJ Doc_9889429_211_224_Chemical) (NN therapy)))))))) (VP (VBD were) (VP (VBN treated) (PP (IN for) (NP (NP (CD 25) (NNS months)) (PP (IN with) (NP (NP (DT a) (JJ Doc_9889429_267_274_Chemical) (NN channel) (NN blocker)) (, ,) (NP (JJ sustained-release) (NNS Doc_9889429_310_320_Chemical)) (, ,))))) (S (VP (TO to) (VP (VB study) (NP (NP (DT the) (JJ clinical) (JJ antihypertensive) (NNS effects)) (CC and) (NP (JJ adverse) (NNS events))) (PP (IN during) (NP (NN treatment))) (PP (IN with) (NP (DT both) (NNS drugs)))))))) (. .)))
9889429	2	(ROOT (S (NP (NP (CD Seven)) (PP (IN of) (NP (DT the) (CD 13) (NNS patients)))) (VP (VBD had) (VP (VBN exhibited) (NP (DT a) (JJ subclinical) (JJ Doc_9889429_475_487_Disease) (NN state)) (PP (IN before) (NP (JJ Doc_9889429_501_514_Chemical) (NN therapy))))) (. .)))
9889429	3	(ROOT (S (S (NP (NP (DT Both) (ADJP (JJ systolic) (CC and) (JJ diastolic)) (NN blood) (NNS pressures)) (PP (IN of) (NP (DT these) (CD 13) (NNS patients)))) (VP (VBD were) (VP (VBN decreased) (ADVP (RB significantly)) (PP (IN after) (NP (NP (CD 4) (NNS weeks)) (PP (IN of) (NP (JJ Doc_9889429_635_645_Chemical) (NN therapy)))))))) (, ,) (CC and) (S (NP (NN blood) (NN pressure)) (VP (VBD was) (VP (VBN maintained) (PP (IN within) (NP (DT the) (JJ normal) (NN range))) (PP (ADVP (RB thereafter)) (IN for) (NP (CD 25) (NNS months)))))) (. .)))
9889429	4	(ROOT (S (NP (NP (DT The) (JJ adverse) (NNS events)) (PP (IN during) (NP (NP (VBN combined) (NN therapy)) (PP (IN with) (NP (NNS Doc_9889429_787_800_Chemical) (CC and) (NNS Doc_9889429_805_815_Chemical)))))) (VP (VBD included) (NP (DT an) (NN increase)) (PP (IN in) (NP (NN blood) (NNS Doc_9889429_846_859_Chemical) (NNS levels))) (PP (IN in) (NP (NP (NP (CD 9)) (PP (IN of) (NP (DT the) (CD 13) (NNS patients)))) (CC and) (NP (NP (NN development)) (PP (IN of) (NP (NP (NNS Doc_9889429_910_930_Disease)) (PP (IN in) (NP (CD 2))))) (PP (IN of) (NP (DT the) (CD 13) (NNS patients))))))) (. .)))
9889429	5	(ROOT (S (NP (PRP$ Our) (NNS findings)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (JJ sustained-release) (NNS Doc_9889429_1001_1011_Chemical)) (VP (VBZ is) (ADJP (JJ useful) (PP (IN for) (NP (JJ Doc_9889429_1026_1038_Disease) (JJ Doc_9889429_1039_1048_Disease) (NNS patients)))) (PP (IN under) (NP (NP (JJ long-term) (NN treatment)) (PP (IN with) (NP (NNS Doc_9889429_1089_1102_Chemical)))))))) (, ,) (CC but) (SBAR (IN that) (S (NP (DT these) (NNS patients)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (PP (IN for) (NP (NNS Doc_9889429_1152_1172_Disease)))))))))) (. .)))
